document_id,xml,document_id,doctype_id
99832,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""12"" size=""14"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""11"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""10"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""9"" size=""31"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""31"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""8"" family=""Times"" color=""#000000""/>
	<fontspec id=""6"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""7"" size=""7"" family=""Times"" color=""#000000""/>
	<fontspec id=""8"" size=""13"" family=""Times"" color=""#000000""/>
<p><text top=""1140"" left=""768"" width=""25"" height=""15"" font=""0"">. /.  </text>
</p><p><text top=""81"" left=""116"" width=""33"" height=""30"" font=""9"">W</text><text top=""86"" left=""149"" width=""82"" height=""24"" font=""10"">ORLD </text><text top=""81"" left=""232"" width=""22"" height=""30"" font=""9"">T</text><text top=""86"" left=""254"" width=""74"" height=""24"" font=""10"">RADE</text><text top=""138"" left=""116"" width=""26"" height=""30"" font=""9"">O</text><text top=""143"" left=""142"" width=""191"" height=""24"" font=""10"">RGANIZATION</text><text top=""105"" left=""599"" width=""95"" height=""15"" font=""11"">WT/DS27/97 </text></p><p><text top=""124"" left=""599"" width=""113"" height=""15"" font=""0"">11 January 2010 </text>
</p><p><text top=""171"" left=""599"" width=""57"" height=""12"" font=""4"">(10-0075) </text>
</p><p><text top=""203"" left=""599"" width=""127"" height=""15"" font=""0"">Original:   English </text>
</p><p><text top=""279"" left=""191"" width=""515"" height=""15"" font=""11"">EUROPEAN COMMUNITIES - REGIME FOR THE IMPORTATION, </text><text top=""298"" left=""286"" width=""324"" height=""15"" font=""11"">SALE AND DISTRIBUTION OF BANANAS </text></p><p><text top=""336"" left=""185"" width=""527"" height=""15"" font=""11"">SECOND RECOURSE TO ARTICLE 21.5 OF THE DSU BY ECUADOR </text></p><p><text top=""373"" left=""260"" width=""367"" height=""15"" font=""0"">Communication from Ecuador and the European Union</text>
<footnote top=""370"" left=""627"" width=""5"" height=""9"" font=""5"" number=""1"" ref="""" dis=""""><ftext top=""1053"" left=""167"" width=""623"" height=""14"" font=""8""> On 1 December 2009, the Treaty of Lisbon amending the Treaty on European Union and the Treaty </ftext>
<ftext top=""1070"" left=""108"" width=""687"" height=""14"" font=""8"">establishing the European Community (done at Lisbon, 13 December 2007) entered into force. On </ftext>
<ftext top=""1088"" left=""108"" width=""681"" height=""14"" font=""8"">29 November 2009, the WTO received a Verbal Note (WT/L/779) from the Council of the European Union and </ftext>
<ftext top=""1105"" left=""108"" width=""686"" height=""14"" font=""8"">the Commission of the European Communities stating that, by virtue of the Treaty of Lisbon, as of </ftext>
<ftext top=""1122"" left=""108"" width=""537"" height=""14"" font=""8"">1 December 2009, the European Union replaces and succeeds the European Community. </ftext>
</footnote>
</p><p><text top=""430"" left=""162"" width=""636"" height=""15"" font=""0"">The following communication, dated 7 January 2010, from the delegation of the </text>
<text top=""449"" left=""108"" width=""683"" height=""15"" font=""0"">European Union and the delegation of Ecuador to the Chairman of the Dispute Settlement Body, is </text>
<text top=""468"" left=""108"" width=""301"" height=""15"" font=""0"">circulated at the request of these delegations. </text>
</p><p><text top=""506"" left=""385"" width=""128"" height=""15"" font=""11"">_______________ </text></p><p><text top=""563"" left=""162"" width=""627"" height=""15"" font=""0"">As reported at the last DSB meeting of 21 December 2009, Ecuador, the European Union and </text>
<text top=""582"" left=""108"" width=""684"" height=""15"" font=""0"">a number of other Members have initialled the so called Geneva Agreement on Trade in Bananas </text>
<text top=""601"" left=""108"" width=""687"" height=""15"" font=""0"">(""hereinafter ""the Agreement""). The Agreement has been notified to the General Council on </text>
<text top=""620"" left=""108"" width=""297"" height=""15"" font=""0"">15 December 2009 in Document WT/L/784. </text>
</p><p><text top=""658"" left=""162"" width=""628"" height=""15"" font=""0"">The Agreement provides, <i>inter alia, </i>that the dispute <i>DS27 European Communities &#8211; Regime </i></text>
</p><p><text top=""677"" left=""108"" width=""681"" height=""15"" font=""12"">for the Importation, Sale and Distribution of Bananas: Second Recourse to Article 21.5 by Ecuador</text> </p><p><text top=""696"" left=""108"" width=""683"" height=""15"" font=""0"">(hereinafter ""the dispute"") shall be settled upon certification of the EU's new banana tariff schedule </text>
<text top=""715"" left=""108"" width=""684"" height=""15"" font=""0"">(paragraph 5 of the Agreement). The European Union will file its new banana tariff schedule for </text>
<text top=""734"" left=""108"" width=""684"" height=""15"" font=""0"">certification as soon as the Agreement has entered into force (paragraph 4(b) of the Agreement). </text>
<text top=""753"" left=""108"" width=""686"" height=""15"" font=""0"">Currently, all necessary steps are being taken to prepare for signature and ratification of the </text>
<text top=""772"" left=""108"" width=""82"" height=""15"" font=""0"">Agreement. </text>
</p><p><text top=""810"" left=""162"" width=""631"" height=""15"" font=""0"">Paragraph 5 of the Agreement further provides that within two weeks after certification, </text>
<text top=""829"" left=""108"" width=""681"" height=""15"" font=""0"">Ecuador and the European Union shall jointly notify the DSB, pursuant to Article 3.6 of the DSU, that </text>
<text top=""848"" left=""108"" width=""652"" height=""15"" font=""0"">they have reached a mutually agreed solution through which they have agreed to end this dispute.  </text>
</p><p><text top=""886"" left=""162"" width=""628"" height=""15"" font=""0"">Pending the settlement of the dispute in accordance with paragraph 5 of the Agreement, and </text>
<text top=""905"" left=""108"" width=""685"" height=""15"" font=""0"">without prejudice to the commitment undertaken under paragraph 6 of the Agreement, Ecuador </text>
<text top=""924"" left=""108"" width=""681"" height=""15"" font=""0"">reserves all of its rights under this dispute and those relating to the surveillance of the implementation </text>
<text top=""943"" left=""108"" width=""683"" height=""15"" font=""0"">of the adopted recommendations and rulings of the DSB, as provided for under Article 21.6 of the </text>
<text top=""962"" left=""108"" width=""41"" height=""15"" font=""0"">DSU. </text>
</p></page>
<page number=""2"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""134"" left=""162"" width=""627"" height=""15"" font=""0"">In light of these circumstances, Ecuador and the European Union agree that it is not necessary </text>
<text top=""153"" left=""108"" width=""681"" height=""15"" font=""0"">for the European Union to continue to provide status reports in this dispute while the European Union </text>
<text top=""172"" left=""108"" width=""682"" height=""15"" font=""0"">is taking the necessary steps to implement the terms of the Agreement.  Instead, the European Union </text>
<text top=""191"" left=""108"" width=""683"" height=""15"" font=""0"">shall keep Ecuador and other interested Members periodically informed of its internal processes to </text>
<text top=""210"" left=""108"" width=""683"" height=""15"" font=""0"">implement the terms of the Agreement. Ecuador and the European Union also agree that under the </text>
<text top=""229"" left=""108"" width=""682"" height=""15"" font=""0"">current circumstances neither will put the implementation of the rulings and recommendations in this </text>
<text top=""248"" left=""108"" width=""683"" height=""15"" font=""0"">dispute on the agenda of the DSB.  However, Ecuador reserves its right to do so should it deem it </text>
<text top=""267"" left=""108"" width=""169"" height=""15"" font=""0"">necessary or appropriate. </text>
</p><p><text top=""305"" left=""405"" width=""87"" height=""15"" font=""11"">__________</text> </p></page>
</pdf2xml>",99832,12
3361,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""7"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""6"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""5"" size=""30"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""30"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
<p><text top=""1194"" left=""768"" width=""17"" height=""15"" font=""0"">. /.</text>
</p><p><text top=""80"" left=""116"" width=""33"" height=""30"" font=""5"">W</text><text top=""85"" left=""149"" width=""82"" height=""24"" font=""6"">ORLD </text><text top=""80"" left=""231"" width=""22"" height=""30"" font=""5"">T</text><text top=""85"" left=""253"" width=""74"" height=""24"" font=""6"">RADE</text><text top=""137"" left=""116"" width=""26"" height=""30"" font=""5"">O</text><text top=""142"" left=""142"" width=""191"" height=""24"" font=""6"">RGANIZATION</text><text top=""104"" left=""599"" width=""91"" height=""15"" font=""7"">WT/DS46/26</text></p><p><text top=""123"" left=""599"" width=""109"" height=""15"" font=""0"">22 January 2001</text>
</p><p><text top=""170"" left=""599"" width=""54"" height=""12"" font=""4"">(01-0374)</text>
</p><p><text top=""202"" left=""599"" width=""123"" height=""15"" font=""0"">Original:   English</text>
</p><p><text top=""278"" left=""198"" width=""496"" height=""15"" font=""7"">BRAZIL &#8211; EXPORT FINANCING PROGRAMME FOR AIRCRAFT</text></p><p><text top=""316"" left=""263"" width=""368"" height=""15"" font=""0"">Second Recourse by Canada to Article 21.5 of the DSU</text>
</p><p><text top=""372"" left=""162"" width=""623"" height=""15"" font=""0"">The following communication, dated 19 January 2001, from the Permanent Mission of</text>
<text top=""391"" left=""108"" width=""677"" height=""15"" font=""0"">Canada to the Chairman of the Dispute Settlement Body, is circulated pursuant to Article 21.5 of the</text>
<text top=""410"" left=""108"" width=""37"" height=""15"" font=""0"">DSU.</text>
</p><p><text top=""449"" left=""384"" width=""124"" height=""15"" font=""7"">_______________</text></p><p><text top=""505"" left=""162"" width=""623"" height=""15"" font=""0"">Canada requests that the following item be placed on the agenda for the Dispute Settlement</text>
<text top=""524"" left=""108"" width=""229"" height=""15"" font=""0"">Body meeting of 1 February 2001:</text>
</p><p><text top=""562"" left=""162"" width=""333"" height=""15"" font=""0"">Brazil &#8211; Export Financing Programme for Aircraft</text>
<text top=""581"" left=""162"" width=""8"" height=""15"" font=""0"">&#8211;</text>
<text top=""581"" left=""216"" width=""315"" height=""15"" font=""0"">Recourse by Canada to Article 21.5 of the DSU</text>
</p><p><text top=""619"" left=""162"" width=""623"" height=""15"" font=""0"">Both the Panel and Appellate Body found the Brazilian measures in dispute to violate</text>
<text top=""638"" left=""108"" width=""677"" height=""15"" font=""0"">Article 3 of the Agreement on Subsidies and Countervailing Measures (the SCM Agreement).  On</text>
<text top=""657"" left=""108"" width=""677"" height=""15"" font=""0"">20 August 1999, the DSB adopted the report of the Appellate Body and the report of the Panel, as</text>
<text top=""676"" left=""108"" width=""677"" height=""15"" font=""0"">modified by the Appellate Body.  The resulting DSB rulings and recommendations included the</text>
<text top=""695"" left=""108"" width=""677"" height=""15"" font=""0"">recommendations that Brazil bring its measures found to be inconsistent with the SCM Agreement</text>
<text top=""714"" left=""108"" width=""677"" height=""15"" font=""0"">into conformity with the provisions of that Agreement and that Brazil withdraw the export subsidies</text>
<text top=""733"" left=""108"" width=""519"" height=""15"" font=""0"">for regional aircraft under PROEX within 90 days, i.e., by 18 November 1999.</text>
</p><p><text top=""771"" left=""162"" width=""623"" height=""15"" font=""0"">On 19 November 1999 Brazil submitted a status report on its implementation to the DSB and</text>
<text top=""790"" left=""108"" width=""677"" height=""15"" font=""0"">indicated that, in Brazil's view, it had taken measures to implement the DSB's rulings and</text>
<text top=""809"" left=""108"" width=""677"" height=""15"" font=""0"">recommendations.  Canada disagreed that the Brazilian measure brought Brazil into conformity with</text>
<text top=""828"" left=""108"" width=""677"" height=""15"" font=""0"">its obligations under the SCM Agreement and on 23 November 1999 requested the establishment of a</text>
<text top=""847"" left=""108"" width=""677"" height=""15"" font=""0"">panel under Article 21.5 of the DSU.  On 9 December 1999, the DSB referred the matter to the</text>
<text top=""866"" left=""108"" width=""256"" height=""15"" font=""0"">original panel pursuant to Article 21.5.</text>
</p><p><text top=""904"" left=""162"" width=""623"" height=""15"" font=""0"">The Article 21.5 Panel report was circulated to Members on 9 May 2000.  The Panel found</text>
<text top=""923"" left=""108"" width=""677"" height=""15"" font=""0"">that Brazil's measures to comply with the Panel's recommendation either did not exist, or were not</text>
<text top=""942"" left=""108"" width=""677"" height=""15"" font=""0"">consistent with the SCM Agreement.  Accordingly, the Panel concluded that Brazil had failed to</text>
<text top=""961"" left=""108"" width=""677"" height=""15"" font=""0"">implement the DSB's 20 August 1999 recommendation that it withdraw the export subsidies for</text>
<text top=""980"" left=""108"" width=""677"" height=""15"" font=""0"">regional aircraft under PROEX within 90 days.  The Appellate Body, in a report circulated to</text>
<text top=""998"" left=""108"" width=""677"" height=""15"" font=""0"">Members on 21 July 2000, upheld the Panel's findings.  The DSB adopted the Appellate Body report</text>
<text top=""1018"" left=""108"" width=""259"" height=""15"" font=""0"">and the Panel report on 4 August 2000.</text>
</p><p><text top=""1056"" left=""162"" width=""623"" height=""15"" font=""0"">In light of Brazil's failure to implement the 20 August 1999 rulings and recommendations of</text>
<text top=""1074"" left=""108"" width=""677"" height=""15"" font=""0"">the DSB, on 12 December 2000 the DSB authorized Canada to take appropriate countermeasures in</text>
<text top=""1094"" left=""108"" width=""269"" height=""15"" font=""0"">the amount of C$344.2 million annually.</text>
</p></page>
<page number=""2"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""133"" left=""162"" width=""623"" height=""15"" font=""0"">On 12 December 2000 Brazil advised the DSB of changes that it had made to the measures at</text>
<text top=""152"" left=""108"" width=""677"" height=""15"" font=""0"">issue in this case and claimed that PROEX had been brought into compliance with Brazil's obligations</text>
<text top=""171"" left=""108"" width=""677"" height=""15"" font=""0"">under the SCM Agreement.  Canada is of the view that Brazil continues to violate its SCM Agreement</text>
<text top=""190"" left=""108"" width=""78"" height=""15"" font=""0"">obligations.</text>
</p><p><text top=""228"" left=""162"" width=""623"" height=""15"" font=""0"">In view of the above, there is a disagreement between Canada and Brazil as to whether the</text>
<text top=""247"" left=""108"" width=""677"" height=""15"" font=""0"">measures taken by Brazil to comply with the 20 August 1999 and 4 August 2000 rulings and</text>
<text top=""266"" left=""108"" width=""677"" height=""15"" font=""0"">recommendations of the DSB bring Brazil into conformity with the provisions of the SCM Agreement</text>
<text top=""285"" left=""108"" width=""569"" height=""15"" font=""0"">and result in the withdrawal of the export subsidies to regional aircraft under PROEX.</text>
</p><p><text top=""323"" left=""162"" width=""623"" height=""15"" font=""0"">Canada requests that this matter be referred to the original Panel, pursuant to Article 21.5 of</text>
<text top=""341"" left=""108"" width=""677"" height=""15"" font=""0"">the DSU.  Canada further requests that the Panel find that Brazil has not taken measures to comply</text>
<text top=""360"" left=""108"" width=""677"" height=""15"" font=""0"">fully with the 20 August 1999 and 4 August 2000 rulings and recommendations of the DSB.  Canada</text>
<text top=""379"" left=""108"" width=""677"" height=""15"" font=""0"">requests that the Panel find, in particular, that Brazil continues to violate its obligations under</text>
<text top=""398"" left=""108"" width=""221"" height=""15"" font=""0"">Article 3 of the SCM Agreement.</text>
</p><p><text top=""436"" left=""162"" width=""623"" height=""15"" font=""0"">This new Article 21.5 proceeding is in no way a precondition to the implementation of the</text>
<text top=""455"" left=""108"" width=""677"" height=""15"" font=""0"">authorized countermeasures.  Although Canada has not yet implemented the countermeasures that</text>
<text top=""474"" left=""108"" width=""677"" height=""15"" font=""0"">were authorized by the DSB on 12 December 2000, it retains the full right to do so at any time.</text>
<text top=""493"" left=""108"" width=""677"" height=""15"" font=""0"">Canada is invoking Article 21.5 in the interest of further legal clarity.  It does so without prejudice to</text>
<text top=""512"" left=""108"" width=""578"" height=""15"" font=""0"">its legal position with respect to the implementation of the authorized countermeasures.</text>
</p><p><text top=""570"" left=""405"" width=""83"" height=""15"" font=""7"">__________</text></p></page>
</pdf2xml>",3361,12
3624,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""9"" size=""14"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""8"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""7"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""6"" size=""30"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""30"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""14"" family=""Times"" color=""#000000""/>
<p><text top=""123"" left=""599"" width=""118"" height=""15"" font=""3"">1 December 2000</text>
</p><p><text top=""170"" left=""599"" width=""54"" height=""12"" font=""4"">(00-5197)</text>
</p><p><text top=""202"" left=""599"" width=""123"" height=""15"" font=""3"">Original:   English</text>
</p><p><text top=""278"" left=""198"" width=""496"" height=""15"" font=""8"">BRAZIL &#8211; EXPORT FINANCING PROGRAMME FOR AIRCRAFT</text></p><p><text top=""316"" left=""289"" width=""315"" height=""15"" font=""3"">Recourse by Canada to Article 22.7 of the DSU</text>
<text top=""334"" left=""314"" width=""265"" height=""15"" font=""3"">and Article 4.10 of the SCM Agreement</text>
</p><p><text top=""391"" left=""162"" width=""623"" height=""15"" font=""3"">The following communication, dated 30 November 2000, from the Permanent Mission of</text>
<text top=""410"" left=""108"" width=""677"" height=""15"" font=""3"">Canada to the Chairman of the Dispute Settlement Body, is being circulated pursuant to Article 22.7</text>
<text top=""429"" left=""108"" width=""349"" height=""15"" font=""3"">of the DSU and Article 4.10 of the SCM Agreement.</text>
</p><p><text top=""468"" left=""384"" width=""124"" height=""15"" font=""8"">_______________</text></p><p><text top=""524"" left=""162"" width=""623"" height=""15"" font=""3"">Canada requests that the following item be placed on the agenda of the Dispute Settlement</text>
<text top=""543"" left=""108"" width=""364"" height=""15"" font=""3"">Body (DSB) meeting to be held on 12 December 2000:</text>
</p><p><text top=""581"" left=""162"" width=""569"" height=""15"" font=""9"">Brazil &#8211; Export Financing Programme for Aircraft:  Recourse by Canada to</text><text top=""600"" left=""162"" width=""569"" height=""15"" font=""9"">Article 22.7 of the Understanding on Rules and Procedures Governing the Settlement</text><text top=""619"" left=""162"" width=""569"" height=""15"" font=""9"">of Disputes (DSU) and Article 4.10 of the Agreement on Subsidies and</text><text top=""638"" left=""162"" width=""316"" height=""15"" font=""9"">Countervailing Measures (the SCM Agreement)</text></p><p><text top=""676"" left=""162"" width=""623"" height=""15"" font=""3"">On 22 May 2000, Canada requested authorization from the DSB to take appropriate</text>
<text top=""695"" left=""108"" width=""677"" height=""15"" font=""3"">countermeasures against Brazil pursuant to Article 4.10 of the SCM Agreement and Article 22.2 of</text>
<text top=""714"" left=""108"" width=""677"" height=""15"" font=""3"">the DSU.  Brazil objected to Canada's proposed level of suspension and the matter was referred to</text>
<text top=""733"" left=""108"" width=""313"" height=""15"" font=""3"">arbitration pursuant to Article 22.6 of the DSU.</text>
</p><p><text top=""771"" left=""162"" width=""623"" height=""15"" font=""3"">In their award of 28 August 2000 (WT/DS46/ARB), the Arbitrators decided that:  ""the</text>
<text top=""790"" left=""108"" width=""677"" height=""15"" font=""3"">suspension by Canada of the application to Brazil of tariff concessions or other obligations under</text>
<text top=""809"" left=""108"" width=""677"" height=""15"" font=""3"">GATT 1994, the Agreement on Textiles and Clothing and the Agreement on Import Licensing</text>
<text top=""828"" left=""108"" width=""677"" height=""15"" font=""3"">Procedures covering trade in a maximum amount of C$344.2 million per year would constitute</text>
<text top=""847"" left=""108"" width=""592"" height=""15"" font=""3"">appropriate countermeasures within the meaning of Article 4.10 of the SCM Agreement"".</text>
</p><p><text top=""885"" left=""162"" width=""623"" height=""15"" font=""3"">At the meeting of the DSB on 12 December 2000, Canada intends to request, pursuant to</text>
<text top=""904"" left=""108"" width=""677"" height=""15"" font=""3"">Article 22.7 of the DSU and Article 4.10 of the SCM Agreement, authorization from the DSB to</text>
<text top=""923"" left=""108"" width=""677"" height=""15"" font=""3"">suspend the application to Brazil of tariff concessions or other obligations under GATT 1994, the</text>
<text top=""942"" left=""108"" width=""677"" height=""15"" font=""3"">Agreement on Textiles and Clothing and the Agreement on Import Licensing Procedures covering</text>
<text top=""961"" left=""108"" width=""378"" height=""15"" font=""3"">trade in a maximum amount of C$344.2 million per year.</text>
</p><p><text top=""999"" left=""405"" width=""83"" height=""15"" font=""8"">__________</text></p></page>
</pdf2xml>",3624,12
1201,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""8"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""7"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""6"" size=""30"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""30"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""14"" family=""Times"" color=""#000000""/>
<p><text top=""123"" left=""599"" width=""109"" height=""15"" font=""3"">12 January 2000</text>
</p><p><text top=""170"" left=""599"" width=""54"" height=""12"" font=""4"">(00-0117)</text>
</p><p><text top=""202"" left=""599"" width=""123"" height=""15"" font=""3"">Original:   English</text>
</p><p><text top=""278"" left=""267"" width=""358"" height=""15"" font=""8"">UNITED STATES - IMPORT PROHIBITION OF</text><text top=""297"" left=""271"" width=""351"" height=""15"" font=""8"">CERTAIN SHRIMP AND SHRIMP PRODUCTS</text></p><p><text top=""334"" left=""264"" width=""366"" height=""15"" font=""3"">Understanding between Malaysia and the United States</text>
<text top=""354"" left=""217"" width=""459"" height=""15"" font=""3"">Regarding Possible Proceedings under Articles 21 and 22 of the DSU</text>
</p><p><text top=""410"" left=""162"" width=""602"" height=""15"" font=""3"">The following communications, dated 22 December 1999, from the Permanent Missions of</text>
<text top=""429"" left=""108"" width=""666"" height=""15"" font=""3"">Malaysia and the United States to the Chairman of the Dispute Settlement Body, are circulated at the</text>
<text top=""448"" left=""108"" width=""187"" height=""15"" font=""3"">request of these delegations.</text>
</p><p><text top=""506"" left=""384"" width=""124"" height=""15"" font=""8"">_______________</text></p><p number=""1."" style=""6""><text top=""562"" left=""108"" width=""12"" height=""15"" font=""3"">1.</text>
<text top=""562"" left=""162"" width=""556"" height=""15"" font=""3"">Letter from H.E. Mr. Hamidon Ali, Ambassador, Permanent Mission of Malaysia to</text>
<text top=""581"" left=""108"" width=""672"" height=""15"" font=""3"">H.E. Ms Rita Hayes, Ambassador,  Permanent Mission of the United States, dated 22 December 1999</text>
<p><text top=""619"" left=""108"" width=""152"" height=""15"" font=""3"">Dear Ms. Ambassador,</text>
</p><p><text top=""657"" left=""162"" width=""623"" height=""15"" font=""3"">Our two Governments have been consulting in good faith on the implementation of the</text>
<text top=""676"" left=""108"" width=""677"" height=""15"" font=""3"">Dispute Settlement Body (DSB) recommendations and rulings in <i>United States - Import Prohibition</i></text>
<text top=""695"" left=""108"" width=""677"" height=""15"" font=""5""><i>of Certain Shrimp and Shrimp Products</i> (WT/DS58);  and are determined to continue such</text>
<text top=""714"" left=""108"" width=""677"" height=""15"" font=""3"">consultations.  This letter is to confirm the understanding reached between the Governments of</text>
<text top=""733"" left=""108"" width=""677"" height=""15"" font=""3"">Malaysia and the United States regarding possible proceedings pursuant to Articles 21 and 22 of the</text>
<text top=""752"" left=""108"" width=""677"" height=""15"" font=""3"">Understanding on Rules and Procedures Governing the Settlement of Disputes (DSU) concerning that</text>
<text top=""771"" left=""108"" width=""108"" height=""15"" font=""3"">implementation.</text>
</p><p><text top=""809"" left=""162"" width=""307"" height=""15"" font=""3"">Our two Governments have agreed as follows:</text>
</p></p><p number=""1."" style=""6""><text top=""847"" left=""108"" width=""12"" height=""15"" font=""3"">1.</text>
<text top=""847"" left=""162"" width=""623"" height=""15"" font=""3"">Malaysia will not at this stage initiate proceedings under Article 21.5 or Article 22 of the</text>
<text top=""866"" left=""108"" width=""37"" height=""15"" font=""3"">DSU.</text>
</p><p number=""2."" style=""6""><text top=""904"" left=""108"" width=""12"" height=""15"" font=""3"">2.</text>
<text top=""904"" left=""162"" width=""623"" height=""15"" font=""3"">If Malaysia at some future date decides that it may wish to initiate proceedings under</text>
<text top=""923"" left=""108"" width=""677"" height=""15"" font=""3"">Articles 21.5 and Article 22 of the DSU, Malaysia will initiate proceedings under Article 21.5 prior to</text>
<text top=""942"" left=""108"" width=""677"" height=""15"" font=""3"">any proceedings under Article 22.  Malaysia will provide the United States advance notice of any</text>
<text top=""961"" left=""108"" width=""677"" height=""15"" font=""3"">proposal to initiate proceedings under Article 21.5 and will consult with the United States before</text>
<text top=""980"" left=""108"" width=""677"" height=""15"" font=""3"">requesting the establishment of a panel under Article 21.5.  Malaysia will not request authorization to</text>
<text top=""998"" left=""108"" width=""677"" height=""15"" font=""3"">suspend concessions or other obligations under Article 22 until the adoption of the Article 21.5 panel</text>
<text top=""1018"" left=""108"" width=""677"" height=""15"" font=""3"">report.  If on the basis of the proceedings under Article 21.5 Malaysia decides to initiate proceedings</text>
<text top=""1036"" left=""108"" width=""677"" height=""15"" font=""3"">under Article 22, the United States will not assert that Malaysia is precluded from obtaining DSB</text>
<text top=""1056"" left=""108"" width=""677"" height=""15"" font=""3"">authorization because Malaysia's request was made outside the 30-day time period specified in the</text>
<text top=""1074"" left=""108"" width=""677"" height=""15"" font=""3"">first sentence of Article 22.6.  This is without prejudice to the rights of the United States to have the</text>
<text top=""1094"" left=""108"" width=""404"" height=""15"" font=""3"">matter referred to arbitration in accordance with Article 22.6.</text>
</p></page>
<page number=""2"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""3."" style=""6""><text top=""133"" left=""108"" width=""12"" height=""15"" font=""3"">3.</text>
<text top=""133"" left=""162"" width=""623"" height=""15"" font=""3"">In light of the fact that the DSB recommendations and rulings in this dispute were based on a</text>
<text top=""152"" left=""108"" width=""677"" height=""15"" font=""3"">report of the Appellate Body, if Malaysia at some future date initiates proceedings under Article 21.5</text>
<text top=""171"" left=""108"" width=""677"" height=""15"" font=""3"">of the DSU, either Malaysia or the United States may appeal the report of the panel established under</text>
<text top=""190"" left=""108"" width=""677"" height=""15"" font=""3"">Article 21.5;  and Article 16.4 of the DSU, which provides in part that the DSB shall not consider the</text>
<text top=""209"" left=""108"" width=""556"" height=""15"" font=""3"">report of that panel for adoption until after the completion of the appeal, shall apply.</text>
<p><text top=""247"" left=""108"" width=""677"" height=""15"" font=""3"">This letter and your letter of confirmation in reply shall constitute an understanding between our two</text>
<text top=""266"" left=""108"" width=""93"" height=""15"" font=""3"">Governments.</text>
</p><p><text top=""304"" left=""162"" width=""108"" height=""15"" font=""3"">Yours sincerely,</text>
</p><p><text top=""341"" left=""162"" width=""91"" height=""15"" font=""3"">Hamidon  Ali</text>
</p></p><p number=""2."" style=""6""><text top=""398"" left=""108"" width=""12"" height=""15"" font=""3"">2.</text>
<text top=""398"" left=""162"" width=""623"" height=""15"" font=""3"">Letter from H.E. Ms Rita D. Hayes, Ambassador,  Permanent Mission of the United States to</text>
<text top=""417"" left=""108"" width=""637"" height=""15"" font=""3"">H.E. Mr. Hamidon Ali, Ambassador, Permanent Mission of Malaysia , dated 22 December 1999</text>
<p><text top=""455"" left=""108"" width=""151"" height=""15"" font=""3"">Dear Mr. Ambassador,</text>
</p><p><text top=""493"" left=""162"" width=""355"" height=""15"" font=""3"">Thank you for your letter of today's date which reads:</text>
</p><p><text top=""531"" left=""162"" width=""623"" height=""15"" font=""3"">""Our two Governments have been consulting in good faith on the implementation of the</text>
<text top=""550"" left=""108"" width=""677"" height=""15"" font=""3"">Dispute Settlement Body (DSB) recommendations and rulings in <i>United States - Import Prohibition</i></text>
<text top=""569"" left=""108"" width=""677"" height=""15"" font=""5""><i>of Certain Shrimp and Shrimp Products</i> (WT/DS58);  and are determined to continue such</text>
<text top=""588"" left=""108"" width=""677"" height=""15"" font=""3"">consultations.  This letter is to confirm the understanding reached between the Governments of</text>
<text top=""607"" left=""108"" width=""677"" height=""15"" font=""3"">Malaysia and the United States regarding possible proceedings pursuant to Articles 21 and 22 of the</text>
<text top=""626"" left=""108"" width=""677"" height=""15"" font=""3"">Understanding on Rules and Procedures Governing the Settlement of Disputes (DSU) concerning that</text>
<text top=""645"" left=""108"" width=""108"" height=""15"" font=""3"">implementation.</text>
</p><p><text top=""683"" left=""162"" width=""307"" height=""15"" font=""3"">Our two Governments have agreed as follows:</text>
</p></p><p number=""1."" style=""6""><text top=""721"" left=""108"" width=""12"" height=""15"" font=""3"">1.</text>
<text top=""721"" left=""162"" width=""623"" height=""15"" font=""3"">Malaysia will not at this stage initiate proceedings under Article 21.5 or Article 22 of the</text>
<text top=""740"" left=""108"" width=""37"" height=""15"" font=""3"">DSU.</text>
</p><p number=""2."" style=""6""><text top=""778"" left=""108"" width=""12"" height=""15"" font=""3"">2.</text>
<text top=""778"" left=""162"" width=""623"" height=""15"" font=""3"">If Malaysia at some future date decides that it may wish to initiate proceedings under</text>
<text top=""797"" left=""108"" width=""677"" height=""15"" font=""3"">Articles 21.5 and Article 22 of the DSU, Malaysia will initiate proceedings under Article 21.5 prior to</text>
<text top=""816"" left=""108"" width=""677"" height=""15"" font=""3"">any proceedings under Article 22.  Malaysia will provide the United States advance notice of any</text>
<text top=""835"" left=""108"" width=""677"" height=""15"" font=""3"">proposal to initiate proceedings under Article 21.5 and will consult with the United States before</text>
<text top=""854"" left=""108"" width=""677"" height=""15"" font=""3"">requesting the establishment of a panel under Article 21.5.  Malaysia will not request authorization to</text>
<text top=""873"" left=""108"" width=""677"" height=""15"" font=""3"">suspend concessions or other obligations under Article 22 until the adoption of the Article 21.5 panel</text>
<text top=""892"" left=""108"" width=""677"" height=""15"" font=""3"">report.  If on the basis of the proceedings under Article 21.5 Malaysia decides to initiate proceedings</text>
<text top=""911"" left=""108"" width=""677"" height=""15"" font=""3"">under Article 22, the United States will not assert that Malaysia is precluded from obtaining DSB</text>
<text top=""930"" left=""108"" width=""677"" height=""15"" font=""3"">authorization because Malaysia's request was made outside the 30-day time period specified in the</text>
<text top=""949"" left=""108"" width=""677"" height=""15"" font=""3"">first sentence of Article 22.6.  This is without prejudice to the rights of the United States to have the</text>
<text top=""968"" left=""108"" width=""404"" height=""15"" font=""3"">matter referred to arbitration in accordance with Article 22.6.</text>
</p><p number=""3."" style=""6""><text top=""1006"" left=""108"" width=""12"" height=""15"" font=""3"">3.</text>
<text top=""1006"" left=""162"" width=""623"" height=""15"" font=""3"">In light of the fact that the DSB recommendations and rulings in this dispute were based on a</text>
<text top=""1025"" left=""108"" width=""677"" height=""15"" font=""3"">report of the Appellate Body, if Malaysia at some future date initiates proceedings under Article 21.5</text>
<text top=""1043"" left=""108"" width=""677"" height=""15"" font=""3"">of the DSU, either Malaysia or the United States may appeal the report of the panel established under</text>
<text top=""1062"" left=""108"" width=""677"" height=""15"" font=""3"">Article 21.5;  and Article 16.4 of the DSU, which provides in part that the DSB shall not consider the</text>
<text top=""1081"" left=""108"" width=""556"" height=""15"" font=""3"">report of that panel for adoption until after the completion of the appeal, shall apply.</text>
<text top=""133"" left=""108"" width=""677"" height=""15"" font=""3"">This letter and your letter of confirmation in reply shall constitute an understanding between our two</text>
<text top=""152"" left=""108"" width=""100"" height=""15"" font=""3"">Governments.""</text>
<p><text top=""190"" left=""162"" width=""518"" height=""15"" font=""3"">I have the honor to confirm this understanding between our two Governments.</text>
</p><p><text top=""228"" left=""162"" width=""66"" height=""15"" font=""3"">Sincerely,</text>
</p><p><text top=""266"" left=""162"" width=""97"" height=""15"" font=""3"">Rita D. Hayes.</text>
</p></p></page>
<page number=""3"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""323"" left=""405"" width=""83"" height=""15"" font=""8"">__________</text></p></page>
</pdf2xml>",1201,12
14970,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""7"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""6"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""5"" size=""30"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""30"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
<p><text top=""124"" left=""599"" width=""126"" height=""15"" font=""3"">20 December 2000</text>
</p><p><text top=""164"" left=""599"" width=""54"" height=""12"" font=""4"">(00-5582)</text>
</p><p><text top=""195"" left=""599"" width=""118"" height=""15"" font=""3"">Original:  English</text>
</p><p><text top=""271"" left=""272"" width=""348"" height=""15"" font=""7"">CANADA - TERM OF PATENT PROTECTION</text></p><p><text top=""309"" left=""301"" width=""292"" height=""15"" font=""3"">Request by the United States for Arbitration</text>
<text top=""328"" left=""337"" width=""218"" height=""15"" font=""3"">under Article 21.3(c) of the DSU</text>
</p><p><text top=""385"" left=""162"" width=""623"" height=""15"" font=""3"">The following communication, dated 15 December 2000, from the Permanent Mission of the</text>
<text top=""404"" left=""108"" width=""677"" height=""15"" font=""3"">United States to the Chairman of the Dispute Settlement Body, is circulated at the request of that</text>
<text top=""423"" left=""108"" width=""73"" height=""15"" font=""3"">delegation.</text>
</p><p><text top=""442"" left=""384"" width=""124"" height=""15"" font=""7"">_______________</text></p><p><text top=""499"" left=""162"" width=""623"" height=""15"" font=""3"">On 12 October 2000, the Dispute Settlement Body (DSB) adopted recommendations and</text>
<text top=""518"" left=""108"" width=""677"" height=""15"" font=""3"">rulings in respect of the panel and Appellate Body reports in ""Canada - Term of Patent Protection"".</text>
<text top=""537"" left=""108"" width=""677"" height=""15"" font=""3"">On 23 October 2000, the Government of Canada confirmed to the DSB its commitment to meet its</text>
<text top=""556"" left=""108"" width=""677"" height=""15"" font=""3"">obligations under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS</text>
<text top=""575"" left=""108"" width=""83"" height=""15"" font=""3"">Agreement).</text>
</p><p><text top=""613"" left=""162"" width=""623"" height=""15"" font=""3"">Since the adoption of the panel and Appellate Body reports, pursuant to Article 21.3(b) of the</text>
<text top=""632"" left=""108"" width=""677"" height=""15"" font=""3"">Understanding on Rules and Procedures Governing the Settlement of Disputes (DSU), we have</text>
<text top=""651"" left=""108"" width=""677"" height=""15"" font=""3"">attempted to reach agreement with Canada on a ""reasonable period of time"" for its implementation of</text>
<text top=""670"" left=""108"" width=""677"" height=""15"" font=""3"">the DSB rulings and recommendations.  Although we have held several bilateral discussions, our</text>
<text top=""689"" left=""108"" width=""677"" height=""15"" font=""3"">governments have not been able to reach agreement.  Accordingly, the United States hereby requests</text>
<text top=""708"" left=""108"" width=""677"" height=""15"" font=""3"">that the ""reasonable period of time"" be determined by binding arbitration pursuant to Article 21.3(c)</text>
<text top=""727"" left=""108"" width=""677"" height=""15"" font=""3"">of the DSU.  Pursuant to footnote 12 to the DSU, the United States will immediately open discussions</text>
<text top=""745"" left=""108"" width=""595"" height=""15"" font=""3"">with Canada with a view of achieving agreement on an arbitrator within the next ten days.</text>
</p><p><text top=""802"" left=""405"" width=""83"" height=""15"" font=""3"">__________</text>
</p></page>
</pdf2xml>",14970,12
42081,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""9"" size=""14"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""8"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""7"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""6"" size=""30"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""30"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""14"" family=""Times"" color=""#000000""/>
<p><text top=""159"" left=""599"" width=""118"" height=""15"" font=""3"">28 February 2001</text>
</p><p><text top=""206"" left=""599"" width=""54"" height=""12"" font=""4"">(01-0991)</text>
</p><p><text top=""238"" left=""599"" width=""123"" height=""15"" font=""3"">Original:   English</text>
</p><p><text top=""314"" left=""271"" width=""351"" height=""15"" font=""8"">CANADA &#8211; TERM OF PATENT PROTECTION</text></p><p><text top=""351"" left=""265"" width=""362"" height=""15"" font=""3"">Arbitration under Article 21.3(c) of the <i>Understanding</i></text>
</p><p><text top=""370"" left=""238"" width=""417"" height=""15"" font=""9"">on Rules and Procedures Governing the Settlement of Disputes</text></p><p><text top=""427"" left=""162"" width=""623"" height=""15"" font=""3"">The following communication, dated 28 February 2001, from the Arbitrator,</text>
<text top=""446"" left=""108"" width=""677"" height=""15"" font=""3"">Mr. C.-D. Ehlermann, to the Chairman of the Dispute Settlement Body, is circulated in accordance</text>
<text top=""465"" left=""108"" width=""677"" height=""15"" font=""3"">with Article 21.3(c) of the  <i>Understanding on Rules and Procedures Governing the Settlement of</i></text>
</p><p><text top=""484"" left=""108"" width=""62"" height=""15"" font=""9"">Disputes.</text></p><p><text top=""523"" left=""384"" width=""124"" height=""15"" font=""8"">_______________</text></p><p><text top=""579"" left=""162"" width=""623"" height=""15"" font=""3"">I am pleased to send you a copy of my Arbitration Award in  <i>Canada &#8211; Term of Patent</i></text>
<text top=""598"" left=""108"" width=""677"" height=""15"" font=""5""><i>Protection</i>, WT/DS170/10, pursuant to Article 21.3(c) of the  <i>Understanding on Rules and</i></text>
<text top=""617"" left=""108"" width=""677"" height=""15"" font=""5""><i>Procedures Governing the Settlement of Disputes</i>.  It will be circulated to the Members of the WTO</text>
<text top=""636"" left=""108"" width=""404"" height=""15"" font=""3"">later today.  It is a confidential document until its circulation.</text>
</p><p><text top=""674"" left=""405"" width=""83"" height=""15"" font=""8"">__________</text></p></page>
</pdf2xml>",42081,12
52928,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""9"" size=""14"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""8"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""7"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""6"" size=""30"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""30"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""14"" family=""Times"" color=""#000000""/>
<p><text top=""159"" left=""599"" width=""109"" height=""15"" font=""3"">10 January 2001</text>
</p><p><text top=""206"" left=""599"" width=""54"" height=""12"" font=""4"">(01-0180)</text>
</p><p><text top=""238"" left=""599"" width=""123"" height=""15"" font=""3"">Original:   English</text>
</p><p><text top=""314"" left=""271"" width=""351"" height=""15"" font=""8"">CANADA &#8211; TERM OF PATENT PROTECTION</text></p><p><text top=""351"" left=""228"" width=""437"" height=""15"" font=""3"">Surveillance of Implementation of Recommendations and Rulings</text>
</p><p><text top=""389"" left=""268"" width=""358"" height=""15"" font=""9"">Appointment of Arbitrator under Article 21.3(c) of the</text><text top=""408"" left=""186"" width=""520"" height=""15"" font=""9"">Understanding on Rules and Procedures Governing the Settlement of Disputes</text></p><p><text top=""465"" left=""162"" width=""623"" height=""15"" font=""3"">The following communication, dated 10 January 2001, from the Permanent Mission of</text>
<text top=""484"" left=""108"" width=""677"" height=""15"" font=""3"">Canada and the Permanent Mission of the United States, to the Director-General, is circulated</text>
<text top=""503"" left=""108"" width=""677"" height=""15"" font=""3"">pursuant to Article 21.3(c) of the <i>Understanding on Rules and Procedures Governing the Settlement</i></text>
<text top=""522"" left=""108"" width=""79"" height=""15"" font=""5""><i>of Disputes</i>.</text>
</p><p><text top=""560"" left=""384"" width=""124"" height=""15"" font=""8"">_______________</text></p><p><text top=""617"" left=""162"" width=""623"" height=""15"" font=""3"">We refer you to the communication from the United States of America, dated</text>
<text top=""636"" left=""108"" width=""677"" height=""15"" font=""3"">15 December 2000, requesting binding arbitration under Article 21.3(c) of the  <i>Understanding on</i></text>
<text top=""655"" left=""108"" width=""677"" height=""15"" font=""5""><i>Rules and Procedures Governing the Settlement of Disputes</i>  (the ""DSU"") to determine the reasonable</text>
<text top=""674"" left=""108"" width=""677"" height=""15"" font=""3"">period of time for Canada to implement the recommendations and rulings of the Dispute Settlement</text>
<text top=""693"" left=""108"" width=""677"" height=""15"" font=""3"">Body (the ""DSB"") in the matter,  <i>Canada &#8211; Term of Patent Protection</i>  (WT/DS170), adopted</text>
<text top=""712"" left=""108"" width=""115"" height=""15"" font=""3"">12 October 2000.</text>
</p><p><text top=""750"" left=""162"" width=""623"" height=""15"" font=""3"">The Parties to the dispute, Canada and the United States, have agreed on an arbitrator,</text>
<text top=""769"" left=""108"" width=""677"" height=""15"" font=""3"">pursuant to footnote 12 to Article 21.3(c) of the DSU:  Mr. Claus-Dieter Ehlermann.  We are writing</text>
<text top=""788"" left=""108"" width=""677"" height=""15"" font=""3"">to request you to convey officially to Mr. Claus-Dieter Ehlermann our agreement that he act as</text>
<text top=""807"" left=""108"" width=""677"" height=""15"" font=""3"">arbitrator in this matter.  We also would appreciate that he be assisted in his functions, as arbitrator</text>
<text top=""826"" left=""108"" width=""530"" height=""15"" font=""3"">under Article 21.3(c) of the DSU, by the staff of the Appellate Body Secretariat.</text>
</p><p><text top=""864"" left=""162"" width=""623"" height=""15"" font=""3"">With respect to the time period for this binding arbitration, Article 21.3(c) of the DSU</text>
<text top=""883"" left=""108"" width=""677"" height=""15"" font=""3"">requires that the reasonable period of time for implementation be determined through binding</text>
<text top=""902"" left=""108"" width=""677"" height=""15"" font=""3"">arbitrations within 90 days after the date of adoption of the recommendations and rulings by the DSB.</text>
<text top=""921"" left=""108"" width=""677"" height=""15"" font=""3"">As the adoption took place on 12 October 2000, this 90-day period will soon expire.  We, the Parties</text>
<text top=""940"" left=""108"" width=""677"" height=""15"" font=""3"">to this dispute, have agreed to extend the period of time for this binding arbitration until</text>
<text top=""959"" left=""108"" width=""28"" height=""15"" font=""3"">28 </text>
<text top=""959"" left=""129"" width=""71"" height=""15"" font=""3"">February </text>
<text top=""959"" left=""192"" width=""593"" height=""15"" font=""3"">2001.  We have agreed that the award of the arbitrator, made no later than</text>
<text top=""977"" left=""108"" width=""677"" height=""15"" font=""3"">28 February 2001, shall be deemed to be the award of the arbitrator for the purposes of Article 21.3(c)</text>
<text top=""997"" left=""108"" width=""677"" height=""15"" font=""3"">of the DSU in determining the reasonable period of time for Canada to implement the</text>
<text top=""1015"" left=""108"" width=""278"" height=""15"" font=""3"">recommendations and rulings of the DSB.</text>
</p><p><text top=""1053"" left=""162"" width=""326"" height=""15"" font=""3"">We are grateful for your assistance in this matter.</text>
</p><p><text top=""1091"" left=""405"" width=""83"" height=""15"" font=""3"">__________</text>
</p></page>
</pdf2xml>",52928,12
68570,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""17"" size=""16"" family=""Times"" color=""#000000"" style=""ib""/><fontspec id=""16"" size=""16"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""15"" size=""19"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""14"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""13"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""12"" size=""30"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""30"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""19"" family=""Times"" color=""#000000""/>
	<fontspec id=""6"" size=""16"" family=""Times"" color=""#000000""/>
<p><text top=""105"" left=""599"" width=""86"" height=""15"" font=""3"">26 July 2002</text>
</p><p><text top=""152"" left=""599"" width=""54"" height=""12"" font=""4"">(02-3877)</text>
</p><p><text top=""489"" left=""144"" width=""605"" height=""19"" font=""15"">UNITED STATES &#8211; DEFINITIVE SAFEGUARD MEASURES ON</text><text top=""513"" left=""118"" width=""656"" height=""19"" font=""15"">IMPORTS OF CIRCULAR WELDED CARBON QUALITY LINE PIPE</text><text top=""537"" left=""373"" width=""146"" height=""19"" font=""15"">FROM KOREA</text></p><p><text top=""752"" left=""405"" width=""83"" height=""16"" font=""17"">Arbitration</text><text top=""772"" left=""346"" width=""201"" height=""16"" font=""17"">under Article 21.3(c) of the</text><text top=""793"" left=""295"" width=""302"" height=""16"" font=""17"">Understanding on Rules and Procedures</text><text top=""814"" left=""308"" width=""277"" height=""16"" font=""17"">Governing the Settlement of Disputes</text></p><p><text top=""1005"" left=""368"" width=""157"" height=""15"" font=""3"">Report of the Arbitrator</text>
<text top=""1024"" left=""384"" width=""125"" height=""15"" font=""3"">Yasuhei Taniguchi</text>
</p></page>
<page number=""2"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
</page>
<page number=""3"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""18"" size=""14"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""7"" size=""10"" family=""Times"" color=""#000000""/>
	<fontspec id=""8"" size=""8"" family=""Times"" color=""#000000""/>
	<fontspec id=""9"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""10"" size=""7"" family=""Times"" color=""#000000""/>
	<fontspec id=""11"" size=""12"" family=""Times"" color=""#000000""/>
<p number=""1."" style=""6""><text top=""133"" left=""108"" width=""17"" height=""15"" font=""3"">1. </text>
<text top=""133"" left=""162"" width=""623"" height=""15"" font=""3"">On 8 March 2002, the Dispute Settlement Body (the ""DSB"") adopted the Appellate Body</text>
<text top=""161"" left=""108"" width=""45"" height=""15"" font=""3"">Report</text>
<footnote top=""158"" left=""156"" width=""5"" height=""9"" font=""8"" number=""1"" ref=""WT/DS202/AB/R"" dis=""""><ftext top=""981"" left=""167"" width=""393"" height=""13"" font=""11"">Appellate Body Report, WT/DS202/AB/R, adopted 8 March 2002.</ftext>
</footnote>
<text top=""161"" left=""161"" width=""159"" height=""15"" font=""3""> and the Panel Report</text>
<footnote top=""158"" left=""323"" width=""5"" height=""9"" font=""8"" number=""2"" ref=""WT/DS202/AB/R|WT/DS202/R"" dis=""""><ftext top=""1005"" left=""167"" width=""618"" height=""13"" font=""11"">Panel Report, WT/DS202/R, adopted 8 March 2002, as modified by the Appellate Body Report,</ftext>
<ftext top=""1023"" left=""108"" width=""110"" height=""13"" font=""11"">WT/DS202/AB/R.</ftext>
</footnote>
<text top=""161"" left=""328"" width=""457"" height=""15"" font=""3"">, as modified by the Appellate Body Report, in  <i>United States  &#8211;</i></text>
<p><text top=""190"" left=""108"" width=""677"" height=""15"" font=""18"">Definitive Safeguard Measures on Imports of Circular Welded Carbon Quality Line Pipe from Korea</text></p><p><text top=""218"" left=""108"" width=""135"" height=""15"" font=""3"">(""<i>US &#8211; Line Pipe</i>"").</text>
<footnote top=""215"" left=""246"" width=""5"" height=""9"" font=""8"" number=""3"" ref=""WT/DS202/13"" dis=""""><ftext top=""1047"" left=""167"" width=""92"" height=""13"" font=""11"">WT/DS202/13.</ftext>
</footnote>
<text top=""218"" left=""251"" width=""534"" height=""15"" font=""3"">  At the DSB meeting of 5 April 2002, the United States informed the DSB,</text>
<text top=""247"" left=""108"" width=""677"" height=""15"" font=""3"">pursuant to Article 21.3 of the  <i>Understanding on Rules and Procedures Governing the Settlement of</i></text>
<text top=""275"" left=""108"" width=""677"" height=""15"" font=""9""><i>Disputes</i>  (the ""DSU""), that it would implement the recommendations and rulings of the DSB in this</text>
<text top=""304"" left=""108"" width=""677"" height=""15"" font=""3"">dispute in a manner that respects its obligations and that it would require a ""reasonable period of time""</text>
<text top=""332"" left=""108"" width=""384"" height=""15"" font=""3"">to do so, pursuant to the terms of Article 21.3 of the DSU.</text>
<footnote top=""329"" left=""495"" width=""5"" height=""9"" font=""8"" number=""4"" ref=""WT/DSB/M/122"" dis=""""><ftext top=""1071"" left=""167"" width=""105"" height=""13"" font=""11"">WT/DSB/M/122.</ftext>
</footnote>
</p></p><p number=""2."" style=""6""><text top=""378"" left=""108"" width=""17"" height=""15"" font=""3"">2. </text>
<text top=""378"" left=""162"" width=""623"" height=""15"" font=""3"">In view of the parties' inability to reach an agreement on the period of time reasonably</text>
<text top=""407"" left=""108"" width=""677"" height=""15"" font=""3"">required for implementation of those recommendations and rulings, Korea requested, in a letter dated</text>
<text top=""435"" left=""108"" width=""677"" height=""15"" font=""3"">29 April 2002, that such period be determined by binding arbitration pursuant to Article 21.3(c) of the</text>
<text top=""464"" left=""108"" width=""37"" height=""15"" font=""3"">DSU.</text>
<footnote top=""460"" left=""148"" width=""5"" height=""9"" font=""8"" number=""5"" ref=""WT/DS202/14"" dis=""""><ftext top=""1095"" left=""167"" width=""92"" height=""13"" font=""11"">WT/DS202/14.</ftext>
</footnote>
</p><p number=""3."" style=""6""><text top=""510"" left=""108"" width=""17"" height=""15"" font=""3"">3. </text>
<text top=""510"" left=""162"" width=""623"" height=""15"" font=""3"">In the absence of an agreement between the parties on the appointment of an arbitrator within</text>
<text top=""539"" left=""108"" width=""677"" height=""15"" font=""3"">10 days after referring the matter to arbitration, Korea requested, in a letter dated 13 May 2002, the</text>
<text top=""567"" left=""108"" width=""677"" height=""15"" font=""3"">Director-General of the World Trade Organization (the ""WTO"") to appoint the arbitrator, as provided</text>
<text top=""596"" left=""108"" width=""677"" height=""15"" font=""3"">for in footnote 12 to Article 21.3(c) of the DSU.  After consultations with the parties, the Director-</text>
<text top=""624"" left=""108"" width=""541"" height=""15"" font=""3"">General decided, on 23 May 2002, to appoint me as the arbitrator in this matter.</text>
<footnote top=""621"" left=""652"" width=""5"" height=""9"" font=""8"" number=""6"" ref=""WT/DS202/16"" dis=""""><ftext top=""1119"" left=""167"" width=""92"" height=""13"" font=""11"">WT/DS202/16.</ftext>
</footnote>
<text top=""624"" left=""657"" width=""128"" height=""15"" font=""3"">  On the same day,</text>
<text top=""653"" left=""108"" width=""499"" height=""15"" font=""3"">the parties were informed of my acceptance of the designation as arbitrator.</text>
</p><p number=""4."" style=""6""><text top=""699"" left=""108"" width=""17"" height=""15"" font=""3"">4. </text>
<text top=""699"" left=""162"" width=""623"" height=""15"" font=""3"">In subsequent letters to me, the parties indicated that they agreed to extend the deadline for</text>
<text top=""727"" left=""108"" width=""677"" height=""15"" font=""3"">completion of the arbitration to 12 July 2002.  Notwithstanding this extension of the 90-day time</text>
<text top=""756"" left=""108"" width=""677"" height=""15"" font=""3"">period stipulated in Article 21.3(c) of the DSU, the parties confirmed that the arbitration award shall</text>
<text top=""784"" left=""108"" width=""444"" height=""15"" font=""3"">be deemed to be an award issued under Article 21.3(c) of the DSU.</text>
<footnote top=""781"" left=""552"" width=""5"" height=""9"" font=""8"" number=""7"" ref="""" dis=""""><ftext top=""1143"" left=""167"" width=""405"" height=""13"" font=""11"">Korea's letter of 30 May 2002;  United States' letter of 3 June 2002.</ftext>
</footnote>
</p><p number=""5."" style=""6""><text top=""831"" left=""108"" width=""17"" height=""15"" font=""3"">5. </text>
<text top=""831"" left=""162"" width=""623"" height=""15"" font=""3"">Written submissions were received from the United States and Korea on 3 June 2002, and an</text>
<text top=""859"" left=""108"" width=""259"" height=""15"" font=""3"">oral hearing was held on 12 June 2002.</text>
</p><p number=""6."" style=""6""><text top=""906"" left=""108"" width=""17"" height=""15"" font=""3"">6. </text>
<text top=""906"" left=""162"" width=""623"" height=""15"" font=""3"">By joint letter of 12 July 2002, the parties requested that I delay the issuance of the award</text>
<text top=""934"" left=""108"" width=""677"" height=""15"" font=""3"">until 22 July 2002, in order to allow time for additional bilateral discussions.  The parties also</text>
<text top=""133"" left=""108"" width=""677"" height=""15"" font=""3"">confirmed that should the arbitration award be issued on 22 July 2002, it would be deemed to be an</text>
<text top=""161"" left=""108"" width=""348"" height=""15"" font=""3"">award issued pursuant to Article 21.3(c) of the DSU.</text>
</p></page>
<page number=""4"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7."" style=""6""><text top=""208"" left=""108"" width=""17"" height=""15"" font=""3"">7. </text>
<text top=""208"" left=""162"" width=""623"" height=""15"" font=""3"">I informed the parties by letter dated 12 July 2002 that I agreed to delay the issuance of the</text>
<text top=""236"" left=""108"" width=""677"" height=""15"" font=""3"">award until 22 July 2002, to give the parties a further opportunity to seek agreement on a reasonable</text>
<text top=""265"" left=""108"" width=""293"" height=""15"" font=""3"">period of time for compliance in this matter.</text>
</p><p number=""8."" style=""6""><text top=""311"" left=""108"" width=""17"" height=""15"" font=""3"">8. </text>
<text top=""311"" left=""162"" width=""623"" height=""15"" font=""3"">Additional joint requests for delay were received on 19 and 22 July 2002, wherein the parties</text>
<text top=""340"" left=""108"" width=""677"" height=""15"" font=""3"">requested that the award pursuant to Article 21.3(c) of the DSU be delayed until 24 July 2002 and</text>
<text top=""368"" left=""108"" width=""677"" height=""15"" font=""3"">26 July 2002, respectively.  I informed the parties by letters dated 19 and 22 July 2002 that I agreed to</text>
<text top=""396"" left=""108"" width=""83"" height=""15"" font=""3"">the requests.</text>
</p><p number=""9."" style=""6""><text top=""443"" left=""108"" width=""17"" height=""15"" font=""3"">9. </text>
<text top=""443"" left=""162"" width=""623"" height=""15"" font=""3"">By letters dated 24 July 2002, the parties informed me that they had reached agreement on the</text>
<text top=""471"" left=""108"" width=""677"" height=""15"" font=""3"">reasonable period of time for compliance in this matter.  Under the circumstances, it will not be</text>
<text top=""500"" left=""108"" width=""352"" height=""15"" font=""3"">necessary for me to issue an award in this arbitration.</text>
<p><text top=""639"" left=""108"" width=""414"" height=""15"" font=""3"">Signed in the original at Geneva this 24th day of July 2002 by:</text>
</p><p><text top=""828"" left=""347"" width=""198"" height=""15"" font=""3"">________________________</text>
<text top=""856"" left=""384"" width=""125"" height=""15"" font=""3"">Yasuhei Taniguchi</text>
<text top=""885"" left=""413"" width=""66"" height=""15"" font=""3"">Arbitrator</text>
</p></p></page>
</pdf2xml>",68570,12
53431,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1188"" width=""918"">
	<fontspec id=""15"" size=""13"" family=""Times"" color=""#000000"" style=""ib""/><fontspec id=""14"" size=""13"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""13"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""12"" size=""13"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""11"" size=""22"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""10"" size=""29"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""13"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""29"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""22"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""13"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""10"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""6"" size=""13"" family=""Times"" color=""#000000""/>
<p><text top=""117"" left=""603"" width=""122"" height=""14"" font=""0"">13 December 2004 </text>
</p><p><text top=""161"" left=""603"" width=""54"" height=""11"" font=""4"">(04-5475) </text>
</p><p><text top=""191"" left=""603"" width=""119"" height=""14"" font=""0"">Original:   English </text>
</p><p><text top=""441"" left=""170"" width=""582"" height=""15"" font=""13"">UNITED STATES &#8211; FINAL DUMPING DETERMINATION ON SOFTWOOD </text><text top=""461"" left=""355"" width=""212"" height=""15"" font=""13"">LUMBER FROM CANADA </text></p><p><text top=""623"" left=""423"" width=""75"" height=""14"" font=""15"">Arbitration</text><text top=""640"" left=""372"" width=""178"" height=""14"" font=""15"">under Article 21.3(c) of the</text><text top=""658"" left=""329"" width=""264"" height=""14"" font=""15"">Understanding on Rules and Procedures </text><text top=""676"" left=""340"" width=""243"" height=""14"" font=""15"">Governing the Settlement of Disputes</text></p><p><text top=""855"" left=""385"" width=""152"" height=""14"" font=""0"">Report of the Arbitrator </text>
<text top=""872"" left=""414"" width=""93"" height=""14"" font=""0"">John Lockhart </text>
</p></page>
<page number=""2"" position=""absolute"" top=""0"" left=""0"" height=""1188"" width=""918"">
</page>
<page number=""3"" position=""absolute"" top=""0"" left=""0"" height=""1188"" width=""918"">
	<fontspec id=""7"" size=""7"" family=""Times"" color=""#000000""/>
	<fontspec id=""8"" size=""13"" family=""Times"" color=""#000000""/>
	<fontspec id=""9"" size=""12"" family=""Times"" color=""#000000""/>
<p number=""1."" style=""6""><text top=""126"" left=""141"" width=""16"" height=""14"" font=""0"">1. </text>
<text top=""126"" left=""191"" width=""592"" height=""14"" font=""0"">On 31 August 2004, the Dispute Settlement Body (the ""DSB"") adopted the Appellate Body </text>
<text top=""153"" left=""141"" width=""42"" height=""14"" font=""0"">Report</text>
<footnote top=""150"" left=""183"" width=""5"" height=""9"" font=""7"" number=""1"" ref=""WT/DS264/AB/R"" dis=""""><ftext top=""954"" left=""196"" width=""242"" height=""13"" font=""9"">Appellate Body Report, WT/DS264/AB/R. </ftext>
</footnote>
<text top=""153"" left=""188"" width=""139"" height=""14"" font=""0""> and the Panel Report</text>
<footnote top=""150"" left=""327"" width=""5"" height=""9"" font=""7"" number=""2"" ref=""WT/DS264/R"" dis=""""><ftext top=""977"" left=""196"" width=""162"" height=""13"" font=""9"">Panel Report, WT/DS264/R. </ftext>
</footnote>
<text top=""153"" left=""332"" width=""451"" height=""14"" font=""0"">, as modified by the Appellate Body Report, in  <i>United States &#8211; Final </i></text>
<text top=""180"" left=""141"" width=""425"" height=""14"" font=""8""><i>Dumping Determination on Softwood Lumber from Canada</i>.</text>
<footnote top=""176"" left=""565"" width=""5"" height=""9"" font=""7"" number=""3"" ref=""WT/DS264/9"" dis=""""><ftext top=""1000"" left=""196"" width=""83"" height=""13"" font=""9"">WT/DS264/9. </ftext>
</footnote>
<text top=""180"" left=""570"" width=""221"" height=""14"" font=""0"">  At the DSB meeting of </text>
<text top=""206"" left=""141"" width=""642"" height=""14"" font=""0"">27 September 2004, the United States confirmed its intention to implement the recommendations and </text>
<text top=""233"" left=""141"" width=""643"" height=""14"" font=""0"">rulings of the DSB in this dispute and stated that it would require a ""reasonable period of time"" in </text>
<text top=""260"" left=""141"" width=""641"" height=""14"" font=""0"">which to do so, pursuant to Article 21.3 of the <i>Understanding on Rules and Procedures Governing the </i></text>
<text top=""287"" left=""141"" width=""227"" height=""14"" font=""8""><i>Settlement of Disputes</i>  (the ""DSU"").</text>
<footnote top=""284"" left=""368"" width=""5"" height=""9"" font=""7"" number=""4"" ref=""WT/DSB/M/176"" dis=""""><ftext top=""1022"" left=""196"" width=""154"" height=""13"" font=""9"">WT/DSB/M/176, para. 34. </ftext>
</footnote>
</p><p number=""2."" style=""6""><text top=""331"" left=""141"" width=""16"" height=""14"" font=""0"">2. </text>
<text top=""331"" left=""191"" width=""590"" height=""14"" font=""0"">On 18 October 2004, Canada informed the DSB that consultations with the United States had </text>
<text top=""357"" left=""141"" width=""643"" height=""14"" font=""0"">not resulted in agreement on the reasonable period of time for implementation.  Canada, therefore, </text>
<text top=""384"" left=""141"" width=""641"" height=""14"" font=""0"">requested that such period be determined by binding arbitration, in accordance with Article 21.3(c) of </text>
<text top=""411"" left=""141"" width=""58"" height=""14"" font=""0"">the DSU.</text>
<footnote top=""408"" left=""198"" width=""5"" height=""9"" font=""7"" number=""5"" ref=""WT/DS264/10"" dis=""""><ftext top=""1045"" left=""196"" width=""90"" height=""13"" font=""9"">WT/DS264/10. </ftext>
</footnote>
</p><p number=""3."" style=""6""><text top=""455"" left=""141"" width=""16"" height=""14"" font=""0"">3. </text>
<text top=""455"" left=""191"" width=""592"" height=""14"" font=""0"">Canada and the United States were unable to agree on an arbitrator within 10 days of the </text>
<text top=""481"" left=""141"" width=""642"" height=""14"" font=""0"">matter being referred to arbitration.  On 29 October 2004, Canada requested the Director-General to </text>
<text top=""508"" left=""141"" width=""645"" height=""14"" font=""0"">appoint an arbitrator to determine a reasonable period of time for implementation, pursuant to </text>
<text top=""535"" left=""141"" width=""642"" height=""14"" font=""0"">footnote 12 to Article 21.3(c) of the DSU.  In a joint letter dated 1 November 2004, Canada and the </text>
<text top=""562"" left=""141"" width=""637"" height=""14"" font=""0"">United States indicated that in discussions that took place following Canada's request to the Director-</text>
<text top=""588"" left=""141"" width=""644"" height=""14"" font=""0"">General, they had ""determined that [I] would be a mutually acceptable arbitrator.""  Accordingly, </text>
<text top=""615"" left=""141"" width=""642"" height=""14"" font=""0"">Canada withdrew its request of 29 October 2004 and both parties requested the Director-General to </text>
<text top=""642"" left=""141"" width=""643"" height=""14"" font=""0"">convey to me their agreement that I act as arbitrator in this matter.  I informed the parties of my </text>
<text top=""669"" left=""141"" width=""402"" height=""14"" font=""0"">acceptance of the appointment by letter dated 4 November 2004.</text>
<footnote top=""666"" left=""542"" width=""5"" height=""9"" font=""7"" number=""6"" ref=""WT/DS264/11"" dis=""""><ftext top=""1067"" left=""196"" width=""90"" height=""13"" font=""9"">WT/DS264/11. </ftext>
</footnote>
</p><p number=""4."" style=""6""><text top=""712"" left=""141"" width=""16"" height=""14"" font=""0"">4. </text>
<text top=""712"" left=""191"" width=""561"" height=""14"" font=""0"">Canada and the United States provided their written submissions on 19 November 2004.   </text>
</p></page>
<page number=""4"" position=""absolute"" top=""0"" left=""0"" height=""1188"" width=""918"">
<p number=""5."" style=""6""><text top=""126"" left=""141"" width=""16"" height=""14"" font=""0"">5. </text>
<text top=""126"" left=""191"" width=""593"" height=""14"" font=""0"">By a joint letter dated 6 December 2004, the parties informed me that they had reached </text>
<text top=""153"" left=""141"" width=""641"" height=""14"" font=""0"">agreement on the reasonable period of time for compliance in this matter.  Under the circumstances, it </text>
<text top=""180"" left=""141"" width=""406"" height=""14"" font=""0"">will not be necessary for me to issue an award in this arbitration. </text>
<p><text top=""267"" left=""141"" width=""398"" height=""14"" font=""0"">Signed in the original at Geneva this 8th of December 2004 by: </text>
</p><p><text top=""445"" left=""366"" width=""190"" height=""14"" font=""0"">________________________ </text>
<text top=""471"" left=""414"" width=""93"" height=""14"" font=""0"">John Lockhart </text>
<text top=""498"" left=""428"" width=""66"" height=""14"" font=""0"">Arbitrator </text>
</p></p></page>
</pdf2xml>",53431,12
53291,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""9"" size=""14"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""8"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""7"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""6"" size=""31"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""31"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""14"" family=""Times"" color=""#000000""/>
<p><text top=""1140"" left=""768"" width=""21"" height=""15"" font=""0"">. /. </text>
</p><p><text top=""81"" left=""116"" width=""33"" height=""30"" font=""6"">W</text><text top=""86"" left=""149"" width=""82"" height=""24"" font=""7"">ORLD </text><text top=""81"" left=""232"" width=""22"" height=""30"" font=""6"">T</text><text top=""86"" left=""254"" width=""74"" height=""24"" font=""7"">RADE</text><text top=""138"" left=""116"" width=""26"" height=""30"" font=""6"">O</text><text top=""143"" left=""142"" width=""191"" height=""24"" font=""7"">RGANIZATION</text><text top=""105"" left=""599"" width=""103"" height=""15"" font=""8"">WT/DS257/16 </text></p><p><text top=""124"" left=""599"" width=""105"" height=""15"" font=""0"">4 January 2005 </text>
</p><p><text top=""171"" left=""599"" width=""57"" height=""12"" font=""4"">(05-0006) </text>
</p><p><text top=""203"" left=""599"" width=""127"" height=""15"" font=""0"">Original:   English </text>
</p><p><text top=""279"" left=""167"" width=""562"" height=""15"" font=""8"">UNITED STATES &#8211; FINAL COUNTERVAILING DUTY DETERMINATION </text><text top=""298"" left=""175"" width=""547"" height=""15"" font=""8"">WITH RESPECT TO CERTAIN SOFTWOOD LUMBER FROM CANADA </text></p><p><text top=""336"" left=""289"" width=""319"" height=""15"" font=""0"">Recourse to Article 22.2 of the DSU by Canada </text>
</p><p><text top=""392"" left=""162"" width=""629"" height=""15"" font=""0"">The following communication, dated 30 December 2004, from the delegation of Canada to </text>
<text top=""411"" left=""108"" width=""654"" height=""15"" font=""0"">the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 22.2 of the DSU. </text>
</p><p><text top=""468"" left=""385"" width=""128"" height=""15"" font=""8"">_______________ </text></p><p><text top=""525"" left=""162"" width=""630"" height=""15"" font=""0"">Canada requests that a special meeting of the Dispute Settlement Body (DSB) be held on </text>
<text top=""544"" left=""108"" width=""372"" height=""15"" font=""0"">14 January 2005 to consider the following agenda item: </text>
</p><p><text top=""582"" left=""162"" width=""629"" height=""15"" font=""9"">United States &#8211; Final Countervailing Duty Determination with Respect to Certain Softwood </text><text top=""601"" left=""162"" width=""147"" height=""15"" font=""9"">Lumber from Canada </text></p><p><text top=""639"" left=""162"" width=""633"" height=""15"" font=""9"">Recourse by Canada to Article 22.2 of the Understanding on Rules and Procedures </text><text top=""658"" left=""162"" width=""251"" height=""15"" font=""9"">Governing the Settlement of Disputes </text></p><p><text top=""696"" left=""162"" width=""628"" height=""15"" font=""0"">The Panel and the Appellate Body in this dispute found that the failure of the Department of </text>
<text top=""715"" left=""108"" width=""683"" height=""15"" font=""0"">Commerce of the United States (Commerce) to conduct a pass-through analysis in respect of arm's </text>
<text top=""734"" left=""108"" width=""686"" height=""15"" font=""0"">length sales of <i>logs</i> by tenure harvesters/sawmills to unrelated sawmills was inconsistent with </text>
<text top=""753"" left=""108"" width=""681"" height=""15"" font=""0"">Articles 10 and 32.1 of the <i>Agreement on Subsidies and Countervailing Measures</i> (<i>SCM Agreement</i>) </text>
<text top=""772"" left=""108"" width=""682"" height=""15"" font=""0"">and Article VI:3 of the <i>General Agreement on Tariffs and Trade 1994</i> (<i>GATT 1994</i>).  The Panel also </text>
<text top=""791"" left=""108"" width=""682"" height=""15"" font=""0"">found that Commerce's failure to conduct a ""pass-through"" analysis in respect of arm's length sales of </text>
<text top=""810"" left=""108"" width=""684"" height=""15"" font=""0"">logs by independent harvesters (<i>i.e.</i>, entities that do not produce softwood lumber products under </text>
<text top=""829"" left=""108"" width=""474"" height=""15"" font=""0"">investigation) to sawmills was inconsistent with these same provisions. </text>
</p><p><text top=""867"" left=""162"" width=""629"" height=""15"" font=""0"">On 17 February 2004, the DSB adopted the Appellate Body and Panel reports.  The United </text>
<text top=""886"" left=""108"" width=""677"" height=""15"" font=""0"">States subsequently stated that it intended to implement the recommendations and rulings of the DSB. </text>
</p><p><text top=""924"" left=""162"" width=""627"" height=""15"" font=""0"">Canada and the United States agreed that the ""reasonable period of time"" for the United States </text>
<text top=""943"" left=""108"" width=""682"" height=""15"" font=""0"">to implement the DSB's recommendations and rulings would expire on 17 December 2004.  On that </text>
<text top=""962"" left=""108"" width=""686"" height=""15"" font=""0"">date, the United States informed the DSB that it had complied with its recommendations and rulings.  </text>
<text top=""981"" left=""108"" width=""683"" height=""15"" font=""0"">Canada considers that the United States has failed to comply with the DSB's recommendations and </text>
<text top=""1000"" left=""108"" width=""683"" height=""15"" font=""0"">rulings with respect to the ""pass-through"" analysis allegedly conducted by Commerce.  Canada is, </text>
<text top=""1019"" left=""108"" width=""686"" height=""15"" font=""0"">therefore, entitled to redress under Article 22 of the <i>Understanding on Rules and Procedures </i></text>
<text top=""1038"" left=""108"" width=""307"" height=""15"" font=""5""><i>Governing the Settlement of Disputes</i> (DSU).  </text>
</p><p><text top=""1076"" left=""162"" width=""628"" height=""15"" font=""0"">Pursuant to Article 22.2 of the DSU, Canada requests authorization from the DSB to suspend </text>
<text top=""1094"" left=""108"" width=""682"" height=""15"" font=""0"">the application to the United States of its concessions or other obligations in an amount that will be </text>
<text top=""1113"" left=""108"" width=""684"" height=""15"" font=""0"">established each year based on the portion of the applicable countervailing duty rate for that year </text>
<text top=""134"" left=""108"" width=""687"" height=""15"" font=""0"">which is illegal due to the failure of Commerce to conduct an appropriate ""pass-through"" analysis.  </text>
<text top=""153"" left=""108"" width=""681"" height=""15"" font=""0"">For 2005, Canada requests authorization to suspend concessions or other obligations covering trade in </text>
<text top=""172"" left=""108"" width=""214"" height=""15"" font=""0"">the amount of C$200,000,000.   </text>
</p></page>
<page number=""2"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""210"" left=""162"" width=""628"" height=""15"" font=""0"">This level of suspension is equivalent to the level of nullification and impairment of benefits </text>
<text top=""229"" left=""108"" width=""685"" height=""15"" font=""0"">accruing to Canada that results from the United States' failure to bring its measures concerning </text>
<text top=""248"" left=""108"" width=""681"" height=""15"" font=""0"">Commerce's ""pass-through"" analysis into compliance by 17 December 2004 with the <i>GATT</i> <i>1994 </i>and </text>
<text top=""267"" left=""108"" width=""601"" height=""15"" font=""0"">the <i>SCM Agreement </i>or to otherwise comply with the DSB's recommendations and rulings. </text>
</p><p><text top=""305"" left=""162"" width=""628"" height=""15"" font=""0"">Canada intends to implement this suspension of tariff concessions and related obligations by </text>
<text top=""324"" left=""108"" width=""682"" height=""15"" font=""0"">imposing duties in excess of the bound rates on products originating in the United States.  Each year, </text>
<text top=""343"" left=""108"" width=""685"" height=""15"" font=""0"">prior to the imposition of the additional duties, Canada will provide the DSB with a final list </text>
<text top=""362"" left=""108"" width=""339"" height=""15"" font=""0"">indicating the level of duties on selected products.  </text>
</p><p><text top=""400"" left=""405"" width=""87"" height=""15"" font=""8"">__________ </text></p></page>
</pdf2xml>",53291,12
90105,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1269"" width=""891"">
</page>
<page number=""2"" position=""absolute"" top=""0"" left=""0"" height=""1269"" width=""891"">
</page>
</pdf2xml>",90105,12
107336,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""14"" size=""8"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""13"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""12"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""11"" size=""31"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""31"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""8"" family=""Times"" color=""#000000""/>
	<fontspec id=""6"" size=""8"" family=""Times"" color=""#000000""/>
	<fontspec id=""7"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""8"" size=""7"" family=""Times"" color=""#000000""/>
	<fontspec id=""9"" size=""13"" family=""Times"" color=""#000000""/>
	<fontspec id=""10"" size=""13"" family=""Times"" color=""#000000""/>
<p><text top=""143"" left=""599"" width=""130"" height=""15"" font=""0"">22 December 2009 </text>
</p><p><text top=""180"" left=""599"" width=""57"" height=""12"" font=""4"">(09-6682) </text>
</p><p><text top=""288"" left=""156"" width=""23"" height=""15"" font=""13"">EC</text><footnote top=""284"" left=""179"" width=""5"" height=""9"" font=""14"" number=""1"" ref="""" dis=""""><ftext top=""1036"" left=""167"" width=""623"" height=""14"" font=""9""> On 1 December 2009, the Treaty of Lisbon amending the Treaty on European Union and the Treaty </ftext>
<ftext top=""1053"" left=""108"" width=""685"" height=""14"" font=""9"">establishing the European Community (done at Lisbon, 13 December 2007) entered into force.  On 29 </ftext>
<ftext top=""1070"" left=""108"" width=""681"" height=""14"" font=""9"">November 2009, the WTO received a Verbal Note (WT/L/779) from the Council of the European Union and the </ftext>
<ftext top=""1088"" left=""108"" width=""683"" height=""14"" font=""9"">Commission of the European Communities stating that, by virtue of the Treaty of Lisbon, as of 1 December </ftext>
<ftext top=""1105"" left=""108"" width=""460"" height=""14"" font=""9"">2009, the European Union replaces and succeeds the European Community. </ftext>
</footnote><text top=""288"" left=""184"" width=""561"" height=""15"" font=""13""> &#8211; REGIME FOR THE IMPORTATION OF BANANAS (DS361) INITIATED  </text><text top=""307"" left=""386"" width=""125"" height=""15"" font=""13"">BY COLOMBIA </text></p><p><text top=""345"" left=""156"" width=""23"" height=""15"" font=""13"">EC</text><footnote top=""777"" left=""364"" width=""5"" height=""9"" font=""6"" number=""2"" ref="""" dis=""""><ftext top=""1122"" left=""167"" width=""612"" height=""14"" font=""9""> <i>European Communities &#8212; Regime for the Importation, Sale and Distribution of Bananas</i>, WT/DS27 </ftext>
</footnote>
</p><p><text top=""780"" left=""369"" width=""421"" height=""15"" font=""0"">, certain aspects of the European Communities banana import </text>
<text top=""799"" left=""108"" width=""682"" height=""15"" font=""0"">regime in force at the time the dispute was initiated in 1996 were found to be inconsistent with WTO </text>
<text top=""818"" left=""108"" width=""684"" height=""15"" font=""0"">law.  A number of proposals by the EC to modify its regime to bring it into compliance with the </text>
<text top=""837"" left=""108"" width=""686"" height=""15"" font=""0"">recommendations and rulings of the Dispute Settlement Body in this dispute were rejected by </text>
<text top=""856"" left=""108"" width=""682"" height=""15"" font=""0"">complaining countries.  In April 2001, an agreement was  reached between the EC, Ecuador and the </text>
<text top=""875"" left=""108"" width=""681"" height=""15"" font=""0"">United States that entailed<i>, inter alia,</i>  the establishment by no later than 1 January 2006 by the EC of </text>
<text top=""894"" left=""108"" width=""683"" height=""15"" font=""0"">a tariff-only import regime for bananas as well as an interim arrangement consisting of: (1) a tariff </text>
<text top=""913"" left=""108"" width=""682"" height=""15"" font=""0"">rate quota scheme for MFN suppliers providing for an  in quota tariff rate of 75 euros per tonne up to </text>
<text top=""932"" left=""108"" width=""683"" height=""15"" font=""0"">2.2 million tons and an out of quota tariff rate of 680 euros per tonne thereafter; and (2) duty-free </text>
<text top=""951"" left=""108"" width=""683"" height=""15"" font=""0"">preferential tariff treatment to bananas for up to 750,000 tonnes originating in ACP countries.  This </text>
<text top=""970"" left=""108"" width=""683"" height=""15"" font=""0"">interim arrangement would be made legally permissible under WTO rules through the adoption of </text>
<text top=""989"" left=""108"" width=""499"" height=""15"" font=""0"">several waivers agreed at the Doha Ministerial, as explained further below. </text>
</p></page>
<page number=""2"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""3."" style=""6""><text top=""153"" left=""108"" width=""17"" height=""15"" font=""0"">3. </text>
<text top=""153"" left=""162"" width=""634"" height=""15"" font=""0"">A waiver from the application of Article I of the GATT was granted in Doha in </text>
<text top=""172"" left=""108"" width=""683"" height=""15"" font=""0"">November 2001 (the ""Doha waiver"") for the Cotonou Agreement trade preference, with a duration </text>
<text top=""191"" left=""108"" width=""682"" height=""15"" font=""0"">commensurate with these trade preferences, i.e., until 31 December  2007. This waiver also covered </text>
<text top=""210"" left=""108"" width=""682"" height=""15"" font=""0"">the trade preference for bananas.  The waiver specified that the European Communities would rebind </text>
<text top=""229"" left=""108"" width=""681"" height=""15"" font=""0"">its WTO-bound import tariff of 680 euros per tonne on bananas at a level that ""would result in at least </text>
<text top=""248"" left=""108"" width=""681"" height=""15"" font=""0"">maintaining total market access for MFN banana suppliers"" comparable to that provided for under the </text>
<text top=""267"" left=""108"" width=""682"" height=""15"" font=""0"">interim arrangement. The waiver further provided for multilateral control over the implementation of </text>
<text top=""286"" left=""108"" width=""681"" height=""15"" font=""0"">this commitment through a two-stage arbitration procedure and specified that both the Article XXVIII </text>
<text top=""305"" left=""108"" width=""682"" height=""15"" font=""0"">negotiations and the arbitration procedures would have to be concluded before the entry into force of </text>
<text top=""324"" left=""108"" width=""682"" height=""15"" font=""0"">the new EC tariff-only regime.  At the same time, a second waiver to cover the temporary duty-free </text>
<text top=""343"" left=""108"" width=""562"" height=""15"" font=""0"">allocation of 750,000 tonnes to ACP countries was granted until 31 December 2005. </text>
</p><p number=""4."" style=""6""><text top=""380"" left=""108"" width=""17"" height=""15"" font=""0"">4. </text>
<text top=""380"" left=""162"" width=""633"" height=""15"" font=""0"">During the course of 2005, the European Communities and interested MFN countries </text>
<text top=""399"" left=""108"" width=""682"" height=""15"" font=""0"">attempted but failed to reach agreement on the level of a new EC tariff rate that would maintain the </text>
<text top=""418"" left=""108"" width=""682"" height=""15"" font=""0"">MFN countries' ""total market access"" as set forth in the Doha waiver.  Two arbitrations were held in </text>
<text top=""436"" left=""108"" width=""685"" height=""15"" font=""0"">accordance with the provisions of this waiver. These arbitrations concluded that the tariff levels </text>
<text top=""455"" left=""108"" width=""683"" height=""15"" font=""0"">proposed by the European Communities would not result in at least maintaining total market access </text>
<text top=""474"" left=""108"" width=""682"" height=""15"" font=""0"">for MFN banana suppliers comparable to that under the interim arrangement, taking into account all </text>
<text top=""493"" left=""108"" width=""682"" height=""15"" font=""0"">EC WTO market access commitments relating to bananas.  The EC was therefore required to rectify </text>
<text top=""512"" left=""108"" width=""75"" height=""15"" font=""0"">the matter. </text>
</p><p number=""5."" style=""6""><text top=""549"" left=""108"" width=""17"" height=""15"" font=""0"">5. </text>
<text top=""549"" left=""162"" width=""632"" height=""15"" font=""0"">In response to the second arbitration award and without the prior agreement of MFN </text>
<text top=""568"" left=""108"" width=""684"" height=""15"" font=""0"">suppliers, the EC implemented a new banana import regime on 1 January 2006 (through Council </text>
<text top=""587"" left=""108"" width=""681"" height=""15"" font=""0"">Regulation 1964/2005).  This was the EC banana regime in force when there was a subsequent request </text>
<text top=""606"" left=""108"" width=""682"" height=""15"" font=""0"">by several of the MFN suppliers for the DG to provide his good offices in this dispute as explained </text>
<text top=""625"" left=""108"" width=""683"" height=""15"" font=""0"">further below. Under this new EC regime, the MFN tariff applied to all bananas regardless of their </text>
<text top=""644"" left=""108"" width=""685"" height=""15"" font=""0"">origin was &#8364; 176 per ton and there were no quantitative restrictions.  In addition, the European </text>
<text top=""663"" left=""108"" width=""682"" height=""15"" font=""0"">Communities offered until the end of 2007 a preference to bananas imported from countries that had </text>
<text top=""682"" left=""108"" width=""226"" height=""15"" font=""0"">signed the ""Cotonou Agreement""</text>
<footnote top=""679"" left=""334"" width=""5"" height=""9"" font=""6"" number=""3"" ref="""" dis=""""><ftext top=""1088"" left=""167"" width=""624"" height=""14"" font=""9""> The Cotonou Agreement obliged the European Communities to accept the importation of products </ftext>
<ftext top=""1105"" left=""108"" width=""681"" height=""14"" font=""9"">originating from Cotonou beneficiary developing countries free of custom duties and charges having equivalent </ftext>
<ftext top=""1122"" left=""108"" width=""389"" height=""14"" font=""9"">effect or, at least, at preferential terms, until 31 December 2007. </ftext>
</footnote>
<text top=""682"" left=""339"" width=""452"" height=""15"" font=""0"">.   This preference took the form of an annual quota of 775,000 </text>
<text top=""701"" left=""108"" width=""682"" height=""15"" font=""0"">tonnes of bananas free of duty from Cotonou participating countries (the ""Cotonou Preference"").  All </text>
<text top=""720"" left=""108"" width=""682"" height=""15"" font=""0"">bananas imported from Cotonou countries beyond this amount were also subject to the tariff of &#8364; 176 </text>
<text top=""739"" left=""108"" width=""55"" height=""15"" font=""0"">per ton. </text>
</p><p number=""6."" style=""6""><text top=""776"" left=""108"" width=""17"" height=""15"" font=""0"">6. </text>
<text top=""776"" left=""162"" width=""629"" height=""15"" font=""0"">In the meantime, at the Hong Kong Ministerial in December 2005, several Latin American </text>
<text top=""795"" left=""108"" width=""693"" height=""15"" font=""0"">countries had expressed serious concern over what they considered to be the EU's </text>
<text top=""814"" left=""108"" width=""682"" height=""15"" font=""0"">non-implementation of the earlier WTO's legal rulings and recommendations from the late 1990s in </text>
<text top=""833"" left=""108"" width=""683"" height=""15"" font=""0"">the banana dispute, particularly in the aftermath of the two arbitrations carried out earlier in 2005 </text>
<text top=""852"" left=""108"" width=""684"" height=""15"" font=""0"">under the Doha Waiver. To address these concerns, I nominated Mr Jonas Store, the Norwegian </text>
<text top=""871"" left=""108"" width=""681"" height=""15"" font=""0"">Foreign Minister, to act as a ""Facilitator"" to assist the parties in trying to find a solution and asked him </text>
<text top=""890"" left=""108"" width=""681"" height=""15"" font=""0"">to report to the General Council in due course.  Minister Store conducted regular meetings for the next </text>
<text top=""909"" left=""108"" width=""684"" height=""15"" font=""0"">18 months, assisting the parties and reporting periodically to the General Council on his efforts. </text>
<text top=""928"" left=""108"" width=""683"" height=""15"" font=""0"">During this process, the participants collected and shared data on imports/exports of bananas in the </text>
<text top=""947"" left=""108"" width=""681"" height=""15"" font=""0"">EU with a view to advancing the search for what should be the appropriate new EC tariff level within </text>
<text top=""966"" left=""108"" width=""428"" height=""15"" font=""0"">the framework of the agreements that had been reached in 2001. </text>
</p><p number=""7."" style=""6""><text top=""1003"" left=""108"" width=""17"" height=""15"" font=""0"">7. </text>
<text top=""1003"" left=""162"" width=""632"" height=""15"" font=""0"">Concurrently, implementation of the EC's new import regime for bananas on 1 January 2006  </text>
<text top=""1022"" left=""108"" width=""683"" height=""15"" font=""0"">also triggered a number of  legal complaints in the WTO by various MFN suppliers in late 2006, </text>
<text top=""1041"" left=""108"" width=""683"" height=""15"" font=""0"">including legal proceedings initiated by Ecuador and the United States under the compliance panel </text>
<text top=""153"" left=""108"" width=""685"" height=""15"" font=""0"">procedures of Article 21.5 (c) of the DSU.  The reports of the two compliance panels and the </text>
<text top=""172"" left=""108"" width=""594"" height=""15"" font=""0"">Appellate Body in these two proceedings, which were adopted by the DSB in late 2008</text>
<footnote top=""168"" left=""702"" width=""5"" height=""9"" font=""6"" number=""4"" ref=""WT/DS27/RW2/ECU|WT/DS27/RW/USA|WT/DS27/AB/RW/USA ; WT/DS27/AB/RW2/ECU"" dis=""DS27""><ftext top=""1019"" left=""167"" width=""622"" height=""14"" font=""9""> See See <i>EC &#8211; Bananas III (Article 21.5 &#8211; Ecuador II),</i> WT/DS27/RW2/ECU and<i> </i></ftext>
<ftext top=""1036"" left=""108"" width=""681"" height=""14"" font=""9"">WT/DS27AB/RW2/ECU adopted on 11 December 2008; and <i>EC &#8211; Bananas III (Article 21.5 &#8211; US)</i>, </ftext>
<ftext top=""1053"" left=""108"" width=""569"" height=""14"" font=""9"">WT/DS27/RW/USA, and WT/DS27/AB/RW/USA and Corr.1,adopted on 22 December 2008. </ftext>
</footnote>
<text top=""172"" left=""708"" width=""83"" height=""15"" font=""0"">, confirmed </text>
<text top=""191"" left=""108"" width=""682"" height=""15"" font=""0"">that the new EC regime on banana introduced on 1 January 2006 was still inconsistent with the EU's </text>
<text top=""210"" left=""108"" width=""123"" height=""15"" font=""0"">WTO obligations. </text>
</p></page>
<page number=""3"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""247"" left=""108"" width=""388"" height=""15"" font=""13"">Use of the Good Offices of the WTO Director-General  </text></p><p number=""8."" style=""6""><text top=""285"" left=""108"" width=""17"" height=""15"" font=""0"">8. </text>
<text top=""285"" left=""162"" width=""633"" height=""15"" font=""0"">On 21 March and 22 June 2007, Colombia and Panama, respectively, requested new </text>
<text top=""304"" left=""108"" width=""682"" height=""15"" font=""0"">consultations under the DSU with the EC regarding its new banana regime of 1 January 2006 as set </text>
<text top=""323"" left=""108"" width=""348"" height=""15"" font=""0"">out in EC Council regulation (EC) No. 1964/2005</text>
<footnote top=""319"" left=""456"" width=""5"" height=""9"" font=""6"" number=""5"" ref=""G/L/818 ; WT/DS361/1|G/L/822 ; WT/DS364/1"" dis=""""><ftext top=""1070"" left=""167"" width=""624"" height=""14"" font=""9""> Colombia's request for consultation available in documents WT/DS361/1 and G/L/818.  Panama's </ftext>
<ftext top=""1088"" left=""108"" width=""375"" height=""14"" font=""9"">request  is available in documents WT/DS364/1 and G/L/822. </ftext>
</footnote>
<text top=""323"" left=""462"" width=""330"" height=""15"" font=""0"">.  When these consultations failed to lead to a </text>
<text top=""342"" left=""108"" width=""682"" height=""15"" font=""0"">satisfactory settlement, pursuant to Article 3.12 of the DSU and the Procedures under Article XXIII &#8211; </text>
<text top=""361"" left=""108"" width=""684"" height=""15"" font=""0"">Decision of 5 April 1966, Colombia and Panama, referred the matter to me on 2 November and </text>
<text top=""380"" left=""108"" width=""684"" height=""15"" font=""0"">14 December 2007, respectively, with the request that, acting in my ex-officio capacity, I use my </text>
<text top=""399"" left=""108"" width=""519"" height=""15"" font=""0"">good offices with a view to facilitating a solution to their dispute with the EC. </text>
</p><p number=""9."" style=""6""><text top=""436"" left=""108"" width=""17"" height=""15"" font=""0"">9. </text>
<text top=""436"" left=""162"" width=""628"" height=""15"" font=""0"">Initially, Colombia and the EC had requested that their good offices process not include any </text>
<text top=""454"" left=""108"" width=""683"" height=""15"" font=""0"">third parties. They foresaw, however, that if they were to make progress, subsequent phases of the </text>
<text top=""473"" left=""108"" width=""684"" height=""15"" font=""0"">process could then involve other principal suppliers and parties in the dispute. In the meantime, </text>
<text top=""492"" left=""108"" width=""682"" height=""15"" font=""0"">however, Panama requested me to carry out a separate good offices procedure for its dispute with the </text>
<text top=""511"" left=""108"" width=""682"" height=""15"" font=""0"">EC.  Colombia, Panama, and the EC then agreed that the two good offices procedures should run in </text>
<text top=""530"" left=""108"" width=""683"" height=""15"" font=""0"">parallel, although it was envisaged that at a later stage the two processes could be merged if there </text>
<text top=""549"" left=""108"" width=""403"" height=""15"" font=""0"">were sufficient progress toward a solution in both processes. </text>
</p><p number=""10."" style=""6""><text top=""586"" left=""108"" width=""25"" height=""15"" font=""0"">10. </text>
<text top=""586"" left=""162"" width=""628"" height=""15"" font=""0"">As this was the first time that the provisions of Article 3.12 of the DSU and the Procedures </text>
<text top=""605"" left=""108"" width=""682"" height=""15"" font=""0"">under Article XXIII &#8211; Decision of 5 April 1966 were used since the inception of the WTO, I initially </text>
<text top=""624"" left=""108"" width=""682"" height=""15"" font=""0"">sought from the parties their expectations as to what should result from the good offices process.  In </text>
<text top=""643"" left=""108"" width=""684"" height=""15"" font=""0"">this regard and in accordance with paragraph 2 of the 1966 procedures, parties were requested to </text>
<text top=""662"" left=""108"" width=""682"" height=""15"" font=""0"">furnish me with all relevant information relating to the matter, including written explanations.  I also </text>
<text top=""681"" left=""108"" width=""686"" height=""15"" font=""0"">requested the parties' views on which other Members or inter-governmental organisations they </text>
<text top=""700"" left=""108"" width=""636"" height=""15"" font=""0"">believed appropriate for me to consult with a view to promoting a mutually acceptable solution. </text>
</p><p number=""11."" style=""6""><text top=""737"" left=""108"" width=""25"" height=""15"" font=""0"">11. </text>
<text top=""737"" left=""162"" width=""629"" height=""15"" font=""0"">The parties stated their preference for a negotiated settlement as opposed to a purely legal </text>
<text top=""756"" left=""108"" width=""684"" height=""15"" font=""0"">process. The parties also agreed in both good offices processes to adhere to confidentiality with </text>
<text top=""775"" left=""108"" width=""681"" height=""15"" font=""0"">respect to the content of the proceedings.  It was in this spirit that the two good offices processes were </text>
<text top=""794"" left=""108"" width=""76"" height=""15"" font=""0"">conducted. </text>
</p><p number=""12."" style=""6""><text top=""831"" left=""108"" width=""25"" height=""15"" font=""0"">12. </text>
<text top=""831"" left=""162"" width=""630"" height=""15"" font=""0"">I held four formal meetings in the Colombia-EC good offices process.  There were also </text>
<text top=""850"" left=""108"" width=""683"" height=""15"" font=""0"">several informal bilateral/plurilateral meetings and contacts between the parties and the parties and </text>
<text top=""869"" left=""108"" width=""686"" height=""15"" font=""0"">myself.  I also held two formal  meetings in the Panama-EC process, with several informal </text>
<text top=""888"" left=""108"" width=""613"" height=""15"" font=""0"">bilateral/plurilateral contacts and meetings between the parties and the parties and myself.</text>
<footnote top=""885"" left=""721"" width=""5"" height=""9"" font=""6"" number=""6"" ref="""" dis=""""><ftext top=""1105"" left=""167"" width=""623"" height=""14"" font=""9""> Formal meetings of the Colombia-EC good offices were held on 6/12/2007; 17/01/2008; 4/02/2008; </ftext>
<ftext top=""1122"" left=""108"" width=""653"" height=""14"" font=""9"">and, 7/02/2008.  Formal meetings of the Panama-EC good offices were held on 26/02/2008 and 10/03/2008. </ftext>
</footnote>
<text top=""888"" left=""727"" width=""64"" height=""15"" font=""0"">  During </text>
<text top=""907"" left=""108"" width=""682"" height=""15"" font=""0"">these two processes, with a view to assisting the parties in recording in text their apparent points of </text>
<text top=""926"" left=""108"" width=""684"" height=""15"" font=""0"">agreement and possible agreement, I put forward a series of written options as to what might be </text>
<text top=""945"" left=""108"" width=""662"" height=""15"" font=""0"">considered by the parties as an acceptable EC import tariff for bananas and under what conditions.   </text>
</p></page>
<page number=""4"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""13."" style=""6""><text top=""153"" left=""108"" width=""25"" height=""15"" font=""0"">13. </text>
<text top=""153"" left=""162"" width=""629"" height=""15"" font=""0"">In parallel to these two formal good offices processes, and in the interest of transparency - </text>
<text top=""172"" left=""108"" width=""684"" height=""15"" font=""0"">which could contribute to an agreement among the parties that would be acceptable to all WTO </text>
<text top=""191"" left=""108"" width=""309"" height=""15"" font=""0"">Members &#8211; I also held a number of formal</text>
<footnote top=""187"" left=""417"" width=""5"" height=""9"" font=""6"" number=""7"" ref="""" dis=""""><ftext top=""1036"" left=""167"" width=""624"" height=""14"" font=""9""> Three formal meetings were held with a group of ACP countries on 14/05/2008; 26/06/2008; and, </ftext>
<ftext top=""1053"" left=""108"" width=""643"" height=""14"" font=""9"">09/07/2008.  A meeting was also held with a group of MFN suppliers/producers/importers on 9/July/2008. </ftext>
</footnote>
<text top=""191"" left=""423"" width=""370"" height=""15"" font=""0""> and informal meetings with other WTO Members, </text>
<text top=""210"" left=""108"" width=""626"" height=""15"" font=""0"">including other MFN suppliers, ACP banana producers, other banana producers and importers.</text>
<footnote top=""206"" left=""734"" width=""5"" height=""9"" font=""6"" number=""8"" ref="""" dis=""""><ftext top=""1070"" left=""167"" width=""623"" height=""14"" font=""9""> Countries involved in these consultations were: China, Costa Rica, Ecuador, Guatemala, Honduras, </ftext>
<ftext top=""1088"" left=""108"" width=""681"" height=""14"" font=""9"">India, Indonesia, Malaysia, Nicaragua, Peru, Philippines, Thailand, United States and Vietnam.  On occasions I </ftext>
<ftext top=""1105"" left=""108"" width=""681"" height=""14"" font=""9"">held informal meetings with representatives of the ACPs, including with Amb Hiwat from Suriname, as head of </ftext>
<ftext top=""1122"" left=""108"" width=""229"" height=""14"" font=""9"">the ACP working group on bananas.   </ftext>
</footnote>
</p><p number=""14."" style=""6""><text top=""247"" left=""108"" width=""25"" height=""15"" font=""0"">14. </text>
<text top=""247"" left=""162"" width=""628"" height=""15"" font=""0"">The good offices processes intensified in the first part of July 2008.  In attempting to reflect </text>
<text top=""266"" left=""108"" width=""681"" height=""15"" font=""0"">the evolving positions of the parties and in an effort to lead them towards a balanced result, I then put </text>
<text top=""285"" left=""108"" width=""684"" height=""15"" font=""0"">forward in writing the elements of a draft comprehensive banana agreement on 12 July 2009.  I </text>
<text top=""304"" left=""108"" width=""683"" height=""15"" font=""0"">informed the parties that these elements were my best effort at helping them find a solution to their </text>
<text top=""323"" left=""108"" width=""565"" height=""15"" font=""0"">disputes.  I reiterated that I remained available should the parties need my assistance. </text>
</p><p number=""15."" style=""6""><text top=""360"" left=""108"" width=""25"" height=""15"" font=""0"">15. </text>
<text top=""360"" left=""162"" width=""629"" height=""15"" font=""0"">Consultations then continued directly between the parties during the latter half of July 2008 </text>
<text top=""379"" left=""108"" width=""682"" height=""15"" font=""0"">and through 2009.  These direct consultations finally resulted in two agreements between the EC and </text>
<text top=""398"" left=""108"" width=""686"" height=""15"" font=""0"">its MFN bananas suppliers &#8211; one with all Latin MFN suppliers and the other with the United States.  </text>
<text top=""417"" left=""108"" width=""681"" height=""15"" font=""0"">These two agreements were initialled by the parties on 15 December 2009.  The text of the agreement </text>
<text top=""436"" left=""108"" width=""681"" height=""15"" font=""0"">between the EC and its Latin MFN suppliers - the ""Geneva Agreement on Trade in Bananas"" was then </text>
<text top=""454"" left=""108"" width=""691"" height=""15"" font=""0"">circulated to the General Council for its information (WT/L/784).  At its meeting of </text>
<text top=""473"" left=""108"" width=""482"" height=""15"" font=""0"">17-18 December 2009, the General Council took note of this agreement. </text>
</p><p><text top=""529"" left=""405"" width=""87"" height=""15"" font=""13"">__________ </text></p></page>
</pdf2xml>",107336,12
94278,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""14"" size=""14"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""13"" size=""8"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""12"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""11"" size=""24"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""10"" size=""31"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""31"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""24"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""8"" family=""Times"" color=""#000000""/>
	<fontspec id=""6"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""7"" size=""8"" family=""Times"" color=""#000000""/>
	<fontspec id=""8"" size=""7"" family=""Times"" color=""#000000""/>
	<fontspec id=""9"" size=""13"" family=""Times"" color=""#000000""/>
<p><text top=""143"" left=""599"" width=""105"" height=""15"" font=""0"">8 January 2010 </text>
</p><p><text top=""180"" left=""599"" width=""57"" height=""12"" font=""4"">(10-0062) </text>
</p><p><text top=""288"" left=""202"" width=""23"" height=""15"" font=""12"">EC</text><footnote top=""284"" left=""225"" width=""5"" height=""9"" font=""13"" number=""1"" ref="""" dis=""""><ftext top=""1053"" left=""167"" width=""623"" height=""14"" font=""9""> On 1 December 2009, the Treaty of Lisbon amending the Treaty on European Union and the Treaty </ftext>
<ftext top=""1070"" left=""108"" width=""687"" height=""14"" font=""9"">establishing the European Community (done at Lisbon, 13 December 2007) entered into force. On </ftext>
<ftext top=""1088"" left=""108"" width=""681"" height=""14"" font=""9"">29 November 2009, the WTO received a Verbal Note (WT/L/779) from the Council of the European Union and </ftext>
<ftext top=""1105"" left=""108"" width=""686"" height=""14"" font=""9"">the Commission of the European Communities stating that, by virtue of the Treaty of Lisbon, as of </ftext>
<ftext top=""1122"" left=""108"" width=""537"" height=""14"" font=""9"">1 December 2009, the European Union replaces and succeeds the European Community. </ftext>
</footnote><text top=""288"" left=""230"" width=""465"" height=""15"" font=""12""> &#8211; REGIME FOR THE IMPORTATION OF BANANAS (DS361) </text><text top=""307"" left=""340"" width=""217"" height=""15"" font=""12"">INITIATED BY COLOMBIA </text></p><p><text top=""345"" left=""202"" width=""23"" height=""15"" font=""12"">EC</text></p></page>
</pdf2xml>",94278,12
31932,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""8"" size=""14"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""7"" size=""14"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""6"" size=""18"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""18"" family=""Times"" color=""#000000""/>
	<fontspec id=""2"" size=""14"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""31"" family=""Times"" color=""#000000""/>
	<fontspec id=""4"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""14"" family=""Times"" color=""#000000""/>
<p><text top=""143"" left=""599"" width=""138"" height=""15"" font=""0"">25 de enero de 2012 </text>
<text top=""161"" left=""599"" width=""57"" height=""12"" font=""4"">(12-0499) </text>
</p><p><text top=""250"" left=""262"" width=""372"" height=""15"" font=""7"">PHILIPPINES &#8211; TAXES ON DISTILLED SPIRITS </text></p><p><text top=""288"" left=""305"" width=""288"" height=""15"" font=""0"">Appellate Body Reports and Panel Reports </text>
</p><p><text top=""326"" left=""320"" width=""258"" height=""15"" font=""8"">Action by the Dispute Settlement Body </text></p><p><text top=""382"" left=""162"" width=""628"" height=""15"" font=""0"">At its meeting on 20 January 2012, the Dispute Settlement Body adopted the Appellate Body </text>
<text top=""401"" left=""108"" width=""684"" height=""15"" font=""0"">reports on <i>Philippines &#8211; Taxes on Distilled Spirits</i> (WT/DS396/AB/R, WT/DS403/AB/R) and the </text>
<text top=""420"" left=""108"" width=""682"" height=""15"" font=""0"">Panel reports (WT/DS396/R, WT/DS403/R), as modified by the Appellate Body reports.  The Panel </text>
<text top=""439"" left=""108"" width=""469"" height=""15"" font=""0"">reports should be read in conjunction with the Appellate Body reports. </text>
</p><p><text top=""518"" left=""223"" width=""451"" height=""15"" font=""7"">PHILIPPINES &#8211; TAXES SUR LES SPIRITUEUX DISTILL&#201;S </text></p><p><text top=""556"" left=""252"" width=""393"" height=""15"" font=""0"">Rapports de l'Organe d'appel et rapports du Groupe sp&#233;cial </text>
</p><p><text top=""594"" left=""246"" width=""406"" height=""15"" font=""8"">Dispositions prises par l'Organe de r&#232;glement des diff&#233;rends </text></p><p><text top=""651"" left=""162"" width=""628"" height=""15"" font=""0"">&#192; sa r&#233;union du 20 janvier 2012, l'Organe de r&#232;glement des diff&#233;rends a adopt&#233; les rapports </text>
<text top=""670"" left=""108"" width=""684"" height=""15"" font=""0"">de l'Organe d'appel sur l'affaire <i>Philippines &#8211; Taxes sur les spiritueux distill&#233;s</i> (WT/DS396/AB/R, </text>
<text top=""689"" left=""108"" width=""683"" height=""15"" font=""0"">WT/DS403/AB/R) et les rapports du Groupe sp&#233;cial (WT/DS396/R, WT/DS403/R) modifi&#233;s par les </text>
<text top=""708"" left=""108"" width=""682"" height=""15"" font=""0"">rapports de l'Organe d'appel.  Les rapports du Groupe sp&#233;cial sont &#224; lire conjointement avec ceux de </text>
<text top=""727"" left=""108"" width=""115"" height=""15"" font=""0"">l'Organe d'appel. </text>
</p><p><text top=""805"" left=""232"" width=""433"" height=""15"" font=""7"">FILIPINAS - IMPUESTOS SOBRE LOS AGUARDIENTES </text></p><p><text top=""843"" left=""229"" width=""438"" height=""15"" font=""0"">Informes del &#211;rgano de Apelaci&#243;n e informes del Grupo Especial </text>
</p><p><text top=""880"" left=""282"" width=""333"" height=""15"" font=""8"">Actuaci&#243;n del &#211;rgano de Soluci&#243;n de Diferencias </text></p><p><text top=""935"" left=""162"" width=""630"" height=""15"" font=""0"">En su reuni&#243;n de 20 de enero de 2012, el &#211;rgano de Soluci&#243;n de Diferencias adopt&#243; los </text>
<text top=""954"" left=""108"" width=""681"" height=""15"" font=""0"">informes del &#211;rgano de Apelaci&#243;n sobre <i>Filipinas - Impuestos sobre los aguardientes</i> </text>
<text top=""973"" left=""108"" width=""692"" height=""15"" font=""0"">(WT/DS396/AB/R, WT/DS403/AB/R) y los informes del Grupo Especial (WT/DS396/R, </text>
<text top=""992"" left=""108"" width=""684"" height=""15"" font=""0"">WT/DS403/R), modificados por los informes del &#211;rgano de Apelaci&#243;n.  Los informes del Grupo </text>
<text top=""1011"" left=""108"" width=""535"" height=""15"" font=""0"">Especial deben leerse conjuntamente con los informes del &#211;rgano de Apelaci&#243;n. </text>
</p><p><text top=""1049"" left=""405"" width=""87"" height=""15"" font=""7"">__________</text> </p></page>
</pdf2xml>",31932,12
133461,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""25"" size=""11"" family=""Times"" color=""#006284"" style=""i""/><fontspec id=""24"" size=""14"" family=""Times"" color=""#006284"" style=""b""/><fontspec id=""23"" size=""11"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""11"" family=""Times"" color=""#ff0000""/>
	<fontspec id=""2"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""11"" family=""Times"" color=""#ff0000""/>
	<fontspec id=""4"" size=""8"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""14"" family=""Times"" color=""#006284""/>
	<fontspec id=""6"" size=""11"" family=""Times"" color=""#006284""/>
	<fontspec id=""7"" size=""11"" family=""Times"" color=""#006284""/>
	<fontspec id=""8"" size=""11"" family=""Times"" color=""#000000""/>
<p><text top=""154"" left=""698"" width=""92"" height=""16"" font=""0"">24 July 2015 </text>
</p><p><text top=""186"" left=""108"" width=""70"" height=""16"" font=""3"">(15-3740)</text>
<text top=""186"" left=""710"" width=""80"" height=""16"" font=""0"">Page: 1/75 </text>
</p><p><text top=""217"" left=""673"" width=""117"" height=""16"" font=""0"">Original: English </text>
</p><p><text top=""291"" left=""185"" width=""572"" height=""20"" font=""24"">UNITED STATES &#8211; MEASURES AFFECTING THE IMPORTATION </text><text top=""311"" left=""206"" width=""487"" height=""20"" font=""24"">OF ANIMALS, MEAT AND OTHER ANIMAL PRODUCTS </text><text top=""331"" left=""361"" width=""176"" height=""20"" font=""24"">FROM ARGENTINA </text></p><p><text top=""369"" left=""368"" width=""162"" height=""16"" font=""6"">REPORT OF THE PANEL </text>
</p><p><text top=""412"" left=""410"" width=""78"" height=""16"" font=""25"">Addendum </text></p><p><text top=""456"" left=""108"" width=""685"" height=""16"" font=""0"">This  <i>addendum</i> contains Annexes A to C to the Report of the Panel to be found in document </text>
<text top=""472"" left=""108"" width=""98"" height=""16"" font=""0"">WT/DS447/R. </text>
</p><p><text top=""521"" left=""374"" width=""149"" height=""16"" font=""23"">_______________ </text></p></page>
<page number=""2"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""27"" size=""9"" family=""Times"" color=""#ffffff"" style=""b""/><fontspec id=""26"" size=""11"" family=""Times"" color=""#006284"" style=""b""/><fontspec id=""9"" size=""11"" family=""Times"" color=""#006284""/>
	<fontspec id=""10"" size=""9"" family=""Times"" color=""#ffffff""/>
	<fontspec id=""11"" size=""9"" family=""Times"" color=""#000000""/>
<p><text top=""87"" left=""431"" width=""35"" height=""16"" font=""0"">- 2 - </text>
</p><p><text top=""164"" left=""379"" width=""140"" height=""16"" font=""26"">LIST OF ANNEXES </text></p><p><text top=""196"" left=""412"" width=""73"" height=""16"" font=""26"">ANNEX A </text></p><p><text top=""231"" left=""311"" width=""275"" height=""16"" font=""6"">WORKING PROCEDURES OF THE PANEL </text>
</p><p><text top=""275"" left=""372"" width=""64"" height=""15"" font=""27"">Contents </text><text top=""275"" left=""732"" width=""37"" height=""15"" font=""27"">Page </text><footnote top=""290"" left=""108"" width=""67"" height=""15"" font=""11"" number=""1"" ref="""" dis=""""/>
</p><p><text top=""290"" left=""212"" width=""201"" height=""15"" font=""11"">Working Procedures of the Panel </text>
<footnote top=""290"" left=""738"" width=""25"" height=""15"" font=""11"" number=""2"" ref="""" dis=""""/>
<footnote top=""304"" left=""738"" width=""25"" height=""15"" font=""11"" number=""7"" ref="""" dis=""""/>
</p><p><text top=""370"" left=""413"" width=""72"" height=""16"" font=""26"">ANNEX B </text></p><p><text top=""404"" left=""344"" width=""209"" height=""16"" font=""6"">ARGUMENTS OF THE PARTIES </text>
</p><p><text top=""448"" left=""406"" width=""86"" height=""16"" font=""25"">ARGENTINA </text></p><p><text top=""492"" left=""372"" width=""64"" height=""15"" font=""27"">Contents </text><text top=""492"" left=""732"" width=""37"" height=""15"" font=""27"">Page </text></p><p><text top=""521"" left=""734"" width=""33"" height=""15"" font=""11"">B-14 </text>
</p><p><text top=""584"" left=""391"" width=""115"" height=""16"" font=""25"">UNITED STATES </text></p><p><text top=""628"" left=""372"" width=""64"" height=""15"" font=""27"">Contents </text><text top=""628"" left=""732"" width=""37"" height=""15"" font=""27"">Page </text><footnote top=""643"" left=""108"" width=""72"" height=""15"" font=""11"" number=""3"" ref="""" dis=""""><ftext top=""860"" left=""212"" width=""353"" height=""15"" font=""11"">Integrated executive summary of the arguments of China </ftext>
</footnote>
</p><p><text top=""643"" left=""212"" width=""493"" height=""15"" font=""11"">First part of the integrated executive summary of the arguments of the </text>
<text top=""657"" left=""212"" width=""86"" height=""15"" font=""11"">United States </text>
<text top=""643"" left=""734"" width=""33"" height=""15"" font=""11"">B-25 </text>
<footnote top=""672"" left=""108"" width=""67"" height=""15"" font=""11"" number=""4"" ref="""" dis=""""><ftext top=""875"" left=""212"" width=""438"" height=""15"" font=""11"">Integrated executive summary of the arguments of the European Union </ftext>
</footnote>
</p><p><text top=""672"" left=""212"" width=""491"" height=""15"" font=""11"">Second part of the integrated executive summary of the arguments of the </text>
<text top=""686"" left=""212"" width=""86"" height=""15"" font=""11"">United States </text>
<text top=""672"" left=""734"" width=""33"" height=""15"" font=""11"">B-37 </text>
</p><p><text top=""738"" left=""413"" width=""72"" height=""16"" font=""26"">ANNEX C </text></p><p><text top=""772"" left=""320"" width=""258"" height=""16"" font=""6"">ARGUMENTS OF THE THIRD PARTIES </text>
</p><p><text top=""816"" left=""372"" width=""64"" height=""15"" font=""27"">Contents </text><text top=""816"" left=""732"" width=""37"" height=""15"" font=""27"">Page </text></p><p><text top=""845"" left=""737"" width=""26"" height=""15"" font=""11"">C-6 </text>
<text top=""860"" left=""738"" width=""26"" height=""15"" font=""11"">C-9 </text>
<text top=""875"" left=""734"" width=""33"" height=""15"" font=""11"">C-13 </text>
</p></page>
<page number=""3"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""424"" width=""50"" height=""16"" font=""0"">- A-1 - </text>
</p><p><text top=""164"" left=""412"" width=""73"" height=""16"" font=""26"">ANNEX A </text></p><p><text top=""198"" left=""311"" width=""275"" height=""16"" font=""6"">WORKING PROCEDURES OF THE PANEL </text>
</p><p><text top=""242"" left=""372"" width=""64"" height=""15"" font=""27"">Contents </text><text top=""242"" left=""732"" width=""37"" height=""15"" font=""27"">Page </text></p><p><text top=""257"" left=""212"" width=""201"" height=""15"" font=""11"">Working Procedures of the Panel </text>
<text top=""271"" left=""212"" width=""460"" height=""15"" font=""11"">Additional Working Procedures on consultations with experts and the World </text>
<text top=""286"" left=""212"" width=""228"" height=""15"" font=""11"">Organisation for Animal Health (OIE) </text>
</p></page>
<page number=""4"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""28"" size=""7"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""12"" size=""7"" family=""Times"" color=""#006284""/>
	<fontspec id=""13"" size=""7"" family=""Times"" color=""#000000""/>
	<fontspec id=""14"" size=""5"" family=""Times"" color=""#000000""/>
<p><text top=""87"" left=""424"" width=""50"" height=""16"" font=""0"">- A-2 - </text>
</p><p><text top=""164"" left=""404"" width=""89"" height=""16"" font=""26"">ANNEX A-1 </text></p><p><text top=""198"" left=""308"" width=""270"" height=""16"" font=""6"">WORKING PROCEDURES OF THE PANEL</text>
<footnote top=""197"" left=""579"" width=""6"" height=""11"" font=""12"" number=""1"" ref="""" dis=""""><ftext top=""1082"" left=""155"" width=""635"" height=""15"" font=""11""> Depending on the Panel's decision on the need to consult experts, the Panel may, after consulting the </ftext>
<ftext top=""1096"" left=""108"" width=""683"" height=""15"" font=""11"">parties, supplement the above working procedures at a later stage in the dispute with provisions governing </ftext>
<ftext top=""1111"" left=""108"" width=""208"" height=""15"" font=""11"">expert selection and consultation. </ftext>
</footnote>
</p><p><text top=""241"" left=""303"" width=""281"" height=""16"" font=""23"">Adopted as modified on 23 May 2014</text><footnote top=""240"" left=""584"" width=""6"" height=""11"" font=""28"" number=""2"" ref="""" dis=""""/></p><p number=""1."" style=""6""><text top=""291"" left=""108"" width=""682"" height=""16"" font=""0"">1.  In its proceedings, the Panel shall follow the relevant provisions of the Understanding on Rules </text>
<text top=""307"" left=""108"" width=""684"" height=""16"" font=""0"">and Procedures Governing the Settlement of Disputes (DSU). In addition, the following Working </text>
<text top=""323"" left=""108"" width=""162"" height=""16"" font=""0"">Procedures shall apply. </text>
</p><p><text top=""358"" left=""108"" width=""63"" height=""16"" font=""23"">General </text></p><p number=""2."" style=""6""><text top=""391"" left=""108"" width=""684"" height=""16"" font=""0"">2.  The deliberations of the Panel and the documents submitted to it shall be kept confidential. </text>
<text top=""407"" left=""108"" width=""682"" height=""16"" font=""0"">Nothing in the DSU or in these Working Procedures shall preclude a party to the dispute (hereafter </text>
<text top=""423"" left=""108"" width=""685"" height=""16"" font=""0"">""party"") from disclosing statements of its own positions to the public. Members shall treat as </text>
<text top=""440"" left=""108"" width=""683"" height=""16"" font=""0"">confidential information submitted to the Panel by another Member which the submitting Member </text>
<text top=""456"" left=""108"" width=""687"" height=""16"" font=""0"">has designated as confidential. Where a party submits a confidential version of its written </text>
<text top=""473"" left=""108"" width=""685"" height=""16"" font=""0"">submissions to the Panel, it shall also, upon request of a Member, provide a non-confidential </text>
<text top=""489"" left=""108"" width=""689"" height=""16"" font=""0"">summary of the information contained in its submissions that could be disclosed to the public.  </text>
<text top=""506"" left=""108"" width=""682"" height=""16"" font=""0"">Non-confidential summaries shall be submitted no later than ten days after the written submission </text>
<text top=""522"" left=""108"" width=""683"" height=""16"" font=""0"">is presented to the Panel, unless a different deadline is granted by the Panel upon a showing of </text>
<text top=""538"" left=""108"" width=""86"" height=""16"" font=""0"">good cause. </text>
</p><p number=""3."" style=""6""><text top=""573"" left=""108"" width=""683"" height=""16"" font=""0"">3.  The Panel shall meet in closed session. The parties, and Members having notified their interest </text>
<text top=""589"" left=""108"" width=""683"" height=""16"" font=""0"">in the dispute to the Dispute Settlement Body in accordance with Article 10 of the DSU (hereafter </text>
<text top=""606"" left=""108"" width=""686"" height=""16"" font=""0"">""third parties""), shall be present at the meetings only when invited by the Panel to appear </text>
<text top=""622"" left=""108"" width=""71"" height=""16"" font=""0"">before it.  </text>
</p><p number=""4."" style=""6""><text top=""656"" left=""108"" width=""684"" height=""16"" font=""0"">4.  Each party and third party has the right to determine the composition of its own delegation </text>
<text top=""673"" left=""108"" width=""685"" height=""16"" font=""0"">when meeting with the Panel. Each party and third party shall have the responsibility for all </text>
<text top=""689"" left=""108"" width=""682"" height=""16"" font=""0"">members of its own delegation and shall ensure that  each  member  of  such  delegation  acts  in </text>
<text top=""706"" left=""108"" width=""689"" height=""16"" font=""0"">accordance with the DSU and these Working Procedures, particularly with regard to the </text>
<text top=""722"" left=""108"" width=""240"" height=""16"" font=""0"">confidentiality of the proceedings.  </text>
</p><p><text top=""756"" left=""108"" width=""100"" height=""16"" font=""23"">Submissions </text></p><p number=""5."" style=""6""><text top=""789"" left=""108"" width=""684"" height=""16"" font=""0"">5.  Before the first substantive meeting of the Panel with the parties, each party shall submit a </text>
<text top=""806"" left=""108"" width=""682"" height=""16"" font=""0"">written submission in which it presents the facts of the case and its arguments, in accordance with </text>
<text top=""822"" left=""108"" width=""682"" height=""16"" font=""0"">the timetable adopted by the Panel. Each party shall also submit to the Panel, prior to the second </text>
<text top=""838"" left=""108"" width=""683"" height=""16"" font=""0"">substantive meeting of the Panel, a written rebuttal, in accordance with the timetable adopted by </text>
<text top=""855"" left=""108"" width=""73"" height=""16"" font=""0"">the Panel. </text>
</p><p number=""6."" style=""6""><text top=""889"" left=""108"" width=""684"" height=""16"" font=""0"">6.  A party shall submit any request for a preliminary ruling at the earliest possible opportunity </text>
<text top=""906"" left=""108"" width=""684"" height=""16"" font=""0"">and in any event no later than in its first written submission to the Panel. If Argentina requests </text>
<text top=""922"" left=""108"" width=""686"" height=""16"" font=""0"">such a ruling, the United States shall submit its response to the request in its first written </text>
<text top=""938"" left=""108"" width=""683"" height=""16"" font=""0"">submission. If the United States requests such a ruling, Argentina shall submit its response to the </text>
<text top=""955"" left=""108"" width=""682"" height=""16"" font=""0"">request prior to the first substantive meeting of the Panel, at a time to be determined by the Panel </text>
<text top=""971"" left=""108"" width=""685"" height=""16"" font=""0"">in light of the request. Exceptions to this procedure shall be granted upon a showing of good </text>
<text top=""988"" left=""108"" width=""48"" height=""16"" font=""0"">cause. </text>
</p><p number=""7."" style=""6""><text top=""1022"" left=""108"" width=""687"" height=""16"" font=""0"">7.  Each party shall submit all factual evidence to the Panel no later than during the first </text>
<text top=""1039"" left=""108"" width=""683"" height=""16"" font=""0"">substantive meeting, except with respect to evidence necessary for purposes of rebuttal, answers </text>
<p><text top=""1126"" left=""155"" width=""628"" height=""15"" font=""11""> The Panel modified paragraph 23(d) of the Working Procedures of the Panel that had been adopted on </text>
<text top=""1140"" left=""108"" width=""105"" height=""15"" font=""11"">30 August 2013. </text>
</p><p><text top=""87"" left=""424"" width=""50"" height=""16"" font=""0"">- A-3 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">to questions or comments on answers provided by the other party. Exceptions to this procedure </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">shall be granted upon a showing of good cause. Where such exception has been granted, the Panel </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">shall accord the other party a period of time for comment, as appropriate, on any new factual </text>
<text top=""177"" left=""108"" width=""385"" height=""16"" font=""0"">evidence submitted after the first substantive meeting.  </text>
</p></p></page>
<page number=""5"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""8."" style=""6""><text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">8.  In order to facilitate the work of the Panel, each party and third party is invited to make its </text>
<text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">submissions in accordance with the annexed WTO Editorial Guide for Panel Submissions, to the </text>
<text top=""244"" left=""108"" width=""241"" height=""16"" font=""0"">extent that it is practical to do so.  </text>
</p><p number=""9."" style=""6""><text top=""278"" left=""108"" width=""687"" height=""16"" font=""0"">9.  To facilitate the maintenance of the record of the dispute and maximize the clarity of </text>
<text top=""295"" left=""108"" width=""685"" height=""16"" font=""0"">submissions, each party and third party shall sequentially number its exhibits throughout the </text>
<text top=""311"" left=""108"" width=""684"" height=""16"" font=""0"">course of the dispute. For example, exhibits submitted by Argentina could be numbered ARG-1, </text>
<text top=""328"" left=""108"" width=""684"" height=""16"" font=""0"">ARG-2, etc. If the last exhibit in connection with the first submission was numbered ARG-5, the </text>
<text top=""344"" left=""108"" width=""468"" height=""16"" font=""0"">first exhibit of the next submission thus would be numbered ARG-6. </text>
</p><p><text top=""378"" left=""108"" width=""80"" height=""16"" font=""23"">Questions </text></p><p number=""10."" style=""6""><text top=""411"" left=""108"" width=""682"" height=""16"" font=""0"">10.  The Panel may at any time pose questions to the parties and third parties, orally in the course </text>
<text top=""428"" left=""108"" width=""496"" height=""16"" font=""0"">of a meeting or in writing, including prior to each substantive meeting.   </text>
</p><p><text top=""462"" left=""108"" width=""174"" height=""16"" font=""23"">Substantive meetings  </text></p><p number=""11."" style=""6""><text top=""495"" left=""108"" width=""683"" height=""16"" font=""0"">11.  Each party shall provide to the Panel the list of members of its delegation in advance of each </text>
<text top=""511"" left=""108"" width=""645"" height=""16"" font=""0"">meeting with the Panel and no later than 5.00 p.m. (Geneva time) the previous working day.  </text>
</p><p number=""12."" style=""6""><text top=""546"" left=""108"" width=""641"" height=""16"" font=""0"">12.  The first substantive meeting of the Panel with the parties shall be conducted as follows: </text>
</p><p number=""a."" style=""2""><text top=""580"" left=""151"" width=""640"" height=""16"" font=""0"">a.  The Panel shall invite Argentina to make an opening statement to present its case first. </text>
<text top=""597"" left=""176"" width=""614"" height=""16"" font=""0"">Subsequently, the Panel shall invite the United States to present its point of view. Before </text>
<text top=""613"" left=""176"" width=""618"" height=""16"" font=""0"">each party takes the floor, it shall provide the Panel and other participants at the </text>
<text top=""629"" left=""176"" width=""621"" height=""16"" font=""0"">meeting with a provisional written version of its statement. In the event that </text>
<text top=""646"" left=""176"" width=""615"" height=""16"" font=""0"">interpretation is needed, each party shall provide additional copies for the interpreters, </text>
<text top=""662"" left=""176"" width=""614"" height=""16"" font=""0"">through the Panel Secretary. Each party shall make available to the Panel and the other </text>
<text top=""679"" left=""176"" width=""614"" height=""16"" font=""0"">party the final version of its statement, preferably at the end of the meeting, and in any </text>
<text top=""695"" left=""176"" width=""617"" height=""16"" font=""0"">event no later than 5.00 p.m. (Geneva time) on the first working day following the </text>
<text top=""711"" left=""176"" width=""65"" height=""16"" font=""0"">meeting. </text>
</p><p number=""b."" style=""2""><text top=""746"" left=""151"" width=""640"" height=""16"" font=""0"">b.  After the conclusion of the statements, the Panel shall give each party the opportunity to </text>
<text top=""762"" left=""176"" width=""615"" height=""16"" font=""0"">ask each other questions or make comments, through the Panel. Each party shall then </text>
<text top=""779"" left=""176"" width=""372"" height=""16"" font=""0"">have an opportunity to answer these questions orally. </text>
</p><p number=""c."" style=""2""><text top=""813"" left=""151"" width=""640"" height=""16"" font=""0"">c.  The Panel may subsequently pose questions to the parties. Each party shall then have an </text>
<text top=""829"" left=""176"" width=""318"" height=""16"" font=""0"">opportunity to answer these questions orally.  </text>
</p><p number=""d."" style=""2""><text top=""864"" left=""151"" width=""640"" height=""16"" font=""0"">d.  Once the questioning has concluded, the Panel shall afford each party an opportunity to </text>
<text top=""880"" left=""176"" width=""545"" height=""16"" font=""0"">present a brief closing statement, with Argentina presenting its statement first. </text>
</p><p number=""e."" style=""2""><text top=""915"" left=""151"" width=""644"" height=""16"" font=""0"">e.  Following the meeting, the Panel shall send in writing, within a timeframe to be </text>
<text top=""931"" left=""176"" width=""614"" height=""16"" font=""0"">determined by it, any questions to the parties to which it wishes to receive a response in </text>
<text top=""947"" left=""176"" width=""617"" height=""16"" font=""0"">writing. Each party shall be invited to respond in writing to such questions within a </text>
<text top=""964"" left=""176"" width=""617"" height=""16"" font=""0"">deadline to be determined by the Panel.  Likewise, each party shall send in writing, </text>
<text top=""980"" left=""176"" width=""615"" height=""16"" font=""0"">within a timeframe to be determined by the Panel, any questions to the other party to </text>
<text top=""997"" left=""176"" width=""614"" height=""16"" font=""0"">which it wishes to receive a response in writing. Each party shall be invited to respond in </text>
<text top=""1013"" left=""176"" width=""615"" height=""16"" font=""0"">writing to the other party's written questions within a deadline to be determined by the </text>
<text top=""1030"" left=""176"" width=""51"" height=""16"" font=""0"">Panel.  </text>
</p><p number=""13."" style=""6""><text top=""1064"" left=""108"" width=""662"" height=""16"" font=""0"">13.  The second substantive meeting of the Panel with the parties shall be conducted as follows: </text>
</p><p number=""a."" style=""2""><text top=""1098"" left=""151"" width=""640"" height=""16"" font=""0"">a.  The Panel shall ask the United States if it wishes to avail itself of the right to present its </text>
<text top=""1115"" left=""176"" width=""614"" height=""16"" font=""0"">case first. If so, the Panel shall invite the United States to present its opening statement, </text>
<text top=""1131"" left=""176"" width=""615"" height=""16"" font=""0"">followed by Argentina. If the United States chooses not to avail itself of that right, the </text>
<p><text top=""87"" left=""424"" width=""50"" height=""16"" font=""0"">- A-4 - </text>
</p><p><text top=""128"" left=""176"" width=""617"" height=""16"" font=""0"">Panel shall invite Argentina to present its opening statement first. Before each party </text>
<text top=""144"" left=""176"" width=""616"" height=""16"" font=""0"">takes the floor, it shall provide the Panel and other participants at the meeting with a </text>
<text top=""160"" left=""176"" width=""615"" height=""16"" font=""0"">provisional written version of its statement. In the event that interpretation is needed, </text>
<text top=""177"" left=""176"" width=""620"" height=""16"" font=""0"">each party shall provide additional copies for the interpreters, through the Panel </text>
<text top=""193"" left=""176"" width=""616"" height=""16"" font=""0"">Secretary. Each party shall make available to the Panel and the other party the final </text>
<text top=""210"" left=""176"" width=""614"" height=""16"" font=""0"">version of its statement, preferably at the end of the meeting, and in any event no later </text>
<text top=""226"" left=""176"" width=""530"" height=""16"" font=""0"">than 5.00 p.m. (Geneva time) of the first working day following the meeting. </text>
</p></p></page>
<page number=""6"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""b."" style=""2""><text top=""260"" left=""151"" width=""640"" height=""16"" font=""0"">b.  After the conclusion of the statements, the Panel shall give each party the opportunity to </text>
<text top=""277"" left=""176"" width=""615"" height=""16"" font=""0"">ask each other questions or make comments, through the Panel. Each party shall then </text>
<text top=""293"" left=""176"" width=""372"" height=""16"" font=""0"">have an opportunity to answer these questions orally. </text>
</p><p number=""c."" style=""2""><text top=""328"" left=""151"" width=""640"" height=""16"" font=""0"">c.  The Panel may subsequently pose questions to the parties. Each party shall then have an </text>
<text top=""344"" left=""176"" width=""313"" height=""16"" font=""0"">opportunity to answer these questions orally. </text>
</p><p number=""d."" style=""2""><text top=""378"" left=""151"" width=""640"" height=""16"" font=""0"">d.  Once the questioning has concluded, the Panel shall afford each party an opportunity to </text>
<text top=""395"" left=""176"" width=""616"" height=""16"" font=""0"">present a brief closing statement, with the party that presented its opening statement </text>
<text top=""411"" left=""176"" width=""300"" height=""16"" font=""0"">first, presenting its closing statement first.  </text>
</p><p number=""e."" style=""2""><text top=""446"" left=""151"" width=""644"" height=""16"" font=""0"">e.  Following the meeting, the Panel shall send in writing, within a timeframe to be </text>
<text top=""462"" left=""176"" width=""614"" height=""16"" font=""0"">determined by it, any questions to the parties to which it wishes to receive a response in </text>
<text top=""479"" left=""176"" width=""617"" height=""16"" font=""0"">writing. Each party shall be invited to respond in writing to such questions within a </text>
<text top=""495"" left=""176"" width=""617"" height=""16"" font=""0"">deadline to be determined by the Panel.  Likewise, each party shall send in writing, </text>
<text top=""511"" left=""176"" width=""615"" height=""16"" font=""0"">within a timeframe to be determined by the Panel, any questions to the other party to </text>
<text top=""528"" left=""176"" width=""614"" height=""16"" font=""0"">which it wishes to receive a response in writing. Each party shall be invited to respond in </text>
<text top=""544"" left=""176"" width=""615"" height=""16"" font=""0"">writing to the other party's written questions within a deadline to be determined by the </text>
<text top=""561"" left=""176"" width=""46"" height=""16"" font=""0"">Panel. </text>
</p><p><text top=""595"" left=""108"" width=""102"" height=""16"" font=""23"">Third parties </text></p><p number=""14."" style=""6""><text top=""628"" left=""108"" width=""683"" height=""16"" font=""0"">14.  The Panel shall invite each third party to transmit to the Panel a written submission prior to </text>
<text top=""644"" left=""108"" width=""686"" height=""16"" font=""0"">the first substantive meeting of the Panel with the parties, in accordance with the timetable </text>
<text top=""661"" left=""108"" width=""158"" height=""16"" font=""0"">adopted by the Panel.  </text>
</p><p number=""15."" style=""6""><text top=""695"" left=""108"" width=""683"" height=""16"" font=""0"">15.  Each third party shall also be invited to present its views orally during a session of this first </text>
<text top=""711"" left=""108"" width=""682"" height=""16"" font=""0"">substantive meeting, set aside for that purpose. Each third party shall provide to the Panel the list </text>
<text top=""728"" left=""108"" width=""682"" height=""16"" font=""0"">of members of its delegation in advance of this session and no later than 5.00 p.m. (Geneva time) </text>
<text top=""744"" left=""108"" width=""187"" height=""16"" font=""0"">the previous working day.  </text>
</p><p number=""16."" style=""6""><text top=""779"" left=""108"" width=""403"" height=""16"" font=""0"">16.  The third-party session shall be conducted as follows: </text>
</p><p number=""a."" style=""2""><text top=""813"" left=""151"" width=""489"" height=""16"" font=""0"">a.  All third parties may be present during the entirety of this session.  </text>
</p><p number=""b."" style=""2""><text top=""847"" left=""151"" width=""640"" height=""16"" font=""0"">b.  The Panel shall first hear the arguments of the third parties in alphabetical order. Third </text>
<text top=""864"" left=""176"" width=""615"" height=""16"" font=""0"">parties present at the third-party session and intending to present their views orally at </text>
<text top=""880"" left=""176"" width=""615"" height=""16"" font=""0"">that session, shall provide the Panel, the parties and other third parties with provisional </text>
<text top=""897"" left=""176"" width=""615"" height=""16"" font=""0"">written versions of their statements before they take the floor. Third parties shall make </text>
<text top=""913"" left=""176"" width=""617"" height=""16"" font=""0"">available to the Panel, the parties and other third parties the final versions of their </text>
<text top=""929"" left=""176"" width=""618"" height=""16"" font=""0"">statements, preferably at the end of the session, and in any event no later than </text>
<text top=""946"" left=""176"" width=""494"" height=""16"" font=""0"">5.00 p.m. (Geneva time) of the first working day following the session.  </text>
</p><p number=""c."" style=""2""><text top=""980"" left=""151"" width=""644"" height=""16"" font=""0"">c.  After the third parties have made their statements, the parties may be given the </text>
<text top=""997"" left=""176"" width=""615"" height=""16"" font=""0"">opportunity, through the Panel, to ask the third parties questions for clarification on any </text>
<text top=""1013"" left=""176"" width=""427"" height=""16"" font=""0"">matter raised in the third parties' submissions or statements.  </text>
</p><p number=""d."" style=""2""><text top=""1048"" left=""151"" width=""641"" height=""16"" font=""0"">d.  The Panel may subsequently pose questions to the third parties. Each third party shall </text>
<text top=""1064"" left=""176"" width=""412"" height=""16"" font=""0"">then have an opportunity to answer these questions orally.  </text>
</p><p number=""e."" style=""2""><text top=""1098"" left=""151"" width=""641"" height=""16"" font=""0"">e.  Following the third party session, the Panel shall send in writing, within a timeframe to </text>
<text top=""1115"" left=""176"" width=""616"" height=""16"" font=""0"">be determined by it, any questions to the third parties to which it wishes to receive a </text>
<text top=""1131"" left=""176"" width=""618"" height=""16"" font=""0"">response in writing. Each third party shall be invited to respond in writing to such </text>
<p><text top=""87"" left=""424"" width=""50"" height=""16"" font=""0"">- A-5 - </text>
</p><p><text top=""128"" left=""176"" width=""616"" height=""16"" font=""0"">questions within a deadline to be determined by the Panel.  Likewise, each party shall </text>
<text top=""144"" left=""176"" width=""616"" height=""16"" font=""0"">send in writing, within a timeframe to be determined by the Panel, any questions to a </text>
<text top=""160"" left=""176"" width=""615"" height=""16"" font=""0"">third party to which it wishes to receive a response in writing. Each third party shall be </text>
<text top=""177"" left=""176"" width=""616"" height=""16"" font=""0"">invited to respond in writing to these questions within a deadline to be determined by </text>
<text top=""193"" left=""176"" width=""73"" height=""16"" font=""0"">the Panel. </text>
</p></p></page>
<page number=""7"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""228"" left=""108"" width=""126"" height=""16"" font=""23"">Descriptive part </text></p><p number=""17."" style=""6""><text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">17.  The description of the arguments of the parties and third parties in the descriptive part of the </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">Panel report shall consist of executive summaries provided by the parties and third parties, which </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">shall be annexed as addenda to the report. These executive summaries shall not in any way serve </text>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">as a substitute for the submissions of the parties and third parties in the Panel's examination of </text>
<text top=""326"" left=""108"" width=""67"" height=""16"" font=""0"">the case. </text>
</p><p number=""18."" style=""6""><text top=""360"" left=""108"" width=""682"" height=""16"" font=""0"">18.  Each party shall submit an integrated executive summary of its arguments as presented in its </text>
<text top=""377"" left=""108"" width=""685"" height=""16"" font=""0"">written submissions, statements and responses and comments to questions in two parts.  The </text>
<text top=""393"" left=""108"" width=""687"" height=""16"" font=""0"">parties shall submit the first part of the integrated executive summary following the first </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">substantive meeting at the latest on the date provided for in the timetable.  The parties shall </text>
<text top=""426"" left=""108"" width=""682"" height=""16"" font=""0"">submit the second part of the integrated executive summary at the latest on the date provided for </text>
<text top=""443"" left=""108"" width=""685"" height=""16"" font=""0"">in the timetable. The total number of pages of the integrated executive summary, both parts </text>
<text top=""459"" left=""108"" width=""685"" height=""16"" font=""0"">combined, shall not exceed 30 pages.  Within those limits, parties are free to determine the </text>
<text top=""475"" left=""108"" width=""450"" height=""16"" font=""0"">structure of the two parts of their integrated executive summary. </text>
</p><p number=""19."" style=""6""><text top=""510"" left=""108"" width=""685"" height=""16"" font=""0"">19.  Each third party shall submit an executive summary of its arguments as presented in its </text>
<text top=""526"" left=""108"" width=""684"" height=""16"" font=""0"">written submission and statement in accordance with the timetable adopted by the Panel. This </text>
<text top=""543"" left=""108"" width=""683"" height=""16"" font=""0"">summary may also include a summary of responses to questions, where relevant. The executive </text>
<text top=""559"" left=""108"" width=""484"" height=""16"" font=""0"">summary to be provided by each third party shall not exceed 6 pages. </text>
</p><p><text top=""593"" left=""108"" width=""118"" height=""16"" font=""23"">Interim review </text></p><p number=""20."" style=""6""><text top=""626"" left=""108"" width=""684"" height=""16"" font=""0"">20.  Following issuance of the interim report, each party may submit a written request to review </text>
<text top=""643"" left=""108"" width=""683"" height=""16"" font=""0"">precise aspects of the interim report and request a further meeting with the Panel, in accordance </text>
<text top=""659"" left=""108"" width=""282"" height=""16"" font=""0"">with the timetable adopted by the Panel. </text>
</p><p number=""21."" style=""6""><text top=""693"" left=""108"" width=""685"" height=""16"" font=""0"">21.  In the event that no further meeting with the Panel is requested, each party may submit </text>
<text top=""710"" left=""108"" width=""686"" height=""16"" font=""0"">written comments on precise aspects of the interim report, in accordance with the timetable </text>
<text top=""726"" left=""108"" width=""685"" height=""16"" font=""0"">adopted by the Panel.  Subsequently, each party may submit written comments on the other </text>
<text top=""743"" left=""108"" width=""286"" height=""16"" font=""0"">party's written interim review comments. </text>
</p><p number=""22."" style=""6""><text top=""777"" left=""108"" width=""685"" height=""16"" font=""0"">22.  The interim report, as well as the final report prior to its official circulation, shall be kept </text>
<text top=""793"" left=""108"" width=""318"" height=""16"" font=""0"">strictly confidential and shall not be disclosed. </text>
</p><p><text top=""828"" left=""108"" width=""168"" height=""16"" font=""23"">Service of documents </text></p><p number=""23."" style=""6""><text top=""861"" left=""108"" width=""508"" height=""16"" font=""0"">23.  The following procedures regarding service of documents shall apply: </text>
</p><p number=""a."" style=""2""><text top=""895"" left=""151"" width=""641"" height=""16"" font=""0"">a.  Each party and third party shall submit all documents to the Panel by filing them with </text>
<text top=""911"" left=""176"" width=""242"" height=""16"" font=""0"">the DS Registry (office No. 2047).  </text>
</p><p number=""b."" style=""2""><text top=""946"" left=""151"" width=""641"" height=""16"" font=""0"">b.  Each party and third party shall file 5 paper copies of all documents it submits to the </text>
<text top=""962"" left=""176"" width=""615"" height=""16"" font=""0"">Panel. However, when exhibits are provided on CD-ROMS/DVDs, 4 CD-ROMS/DVDs and </text>
<text top=""979"" left=""176"" width=""619"" height=""16"" font=""0"">4 paper copies of those exhibits shall be filed. The DS Registrar shall stamp the </text>
<text top=""995"" left=""176"" width=""616"" height=""16"" font=""0"">documents with the date and time of the filing. The paper version shall constitute the </text>
<text top=""1012"" left=""176"" width=""415"" height=""16"" font=""0"">official version for the purposes of the record of the dispute. </text>
</p><p number=""c."" style=""2""><text top=""1046"" left=""151"" width=""643"" height=""16"" font=""0"">c.  Each party and third party shall also provide an electronic copy of all documents it </text>
<text top=""1062"" left=""176"" width=""616"" height=""16"" font=""0"">submits to the Panel at the same time as the paper versions, preferably in Microsoft </text>
<text top=""1079"" left=""176"" width=""615"" height=""16"" font=""0"">Word format, either on a CD-ROM, a DVD or as an e-mail attachment. If the electronic </text>
<text top=""1095"" left=""176"" width=""616"" height=""16"" font=""0"">copy is provided by e-mail, it should be addressed to *****@wto.org, with a copy to </text>
<text top=""1112"" left=""176"" width=""672"" height=""16"" font=""0"">*****.*****@wto.org, *****.*****@wto.org, *****.*****@wto.org, </text>
<p><text top=""87"" left=""424"" width=""50"" height=""16"" font=""0"">- A-6 - </text>
</p><p><text top=""128"" left=""176"" width=""615"" height=""16"" font=""0"">*****.*****@wto.org, and *****.*****@wto.org. If a CD-ROM or DVD is provided, it </text>
<text top=""144"" left=""176"" width=""245"" height=""16"" font=""0"">shall be filed with the DS Registry.  </text>
</p></p></page>
<page number=""8"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""d."" style=""2""><text top=""178"" left=""151"" width=""640"" height=""16"" font=""0"">d.  Each party shall serve any document submitted to the Panel directly on the other party. </text>
<text top=""195"" left=""176"" width=""615"" height=""16"" font=""0"">However, in the case of submissions that must be filed contemporaneously, each party </text>
<text top=""211"" left=""176"" width=""617"" height=""16"" font=""0"">shall file the documents for the other party only with the DS Registrar, in the same </text>
<text top=""228"" left=""176"" width=""615"" height=""16"" font=""0"">manner as set forth in paragraph 23(b). The DS Registrar will serve the documents on </text>
<text top=""244"" left=""176"" width=""616"" height=""16"" font=""0"">the other party only after having received the submissions of both parties. Each party </text>
<text top=""260"" left=""176"" width=""614"" height=""16"" font=""0"">shall, in addition, serve on all third parties its written submissions in advance of the first </text>
<text top=""277"" left=""176"" width=""620"" height=""16"" font=""0"">substantive meeting with the Panel. Each third party shall serve any document </text>
<text top=""293"" left=""176"" width=""615"" height=""16"" font=""0"">submitted to the Panel directly on the parties and all other third parties. Each party and </text>
<text top=""310"" left=""176"" width=""614"" height=""16"" font=""0"">third party shall confirm, in writing, that copies have been served as required at the time </text>
<text top=""326"" left=""176"" width=""276"" height=""16"" font=""0"">it provides each document to the Panel. </text>
</p><p number=""e."" style=""2""><text top=""360"" left=""151"" width=""640"" height=""16"" font=""0"">e.  Each party and third party shall file its documents with the DS Registry and serve copies </text>
<text top=""377"" left=""176"" width=""615"" height=""16"" font=""0"">on the other party (and third parties where appropriate) by 5.00 p.m. (Geneva time) on </text>
<text top=""393"" left=""176"" width=""614"" height=""16"" font=""0"">the due dates established by the Panel. A party or third party may submit its documents </text>
<text top=""410"" left=""176"" width=""614"" height=""16"" font=""0"">to another party or third party in electronic format only, subject to the recipient party or </text>
<text top=""426"" left=""176"" width=""615"" height=""16"" font=""0"">third party's prior written approval and provided that the Panel Secretary is notified. As </text>
<text top=""443"" left=""176"" width=""622"" height=""16"" font=""0"">noted in paragraph 23(d), if the submissions of both parties are to be filed </text>
<text top=""459"" left=""176"" width=""618"" height=""16"" font=""0"">contemporaneously, each party shall serve the copies only on the DS Registrar by </text>
<text top=""475"" left=""176"" width=""616"" height=""16"" font=""0"">5:00 p.m. (Geneva time) and the DS Registrar will serve the documents on the other </text>
<text top=""492"" left=""176"" width=""412"" height=""16"" font=""0"">party after having received the submissions of both parties. </text>
</p><p number=""f."" style=""2""><text top=""526"" left=""151"" width=""640"" height=""16"" font=""0"">f.  The Panel shall provide the parties with an electronic version of the descriptive part, the </text>
<text top=""543"" left=""176"" width=""615"" height=""16"" font=""0"">interim report and the final report, as well as of other documents as appropriate. When </text>
<text top=""559"" left=""176"" width=""614"" height=""16"" font=""0"">the Panel transmits to the parties or third parties both paper and electronic versions of a </text>
<text top=""575"" left=""176"" width=""615"" height=""16"" font=""0"">document, the paper version shall constitute the official version for the purposes of the </text>
<text top=""592"" left=""176"" width=""152"" height=""16"" font=""0"">record of the dispute. </text>
<p><text top=""87"" left=""424"" width=""50"" height=""16"" font=""0"">- A-7 - </text>
</p></p></page>
<page number=""9"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""164"" left=""404"" width=""89"" height=""16"" font=""26"">ANNEX A-2 </text></p><p><text top=""198"" left=""188"" width=""521"" height=""16"" font=""6"">ADDITIONAL WORKING PROCEDURES ON CONSULTATIONS WITH EXPERTS </text>
<text top=""214"" left=""236"" width=""427"" height=""16"" font=""6"">AND THE WORLD ORGANISATION FOR ANIMAL HEALTH (OIE) </text>
</p><p><text top=""258"" left=""349"" width=""199"" height=""16"" font=""23"">Adopted on 4 March 2014 </text></p><p><text top=""307"" left=""108"" width=""683"" height=""16"" font=""0"">Should the Panel determine that there is a need to seek expert advice, the following procedures </text>
<text top=""323"" left=""108"" width=""83"" height=""16"" font=""0"">shall apply: </text>
</p><p number=""1."" style=""6""><text top=""356"" left=""108"" width=""684"" height=""16"" font=""0"">1.  Consistent with Article 13 of the DSU and Article 11.2 of the SPS Agreement, the Panel may </text>
<text top=""373"" left=""108"" width=""589"" height=""16"" font=""0"">seek expert advice from experts and from international organizations, as appropriate. </text>
</p><p number=""2."" style=""6""><text top=""405"" left=""108"" width=""682"" height=""16"" font=""0"">2.  The Panel may ask the Secretariat of the World Organization for Animal Health (OIE) as well as </text>
<text top=""422"" left=""108"" width=""684"" height=""16"" font=""0"">the parties for suggestions of possible experts. Parties shall not engage in direct contacts with </text>
<text top=""438"" left=""108"" width=""504"" height=""16"" font=""0"">individuals suggested with respect to the matters at issue in this dispute. </text>
</p><p number=""3."" style=""6""><text top=""471"" left=""108"" width=""682"" height=""16"" font=""0"">3.  The Panel will provide the parties with a list of the names of possible experts, their <i>curricula </i></text>
<text top=""488"" left=""108"" width=""390"" height=""16"" font=""8""><i>vitae, </i>and declarations of potential conflicts of interest.   </text>
</p><p number=""4."" style=""6""><text top=""520"" left=""108"" width=""683"" height=""16"" font=""0"">4.  Parties will have an opportunity to present their comments and to make known any compelling </text>
<text top=""537"" left=""108"" width=""492"" height=""16"" font=""0"">objections to any particular expert at the time designated by the Panel. </text>
</p><p number=""5."" style=""6""><text top=""570"" left=""108"" width=""682"" height=""16"" font=""0"">5.  The Panel will select the experts on the basis of their qualifications and the need for specialized </text>
<text top=""586"" left=""108"" width=""684"" height=""16"" font=""0"">scientific expertise, and shall not select experts that the Panel has determined have a relevant </text>
<text top=""602"" left=""108"" width=""682"" height=""16"" font=""0"">conflict of interest. The Panel will decide the number of experts in light of the number and type of </text>
<text top=""619"" left=""108"" width=""682"" height=""16"" font=""0"">issues on which advice will be sought, as well as of the different areas on which each expert can </text>
<text top=""635"" left=""108"" width=""127"" height=""16"" font=""0"">provide expertise. </text>
</p><p number=""6."" style=""6""><text top=""668"" left=""108"" width=""683"" height=""16"" font=""0"">6.  The Panel will inform the parties of the experts it has selected. Individual experts shall act in </text>
<text top=""684"" left=""108"" width=""684"" height=""16"" font=""0"">their personal capacities and not as representatives of any entity. They shall be subject to the </text>
<text top=""701"" left=""108"" width=""683"" height=""16"" font=""0"">DSB's <i>Rules of Conduct for the Understanding on Rules and Procedures Governing the Settlement </i></text>
<text top=""717"" left=""108"" width=""662"" height=""16"" font=""8""><i>of Disputes</i> (WT/DSB/RC/1), an electronic copy of which will be provided to them by the Panel.   </text>
</p><p number=""7."" style=""6""><text top=""750"" left=""108"" width=""686"" height=""16"" font=""0"">7.  The Panel may also seek information from the OIE with regard to its relevant standards, </text>
<text top=""766"" left=""108"" width=""683"" height=""16"" font=""0"">guidelines, recommendations and procedures. The OIE will be asked to confirm, in writing to the </text>
<text top=""783"" left=""108"" width=""683"" height=""16"" font=""0"">WTO, that its officials, in assisting the Panel, will abide both by its own staff rules of conduct and </text>
<text top=""799"" left=""108"" width=""683"" height=""16"" font=""0"">by the WTO Rules of Conduct. The WTO will provide a copy of the WTO Rules of Conduct to the </text>
<text top=""816"" left=""108"" width=""517"" height=""16"" font=""0"">OIE and ask it to provide the Panel with a copy of its staff rules of conduct. </text>
</p><p number=""8."" style=""6""><text top=""848"" left=""108"" width=""682"" height=""16"" font=""0"">8.  The Panel will prepare written questions for the experts and relevant organizations. Parties will </text>
<text top=""865"" left=""108"" width=""683"" height=""16"" font=""0"">have the opportunity to provide suggested questions to the Panel before the Panel decides on the </text>
<text top=""881"" left=""108"" width=""683"" height=""16"" font=""0"">final questions to be sent to the experts and the OIE. The Panel may provide the experts and the </text>
<text top=""898"" left=""108"" width=""683"" height=""16"" font=""0"">OIE, on a confidential basis, with relevant parts of the parties' submissions, including exhibits, as </text>
<text top=""914"" left=""108"" width=""683"" height=""16"" font=""0"">well as with any additional information deemed necessary. The experts and the OIE will have the </text>
<text top=""931"" left=""108"" width=""683"" height=""16"" font=""0"">opportunity to request, through the Panel, additional factual information or clarifications from the </text>
<text top=""947"" left=""108"" width=""437"" height=""16"" font=""0"">parties, if it will assist them in answering the Panel&#8217;s questions. </text>
</p><p number=""9."" style=""6""><text top=""980"" left=""108"" width=""685"" height=""16"" font=""0"">9.  Experts and the OIE will be requested to provide responses in writing within a time-period </text>
<text top=""996"" left=""108"" width=""684"" height=""16"" font=""0"">specified by the Panel. Experts and the OIE will be requested only to respond to questions on </text>
<text top=""1013"" left=""108"" width=""682"" height=""16"" font=""0"">which they have sufficient knowledge. Copies of the responses will be provided by the Panel to the </text>
<text top=""1029"" left=""108"" width=""684"" height=""16"" font=""0"">parties. The parties will have the opportunity to comment in writing on the responses from the </text>
<text top=""1045"" left=""108"" width=""683"" height=""16"" font=""0"">experts and the OIE. The Panel will provide the parties with a compilation of the experts' and the </text>
<text top=""1062"" left=""108"" width=""229"" height=""16"" font=""0"">OIE's answers for use in citation. </text>
</p><p number=""10."" style=""6""><text top=""1095"" left=""108"" width=""687"" height=""16"" font=""0"">10.  The Panel may schedule a meeting with the experts and the OIE, prior to the second </text>
<text top=""1111"" left=""108"" width=""685"" height=""16"" font=""0"">substantive meeting with the parties. Prior to this meeting, the Panel will ensure that: (i) the </text>
<text top=""1127"" left=""108"" width=""690"" height=""16"" font=""0"">parties' comments on the experts' responses are provided to the experts and relevant </text>
<p><text top=""87"" left=""424"" width=""50"" height=""16"" font=""0"">- A-8 - </text>
</p><p><text top=""128"" left=""108"" width=""689"" height=""16"" font=""0"">organizations; (ii) the experts are individually provided with the other experts' and the </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">organizations' responses to the Panel's questions; (iii) if they desire the parties may prepare </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">""advance"" questions to be communicated to the experts and relevant organizations through the </text>
<text top=""177"" left=""108"" width=""358"" height=""16"" font=""0"">Panel to assist them in preparation for the meeting. </text>
</p></p></page>
<page number=""10"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""11."" style=""6""><text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">11.  During the meeting, the Panel will pose questions to the experts and the OIE. The Panel will </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">then invite the parties to pose questions to the experts and the OIE including, but not limited to, </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">the ""advance"" questions sent by the parties. The Panel may schedule additional meetings with the </text>
<text top=""259"" left=""108"" width=""350"" height=""16"" font=""0"">experts and the OIE if necessary and appropriate.  </text>
</p><p number=""12."" style=""6""><text top=""292"" left=""108"" width=""685"" height=""16"" font=""0"">12.  The Secretariat will prepare a compilation of the experts' and the OIE's written replies to </text>
<text top=""308"" left=""108"" width=""683"" height=""16"" font=""0"">questions, as well as a transcript of any meeting with the experts and the OIE for inclusion in the </text>
<text top=""324"" left=""108"" width=""682"" height=""16"" font=""0"">record of the Panel proceeding. The experts and the OIE will be given an opportunity to verify the </text>
<text top=""341"" left=""108"" width=""683"" height=""16"" font=""0"">drafts of these texts to ensure that they actually reflect the information they provided before the </text>
<text top=""357"" left=""108"" width=""683"" height=""16"" font=""0"">texts are finalized. The parties will likewise be given an opportunity to verify that the transcript of </text>
<text top=""374"" left=""108"" width=""686"" height=""16"" font=""0"">any meeting with the experts and relevant organizations accurately reflects the parties' own </text>
<text top=""390"" left=""108"" width=""103"" height=""16"" font=""0"">interventions.  </text>
</p><p><text top=""457"" left=""374"" width=""149"" height=""16"" font=""23"">_______________ </text></p></page>
<page number=""11"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- B-1 - </text>
</p><p><text top=""164"" left=""413"" width=""72"" height=""16"" font=""26"">ANNEX B </text></p><p><text top=""198"" left=""344"" width=""209"" height=""16"" font=""6"">ARGUMENTS OF THE PARTIES </text>
</p><p><text top=""241"" left=""406"" width=""86"" height=""16"" font=""25"">ARGENTINA </text></p><p><text top=""286"" left=""372"" width=""64"" height=""15"" font=""27"">Contents </text><text top=""286"" left=""732"" width=""37"" height=""15"" font=""27"">Page </text></p><p><text top=""300"" left=""108"" width=""67"" height=""15"" font=""11"">Annex B-1 </text>
<text top=""300"" left=""212"" width=""474"" height=""15"" font=""11"">First part of the integrated executive summary of the arguments of Argentina </text>
<footnote top=""300"" left=""738"" width=""26"" height=""15"" font=""11"" number=""2"" ref="""" dis=""""><ftext top=""315"" left=""212"" width=""494"" height=""15"" font=""11"">Second part of the integrated executive summary of the arguments of </ftext>
<ftext top=""329"" left=""212"" width=""63"" height=""15"" font=""11"">Argentina </ftext>
</footnote>
<text top=""315"" left=""734"" width=""33"" height=""15"" font=""11"">B-14 </text>
</p><p><text top=""377"" left=""391"" width=""115"" height=""16"" font=""25"">UNITED STATES </text></p><p><text top=""422"" left=""372"" width=""64"" height=""15"" font=""27"">Contents </text><text top=""422"" left=""732"" width=""37"" height=""15"" font=""27"">Page </text></p><p><text top=""436"" left=""108"" width=""68"" height=""15"" font=""11"">Annex B-3 </text>
<text top=""436"" left=""212"" width=""489"" height=""15"" font=""11"">First part of the integrated executive summary of the arguments of the United </text>
<text top=""451"" left=""212"" width=""42"" height=""15"" font=""11"">States </text>
<text top=""436"" left=""734"" width=""33"" height=""15"" font=""11"">B-25 </text>
</p><p><text top=""465"" left=""108"" width=""67"" height=""15"" font=""11"">Annex B-4 </text>
<text top=""465"" left=""212"" width=""491"" height=""15"" font=""11"">Second part of the integrated executive summary of the arguments of the </text>
<text top=""480"" left=""212"" width=""86"" height=""15"" font=""11"">United States </text>
<text top=""465"" left=""734"" width=""33"" height=""15"" font=""11"">B-37 </text>
</p></page>
<page number=""12"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- B-2 - </text>
</p><p><text top=""164"" left=""405"" width=""89"" height=""16"" font=""26"">ANNEX B-1 </text></p><p><text top=""198"" left=""254"" width=""389"" height=""16"" font=""6"">FIRST PART OF THE INTEGRATED EXECUTIVE SUMMARY </text>
<text top=""214"" left=""321"" width=""255"" height=""16"" font=""6"">OF THE ARGUMENTS OF ARGENTINA </text>
</p><p number=""I."" style=""0""><text top=""258"" left=""108"" width=""194"" height=""16"" font=""23"">I. INTRODUCTION </text></p><p number=""1."" style=""6""><text top=""291"" left=""108"" width=""20"" height=""16"" font=""0"">1. </text>
<text top=""291"" left=""151"" width=""641"" height=""16"" font=""0"">There are three major aspects of this case. First, the United States maintains a prohibition </text>
<text top=""307"" left=""108"" width=""683"" height=""16"" font=""0"">on imports of fresh (chilled or frozen) beef from Argentina as a whole. This is a product-specific </text>
<text top=""323"" left=""108"" width=""684"" height=""16"" font=""0"">ban, the maintenance of which is being challenged by Argentina. Second, the United States has </text>
<text top=""340"" left=""108"" width=""683"" height=""16"" font=""0"">maintained a ban on imports of animals, meat and animal products from the Patagonia Region &#8211; </text>
<text top=""356"" left=""108"" width=""684"" height=""16"" font=""0"">comprising the areas known as Patagonia South and Patagonia North B. Third, while Argentina </text>
<text top=""373"" left=""108"" width=""682"" height=""16"" font=""0"">considers that the fundamental issue here is the denial of rights that is the  core issue, it is also </text>
<text top=""389"" left=""108"" width=""683"" height=""16"" font=""0"">indisputable that there has been undue delay in the processing of Argentina's requests for import </text>
<text top=""405"" left=""108"" width=""609"" height=""16"" font=""0"">authorization for fresh beef and for the recognition of the Patagonia Region as FMD-free. </text>
</p><p number=""2."" style=""6""><text top=""440"" left=""108"" width=""20"" height=""16"" font=""0"">2. </text>
<text top=""440"" left=""151"" width=""641"" height=""16"" font=""0"">This is an ""as applied"" case. Rather than challenging the U.S. law or regulations related to </text>
<text top=""456"" left=""108"" width=""687"" height=""16"" font=""0"">the importation of animal and animal products in the United States ""as such"", Argentina is </text>
<text top=""473"" left=""108"" width=""683"" height=""16"" font=""0"">challenging the maintenance for over 11 years of the application of those regulations to imports </text>
<text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">from Argentina, without a valid risk assessment. The application of those measures lack scientific </text>
<text top=""506"" left=""108"" width=""691"" height=""16"" font=""0"">justification, constitute an arbitrary discrimination and a straight-forward restriction on </text>
<text top=""522"" left=""108"" width=""140"" height=""16"" font=""0"">international trade.  </text>
</p><p number=""3."" style=""6""><text top=""556"" left=""108"" width=""19"" height=""16"" font=""0"">3. </text>
<text top=""556"" left=""151"" width=""640"" height=""16"" font=""0"">The import prohibitions on the subject products have been maintained by the United States </text>
<text top=""573"" left=""108"" width=""683"" height=""16"" font=""0"">without a valid risk assessment for more than a decade despite evidence that Argentina has been </text>
<text top=""589"" left=""108"" width=""682"" height=""16"" font=""0"">FMD-free for over seven years as a country and the Patagonia Region has been FMD-free for more </text>
<text top=""606"" left=""108"" width=""682"" height=""16"" font=""0"">than 20 years. Indeed, Argentina is recognized by the OIE as FMD-free: Patagonia South has been </text>
<text top=""622"" left=""108"" width=""683"" height=""16"" font=""0"">recognized by the OIE as FMD-free without vaccination since 2002, in 2007 the OIE extended the </text>
<text top=""638"" left=""108"" width=""684"" height=""16"" font=""0"">recognition of FMD-free zone up to the r&#237;o Negro (to include Patagonia North B); the rest of the </text>
<text top=""655"" left=""108"" width=""684"" height=""16"" font=""0"">country is recognized as FMD-free with vaccination since 2007. These designations are annually </text>
<text top=""671"" left=""108"" width=""561"" height=""16"" font=""0"">renewed and the United States joined the consensus in all of these OIE decisions. </text>
</p><p number=""4."" style=""6""><text top=""706"" left=""108"" width=""19"" height=""16"" font=""0"">4. </text>
<text top=""706"" left=""151"" width=""640"" height=""16"" font=""0"">The United States has never enunciated a clear and consistently applied appropriate level of </text>
<text top=""722"" left=""108"" width=""684"" height=""16"" font=""0"">protection (""ALOP""). The United States is then required to conduct a valid risk assessment. The </text>
<text top=""738"" left=""108"" width=""686"" height=""16"" font=""0"">United States has taken neither of those steps. Prior to the establishment of the Panel, the </text>
<text top=""755"" left=""108"" width=""686"" height=""16"" font=""0"">United States has only conducted a risk assessment for Patagonia South in 2005 and it was </text>
<text top=""771"" left=""108"" width=""685"" height=""16"" font=""0"">favorable; it then failed to finalize its regulatory processes. In addition, the United States has </text>
<text top=""788"" left=""108"" width=""684"" height=""16"" font=""0"">stated and implied on various occasions that it has sufficient scientific evidence to press ahead </text>
<text top=""804"" left=""108"" width=""596"" height=""16"" font=""0"">favorably on all of Argentina's pending requests. It simply has failed to actually do so.  </text>
</p><p number=""5."" style=""6""><text top=""838"" left=""108"" width=""22"" height=""16"" font=""0"">5. </text>
<text top=""838"" left=""151"" width=""643"" height=""16"" font=""0"">Further, in processing Argentina's pending applications the United States has acted with </text>
<text top=""855"" left=""108"" width=""684"" height=""16"" font=""0"">undue delay and let politics interfere with, and derail, the regulatory process. The United States </text>
<text top=""871"" left=""108"" width=""683"" height=""16"" font=""0"">clearly has recognized these failures to move its processes forward in its statements to Argentina </text>
<text top=""888"" left=""108"" width=""177"" height=""16"" font=""0"">and the SPS Committee.  </text>
</p><p number=""II."" style=""0""><text top=""922"" left=""108"" width=""24"" height=""16"" font=""23"">II. </text><text top=""922"" left=""151"" width=""426"" height=""16"" font=""23"">THE UNITED STATES IMPORT AUTHORIZATION SYSTEM </text></p><p number=""6."" style=""6""><text top=""955"" left=""108"" width=""20"" height=""16"" font=""0"">6. </text>
<text top=""955"" left=""151"" width=""634"" height=""16"" font=""0"">The United States system is based on an assumption regarding the existence of foot-and-</text>
<text top=""971"" left=""108"" width=""682"" height=""16"" font=""0"">mouth disease in the world. The general ban is set forth in Section 94.1 of Title 9 of the U.S. Code </text>
<text top=""988"" left=""108"" width=""694"" height=""16"" font=""0"">of Federal Regulations (""C.F.R.""). Section 94.1(a) states that APHIS, the U.S. competent  </text>
<text top=""1004"" left=""108"" width=""684"" height=""16"" font=""0"">administrative agency, considers FMD to exist in all the regions of the world, except for those </text>
<text top=""1021"" left=""108"" width=""684"" height=""16"" font=""0"">countries and regions listed under Section 94.1(a)(1). Then, in Section 94.1(b), APHIS bans all </text>
<text top=""1037"" left=""108"" width=""682"" height=""16"" font=""0"">imports of ""any ruminant or swine or any fresh (chilled or frozen) meat of any ruminant or swine,"" </text>
<text top=""1053"" left=""108"" width=""682"" height=""16"" font=""0"">from all countries and regions other than those on the list referenced in Section 94.1(a)(1), except </text>
<text top=""1070"" left=""108"" width=""682"" height=""16"" font=""0"">as otherwise provided &#167;94.1(b)(4). However, in &#167;94.1(b)(4) APHIS has inserted certain provisions </text>
<text top=""1086"" left=""108"" width=""685"" height=""16"" font=""0"">to authorize imports of certain products from other countries or regions where vaccination is </text>
<text top=""1103"" left=""108"" width=""685"" height=""16"" font=""0"">practiced. Until 2001, &#167;94.21 allowed imports of fresh beef from Argentina. Currently, &#167;94.22 </text>
<text top=""1119"" left=""108"" width=""682"" height=""16"" font=""0"">allows imports of beef and ovine meat from Uruguay and APHIS has proposed to also grant import </text>
<text top=""1135"" left=""108"" width=""628"" height=""16"" font=""0"">rights for fresh beef to a region of 14 Brazilian states through a similar addition to Part 94.  </text>
<p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- B-3 - </text>
</p></p></page>
<page number=""13"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""15"" size=""7"" family=""Times"" color=""#000000""/>
<p number=""7."" style=""6""><text top=""128"" left=""108"" width=""21"" height=""16"" font=""0"">7. </text>
<text top=""128"" left=""151"" width=""642"" height=""16"" font=""0"">The United States regulations in 9 C.F.R. &#167;94 are structured in a fundamentally different </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">manner than the OIE standards, guidelines and recommendations. The OIE specifically recognizes </text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""0"">two distinct categories of FMD-free status: there are countries and zones that are FMD-free </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">without vaccination and FMD-free with vaccination. These two categories stand as co-equals in the </text>
<text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">scheme of the OIE standards, guidelines and recommendations. In contrast, the United States </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">does not recognize the whole category of FMD-free with vaccination. Under the U.S. regulations, </text>
<text top=""226"" left=""108"" width=""684"" height=""16"" font=""0"">such countries or zones are considered FMD-infected. As applied to Argentina, the difference is </text>
<text top=""242"" left=""108"" width=""686"" height=""16"" font=""0"">even more stark; the United States imposes a ban on imports which is contrary to the OIE </text>
<text top=""259"" left=""108"" width=""663"" height=""16"" font=""0"">standards, guidelines and recommendations which, in fact, would allow imports from Argentina.  </text>
</p><p number=""8."" style=""6""><text top=""293"" left=""108"" width=""19"" height=""16"" font=""0"">8. </text>
<text top=""293"" left=""151"" width=""640"" height=""16"" font=""0"">The regulatory process for seeking approval to import a particular product from a country or </text>
<text top=""310"" left=""108"" width=""687"" height=""16"" font=""0"">region  <i>(i.e.</i> a commodity request) or for the recognitions of a region as FMD-free (<i>i.e.</i> a </text>
<text top=""326"" left=""108"" width=""688"" height=""16"" font=""0"">regionalization request) is governed by a different part of the C.F.R. &#8211; Section 92.2. The </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">United States applies &#167;92.2 equally to requests for authorization to import a particular commodity </text>
<text top=""359"" left=""108"" width=""685"" height=""16"" font=""0"">and requests for recognition of FMD-free status and those regulations are <i>the only path</i> for a </text>
<text top=""375"" left=""108"" width=""469"" height=""16"" font=""0"">country or region to obtain approval to import in the United States.  </text>
</p><p number=""III."" style=""0""><text top=""410"" left=""108"" width=""689"" height=""16"" font=""23"">III.  BACKGROUND ON THE U.S. BAN ON IMPORTS FROM ARGENTINA AND ITS </text><text top=""426"" left=""151"" width=""277"" height=""16"" font=""23"">MAINTENANCE FOR OVER 11 YEARS </text></p><p number=""A."" style=""1""><text top=""459"" left=""151"" width=""20"" height=""16"" font=""23"">A. </text><text top=""459"" left=""193"" width=""374"" height=""16"" font=""23"">Request for Import Authorization for Fresh Beef  </text></p><p number=""9."" style=""6""><text top=""492"" left=""108"" width=""18"" height=""16"" font=""0"">9. </text>
<text top=""492"" left=""151"" width=""640"" height=""16"" font=""0"">In 1997, the United States approved imports of fresh (chilled or frozen) beef from Argentina, </text>
<text top=""508"" left=""108"" width=""683"" height=""16"" font=""0"">under a protocol with multiple layers of protections against the risk of FMD. Argentina unilaterally </text>
<text top=""525"" left=""108"" width=""683"" height=""16"" font=""0"">suspended its exports in 2001 following an FMD outbreak. The United States published an interim </text>
<text top=""541"" left=""108"" width=""683"" height=""16"" font=""0"">rule on June 4, 2001 and on December 11, 2001, APHIS imposed the ban indefinitely, as a final </text>
<text top=""557"" left=""108"" width=""687"" height=""16"" font=""0"">rule. The effect of the 2001 Regulations was that Argentina became subject again to the </text>
<text top=""574"" left=""108"" width=""682"" height=""16"" font=""0"">prohibition contained at 9 C.F.R. &#167; 94.1(b). The 2001 Regulations and the application to Argentina </text>
<text top=""590"" left=""108"" width=""600"" height=""16"" font=""0"">of the prohibition contained at 9 C.F.R. &#167; 94.1(b) are still in full force and effect today.  </text>
</p><p number=""10."" style=""6""><text top=""625"" left=""108"" width=""685"" height=""16"" font=""0"">10.  In November 2002, Argentina's National Service of Agricultural Food Health and Quality </text>
<text top=""641"" left=""108"" width=""683"" height=""16"" font=""0"">(""SENASA""), submitted a formal request to APHIS under 9 C.F.R. &#167;92.2, to allow the importation </text>
<text top=""657"" left=""108"" width=""359"" height=""16"" font=""0"">of fresh beef from Argentina into the United States.</text>
<footnote top=""656"" left=""467"" width=""6"" height=""11"" font=""15"" number=""1"" ref="""" dis=""""><ftext top=""1082"" left=""155"" width=""633"" height=""15"" font=""11""> While this application was titled ""Information provided by SENASA for the recognition of Argentina as a </ftext>
<ftext top=""1096"" left=""108"" width=""669"" height=""15"" font=""11"">Region comprised in Article 92.2 Title 9, Code of Federal Regulations in regards to FMD"" (ARG-31), consistent </ftext>
<ftext top=""1111"" left=""108"" width=""651"" height=""15"" font=""11"">with the name of the 92.2 regulations, Argentina's request was treated by the United States as one for the </ftext>
<ftext top=""1126"" left=""108"" width=""633"" height=""15"" font=""11"">approval of imports of fresh (chilled or frozen) beef from Argentina and not a request to recognize all of </ftext>
<ftext top=""1140"" left=""108"" width=""316"" height=""15"" font=""11"">Argentina as FMD-free under 9 C.F.R. &#167;94.1(a)(1).  </ftext>
</footnote>
<text top=""657"" left=""473"" width=""318"" height=""16"" font=""0"">  This was a commodity approval request for </text>
<text top=""674"" left=""108"" width=""406"" height=""16"" font=""0"">fresh beef, filed under the applicable regulations at &#167;92.2.  </text>
</p><p number=""11."" style=""6""><text top=""708"" left=""108"" width=""682"" height=""16"" font=""0"">11.  Two limited and quickly reported and contained FMD outbreaks occurred in the Northern part </text>
<text top=""725"" left=""108"" width=""684"" height=""16"" font=""0"">of Argentina in 2003 and 2006. The first one was limited to Tartagal (Salta) and the latter, in </text>
<text top=""741"" left=""108"" width=""687"" height=""16"" font=""0"">February 2006, occurred in one department of the Province of Corrientes, in proximity of </text>
<text top=""757"" left=""108"" width=""687"" height=""16"" font=""0"">Argentina's border with Paraguay. In response to a request from APHIS, SENASA promptly </text>
<text top=""774"" left=""108"" width=""685"" height=""16"" font=""0"">provided information regarding the outbreak. The information provided by Argentina was then </text>
<text top=""790"" left=""108"" width=""684"" height=""16"" font=""0"">reviewed by APHIS and following the 2006 outbreak, APHIS requested a site visit in September </text>
<text top=""807"" left=""108"" width=""683"" height=""16"" font=""0"">2006. APHIS' report of that visit was favorable, including many positive assessments of SENASA. </text>
<text top=""823"" left=""108"" width=""682"" height=""16"" font=""0"">The 2006 outbreak was the last sanitary event in Argentina and was limited to a single department </text>
<text top=""839"" left=""108"" width=""682"" height=""16"" font=""0"">in Corrientes &#8211; San Luis del Palmar. It was very limited both geographically and quantitatively. The </text>
<text top=""856"" left=""108"" width=""686"" height=""16"" font=""0"">EU, for instance, closed its market only in respect of the 8 departments of the province of </text>
<text top=""872"" left=""108"" width=""683"" height=""16"" font=""0"">Corrientes declared in sanitary emergency by SENASA in March 2006. Other WTO Members have </text>
<text top=""889"" left=""108"" width=""683"" height=""16"" font=""0"">had outbreaks in the same time frame and even more recently and have been able to access the </text>
<text top=""905"" left=""108"" width=""515"" height=""16"" font=""0"">U.S. regulatory system and regain the right to export to the United States. </text>
</p><p number=""12."" style=""6""><text top=""940"" left=""108"" width=""686"" height=""16"" font=""0"">12.  In May 2007, the OIE restored the status of ""FMD-free zone with vaccination"" to the </text>
<text top=""956"" left=""108"" width=""682"" height=""16"" font=""0"">Argentine territory located North of the 42nd Parallel South. Moreover, the same OIE Resolution<b> </b></text>
<text top=""972"" left=""108"" width=""682"" height=""16"" font=""0"">recognized the extension of the FMD-free zone without vaccination from the 42nd Parallel South up </text>
<text top=""989"" left=""108"" width=""455"" height=""16"" font=""0"">to the r&#237;o Negro (covering the area known as Patagonia North B). <b> </b></text>
</p><p number=""13."" style=""6""><text top=""1023"" left=""108"" width=""683"" height=""16"" font=""0"">13.  Despite these positive developments in Argentina's sanitary status, after the 2006 site visit </text>
<text top=""1040"" left=""108"" width=""685"" height=""16"" font=""0"">by APHIS there has been a complete breakdown in the U.S. regulatory process as applied to </text>
<p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- B-4 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina. Despite repeated formal requests from Argentina, to complete the approval process </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">started under &#167;92.2, a risk assessment was never issued and the rulemaking was never initiated. </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">Not coincidentally, the inaction of APHIS came in the context of intense political pressure opposing </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">action to allow imports of Argentine beef. A prime example of this political pressure is reflected in </text>
<text top=""193"" left=""108"" width=""319"" height=""16"" font=""0"">Section 737 of the 2009 appropriations law.</text>
<footnote top=""192"" left=""427"" width=""6"" height=""11"" font=""15"" number=""2"" ref="""" dis=""""><ftext top=""1140"" left=""155"" width=""451"" height=""15"" font=""11""> 2009 Omnibus Appropriations Act, H.R. 1105, 111th Congress. (ARG-45) </ftext>
</footnote>
<text top=""193"" left=""433"" width=""361"" height=""16"" font=""0""> Section 737 essentially imposed a ban on such </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">imports until ""the Secretary of Agriculture has reviewed the domestic animal health aspects of the </text>
<text top=""226"" left=""108"" width=""682"" height=""16"" font=""0"">pending proposal to allow the importation of such products into the United States and has issued a </text>
<text top=""242"" left=""108"" width=""143"" height=""16"" font=""0"">report"" to Congress. </text>
</p></p></page>
<page number=""14"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""14."" style=""6""><text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">14.  In June 2011 and October 2011, statements by the U.S. delegate to the SPS Committee in </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">response to inquiries by Argentina assured Argentina that a risk analysis was completed and that a </text>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">draft rule allowing importation was forthcoming. But as with the preceding decade, there was no </text>
<text top=""326"" left=""108"" width=""688"" height=""16"" font=""0"">action taken by the U.S. Government. The facts clearly show that the United States has </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">maintained, for more than eleven years, the application of the prohibition on imports of fresh beef </text>
<text top=""359"" left=""108"" width=""335"" height=""16"" font=""0"">from Argentina without a valid risk assessment.  </text>
</p><p number=""B."" style=""1""><text top=""393"" left=""151"" width=""20"" height=""16"" font=""23"">B. </text><text top=""393"" left=""193"" width=""354"" height=""16"" font=""23"">Request to Recognize Patagonia As FMD-Free  </text></p><p number=""15."" style=""6""><text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">15.  On August 28, 2003, SENASA submitted a request under 9 C.F.R. &#167;92.2 for the recognition </text>
<text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">of Patagonia South as a region free of FMD. There have been no outbreaks of FMD in Patagonia </text>
<text top=""459"" left=""108"" width=""685"" height=""16"" font=""0"">South since 1976, and in Patagonia North B since 1994. In May 2002, the OIE recognized the </text>
<text top=""475"" left=""108"" width=""150"" height=""16"" font=""0"">territory below the 42</text>
<text top=""474"" left=""258"" width=""11"" height=""11"" font=""0"">nd</text>
<text top=""475"" left=""269"" width=""521"" height=""16"" font=""0""> Parallel South as an FMD-free zone where vaccination is not practiced and </text>
<text top=""492"" left=""108"" width=""685"" height=""16"" font=""0"">in 2007 extended the recognition to include Patagonia North B. The Patagonia region was not </text>
<text top=""508"" left=""108"" width=""365"" height=""16"" font=""0"">affected by the limited outbreaks in 2003 and 2006.  </text>
</p><p number=""16."" style=""6""><text top=""543"" left=""108"" width=""683"" height=""16"" font=""0"">16.  In December 2003, APHIS made a technical visit to Patagonia South, with the objective of </text>
<text top=""559"" left=""108"" width=""685"" height=""16"" font=""0"">assessing the sanitary status of that region. In follow-up to the site visit, in November 2004, </text>
<text top=""575"" left=""108"" width=""685"" height=""16"" font=""0"">SENASA submitted additional information requested by APHIS. Then, on June 5, 2005, APHIS </text>
<text top=""592"" left=""108"" width=""507"" height=""16"" font=""0"">issued a risk analysis finding that the likelihood of an outbreak was ""low."" </text>
</p><p number=""17."" style=""6""><text top=""626"" left=""108"" width=""684"" height=""16"" font=""0"">17.  On January 5, 2007, APHIS published the proposed rule to recognize Patagonia South as </text>
<text top=""643"" left=""108"" width=""686"" height=""16"" font=""0"">FMD-free. However, following the 60 days comment period there was no final rulemaking by </text>
<text top=""659"" left=""108"" width=""685"" height=""16"" font=""0"">APHIS. Instead, more than one a half years later APHIS requested another visit to Patagonia. </text>
<text top=""675"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina accepted this visit to include Patagonia North B, due to the international recognition of </text>
<text top=""692"" left=""108"" width=""355"" height=""16"" font=""0"">its sanitary status as FMD-free without vaccination. </text>
</p><p number=""18."" style=""6""><text top=""726"" left=""108"" width=""689"" height=""16"" font=""0"">18.  Another site visit took place in February 2009, and it included livestock breeding </text>
<text top=""743"" left=""108"" width=""683"" height=""16"" font=""0"">establishments and control posts in Patagonia South and Patagonia North B. Following that visit, </text>
<text top=""759"" left=""108"" width=""682"" height=""16"" font=""0"">APHIS sent a letter to SENASA confirming that APHIS had all the information it needed to complete </text>
<text top=""775"" left=""108"" width=""688"" height=""16"" font=""0"">a risk assessment. However, instead of proceeding, the United States again failed to act. </text>
<text top=""792"" left=""108"" width=""687"" height=""16"" font=""0"">Section 737 of the Appropriations Act blocked APHIS from taking any action on Argentina's </text>
<text top=""808"" left=""108"" width=""685"" height=""16"" font=""0"">applications and thus the ban on imports of animals and animal products from the Patagonia </text>
<text top=""825"" left=""108"" width=""682"" height=""16"" font=""0"">Region continues. The U.S. delegate at the SPS Committee assured Argentina in October 2011 that </text>
<text top=""841"" left=""108"" width=""686"" height=""16"" font=""0"">APHIS had completed and updated the risk analysis for Patagonia, but that also has proved </text>
<text top=""857"" left=""108"" width=""266"" height=""16"" font=""0"">incorrect as the bans remain in place.  </text>
</p><p number=""19."" style=""6""><text top=""892"" left=""108"" width=""687"" height=""16"" font=""0"">19.  After the establishment of the Panel, in December 2014 APHIS released a new risk </text>
<text top=""908"" left=""108"" width=""683"" height=""16"" font=""0"">assessment for the Patagonia Region and rulemaking notice proposing to recognize the Patagonia </text>
<text top=""925"" left=""108"" width=""684"" height=""16"" font=""0"">Region as FMD-free and confirming its previous positive assessments of SENASA, among other </text>
<text top=""941"" left=""108"" width=""682"" height=""16"" font=""0"">things. However, the fact remains that as of the establishment of the Panel, the United States has </text>
<text top=""958"" left=""108"" width=""683"" height=""16"" font=""0"">maintained, for more than eleven years, the application of the prohibitions on imports of animals, </text>
<text top=""974"" left=""108"" width=""687"" height=""16"" font=""0"">meat, and other animal products from Patagonia, without scientific justification. In fact the </text>
<text top=""990"" left=""108"" width=""684"" height=""16"" font=""0"">maintenance of the ban for 11 years is in direct conflict with APHIS' findings on the risk of FMD </text>
<text top=""1007"" left=""108"" width=""283"" height=""16"" font=""0"">associated with imports from Patagonia.  </text>
<p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- B-5 - </text>
</p></p></page>
<page number=""15"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""16"" size=""9"" family=""Times"" color=""#000000""/>
<p number=""IV."" style=""0""><text top=""128"" left=""108"" width=""110"" height=""16"" font=""23"">IV. LEGAL </text><text top=""128"" left=""203"" width=""79"" height=""16"" font=""23"">CLAIMS </text></p><p number=""A."" style=""1""><text top=""160"" left=""151"" width=""22"" height=""16"" font=""23"">A. </text><text top=""160"" left=""193"" width=""599"" height=""16"" font=""23"">The U.S. Measures Prohibiting Imports of Fresh Beef Are Inconsistent With </text><text top=""177"" left=""193"" width=""305"" height=""16"" font=""23"">the SPS Agreement and the GATT 1994  </text></p><p number=""20."" style=""6""><text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">20.  It is inconsistent with the SPS Agreement to apply and maintain for more than 11 years the </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">ban contained in 9 C.F.R. &#167;94.1(b) to Argentina (the ""U.S. Measure against Argentine Beef"") </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">without a current, valid risk assessment. Argentina also challenges the continued application of the </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">2001 Regulations which removed the previous authorization to import Argentine beef, contained in </text>
<text top=""275"" left=""108"" width=""122"" height=""16"" font=""0"">9 C.F.R. &#167;94.21.  </text>
</p><p number=""21."" style=""6""><text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">21.  The U.S. Measure against Argentine Beef and the 2001 Regulations are SPS measures in the </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">sense of Article 1.1 of the SPS Agreement as they aim to protect the health and life of animals in </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">the U.S. territory from risks arising from the entry, establishment or spread of FMD. In addition, </text>
<text top=""359"" left=""108"" width=""686"" height=""16"" font=""0"">application of the ""U.S. Measure against Argentine Beef"", as an import ban, directly affects </text>
<text top=""375"" left=""108"" width=""690"" height=""16"" font=""0"">international trade and is inconsistent with, <i>inter alia</i>, Articles 2, 3, 5 and 10 of the </text>
<text top=""392"" left=""108"" width=""684"" height=""16"" font=""0"">SPS Agreement. Thus, application of the ""U.S. Measure against Argentine Beef"" and of the 2001 </text>
<text top=""408"" left=""108"" width=""298"" height=""16"" font=""0"">Regulations is inconsistent with Article 1.1. </text>
</p><p number=""22."" style=""6""><text top=""443"" left=""108"" width=""689"" height=""16"" font=""0"">22.  Application of the ban on imports of fresh beef from Argentina, as contained in </text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">9 C.F.R. &#167;94.1(b), is inconsistent with Article 3.1 of the SPS Agreement. The OIE sets standards </text>
<text top=""475"" left=""108"" width=""686"" height=""16"" font=""0"">and procedures for imports of beef from FMD-free countries or regions: Article 8.6.22 of the </text>
<text top=""492"" left=""108"" width=""686"" height=""16"" font=""0"">OIE Code provides for importation from countries that are FMD-free without vaccination, and </text>
<text top=""508"" left=""108"" width=""682"" height=""16"" font=""0"">Article 8.6.23 provides for importation from countries or zones that are FMD-free with vaccination. </text>
<text top=""525"" left=""108"" width=""682"" height=""16"" font=""0"">The U.S. failure to recognize FMD-free with vaccination status renders Terrestrial Code 8.6.25 also </text>
<text top=""541"" left=""108"" width=""685"" height=""16"" font=""0"">relevant. It is worth noting that in all cases the OIE aimed to preserve trade, with mitigating </text>
<text top=""557"" left=""108"" width=""683"" height=""16"" font=""0"">protocols when needed. In contrast, the United States takes a qualitatively different approach and </text>
<text top=""574"" left=""108"" width=""682"" height=""16"" font=""0"">does not recognize the category ""FMD-free with vaccination,"" which is the status recognized by the </text>
<text top=""590"" left=""108"" width=""274"" height=""16"" font=""0"">OIE for Argentina, north of Parallel 42</text>
<text top=""589"" left=""382"" width=""11"" height=""11"" font=""0"">nd</text>
<text top=""590"" left=""393"" width=""399"" height=""16"" font=""0"">. Because the application of the ""U.S. Measure against </text>
<text top=""607"" left=""108"" width=""682"" height=""16"" font=""0"">Argentine Beef"" has the exact opposite meaning and effect of the international standards it cannot </text>
<text top=""623"" left=""108"" width=""683"" height=""16"" font=""0"">be said to be ""based on,"" ""standing upon"" or having been ""built"" or ""founded upon"" the OIE Code </text>
<text top=""639"" left=""108"" width=""671"" height=""16"" font=""0"">standards, as required under Article 3.1 and interpreted by the Appellate Body in <i>EC &#8211; Hormones</i>.</text>
<footnote top=""638"" left=""779"" width=""6"" height=""11"" font=""15"" number=""3"" ref="""" dis=""""/>
<text top=""656"" left=""108"" width=""684"" height=""16"" font=""0"">Similarly, the 2001 Regulations were imposed permanently and have been maintained for over </text>
<text top=""672"" left=""108"" width=""32"" height=""16"" font=""0"">11 </text>
<text top=""672"" left=""130"" width=""670"" height=""16"" font=""0"">years without any reference to, or reliance upon, OIE standards, guidelines and </text>
<text top=""689"" left=""108"" width=""445"" height=""16"" font=""0"">recommendations, contrary to Article 3.1 of the SPS Agreement. </text>
</p><p number=""23."" style=""6""><text top=""723"" left=""108"" width=""682"" height=""16"" font=""0"">23.  While the United States claims that its regulations are based on OIE standards, guidelines or </text>
<text top=""739"" left=""108"" width=""682"" height=""16"" font=""0"">recommendations in the sense of Article 3.1, that  argument  is  flatly  contradicted  by  APHIS' </text>
<text top=""756"" left=""108"" width=""684"" height=""16"" font=""0"">rulemakings. APHIS has affirmatively stated that it does not base its FMD standards on the OIE </text>
<text top=""772"" left=""108"" width=""72"" height=""16"" font=""0"">standards.</text>
<footnote top=""771"" left=""180"" width=""6"" height=""11"" font=""15"" number=""4"" ref="""" dis=""""><ftext top=""1140"" left=""155"" width=""627"" height=""15"" font=""11""> <i>Importation of Beef from Uruguay</i>, 68 Fed. Reg. 31940, 31946 (USDA/APHIS May 29, 2013) (ARG-8). </ftext>
</footnote>
<text top=""772"" left=""185"" width=""607"" height=""16"" font=""0""> The United States permits beef imports from Uruguay, a country recognized by the </text>
<text top=""789"" left=""108"" width=""687"" height=""16"" font=""0"">OIE as FMD-free with vaccination, but only pursuant to a risk assessment and rulemaking </text>
<text top=""805"" left=""108"" width=""405"" height=""16"" font=""0"">conducted according to APHIS' own ""stringent standards.""  </text>
</p><p number=""24."" style=""6""><text top=""839"" left=""108"" width=""77"" height=""16"" font=""0"">24. In </text>
<text top=""839"" left=""173"" width=""620"" height=""16"" font=""8""><i>EC &#8211; Hormones</i>, the Appellate Body found that Article 3.3 is not an exception from </text>
<text top=""856"" left=""108"" width=""682"" height=""16"" font=""0"">Article 3.1, but an autonomous right of Members. However, that does not alter the basic structure </text>
<text top=""872"" left=""108"" width=""682"" height=""16"" font=""0"">and plain language of Article 3.1 that posits a binary choice: either Article 3.1 applies or Article 3.3 </text>
<text top=""889"" left=""108"" width=""687"" height=""16"" font=""0"">applies. Accordingly, the prohibition resulting from application of the ""U.S. Measure against </text>
<text top=""905"" left=""108"" width=""683"" height=""16"" font=""0"">Argentine Beef"" is not based on international standards and, as discussed below, is not otherwise </text>
<text top=""922"" left=""108"" width=""684"" height=""16"" font=""0"">justified by Article 3.3. In order for the United States to be found acting in a manner consistent </text>
<text top=""938"" left=""108"" width=""683"" height=""16"" font=""0"">with the requirements of Article 3.3, which allows a Member to apply a higher standard than the </text>
<text top=""954"" left=""108"" width=""684"" height=""16"" font=""0"">international ones, it must have based its measure banning the imports of Argentine beef on a </text>
<text top=""971"" left=""108"" width=""608"" height=""16"" font=""0"">valid risk assessment based on the appropriate level of risk determined by the Member.  </text>
</p><p number=""25."" style=""6""><text top=""1005"" left=""108"" width=""687"" height=""16"" font=""0"">25.  However, the United States cannot possibly meet the requirements of Article 3.3. The </text>
<text top=""1022"" left=""108"" width=""683"" height=""16"" font=""0"">application of the prohibition in &#167;94.1(b) is not justified by scientific evidence. Moreover, the U.S. </text>
<text top=""1038"" left=""108"" width=""682"" height=""16"" font=""0"">has not even articulated what it considers to be an appropriate level of sanitary protection against </text>
<text top=""1054"" left=""108"" width=""685"" height=""16"" font=""0"">the threat of FMD that could encompass imports of fresh beef. Thus, application of the ""U.S. </text>
<text top=""1071"" left=""108"" width=""683"" height=""16"" font=""0"">Measure against Argentine Beef"" is not a consequence of a level of sanitary protection determined </text>
<p><text top=""1126"" left=""155"" width=""309"" height=""15"" font=""11""> Appellate Body Report in <i>EC- Hormones</i> at &#182; 163. </text>
</p><p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- B-6 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">by the United States in accordance with paragraphs 1 through 8 of Article 5. Consequently, the </text>
<text top=""144"" left=""108"" width=""676"" height=""16"" font=""0"">""U.S. Measure against Argentine Beef"" and the 2001 Regulations are inconsistent with Article 3.3.  </text>
</p></p></page>
<page number=""16"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""26."" style=""6""><text top=""178"" left=""108"" width=""684"" height=""16"" font=""0"">26.  Article 5.1 of the SPS Agreement requires, among other things, that import measures be </text>
<text top=""195"" left=""108"" width=""682"" height=""16"" font=""0"">based on a risk assessment. Article 5.2 contains a list of factors that must be taken into account in </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">a risk assessment. Yet, here, like in <i>U.S. &#8211; Poultry (China)</i>, the Panel is faced with a situation </text>
<text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">where there is no current U.S. risk assessment for beef from Argentina. Consequently, application </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">of the prohibition contained in 9 C.F.R., Part 94.1(b) without a risk assessment is clearly contrary </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">to the provisions of Article 5.1 of the SPS Agreement. Given the lack of a risk assessment and of </text>
<text top=""277"" left=""108"" width=""689"" height=""16"" font=""0"">sufficient scientific evidence underpinning the ""U.S. Measure against Argentine Beef"", the </text>
<text top=""293"" left=""108"" width=""320"" height=""16"" font=""0"">United States is also in violation of Article 5.2. </text>
</p><p number=""27."" style=""6""><text top=""328"" left=""108"" width=""685"" height=""16"" font=""0"">27.  The same conclusion applies for the 2001 Regulations that re-imposed the general ban </text>
<text top=""344"" left=""108"" width=""684"" height=""16"" font=""0"">contained in 9 C.F.R. &#167; 94.1(b). The 2001 Regulations were nothing more than a recitation of </text>
<text top=""360"" left=""108"" width=""682"" height=""16"" font=""0"">facts, as well as a statement of the potential negative economic impact of an FMD outbreak. As the </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">United States admitted in the <i>United States &#8211; &#8211; Poultry (China)</i>, this approach does not constitute </text>
<text top=""393"" left=""108"" width=""177"" height=""16"" font=""0"">a valid risk assessment. . </text>
</p><p number=""28."" style=""6""><text top=""428"" left=""108"" width=""682"" height=""16"" font=""0"">28.  As the Appellate Body has reaffirmed in <i>Australia &#8211; &#8211; Apples</i>, a measure that is inconsistent </text>
<text top=""444"" left=""108"" width=""683"" height=""16"" font=""0"">with the requirements of Articles 5.1 and 5.2 because it is not based on a proper risk assessment </text>
<text top=""461"" left=""108"" width=""683"" height=""16"" font=""0"">will also necessarily be inconsistent with Article 2.2. Because the ""U.S. Measure against Argentine </text>
<text top=""477"" left=""108"" width=""683"" height=""16"" font=""0"">Beef"" has been maintained for many years without any risk assessment at all, it follows that the </text>
<text top=""493"" left=""108"" width=""682"" height=""16"" font=""0"">United States has not based the application of the measure on the scientific evidence. Indeed, the </text>
<text top=""510"" left=""108"" width=""686"" height=""16"" font=""0"">U.S. delegate to the SPS Committee has indicated that there is, in fact, sufficient scientific </text>
<text top=""526"" left=""108"" width=""683"" height=""16"" font=""0"">evidence to support a <i>favorable</i> risk assessment for Argentine beef. Additionally, the measure is </text>
<text top=""543"" left=""108"" width=""682"" height=""16"" font=""0"">applied in a manner far more restrictive than is necessary for the protection of animal health. This </text>
<text top=""559"" left=""108"" width=""682"" height=""16"" font=""0"">is demonstrated, among other ways, by comparison to Uruguay, a country that is essentially in the </text>
<text top=""575"" left=""108"" width=""682"" height=""16"" font=""0"">same sanitary situation as Argentina North of the r&#237;o Negro, but which is allowed to import into the </text>
<text top=""592"" left=""108"" width=""610"" height=""16"" font=""0"">United States subject to certain protocols, similar to those applied to Argentina in 1997.  </text>
</p><p number=""29."" style=""6""><text top=""626"" left=""108"" width=""686"" height=""16"" font=""0"">29.  Argentina has also demonstrated that Article 5.7 does not apply in regard to the 2001 </text>
<text top=""643"" left=""108"" width=""687"" height=""16"" font=""0"">Regulations or the prohibition contained in 9 C.F.R., Part 94.1(b) on imports of beef from </text>
<text top=""659"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina. In <i>Japan &#8211; Agricultural Products II</i>, the Appellate Body laid out four cumulative steps to </text>
<text top=""675"" left=""108"" width=""167"" height=""16"" font=""0"">the Article 5.7 analysis;</text>
<footnote top=""674"" left=""275"" width=""11"" height=""11"" font=""15"" number=""5"" ref="""" dis=""""/>
<text top=""675"" left=""286"" width=""506"" height=""16"" font=""0"">a failure to meet any one will mean the measure is not a provisional </text>
<text top=""692"" left=""108"" width=""683"" height=""16"" font=""0"">measure within the meaning of Article 5.7. A Member may avail itself of Article 5.7 only in cases </text>
<text top=""708"" left=""108"" width=""684"" height=""16"" font=""0"">where ""the scientific evidence is insufficient."" Here, as both parties have acknowledged and the </text>
<text top=""725"" left=""108"" width=""684"" height=""16"" font=""0"">OIE makes clear, FMD is a well-known disease. To the extent that ""scientific evidence"" may be </text>
<text top=""741"" left=""108"" width=""682"" height=""16"" font=""0"">read to encompass evidence on the ground in Argentina regarding the risk of importation for FMD, </text>
<text top=""757"" left=""108"" width=""684"" height=""16"" font=""0"">the United States has not indicated any lack of information from Argentina. To the contrary, the </text>
<text top=""774"" left=""108"" width=""685"" height=""16"" font=""0"">U.S. delegates to the SPS Committee have indicated the only delaying factors to be domestic </text>
<text top=""790"" left=""108"" width=""683"" height=""16"" font=""0"">concerns, not lack of data. Furthermore, by ejecting Argentina from the U.S. regulatory system in </text>
<text top=""807"" left=""108"" width=""684"" height=""16"" font=""0"">2001 and requiring Argentina to reapply <i>de novo</i> as if it had never had import permission, the </text>
<text top=""823"" left=""108"" width=""683"" height=""16"" font=""0"">United States failed to satisfy the requirement under Article 5.7 to take the initiative and seek out </text>
<text top=""839"" left=""108"" width=""393"" height=""16"" font=""0"">the scientific information that it considered to be lacking. </text>
</p><p number=""30."" style=""6""><text top=""874"" left=""108"" width=""684"" height=""16"" font=""0"">30.  Finally, the extended lapse of time since the ban was imposed means that the prohibition </text>
<text top=""890"" left=""108"" width=""682"" height=""16"" font=""0"">applied through 2001 Regulations and the ""U.S. Measure against Argentine Beef"" cannot be a valid </text>
<text top=""907"" left=""108"" width=""686"" height=""16"" font=""0"">provisional measure. The prohibition was re-imposed after an FMD outbreak in 2001. In its </text>
<text top=""923"" left=""108"" width=""686"" height=""16"" font=""0"">rulemaking for Uruguay, the United States rejected even a three to five-year waiting period, </text>
<text top=""940"" left=""108"" width=""683"" height=""16"" font=""0"">stating that such a long period was unnecessary. Its guidelines say one year is sufficient. In this </text>
<text top=""956"" left=""108"" width=""683"" height=""16"" font=""0"">context, even the United States' own positions and statements are conclusive that the measure is </text>
<text top=""972"" left=""108"" width=""553"" height=""16"" font=""0"">not being applied as a provisional measure after all the years that have passed.  </text>
</p><p number=""31."" style=""6""><text top=""1007"" left=""108"" width=""682"" height=""16"" font=""0"">31.  Contrary to the United States' position, this case has nothing to do with Article 5.7. The U.S. </text>
<text top=""1023"" left=""108"" width=""682"" height=""16"" font=""0"">argument on Article 5.7 completely distorts its meaning and its functioning. Instead of the Member </text>
<text top=""1040"" left=""108"" width=""687"" height=""16"" font=""0"">imposing the measure indicating what information it needed and then seeking it out in a </text>
<text top=""1056"" left=""108"" width=""684"" height=""16"" font=""0"">reasonable period of time, the United States' approach would simply erase those obligations and </text>
<text top=""1072"" left=""108"" width=""686"" height=""16"" font=""0"">shift the burden to the exporting Member. In other words, the United States' approach is to </text>
<text top=""1089"" left=""108"" width=""686"" height=""16"" font=""0"">impose a permanent ban that leaves the exporting Member without recourse. The exporting </text>
<text top=""1105"" left=""108"" width=""683"" height=""16"" font=""0"">Member has to initiate a new regulatory application and present its information to the importing </text>
<p><text top=""1140"" left=""155"" width=""405"" height=""15"" font=""11""> Appellate Body Report in <i>Japan &#8211; Agricultural Products II </i>at &#182; 89. </text>
</p><p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- B-7 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">Member, as if it had never exported that product to the United States. The Panel should reject </text>
<text top=""144"" left=""108"" width=""271"" height=""16"" font=""0"">such a distorted reading of Article 5.7.  </text>
</p></p></page>
<page number=""17"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""32."" style=""6""><text top=""178"" left=""108"" width=""687"" height=""16"" font=""0"">32.  The U.S. measures fail also the obligations of Article 5.4. The United States does not </text>
<text top=""195"" left=""108"" width=""687"" height=""16"" font=""0"">approach the establishment of an ALOP in a coherent manner so as to allow Members to </text>
<text top=""211"" left=""108"" width=""682"" height=""16"" font=""0"">understand which ALOP they should measure against. Therefore, the United States cannot possibly </text>
<text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">claim to minimize negative trade effects and act consistently with Article 5.4, where Members are </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">left in the dark as to the applicable ALOP. Moreover, the application of the ""U.S. Measure against </text>
<text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">Argentine Beef"" to Argentina, which should reflect the U.S. ALOP in regards to FMD, results in a </text>
<text top=""277"" left=""108"" width=""682"" height=""16"" font=""0"">ban on imports that maximizes negative trade effects and is inconsistent with the requirement set </text>
<text top=""293"" left=""108"" width=""688"" height=""16"" font=""0"">in Article 5.4. This constitutes both a direct violation of Article 5.4 and should inform the </text>
<text top=""310"" left=""108"" width=""686"" height=""16"" font=""0"">interpretation of the remainder of the SPS Agreement in evaluating the maintenance of the </text>
<text top=""326"" left=""108"" width=""488"" height=""16"" font=""0"">application of the ""U.S. Measure against Argentine Beef"" to Argentina.  </text>
</p><p number=""33."" style=""6""><text top=""360"" left=""108"" width=""685"" height=""16"" font=""0"">33.  We recall that the ""U.S. Measure against Argentine Beef"" imposes a total prohibition on </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">imports of fresh (chilled or frozen) beef from Argentina. By definition, therefore, the application of </text>
<text top=""393"" left=""108"" width=""682"" height=""16"" font=""0"">the ""U.S. Measure against Argentine Beef"" is not only more restrictive than necessary to meet the </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">U.S. ALOP as required under Article 5.6, but it is <i>the most</i> trade restrictive possible. Under an </text>
<text top=""426"" left=""108"" width=""684"" height=""16"" font=""0"">Article 5.6 analysis the issue becomes whether there are any measures that (i) are reasonably </text>
<text top=""443"" left=""108"" width=""682"" height=""16"" font=""0"">available taking into account technical and economic feasibility (ii) achieve the Member's ALOP and </text>
<text top=""459"" left=""108"" width=""310"" height=""16"" font=""0"">(iii) are significantly less trade restrictive.</text>
<footnote top=""457"" left=""418"" width=""14"" height=""11"" font=""15"" number=""6"" ref="""" dis=""""/>
<text top=""459"" left=""432"" width=""363"" height=""16"" font=""0"">  Because these three conditions are met, the </text>
<text top=""475"" left=""108"" width=""445"" height=""16"" font=""0"">application of the U.S. measures is inconsistent with Article 5.6.  </text>
</p><p number=""34."" style=""6""><text top=""510"" left=""108"" width=""683"" height=""16"" font=""0"">34.  There are reasonably available alternative measures the United States could use instead of </text>
<text top=""526"" left=""108"" width=""683"" height=""16"" font=""0"">the complete prohibition on imports. The United States could use the OIE guidelines to establish </text>
<text top=""543"" left=""108"" width=""684"" height=""16"" font=""0"">alternative measures for imports from Argentina; alternatively, the United States could establish </text>
<text top=""559"" left=""108"" width=""682"" height=""16"" font=""0"">mitigating protocols for imports of fresh beef from Argentina, such as those provided in 9 C.F.R. &#167; </text>
<text top=""575"" left=""108"" width=""686"" height=""16"" font=""0"">94.22 for imports of fresh beef from Uruguay. Because they already work for imports from </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">Uruguay, they clearly are technically and economically feasible. These alternative measures would </text>
<text top=""608"" left=""108"" width=""683"" height=""16"" font=""0"">also achieve the U.S. ALOP in regards to FMD, considering that they already achieve that level in </text>
<text top=""625"" left=""108"" width=""683"" height=""16"" font=""0"">respect to imports from Uruguay; Uruguay and the territory of Argentina located north of the r&#237;o </text>
<text top=""641"" left=""108"" width=""683"" height=""16"" font=""0"">Negro are in essentially similar sanitary situations. It goes without saying that permitting imports </text>
<text top=""657"" left=""108"" width=""684"" height=""16"" font=""0"">subject to appropriate protocols, such as the Uruguay protocols, is less trade restrictive than a </text>
<text top=""674"" left=""108"" width=""687"" height=""16"" font=""0"">total prohibition on imports which is what the United States currently applies to beef from </text>
<text top=""690"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina. Thus, because there are alternative measures that are technically feasible, would </text>
<text top=""707"" left=""108"" width=""684"" height=""16"" font=""0"">achieve the appropriate level of sanitary protection and would be less trade restrictive than the </text>
<text top=""723"" left=""108"" width=""685"" height=""16"" font=""0"">prohibition currently applied to Argentine beef, the United States is not in conformity with its </text>
<text top=""739"" left=""108"" width=""356"" height=""16"" font=""0"">obligations under Article 5.6 of the SPS Agreement. </text>
</p><p number=""35."" style=""6""><text top=""774"" left=""108"" width=""682"" height=""16"" font=""0"">35.  The application of the ""U.S. Measure against Argentine Beef"" is inconsistent with Article 2.3. </text>
<text top=""790"" left=""108"" width=""684"" height=""16"" font=""0"">It is manifestly discriminatory because Argentina is in a similar position to its neighbor Uruguay </text>
<text top=""807"" left=""108"" width=""682"" height=""16"" font=""0"">which is FMD-free with vaccination and is permitted imports of beef into the United States under a </text>
<text top=""823"" left=""108"" width=""686"" height=""16"" font=""0"">protocol similar to the one applied to Argentina prior to 2001. In regards to the substantive </text>
<text top=""839"" left=""108"" width=""683"" height=""16"" font=""0"">discrimination, Argentina (the part of the country north of the Patagonia Region) and Uruguay are </text>
<text top=""856"" left=""108"" width=""683"" height=""16"" font=""0"">in essentially similar sanitary situations. Both are FMD-free with vaccination as recognized by the </text>
<text top=""872"" left=""108"" width=""682"" height=""16"" font=""0"">OIE. The physical and institutional situations in both countries are similar, as has been recognized </text>
<text top=""889"" left=""108"" width=""683"" height=""16"" font=""0"">by APHIS. Yet, Uruguay is permitted to export beef to the United States under protocols similar to </text>
<text top=""905"" left=""108"" width=""682"" height=""16"" font=""0"">those previously applicable to Argentina, and the U.S. is also about to grant approval to imports of </text>
<text top=""922"" left=""108"" width=""684"" height=""16"" font=""0"">beef from 14 Brazilian States, while application of the ""U.S. Measure against Argentine Beef"" to </text>
<text top=""938"" left=""108"" width=""473"" height=""16"" font=""0"">Argentina results in a total prohibition on imports of Argentine beef.  </text>
</p><p number=""36."" style=""6""><text top=""972"" left=""108"" width=""686"" height=""16"" font=""0"">36.  From the perspective of the regulatory process, a risk assessment and final favorable </text>
<text top=""989"" left=""108"" width=""683"" height=""16"" font=""0"">rulemaking were conducted for Uruguay within two years of the last outbreak in that country. In </text>
<text top=""1005"" left=""108"" width=""682"" height=""16"" font=""0"">contrast, it has been over seven years since there was an outbreak in Argentina, yet the U.S. ban </text>
<text top=""1022"" left=""108"" width=""682"" height=""16"" font=""0"">is still applied to Argentine imports. Yet, Argentina is totally blocked from access to the regulatory </text>
<text top=""1038"" left=""108"" width=""683"" height=""16"" font=""0"">process despite repeated promises and assurances from the U.S. Government. The restrictions on </text>
<text top=""1054"" left=""108"" width=""684"" height=""16"" font=""0"">commerce entailed in the prohibition on Argentine beef exports are disguised only in the sense </text>
<text top=""1071"" left=""108"" width=""683"" height=""16"" font=""0"">that they purport to be SPS measures. However, there is no rational, logical or scientific basis for </text>
<text top=""1087"" left=""108"" width=""684"" height=""16"" font=""0"">the continued application of the ""U.S. Measure against Argentine Beef"". The ban maintained for </text>
<p><text top=""1126"" left=""155"" width=""581"" height=""15"" font=""11""> Appellate Body Report in <i>Australia &#8211; Apples</i> at &#182; 337; citing Appellate Body Report, <i>Australia &#8211; </i></text>
<text top=""1140"" left=""108"" width=""93"" height=""15"" font=""16""><i>Salmon</i>, &#182; 194 </text>
</p><p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- B-8 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">eleven years is a straight-forward restriction on international trade. For all these reasons, the </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">application of the ""U.S. Measure against Argentine Beef"" is inconsistent with Article 2.3 of the </text>
<text top=""160"" left=""108"" width=""116"" height=""16"" font=""0"">SPS Agreement. </text>
</p></p></page>
<page number=""18"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""17"" size=""11"" family=""Times"" color=""#000000""/>
<p number=""37."" style=""6""><text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">37.  Last, the United States has not accorded Argentina special and differential treatment in the </text>
<text top=""211"" left=""108"" width=""682"" height=""16"" font=""0"">application of its SPS measures on beef imports, as required by Article 10.1. Article 10.1 imposes a </text>
<text top=""228"" left=""108"" width=""686"" height=""16"" font=""0"">broad and unqualified obligation to take account of the special needs of developing country </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">Members, with a view to maintain trade flows from developing country Members to the maximum </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">extent possible, as specified in Article 10.2. However, in the present case, the United States has </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">taken every effort to <i><b>stop  </b></i>the flow of trade from Argentina, on a commodity of particular trade </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">interest for Argentina, not maintain it. Argentina has been effectively denied access to the U.S. </text>
<text top=""310"" left=""108"" width=""684"" height=""16"" font=""0"">administrative process. In contrast to the high level of access and speed accorded to developed </text>
<text top=""326"" left=""108"" width=""682"" height=""16"" font=""0"">country Members, the United States has responded to repeated requests and pleas for access from </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina with years of delays and false promises. This is exactly the opposite of the special and </text>
<text top=""359"" left=""108"" width=""682"" height=""16"" font=""0"">differential treatment that should be accorded to Argentina. Therefore, the United States has failed </text>
<text top=""375"" left=""108"" width=""686"" height=""16"" font=""0"">to accord Argentina special and differential treatment in application of its SPS measures as </text>
<text top=""392"" left=""108"" width=""326"" height=""16"" font=""0"">required by Article 10.1 of the SPS Agreement. </text>
</p><p number=""38."" style=""6""><text top=""426"" left=""108"" width=""682"" height=""16"" font=""0"">38.  The facts here show that the United States has offered advantages to other Members that it </text>
<text top=""443"" left=""108"" width=""688"" height=""16"" font=""0"">has not accorded Argentina immediately and unconditionally. These include the advantage </text>
<text top=""459"" left=""108"" width=""683"" height=""16"" font=""0"">provided Uruguay to export fresh beef subject to certain protocols, while Argentina is subject to a </text>
<text top=""475"" left=""108"" width=""683"" height=""16"" font=""0"">prohibition maintained through the ""U.S. Measure against Argentine Beef"". The United States has </text>
<text top=""492"" left=""108"" width=""684"" height=""16"" font=""0"">accorded other Members, including Uruguay, Brazil, the United Kingdom and Japan, prompt and </text>
<text top=""508"" left=""108"" width=""685"" height=""16"" font=""0"">efficient access to the regulatory processes, while Argentina has been denied access to these </text>
<text top=""525"" left=""108"" width=""682"" height=""16"" font=""0"">administrative processes for years. The products at issue are clearly like and the same advantages </text>
<text top=""541"" left=""108"" width=""685"" height=""16"" font=""0"">have not been accorded to Argentina immediately and unconditionally; indeed, the advantages </text>
<text top=""557"" left=""108"" width=""683"" height=""16"" font=""0"">have been denied seemingly in perpetuity. Accordingly, the ""U.S. Measure against Argentine Beef"" </text>
<text top=""574"" left=""108"" width=""687"" height=""16"" font=""0"">is being applied in a manner inconsistent with the U.S. obligations under Article I:1 of the </text>
<text top=""590"" left=""108"" width=""85"" height=""16"" font=""0"">GATT 1994. </text>
</p><p number=""39."" style=""6""><text top=""625"" left=""108"" width=""684"" height=""16"" font=""0"">39.  The analysis in regard to Article XI:1 is straight-forward. Application of the ""U.S. Measure </text>
<text top=""641"" left=""108"" width=""682"" height=""16"" font=""0"">against Argentine Beef"" results in a prohibition on importation of fresh (chilled or frozen) beef from </text>
<text top=""657"" left=""108"" width=""71"" height=""16"" font=""0"">Argentina.</text>
<footnote top=""656"" left=""179"" width=""6"" height=""11"" font=""15"" number=""7"" ref="""" dis=""""><ftext top=""1140"" left=""155"" width=""357"" height=""15"" font=""11""> Panel Report in <i>U.S. &#8211; Poultry (China)</i> at &#182;&#182; 7.456-7.457. </ftext>
</footnote>
<text top=""657"" left=""184"" width=""610"" height=""16"" font=""0""> This operates as a zero quota and thus clearly is prohibited by Article XI of the </text>
<text top=""674"" left=""108"" width=""85"" height=""16"" font=""0"">GATT 1994. </text>
</p><p number=""40."" style=""6""><text top=""708"" left=""108"" width=""685"" height=""16"" font=""0"">40.  Argentina has demonstrated that the application of the ""U.S. Measure against Argentine </text>
<text top=""725"" left=""108"" width=""684"" height=""16"" font=""0"">Beef"" and the 2001 Regulations are inconsistent with Articles 1.1; 2.2; 2.3; 3.1; 3.3; 5.1; 5.2; </text>
<text top=""741"" left=""108"" width=""664"" height=""16"" font=""0"">5.4; 5.6; and 10.1 of the SPS Agreement as well as with Articles I:1 and XI:1 of the GATT 1994. </text>
</p><p number=""B."" style=""1""><text top=""775"" left=""151"" width=""21"" height=""16"" font=""23"">B. </text><text top=""775"" left=""193"" width=""598"" height=""16"" font=""23"">The Prohibitions on the Imports of Animals, Meat and Animal Products from </text><text top=""792"" left=""193"" width=""602"" height=""16"" font=""23"">the Patagonia Region Are Inconsistent with the SPS Agreement and the </text><text top=""808"" left=""193"" width=""87"" height=""16"" font=""23"">GATT 1994 </text></p><p number=""41."" style=""6""><text top=""841"" left=""108"" width=""684"" height=""16"" font=""0"">41.  Argentina challenges the application of the prohibitions contained in Part 94 Title 9 of the </text>
<text top=""857"" left=""108"" width=""683"" height=""16"" font=""0"">C.F.R., that have been maintained by the United States for more than eleven years, on imports of </text>
<text top=""874"" left=""108"" width=""688"" height=""16"" font=""0"">animals, meat and other animal products from the Patagonia region, as a result of the </text>
<text top=""890"" left=""108"" width=""622"" height=""16"" font=""0"">United States' failure to recognize this region as FMD-free (the ""U.S. Patagonia Measure""). </text>
</p><p number=""42."" style=""6""><text top=""925"" left=""108"" width=""683"" height=""16"" font=""0"">42.  The ""U.S. Patagonia Measure"" is an SPS measure because it aims to protect the health and </text>
<text top=""941"" left=""108"" width=""683"" height=""16"" font=""0"">life of animals in the U.S. territory from risks arising from the entry, establishment or spread of </text>
<text top=""958"" left=""108"" width=""683"" height=""16"" font=""0"">FMD. In addition, as an import ban, application of this measure directly affects international trade </text>
<text top=""974"" left=""108"" width=""682"" height=""16"" font=""0"">and is inconsistent with, <i>inter alia</i>, Articles 2, 3, 5, 6 and 10 of the SPS agreement. Thus, the U.S. </text>
<text top=""990"" left=""108"" width=""347"" height=""16"" font=""0"">Patagonia Measure is inconsistent with Article 1.1. </text>
</p><p number=""43."" style=""6""><text top=""1025"" left=""108"" width=""689"" height=""16"" font=""0"">43.  The U.S. Patagonia Measure is not based on international standards, guidelines or </text>
<text top=""1041"" left=""108"" width=""689"" height=""16"" font=""0"">recommendations as required under Article 3.1. While the United States has promulgated </text>
<text top=""1058"" left=""108"" width=""686"" height=""16"" font=""0"">regulations that appear to recognize OIE standards in regard to regionalization, in regard to </text>
<text top=""1074"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina they are empty words. The favorable risk assessment for Patagonia South in 2005 and </text>
<text top=""1090"" left=""108"" width=""573"" height=""16"" font=""0"">the proposed rulemaking in 2007 have not been followed up with final rulemaking.  </text>
<p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- B-9 - </text>
</p></p></page>
<page number=""19"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""44."" style=""6""><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">44.  The United States cannot claim that it has based its measures on international standards </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">simply because it speaks words along those lines. It must apply them in practice. In regards to </text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina and the issue of regionalization, the United States has acted in the exact opposite </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">manner of the OIE standards. OIE standards expressly embrace regionalization and have been </text>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">applied to Argentina for over a decade. The United States, however, has studiously avoided the </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">regional approach to Argentina for more than 11 years. A measure cannot be said to be based on, </text>
<text top=""226"" left=""108"" width=""682"" height=""16"" font=""0"">built upon or supported by that which it is opposite to. Thus, it is clear that application of the ""U.S. </text>
<text top=""242"" left=""108"" width=""686"" height=""16"" font=""0"">Patagonia Measure"" is not based on the OIE standards for regionalization and is, therefore, </text>
<text top=""259"" left=""108"" width=""358"" height=""16"" font=""0"">inconsistent with Article 3.1 of the SPS Agreement.  </text>
</p><p number=""45."" style=""6""><text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">45.  There has been no FMD outbreak in Patagonia for over 20 years &#8211; since 1976 in Patagonia </text>
<text top=""310"" left=""108"" width=""684"" height=""16"" font=""0"">South and since 1994 in Patagonia North B. The 2005 risk assessment for the region has been </text>
<text top=""326"" left=""108"" width=""685"" height=""16"" font=""0"">positive; another risk assessment issued after the establishment of the Panel is also positive, </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">therefore, the continuing application of the prohibitions cannot be based on a valid risk assessment </text>
<text top=""359"" left=""108"" width=""685"" height=""16"" font=""0"">justified by the scientific evidence. The import prohibitions on animals, meat and other animal </text>
<text top=""375"" left=""108"" width=""683"" height=""16"" font=""0"">products resulting from the application of the ""U.S. Patagonia Measure"" are not a consequence of </text>
<text top=""392"" left=""108"" width=""684"" height=""16"" font=""0"">the U.S. ALOP determined in accordance with Article 5. Thus, application of the ""U.S. Patagonia </text>
<text top=""408"" left=""108"" width=""437"" height=""16"" font=""0"">Measure"" is inconsistent with Article 3.3 of the SPS Agreement. </text>
</p><p number=""46."" style=""6""><text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">46.  In order to be consistent with Articles 5.1 and 5.2 there must be a rational and objective </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">relationship between the U.S. Patagonia Measure and the risk assessment. For Patagonia South, a </text>
<text top=""475"" left=""108"" width=""682"" height=""16"" font=""0"">region that has been FMD free since 1976 and for which APHIS issued a favorable risk assessment </text>
<text top=""492"" left=""108"" width=""687"" height=""16"" font=""0"">in 2005, it is clear that there can be no such rational and objective relationship. To the contrary &#8211;  </text>
<text top=""508"" left=""108"" width=""682"" height=""16"" font=""0"">the only risk assessment is favorable but the U.S. measure is applied to Argentina as a prohibition. </text>
<text top=""525"" left=""108"" width=""684"" height=""16"" font=""0"">For Patagonia North B, as of the date of establishment of the Panel APHIS had not issued a risk </text>
<text top=""541"" left=""108"" width=""687"" height=""16"" font=""0"">assessment despite having the necessary information to do so. However, even if the Panel </text>
<text top=""557"" left=""108"" width=""684"" height=""16"" font=""0"">considered the favorable 2014 risk assessment for the entire Patagonia region, its results are at </text>
<text top=""574"" left=""108"" width=""687"" height=""16"" font=""0"">odds with the U.S. measure. Accordingly, the U.S. Patagonia Measure is not rationally and </text>
<text top=""590"" left=""108"" width=""411"" height=""16"" font=""0"">objectively related to the risk assessment under Article 5.1  </text>
</p><p number=""47."" style=""6""><text top=""625"" left=""108"" width=""683"" height=""16"" font=""0"">47.  With respect to Article 5.2, to the extent the risk assessor consulted the scientific evidence, </text>
<text top=""641"" left=""108"" width=""686"" height=""16"" font=""0"">such evidence supported the<i> opposite</i> conclusion from the prohibitive measure that is being </text>
<text top=""657"" left=""108"" width=""683"" height=""16"" font=""0"">applied. APHIS has issued a risk assessment for Patagonia South, its conclusions do not support </text>
<text top=""674"" left=""108"" width=""685"" height=""16"" font=""0"">the measure at issue, in the sense of Article 5.1. Additionally, the prohibitions are applied to </text>
<text top=""690"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia North B with no underlying risk assessment. Thus, in the absence of sufficient scientific </text>
<text top=""707"" left=""108"" width=""684"" height=""16"" font=""0"">evidence supporting the import prohibitions imposed by application of the measure at issue, the </text>
<text top=""723"" left=""108"" width=""618"" height=""16"" font=""0"">United States is also in violation of its obligations under Article 5.2 of the SPS Agreement<i><b>. </b></i></text>
</p><p number=""48."" style=""6""><text top=""757"" left=""108"" width=""689"" height=""16"" font=""0"">48.  Argentina considers that, since the application of the ""U.S. Patagonia Measure"" is </text>
<text top=""774"" left=""108"" width=""683"" height=""16"" font=""0"">inconsistent with Articles 5.1 and 5.2 of the SPS Agreement, by implication it is also inconsistent </text>
<text top=""790"" left=""108"" width=""683"" height=""16"" font=""0"">with Article 2.2. Moreover, even if one assumes, <i>arguendo</i>, that there has been a risk assessment </text>
<text top=""807"" left=""108"" width=""685"" height=""16"" font=""0"">conducted and applied in support of the prohibitions of imports of animals, meat and animal </text>
<text top=""823"" left=""108"" width=""684"" height=""16"" font=""0"">products from Patagonia, it is clear that the ""U.S. Patagonia Measure"" is applied beyond what is </text>
<text top=""839"" left=""108"" width=""683"" height=""16"" font=""0"">necessary to protect animal life or health and is not based on scientific principles nor maintained </text>
<text top=""856"" left=""108"" width=""685"" height=""16"" font=""0"">with sufficient scientific evidence. Both the 2005 and the 2014 risk assessments for Patagonia </text>
<text top=""872"" left=""108"" width=""682"" height=""16"" font=""0"">South and Patagonia up to the rio Negro, respectively, were favorable to recognition of the region </text>
<text top=""889"" left=""108"" width=""687"" height=""16"" font=""0"">as FMD-free. Considering the previous panel and Appellate Body views that a measure not </text>
<text top=""905"" left=""108"" width=""682"" height=""16"" font=""0"">supported by a valid risk assessment is necessarily not supported by scientific evidence within the </text>
<text top=""922"" left=""108"" width=""682"" height=""16"" font=""0"">meaning of Article 2.2, it must follow that application of the ""U.S. Patagonia Measure"" in a manner </text>
<text top=""938"" left=""108"" width=""508"" height=""16"" font=""0"">inconsistent with Articles 5.1 and 5.2 is also inconsistent with Article 2.2.  </text>
</p><p number=""49."" style=""6""><text top=""972"" left=""108"" width=""685"" height=""16"" font=""0"">49.  Argentina has also demonstrated that Article 5.7 does not apply. In <i>Japan &#8211; Agricultural </i></text>
<text top=""989"" left=""108"" width=""612"" height=""16"" font=""8""><i>Products II</i>, the Appellate Body laid out four cumulative steps to the Article 5.7 analysis;</text>
<footnote top=""987"" left=""720"" width=""9"" height=""11"" font=""15"" number=""8"" ref="""" dis=""""/>
<text top=""989"" left=""729"" width=""61"" height=""16"" font=""0"">a failure </text>
<text top=""1005"" left=""108"" width=""685"" height=""16"" font=""0"">to meet any one will mean the measure is not a provisional measure within the meaning of </text>
<text top=""1022"" left=""108"" width=""685"" height=""16"" font=""0"">Article 5.7. The United States has concurred at the OIE that the scientific information justified </text>
<text top=""1038"" left=""108"" width=""683"" height=""16"" font=""0"">designation of the Patagonia region as FMD-free without vaccination. The United States conducted </text>
<text top=""1054"" left=""108"" width=""683"" height=""16"" font=""0"">a risk assessment in 2005 and confirmed its view of the scientific evidence in regard to Patagonia </text>
<text top=""1071"" left=""108"" width=""687"" height=""16"" font=""0"">South. The United States has received updated information on Patagonia South, as well as </text>
<text top=""1087"" left=""108"" width=""684"" height=""16"" font=""0"">Patagonia North B, in 2008 and has conducted further site visits in 2009. Certainly, there is no </text>
<text top=""1104"" left=""108"" width=""684"" height=""16"" font=""0"">contrary scientific evidence on the Patagonia region. Thus, the United States has acknowledged </text>
<p><text top=""1140"" left=""155"" width=""409"" height=""15"" font=""11""> Appellate Body Report in  <i>Japan &#8211; Agricultural Products II </i>at &#182; 89. </text>
</p><p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-10 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">that there is sufficient information to evaluate the risks and, therefore, has failed to fulfill the first </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">step of the requirements for a provisional measure. If any further evidence is required, the </text>
<text top=""160"" left=""108"" width=""685"" height=""16"" font=""0"">United States has not sought it; the United States has put the full burden on Argentina, thus </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">flipping the whole structure of Article 5.7 upside down. And, finally, because the application of </text>
<text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">measure has been maintained far beyond a reasonable period of time, it is not justified as a </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">provisional measure under Article 5.7, therefore application of the ""U.S. Patagonia Measure"" is not </text>
<text top=""226"" left=""108"" width=""346"" height=""16"" font=""0"">consistent with Article 2.2 of the SPS Agreement.  </text>
</p></p></page>
<page number=""20"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""50."" style=""6""><text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">50.  Under Article 5.4, the United States has an obligation to establish its ALOP with a goal of </text>
<text top=""277"" left=""108"" width=""686"" height=""16"" font=""0"">minimizing negative trade effects. By not determining its ALOP in a consistent and properly </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">articulated manner to allow Members to understand which ALOP they should measure against, the </text>
<text top=""310"" left=""108"" width=""684"" height=""16"" font=""0"">United States cannot possibly claim to minimize negative trade effects and act consistently with </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">Article 5.4. Moreover, the application of the ""U.S. Patagonia Measure"" to Argentina, which reflects </text>
<text top=""342"" left=""108"" width=""685"" height=""16"" font=""0"">the U.S. ALOP in regards to FMD, results in a ban on imports that maximizes negative trade </text>
<text top=""359"" left=""108"" width=""386"" height=""16"" font=""0"">effects. This constitutes a direct violation of Article 5.4.  </text>
</p><p number=""51."" style=""6""><text top=""393"" left=""108"" width=""684"" height=""16"" font=""0"">51.  Application of the U.S. Patagonia Measure is more restrictive than necessary to meet the </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">U.S. ALOP, as required under Article 5.6. Therefore, the issue becomes whether there are other </text>
<text top=""426"" left=""108"" width=""684"" height=""16"" font=""0"">measures reasonably available taking into account technical and economic feasibility to achieve </text>
<text top=""443"" left=""108"" width=""397"" height=""16"" font=""0"">the U.S. ALOP, that are significantly less trade restrictive.</text>
<footnote top=""441"" left=""505"" width=""6"" height=""11"" font=""15"" number=""9"" ref="""" dis=""""/>
<text top=""443"" left=""511"" width=""280"" height=""16"" font=""0"">  Such alternative measures exist. First, </text>
<text top=""459"" left=""108"" width=""688"" height=""16"" font=""0"">the United States can easily apply the available OIE recommendations on zoning and on </text>
<text top=""475"" left=""108"" width=""683"" height=""16"" font=""0"">recognition of a region' sanitary status. Second, as Argentina demonstrated, the Patagonia region </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">should be treated as FMD-free in the same manner as the Brazilian State of Santa Catarina. The </text>
<text top=""508"" left=""108"" width=""684"" height=""16"" font=""0"">sanitary situation in Santa Catarina is similar in that it is internationally classified as FMD-free </text>
<text top=""525"" left=""108"" width=""686"" height=""16"" font=""0"">without vaccination although it borders regions that are FMD-free with vaccination. The only </text>
<text top=""541"" left=""108"" width=""685"" height=""16"" font=""0"">conditions imposed on imports from Santa Catarina are the requirements of 9 C.F.R. &#167; 94.11 </text>
<text top=""557"" left=""108"" width=""684"" height=""16"" font=""0"">which are applicable to a number of countries and regions in proximity to FMD-affected areas. </text>
<text top=""574"" left=""108"" width=""683"" height=""16"" font=""0"">These would be acceptable and sufficient to achieve the United States' ALOP in regard to imports </text>
<text top=""590"" left=""108"" width=""685"" height=""16"" font=""0"">from the Patagonia region too. Clearly, they would also be less trade restrictive that the total </text>
<text top=""607"" left=""108"" width=""683"" height=""16"" font=""0"">import prohibition currently in place. Therefore, the application of the ""U.S. Patagonia Measure"" is </text>
<text top=""623"" left=""108"" width=""353"" height=""16"" font=""0"">inconsistent with Article 5.6 of the SPS Agreement. </text>
</p><p number=""52."" style=""6""><text top=""657"" left=""108"" width=""682"" height=""16"" font=""0"">52.  Further, application of the ""U.S. Patagonia Measure"" arbitrarily or unjustifiably discriminates </text>
<text top=""674"" left=""108"" width=""686"" height=""16"" font=""0"">against imports from Patagonia and constitutes a disguised restriction on international trade </text>
<text top=""690"" left=""108"" width=""683"" height=""16"" font=""0"">inconsistent with Article 2.3. This discrimination takes two forms. On the one hand, Argentina has </text>
<text top=""707"" left=""108"" width=""686"" height=""16"" font=""0"">been denied effective access to the United States regulatory processes while other Members, </text>
<text top=""723"" left=""108"" width=""562"" height=""16"" font=""0"">including Brazil, Japan, the United Kingdom and Uruguay have had ready access.  </text>
</p><p number=""53."" style=""6""><text top=""757"" left=""108"" width=""682"" height=""16"" font=""0"">53.  On the other hand, in regard to substantive discrimination, Patagonia has been arbitrarily or </text>
<text top=""774"" left=""108"" width=""682"" height=""16"" font=""0"">unjustifiably discriminated against, as compared to the Brazilian State of Santa Catarina and Chile. </text>
<text top=""790"" left=""108"" width=""683"" height=""16"" font=""0"">The United States has affirmatively stated that the situation in Patagonia South is the same as in </text>
<text top=""807"" left=""108"" width=""686"" height=""16"" font=""0"">Chile. Given the subsequent international recognition that Patagonia North B is in the same </text>
<text top=""823"" left=""108"" width=""684"" height=""16"" font=""0"">sanitary situation as Patagonia South, it follows that the Patagonia region is similar to Chile for </text>
<text top=""839"" left=""108"" width=""687"" height=""16"" font=""0"">these purposes. In regard to Santa Catarina, the sanitary situations are similar; the only </text>
<text top=""856"" left=""108"" width=""683"" height=""16"" font=""0"">distinction is that Brazil was able to obtain access pursuant to a settlement of an unrelated WTO </text>
<text top=""872"" left=""108"" width=""687"" height=""16"" font=""0"">dispute. Finally, the application of the prohibitions purports to be SPS-based and has been </text>
<text top=""889"" left=""108"" width=""687"" height=""16"" font=""0"">maintained for more than eleven years. However, considering the OIE classification of the </text>
<text top=""905"" left=""108"" width=""682"" height=""16"" font=""0"">Patagonia region, the way other Members have been treated and the sort of concerns expressed in </text>
<text top=""922"" left=""108"" width=""684"" height=""16"" font=""0"">relation to the 2007 proposed rule, the application of the ""U.S. Patagonia Measure"" obviously is </text>
<text top=""938"" left=""108"" width=""682"" height=""16"" font=""0"">politically driven and is a disguised restriction on international trade. For those reasons, Argentina </text>
<text top=""954"" left=""108"" width=""675"" height=""16"" font=""0"">considers that the ""U.S. Patagonia Measure"" is inconsistent with Article 2.3 of the SPS Agreement. </text>
</p><p number=""54."" style=""6""><text top=""989"" left=""108"" width=""684"" height=""16"" font=""0"">54.  The United States has failed to observe the regionalization obligations in Articles 6.1 and </text>
<text top=""1005"" left=""108"" width=""682"" height=""16"" font=""0"">6.2. First, the United States has not accorded proper consideration to the long periods of FMD-free </text>
<text top=""1022"" left=""108"" width=""686"" height=""16"" font=""0"">status of the Patagonia region. While this was taken into account for Santa Catarina, it was </text>
<text top=""1038"" left=""108"" width=""683"" height=""16"" font=""0"">obviously not for the Patagonia region. The United States has repeatedly stated its confidence in </text>
<text top=""1054"" left=""108"" width=""683"" height=""16"" font=""0"">the Argentine veterinary service SENASA, yet it was not properly considered. Given that the U.S. </text>
<text top=""1071"" left=""108"" width=""682"" height=""16"" font=""0"">Patagonia Measure is not adapted to the sanitary characteristics of the Patagonia Region and does </text>
<text top=""1087"" left=""108"" width=""685"" height=""16"" font=""0"">not take into account the level of prevalence of specific diseases or pests nor the appropriate </text>
<p><text top=""1126"" left=""155"" width=""581"" height=""15"" font=""11""> Appellate Body Report in <i>Australia &#8211; Apples</i> at &#182; 337; citing Appellate Body Report, <i>Australia &#8211; </i></text>
<text top=""1140"" left=""108"" width=""93"" height=""15"" font=""16""><i>Salmon</i>, &#182; 194 </text>
</p><p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-11 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">criteria or guidelines of the OIE, the U.S. Patagonia Measure is not consistent with Article 6.1. </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">Further, because the obligations contained in Article 6.2 particularize and supplement the more </text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""0"">broad obligations established by Article 6.1, there is also a violation of Article 6.2. From the </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">language of the provision and its location within Article 6, it is clear that the lack of recognition of </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">the Patagonia region demonstrates that the recognition of the concept of disease-free areas by the </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">United States is not based on the factors listed in Article 6.2. However, given the favorable nature </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">of all these factors, which have essentially been agreed to by the U.S. authorities, it is clear that </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">the United States, in maintaining the application of the prohibitions contained in Part 94, Title 9 of </text>
<text top=""259"" left=""108"" width=""650"" height=""16"" font=""0"">the CFR to Patagonia Region has not acted in conformity with its obligations under Article 6.2.  </text>
</p></p></page>
<page number=""21"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""55."" style=""6""><text top=""293"" left=""108"" width=""686"" height=""16"" font=""0"">55.  The United States has not accorded Argentina special and differential treatment in the </text>
<text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">application of the U.S. Patagonia Measure. Article 10.1, read together with Article 10.2,  imposes a </text>
<text top=""326"" left=""108"" width=""686"" height=""16"" font=""0"">broad and unqualified obligation to take account of the special needs of developing country </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">Members,  with  a  view  to  maintain  trade  flows  from  developing  country  Members.  Here,  the </text>
<text top=""359"" left=""108"" width=""687"" height=""16"" font=""0"">United States acted swiftly to reopen access to the U.S. market to imports from developed </text>
<text top=""375"" left=""108"" width=""683"" height=""16"" font=""0"">countries like Japan and the U.K. after they experienced an outbreak. In contrast, the Patagonia </text>
<text top=""392"" left=""108"" width=""684"" height=""16"" font=""0"">Region has not enjoyed full and effective access to the U.S. regulatory processes despite being </text>
<text top=""408"" left=""108"" width=""686"" height=""16"" font=""0"">FMD-free for more than 20 years. This is exactly the opposite of the special and differential </text>
<text top=""425"" left=""108"" width=""682"" height=""16"" font=""0"">treatment that should be accorded Argentina. As a developing country it should have better access </text>
<text top=""441"" left=""108"" width=""687"" height=""16"" font=""0"">for risk assessments and rulemakings, not pushed aside for years while developed country </text>
<text top=""457"" left=""108"" width=""684"" height=""16"" font=""0"">Members have their interests taken care of promptly. Therefore, the United States has failed to </text>
<text top=""474"" left=""108"" width=""683"" height=""16"" font=""0"">accord Argentina special and differential treatment in application of its SPS measures as required </text>
<text top=""490"" left=""108"" width=""270"" height=""16"" font=""0"">by Article 10:1 of the SPS Agreement.  </text>
</p><p number=""56."" style=""6""><text top=""525"" left=""108"" width=""684"" height=""16"" font=""0"">56.  Last, the United States has acted inconsistently with its obligations under Articles I:1 and </text>
<text top=""541"" left=""108"" width=""686"" height=""16"" font=""0"">XI:1 of the GATT 1994. As to Article I:1, the United States has offered advantages to other </text>
<text top=""557"" left=""108"" width=""682"" height=""16"" font=""0"">Members that it has not accorded immediately and unconditionally to Argentina. These include the </text>
<text top=""574"" left=""108"" width=""685"" height=""16"" font=""0"">advantage provided Brazil (and its State of Santa Catarina) in its ability to export subject to </text>
<text top=""590"" left=""108"" width=""684"" height=""16"" font=""0"">certain protocols, while Argentina's territory located south of the r&#237;o Negro is subject to several </text>
<text top=""607"" left=""108"" width=""682"" height=""16"" font=""0"">prohibitions maintained through the ""U.S. Patagonia Measure"". Furthermore, the United States has </text>
<text top=""623"" left=""108"" width=""684"" height=""16"" font=""0"">accorded other Members, including Uruguay, Brazil, the United Kingdom and Japan, prompt and </text>
<text top=""639"" left=""108"" width=""684"" height=""16"" font=""0"">efficient access to the required regulatory processes while Argentina has been denied access to </text>
<text top=""656"" left=""108"" width=""682"" height=""16"" font=""0"">these administrative processes for years. The products at issue are clearly like and the advantages </text>
<text top=""672"" left=""108"" width=""683"" height=""16"" font=""0"">have not been accorded to Argentina immediately and unconditionally. In regard to Article XI, the </text>
<text top=""689"" left=""108"" width=""684"" height=""16"" font=""0"">analysis is straight-forward. The U.S. Patagonia Measure applies and maintains a prohibition on </text>
<text top=""705"" left=""108"" width=""683"" height=""16"" font=""0"">importation on animals, meat and other animal products from the FMD-free region of Patagonia. </text>
<text top=""721"" left=""108"" width=""641"" height=""16"" font=""0"">This operates as a zero quota and thus clearly is prohibited by Article XI:1 of the GATT 1994. </text>
</p><p number=""57."" style=""6""><text top=""756"" left=""108"" width=""687"" height=""16"" font=""0"">57.  Argentina has demonstrated that the application of the ""U.S. Patagonia Measure "" is </text>
<text top=""772"" left=""108"" width=""684"" height=""16"" font=""0"">inconsistent with Articles 1.1; 2.2; 2.3; 3.1; 3.3; 5.1; 5.2; 5.4; 5.6; 6.1; 6.2 and 10.1 of the </text>
<text top=""789"" left=""108"" width=""488"" height=""16"" font=""0"">SPS Agreement as well as with Articles I:1 and XI:1 of the GATT 1994. </text>
</p><p number=""C."" style=""1""><text top=""823"" left=""151"" width=""19"" height=""16"" font=""23"">C. </text><text top=""823"" left=""193"" width=""383"" height=""16"" font=""23"">Undue Delay in the Approval Procedures at &#167;92.2  </text></p><p number=""58."" style=""6""><text top=""856"" left=""108"" width=""684"" height=""16"" font=""0"">58.  The U.S. has failed to comply with the requirements of Article 8 and Annex C(1)(a) of the </text>
<text top=""872"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Agreement. These provisions require that ""with respect to any procedure to check and ensure </text>
<text top=""889"" left=""108"" width=""687"" height=""16"" font=""0"">fulfillment of sanitary and phytosanitary measures, &#8230; such procedures are undertaken and </text>
<text top=""905"" left=""108"" width=""682"" height=""16"" font=""0"">completed without undue delay &#8230;"" The APHIS procedures to (1) allow the importation of fresh beef </text>
<text top=""922"" left=""108"" width=""684"" height=""16"" font=""0"">from Argentina and (2) for the recognition of the Patagonia Region as FMD-free, initiated under </text>
<text top=""938"" left=""108"" width=""682"" height=""16"" font=""0"">APHIS' regulations at 9 C.F.R. &#167; 92.2 (the ""Approval Procedures"") are subject to the requirements </text>
<text top=""954"" left=""108"" width=""179"" height=""16"" font=""0"">of Article 8 and Annex C.  </text>
</p><p number=""59."" style=""6""><text top=""989"" left=""108"" width=""691"" height=""16"" font=""0"">59.  First, the regulatory process under &#167;92.2 is an ""approval procedure"" under the </text>
<text top=""1005"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Agreement. Annex C broadly defines ""approval procedures"" as including, <i>inter alia</i>, procedures </text>
<text top=""1022"" left=""108"" width=""682"" height=""16"" font=""0"">for ""sampling, testing and certification."" Because imports of a specific commodity or of all animals </text>
<text top=""1038"" left=""108"" width=""684"" height=""16"" font=""0"">or animal products from a region or country are conditioned upon the evaluation of its animal </text>
<text top=""1054"" left=""108"" width=""685"" height=""16"" font=""0"">health status under 9 C.F.R. &#167; 92.2, these procedures are analogous to those exemplified in </text>
<text top=""1071"" left=""108"" width=""683"" height=""16"" font=""0"">Annex C. Second, the Approval Procedures are imposed to ""ensure"" that the U.S. prohibitions in </text>
<text top=""1087"" left=""108"" width=""683"" height=""16"" font=""0"">Part 94 to allow importation only from those countries and regions which APHIS has declared free </text>
<text top=""1104"" left=""108"" width=""683"" height=""16"" font=""0"">of FMD, or has approved imports of a particular product from a region not considered FMD-free, </text>
<text top=""1120"" left=""108"" width=""684"" height=""16"" font=""0"">are met. In other words, the approval process in &#167; 92.2 serves to ""check and ensure"" that the </text>
<text top=""1136"" left=""108"" width=""685"" height=""16"" font=""0"">prohibitions on imports in 9 C.F.R. part 94 are maintained consistent with APHIS' regulations. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-12 - </text>
</p><p><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">Therefore, the Approval Procedures must comply with Article 8 and Annex C, including the </text>
<text top=""144"" left=""108"" width=""588"" height=""16"" font=""0"">obligation that such procedures be ""undertaken and completed without undue delay."" </text>
</p></p></page>
<page number=""22"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""60."" style=""6""><text top=""178"" left=""108"" width=""685"" height=""16"" font=""0"">60.  The U.S. claims that the procedures at 9 C.F.R. &#167;92.2 to determine the sanitary health </text>
<text top=""195"" left=""108"" width=""686"" height=""16"" font=""0"">status of a region are not within the scope of Article 8 and Annex C because they are not </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">enumerated along with ""control, inspection and approval procedures,"" but Annex C(1) expressly </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">provides a general obligation to ensure that ""<i>any procedure</i>"", which aims to check and ensure the </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">fulfillment of SPS measures complies with those obligations. As the Panel in <i>US-Poultry </i>explains, </text>
<text top=""260"" left=""108"" width=""686"" height=""16"" font=""0"">Annex (C)(1) does not specify nor exclude any type of procedure, as long as it is aimed at </text>
<text top=""277"" left=""108"" width=""688"" height=""16"" font=""0"">checking and ensuring the fulfillment of SPS measures. Nor does Article 8 or Annex C(1) </text>
<text top=""293"" left=""108"" width=""685"" height=""16"" font=""0"">distinguish between procedures covering a specific product or multiple products as the U.S. claims.  </text>
</p><p number=""61."" style=""6""><text top=""328"" left=""108"" width=""682"" height=""16"" font=""0"">61.  The term undue delay is not defined in Annex C. The Appellate Body in <i>Australia &#8211; Apples</i> </text>
<text top=""344"" left=""108"" width=""684"" height=""16"" font=""0"">explained that Annex C(1)(a) requires that relevant procedures ""are undertaken and completed </text>
<text top=""360"" left=""108"" width=""683"" height=""16"" font=""0"">with appropriate dispatch, that is, that they do not involve periods of time that are unwarranted, </text>
<text top=""377"" left=""108"" width=""399"" height=""16"" font=""0"">or otherwise excessive, disproportionate or unjustifiable.""</text>
<footnote top=""375"" left=""507"" width=""11"" height=""11"" font=""15"" number=""10"" ref="""" dis=""""/>
<text top=""377"" left=""519"" width=""272"" height=""16"" font=""0""> To recall the rationale of the Panel in </text>
<text top=""393"" left=""108"" width=""684"" height=""16"" font=""8""><i>EC &#8211; Biotech</i>, ""it is therefore important always to bear in mind that Annex C(1)(a), first clause, </text>
<text top=""410"" left=""108"" width=""623"" height=""16"" font=""0"">implies as a core obligation the obligation to come to a decision on an application.""</text>
<footnote top=""408"" left=""731"" width=""11"" height=""11"" font=""15"" number=""11"" ref=""WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R ; WT/DS292/R ; WT/DS293/R"" dis=""DS293|DS291|DS292""><ftext top=""1140"" left=""160"" width=""497"" height=""15"" font=""11""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, at para. 7.1523. </ftext>
</footnote>
<text top=""410"" left=""742"" width=""47"" height=""16"" font=""0"">    The </text>
<text top=""426"" left=""108"" width=""305"" height=""16"" font=""0"">United States is in breach of that obligation. </text>
</p><p number=""62."" style=""6""><text top=""461"" left=""108"" width=""685"" height=""16"" font=""0"">62.  The time taken by APHIS on Argentina's request to allow the importation of fresh beef </text>
<text top=""477"" left=""108"" width=""683"" height=""16"" font=""0"">clearly exceeds what is reasonably necessary. Between November 2002 and end of 2006, APHIS </text>
<text top=""493"" left=""108"" width=""683"" height=""16"" font=""0"">made additional requests for information to which SENASA responded fully, APHIS made two site </text>
<text top=""510"" left=""108"" width=""684"" height=""16"" font=""0"">visits to Argentina to confirm the information received and seek out data for a quantitative risk </text>
<text top=""526"" left=""108"" width=""682"" height=""16"" font=""0"">assessment. However, since the visit in September 2006, there has been no further progress. The </text>
<text top=""543"" left=""108"" width=""682"" height=""16"" font=""0"">inaction of APHIS was not explained to Argentina, despite specific requests to do so, and is all the </text>
<text top=""559"" left=""108"" width=""683"" height=""16"" font=""0"">more unjustifiable as the sanitary conditions in Argentina continued to improve. This is evidenced </text>
<text top=""575"" left=""108"" width=""677"" height=""16"" font=""0"">by (a) the absence of an outbreak since February 2006;  (b) the recognition of Argentina as FMD-</text>
<text top=""592"" left=""108"" width=""684"" height=""16"" font=""0"">free by the OIE: since 2002, Patagonia South is classified as FMD-free without vaccination, and </text>
<text top=""608"" left=""108"" width=""682"" height=""16"" font=""0"">that recognition was extended up to the r&#237;o Negro in 2007, the rest of the country is FMD-free with </text>
<text top=""625"" left=""108"" width=""683"" height=""16"" font=""0"">vaccination since 2007; (c) and the change in leadership and strengthening of SENASA after the </text>
<text top=""641"" left=""108"" width=""687"" height=""16"" font=""0"">2001 outbreak. While the period of inaction on Argentina's request coincides with political </text>
<text top=""657"" left=""108"" width=""685"" height=""16"" font=""0"">measures in the U.S., such as Section 737, aimed at blocking imports of Argentine beef, the </text>
<text top=""674"" left=""108"" width=""688"" height=""16"" font=""0"">political pressure does not legally excuse nor justify the delay. APHIS completed its risk </text>
<text top=""690"" left=""108"" width=""686"" height=""16"" font=""0"">assessment of Uruguay for FMD purposes in the span of one year from its last outbreak. In </text>
<text top=""707"" left=""108"" width=""682"" height=""16"" font=""0"">contrast, Argentina is still waiting for a risk assessment almost seven years after its last outbreak, </text>
<text top=""723"" left=""108"" width=""282"" height=""16"" font=""0"">far longer than is reasonably necessary.  </text>
</p><p number=""63."" style=""6""><text top=""757"" left=""108"" width=""683"" height=""16"" font=""0"">63.  Similarly, there is no justification for the U.S. delay to complete the Approval Procedures to </text>
<text top=""774"" left=""108"" width=""684"" height=""16"" font=""0"">recognize the Patagonia region as an FMD-free zone. Patagonia South has been FMD-free since </text>
<text top=""790"" left=""108"" width=""683"" height=""16"" font=""0"">1976 and Patagonia North B since 1994. The formal approval process was initiated over a decade </text>
<text top=""807"" left=""108"" width=""684"" height=""16"" font=""0"">ago and as of early 2007 it was only one step short of being completed &#8211; that is, the only step </text>
<text top=""823"" left=""108"" width=""683"" height=""16"" font=""0"">missing was the final rulemaking. APHIS' 2005 risk assessment provided a favorable assessment </text>
<text top=""839"" left=""108"" width=""682"" height=""16"" font=""0"">of the sanitary status of Patagonia South. On the basis of this assessment animals, meat and other </text>
<text top=""856"" left=""108"" width=""683"" height=""16"" font=""0"">animal products from Patagonia South should have been allowed access on the U.S. market more </text>
<text top=""872"" left=""108"" width=""683"" height=""16"" font=""0"">than seven years ago. In the six years since 2007, nothing has changed except that the in May </text>
<text top=""889"" left=""108"" width=""682"" height=""16"" font=""0"">2007, the OIE extended the recognition of Patagonia as a region free of FMD up to the rio Negro to </text>
<text top=""905"" left=""108"" width=""684"" height=""16"" font=""0"">include Patagonia North B. APHIS's site visit in February 2009 to Patagonia, including Patagonia </text>
<text top=""922"" left=""108"" width=""683"" height=""16"" font=""0"">North B, confirmed that all requirements for the recognition of Patagonia as FMD-free have been </text>
<text top=""938"" left=""108"" width=""682"" height=""16"" font=""0"">met all along. Considering that all the information regarding Patagonia is favorable to the proposed </text>
<text top=""954"" left=""108"" width=""683"" height=""16"" font=""0"">action, APHIS' failure to take the final step in the approval process &#8211; <i>i.e.</i> the issuance of the final </text>
<text top=""971"" left=""108"" width=""682"" height=""16"" font=""0"">rule &#8211; is a clear example of undue delay. Thus, the failure to complete the Approval Procedures for </text>
<text top=""987"" left=""108"" width=""683"" height=""16"" font=""0"">the importation of fresh beef and for the recognition of the Patagonia Region as FMD-free without </text>
<text top=""1004"" left=""108"" width=""666"" height=""16"" font=""0"">undue delay is a violation of Annex C(1)(a) and consequently of Article 8 of the SPS Agreement.  </text>
</p><p number=""64."" style=""6""><text top=""1038"" left=""108"" width=""689"" height=""16"" font=""0"">64.  The U.S. is also in breach of its procedural obligations under Annex C(1)(b) and </text>
<text top=""1054"" left=""108"" width=""683"" height=""16"" font=""0"">consequently in violation of Article 8. With respect to both of Argentina's pending requests under </text>
<text top=""1071"" left=""108"" width=""683"" height=""16"" font=""0"">&#167;92.2 the U.S. never communicated the anticipated processing period despite Argentina's specific </text>
<text top=""1087"" left=""108"" width=""684"" height=""16"" font=""0"">inquiries on this matter. Following APHIS' site visit to Corrientes in September 2006 there has </text>
<p><text top=""1126"" left=""160"" width=""332"" height=""15"" font=""11""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 437. </text>
</p><p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-13 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">been no further communication to Argentina on the results of APHIS' sanitary assessment. This is </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">also true for the Patagonia Region. Following APHIS' site visit in February 2009, APHIS indicated </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">that it did not require additional information to proceed, but no risk assessment was produced as </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">of the date of the Panel establishment. Thus, the results of APHIS' evaluation have not been </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">promptly communicated to Argentina so that corrective action may be taken if necessary. Finally, </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">the U.S. has not explained the delays in the regulatory process for either of Argentina's pending </text>
<text top=""226"" left=""108"" width=""95"" height=""16"" font=""0"">applications.  </text>
</p></p></page>
<page number=""23"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""65."" style=""6""><text top=""260"" left=""108"" width=""218"" height=""16"" font=""0"">65.  Therefore, the United </text>
<text top=""260"" left=""318"" width=""392"" height=""16"" font=""0"">States has breached its obligations under Annex </text>
<text top=""260"" left=""702"" width=""97"" height=""16"" font=""0"">C(1)(b) to: </text>
<text top=""277"" left=""108"" width=""687"" height=""16"" font=""0"">(i) communicate the processing period, (ii) transmit as soon as possible the results of the </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">procedure in a precise and complete manner, and (iii) provide information about the stage of the </text>
<text top=""310"" left=""108"" width=""688"" height=""16"" font=""0"">procedure and an explanation of the delays. It follows that the United States has acted </text>
<text top=""326"" left=""108"" width=""520"" height=""16"" font=""0"">inconsistently with both Annex C(1)(b) and Article 8 of the SPS Agreement. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-14 - </text>
</p></p></page>
<page number=""24"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""164"" left=""405"" width=""89"" height=""16"" font=""26"">ANNEX B-2 </text></p><p><text top=""198"" left=""245"" width=""407"" height=""16"" font=""6"">SECOND PART OF THE INTEGRATED EXECUTIVE SUMMARY </text>
<text top=""214"" left=""321"" width=""255"" height=""16"" font=""6"">OF THE ARGUMENTS OF ARGENTINA </text>
</p><p number=""I."" style=""0""><text top=""258"" left=""108"" width=""194"" height=""16"" font=""23"">I. INTRODUCTION </text></p><p number=""1."" style=""6""><text top=""291"" left=""108"" width=""21"" height=""16"" font=""0"">1. </text>
<text top=""291"" left=""151"" width=""642"" height=""16"" font=""0"">The principal issues in this dispute remain straightforward. The U.S. has maintained, for </text>
<text top=""307"" left=""108"" width=""683"" height=""16"" font=""0"">more than twelve years, a prohibition on imports of fresh (chilled or frozen) beef from Argentina </text>
<text top=""323"" left=""108"" width=""684"" height=""16"" font=""0"">as a whole and on imports from Patagonia, without scientific justification and has failed to act </text>
<text top=""340"" left=""108"" width=""683"" height=""16"" font=""0"">without undue delay on both of Argentina's pending applications. In fact, the maintenance of the </text>
<text top=""356"" left=""108"" width=""683"" height=""16"" font=""0"">ban for over a decade is in direct conflict with APHIS' findings in the risk assessment of FMD for </text>
<text top=""373"" left=""108"" width=""683"" height=""16"" font=""0"">the Patagonia Region. The ban on imports of beef from Argentina has been maintained without a </text>
<text top=""389"" left=""108"" width=""687"" height=""16"" font=""0"">risk assessment despite the passage of twelve years since Argentina made the request for </text>
<text top=""405"" left=""108"" width=""686"" height=""16"" font=""0"">authorization to import fresh (chilled or frozen) beef, although a recently issued ""draft"" risk </text>
<text top=""422"" left=""108"" width=""587"" height=""16"" font=""0"">assessment for beef from APHIS has corroborated the essential claims of Argentina.   </text>
</p><p number=""2."" style=""6""><text top=""455"" left=""108"" width=""20"" height=""16"" font=""0"">2. </text>
<text top=""455"" left=""151"" width=""641"" height=""16"" font=""0"">The maintenance of these bans for over twelve years is not just a matter of undue delay, </text>
<text top=""471"" left=""108"" width=""688"" height=""16"" font=""0"">but a complete failure of the U.S. system as applied to Argentina. First, contrary to the </text>
<text top=""488"" left=""108"" width=""683"" height=""16"" font=""0"">U.S. arguments, the application of its measures results in a ban on trade in a situation where the </text>
<text top=""504"" left=""108"" width=""683"" height=""16"" font=""0"">OIE Terrestrial Code provides no basis for a ban. In the meeting with the Experts and the Panel, </text>
<text top=""520"" left=""108"" width=""685"" height=""16"" font=""0"">the OIE has confirmed that OIE Terrestrial Code Chapter 8.5 protocols are available alternative </text>
<text top=""537"" left=""108"" width=""682"" height=""16"" font=""0"">measures scientifically accepted at an international level for imports of beef from Argentina and for </text>
<text top=""553"" left=""108"" width=""687"" height=""16"" font=""0"">imports from the Patagonia Region, such that a ban is not justified. Second, the U.S. has </text>
<text top=""570"" left=""108"" width=""684"" height=""16"" font=""0"">discriminated against Argentina as compared to its treatment of the imports of other Members. </text>
<text top=""586"" left=""108"" width=""682"" height=""16"" font=""0"">While the United States rejected the OIE protocols as alternative measures because it asserts that </text>
<text top=""602"" left=""108"" width=""683"" height=""16"" font=""0"">it sets higher standards than the OIE, it also rejected measures that the U.S. already implements </text>
<text top=""619"" left=""108"" width=""682"" height=""16"" font=""0"">with respect to imports from other Members. The OIE and the individual experts appointed by the </text>
<text top=""635"" left=""108"" width=""685"" height=""16"" font=""0"">Panel have reviewed the evidence on the record and their answers unequivocally support the </text>
<text top=""652"" left=""108"" width=""686"" height=""16"" font=""0"">validity of the alternative measures proposed by Argentina, consistent with Article 5.6 of the </text>
<text top=""668"" left=""108"" width=""684"" height=""16"" font=""0"">SPS Agreement that would allow imports from Argentina subject to certain mitigation measures. </text>
<text top=""684"" left=""108"" width=""682"" height=""16"" font=""0"">These alternative measures would guarantee the safe trade of beef from Argentina and of imports </text>
<text top=""701"" left=""108"" width=""200"" height=""16"" font=""0"">from the Patagonia Region.   </text>
</p><p number=""3."" style=""6""><text top=""734"" left=""108"" width=""18"" height=""16"" font=""0"">3. </text>
<text top=""734"" left=""151"" width=""639"" height=""16"" font=""0"">The U.S. main defense is based on Article 5.7, which provides for a qualified exemption from </text>
<text top=""750"" left=""108"" width=""683"" height=""16"" font=""0"">the requirements of Article 2.2. However, at this stage it has become abundantly clear that there </text>
<text top=""766"" left=""108"" width=""683"" height=""16"" font=""0"">never were any U.S. measures covered by Article 5.7. The U.S. arguments have spanned a gamut </text>
<text top=""783"" left=""108"" width=""685"" height=""16"" font=""0"">of positions, one more extreme than the other, from claiming the simultaneous application of </text>
<text top=""799"" left=""108"" width=""686"" height=""16"" font=""0"">Articles 5.1 and 5.7, to the argument that the 2001 Regulations are justified by events that </text>
<text top=""816"" left=""108"" width=""682"" height=""16"" font=""0"">occurred in 2002, to an entire non-textual re-write of Article 5.7 that would support a <i>constructive</i> </text>
<text top=""832"" left=""108"" width=""684"" height=""16"" font=""0"">adoption of a measure. All of these arguments are in error as they are based on a fundamental </text>
<text top=""848"" left=""108"" width=""683"" height=""16"" font=""0"">misunderstanding of Articles 5.1 and 5.7 in regard to the 2001 Regulations and 9 C.F.R. &#167;94.1(b), </text>
<text top=""865"" left=""108"" width=""365"" height=""16"" font=""0"">as well as the broader part 94 of Title 9 of the C.F.R. </text>
</p><p number=""4."" style=""6""><text top=""898"" left=""108"" width=""22"" height=""16"" font=""0"">4. </text>
<text top=""898"" left=""151"" width=""643"" height=""16"" font=""0"">Last, there has been undue delay in the processing of Argentina's requests for import </text>
<text top=""914"" left=""108"" width=""685"" height=""16"" font=""0"">authorization for fresh beef and for the recognition of the Patagonia Region as FMD-free. The </text>
<text top=""931"" left=""108"" width=""682"" height=""16"" font=""0"">undue &#8211; and, in fact, unjustifiable &#8211; delay has been so long now that the United States is left with </text>
<text top=""947"" left=""108"" width=""684"" height=""16"" font=""0"">nothing more than a technical argument that Article 8 and Annex C do not apply to the facts of </text>
<text top=""963"" left=""108"" width=""352"" height=""16"" font=""0"">this case. That is a legally unsustainable position.   </text>
</p><p number=""II."" style=""0""><text top=""996"" left=""108"" width=""24"" height=""16"" font=""23"">II. </text><text top=""996"" left=""150"" width=""337"" height=""16"" font=""23"">CHRONOLOGY OF EVENTS AND MAIN FACTS </text></p><p number=""5."" style=""6""><text top=""1029"" left=""108"" width=""23"" height=""16"" font=""0"">5. </text>
<text top=""1029"" left=""151"" width=""644"" height=""16"" font=""0"">At all stages of these proceedings, the U.S. has mis-stated the scope and content of </text>
<text top=""1045"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina's claims and APHIS' regulations as well, and has followed a strategy of distracting </text>
<text top=""1062"" left=""108"" width=""685"" height=""16"" font=""0"">attention from the relevant facts and characterizing Argentina's claims as being about nothing </text>
<text top=""1078"" left=""108"" width=""683"" height=""16"" font=""0"">more than delay. For more than twelve years the U.S. market has been closed to imports of fresh </text>
<text top=""1095"" left=""108"" width=""683"" height=""16"" font=""0"">beef from Argentina; for eleven years, Argentina has been engaged in the sole procedure under </text>
<text top=""1111"" left=""108"" width=""682"" height=""16"" font=""0"">the U.S. system (the procedure at 9 C.F.R. &#167; 92.2) by which a country or region can gain access to </text>
<text top=""1127"" left=""108"" width=""684"" height=""16"" font=""0"">the U.S. market for its animal products, whether for a specific commodity &#8211;fresh beef- or for a </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-15 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">recognition of a region as free of FMD &#8211;Patagonia Region-.  The most important facts that underlie </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">this dispute are, first, that the United States has not issued a risk assessment for beef from </text>
<text top=""160"" left=""108"" width=""688"" height=""16"" font=""0"">Argentina since the import ban went into effect in 2001, and up to the date of Panel </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">establishment. Second, at the time of the establishment of the Panel, the only published risk </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">assessment for Patagonia -for Patagonia South- was completed nine years ago, and was favorable </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">for importation. In January 2014, after the establishment of the Panel, the United States issued </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">another risk assessment for the Patagonia Region, covering Patagonia South and Patagonia North </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">B, which was also favorable for importation. In August 2014, APHIS further issued a final Notice </text>
<text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">for Patagonia, as well as a ""draft"" risk assessment and a proposed rule for beef, just days before </text>
<text top=""275"" left=""108"" width=""187"" height=""16"" font=""0"">the Second Panel meeting. </text>
</p></p></page>
<page number=""25"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""6."" style=""6""><text top=""308"" left=""108"" width=""21"" height=""16"" font=""0"">6. </text>
<text top=""308"" left=""151"" width=""642"" height=""16"" font=""0"">There is ample evidence on the record showing that the sanitary status of Argentina has </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">improved dramatically compared to the circumstances in 2001: (a) Argentina has not had an FMD </text>
<text top=""341"" left=""108"" width=""684"" height=""16"" font=""0"">outbreak in any part of the country since 2006 (which was very limited, quickly contained and </text>
<text top=""357"" left=""108"" width=""685"" height=""16"" font=""0"">immediately reported), and has not had an FMD outbreak in the Patagonia South region since </text>
<text top=""374"" left=""108"" width=""682"" height=""16"" font=""0"">1976 nor in Patagonia North B since 1994; (b) Patagonia South has been recognized by the OIE as </text>
<text top=""390"" left=""108"" width=""687"" height=""16"" font=""0"">FMD-free without vaccination since 2002, Patagonia North B since 2007 and Argentina has </text>
<text top=""407"" left=""108"" width=""683"" height=""16"" font=""0"">recovered OIE FMD-free with vaccination status in 2007; and those statuses have been confirmed </text>
<text top=""423"" left=""108"" width=""116"" height=""16"" font=""0"">year after year.  </text>
</p><p number=""7."" style=""6""><text top=""456"" left=""108"" width=""19"" height=""16"" font=""0"">7. </text>
<text top=""456"" left=""151"" width=""640"" height=""16"" font=""0"">The United States has identified the supposed unreliability of SENASA as its primary excuse </text>
<text top=""472"" left=""108"" width=""682"" height=""16"" font=""0"">for not moving forward with its regulatory processes for beef and the Patagonia Region. However, </text>
<text top=""489"" left=""108"" width=""685"" height=""16"" font=""0"">this argument is yet another attempt to distract the Panel from the relevant facts. Argentina </text>
<text top=""505"" left=""108"" width=""686"" height=""16"" font=""0"">demonstrated that SENASA has been reorganized and strengthened, a fact confirmed by the </text>
<text top=""521"" left=""108"" width=""686"" height=""16"" font=""0"">assessment of other importing members such as Chile and the E.U., which found SENASA's </text>
<text top=""538"" left=""108"" width=""685"" height=""16"" font=""0"">capabilities to be adequate. These positive assessments are confirmed by the OIE, where the </text>
<text top=""554"" left=""108"" width=""687"" height=""16"" font=""0"">United States has joined in the consensus on the upgrading of Argentina's and Patagonia's </text>
<text top=""571"" left=""108"" width=""406"" height=""16"" font=""0"">officially recognized status for FMD over the past 12 years. </text>
</p><p number=""8."" style=""6""><text top=""603"" left=""108"" width=""19"" height=""16"" font=""0"">8. </text>
<text top=""603"" left=""151"" width=""640"" height=""16"" font=""0"">Further, the United States has specifically approved the efficacy of SENASA and its systems </text>
<text top=""620"" left=""108"" width=""685"" height=""16"" font=""0"">in the 2005 and 2014 risk assessments for Patagonia. Both of these risk assessments give a </text>
<text top=""636"" left=""108"" width=""683"" height=""16"" font=""0"">satisfactory evaluation of SENASA on a comprehensive basis, not just in relation to the Patagonia </text>
<text top=""653"" left=""108"" width=""683"" height=""16"" font=""0"">Region. This was further confirmed in the ""draft"" risk assessment for fresh beef issued in August </text>
<text top=""669"" left=""108"" width=""682"" height=""16"" font=""0"">2014, which was favorable for importation under the same protocols as have been applied to fresh </text>
<text top=""685"" left=""108"" width=""216"" height=""16"" font=""0"">beef from Uruguay since 2003. </text>
</p><p number=""9."" style=""6""><text top=""718"" left=""108"" width=""19"" height=""16"" font=""0"">9. </text>
<text top=""718"" left=""151"" width=""640"" height=""16"" font=""0"">With respect to any progress on Argentina's commodity request for fresh beef, remarkably, </text>
<text top=""735"" left=""108"" width=""684"" height=""16"" font=""0"">the United States has very little to say. Indeed, with respect to the fresh beef claim, there has </text>
<text top=""751"" left=""108"" width=""685"" height=""16"" font=""0"">been no further progress on Argentina's request after APHIS visited the country in September </text>
<text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">2006, when it traveled to the site of the 2006 outbreak to gather new information. In September, </text>
<text top=""784"" left=""108"" width=""683"" height=""16"" font=""0"">2010, the U.S. assured Argentina that it was actually drafting a proposed rule for beef, but, as of </text>
<text top=""800"" left=""108"" width=""357"" height=""16"" font=""0"">the date of Panel establishment, nothing happened. </text>
</p><p number=""10."" style=""6""><text top=""833"" left=""108"" width=""683"" height=""16"" font=""0"">10.  The U.S. now claims that it did not collect all of the information it needed for both the beef </text>
<text top=""850"" left=""108"" width=""686"" height=""16"" font=""0"">and the Patagonia requests until its site visit to Argentina in November 2013. However, in </text>
<text top=""866"" left=""108"" width=""683"" height=""16"" font=""0"">response to direct questions from the Panel, the United States was unable to identify specifically </text>
<text top=""882"" left=""108"" width=""684"" height=""16"" font=""0"">any information that was missing. Indeed, no further information was requested by APHIS after </text>
<text top=""899"" left=""108"" width=""388"" height=""16"" font=""0"">Dr. Clifford's letters of April 2009 and September 2010.  </text>
</p><p number=""11."" style=""6""><text top=""932"" left=""108"" width=""686"" height=""16"" font=""0"">11.  Argentina did not object to the entry into evidence of the 2014 risk assessments and </text>
<text top=""948"" left=""108"" width=""682"" height=""16"" font=""0"">rulemakings introduced by the United States. In particular, the risk assessment and proposed rule </text>
<text top=""964"" left=""108"" width=""684"" height=""16"" font=""0"">for authorizing beef imports from Argentina corroborate key facts and aspects of the arguments </text>
<text top=""981"" left=""108"" width=""687"" height=""16"" font=""0"">that have been made by Argentina in this dispute. Specifically, it is now corroborated and </text>
<text top=""997"" left=""108"" width=""685"" height=""16"" font=""0"">confirmed that the import measures applied to trade in beef from Uruguay would satisfy the </text>
<text top=""1014"" left=""108"" width=""684"" height=""16"" font=""0"">U.S. appropriate level of phytosanitary protection (""ALOP""), whatever precisely that ALOP might </text>
<text top=""1030"" left=""108"" width=""683"" height=""16"" font=""0"">be. Additionally, it cannot be disputed that the sanitary conditions relating to FMD in Uruguay are </text>
<text top=""1046"" left=""108"" width=""683"" height=""16"" font=""0"">similar to those in Argentina from the perspective of Article 2.3 and that the ban on imports from </text>
<text top=""1063"" left=""108"" width=""207"" height=""16"" font=""0"">Argentina was discriminatory. </text>
</p><p number=""12."" style=""6""><text top=""1096"" left=""108"" width=""683"" height=""16"" font=""0"">12.  These developments do not change the nature of Argentina's claims which are based on the </text>
<text top=""1112"" left=""108"" width=""683"" height=""16"" font=""0"">measures as they existed at the time of Panel establishment. Moreover, Argentina does not have </text>
<text top=""1128"" left=""108"" width=""691"" height=""16"" font=""0"">yet the ability to export any beef nor any products from the Patagonia Region to the United States.   </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-16 - </text>
</p></p></page>
<page number=""26"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""III."" style=""0""><text top=""144"" left=""108"" width=""207"" height=""16"" font=""23"">III.  ORDER OF ANALYSIS </text></p><p number=""13."" style=""6""><text top=""177"" left=""108"" width=""686"" height=""16"" font=""0"">13.  The U.S. response to the evidence and arguments presented by Argentina has been to </text>
<text top=""193"" left=""108"" width=""687"" height=""16"" font=""0"">mischaracterize Argentina's claims as being subsumed in its undue delay claims. Thus, the </text>
<text top=""210"" left=""108"" width=""686"" height=""16"" font=""0"">U.S. argues that the Panel should limit its review of Argentina's claims under Articles 8 and </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">Article 5.7. The U.S. approach is deeply flawed because it fails to distinguish between Argentina's </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">claims and the U.S. measures being challenged. Argentina raised several substantive autonomous </text>
<text top=""259"" left=""108"" width=""687"" height=""16"" font=""0"">claims under the SPS Agreement and the GATT 1994, which do not depend on the Panel's </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">resolution of Argentina's claims of undue delay under Article 8 and Annex C and which are based </text>
<text top=""292"" left=""108"" width=""683"" height=""16"" font=""0"">on different U.S. provisions. The Panel should proceed with the analysis of claims in the order in </text>
<text top=""308"" left=""108"" width=""473"" height=""16"" font=""0"">which Argentina has presented them in its First Written Submission.  </text>
</p><p number=""IV."" style=""0""><text top=""341"" left=""108"" width=""110"" height=""16"" font=""23"">IV. LEGAL </text><text top=""341"" left=""203"" width=""79"" height=""16"" font=""23"">CLAIMS </text></p><p number=""A."" style=""1""><text top=""374"" left=""151"" width=""21"" height=""16"" font=""23"">A. </text><text top=""374"" left=""193"" width=""597"" height=""16"" font=""23"">THE U.S. MEASURES ARE NOT BASED ON THE OIE ""STANDARDS, GUIDELINES </text><text top=""390"" left=""193"" width=""202"" height=""16"" font=""23"">OR RECOMMENDATIONS""  </text></p><p number=""14."" style=""6""><text top=""423"" left=""108"" width=""682"" height=""16"" font=""0"">14.  The U.S. maintains a ban on imports of fresh, chilled and frozen beef from Argentina and on </text>
<text top=""439"" left=""108"" width=""683"" height=""16"" font=""0"">imports from the Patagonia Region which is directly the opposite of the OIE standards, guidelines </text>
<text top=""456"" left=""108"" width=""683"" height=""16"" font=""0"">and recommendations because those standards, guidelines or recommendations provide that beef </text>
<text top=""472"" left=""108"" width=""683"" height=""16"" font=""0"">from Argentina is safe to import under the conditions contained in Article 8.5.23 of the Terrestrial </text>
<text top=""489"" left=""108"" width=""260"" height=""16"" font=""0"">Code or even those in Article 8.5.25.  </text>
</p><p number=""15."" style=""6""><text top=""521"" left=""108"" width=""684"" height=""16"" font=""0"">15.  This case is not about a review of the U.S. regulations <i>as such</i>. What is legally relevant </text>
<text top=""538"" left=""108"" width=""683"" height=""16"" font=""0"">under the Article 3.1 analysis is how the U.S. measures are applied to Argentina in comparison to </text>
<text top=""554"" left=""108"" width=""690"" height=""16"" font=""0"">OIE ""standards, guidelines or recommendations."" The issue under Article 3.1 is that the </text>
<text top=""571"" left=""108"" width=""685"" height=""16"" font=""0"">United States imposes measures which produce the exact opposite result of the OIE standards, </text>
<text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">guidelines or recommendations. As such it cannot be said that the U.S. measures are ""based on"" </text>
<text top=""603"" left=""108"" width=""684"" height=""16"" font=""0"">such guidelines. Thus, the U.S. claim that its measures are based on international standards in </text>
<text top=""620"" left=""108"" width=""477"" height=""16"" font=""0"">accordance with Article 3.1 of the SPS Agreement is unsustainable.    </text>
</p><p number=""16."" style=""6""><text top=""653"" left=""108"" width=""684"" height=""16"" font=""0"">16.  Argentina is, in fact, FMD-free. This is recognized by the whole international community, </text>
<text top=""669"" left=""108"" width=""683"" height=""16"" font=""0"">including the United States, through the country status designation of the OIE General Assembly. </text>
<text top=""685"" left=""108"" width=""682"" height=""16"" font=""0"">The U.S. claims to apply a higher standard because it categorizes countries that are FMD-free with </text>
<text top=""702"" left=""108"" width=""683"" height=""16"" font=""0"">vaccination as not being FMD-free. However, even under that approach, a ban on imports is not </text>
<text top=""718"" left=""108"" width=""683"" height=""16"" font=""0"">justified. As the OIE explained, it may be impossible to eradicate FMD from a country or zone in </text>
<text top=""735"" left=""108"" width=""214"" height=""16"" font=""0"">the short term, but even then: </text>
<p><text top=""767"" left=""151"" width=""597"" height=""16"" font=""0"">However, this situation does not justify banning the export of ruminants and ruminant </text>
<text top=""784"" left=""151"" width=""600"" height=""16"" font=""0"">products from these countries. To take such a position would be contrary to the </text>
<text top=""800"" left=""151"" width=""598"" height=""16"" font=""0"">principles in the SPS Agreement, as it would be highly restrictive to trade and would </text>
<text top=""817"" left=""151"" width=""169"" height=""16"" font=""0"">not be based on science.</text>
<footnote top=""815"" left=""319"" width=""6"" height=""11"" font=""15"" number=""1"" ref="""" dis=""""/>
</p></p><p number=""17."" style=""6""><text top=""851"" left=""108"" width=""683"" height=""16"" font=""0"">17.  The United States has consistently attempted to argue that Argentina's claims in regard to </text>
<text top=""868"" left=""108"" width=""687"" height=""16"" font=""0"">Articles 3.1 and 3.3 are based on the U.S. procedures contained in 9 C.F.R. &#167;92.2. Those </text>
<text top=""884"" left=""108"" width=""683"" height=""16"" font=""0"">procedures, to the extent they are actually a ""measure,"" are not the subject of Argentina's claims </text>
<text top=""900"" left=""108"" width=""443"" height=""16"" font=""0"">in regard to fresh beef and imports from the Patagonia Region.</text>
<footnote top=""899"" left=""551"" width=""6"" height=""11"" font=""15"" number=""2"" ref="""" dis=""""><ftext top=""1140"" left=""155"" width=""352"" height=""15"" font=""11""> These procedures are related to the undue delay claim.   </ftext>
</footnote>
<text top=""900"" left=""557"" width=""234"" height=""16"" font=""0""> Argentina's claims are based on </text>
<text top=""917"" left=""108"" width=""684"" height=""16"" font=""0"">the maintenance of the bans on those imports as provided for in the 2001 Regulations and the </text>
<text top=""933"" left=""108"" width=""242"" height=""16"" font=""0"">regulations in 9 C.F.R. Chapter 94. </text>
</p><p number=""18."" style=""6""><text top=""966"" left=""108"" width=""683"" height=""16"" font=""0"">18.  The United States argument that the OIE's disease status recognitions are not a ""standard, </text>
<text top=""982"" left=""108"" width=""683"" height=""16"" font=""0"">guideline, or recommendation"" for purposes of the SPS Agreement and that Members cannot rely </text>
<text top=""999"" left=""108"" width=""682"" height=""16"" font=""0"">on them is both incorrect and illogical when read in the context of the remainder of Article 3. If the </text>
<text top=""1015"" left=""108"" width=""682"" height=""16"" font=""0"">OIE country status recognitions are written out of the SPS Agreement then Members can no longer </text>
<text top=""1032"" left=""108"" width=""686"" height=""16"" font=""0"">rely on the safe harbor of Article 3.2. Such an interpretation would severely undermine the </text>
<text top=""1048"" left=""108"" width=""684"" height=""16"" font=""0"">OIE and prejudice the rights of the vast majority of Members who do not have the resources to </text>
<text top=""1064"" left=""108"" width=""683"" height=""16"" font=""0"">conduct their own risk assessments. Further, the interpretation is incorrect based on the ordinary </text>
<text top=""1081"" left=""108"" width=""683"" height=""16"" font=""0"">meaning of the term ""standards, guidelines or recommendations."" This term is the same in both </text>
<p><text top=""1126"" left=""155"" width=""190"" height=""15"" font=""11""> OIE Response to Question 10. </text>
</p><p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-17 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">Articles 3.1 and 3.2 and there is no textual reason why the exact same term should have different </text>
<text top=""144"" left=""108"" width=""259"" height=""16"" font=""0"">meanings in these two paragraphs.    </text>
</p></p></page>
<page number=""27"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""B."" style=""1""><text top=""177"" left=""151"" width=""22"" height=""16"" font=""23"">B. </text><text top=""177"" left=""193"" width=""598"" height=""16"" font=""23"">THE UNITED STATES HAS ACTED INCONSISTENTLY WITH ITS OBLIGATIONS </text><text top=""193"" left=""193"" width=""156"" height=""16"" font=""23"">UNDER ARTICLE 3.3 </text></p><p number=""19."" style=""6""><text top=""226"" left=""108"" width=""684"" height=""16"" font=""0"">19.  The U.S. also asserts the right under Article 3.3 to apply a higher standard than the OIE, </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">which means that the U.S. measures can only be justified in accordance with Article 3.3. However, </text>
<text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">the text of the SPS Agreement as interpreted by the Appellate Body in <i>EC &#8211; Hormones</i> indicates </text>
<text top=""275"" left=""108"" width=""498"" height=""16"" font=""0"">that a measure is consistent with Article 3.1 <i>or</i> is covered by Article 3.3. </text>
</p><p number=""20."" style=""6""><text top=""308"" left=""108"" width=""683"" height=""16"" font=""0"">20.  In this regard, the United States still has never explained the meaning of the term ""except"" </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">in Article 3.1, unless it is meant to set up a binary, ""either/or"" distinction between Members who </text>
<text top=""341"" left=""108"" width=""687"" height=""16"" font=""0"">base their measures on OIE standards, guidelines or recommendations and those Members </text>
<text top=""357"" left=""108"" width=""182"" height=""16"" font=""0"">asserting a higher ALOP.   </text>
</p><p number=""21."" style=""6""><text top=""390"" left=""108"" width=""687"" height=""16"" font=""0"">21.  Argentina recalls its concern at the outset of this dispute that the United States was </text>
<text top=""407"" left=""108"" width=""685"" height=""16"" font=""0"">attempting to set up a back-door safe harbor by which it could claim that its measures were </text>
<text top=""423"" left=""108"" width=""688"" height=""16"" font=""0"">""based on"" OIE standards and therefore be relieved of the obligations of the rest of the </text>
<text top=""439"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Agreement. Obviously, this would be an absurd result that would allow a Member meeting the </text>
<text top=""456"" left=""108"" width=""685"" height=""16"" font=""0"">lower threshold of ""based on"" in Article 3.1 to have the same or better legal protection as a </text>
<text top=""472"" left=""108"" width=""472"" height=""16"" font=""0"">Member meeting the higher threshold of ""conform to"" in Article 3.2.  </text>
</p><p number=""22."" style=""6""><text top=""505"" left=""108"" width=""682"" height=""16"" font=""0"">22.  Argentina also notes that Article 3.3 independently requires that there be a determination by </text>
<text top=""521"" left=""108"" width=""682"" height=""16"" font=""0"">a Member of its ALOP. The United States has failed to make such a determination. The U.S. states </text>
<text top=""538"" left=""108"" width=""684"" height=""16"" font=""0"">that the <i>sole</i> standard for its ALOP is the very vague statutory authority provided in the Animal </text>
<text top=""554"" left=""108"" width=""683"" height=""16"" font=""0"">Health Protection Act found at 7 U.S.C. &#167;8303. Read literally, this provision would mean that the </text>
<text top=""571"" left=""108"" width=""603"" height=""16"" font=""0"">ALOP is whatever the Secretary of Agriculture determines it to be at any given moment.</text>
<footnote top=""569"" left=""710"" width=""6"" height=""11"" font=""15"" number=""3"" ref="""" dis=""""/>
<text top=""571"" left=""716"" width=""74"" height=""16"" font=""0""> However, </text>
<text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">this provision states nothing of substance whatever, such that it is impossible to understand what </text>
<text top=""603"" left=""108"" width=""682"" height=""16"" font=""0"">the U.S. position is in regard to FMD.  However, the lack of any sort of properly articulated ALOP </text>
<text top=""620"" left=""108"" width=""417"" height=""16"" font=""0"">is, in itself, inconsistent with the requirements of Article 3.3. </text>
</p><p number=""C."" style=""1""><text top=""653"" left=""151"" width=""19"" height=""16"" font=""23"">C. </text><text top=""653"" left=""193"" width=""497"" height=""16"" font=""23"">THE IMPORT BANS ARE NOT SUPPORTED BY ART. 5.1, 5.2 OR 2.2 </text></p><p number=""23."" style=""6""><text top=""685"" left=""108"" width=""687"" height=""16"" font=""0"">23.  Argentina's claims in regard to Article 5.1 relate to the bans contained in the 2001 </text>
<text top=""702"" left=""108"" width=""683"" height=""16"" font=""0"">Regulations and the regulations in 9 C.F.R. Chapter 94 on beef and the subject products from the </text>
<text top=""718"" left=""108"" width=""682"" height=""16"" font=""0"">Patagonia Region. The legal issue is whether the maintenance of the application of those measures </text>
<text top=""735"" left=""108"" width=""688"" height=""16"" font=""0"">over a decade later is pursuant to a valid risk assessment conducted in accordance with </text>
<text top=""751"" left=""108"" width=""688"" height=""16"" font=""0"">Article 5.1. The U.S. argues that the measures at issue were imposed pursuant to a risk </text>
<text top=""767"" left=""108"" width=""227"" height=""16"" font=""0"">assessment under Article 5.1.     </text>
</p><p number=""24."" style=""6""><text top=""800"" left=""108"" width=""682"" height=""16"" font=""0"">24.  The 2001 Regulations were a statement of facts and intentions along with a recitation of the </text>
<text top=""817"" left=""108"" width=""682"" height=""16"" font=""0"">well-known risk of FMD spread. This sort of situation has been addressed before by panels and the </text>
<text top=""833"" left=""108"" width=""690"" height=""16"" font=""0"">Appellate Body, most recently in <i>US &#8211; Poultry (China)</i>, where the Panel rejected the </text>
<text top=""850"" left=""108"" width=""683"" height=""16"" font=""0"">U.S. contention that recitations of risk combined with generalize statements of purported risk do </text>
<text top=""866"" left=""108"" width=""524"" height=""16"" font=""0"">not meet the requirements of a risk assessment under Articles 5.1 and 5.2.  </text>
</p><p number=""25."" style=""6""><text top=""899"" left=""108"" width=""96"" height=""16"" font=""0"">25. Even </text>
<text top=""899"" left=""192"" width=""90"" height=""16"" font=""0"">assuming, </text>
<text top=""899"" left=""269"" width=""524"" height=""16"" font=""8""><i>arguendo</i>, that the 2001 Regulations constituted a risk assessment, the </text>
<text top=""915"" left=""108"" width=""682"" height=""16"" font=""0"">facts underlying them are far out of date. The Panel in <i>Japan &#8211; Apples</i> made it very clear that risk </text>
<text top=""932"" left=""108"" width=""672"" height=""16"" font=""0"">assessments are not static; they must be reviewed or renewed as the scientific evidence evolves.</text>
<footnote top=""930"" left=""779"" width=""6"" height=""11"" font=""15"" number=""4"" ref=""WT/DS245/R|WT/DS245/RW"" dis=""DS245""><ftext top=""1140"" left=""155"" width=""283"" height=""15"" font=""11""> Panel Report in <i>Japan &#8211; Apples</i> at para. 7.12. </ftext>
</footnote>
<text top=""948"" left=""108"" width=""683"" height=""16"" font=""0"">A Member cannot simply conduct a risk assessment and then maintain a ban on imports without </text>
<text top=""964"" left=""108"" width=""688"" height=""16"" font=""0"">the requirement of revisions, as the United States has done. It is deeply ironic that the </text>
<text top=""981"" left=""108"" width=""683"" height=""16"" font=""0"">United States could try to claim that the 2005 Patagonia risk assessment was out of date and yet </text>
<text top=""997"" left=""108"" width=""437"" height=""16"" font=""0"">still claim to rely on a purported 2001 risk assessment in 2014. </text>
</p><p number=""26."" style=""6""><text top=""1030"" left=""108"" width=""683"" height=""16"" font=""0"">26.  The appropriate time periods for conducting risk assessments are determined by the text of </text>
<text top=""1046"" left=""108"" width=""687"" height=""16"" font=""0"">Article 5.1  itself,  <i>i.e.,</i> as appropriate to the circumstances and taking into account the risk </text>
<text top=""1063"" left=""108"" width=""683"" height=""16"" font=""0"">assessment techniques developed by the OIE. The U.S. attempt to assert that the time period for </text>
<text top=""1079"" left=""108"" width=""683"" height=""16"" font=""0"">the qualified exemption in Article 5.7 controls the whole of the SPS Agreement is illogical and not </text>
<p><text top=""1126"" left=""155"" width=""404"" height=""15"" font=""11""> US Responses to the First Questions from the Panel at para. 179. </text>
</p><p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-18 - </text>
</p><p><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">supported by the text. Argentina's approach is also supported by the terms of Article 8 and </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">Annex C, which more broadly require that Members implement their administrative processes </text>
<text top=""160"" left=""108"" width=""158"" height=""16"" font=""0"">without undue delay.   </text>
</p></p></page>
<page number=""28"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""27."" style=""6""><text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">27.  For the beef claim, prior to the establishment of the Panel there has been no review or risk </text>
<text top=""210"" left=""108"" width=""685"" height=""16"" font=""0"">assessment undertaken since 2001, yet many things have changed since that time, as APHIS </text>
<text top=""226"" left=""108"" width=""682"" height=""16"" font=""0"">acknowledged in correspondence on the record. While the U.S. has raised many <i>ex post facto</i> </text>
<text top=""242"" left=""108"" width=""690"" height=""16"" font=""0"">justifications during the course of the dispute for its endless process, none of these </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">U.S. arguments legally excuse the inaction. The United States has acted contrary to its obligations </text>
<text top=""275"" left=""108"" width=""609"" height=""16"" font=""0"">under Articles 5.1 and 5.2 to apply measures that are based on valid risk assessments.   </text>
</p><p number=""28."" style=""6""><text top=""308"" left=""108"" width=""685"" height=""16"" font=""0"">28.  With regard to Patagonia, the United States issued a favorable risk assessment in 2005, </text>
<text top=""324"" left=""108"" width=""684"" height=""16"" font=""0"">followed by a proposed rule in January 2007 to include Patagonia South in the list of FMD free </text>
<text top=""341"" left=""108"" width=""682"" height=""16"" font=""0"">regions referenced at 9 C.F.R. &#167; 94.1(a). However, that favorable risk assessment was never acted </text>
<text top=""357"" left=""108"" width=""683"" height=""16"" font=""0"">on. Article 5.1 requires that a Member's SPS measures be based on a valid risk assessment, but </text>
<text top=""374"" left=""108"" width=""684"" height=""16"" font=""0"">that is not what happened here. There can be no valid excuse for continuing a ban on imports </text>
<text top=""390"" left=""108"" width=""683"" height=""16"" font=""0"">when the only risk assessment on the record prior to the Panel establishment was favorable. The </text>
<text top=""407"" left=""108"" width=""546"" height=""16"" font=""0"">2014 risk assessment for Patagonia, also favorable, reinforces that conclusion.  </text>
</p><p number=""29."" style=""6""><text top=""439"" left=""108"" width=""682"" height=""16"" font=""0"">29.  Because the U.S. measures are inconsistent with the requirements of Articles 5.1 and 5.2, it </text>
<text top=""456"" left=""108"" width=""683"" height=""16"" font=""0"">is Argentina's position that they are also necessarily inconsistent with Article 2.2. In its FWS and </text>
<text top=""472"" left=""108"" width=""682"" height=""16"" font=""0"">SWS Argentina presented considerable evidence that the science of FMD provides for safe trade in </text>
<text top=""489"" left=""108"" width=""451"" height=""16"" font=""0"">beef from Argentina and for imports from the Patagonia Region.   </text>
</p><p number=""D."" style=""1""><text top=""521"" left=""151"" width=""21"" height=""16"" font=""23"">D. </text><text top=""521"" left=""193"" width=""425"" height=""16"" font=""23"">ARTICLE 5.7 HAS NO APPLICABILITY TO THIS DISPUTE </text></p><p number=""30."" style=""6""><text top=""554"" left=""108"" width=""687"" height=""16"" font=""0"">30.  In response to Argentina's argument that the United States failed to comply with its </text>
<text top=""571"" left=""108"" width=""355"" height=""16"" font=""0"">obligations under Article 2.2 of the SPS Agreement,</text>
<footnote top=""569"" left=""463"" width=""6"" height=""11"" font=""15"" number=""5"" ref=""WT/DS367/AB/R"" dis=""DS367""><ftext top=""1082"" left=""155"" width=""635"" height=""15"" font=""11""> As Argentina discussed in its First Written Submission, the Appellate Body has found that a measure </ftext>
<ftext top=""1096"" left=""108"" width=""683"" height=""15"" font=""11"">that was inconsistent with Articles 5.1 and 5.2 of the SPS Agreement was ""by implication"" also inconsistent </ftext>
<ftext top=""1111"" left=""108"" width=""682"" height=""15"" font=""11"">with Article 2.2. <i>See</i> Appellate Body Report in <i>Australia &#8211; Apples</i> at para. 262, citing Appellate Body Report in </ftext>
</footnote>
<text top=""571"" left=""468"" width=""322"" height=""16"" font=""0""> the U.S. has asserted that its measures were </text>
<text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">simultaneously imposed pursuant to risk assessments under Article 5.1 and provisional measures </text>
<text top=""603"" left=""108"" width=""682"" height=""16"" font=""0"">under Article 5.7. Of course, this is a literal impossibility, but it is only one of many problems with </text>
<text top=""620"" left=""108"" width=""77"" height=""16"" font=""0"">the U.S. </text>
<text top=""620"" left=""177"" width=""195"" height=""16"" font=""0"">arguments under Article </text>
<text top=""620"" left=""363"" width=""435"" height=""16"" font=""0"">5.7 in regard to the 2001 Regulations and 9 C.F.R. </text>
<text top=""636"" left=""108"" width=""460"" height=""16"" font=""0"">Chapter 94.1(b) and in the broader part 94 of Title 9 of the C.F.R.  </text>
</p><p number=""31."" style=""6""><text top=""669"" left=""108"" width=""687"" height=""16"" font=""0"">31.  First, it is impossible to argue that Articles 5.1 and 5.7 are simultaneously applicable </text>
<text top=""685"" left=""108"" width=""686"" height=""16"" font=""0"">because the two positions are mutually exclusive. If there is <i>sufficient</i> scientific evidence to </text>
<text top=""702"" left=""108"" width=""685"" height=""16"" font=""0"">conduct a risk assessment under Article 5.1, then, by definition, there cannot be the requisite </text>
<text top=""718"" left=""108"" width=""682"" height=""16"" font=""8""><i>insufficiency</i> of scientific evidence required to invoke Article 5.7. That is to say <i>either</i> the ""relevant </text>
<text top=""735"" left=""108"" width=""682"" height=""16"" font=""0"">scientific evidence is sufficient to perform a risk assessment"" to adopt a measure (Article 5.1.) <i>or</i> </text>
<text top=""751"" left=""108"" width=""683"" height=""16"" font=""0"">the relevant scientific evidence is insufficient to perform a risk assessment and the measure may </text>
<text top=""767"" left=""108"" width=""464"" height=""16"" font=""0"">provisionally be adopted under certain circumstances (Article 5.7.). </text>
</p><p number=""32."" style=""6""><text top=""800"" left=""108"" width=""683"" height=""16"" font=""0"">32.  Second, there never were any U.S. measures covered by Article 5.7. The United States has </text>
<text top=""817"" left=""108"" width=""683"" height=""16"" font=""0"">been reduced to arguing that its 2001 Regulations were justified by events that occurred in 2002, </text>
<text top=""833"" left=""108"" width=""683"" height=""16"" font=""0"">which of course is impossible. It is an indisputable fact that the United States did not adopt any </text>
<text top=""850"" left=""108"" width=""684"" height=""16"" font=""0"">measures whatever in 2002. In response to a question from the Panel to identify the measure </text>
<text top=""866"" left=""108"" width=""684"" height=""16"" font=""0"">adopted in 2002, the U.S. could not respond. Instead, it argued for a reading of Article 5.7 that </text>
<text top=""882"" left=""108"" width=""682"" height=""16"" font=""0"">would allow for a ""constructive"" adoption of a measure, although there is no textual basis for this. </text>
<text top=""899"" left=""108"" width=""547"" height=""16"" font=""0"">But all that happened in 2002 was that Argentina submitted an application</text>
<footnote top=""897"" left=""655"" width=""6"" height=""11"" font=""15"" number=""6"" ref="""" dis=""""/>
<text top=""899"" left=""661"" width=""133"" height=""16"" font=""0"">. In essence, the </text>
<text top=""915"" left=""108"" width=""685"" height=""16"" font=""0"">U.S. approach is equivalent to saying that either the U.S. measure transformed itself upon the </text>
<text top=""932"" left=""108"" width=""686"" height=""16"" font=""0"">2002 application by Argentina or it was Argentina that actually adopted the measure for the </text>
<text top=""948"" left=""108"" width=""683"" height=""16"" font=""0"">United States when it filed its <i>de novo</i> application under 9 C.F.R. &#167; 92.2. The Panel should reject </text>
<text top=""964"" left=""108"" width=""684"" height=""16"" font=""0"">such a distorted reading of Article 5.7. Thus, the U.S. argument fails the most basic test under </text>
<text top=""981"" left=""108"" width=""687"" height=""16"" font=""0"">Article 5.7 that it only provides authority for Members to ""provisionally adopt sanitary and </text>
<text top=""997"" left=""108"" width=""570"" height=""16"" font=""0"">phytosanitary measures."" That is, there must be (1) an adoption, (2) of measures. </text>
</p><p number=""33."" style=""6""><text top=""1030"" left=""108"" width=""686"" height=""16"" font=""0"">33.  Obviously, what the United States is trying to do here is contort the language of the </text>
<text top=""1046"" left=""108"" width=""685"" height=""16"" font=""0"">SPS Agreement to fit the form of the <i>U.S. regulations</i>. But that is completely backwards. The </text>
<p><text top=""1126"" left=""108"" width=""202"" height=""15"" font=""16""><i>Australia &#8211; Salmon</i> at para. 138. </text>
<text top=""1140"" left=""155"" width=""588"" height=""15"" font=""11""> Argentina also submitted an application in August 2003 for imports from the Patagonia Region.  </text>
</p><p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-19 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">United States must implement its measures in conformity with the SPS Agreement, not demand </text>
<text top=""144"" left=""108"" width=""589"" height=""16"" font=""0"">that the Panel twist the interpretation of the SPS Agreement to fit the U.S. measures. </text>
</p></p></page>
<page number=""29"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""34."" style=""6""><text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">34.  Third, while the necessary condition to invoke Article 5.7 in the first place is insufficiency of </text>
<text top=""193"" left=""108"" width=""686"" height=""16"" font=""0"">the scientific evidence, the United States has been unable to identify any scientific evidence </text>
<text top=""210"" left=""108"" width=""685"" height=""16"" font=""0"">(regardless of the breadth of the definition of that term) that was unknown at the time. The </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">U.S. regulations do not include any provision for the United States to seek out the allegedly </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">missing information; instead, the United States ejected Argentina from its regulatory system and </text>
<text top=""259"" left=""108"" width=""685"" height=""16"" font=""0"">put the burden wholly on Argentina to start a <i>de novo</i> application process. There was neither </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">insufficiency of evidence nor any temporal aspect to either the 2001 Regulations or the 9 C.F.R. &#167; </text>
<text top=""292"" left=""108"" width=""130"" height=""16"" font=""0"">94.1 regulations.   </text>
</p><p number=""35."" style=""6""><text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">35.  In its second round of responses to the Panel the United States admits that it did not seek </text>
<text top=""341"" left=""108"" width=""142"" height=""16"" font=""0"">out any information.</text>
<footnote top=""339"" left=""250"" width=""6"" height=""11"" font=""15"" number=""7"" ref="""" dis=""""><ftext top=""1126"" left=""155"" width=""584"" height=""15"" font=""11""> Responses of the United States to the Panel's Questions Following the Second Panel Meeting at </ftext>
</footnote>
<text top=""341"" left=""256"" width=""535"" height=""16"" font=""0""> Rather, its procedures were triggered by the application filed by Argentina </text>
<text top=""357"" left=""108"" width=""685"" height=""16"" font=""0"">under 9 C.F.R. &#167;92.2. Without an initiative from Argentina in the form of its application, the </text>
<text top=""374"" left=""108"" width=""688"" height=""16"" font=""0"">U.S. measures would be applied without any review. That is simply inconsistent with the </text>
<text top=""390"" left=""108"" width=""683"" height=""16"" font=""0"">requirement of Article 5.7 that the importing Member seeks out the missing evidence and review </text>
<text top=""407"" left=""108"" width=""682"" height=""16"" font=""0"">the measure. The obligation of the importing Member is not just to sit back and wait to see if some </text>
<text top=""423"" left=""108"" width=""682"" height=""16"" font=""0"">new evidence happens to be submitted. The obligation is for the importing Member to seek out the </text>
<text top=""439"" left=""108"" width=""690"" height=""16"" font=""0"">evidence to complete what it considered insufficient, when it provisionally adopted an </text>
<text top=""456"" left=""108"" width=""302"" height=""16"" font=""0"">SPS measure because of that insufficiency.  </text>
</p><p number=""36."" style=""6""><text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">36.  Another problem of the U.S. argument on regard to Article 5.7 is the implication that it can </text>
<text top=""505"" left=""108"" width=""690"" height=""16"" font=""0"">maintain a ban under Article 5.7 indefinitely until the exporting Member proves to the </text>
<text top=""521"" left=""108"" width=""685"" height=""16"" font=""0"">United States that there is sufficient evidence to support a risk assessment. That is not what </text>
<text top=""538"" left=""108"" width=""683"" height=""16"" font=""0"">Article 5.7 says. Article 5.7 applies only when there is insufficient scientific evidence. The implied </text>
<text top=""554"" left=""108"" width=""686"" height=""16"" font=""0"">U.S. position is belied by the 2001 Regulations which it asserts were fully supported by the </text>
<text top=""571"" left=""108"" width=""685"" height=""16"" font=""0"">evidence ""through 2002."" If the U.S. considered that there was sufficient evidence during the </text>
<text top=""587"" left=""108"" width=""684"" height=""16"" font=""0"">period from 2002 to 2013, then it was obligated to present such evidence in the form of a risk </text>
<text top=""603"" left=""108"" width=""295"" height=""16"" font=""0"">assessment. However, it has not done so.  </text>
</p><p number=""37."" style=""6""><text top=""636"" left=""108"" width=""683"" height=""16"" font=""0"">37.  Furthermore, it is obvious from these points, that, even were the original U.S. measures in </text>
<text top=""653"" left=""108"" width=""683"" height=""16"" font=""0"">2001 characterized as provisionally adopted measures, certainly after all the passage of time and </text>
<text top=""669"" left=""108"" width=""683"" height=""16"" font=""0"">all the U.S. correspondence and statements over the past several years and the completeness of </text>
<text top=""685"" left=""108"" width=""682"" height=""16"" font=""0"">the information Argentina has submitted, the continued application of the measures cannot still be </text>
<text top=""702"" left=""108"" width=""684"" height=""16"" font=""0"">justified under Article 5.7. The United States admitted there was sufficient scientific evidence in </text>
<text top=""718"" left=""108"" width=""689"" height=""16"" font=""0"">the Clifford letters of April 2009 and September 2010 and in statements made by the </text>
<text top=""735"" left=""108"" width=""301"" height=""16"" font=""0"">U.S. Representative to the SPS Committee. </text>
</p><p number=""38."" style=""6""><text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">38.  The United States has argued that Article 6.3 is integral to an understanding of Article 5.7. </text>
<text top=""784"" left=""108"" width=""687"" height=""16"" font=""0"">This is an incorrect statement of law. The United States' Article 6.3 and 5.7 defenses are </text>
<text top=""800"" left=""108"" width=""682"" height=""16"" font=""0"">incompatible. Article 6.3 stands as a potential affirmative defense by a respondent to claims under </text>
<text top=""817"" left=""108"" width=""687"" height=""16"" font=""0"">Articles 6.1 and 6.2. Article 5.7 applies only in the very narrow situation of insufficiency of </text>
<text top=""833"" left=""108"" width=""687"" height=""16"" font=""0"">scientific evidence and allows a Member to ""provisionally adopt&#8230;measures."" Thus, the two </text>
<text top=""850"" left=""108"" width=""574"" height=""16"" font=""0"">provisions cover entirely different situations and have contrary legal requirements.  </text>
</p><p number=""39."" style=""6""><text top=""882"" left=""108"" width=""682"" height=""16"" font=""0"">39.  The whole premise of the U.S.' Article 6.3 defense is that there is a process that takes place </text>
<text top=""899"" left=""108"" width=""682"" height=""16"" font=""0"">when a Member claims that areas within its territory are disease-free or of low disease prevalence. </text>
<text top=""915"" left=""108"" width=""682"" height=""16"" font=""0"">At that point, a process is begun including permitting reasonable access to the exporting Member's </text>
<text top=""932"" left=""108"" width=""683"" height=""16"" font=""0"">territory. This is an entirely different matter than when a Member provisionally adopts a measure. </text>
<text top=""948"" left=""108"" width=""683"" height=""16"" font=""0"">If the United States argues that it firmly knew about FMD risks from imports of Argentine beef in </text>
<text top=""964"" left=""108"" width=""683"" height=""16"" font=""0"">2001, it cannot simultaneously assert the application of Article 5.7. Similarly, if the United States </text>
<text top=""981"" left=""108"" width=""686"" height=""16"" font=""0"">claims that its process was covered by the terms of Article 6.3, then, there is no issue of </text>
<text top=""997"" left=""108"" width=""686"" height=""16"" font=""0"">provisional adoption of a measure in Article 6.3. Among other things, Article 6.3 requires the </text>
<text top=""1014"" left=""108"" width=""684"" height=""16"" font=""0"">applicant to take the initiative in providing comprehensive information, whereas Article 5.7 puts </text>
<text top=""1030"" left=""108"" width=""683"" height=""16"" font=""0"">the burden on the importing Member to seek out the information that it finds insufficient. Clearly, </text>
<text top=""1046"" left=""108"" width=""682"" height=""16"" font=""0"">the two articles cannot be interpreted to apply in the same situation because that would amount to </text>
<text top=""1063"" left=""108"" width=""161"" height=""16"" font=""0"">conflicting obligations.  </text>
<p><text top=""1140"" left=""108"" width=""86"" height=""15"" font=""11"">paras. 29-30. </text>
</p><p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-20 - </text>
</p></p></page>
<page number=""30"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""40."" style=""6""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">40.  Argentina recalls that it has raised claims under Article 6 only with respect to its Patagonia </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">claims. Therefore, even if Article 5.7, which does not apply here, is ""informed"" by Article 6.3, as </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">the U.S. argues, that interpretation of Article 5.7 would not apply with respect to Argentina's fresh </text>
<text top=""177"" left=""108"" width=""86"" height=""16"" font=""0"">beef claims. </text>
</p><p number=""41."" style=""6""><text top=""210"" left=""108"" width=""96"" height=""16"" font=""0"">41. Even </text>
<text top=""210"" left=""195"" width=""90"" height=""16"" font=""0"">assuming, </text>
<text top=""210"" left=""275"" width=""521"" height=""16"" font=""8""><i>arguendo</i>, that Article 6.3 would be relevant to an interpretation of </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">Article 5.7, based on the facts of this dispute, the United States has nothing to gain from this </text>
<text top=""242"" left=""108"" width=""684"" height=""16"" font=""0"">argument because it has not identified a single information request that remained unanswered. </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina has satisfied every single information request made by APHIS and it has done so a long </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">time ago. The correspondence from Dr. Clifford in 2009 and 2010 necessarily implies that APHIS </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">has long had all the information necessary to complete the regulatory process. This was repeatedly </text>
<text top=""308"" left=""108"" width=""394"" height=""16"" font=""0"">confirmed by the U.S. statements in the SPS Committee. </text>
</p><p number=""E."" style=""1""><text top=""341"" left=""151"" width=""19"" height=""16"" font=""23"">E. </text><text top=""341"" left=""193"" width=""451"" height=""16"" font=""23"">THE U.S. HAS ACTED INCONSISTENTLY WITH ARTICLE 5.4  </text></p><p number=""42."" style=""6""><text top=""374"" left=""108"" width=""682"" height=""16"" font=""0"">42.  The United States has asserted that Article 5.4 imposes no affirmative obligations because it </text>
<text top=""390"" left=""108"" width=""685"" height=""16"" font=""0"">uses the word ""should."" However, that position is not supported by the plain language of the </text>
<text top=""407"" left=""108"" width=""683"" height=""16"" font=""0"">Article 5.4 and the ordinary meaning of ""should"", which, although not as strong as the imperative </text>
<text top=""423"" left=""108"" width=""686"" height=""16"" font=""0"">""shall,"" is affirmative in nature. The Appellate Body has confirmed that ""should"" can, indeed, </text>
<text top=""439"" left=""108"" width=""683"" height=""16"" font=""0"">impose affirmative obligations. Although the requirement to take something into account did not </text>
<text top=""456"" left=""108"" width=""682"" height=""16"" font=""0"">mean that a specific result must be achieved, the obligation is real, it is affirmative and it must be </text>
<text top=""472"" left=""108"" width=""202"" height=""16"" font=""0"">shown in the documentation.</text>
<footnote top=""471"" left=""310"" width=""6"" height=""11"" font=""15"" number=""8"" ref="""" dis=""""/>
<text top=""472"" left=""315"" width=""476"" height=""16"" font=""0""> Therefore, the U.S. has an affirmative obligation to adopt an ALOP </text>
<text top=""489"" left=""108"" width=""298"" height=""16"" font=""0"">which minimizes negative trade effects.      </text>
</p><p number=""43."" style=""6""><text top=""521"" left=""108"" width=""684"" height=""16"" font=""0"">43.  No such efforts of minimizing negative trade effects can be ascertained in this case. In its </text>
<text top=""538"" left=""108"" width=""685"" height=""16"" font=""0"">FWS and SWS Argentina demonstrated that that the U.S. was applying an ALOP in regard to </text>
<text top=""554"" left=""108"" width=""682"" height=""16"" font=""0"">Argentine beef and imports from Patagonia as if it were applying an ALOP based on ""zero risk."" In </text>
<text top=""571"" left=""108"" width=""685"" height=""16"" font=""0"">fact, in its Comments on the experts' responses, the United States has stated that zero risk is </text>
<text top=""587"" left=""108"" width=""274"" height=""16"" font=""0"">exactly what it is requiring of Argentina.</text>
<footnote top=""585"" left=""382"" width=""6"" height=""11"" font=""15"" number=""9"" ref="""" dis=""""/>
</p><p number=""44."" style=""6""><text top=""620"" left=""108"" width=""685"" height=""16"" font=""0"">44.  The ability of the United States to impose this impossible ALOP on Argentina appears to </text>
<text top=""636"" left=""108"" width=""683"" height=""16"" font=""0"">arise from its adoption of a statement of general authorization for the Secretary of Agriculture to </text>
<text top=""653"" left=""108"" width=""683"" height=""16"" font=""0"">protect the population, as its ALOP. That has allowed the United States to arbitrarily declare that </text>
<text top=""669"" left=""108"" width=""687"" height=""16"" font=""0"">nothing Argentina does ever meet this moving standard. It also falls short of a clear and </text>
<text top=""685"" left=""108"" width=""683"" height=""16"" font=""0"">understandable ALOP. The Appellate Body has found that ""the SPS Agreement contains an implicit </text>
<text top=""702"" left=""108"" width=""413"" height=""16"" font=""0"">obligation to determine the appropriate level of protection.""</text>
<footnote top=""700"" left=""521"" width=""11"" height=""11"" font=""15"" number=""10"" ref=""WT/DS18/AB/R"" dis=""DS18""><ftext top=""1111"" left=""160"" width=""397"" height=""15"" font=""11""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, paras. 205 and 207. </ftext>
</footnote>
<text top=""702"" left=""532"" width=""258"" height=""16"" font=""0""> Although it need not be determined </text>
<text top=""718"" left=""108"" width=""686"" height=""16"" font=""0"">in quantitative terms, the level of protection cannot be determined ""with such vagueness or </text>
<text top=""735"" left=""108"" width=""685"" height=""16"" font=""0"">equivocation that the application of the relevant provisions of the SPS Agreement &#8230; becomes </text>
<text top=""751"" left=""108"" width=""83"" height=""16"" font=""0"">impossible.""</text>
<footnote top=""750"" left=""190"" width=""11"" height=""11"" font=""15"" number=""11"" ref="""" dis=""""/>
</p><p number=""45."" style=""6""><text top=""784"" left=""108"" width=""687"" height=""16"" font=""0"">45.  By not determining its ALOP in a consistent and properly articulated manner so that </text>
<text top=""800"" left=""108"" width=""687"" height=""16"" font=""0"">Members can understand which ALOP they should meet, the U.S. cannot possibly claim to </text>
<text top=""817"" left=""108"" width=""682"" height=""16"" font=""0"">minimize negative trade effects and act consistently with Article 5.4. Argentina has also noted that </text>
<text top=""833"" left=""108"" width=""685"" height=""16"" font=""0"">the failure to apply a valid ALOP to imports from Argentina means that the U.S. has also not </text>
<text top=""850"" left=""108"" width=""687"" height=""16"" font=""0"">satisfied the requirements of Article 3.3 and, further, should inform the Panel's analyses of </text>
<text top=""866"" left=""108"" width=""138"" height=""16"" font=""0"">Articles 2.3 and 5.6.</text>
<footnote top=""864"" left=""246"" width=""11"" height=""11"" font=""15"" number=""12"" ref="""" dis=""""/>
</p><p number=""F."" style=""1""><text top=""899"" left=""151"" width=""20"" height=""16"" font=""23"">F. </text><text top=""899"" left=""193"" width=""598"" height=""16"" font=""23"">THE US MEASURES BREACH ARTICLE 5.6 BECAUSE THERE ARE REASONABLY </text><text top=""915"" left=""193"" width=""419"" height=""16"" font=""23"">AVAILABLE AND LESS TRADE RESTRICTIVE MEASURES </text></p><p number=""46."" style=""6""><text top=""948"" left=""108"" width=""685"" height=""16"" font=""0"">46.  The U.S. has acted inconsistently with Article 5.6 because there are reasonably available </text>
<text top=""964"" left=""108"" width=""684"" height=""16"" font=""0"">measures - either the OIE Terrestrial Code recommendations or the import protocols applied by </text>
<text top=""981"" left=""108"" width=""683"" height=""16"" font=""0"">the U.S. to other members &#8211; that would achieve the U.S. ALOP (whatever that may be) because </text>
<text top=""997"" left=""108"" width=""682"" height=""16"" font=""0"">they provide a higher level of protection. These alternative measures are also less trade restrictive </text>
<text top=""1014"" left=""108"" width=""215"" height=""16"" font=""0"">since they allow for safe trade. </text>
<p><text top=""1067"" left=""155"" width=""580"" height=""15"" font=""11""> Appellate Body Report, <i>China &#8211; GOES, </i>para. 132.  The Appellate Body had previously found at </text>
<text top=""1082"" left=""108"" width=""550"" height=""15"" font=""11"">paragraph 130 that the word ""consider"" and ""taking into account"" had the same meaning. </text>
<text top=""1096"" left=""155"" width=""346"" height=""15"" font=""11""> U.S. Comments on Experts' Responses at paras. 18-19. </text>
</p><p><text top=""1126"" left=""160"" width=""113"" height=""15"" font=""11""> <i>Id</i>., at para. 203. </text>
<text top=""1140"" left=""160"" width=""496"" height=""15"" font=""11""> Opening Statement of Argentina at the Second Meeting of the Panel at para. 82. </text>
</p><p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-21 - </text>
</p></p></page>
<page number=""31"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""47."" style=""6""><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">47.  Argentina has suggested that OIE Terrestrial Code Chapter 8.5 protocols are available </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">alternative measures scientifically accepted at the international level for imports of beef from </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina and for imports from the Patagonia Region. The OIE explained in detail in its responses </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">to the Panel that the standards within the OIE Terrestrial Code are based on the highest level of </text>
<text top=""193"" left=""108"" width=""399"" height=""16"" font=""0"">scientific knowledge and expertise. As the OIE explained,  </text>
<p><text top=""226"" left=""151"" width=""598"" height=""16"" font=""0"">""the recommendations in the disease chapters &#8230; are designed to prevent the disease </text>
<text top=""242"" left=""151"" width=""604"" height=""16"" font=""0"">in question being introduced into the importing country. &#8230; Correctly applied, </text>
<text top=""259"" left=""151"" width=""598"" height=""16"" font=""0"">OIE recommendations provide for trade in animals and animal products to take place </text>
<text top=""275"" left=""151"" width=""597"" height=""16"" font=""0"">with an optimal level of animal health security based on the most up to date scientific </text>
<text top=""292"" left=""151"" width=""266"" height=""16"" font=""0"">information and available techniques."" </text>
</p></p><p number=""48."" style=""6""><text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">48.  Thus, it is quite clear that the OIE recommendations are designed to achieve a high ALOP. </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">United States rejected these suggested alternative measures because it asserts that it sets higher </text>
<text top=""359"" left=""108"" width=""177"" height=""16"" font=""0"">standards than the OIE.   </text>
</p><p number=""49."" style=""6""><text top=""392"" left=""108"" width=""682"" height=""16"" font=""0"">49.  However, Argentina has also suggested that in regard to fresh beef, the U.S. could apply the </text>
<text top=""408"" left=""108"" width=""684"" height=""16"" font=""0"">protocol that it applies to Uruguay, found in 9 C.F.R. &#167;94.22, since both Uruguay and Northern </text>
<text top=""425"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina have the same OIE officially recognized FMD status of FMD-free with vaccination. In </text>
<text top=""441"" left=""108"" width=""682"" height=""16"" font=""0"">regard to Patagonia, Argentina has suggested applying the same protocols applied to the FMD free </text>
<text top=""457"" left=""108"" width=""686"" height=""16"" font=""0"">Brazilian State of Santa Catarina (found in 9 C.F.R. &#167;94.11). Considering that the Patagonia </text>
<text top=""474"" left=""108"" width=""685"" height=""16"" font=""0"">Region and Santa Catarina have the same OIE officially-recognized FMD status of free without </text>
<text top=""490"" left=""108"" width=""684"" height=""16"" font=""0"">vaccination, application of the same protocols would respond to the same level of risk and thus </text>
<text top=""507"" left=""108"" width=""682"" height=""16"" font=""0"">provide the same risk mitigation requirements. The U.S. cannot argue that the Uruguay protocol is </text>
<text top=""523"" left=""108"" width=""684"" height=""16"" font=""0"">not a valid alternative measure under Article 5.6, when the U.S. is currently allowing imports of </text>
<text top=""539"" left=""108"" width=""683"" height=""16"" font=""0"">fresh beef from Uruguay and from the FMD free Santa Catarina under these mitigating protocols. </text>
<text top=""556"" left=""108"" width=""686"" height=""16"" font=""0"">Further, these protocols will provide for safe imports that meet the U.S. ALOP because they </text>
<text top=""572"" left=""108"" width=""101"" height=""16"" font=""0"">already do so. </text>
</p><p number=""50."" style=""6""><text top=""605"" left=""108"" width=""683"" height=""16"" font=""0"">50.  The mitigation measure the United States applies to Uruguay beef can safely be applied to </text>
<text top=""621"" left=""108"" width=""682"" height=""16"" font=""0"">Argentine beef. It is similar in nature to the OIE recommendation for infected areas with an official </text>
<text top=""638"" left=""108"" width=""686"" height=""16"" font=""0"">vaccination program, whereas Uruguay is FMD-free with vaccination, just like Argentina. The </text>
<text top=""654"" left=""108"" width=""683"" height=""16"" font=""0"">Uruguay protocols are highly redundant and very safe. The answers provided by the OIE and the </text>
<text top=""671"" left=""108"" width=""686"" height=""16"" font=""0"">individual experts unequivocally support the validity of the alternative measures proposed by </text>
<text top=""687"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina, consistent with Article 5.6, that would allow imports from Argentina subject to certain </text>
<text top=""703"" left=""108"" width=""158"" height=""16"" font=""0"">mitigation measures.   </text>
</p><p number=""51."" style=""6""><text top=""736"" left=""108"" width=""682"" height=""16"" font=""0"">51.  All the experts were in agreement that trade in fresh beef from a country that is FMD-free </text>
<text top=""753"" left=""108"" width=""683"" height=""16"" font=""0"">with vaccination pursuant to the recommendation in Article 8.5.25 of the Terrestrial Code is safe. </text>
<text top=""769"" left=""108"" width=""685"" height=""16"" font=""0"">As the United States also acknowledges, there are no known instances of beef exported under </text>
<text top=""785"" left=""108"" width=""684"" height=""16"" font=""0"">these recommendations transmitting FMD. As confirmed by a consensus of the experts, there is </text>
<text top=""802"" left=""108"" width=""683"" height=""16"" font=""0"">substantial evidence on the record in this dispute that the protocols contained in 9 C.F.R. &#167;94.22 </text>
<text top=""818"" left=""108"" width=""688"" height=""16"" font=""0"">would provide for safe trade in imports of Argentine beef into the United States. This is </text>
<text top=""835"" left=""108"" width=""682"" height=""16"" font=""0"">corroborated by the August 2014 risk assessment and Proposed Rule for fresh beef introduced into </text>
<text top=""851"" left=""108"" width=""160"" height=""16"" font=""0"">evidence by the U.S.    </text>
</p><p number=""52."" style=""6""><text top=""884"" left=""108"" width=""684"" height=""16"" font=""0"">52.  Similarly, the protocol applied to Santa Catarina under 9 C.F.R. &#167; 94.11 would also be an </text>
<text top=""900"" left=""108"" width=""684"" height=""16"" font=""0"">adequate safeguard for the subject products from the Patagonia Region. The United States does </text>
<text top=""917"" left=""108"" width=""683"" height=""16"" font=""0"">not even contest this, as is confirmed by the January 2014 risk assessment. This conclusion was </text>
<text top=""933"" left=""108"" width=""687"" height=""16"" font=""0"">now definitively confirmed by the United States in the recent final notice to recognize the </text>
<text top=""950"" left=""108"" width=""214"" height=""16"" font=""0"">Patagonia Region as FMD-free. </text>
</p><p number=""53."" style=""6""><text top=""982"" left=""108"" width=""683"" height=""16"" font=""0"">53.  It is important to recall that the 2014 risk assessment for Patagonia found that the controls </text>
<text top=""999"" left=""108"" width=""683"" height=""16"" font=""0"">implemented by SENASA in northern Argentina resulted in a very low risk of introduction of FMD </text>
<text top=""1015"" left=""108"" width=""683"" height=""16"" font=""0"">into the Patagonia Region. The experts examined this at the request of the Panel and concluded </text>
<text top=""1032"" left=""108"" width=""683"" height=""16"" font=""0"">that the same assessment would apply to the very low risk of transmission from imports of fresh </text>
<text top=""1048"" left=""108"" width=""683"" height=""16"" font=""0"">beef from northern Argentina to the United States. Dr. Cupit stated that there is no evidence on </text>
<text top=""1064"" left=""108"" width=""683"" height=""16"" font=""0"">the record to detract from APHIS' conclusion that matured, deboned fresh beef imported into the </text>
<text top=""1081"" left=""108"" width=""682"" height=""16"" font=""0"">Patagonia Region from zones in Argentina's territory north of the rio Negro ""<i>has a very low risk of </i></text>
<text top=""1097"" left=""108"" width=""340"" height=""16"" font=""8""><i>introducing the FMD virus</i> <i>into the export region.""</i></text>
<footnote top=""1096"" left=""448"" width=""11"" height=""11"" font=""15"" number=""13"" ref="""" dis=""""><ftext top=""1140"" left=""160"" width=""298"" height=""15"" font=""11""> Dr. Cupit response to Question 46 at para. 384. </ftext>
</footnote>
<text top=""1097"" left=""459"" width=""331"" height=""16"" font=""0""> Similarly, Dr. Batho said that ""The evidence on </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-22 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">the record supports the conclusion that there is a very low risk of matured and deboned fresh beef </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">meat introducing FMD virus into Patagonia. Following on from this, it is obvious that the evidence </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">also supports the conclusion that matured and deboned beef from the rest of Argentina poses a </text>
<text top=""177"" left=""108"" width=""466"" height=""16"" font=""0"">similar or identical risk to other markets as it does to Patagonia.""</text>
<footnote top=""175"" left=""574"" width=""11"" height=""11"" font=""15"" number=""14"" ref="""" dis=""""><ftext top=""1126"" left=""160"" width=""310"" height=""15"" font=""11""> Dr. Batho response to Question 46, at para. 386.  </ftext>
</footnote>
<text top=""177"" left=""585"" width=""206"" height=""16"" font=""0""> All of these conclusions are </text>
<text top=""193"" left=""108"" width=""538"" height=""16"" font=""0"">corroborated by the risk assessment and the proposed rule for fresh beef</text>
<footnote top=""192"" left=""646"" width=""11"" height=""11"" font=""15"" number=""15"" ref="""" dis=""""><ftext top=""1140"" left=""160"" width=""219"" height=""15"" font=""11""> Exhibit USA &#8211; 168, at page 51509. </ftext>
</footnote>
<text top=""193"" left=""657"" width=""136"" height=""16"" font=""0""> published by the </text>
<text top=""210"" left=""108"" width=""306"" height=""16"" font=""0"">United States after the Panel establishment. </text>
</p></p></page>
<page number=""32"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""54."" style=""6""><text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">54.  These alternative measures are clearly less trade restrictive than the current ban on imports </text>
<text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">from Argentina. Finally, the Panel must reject the U.S. argument that the Panel should decline to </text>
<text top=""275"" left=""108"" width=""684"" height=""16"" font=""0"">make findings in regard to Article 5.6. The United States claims that if a domestic regulator has </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">failed to conduct a risk assessment in regard to the proposed alternative measure, then a Member </text>
<text top=""308"" left=""108"" width=""688"" height=""16"" font=""0"">can completely avoid its obligations under Article 5.6 (and Article 2.3). This is manifestly </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">inconsistent with the plain language of Article 5.6 and also with the jurisprudence. There is ample </text>
<text top=""341"" left=""108"" width=""683"" height=""16"" font=""0"">evidence on the record that the protocols applied to Uruguay's imports of fresh beef are safe and </text>
<text top=""357"" left=""108"" width=""684"" height=""16"" font=""0"">applying them, or any similar ones, to Argentine beef would satisfy the U.S. ALOP (whatever it </text>
<text top=""374"" left=""108"" width=""683"" height=""16"" font=""0"">might be). The Panel should find that protocols similar to those in 9 C.F.R. &#167; 94.22 would satisfy </text>
<text top=""390"" left=""108"" width=""429"" height=""16"" font=""0"">the U.S. ALOP regarding imports of fresh beef from Argentina. </text>
</p><p number=""G."" style=""1""><text top=""423"" left=""151"" width=""652"" height=""16"" font=""23"">G.  THE UNITED STATES FAILED TO OBSERVE ITS REGIONALIZATION </text><text top=""439"" left=""193"" width=""311"" height=""16"" font=""23"">OBLIGATIONS IN ARTICLES 6.1 AND 6.2 </text></p><p number=""55."" style=""6""><text top=""472"" left=""108"" width=""690"" height=""16"" font=""0"">55.  Argentina has asserted a violation of Article 6 only with respect to its Patagonia claim.  </text>
<text top=""489"" left=""108"" width=""686"" height=""16"" font=""0"">Therefore, as a jurisdictional matter, Article 6 is not applicable to the fresh beef claim. The </text>
<text top=""505"" left=""108"" width=""683"" height=""16"" font=""0"">U.S. reasoning that Article 6 applies to commodity requests because the word ""product"" is used in </text>
<text top=""521"" left=""108"" width=""683"" height=""16"" font=""0"">Article 6.1 is very unconvincing because the SPS Agreement in general relates to the possibility of </text>
<text top=""538"" left=""108"" width=""499"" height=""16"" font=""0"">one Member exporting a product into the territory of another Member.    </text>
</p><p number=""56."" style=""6""><text top=""571"" left=""108"" width=""686"" height=""16"" font=""0"">56.  What Article 6 directly relates to is a broad statement that Members shall ensure that </text>
<text top=""587"" left=""108"" width=""684"" height=""16"" font=""0"">SPS measures are to be adapted to the sanitary characteristics of the area. Article 6.1 requires </text>
<text top=""603"" left=""108"" width=""685"" height=""16"" font=""0"">Members to take measures that account for the fact that different exporting areas may have </text>
<text top=""620"" left=""108"" width=""683"" height=""16"" font=""0"">different characteristics. Article 6.2 requires recognition of ""concepts"" &#8211; specifically, the ""concepts </text>
<text top=""636"" left=""108"" width=""520"" height=""16"" font=""0"">of pest- or disease-free areas and areas of low pest or disease prevalence."" </text>
</p><p number=""57."" style=""6""><text top=""669"" left=""108"" width=""683"" height=""16"" font=""0"">57.  While the U.S. claims to recognize the ""concepts"" of disease free areas with respect to the </text>
<text top=""685"" left=""108"" width=""685"" height=""16"" font=""0"">Patagonia Region, as illustrated by the 2005 risk assessment and the 2007 proposed rule on </text>
<text top=""702"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia South, it has failed to act on these assessments. Therefore, the U.S. conduct over the </text>
<text top=""718"" left=""108"" width=""684"" height=""16"" font=""0"">last eleven years belies the U.S. contentions on regionalization. That the United States has not </text>
<text top=""735"" left=""108"" width=""682"" height=""16"" font=""0"">complied with Articles 6.1 and 6.2 is confirmed by its failure to complete the regulatory process for </text>
<text top=""751"" left=""108"" width=""687"" height=""16"" font=""0"">the Patagonia Region prior to the date of Panel establishment, although it had all of the </text>
<text top=""767"" left=""108"" width=""533"" height=""16"" font=""0"">information necessary for its assessment following its visit in February 2009.  </text>
</p><p number=""58."" style=""6""><text top=""800"" left=""108"" width=""683"" height=""16"" font=""0"">58.  Argentina never requested a regionalization determination (i.e. to be recognized as free of </text>
<text top=""817"" left=""108"" width=""690"" height=""16"" font=""0"">FMD) for the entire country, because it knew that it would be impossible under the </text>
<text top=""833"" left=""108"" width=""684"" height=""16"" font=""0"">U.S. regulations, which do not recognize the category FDM-free with vaccination. Therefore, for </text>
<text top=""850"" left=""108"" width=""687"" height=""16"" font=""0"">beef, Argentina has simply requested an import authorization for fresh beef under certain </text>
<text top=""866"" left=""108"" width=""682"" height=""16"" font=""0"">mitigation measures. In the absence of a claim by Argentina with respect to fresh beef, neither the </text>
<text top=""882"" left=""108"" width=""684"" height=""16"" font=""0"">language of Article 6 nor logic support the application of Article 6 in reference to the fresh beef </text>
<text top=""899"" left=""108"" width=""50"" height=""16"" font=""0"">claim.  </text>
</p><p number=""H."" style=""1""><text top=""932"" left=""151"" width=""21"" height=""16"" font=""23"">H. </text><text top=""932"" left=""193"" width=""428"" height=""16"" font=""23"">THE U.S. HAS ACTED INCONSISTENT WITH ARTICLE 2.3 </text></p><p number=""59."" style=""6""><text top=""964"" left=""108"" width=""682"" height=""16"" font=""0"">59.  There is no valid reason for the United States' disparate treatment of imports from Argentina </text>
<text top=""981"" left=""108"" width=""683"" height=""16"" font=""0"">compared with imports from other Members. This disparate treatment constitutes a breach of the </text>
<text top=""997"" left=""108"" width=""194"" height=""16"" font=""0"">first sentence of Article 2.3. </text>
</p><p number=""60."" style=""6""><text top=""1030"" left=""108"" width=""682"" height=""16"" font=""0"">60.  The U.S. measures unjustifiably discriminate against Argentine imports by maintaining a ban </text>
<text top=""1046"" left=""108"" width=""683"" height=""16"" font=""0"">for more than twelve years, while imports from Argentina's neighbors such as Uruguay and Brazil </text>
<text top=""1063"" left=""108"" width=""682"" height=""16"" font=""0"">are able to access the U.S. market. The United States admitted in several instances that it was, in </text>
<text top=""1079"" left=""108"" width=""683"" height=""16"" font=""0"">fact, applying a zero risk ALOP to Argentina. Yet, it is clear from the record evidence that such a </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-23 - </text>
</p><p><text top=""128"" left=""108"" width=""426"" height=""16"" font=""0"">standard is not applied to other Members, such as Uruguay.</text>
<footnote top=""126"" left=""534"" width=""11"" height=""11"" font=""15"" number=""16"" ref="""" dis=""""/>
<text top=""128"" left=""545"" width=""246"" height=""16"" font=""0""> That failure to apply a consistent </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">and transparent ALOP to Argentina in contrast to other Members is, in itself, a basis for finding </text>
<text top=""160"" left=""108"" width=""389"" height=""16"" font=""0"">that the United States has not complied with Article 2.3. </text>
</p></p></page>
<page number=""33"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""61."" style=""6""><text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">61.  There is ample evidence on the record to confirm the United States discrimination against </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina, both on a substantive basis and in regard to APHIS' regulatory processes. In regard to </text>
<text top=""226"" left=""108"" width=""689"" height=""16"" font=""0"">substantive discrimination, in addition to all the evidence submitted to the OIE which is </text>
<text top=""242"" left=""108"" width=""686"" height=""16"" font=""0"">scientifically valid, there is confirmation in the U.S. risk assessments and rulemakings of the </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">essential similarity between Argentina and Uruguay and between Patagonia and Santa Catarina. In </text>
<text top=""275"" left=""108"" width=""682"" height=""16"" font=""0"">regard  to  the  U.S. regulatory  processes,  it  is  indisputable  that,  countries  such  as  the  U.K.  and </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">Japan -which have had outbreaks in the same or  more  recent  time  frames-,  have  been  given </text>
<text top=""308"" left=""108"" width=""683"" height=""16"" font=""0"">prompt access to the U.S. processes and regained the right to export to the United States, all of </text>
<text top=""324"" left=""108"" width=""218"" height=""16"" font=""0"">which was denied to Argentina. </text>
</p><p number=""62."" style=""6""><text top=""357"" left=""108"" width=""682"" height=""16"" font=""0"">62.  In regard to the sanitary conditions, the situations in Uruguay and the north of Argentina are </text>
<text top=""374"" left=""108"" width=""686"" height=""16"" font=""0"">similar in all relevant ways. In particular, the experts confirmed that Argentina's surveillance </text>
<text top=""390"" left=""108"" width=""684"" height=""16"" font=""0"">program was effective and in full conformity with international standards, that the measures for </text>
<text top=""407"" left=""108"" width=""686"" height=""16"" font=""0"">animal identification and census produced equivalent results and that SENASA has similar or </text>
<text top=""423"" left=""108"" width=""686"" height=""16"" font=""0"">identical capacity to prevent and control FMD outbreaks in Argentina just as the veterinary </text>
<text top=""439"" left=""108"" width=""684"" height=""16"" font=""0"">authorities in Uruguay or Japan do for their own territory.  Dr. Batho stated that there were no </text>
<text top=""456"" left=""108"" width=""682"" height=""16"" font=""0"">differences in conditions in northern Argentina and Uruguay and that there was no reason to have </text>
<text top=""472"" left=""108"" width=""683"" height=""16"" font=""0"">different levels of protection. Thus, the experts concluded that the evidence on the record would </text>
<text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">lead to a conclusion that the conditions in northern Argentina and Uruguay were similar and the </text>
<text top=""505"" left=""108"" width=""686"" height=""16"" font=""0"">protocols applied to beef from Uruguay would also provide for safe trade if applied to beef </text>
<text top=""521"" left=""108"" width=""178"" height=""16"" font=""0"">imported from Argentina. </text>
</p><p number=""63."" style=""6""><text top=""554"" left=""108"" width=""684"" height=""16"" font=""0"">63.  Thus, it is clear that the import ban maintained on Argentine beef is discriminatory when </text>
<text top=""571"" left=""108"" width=""687"" height=""16"" font=""0"">compared to the permission to import beef granted to Uruguay pursuant to the protocols </text>
<text top=""587"" left=""108"" width=""685"" height=""16"" font=""0"">established in 9 C.F.R. &#167;94.22. This is corroborated by the August 2014 risk assessment and </text>
<text top=""603"" left=""108"" width=""268"" height=""16"" font=""0"">proposed rule for beef from Argentina. </text>
</p><p number=""64."" style=""6""><text top=""636"" left=""108"" width=""683"" height=""16"" font=""0"">64.  In regard to Patagonia, the 2005 risk assessment, the findings of which were confirmed by </text>
<text top=""653"" left=""108"" width=""683"" height=""16"" font=""0"">the 2014 risk assessment, illustrate the great similarity between Patagonia and Santa Catarina in </text>
<text top=""669"" left=""108"" width=""683"" height=""16"" font=""0"">most if not all of the criteria used by the United States in 9 C.F.R. &#167;92.2 to grant recognition of </text>
<text top=""685"" left=""108"" width=""487"" height=""16"" font=""0"">FMD-free status. There is also consensus of the experts on this point.   </text>
</p><p number=""65."" style=""6""><text top=""718"" left=""108"" width=""684"" height=""16"" font=""0"">65.  In response to the U.S. argument that the Panel should decline to make findings on the </text>
<text top=""735"" left=""108"" width=""682"" height=""16"" font=""0"">Article 2.3 claims because the U.S. has not completed a risk assessment prior to the date of Panel </text>
<text top=""751"" left=""108"" width=""684"" height=""16"" font=""0"">establishment, that argument is unavailing. Argentina's rights cannot be denied because of the </text>
<text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">failure of the United States to comply with another provision of the SPS Agreement, in this case, </text>
<text top=""784"" left=""108"" width=""352"" height=""16"" font=""0"">the Article 5.1 requirement of a risk assessment.    </text>
</p><p number=""I."" style=""0""><text top=""817"" left=""151"" width=""24"" height=""16"" font=""23"">I. </text><text top=""817"" left=""193"" width=""604"" height=""16"" font=""23"">THE U.S. DID NOT TAKE INTO ACCOUNT ARGENTINA'S SPECIAL NEEDS </text><text top=""833"" left=""193"" width=""166"" height=""16"" font=""23"">UNDER ARTICLE 10.1 </text></p><p number=""66."" style=""6""><text top=""866"" left=""108"" width=""688"" height=""16"" font=""0"">66.  Argentina's special needs under Art. 10.1 referred to (1) preferential access to the </text>
<text top=""882"" left=""108"" width=""687"" height=""16"" font=""0"">regulatory process, especially considering that beef was an export of particular interest to </text>
<text top=""899"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina, or (2) in providing sanitary support, <i>when compared to developed country Members</i>. On </text>
<text top=""915"" left=""108"" width=""682"" height=""16"" font=""0"">the question of access to the processes, the United States was obligated under Article 10.1 to give </text>
<text top=""932"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina special and differential treatment in this regard. Developing country economies tend to </text>
<text top=""948"" left=""108"" width=""683"" height=""16"" font=""0"">be more dependent on commodities than developed countries and beef is a well-known signature </text>
<text top=""964"" left=""108"" width=""687"" height=""16"" font=""0"">commodity for Argentina. The United States should have provided preferential access to its </text>
<text top=""981"" left=""108"" width=""683"" height=""16"" font=""0"">regulatory processes for Argentina and provided assistance on any and all issues where it claimed </text>
<text top=""997"" left=""108"" width=""686"" height=""16"" font=""0"">a shortfall in capability. There is no evidence on the record that the United States took into </text>
<text top=""1014"" left=""108"" width=""386"" height=""16"" font=""0"">consideration Argentina's special needs under Art. 10.1. </text>
<p><text top=""1140"" left=""160"" width=""346"" height=""15"" font=""11""> U.S. Comments on Experts' Responses at paras. 18-19. </text>
</p><p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-24 - </text>
</p></p></page>
<page number=""34"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""J."" style=""1""><text top=""128"" left=""151"" width=""21"" height=""16"" font=""23"">J. </text><text top=""128"" left=""193"" width=""600"" height=""16"" font=""23"">THE U.S. MEASURES ARE INCONSISTENT WITH ARTICLES I:1 AND XI:1 OF </text><text top=""144"" left=""193"" width=""122"" height=""16"" font=""23"">THE GATT 1994 </text></p><p number=""67."" style=""6""><text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">67.  The U.S. measures are not in conformity with numerous provisions of the SPS Agreement, </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">as Argentina has demonstrated. The United States has offered no other reasons why its measures </text>
<text top=""210"" left=""108"" width=""395"" height=""16"" font=""0"">would be consistent with GATT 1994 Articles I:1 or XI:1.  </text>
</p><p number=""68."" style=""6""><text top=""242"" left=""108"" width=""687"" height=""16"" font=""0"">68.  In regard to the GATT 1994 claims, the United States appears to have conceded the </text>
<text top=""259"" left=""108"" width=""685"" height=""16"" font=""0"">violation of Article XI:1. The products at issue are commodities, which are by definition, ""like"" </text>
<text top=""275"" left=""108"" width=""685"" height=""16"" font=""0"">within the meaning of Article I. Further, a comparison of the economic impact portions of the </text>
<text top=""292"" left=""108"" width=""687"" height=""16"" font=""0"">U.S. risk analyses and rulemakings shows quite clearly that the United States considers the </text>
<text top=""308"" left=""108"" width=""685"" height=""16"" font=""0"">imports from Uruguay and Argentina to be like the domestic product and, therefore, like each </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">other. The only United States defense to the GATT 1994 claims is an assertion of the affirmative </text>
<text top=""341"" left=""108"" width=""685"" height=""16"" font=""0"">defense of Article XX(b). However, the United States has not been able to carry its burden to </text>
<text top=""357"" left=""108"" width=""687"" height=""16"" font=""0"">demonstrate that the bans on imports were necessary in light of the less trade restrictive </text>
<text top=""374"" left=""108"" width=""682"" height=""16"" font=""0"">measures that would support safe trade in beef and imports from Patagonia. The United States has </text>
<text top=""390"" left=""108"" width=""684"" height=""16"" font=""0"">also failed to demonstrate that it has satisfied the requirements of the chapeau of Article XX in </text>
<text top=""407"" left=""108"" width=""250"" height=""16"" font=""0"">light of the proposed alternatives.    </text>
</p><p number=""K."" style=""1""><text top=""439"" left=""151"" width=""20"" height=""16"" font=""23"">K. </text><text top=""439"" left=""193"" width=""504"" height=""16"" font=""23"">THE U.S. HAS FAILED TO COMPLY WITH ARTICLE 8 AND ANNEX C  </text></p><p number=""69."" style=""6""><text top=""472"" left=""108"" width=""684"" height=""16"" font=""0"">69.  The U.S response to Argentina's claims of undue delay under Article 8 and Annex C is to </text>
<text top=""489"" left=""108"" width=""689"" height=""16"" font=""0"">repeat its flawed textual interpretation of Annex C as being very narrow in scope. The </text>
<text top=""505"" left=""108"" width=""682"" height=""16"" font=""0"">United States claims that the procedures at 9 C.F.R. &#167;92.2 to determine the sanitary health status </text>
<text top=""521"" left=""108"" width=""684"" height=""16"" font=""0"">of a region are not within the scope of Article 8 and Annex C because they are not enumerated </text>
<text top=""538"" left=""108"" width=""683"" height=""16"" font=""0"">along with ""control, inspection and approval procedures."" However, Annex C(1) is very clear that </text>
<text top=""554"" left=""108"" width=""684"" height=""16"" font=""0"">the obligation to act without undue delay applies with respect to ""<i>any procedure</i>"" that aims to </text>
<text top=""571"" left=""108"" width=""683"" height=""16"" font=""0"">check and ensure the fulfillment of an SPS measure. The approval procedure under &#167;92.2 is just </text>
<text top=""587"" left=""108"" width=""682"" height=""16"" font=""0"">such a procedure to check and ensure the fulfillment of SPS measures. As the Panel in <i>US-Poultry </i></text>
<text top=""603"" left=""108"" width=""682"" height=""16"" font=""0"">explained, Annex (C)(1) does not specify nor exclude any type of procedure, as long as it is aimed </text>
<text top=""620"" left=""108"" width=""687"" height=""16"" font=""0"">at checking and ensuring the fulfillment of SPS measures. Nor does Article 8 or Annex C(1) </text>
<text top=""636"" left=""108"" width=""689"" height=""16"" font=""0"">distinguish between procedures covering a specific product or multiple products, as the </text>
<text top=""653"" left=""108"" width=""241"" height=""16"" font=""0"">United States erroneously argues.  </text>
</p><p number=""70."" style=""6""><text top=""685"" left=""108"" width=""685"" height=""16"" font=""0"">70.  The U.S. interpretation must be rejected because it would lead to absurd results. If the </text>
<text top=""702"" left=""108"" width=""682"" height=""16"" font=""0"">Annex C provisions were to be applied exclusively to specific product requests, as the U.S. argues, </text>
<text top=""718"" left=""108"" width=""685"" height=""16"" font=""0"">then procedures related to the determinations of disease-free status (regionalization) would be </text>
<text top=""735"" left=""108"" width=""683"" height=""16"" font=""0"">neither covered by Article 8 and Annex C nor by any similar provision of the SPS Agreement. This </text>
<text top=""751"" left=""108"" width=""685"" height=""16"" font=""0"">is in conflict with Article 6 and its Guidelines, the latter of which states that ""Members should </text>
<text top=""767"" left=""108"" width=""400"" height=""16"" font=""0"">proceed with a recognition process without undue delay.""  </text>
</p><p number=""71."" style=""6""><text top=""800"" left=""108"" width=""685"" height=""16"" font=""0"">71.  In other words, if an exporting Member's application for FMD-free recognition would fall </text>
<text top=""817"" left=""108"" width=""685"" height=""16"" font=""0"">outside the scope of Annex C, as the U.S. argues, then the exporting Member would have no </text>
<text top=""833"" left=""108"" width=""688"" height=""16"" font=""0"">recourse in the event of undue delays in the processing of those applications. Thus, the </text>
<text top=""850"" left=""108"" width=""57"" height=""16"" font=""0"">United </text>
<text top=""850"" left=""157"" width=""642"" height=""16"" font=""0"">States would effectively control another Member's ability to seek review of the </text>
<text top=""866"" left=""108"" width=""326"" height=""16"" font=""0"">U.S.' actions. This position is simply untenable. </text>
</p><p number=""72."" style=""6""><text top=""899"" left=""108"" width=""683"" height=""16"" font=""0"">72.  With respect to the reason for the delays of several years, affecting both the beef and the </text>
<text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia requests, the U.S.' only response is that such delays are not undue, apparently based </text>
<text top=""932"" left=""108"" width=""683"" height=""16"" font=""0"">on the events of 2001. However, the United States remains silent with respect to APHIS' reasons </text>
<text top=""948"" left=""108"" width=""517"" height=""16"" font=""0"">for inaction during the many years prior to the establishment of the Panel.  </text>
</p><p number=""V."" style=""0""><text top=""981"" left=""108"" width=""20"" height=""16"" font=""23"">V. </text><text top=""981"" left=""151"" width=""352"" height=""16"" font=""23"">CONCLUSIONS AND REQUESTS TO THE PANEL </text></p><p number=""73."" style=""6""><text top=""1014"" left=""108"" width=""683"" height=""16"" font=""0"">73.  Argentina has demonstrated that the U.S. measures are inconsistent with Articles 1.1; 2.2; </text>
<text top=""1030"" left=""108"" width=""685"" height=""16"" font=""0"">2.3; 3.1; 3.3; 5.1; 5.2; 5.4; 5.6; 6.1; 6.2 and 10.1 of the SPS Agreement, as well as with </text>
<text top=""1046"" left=""108"" width=""685"" height=""16"" font=""0"">Articles I:1 and XI:1 of the GATT 1994. Argentina respectfully requests that the Panel find the </text>
<text top=""1063"" left=""108"" width=""658"" height=""16"" font=""0"">U.S. measures inconsistent with the U.S. obligations under the SPS Agreement and GATT 1994. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-25 - </text>
</p></p></page>
<page number=""35"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""29"" size=""8"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""18"" size=""8"" family=""Times"" color=""#000000""/>
<p><text top=""164"" left=""405"" width=""89"" height=""16"" font=""26"">ANNEX B-3 </text></p><p><text top=""198"" left=""254"" width=""389"" height=""16"" font=""6"">FIRST PART OF THE INTEGRATED EXECUTIVE SUMMARY </text>
<text top=""214"" left=""291"" width=""316"" height=""16"" font=""6"">OF THE ARGUMENTS OF THE UNITED STATES </text>
</p><p><text top=""258"" left=""108"" width=""171"" height=""16"" font=""23"">OPENING STATEMENT </text></p><p number=""A."" style=""1""><text top=""291"" left=""108"" width=""53"" height=""16"" font=""23"">A. K</text><text top=""294"" left=""161"" width=""19"" height=""13"" font=""29"">EY </text><text top=""291"" left=""180"" width=""9"" height=""16"" font=""23"">F</text><text top=""294"" left=""188"" width=""63"" height=""13"" font=""29"">ACTS AND </text><text top=""291"" left=""252"" width=""10"" height=""16"" font=""23"">C</text><text top=""294"" left=""261"" width=""98"" height=""13"" font=""29"">IRCUMSTANCES </text><text top=""291"" left=""359"" width=""11"" height=""16"" font=""23"">U</text><text top=""294"" left=""370"" width=""74"" height=""13"" font=""29"">NDERLYING </text><text top=""291"" left=""444"" width=""9"" height=""16"" font=""23"">T</text><text top=""294"" left=""453"" width=""26"" height=""13"" font=""29"">HIS </text><text top=""291"" left=""479"" width=""11"" height=""16"" font=""23"">D</text><text top=""294"" left=""490"" width=""44"" height=""13"" font=""29"">ISPUTE</text></p><p number=""1."" style=""6""><text top=""323"" left=""108"" width=""21"" height=""16"" font=""0"">1. </text>
<text top=""323"" left=""151"" width=""642"" height=""16"" font=""0"">FMD is considered widely to be one of the most infectious and economically devastating </text>
<text top=""340"" left=""108"" width=""683"" height=""16"" font=""0"">livestock diseases. Argentina is no stranger to FMD. FMD has been present in Argentina since the </text>
<text top=""356"" left=""108"" width=""17"" height=""16"" font=""0"">19</text>
<text top=""355"" left=""125"" width=""9"" height=""11"" font=""0"">th</text>
<text top=""356"" left=""134"" width=""658"" height=""16"" font=""0""> century. And Argentina has struggled for decades to control the disease. The United States </text>
<text top=""373"" left=""108"" width=""684"" height=""16"" font=""0"">has not had a single case of FMD for over 80 years. Today, livestock in the United States is not </text>
<text top=""389"" left=""108"" width=""684"" height=""16"" font=""0"">vaccinated against FMD. The record shows that the APHIS review of Argentina's applications is </text>
<text top=""405"" left=""108"" width=""536"" height=""16"" font=""0"">active and, while the pace may not be to Argentina's liking, it is fully justified. </text>
</p><p number=""2."" style=""6""><text top=""438"" left=""108"" width=""19"" height=""16"" font=""0"">2. </text>
<text top=""438"" left=""151"" width=""640"" height=""16"" font=""0"">There has been no denial of any of Argentina's pending applications. Rather, the regulatory </text>
<text top=""455"" left=""108"" width=""682"" height=""16"" font=""0"">process is moving forward, and the time involved is reasonable in light of unstable FMD conditions </text>
<text top=""471"" left=""108"" width=""683"" height=""16"" font=""0"">in Argentina, the changes in Argentina's applications, and its history with respect to transparency </text>
<text top=""488"" left=""108"" width=""184"" height=""16"" font=""0"">and ability to control FMD. </text>
</p><p number=""B."" style=""1""><text top=""520"" left=""108"" width=""52"" height=""16"" font=""23"">B. T</text><text top=""523"" left=""160"" width=""20"" height=""13"" font=""29"">HE </text><text top=""520"" left=""180"" width=""10"" height=""16"" font=""23"">C</text><text top=""523"" left=""190"" width=""28"" height=""13"" font=""29"">ORE </text><text top=""520"" left=""219"" width=""9"" height=""16"" font=""23"">L</text><text top=""523"" left=""228"" width=""34"" height=""13"" font=""29"">EGAL </text><text top=""520"" left=""263"" width=""7"" height=""16"" font=""23"">I</text><text top=""523"" left=""271"" width=""88"" height=""13"" font=""29"">SSUE IN THIS </text><text top=""520"" left=""359"" width=""11"" height=""16"" font=""23"">D</text><text top=""523"" left=""370"" width=""47"" height=""13"" font=""29"">ISPUTE </text><text top=""520"" left=""419"" width=""11"" height=""16"" font=""23"">R</text><text top=""523"" left=""429"" width=""97"" height=""13"" font=""29"">ELATES TO THE </text><text top=""520"" left=""526"" width=""9"" height=""16"" font=""23"">T</text><text top=""523"" left=""536"" width=""27"" height=""13"" font=""29"">IME </text><text top=""520"" left=""563"" width=""9"" height=""16"" font=""23"">T</text><text top=""523"" left=""572"" width=""58"" height=""13"" font=""29"">AKEN TO </text><text top=""520"" left=""630"" width=""10"" height=""16"" font=""23"">C</text><text top=""523"" left=""640"" width=""59"" height=""13"" font=""29"">ONSIDER </text><text top=""520"" left=""700"" width=""10"" height=""16"" font=""23"">A</text><text top=""523"" left=""710"" width=""63"" height=""13"" font=""29"">RGENTINA</text><text top=""520"" left=""773"" width=""4"" height=""16"" font=""23"">'</text><text top=""523"" left=""778"" width=""11"" height=""13"" font=""29"">S </text><text top=""537"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""540"" left=""161"" width=""82"" height=""13"" font=""29"">PPLICATIONS</text></p><p number=""3."" style=""6""><text top=""570"" left=""108"" width=""21"" height=""16"" font=""0"">3. </text>
<text top=""570"" left=""151"" width=""642"" height=""16"" font=""0"">The core legal issue in this dispute relates to the time taken to consider Argentina's two </text>
<text top=""586"" left=""108"" width=""686"" height=""16"" font=""0"">pending applications. This conclusion is supported by the Argentina's own arguments, by the </text>
<text top=""602"" left=""108"" width=""631"" height=""16"" font=""0"">factual record, and the relationship between the relevant provisions of the SPS Agreement.  </text>
</p><p number=""4."" style=""6""><text top=""635"" left=""108"" width=""19"" height=""16"" font=""0"">4. </text>
<text top=""635"" left=""151"" width=""640"" height=""16"" font=""0"">Although there is no prescribed way for analyzing a number of inter-related SPS provisions, </text>
<text top=""652"" left=""108"" width=""682"" height=""16"" font=""0"">in this instance, the most helpful approach is to start with the language of Article 6. Given that this </text>
<text top=""668"" left=""108"" width=""683"" height=""16"" font=""0"">dispute involves Argentina's pending applications for disease free status, Article 6 is most directly </text>
<text top=""684"" left=""108"" width=""684"" height=""16"" font=""0"">relevant. Articles 6.1 and 6.2 set out the general principles that measures must be adapted to </text>
<text top=""701"" left=""108"" width=""688"" height=""16"" font=""0"">regional conditions, and that Members must recognize the concept of disease-free areas. </text>
<text top=""717"" left=""108"" width=""511"" height=""16"" font=""0"">Article 6.3 sets out the process for making determinations under Article 6. </text>
</p><p number=""5."" style=""6""><text top=""750"" left=""108"" width=""20"" height=""16"" font=""0"">5. </text>
<text top=""750"" left=""151"" width=""641"" height=""16"" font=""0"">Although Article 6.3 does not say that the evaluation must be completed in any particular </text>
<text top=""766"" left=""108"" width=""687"" height=""16"" font=""0"">time period, the United States does agree with the general proposition &#8211; as presented by </text>
<text top=""783"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina &#8211; that an importing Member cannot take unlimited time to review an application. The </text>
<text top=""799"" left=""108"" width=""688"" height=""16"" font=""0"">SPS Agreement does contain disciplines on timeliness of decision-making, most notably in </text>
<text top=""816"" left=""108"" width=""685"" height=""16"" font=""0"">Article 5.7 and in Annex C. The United States and Argentina, while agreeing that timeliness is </text>
<text top=""832"" left=""108"" width=""493"" height=""16"" font=""0"">addressed by the SPS Agreement, disagree on which provision applies.  </text>
</p><p number=""C."" style=""1""><text top=""865"" left=""108"" width=""15"" height=""16"" font=""23"">C.</text><text top=""865"" left=""126"" width=""55"" height=""16"" font=""23""> U.S.</text><text top=""865"" left=""185"" width=""13"" height=""16"" font=""23"">M</text><text top=""868"" left=""197"" width=""58"" height=""13"" font=""29"">EASURES </text><text top=""865"" left=""255"" width=""10"" height=""16"" font=""23"">A</text><text top=""868"" left=""266"" width=""19"" height=""13"" font=""29"">RE </text><text top=""865"" left=""285"" width=""7"" height=""16"" font=""23"">J</text><text top=""868"" left=""292"" width=""61"" height=""13"" font=""29"">USTIFIED </text><text top=""865"" left=""353"" width=""11"" height=""16"" font=""23"">U</text><text top=""868"" left=""364"" width=""37"" height=""13"" font=""29"">NDER </text><text top=""865"" left=""401"" width=""10"" height=""16"" font=""23"">A</text><text top=""868"" left=""411"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""865"" left=""454"" width=""33"" height=""16"" font=""23""> 5.7 </text></p><p number=""6."" style=""6""><text top=""898"" left=""108"" width=""21"" height=""16"" font=""0"">6. </text>
<text top=""898"" left=""151"" width=""642"" height=""16"" font=""0"">The actions of the United States to verify and to ensure that FMD from Argentina is not </text>
<text top=""914"" left=""108"" width=""684"" height=""16"" font=""0"">introduced and established in the United States are envisioned by Articles 5.2 and 5.3, and are </text>
<text top=""931"" left=""108"" width=""390"" height=""16"" font=""0"">fully justified under Article 5.7 as a provisional measure. </text>
</p><p number=""7."" style=""6""><text top=""963"" left=""108"" width=""20"" height=""16"" font=""0"">7. </text>
<text top=""963"" left=""151"" width=""641"" height=""16"" font=""0"">The United States, in seeking to make a scientific determination of the present FMD threat </text>
<text top=""980"" left=""108"" width=""686"" height=""16"" font=""0"">from Argentina, is in the process of obtaining and analyzing scientific information related, to </text>
<text top=""996"" left=""108"" width=""682"" height=""16"" font=""0"">factors including: (1) the FMD situation in the country; (2) the capacity of the country's regulatory </text>
<text top=""1013"" left=""108"" width=""686"" height=""16"" font=""0"">structure to prevent and control FMD outbreaks; and (3) the reliability of those responsible </text>
<text top=""1029"" left=""108"" width=""549"" height=""16"" font=""0"">agencies to implement oversight and reporting obligations, including disclosure. </text>
</p><p number=""8."" style=""6""><text top=""1062"" left=""108"" width=""20"" height=""16"" font=""0"">8. </text>
<text top=""1062"" left=""151"" width=""641"" height=""16"" font=""0"">At the time of Argentina's 2002 request, it was clear that: (1) FMD was highly contagious </text>
<text top=""1078"" left=""108"" width=""684"" height=""16"" font=""0"">and dangerous; (2) Argentina's systems had recently failed to control FMD on a massive scale; </text>
<text top=""1095"" left=""108"" width=""685"" height=""16"" font=""0"">and (3) it was not known whether Argentina had FMD and whether its internal systems could </text>
<text top=""1111"" left=""108"" width=""522"" height=""16"" font=""0"">control FMD such that exports to the United States would not pose a threat. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-26 - </text>
</p></p></page>
<page number=""36"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""9."" style=""6""><text top=""128"" left=""108"" width=""19"" height=""16"" font=""0"">9. </text>
<text top=""128"" left=""151"" width=""640"" height=""16"" font=""0"">The Appellate Body recognized in <i>Japan &#8211; Agricultural Products II</i> that what is a ""reasonable </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">period of time"" to review a provisional measure ""depends on the specific circumstances of each </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">case."" In this case, the Panel should look to what is reasonable given the total circumstances of </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">the record, particularly (1) Argentina's delays in responding to requests by the United States for </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">site visits and answers to questions, (2) Argentina's three relatively recent FMD outbreaks, and (3) </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">the country's history of intentional concealment and delayed reporting of outbreaks. Based on this </text>
<text top=""226"" left=""108"" width=""418"" height=""16"" font=""0"">record, the pace of APHIS review and analysis is reasonable. </text>
</p><p number=""D."" style=""1""><text top=""259"" left=""108"" width=""96"" height=""16"" font=""23"">D. APHIS'</text><text top=""259"" left=""216"" width=""11"" height=""16"" font=""23"">R</text><text top=""262"" left=""226"" width=""75"" height=""13"" font=""29"">EGULATORY </text><text top=""259"" left=""309"" width=""10"" height=""16"" font=""23"">A</text><text top=""262"" left=""320"" width=""59"" height=""13"" font=""29"">PPROVAL </text><text top=""259"" left=""387"" width=""10"" height=""16"" font=""23"">P</text><text top=""262"" left=""397"" width=""50"" height=""13"" font=""29"">ROCESS </text><text top=""259"" left=""456"" width=""7"" height=""16"" font=""23"">I</text><text top=""262"" left=""463"" width=""11"" height=""13"" font=""29"">S </text><text top=""259"" left=""483"" width=""10"" height=""16"" font=""23"">B</text><text top=""262"" left=""493"" width=""73"" height=""13"" font=""29"">ASED ON </text><text top=""259"" left=""566"" width=""7"" height=""16"" font=""23"">I</text><text top=""262"" left=""574"" width=""98"" height=""13"" font=""29"">NTERNATIONAL </text><text top=""259"" left=""680"" width=""10"" height=""16"" font=""23"">S</text><text top=""262"" left=""689"" width=""108"" height=""13"" font=""29"">TANDARD AND </text><text top=""275"" left=""151"" width=""10"" height=""16"" font=""23"">C</text><text top=""278"" left=""160"" width=""109"" height=""13"" font=""29"">ONSISTENT WITH </text><text top=""275"" left=""270"" width=""10"" height=""16"" font=""23"">A</text><text top=""278"" left=""280"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""275"" left=""323"" width=""19"" height=""16"" font=""23""> 3 </text></p><p number=""10."" style=""6""><text top=""308"" left=""108"" width=""683"" height=""16"" font=""0"">10.  With regard to Argentina's claim under Article 3.1, Argentina has failed to provide any legal </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">or factual basis. The record shows that APHIS has created and implemented a system to control </text>
<text top=""341"" left=""108"" width=""686"" height=""16"" font=""0"">FMD based on the OIE's framework, consistent with Article 3.1. Argentina has the burden to </text>
<text top=""357"" left=""108"" width=""684"" height=""16"" font=""0"">demonstrate that the APHIS system is inconsistent with Article 3.1, a burden that Argentina has </text>
<text top=""374"" left=""108"" width=""118"" height=""16"" font=""0"">failed to satisfy.  </text>
</p><p number=""11."" style=""6""><text top=""407"" left=""108"" width=""685"" height=""16"" font=""0"">11.  The Appellate Body stated that a measure under Article 3.1 may embody some but not </text>
<text top=""423"" left=""108"" width=""683"" height=""16"" font=""0"">necessarily all of the elements of an international standard. Unlike Article 3.2, a measure that is </text>
<text top=""439"" left=""108"" width=""687"" height=""16"" font=""0"">based on an international standard does not need to conform to or embody the standard </text>
<text top=""456"" left=""108"" width=""83"" height=""16"" font=""0"">completely. </text>
</p><p number=""12."" style=""6""><text top=""489"" left=""108"" width=""686"" height=""16"" font=""0"">12.  The record shows that the U.S. system for controlling FMD is built upon the relevant </text>
<text top=""505"" left=""108"" width=""683"" height=""16"" font=""0"">international standard established by the OIE. Three core principles common to both the OIE and </text>
<text top=""521"" left=""108"" width=""682"" height=""16"" font=""0"">the APHIS approach are the following: (1) Unless a country can show it does not have FMD, it is to </text>
<text top=""538"" left=""108"" width=""682"" height=""16"" font=""0"">be treated as an FMD-infected zone; (2) No decision is made about a country's FMD situation until </text>
<text top=""554"" left=""108"" width=""684"" height=""16"" font=""0"">an application is made by a country. In that application, both APHIS and the OIE consider the </text>
<text top=""571"" left=""108"" width=""682"" height=""16"" font=""0"">ability of the country in question to control and eradicate FMD as critical to the determination; and </text>
<text top=""587"" left=""108"" width=""406"" height=""16"" font=""0"">(3) An outbreak can result in the removal of FMD freedom. </text>
</p><p number=""13."" style=""6""><text top=""620"" left=""108"" width=""423"" height=""16"" font=""0"">13.  The United States has acted consistently with Article 3. </text>
</p><p number=""E."" style=""1""><text top=""653"" left=""108"" width=""14"" height=""16"" font=""23"">E.</text><text top=""653"" left=""126"" width=""73"" height=""16"" font=""23""> APHIS</text><text top=""653"" left=""209"" width=""10"" height=""16"" font=""23"">A</text><text top=""656"" left=""220"" width=""49"" height=""13"" font=""29"">CTIONS </text><text top=""653"" left=""275"" width=""15"" height=""16"" font=""23"">W</text><text top=""656"" left=""291"" width=""25"" height=""13"" font=""29"">ITH </text><text top=""653"" left=""322"" width=""11"" height=""16"" font=""23"">R</text><text top=""656"" left=""333"" width=""80"" height=""13"" font=""29"">ESPECT TO </text><text top=""653"" left=""413"" width=""10"" height=""16"" font=""23"">P</text><text top=""656"" left=""423"" width=""67"" height=""13"" font=""29"">ATAGONIA </text><text top=""653"" left=""496"" width=""10"" height=""16"" font=""23"">A</text><text top=""656"" left=""507"" width=""19"" height=""13"" font=""29"">RE </text><text top=""653"" left=""532"" width=""10"" height=""16"" font=""23"">C</text><text top=""656"" left=""542"" width=""72"" height=""13"" font=""29"">ONSISTENT </text><text top=""653"" left=""621"" width=""15"" height=""16"" font=""23"">W</text><text top=""656"" left=""636"" width=""25"" height=""13"" font=""29"">ITH </text><text top=""653"" left=""668"" width=""10"" height=""16"" font=""23"">A</text><text top=""656"" left=""678"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""653"" left=""721"" width=""29"" height=""16"" font=""23""> 6.1</text><text top=""656"" left=""749"" width=""46"" height=""13"" font=""29""> AND </text><text top=""669"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""672"" left=""161"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""669"" left=""204"" width=""33"" height=""16"" font=""23""> 6.2 </text></p><p number=""14."" style=""6""><text top=""702"" left=""108"" width=""684"" height=""16"" font=""0"">14.  Article 6.1 sets out the general principle that Members have an obligation to ensure that </text>
<text top=""718"" left=""108"" width=""687"" height=""16"" font=""0"">their measures are adapted to the conditions of the region from which products originate. </text>
<text top=""735"" left=""108"" width=""682"" height=""16"" font=""0"">Article 6.2 of the SPS Agreement provides that Members are required to recognize the concepts of </text>
<text top=""751"" left=""108"" width=""501"" height=""16"" font=""0"">pest- or disease-free areas and areas of low pest or disease prevalence.  </text>
</p><p number=""15."" style=""6""><text top=""784"" left=""108"" width=""685"" height=""16"" font=""0"">15.  APHIS regulations at 9 C.F.R. Section 92.2 direct it to consider applications from foreign </text>
<text top=""800"" left=""108"" width=""684"" height=""16"" font=""0"">countries to determine regions to be free of FMD. Section 92.2 sets forth the factors that it will </text>
<text top=""817"" left=""108"" width=""683"" height=""16"" font=""0"">consider in its determination and for which it requires documentation from the applicant country. </text>
<text top=""833"" left=""108"" width=""683"" height=""16"" font=""0"">These factors closely match those listed in Article 6, including geography, status of the disease in </text>
<text top=""850"" left=""108"" width=""684"" height=""16"" font=""0"">the country, extent of the country's disease control program, and structure and effectiveness of </text>
<text top=""866"" left=""108"" width=""683"" height=""16"" font=""0"">veterinary services. Thus, APHIS's regulations demonstrate that the United States recognizes the </text>
<text top=""882"" left=""108"" width=""408"" height=""16"" font=""0"">concepts of disease-free areas, consistent with Article 6.2.  </text>
</p><p number=""16."" style=""6""><text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">16.  The application process described in Section 92.2 is also consistent with reading Article 6.3 </text>
<text top=""932"" left=""108"" width=""688"" height=""16"" font=""0"">together with Article 6.1 and Article 6.2. As discussed earlier, Article 6.3 requires Members </text>
<text top=""948"" left=""108"" width=""682"" height=""16"" font=""0"">claiming that a region is free of a disease to provide necessary evidence. Section 92.2 is consistent </text>
<text top=""964"" left=""108"" width=""170"" height=""16"" font=""0"">with this understanding. </text>
</p><p number=""17."" style=""6""><text top=""997"" left=""108"" width=""686"" height=""16"" font=""0"">17.  Further evidence that the United States recognizes the concept of disease-free areas is </text>
<text top=""1014"" left=""108"" width=""687"" height=""16"" font=""0"">evident in relation to Argentina's applications. On January 23, 2014, APHIS promulgated a </text>
<text top=""1030"" left=""108"" width=""684"" height=""16"" font=""0"">regulatory notice advising the public that it has determined that the Patagonia region is free of </text>
<text top=""1046"" left=""108"" width=""397"" height=""16"" font=""0"">FMD, consistent with Section 94.1 of APHIS's regulations. </text>
</p><p number=""18."" style=""6""><text top=""1079"" left=""108"" width=""683"" height=""16"" font=""0"">18.  The risk analysis addresses the factors that the SPS Agreement asks members to ""take into </text>
<text top=""1096"" left=""108"" width=""687"" height=""16"" font=""0"">account"" under Article 6.1&#8212;namely, the level of prevalence of FMD, the control program in </text>
<text top=""1112"" left=""108"" width=""682"" height=""16"" font=""0"">Patagonia, and appropriate criteria of guidelines from the OIE. The risk analysis also considers the </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-27 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">factors identified in Article 6.2, such as geography, ecosystems, epidemiological surveillance, and </text>
<text top=""144"" left=""108"" width=""265"" height=""16"" font=""0"">the effectiveness of sanitary controls.  </text>
</p></p></page>
<page number=""37"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""19."" style=""6""><text top=""177"" left=""108"" width=""628"" height=""16"" font=""0"">19.  For these reasons, the United States has acted consistently with Articles 6.1 and 6.2. </text>
</p><p number=""F."" style=""1""><text top=""210"" left=""108"" width=""14"" height=""16"" font=""23"">F.</text><text top=""210"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""213"" left=""161"" width=""66"" height=""13"" font=""29"">RGENTINA </text><text top=""210"" left=""227"" width=""7"" height=""16"" font=""23"">I</text><text top=""213"" left=""235"" width=""76"" height=""13"" font=""29"">NTRODUCES </text><text top=""210"" left=""311"" width=""11"" height=""16"" font=""23"">N</text><text top=""213"" left=""322"" width=""13"" height=""13"" font=""29"">O </text><text top=""210"" left=""335"" width=""10"" height=""16"" font=""23"">S</text><text top=""213"" left=""345"" width=""66"" height=""13"" font=""29"">CIENTIFIC </text><text top=""210"" left=""410"" width=""9"" height=""16"" font=""23"">E</text><text top=""213"" left=""420"" width=""77"" height=""13"" font=""29"">VIDENCE TO </text><text top=""210"" left=""496"" width=""10"" height=""16"" font=""23"">S</text><text top=""213"" left=""506"" width=""64"" height=""13"" font=""29"">UPPORT A </text><text top=""210"" left=""569"" width=""10"" height=""16"" font=""23"">C</text><text top=""213"" left=""579"" width=""34"" height=""13"" font=""29"">LAIM </text><text top=""210"" left=""613"" width=""11"" height=""16"" font=""23"">U</text><text top=""213"" left=""624"" width=""37"" height=""13"" font=""29"">NDER </text><text top=""210"" left=""661"" width=""10"" height=""16"" font=""23"">A</text><text top=""213"" left=""671"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""210"" left=""714"" width=""33"" height=""16"" font=""23""> 5.6 </text></p><p number=""20."" style=""6""><text top=""242"" left=""108"" width=""684"" height=""16"" font=""0"">20.  With regard to Argentina's claim under Article 5.6, Argentina fails to meet its evidentiary </text>
<text top=""259"" left=""108"" width=""686"" height=""16"" font=""0"">burden or otherwise to explain the basis for its claim. Rather, Argentina's claim is based on </text>
<text top=""275"" left=""108"" width=""495"" height=""16"" font=""0"">hypothetical factual scenario unsupported by the record in this dispute.  </text>
</p><p number=""21."" style=""6""><text top=""308"" left=""108"" width=""682"" height=""16"" font=""0"">21.  Argentina has not made this showing. It merely asserts that either the OIE guidelines or the </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">set of measures applied to Uruguay would meet the appropriate level of sanitary protection of the </text>
<text top=""341"" left=""108"" width=""688"" height=""16"" font=""0"">United States. But Argentina has not submitted any scientific evidence in the record that </text>
<text top=""357"" left=""108"" width=""683"" height=""16"" font=""0"">establishes that the scientific analysis that applies to Uruguay is applicable to Argentina and that </text>
<text top=""374"" left=""108"" width=""677"" height=""16"" font=""0"">therefore the measure is scientifically appropriate. As the Appellate Body also stated in <i>Australia &#8211;</i></text>
<text top=""390"" left=""108"" width=""683"" height=""16"" font=""8""><i>Apples</i>, ""we cannot conceive of how a complainant could satisfy its burden of demonstrating that </text>
<text top=""407"" left=""108"" width=""683"" height=""16"" font=""0"">its proposed alternative measure would meet the appropriate level of protection under Article 5.6 </text>
<text top=""423"" left=""108"" width=""381"" height=""16"" font=""8""><i>without </i>relying on evidence that is scientific in nature."" </text>
</p><p number=""G."" style=""1""><text top=""456"" left=""108"" width=""16"" height=""16"" font=""23"">G.</text><text top=""456"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""459"" left=""161"" width=""66"" height=""13"" font=""29"">RGENTINA </text><text top=""456"" left=""227"" width=""10"" height=""16"" font=""23"">C</text><text top=""459"" left=""237"" width=""46"" height=""13"" font=""29"">ANNOT </text><text top=""456"" left=""283"" width=""13"" height=""16"" font=""23"">M</text><text top=""459"" left=""296"" width=""25"" height=""13"" font=""29"">EET </text><text top=""456"" left=""321"" width=""7"" height=""16"" font=""23"">I</text><text top=""459"" left=""328"" width=""18"" height=""13"" font=""29"">TS </text><text top=""456"" left=""346"" width=""10"" height=""16"" font=""23"">B</text><text top=""459"" left=""357"" width=""65"" height=""13"" font=""29"">URDEN TO </text><text top=""456"" left=""421"" width=""10"" height=""16"" font=""23"">S</text><text top=""459"" left=""431"" width=""64"" height=""13"" font=""29"">UPPORT A </text><text top=""456"" left=""494"" width=""10"" height=""16"" font=""23"">C</text><text top=""459"" left=""504"" width=""34"" height=""13"" font=""29"">LAIM </text><text top=""456"" left=""538"" width=""11"" height=""16"" font=""23"">U</text><text top=""459"" left=""549"" width=""37"" height=""13"" font=""29"">NDER </text><text top=""456"" left=""586"" width=""10"" height=""16"" font=""23"">A</text><text top=""459"" left=""596"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""456"" left=""639"" width=""33"" height=""16"" font=""23""> 2.3 </text></p><p number=""22."" style=""6""><text top=""489"" left=""108"" width=""684"" height=""16"" font=""0"">22.  Because Argentina fails to show how its FMD circumstances and FMD control systems are </text>
<text top=""505"" left=""108"" width=""684"" height=""16"" font=""0"">similar to that of Uruguay, Santa Catarina (Brazil), Japan, and the United Kingdom, Argentina's </text>
<text top=""521"" left=""108"" width=""254"" height=""16"" font=""0"">claim under Article 2.3 too must fail. </text>
</p><p number=""23."" style=""6""><text top=""554"" left=""108"" width=""684"" height=""16"" font=""0"">23.  Just as with Argentina's claim under Article 5.6, Argentina makes broad conclusions about </text>
<text top=""571"" left=""108"" width=""682"" height=""16"" font=""0"">the similarity between it and other countries. But nowhere does Argentina rely on specific evidence </text>
<text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">that shows that its regulatory infrastructure, disease history, geographical position, and any other </text>
<text top=""603"" left=""108"" width=""683"" height=""16"" font=""0"">host of factors compel the same conclusion as reached by APHIS with respect to those countries. </text>
<text top=""620"" left=""108"" width=""683"" height=""16"" font=""0"">And in none of those countries was there shown to be a systematic failure to disclose FMD and to </text>
<text top=""636"" left=""108"" width=""231"" height=""16"" font=""0"">limit information as to its spread. </text>
</p><p><text top=""669"" left=""108"" width=""232"" height=""16"" font=""23"">FIRST WRITTEN SUBMISSION </text></p><p number=""24."" style=""6""><text top=""702"" left=""108"" width=""687"" height=""16"" font=""0"">24.  Argentina's first written submission starts with the assertion that ""This is a simple dispute.""  </text>
<text top=""718"" left=""108"" width=""683"" height=""16"" font=""0"">But after reviewing Argentina's submission, the natural question is whether Argentina's assertion </text>
<text top=""735"" left=""108"" width=""687"" height=""16"" font=""0"">was made with a sense of irony. Argentina presents approximately 40 separate claims. Its </text>
<text top=""751"" left=""108"" width=""683"" height=""16"" font=""0"">submission is well over 160 pages, accompanied by over 90 exhibits. And the dispute addresses </text>
<text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">issues involving the appropriate reaction to Argentina's failure to control outbreaks of the world's </text>
<text top=""784"" left=""108"" width=""682"" height=""16"" font=""0"">most infectious and economically devastating livestock disease &#8211; FMD. One wonders what, exactly, </text>
<text top=""800"" left=""108"" width=""182"" height=""16"" font=""0"">is ""simple"" in this dispute. </text>
</p><p number=""25."" style=""6""><text top=""833"" left=""108"" width=""682"" height=""16"" font=""0"">25.  The United States believes that an appropriate starting point for evaluating this dispute is to </text>
<text top=""850"" left=""108"" width=""683"" height=""16"" font=""0"">consider issues of time and timeliness. Indeed, such issues underlay the scientific, technical, and </text>
<text top=""866"" left=""108"" width=""264"" height=""16"" font=""0"">legal questions raised by the dispute.  </text>
</p><p number=""26."" style=""6""><text top=""899"" left=""108"" width=""684"" height=""16"" font=""0"">26.  First, Argentina does not dispute, and cannot dispute, that at the time the United States </text>
<text top=""915"" left=""108"" width=""682"" height=""16"" font=""0"">revoked Argentina's FMD status in 2001 in response to an Argentine FMD outbreak, the U.S. action </text>
<text top=""932"" left=""108"" width=""685"" height=""16"" font=""0"">was completely justified and fully consistent with U.S. obligations under the WTO Agreement. </text>
<text top=""948"" left=""108"" width=""682"" height=""16"" font=""0"">Indeed, Argentina itself stopped its exporters from shipping affected products. Instead, Argentina's </text>
<text top=""964"" left=""108"" width=""684"" height=""16"" font=""0"">complaint is based on the contention that the United States has not acted promptly enough to </text>
<text top=""981"" left=""108"" width=""688"" height=""16"" font=""0"">review and modify the U.S. 2001 action in light of what Argentina asserts are changed </text>
<text top=""997"" left=""108"" width=""683"" height=""16"" font=""0"">circumstances involving Argentina's FMD status and Argentina's control measures. Thus, the core </text>
<text top=""1014"" left=""108"" width=""683"" height=""16"" font=""0"">legal and factual issues in this dispute revolve around the timeliness of a regulatory response to </text>
<text top=""1030"" left=""108"" width=""372"" height=""16"" font=""0"">alleged changes in conditions in an exporting country. </text>
</p><p number=""27."" style=""6""><text top=""1063"" left=""108"" width=""685"" height=""16"" font=""0"">27.  Second, the United States has not had an FMD outbreak in approximately 80 years. The </text>
<text top=""1079"" left=""108"" width=""685"" height=""16"" font=""0"">long-term U.S. success in the prevention of FMD outbreaks is the result of the very types of </text>
<text top=""1096"" left=""108"" width=""684"" height=""16"" font=""0"">prudent regulatory action that Argentina now challenges. In contrast, Argentina has had a long </text>
<text top=""1112"" left=""108"" width=""684"" height=""16"" font=""0"">history of FMD outbreaks, including three separate FMD outbreaks since 2000. In light of these </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-28 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">radically different experiences in controlling FMD, Argentina has no basis for arguing that U.S. </text>
<text top=""144"" left=""108"" width=""637"" height=""16"" font=""0"">regulators should cut corners and rush to conclusions about Argentina's current FMD status.  </text>
</p></p></page>
<page number=""38"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""28."" style=""6""><text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">28.  Third, the record will show that time is of the essence in preventing and controlling FMD </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">outbreaks. As the United States has not had an FMD outbreak in 80 years, U.S. livestock are not </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">vaccinated for FMD. As a result, even a single shipment of an FMD-infected product could cause </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">massive economic damage. In these circumstances, it is not sufficient to learn after the fact that </text>
<text top=""242"" left=""108"" width=""686"" height=""16"" font=""0"">an exporting country has had an FMD outbreak. Rather, a prudent regulator has to consider </text>
<text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">whether the exporting country has adequate controls in place so as to prevent outbreaks, and &#8211; </text>
<text top=""275"" left=""108"" width=""533"" height=""16"" font=""0"">should an outbreak nonetheless occur &#8211; to report any outbreak immediately.  </text>
</p><p number=""29."" style=""6""><text top=""308"" left=""108"" width=""684"" height=""16"" font=""0"">29.  Fourth, while Argentina argues that its FMD status is radically different than when it had </text>
<text top=""324"" left=""108"" width=""682"" height=""16"" font=""0"">outbreaks in 2000-2002, 2003, or 2006, Argentina presents the U.S. regulatory situation as static. </text>
<text top=""341"" left=""108"" width=""689"" height=""16"" font=""0"">The record shows, however, that Argentina's depiction of the U.S. regulatory process is </text>
<text top=""357"" left=""108"" width=""689"" height=""16"" font=""0"">misleading. In fact, the United States is actively considering Argentina's two outstanding </text>
<text top=""374"" left=""108"" width=""349"" height=""16"" font=""0"">applications for changes to Argentina's FMD status </text>
</p><p number=""30."" style=""6""><text top=""407"" left=""108"" width=""682"" height=""16"" font=""0"">30.  Finally, given that U.S. regulatory procedures are continuing and may be completed in about </text>
<text top=""423"" left=""108"" width=""684"" height=""16"" font=""0"">the same amount of time as involved in the completion of a complex SPS dispute, the question </text>
<text top=""439"" left=""108"" width=""682"" height=""16"" font=""0"">arises as to why Argentina has initiated this dispute at this time. Only Argentina knows the answer </text>
<text top=""456"" left=""108"" width=""689"" height=""16"" font=""0"">to this question. The United States would note, however, the following publicly available </text>
<text top=""472"" left=""108"" width=""689"" height=""16"" font=""0"">information: On May 25, 2012, the EU requested consultations with Argentina regarding </text>
<text top=""489"" left=""108"" width=""690"" height=""16"" font=""0"">Argentina's wide-ranging non-automatic import licensing measures. Within several weeks, </text>
<text top=""505"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina requested consultations with the EU regarding the importation of biodiesel products. On </text>
<text top=""521"" left=""108"" width=""682"" height=""16"" font=""0"">August 21, the United States joined the EU dispute by presenting its own request for consultations </text>
<text top=""538"" left=""108"" width=""686"" height=""16"" font=""0"">addressed to Argentina's non-automatic import licensing measures. Within 9 days, Argentina </text>
<text top=""554"" left=""108"" width=""682"" height=""16"" font=""0"">initiated this dispute by requesting consultations on the U.S. 2001 regulatory action. This sequence </text>
<text top=""571"" left=""108"" width=""682"" height=""16"" font=""0"">of events may shed light on why Argentina has decided to launch a dispute at this time concerning </text>
<text top=""587"" left=""108"" width=""216"" height=""16"" font=""0"">an ongoing regulatory process. </text>
</p><p number=""31."" style=""6""><text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">31.  At core, Argentina's legal complaints are about the length of time taken by the United States </text>
<text top=""636"" left=""108"" width=""684"" height=""16"" font=""0"">to decide whether or not Argentina has sufficiently established any credibility over its claims to </text>
<text top=""653"" left=""108"" width=""684"" height=""16"" font=""0"">have controlled FMD. The United States believes that this is the question that this Panel should </text>
<text top=""669"" left=""108"" width=""467"" height=""16"" font=""0"">tackle first under Annex C(1) and Article 5.7 of the SPS Agreement. </text>
</p><p number=""A."" style=""1""><text top=""702"" left=""108"" width=""53"" height=""16"" font=""23"">A. R</text><text top=""705"" left=""161"" width=""57"" height=""13"" font=""29"">ELEVANT </text><text top=""702"" left=""218"" width=""11"" height=""16"" font=""23"">D</text><text top=""705"" left=""229"" width=""103"" height=""13"" font=""29"">ISCIPLINES AND </text><text top=""702"" left=""332"" width=""11"" height=""16"" font=""23"">O</text><text top=""705"" left=""344"" width=""55"" height=""13"" font=""29"">RDER OF </text><text top=""702"" left=""399"" width=""10"" height=""16"" font=""23"">A</text><text top=""705"" left=""410"" width=""52"" height=""13"" font=""29"">NALYSIS</text></p><p number=""32."" style=""6""><text top=""735"" left=""108"" width=""683"" height=""16"" font=""0"">32.  The nucleus of Argentina's complaint is this: Argentina applied for import authorization and </text>
<text top=""751"" left=""108"" width=""685"" height=""16"" font=""0"">""no decision on the matter has been made by the United States authorities to date."" At base, </text>
<text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina's allegations are related to measures that govern the timeliness of the U.S. process for </text>
<text top=""784"" left=""108"" width=""683"" height=""16"" font=""0"">reviewing and amending a measure that Argentina itself recognizes was warranted at the time of </text>
<text top=""800"" left=""108"" width=""683"" height=""16"" font=""0"">adoption. Argentina is arguing that the process provided for receiving and processing applications </text>
<text top=""817"" left=""108"" width=""684"" height=""16"" font=""0"">for import authorization and designations of FMD status was not concluded in a time consistent </text>
<text top=""833"" left=""108"" width=""302"" height=""16"" font=""0"">with obligations under the SPS Agreement.  </text>
</p><p number=""33."" style=""6""><text top=""866"" left=""108"" width=""684"" height=""16"" font=""0"">33.  The SPS Agreement has two relevant disciplines on the timeliness of decisionmaking: the </text>
<text top=""882"" left=""108"" width=""682"" height=""16"" font=""0"">Annex C(1)(a) requirement ""that procedures are undertaken and completed without undue delay,"" </text>
<text top=""899"" left=""108"" width=""685"" height=""16"" font=""0"">and the Article 5.7 requirement that ""Members shall seek to obtain the additional information </text>
<text top=""915"" left=""108"" width=""687"" height=""16"" font=""0"">necessary for a more objective assessment of risk and review the [SPS] measure within a </text>
<text top=""932"" left=""108"" width=""682"" height=""16"" font=""0"">reasonable period of time."" Argentina addresses both Annex C(1)(a) and Article 5.7, and these are </text>
<text top=""948"" left=""108"" width=""683"" height=""16"" font=""0"">the provisions that fit Argentina's stated concerns with the U.S. measure. Accordingly, those are </text>
<text top=""964"" left=""108"" width=""476"" height=""16"" font=""0"">the provisions that the Panel should examine to resolve this dispute.  </text>
</p><p number=""B."" style=""1""><text top=""997"" left=""108"" width=""53"" height=""16"" font=""23"">B. A</text><text top=""1000"" left=""161"" width=""66"" height=""13"" font=""29"">RGENTINA </text><text top=""997"" left=""235"" width=""11"" height=""16"" font=""23"">H</text><text top=""1000"" left=""247"" width=""19"" height=""13"" font=""29"">AS </text><text top=""997"" left=""274"" width=""11"" height=""16"" font=""23"">N</text><text top=""1000"" left=""285"" width=""20"" height=""13"" font=""29"">OT </text><text top=""997"" left=""313"" width=""10"" height=""16"" font=""23"">S</text><text top=""1000"" left=""323"" width=""128"" height=""13"" font=""29"">HOWN THAT THE </text><text top=""997"" left=""450"" width=""11"" height=""16"" font=""23"">U</text><text top=""1000"" left=""461"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""997"" left=""499"" width=""14"" height=""16"" font=""23""> S</text><text top=""1000"" left=""513"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""997"" left=""562"" width=""10"" height=""16"" font=""23"">B</text><text top=""1000"" left=""572"" width=""59"" height=""13"" font=""29"">REACHED </text><text top=""997"" left=""640"" width=""29"" height=""16"" font=""23"">SPS</text><text top=""997"" left=""680"" width=""10"" height=""16"" font=""23"">A</text><text top=""1000"" left=""691"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""997"" left=""734"" width=""14"" height=""16"" font=""23""> 8</text><text top=""1000"" left=""748"" width=""49"" height=""13"" font=""29""> AND </text><text top=""1014"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""1017"" left=""161"" width=""33"" height=""13"" font=""29"">NNEX</text><text top=""1014"" left=""194"" width=""39"" height=""16"" font=""23""> C(1)</text><text top=""1017"" left=""233"" width=""42"" height=""13"" font=""29""> WITH </text><text top=""1014"" left=""275"" width=""11"" height=""16"" font=""23"">R</text><text top=""1017"" left=""285"" width=""69"" height=""13"" font=""29"">ESPECT TO </text><text top=""1014"" left=""354"" width=""10"" height=""16"" font=""23"">A</text><text top=""1017"" left=""365"" width=""63"" height=""13"" font=""29"">RGENTINA</text><text top=""1014"" left=""427"" width=""4"" height=""16"" font=""23"">'</text><text top=""1017"" left=""432"" width=""11"" height=""13"" font=""29"">S </text><text top=""1014"" left=""443"" width=""11"" height=""16"" font=""23"">R</text><text top=""1017"" left=""454"" width=""86"" height=""13"" font=""29"">EQUESTS FOR </text><text top=""1014"" left=""540"" width=""9"" height=""16"" font=""23"">T</text><text top=""1017"" left=""549"" width=""20"" height=""13"" font=""29"">HE </text><text top=""1014"" left=""570"" width=""11"" height=""16"" font=""23"">R</text><text top=""1017"" left=""580"" width=""102"" height=""13"" font=""29"">ECOGNITION OF </text><text top=""1014"" left=""682"" width=""10"" height=""16"" font=""23"">A</text><text top=""1017"" left=""692"" width=""97"" height=""13"" font=""29"">RGENTINA AND </text><text top=""1030"" left=""151"" width=""10"" height=""16"" font=""23"">P</text><text top=""1033"" left=""160"" width=""87"" height=""13"" font=""29"">ATAGONIA AS </text><text top=""1030"" left=""247"" width=""7"" height=""16"" font=""23"">I</text><text top=""1033"" left=""254"" width=""84"" height=""13"" font=""29"">NDEPENDENT </text><text top=""1030"" left=""338"" width=""39"" height=""16"" font=""23"">FMD-</text><text top=""1033"" left=""378"" width=""33"" height=""13"" font=""29"">FREE </text><text top=""1030"" left=""411"" width=""11"" height=""16"" font=""23"">R</text><text top=""1033"" left=""421"" width=""50"" height=""13"" font=""29"">EGIONS </text></p><p number=""34."" style=""6""><text top=""1063"" left=""108"" width=""682"" height=""16"" font=""0"">34.  Argentina asserts, but does not show, that the type of determination at issue in this dispute </text>
<text top=""1079"" left=""108"" width=""682"" height=""16"" font=""0"">falls within the scope of SPS Article 8. Argentina cannot support this assertion. To the contrary, an </text>
<text top=""1096"" left=""108"" width=""683"" height=""16"" font=""0"">examination of the text of the SPS Agreement shows that this type of determination &#8211; involving </text>
<text top=""1112"" left=""108"" width=""572"" height=""16"" font=""0"">disease-free areas of potential exporters &#8211;does not fall within the scope of Article 8 </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-29 - </text>
</p></p></page>
<page number=""39"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""35."" style=""6""><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">35.  The approval procedures serve to ""check and ensure the fulfillment of SPS measures"", and a </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">Member must have reasonable time to complete the procedure. In <i>EC &#8211; Biotech</i>, the panel </text>
<text top=""160"" left=""108"" width=""687"" height=""16"" font=""0"">acknowledged the importance of the process, and of the fact that ""Members applying such </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">procedures must in principle be allowed to take the time that is reasonably needed to determine </text>
<text top=""193"" left=""108"" width=""689"" height=""16"" font=""0"">with adequate confidence whether their relevant SPS requirements are fulfilled, if these </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">requirements are WTO-consistent."" As an example, the panel stated that additional information </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">becoming available at a late stage of the approval procedure, which may impact a determination, </text>
<text top=""242"" left=""108"" width=""151"" height=""16"" font=""0"">could justify a delay.  </text>
</p><p number=""36."" style=""6""><text top=""275"" left=""108"" width=""690"" height=""16"" font=""0"">36.  Argentina asserts that its application process suffered ""undue delay"" because the </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">United States has not concluded the evaluation of Argentina's request to be recognized as a region </text>
<text top=""308"" left=""108"" width=""684"" height=""16"" font=""0"">free of FMD. In fact, the record shows that any interruptions in Argentina's application process </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">were due to changing FMD conditions in Argentina, such as additional FMD outbreaks, regulatory </text>
<text top=""341"" left=""108"" width=""686"" height=""16"" font=""0"">changes that altered sanitary boundaries, and time attributable to Argentina's preparation of </text>
<text top=""357"" left=""108"" width=""310"" height=""16"" font=""0"">responses to questions by the United States. </text>
</p><p number=""37."" style=""6""><text top=""390"" left=""108"" width=""685"" height=""16"" font=""0"">37.  Argentina relies on the overall length of time (11 years) that have been involved in the </text>
<text top=""407"" left=""108"" width=""682"" height=""16"" font=""0"">evaluation process But this type of argument &#8211; involving a total period of time &#8211; represents exactly </text>
<text top=""423"" left=""108"" width=""682"" height=""16"" font=""0"">the wrong type of analysis under Annex C(1)(a). It completely avoids any discussion of the specific </text>
<text top=""439"" left=""108"" width=""685"" height=""16"" font=""0"">facts and circumstances. In short, the total period of time involved in a regulatory process &#8211; </text>
<text top=""456"" left=""108"" width=""374"" height=""16"" font=""0"">standing alone &#8211; is not determinative of undue delay.  </text>
</p><p number=""38."" style=""6""><text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">38.  The United States would like to highlight in particular Argentina's failure to mention its own </text>
<text top=""505"" left=""108"" width=""684"" height=""16"" font=""0"">impact on the time period involved in the regulatory process. In this regard, the United States </text>
<text top=""521"" left=""108"" width=""683"" height=""16"" font=""0"">recalls the finding in <i>EC &#8211; Biotech</i> that delays caused by an applicant cannot be legally attributed </text>
<text top=""538"" left=""108"" width=""683"" height=""16"" font=""0"">to a Member. In other words, any interruption caused by the applicant is not the responsibility of </text>
<text top=""554"" left=""108"" width=""683"" height=""16"" font=""0"">the Member, and any consequential delays are justified. During the evaluation process, Argentina </text>
<text top=""571"" left=""108"" width=""688"" height=""16"" font=""0"">has caused numerous delays. Here, the delay between the receipt of application and the </text>
<text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">submission of additional information is attributable to Argentina. Argentina's initial request lacked </text>
<text top=""603"" left=""108"" width=""685"" height=""16"" font=""0"">adequate information necessary for the United States to perform and complete the evaluation </text>
<text top=""620"" left=""108"" width=""61"" height=""16"" font=""0"">process. </text>
</p><p number=""39."" style=""6""><text top=""653"" left=""108"" width=""683"" height=""16"" font=""0"">39.  Argentina also has failed to demonstrate that the United States acted with ""undue delay"" in </text>
<text top=""669"" left=""108"" width=""684"" height=""16"" font=""0"">the evaluation of Argentina's application for the recognition of Patagonia as region free of FMD. </text>
<text top=""685"" left=""108"" width=""600"" height=""16"" font=""0"">Argentina has no basis for claiming that the United States has engaged in undue delay. </text>
</p><p number=""40."" style=""6""><text top=""718"" left=""108"" width=""683"" height=""16"" font=""0"">40.  Argentina has failed to demonstrate that legislation, which has expired years ago and was </text>
<text top=""735"" left=""108"" width=""684"" height=""16"" font=""0"">never enacted into law, results in undue delay in the evaluation process. Neither Section 737 of </text>
<text top=""751"" left=""108"" width=""685"" height=""16"" font=""0"">the 2009 Omnibus Appropriations Act nor the Foot and Mouth Disease Prevention Act of 2008 </text>
<text top=""767"" left=""108"" width=""685"" height=""16"" font=""0"">resulted in any delay, and therefore did not cause an undue delay under Annex C (1)(a), first </text>
<text top=""784"" left=""108"" width=""148"" height=""16"" font=""0"">clause, and Article 8. </text>
</p><p number=""C."" style=""1""><text top=""817"" left=""108"" width=""73"" height=""16"" font=""23"">C. U.S.</text><text top=""817"" left=""185"" width=""13"" height=""16"" font=""23"">M</text><text top=""820"" left=""197"" width=""95"" height=""13"" font=""29"">EASURES WITH </text><text top=""817"" left=""292"" width=""11"" height=""16"" font=""23"">R</text><text top=""820"" left=""303"" width=""67"" height=""13"" font=""29"">ESPECT TO </text><text top=""817"" left=""370"" width=""10"" height=""16"" font=""23"">A</text><text top=""820"" left=""381"" width=""66"" height=""13"" font=""29"">RGENTINA </text><text top=""817"" left=""447"" width=""10"" height=""16"" font=""23"">A</text><text top=""820"" left=""457"" width=""19"" height=""13"" font=""29"">RE </text><text top=""817"" left=""477"" width=""7"" height=""16"" font=""23"">J</text><text top=""820"" left=""484"" width=""61"" height=""13"" font=""29"">USTIFIED </text><text top=""817"" left=""545"" width=""11"" height=""16"" font=""23"">U</text><text top=""820"" left=""556"" width=""37"" height=""13"" font=""29"">NDER </text><text top=""817"" left=""592"" width=""10"" height=""16"" font=""23"">A</text><text top=""820"" left=""603"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""817"" left=""646"" width=""33"" height=""16"" font=""23""> 5.7 </text></p><p number=""41."" style=""6""><text top=""850"" left=""108"" width=""684"" height=""16"" font=""0"">41.  SPS Article 5.7 provides that ""[i]n cases where relevant scientific evidence is insufficient,"" </text>
<text top=""866"" left=""108"" width=""685"" height=""16"" font=""0"">Members may take provisional measures based on ""available pertinent information."" In those </text>
<text top=""882"" left=""108"" width=""682"" height=""16"" font=""0"">instances, Members ""shall seek to obtain the additional information necessary for a more objective </text>
<text top=""899"" left=""108"" width=""687"" height=""16"" font=""0"">assessment of risk and review the sanitary or phytosanitary measure accordingly, within a </text>
<text top=""915"" left=""108"" width=""190"" height=""16"" font=""0"">reasonable period of time."" </text>
</p><p number=""42."" style=""6""><text top=""948"" left=""108"" width=""687"" height=""16"" font=""0"">42.  Argentina's complaints concern the alleged failure of the United States to complete a </text>
<text top=""964"" left=""108"" width=""683"" height=""16"" font=""0"">regulatory process based on an application submitted by Argentina for (1) authorization to import </text>
<text top=""981"" left=""108"" width=""682"" height=""16"" font=""0"">fresh, chilled and frozen beef and (2) designation of Patagonia South as an FMD-free region under </text>
<text top=""997"" left=""108"" width=""683"" height=""16"" font=""0"">APHIS regulation. In short, Argentina seeks the completion of the rulemaking phase and issuance </text>
<text top=""1014"" left=""108"" width=""143"" height=""16"" font=""0"">of the authorization. </text>
</p><p number=""43."" style=""6""><text top=""1046"" left=""108"" width=""77"" height=""16"" font=""0"">43. In </text>
<text top=""1046"" left=""170"" width=""620"" height=""16"" font=""8""><i>Japan &#8211; Agricultural Products II</i>, the Appellate Body articulated four prongs to determine </text>
<text top=""1063"" left=""108"" width=""682"" height=""16"" font=""0"">whether a measure was properly deemed provisional: (1) the measure was imposed in a situation </text>
<text top=""1079"" left=""108"" width=""683"" height=""16"" font=""0"">where relevant scientific information is insufficient to conduct a risk assessment; (2) the measure </text>
<text top=""1096"" left=""108"" width=""687"" height=""16"" font=""0"">was adopted on the basis of available pertinent information; (3) the Member imposing the </text>
<text top=""1112"" left=""108"" width=""683"" height=""16"" font=""0"">measure seeks additional information necessary for a more objective assessment of risk; and (4) </text>
<text top=""1128"" left=""108"" width=""475"" height=""16"" font=""0"">the Member reviews the measure within a reasonable period of time. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-30 - </text>
</p></p></page>
<page number=""40"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""44."" style=""6""><text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">44.  The application of the APHIS system and the 2001 Regulations were clearly justified when </text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""0"">adopted as Argentina implicitly concedes. Subsequent to their adoption, Argentina submitted </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">applications in which it claimed to have regained disease-free status for parts of its territory. While </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">the U.S. review of Argentina's requests for recognition as disease-free is ongoing, the regulations </text>
<text top=""210"" left=""108"" width=""629"" height=""16"" font=""0"">are justified under Article 5.7 and fully conform to the procedural obligations of that article. </text>
</p><p number=""45."" style=""6""><text top=""242"" left=""108"" width=""686"" height=""16"" font=""0"">45.  First, the APHIS system and 2001 Regulations were effective during a period in which </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina had been experiencing FMD outbreaks for months. Second, the measures were based on </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">available information &#8211; the reports and acknowledgment by Argentina of serious FMD outbreaks. </text>
<text top=""292"" left=""108"" width=""691"" height=""16"" font=""0"">Third, upon Argentina's request for re-authorization to import in November 2002, the </text>
<text top=""308"" left=""108"" width=""688"" height=""16"" font=""0"">United States, through the provisions of 9 C.F.R. &#167; 92.2, sought and requested additional </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">information to ascertain the FMD status of Argentina. Fourth, considering the ongoing attempt of </text>
<text top=""341"" left=""108"" width=""684"" height=""16"" font=""0"">the United States to seek information from Argentina, and the latter's response time, the period </text>
<text top=""357"" left=""108"" width=""682"" height=""16"" font=""0"">for review has been reasonable. The United States is committed to completing the review process, </text>
<text top=""374"" left=""108"" width=""566"" height=""16"" font=""0"">of which a necessary step is the site visit which it will conduct in November 2013.  </text>
</p><p number=""46."" style=""6""><text top=""407"" left=""108"" width=""687"" height=""16"" font=""0"">46.  Similary, the continuing review of Argentina's request to consider Patagonia South as </text>
<text top=""423"" left=""108"" width=""684"" height=""16"" font=""0"">disease-free also fulfills the Article 5.7 criteria discussed above. First, at the time of Argentina's </text>
<text top=""439"" left=""108"" width=""688"" height=""16"" font=""0"">application to APHIS to consider that the region of Patagonia South as disease-free, the </text>
<text top=""456"" left=""108"" width=""683"" height=""16"" font=""0"">United States had insufficient data to make any judgment on the status of Patagonia South. Until </text>
<text top=""472"" left=""108"" width=""683"" height=""16"" font=""0"">the time of Argentina's application, Patagonia South had been considered to be part of the larger </text>
<text top=""489"" left=""108"" width=""685"" height=""16"" font=""0"">sanitary region of Argentina. In fact, Argentina's application for authorization to import fresh, </text>
<text top=""505"" left=""108"" width=""573"" height=""16"" font=""0"">chilled, and frozen beef was to cover the whole country, including Patagonia South. </text>
</p><p number=""47."" style=""6""><text top=""538"" left=""108"" width=""682"" height=""16"" font=""0"">47.  Second, the U.S. review of Argentina's application is clearly designed to obtain the additional </text>
<text top=""554"" left=""108"" width=""682"" height=""16"" font=""0"">information from Argentina necessary to conclude whether Patagonia South is FMD free and review </text>
<text top=""571"" left=""108"" width=""478"" height=""16"" font=""0"">the 2001 Regulations accordingly within a reasonable period of time.  </text>
</p><p number=""48."" style=""6""><text top=""603"" left=""108"" width=""690"" height=""16"" font=""0"">48.  Third, APHIS sought information from Argentina through its review of Argentina's </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">application. It continued to seek information after the draft rule on Patagonia South because of the </text>
<text top=""636"" left=""108"" width=""495"" height=""16"" font=""0"">changing sanitary conditions in Patagonia South and Patagonia North B. </text>
</p><p number=""49."" style=""6""><text top=""669"" left=""108"" width=""683"" height=""16"" font=""0"">49.  Fourth, given the complex procedural process and historical timeline, the period for review </text>
<text top=""685"" left=""108"" width=""682"" height=""16"" font=""0"">has been reasonable. The facts and issues raised claims under Article 8 and Annex C(1) are similar </text>
<text top=""702"" left=""108"" width=""683"" height=""16"" font=""0"">in nature to the ones discussed under Article 5.7. For the same reasons, there is no basis for the </text>
<text top=""718"" left=""108"" width=""684"" height=""16"" font=""0"">panel to find that APHIS violated the ""reasonable period of time"" standard. The United States is </text>
<text top=""735"" left=""108"" width=""684"" height=""16"" font=""0"">committed to completing the review process, of which a necessary step is the site visit which it </text>
<text top=""751"" left=""108"" width=""210"" height=""16"" font=""0"">conducted in November 2013. </text>
</p><p number=""50."" style=""6""><text top=""784"" left=""108"" width=""614"" height=""16"" font=""0"">50.  For the foregoing reasons, the U.S. measures fulfill the requirements of Article 5.7. </text>
</p><p number=""D."" style=""1""><text top=""817"" left=""108"" width=""73"" height=""16"" font=""23"">D. U.S.</text><text top=""817"" left=""189"" width=""10"" height=""16"" font=""23"">A</text><text top=""820"" left=""199"" width=""95"" height=""13"" font=""29"">CTIONS WITH </text><text top=""817"" left=""294"" width=""11"" height=""16"" font=""23"">R</text><text top=""820"" left=""304"" width=""76"" height=""13"" font=""29"">ESPECT TO </text><text top=""817"" left=""380"" width=""10"" height=""16"" font=""23"">A</text><text top=""820"" left=""391"" width=""63"" height=""13"" font=""29"">RGENTINA</text><text top=""817"" left=""453"" width=""4"" height=""16"" font=""23"">'</text><text top=""820"" left=""458"" width=""11"" height=""13"" font=""29"">S </text><text top=""817"" left=""473"" width=""7"" height=""16"" font=""23"">I</text><text top=""820"" left=""480"" width=""112"" height=""13"" font=""29"">MPORTATION OF </text><text top=""817"" left=""592"" width=""10"" height=""16"" font=""23"">B</text><text top=""820"" left=""603"" width=""25"" height=""13"" font=""29"">EEF </text><text top=""817"" left=""632"" width=""10"" height=""16"" font=""23"">A</text><text top=""820"" left=""642"" width=""19"" height=""13"" font=""29"">RE </text><text top=""817"" left=""665"" width=""10"" height=""16"" font=""23"">C</text><text top=""820"" left=""675"" width=""118"" height=""13"" font=""29"">ONSISTENT WITH </text><text top=""833"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""836"" left=""161"" width=""54"" height=""13"" font=""29"">RTICLES </text><text top=""833"" left=""215"" width=""24"" height=""16"" font=""23"">5.1</text><text top=""836"" left=""239"" width=""33"" height=""13"" font=""29""> AND </text><text top=""833"" left=""272"" width=""24"" height=""16"" font=""23"">5.2</text><text top=""836"" left=""296"" width=""50"" height=""13"" font=""29""> OF THE </text><text top=""833"" left=""345"" width=""29"" height=""16"" font=""23"">SPS</text><text top=""833"" left=""378"" width=""10"" height=""16"" font=""23"">A</text><text top=""836"" left=""389"" width=""64"" height=""13"" font=""29"">GREEMENT</text></p><p number=""51."" style=""6""><text top=""866"" left=""108"" width=""684"" height=""16"" font=""0"">51.  The core concern articulated by Argentina is that the United States has not completed its </text>
<text top=""882"" left=""108"" width=""682"" height=""16"" font=""0"">review of Argentina's requests for import authorization due to an alleged change in disease status. </text>
<text top=""899"" left=""108"" width=""682"" height=""16"" font=""0"">That procedural concern is one that may be examined in the light the procedural obligations in SPS </text>
<text top=""915"" left=""108"" width=""685"" height=""16"" font=""0"">Article 5.7. Because it is justified under Article 5.7, the U.S. 2001 Regulations currently under </text>
<text top=""932"" left=""108"" width=""331"" height=""16"" font=""0"">review are consistent with Articles 5.1 and 5.2.  </text>
</p><p number=""52."" style=""6""><text top=""964"" left=""108"" width=""683"" height=""16"" font=""0"">52.  Article 5.1 states that ""Members shall ensure that their sanitary or phytosanitary measures </text>
<text top=""981"" left=""108"" width=""682"" height=""16"" font=""0"">are based on an assessment, as appropriate to the circumstances, of the risks to human, animal or </text>
<text top=""997"" left=""108"" width=""685"" height=""16"" font=""0"">plant life or health, taking into account risk assessment techniques developed by the relevant </text>
<text top=""1014"" left=""108"" width=""684"" height=""16"" font=""0"">international organizations."" In <i>Australia &#8211; Apples</i>,<i>  </i>the Appellate Body clarified that compliance </text>
<text top=""1030"" left=""108"" width=""685"" height=""16"" font=""0"">with Article 5.1 requires an evaluation of whether there is a ""rational or objective relationship </text>
<text top=""1046"" left=""108"" width=""682"" height=""16"" font=""0"">between the SPS measures and the scientific evidence and between the SPS measures and the risk </text>
<text top=""1063"" left=""108"" width=""684"" height=""16"" font=""0"">assessment."" The U.S. measures are rationally and objectively connected to both the scientific </text>
<text top=""1079"" left=""108"" width=""239"" height=""16"" font=""0"">evidence and the risk assessment. </text>
</p><p number=""53."" style=""6""><text top=""1112"" left=""108"" width=""683"" height=""16"" font=""0"">53.  Elaborating upon Article 5.1's assessment of risks, Article 5.2 provides that ""Members shall </text>
<text top=""1128"" left=""108"" width=""687"" height=""16"" font=""0"">take into account available scientific evidence; relevant processes and production methods; </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-31 - </text>
</p><p><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">relevant inspection, sampling and testing methods; prevalence of specific diseases or pests; </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">existence of pest- or disease-free areas; relevant ecological and environmental conditions; and </text>
<text top=""160"" left=""108"" width=""124"" height=""16"" font=""0"">other treatment."" </text>
</p></p></page>
<page number=""41"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""54."" style=""6""><text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">54.  In removing the import authorization, the United States was not permanently prohibiting </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina from regaining its import authorization. Instead, the removal returned Argentina to the </text>
<text top=""226"" left=""108"" width=""687"" height=""16"" font=""0"">status quo ante that if Argentina sought to export to the United States, it would have to </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">demonstrate that it had reduced the risk of FMD to a level that would not allow the introduction </text>
<text top=""259"" left=""108"" width=""687"" height=""16"" font=""0"">and dissemination of FMD into the United States. This is the very same process &#8211; loss of </text>
<text top=""275"" left=""108"" width=""434"" height=""16"" font=""0"">designation followed by reapplication &#8211; that the OIE employed. </text>
</p><p number=""55."" style=""6""><text top=""308"" left=""108"" width=""686"" height=""16"" font=""0"">55.  The 2001 Regulations were justified as a response to the massive FMD outbreak from </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">2000-2002. They continue to be justified by the assessment made at the time as APHIS is in the </text>
<text top=""341"" left=""108"" width=""682"" height=""16"" font=""0"">process of reviewing and evaluating Argentina's application. This current review and evaluation by </text>
<text top=""357"" left=""108"" width=""685"" height=""16"" font=""0"">APHIS is the basis for the position of the United States that claims under Article 5 are more </text>
<text top=""374"" left=""108"" width=""264"" height=""16"" font=""0"">appropriately addressed by Article 5.7 </text>
</p><p number=""56."" style=""6""><text top=""407"" left=""108"" width=""684"" height=""16"" font=""0"">56.  As in the case of Argentina's application for authorization to import certain beef products, </text>
<text top=""423"" left=""108"" width=""682"" height=""16"" font=""0"">the application for Patagonia was not a simple situation. There were a number of moving parts in a </text>
<text top=""439"" left=""108"" width=""684"" height=""16"" font=""0"">rather complex FMD sanitary situation. Argentina points out multiple times that South Patagonia </text>
<text top=""456"" left=""108"" width=""682"" height=""16"" font=""0"">had not had an FMD outbreak since 1976 &#8211; that fact alone is not dispositive of the inquiry. The fact </text>
<text top=""472"" left=""108"" width=""683"" height=""16"" font=""0"">is that an inquiry into the risks posed by a particular region is one into the sanitary controls and </text>
<text top=""489"" left=""108"" width=""213"" height=""16"" font=""0"">the changes in that landscape. </text>
</p><p number=""57."" style=""6""><text top=""521"" left=""108"" width=""683"" height=""16"" font=""0"">57.  All this points to the fact that APHIS requested permission from Argentina to conduct a site </text>
<text top=""538"" left=""108"" width=""685"" height=""16"" font=""0"">visit to review the system and situation in Argentina in 2012. Argentina did not respond until </text>
<text top=""554"" left=""108"" width=""682"" height=""16"" font=""0"">July 2013, and requested that the site visit occur in November 2013. Argentina insists on pursuing </text>
<text top=""571"" left=""108"" width=""550"" height=""16"" font=""0"">litigation, when the United States is moving forward with its regulatory process. </text>
</p><p number=""E."" style=""1""><text top=""603"" left=""108"" width=""73"" height=""16"" font=""23"">E. U.S.</text><text top=""603"" left=""188"" width=""13"" height=""16"" font=""23"">M</text><text top=""606"" left=""200"" width=""101"" height=""13"" font=""29"">EASURES WITH </text><text top=""603"" left=""302"" width=""11"" height=""16"" font=""23"">R</text><text top=""606"" left=""312"" width=""74"" height=""13"" font=""29"">ESPECT TO </text><text top=""603"" left=""386"" width=""10"" height=""16"" font=""23"">A</text><text top=""606"" left=""396"" width=""63"" height=""13"" font=""29"">RGENTINA</text><text top=""603"" left=""459"" width=""4"" height=""16"" font=""23"">'</text><text top=""606"" left=""464"" width=""11"" height=""13"" font=""29"">S </text><text top=""603"" left=""478"" width=""7"" height=""16"" font=""23"">I</text><text top=""606"" left=""485"" width=""110"" height=""13"" font=""29"">MPORTATION OF </text><text top=""603"" left=""595"" width=""10"" height=""16"" font=""23"">B</text><text top=""606"" left=""606"" width=""25"" height=""13"" font=""29"">EEF </text><text top=""603"" left=""634"" width=""10"" height=""16"" font=""23"">A</text><text top=""606"" left=""644"" width=""19"" height=""13"" font=""29"">RE </text><text top=""603"" left=""666"" width=""10"" height=""16"" font=""23"">C</text><text top=""606"" left=""676"" width=""116"" height=""13"" font=""29"">ONSISTENT WITH </text><text top=""620"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""623"" left=""161"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""620"" left=""204"" width=""29"" height=""16"" font=""23""> 2.2</text><text top=""623"" left=""232"" width=""50"" height=""13"" font=""29""> OF THE </text><text top=""620"" left=""282"" width=""29"" height=""16"" font=""23"">SPS</text><text top=""620"" left=""315"" width=""10"" height=""16"" font=""23"">A</text><text top=""623"" left=""325"" width=""64"" height=""13"" font=""29"">GREEMENT</text></p><p number=""58."" style=""6""><text top=""653"" left=""108"" width=""683"" height=""16"" font=""0"">58.  The United States maintains that its measures are consistent with Article 2.2 because they </text>
<text top=""669"" left=""108"" width=""683"" height=""16"" font=""0"">are consistent with Article 5.7. As set out in Article 2.2, the obligation not to maintain a measure </text>
<text top=""685"" left=""108"" width=""684"" height=""16"" font=""0"">without sufficient scientific evidence expressly sets out an exception: ""except as provided for in </text>
<text top=""702"" left=""108"" width=""685"" height=""16"" font=""0"">paragraph 7 of Article 5."" Therefore, a measure that is consistent with Article 5.7 will not be </text>
<text top=""718"" left=""108"" width=""198"" height=""16"" font=""0"">inconsistent with Article 2.2. </text>
</p><p number=""59."" style=""6""><text top=""751"" left=""108"" width=""682"" height=""16"" font=""0"">59.  Article 2.2 contains three separate requirements: ""(i) the requirement that SPS measures be </text>
<text top=""767"" left=""108"" width=""685"" height=""16"" font=""0"">applied only to the extent necessary to protect human, animal or plant life or health; (ii) the </text>
<text top=""784"" left=""108"" width=""684"" height=""16"" font=""0"">requirement that SPS measures be based on scientific principles; and (iii) the requirement that </text>
<text top=""800"" left=""108"" width=""496"" height=""16"" font=""0"">SPS measures not be maintained without sufficient scientific evidence.""  </text>
</p><p number=""60."" style=""6""><text top=""833"" left=""108"" width=""685"" height=""16"" font=""0"">60.  Argentina's only argument for satisfying the first requirement of Article 2.2 is this: ""The </text>
<text top=""850"" left=""108"" width=""684"" height=""16"" font=""0"">circumstances that motivated the withdrawal of the authorization of imports of fresh beef from </text>
<text top=""866"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina &#8230; are outdated by several years."" This is mere assertion, without any relevant scientific </text>
<text top=""882"" left=""108"" width=""687"" height=""16"" font=""0"">evidence for support. Argentina states that its last outbreak was in 2006&#8212;yet this is not </text>
<text top=""899"" left=""108"" width=""683"" height=""16"" font=""0"">dispositive of the matter. The FMD risk of a country is not only determined by when was its last </text>
<text top=""915"" left=""108"" width=""685"" height=""16"" font=""0"">outbreak, but also by a series of other factors including the quality of the country's internal </text>
<text top=""932"" left=""108"" width=""438"" height=""16"" font=""0"">controls and its credibility in disease surveillance and reporting. </text>
</p><p number=""61."" style=""6""><text top=""964"" left=""108"" width=""687"" height=""16"" font=""0"">61.  The 2001 Regulations and the requirement that Argentina obtain re-authorization for </text>
<text top=""981"" left=""108"" width=""683"" height=""16"" font=""0"">importation has a ""rational or objective relationship"" to the scientific evidence because all parties, </text>
<text top=""997"" left=""108"" width=""685"" height=""16"" font=""0"">including Argentina, agree with the OIE that FMD is an extremely dangerous, contagious and </text>
<text top=""1014"" left=""108"" width=""685"" height=""16"" font=""0"">debilitating animal disease. As the OIE Code itself provides: ""Before trade in animals or their </text>
<text top=""1030"" left=""108"" width=""684"" height=""16"" font=""0"">products may occur, an importing country must be satisfied that its animal health status will be </text>
<text top=""1046"" left=""108"" width=""683"" height=""16"" font=""0"">appropriately protected"" Maintaining the 2001 Regulations in the meantime is based on scientific </text>
<text top=""1063"" left=""108"" width=""480"" height=""16"" font=""0"">principles related to transmissibility and consequences of the disease. </text>
</p><p number=""62."" style=""6""><text top=""1096"" left=""108"" width=""685"" height=""16"" font=""0"">62.  In relation to the adoption of the 2001 regulations and the requirement that Argentina </text>
<text top=""1112"" left=""108"" width=""684"" height=""16"" font=""0"">obtain import re-authorization, the record is replete with sufficient scientific evidence to support </text>
<text top=""1128"" left=""108"" width=""682"" height=""16"" font=""0"">those measures. After submitting its application for import authorization in late 2002, months after </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-32 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">the devastating outbreaks of 2000-2002, which were exacerbated by cover ups, Argentina had an </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">outbreak in 2003. This was then followed by another outbreak in 2006. It is fully consistent with </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">the scientific record for APHIS to maintain the 2001 Regulation while APHIS conducts a review of </text>
<text top=""177"" left=""108"" width=""464"" height=""16"" font=""0"">Argentina's FMD situation and the credibility of its internal controls. </text>
</p></p></page>
<page number=""42"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""63."" style=""6""><text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">63.  Argentina has provided no scientific evidence to meet its burden of proof. Argentina returns </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">to the point that there were favorable risk assessments in 1997 and 2000 &#8211; and obliquely </text>
<text top=""242"" left=""108"" width=""604"" height=""16"" font=""0"">acknowledges the massive outbreaks in 2001 with the nuanced phrase ""events in 2001. </text>
</p><p number=""64."" style=""6""><text top=""275"" left=""108"" width=""689"" height=""16"" font=""0"">64.  With respect to Patagonia, not only are the above considerations relevant because </text>
<text top=""292"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina's SENASA exercises regulatory authority over the whole country, but also the record </text>
<text top=""308"" left=""108"" width=""432"" height=""16"" font=""0"">provides an additional basis for support of the U.S. measures.  </text>
</p><p number=""65."" style=""6""><text top=""341"" left=""108"" width=""682"" height=""16"" font=""0"">65.  It is well established that ""it rests upon the complaining party to establish a prima facie case </text>
<text top=""357"" left=""108"" width=""682"" height=""16"" font=""0"">of inconsistency with a particular provision of the SPS Agreement. Argentina simply has not met its </text>
<text top=""374"" left=""108"" width=""57"" height=""16"" font=""0"">burden. </text>
</p><p number=""F."" style=""1""><text top=""407"" left=""108"" width=""55"" height=""16"" font=""23"">F. M</text><text top=""410"" left=""163"" width=""58"" height=""13"" font=""29"">EASURES </text><text top=""407"" left=""221"" width=""9"" height=""16"" font=""23"">T</text><text top=""410"" left=""230"" width=""82"" height=""13"" font=""29"">AKEN BY THE </text><text top=""407"" left=""312"" width=""11"" height=""16"" font=""23"">U</text><text top=""410"" left=""323"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""407"" left=""361"" width=""14"" height=""16"" font=""23""> S</text><text top=""410"" left=""375"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""407"" left=""416"" width=""10"" height=""16"" font=""23"">A</text><text top=""410"" left=""426"" width=""19"" height=""13"" font=""29"">RE </text><text top=""407"" left=""445"" width=""10"" height=""16"" font=""23"">C</text><text top=""410"" left=""455"" width=""110"" height=""13"" font=""29"">ONSISTENT WITH </text><text top=""407"" left=""565"" width=""10"" height=""16"" font=""23"">A</text><text top=""410"" left=""575"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""407"" left=""618"" width=""33"" height=""16"" font=""23""> 5.4 </text></p><p number=""66."" style=""6""><text top=""439"" left=""108"" width=""682"" height=""16"" font=""0"">66.  Article 5.4 states that a Member ""should, when determining the appropriate level of sanitary </text>
<text top=""456"" left=""108"" width=""683"" height=""16"" font=""0"">or phytosanitary protection, take into account the objective of minimizing negative trade effects."" </text>
<text top=""472"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina simply does not read this text according to its plain meaning. The provision, by its </text>
<text top=""489"" left=""108"" width=""415"" height=""16"" font=""0"">terms, does not impose affirmative obligations on Members. </text>
</p><p number=""67."" style=""6""><text top=""521"" left=""108"" width=""685"" height=""16"" font=""0"">67.  Minimizing negative trade effects in the context of FMD threats means that appropriate </text>
<text top=""538"" left=""108"" width=""685"" height=""16"" font=""0"">regulatory pathways should be in place to ensure that the importation of animals and animal </text>
<text top=""554"" left=""108"" width=""682"" height=""16"" font=""0"">products  does  not  lead  to  the  spread  of  FMD.  The  review  of  Argentina's  requests  for  import </text>
<text top=""571"" left=""108"" width=""686"" height=""16"" font=""0"">reauthorization in relation to the 2001 Regulation is not only consistent with the OIE's own </text>
<text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">approach, but also consistent with the OIE's own larger strategy to support economic and human </text>
<text top=""603"" left=""108"" width=""102"" height=""16"" font=""0"">development.  </text>
</p><p number=""G."" style=""1""><text top=""636"" left=""108"" width=""55"" height=""16"" font=""23"">G. M</text><text top=""639"" left=""163"" width=""58"" height=""13"" font=""29"">EASURES </text><text top=""636"" left=""221"" width=""9"" height=""16"" font=""23"">T</text><text top=""639"" left=""230"" width=""82"" height=""13"" font=""29"">AKEN BY THE </text><text top=""636"" left=""312"" width=""11"" height=""16"" font=""23"">U</text><text top=""639"" left=""323"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""636"" left=""361"" width=""14"" height=""16"" font=""23""> S</text><text top=""639"" left=""375"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""636"" left=""416"" width=""10"" height=""16"" font=""23"">A</text><text top=""639"" left=""426"" width=""19"" height=""13"" font=""29"">RE </text><text top=""636"" left=""445"" width=""10"" height=""16"" font=""23"">C</text><text top=""639"" left=""455"" width=""110"" height=""13"" font=""29"">ONSISTENT WITH </text><text top=""636"" left=""565"" width=""10"" height=""16"" font=""23"">A</text><text top=""639"" left=""575"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""636"" left=""618"" width=""33"" height=""16"" font=""23""> 5.6 </text></p><p number=""68."" style=""6""><text top=""669"" left=""108"" width=""688"" height=""16"" font=""0"">68.  Article 5.6 provides that ""when establishing or maintaining sanitary or phytosanitary </text>
<text top=""685"" left=""108"" width=""683"" height=""16"" font=""0"">measures to achieve the appropriate level of sanitary or phytosanitary protection, Members shall </text>
<text top=""702"" left=""108"" width=""688"" height=""16"" font=""0"">ensure that such measures are not more trade-restrictive than required to achieve their </text>
<text top=""718"" left=""108"" width=""688"" height=""16"" font=""0"">appropriate level of sanitary or phytosanitary protection, taking into account technical and </text>
<text top=""735"" left=""108"" width=""149"" height=""16"" font=""0"">economic feasibility."" </text>
</p><p number=""69."" style=""6""><text top=""767"" left=""108"" width=""682"" height=""16"" font=""0"">69.  A breach of Article 5.6 can only be found once ""there is a measure, other than the contested </text>
<text top=""784"" left=""108"" width=""687"" height=""16"" font=""0"">measure,"" that satisfies these three conditions: (1) the alternative measure is ""reasonably </text>
<text top=""800"" left=""108"" width=""686"" height=""16"" font=""0"">available taking into account technical and economic feasibility""; (2) the alternative measure </text>
<text top=""817"" left=""108"" width=""685"" height=""16"" font=""0"">""achieves the Member's appropriate level of sanitary or phytosanitary protection""; and (3) the </text>
<text top=""833"" left=""108"" width=""653"" height=""16"" font=""0"">alternative measure is ""significantly less restrictive to trade than the SPS measure contested.""  </text>
</p><p number=""70."" style=""6""><text top=""866"" left=""108"" width=""683"" height=""16"" font=""0"">70.  The U.S. review of Argentina's requests to revise the 2001 regulations is a process that is </text>
<text top=""882"" left=""108"" width=""683"" height=""16"" font=""0"">consistent with the international standard for handling trade in animals and animal products that </text>
<text top=""899"" left=""108"" width=""686"" height=""16"" font=""0"">can spread FMD. The OIE Code outlines a number of different approaches for importation of </text>
<text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">product depending upon a determination of the FMD situation in an applicant country &#8211; the point </text>
<text top=""932"" left=""108"" width=""683"" height=""16"" font=""0"">here is that the importing country must ascertain the situation in the applicant country through a </text>
<text top=""948"" left=""108"" width=""132"" height=""16"" font=""0"">systematic review. </text>
</p><p number=""71."" style=""6""><text top=""981"" left=""108"" width=""685"" height=""16"" font=""0"">71.  This systematic review starts with an application by an exporting country that provides </text>
<text top=""997"" left=""108"" width=""684"" height=""16"" font=""0"">information about the status of FMD and the country's internal controls. APHIS reviews this and </text>
<text top=""1014"" left=""108"" width=""685"" height=""16"" font=""0"">must also conduct its own independent due diligence in order to ascertain the situation in the </text>
<text top=""1030"" left=""108"" width=""683"" height=""16"" font=""0"">exporting country. These decisions are very sensitive, because inaccurate judgments can lead to </text>
<text top=""1046"" left=""108"" width=""684"" height=""16"" font=""0"">an epidemic. Argentina's own FMD situation with respect to its border is a cautionary tale about </text>
<text top=""1063"" left=""108"" width=""452"" height=""16"" font=""0"">how easily FMD can be spread, and how difficult it is to eradicate. </text>
</p><p number=""72."" style=""6""><text top=""1096"" left=""108"" width=""687"" height=""16"" font=""0"">72.  Whether there are appropriate alternative measures for safe importation of beef from </text>
<text top=""1112"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina depends on what the factual situation on the ground in Argentina is with respect to not </text>
<text top=""1128"" left=""108"" width=""684"" height=""16"" font=""0"">simply its geography and disease status but the credibility of its regulatory and control system. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-33 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">While the U.S. review of Argentina's requests is ongoing to permit a more objective assessment of </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">risk, maintaining the 2001 regulations is not more trade-restrictive than required to achieve the </text>
<text top=""160"" left=""108"" width=""254"" height=""16"" font=""0"">U.S. appropriate level of protection.  </text>
</p></p></page>
<page number=""43"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""73."" style=""6""><text top=""193"" left=""108"" width=""686"" height=""16"" font=""0"">73.  Argentina asserts that measures applied to Uruguay's exports to the United States are </text>
<text top=""210"" left=""108"" width=""688"" height=""16"" font=""0"">appropriate and readily available to be applied to Argentina. However, Argentina has not </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">established the premise of the argument&#8212;that Uruguay is a proper basis of comparison for </text>
<text top=""242"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina. In fact, Argentina asserts that Uruguay's measures are applicable to it since ""the </text>
<text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">sanitary situations are essentially similar."" The above argument applies as well to Santa Catarina </text>
<text top=""275"" left=""108"" width=""686"" height=""16"" font=""0"">and Patagonia. The difference here is the fact that Argentina first applied for recognition of </text>
<text top=""292"" left=""108"" width=""551"" height=""16"" font=""0"">Patagonia South, which had a separate sanitary status from Patagonia North B.  </text>
</p><p number=""H."" style=""1""><text top=""324"" left=""108"" width=""55"" height=""16"" font=""23"">H. M</text><text top=""327"" left=""163"" width=""58"" height=""13"" font=""29"">EASURES </text><text top=""324"" left=""225"" width=""9"" height=""16"" font=""23"">T</text><text top=""327"" left=""234"" width=""92"" height=""13"" font=""29"">AKEN BY THE </text><text top=""324"" left=""326"" width=""11"" height=""16"" font=""23"">U</text><text top=""327"" left=""337"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""324"" left=""374"" width=""14"" height=""16"" font=""23""> S</text><text top=""327"" left=""389"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""324"" left=""433"" width=""10"" height=""16"" font=""23"">A</text><text top=""327"" left=""443"" width=""19"" height=""13"" font=""29"">RE </text><text top=""324"" left=""465"" width=""11"" height=""16"" font=""23"">N</text><text top=""327"" left=""477"" width=""20"" height=""13"" font=""29"">OT </text><text top=""324"" left=""500"" width=""7"" height=""16"" font=""23"">I</text><text top=""327"" left=""507"" width=""133"" height=""13"" font=""29"">NCONSISTENT WITH </text><text top=""324"" left=""640"" width=""10"" height=""16"" font=""23"">A</text><text top=""327"" left=""650"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""324"" left=""693"" width=""29"" height=""16"" font=""23""> 2.3</text><text top=""324"" left=""729"" width=""10"" height=""16"" font=""23"">B</text><text top=""327"" left=""739"" width=""50"" height=""13"" font=""29"">ECAUSE </text><text top=""341"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""344"" left=""161"" width=""66"" height=""13"" font=""29"">RGENTINA </text><text top=""341"" left=""227"" width=""7"" height=""16"" font=""23"">I</text><text top=""344"" left=""235"" width=""11"" height=""13"" font=""29"">S </text><text top=""341"" left=""246"" width=""11"" height=""16"" font=""23"">N</text><text top=""344"" left=""257"" width=""20"" height=""13"" font=""29"">OT </text><text top=""341"" left=""277"" width=""10"" height=""16"" font=""23"">B</text><text top=""344"" left=""287"" width=""34"" height=""13"" font=""29"">EING </text><text top=""341"" left=""321"" width=""10"" height=""16"" font=""23"">A</text><text top=""344"" left=""332"" width=""98"" height=""13"" font=""29"">RBITRARILY OR </text><text top=""341"" left=""430"" width=""11"" height=""16"" font=""23"">U</text><text top=""344"" left=""441"" width=""90"" height=""13"" font=""29"">NJUSTIFIABLY </text><text top=""341"" left=""531"" width=""11"" height=""16"" font=""23"">D</text><text top=""344"" left=""542"" width=""94"" height=""13"" font=""29"">ISCRIMINATED </text><text top=""341"" left=""636"" width=""10"" height=""16"" font=""23"">A</text><text top=""344"" left=""647"" width=""46"" height=""13"" font=""29"">GAINST</text></p><p number=""74."" style=""6""><text top=""374"" left=""108"" width=""683"" height=""16"" font=""0"">74.  Argentina fails to show that its situation is identical or similar to that of Uruguay, Japan or </text>
<text top=""390"" left=""108"" width=""683"" height=""16"" font=""0"">the United Kingdom, and thus it cannot sustain its challenge under Article 2.3. As the discussion </text>
<text top=""407"" left=""108"" width=""685"" height=""16"" font=""0"">below illustrates, Argentina's record on issues such as geography and history are distinct from </text>
<text top=""423"" left=""108"" width=""526"" height=""16"" font=""0"">those of Uruguay, Japan, or the United Kingdom for purposes of Article 2.3.  </text>
</p><p number=""75."" style=""6""><text top=""456"" left=""108"" width=""684"" height=""16"" font=""0"">75.  To find a breach of Article 2.3's provision against arbitrary or unjustifiable discrimination, </text>
<text top=""472"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina must show: (1) ""the measure discriminates between the territories of Members other </text>
<text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">than the Member imposing the measure[;] (2) the discrimination is arbitrary or unjustifiable; and </text>
<text top=""505"" left=""108"" width=""587"" height=""16"" font=""0"">(3) identical or similar conditions prevail in the territory of the Members compared.""   </text>
</p><p number=""76."" style=""6""><text top=""538"" left=""108"" width=""682"" height=""16"" font=""0"">76.  Argentina's complaint is that it has not completed the APHIS regulatory process in the same </text>
<text top=""554"" left=""108"" width=""685"" height=""16"" font=""0"">time that other countries have completed it. However, in the first instance, the review by of </text>
<text top=""571"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina's requests is not a ""sanitary or phytosanitary measure"" subject to Article 2.3. An SPS </text>
<text top=""587"" left=""108"" width=""685"" height=""16"" font=""0"">measure (in pertinent part) is ""applied"" to ""protect animal &#8230; life or health"" and may include </text>
<text top=""603"" left=""108"" width=""682"" height=""16"" font=""0"">""provisions on &#8230; methods of risk assessment"" (Annex A, para. 1). But Argentina is not challenging </text>
<text top=""620"" left=""108"" width=""685"" height=""16"" font=""0"">a method of risk assessment that discriminates against it, and there is nothing in U.S. law or </text>
<text top=""636"" left=""108"" width=""346"" height=""16"" font=""0"">regulations on risk assessment that discriminates. </text>
</p><p number=""77."" style=""6""><text top=""669"" left=""108"" width=""682"" height=""16"" font=""0"">77.  In substance, Argentina's claim of discrimination based simply on alleged differences in time </text>
<text top=""685"" left=""108"" width=""684"" height=""16"" font=""0"">to review its requests is not a sufficient basis to establish discrimination. A determination of a </text>
<text top=""702"" left=""108"" width=""683"" height=""16"" font=""0"">country's FMD situation is not the same as inspecting automobiles on a factory assembly line. The </text>
<text top=""718"" left=""108"" width=""682"" height=""16"" font=""0"">process for reaching conclusion on an application for FMD status depends upon a variety of factors, </text>
<text top=""735"" left=""108"" width=""376"" height=""16"" font=""0"">not all of which are in the control of the United States. </text>
</p><p number=""78."" style=""6""><text top=""767"" left=""108"" width=""682"" height=""16"" font=""0"">78.  Review of an application is dependent on many factors, and is a particularized review of the </text>
<text top=""784"" left=""108"" width=""684"" height=""16"" font=""0"">animal health status of a country or region with very specific characteristics. Argentina devotes </text>
<text top=""800"" left=""108"" width=""683"" height=""16"" font=""0"">substantial space to describing the conditions under which Uruguay is permitted to import animal </text>
<text top=""817"" left=""108"" width=""684"" height=""16"" font=""0"">products into the United States. It merely asserts, however, that ""the physical situation and the </text>
<text top=""833"" left=""108"" width=""683"" height=""16"" font=""0"">institutional structures are similar in Uruguay and Argentina."" Argentina's Article 2.3 claim cannot </text>
<text top=""850"" left=""108"" width=""408"" height=""16"" font=""0"">be sustained on the basis of its selective and meager facts. </text>
</p><p number=""79."" style=""6""><text top=""882"" left=""108"" width=""677"" height=""16"" font=""0"">79.  Uruguay and Argentina are not similarly situated in terms of geography and risks of cross-</text>
<text top=""899"" left=""108"" width=""684"" height=""16"" font=""0"">border FMD introduction, populations of livestock susceptible to FMD, and volume of veterinary </text>
<text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">resources. Another key difference between the two countries is each one's recent FMD history. In </text>
<text top=""932"" left=""108"" width=""684"" height=""16"" font=""0"">fact, difference between the two countries can be encapsulated by the fact that since the 2001 </text>
<text top=""948"" left=""108"" width=""685"" height=""16"" font=""0"">outbreak, there has not been a reported outbreak in Uruguay. On the other hand, Argentina </text>
<text top=""964"" left=""108"" width=""460"" height=""16"" font=""0"">suffered two more outbreaks in the same period after 2000-2001.  </text>
</p><p number=""80."" style=""6""><text top=""997"" left=""108"" width=""684"" height=""16"" font=""0"">80.  Argentina's claim with respect to Japan should fail based on its own admission that ""[t]he </text>
<text top=""1014"" left=""108"" width=""682"" height=""16"" font=""0"">point here is not that the substantive situation of Argentina, on the one hand &#8230; and Japan, on the </text>
<text top=""1030"" left=""108"" width=""684"" height=""16"" font=""0"">other, are identical."" In fact, that is the point: one key prong of the Article 2.3 analysis is ""that </text>
<text top=""1046"" left=""108"" width=""687"" height=""16"" font=""0"">identical or similar conditions prevail in the territory of the Members compared."" A notable </text>
<text top=""1063"" left=""108"" width=""685"" height=""16"" font=""0"">difference between Argentina and Japan is the fact that Japan is an island chain comprised of </text>
<text top=""1079"" left=""108"" width=""682"" height=""16"" font=""0"">6,852 islands. Because of its island geography, land crossings of infected FMD animals over a long </text>
<text top=""1096"" left=""108"" width=""683"" height=""16"" font=""0"">border (such as that which occurred in Argentina during the decade of the 2000s) is not possible. </text>
<text top=""1112"" left=""108"" width=""682"" height=""16"" font=""0"">Japan's situation is so different from Argentina's such that Argentina's claim against the application </text>
<text top=""1128"" left=""108"" width=""125"" height=""16"" font=""0"">process must fail. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-34 - </text>
</p></p></page>
<page number=""44"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""81."" style=""6""><text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">81.  Argentina's claim with respect to the United Kingdom should fail based on its own admission </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">that ""[t]he point here is not that the substantive situation of Argentina, on the one hand and the </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">United Kingdom &#8230; , on the other, are identical."" Similar to Japan, the United Kingdom is an island, </text>
<text top=""193"" left=""108"" width=""686"" height=""16"" font=""0"">and thus land crossings of FMD animals over a long border (such as that which occurred in </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina) is not possible. The United Kingdom's FMD history includes an outbreak in 2000- 2001, </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">and an outbreak in 2008. While the 2000 outbreak was significant, it differed in a number of </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">respects from the one in Argentina.  Other than that, the OIE database records the last outbreak </text>
<text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">as 1981. The source of the smaller 2008 outbreak was an official laboratory conducting research </text>
<text top=""275"" left=""108"" width=""685"" height=""16"" font=""0"">into the FMD virus. The United Kingdom's situation is so different from Argentina's such that </text>
<text top=""292"" left=""108"" width=""405"" height=""16"" font=""0"">Argentina's claim against the application process must fail. </text>
</p><p number=""82."" style=""6""><text top=""324"" left=""108"" width=""682"" height=""16"" font=""0"">82.  The key differentiation between Santa Catarina's situation and that of Patagonia was the fact </text>
<text top=""341"" left=""108"" width=""683"" height=""16"" font=""0"">that Argentina had introduced new changes to the sanitary boundaries between Patagonia South </text>
<text top=""357"" left=""108"" width=""682"" height=""16"" font=""0"">and Patagonia North B in 2008. This factor added a new confounding element because Argentina's </text>
<text top=""374"" left=""108"" width=""683"" height=""16"" font=""0"">application in 2003 was for the region defined as Patagonia South, which was premised on certain </text>
<text top=""390"" left=""108"" width=""684"" height=""16"" font=""0"">controls with Patagonia North B. Santa Catarina, by contrast, had no sanitary boundary changes </text>
<text top=""407"" left=""108"" width=""683"" height=""16"" font=""0"">during the period of consideration, simplifying the process. It is reasonable, based on these facts, </text>
<text top=""423"" left=""108"" width=""684"" height=""16"" font=""0"">to understand how such changes could result in a difference in review periods and to see why </text>
<text top=""439"" left=""108"" width=""280"" height=""16"" font=""0"">Argentina's claim on this point must fail. </text>
</p><p number=""83."" style=""6""><text top=""472"" left=""108"" width=""682"" height=""16"" font=""0"">83.  Article 2.3 provides that SPS measures not be ""applied in a manner which would constitute a </text>
<text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">disguised restriction on international trade."" As this phrase calls upon the chapeau of Article XX of </text>
<text top=""505"" left=""108"" width=""682"" height=""16"" font=""0"">the GATT, it is worth noting that no ""single test might uniformly apply in all cases to determine the </text>
<text top=""521"" left=""108"" width=""420"" height=""16"" font=""0"">existence of a 'disguised restriction on international trade.'""   </text>
</p><p number=""84."" style=""6""><text top=""554"" left=""108"" width=""682"" height=""16"" font=""0"">84.  A ""disguised"" restriction on international trade may mean ""hidden"" or ""dissimulated."" This is </text>
<text top=""571"" left=""108"" width=""684"" height=""16"" font=""0"">not the case with respect to Argentina's applications. The record is clear as to Argentina's FMD </text>
<text top=""587"" left=""108"" width=""685"" height=""16"" font=""0"">history, the series of outbreaks since 2000, the deliberate cover-up of outbreaks, and shifting </text>
<text top=""603"" left=""108"" width=""684"" height=""16"" font=""0"">sanitary boundaries within the country. The process of reviewing the conditions in Argentina to </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">determine under what terms that country can safely export to the United States must be thorough </text>
<text top=""636"" left=""108"" width=""684"" height=""16"" font=""0"">based on that record. It is a process that the United States undertook in ""the principle of good </text>
<text top=""653"" left=""108"" width=""283"" height=""16"" font=""0"">faith"" consistent with its SPS obligations. </text>
</p><p number=""I."" style=""0""><text top=""685"" left=""108"" width=""73"" height=""16"" font=""23"">I. U.S.</text><text top=""685"" left=""186"" width=""10"" height=""16"" font=""23"">A</text><text top=""688"" left=""196"" width=""78"" height=""13"" font=""29"">PPLICATION </text><text top=""685"" left=""275"" width=""10"" height=""16"" font=""23"">S</text><text top=""688"" left=""285"" width=""65"" height=""13"" font=""29"">YSTEM TO </text><text top=""685"" left=""350"" width=""10"" height=""16"" font=""23"">P</text><text top=""688"" left=""360"" width=""50"" height=""13"" font=""29"">REVENT </text><text top=""685"" left=""411"" width=""33"" height=""16"" font=""23"">FMD</text><text top=""685"" left=""449"" width=""7"" height=""16"" font=""23"">I</text><text top=""688"" left=""456"" width=""11"" height=""13"" font=""29"">S </text><text top=""685"" left=""468"" width=""10"" height=""16"" font=""23"">C</text><text top=""688"" left=""478"" width=""112"" height=""13"" font=""29"">ONSISTENT WITH </text><text top=""685"" left=""590"" width=""10"" height=""16"" font=""23"">A</text><text top=""688"" left=""600"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""685"" left=""643"" width=""14"" height=""16"" font=""23""> 3</text><text top=""688"" left=""657"" width=""53"" height=""13"" font=""29""> OF THE </text><text top=""685"" left=""710"" width=""10"" height=""16"" font=""23"">A</text><text top=""688"" left=""721"" width=""68"" height=""13"" font=""29"">GREEMENT </text><text top=""705"" left=""151"" width=""21"" height=""13"" font=""29"">ON </text><text top=""702"" left=""172"" width=""10"" height=""16"" font=""23"">S</text><text top=""705"" left=""182"" width=""87"" height=""13"" font=""29"">ANITARY AND </text><text top=""702"" left=""269"" width=""10"" height=""16"" font=""23"">P</text><text top=""705"" left=""279"" width=""98"" height=""13"" font=""29"">HYTOSANITARY </text><text top=""702"" left=""376"" width=""13"" height=""16"" font=""23"">M</text><text top=""705"" left=""389"" width=""54"" height=""13"" font=""29"">EASURES</text></p><p number=""85."" style=""6""><text top=""735"" left=""108"" width=""684"" height=""16"" font=""0"">85.  Argentina identifies the application of  9 C.F.R. &#167; 94.1 and the 2001 Regulations to it as </text>
<text top=""751"" left=""108"" width=""687"" height=""16"" font=""0"">inconsistent with Article 3 because they are allegedly not measures based on international </text>
<text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">standard. However, 9 C.F.R. &#167; 94.1 (together with 9 C.F.R. &#167; 92.2) represent an approach that is </text>
<text top=""784"" left=""108"" width=""685"" height=""16"" font=""0"">entirely consistent with the OIE. Because the APHIS application system and the OIE approach </text>
<text top=""800"" left=""108"" width=""682"" height=""16"" font=""0"">reflected in the Code and in its internal process are so similar, it is clear that the former is ""based </text>
<text top=""817"" left=""108"" width=""409"" height=""16"" font=""0"">on"" the latter. Argentina's claim under Article 3.1 must fail. </text>
</p><p number=""86."" style=""6""><text top=""850"" left=""108"" width=""572"" height=""16"" font=""0"">86.  Under the APHIS application system, the same principled framework applies: </text>
</p><p number=""87."" style=""6""><text top=""882"" left=""108"" width=""683"" height=""16"" font=""0"">87.  First, just as in the OIE approach, 9 C.F.R. &#167; 94.1(a) establishes that a country or region is </text>
<text top=""899"" left=""108"" width=""682"" height=""16"" font=""0"">to be considered the equivalent of an ""FMD infected zone"" unless it has been determined to be free </text>
<text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">of FMD after an examination of an application provided under 9 C.F.R. &#167; 92.2. This is consistent </text>
<text top=""932"" left=""108"" width=""684"" height=""16"" font=""0"">with the OIE's approach and the underlying science that FMD is a dangerous, highly contagious </text>
<text top=""948"" left=""108"" width=""115"" height=""16"" font=""0"">animal disease.  </text>
</p><p number=""88."" style=""6""><text top=""981"" left=""108"" width=""684"" height=""16"" font=""0"">88.  Second, just as in the OIE approach, no decision is made about a country's FMD situation </text>
<text top=""997"" left=""108"" width=""685"" height=""16"" font=""0"">until an application is made by a country. APHIS does not take action in the abstract, in the </text>
<text top=""1014"" left=""108"" width=""683"" height=""16"" font=""0"">absence of an application. The process outlined in 9 C.F.R. &#167; 92.2 permits APHIS to authorize the </text>
<text top=""1030"" left=""108"" width=""686"" height=""16"" font=""0"">importation of animals and animal products after the submission by an applicant country is </text>
<text top=""1046"" left=""108"" width=""682"" height=""16"" font=""0"">received, reviewed, and a conclusion is reached. The topics that APHIS asks applicants to respond </text>
<text top=""1063"" left=""108"" width=""687"" height=""16"" font=""0"">to include: Geographic description, disease history, veterinary system, history and situation </text>
<text top=""1079"" left=""108"" width=""683"" height=""16"" font=""0"">related to FMD surveillance, prevention, and control measures. The topics requested mirror those </text>
<text top=""1096"" left=""108"" width=""127"" height=""16"" font=""0"">asked by the OIE. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-35 - </text>
</p></p></page>
<page number=""45"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""89."" style=""6""><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">89.  Third, just as in the OIE approach, an outbreak can result in the removal of authorization </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">under 9 C.F.R. &#167; 94.1(a)(2). A region can be reauthorized by resubmitting its information under 9 </text>
<text top=""160"" left=""108"" width=""585"" height=""16"" font=""0"">C.F.R. &#167; 92.2 or &#167; 92.4 as appropriate. The OIE also has a process for re-application. </text>
</p><p number=""90."" style=""6""><text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">90.  It may be the case (and, in fact, it may often be the case) that the timeframe upon which </text>
<text top=""210"" left=""108"" width=""685"" height=""16"" font=""0"">OIE makes its designation might not be synchronized with the timeframes of the appropriate </text>
<text top=""226"" left=""108"" width=""682"" height=""16"" font=""0"">regulatory authorities in Member countries. There could be many reasons for this: for example, the </text>
<text top=""242"" left=""108"" width=""684"" height=""16"" font=""0"">OIE generally does not conduct site visits to countries that are applying for an FMD designation. </text>
<text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">Moreover, some countries might seek OIE designation but not seek particular import authorization </text>
<text top=""275"" left=""108"" width=""682"" height=""16"" font=""0"">from a specific Member state. These are procedural and policy issues that, at least in this context, </text>
<text top=""292"" left=""108"" width=""436"" height=""16"" font=""0"">cannot be swept into the ambit of an Article 3.3 legal analysis.  </text>
</p><p number=""91."" style=""6""><text top=""324"" left=""108"" width=""686"" height=""16"" font=""0"">91.  Argentina is a good example of the problem in synchronized designations. Argentina's </text>
<text top=""341"" left=""108"" width=""686"" height=""16"" font=""0"">designation status has fluctuated significantly because of its unstable FMD situation. The OIE </text>
<text top=""357"" left=""108"" width=""685"" height=""16"" font=""0"">suspended Argentina's status once Argentina ceased concealing the 2000-2002 outbreaks and </text>
<text top=""374"" left=""108"" width=""683"" height=""16"" font=""0"">finally notified the OIE. It regained its OIE status in 2003 for only a month before losing it again </text>
<text top=""390"" left=""108"" width=""684"" height=""16"" font=""0"">due to another outbreak. It then regained its OIE status in 2005, but lost it again 2006 due to </text>
<text top=""407"" left=""108"" width=""396"" height=""16"" font=""0"">another outbreak. This OIE status was regained in 2007.  </text>
</p><p number=""92."" style=""6""><text top=""439"" left=""108"" width=""683"" height=""16"" font=""0"">92.  Even if this Panel were to find that Article 3.3 applies to the U.S. measures despite the fact </text>
<text top=""456"" left=""108"" width=""683"" height=""16"" font=""0"">that the United States has not rejected the specific OIE designation, Article 3.3 provides that such </text>
<text top=""472"" left=""108"" width=""683"" height=""16"" font=""0"">measures are consistent with Article 3 ""if there is a scientific justification."" Based on the facts of </text>
<text top=""489"" left=""108"" width=""452"" height=""16"" font=""0"">this dispute, the U.S. measures at issue in fact are fully justified.  </text>
</p><p number=""J."" style=""1""><text top=""521"" left=""108"" width=""52"" height=""16"" font=""23"">J. T</text><text top=""524"" left=""160"" width=""20"" height=""13"" font=""29"">HE </text><text top=""521"" left=""184"" width=""49"" height=""16"" font=""23"">APHIS</text><text top=""521"" left=""240"" width=""10"" height=""16"" font=""23"">A</text><text top=""524"" left=""251"" width=""78"" height=""13"" font=""29"">PPLICATION </text><text top=""521"" left=""333"" width=""10"" height=""16"" font=""23"">S</text><text top=""524"" left=""343"" width=""43"" height=""13"" font=""29"">YSTEM </text><text top=""521"" left=""390"" width=""10"" height=""16"" font=""23"">P</text><text top=""524"" left=""400"" width=""49"" height=""13"" font=""29"">ERMITS </text><text top=""521"" left=""454"" width=""10"" height=""16"" font=""23"">A</text><text top=""524"" left=""464"" width=""102"" height=""13"" font=""29"">DAPTATION OF </text><text top=""521"" left=""566"" width=""13"" height=""16"" font=""23"">M</text><text top=""524"" left=""579"" width=""117"" height=""13"" font=""29"">EASURES TO THE </text><text top=""521"" left=""696"" width=""10"" height=""16"" font=""23"">S</text><text top=""524"" left=""706"" width=""87"" height=""13"" font=""29"">ANITARY OR </text><text top=""538"" left=""151"" width=""10"" height=""16"" font=""23"">P</text><text top=""541"" left=""160"" width=""98"" height=""13"" font=""29"">HYTOSANITARY </text><text top=""538"" left=""258"" width=""10"" height=""16"" font=""23"">C</text><text top=""541"" left=""268"" width=""148"" height=""13"" font=""29"">HARACTERISTICS OF AN </text><text top=""538"" left=""416"" width=""10"" height=""16"" font=""23"">A</text><text top=""541"" left=""426"" width=""27"" height=""13"" font=""29"">REA </text><text top=""538"" left=""454"" width=""10"" height=""16"" font=""23"">C</text><text top=""541"" left=""463"" width=""110"" height=""13"" font=""29"">ONSISTENT WITH </text><text top=""538"" left=""573"" width=""10"" height=""16"" font=""23"">A</text><text top=""541"" left=""583"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""538"" left=""626"" width=""33"" height=""16"" font=""23""> 6.1 </text></p><p number=""93."" style=""6""><text top=""571"" left=""108"" width=""687"" height=""16"" font=""0"">93.  The United States, in adopting the 2001 regulations, ensured that its measures were </text>
<text top=""587"" left=""108"" width=""685"" height=""16"" font=""0"">adapted to the SPS characteristics of Argentina in light of its FMD outbreak. Since Argentina's </text>
<text top=""603"" left=""108"" width=""684"" height=""16"" font=""0"">request to recognize a change in its disease status, particularly for Patagonia, the United States </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">has been undertaking to ascertain, inter alia, the level of prevalence of the disease and Argentina's </text>
<text top=""636"" left=""108"" width=""682"" height=""16"" font=""0"">control procedures in light of the evidence Argentina, as the party seeking to establish that disease </text>
<text top=""653"" left=""108"" width=""308"" height=""16"" font=""0"">status, must present pursuant to Article 6.3. </text>
<p><text top=""685"" left=""108"" width=""688"" height=""16"" font=""0"">The United States is currently applying the process laid out in Article 6.1 with respect to </text>
<text top=""702"" left=""108"" width=""688"" height=""16"" font=""0"">Argentina's Patagonia application. Under 9 C.F.R. &#167; 92.2, an applicant country that seeks </text>
<text top=""718"" left=""108"" width=""684"" height=""16"" font=""0"">designation of a region as free of FMD submits documentation to address the following factors: </text>
<text top=""735"" left=""108"" width=""683"" height=""16"" font=""0"">(1) Scope of the evaluation (the region); (2) Veterinary control and oversight; (3) Disease history </text>
<text top=""751"" left=""108"" width=""686"" height=""16"" font=""0"">and vaccination practices; (4) Epidemiological separation from potential sources of infection; </text>
<text top=""767"" left=""108"" width=""686"" height=""16"" font=""0"">(5) Surveillance; (6) Diagnostic laboratory capabilities; and (7) Emergency preparedness and </text>
<text top=""784"" left=""108"" width=""436"" height=""16"" font=""0"">response. These factors track the elements listed in Article 6.1. </text>
</p></p><p number=""94."" style=""6""><text top=""817"" left=""108"" width=""682"" height=""16"" font=""0"">94.  The APHIS application system takes into account appropriate criteria or guidelines developed </text>
<text top=""833"" left=""108"" width=""686"" height=""16"" font=""0"">by international organizations including the WTO and the OIE. In fact, the APHIS application </text>
<text top=""850"" left=""108"" width=""683"" height=""16"" font=""0"">system tracks closely the SPS Committee's ""Guidelines to Further the Practical Implementation of </text>
<text top=""866"" left=""108"" width=""598"" height=""16"" font=""0"">Article 6 of the Agreement on the Application of Sanitary and Phytosanitary Measures"". </text>
</p><p number=""95."" style=""6""><text top=""899"" left=""108"" width=""684"" height=""16"" font=""0"">95.  A review of the record clearly demonstrates that the United States is taking into account </text>
<text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">factors consistent with Article 6 of the SPS Agreement with respect to Argentina's application for </text>
<text top=""932"" left=""108"" width=""685"" height=""16"" font=""0"">Patagonia. The United States is committed to completing the process for Patagonia, consistent </text>
<text top=""948"" left=""108"" width=""683"" height=""16"" font=""0"">with Article 6.1., and requires that Argentina provide the necessary information, including access </text>
<text top=""964"" left=""108"" width=""284"" height=""16"" font=""0"">within Argentina, pursuant to Article 6.3. </text>
</p><p number=""K."" style=""1""><text top=""997"" left=""108"" width=""52"" height=""16"" font=""23"">K. T</text><text top=""1000"" left=""160"" width=""20"" height=""13"" font=""29"">HE </text><text top=""997"" left=""181"" width=""49"" height=""16"" font=""23"">APHIS</text><text top=""997"" left=""235"" width=""10"" height=""16"" font=""23"">A</text><text top=""1000"" left=""245"" width=""78"" height=""13"" font=""29"">PPLICATION </text><text top=""997"" left=""325"" width=""10"" height=""16"" font=""23"">S</text><text top=""1000"" left=""334"" width=""43"" height=""13"" font=""29"">YSTEM </text><text top=""997"" left=""379"" width=""11"" height=""16"" font=""23"">R</text><text top=""1000"" left=""390"" width=""102"" height=""13"" font=""29"">ECOGNIZES THE </text><text top=""997"" left=""492"" width=""10"" height=""16"" font=""23"">C</text><text top=""1000"" left=""501"" width=""81"" height=""13"" font=""29"">ONCEPTS OF </text><text top=""997"" left=""582"" width=""10"" height=""16"" font=""23"">P</text><text top=""1000"" left=""592"" width=""22"" height=""13"" font=""29"">EST</text><text top=""997"" left=""614"" width=""6"" height=""16"" font=""23"">-</text><text top=""1000"" left=""621"" width=""28"" height=""13"" font=""29""> OR </text><text top=""997"" left=""648"" width=""11"" height=""16"" font=""23"">D</text><text top=""1000"" left=""659"" width=""43"" height=""13"" font=""29"">ISEASE</text><text top=""997"" left=""702"" width=""6"" height=""16"" font=""23"">-</text><text top=""1000"" left=""709"" width=""33"" height=""13"" font=""29"">FREE </text><text top=""997"" left=""743"" width=""10"" height=""16"" font=""23"">A</text><text top=""1000"" left=""754"" width=""35"" height=""13"" font=""29"">REAS </text><text top=""1014"" left=""151"" width=""10"" height=""16"" font=""23"">C</text><text top=""1017"" left=""160"" width=""109"" height=""13"" font=""29"">ONSISTENT WITH </text><text top=""1014"" left=""270"" width=""10"" height=""16"" font=""23"">A</text><text top=""1017"" left=""280"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""1014"" left=""323"" width=""33"" height=""16"" font=""23""> 6.2 </text></p><p number=""96."" style=""6""><text top=""1046"" left=""108"" width=""682"" height=""16"" font=""0"">96.  It is clear that the United States does recognize the concept of pest- or disease-free areas in </text>
<text top=""1063"" left=""108"" width=""683"" height=""16"" font=""0"">9 C.F.R. &#167; 94.1 and in the definition of ""region"" in 9 C.F.R. &#167; 92.1. Section 94.1(a)(2) states that </text>
<text top=""1079"" left=""108"" width=""683"" height=""16"" font=""0"">""APHIS will add a region to the list of those it has declared free of &#8230; . foot-and-mouth disease &#8230; </text>
<text top=""1096"" left=""108"" width=""685"" height=""16"" font=""0"">after it conducts an evaluation of the region in accordance with Section 92.2."" 92.1 defines a </text>
<text top=""1112"" left=""108"" width=""684"" height=""16"" font=""0"">region as ""[a]ny defined geographic land region identifiable by geological, political, or surveyed </text>
<text top=""1128"" left=""108"" width=""682"" height=""16"" font=""0"">boundaries. A region may consist of &#8230; [a] national entity[,] [or] [p]art of a national entity &#8230; ."" The </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-36 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">evaluation referred to in Section 92.2 is based upon an application that considers factors such as </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">""livestock demographics and traceability,"" ""disease history and vaccination practices,"" ""veterinary </text>
<text top=""160"" left=""108"" width=""691"" height=""16"" font=""0"">control and oversight,"" ""epidemiological separation from potential sources of infection,"" </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">""surveillance,"" ""diagnostic laboratory capabilities,"" ""emergency preparedness and response."" These </text>
<text top=""193"" left=""108"" width=""686"" height=""16"" font=""0"">factors cover the factors listed by Article 6, such as ""geography, ecosystems, epidemiological </text>
<text top=""210"" left=""108"" width=""503"" height=""16"" font=""0"">surveillance, and the effectiveness of sanitary or phytosanitary controls."" </text>
</p></p></page>
<page number=""46"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""L."" style=""1""><text top=""242"" left=""108"" width=""52"" height=""16"" font=""23"">L. T</text><text top=""245"" left=""160"" width=""20"" height=""13"" font=""29"">HE </text><text top=""242"" left=""181"" width=""11"" height=""16"" font=""23"">U</text><text top=""245"" left=""192"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""242"" left=""230"" width=""14"" height=""16"" font=""23""> S</text><text top=""245"" left=""244"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""242"" left=""287"" width=""10"" height=""16"" font=""23"">S</text><text top=""245"" left=""296"" width=""82"" height=""13"" font=""29"">UFFICIENTLY </text><text top=""242"" left=""381"" width=""10"" height=""16"" font=""23"">A</text><text top=""245"" left=""391"" width=""91"" height=""13"" font=""29"">CCOUNTS FOR </text><text top=""242"" left=""482"" width=""11"" height=""16"" font=""23"">D</text><text top=""245"" left=""494"" width=""72"" height=""13"" font=""29"">EVELOPING </text><text top=""242"" left=""568"" width=""10"" height=""16"" font=""23"">C</text><text top=""245"" left=""578"" width=""53"" height=""13"" font=""29"">OUNTRY </text><text top=""242"" left=""633"" width=""7"" height=""16"" font=""23"">I</text><text top=""245"" left=""640"" width=""64"" height=""13"" font=""29"">NTERESTS </text><text top=""242"" left=""707"" width=""11"" height=""16"" font=""23"">U</text><text top=""245"" left=""717"" width=""37"" height=""13"" font=""29"">NDER </text><text top=""242"" left=""756"" width=""29"" height=""16"" font=""23"">SPS</text><text top=""259"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""262"" left=""161"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""259"" left=""204"" width=""43"" height=""16"" font=""23""> 10.1 </text></p><p number=""97."" style=""6""><text top=""292"" left=""108"" width=""683"" height=""16"" font=""0"">97.  The United States, to the extent possible, takes into account developing country Members' </text>
<text top=""308"" left=""108"" width=""684"" height=""16"" font=""0"">needs in meeting its SPS obligations. Many countries at or even below Argentina's income level </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">obtain import authorization and have been designated as FMD free. Also, Article 10.1 specifically </text>
<text top=""341"" left=""108"" width=""684"" height=""16"" font=""0"">points out ""special needs"" to be taken into account, however, nowhere in Argentina's discussion </text>
<text top=""357"" left=""108"" width=""475"" height=""16"" font=""0"">does it assert what ""special needs"" related to its status it is claiming. </text>
</p><p number=""M."" style=""1""><text top=""390"" left=""108"" width=""52"" height=""16"" font=""23"">M. T</text><text top=""393"" left=""160"" width=""20"" height=""13"" font=""29"">HE </text><text top=""390"" left=""181"" width=""11"" height=""16"" font=""23"">U</text><text top=""393"" left=""192"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""390"" left=""230"" width=""14"" height=""16"" font=""23""> S</text><text top=""393"" left=""244"" width=""37"" height=""13"" font=""29"">TATES</text><text top=""390"" left=""281"" width=""4"" height=""16"" font=""23"">'</text><text top=""390"" left=""291"" width=""10"" height=""16"" font=""23"">A</text><text top=""393"" left=""301"" width=""78"" height=""13"" font=""29"">PPLICATION </text><text top=""390"" left=""381"" width=""10"" height=""16"" font=""23"">S</text><text top=""393"" left=""390"" width=""183"" height=""13"" font=""29"">YSTEM IS CONSISTENT WITH </text><text top=""390"" left=""573"" width=""10"" height=""16"" font=""23"">A</text><text top=""393"" left=""584"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""390"" left=""626"" width=""27"" height=""16"" font=""23""> I:1</text><text top=""393"" left=""653"" width=""36"" height=""13"" font=""29""> AND </text><text top=""390"" left=""689"" width=""10"" height=""16"" font=""23"">A</text><text top=""393"" left=""700"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""390"" left=""743"" width=""22"" height=""16"" font=""23""> XI</text><text top=""390"" left=""770"" width=""15"" height=""16"" font=""23"">:1</text><text top=""410"" left=""151"" width=""46"" height=""13"" font=""29"">OF THE </text><text top=""407"" left=""197"" width=""40"" height=""16"" font=""23"">GATT</text><text top=""407"" left=""240"" width=""43"" height=""16"" font=""23"">1994 </text></p><p number=""98."" style=""6""><text top=""439"" left=""108"" width=""689"" height=""16"" font=""0"">98.  Argentina argues that the United States' Application System violates Article I:1 and </text>
<text top=""456"" left=""108"" width=""683"" height=""16"" font=""0"">Article XI:1 of the GATT 1994 because the system offers other Members advantages that are not </text>
<text top=""472"" left=""108"" width=""686"" height=""16"" font=""0"">accorded immediately and unconditionally to Argentina. The Application System, however, is </text>
<text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">necessary to protect animal life or health, consistent with the SPS Agreement, and the disciplines </text>
<text top=""505"" left=""108"" width=""683"" height=""16"" font=""0"">of Article XX (b). Pursuant to Article 2.4 of the SPS Agreement, if a measure conforms to the SPS </text>
<text top=""521"" left=""108"" width=""684"" height=""16"" font=""0"">Agreement, then it is presumed to comply with Article XX(b). The Application System does not </text>
<text top=""538"" left=""108"" width=""687"" height=""16"" font=""0"">constitute a means of arbitrary or unjustifiable discrimination, or a disguised restriction on </text>
<text top=""554"" left=""108"" width=""682"" height=""16"" font=""0"">international trade against Argentina. Because the United States has satisfied its obligations under </text>
<text top=""571"" left=""108"" width=""482"" height=""16"" font=""0"">the SPS Agreement and Article XX (b), it has not breached Article I:1. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-37 - </text>
</p></p></page>
<page number=""47"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""164"" left=""405"" width=""89"" height=""16"" font=""26"">ANNEX B-4 </text></p><p><text top=""198"" left=""245"" width=""407"" height=""16"" font=""6"">SECOND PART OF THE INTEGRATED EXECUTIVE SUMMARY </text>
<text top=""214"" left=""291"" width=""316"" height=""16"" font=""6"">OF THE ARGUMENTS OF THE UNITED STATES </text>
</p><p><text top=""258"" left=""108"" width=""426"" height=""16"" font=""23"">OPENING STATEMENT AT THE SECOND PANEL MEETING </text></p><p number=""1."" style=""6""><text top=""291"" left=""108"" width=""21"" height=""16"" font=""0"">1. </text>
<text top=""291"" left=""151"" width=""642"" height=""16"" font=""0"">The core factual issues involve two regulatory proceedings: one involving Patagonia, one </text>
<text top=""307"" left=""108"" width=""685"" height=""16"" font=""0"">involving Northern Argentina. Argentina's basic complaint is that the failure to complete these </text>
<text top=""323"" left=""108"" width=""685"" height=""16"" font=""0"">processes ""is a straightforward restriction on international trade"" without scientific justification, </text>
<text top=""340"" left=""108"" width=""501"" height=""16"" font=""0"">and constitutes ""arbitrary discrimination"" <i>vis-&#224;-vis</i> other WTO Members.  </text>
</p><p number=""2."" style=""6""><text top=""373"" left=""108"" width=""20"" height=""16"" font=""0"">2. </text>
<text top=""373"" left=""151"" width=""641"" height=""16"" font=""0"">However, the factual landscape has fundamentally shifted since this dispute was initiated. </text>
<text top=""389"" left=""108"" width=""684"" height=""16"" font=""0"">First, the United States has issued a formal determination that recognizes Patagonia as a region </text>
<text top=""405"" left=""108"" width=""685"" height=""16"" font=""0"">that is FMD free. Second, the United States has issued a proposed rule to allow imports from </text>
<text top=""422"" left=""108"" width=""685"" height=""16"" font=""0"">Northern Argentina, with appropriate control measures that Argentina acknowledges would be </text>
<text top=""438"" left=""108"" width=""87"" height=""16"" font=""0"">acceptable.  </text>
</p><p number=""3."" style=""6""><text top=""471"" left=""108"" width=""19"" height=""16"" font=""0"">3. </text>
<text top=""471"" left=""151"" width=""640"" height=""16"" font=""0"">With respect to the legal framework of Argentina's challenge, the critical issue has been and </text>
<text top=""488"" left=""108"" width=""684"" height=""16"" font=""0"">continues to be this: what obligations apply under the SPS Agreement and how do they operate </text>
<text top=""504"" left=""108"" width=""682"" height=""16"" font=""0"">when an exporting Member claims either that its territory, in whole or in part, is free of disease, or </text>
<text top=""520"" left=""108"" width=""656"" height=""16"" font=""0"">that it is of low disease prevalence in relation to a disease of concern to an importing Member?  </text>
</p><p number=""4."" style=""6""><text top=""553"" left=""108"" width=""21"" height=""16"" font=""0"">4. </text>
<text top=""553"" left=""151"" width=""642"" height=""16"" font=""0"">The SPS Agreement addresses this through Articles 2, 5, and 6. The provisions of these </text>
<text top=""570"" left=""108"" width=""682"" height=""16"" font=""0"">three articles must be read together, in a manner that reflects the drafters' intention of providing a </text>
<text top=""586"" left=""108"" width=""684"" height=""16"" font=""0"">coherent, workable set of obligations governing claims of disease-free or low-disease-prevalence </text>
<text top=""602"" left=""108"" width=""682"" height=""16"" font=""0"">status. Under these provisions, the process starts when the Member making the claim of a certain </text>
<text top=""619"" left=""108"" width=""682"" height=""16"" font=""0"">disease status makes a request to the importing Member. The importing Member then must begin </text>
<text top=""635"" left=""108"" width=""682"" height=""16"" font=""0"">an assessment and seek to obtain necessary information from the exporting Member. At the same </text>
<text top=""652"" left=""108"" width=""682"" height=""16"" font=""0"">time, the exporting Member is obligated to provide the necessary information to validate its claim. </text>
<text top=""668"" left=""108"" width=""684"" height=""16"" font=""0"">Pending the completion of the information collection and review process, the importing Member </text>
<text top=""684"" left=""108"" width=""684"" height=""16"" font=""0"">may maintain provisionally a measure affecting the importation of the product that is based on </text>
<text top=""701"" left=""108"" width=""686"" height=""16"" font=""0"">pertinent available information. During this period, the importing Member collects information </text>
<text top=""717"" left=""108"" width=""686"" height=""16"" font=""0"">necessary for a more objective assessment of the risk and reviews its existing SPS measure </text>
<text top=""734"" left=""108"" width=""682"" height=""16"" font=""0"">accordingly within a reasonable period of time. Once the importing Member has completed its risk </text>
<text top=""750"" left=""108"" width=""613"" height=""16"" font=""0"">assessment, it adopts a measure that is based on the assessment and achieves its ALOP. </text>
</p><p number=""5."" style=""6""><text top=""783"" left=""108"" width=""19"" height=""16"" font=""0"">5. </text>
<text top=""783"" left=""151"" width=""640"" height=""16"" font=""0"">According to the logic of Argentina's arguments, when an exporting Member claims it is free </text>
<text top=""799"" left=""108"" width=""682"" height=""16"" font=""0"">of disease, the importing Member must either immediately produce an assessment specific to that </text>
<text top=""816"" left=""108"" width=""689"" height=""16"" font=""0"">Member or permit the product to enter. This view is not grounded in the text of the </text>
<text top=""832"" left=""108"" width=""684"" height=""16"" font=""0"">SPS Agreement, does not make sense of the inter-relationship of the relevant provisions, and is </text>
<text top=""848"" left=""108"" width=""685"" height=""16"" font=""0"">not the approach taken by any responsible regulatory authority. As was confirmed during the </text>
<text top=""865"" left=""108"" width=""684"" height=""16"" font=""0"">meeting with the individual experts and the OIE, neither is this view reflected in the practice of </text>
<text top=""881"" left=""108"" width=""401"" height=""16"" font=""0"">other Members nor the procedure and practice of the OIE. </text>
</p><p number=""6."" style=""6""><text top=""914"" left=""108"" width=""20"" height=""16"" font=""0"">6. </text>
<text top=""914"" left=""151"" width=""641"" height=""16"" font=""0"">The expert consultation process further confirms the need for importing Members to make </text>
<text top=""931"" left=""108"" width=""684"" height=""16"" font=""0"">careful assessments of disease-free or low-disease-prevalence status, and the complexity of this </text>
<text top=""947"" left=""108"" width=""682"" height=""16"" font=""0"">task. For example, the individual experts stated that importing Members conducting an evaluation </text>
<text top=""963"" left=""108"" width=""686"" height=""16"" font=""0"">process must assess the effectiveness of a multitude of complex systems within a country. </text>
<text top=""980"" left=""108"" width=""687"" height=""16"" font=""0"">Further, the OIE itself stated that its country designations do not constitute an import risk </text>
<text top=""996"" left=""108"" width=""682"" height=""16"" font=""0"">assessment. The OIE also confirmed that the paper dossier &#8211; that is, the factual submission of the </text>
<text top=""1013"" left=""108"" width=""684"" height=""16"" font=""0"">Member seeking an official disease status &#8211; is not shared with other OIE Members. The experts </text>
<text top=""1029"" left=""108"" width=""686"" height=""16"" font=""0"">also noted that the OIE's designation process does not involve the preparation of a full risk </text>
<text top=""1045"" left=""108"" width=""683"" height=""16"" font=""0"">assessment. Dr. Bonbon observed that a risk assessment is a detailed evaluation, and must take </text>
<text top=""1062"" left=""108"" width=""582"" height=""16"" font=""0"">account of the particularized situation of both the exporting and importing Members. </text>
</p><p number=""7."" style=""6""><text top=""1095"" left=""108"" width=""23"" height=""16"" font=""0"">7. </text>
<text top=""1095"" left=""151"" width=""644"" height=""16"" font=""0"">On January 23, 2014, APHIS published a proposed notice to designate the region of </text>
<text top=""1111"" left=""108"" width=""685"" height=""16"" font=""0"">Patagonia as free of FMD. APHIS also published its 87-page risk analysis, based on a careful </text>
<text top=""1127"" left=""108"" width=""686"" height=""16"" font=""0"">examination of the scientific evidence related to the disease and region. In the intervening </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-38 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">months, APHIS received, analyzed, and answered comments provided by the public. On August </text>
<text top=""144"" left=""108"" width=""645"" height=""16"" font=""0"">29, APHIS published its final notice, which determines that Patagonia is a region free of FMD.  </text>
</p></p></page>
<page number=""48"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""8."" style=""6""><text top=""177"" left=""108"" width=""18"" height=""16"" font=""0"">8. </text>
<text top=""177"" left=""151"" width=""640"" height=""16"" font=""0"">APHIS has also taken action on the second regulatory proceeding at issue in this dispute. On </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">August 29, APHIS published a proposal to permit the importation of fresh beef from the Northern </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina region under certain conditions. The 103-page draft risk analysis is based on a careful </text>
<text top=""226"" left=""108"" width=""524"" height=""16"" font=""0"">examination of the scientific evidence related to the disease and this region. </text>
</p><p number=""9."" style=""6""><text top=""259"" left=""108"" width=""21"" height=""16"" font=""0"">9. </text>
<text top=""259"" left=""151"" width=""642"" height=""16"" font=""0"">While it took the United States time to reach preliminary and final decisions for Northern </text>
<text top=""275"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina and Patagonia, respectively, length of time is not the appropriate standard with which to </text>
<text top=""292"" left=""108"" width=""686"" height=""16"" font=""0"">reach a legal conclusion on the issue of timeliness. Rather, under SPS Article 5.7, the legal </text>
<text top=""308"" left=""108"" width=""687"" height=""16"" font=""0"">question is whether the period of time taken ""to seek to obtain the additional information </text>
<text top=""324"" left=""108"" width=""686"" height=""16"" font=""0"">necessary for a more objective assessment of risk and review the sanitary or phytosanitary </text>
<text top=""341"" left=""108"" width=""267"" height=""16"" font=""0"">measure accordingly"" is ""reasonable.""  </text>
</p><p number=""A."" style=""1""><text top=""374"" left=""108"" width=""63"" height=""16"" font=""23"">A. T</text><text top=""377"" left=""171"" width=""26"" height=""13"" font=""29"">HIS </text><text top=""374"" left=""200"" width=""11"" height=""16"" font=""23"">D</text><text top=""377"" left=""212"" width=""47"" height=""13"" font=""29"">ISPUTE </text><text top=""374"" left=""263"" width=""10"" height=""16"" font=""23"">S</text><text top=""377"" left=""272"" width=""45"" height=""13"" font=""29"">HOULD </text><text top=""374"" left=""321"" width=""10"" height=""16"" font=""23"">B</text><text top=""377"" left=""331"" width=""11"" height=""13"" font=""29"">E </text><text top=""374"" left=""346"" width=""10"" height=""16"" font=""23"">A</text><text top=""377"" left=""356"" width=""58"" height=""13"" font=""29"">NALYZED </text><text top=""374"" left=""418"" width=""7"" height=""16"" font=""23"">I</text><text top=""377"" left=""425"" width=""13"" height=""13"" font=""29"">N </text><text top=""374"" left=""441"" width=""9"" height=""16"" font=""23"">L</text><text top=""377"" left=""450"" width=""91"" height=""13"" font=""29"">IGHT OF THE </text><text top=""374"" left=""540"" width=""11"" height=""16"" font=""23"">O</text><text top=""377"" left=""552"" width=""105"" height=""13"" font=""29"">BLIGATIONS OF </text><text top=""374"" left=""657"" width=""10"" height=""16"" font=""23"">A</text><text top=""377"" left=""668"" width=""54"" height=""13"" font=""29"">RTICLES </text><text top=""374"" left=""725"" width=""29"" height=""16"" font=""23"">2.2,</text><text top=""374"" left=""761"" width=""24"" height=""16"" font=""23"">5.7</text><text top=""393"" left=""162"" width=""26"" height=""13"" font=""29"">AND</text><text top=""390"" left=""188"" width=""29"" height=""16"" font=""23""> 6.3</text><text top=""393"" left=""217"" width=""50"" height=""13"" font=""29""> OF THE </text><text top=""390"" left=""266"" width=""44"" height=""16"" font=""23"">SPS A</text><text top=""393"" left=""310"" width=""64"" height=""13"" font=""29"">GREEMENT</text></p><p number=""10."" style=""6""><text top=""423"" left=""108"" width=""684"" height=""16"" font=""0"">10.  When an assertion of the disease status of the exporting Member is made, the importing </text>
<text top=""439"" left=""108"" width=""684"" height=""16"" font=""0"">Member is not likely to have all the scientific information needed to review its existing measure </text>
<text top=""456"" left=""108"" width=""688"" height=""16"" font=""0"">and determine whether changes are appropriate, as was the case here. Recognizing this, </text>
<text top=""472"" left=""108"" width=""682"" height=""16"" font=""0"">Article 5.7 obligates the importing Member to ""seek to obtain the additional information necessary </text>
<text top=""489"" left=""108"" width=""682"" height=""16"" font=""0"">for a more objective assessment of the risk,"" and to ""review the SPS measures accordingly."" In the </text>
<text top=""505"" left=""108"" width=""684"" height=""16"" font=""0"">context of an assessment of a claim of disease-free status, the exporting Member will need to </text>
<text top=""521"" left=""108"" width=""682"" height=""16"" font=""0"">initiate data requests and collect information from the most relevant party &#8211; the exporting Member </text>
<text top=""538"" left=""108"" width=""684"" height=""16"" font=""0"">&#8211; and use the additional information in reviewing the existing SPS measure. This process is not </text>
<text top=""554"" left=""108"" width=""477"" height=""16"" font=""0"">indefinite; it must be completed within ""a reasonable period of time."" </text>
</p><p number=""11."" style=""6""><text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">11.  Article 6 complements and reinforces this understanding of how Article 5.7 applies in these </text>
<text top=""603"" left=""108"" width=""143"" height=""16"" font=""0"">situations. Article </text>
<text top=""603"" left=""241"" width=""559"" height=""16"" font=""0"">6.1 obligates the importing Member to adapt its measures to the </text>
<text top=""620"" left=""108"" width=""687"" height=""16"" font=""0"">SPS characteristics of the exporting Member, and those characteristics include the ""level of </text>
<text top=""636"" left=""108"" width=""684"" height=""16"" font=""0"">prevalence of specific diseases."" In particular, when the exporting Member makes the assertion </text>
<text top=""653"" left=""108"" width=""686"" height=""16"" font=""0"">that its territories are free of disease or of low disease prevalence as described, Article 6.3 </text>
<text top=""669"" left=""108"" width=""686"" height=""16"" font=""0"">obligates it to ""provide the necessary evidence."" During this process of risk assessment, the </text>
<text top=""685"" left=""108"" width=""684"" height=""16"" font=""0"">importing Member is permitted to maintain measures to restrict importation of product from the </text>
<text top=""702"" left=""108"" width=""262"" height=""16"" font=""0"">exporting Member, under Article 5.7.  </text>
</p><p number=""B."" style=""1""><text top=""735"" left=""108"" width=""15"" height=""16"" font=""23"">B.</text><text top=""735"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""738"" left=""161"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""735"" left=""204"" width=""29"" height=""16"" font=""23""> 5.7</text><text top=""735"" left=""236"" width=""10"" height=""16"" font=""23"">A</text><text top=""738"" left=""246"" width=""98"" height=""13"" font=""29"">PPLIES TO THIS </text><text top=""735"" left=""345"" width=""9"" height=""16"" font=""23"">F</text><text top=""738"" left=""354"" width=""50"" height=""13"" font=""29"">ACTUAL </text><text top=""735"" left=""403"" width=""10"" height=""16"" font=""23"">S</text><text top=""738"" left=""413"" width=""60"" height=""13"" font=""29"">ITUATION</text></p><p number=""12."" style=""6""><text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">12.  Article 2.2 is crucial in understanding Article 5.7, because it is only through Article 2.2 that </text>
<text top=""784"" left=""108"" width=""683"" height=""16"" font=""0"">Article 5.7 is tied to the obligations under the SPS Agreement. Notably, Article 2.2 speaks to the </text>
<text top=""800"" left=""108"" width=""684"" height=""16"" font=""0"">""maintenance"" of a measure.  A measure must not be ""maintained"" without sufficient scientific </text>
<text top=""817"" left=""108"" width=""689"" height=""16"" font=""0"">evidence. The application of the ""sufficient scientific evidence"" language in Article 2.2 is </text>
<text top=""833"" left=""108"" width=""686"" height=""16"" font=""0"">particularly difficult when that evidence changes over time &#8211; and this of course is the issue </text>
<text top=""850"" left=""108"" width=""683"" height=""16"" font=""0"">presented in this dispute. The issue is this: when the evidence changes, so that past evidence (in </text>
<text top=""866"" left=""108"" width=""686"" height=""16"" font=""0"">this dispute, a regulatory failure and an ongoing FMD outbreak) may no longer support an </text>
<text top=""882"" left=""108"" width=""685"" height=""16"" font=""0"">SPS control measure, is the importing Member immediately in breach?  This is not a tenable </text>
<text top=""899"" left=""108"" width=""686"" height=""16"" font=""0"">reading of the Agreement. And indeed, Article 5.7 provides both an exception, and additional </text>
<text top=""915"" left=""108"" width=""257"" height=""16"" font=""0"">disciplines on the importing Member. </text>
</p><p number=""13."" style=""6""><text top=""948"" left=""108"" width=""685"" height=""16"" font=""0"">13.  Before turning to Article 5.7, the United States also recalls the text of Article 5.1. First, </text>
<text top=""964"" left=""108"" width=""686"" height=""16"" font=""0"">Article 5.1 includes no specific reference to the exception set out in Article 5.7. However, as </text>
<text top=""981"" left=""108"" width=""687"" height=""16"" font=""0"">Argentina acknowledges, and as many past panel and Appellate Body reports have found, </text>
<text top=""997"" left=""108"" width=""682"" height=""16"" font=""0"">Article 5.7 is viewed as an exception to Article 5.1. The second notable aspect of Article 5.1 is that </text>
<text top=""1014"" left=""108"" width=""682"" height=""16"" font=""0"">it uses the verb ""based on"" &#8211; that is, a measure must be ""based on"" an appropriate assessment of </text>
<text top=""1030"" left=""108"" width=""684"" height=""16"" font=""0"">the risks. This obligation also applies over time, so that a measure's compliance with Article 5.1 </text>
<text top=""1046"" left=""108"" width=""428"" height=""16"" font=""0"">may change over time, based on evolving scientific evidence.  </text>
</p><p number=""14."" style=""6""><text top=""1079"" left=""108"" width=""683"" height=""16"" font=""0"">14.  It cannot be the case that the instant scientific evidence changes, a Member is in breach of </text>
<text top=""1096"" left=""108"" width=""682"" height=""16"" font=""0"">its Article 5.1 obligations. Rather, read in context, Article 5.7 must be available &#8211; both to allow the </text>
<text top=""1112"" left=""108"" width=""682"" height=""16"" font=""0"">importing Member time to evaluate the new evidence, and at the same time, to impose obligations </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-39 - </text>
</p><p><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">on the importing Member to seek additional information and to complete its review within a </text>
<text top=""144"" left=""108"" width=""184"" height=""16"" font=""0"">reasonable period of time. </text>
</p></p></page>
<page number=""49"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""15."" style=""6""><text top=""177"" left=""108"" width=""686"" height=""16"" font=""0"">15.  In light of the context of these provisions, and for Article 5.7 to serve its role as an </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">exception to those provisions, it must not be read as being limited to the formal adoption &#8211; in the </text>
<text top=""210"" left=""108"" width=""686"" height=""16"" font=""0"">sense of promulgation &#8211; of completely new measures addressed to a new product from an </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">exporting Member. Rather, Article 5.7 must be read to also apply to evolving situations where </text>
<text top=""242"" left=""108"" width=""685"" height=""16"" font=""0"">measures are maintained without sufficient scientific evidence, and/or where a measure is no </text>
<text top=""259"" left=""108"" width=""378"" height=""16"" font=""0"">longer ""based"" on an appropriate assessment of risks.  </text>
</p><p number=""C."" style=""1""><text top=""292"" left=""108"" width=""52"" height=""16"" font=""23"">C. T</text><text top=""295"" left=""160"" width=""20"" height=""13"" font=""29"">HE </text><text top=""292"" left=""179"" width=""11"" height=""16"" font=""23"">U</text><text top=""295"" left=""190"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""292"" left=""228"" width=""14"" height=""16"" font=""23""> S</text><text top=""295"" left=""242"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""292"" left=""283"" width=""13"" height=""16"" font=""23"">M</text><text top=""295"" left=""296"" width=""59"" height=""13"" font=""29"">EETS THE </text><text top=""292"" left=""355"" width=""11"" height=""16"" font=""23"">R</text><text top=""295"" left=""366"" width=""90"" height=""13"" font=""29"">EQUIREMENTS </text><text top=""292"" left=""455"" width=""9"" height=""16"" font=""23"">E</text><text top=""295"" left=""465"" width=""97"" height=""13"" font=""29"">STABLISHED IN </text><text top=""292"" left=""562"" width=""10"" height=""16"" font=""23"">A</text><text top=""295"" left=""572"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""292"" left=""615"" width=""33"" height=""16"" font=""23""> 5.7 </text></p><p number=""16."" style=""6""><text top=""324"" left=""108"" width=""685"" height=""16"" font=""0"">16.  Contrary to Argentina's arguments, the United States did ""seek"" information, as required </text>
<text top=""341"" left=""108"" width=""683"" height=""16"" font=""0"">under Article 5.7. In particular, the United States requested that Argentina provide information as </text>
<text top=""357"" left=""108"" width=""145"" height=""16"" font=""0"">to its disease status. </text>
</p><p number=""17."" style=""6""><text top=""390"" left=""108"" width=""684"" height=""16"" font=""0"">17.  The United States also met the reasonable period of time requirement. The record shows </text>
<text top=""407"" left=""108"" width=""684"" height=""16"" font=""0"">that APHIS and SENASA exchanged information over the period in question and that site visits </text>
<text top=""423"" left=""108"" width=""682"" height=""16"" font=""0"">were conducted in several areas and on a number of occasions. These information exchanges need </text>
<text top=""439"" left=""108"" width=""685"" height=""16"" font=""0"">to be seen in context of the changing situations in Argentina and on Argentina's own shifting </text>
<text top=""456"" left=""108"" width=""685"" height=""16"" font=""0"">requests for import authorization. Argentina first wanted one review of the country for import </text>
<text top=""472"" left=""108"" width=""682"" height=""16"" font=""0"">authorization for fresh beef. Then it submitted an application for Patagonia South, which initiated a </text>
<text top=""489"" left=""108"" width=""684"" height=""16"" font=""0"">separate, new review process. During this time, there were two outbreaks of FMD in Argentina. </text>
<text top=""505"" left=""108"" width=""684"" height=""16"" font=""0"">Shortly afterwards, Argentina asked that a third area, Patagonia North B be reviewed, and then </text>
<text top=""521"" left=""108"" width=""446"" height=""16"" font=""0"">asked that the area be combined together with Patagonia South. </text>
</p><p number=""D."" style=""1""><text top=""554"" left=""108"" width=""96"" height=""16"" font=""23"">D. APHIS'</text><text top=""557"" left=""204"" width=""11"" height=""13"" font=""29"">S </text><text top=""554"" left=""215"" width=""11"" height=""16"" font=""23"">R</text><text top=""557"" left=""225"" width=""75"" height=""13"" font=""29"">EGULATORY </text><text top=""554"" left=""300"" width=""10"" height=""16"" font=""23"">A</text><text top=""557"" left=""311"" width=""59"" height=""13"" font=""29"">PPROVAL </text><text top=""554"" left=""370"" width=""10"" height=""16"" font=""23"">P</text><text top=""557"" left=""379"" width=""50"" height=""13"" font=""29"">ROCESS </text><text top=""554"" left=""430"" width=""7"" height=""16"" font=""23"">I</text><text top=""557"" left=""437"" width=""11"" height=""13"" font=""29"">S </text><text top=""554"" left=""448"" width=""10"" height=""16"" font=""23"">B</text><text top=""557"" left=""459"" width=""57"" height=""13"" font=""29"">ASED ON </text><text top=""554"" left=""515"" width=""7"" height=""16"" font=""23"">I</text><text top=""557"" left=""522"" width=""98"" height=""13"" font=""29"">NTERNATIONAL </text><text top=""554"" left=""620"" width=""10"" height=""16"" font=""23"">S</text><text top=""557"" left=""630"" width=""65"" height=""13"" font=""29"">TANDARDS</text></p><p number=""18."" style=""6""><text top=""587"" left=""108"" width=""684"" height=""16"" font=""0"">18.  APHIS's regulatory approval process is based on international standards and is consistent </text>
<text top=""603"" left=""108"" width=""259"" height=""16"" font=""0"">with Article 3 of the SPS Agreement.  </text>
</p><p number=""19."" style=""6""><text top=""636"" left=""108"" width=""690"" height=""16"" font=""0"">19.  First, the OIE process in evaluating FMD disease status is similar to that of the </text>
<text top=""653"" left=""108"" width=""686"" height=""16"" font=""0"">United States. Starting with a higher level of generality, the basic process is the same: the </text>
<text top=""669"" left=""108"" width=""685"" height=""16"" font=""0"">United States recalls (1) the OIE only issues official status designations upon application of a </text>
<text top=""685"" left=""108"" width=""683"" height=""16"" font=""0"">Member; (2) the OIE immediately rescinds official status designations upon the occurrence of an </text>
<text top=""702"" left=""108"" width=""683"" height=""16"" font=""0"">FMD outbreak; (3) regaining official status after a claim by a Member of disease freedom is based </text>
<text top=""718"" left=""108"" width=""686"" height=""16"" font=""0"">on an application to the OIE; and (4) official status is only gained after review of the data </text>
<text top=""735"" left=""108"" width=""684"" height=""16"" font=""0"">submitted by the Member seeking status. As the United States has stated from the beginning of </text>
<text top=""751"" left=""108"" width=""454"" height=""16"" font=""0"">this dispute: this process is the same as that employed by APHIS. </text>
</p><p number=""20."" style=""6""><text top=""784"" left=""108"" width=""688"" height=""16"" font=""0"">20.  Second, Argentina has contended that the United States must follow the OIE status </text>
<text top=""800"" left=""108"" width=""682"" height=""16"" font=""0"">designation because it is a ""standard, guideline, or recommendation"" under the SPS Agreement. It </text>
<text top=""817"" left=""108"" width=""685"" height=""16"" font=""0"">urges the Panel ""not to try to parse the term 'standards, guidelines, or recommendations' too </text>
<text top=""833"" left=""108"" width=""685"" height=""16"" font=""0"">closely."" However, application of the term ""standards, guidelines, or recommendations"" to any </text>
<text top=""850"" left=""108"" width=""687"" height=""16"" font=""0"">particular OIE statement or document is a fact-specific, legal issue. Here, the designations </text>
<text top=""866"" left=""108"" width=""684"" height=""16"" font=""0"">themselves &#8211; even on their face &#8211; do not look like standards, guidelines, or recommendations. </text>
<text top=""882"" left=""108"" width=""683"" height=""16"" font=""0"">Further, the difference between the process of adopting, on the one hand, the OIE Code, and on </text>
<text top=""899"" left=""108"" width=""683"" height=""16"" font=""0"">the other, the annual status designations, is striking. Indeed, in its papers and in its remarks, the </text>
<text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">OIE showed that the process of adopting the official status designation is in actuality nothing like </text>
<text top=""932"" left=""108"" width=""455"" height=""16"" font=""0"">the process used for the standards set out in the Terrestrial Code. </text>
</p><p number=""21."" style=""6""><text top=""964"" left=""108"" width=""682"" height=""16"" font=""0"">21.  Third, Argentina's arguments concerning Articles 8.5.23 and 8.5.25 of the OIE Code have no </text>
<text top=""981"" left=""108"" width=""684"" height=""16"" font=""0"">merit. The OIE stated that after the loss of status, a Member ""has no status"" and therefore the </text>
<text top=""997"" left=""108"" width=""683"" height=""16"" font=""0"">recommendations that apply in the meantime are for infected regions&#8212;in this case, this meant no </text>
<text top=""1014"" left=""108"" width=""684"" height=""16"" font=""0"">trade in fresh beef. The determination of how to treat the importing Member's product is then </text>
<text top=""1030"" left=""108"" width=""686"" height=""16"" font=""0"">subject to a review of the disease status situation in the importing Member to consider the </text>
<text top=""1046"" left=""108"" width=""687"" height=""16"" font=""0"">applicability of another provision. That is precisely the process that the United States was </text>
<text top=""1063"" left=""108"" width=""300"" height=""16"" font=""0"">undergoing when this dispute was brought. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-40 - </text>
</p></p></page>
<page number=""50"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""E."" style=""1""><text top=""128"" left=""108"" width=""14"" height=""16"" font=""23"">E.</text><text top=""128"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""131"" left=""161"" width=""66"" height=""13"" font=""29"">RGENTINA </text><text top=""128"" left=""227"" width=""11"" height=""16"" font=""23"">H</text><text top=""131"" left=""239"" width=""19"" height=""13"" font=""29"">AS </text><text top=""128"" left=""258"" width=""11"" height=""16"" font=""23"">N</text><text top=""131"" left=""269"" width=""20"" height=""13"" font=""29"">OT </text><text top=""128"" left=""289"" width=""13"" height=""16"" font=""23"">M</text><text top=""131"" left=""302"" width=""18"" height=""13"" font=""29"">ET </text><text top=""128"" left=""320"" width=""7"" height=""16"" font=""23"">I</text><text top=""131"" left=""327"" width=""18"" height=""13"" font=""29"">TS </text><text top=""128"" left=""345"" width=""9"" height=""16"" font=""23"">E</text><text top=""131"" left=""355"" width=""79"" height=""13"" font=""29"">VIDENTIARY </text><text top=""128"" left=""434"" width=""10"" height=""16"" font=""23"">B</text><text top=""131"" left=""444"" width=""45"" height=""13"" font=""29"">URDEN </text><text top=""128"" left=""489"" width=""11"" height=""16"" font=""23"">U</text><text top=""131"" left=""500"" width=""37"" height=""13"" font=""29"">NDER </text><text top=""128"" left=""537"" width=""10"" height=""16"" font=""23"">A</text><text top=""131"" left=""547"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""128"" left=""590"" width=""33"" height=""16"" font=""23""> 5.6 </text></p><p number=""22."" style=""6""><text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">22.  Argentina has not met its burden to show that the protocols applied to Uruguay could be </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">applied to Argentina in a way so as to meet the U.S. ALOP. To do so, Argentina would have had to </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">have prepared a document comparable to the full APHIS risk assessment now on the record in this </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">dispute. But of course, Argentina has not done so; instead it relies on assertions that Argentina is </text>
<text top=""226"" left=""108"" width=""689"" height=""16"" font=""0"">like Uruguay. But as the OIE confirmed, OIE status designations are not intended to be </text>
<text top=""242"" left=""108"" width=""286"" height=""16"" font=""0"">comparisons between different countries. </text>
</p><p number=""23."" style=""6""><text top=""275"" left=""108"" width=""684"" height=""16"" font=""0"">23.  Even if one examines the experts' evaluation of the risks &#8211; which is not a proper use of </text>
<text top=""292"" left=""108"" width=""684"" height=""16"" font=""0"">experts &#8211; Argentina does not meet its burden. In fact, the individual experts were not able to </text>
<text top=""308"" left=""108"" width=""685"" height=""16"" font=""0"">agree and to assess whether relevant animal control systems in Argentina and Uruguay were </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">similar enough to meet the appropriate level of protection of the United States. The same is true </text>
<text top=""341"" left=""108"" width=""683"" height=""16"" font=""0"">for Patagonia. Argentina has not shown that measures that were applied to Santa Catarina would </text>
<text top=""357"" left=""108"" width=""684"" height=""16"" font=""0"">be appropriate for the Patagonia region &#8211; Patagonia South and Patagonia North B &#8211; the regions </text>
<text top=""374"" left=""108"" width=""683"" height=""16"" font=""0"">relevant to this dispute. The fact that APHIS proposed to extend FMD-free status to Patagonia in </text>
<text top=""390"" left=""108"" width=""685"" height=""16"" font=""0"">January 2014 based on a risk assessment that accompanied the regulatory notice cannot help </text>
<text top=""407"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina make its case now. Argentina must meet its burden with the evidence as of panel </text>
<text top=""423"" left=""108"" width=""266"" height=""16"" font=""0"">establishment, and it has not done so. </text>
</p><p number=""24."" style=""6""><text top=""456"" left=""108"" width=""682"" height=""16"" font=""0"">24.  Animals and animal products that are vaccinated pose an FMD threat. The individual experts </text>
<text top=""472"" left=""108"" width=""682"" height=""16"" font=""0"">confirmed that the risk of FMD transmission still exists even with the use of vaccination. Argentina </text>
<text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">does not and cannot dispute the fact that vaccination poses a risk that, without the use of certain </text>
<text top=""505"" left=""108"" width=""344"" height=""16"" font=""0"">control measures, some Members cannot accept.  </text>
</p><p number=""F."" style=""1""><text top=""538"" left=""108"" width=""14"" height=""16"" font=""23"">F.</text><text top=""538"" left=""162"" width=""9"" height=""16"" font=""23"">E</text><text top=""541"" left=""171"" width=""109"" height=""13"" font=""29"">VIDENCE ON THE </text><text top=""538"" left=""280"" width=""11"" height=""16"" font=""23"">R</text><text top=""541"" left=""291"" width=""44"" height=""13"" font=""29"">ECORD </text><text top=""538"" left=""336"" width=""11"" height=""16"" font=""23"">D</text><text top=""541"" left=""347"" width=""27"" height=""13"" font=""29"">OES </text><text top=""538"" left=""376"" width=""11"" height=""16"" font=""23"">N</text><text top=""541"" left=""387"" width=""20"" height=""13"" font=""29"">OT </text><text top=""538"" left=""408"" width=""10"" height=""16"" font=""23"">S</text><text top=""541"" left=""418"" width=""52"" height=""13"" font=""29"">UPPORT </text><text top=""538"" left=""471"" width=""10"" height=""16"" font=""23"">A</text><text top=""541"" left=""481"" width=""63"" height=""13"" font=""29"">RGENTINA</text><text top=""538"" left=""544"" width=""4"" height=""16"" font=""23"">'</text><text top=""541"" left=""548"" width=""11"" height=""13"" font=""29"">S </text><text top=""538"" left=""561"" width=""10"" height=""16"" font=""23"">C</text><text top=""541"" left=""570"" width=""34"" height=""13"" font=""29"">LAIM </text><text top=""538"" left=""606"" width=""11"" height=""16"" font=""23"">U</text><text top=""541"" left=""617"" width=""37"" height=""13"" font=""29"">NDER </text><text top=""538"" left=""655"" width=""10"" height=""16"" font=""23"">A</text><text top=""541"" left=""665"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""538"" left=""708"" width=""29"" height=""16"" font=""23""> 2.3</text><text top=""541"" left=""736"" width=""53"" height=""13"" font=""29""> OF THE </text><text top=""554"" left=""162"" width=""44"" height=""16"" font=""23"">SPS A</text><text top=""557"" left=""206"" width=""64"" height=""13"" font=""29"">GREEMENT</text></p><p number=""25."" style=""6""><text top=""587"" left=""108"" width=""688"" height=""16"" font=""0"">25.  Argentina has not met its burden and established that the United States has acted </text>
<text top=""603"" left=""108"" width=""685"" height=""16"" font=""0"">inconsistently with Article 2.3 of the SPS Agreement. With respect to Argentina, Uruguay, and </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">Japan, the individual experts were not able to conclude unanimously that the systems were similar </text>
<text top=""636"" left=""108"" width=""686"" height=""16"" font=""0"">with respect to surveillance, animal identification and census, movement controls, or sanitary </text>
<text top=""653"" left=""108"" width=""684"" height=""16"" font=""0"">situations. With respect to Patagonia and Santa Catarina, although the individual experts made </text>
<text top=""669"" left=""108"" width=""684"" height=""16"" font=""0"">some statements as to comparability, it must be made clear that they made those statements </text>
<text top=""685"" left=""108"" width=""684"" height=""16"" font=""0"">using the APHIS risk assessment published in January 2014, which was after the date of panel </text>
<text top=""702"" left=""108"" width=""683"" height=""16"" font=""0"">establishment. As such, they are relying on APHIS's own findings and proposal to determine that </text>
<text top=""718"" left=""108"" width=""685"" height=""16"" font=""0"">Patagonia (the whole region) is free of FMD. In fact, APHIS made that determination final on </text>
<text top=""735"" left=""108"" width=""123"" height=""16"" font=""0"">August 29, 2014. </text>
</p><p number=""26."" style=""6""><text top=""767"" left=""108"" width=""685"" height=""16"" font=""0"">26.  The OIE's official recognition of the FMD status of a country or area is not sufficient to </text>
<text top=""784"" left=""108"" width=""682"" height=""16"" font=""0"">establish that regions have identical or similar conditions within the meaning of Article 2.3. As the </text>
<text top=""800"" left=""108"" width=""685"" height=""16"" font=""0"">OIE and the individual experts agree: the OIE official status designation is not an import risk </text>
<text top=""817"" left=""108"" width=""683"" height=""16"" font=""0"">assessment. Accordingly, it cannot be used to conclude that the risk from two Members with the </text>
<text top=""833"" left=""108"" width=""682"" height=""16"" font=""0"">same status designation is the same or similar. Its only use is to confirm that a Member meets the </text>
<text top=""850"" left=""108"" width=""183"" height=""16"" font=""0"">OIE's minimum standard.  </text>
</p><p number=""27."" style=""6""><text top=""882"" left=""108"" width=""687"" height=""16"" font=""0"">27.  Neither is Argentina's complaint that the United States has not completed the APHIS </text>
<text top=""899"" left=""108"" width=""683"" height=""16"" font=""0"">regulatory process in the same time that other countries have completed it a claim recognizable </text>
<text top=""915"" left=""108"" width=""123"" height=""16"" font=""0"">under Article 2.3. </text>
</p><p number=""G."" style=""1""><text top=""948"" left=""108"" width=""16"" height=""16"" font=""23"">G.</text><text top=""948"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""951"" left=""161"" width=""63"" height=""13"" font=""29"">RGENTINA</text><text top=""948"" left=""224"" width=""4"" height=""16"" font=""23"">'</text><text top=""951"" left=""228"" width=""11"" height=""13"" font=""29"">S </text><text top=""948"" left=""239"" width=""10"" height=""16"" font=""23"">A</text><text top=""951"" left=""250"" width=""37"" height=""13"" font=""29"">NNEX </text><text top=""948"" left=""286"" width=""41"" height=""16"" font=""23"">C(1)(</text><text top=""951"" left=""328"" width=""8"" height=""13"" font=""29"">B</text><text top=""948"" left=""336"" width=""7"" height=""16"" font=""23"">)</text><text top=""948"" left=""347"" width=""10"" height=""16"" font=""23"">C</text><text top=""951"" left=""356"" width=""34"" height=""13"" font=""29"">LAIM </text><text top=""948"" left=""391"" width=""9"" height=""16"" font=""23"">F</text><text top=""951"" left=""399"" width=""28"" height=""13"" font=""29"">AILS</text></p><p number=""28."" style=""6""><text top=""981"" left=""108"" width=""685"" height=""16"" font=""0"">28.  Contrary to Argentina's contention, the United States does not accept Argentina's claims </text>
<text top=""997"" left=""108"" width=""683"" height=""16"" font=""0"">under Annex C(1)(b). As an initial matter, as the United States has explained, Annex C does not </text>
<text top=""1014"" left=""108"" width=""323"" height=""16"" font=""0"">apply to determinations of disease-free status. </text>
</p><p number=""29."" style=""6""><text top=""1046"" left=""108"" width=""683"" height=""16"" font=""0"">29.  The United States also does not agree that Argentina has shown a breach of any obligation </text>
<text top=""1063"" left=""108"" width=""683"" height=""16"" font=""0"">under Annex C(1)(b). The only Annex C(1)(b) claim mentioned in Argentina's panel request is a </text>
<text top=""1079"" left=""108"" width=""684"" height=""16"" font=""0"">reference to the fifth clause, involving the explanations for delay. This is a jurisdictional matter, </text>
<text top=""1096"" left=""108"" width=""682"" height=""16"" font=""0"">and it is Argentina's responsibility to ensure that each one of its dozens of claims was actually set </text>
<text top=""1112"" left=""108"" width=""204"" height=""16"" font=""0"">out in its own panel request.  </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-41 - </text>
</p></p></page>
<page number=""51"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""30."" style=""6""><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">30.  Further, the record does not support Argentina's arguments. With respect to Argentina's </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">applications, APHIS (1) promptly examined Argentina's applications for completeness upon receipt, </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">and notified SENASA of deficiencies on multiple occasions; and (2) proceeded as far as practicable </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">with its evaluation even when SENASA's applications had deficiencies. Argentina has also asserted </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">that APHIS failed to transmit final results of the evaluation process; however, this claim fails for a </text>
<text top=""210"" left=""108"" width=""508"" height=""16"" font=""0"">simple and clear reason: there were no ""results"" to transmit to Argentina. </text>
</p><p><text top=""242"" left=""108"" width=""249"" height=""16"" font=""23"">SECOND WRITTEN SUBMISSION </text></p><p number=""31."" style=""6""><text top=""275"" left=""108"" width=""684"" height=""16"" font=""0"">31.  This dispute is about timing and the mutual obligations under the SPS Agreement when a </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">claim is made that an exporting Member's territory, in whole or in part, is free of disease or of low </text>
<text top=""308"" left=""108"" width=""683"" height=""16"" font=""0"">disease prevalence in relation to disease of concern to an importing Member. The SPS Agreement </text>
<text top=""324"" left=""108"" width=""684"" height=""16"" font=""0"">addresses this in Articles 5.7 and 6. The importing Member begins an assessment of risks and </text>
<text top=""341"" left=""108"" width=""687"" height=""16"" font=""0"">seeks to obtain necessary information from the exporting Member. At the same time, the </text>
<text top=""357"" left=""108"" width=""685"" height=""16"" font=""0"">exporting Member is obligated to provide the necessary information to validate its claim. The </text>
<text top=""374"" left=""108"" width=""686"" height=""16"" font=""0"">importing Member collects information necessary for an objective assessment of the risk and </text>
<text top=""390"" left=""108"" width=""685"" height=""16"" font=""0"">reviews its existing SPS measure accordingly within a reasonable period of time. Pending the </text>
<text top=""407"" left=""108"" width=""683"" height=""16"" font=""0"">completion of the information collection and review process, the importing Member may maintain </text>
<text top=""423"" left=""108"" width=""453"" height=""16"" font=""0"">provisionally its measure affecting the importation of the product. </text>
</p><p number=""32."" style=""6""><text top=""456"" left=""108"" width=""682"" height=""16"" font=""0"">32.  According to Argentina, when an exporting Member claims it is free of disease, the importing </text>
<text top=""472"" left=""108"" width=""684"" height=""16"" font=""0"">Member must either immediately produce an assessment specific to that Member or permit the </text>
<text top=""489"" left=""108"" width=""682"" height=""16"" font=""0"">product to enter. This view is not grounded in the text of the Agreement and is not reflected in the </text>
<text top=""505"" left=""108"" width=""685"" height=""16"" font=""0"">practice of other Members, which conduct investigations to assess claims made as to disease </text>
<text top=""521"" left=""108"" width=""686"" height=""16"" font=""0"">status before accepting those claims as valid. Nor is Argentina's position consistent with the </text>
<text top=""538"" left=""108"" width=""683"" height=""16"" font=""0"">OIE system. The OIE does not take a Member's claim of disease freedom at face value. A Member </text>
<text top=""554"" left=""108"" width=""683"" height=""16"" font=""0"">seeking OIE recognition must submit scientific information so that a committee within the OIE can </text>
<text top=""571"" left=""108"" width=""139"" height=""16"" font=""0"">evaluate the claim.  </text>
</p><p number=""33."" style=""6""><text top=""603"" left=""108"" width=""684"" height=""16"" font=""0"">33.  In this dispute, the U.S. measure is based on the international standard, and reflects the </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">practice followed by other Members and the OIE. In 2002, Argentina claimed that it was free of the </text>
<text top=""636"" left=""108"" width=""682"" height=""16"" font=""0"">FMD disease and sought to export beef to the United States. The United States began a process of </text>
<text top=""653"" left=""108"" width=""685"" height=""16"" font=""0"">requesting information from Argentina, conducting site visits to the country, and analyzing the </text>
<text top=""669"" left=""108"" width=""682"" height=""16"" font=""0"">data that it collected. The FMD situation in Argentina and the country's ability to prevent outbreaks </text>
<text top=""685"" left=""108"" width=""685"" height=""16"" font=""0"">has been in question throughout this process, especially with recurring outbreaks in 2003 and </text>
<text top=""702"" left=""108"" width=""683"" height=""16"" font=""0"">2006. Argentina also caused delays in the process by revising its requests to include more regions </text>
<text top=""718"" left=""108"" width=""685"" height=""16"" font=""0"">and then delaying responses to APHIS questions. Nevertheless, the United States continues to </text>
<text top=""735"" left=""108"" width=""682"" height=""16"" font=""0"">process Argentina's applications and is doing so within a reasonable period of time, consistent with </text>
<text top=""751"" left=""108"" width=""79"" height=""16"" font=""0"">Article 5.7. </text>
</p><p number=""34."" style=""6""><text top=""784"" left=""108"" width=""684"" height=""16"" font=""0"">34.  Argentina has asserted that the United States breached Article 5.6 and Article 2.3 because </text>
<text top=""800"" left=""108"" width=""682"" height=""16"" font=""0"">the United States did not apply the measures to Argentina that it extended to Uruguay and Brazil. </text>
<text top=""817"" left=""108"" width=""685"" height=""16"" font=""0"">However, the United States is continuing to review conditions in Argentina, and Argentina has </text>
<text top=""833"" left=""108"" width=""683"" height=""16"" font=""0"">failed to present any scientific evidence that the conditions extended to Uruguay or Brazil to meet </text>
<text top=""850"" left=""108"" width=""682"" height=""16"" font=""0"">the U.S. ALOP would meet the U.S. ALOP when extended to Argentina. With respect to Article 2.3, </text>
<text top=""866"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina similarly fails to provide any evidence that comparisons with Uruguay, Brazil, Japan or </text>
<text top=""882"" left=""108"" width=""345"" height=""16"" font=""0"">the United Kingdom are relevant and appropriate. </text>
</p><p number=""35."" style=""6""><text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">35.  Argentina provides no argument that should persuade this Panel to reject the reasoning of </text>
<text top=""932"" left=""108"" width=""683"" height=""16"" font=""0"">prior panels and the Appellate Body that Article 5.4 does not impose affirmative obligations, and </text>
<text top=""948"" left=""108"" width=""470"" height=""16"" font=""0"">that Article 10.1 does not prescribe a specific result to be achieved.  </text>
</p><p number=""A."" style=""1""><text top=""981"" left=""108"" width=""63"" height=""16"" font=""23"">A. T</text><text top=""984"" left=""171"" width=""26"" height=""13"" font=""29"">HIS </text><text top=""981"" left=""200"" width=""11"" height=""16"" font=""23"">D</text><text top=""984"" left=""212"" width=""47"" height=""13"" font=""29"">ISPUTE </text><text top=""981"" left=""263"" width=""10"" height=""16"" font=""23"">S</text><text top=""984"" left=""272"" width=""45"" height=""13"" font=""29"">HOULD </text><text top=""981"" left=""321"" width=""10"" height=""16"" font=""23"">B</text><text top=""984"" left=""331"" width=""11"" height=""13"" font=""29"">E </text><text top=""981"" left=""346"" width=""10"" height=""16"" font=""23"">A</text><text top=""984"" left=""356"" width=""58"" height=""13"" font=""29"">NALYZED </text><text top=""981"" left=""418"" width=""7"" height=""16"" font=""23"">I</text><text top=""984"" left=""425"" width=""13"" height=""13"" font=""29"">N </text><text top=""981"" left=""441"" width=""9"" height=""16"" font=""23"">L</text><text top=""984"" left=""450"" width=""91"" height=""13"" font=""29"">IGHT OF THE </text><text top=""981"" left=""540"" width=""11"" height=""16"" font=""23"">O</text><text top=""984"" left=""552"" width=""105"" height=""13"" font=""29"">BLIGATIONS OF </text><text top=""981"" left=""657"" width=""10"" height=""16"" font=""23"">A</text><text top=""984"" left=""668"" width=""54"" height=""13"" font=""29"">RTICLES </text><text top=""981"" left=""725"" width=""29"" height=""16"" font=""23"">2.2,</text><text top=""981"" left=""761"" width=""24"" height=""16"" font=""23"">5.7</text><text top=""1000"" left=""162"" width=""26"" height=""13"" font=""29"">AND</text><text top=""997"" left=""188"" width=""33"" height=""16"" font=""23""> 6.3 </text></p><p number=""36."" style=""6""><text top=""1030"" left=""108"" width=""684"" height=""16"" font=""0"">36.  This dispute is about determining the obligations under the SPS Agreement in connection </text>
<text top=""1046"" left=""108"" width=""683"" height=""16"" font=""0"">with an exporting Member's assertion that its products should be allowed to enter the territory of </text>
<text top=""1063"" left=""108"" width=""682"" height=""16"" font=""0"">an importing Member because the exporting Member's territories are alleged to be disease-free or </text>
<text top=""1079"" left=""108"" width=""684"" height=""16"" font=""0"">of low disease prevalence. The proper disposition of this scenario, as envisioned by Articles 5.7 </text>
<text top=""1096"" left=""108"" width=""683"" height=""16"" font=""0"">and 6, is that the importing Member collects additional information needed to assess the risks of </text>
<text top=""1112"" left=""108"" width=""682"" height=""16"" font=""0"">the imported product and reviews its measure accordingly, making use of the relevant information </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-42 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">provided by the exporting Member. While this process is underway, the importing Member can </text>
<text top=""144"" left=""108"" width=""490"" height=""16"" font=""0"">maintain provisionally its measure affecting importation of the product. </text>
</p></p></page>
<page number=""52"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""37."" style=""6""><text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">37.  The SPS Agreement &#8211; through Articles 2.2 and 5.7, as informed by Articles 6 and 6.3 in </text>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">particular &#8211; addresses precisely this situation. Article 2.2 states that Members shall ensure that </text>
<text top=""210"" left=""108"" width=""686"" height=""16"" font=""0"">SPS measures are not maintained without sufficient scientific evidence, except as provided in </text>
<text top=""226"" left=""108"" width=""682"" height=""16"" font=""0"">Article 5.7. Article 5.7 in turn sets out the rules that apply when ""scientific evidence is insufficient"" </text>
<text top=""242"" left=""108"" width=""685"" height=""16"" font=""0"">to complete an assessment of risks. When an assertion of the disease status of the exporting </text>
<text top=""259"" left=""108"" width=""684"" height=""16"" font=""0"">Member is made, the importing Member is not likely to have all the scientific information it will </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">need to review its existing measure and determine whether changes are appropriate, as was the </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">case here. Notably, the importing Member does not readily have access to the exporting Member's </text>
<text top=""308"" left=""108"" width=""682"" height=""16"" font=""0"">regulatory experts and the wide range of scientific technical information necessary to form a basis </text>
<text top=""324"" left=""108"" width=""134"" height=""16"" font=""0"">for an assessment. </text>
</p><p number=""38."" style=""6""><text top=""357"" left=""108"" width=""688"" height=""16"" font=""0"">38.  Recognizing this, Article 5.7 obligates the importing Member to ""seek to obtain the </text>
<text top=""374"" left=""108"" width=""683"" height=""16"" font=""0"">additional information necessary for a more objective assessment of the risk,"" and to ""review the </text>
<text top=""390"" left=""108"" width=""683"" height=""16"" font=""0"">SPS measures accordingly."" In the context of an assessment of a claim of disease-free status, the </text>
<text top=""407"" left=""108"" width=""686"" height=""16"" font=""0"">exporting Member will need to initiate data requests and collect information from the most </text>
<text top=""423"" left=""108"" width=""684"" height=""16"" font=""0"">relevant party &#8211; the exporting Member, and will use the additional information in reviewing the </text>
<text top=""439"" left=""108"" width=""683"" height=""16"" font=""0"">existing SPS measure. This process is not indefinite, but must be completed within ""a reasonable </text>
<text top=""456"" left=""108"" width=""111"" height=""16"" font=""0"">period of time."" </text>
</p><p number=""39."" style=""6""><text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">39.  Article 6 complements and reinforces this understanding of how Article 5.7 applies in these </text>
<text top=""505"" left=""108"" width=""143"" height=""16"" font=""0"">situations. Article </text>
<text top=""505"" left=""241"" width=""559"" height=""16"" font=""0"">6.1 obligates the importing Member to adapt its measures to the </text>
<text top=""521"" left=""108"" width=""687"" height=""16"" font=""0"">SPS characteristics of the exporting Member, and those characteristics include the ""level of </text>
<text top=""538"" left=""108"" width=""684"" height=""16"" font=""0"">prevalence of specific diseases."" In particular, when the exporting Member makes the assertion </text>
<text top=""554"" left=""108"" width=""683"" height=""16"" font=""0"">that its territories are free of disease or of low disease prevalence as described above, Article 6.3 </text>
<text top=""571"" left=""108"" width=""339"" height=""16"" font=""0"">obligates it to ""provide the necessary evidence.""  </text>
</p><p number=""40."" style=""6""><text top=""603"" left=""108"" width=""683"" height=""16"" font=""0"">40.  During this process of risk assessment, the importing Member is provisionally permitted to </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">maintain and adopt measures to restrict importation of product from the exporting Member, under </text>
<text top=""636"" left=""108"" width=""685"" height=""16"" font=""0"">Article 5.7. And there is no basis to accept &#8211; as Argentina appears to argue &#8211; that importing </text>
<text top=""653"" left=""108"" width=""685"" height=""16"" font=""0"">Members must modify their measures immediately upon an exporting Member's assertion that </text>
<text top=""669"" left=""108"" width=""688"" height=""16"" font=""0"">disease freedom or low disease prevalence is sufficient to meet the importing Member's </text>
<text top=""685"" left=""108"" width=""683"" height=""16"" font=""0"">appropriate level of protection. Such an interpretation of the SPS Agreement would be contrary to </text>
<text top=""702"" left=""108"" width=""682"" height=""16"" font=""0"">the core principle of the SPS Agreement, stated in Article 2.1, which is that each Member has ""the </text>
<text top=""718"" left=""108"" width=""683"" height=""16"" font=""0"">right to take sanitary and phytosanitary measures necessary for the protection of human, animal </text>
<text top=""735"" left=""108"" width=""159"" height=""16"" font=""0"">or plant life or health."" </text>
</p><p number=""B."" style=""1""><text top=""767"" left=""108"" width=""53"" height=""16"" font=""23"">B. A</text><text top=""770"" left=""161"" width=""63"" height=""13"" font=""29"">RGENTINA</text><text top=""767"" left=""224"" width=""4"" height=""16"" font=""23"">'</text><text top=""770"" left=""228"" width=""11"" height=""13"" font=""29"">S </text><text top=""767"" left=""239"" width=""10"" height=""16"" font=""23"">A</text><text top=""770"" left=""250"" width=""70"" height=""13"" font=""29"">RGUMENTS </text><text top=""767"" left=""319"" width=""9"" height=""16"" font=""23"">F</text><text top=""770"" left=""328"" width=""44"" height=""13"" font=""29"">AIL TO </text><text top=""767"" left=""372"" width=""10"" height=""16"" font=""23"">A</text><text top=""770"" left=""382"" width=""78"" height=""13"" font=""29"">DDRESS THE </text><text top=""767"" left=""460"" width=""10"" height=""16"" font=""23"">K</text><text top=""770"" left=""471"" width=""19"" height=""13"" font=""29"">EY </text><text top=""767"" left=""489"" width=""9"" height=""16"" font=""23"">L</text><text top=""770"" left=""498"" width=""34"" height=""13"" font=""29"">EGAL </text><text top=""767"" left=""532"" width=""7"" height=""16"" font=""23"">I</text><text top=""770"" left=""539"" width=""87"" height=""13"" font=""29"">SSUES IN THE </text><text top=""767"" left=""626"" width=""11"" height=""16"" font=""23"">D</text><text top=""770"" left=""637"" width=""47"" height=""13"" font=""29"">ISPUTE </text></p><p number=""41."" style=""6""><text top=""800"" left=""108"" width=""685"" height=""16"" font=""0"">41.  Article 2.2 states that SPS measures shall not be maintained ""without sufficient scientific </text>
<text top=""817"" left=""108"" width=""683"" height=""16"" font=""0"">evidence, except as provided for in paragraph 7 of Article 5."" Article 5.7 is a ""qualified"" right and </text>
<text top=""833"" left=""108"" width=""685"" height=""16"" font=""0"">when its requirements are satisfied, Article 2.2's obligation not to maintain a measure without </text>
<text top=""850"" left=""108"" width=""684"" height=""16"" font=""0"">sufficient scientific evidence is ""not applicable to the challenged measure."" Article 5.7 applies in </text>
<text top=""866"" left=""108"" width=""684"" height=""16"" font=""0"">cases in which ""relevant scientific evidence is insufficient"" to conduct a risk assessment, and in </text>
<text top=""882"" left=""108"" width=""687"" height=""16"" font=""0"">these instances, the panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> concluded </text>
<text top=""899"" left=""108"" width=""682"" height=""16"" font=""0"">""Article 5.7 permits Members to do, in certain circumstances, what they would not be permitted to </text>
<text top=""915"" left=""108"" width=""156"" height=""16"" font=""0"">do under Article 5.1.""  </text>
</p><p number=""42."" style=""6""><text top=""948"" left=""108"" width=""687"" height=""16"" font=""0"">42.  If the Panel were to find that Article 5.7 does not apply to this case, the systemic </text>
<text top=""964"" left=""108"" width=""685"" height=""16"" font=""0"">implications for national animal health protection regulatory authorities would be significant. It </text>
<text top=""981"" left=""108"" width=""683"" height=""16"" font=""0"">would mean that any measure validly taken to stop imports because of risks raised by an animal </text>
<text top=""997"" left=""108"" width=""683"" height=""16"" font=""0"">disease could be found inconsistent with the SPS Agreement when the exporting Member merely </text>
<text top=""1014"" left=""108"" width=""303"" height=""16"" font=""0"">declares that circumstances have changed.  </text>
</p><p number=""C."" style=""1""><text top=""1046"" left=""108"" width=""64"" height=""16"" font=""23"">C. A</text><text top=""1049"" left=""172"" width=""63"" height=""13"" font=""29"">RGENTINA</text><text top=""1046"" left=""235"" width=""4"" height=""16"" font=""23"">'</text><text top=""1049"" left=""240"" width=""11"" height=""13"" font=""29"">S </text><text top=""1046"" left=""252"" width=""10"" height=""16"" font=""23"">A</text><text top=""1049"" left=""262"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""1046"" left=""305"" width=""14"" height=""16"" font=""23""> 6</text><text top=""1046"" left=""323"" width=""11"" height=""16"" font=""23"">D</text><text top=""1049"" left=""335"" width=""140"" height=""13"" font=""29"">ISTINCTION BETWEEN </text><text top=""1046"" left=""474"" width=""18"" height=""16"" font=""23"">""C</text><text top=""1049"" left=""492"" width=""67"" height=""13"" font=""29"">OMMODITY</text><text top=""1046"" left=""559"" width=""8"" height=""16"" font=""23"">""</text><text top=""1049"" left=""567"" width=""35"" height=""13"" font=""29""> AND </text><text top=""1046"" left=""601"" width=""18"" height=""16"" font=""23"">""R</text><text top=""1049"" left=""620"" width=""106"" height=""13"" font=""29"">EGIONALIZATION</text><text top=""1046"" left=""726"" width=""8"" height=""16"" font=""23"">""</text><text top=""1046"" left=""738"" width=""7"" height=""16"" font=""23"">I</text><text top=""1049"" left=""746"" width=""11"" height=""13"" font=""29"">S </text><text top=""1046"" left=""758"" width=""11"" height=""16"" font=""23"">N</text><text top=""1049"" left=""769"" width=""20"" height=""13"" font=""29"">OT </text><text top=""1063"" left=""162"" width=""10"" height=""16"" font=""23"">A</text><text top=""1063"" left=""176"" width=""11"" height=""16"" font=""23"">D</text><text top=""1066"" left=""187"" width=""77"" height=""13"" font=""29"">ISTINCTION </text><text top=""1063"" left=""264"" width=""11"" height=""16"" font=""23"">R</text><text top=""1066"" left=""275"" width=""119"" height=""13"" font=""29"">ECOGNIZED IN THE </text><text top=""1063"" left=""393"" width=""44"" height=""16"" font=""23"">SPS A</text><text top=""1066"" left=""437"" width=""64"" height=""13"" font=""29"">GREEMENT</text></p><p number=""43."" style=""6""><text top=""1096"" left=""108"" width=""683"" height=""16"" font=""0"">43.  Article 6.1 provides that the importing Member should ensure that measures relating to the </text>
<text top=""1112"" left=""108"" width=""684"" height=""16"" font=""0"">import of the product are adapted to the SPS characteristics of the area in question. Article 6.3 </text>
<text top=""1128"" left=""108"" width=""682"" height=""16"" font=""0"">directly relates to Article 6.1 because, when a Member seeking to export a product (or commodity) </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-43 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">bases its request on the assertion that its territory is an area of disease freedom or of low disease </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">prevalence, it should provide the necessary evidence to the importing Member. These Articles do </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">not draw any distinction articulated by Argentina between a so-called ""regionalization"" request and </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">a ""commodity"" request. Argentina's assertion to the United States, for all intents and purposes, is </text>
<text top=""193"" left=""108"" width=""617"" height=""16"" font=""0"">that it is free of FMD, and accordingly, seeks to export fresh beef from the whole country. </text>
</p></p></page>
<page number=""53"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""44."" style=""6""><text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">44.  Argentina cannot arbitrarily limit the scope of applicability of Article 6. Argentina's position </text>
<text top=""242"" left=""108"" width=""686"" height=""16"" font=""0"">requires it to disregard the relevance of Article 6, and particularly Article 6.3, which directly </text>
<text top=""259"" left=""108"" width=""684"" height=""16"" font=""0"">obligates the exporting Member to provide the necessary evidence before an importing Member </text>
<text top=""275"" left=""108"" width=""520"" height=""16"" font=""0"">makes a decision on the disease status of the exporting Member's territory. </text>
</p><p number=""D."" style=""1""><text top=""308"" left=""108"" width=""55"" height=""16"" font=""23"">D. M</text><text top=""311"" left=""163"" width=""58"" height=""13"" font=""29"">EASURES </text><text top=""308"" left=""221"" width=""9"" height=""16"" font=""23"">T</text><text top=""311"" left=""230"" width=""82"" height=""13"" font=""29"">AKEN BY THE </text><text top=""308"" left=""312"" width=""11"" height=""16"" font=""23"">U</text><text top=""311"" left=""323"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""308"" left=""361"" width=""14"" height=""16"" font=""23""> S</text><text top=""311"" left=""375"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""308"" left=""416"" width=""10"" height=""16"" font=""23"">A</text><text top=""311"" left=""426"" width=""19"" height=""13"" font=""29"">RE </text><text top=""308"" left=""445"" width=""7"" height=""16"" font=""23"">J</text><text top=""311"" left=""453"" width=""61"" height=""13"" font=""29"">USTIFIED </text><text top=""308"" left=""514"" width=""11"" height=""16"" font=""23"">U</text><text top=""311"" left=""525"" width=""37"" height=""13"" font=""29"">NDER </text><text top=""308"" left=""561"" width=""10"" height=""16"" font=""23"">A</text><text top=""311"" left=""572"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""308"" left=""614"" width=""33"" height=""16"" font=""23""> 5.7 </text></p><p number=""45."" style=""6""><text top=""341"" left=""108"" width=""682"" height=""16"" font=""0"">45.  In November 2002, at the time in which Argentina made its assertion of the status of FMD in </text>
<text top=""357"" left=""108"" width=""682"" height=""16"" font=""0"">its territory, there was insufficient scientific evidence as to the FMD situation in Argentina and that </text>
<text top=""374"" left=""108"" width=""685"" height=""16"" font=""0"">country's ability to impose and maintain internal controls so as to prevent FMD incidents from </text>
<text top=""390"" left=""108"" width=""573"" height=""16"" font=""0"">occurring so as to allow the United States to review the pre-existing SPS measure.  </text>
</p><p number=""46."" style=""6""><text top=""423"" left=""108"" width=""683"" height=""16"" font=""0"">46.  Although much is known about the modes of transmission of FMD, the scientific, technical, </text>
<text top=""439"" left=""108"" width=""683"" height=""16"" font=""0"">and administrative issues involved in a successful control program are quite complex. The record </text>
<text top=""456"" left=""108"" width=""677"" height=""16"" font=""0"">demonstrates the complexity of the issue: even after Argentina claimed to have resolved its 2000-</text>
<text top=""472"" left=""108"" width=""683"" height=""16"" font=""0"">2002 FMD outbreaks, Argentina suffered FMD outbreaks in both 2003 and 2006. At the time that </text>
<text top=""489"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina sought access to the United States market in November 2002, the United States did not </text>
<text top=""505"" left=""108"" width=""682"" height=""16"" font=""0"">have information regarding Argentina's current disease situation and its regulatory system's ability </text>
<text top=""521"" left=""108"" width=""687"" height=""16"" font=""0"">to ""handle products that are susceptible to the disease"" and its ability to impose ""import </text>
<text top=""538"" left=""108"" width=""687"" height=""16"" font=""0"">protocols."" That is why the United States undertook a process of obtaining that information </text>
<text top=""554"" left=""108"" width=""302"" height=""16"" font=""0"">through information requests to Argentina.  </text>
</p><p number=""47."" style=""6""><text top=""587"" left=""108"" width=""686"" height=""16"" font=""0"">47.  Argentina argues that the United States ""adopted"" no measures in 2002, and that the </text>
<text top=""603"" left=""108"" width=""683"" height=""16"" font=""0"">""application by Argentina to APHIS was an action by Argentina."" If Argentina is arguing that the </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">United States was required under Article 5.7 to issue some sort of legislation or statute in order for </text>
<text top=""636"" left=""108"" width=""682"" height=""16"" font=""0"">the measure to be fall within the scope of Article 5.7, this legal position is untenable from a textual </text>
<text top=""653"" left=""108"" width=""173"" height=""16"" font=""0"">and practical standpoint. </text>
</p><p number=""48."" style=""6""><text top=""685"" left=""108"" width=""682"" height=""16"" font=""0"">48.  Argentina ignores the plain text of Article 2.2 &#8211; which is the provision that operationally ties </text>
<text top=""702"" left=""108"" width=""682"" height=""16"" font=""0"">Article 5.7 into the rest of the SPS Agreement. The United States recalls that Article 2.2 states that </text>
<text top=""718"" left=""108"" width=""685"" height=""16"" font=""0"">""Members shall ensure that measures are not maintained without sufficient scientific evidence, </text>
<text top=""735"" left=""108"" width=""683"" height=""16"" font=""0"">except as provided in Article 5.7."" The text of Article 2.2 text shows that Article 5.7 is not limited </text>
<text top=""751"" left=""108"" width=""684"" height=""16"" font=""0"">to newly ""adopted"" measures in the terms that Argentina is implying, but rather Article 5.7 also </text>
<text top=""767"" left=""108"" width=""687"" height=""16"" font=""0"">applies to situations where an existing measure is ""maintained"" without sufficient scientific </text>
<text top=""784"" left=""108"" width=""69"" height=""16"" font=""0"">evidence. </text>
</p><p number=""49."" style=""6""><text top=""817"" left=""108"" width=""684"" height=""16"" font=""0"">49.  Furthermore, Argentina's argument &#8211; if adopted &#8211; would mean that the drafters intended </text>
<text top=""833"" left=""108"" width=""682"" height=""16"" font=""0"">the following unreasonable result: when new information comes to light with respect to an existing </text>
<text top=""850"" left=""108"" width=""682"" height=""16"" font=""0"">measure &#8211; whether it be a claim of disease-free status or indeed any scientific information relating </text>
<text top=""866"" left=""108"" width=""685"" height=""16"" font=""0"">to any type of SPS measure &#8211; the importing Member would immediately have to remove its </text>
<text top=""882"" left=""108"" width=""686"" height=""16"" font=""0"">existing measure an re-adopt the same measure, labeling it as provisional.  Otherwise, the </text>
<text top=""899"" left=""108"" width=""687"" height=""16"" font=""0"">existing measures would be inconsistent with Article 2.2 because it was maintained without </text>
<text top=""915"" left=""108"" width=""684"" height=""16"" font=""0"">sufficient scientific evidence, and Article 5.7 could not apply because &#8211; according to Argentina &#8211; </text>
<text top=""932"" left=""108"" width=""354"" height=""16"" font=""0"">that article only applies to newly adopted measure. </text>
</p><p number=""50."" style=""6""><text top=""964"" left=""108"" width=""682"" height=""16"" font=""0"">50.  To the extent that Argentina is arguing that some sort of ""adoption"" must be found to make </text>
<text top=""981"" left=""108"" width=""682"" height=""16"" font=""0"">Article 5.7 applicable, and leaving aside the fact that Argentina's interpretation is plainly untenable </text>
<text top=""997"" left=""108"" width=""687"" height=""16"" font=""0"">in light of the clear text of Article 2.2, the United States did adopt actions in response to </text>
<text top=""1014"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina's request. APHIS took action to receive and review the application of Argentina within a </text>
<text top=""1030"" left=""108"" width=""683"" height=""16"" font=""0"">reasonable period of time while maintaining provisionally its prohibition on Argentina's beef until </text>
<text top=""1046"" left=""108"" width=""683"" height=""16"" font=""0"">APHIS made a decision on that application. In evaluating Argentina's sanitary situation in order to </text>
<text top=""1063"" left=""108"" width=""687"" height=""16"" font=""0"">reach ""a more objective assessment of risk,"" the United States has been seeking to obtain </text>
<text top=""1079"" left=""108"" width=""685"" height=""16"" font=""0"">additional information necessary, in accord with Article 5.7. It has sought information including </text>
<text top=""1096"" left=""108"" width=""684"" height=""16"" font=""0"">that related to veterinary control and oversight, history of the disease in Argentina, surveillance </text>
<text top=""1112"" left=""108"" width=""684"" height=""16"" font=""0"">information and others, consistent with 9 C.F.R. Section 92.2 for both Argentina and areas that </text>
<text top=""1128"" left=""108"" width=""685"" height=""16"" font=""0"">comprise Patagonia. It sought further information from Argentina on other occasions on topics </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-44 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">such as veterinarian licensing, the functions performed by the National Agrifood Inspection Service </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">of Argentina, and additional detailed information on particular issues related to the FMD outbreaks </text>
<text top=""160"" left=""108"" width=""130"" height=""16"" font=""0"">in 2001 and 2002. </text>
</p></p></page>
<page number=""54"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""51."" style=""6""><text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">51.  Argentina contends that Article 5.7 requires the importing Member ""to identify the specific </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">pertinent information it is missing at the time of imposition of the provisional measure"" and that </text>
<text top=""226"" left=""108"" width=""684"" height=""16"" font=""0"">the United States did not do so. However, as discussed above, it is clear that the United States </text>
<text top=""242"" left=""108"" width=""510"" height=""16"" font=""0"">was requesting information on the topics named in 9 C.F.R. Section 92.2.  </text>
</p><p number=""52."" style=""6""><text top=""275"" left=""108"" width=""684"" height=""16"" font=""0"">52.  Argentina then objects that Article 5.7 ""puts the burden on the importing Member to seek </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">such missing information,"" while the United States ""put[s] the burden on the exporting Member to </text>
<text top=""308"" left=""108"" width=""685"" height=""16"" font=""0"">provide information."" This is a mischaracterization. Argentina came forth and made a claim of </text>
<text top=""324"" left=""108"" width=""682"" height=""16"" font=""0"">changed circumstances. The United States then requested that Argentina provide information. The </text>
<text top=""341"" left=""108"" width=""684"" height=""16"" font=""0"">text of Article 5.7 obligates the Member taking the provisional measure to ""seek to obtain"" the </text>
<text top=""357"" left=""108"" width=""683"" height=""16"" font=""0"">additional necessary information, and that is what the United States did upon receiving the claim </text>
<text top=""374"" left=""108"" width=""689"" height=""16"" font=""0"">of changed circumstances&#8212;it sought to obtain the information from SENASA, which has </text>
<text top=""390"" left=""108"" width=""353"" height=""16"" font=""0"">jurisdiction in Argentina for animal health issues.    </text>
</p><p number=""E."" style=""1""><text top=""423"" left=""108"" width=""52"" height=""16"" font=""23"">E. T</text><text top=""426"" left=""160"" width=""20"" height=""13"" font=""29"">HE </text><text top=""423"" left=""179"" width=""11"" height=""16"" font=""23"">U</text><text top=""426"" left=""190"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""423"" left=""228"" width=""14"" height=""16"" font=""23""> S</text><text top=""426"" left=""242"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""423"" left=""283"" width=""7"" height=""16"" font=""23"">I</text><text top=""426"" left=""290"" width=""11"" height=""13"" font=""29"">S </text><text top=""423"" left=""301"" width=""11"" height=""16"" font=""23"">R</text><text top=""426"" left=""312"" width=""93"" height=""13"" font=""29"">EVIEWING THE </text><text top=""423"" left=""405"" width=""13"" height=""16"" font=""23"">M</text><text top=""426"" left=""418"" width=""50"" height=""13"" font=""29"">EASURE </text><text top=""423"" left=""468"" width=""15"" height=""16"" font=""23"">W</text><text top=""426"" left=""484"" width=""52"" height=""13"" font=""29"">ITHIN A </text><text top=""423"" left=""535"" width=""11"" height=""16"" font=""23"">R</text><text top=""426"" left=""546"" width=""74"" height=""13"" font=""29"">EASONABLE </text><text top=""423"" left=""620"" width=""10"" height=""16"" font=""23"">P</text><text top=""426"" left=""630"" width=""62"" height=""13"" font=""29"">ERIOD OF </text><text top=""423"" left=""692"" width=""9"" height=""16"" font=""23"">T</text><text top=""426"" left=""701"" width=""23"" height=""13"" font=""29"">IME</text></p><p number=""53."" style=""6""><text top=""456"" left=""108"" width=""684"" height=""16"" font=""0"">53.  The United States fully agrees that when a Member provisionally adopts a measure under </text>
<text top=""472"" left=""108"" width=""685"" height=""16"" font=""0"">Article 5.7, it must seek to obtain the necessary information and review the measure within a </text>
<text top=""489"" left=""108"" width=""184"" height=""16"" font=""0"">reasonable period of time. </text>
</p><p number=""54."" style=""6""><text top=""521"" left=""108"" width=""684"" height=""16"" font=""0"">54.  Argentina suggests in its responses to the Panel that a period of less than two years was </text>
<text top=""538"" left=""108"" width=""685"" height=""16"" font=""0"">""beyond what was reasonable"" in <i>Japan &#8211; Agricultural Products II</i>. However, Argentina fails to </text>
<text top=""554"" left=""108"" width=""686"" height=""16"" font=""0"">reference the Appellate Body's guidance that the assessment of what is reasonable must be </text>
<text top=""571"" left=""108"" width=""683"" height=""16"" font=""0"">conducted on a ""case-by-case"" basis. At issue in <i>Japan &#8211; Agricultural Products II</i> was whether a </text>
<text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">testing method used by Japan was appropriate. It appears to have been an experimental science </text>
<text top=""603"" left=""108"" width=""684"" height=""16"" font=""0"">issue, where the data was accessible.  That is quite a different set of circumstances from this </text>
<text top=""620"" left=""108"" width=""684"" height=""16"" font=""0"">dispute, in which the data is (1) not in the United States, (2) of substantial scientific scope and </text>
<text top=""636"" left=""108"" width=""690"" height=""16"" font=""0"">breadth including geographical information, internal and cross-border animal movements, </text>
<text top=""653"" left=""108"" width=""682"" height=""16"" font=""0"">quarantine processes, and veterinary infrastructure; and (3) only accessible with the permission of </text>
<text top=""669"" left=""108"" width=""354"" height=""16"" font=""0"">or provided by Argentina's regulatory authority.      </text>
</p><p number=""55."" style=""6""><text top=""702"" left=""108"" width=""685"" height=""16"" font=""0"">55.  In this dispute, collecting the necessary additional information is not easy. Exchanges of </text>
<text top=""718"" left=""108"" width=""683"" height=""16"" font=""0"">information between APHIS and SENASA need to be seen in context of the changing situations in </text>
<text top=""735"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina and on Argentina's own shifting requests for import authorization. First, Argentina </text>
<text top=""751"" left=""108"" width=""684"" height=""16"" font=""0"">wanted one review of the country for import authorization for fresh beef. Then it submitted an </text>
<text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">application for Patagonia South, which initiated a separate, new review process. During this time, </text>
<text top=""784"" left=""108"" width=""684"" height=""16"" font=""0"">there were two outbreaks of FMD in Argentina. Shortly afterwards, Argentina asked that a third </text>
<text top=""800"" left=""108"" width=""617"" height=""16"" font=""0"">area, Patagonia North B be reviewed, and then combined together with Patagonia South.  </text>
</p><p number=""56."" style=""6""><text top=""833"" left=""108"" width=""683"" height=""16"" font=""0"">56.  Even if one were to take the statement that all the information was in hand in April 2009, </text>
<text top=""850"" left=""108"" width=""683"" height=""16"" font=""0"">Article 5.7 clearly recognizes that a reasonable period of time is necessary to ""review the sanitary </text>
<text top=""866"" left=""108"" width=""683"" height=""16"" font=""0"">&#8230; measure."" Given the complex nature of the review, which is not simply whether FMD exists or </text>
<text top=""882"" left=""108"" width=""684"" height=""16"" font=""0"">not in the country, but is also whether the country has the capacity to maintain and to prevent </text>
<text top=""899"" left=""108"" width=""683"" height=""16"" font=""0"">future FMD incidents, the time elapsed is reasonable. The U.S. process is working, and the APHIS </text>
<text top=""915"" left=""108"" width=""480"" height=""16"" font=""0"">proposed determination of Patagonia as FMD-free demonstrates this.  </text>
</p><p number=""57."" style=""6""><text top=""948"" left=""108"" width=""684"" height=""16"" font=""0"">57.  Argentina argues that actions taken by the EU and documents issued with respect to the </text>
<text top=""964"" left=""108"" width=""687"" height=""16"" font=""0"">EU's own decisions on import authorization for Argentina's beef are ""particularly relevant."" </text>
<text top=""981"" left=""108"" width=""683"" height=""16"" font=""0"">However, the documents provided by Argentina are neither determinative of either the sufficiency </text>
<text top=""997"" left=""108"" width=""688"" height=""16"" font=""0"">of the scientific evidence or the applicable reasonable period of time with respect to the </text>
<text top=""1014"" left=""108"" width=""684"" height=""16"" font=""0"">United States because: (1) Argentina has not demonstrated that any conclusions reached by the </text>
<text top=""1030"" left=""108"" width=""682"" height=""16"" font=""0"">EU are applicable to the United States since it has not shown that the two Members have the same </text>
<text top=""1046"" left=""108"" width=""683"" height=""16"" font=""0"">appropriate level of protection; and (2) the documents themselves are reports and summaries of </text>
<text top=""1063"" left=""108"" width=""683"" height=""16"" font=""0"">site visits by EU authorities, for which the comprehensiveness is not clear and for which the raw </text>
<text top=""1079"" left=""108"" width=""147"" height=""16"" font=""0"">data is not available. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-45 - </text>
</p></p></page>
<page number=""55"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""F."" style=""1""><text top=""128"" left=""108"" width=""63"" height=""16"" font=""23"">F. T</text><text top=""131"" left=""171"" width=""20"" height=""13"" font=""29"">HE </text><text top=""128"" left=""194"" width=""11"" height=""16"" font=""23"">U</text><text top=""131"" left=""205"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""128"" left=""243"" width=""14"" height=""16"" font=""23""> S</text><text top=""131"" left=""257"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""128"" left=""301"" width=""10"" height=""16"" font=""23"">A</text><text top=""131"" left=""312"" width=""78"" height=""13"" font=""29"">PPLICATION </text><text top=""128"" left=""393"" width=""10"" height=""16"" font=""23"">S</text><text top=""131"" left=""403"" width=""43"" height=""13"" font=""29"">YSTEM </text><text top=""128"" left=""449"" width=""11"" height=""16"" font=""23"">H</text><text top=""131"" left=""460"" width=""19"" height=""13"" font=""29"">AS </text><text top=""128"" left=""483"" width=""10"" height=""16"" font=""23"">B</text><text top=""131"" left=""493"" width=""27"" height=""13"" font=""29"">EEN </text><text top=""128"" left=""523"" width=""10"" height=""16"" font=""23"">A</text><text top=""131"" left=""534"" width=""47"" height=""13"" font=""29"">PPLIED </text><text top=""128"" left=""585"" width=""9"" height=""16"" font=""23"">T</text><text top=""131"" left=""594"" width=""12"" height=""13"" font=""29"">O </text><text top=""128"" left=""610"" width=""10"" height=""16"" font=""23"">A</text><text top=""131"" left=""620"" width=""66"" height=""13"" font=""29"">RGENTINA </text><text top=""128"" left=""690"" width=""7"" height=""16"" font=""23"">I</text><text top=""131"" left=""697"" width=""13"" height=""13"" font=""29"">N </text><text top=""128"" left=""713"" width=""10"" height=""16"" font=""23"">A</text><text top=""128"" left=""731"" width=""13"" height=""16"" font=""23"">M</text><text top=""131"" left=""743"" width=""45"" height=""13"" font=""29"">ANNER </text><text top=""144"" left=""162"" width=""10"" height=""16"" font=""23"">C</text><text top=""147"" left=""172"" width=""72"" height=""13"" font=""29"">ONSISTENT </text><text top=""144"" left=""244"" width=""15"" height=""16"" font=""23"">W</text><text top=""147"" left=""259"" width=""25"" height=""13"" font=""29"">ITH </text><text top=""144"" left=""285"" width=""10"" height=""16"" font=""23"">A</text><text top=""147"" left=""295"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""144"" left=""338"" width=""14"" height=""16"" font=""23""> 8</text><text top=""147"" left=""352"" width=""33"" height=""13"" font=""29""> AND </text><text top=""144"" left=""385"" width=""10"" height=""16"" font=""23"">A</text><text top=""147"" left=""395"" width=""36"" height=""13"" font=""29"">NNEX </text><text top=""144"" left=""432"" width=""10"" height=""16"" font=""23"">C</text><text top=""144"" left=""445"" width=""11"" height=""16"" font=""23"">O</text><text top=""147"" left=""457"" width=""10"" height=""13"" font=""29"">F </text><text top=""144"" left=""467"" width=""9"" height=""16"" font=""23"">T</text><text top=""147"" left=""476"" width=""20"" height=""13"" font=""29"">HE </text><text top=""144"" left=""496"" width=""44"" height=""16"" font=""23"">SPS A</text><text top=""147"" left=""540"" width=""64"" height=""13"" font=""29"">GREEMENT</text></p><p number=""58."" style=""6""><text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">58.  Measures falling within the scope of Article 8 and Annex C do not include the determinations </text>
<text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">at issue in this dispute. The text of the SPS Agreement does not provide that determinations </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">involving disease-free areas of potential exporters are covered by Article 8. Argentina, however, </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">argues that Article 8 and Annex C(1) have a broad scope of coverage, suggesting that the </text>
<text top=""242"" left=""108"" width=""495"" height=""16"" font=""0"">determinations at issue in this dispute necessarily fall within that scope. </text>
</p><p number=""59."" style=""6""><text top=""275"" left=""108"" width=""684"" height=""16"" font=""0"">59.  Article 8 and Annex C apply specifically to ""control, inspection and approval procedures."" </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">Article 8 incorporates Annex C; its text must be taken into account when interpreting the scope of </text>
<text top=""308"" left=""108"" width=""683"" height=""16"" font=""0"">measures covered by Annex C. And Article 8 is clear that the types of measures covered in Annex </text>
<text top=""324"" left=""108"" width=""682"" height=""16"" font=""0"">C do not include every type of SPS procedure, but a limited class of procedures: namely, ""control, </text>
<text top=""341"" left=""108"" width=""688"" height=""16"" font=""0"">inspection and approval procedures."" In addition, the context provided by the substantive </text>
<text top=""357"" left=""108"" width=""686"" height=""16"" font=""0"">obligations contained in Annex C shows that the types of ""control, inspection, and approval </text>
<text top=""374"" left=""108"" width=""683"" height=""16"" font=""0"">procedures"" covered by Annex C pertain to the administration of such procedures with respect to </text>
<text top=""390"" left=""108"" width=""684"" height=""16"" font=""0"">products (and not with respect to all other SPS matters, such as determinations of disease-free </text>
<text top=""407"" left=""108"" width=""57"" height=""16"" font=""0"">status). </text>
</p><p number=""60."" style=""6""><text top=""439"" left=""108"" width=""682"" height=""16"" font=""0"">60.  The panel in <i>US &#8211; Poultry (China) </i>stopped short of accepting the view that the provisions of </text>
<text top=""456"" left=""108"" width=""682"" height=""16"" font=""0"">Article 8 and Annex C apply to all types of ""control, inspection, and approval procedures,"" deciding </text>
<text top=""472"" left=""108"" width=""682"" height=""16"" font=""0"">that it was unnecessary to define the whole universe of what falls within its scope. And indeed, the </text>
<text top=""489"" left=""108"" width=""640"" height=""16"" font=""0"">panel did not explain how such an interpretation could fit with the plain meaning of the text.  </text>
</p><p number=""61."" style=""6""><text top=""521"" left=""108"" width=""687"" height=""16"" font=""0"">61.  Argentina has failed to acknowledge the inherent differences between the procedures </text>
<text top=""538"" left=""108"" width=""684"" height=""16"" font=""0"">contemplated by Article 8 and Annex C(1) and the procedures at issue in this dispute. It simply </text>
<text top=""554"" left=""108"" width=""682"" height=""16"" font=""0"">argues that there are no limits to procedures falling under the scope of Article 8 and Annex C, and </text>
<text top=""571"" left=""108"" width=""688"" height=""16"" font=""0"">therefore the disease-status determinations must be subject to these provisions. However, </text>
<text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">accepting Argentina's construction would be problematic, as it would ignore that plain text of the </text>
<text top=""603"" left=""108"" width=""528"" height=""16"" font=""0"">SPS Agreement's limitation to ""control, inspection and approval"" procedures. </text>
</p><p number=""62."" style=""6""><text top=""636"" left=""108"" width=""684"" height=""16"" font=""0"">62.  Even if the Panel finds that the disease-free status determinations fall within the scope of </text>
<text top=""653"" left=""108"" width=""683"" height=""16"" font=""0"">Article 8 and Annex C, Argentina has failed to show that the United States has engaged in undue </text>
<text top=""669"" left=""108"" width=""683"" height=""16"" font=""0"">delay. The time taken by other Members to perform evaluations of a region's FMD situation and </text>
<text top=""685"" left=""108"" width=""682"" height=""16"" font=""0"">complete its procedure is not of special relevance to and dispositive of the Panel's determination of </text>
<text top=""702"" left=""108"" width=""687"" height=""16"" font=""0"">whether the United States engaged in undue delay in violation of Annex C(1)(a). First, the </text>
<text top=""718"" left=""108"" width=""682"" height=""16"" font=""0"">processing period itself is not indicative of whether a Member acted with undue delay. Second, the </text>
<text top=""735"" left=""108"" width=""685"" height=""16"" font=""0"">assessment of undue delay requires a consideration of the facts of the given dispute, not an </text>
<text top=""751"" left=""108"" width=""685"" height=""16"" font=""0"">abstract analysis. Third, as indicated above, Argentina has merely identified the time periods </text>
<text top=""767"" left=""108"" width=""686"" height=""16"" font=""0"">associated with its applications; Argentina has failed to show that these periods have been </text>
<text top=""784"" left=""108"" width=""682"" height=""16"" font=""0"">unjustified, and, furthermore, that the U.S. review period should have been similar to those taken </text>
<text top=""800"" left=""108"" width=""144"" height=""16"" font=""0"">by Chile and the EU. </text>
</p><p number=""G."" style=""1""><text top=""833"" left=""108"" width=""52"" height=""16"" font=""23"">G. T</text><text top=""836"" left=""160"" width=""20"" height=""13"" font=""29"">HE </text><text top=""833"" left=""179"" width=""11"" height=""16"" font=""23"">U</text><text top=""836"" left=""190"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""833"" left=""228"" width=""14"" height=""16"" font=""23""> S</text><text top=""836"" left=""242"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""833"" left=""283"" width=""11"" height=""16"" font=""23"">H</text><text top=""836"" left=""294"" width=""19"" height=""13"" font=""29"">AS </text><text top=""833"" left=""313"" width=""11"" height=""16"" font=""23"">N</text><text top=""836"" left=""325"" width=""20"" height=""13"" font=""29"">OT </text><text top=""833"" left=""345"" width=""10"" height=""16"" font=""23"">A</text><text top=""836"" left=""355"" width=""34"" height=""13"" font=""29"">CTED </text><text top=""833"" left=""389"" width=""7"" height=""16"" font=""23"">I</text><text top=""836"" left=""397"" width=""89"" height=""13"" font=""29"">NCONSISTENT </text><text top=""833"" left=""486"" width=""15"" height=""16"" font=""23"">W</text><text top=""836"" left=""501"" width=""25"" height=""13"" font=""29"">ITH </text><text top=""833"" left=""526"" width=""44"" height=""16"" font=""23"">SPS A</text><text top=""836"" left=""570"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""833"" left=""613"" width=""14"" height=""16"" font=""23""> 3</text></p><p number=""63."" style=""6""><text top=""866"" left=""108"" width=""686"" height=""16"" font=""0"">63.  The APHIS application system is clearly based on the OIE Terrestrial Code. Argentina's </text>
<text top=""882"" left=""108"" width=""683"" height=""16"" font=""0"">argument in response is based on the conclusory allegation of ""complete disharmony between the </text>
<text top=""899"" left=""108"" width=""687"" height=""16"" font=""0"">U.S. regulatory structure and the OIE."" Argentina cannot support this allegation. Argentina </text>
<text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">continues to conflate Article 3.1' ""based on"" requirement with the Article 3.2's different ""conform </text>
<text top=""932"" left=""108"" width=""683"" height=""16"" font=""0"">to"" concept. At most, Argentina points to some minor differences between the APHIS process and </text>
<text top=""948"" left=""108"" width=""682"" height=""16"" font=""0"">the OIE Code, and nothing that comes near to meeting Argentina's burden to show that the APHIS </text>
<text top=""964"" left=""108"" width=""274"" height=""16"" font=""0"">system is not ""based on"" the OIE Code. </text>
</p><p number=""64."" style=""6""><text top=""997"" left=""108"" width=""140"" height=""16"" font=""0"">64.  The United </text>
<text top=""997"" left=""239"" width=""561"" height=""16"" font=""0"">States notes that Argentina's argument is founded on an erroneous </text>
<text top=""1014"" left=""108"" width=""683"" height=""16"" font=""0"">interpretation of what it means to be <i>based on</i> the international standards, recommendations and </text>
<text top=""1030"" left=""108"" width=""684"" height=""16"" font=""0"">guidelines that is inconsistent with the guidance of the Appellate Body in <i>EC &#8211; Hormones</i>. The </text>
<text top=""1046"" left=""108"" width=""687"" height=""16"" font=""0"">Appellate Body explained that the requirement for a Member to base its SPS measure on </text>
<text top=""1063"" left=""108"" width=""638"" height=""16"" font=""0"">international standards does not require it to embody the international standard completely.  </text>
</p><p number=""65."" style=""6""><text top=""1096"" left=""108"" width=""687"" height=""16"" font=""0"">65.  Further, an SPS measure under Article 3.1 does not benefit from the presumption of </text>
<text top=""1112"" left=""108"" width=""683"" height=""16"" font=""0"">consistency with the relevant provisions of the SPS Agreement and the GATT 1994; however, the </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-46 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">complainant still must meet its burden &#8211; to show that the measure has not adopted some of the </text>
<text top=""144"" left=""108"" width=""271"" height=""16"" font=""0"">elements of the international standard. </text>
</p></p></page>
<page number=""56"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""66."" style=""6""><text top=""177"" left=""108"" width=""686"" height=""16"" font=""0"">66.  As the United States has observed, the relevant international standards, guidelines and </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">recommendations are contained in Chapters 1.6, 2.1 and 8.6 of the OIE Code. The United States </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">has demonstrated that the relevant sections of the APHIS application system are based on the </text>
<text top=""226"" left=""108"" width=""682"" height=""16"" font=""0"">relevant corresponding provisions of the OIE Terrestrial Code. The application process outlined at 9 </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">C.F.R. &#167;92.2(b) incorporates seven of the eight criteria contained in Article 1.6.5 of the OIE Code. </text>
<text top=""259"" left=""108"" width=""687"" height=""16"" font=""0"">The United States system also permits for re-instatement. This procedure is similar to the </text>
<text top=""275"" left=""108"" width=""682"" height=""16"" font=""0"">OIE process for the recovery of FMD-free status in Article 8.6.9 of the OIE Code. Under both APHIS </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">and the OIE systems, a region loses its FMD-free status upon experiencing an FMD outbreak, until </text>
<text top=""308"" left=""108"" width=""388"" height=""16"" font=""0"">its FMD situation is reassessed and its status reinstated. </text>
</p><p number=""67."" style=""6""><text top=""341"" left=""108"" width=""682"" height=""16"" font=""0"">67.   In light of Argentina's submissions, its argument under SPS Article 3.1 relies squarely on its </text>
<text top=""357"" left=""108"" width=""688"" height=""16"" font=""0"">proposition that the APHIS system for FMD status classification does not conform to the </text>
<text top=""374"" left=""108"" width=""687"" height=""16"" font=""0"">OIE approach in Chapter 8.6 of the OIE Code. Notwithstanding the fact that the approach </text>
<text top=""390"" left=""108"" width=""682"" height=""16"" font=""0"">advanced by Argentina is improper because an analysis under Article 3.1 should consider all of the </text>
<text top=""407"" left=""108"" width=""683"" height=""16"" font=""0"">relevant provisions of the international standard, the APHIS application system pertaining to FMD </text>
<text top=""423"" left=""108"" width=""172"" height=""16"" font=""0"">is based on Chapter 8.6. </text>
</p><p number=""68."" style=""6""><text top=""456"" left=""108"" width=""684"" height=""16"" font=""0"">68.  Argentina's position on the relevance of the OIE's FMD-free where vaccination is practiced </text>
<text top=""472"" left=""108"" width=""683"" height=""16"" font=""0"">designation is somewhat confusing. On the one hand, Argentina implies that the United States is </text>
<text top=""489"" left=""108"" width=""684"" height=""16"" font=""0"">not ""based on"" the relevant international standard of the OIE because APHIS regulations do not </text>
<text top=""505"" left=""108"" width=""684"" height=""16"" font=""0"">contain an express designation of FMD-free where vaccination is practiced. On the other hand, </text>
<text top=""521"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina ""is not challenging the U.S. standards and regulatory structure as such"" or ""contesting </text>
<text top=""538"" left=""108"" width=""682"" height=""16"" font=""0"">here as a legal matter the U.S. standard on vaccination."" The status of FMD-free where vaccination </text>
<text top=""554"" left=""108"" width=""684"" height=""16"" font=""0"">is practiced is not a legal matter before the Panel. Therefore, the FMD-free where vaccination is </text>
<text top=""571"" left=""108"" width=""682"" height=""16"" font=""0"">practiced designation is neither relevant to nor dispositive of the determination of whether the U.S </text>
<text top=""587"" left=""108"" width=""314"" height=""16"" font=""0"">approach to FMD is ""based on"" the OIE Code. </text>
</p><p number=""H."" style=""1""><text top=""620"" left=""108"" width=""52"" height=""16"" font=""23"">H. T</text><text top=""623"" left=""160"" width=""20"" height=""13"" font=""29"">HE </text><text top=""620"" left=""181"" width=""65"" height=""16"" font=""23"">OIE FMD</text><text top=""620"" left=""252"" width=""10"" height=""16"" font=""23"">S</text><text top=""623"" left=""262"" width=""42"" height=""13"" font=""29"">TATUS </text><text top=""620"" left=""306"" width=""10"" height=""16"" font=""23"">A</text><text top=""623"" left=""316"" width=""87"" height=""13"" font=""29"">TTRIBUTIONS </text><text top=""620"" left=""405"" width=""10"" height=""16"" font=""23"">A</text><text top=""623"" left=""415"" width=""19"" height=""13"" font=""29"">RE </text><text top=""620"" left=""436"" width=""11"" height=""16"" font=""23"">N</text><text top=""623"" left=""448"" width=""20"" height=""13"" font=""29"">OT </text><text top=""620"" left=""469"" width=""10"" height=""16"" font=""23"">S</text><text top=""623"" left=""479"" width=""65"" height=""13"" font=""29"">TANDARDS</text><text top=""620"" left=""544"" width=""5"" height=""16"" font=""23"">,</text><text top=""620"" left=""555"" width=""11"" height=""16"" font=""23"">G</text><text top=""623"" left=""566"" width=""94"" height=""13"" font=""29"">UIDELINES OR </text><text top=""620"" left=""660"" width=""11"" height=""16"" font=""23"">R</text><text top=""623"" left=""670"" width=""118"" height=""13"" font=""29"">ECOMMENDATIONS </text><text top=""636"" left=""108"" width=""9"" height=""16"" font=""23"">F</text><text top=""639"" left=""117"" width=""21"" height=""13"" font=""29"">OR </text><text top=""636"" left=""138"" width=""9"" height=""16"" font=""23"">T</text><text top=""639"" left=""147"" width=""20"" height=""13"" font=""29"">HE </text><text top=""636"" left=""166"" width=""10"" height=""16"" font=""23"">P</text><text top=""639"" left=""176"" width=""59"" height=""13"" font=""29"">URPOSES </text><text top=""636"" left=""235"" width=""11"" height=""16"" font=""23"">O</text><text top=""639"" left=""247"" width=""10"" height=""13"" font=""29"">F </text><text top=""636"" left=""257"" width=""10"" height=""16"" font=""23"">A</text><text top=""639"" left=""268"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""636"" left=""310"" width=""14"" height=""16"" font=""23""> 3</text><text top=""636"" left=""328"" width=""11"" height=""16"" font=""23"">O</text><text top=""639"" left=""339"" width=""10"" height=""13"" font=""29"">F </text><text top=""636"" left=""350"" width=""9"" height=""16"" font=""23"">T</text><text top=""639"" left=""359"" width=""20"" height=""13"" font=""29"">HE </text><text top=""636"" left=""379"" width=""44"" height=""16"" font=""23"">SPS A</text><text top=""639"" left=""423"" width=""68"" height=""13"" font=""29"">GREEMENT</text> </p><p number=""69."" style=""6""><text top=""669"" left=""108"" width=""686"" height=""16"" font=""0"">69.  The United States has observed, and Argentina agrees, that a standard, guideline and </text>
<text top=""685"" left=""108"" width=""683"" height=""16"" font=""0"">recommendation encompass the same concept representing the international approach within the </text>
<text top=""702"" left=""108"" width=""687"" height=""16"" font=""0"">context of the SPS Agreement. Notwithstanding this understanding, the Panel may derive a </text>
<text top=""718"" left=""108"" width=""684"" height=""16"" font=""0"">complete understanding of the terms ""standard,"" ""guideline,"" and ""recommendation"" within the </text>
<text top=""735"" left=""108"" width=""521"" height=""16"" font=""0"">context of the SPS Agreement through understanding the terms as defined. </text>
</p><p number=""70."" style=""6""><text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">70.  The common denominator for these three terms is the sense that the United States has put </text>
<text top=""784"" left=""108"" width=""689"" height=""16"" font=""0"">forward: that standards, guidelines, and recommendations are not the conclusion of the </text>
<text top=""800"" left=""108"" width=""683"" height=""16"" font=""0"">application of country-specific facts to rules or norms. That understanding can be satisfied by all </text>
<text top=""817"" left=""108"" width=""307"" height=""16"" font=""0"">three terms. Argentina's contention cannot.  </text>
</p><p number=""71."" style=""6""><text top=""850"" left=""108"" width=""684"" height=""16"" font=""0"">71.  Based on these definitions and the understanding of the terms within the context of the </text>
<text top=""866"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Agreement, it is evident that the OIE Terrestrial Animal Health Code is the system that guides </text>
<text top=""882"" left=""108"" width=""688"" height=""16"" font=""0"">and directs Members on the OIE's recommended approach to FMD, not a list of status </text>
<text top=""899"" left=""108"" width=""95"" height=""16"" font=""0"">designations. </text>
</p><p number=""I."" style=""0""><text top=""932"" left=""108"" width=""52"" height=""16"" font=""23"">I. T</text><text top=""935"" left=""160"" width=""20"" height=""13"" font=""29"">HE </text><text top=""932"" left=""179"" width=""11"" height=""16"" font=""23"">U</text><text top=""935"" left=""190"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""932"" left=""228"" width=""14"" height=""16"" font=""23""> S</text><text top=""935"" left=""242"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""932"" left=""283"" width=""11"" height=""16"" font=""23"">H</text><text top=""935"" left=""294"" width=""19"" height=""13"" font=""29"">AS </text><text top=""932"" left=""313"" width=""11"" height=""16"" font=""23"">N</text><text top=""935"" left=""325"" width=""20"" height=""13"" font=""29"">OT </text><text top=""932"" left=""345"" width=""10"" height=""16"" font=""23"">A</text><text top=""935"" left=""355"" width=""34"" height=""13"" font=""29"">CTED </text><text top=""932"" left=""389"" width=""7"" height=""16"" font=""23"">I</text><text top=""935"" left=""397"" width=""89"" height=""13"" font=""29"">NCONSISTENT </text><text top=""932"" left=""486"" width=""15"" height=""16"" font=""23"">W</text><text top=""935"" left=""501"" width=""25"" height=""13"" font=""29"">ITH </text><text top=""932"" left=""526"" width=""10"" height=""16"" font=""23"">A</text><text top=""935"" left=""536"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""932"" left=""579"" width=""33"" height=""16"" font=""23""> 3.3 </text></p><p number=""72."" style=""6""><text top=""964"" left=""108"" width=""683"" height=""16"" font=""0"">72.  Article 3.3 authorizes Members to introduce and maintain SPS measures based on scientific </text>
<text top=""981"" left=""108"" width=""683"" height=""16"" font=""0"">justification. The United States' regulatory approach to FMD is based on the relevant provisions of </text>
<text top=""997"" left=""108"" width=""684"" height=""16"" font=""0"">the OIE Code. As applied to Argentina, APHIS is currently performing its scientific evaluation to </text>
<text top=""1014"" left=""108"" width=""683"" height=""16"" font=""0"">determine the FMD situation in the regions requested by Argentina. However, because APHIS has </text>
<text top=""1030"" left=""108"" width=""683"" height=""16"" font=""0"">not concluded its scientific evaluation of Argentina's requests, it has not come to a final resolution </text>
<text top=""1046"" left=""108"" width=""683"" height=""16"" font=""0"">of its process. Therefore, Article 3.3 is not applicable in this matter, and consequently, Argentina </text>
<text top=""1063"" left=""108"" width=""683"" height=""16"" font=""0"">has failed to demonstrate that the United States has acted inconsistent with its obligations under </text>
<text top=""1079"" left=""108"" width=""256"" height=""16"" font=""0"">this provision of the SPS Agreement. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-47 - </text>
</p></p></page>
<page number=""57"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""J."" style=""1""><text top=""128"" left=""108"" width=""55"" height=""16"" font=""23"">J. M</text><text top=""131"" left=""163"" width=""104"" height=""13"" font=""29"">EASURES BY THE </text><text top=""128"" left=""267"" width=""11"" height=""16"" font=""23"">U</text><text top=""131"" left=""278"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""128"" left=""316"" width=""14"" height=""16"" font=""23""> S</text><text top=""131"" left=""330"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""128"" left=""371"" width=""10"" height=""16"" font=""23"">A</text><text top=""131"" left=""381"" width=""19"" height=""13"" font=""29"">RE </text><text top=""128"" left=""400"" width=""10"" height=""16"" font=""23"">C</text><text top=""131"" left=""410"" width=""109"" height=""13"" font=""29"">ONSISTENT WITH </text><text top=""128"" left=""519"" width=""10"" height=""16"" font=""23"">A</text><text top=""131"" left=""530"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""128"" left=""572"" width=""29"" height=""16"" font=""23""> 5.6</text></p><p number=""73."" style=""6""><text top=""160"" left=""108"" width=""685"" height=""16"" font=""0"">73.  It cannot be ""more trade restrictive than required"" when a Member takes a provisional </text>
<text top=""177"" left=""108"" width=""686"" height=""16"" font=""0"">measure to review an assertion by another Member of its disease status in accordance with </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">Articles 5.7 and 6. This is not, as Argentina alleges, a ""a de facto 'zero risk level.'"" As discussed </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">above, Article 5.7 and Article 6 contemplate a process in which product is not imported prior to the </text>
<text top=""226"" left=""108"" width=""684"" height=""16"" font=""0"">completion of the review of the exporting Member's assertion of disease status. This is entirely </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">consistent with the OIE's own approach to its FMD list designations, in which a designation is not </text>
<text top=""259"" left=""108"" width=""690"" height=""16"" font=""0"">attributed until the review of the applying Member's dossier. In other words, as the </text>
<text top=""275"" left=""108"" width=""685"" height=""16"" font=""0"">OIE emphasizes: ""[b]efore trade in animals or their products may occur, an importing country </text>
<text top=""292"" left=""108"" width=""540"" height=""16"" font=""0"">must be satisfied that its animal health status will be appropriately protected."" </text>
</p><p number=""74."" style=""6""><text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">74.  The United States has explained that animals and animal products that are vaccinated still </text>
<text top=""341"" left=""108"" width=""684"" height=""16"" font=""0"">pose an FMD threat that does not meet the appropriate level of protection of the United States. </text>
<text top=""357"" left=""108"" width=""683"" height=""16"" font=""0"">Article 8.6.23 of the OIE Code addresses the export of fresh meat of cattle for ""FMD free country </text>
<text top=""374"" left=""108"" width=""683"" height=""16"" font=""0"">or zones where vaccination is practiced"" and essentially treats such meat the same as meat from </text>
<text top=""390"" left=""108"" width=""684"" height=""16"" font=""0"">FMD free countries without vaccination&#8212;that is, without any conditions. The United States finds </text>
<text top=""407"" left=""108"" width=""677"" height=""16"" font=""0"">that this treatment does not achieve the appropriate level of protection in which imports of FMD-</text>
<text top=""423"" left=""108"" width=""684"" height=""16"" font=""0"">susceptible animals and animal products must be safe, meaning they must not introduce into or </text>
<text top=""439"" left=""108"" width=""359"" height=""16"" font=""0"">disseminate within the United States the FMD virus. </text>
</p><p number=""75."" style=""6""><text top=""472"" left=""108"" width=""684"" height=""16"" font=""0"">75.  Accordingly, OIE guidelines should not be considered as achieving the appropriate level of </text>
<text top=""489"" left=""108"" width=""219"" height=""16"" font=""0"">protection of the United States. </text>
</p><p number=""76."" style=""6""><text top=""521"" left=""108"" width=""27"" height=""16"" font=""0"">76. </text>
<text top=""521"" left=""154"" width=""637"" height=""16"" font=""0"">Argentina has asserted in this litigation that the mitigation protocols that apply to Uruguay </text>
<text top=""538"" left=""108"" width=""685"" height=""16"" font=""0"">are appropriate for Argentina because the sanitary situations are ""similar."" It makes the same </text>
<text top=""554"" left=""108"" width=""433"" height=""16"" font=""0"">argument with respect to Santa Catarina and Patagonia South. </text>
</p><p number=""77."" style=""6""><text top=""587"" left=""108"" width=""682"" height=""16"" font=""0"">77.  Simply because two items are considered ""the same"" for purposes of one set of criteria does </text>
<text top=""603"" left=""108"" width=""381"" height=""16"" font=""0"">not mean that they are in fact identical, or even close.  </text>
</p><p number=""78."" style=""6""><text top=""636"" left=""108"" width=""683"" height=""16"" font=""0"">78.  Argentina further argues that the OIE status ""has probative value"" and that ""Members can </text>
<text top=""653"" left=""108"" width=""682"" height=""16"" font=""0"">and do reasonably rely"" on that status. Regardless of the accuracy of these assertions, Argentina's </text>
<text top=""669"" left=""108"" width=""685"" height=""16"" font=""0"">argument does not establish that a particular OIE designation should necessarily be accepted, </text>
<text top=""685"" left=""108"" width=""684"" height=""16"" font=""0"">without any further review, by the United States or any other Member. As noted, given that the </text>
<text top=""702"" left=""108"" width=""686"" height=""16"" font=""0"">OIE designation is not useful in evaluating finer gradations of risk than that entailed by the </text>
<text top=""718"" left=""108"" width=""683"" height=""16"" font=""0"">particular OIE disease status, the OIE designation is not conclusive as to whether a measure that </text>
<text top=""735"" left=""108"" width=""662"" height=""16"" font=""0"">made use of that OIE status would meet the importing Member's appropriate level of protection. </text>
</p><p number=""79."" style=""6""><text top=""767"" left=""108"" width=""682"" height=""16"" font=""0"">79.  Argentina also asserts that the Uruguay conditions apply to it since (1) the conditions under </text>
<text top=""784"" left=""108"" width=""683"" height=""16"" font=""0"">which product from Uruguay enters the United States is similar to the conditions in the OIE Code </text>
<text top=""800"" left=""108"" width=""683"" height=""16"" font=""0"">at Article 8.6.25 that apply to FMD-affected regions that have an official control program, and (2) </text>
<text top=""817"" left=""108"" width=""682"" height=""16"" font=""0"">that because the rest of Argentina has an FMD-free with vaccination designation, it necessarily has </text>
<text top=""833"" left=""108"" width=""516"" height=""16"" font=""0"">a better situation than FMD-affected areas with an official control program. </text>
</p><p number=""80."" style=""6""><text top=""866"" left=""108"" width=""683"" height=""16"" font=""0"">80.  This argument is additionally unsound because OIE Code Article 8.6.25 does not contain the </text>
<text top=""882"" left=""108"" width=""549"" height=""16"" font=""0"">same conditions under which Uruguay can export product to the United States.  </text>
</p><p number=""81."" style=""6""><text top=""915"" left=""108"" width=""685"" height=""16"" font=""0"">81.  Accordingly, Argentina cannot simply state that because it has the OIE's designation for </text>
<text top=""932"" left=""108"" width=""682"" height=""16"" font=""0"">FMD-free with vaccination status, that it must, <i>a fortiori</i>,  be  able  to  meet  the  standard  for  a </text>
<text top=""948"" left=""108"" width=""684"" height=""16"" font=""0"">""lower"" status such as OIE Code Article 8.6.25, and that therefore, it must be able to meet the </text>
<text top=""964"" left=""108"" width=""684"" height=""16"" font=""0"">conditions extended to Uruguay, for the simple reason that the conditions extended to Uruguay </text>
<text top=""981"" left=""108"" width=""384"" height=""16"" font=""0"">are not the same conditions as OIE Code Article 8.6.25. </text>
</p><p number=""K."" style=""1""><text top=""1014"" left=""108"" width=""53"" height=""16"" font=""23"">K. A</text><text top=""1017"" left=""161"" width=""66"" height=""13"" font=""29"">RGENTINA </text><text top=""1014"" left=""228"" width=""11"" height=""16"" font=""23"">H</text><text top=""1017"" left=""239"" width=""19"" height=""13"" font=""29"">AS </text><text top=""1014"" left=""259"" width=""9"" height=""16"" font=""23"">F</text><text top=""1017"" left=""268"" width=""40"" height=""13"" font=""29"">AILED </text><text top=""1014"" left=""309"" width=""9"" height=""16"" font=""23"">T</text><text top=""1017"" left=""318"" width=""13"" height=""13"" font=""29"">O </text><text top=""1014"" left=""331"" width=""9"" height=""16"" font=""23"">E</text><text top=""1017"" left=""340"" width=""63"" height=""13"" font=""29"">STABLISH </text><text top=""1014"" left=""404"" width=""9"" height=""16"" font=""23"">T</text><text top=""1017"" left=""413"" width=""28"" height=""13"" font=""29"">HAT </text><text top=""1014"" left=""441"" width=""9"" height=""16"" font=""23"">T</text><text top=""1017"" left=""451"" width=""20"" height=""13"" font=""29"">HE </text><text top=""1014"" left=""471"" width=""11"" height=""16"" font=""23"">U</text><text top=""1017"" left=""482"" width=""38"" height=""13"" font=""29"">NITED</text><text top=""1014"" left=""519"" width=""14"" height=""16"" font=""23""> S</text><text top=""1017"" left=""534"" width=""41"" height=""13"" font=""29"">TATES </text><text top=""1014"" left=""575"" width=""11"" height=""16"" font=""23"">H</text><text top=""1017"" left=""586"" width=""19"" height=""13"" font=""29"">AS </text><text top=""1014"" left=""606"" width=""10"" height=""16"" font=""23"">A</text><text top=""1017"" left=""617"" width=""34"" height=""13"" font=""29"">CTED </text><text top=""1014"" left=""651"" width=""7"" height=""16"" font=""23"">I</text><text top=""1017"" left=""659"" width=""89"" height=""13"" font=""29"">NCONSISTENT </text><text top=""1014"" left=""748"" width=""15"" height=""16"" font=""23"">W</text><text top=""1017"" left=""763"" width=""25"" height=""13"" font=""29"">ITH </text><text top=""1030"" left=""151"" width=""10"" height=""16"" font=""23"">A</text><text top=""1033"" left=""161"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""1030"" left=""204"" width=""29"" height=""16"" font=""23""> 2.3</text></p><p number=""82."" style=""6""><text top=""1063"" left=""108"" width=""683"" height=""16"" font=""0"">82.  To establish that the United States has acted inconsistent with Article 2.3, Argentina carries </text>
<text top=""1079"" left=""108"" width=""683"" height=""16"" font=""0"">the burden of showing that: (1) the measure discriminates between territories of Members other </text>
<text top=""1096"" left=""108"" width=""684"" height=""16"" font=""0"">than the Member imposing the measure; (2) the discrimination is arbitrary or unjustifiable; and </text>
<text top=""1112"" left=""108"" width=""683"" height=""16"" font=""0"">(3) identical or similar conditions prevail in the territory of Members compared. Argentina has not </text>
<text top=""1128"" left=""108"" width=""291"" height=""16"" font=""0"">met its burden of proving these elements. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- B-48 - </text>
</p></p></page>
<page number=""58"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""83."" style=""6""><text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">83.  Argentina has maintained that the United States has acted inconsistent with Article 2.3, </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">alleging that the United States has applied its regulations in a contrary manner to Argentina as </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">compared to other Members. However, Argentina has failed to establish that identical or similar </text>
<text top=""193"" left=""108"" width=""687"" height=""16"" font=""0"">conditions prevail. The OIE's FMD status designations reflect that (1) the OIE has accepted </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">documentary evidence of a region's record of regular and prompt animal disease reporting, FMD </text>
<text top=""226"" left=""108"" width=""684"" height=""16"" font=""0"">surveillance and regulatory measures for early detection; (2) there have been no reported FMD </text>
<text top=""242"" left=""108"" width=""685"" height=""16"" font=""0"">outbreaks, evidence of FMDV infections or vaccination against FMD in the preceding 12 month </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">period; and (3) the OIE is comfortable with the detailed description of the region's boundaries and </text>
<text top=""275"" left=""108"" width=""687"" height=""16"" font=""0"">protection zones, if applicable. These factors do not consider additional, important regional </text>
<text top=""292"" left=""108"" width=""687"" height=""16"" font=""0"">dynamics, including whether the region accepts imports from FMD-infected regions and the </text>
<text top=""308"" left=""108"" width=""545"" height=""16"" font=""0"">veterinary services' capacity to detect, prevent and control the spread of FMD.  </text>
</p><p><text top=""357"" left=""374"" width=""149"" height=""16"" font=""23"">_______________ </text></p></page>
<page number=""59"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- C-1 - </text>
</p><p><text top=""164"" left=""413"" width=""72"" height=""16"" font=""26"">ANNEX C </text></p><p><text top=""198"" left=""336"" width=""226"" height=""16"" font=""6"">ARGUMENTS OF THIRD PARTIES </text>
</p><p><text top=""242"" left=""372"" width=""64"" height=""15"" font=""27"">Contents </text><text top=""242"" left=""732"" width=""37"" height=""15"" font=""27"">Page </text><footnote top=""257"" left=""108"" width=""68"" height=""15"" font=""11"" number=""1"" ref="""" dis=""""><ftext top=""1111"" left=""155"" width=""410"" height=""15"" font=""11""> Argentina's first written submission, paras. 185-206 and 415-428. </ftext>
</footnote>
</p><p><text top=""257"" left=""212"" width=""372"" height=""15"" font=""11"">Integrated executive summary of the arguments of Australia </text>
<footnote top=""257"" left=""738"" width=""26"" height=""15"" font=""11"" number=""2"" ref="""" dis=""""/>
<text top=""271"" left=""737"" width=""26"" height=""15"" font=""11"">C-6 </text>
<footnote top=""286"" left=""108"" width=""67"" height=""15"" font=""11"" number=""3"" ref="""" dis=""""/>
<text top=""286"" left=""212"" width=""353"" height=""15"" font=""11"">Integrated executive summary of the arguments of China </text>
<text top=""286"" left=""738"" width=""26"" height=""15"" font=""11"">C-9 </text>
<text top=""301"" left=""108"" width=""68"" height=""15"" font=""11"">Annex C-4 </text>
<text top=""301"" left=""212"" width=""438"" height=""15"" font=""11"">Integrated executive summary of the arguments of the European Union </text>
<text top=""301"" left=""734"" width=""33"" height=""15"" font=""11"">C-13 </text>
</p></page>
<page number=""60"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- C-2 - </text>
</p><p><text top=""164"" left=""405"" width=""88"" height=""16"" font=""26"">ANNEX C-1 </text></p><p><text top=""198"" left=""198"" width=""501"" height=""16"" font=""6"">INTEGRATED EXECUTIVE SUMMARY OF THE ARGUMENTS OF AUSTRALIA </text>
</p><p number=""I."" style=""0""><text top=""241"" left=""108"" width=""22"" height=""16"" font=""23"">I. </text><text top=""241"" left=""151"" width=""644"" height=""16"" font=""23"">ARTICLE 3 OF THE SPS AGREEMENT &#8211; RECOGNITION OF THE RIGHT OF WTO </text><text top=""258"" left=""151"" width=""545"" height=""16"" font=""23"">MEMBERS TO DETERMINE THEIR APPROPRIATE LEVEL OF PROTECTION </text></p><p number=""1."" style=""6""><text top=""291"" left=""108"" width=""19"" height=""16"" font=""0"">1. </text>
<text top=""291"" left=""151"" width=""640"" height=""16"" font=""0"">In its first written submission, Argentina argues that application of the ""US Measure against </text>
<text top=""307"" left=""108"" width=""683"" height=""16"" font=""0"">Argentine Beef"" is inconsistent with Article 3.1 because it is not based on international standards </text>
<text top=""323"" left=""108"" width=""368"" height=""16"" font=""0"">and is not otherwise justified by the SPS agreement.  </text>
</p><p number=""2."" style=""6""><text top=""356"" left=""108"" width=""20"" height=""16"" font=""0"">2. </text>
<text top=""356"" left=""151"" width=""641"" height=""16"" font=""0"">The same argument is made in relation to the United States' 2001 Regulations and also in </text>
<text top=""373"" left=""108"" width=""686"" height=""16"" font=""0"">relation to the prohibitions on imports of animals, meat and other animal products from the </text>
<text top=""389"" left=""108"" width=""119"" height=""16"" font=""0"">Patagonia region.</text>
<p><text top=""1126"" left=""155"" width=""441"" height=""15"" font=""11""> Appellate Body Report, <i>US/Canada &#8211; Continued Suspension, </i>para. 692. </text>
<text top=""1140"" left=""155"" width=""316"" height=""15"" font=""11""> Appellate Body Report, <i>EC &#8211; Hormones, </i>para. 165. </text>
</p><p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- C-3 - </text>
</p></p></page>
<page number=""61"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7."" style=""6""><text top=""128"" left=""108"" width=""18"" height=""16"" font=""0"">7. </text>
<text top=""128"" left=""151"" width=""400"" height=""16"" font=""0"">The Appellate Body further stated in <i>EC &#8211; Hormones</i> that: </text>
<p><text top=""160"" left=""151"" width=""597"" height=""16"" font=""0"">The ultimate goal of the harmonization of SPS measures is to prevent the use of such </text>
<text top=""177"" left=""151"" width=""602"" height=""16"" font=""0"">measures for arbitrary or unjustifiable discrimination between Members or as a </text>
<text top=""193"" left=""151"" width=""604"" height=""16"" font=""0"">disguised restriction on international trade, without preventing Members from </text>
<text top=""210"" left=""151"" width=""598"" height=""16"" font=""0"">adopting or enforcing measures which are both ""necessary to protect"" human life or </text>
<text top=""226"" left=""151"" width=""597"" height=""16"" font=""0"">health and ""based on scientific principles"", and without requiring them to change their </text>
<text top=""242"" left=""151"" width=""210"" height=""16"" font=""0"">appropriate level of protection.</text>
<footnote top=""241"" left=""361"" width=""6"" height=""11"" font=""15"" number=""4"" ref="""" dis=""""/>
</p></p><p number=""8."" style=""6""><text top=""277"" left=""108"" width=""19"" height=""16"" font=""0"">8. </text>
<text top=""277"" left=""151"" width=""640"" height=""16"" font=""0"">Australia considers that these findings of the Appellate Body appropriately reflect the object </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">and purpose of Article 3 of the SPS Agreement, particularly with regard to the role to be played by </text>
<text top=""310"" left=""108"" width=""505"" height=""16"" font=""0"">each WTO Member in determining its own appropriate level of protection. </text>
</p><p number=""II."" style=""0""><text top=""342"" left=""108"" width=""684"" height=""16"" font=""23"">II.  ARTICLE 3 OF THE SPS AGREEMENT &#8211; THE DISTINCTION BETWEEN ""BASED ON"" </text><text top=""359"" left=""151"" width=""653"" height=""16"" font=""23"">AND ""CONFORMING TO"" INTERNATIONAL STANDARDS, GUIDELINES OR </text><text top=""375"" left=""151"" width=""163"" height=""16"" font=""23"">RECOMMENDATIONS </text></p><p number=""9."" style=""6""><text top=""408"" left=""108"" width=""18"" height=""16"" font=""0"">9. </text>
<text top=""408"" left=""151"" width=""639"" height=""16"" font=""0"">Both parties have commented in their written submissions on the wording used in Article 3.1 </text>
<text top=""425"" left=""108"" width=""685"" height=""16"" font=""0"">of the SPS Agreement, which requires Members to base their SPS measures on ""international </text>
<text top=""441"" left=""108"" width=""683"" height=""16"" font=""0"">standards, guidelines or recommendations, where they exist, except as otherwise provided for in </text>
<text top=""457"" left=""108"" width=""340"" height=""16"" font=""0"">this Agreement and in particular in paragraph 3"". </text>
</p><p number=""10."" style=""6""><text top=""490"" left=""108"" width=""683"" height=""16"" font=""0"">10.  Argentina has argued that the application of the ""US Measure against Argentine Beef"", the </text>
<text top=""507"" left=""108"" width=""687"" height=""16"" font=""0"">United States' 2001 Regulations and the ""US Patagonia measure"" are all inconsistent with </text>
<text top=""523"" left=""108"" width=""683"" height=""16"" font=""0"">Article 3.1 because they are not based on international standards and are not otherwise justified </text>
<text top=""539"" left=""108"" width=""159"" height=""16"" font=""0"">by the SPS Agreement.</text>
<footnote top=""538"" left=""267"" width=""6"" height=""11"" font=""15"" number=""5"" ref="""" dis=""""><ftext top=""1111"" left=""155"" width=""410"" height=""15"" font=""11""> Argentina's first written submission, paras. 185-206 and 415-428. </ftext>
</footnote>
</p><p number=""11."" style=""6""><text top=""572"" left=""108"" width=""77"" height=""16"" font=""0"">11. In </text>
<text top=""572"" left=""172"" width=""620"" height=""16"" font=""8""><i>EC &#8211; Hormones</i>, the Appellate Body clarified what it means to say that Members shall </text>
<text top=""589"" left=""108"" width=""566"" height=""16"" font=""8""><i>base</i> their measures on international standards, guidelines and recommendations: </text>
<p><text top=""621"" left=""151"" width=""600"" height=""16"" font=""0"">&#8230; the ordinary meaning of ""based on"" is quite different from the plain or natural </text>
<text top=""638"" left=""151"" width=""597"" height=""16"" font=""0"">import of ""conform to"". A thing is commonly said to be ""based on"" another thing when </text>
<text top=""654"" left=""151"" width=""598"" height=""16"" font=""0"">the former ""stands"" or is ""founded"" or ""built"" upon or ""is supported by"" the latter. In </text>
<text top=""671"" left=""151"" width=""598"" height=""16"" font=""0"">contrast, much more is required before one thing may be regarded as ""conform[ing] </text>
<text top=""687"" left=""151"" width=""600"" height=""16"" font=""0"">to"" another: the former must ""comply with"", ""yield or show compliance"" with the </text>
<text top=""703"" left=""151"" width=""41"" height=""16"" font=""0"">latter.</text>
<footnote top=""702"" left=""192"" width=""6"" height=""11"" font=""15"" number=""6"" ref="""" dis=""""><ftext top=""979"" left=""534"" width=""8"" height=""9"" font=""11"">th</ftext>
<ftext top=""980"" left=""542"" width=""224"" height=""15"" font=""11""> ed.), Volume 2 N-Z, 2007, p. 2521. </ftext>
</footnote>
</p></p><p number=""12."" style=""6""><text top=""738"" left=""108"" width=""683"" height=""16"" font=""0"">12.  Australia is also of the view that there is a distinction between the term ""based on"" and the </text>
<text top=""754"" left=""108"" width=""506"" height=""16"" font=""0"">term ""conform to"". In our view, ""conform to"" imposes a higher standard.  </text>
</p><p number=""III."" style=""0""><text top=""787"" left=""108"" width=""688"" height=""16"" font=""23"">III.  WHETHER ARTICLE 5.4 OF THE SPS AGREEMENT IMPOSES AN AFFIRMATIVE </text><text top=""803"" left=""151"" width=""103"" height=""16"" font=""23"">OBLIGATION </text></p><p number=""13."" style=""6""><text top=""836"" left=""108"" width=""324"" height=""16"" font=""0"">13.  Article 5.4 of the SPS Agreement states: </text>
<p><text top=""869"" left=""151"" width=""598"" height=""16"" font=""0"">Members should, when determining the appropriate level of sanitary or phytosanitary </text>
<text top=""886"" left=""151"" width=""552"" height=""16"" font=""0"">protection, take into account the objective of minimizing negative trade effects.  </text>
</p></p><p number=""14."" style=""6""><text top=""920"" left=""108"" width=""375"" height=""16"" font=""0"">14.  In its first written submission, Argentina stated: </text>
<p><text top=""953"" left=""151"" width=""602"" height=""16"" font=""0"">&#8230; Argentina respectfully disagrees with any conclusion that Article 5.4 does not </text>
<text top=""969"" left=""151"" width=""598"" height=""16"" font=""0"">impose an affirmative obligation. The drafters of the treaty would not have inserted a </text>
<text top=""986"" left=""151"" width=""441"" height=""16"" font=""0"">paragraph in the middle of Article 5 that had no operative effect.</text>
<footnote top=""984"" left=""592"" width=""6"" height=""11"" font=""15"" number=""7"" ref="""" dis=""""/>
</p></p><p number=""15."" style=""6""><text top=""1020"" left=""108"" width=""614"" height=""16"" font=""0"">15.  With respect to this issue, Australia disagrees. The panel in <i>EC &#8211; Hormones </i>stated: </text>
<p><text top=""1096"" left=""155"" width=""316"" height=""15"" font=""11""> Appellate Body Report, <i>EC &#8211; Hormones, </i>para. 177. </text>
</p><p><text top=""1126"" left=""155"" width=""316"" height=""15"" font=""11""> Appellate Body Report, <i>EC &#8211; Hormones, </i>para. 163. </text>
<text top=""1140"" left=""155"" width=""293"" height=""15"" font=""11""> Argentina's first written submission, para. 293. </text>
</p><p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- C-4 - </text>
</p><p><text top=""128"" left=""151"" width=""597"" height=""16"" font=""0"">Guided by the wording of Article 5.4, in particular the words ""should"" (not ""shall"") and </text>
<text top=""144"" left=""151"" width=""597"" height=""16"" font=""0"">""objective"", we consider that this provision of the SPS Agreement does not impose an </text>
<text top=""160"" left=""151"" width=""71"" height=""16"" font=""0"">obligation.</text>
<footnote top=""159"" left=""222"" width=""6"" height=""11"" font=""15"" number=""8"" ref="""" dis=""""><ftext top=""951"" left=""155"" width=""260"" height=""15"" font=""11""> Panel Report, <i>EC-Hormones, </i>para. 8.169. </ftext>
</footnote>
</p></p></page>
<page number=""62"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""16."" style=""6""><text top=""195"" left=""108"" width=""636"" height=""16"" font=""0"">16.  As such, Australia considers that Article 5.4 does not impose an affirmative obligation. </text>
</p><p number=""IV."" style=""0""><text top=""228"" left=""108"" width=""641"" height=""16"" font=""23"">IV.  ARTICLE 5.7 AND THE INSUFFICIENCY OF ""RELEVANT SCIENTIFIC EVIDENCE"" </text></p><p number=""17."" style=""6""><text top=""260"" left=""108"" width=""690"" height=""16"" font=""0"">17.  To be able to adopt or maintain a provisional measure under Article 5.7 of the </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">SPS Agreement, a Member must fulfil the four cumulative criteria set out under that provision. </text>
<text top=""293"" left=""108"" width=""86"" height=""16"" font=""0"">Specifically: </text>
</p><p number=""(i)"" style=""3""><text top=""326"" left=""151"" width=""21"" height=""16"" font=""0"">(i) </text>
<text top=""326"" left=""193"" width=""567"" height=""16"" font=""0"">The measure can only be imposed when relevant scientific evidence is insufficient; </text>
</p><p number=""(ii)"" style=""3""><text top=""359"" left=""151"" width=""24"" height=""16"" font=""0"">(ii) </text>
<text top=""359"" left=""193"" width=""499"" height=""16"" font=""0"">The measure must be adopted based on available pertinent information; </text>
</p><p number=""(iii)"" style=""3""><text top=""392"" left=""151"" width=""640"" height=""16"" font=""0"">(iii)  The measure cannot be maintained unless the Member seeks to obtain the additional </text>
<text top=""408"" left=""193"" width=""464"" height=""16"" font=""0"">information necessary for a more objective assessment of risk; and </text>
</p><p number=""(iv)"" style=""3""><text top=""441"" left=""151"" width=""640"" height=""16"" font=""0"">(iv)  The measure cannot be maintained unless the Member reviews the measure within a </text>
<text top=""457"" left=""193"" width=""179"" height=""16"" font=""0"">reasonable period of time.</text>
<footnote top=""456"" left=""372"" width=""6"" height=""11"" font=""15"" number=""9"" ref="""" dis=""""/>
</p><p number=""18."" style=""6""><text top=""490"" left=""108"" width=""685"" height=""16"" font=""0"">18.  Existing Panel and Appellate Body reports have focused on the question of ""sufficiency"" </text>
<text top=""507"" left=""108"" width=""341"" height=""16"" font=""0"">rather than the ""relevance"" of scientific evidence. </text>
</p><p number=""19."" style=""6""><text top=""539"" left=""108"" width=""682"" height=""16"" font=""0"">19.  The Oxford English Dictionary defines ""relevant"" as ""bearing on, connected with, or pertinent </text>
<text top=""556"" left=""108"" width=""163"" height=""16"" font=""0"">to the matter in hand"".</text>
<footnote top=""554"" left=""271"" width=""11"" height=""11"" font=""15"" number=""10"" ref="""" dis=""""/>
<text top=""556"" left=""282"" width=""509"" height=""16"" font=""0""> Although we are not aware of any WTO Panel or Appellate Body report </text>
<text top=""572"" left=""108"" width=""684"" height=""16"" font=""0"">having considered the meaning of ""relevant"" in the context of Article 5.7 of the SPS Agreement, </text>
<text top=""589"" left=""108"" width=""686"" height=""16"" font=""0"">reports considering the term in other areas of the WTO Agreement reflect the approach of </text>
<text top=""605"" left=""108"" width=""370"" height=""16"" font=""0"">adopting the ordinary meaning of the word ""relevant"".</text>
<footnote top=""603"" left=""478"" width=""11"" height=""11"" font=""15"" number=""11"" ref="""" dis=""""/>
</p><p number=""20."" style=""6""><text top=""638"" left=""108"" width=""684"" height=""16"" font=""0"">20.  We note that Article 5.1 of the SPS Agreement provides that ""Members shall ensure that </text>
<text top=""654"" left=""108"" width=""686"" height=""16"" font=""0"">their sanitary or phytosanitary measures are based on an assessment, as appropriate to the </text>
<text top=""671"" left=""108"" width=""683"" height=""16"" font=""0"">circumstances, of the risks to human, animal or plant life or health"". Similarly, Article 2.2 of the </text>
<text top=""687"" left=""108"" width=""684"" height=""16"" font=""0"">SPS Agreement provides that ""Members shall ensure that any sanitary&#8230;measure &#8230; is based on </text>
<text top=""703"" left=""108"" width=""683"" height=""16"" font=""0"">scientific principles and is not maintained without sufficient scientific evidence, except as provided </text>
<text top=""720"" left=""108"" width=""687"" height=""16"" font=""0"">for in paragraph 7 of Article 5."" Article 5.7 therefore acts as a ""qualified exception"" to the </text>
<text top=""736"" left=""108"" width=""557"" height=""16"" font=""0"">obligation in Article 2.2 to not maintain SPS measures without scientific evidence.</text>
<footnote top=""735"" left=""665"" width=""11"" height=""11"" font=""15"" number=""12"" ref="""" dis=""""/>
</p><p number=""21."" style=""6""><text top=""769"" left=""108"" width=""685"" height=""16"" font=""0"">21.  Article 2.2 is closely related to Articles 5.1 and 5.2. The Appellate Body has stated that </text>
<text top=""785"" left=""108"" width=""688"" height=""16"" font=""0"">""Article 5.1 may be viewed as a specific application of the basic obligations contained in </text>
<text top=""802"" left=""108"" width=""81"" height=""16"" font=""0"">Article 2.2"".</text>
<footnote top=""800"" left=""189"" width=""11"" height=""11"" font=""15"" number=""13"" ref="""" dis=""""/>
<text top=""802"" left=""200"" width=""589"" height=""16"" font=""0"">  The Appellate Body concluded that a violation of Articles 5.1 and 5.2 is <i>ipso facto </i>a </text>
<text top=""818"" left=""108"" width=""150"" height=""16"" font=""0"">violation of Article 2.2</text>
<footnote top=""817"" left=""257"" width=""11"" height=""11"" font=""15"" number=""14"" ref="""" dis=""""><ftext top=""1067"" left=""160"" width=""609"" height=""15"" font=""11""> Ibid. ""In the event a sanitary measure is not based on a risk assessment as required in Articles 5.1 </ftext>
<ftext top=""1082"" left=""108"" width=""637"" height=""15"" font=""11"">and 5.2, this measure can be presumed, more generally, not to be based on scientific principles or to be </ftext>
<ftext top=""1096"" left=""108"" width=""676"" height=""15"" font=""11"">maintained without sufficient scientific evidence. We conclude, therefore, that if we find a violation of the more </ftext>
<ftext top=""1111"" left=""108"" width=""665"" height=""15"" font=""11"">specific Article 5.1 or 5.2 such finding can be presumed to imply a violation of the more general provisions of </ftext>
<ftext top=""1126"" left=""108"" width=""76"" height=""15"" font=""11"">Article 2.2"". </ftext>
</footnote>
<text top=""818"" left=""269"" width=""383"" height=""16"" font=""0""> and that the Articles should therefore be read together.</text>
<footnote top=""817"" left=""652"" width=""11"" height=""11"" font=""15"" number=""15"" ref="""" dis=""""><ftext top=""1140"" left=""160"" width=""36"" height=""15"" font=""11""> Ibid. </ftext>
</footnote>
</p><p number=""22."" style=""6""><text top=""851"" left=""108"" width=""682"" height=""16"" font=""0"">22.  We therefore consider that there is an important link between Article 2.2, Article 5.1 and the </text>
<text top=""868"" left=""108"" width=""686"" height=""16"" font=""0"">assessment in Article 5.7 of what is sufficient relevant scientific evidence. ""Relevant scientific </text>
<text top=""884"" left=""108"" width=""684"" height=""16"" font=""0"">evidence"" is information that would contribute to the assessment of risk required by Article 5.1. </text>
<text top=""900"" left=""108"" width=""682"" height=""16"" font=""0"">The question of what evidence is ""relevant"" to such a risk assessment would need to be answered </text>
<p><text top=""965"" left=""155"" width=""406"" height=""15"" font=""11""> Appellate Body Report, <i>Japan &#8211; Agricultural Products II, </i>para. 89. </text>
</p><p><text top=""994"" left=""160"" width=""602"" height=""15"" font=""11""> Appellate Body Report, <i>European Communities &#8211; Trade Descriptions of Sardines, </i>para. 230; Panel </text>
<text top=""1009"" left=""108"" width=""674"" height=""15"" font=""11"">Report, <i>United States &#8211; Measures Concerning the Importation, Marketing and Sale of Tuna and Tuna Products, </i></text>
<text top=""1024"" left=""108"" width=""79"" height=""15"" font=""11"">para. 7.700. </text>
<text top=""1038"" left=""160"" width=""406"" height=""15"" font=""11""> Appellate Body Report, <i>Japan &#8211; Agricultural Products II, </i>para. 80. </text>
<text top=""1053"" left=""160"" width=""316"" height=""15"" font=""11""> Appellate Body Report, <i>EC &#8211; Hormones, </i>para. 180. </text>
</p><p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- C-5 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">on a case by case basis. This could depend, for instance, on the type, purpose and subject of the </text>
<text top=""144"" left=""108"" width=""169"" height=""16"" font=""0"">particular SPS measure. </text>
</p></p></page>
<page number=""63"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""23."" style=""6""><text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">23.  Given that Article 5.7 only contemplates reliance on ""available pertinent information"" where </text>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">""relevant scientific evidence"" is not available, we consider that ""available pertinent information"" </text>
<text top=""210"" left=""108"" width=""687"" height=""16"" font=""0"">would represent a more limited range of evidence than ""relevant scientific evidence"". Such </text>
<text top=""226"" left=""108"" width=""687"" height=""16"" font=""0"">""available pertinent information"" can include information obtained from relevant information </text>
<text top=""242"" left=""108"" width=""476"" height=""16"" font=""0"">organisations, or from the SPS measures applied by other Members.</text>
<footnote top=""241"" left=""584"" width=""11"" height=""11"" font=""15"" number=""16"" ref="""" dis=""""><ftext top=""1082"" left=""160"" width=""622"" height=""15"" font=""11""> Article 5.7, <i>Agreement on the Application of Sanitary and Phytosanitary Measures. </i>See also Appellate </ftext>
</footnote>
<text top=""242"" left=""596"" width=""194"" height=""16"" font=""0"">  We also consider that the </text>
<text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">use of the word ""information"" rather than the word ""evidence"" in the phrase ""available pertinent </text>
<text top=""275"" left=""108"" width=""685"" height=""16"" font=""0"">information"" is intended to suggest a concept less rigorous than that represented by the term </text>
<text top=""292"" left=""108"" width=""206"" height=""16"" font=""0"">""relevant scientific evidence"". </text>
</p><p number=""24."" style=""6""><text top=""324"" left=""108"" width=""690"" height=""16"" font=""0"">24.  The requirement for the provisional measure to be based on ""available pertinent </text>
<text top=""341"" left=""108"" width=""682"" height=""16"" font=""0"">information"" is supplemented by the requirement that the Member seek the ""additional information </text>
<text top=""357"" left=""108"" width=""682"" height=""16"" font=""0"">necessary"" for a more objective assessment of risk, and the requirement that the SPS measure be </text>
<text top=""374"" left=""108"" width=""684"" height=""16"" font=""0"">reviewed within a reasonable period of time. Based on the ordinary meaning of the text in the </text>
<text top=""390"" left=""108"" width=""684"" height=""16"" font=""0"">context of the provision as a whole, the requirement for a ""more objective assessment of risk"" </text>
<text top=""407"" left=""108"" width=""682"" height=""16"" font=""0"">once the Member obtains additional information suggests that the ""available pertinent information"" </text>
<text top=""423"" left=""108"" width=""684"" height=""16"" font=""0"">could permit a less objective assessment. The information that the Member must seek must be </text>
<text top=""439"" left=""108"" width=""412"" height=""16"" font=""0"">""germane"" to conducting the objective assessment of risk.</text>
<footnote top=""438"" left=""519"" width=""11"" height=""11"" font=""15"" number=""17"" ref="""" dis=""""/>
<text top=""439"" left=""531"" width=""261"" height=""16"" font=""0"">  Ultimately, the Member must take </text>
<text top=""456"" left=""108"" width=""685"" height=""16"" font=""0"">steps to remedy the insufficiency of the ""relevant scientific evidence"", in order to come to a </text>
<text top=""472"" left=""108"" width=""418"" height=""16"" font=""0"">conclusion on whether a permanent SPS measure is justified.</text>
<footnote top=""471"" left=""526"" width=""11"" height=""11"" font=""15"" number=""18"" ref="""" dis=""""/>
</p><p number=""25."" style=""6""><text top=""505"" left=""108"" width=""685"" height=""16"" font=""0"">25.  Paragraph 4 of Annex A of the SPS Agreement sets out a definition of risk assessment, </text>
<text top=""521"" left=""108"" width=""682"" height=""16"" font=""0"">namely, the evaluation of the likelihood of entry, establishment or spread of a pest or disease and </text>
<text top=""538"" left=""108"" width=""683"" height=""16"" font=""0"">the associated potential biological and economic consequences, or the evaluation of the potential </text>
<text top=""554"" left=""108"" width=""684"" height=""16"" font=""0"">for adverse effects from additives, contaminants, toxins or disease-causing organisms in foods. </text>
<text top=""571"" left=""108"" width=""684"" height=""16"" font=""0"">The ""relevant scientific evidence"" and ""available pertinent information"" referred to in Article 5.7 </text>
<text top=""587"" left=""108"" width=""686"" height=""16"" font=""0"">would logically be evidence or information that would contribute to such a risk assessment, </text>
<text top=""603"" left=""108"" width=""687"" height=""16"" font=""0"">including evidence or information related to the factors set out in Article 5.2 and 5.3 for </text>
<text top=""620"" left=""108"" width=""255"" height=""16"" font=""0"">consideration in assessment of risks. </text>
</p><p number=""26."" style=""6""><text top=""653"" left=""108"" width=""683"" height=""16"" font=""0"">26.  Article 5.7 is applicable both in situations where the insufficiency of evidence relates to the </text>
<text top=""669"" left=""108"" width=""684"" height=""16"" font=""0"">risk associated with products originating in a specific country or region, as well as in situations </text>
<text top=""685"" left=""108"" width=""683"" height=""16"" font=""0"">where the insufficiency of evidence relates to the science on the risks associated with a particular </text>
<text top=""702"" left=""108"" width=""60"" height=""16"" font=""0"">disease. </text>
</p><p number=""27."" style=""6""><text top=""735"" left=""108"" width=""384"" height=""16"" font=""0"">27.  The Appellate Body in <i>Japan &#8211; Apples </i>noted that: </text>
<p><text top=""767"" left=""151"" width=""598"" height=""16"" font=""0"">""relevant scientific evidence"" will be ""insufficient"" within the meaning of Article 5.7 if </text>
<text top=""784"" left=""151"" width=""598"" height=""16"" font=""0"">the body of available scientific evidence does not allow, in quantitative or qualitative </text>
<text top=""800"" left=""151"" width=""602"" height=""16"" font=""0"">terms, the performance of an adequate assessment of risks as required under </text>
<text top=""817"" left=""151"" width=""597"" height=""16"" font=""0"">Article 5.1 and as defined in Annex A to the SPS Agreement. Thus, the question is not </text>
<text top=""833"" left=""151"" width=""598"" height=""16"" font=""0"">whether there is sufficient evidence of a general nature or whether there is sufficient </text>
<text top=""850"" left=""151"" width=""597"" height=""16"" font=""0"">evidence related to a specific aspect of a phytosanitary problem, or a specific risk. The </text>
<text top=""866"" left=""151"" width=""598"" height=""16"" font=""0"">question is whether the relevant evidence, be it ""general"" or ""specific"", in the Panel's </text>
<text top=""882"" left=""151"" width=""597"" height=""16"" font=""0"">parlance, is sufficient to permit the evaluation of the likelihood of entry, establishment </text>
<text top=""899"" left=""151"" width=""309"" height=""16"" font=""0"">or spread of, in this case, fire blight in Japan.</text>
<footnote top=""897"" left=""460"" width=""11"" height=""11"" font=""15"" number=""19"" ref="""" dis=""""/>
</p></p><p number=""28."" style=""6""><text top=""933"" left=""108"" width=""682"" height=""16"" font=""0"">28.  With the Appellate Body's statement in mind, we consider that the ""risk assessment"" defined </text>
<text top=""950"" left=""108"" width=""683"" height=""16"" font=""0"">in paragraph 4 of Annex A of the SPS Agreement includes an implicit reference to the country or </text>
<text top=""966"" left=""108"" width=""683"" height=""16"" font=""0"">region of origin of the relevant products. Conduct of such a risk assessment may require evidence </text>
<text top=""982"" left=""108"" width=""683"" height=""16"" font=""0"">relating to the possibility that a product from a particular country or region could carry a specific </text>
<text top=""999"" left=""108"" width=""685"" height=""16"" font=""0"">disease. As such, Article 5.7 could apply both where there is insufficient evidence of the risk </text>
<text top=""1015"" left=""108"" width=""685"" height=""16"" font=""0"">associated with the origin of the product, and where there is insufficient evidence of the risks </text>
<text top=""1032"" left=""108"" width=""251"" height=""16"" font=""0"">associated with a particular disease. </text>
<p><text top=""1096"" left=""108"" width=""376"" height=""15"" font=""11"">Body Report, <i>US/Canada &#8211; Continued Suspension, </i>para. 678. </text>
<text top=""1111"" left=""160"" width=""406"" height=""15"" font=""11""> Appellate Body Report, <i>Japan &#8211; Agricultural Products II, </i>para. 92. </text>
<text top=""1126"" left=""160"" width=""441"" height=""15"" font=""11""> Appellate Body Report, <i>US/Canada &#8211; Continued Suspension, </i>para. 679. </text>
<text top=""1140"" left=""160"" width=""314"" height=""15"" font=""11""> <i>Appellate Body Report, Japan &#8211; Apples, </i>para. 179. </text>
</p><p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- C-6 - </text>
</p></p></page>
<page number=""64"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""164"" left=""405"" width=""88"" height=""16"" font=""26"">ANNEX C-2 </text></p><p><text top=""198"" left=""212"" width=""474"" height=""16"" font=""6"">INTEGRATED EXECUTIVE SUMMARY OF THE ARGUMENTS OF BRAZIL </text>
</p><p number=""I."" style=""0""><text top=""241"" left=""108"" width=""22"" height=""16"" font=""23"">I. </text><text top=""241"" left=""151"" width=""644"" height=""16"" font=""23"">A RISK ASSESSMENT IS NECESSARY IN SPS MEASURES WHICH RESULT IN A </text><text top=""258"" left=""151"" width=""245"" height=""16"" font=""23"">HIGHER LEVEL OF PROTECTION </text></p><p number=""1."" style=""6""><text top=""291"" left=""108"" width=""23"" height=""16"" font=""0"">1. </text>
<text top=""291"" left=""151"" width=""644"" height=""16"" font=""0"">Brazil does not dispute the right of any Member to promote higher levels of sanitary </text>
<text top=""307"" left=""108"" width=""685"" height=""16"" font=""0"">protection than would be achieved by measures based on the relevant international standards. </text>
<text top=""323"" left=""108"" width=""684"" height=""16"" font=""0"">Brazil believes that Article 3.3 of the SPS Agreement establishes a proper balance between the </text>
<text top=""340"" left=""108"" width=""684"" height=""16"" font=""0"">adoption of measures based on international standards and the rights of Members to determine </text>
<text top=""356"" left=""108"" width=""242"" height=""16"" font=""0"">their appropriate level of protection</text>
<footnote top=""355"" left=""350"" width=""6"" height=""11"" font=""15"" number=""1"" ref="""" dis=""""/>
<text top=""356"" left=""356"" width=""434"" height=""16"" font=""0""> when designing their SPS measures. However, when imposing </text>
<text top=""373"" left=""108"" width=""684"" height=""16"" font=""0"">measures resulting in a higher level of protection than the one established by the international </text>
<text top=""389"" left=""108"" width=""682"" height=""16"" font=""0"">standard, Members shall ensure that they are applied in a manner consistent with the provisions of </text>
<text top=""405"" left=""108"" width=""686"" height=""16"" font=""0"">the SPS Agreement and do not constitute a disguised restriction on international trade or an </text>
<text top=""422"" left=""108"" width=""684"" height=""16"" font=""0"">arbitrary and unjustifiable discrimination between Members where identical or similar conditions </text>
<text top=""438"" left=""108"" width=""55"" height=""16"" font=""0"">prevail. </text>
</p><p number=""2."" style=""6""><text top=""471"" left=""108"" width=""19"" height=""16"" font=""0"">2. </text>
<text top=""471"" left=""151"" width=""640"" height=""16"" font=""0"">The SPS Agreement establishes that Members should only adopt SPS measures which result </text>
<text top=""488"" left=""108"" width=""684"" height=""16"" font=""0"">in a higher level of protection either (i) if there is a scientific justification or (ii) if they are in </text>
<text top=""504"" left=""108"" width=""690"" height=""16"" font=""0"">accordance with the relevant provisions of paragraphs 1 through 8 of Article 5 of the </text>
<text top=""520"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Agreement. Thus, the right to adopt measures that deviate from international standards is not </text>
<text top=""537"" left=""108"" width=""638"" height=""16"" font=""0"">an ""absolute or unqualified right"", as stated by the Appellate Body in <i>EC &#8211; Hormones</i>.</text>
<footnote top=""535"" left=""746"" width=""6"" height=""11"" font=""15"" number=""2"" ref="""" dis=""""/>
<text top=""537"" left=""751"" width=""42"" height=""16"" font=""0""> The </text>
<text top=""553"" left=""108"" width=""683"" height=""16"" font=""0"">Appellate Body understood that the examination and evaluation of available scientific information </text>
<text top=""570"" left=""108"" width=""682"" height=""16"" font=""0"">referred in this provision would appear ""to partake of the nature of the risk assessment required in </text>
<text top=""586"" left=""108"" width=""81"" height=""16"" font=""0"">Article 5.1.""</text>
<footnote top=""584"" left=""189"" width=""6"" height=""11"" font=""15"" number=""3"" ref="""" dis=""""/>
<text top=""586"" left=""194"" width=""596"" height=""16"" font=""0""> Therefore, the risk assessment seems to be a necessary instrument for a Member to </text>
<text top=""602"" left=""108"" width=""682"" height=""16"" font=""0"">fulfill the requirement of providing ""scientific justification"" for its SPS measures in order to adopt a </text>
<text top=""619"" left=""108"" width=""180"" height=""16"" font=""0"">higher level of protection. </text>
</p><p number=""3."" style=""6""><text top=""652"" left=""108"" width=""25"" height=""16"" font=""0"">3. </text>
<text top=""652"" left=""151"" width=""646"" height=""16"" font=""0"">Furthermore, the adoption of the appropriate level of protection by the Member in </text>
<text top=""668"" left=""108"" width=""684"" height=""16"" font=""0"">accordance with Article 5 of the SPS Agreement also requires the measure adopted to be based </text>
<text top=""684"" left=""108"" width=""178"" height=""16"" font=""0"">upon a risk assessment,</text>
<footnote top=""683"" left=""286"" width=""6"" height=""11"" font=""15"" number=""4"" ref="""" dis=""""><ftext top=""1082"" left=""155"" width=""603"" height=""15"" font=""11""> As the Appellate Body stated ""the distinction made in Article 3.3 between two situations [scientific </ftext>
</footnote>
<text top=""684"" left=""292"" width=""502"" height=""16"" font=""0""> since Article 5.1 establishes that ""Members shall ensure that their </text>
<text top=""701"" left=""108"" width=""683"" height=""16"" font=""0"">sanitary or phytosanitary measures are based on an assessment of the risks to human, animal or </text>
<text top=""717"" left=""108"" width=""682"" height=""16"" font=""0"">plant life or health."" Therefore, Brazil understands that SPS measures adopted by a Member which </text>
<text top=""734"" left=""108"" width=""684"" height=""16"" font=""0"">result in a higher level of sanitary or phytosanitary protection than the one established by the </text>
<text top=""750"" left=""108"" width=""683"" height=""16"" font=""0"">international standard must, in any case, be based on the relevant risk assessment in order to be </text>
<text top=""766"" left=""108"" width=""327"" height=""16"" font=""0"">considered consistent with the SPS Agreement. </text>
</p><p number=""4."" style=""6""><text top=""799"" left=""108"" width=""21"" height=""16"" font=""0"">4. </text>
<text top=""799"" left=""151"" width=""642"" height=""16"" font=""0"">Based on Paragraph 4 of Annex A of the SPS Agreement, the risk assessment implies, in </text>
<text top=""816"" left=""108"" width=""685"" height=""16"" font=""0"">general terms, an evaluation of the likelihood of entry, establishment or spread of a pest or </text>
<text top=""832"" left=""108"" width=""684"" height=""16"" font=""0"">disease within the territory of an importing Member according to the sanitary or phytosanitary </text>
<text top=""848"" left=""108"" width=""683"" height=""16"" font=""0"">measures which might be applied and also an evaluation of the associated potential biological and </text>
<text top=""865"" left=""108"" width=""173"" height=""16"" font=""0"">economic consequences. </text>
</p><p number=""5."" style=""6""><text top=""898"" left=""108"" width=""22"" height=""16"" font=""0"">5. </text>
<text top=""898"" left=""151"" width=""643"" height=""16"" font=""0"">For that, according to the panel in <i>Australia &#8211; Salmon, </i>a three-pronged test should be </text>
<text top=""914"" left=""108"" width=""686"" height=""16"" font=""0"">applicable: (i) identification of the pests or diseases whose entry, establishment or spread a </text>
<text top=""931"" left=""108"" width=""688"" height=""16"" font=""0"">Member wants to prevent, as well as the potential biological and economic consequences </text>
<text top=""947"" left=""108"" width=""684"" height=""16"" font=""0"">associated with the entry, establishment or spread of such pests/diseases; (ii) evaluation of the </text>
<text top=""963"" left=""108"" width=""687"" height=""16"" font=""0"">likelihood of entry, establishment or spread of these pests or diseases and the associated </text>
<text top=""980"" left=""108"" width=""682"" height=""16"" font=""0"">biological and economic consequences; and (iii) evaluation of the likelihood of entry, establishment </text>
<text top=""996"" left=""108"" width=""618"" height=""16"" font=""0"">or spread of these pests or diseases according to the SPS measures that might be applied.</text>
<footnote top=""995"" left=""726"" width=""6"" height=""11"" font=""15"" number=""5"" ref="""" dis=""DS18""><ftext top=""1140"" left=""155"" width=""284"" height=""15"" font=""11""> <i>Australia &#8211; Salmon</i>, Panel Report, para. 8.72. </ftext>
</footnote>
<p><text top=""1038"" left=""155"" width=""447"" height=""15"" font=""11""> <i>US/Canada &#8211; Continued Suspension</i>, Appellate Body Reports, para. 692. </text>
<footnote top=""1053"" left=""155"" width=""316"" height=""15"" font=""11"" number=""173"" ref="""" dis=""""/>
</p><p><text top=""1067"" left=""155"" width=""316"" height=""15"" font=""11""> <i>EC &#8211; Hormones</i>, Appellate Body Report, para. 175. </text>
</p><p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- C-7 - </text>
</p></p></page>
<page number=""65"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""30"" size=""7"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""19"" size=""7"" family=""Times"" color=""#000000""/>
	<fontspec id=""20"" size=""9"" family=""Times"" color=""#000000""/>
	<fontspec id=""21"" size=""9"" family=""Times"" color=""#0000ff""/>
<p number=""6."" style=""6""><text top=""144"" left=""108"" width=""21"" height=""16"" font=""0"">6. </text>
<text top=""144"" left=""151"" width=""642"" height=""16"" font=""0"">As for the analysis of economic consequences, Brazil highlights that the risk assessment </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">should take into account the elements indicated in Article 5.3 and 5.4 of the SPS Agreement: the </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">potential damage in terms of loss of production or sales; the costs of control or eradication in the </text>
<text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">territory of the importing Member; the relative cost-effectiveness of alternative approaches to </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">limiting risks; and the objective of minimizing negative trade effects. Brazil is of the view that </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">addressing other types of analysis of economic impact in the risk assessment which are not </text>
<text top=""242"" left=""108"" width=""686"" height=""16"" font=""0"">specifically related to the SPS Agreement would most likely  be found inconsistent with this </text>
<text top=""259"" left=""108"" width=""89"" height=""16"" font=""0"">Agreement.  </text>
</p><p number=""II."" style=""0""><text top=""292"" left=""108"" width=""24"" height=""16"" font=""23"">II. </text><text top=""292"" left=""151"" width=""565"" height=""16"" font=""23"">THE RISK ASSESSMENT AND ITS RELATIONSHIP WITH THE SPS MEASURE </text></p><p number=""7."" style=""6""><text top=""324"" left=""108"" width=""19"" height=""16"" font=""0"">7. </text>
<text top=""324"" left=""151"" width=""484"" height=""16"" font=""0"">Brazil recalls the interpretation by the Appellate Body in <i>EC &#8211; Biotech</i></text>
<footnote top=""323"" left=""635"" width=""6"" height=""11"" font=""30"" number=""6"" ref="""" dis=""""><ftext top=""1067"" left=""155"" width=""566"" height=""15"" font=""11""> <b> </b>According to the panel, ""[&#8230;] if we were to allow Austria effectively to ignore favourable risk </ftext>
<ftext top=""1082"" left=""108"" width=""662"" height=""15"" font=""11"">assessments, we would turn these assessments into documents without any substantive importance and the </ftext>
<ftext top=""1096"" left=""108"" width=""607"" height=""15"" font=""11"">conduct of these assessments into a mere formality. Yet, the requirement in Article 5.1 to 'base' an </ftext>
<ftext top=""1111"" left=""108"" width=""667"" height=""15"" font=""11"">SPS measure on a risk assessment is plainly a substantive requirement, and not simply a formal requirement </ftext>
<ftext top=""1126"" left=""108"" width=""494"" height=""15"" font=""11"">to accompany an SPS measure by a risk assessment."" (<i>EC-Biotech</i>, Panel Report,</ftext>
<ftext top=""1126"" left=""606"" width=""92"" height=""15"" font=""11"">para. 7.3067). </ftext>
</footnote><text top=""324"" left=""641"" width=""149"" height=""16"" font=""8""><i> </i>and <i>EC &#8211; Hormones</i> </text>
<text top=""341"" left=""108"" width=""685"" height=""16"" font=""0"">on the scope of the obligation set forth in Article 5.1 of the SPS Agreement. In the latter, the </text>
<text top=""357"" left=""108"" width=""683"" height=""16"" font=""0"">Appellate Body understood that the expression ""based on"" &#8211; related to the assessment of the risk </text>
<text top=""374"" left=""108"" width=""685"" height=""16"" font=""0"">&#8211; should be interpreted to mean that the SPS measure should be ""sufficiently warranted by"", </text>
<text top=""390"" left=""108"" width=""381"" height=""16"" font=""0"">""reasonably supported by"" or ""rationally related to""</text>
<footnote top=""389"" left=""489"" width=""6"" height=""11"" font=""15"" number=""7"" ref="""" dis=""DS26""><ftext top=""1140"" left=""155"" width=""245"" height=""15"" font=""11""> <i>EC &#8211; Hormones</i>, Appellate Body Report,</ftext>
</footnote>
<text top=""390"" left=""495"" width=""300"" height=""16"" font=""0""> the risk assessment. This means that </text>
<text top=""407"" left=""108"" width=""685"" height=""16"" font=""0"">Members are not supposed to disregard the elements brought by the risk assessment in the </text>
<text top=""423"" left=""108"" width=""214"" height=""16"" font=""0"">designing of the SPS measure. </text>
</p><p number=""8."" style=""6""><text top=""456"" left=""108"" width=""21"" height=""16"" font=""0"">8. </text>
<text top=""456"" left=""151"" width=""642"" height=""16"" font=""0"">Based on this reasoning, it seems clear that the SPS measure and the risk assessment </text>
<text top=""472"" left=""108"" width=""685"" height=""16"" font=""0"">should be closely connected or, in the words of the Appellate Body, they should be ""rationally </text>
<text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">related"". Therefore, in case there is a risk assessment indicating the inexistence of a risk or that </text>
<text top=""505"" left=""108"" width=""683"" height=""16"" font=""0"">the risk is negligible for the importing country, then this element should be taken into account in </text>
<text top=""521"" left=""108"" width=""442"" height=""16"" font=""0"">the formulation and/or application of the relevant SPS measure. </text>
</p><p number=""III."" style=""0""><text top=""554"" left=""108"" width=""691"" height=""16"" font=""23"">III.  THE REGIONALIZATION PRINCIPLE AND THE MAIN OBLIGATIONS ON THE </text><text top=""571"" left=""151"" width=""131"" height=""16"" font=""23"">SPS AGREEMENT </text></p><p number=""9."" style=""6""><text top=""603"" left=""108"" width=""20"" height=""16"" font=""0"">9. </text>
<text top=""603"" left=""151"" width=""641"" height=""16"" font=""0"">Brazil contends that Article 6 of the SPS Agreement requires Members to ensure that their </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">SPS measures are adapted to the sanitary and phytosanitary characteristics of the area from which </text>
<text top=""636"" left=""108"" width=""685"" height=""16"" font=""0"">the product originated and to which the product is destined. More importantly, Members shall </text>
<text top=""653"" left=""108"" width=""682"" height=""16"" font=""0"">recognize the concepts of pest- or disease-free areas and areas of low pest or disease prevalence. </text>
<text top=""669"" left=""108"" width=""682"" height=""16"" font=""0"">Regionalization is a key concept in the SPS Agreement. It helps SPS measures to be more effective </text>
<text top=""685"" left=""108"" width=""683"" height=""16"" font=""0"">and less trade restrictive. Once a Member has an area of its territory considered a ""disease-free </text>
<text top=""702"" left=""108"" width=""687"" height=""16"" font=""0"">area"" and has offered satisfactory evidence and given access to the importing Member for </text>
<text top=""718"" left=""108"" width=""684"" height=""16"" font=""0"">inspection and testing, under Article 6.3 of the SPS Agreement, trade restrictions diverging from </text>
<text top=""735"" left=""108"" width=""662"" height=""16"" font=""0"">the regionalization principle could be imposed only as a result of science-based risk assessment. </text>
</p><p number=""10."" style=""6""><text top=""767"" left=""108"" width=""684"" height=""16"" font=""0"">10.  By stating that Members shall ensure that their sanitary and phytosanitary measures are </text>
<text top=""784"" left=""108"" width=""685"" height=""16"" font=""0"">adapted to the characteristics of the area which the product is originated, the SPS Agreement </text>
<text top=""800"" left=""108"" width=""687"" height=""16"" font=""0"">requires that the concepts of pest or disease-free areas and areas of low pest or disease </text>
<text top=""817"" left=""108"" width=""682"" height=""16"" font=""0"">prevalence (the principle of regionalization) be recognized and fully implemented. For this purpose, </text>
<text top=""833"" left=""108"" width=""686"" height=""16"" font=""0"">Members shall take into account, among other factors, the appropriate criteria or guidelines </text>
<text top=""850"" left=""108"" width=""689"" height=""16"" font=""0"">developed by the relevant international organizations, particularly the <i>Codex Alimentarius </i></text>
<text top=""866"" left=""108"" width=""684"" height=""16"" font=""8""><i>Commission  </i>(""Codex""), the World Organization for Animal Health (""OIE""), and the International </text>
<text top=""882"" left=""108"" width=""338"" height=""16"" font=""0"">Plant Protection Convention Secretariat (""IPPC""). </text>
</p><p number=""11."" style=""6""><text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">11.  Here again, a Member is allowed to depart from these criteria and adopt a higher level of </text>
<text top=""932"" left=""108"" width=""683"" height=""16"" font=""0"">protection. However, Articles 3.2 and 3.3, together with Article 5.1 of the SPS Agreement, require </text>
<text top=""948"" left=""108"" width=""682"" height=""16"" font=""0"">that such a higher level of protection in the context of Article 6 should only be adopted based upon </text>
<text top=""964"" left=""108"" width=""464"" height=""16"" font=""0"">a scientific justification or, as already explained, a risk assessment. </text>
</p><p number=""12."" style=""6""><text top=""997"" left=""108"" width=""685"" height=""16"" font=""0"">12.  In Brazil's view, this interpretation would allow the adoption of the appropriate level of </text>
<text top=""1014"" left=""108"" width=""684"" height=""16"" font=""0"">protection by each Member, in the case of pest- or disease-free areas, and at the same time it </text>
<text top=""1030"" left=""108"" width=""684"" height=""16"" font=""0"">would ensure that no arbitrary, unjustifiable or disguised restrictions on international trade are </text>
<p><text top=""1140"" left=""405"" width=""67"" height=""15"" font=""11"">para. 193. </text>
</p><p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- C-8 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">created. Moreover, it would reinforce the necessary respect for the principle of regionalization, </text>
<text top=""144"" left=""108"" width=""687"" height=""16"" font=""0"">which is, as already mentioned, a fundamental step toward a freer and fairer world trade, </text>
<text top=""160"" left=""108"" width=""617"" height=""16"" font=""0"">facilitating trade in agricultural products without increasing risk to the importing country.  </text>
</p></p></page>
<page number=""66"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""IV."" style=""0""><text top=""193"" left=""108"" width=""684"" height=""16"" font=""23"">IV.  THE OIE'S ATTRIBUTION OF AN FMD STATUS TO A SPECIFIC COUNTRY IS DONE </text><text top=""210"" left=""151"" width=""641"" height=""16"" font=""23"">PERSUANT TO PROCEDURES APPLICABLE TO THE ADOPTION OF STANDARDS AND </text><text top=""226"" left=""151"" width=""167"" height=""16"" font=""23"">RECOMMENDATIONS  </text></p><p number=""13."" style=""6""><text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">13.  Brazil is of the view all that standards, guidelines and recommendations have equal status </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">under the SPS Agreement. These terms are always described together, including in the definitions </text>
<text top=""292"" left=""108"" width=""683"" height=""16"" font=""0"">of Annex A, but there is no description of what is their meaning, differently from what happens in </text>
<text top=""308"" left=""108"" width=""687"" height=""16"" font=""0"">the TBT Agreement (which defines ""standard"" in Annex 1). Usually, it is for the respective </text>
<text top=""324"" left=""108"" width=""485"" height=""16"" font=""0"">international organization to define them as it deems appropriate.</text>
<footnote top=""323"" left=""593"" width=""6"" height=""11"" font=""15"" number=""8"" ref="""" dis=""""><ftext top=""1053"" left=""155"" width=""632"" height=""15"" font=""11""> See for instance the ""Clarification of References to Codex Texts"" (G/SPS/W/86/Rev.1, 18 March 1998). </ftext>
</footnote>
<text top=""324"" left=""599"" width=""195"" height=""16"" font=""0""> In the case of the OIE, </text>
<text top=""341"" left=""108"" width=""682"" height=""16"" font=""0"">FMD-free areas are established according to the procedures applicable to the adoption of standards </text>
<text top=""357"" left=""108"" width=""684"" height=""16"" font=""0"">and recommendations (""Procedures used by the OIE to set Standards and Recommendations for </text>
<text top=""374"" left=""108"" width=""594"" height=""16"" font=""0"">international Trade, with a Focus on the Terrestrial and Aquatic Animal Health Codes"").</text>
<footnote top=""372"" left=""702"" width=""6"" height=""11"" font=""15"" number=""9"" ref="""" dis=""""/>
</p><p number=""V."" style=""0""><text top=""407"" left=""108"" width=""124"" height=""16"" font=""23"">V. UNDUE </text><text top=""407"" left=""209"" width=""77"" height=""16"" font=""23"">DELAY </text></p><p number=""14."" style=""6""><text top=""439"" left=""108"" width=""683"" height=""16"" font=""0"">14.  The SPS Agreement establishes the requirement that SPS procedures are to be undertaken </text>
<text top=""456"" left=""108"" width=""683"" height=""16"" font=""0"">and completed without undue delay. This obligation, as set out in Article 8 and Annex C(1)(a) of </text>
<text top=""472"" left=""108"" width=""683"" height=""16"" font=""0"">the SPS Agreement, aims to prevent Members from using lengthy and unjustified SPS procedures </text>
<text top=""489"" left=""108"" width=""686"" height=""16"" font=""0"">as a trade barrier to other Members' imports. However, the SPS Agreement does not define </text>
<text top=""505"" left=""108"" width=""683"" height=""16"" font=""0"">specific deadlines for the conclusion of sanitary or phytosanitary procedures undertaken under its </text>
<text top=""521"" left=""108"" width=""68"" height=""16"" font=""0"">auspices. </text>
</p><p number=""15."" style=""6""><text top=""554"" left=""108"" width=""683"" height=""16"" font=""0"">15.  Both the preamble and Article 2.3 of the SPS Agreement, which can be considered context </text>
<text top=""571"" left=""108"" width=""685"" height=""16"" font=""0"">for the interpretation of the rest of the Agreement, indicate that SPS measures should not be </text>
<text top=""587"" left=""108"" width=""684"" height=""16"" font=""0"">applied in a manner which would constitute a disguised restriction on international trade. Thus, </text>
<text top=""603"" left=""108"" width=""683"" height=""16"" font=""0"">allowing Members to have endless periods for any procedure, especially the review of documents </text>
<text top=""620"" left=""108"" width=""595"" height=""16"" font=""0"">and applications related to SPS procedures, could lead to unjustified trade restrictions. </text>
</p><p number=""16."" style=""6""><text top=""653"" left=""108"" width=""685"" height=""16"" font=""0"">16.  Although Brazil does not take a position on whether or not there has been undue delay </text>
<text top=""669"" left=""108"" width=""683"" height=""16"" font=""0"">under the challenged U.S. procedures in the present case, it considers that a proper consideration </text>
<text top=""685"" left=""108"" width=""682"" height=""16"" font=""0"">for a period to the conclusion of these procedures under the SPS Agreement provisions should take </text>
<text top=""702"" left=""108"" width=""683"" height=""16"" font=""0"">into account a ""reasonable"" timeframe for a country to review the above-mentioned applications. </text>
<text top=""718"" left=""108"" width=""682"" height=""16"" font=""0"">In order to avoid disguised restrictions on international trade, a ""reasonable timeframe"" should be </text>
<text top=""735"" left=""108"" width=""683"" height=""16"" font=""0"">defined in most cases as strictly as possible, affording consideration to the difficulties a Member </text>
<text top=""751"" left=""108"" width=""247"" height=""16"" font=""0"">may face in a given SPS procedure. </text>
</p><p number=""17."" style=""6""><text top=""784"" left=""108"" width=""682"" height=""16"" font=""0"">17.  Therefore, there should be a case-by-case analysis, taking into account the specific features </text>
<text top=""800"" left=""108"" width=""686"" height=""16"" font=""0"">of the case, in order to define what would be a reasonable time for the conclusion of the </text>
<text top=""817"" left=""108"" width=""683"" height=""16"" font=""0"">procedure. This interpretation would confer the proper balance between the required period for a </text>
<text top=""833"" left=""108"" width=""689"" height=""16"" font=""0"">Member to receive and process the information received and the obligation set by the </text>
<text top=""850"" left=""108"" width=""451"" height=""16"" font=""0"">SPS Agreement to complete the procedures without undue delay. </text>
<p><text top=""1067"" left=""108"" width=""656"" height=""15"" font=""11"">In October 1997, with a view to seek a definition for these terms, the Secretariat of the <i>Codex Alimentarius </i></text>
<text top=""1082"" left=""108"" width=""668"" height=""15"" font=""16""><i>Commission</i> (CAC) sent a letter to the Chairman of the WTO SPS Committee, requesting a clarification on the </text>
<text top=""1096"" left=""108"" width=""635"" height=""15"" font=""11"">scope of these terms. After discussing this issue, the Committee understood that the decision on how to </text>
<text top=""1111"" left=""108"" width=""642"" height=""15"" font=""11"">classify them should be ""an internal decision of the <i>Codex Alimentarius Commission</i> regarding the type and </text>
<text top=""1126"" left=""108"" width=""357"" height=""15"" font=""11"">content of the texts it develops to address issues before it."" </text>
<text top=""1140"" left=""155"" width=""345"" height=""15"" font=""11""> Available at ""http://www.oie.int/doc/ged/D11140.PDF"". </text>
</p><p><text top=""87"" left=""424"" width=""51"" height=""16"" font=""0"">- C-9 - </text>
</p></p></page>
<page number=""67"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""164"" left=""405"" width=""88"" height=""16"" font=""26"">ANNEX C-3 </text></p><p><text top=""198"" left=""215"" width=""468"" height=""16"" font=""6"">INTEGRATED EXECUTIVE SUMMARY OF THE ARGUMENTS OF CHINA </text>
</p><p number=""I."" style=""0""><text top=""241"" left=""108"" width=""169"" height=""16"" font=""23"">I. Introduction </text></p><p number=""1."" style=""6""><text top=""274"" left=""108"" width=""19"" height=""16"" font=""0"">1. </text>
<text top=""274"" left=""151"" width=""640"" height=""16"" font=""0"">The People's Republic of China intervenes in this case because of its systemic interest in the </text>
<text top=""291"" left=""108"" width=""684"" height=""16"" font=""0"">correct interpretation of the SPS Agreement and the GATT 1994. As a third party, China makes </text>
<text top=""307"" left=""108"" width=""687"" height=""16"" font=""0"">certain observations in its written submission, oral statement and responses to the Panel's </text>
<text top=""323"" left=""108"" width=""309"" height=""16"" font=""0"">questions, which are summarized as follows. </text>
</p><p number=""II."" style=""0""><text top=""356"" left=""108"" width=""24"" height=""16"" font=""23"">II. </text><text top=""356"" left=""151"" width=""140"" height=""16"" font=""23"">Measures at issue </text></p><p number=""2."" style=""6""><text top=""389"" left=""108"" width=""20"" height=""16"" font=""0"">2. </text>
<text top=""389"" left=""151"" width=""641"" height=""16"" font=""0"">In the present dispute, Argentina makes two types of claims with respect to two types of </text>
<text top=""405"" left=""108"" width=""682"" height=""16"" font=""0"">measures. First, Argentina claims that the measures of import ban, adopted and maintained by the </text>
<text top=""422"" left=""108"" width=""682"" height=""16"" font=""0"">U.S. on fresh beef from Argentina and animal products from the Patagonia Region, are inconsistent </text>
<text top=""438"" left=""108"" width=""683"" height=""16"" font=""0"">with various substantive obligations of the U.S. under the SPS Agreement, e.g., Articles 2.2, 2.3, </text>
<text top=""455"" left=""108"" width=""682"" height=""16"" font=""0"">3.1, 3.3, 5.1, 5.2, 5.6 and 10.1. Second, Argentina claims that the relevant approval procedures of </text>
<text top=""471"" left=""108"" width=""684"" height=""16"" font=""0"">the U.S. violate procedural obligations under Article 8 and Annex C(1). China considers that the </text>
<text top=""488"" left=""108"" width=""685"" height=""16"" font=""0"">Panel should evaluate these two types of claims separately. A finding that the U.S. approval </text>
<text top=""504"" left=""108"" width=""682"" height=""16"" font=""0"">procedures are consistent or inconsistent with Article 8 and Annex C(1) may not prevent the Panel </text>
<text top=""520"" left=""108"" width=""478"" height=""16"" font=""0"">from evaluating separately the claims with respect to the import ban. </text>
</p><p number=""III."" style=""0""><text top=""553"" left=""108"" width=""366"" height=""16"" font=""23"">III.  Articles 3.1 and 3.3 of the SPS Agreement </text></p><p number=""3."" style=""6""><text top=""586"" left=""108"" width=""19"" height=""16"" font=""0"">3. </text>
<text top=""586"" left=""151"" width=""640"" height=""16"" font=""0"">First, China considers that the OIE standard itself does not support a general import ban on </text>
<text top=""602"" left=""108"" width=""685"" height=""16"" font=""0"">animal products, such as the measures applied by the U.S. This is because the OIE standard </text>
<text top=""619"" left=""108"" width=""686"" height=""16"" font=""0"">requires Members to consider the animal health situation in the countries concerned before </text>
<text top=""635"" left=""108"" width=""683"" height=""16"" font=""0"">determining the requirements for trade and one of the important purposes of the OIE standard is </text>
<text top=""652"" left=""108"" width=""682"" height=""16"" font=""0"">to avoid unjustified trade barriers. Even assuming, <i>arguendo</i>, that the U.S. measures are based on </text>
<text top=""668"" left=""108"" width=""683"" height=""16"" font=""0"">international standards, these measures are still subject to the disciplines of Articles 2.2, 5.1, 5.6 </text>
<text top=""684"" left=""108"" width=""684"" height=""16"" font=""0"">as well as other relevant provisions of the SPS Agreement, because, as found by the Appellate </text>
<text top=""701"" left=""108"" width=""685"" height=""16"" font=""0"">Body in <i>EC &#8211; Hormones</i>, measures that are ""based on"" but do not ""conform to"" international </text>
<text top=""717"" left=""108"" width=""553"" height=""16"" font=""0"">standards do not benefit from the presumption of consistency under Article 3.2.  </text>
</p><p number=""4."" style=""6""><text top=""750"" left=""108"" width=""22"" height=""16"" font=""0"">4. </text>
<text top=""750"" left=""151"" width=""643"" height=""16"" font=""0"">Second, China notes that the U.S. acknowledges that its appropriate level of protection </text>
<text top=""766"" left=""108"" width=""686"" height=""16"" font=""0"">(ALOP) is higher than the OIE standard. Thus the U.S. measures should be examined under </text>
<text top=""783"" left=""108"" width=""684"" height=""16"" font=""0"">Article 3.3. For a measure to be consistent with Article 3.3, the Member concerned must comply </text>
<text top=""799"" left=""108"" width=""683"" height=""16"" font=""0"">with the requirements under ""relevant provisions of [the SPS] Agreement"" or ""relevant provisions </text>
<text top=""816"" left=""108"" width=""686"" height=""16"" font=""0"">of paragraphs 1 through 8 of Article 5 [of the Agreement]"", and the measure ""shall not be </text>
<text top=""832"" left=""108"" width=""682"" height=""16"" font=""0"">inconsistent with any other provisions of [the SPS] Agreement"". Thus before reaching a conclusion </text>
<text top=""848"" left=""108"" width=""683"" height=""16"" font=""0"">under Article 3.3, the Panel has to examine the U.S. measures under other relevant provisions of </text>
<text top=""865"" left=""108"" width=""334"" height=""16"" font=""0"">the SPS Agreement, and, in particular, Article 5. </text>
</p><p number=""IV."" style=""0""><text top=""898"" left=""108"" width=""433"" height=""16"" font=""23"">IV.  Articles 2.2, 5.1, 5.2 and 5.7 of the SPS Agreement </text></p><p number=""5."" style=""6""><text top=""931"" left=""108"" width=""19"" height=""16"" font=""0"">5. </text>
<text top=""931"" left=""151"" width=""640"" height=""16"" font=""0"">Argentina claims the U.S. measures are inconsistent with Articles 2.2, 5.1 and 5.2, and not </text>
<text top=""947"" left=""108"" width=""682"" height=""16"" font=""0"">justified under Article 5.7. The U.S. argues that its measures are justified under Article 5.7 and not </text>
<text top=""963"" left=""108"" width=""299"" height=""16"" font=""0"">inconsistent with Articles 2.2, 5.1 and 5.2.  </text>
</p><p number=""A."" style=""1""><text top=""996"" left=""108"" width=""20"" height=""16"" font=""23"">A. </text><text top=""996"" left=""151"" width=""388"" height=""16"" font=""23"">Relationship between Articles 2.2, 5.1, 5.2 and 5.7 </text></p><p number=""6."" style=""6""><text top=""1029"" left=""108"" width=""20"" height=""16"" font=""0"">6. </text>
<text top=""1029"" left=""151"" width=""641"" height=""16"" font=""0"">First, Articles 5.1 and 5.2 are specific application of the basic obligations established under </text>
<text top=""1045"" left=""108"" width=""684"" height=""16"" font=""0"">Article 2.2. In the event an SPS measure is not based on a risk assessment as required under </text>
<text top=""1062"" left=""108"" width=""685"" height=""16"" font=""0"">Articles 5.1 and 5.2, this measure is neither based on scientific principles nor maintained with </text>
<text top=""1078"" left=""108"" width=""686"" height=""16"" font=""0"">sufficient scientific evidence within the meaning of Article 2.2. In other words, a violation of </text>
<text top=""1095"" left=""108"" width=""683"" height=""16"" font=""0"">Articles 5.1 and 5.2 would be, by implication, a violation of Article 2.2. When facing simultaneous </text>
<text top=""1111"" left=""108"" width=""684"" height=""16"" font=""0"">claims under Articles 2.2, 5.1 and 5.2 in a dispute like the present one, a panel is suggested to </text>
<text top=""1127"" left=""108"" width=""523"" height=""16"" font=""0"">begin its analysis with the ""more specific"" claims under Articles 5.1 and 5.2. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- C-10 - </text>
</p></p></page>
<page number=""68"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7."" style=""6""><text top=""144"" left=""108"" width=""24"" height=""16"" font=""0"">7. </text>
<text top=""144"" left=""151"" width=""645"" height=""16"" font=""0"">Second, Article 2.2 does not apply in cases where an SPS measure is adopted and </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">maintained pursuant to Article 5.7. Neither do Articles 5.1 and 5.2, which are specific application </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">of Article 2.2. Given that the U.S. has invoked Article 5.7 to justify its measures, the Panel is </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">anticipated to first determine whether the U.S. measures, i.e., the import ban, are justified under </text>
<text top=""210"" left=""108"" width=""125"" height=""16"" font=""0"">Article 5.7 or not. </text>
</p><p number=""B."" style=""1""><text top=""242"" left=""108"" width=""20"" height=""16"" font=""23"">B. </text><text top=""242"" left=""151"" width=""97"" height=""16"" font=""23"">Article 5.7    </text></p><p number=""8."" style=""6""><text top=""275"" left=""108"" width=""19"" height=""16"" font=""0"">8. </text>
<text top=""275"" left=""151"" width=""640"" height=""16"" font=""0"">Article 5.7 allows a Member to adopt and maintain a provisional SPS measure, provided that </text>
<text top=""292"" left=""108"" width=""684"" height=""16"" font=""0"">four cumulative requirements are met. The provisional measure must be: (1) imposed in cases </text>
<text top=""308"" left=""108"" width=""683"" height=""16"" font=""0"">where ""relevant scientific evidence is insufficient"" to conduct an appropriate risk assessment, and </text>
<text top=""324"" left=""108"" width=""684"" height=""16"" font=""0"">(2) adopted ""on the basis of available pertinent information""; and the Member concerned must: </text>
<text top=""341"" left=""108"" width=""683"" height=""16"" font=""0"">(3) ""seek to obtain the additional information necessary for a more objective assessment of risk""; </text>
<text top=""357"" left=""108"" width=""437"" height=""16"" font=""0"">and (4) review the measure within a reasonable period of time. </text>
</p><p number=""9."" style=""6""><text top=""390"" left=""108"" width=""21"" height=""16"" font=""0"">9. </text>
<text top=""390"" left=""151"" width=""641"" height=""16"" font=""0"">At the outset, the measures permitted under Article 5.7 must be provisional measures. A </text>
<text top=""407"" left=""108"" width=""686"" height=""16"" font=""0"">provisional measure is a measure adopted temporarily before a definitive or final measure is </text>
<text top=""423"" left=""108"" width=""685"" height=""16"" font=""0"">taken. And a definitive measure adopted pursuant to Article 5.1 cannot become a provisional </text>
<text top=""439"" left=""108"" width=""686"" height=""16"" font=""0"">measure within the meaning of Article 5.7 afterwards. This is because whether a measure is </text>
<text top=""456"" left=""108"" width=""688"" height=""16"" font=""0"">provisional should be assessed by reference to the time the measure was adopted, and </text>
<text top=""472"" left=""108"" width=""684"" height=""16"" font=""0"">furthermore, whether the relevant scientific evidence was insufficient must also be assessed by </text>
<text top=""489"" left=""108"" width=""339"" height=""16"" font=""0"">reference to the time the measure was adopted.  </text>
</p><p number=""10."" style=""6""><text top=""521"" left=""108"" width=""683"" height=""16"" font=""0"">10.  When evaluating an argument that a measure is justified under Article 5.7, an adjudicator </text>
<text top=""538"" left=""108"" width=""682"" height=""16"" font=""0"">may be confronted with an underlying argument that the measure was based on a risk assessment </text>
<text top=""554"" left=""108"" width=""684"" height=""16"" font=""0"">at the time of imposition. On the one hand, a provisional measure must be based on available </text>
<text top=""571"" left=""108"" width=""683"" height=""16"" font=""0"">pertinent information, which means there must be ""some evidentiary basis indicating the possible </text>
<text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">existence of a risk"" and there must be a rational and objective relationship between the risk and </text>
<text top=""603"" left=""108"" width=""683"" height=""16"" font=""0"">the measure. Thus, some kind of assessment of risks is necessary under Article 5.7. On the other </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">hand, a provisional measure is adopted in cases where relevant scientific evidence is insufficient to </text>
<text top=""636"" left=""108"" width=""688"" height=""16"" font=""0"">perform ""an adequate assessment of risks as required under Article 5.1"". Accordingly, the </text>
<text top=""653"" left=""108"" width=""683"" height=""16"" font=""0"">assessment of risks envisaged under Article 5.7 should be distinguished from the risk assessment </text>
<text top=""669"" left=""108"" width=""683"" height=""16"" font=""0"">under Article 5.1. A Member may not put forward an argument that its measure was based on a </text>
<text top=""685"" left=""108"" width=""579"" height=""16"" font=""0"">risk assessment under Article 5.1 and, at the same time, justified under Article 5.7.  </text>
</p><p number=""11."" style=""6""><text top=""718"" left=""108"" width=""686"" height=""16"" font=""0"">11.  During the evaluation under Article 5.7, an adjudicator may also be confronted with a </text>
<text top=""735"" left=""108"" width=""689"" height=""16"" font=""0"">counterargument by the complainant that an international standard or a completed risk </text>
<text top=""751"" left=""108"" width=""688"" height=""16"" font=""0"">assessment exists on the same matter. According to the Appellate Body, existence of an </text>
<text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">international standard or a completed risk assessment by an international organization or another </text>
<text top=""784"" left=""108"" width=""683"" height=""16"" font=""0"">Member could be offered as evidence to an argument that the relevant scientific evidence is not </text>
<text top=""800"" left=""108"" width=""688"" height=""16"" font=""0"">insufficient within the meaning of Article 5.7, but does not create a legal presumption of </text>
<text top=""817"" left=""108"" width=""85"" height=""16"" font=""0"">sufficiency.  </text>
</p><p number=""12."" style=""6""><text top=""850"" left=""108"" width=""682"" height=""16"" font=""0"">12.  As to the burden of proof under Article 5.7, China notes that the Appellate Body has not yet </text>
<text top=""866"" left=""108"" width=""682"" height=""16"" font=""0"">decided this specific issue and the views of WTO panels in this respect are not perfectly consistent </text>
<text top=""882"" left=""108"" width=""682"" height=""16"" font=""0"">with one another. Based on the general principle of allocation of burden of proof established by the </text>
<text top=""899"" left=""108"" width=""682"" height=""16"" font=""0"">Appellate Body, China considers that it is necessary for the Panel to decide whether Article 5.7 has </text>
<text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">been invoked, in this case, to assert an affirmative claim by Argentina or to assert an affirmative </text>
<text top=""932"" left=""108"" width=""207"" height=""16"" font=""0"">defence by the United States. </text>
</p><p number=""13."" style=""6""><text top=""964"" left=""108"" width=""683"" height=""16"" font=""0"">13.  In the present case, according to its arguments under Articles 5.1 and 5.2, the U.S. seems </text>
<text top=""981"" left=""108"" width=""687"" height=""16"" font=""0"">to argue that it had possessed sufficient scientific evidence and made an appropriate risk </text>
<text top=""997"" left=""108"" width=""685"" height=""16"" font=""0"">assessment before it adopted the import ban. This appears to imply that the import ban was </text>
<text top=""1014"" left=""108"" width=""687"" height=""16"" font=""0"">adopted as a definitive measure, instead of a provisional measure adopted in cases where </text>
<text top=""1030"" left=""108"" width=""679"" height=""16"" font=""0"">scientific evidence is insufficient. Therefore, the import ban could not be justified under Article 5.7. </text>
</p><p number=""C."" style=""1""><text top=""1063"" left=""108"" width=""19"" height=""16"" font=""23"">C. </text><text top=""1063"" left=""151"" width=""186"" height=""16"" font=""23"">Articles 2.2, 5.1 and 5.2 </text></p><p number=""14."" style=""6""><text top=""1096"" left=""108"" width=""683"" height=""16"" font=""0"">14.  An inquiry under Article 5.1 is a two-step process: (1) was an appropriate risk assessment </text>
<text top=""1112"" left=""108"" width=""686"" height=""16"" font=""0"">conducted? (2) was the SPS measure based on that risk assessment?  More relevantly, the </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- C-11 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">Appellate Body has found that it would be sufficient for a complainant to raise a presumption that </text>
<text top=""144"" left=""108"" width=""317"" height=""16"" font=""0"">no relevant scientific studies or reports exist.  </text>
</p></p></page>
<page number=""69"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""15."" style=""6""><text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">15.  In this case, it appears that Argentina does not argue that the import ban was not based on </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">a risk assessment, but argues that these measures are maintained without valid risk assessment </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""8""><i>at all</i>. China thus considers that if the Panel were to find that the presumption of ""no relevant </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">scientific studies or reports exist"" is established by Argentina, it is for the U.S. to rebut such </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">presumption. Failure of this, Argentina's claims under Articles 5.1 and 5.2 should prevail, and, as a </text>
<text top=""259"" left=""108"" width=""382"" height=""16"" font=""0"">consequence, the claims under Article 2.2 also prevail.  </text>
</p><p number=""V."" style=""0""><text top=""292"" left=""108"" width=""20"" height=""16"" font=""23"">V. </text><text top=""292"" left=""151"" width=""254"" height=""16"" font=""23"">Article 5.6 of the SPS Agreement </text></p><p number=""16."" style=""6""><text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">16.  To establish the inconsistency with Article 5.6 of the measures at issue, the complainant is </text>
<text top=""341"" left=""108"" width=""685"" height=""16"" font=""0"">required to identify an alternative SPS measure which: (1) is reasonably available taking into </text>
<text top=""357"" left=""108"" width=""683"" height=""16"" font=""0"">account technical and economic feasibility; (2) achieves the importing Member's ALOP; and (3) is </text>
<text top=""374"" left=""108"" width=""484"" height=""16"" font=""0"">significantly less restrictive to trade than the SPS measure contested.  </text>
</p><p number=""17."" style=""6""><text top=""407"" left=""108"" width=""686"" height=""16"" font=""0"">17.  It is also established by the Appellate Body that the role of the Panel in making an </text>
<text top=""423"" left=""108"" width=""683"" height=""16"" font=""0"">assessment under Article 5.6 is different from its role in making an assessment under Article 5.1. </text>
<text top=""439"" left=""108"" width=""685"" height=""16"" font=""0"">Under Article 5.1, a panel's task is to review the risk assessment performed by the importing </text>
<text top=""456"" left=""108"" width=""683"" height=""16"" font=""0"">Member. In contrast, a panel, under Article 5.6, is required to undertake its own analysis on the </text>
<text top=""472"" left=""108"" width=""686"" height=""16"" font=""0"">question of whether the alternative measure would achieve the importing Member' ALOP. In </text>
<text top=""489"" left=""108"" width=""684"" height=""16"" font=""0"">making its own analysis, the panel shall evaluate whether the totality of the evidence identified </text>
<text top=""505"" left=""108"" width=""682"" height=""16"" font=""0"">and/or adduced by the complainant, which should be scientific in nature, is sufficient to establish a </text>
<text top=""521"" left=""108"" width=""682"" height=""16"" font=""0"">presumption that the alternative measure would achieve the ALOP. And this evaluation is a matter </text>
<text top=""538"" left=""108"" width=""682"" height=""16"" font=""0"">of legal characterization and not a scientific assessment of risk that must conform to the first three </text>
<text top=""554"" left=""108"" width=""170"" height=""16"" font=""0"">paragraphs of Article 5.  </text>
</p><p number=""18."" style=""6""><text top=""587"" left=""108"" width=""685"" height=""16"" font=""0"">18.  In the present case, since the import ban is most trade restrictive, the U.S. measures </text>
<text top=""603"" left=""108"" width=""684"" height=""16"" font=""0"">currently applying to Uruguay and Santa Catarina of Brazil could be alternative measures which </text>
<text top=""620"" left=""108"" width=""683"" height=""16"" font=""0"">are significantly less restrictive to trade. In addition, since these measures are currently applying </text>
<text top=""636"" left=""108"" width=""685"" height=""16"" font=""0"">to Uruguay and Santa Catarina, it could be reasonably assumed that these measures properly </text>
<text top=""653"" left=""108"" width=""684"" height=""16"" font=""0"">achieve the U.S. ALOP. Thus, the key factual question to be asked by the Panel is whether the </text>
<text top=""669"" left=""108"" width=""682"" height=""16"" font=""0"">sanitary situation of Argentina is comparable to those of Uruguay and Santa Catarina, and whether </text>
<text top=""685"" left=""108"" width=""683"" height=""16"" font=""0"">these measures are reasonably available with respect to Argentinian products taking into account </text>
<text top=""702"" left=""108"" width=""243"" height=""16"" font=""0"">technique and economic feasibility. </text>
</p><p number=""VI."" style=""0""><text top=""735"" left=""108"" width=""296"" height=""16"" font=""23"">VI.  Article 2.3 of the SPS Agreement </text></p><p number=""19."" style=""6""><text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">19.  Unlike the U.S., China considers that the import ban is an SPS measure which is subject to </text>
<text top=""784"" left=""108"" width=""683"" height=""16"" font=""0"">the discipline of Article 2.3. To establish the inconsistency of a measure with the first sentence of </text>
<text top=""800"" left=""108"" width=""688"" height=""16"" font=""0"">Article 2.3, three requirements must be met: (1) the measure discriminates between the </text>
<text top=""817"" left=""108"" width=""685"" height=""16"" font=""0"">territories of Members; (2) the discrimination is arbitrary or unjustifiable; and (3) identical or </text>
<text top=""833"" left=""108"" width=""682"" height=""16"" font=""0"">similar conditions prevail in the territory of the Members compared. Based on the interpretation of </text>
<text top=""850"" left=""108"" width=""682"" height=""16"" font=""0"">the Appellate Body on ""arbitrary or unjustifiable discrimination"" in the chapeau of Article XX of the </text>
<text top=""866"" left=""108"" width=""685"" height=""16"" font=""0"">GATT 1994, the assessment of whether discrimination is ""arbitrary or unjustifiable"" should be </text>
<text top=""882"" left=""108"" width=""684"" height=""16"" font=""0"">made in light of the objectives of the measure and whether the discrimination bears a rational </text>
<text top=""899"" left=""108"" width=""363"" height=""16"" font=""0"">connection to the stated objective of the measure.    </text>
</p><p number=""20."" style=""6""><text top=""932"" left=""108"" width=""682"" height=""16"" font=""0"">20.  In light of the above, it is upon the Panel to determine the factual issues whether identical or </text>
<text top=""948"" left=""108"" width=""687"" height=""16"" font=""0"">similar conditions exist between Argentina and Uruguay, Japan, United Kingdom, and Santa </text>
<text top=""964"" left=""108"" width=""682"" height=""16"" font=""0"">Caratina, whether discrimination exists and whether the discrimination is arbitrary or unjustifiable.  </text>
</p><p number=""VII."" style=""0""><text top=""997"" left=""108"" width=""306"" height=""16"" font=""23"">VII.  Article 10.1 of the SPS Agreement </text></p><p number=""21."" style=""6""><text top=""1030"" left=""108"" width=""684"" height=""16"" font=""0"">21.  Although the term ""take account of"" in Article 10.1, as interpreted by panels in previous </text>
<text top=""1046"" left=""108"" width=""683"" height=""16"" font=""0"">cases, does not mean to achieve a specific result, i.e. accord special and differential treatment to </text>
<text top=""1063"" left=""108"" width=""684"" height=""16"" font=""0"">developing country Members, Members do have a mandatory obligation to consider the special </text>
<text top=""1079"" left=""108"" width=""686"" height=""16"" font=""0"">needs of developing country Members, and such consideration must be reflected in relevant </text>
<text top=""1096"" left=""108"" width=""685"" height=""16"" font=""0"">documentation. The burden of proof of developing country Members in this regard should be </text>
<text top=""1112"" left=""108"" width=""685"" height=""16"" font=""0"">treated with special care. In particular, where a developed country Member simply ignores its </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- C-12 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">obligation under Article 10.1, the developing country Members should not be required to prove </text>
<text top=""144"" left=""108"" width=""218"" height=""16"" font=""0"">something that does not exist.  </text>
</p></p></page>
<page number=""70"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<fontspec id=""31"" size=""11"" family=""Times"" color=""#000000"" style=""i""/><p number=""22."" style=""6""><text top=""177"" left=""108"" width=""686"" height=""16"" font=""0"">22.  As to the question whether the terms ""developing countries"" in Article 10.1 means all </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">developing countries or individual developing countries, China first recalls that the Appellate Body </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">has found that the phrase ""developing countries"" in paragraph 2 of the Enabling Clause does not </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">mean ""all developing countries"", and China considers this interpretation may shed light on the </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">interpretation of the same term in Article 10.1. China also notes that Article 2 of <i>the Procedure to </i></text>
<p><text top=""259"" left=""108"" width=""686"" height=""16"" font=""31"">Enhance Transparency of Special and Differential Treatment in Favour of Developing Country </text></p><p><text top=""275"" left=""108"" width=""683"" height=""16"" font=""8""><i>Members</i> adopted by the SPS Committee appears to imply that Article 10.1 requires members to </text>
<text top=""292"" left=""108"" width=""497"" height=""16"" font=""0"">take account of the special needs of ""an"" individual developing country.  </text>
</p></p><p number=""23."" style=""6""><text top=""324"" left=""108"" width=""684"" height=""16"" font=""0"">23.  As to the meaning of the ""special needs"" in Article 10.1, China considers that it includes, </text>
<text top=""341"" left=""108"" width=""688"" height=""16"" font=""8""><i>inter alia</i>, special financial, trade and development needs, according to its context. First, </text>
<text top=""357"" left=""108"" width=""687"" height=""16"" font=""0"">Article 10.3 of the SPS Agreement enables the SPS Committee to give special treatment to </text>
<text top=""374"" left=""108"" width=""683"" height=""16"" font=""0"">developing country Members by taking into account their financial, trade and development needs. </text>
<text top=""390"" left=""108"" width=""682"" height=""16"" font=""0"">Second, as the ""equivalent provision"" to Article 10.1 of the SPS Agreement, Article 12.3 of the TBT </text>
<text top=""407"" left=""108"" width=""685"" height=""16"" font=""0"">Agreement requires Members to take account of the special development, financial and trade </text>
<text top=""423"" left=""108"" width=""682"" height=""16"" font=""0"">needs of developing country Members. Finally, Article 10.2 also constitutes relevant context for the </text>
<text top=""439"" left=""108"" width=""683"" height=""16"" font=""0"">interpretation of Article 10.1. It requires Members to take account of special trade needs (i.e., to </text>
<text top=""456"" left=""108"" width=""684"" height=""16"" font=""0"">maintain opportunities for exports) of developing country Members by phasing introduction of a </text>
<text top=""472"" left=""108"" width=""132"" height=""16"" font=""0"">new SPS measure. </text>
</p><p number=""VIII."" style=""0""><text top=""505"" left=""108"" width=""405"" height=""16"" font=""23"">VIII. Article 8 and Annex C(1) of the SPS Agreement </text></p><p number=""24."" style=""6""><text top=""538"" left=""108"" width=""686"" height=""16"" font=""0"">24.  With respect to the U.S. argument that determinations involving disease-free areas fall </text>
<text top=""554"" left=""108"" width=""683"" height=""16"" font=""0"">outside the scope of Article 8 and Annex C of the SPS Agreement, China recalls that the Appellate </text>
<text top=""571"" left=""108"" width=""686"" height=""16"" font=""0"">Body and panels have confirmed that Article 8 and Annex C(1) have a broad coverage. The </text>
<text top=""587"" left=""108"" width=""685"" height=""16"" font=""0"">provisions do not specify or exclude any type of measures from its application, but cover any </text>
<text top=""603"" left=""108"" width=""685"" height=""16"" font=""0"">measure that is aimed at checking and ensuring the fulfilment of SPS measures. In fact, the </text>
<text top=""620"" left=""108"" width=""685"" height=""16"" font=""0"">determination of disease-free areas is one prerequisite step within the relevant U.S. approval </text>
<text top=""636"" left=""108"" width=""428"" height=""16"" font=""0"">procedures and it is thus subject to Article 8 and Annex C(1).  </text>
</p><p number=""25."" style=""6""><text top=""669"" left=""108"" width=""682"" height=""16"" font=""0"">25.  According to the interpretation of previous panels, Annex C(1)(a) first clause was essentially </text>
<text top=""685"" left=""108"" width=""685"" height=""16"" font=""0"">a good faith obligation, requiring Members to not only undertake but also complete approval </text>
<text top=""702"" left=""108"" width=""684"" height=""16"" font=""0"">procedures as promptly as possible. The phrase ""undue delay"" as used in Annex C(1)(a) means </text>
<text top=""718"" left=""108"" width=""683"" height=""16"" font=""0"">""an unjustified loss of time"", which is determined not by the length of the delay, but by whether </text>
<text top=""735"" left=""108"" width=""684"" height=""16"" font=""0"">the delay is justified. In the present case, it appears that a decade-long waiting period for the </text>
<text top=""751"" left=""108"" width=""684"" height=""16"" font=""0"">contested approval procedures yet to be completed constitutes a delay. Thus, the focus of the </text>
<text top=""767"" left=""108"" width=""461"" height=""16"" font=""0"">dispute would be whether there is justifiable reason for this delay.  </text>
</p><p number=""26."" style=""6""><text top=""800"" left=""108"" width=""683"" height=""16"" font=""0"">26.  As to Section 737 of 2009 Omnibus Appropriations Act, China anticipates that the Panel will </text>
<text top=""817"" left=""108"" width=""682"" height=""16"" font=""0"">be guided by the Panel Report in <i>US &#8211; Poultry (China)</i>. First, China concurs that Section 737 is an </text>
<text top=""833"" left=""108"" width=""683"" height=""16"" font=""0"">SPS measure which is subject to the disciplines of articles 2, 3, 5, as well as 8 and Annex C(1). </text>
<text top=""850"" left=""108"" width=""687"" height=""16"" font=""0"">Second, Section 737 imposed ""undue delays"" on the U.S. approval procedures to allow the </text>
<text top=""866"" left=""108"" width=""684"" height=""16"" font=""0"">importation of fresh bovine meat from Argentina and for the recognition of Patagonia Region as </text>
<text top=""882"" left=""108"" width=""684"" height=""16"" font=""0"">FMD-free Zone by precluding the U.S. authority from issuing a risk assessment and from even </text>
<text top=""899"" left=""108"" width=""483"" height=""16"" font=""0"">initiating a rulemaking procedure to allow importation from Argentina. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- C-13 - </text>
</p></p></page>
<page number=""71"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""32"" size=""8"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""22"" size=""8"" family=""Times"" color=""#000000""/>
<p><text top=""164"" left=""405"" width=""88"" height=""16"" font=""26"">ANNEX C-4 </text></p><p><text top=""198"" left=""158"" width=""581"" height=""16"" font=""6"">INTEGRATED EXECUTIVE SUMMARY OF THE ARGUMENTS OF THE EUROPEAN UNION </text>
</p><p number=""1."" style=""6""><text top=""241"" left=""108"" width=""52"" height=""16"" font=""23"">1. T</text><text top=""244"" left=""160"" width=""261"" height=""13"" font=""29"">HE MEASURES IN RELATION TO FRESH BEEF</text></p><p number=""1.1"" style=""8""><text top=""274"" left=""151"" width=""52"" height=""16"" font=""31"">1.1. A</text><text top=""277"" left=""202"" width=""56"" height=""13"" font=""32"">RGENTINA</text><text top=""274"" left=""258"" width=""4"" height=""16"" font=""31"">'</text><text top=""277"" left=""262"" width=""96"" height=""13"" font=""32"">S CLAIMS UNDER </text><text top=""274"" left=""358"" width=""9"" height=""16"" font=""31"">A</text><text top=""277"" left=""367"" width=""38"" height=""13"" font=""32"">RTICLE</text><text top=""274"" left=""406"" width=""27"" height=""16"" font=""31""> 1.1</text><text top=""277"" left=""432"" width=""46"" height=""13"" font=""32""> OF THE </text><text top=""274"" left=""479"" width=""41"" height=""16"" font=""31"">SPS A</text><text top=""277"" left=""519"" width=""59"" height=""13"" font=""32"">GREEMENT</text></p><p number=""1."" style=""6""><text top=""307"" left=""108"" width=""19"" height=""16"" font=""0"">1. </text>
<text top=""307"" left=""151"" width=""640"" height=""16"" font=""0"">The European Union doubts that Article 1.1 of the SPS Agreement, by itself, may serve as a </text>
<text top=""323"" left=""108"" width=""684"" height=""16"" font=""0"">legal basis for a claim in WTO dispute settlement proceedings. Neither Article 1.1, nor any other </text>
<text top=""340"" left=""108"" width=""684"" height=""16"" font=""0"">paragraph of Article 1 of the SPS Agreement contains any specific obligation for WTO Members, </text>
<text top=""356"" left=""108"" width=""682"" height=""16"" font=""0"">which is independent from the obligations contained in the other provisions of the SPS Agreement. </text>
<text top=""373"" left=""108"" width=""683"" height=""16"" font=""0"">This differentiates Article 1.1 from Article 2.2 of the SPS Agreement, which enumerates a number </text>
<text top=""389"" left=""108"" width=""683"" height=""16"" font=""0"">of clearly defined and specific obligations, which may sometimes be related to the Members' other </text>
<text top=""405"" left=""108"" width=""683"" height=""16"" font=""0"">obligations, but which are independent from them. The consequence is that there can be no legal </text>
<text top=""422"" left=""108"" width=""384"" height=""16"" font=""0"">claim based <i>solely</i> on Article 1.1 of the SPS Agreement. </text>
</p><p number=""1.2"" style=""8""><text top=""455"" left=""151"" width=""52"" height=""16"" font=""31"">1.2. A</text><text top=""458"" left=""202"" width=""56"" height=""13"" font=""32"">RGENTINA</text><text top=""455"" left=""258"" width=""4"" height=""16"" font=""31"">'</text><text top=""458"" left=""262"" width=""96"" height=""13"" font=""32"">S CLAIMS UNDER </text><text top=""455"" left=""358"" width=""9"" height=""16"" font=""31"">A</text><text top=""458"" left=""367"" width=""38"" height=""13"" font=""32"">RTICLE</text><text top=""455"" left=""406"" width=""27"" height=""16"" font=""31""> 3.1</text><text top=""458"" left=""432"" width=""46"" height=""13"" font=""32""> OF THE </text><text top=""455"" left=""479"" width=""41"" height=""16"" font=""31"">SPS A</text><text top=""458"" left=""519"" width=""59"" height=""13"" font=""32"">GREEMENT</text></p><p number=""2."" style=""6""><text top=""488"" left=""108"" width=""21"" height=""16"" font=""0"">2. </text>
<text top=""488"" left=""151"" width=""642"" height=""16"" font=""0"">The European Union does not consider that the ""standards"" relied upon by Argentina are </text>
<text top=""504"" left=""108"" width=""686"" height=""16"" font=""0"">relevant for the analysis of the challenged measure, i.e. Section 94.1(b), because they have </text>
<text top=""520"" left=""108"" width=""684"" height=""16"" font=""0"">different scope and coverage. The ""standards"" deal with regions and countries that are free of </text>
<text top=""537"" left=""108"" width=""683"" height=""16"" font=""0"">foot-and-mouth disease, while Section 94.1(b) deals with regions and countries that are <i>not</i> free </text>
<text top=""553"" left=""108"" width=""683"" height=""16"" font=""0"">of foot-and-mouth disease. In addition, Argentina asserts that it is ""internationally recognised as </text>
<text top=""570"" left=""108"" width=""683"" height=""16"" font=""0"">FMD-free with vaccination"", or ""without vaccination"", depending on the region. However, the two </text>
<text top=""586"" left=""108"" width=""682"" height=""16"" font=""0"">Articles of the OIE Terrestrial Code, to which Argentina refers, do not provide any recommendation </text>
<text top=""602"" left=""108"" width=""682"" height=""16"" font=""0"">as to the <i>conditions</i> that a country or region should fulfil, in order to fall within one of the relevant </text>
<text top=""619"" left=""108"" width=""684"" height=""16"" font=""0"">categories (e.g., FMD free; FMD free without vaccination; FMD free with vaccination). Argentina </text>
<text top=""635"" left=""108"" width=""683"" height=""16"" font=""0"">does not provide those Articles of the OIE Terrestrial Code which would address the procedures to </text>
<text top=""652"" left=""108"" width=""677"" height=""16"" font=""0"">be followed in relation to imports of meat from areas that are <i>not</i> considered to be free of foot-</text>
<text top=""668"" left=""108"" width=""686"" height=""16"" font=""0"">and-mouth disease, which is the situation that Section 94.1(b) is dealing with. Consequently, </text>
<text top=""684"" left=""108"" width=""688"" height=""16"" font=""0"">Argentina has failed to make a <i>prima facie</i> case for its claims under Article 3.1 of the </text>
<text top=""701"" left=""108"" width=""116"" height=""16"" font=""0"">SPS Agreement. </text>
</p><p number=""1.3"" style=""8""><text top=""734"" left=""151"" width=""52"" height=""16"" font=""31"">1.3. A</text><text top=""737"" left=""202"" width=""56"" height=""13"" font=""32"">RGENTINA</text><text top=""734"" left=""258"" width=""4"" height=""16"" font=""31"">'</text><text top=""737"" left=""262"" width=""96"" height=""13"" font=""32"">S CLAIMS UNDER </text><text top=""734"" left=""358"" width=""9"" height=""16"" font=""31"">A</text><text top=""737"" left=""367"" width=""38"" height=""13"" font=""32"">RTICLE</text><text top=""734"" left=""406"" width=""27"" height=""16"" font=""31""> 3.3</text><text top=""737"" left=""432"" width=""46"" height=""13"" font=""32""> OF THE </text><text top=""734"" left=""479"" width=""41"" height=""16"" font=""31"">SPS A</text><text top=""737"" left=""519"" width=""59"" height=""13"" font=""32"">GREEMENT</text></p><p number=""3."" style=""6""><text top=""766"" left=""108"" width=""18"" height=""16"" font=""0"">3. </text>
<text top=""766"" left=""151"" width=""640"" height=""16"" font=""0"">Article 3.3 of the SPS Agreement applies only where the challenged measure is not based on </text>
<text top=""783"" left=""108"" width=""682"" height=""16"" font=""0"">the ""relevant international standards"". This means that, in order to make a <i>prima facie</i> case under </text>
<text top=""799"" left=""108"" width=""685"" height=""16"" font=""0"">Article 3.3 of the SPS Agreement, the complaining party should first (a) provide the ""relevant </text>
<text top=""816"" left=""108"" width=""687"" height=""16"" font=""0"">international standard""; and (b) show that the challenged measure is not ""based on"" this </text>
<text top=""832"" left=""108"" width=""682"" height=""16"" font=""0"">international standard. In the present case, Argentina has not provided the ""relevant international </text>
<text top=""848"" left=""108"" width=""683"" height=""16"" font=""0"">standard"" that should have been the basis of Section 94.1(b). Consequently, Argentina has failed </text>
<text top=""865"" left=""108"" width=""690"" height=""16"" font=""0"">to show <i>prima facie</i> that the provisions of Article 3.3 of the SPS Agreement apply to </text>
<text top=""881"" left=""108"" width=""116"" height=""16"" font=""0"">Section 94.1(b). </text>
</p><p number=""1.4"" style=""8""><text top=""914"" left=""151"" width=""52"" height=""16"" font=""31"">1.4. A</text><text top=""917"" left=""202"" width=""56"" height=""13"" font=""32"">RGENTINA</text><text top=""914"" left=""258"" width=""4"" height=""16"" font=""31"">'</text><text top=""917"" left=""262"" width=""96"" height=""13"" font=""32"">S CLAIMS UNDER </text><text top=""914"" left=""358"" width=""9"" height=""16"" font=""31"">A</text><text top=""917"" left=""367"" width=""38"" height=""13"" font=""32"">RTICLE</text><text top=""914"" left=""406"" width=""13"" height=""16"" font=""31""> 5</text><text top=""917"" left=""419"" width=""46"" height=""13"" font=""32""> OF THE </text><text top=""914"" left=""465"" width=""41"" height=""16"" font=""31"">SPS A</text><text top=""917"" left=""506"" width=""59"" height=""13"" font=""32"">GREEMENT</text></p><p number=""1.4"" style=""8""><text top=""947"" left=""193"" width=""48"" height=""16"" font=""23"">1.4.1. </text><text top=""947"" left=""278"" width=""447"" height=""16"" font=""23"">Argentina's claims under Article 5.1 of the SPS Agreement </text></p><p number=""4."" style=""6""><text top=""980"" left=""108"" width=""18"" height=""16"" font=""0"">4. </text>
<text top=""980"" left=""151"" width=""639"" height=""16"" font=""0"">The import ban on animals and meat from areas where foot-and-mouth disease exists would </text>
<text top=""996"" left=""108"" width=""685"" height=""16"" font=""0"">comply with Article 5.1 of the SPS Agreement, if it was supported by a risk assessment that </text>
<text top=""1013"" left=""108"" width=""684"" height=""16"" font=""0"">showed (a) that foot-and-mouth disease poses risks to human or animal health or life; and (b) </text>
<text top=""1029"" left=""108"" width=""683"" height=""16"" font=""0"">that preventing the introduction of infected animals or fresh meat made of infected animals is a </text>
<text top=""1045"" left=""108"" width=""682"" height=""16"" font=""0"">proper response to the risks posed by foot-and-mouth disease. This risk assessment does not need </text>
<text top=""1062"" left=""108"" width=""677"" height=""16"" font=""0"">to include an analysis of which specific regions in the world are actually infected with foot-and-</text>
<text top=""1078"" left=""108"" width=""677"" height=""16"" font=""0"">mouth disease. Section 94.1(b) provides for a general import ban from <i>any</i> region where foot-and-</text>
<text top=""1095"" left=""108"" width=""684"" height=""16"" font=""0"">mouth disease exists: it does not include the list of infected regions. The relevant time for the </text>
<text top=""1111"" left=""108"" width=""682"" height=""16"" font=""0"">existence of such a risk assessment is the time at which the general import ban of Section 94.1(b) </text>
<text top=""1127"" left=""108"" width=""113"" height=""16"" font=""0"">was introduced. </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- C-14 - </text>
</p></p></page>
<page number=""72"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""1.4"" style=""8""><text top=""144"" left=""193"" width=""48"" height=""16"" font=""23"">1.4.2. </text><text top=""144"" left=""278"" width=""447"" height=""16"" font=""23"">Argentina's claims under Article 5.4 of the SPS Agreement </text></p><p number=""5."" style=""6""><text top=""177"" left=""108"" width=""20"" height=""16"" font=""0"">5. </text>
<text top=""177"" left=""151"" width=""641"" height=""16"" font=""0"">The European Union considers that the Panel's conclusion in <i>EC &#8211; Hormones</i> is correct, for </text>
<text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">the reasons discussed in that Panel's Report. Therefore, Argentina's autonomous claims under </text>
<text top=""210"" left=""108"" width=""475"" height=""16"" font=""0"">Article 5.4 of the SPS Agreement should be rejected in their entirety. </text>
</p><p number=""1.4"" style=""8""><text top=""242"" left=""193"" width=""48"" height=""16"" font=""23"">1.4.3. </text><text top=""242"" left=""278"" width=""447"" height=""16"" font=""23"">Argentina's claims under Article 5.6 of the SPS Agreement </text></p><p number=""6."" style=""6""><text top=""275"" left=""108"" width=""21"" height=""16"" font=""0"">6. </text>
<text top=""275"" left=""151"" width=""642"" height=""16"" font=""0"">Article 8.5.4 of the OIE Terrestrial Code states that ""susceptible animals in the FMD free </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">zone should be protected from the rest of the country and from neighbouring countries if they are </text>
<text top=""308"" left=""108"" width=""684"" height=""16"" font=""0"">of a different animal health status by the application of animal health measures that effectively </text>
<text top=""324"" left=""108"" width=""682"" height=""16"" font=""0"">prevent the entry of the virus"". It also states that ""these measures may include a protection zone"". </text>
<text top=""341"" left=""108"" width=""685"" height=""16"" font=""0"">Therefore, the ""recommendations"" developed by the relevant international organization include </text>
<text top=""357"" left=""108"" width=""684"" height=""16"" font=""0"">import bans. If indeed Section 94.1(b) conforms to such international recommendations, then it </text>
<text top=""374"" left=""108"" width=""682"" height=""16"" font=""0"">should be presumed to be consistent with the SPS Agreement. Argentina does not contest the fact </text>
<text top=""390"" left=""108"" width=""682"" height=""16"" font=""0"">that the territory of the United States is a region that is free of foot-and-mouth disease. Argentina </text>
<text top=""407"" left=""108"" width=""683"" height=""16"" font=""0"">also does not challenge Section 94.1(a), which provides that Argentina is <i>not</i> a region that is free </text>
<text top=""423"" left=""108"" width=""682"" height=""16"" font=""0"">of foot-and-mouth disease. Therefore, the import ban imposed by Section 94.1(b) seems to create </text>
<text top=""439"" left=""108"" width=""683"" height=""16"" font=""0"">a ""protection zone"", such as the one recommended by the OIE Terrestrial Code. The Panel should </text>
<text top=""456"" left=""108"" width=""685"" height=""16"" font=""0"">accept Argentina's claims under Article 5.6 of the SPS Agreement only if the facts of the case </text>
<text top=""472"" left=""108"" width=""684"" height=""16"" font=""0"">establish that a ban on imports from territories where foot-and-mouth disease exists is not an </text>
<text top=""489"" left=""108"" width=""686"" height=""16"" font=""0"">acceptable measure to prevent the introduction of foot-and-mouth disease into the protected </text>
<text top=""505"" left=""108"" width=""684"" height=""16"" font=""0"">territories, taking into consideration the guidance provided by the recommendations of the OIE </text>
<text top=""521"" left=""108"" width=""118"" height=""16"" font=""0"">Terrestrial Code. </text>
</p><p number=""1.4"" style=""8""><text top=""554"" left=""193"" width=""48"" height=""16"" font=""23"">1.4.4. </text><text top=""554"" left=""278"" width=""447"" height=""16"" font=""23"">Argentina's claims under Article 5.7 of the SPS Agreement </text></p><p number=""7."" style=""6""><text top=""587"" left=""108"" width=""25"" height=""16"" font=""0"">7. </text>
<text top=""587"" left=""151"" width=""646"" height=""16"" font=""0"">The European Union observes that there is a penumbra to the distinction between </text>
<text top=""603"" left=""108"" width=""685"" height=""16"" font=""0"">""definitive"" and ""provisional"" measures. In the ""provisional"" context of Article 5.7 what weighs </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">particularly heavily in the assessment are the need for urgent action and the objective of avoiding </text>
<text top=""636"" left=""108"" width=""682"" height=""16"" font=""0"">loss to the protected interest. Science and other information, whilst relevant to the extent present, </text>
<text top=""653"" left=""108"" width=""684"" height=""16"" font=""0"">carry less weight, simply because they are less complete. On the other hand, in the ""definitive"" </text>
<text top=""669"" left=""108"" width=""686"" height=""16"" font=""0"">context the proposition is that sufficient time has elapsed to permit a more considered and </text>
<text top=""685"" left=""108"" width=""683"" height=""16"" font=""0"">ultimately balanced consideration of the issue, based on more complete information: time carries </text>
<text top=""702"" left=""108"" width=""682"" height=""16"" font=""0"">less weight and science more weight. Where the measure is in the nature of an <i>omission</i>, a better </text>
<text top=""718"" left=""108"" width=""682"" height=""16"" font=""0"">approach may be to examine whether the available information reasonably supports the position of </text>
<text top=""735"" left=""108"" width=""686"" height=""16"" font=""0"">the complaining Member or the position of the defending Member. The European Union also </text>
<text top=""751"" left=""108"" width=""687"" height=""16"" font=""0"">observes that there are situations in which the science is uncontroversial, but in which an </text>
<text top=""767"" left=""108"" width=""686"" height=""16"" font=""0"">importing Member might receive information about a particular region, or indeed a particular </text>
<text top=""784"" left=""108"" width=""684"" height=""16"" font=""0"">product or establishment, which could justify provisional action under Article 5.7. The European </text>
<text top=""800"" left=""108"" width=""682"" height=""16"" font=""0"">Union also considers that an application in a specific case may remain pending, without a decision, </text>
<text top=""817"" left=""108"" width=""687"" height=""16"" font=""0"">positive or negative, without this necessarily meaning that there is undue delay within the </text>
<text top=""833"" left=""108"" width=""681"" height=""16"" font=""0"">meaning of Article 8 and Annex C. A panel should take into account also Article 5.7 in this analysis. </text>
</p><p number=""1.5"" style=""8""><text top=""866"" left=""151"" width=""52"" height=""16"" font=""31"">1.5. A</text><text top=""869"" left=""202"" width=""56"" height=""13"" font=""32"">RGENTINA</text><text top=""866"" left=""258"" width=""4"" height=""16"" font=""31"">'</text><text top=""869"" left=""262"" width=""96"" height=""13"" font=""32"">S CLAIMS UNDER </text><text top=""866"" left=""358"" width=""9"" height=""16"" font=""31"">A</text><text top=""869"" left=""367"" width=""38"" height=""13"" font=""32"">RTICLE</text><text top=""866"" left=""406"" width=""27"" height=""16"" font=""31""> 2.3</text><text top=""869"" left=""432"" width=""46"" height=""13"" font=""32""> OF THE </text><text top=""866"" left=""479"" width=""41"" height=""16"" font=""31"">SPS A</text><text top=""869"" left=""519"" width=""59"" height=""13"" font=""32"">GREEMENT</text></p><p number=""8."" style=""6""><text top=""899"" left=""108"" width=""19"" height=""16"" font=""0"">8. </text>
<text top=""899"" left=""151"" width=""640"" height=""16"" font=""0"">Argentina's claims under Article 2.3 of the SPS Agreement are based on a comparison of its </text>
<text top=""915"" left=""108"" width=""682"" height=""16"" font=""0"">own status as a foot-and-mouth <i>not</i> free region in the US domestic rules, with the status of other </text>
<text top=""932"" left=""108"" width=""685"" height=""16"" font=""0"">countries or regions, which are considered by the US domestic rules as foot-and-mouth free. </text>
<text top=""948"" left=""108"" width=""685"" height=""16"" font=""0"">However, the domestic measures challenged by Argentina do not determine which regions are </text>
<text top=""964"" left=""108"" width=""683"" height=""16"" font=""0"">free, or not-free, of foot-and-mouth disease. They do not seem to involve any different treatment </text>
<text top=""981"" left=""108"" width=""685"" height=""16"" font=""0"">of various regions or countries. Therefore, the European Union does not see how Argentina's </text>
<text top=""997"" left=""108"" width=""461"" height=""16"" font=""0"">claims under Article 2.3 of the SPS Agreement could be successful. </text>
</p><p number=""1.6"" style=""8""><text top=""1030"" left=""151"" width=""52"" height=""16"" font=""31"">1.6. A</text><text top=""1033"" left=""202"" width=""56"" height=""13"" font=""32"">RGENTINA</text><text top=""1030"" left=""258"" width=""4"" height=""16"" font=""31"">'</text><text top=""1033"" left=""262"" width=""96"" height=""13"" font=""32"">S CLAIMS UNDER </text><text top=""1030"" left=""358"" width=""9"" height=""16"" font=""31"">A</text><text top=""1033"" left=""367"" width=""38"" height=""13"" font=""32"">RTICLE</text><text top=""1030"" left=""406"" width=""35"" height=""16"" font=""31""> 10.1</text><text top=""1033"" left=""441"" width=""46"" height=""13"" font=""32""> OF THE </text><text top=""1030"" left=""487"" width=""41"" height=""16"" font=""31"">SPS A</text><text top=""1033"" left=""528"" width=""59"" height=""13"" font=""32"">GREEMENT</text></p><p number=""9."" style=""6""><text top=""1063"" left=""108"" width=""21"" height=""16"" font=""0"">9. </text>
<text top=""1063"" left=""151"" width=""642"" height=""16"" font=""0"">It is not clear whether Article 10.1 of the SPS Agreement can serve as a legal basis for </text>
<text top=""1079"" left=""108"" width=""683"" height=""16"" font=""0"">claims in dispute settlement proceedings. It is framed in very general and vague terms which do </text>
<text top=""1096"" left=""108"" width=""684"" height=""16"" font=""0"">not clearly spell out any specific obligation for positive action for any WTO Member. The text of </text>
<text top=""1112"" left=""108"" width=""683"" height=""16"" font=""0"">Article 10.1 of the SPS Agreement has a certain resemblance with some of the provisions of Part </text>
<text top=""1128"" left=""108"" width=""682"" height=""16"" font=""0"">IV of the GATT. Prior to the creation of the WTO, various GATT contracting parties sought to base </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- C-15 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">claims, or defences, on the provisions of Part IV of the GATT, but none was successful. Likewise, </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">following the creation of the WTO, no Panel has ever entertained a claim under Article 10.1 of the </text>
<text top=""160"" left=""108"" width=""116"" height=""16"" font=""0"">SPS Agreement. </text>
</p></p></page>
<page number=""73"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""10."" style=""6""><text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">10.  Even if Article 10.1 of the SPS Agreement could serve as a legal basis for claims in dispute </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">settlement proceedings, Argentina's assertion that the United States' ""preparation and application"" </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">of the SPS measure failed to ""take account"" of the developing countries' ""special needs"" is </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">contradicted by Argentina's assertion that the United States' ""application"" of the SPS measure was </text>
<text top=""259"" left=""108"" width=""684"" height=""16"" font=""0"">more favourable to Uruguay and a certain region of Brazil, which are both developing countries. </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">The fact that Argentina acknowledges that the United States' ""preparation and application"" of its </text>
<text top=""292"" left=""108"" width=""683"" height=""16"" font=""0"">SPS measure is favourable to other developing countries would seem to indicate that the United </text>
<text top=""308"" left=""108"" width=""683"" height=""16"" font=""0"">States does ""take account"" of the developing countries' ""special needs"" and, therefore, that there </text>
<text top=""324"" left=""108"" width=""591"" height=""16"" font=""0"">is no breach of whatever obligation is embodied in Article 10.1 of the SPS Agreement. </text>
</p><p number=""1.7"" style=""8""><text top=""357"" left=""151"" width=""51"" height=""16"" font=""31"">1.7. T</text><text top=""360"" left=""201"" width=""133"" height=""13"" font=""32"">HE RELATION BETWEEN </text><text top=""357"" left=""334"" width=""9"" height=""16"" font=""31"">A</text><text top=""360"" left=""343"" width=""56"" height=""13"" font=""32"">RGENTINA</text><text top=""357"" left=""399"" width=""4"" height=""16"" font=""31"">'</text><text top=""360"" left=""403"" width=""123"" height=""13"" font=""32"">S CLAIMS UNDER THE </text><text top=""357"" left=""525"" width=""41"" height=""16"" font=""31"">SPS A</text><text top=""360"" left=""566"" width=""223"" height=""13"" font=""32"">GREEMENT AND ITS CLAIMS UNDER THE </text><text top=""374"" left=""193"" width=""41"" height=""16"" font=""31"">GATT </text></p><p number=""11."" style=""6""><text top=""407"" left=""108"" width=""687"" height=""16"" font=""0"">11.  The European Union doubts that a finding of inconsistency with any provision of the </text>
<text top=""423"" left=""108"" width=""685"" height=""16"" font=""0"">SPS Agreement automatically means, mechanistically and as a matter of law, that there is no </text>
<text top=""439"" left=""108"" width=""682"" height=""16"" font=""0"">more scope for the application of Article XX(b) of the GATT in relation to claims brought under the </text>
<text top=""456"" left=""108"" width=""684"" height=""16"" font=""0"">GATT. This would imply complete identity of scope between Article XX(b) of the GATT and the </text>
<text top=""472"" left=""108"" width=""684"" height=""16"" font=""0"">SPS Agreement in relation to measures that meet the definition of ""SPS measure"", as set out in </text>
<text top=""489"" left=""108"" width=""683"" height=""16"" font=""0"">Article 1.1 and Annex A.1 of the SPS Agreement. However, neither the text of the GATT, nor the </text>
<text top=""505"" left=""108"" width=""687"" height=""16"" font=""0"">text of the SPS Agreement expressly provides for such identity of scope. Article 2.4 of the </text>
<text top=""521"" left=""108"" width=""684"" height=""16"" font=""0"">SPS Agreement provides that measures that conform with the provisions of the SPS Agreement </text>
<text top=""538"" left=""108"" width=""682"" height=""16"" font=""0"">shall be <i>presumed</i>  to  be  in  accordance  with  the  GATT  and,  in  particular,  Article XX(b).  However, </text>
<text top=""554"" left=""108"" width=""395"" height=""16"" font=""0"">there is no reverse presumption. Neither Article </text>
<text top=""554"" left=""494"" width=""305"" height=""16"" font=""0"">2.4, nor any other provision of the </text>
<text top=""571"" left=""108"" width=""684"" height=""16"" font=""0"">SPS Agreement, provides that a measure that fails to conform with the SPS Agreement shall be </text>
<text top=""587"" left=""108"" width=""684"" height=""16"" font=""0"">presumed to be inconsistent with Article XX(b). The Appellate Body has implicitly confirmed that </text>
<text top=""603"" left=""108"" width=""682"" height=""16"" font=""0"">Article XX(b)  can  be  used  to  defend  an  SPS  measure  from  claims  raised  under  the  GATT  in  its </text>
<text top=""620"" left=""108"" width=""682"" height=""16"" font=""0"">report in <i>Brazil-Retreaded Tyres</i>. The Appellate Body did not state that the analysis of Article XX(b) </text>
<text top=""636"" left=""108"" width=""686"" height=""16"" font=""0"">included the measure's consistency with the SPS Agreement. The Appellate Body went on to </text>
<text top=""653"" left=""108"" width=""684"" height=""16"" font=""0"">interpret and apply Article XX(b) of the GATT without any reference to the SPS Agreement. The </text>
<text top=""669"" left=""108"" width=""562"" height=""16"" font=""0"">same conclusion is drawn from the report of the Appellate Body in <i>EC &#8211; Asbestos</i>. </text>
</p><p number=""12."" style=""6""><text top=""702"" left=""108"" width=""682"" height=""16"" font=""0"">12.  Moreover, if the SPS Agreement is considered to contain an entire and complete set of rules </text>
<text top=""718"" left=""108"" width=""682"" height=""16"" font=""0"">relating to SPS measures, then it should also be accepted that this set of rules would pre-empt the </text>
<text top=""735"" left=""108"" width=""682"" height=""16"" font=""0"">application of all GATT provisions (including Article I and Article XI of the GATT) on SPS measures, </text>
<text top=""751"" left=""108"" width=""683"" height=""16"" font=""0"">and not only the application of Article XX(b). Therefore, one of the following interpretations must </text>
<text top=""767"" left=""108"" width=""682"" height=""16"" font=""0"">be accepted. One, the SPS Agreement constitutes a complete, self-standing elaboration of <i>all</i> GATT </text>
<text top=""784"" left=""108"" width=""682"" height=""16"" font=""0"">provisions relating to SPS measures. The logical consequence would be that the complaining party </text>
<text top=""800"" left=""108"" width=""686"" height=""16"" font=""0"">would be precluded from raising any <i>separate</i> claims against that measure under the GATT, </text>
<text top=""817"" left=""108"" width=""684"" height=""16"" font=""0"">because the entire set of GATT obligations relating to SPS measures would be ""elaborated"" and </text>
<text top=""833"" left=""108"" width=""685"" height=""16"" font=""0"">contained in the SPS Agreement. Two, a complaining party may be able to challenge the SPS </text>
<text top=""850"" left=""108"" width=""684"" height=""16"" font=""0"">measures under the GATT, in addition to its challenge under the SPS Agreement. However, the </text>
<text top=""866"" left=""108"" width=""682"" height=""16"" font=""0"">defending party would also have the right to defend its measure against the GATT claims raised by </text>
<text top=""882"" left=""108"" width=""683"" height=""16"" font=""0"">the complaining party, including by relying on Article XX(b) of the GATT, irrespective of whether </text>
<text top=""899"" left=""108"" width=""383"" height=""16"" font=""0"">the measure conforms with the SPS Agreement or not.  </text>
</p><p number=""2."" style=""6""><text top=""932"" left=""108"" width=""52"" height=""16"" font=""23"">2. T</text><text top=""935"" left=""160"" width=""165"" height=""13"" font=""29"">HE CLAIM OF UNDUE DELAY</text></p><p number=""13."" style=""6""><text top=""964"" left=""108"" width=""687"" height=""16"" font=""0"">13.  The European Union considers that Article 8 and Annex C of the SPS Agreement, and </text>
<text top=""981"" left=""108"" width=""683"" height=""16"" font=""0"">specifically the rule against undue delay, apply to control, inspection and approval procedures as </text>
<text top=""997"" left=""108"" width=""232"" height=""16"" font=""0"">regard both products and regions </text>
</p><p number=""14."" style=""6""><text top=""1030"" left=""108"" width=""684"" height=""16"" font=""0"">14.  One interesting question is whether or not an importing Member that sets up framework </text>
<text top=""1046"" left=""108"" width=""682"" height=""16"" font=""0"">legislation requiring prior authorisation, and that is in receipt of an application that it does not yet </text>
<text top=""1063"" left=""108"" width=""684"" height=""16"" font=""0"">find complete or convincing, is necessarily required to adopt a negative decision, or may rather </text>
<text top=""1079"" left=""108"" width=""683"" height=""16"" font=""0"">continue to rely on the general and provisional prohibition contained in the framework legislation </text>
<text top=""1096"" left=""108"" width=""683"" height=""16"" font=""0"">establishing the requirement of prior authorisation. The European Union considers that there may </text>
<text top=""1112"" left=""108"" width=""682"" height=""16"" font=""0"">be no absolute answer to this question in abstract terms. Rather, it is something that may need to </text>
<text top=""1128"" left=""108"" width=""683"" height=""16"" font=""0"">be considered on a case-by-case basis. The European Union can envisage some circumstances in </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- C-16 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">which an application is complete and ripe for what will probably be a more or less final decision. In </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">this kind of situation, once the file is complete, importing Members should issue a negative </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">decision, which exporting Members may then contest in the WTO should they wish to do so. Failure </text>
<text top=""177"" left=""108"" width=""437"" height=""16"" font=""0"">to issue such a negative decision could amount to undue delay. </text>
</p></p></page>
<page number=""74"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""15."" style=""6""><text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">15.  At the same time, the European Union can also envisage some circumstances in which the </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">time-frames involved are such that the framework legislation requiring prior authorisation already </text>
<text top=""242"" left=""108"" width=""685"" height=""16"" font=""0"">more than adequately sketches out the types of considerations indicated in Article 5.7 of the </text>
<text top=""259"" left=""108"" width=""685"" height=""16"" font=""0"">SPS Agreement; in which there is real and genuine controversy over whether an application is </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">complete, in the sense that it has adequately explored and allayed the concerns of the importing </text>
<text top=""292"" left=""108"" width=""685"" height=""16"" font=""0"">Member and its citizens; and in which it is reasonable to rely on the (provisional) prohibition </text>
<text top=""308"" left=""108"" width=""682"" height=""16"" font=""0"">contained in the framework legislation. In these circumstances, the absence of a negative decision </text>
<text top=""324"" left=""108"" width=""682"" height=""16"" font=""0"">would not amount to undue delay. Rather, the question of whether or not there is undue delay will </text>
<text top=""341"" left=""108"" width=""349"" height=""16"" font=""0"">need to be considered on the basis of all the facts. </text>
</p><p number=""16."" style=""6""><text top=""374"" left=""108"" width=""686"" height=""16"" font=""0"">16.  A distinct but related question is burden of proof. There may not be a ""record"" of an </text>
<text top=""390"" left=""108"" width=""683"" height=""16"" font=""0"">administrative proceeding, and the set of facts and evidence potentially relevant to assessing an </text>
<text top=""407"" left=""108"" width=""684"" height=""16"" font=""0"">SPS dispute may remain open, whether or not the importing Member has acted (by adopting a </text>
<text top=""423"" left=""108"" width=""685"" height=""16"" font=""0"">negative decision, whether final or provisional) or not yet acted. In principle, the complaining </text>
<text top=""439"" left=""108"" width=""684"" height=""16"" font=""0"">Member has the burden of making its case in WTO proceedings, and the defending Member its </text>
<text top=""456"" left=""108"" width=""682"" height=""16"" font=""0"">defence. In this respect, it should be noted that Article 6 of the SPS Agreement requires importing </text>
<text top=""472"" left=""108"" width=""687"" height=""16"" font=""0"">Members to adapt their SPS measures to the region from which a product originates, but, </text>
<text top=""489"" left=""108"" width=""687"" height=""16"" font=""0"">significantly, Article 6.3 provides that exporting Members claiming disease-free status ""shall </text>
<text top=""505"" left=""108"" width=""685"" height=""16"" font=""0"">provide the necessary evidence thereof in order to objectively demonstrate"" that the relevant </text>
<text top=""521"" left=""108"" width=""156"" height=""16"" font=""0"">region is disease-free. </text>
</p><p number=""17."" style=""6""><text top=""554"" left=""108"" width=""683"" height=""16"" font=""0"">17.  In the absence of a specific negative decision, one might also expect the defending Member </text>
<text top=""571"" left=""108"" width=""683"" height=""16"" font=""0"">to provide an exhaustive and duly evidenced description of any additional material relevant to the </text>
<text top=""587"" left=""108"" width=""683"" height=""16"" font=""0"">question of the passage of time, whether or not supportive of such delay. Only then could a panel </text>
<text top=""603"" left=""108"" width=""555"" height=""16"" font=""0"">make an objective assessment of whether or not the passage of time is justified. </text>
</p><p number=""18."" style=""6""><text top=""636"" left=""108"" width=""682"" height=""16"" font=""0"">18.  To the extent that such information is not part of the record of the proceedings, a panel may </text>
<text top=""653"" left=""108"" width=""684"" height=""16"" font=""0"">need to consider why that is the case; what inferences, if any, it may draw from what it does </text>
<text top=""669"" left=""108"" width=""684"" height=""16"" font=""0"">know; whether or not such inferences might or might not be adverse to the interests of either </text>
<text top=""685"" left=""108"" width=""682"" height=""16"" font=""0"">party; and whether or not such party has had a fair opportunity to adduce the relevant information </text>
<text top=""702"" left=""108"" width=""683"" height=""16"" font=""0"">and to reasonably understand what the consequences of not doing so may be, in accordance with </text>
<text top=""718"" left=""108"" width=""197"" height=""16"" font=""0"">the principle of due process. </text>
</p><p number=""3."" style=""6""><text top=""751"" left=""108"" width=""54"" height=""16"" font=""23"">3. O</text><text top=""754"" left=""162"" width=""55"" height=""13"" font=""29"">RDER OF </text><text top=""751"" left=""217"" width=""10"" height=""16"" font=""23"">A</text><text top=""754"" left=""228"" width=""52"" height=""13"" font=""29"">NALYSIS</text></p><p number=""19."" style=""6""><text top=""784"" left=""108"" width=""682"" height=""16"" font=""0"">19.  It would seem that Argentina complains mainly about the United States' failure to respond in </text>
<text top=""800"" left=""108"" width=""685"" height=""16"" font=""0"">a timely manner to Argentina's ""formal request"" for a change of status. Therefore, the Panel </text>
<text top=""817"" left=""108"" width=""683"" height=""16"" font=""0"">should first examine Argentina's claims on ""undue delay"". As a matter of logic, the Panel should </text>
<text top=""833"" left=""108"" width=""683"" height=""16"" font=""0"">first determine whether the United States is under the obligation to adopt a decision accepting, or </text>
<text top=""850"" left=""108"" width=""684"" height=""16"" font=""0"">rejecting, Argentina's ""formal request"" for a change of status. Logically, the compatibility of the </text>
<text top=""866"" left=""108"" width=""686"" height=""16"" font=""0"">content of such a decision with the covered agreements should be examined only after that </text>
<text top=""882"" left=""108"" width=""174"" height=""16"" font=""0"">content becomes known. </text>
</p><p number=""20."" style=""6""><text top=""915"" left=""108"" width=""683"" height=""16"" font=""0"">20.  Moreover, Argentina does not claim that the United States should change the way it treats </text>
<text top=""932"" left=""108"" width=""682"" height=""16"" font=""0"">countries that are <i>not</i> free of foot-and-mouth disease. Argentina simply wants the United States to </text>
<text top=""948"" left=""108"" width=""684"" height=""16"" font=""0"">change the status of Argentina and afford it the treatment it offers to countries that <i>are</i> free of </text>
<text top=""964"" left=""108"" width=""683"" height=""16"" font=""0"">foot-and-mouth disease. In these circumstances, the United States' measures relating to products </text>
<text top=""981"" left=""108"" width=""682"" height=""16"" font=""0"">coming from countries that are <i>not</i> free of foot-and-mouth disease are outside the Panel's terms of </text>
<text top=""997"" left=""108"" width=""683"" height=""16"" font=""0"">reference. The Panel should avoid making any statements in relation to the compatibility with the </text>
<text top=""1014"" left=""108"" width=""677"" height=""16"" font=""0"">covered agreements of the United States' measures relating to countries that are <i>not</i> free of foot-</text>
<text top=""1030"" left=""108"" width=""140"" height=""16"" font=""0"">and-mouth disease. </text>
</p><p number=""4."" style=""6""><text top=""1063"" left=""108"" width=""52"" height=""16"" font=""23"">4. T</text><text top=""1066"" left=""160"" width=""182"" height=""13"" font=""29"">HE MEASURE IN RELATION TO </text><text top=""1063"" left=""342"" width=""10"" height=""16"" font=""23"">P</text><text top=""1066"" left=""352"" width=""97"" height=""13"" font=""29"">ATAGONIA AND </text><text top=""1063"" left=""449"" width=""10"" height=""16"" font=""23"">A</text><text top=""1066"" left=""459"" width=""43"" height=""13"" font=""29"">RTICLE</text><text top=""1063"" left=""502"" width=""14"" height=""16"" font=""23""> 6</text><text top=""1066"" left=""516"" width=""50"" height=""13"" font=""29""> OF THE </text><text top=""1063"" left=""565"" width=""44"" height=""16"" font=""23"">SPS A</text><text top=""1066"" left=""609"" width=""64"" height=""13"" font=""29"">GREEMENT</text></p><p number=""21."" style=""6""><text top=""1096"" left=""108"" width=""688"" height=""16"" font=""0"">21.  The European Union notes that Article 6.3 of the SPS Agreement imposes a specific </text>
<text top=""1112"" left=""108"" width=""682"" height=""16"" font=""0"">obligation on exporting Members wishing to show that certain parts of their territory should not be </text>
<text top=""1128"" left=""108"" width=""683"" height=""16"" font=""0"">subject to SPS measures of importing Members. Exporting Members have the burden of providing </text>
<p><text top=""87"" left=""419"" width=""59"" height=""16"" font=""0"">- C-17 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">to the authorities of the importing Members the ""evidence"" which is ""necessary"" ""in order to </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">objectively demonstrate"" that certain areas are free of the disease ""and are likely to remain"" free </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">of the disease in the future. The combined reading of all three paragraphs of that Article shows </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">that Article 6 of the SPS Agreement creates a balance of rights and obligations between exporting </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">and importing Members, where the action of each Member is conditioned upon the action of the </text>
<text top=""210"" left=""108"" width=""105"" height=""16"" font=""0"">other Member. </text>
</p></p></page>
<page number=""75"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""22."" style=""6""><text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">22.  This means that an exporting Member bringing a claim based on Article 6.1 or Article 6.2 will </text>
<text top=""259"" left=""108"" width=""686"" height=""16"" font=""0"">likely have to engage with Article 6.3. The three paragraphs of Article 6 constitute a single </text>
<text top=""275"" left=""108"" width=""686"" height=""16"" font=""0"">discipline which may need to be analysed in unison. Moreover, the actions required by the </text>
<text top=""292"" left=""108"" width=""684"" height=""16"" font=""0"">exporting Member under Article 6.3 are a prerequisite for the actions of the importing Member </text>
<text top=""308"" left=""108"" width=""684"" height=""16"" font=""0"">under Articles 6.1 and 6.2. This means that an exporting Member asserting the existence of a </text>
<text top=""324"" left=""108"" width=""684"" height=""16"" font=""0"">particular fact, such as that the evidence it has provided objectively establishes the current and </text>
<text top=""341"" left=""108"" width=""685"" height=""16"" font=""0"">likely future absence of the disease in a particular area, may well have the burden to adduce </text>
<text top=""357"" left=""108"" width=""263"" height=""16"" font=""0"">evidence in support of such assertion. </text>
</p><p><text top=""407"" left=""398"" width=""101"" height=""16"" font=""23"">__________</text> </p></page>
</pdf2xml>",133461,12
133460,"<!DOCTYPE pdf2xml SYSTEM ""pdf2xml.dtd"">
<pdf2xml producer=""poppler"" version=""0.47.0"">
<page number=""1"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""7"" size=""14"" family=""Times"" color=""#000000""/>
<fontspec id=""27"" size=""14"" family=""Times"" color=""#006284"" style=""b""/><fontspec id=""26"" size=""11"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""0"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""1"" size=""11"" family=""Times"" color=""#ff0000""/>
	<fontspec id=""2"" size=""11"" family=""Times"" color=""#000000""/>
	<fontspec id=""3"" size=""11"" family=""Times"" color=""#ff0000""/>
	<fontspec id=""4"" size=""8"" family=""Times"" color=""#000000""/>
	<fontspec id=""5"" size=""14"" family=""Times"" color=""#006284""/>
	<fontspec id=""6"" size=""11"" family=""Times"" color=""#006284""/>
<p><text top=""154"" left=""698"" width=""92"" height=""16"" font=""0"">24 July 2015 </text>
</p><p><text top=""186"" left=""108"" width=""75"" height=""16"" font=""3"">(15-3739) </text>
<text top=""186"" left=""701"" width=""89"" height=""16"" font=""0"">Page: 1/235 </text>
</p><p><text top=""217"" left=""673"" width=""117"" height=""16"" font=""0"">Original: English </text>
</p><p><text top=""291"" left=""163"" width=""572"" height=""20"" font=""27"">UNITED STATES &#8211; MEASURES AFFECTING THE IMPORTATION </text><text top=""311"" left=""206"" width=""487"" height=""20"" font=""27"">OF ANIMALS, MEAT AND OTHER ANIMAL PRODUCTS </text><text top=""331"" left=""361"" width=""176"" height=""20"" font=""27"">FROM ARGENTINA </text></p><p><text top=""369"" left=""368"" width=""162"" height=""16"" font=""6"">REPORT OF THE PANEL </text>
</p></page>
<page number=""7"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""30"" size=""11"" family=""Times"" color=""#006284"" style=""i""/><fontspec id=""29"" size=""9"" family=""Times"" color=""#ffffff"" style=""b""/><fontspec id=""28"" size=""11"" family=""Times"" color=""#006284"" style=""b""/><fontspec id=""8"" size=""11"" family=""Times"" color=""#006284""/>
	<fontspec id=""9"" size=""9"" family=""Times"" color=""#ffffff""/>
	<fontspec id=""10"" size=""9"" family=""Times"" color=""#000000""/>
	<fontspec id=""11"" size=""11"" family=""Times"" color=""#006284""/>
<p><text top=""87"" left=""431"" width=""35"" height=""16"" font=""0"">- 7 - </text>
</p><p><text top=""128"" left=""444"" width=""73"" height=""16"" font=""28"">ANNEX A </text></p><p><text top=""162"" left=""311"" width=""275"" height=""16"" font=""6"">WORKING PROCEDURES OF THE PANEL </text>
</p><p><text top=""206"" left=""372"" width=""64"" height=""15"" font=""29"">Contents </text><text top=""206"" left=""732"" width=""37"" height=""15"" font=""29"">Page </text><footnote top=""221"" left=""108"" width=""67"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""><ftext top=""762"" left=""212"" width=""372"" height=""15"" font=""10"">Integrated executive summary of the arguments of Australia </ftext>
</footnote>
</p><p><text top=""221"" left=""212"" width=""201"" height=""15"" font=""10"">Working Procedures of the Panel </text>
<footnote top=""221"" left=""738"" width=""25"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""><ftext top=""777"" left=""212"" width=""352"" height=""15"" font=""10"">Integrated executive summary of the arguments of Brazil </ftext>
</footnote>
<text top=""235"" left=""738"" width=""25"" height=""15"" font=""10"">A-7 </text>
</p><p><text top=""301"" left=""413"" width=""72"" height=""16"" font=""28"">ANNEX B </text></p><p><text top=""336"" left=""344"" width=""209"" height=""16"" font=""6"">ARGUMENTS OF THE PARTIES </text>
</p><p><text top=""379"" left=""406"" width=""86"" height=""16"" font=""30"">ARGENTINA </text></p><p><text top=""423"" left=""372"" width=""64"" height=""15"" font=""29"">Contents </text><text top=""423"" left=""732"" width=""37"" height=""15"" font=""29"">Page </text></p><p><text top=""452"" left=""734"" width=""33"" height=""15"" font=""10"">B-14 </text>
</p><p><text top=""515"" left=""391"" width=""115"" height=""16"" font=""30"">UNITED STATES </text></p><p><text top=""559"" left=""372"" width=""64"" height=""15"" font=""29"">Contents </text><text top=""559"" left=""732"" width=""37"" height=""15"" font=""29"">Page </text><footnote top=""574"" left=""108"" width=""72"" height=""15"" font=""10"" number=""3"" ref="""" dis=""""><ftext top=""791"" left=""212"" width=""353"" height=""15"" font=""10"">Integrated executive summary of the arguments of China </ftext>
</footnote>
</p><p><text top=""574"" left=""212"" width=""493"" height=""15"" font=""10"">First part of the integrated executive summary of the arguments of the </text>
<text top=""588"" left=""212"" width=""86"" height=""15"" font=""10"">United States </text>
<text top=""574"" left=""734"" width=""33"" height=""15"" font=""10"">B-25 </text>
<footnote top=""603"" left=""108"" width=""67"" height=""15"" font=""10"" number=""4"" ref="""" dis=""""><ftext top=""806"" left=""212"" width=""438"" height=""15"" font=""10"">Integrated executive summary of the arguments of the European Union </ftext>
</footnote>
</p><p><text top=""603"" left=""212"" width=""491"" height=""15"" font=""10"">Second part of the integrated executive summary of the arguments of the </text>
<text top=""618"" left=""212"" width=""86"" height=""15"" font=""10"">United States </text>
<text top=""603"" left=""734"" width=""33"" height=""15"" font=""10"">B-37 </text>
</p><p><text top=""669"" left=""413"" width=""72"" height=""16"" font=""28"">ANNEX C </text></p><p><text top=""703"" left=""320"" width=""258"" height=""16"" font=""6"">ARGUMENTS OF THE THIRD PARTIES </text>
</p><p><text top=""747"" left=""372"" width=""64"" height=""15"" font=""29"">Contents </text><text top=""747"" left=""732"" width=""37"" height=""15"" font=""29"">Page </text></p><p><text top=""777"" left=""737"" width=""26"" height=""15"" font=""10"">C-6 </text>
<text top=""791"" left=""738"" width=""26"" height=""15"" font=""10"">C-9 </text>
<text top=""806"" left=""734"" width=""33"" height=""15"" font=""10"">C-13 </text>
</p></page>
<page number=""8"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""31"" size=""9"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""12"" size=""9"" family=""Times"" color=""#000000""/>
<p><text top=""87"" left=""431"" width=""35"" height=""16"" font=""0"">- 8 - </text>
</p><p><text top=""128"" left=""341"" width=""215"" height=""16"" font=""6"">CASES CITED IN THIS REPORT </text>
</p><p><text top=""172"" left=""176"" width=""75"" height=""15"" font=""29"">Short Title </text><text top=""172"" left=""467"" width=""184"" height=""15"" font=""29"">Full Case Title and Citation </text></p><p><text top=""191"" left=""108"" width=""113"" height=""15"" font=""31"">Australia &#8211; Apples </text></p><p><text top=""191"" left=""330"" width=""442"" height=""15"" font=""10"">Appellate Body Report, <i>Australia &#8211; Measures Affecting the Importation of </i></text>
<text top=""205"" left=""330"" width=""446"" height=""15"" font=""12""><i>Apples from New Zealand</i>, WT/DS367/AB/R, adopted 17 December 2010, </text>
<text top=""220"" left=""330"" width=""134"" height=""15"" font=""10"">DSR 2010:V, p. 2175 </text>
</p><p><text top=""244"" left=""108"" width=""113"" height=""15"" font=""31"">Australia &#8211; Apples </text></p><p><text top=""244"" left=""330"" width=""430"" height=""15"" font=""10"">Panel Report, <i>Australia &#8211; Measures Affecting the Importation of Apples </i></text>
<text top=""258"" left=""330"" width=""452"" height=""15"" font=""12""><i>from New Zealand</i>, WT/DS367/R, adopted 17 December 2010, as modified </text>
<text top=""273"" left=""330"" width=""400"" height=""15"" font=""10"">by Appellate Body Report WT/DS367/AB/R, DSR 2010:VI, p. 2371 </text>
</p><p><text top=""296"" left=""108"" width=""118"" height=""15"" font=""31"">Australia &#8211; Salmon </text></p><p><text top=""296"" left=""330"" width=""422"" height=""15"" font=""10"">Appellate Body Report, <i>Australia &#8211; Measures Affecting Importation of </i></text>
<text top=""311"" left=""330"" width=""423"" height=""15"" font=""12""><i>Salmon</i>, WT/DS18/AB/R, adopted 6 November 1998, DSR 1998:VIII, </text>
<text top=""326"" left=""330"" width=""51"" height=""15"" font=""10"">p. 3327 </text>
</p><p><text top=""349"" left=""108"" width=""118"" height=""15"" font=""31"">Australia &#8211; Salmon </text></p><p><text top=""349"" left=""330"" width=""418"" height=""15"" font=""10"">Panel Report, <i>Australia &#8211; Measures Affecting Importation of Salmon</i>, </text>
<text top=""364"" left=""330"" width=""411"" height=""15"" font=""10"">WT/DS18/R and Corr.1, adopted 6 November 1998, as modified by </text>
<text top=""378"" left=""330"" width=""389"" height=""15"" font=""10"">Appellate Body Report WT/DS18/AB/R, DSR 1998:VIII, p. 3407 </text>
</p><p><text top=""402"" left=""108"" width=""118"" height=""15"" font=""31"">Australia &#8211; Salmon </text><text top=""416"" left=""108"" width=""146"" height=""15"" font=""31"">(Article 21.5 &#8211; Canada) </text></p><p><text top=""402"" left=""330"" width=""425"" height=""15"" font=""10"">Panel Report, <i>Australia &#8211; Measures Affecting Importation of Salmon &#8211; </i></text>
<text top=""416"" left=""330"" width=""436"" height=""15"" font=""12""><i>Recourse to Article 21.5 of the DSU by Canada</i>, WT/DS18/RW, adopted </text>
<text top=""431"" left=""330"" width=""238"" height=""15"" font=""10"">20 March 2000, DSR 2000:IV, p. 2031 </text>
</p><p><text top=""455"" left=""108"" width=""98"" height=""15"" font=""31"">Brazil &#8211; Aircraft </text></p><p><text top=""455"" left=""330"" width=""387"" height=""15"" font=""10"">Panel Report, <i>Brazil &#8211; Export Financing Programme for Aircraft</i>, </text>
<text top=""469"" left=""330"" width=""425"" height=""15"" font=""10"">WT/DS46/R, adopted 20 August 1999, as modified by Appellate Body </text>
<text top=""484"" left=""330"" width=""287"" height=""15"" font=""10"">Report WT/DS46/AB/R, DSR 1999:III, p. 1221 </text>
</p><p><text top=""507"" left=""108"" width=""172"" height=""15"" font=""31"">Brazil &#8211; Desiccated Coconut </text></p><p><text top=""507"" left=""330"" width=""438"" height=""15"" font=""10"">Appellate Body Report, <i>Brazil &#8211; Measures Affecting Desiccated Coconut</i>, </text>
<text top=""522"" left=""330"" width=""377"" height=""15"" font=""10"">WT/DS22/AB/R, adopted 20 March 1997, DSR 1997:I, p. 167 </text>
</p><p><text top=""546"" left=""108"" width=""153"" height=""15"" font=""31"">Brazil &#8211; Retreaded Tyres </text></p><p><text top=""546"" left=""330"" width=""445"" height=""15"" font=""10"">Appellate Body Report, <i>Brazil &#8211; Measures Affecting Imports of Retreaded </i></text>
<text top=""560"" left=""330"" width=""416"" height=""15"" font=""12""><i>Tyres</i>, WT/DS332/AB/R, adopted 17 December 2007, DSR 2007:IV, </text>
<text top=""575"" left=""330"" width=""51"" height=""15"" font=""10"">p. 1527 </text>
</p><p><text top=""598"" left=""108"" width=""153"" height=""15"" font=""31"">Brazil &#8211; Retreaded Tyres </text></p><p><text top=""598"" left=""330"" width=""428"" height=""15"" font=""10"">Panel Report, <i>Brazil &#8211; Measures Affecting Imports of Retreaded Tyres</i>, </text>
<text top=""613"" left=""330"" width=""452"" height=""15"" font=""10"">WT/DS332/R, adopted 17 December 2007, as modified by Appellate Body </text>
<text top=""627"" left=""330"" width=""287"" height=""15"" font=""10"">Report WT/DS332/AB/R, DSR 2007:V, p. 1649 </text>
</p><p><text top=""651"" left=""108"" width=""110"" height=""15"" font=""31"">Canada &#8211; Aircraft </text></p><p><text top=""651"" left=""330"" width=""453"" height=""15"" font=""10"">Appellate Body Report, <i>Canada &#8211; Measures Affecting the Export of Civilian </i></text>
<text top=""666"" left=""330"" width=""453"" height=""15"" font=""12""><i>Aircraft</i>, WT/DS70/AB/R, adopted 20 August 1999, DSR 1999:III, p. 1377 </text>
</p><p><text top=""689"" left=""108"" width=""99"" height=""15"" font=""31"">Canada &#8211; Autos </text></p><p><text top=""689"" left=""330"" width=""394"" height=""15"" font=""10"">Appellate Body Report, <i>Canada &#8211; Certain Measures Affecting the </i></text>
<text top=""704"" left=""330"" width=""404"" height=""15"" font=""12""><i>Automotive Industry</i>, WT/DS139/AB/R, WT/DS142/AB/R, adopted </text>
<text top=""718"" left=""330"" width=""229"" height=""15"" font=""10"">19 June 2000, DSR 2000:VI, p. 2985 </text>
</p><p><text top=""742"" left=""108"" width=""199"" height=""15"" font=""31"">Canada &#8211; Continued Suspension </text></p><p><text top=""742"" left=""330"" width=""445"" height=""15"" font=""10"">Appellate Body Report, <i>Canada &#8211; Continued Suspension of Obligations in </i></text>
<text top=""757"" left=""330"" width=""423"" height=""15"" font=""12""><i>the EC &#8211; Hormones Dispute</i>, WT/DS321/AB/R, adopted 14 November </text>
<text top=""771"" left=""330"" width=""186"" height=""15"" font=""10"">2008, DSR 2008:XIV, p. 5373 </text>
</p><p><text top=""795"" left=""108"" width=""199"" height=""15"" font=""31"">Canada &#8211; Continued Suspension </text></p><p><text top=""795"" left=""330"" width=""443"" height=""15"" font=""10"">Panel Report, <i>Canada &#8211; Continued Suspension of Obligations in the EC &#8211; </i></text>
<text top=""809"" left=""330"" width=""403"" height=""15"" font=""12""><i>Hormones Dispute</i>, WT/DS321/R, adopted 14 November 2008, as </text>
<text top=""824"" left=""330"" width=""414"" height=""15"" font=""10"">modified by Appellate Body Report WT/DS321/AB/R, DSR 2008:XV, </text>
<text top=""838"" left=""330"" width=""51"" height=""15"" font=""10"">p. 5757 </text>
</p><p><text top=""862"" left=""108"" width=""97"" height=""15"" font=""31"">Canada &#8211; Dairy </text><text top=""877"" left=""108"" width=""200"" height=""15"" font=""31"">(Article 21.5 &#8211; New Zealand and </text><text top=""891"" left=""108"" width=""41"" height=""15"" font=""31"">US II) </text></p><p><text top=""862"" left=""330"" width=""435"" height=""15"" font=""10"">Panel Report, <i>Canada &#8211; Measures Affecting the Importation of Milk and </i></text>
</p><p><text top=""877"" left=""330"" width=""454"" height=""15"" font=""31"">the Exportation of Dairy Products &#8211; Second Recourse to Article 21.5 of the </text></p><p><text top=""891"" left=""330"" width=""379"" height=""15"" font=""12""><i>DSU by New Zealand and the United States</i>, WT/DS103/RW2, </text>
<text top=""906"" left=""330"" width=""457"" height=""15"" font=""10"">WT/DS113/RW2, adopted 17 January 2003, as modified by Appellate Body </text>
<text top=""920"" left=""330"" width=""425"" height=""15"" font=""10"">Report WT/DS103/AB/RW2, WT/DS113/AB/RW2, DSR 2003:I, p. 255 </text>
</p><p><text top=""944"" left=""108"" width=""211"" height=""15"" font=""31"">Canada &#8211; Pharmaceutical Patents  </text><text top=""959"" left=""108"" width=""102"" height=""15"" font=""31"">(Article 21.3(c)) </text></p><p><text top=""944"" left=""330"" width=""429"" height=""15"" font=""10"">Award of the Arbitrator, <i>Canada &#8211; Patent Protection of Pharmaceutical </i></text>
<text top=""959"" left=""330"" width=""435"" height=""15"" font=""12""><i>Products &#8211; Arbitration under Article 21.3(c) of the DSU</i>, WT/DS114/13, </text>
<text top=""973"" left=""330"" width=""212"" height=""15"" font=""10"">18 August 2000, DSR 2002:I, p. 3 </text>
</p><p><text top=""997"" left=""108"" width=""186"" height=""15"" font=""31"">Canada &#8211; Renewable Energy / </text><text top=""1011"" left=""108"" width=""206"" height=""15"" font=""31"">Canada &#8211; Feed-in Tariff Program  </text></p><p><text top=""997"" left=""330"" width=""391"" height=""15"" font=""10"">Appellate Body Reports, <i>Canada &#8211; Certain Measures Affecting the </i></text>
</p><p><text top=""1011"" left=""330"" width=""444"" height=""15"" font=""31"">Renewable Energy Generation Sector / Canada &#8211; Measures Relating to the </text></p><p><text top=""1026"" left=""330"" width=""412"" height=""15"" font=""12""><i>Feed-in Tariff Program</i>, WT/DS412/AB/R / WT/DS426/AB/R, adopted </text>
<text top=""1040"" left=""330"" width=""81"" height=""15"" font=""10"">24 May 2013 </text>
</p><p><text top=""1064"" left=""108"" width=""180"" height=""15"" font=""31"">Canada &#8211; Wheat Exports and </text><text top=""1079"" left=""108"" width=""89"" height=""15"" font=""31"">Grain Imports </text></p><p><text top=""1064"" left=""330"" width=""443"" height=""15"" font=""10"">Appellate Body Report, <i>Canada &#8211; Measures Relating to Exports of Wheat </i></text>
<text top=""1079"" left=""330"" width=""373"" height=""15"" font=""12""><i>and Treatment of Imported Grain</i>, WT/DS276/AB/R, adopted </text>
<text top=""1093"" left=""330"" width=""268"" height=""15"" font=""10"">27 September 2004, DSR 2004:VI, p. 2739 </text>
</p></page>
<page number=""9"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""13"" size=""10"" family=""Times"" color=""#000000""/>
<p><text top=""87"" left=""431"" width=""35"" height=""16"" font=""0"">- 9 - </text>
</p><p><text top=""128"" left=""176"" width=""75"" height=""15"" font=""29"">Short Title </text><text top=""128"" left=""467"" width=""184"" height=""15"" font=""29"">Full Case Title and Citation </text></p><p><text top=""147"" left=""108"" width=""150"" height=""15"" font=""31"">China &#8211; Broiler Products </text></p><p><text top=""147"" left=""330"" width=""124"" height=""15"" font=""10"">Panel Report, <i>China </i></text>
<text top=""147"" left=""454"" width=""7"" height=""15"" font=""13"">&#61485;</text>
</p><p><text top=""147"" left=""461"" width=""323"" height=""15"" font=""31""> Anti-Dumping and Countervailing Duty Measures on </text></p><p><text top=""162"" left=""330"" width=""452"" height=""15"" font=""12""><i>Broiler Products from the United States</i>, WT/DS427/R and Add.1, adopted </text>
<text top=""177"" left=""330"" width=""125"" height=""15"" font=""10"">25 September 2013 </text>
</p><p><text top=""200"" left=""108"" width=""89"" height=""15"" font=""31"">China &#8211; GOES </text></p><p><text top=""200"" left=""330"" width=""457"" height=""15"" font=""10"">Appellate Body Report, <i>China &#8211; Countervailing and Anti-Dumping Duties on </i></text>
<text top=""215"" left=""330"" width=""401"" height=""15"" font=""12""><i>Grain Oriented Flat-Rolled Electrical Steel from the United States</i>, </text>
<text top=""229"" left=""330"" width=""431"" height=""15"" font=""10"">WT/DS414/AB/R, adopted 16 November 2012, DSR 2012:XII, p. 6251 </text>
</p><p><text top=""253"" left=""108"" width=""89"" height=""15"" font=""31"">China &#8211; GOES </text></p><p><text top=""253"" left=""330"" width=""439"" height=""15"" font=""10"">Panel Report, <i>China &#8211; Countervailing and Anti-Dumping Duties on Grain </i></text>
<text top=""268"" left=""330"" width=""447"" height=""15"" font=""12""><i>Oriented Flat-Rolled Electrical Steel from the United States</i>, WT/DS414/R </text>
<text top=""282"" left=""330"" width=""450"" height=""15"" font=""10"">and Add.1, adopted 16 November 2012, upheld by Appellate Body Report </text>
<text top=""297"" left=""330"" width=""253"" height=""15"" font=""10"">WT/DS414/AB/R, DSR 2012:XII, p. 6369 </text>
</p><p><text top=""320"" left=""108"" width=""152"" height=""15"" font=""31"">China &#8211; Publications and </text><text top=""335"" left=""108"" width=""129"" height=""15"" font=""31"">Audiovisual Products </text></p><p><text top=""320"" left=""330"" width=""446"" height=""15"" font=""10"">Panel Report, <i>China &#8211;</i> <i>Measures Affecting Trading Rights and Distribution </i></text>
<text top=""335"" left=""330"" width=""449"" height=""15"" font=""12""><i>Services for Certain Publications and Audiovisual Entertainment Products</i>, </text>
<text top=""350"" left=""330"" width=""412"" height=""15"" font=""10"">WT/DS363/R and Corr.1, adopted 19 January 2010, as modified by </text>
<text top=""364"" left=""330"" width=""376"" height=""15"" font=""10"">Appellate Body Report WT/DS363/AB/R, DSR 2010:II, p. 261 </text>
</p><p><text top=""388"" left=""108"" width=""138"" height=""15"" font=""31"">China &#8211; Raw Materials </text></p><p><text top=""388"" left=""330"" width=""436"" height=""15"" font=""10"">Appellate Body Reports, <i>China &#8211; Measures Related to the Exportation of </i></text>
<text top=""402"" left=""330"" width=""371"" height=""15"" font=""12""><i>Various Raw Materials</i>, WT/DS394/AB/R / WT/DS395/AB/R / </text>
<text top=""417"" left=""330"" width=""423"" height=""15"" font=""10"">WT/DS398/AB/R, adopted 22 February 2012, DSR 2012:VII, p. 3295 </text>
</p><p><text top=""440"" left=""108"" width=""207"" height=""15"" font=""31"">Dominican Republic &#8211; Import and </text><text top=""455"" left=""108"" width=""111"" height=""15"" font=""31"">Sale of Cigarettes </text></p><p><text top=""440"" left=""330"" width=""420"" height=""15"" font=""10"">Appellate Body Report, <i>Dominican Republic &#8211; Measures Affecting the </i></text>
<text top=""455"" left=""330"" width=""432"" height=""15"" font=""12""><i>Importation and Internal Sale of Cigarettes</i>, WT/DS302/AB/R, adopted </text>
<text top=""470"" left=""330"" width=""229"" height=""15"" font=""10"">19 May 2005, DSR 2005:XV, p. 7367 </text>
</p><p><text top=""493"" left=""108"" width=""196"" height=""15"" font=""31"">EC &#8211; Approval and Marketing of </text><text top=""508"" left=""108"" width=""105"" height=""15"" font=""31"">Biotech Products </text></p><p><text top=""493"" left=""330"" width=""447"" height=""15"" font=""10"">Panel Reports, <i>European Communities &#8211; Measures Affecting the Approval </i></text>
<text top=""508"" left=""330"" width=""401"" height=""15"" font=""12""><i>and Marketing of Biotech Products</i>, WT/DS291/R / WT/DS292/R / </text>
<text top=""522"" left=""330"" width=""437"" height=""15"" font=""10"">WT/DS293/R, Add.1 to Add.9, and Corr.1, adopted 21 November 2006, </text>
<text top=""537"" left=""330"" width=""133"" height=""15"" font=""10"">DSR 2006:III, p. 847 </text>
</p><p><text top=""561"" left=""108"" width=""90"" height=""15"" font=""31"">EC &#8211; Asbestos </text></p><p><text top=""561"" left=""330"" width=""418"" height=""15"" font=""10"">Appellate Body Report, <i>European Communities &#8211; Measures Affecting </i></text>
<text top=""575"" left=""330"" width=""447"" height=""15"" font=""12""><i>Asbestos and Asbestos-Containing Products</i>, WT/DS135/AB/R, adopted 5 </text>
<text top=""590"" left=""330"" width=""214"" height=""15"" font=""10"">April 2001, DSR 2001:VII, p. 3243 </text>
</p><p><text top=""613"" left=""108"" width=""107"" height=""15"" font=""31"">EC &#8211; Bananas III </text></p><p><text top=""613"" left=""330"" width=""393"" height=""15"" font=""10"">Appellate Body Report, <i>European Communities &#8211; Regime for the </i></text>
<footnote top=""628"" left=""330"" width=""441"" height=""15"" font=""12"" number=""27"" ref=""WT/DS27/AB/RW/USA ; WT/DS27/AB/RW2/ECU|WT/DS397/AB/RW/Add.1|WT/DS397/AB/R|WT/DS269/R|WT/DS27/AB/RW/USA/Corr.1 ; WT/DS27/AB/RW2/ECU/Corr.1|WT/DS27/AB/R|WT/DS269/AB/R/Corr.1 ; WT/DS286/AB/R/Corr.1|WT/DS269/AB/R ; WT/DS286/AB/R|WT/DS27/R/USA|WT/DS286/R|WT/DS397/AB/RW"" dis=""DS269|DS397|DS27|DS286""><ftext top=""830"" left=""330"" width=""413"" height=""15"" font=""10"">adopted 25 September 1997, as modified by Appellate Body Report </ftext>
<ftext top=""844"" left=""330"" width=""230"" height=""15"" font=""10"">WT/DS27/AB/R, DSR 1997:II, p. 803 </ftext>
<ftext top=""868"" left=""108"" width=""139"" height=""15"" font=""31"">EC &#8211; Bananas III (US) </ftext><ftext top=""868"" left=""330"" width=""446"" height=""15"" font=""10"">Panel Report, <i>European Communities &#8211; Regime for the Importation, Sale </i></ftext>
<ftext top=""883"" left=""330"" width=""374"" height=""15"" font=""12""><i>and Distribution of Bananas, Complaint by the United States</i>, </ftext>
<ftext top=""897"" left=""330"" width=""445"" height=""15"" font=""10"">WT/DS27/R/USA, adopted 25 September 1997, as modified by Appellate </ftext>
<ftext top=""912"" left=""330"" width=""308"" height=""15"" font=""10"">Body Report WT/DS27/AB/R, DSR 1997:II, p. 943 </ftext>
<ftext top=""935"" left=""108"" width=""115"" height=""15"" font=""31"">EC &#8211; Chicken Cuts </ftext><ftext top=""935"" left=""330"" width=""454"" height=""15"" font=""10"">Appellate Body Report, <i>European</i> <i>Communities &#8211; Customs Classification of </i></ftext>
<ftext top=""950"" left=""330"" width=""408"" height=""15"" font=""12""><i>Frozen Boneless Chicken Cuts</i>, WT/DS269/AB/R, WT/DS286/AB/R, </ftext>
<ftext top=""965"" left=""330"" width=""402"" height=""15"" font=""10"">adopted 27 September 2005, and Corr.1, DSR 2005:XIX, p. 9157 </ftext>
<ftext top=""988"" left=""108"" width=""144"" height=""15"" font=""31"">EC &#8211; Fasteners (China) </ftext><ftext top=""988"" left=""330"" width=""445"" height=""15"" font=""10"">Appellate Body Report, <i>European Communities &#8211; Definitive Anti-Dumping </i></ftext>
</footnote>
</p><p><text top=""642"" left=""330"" width=""257"" height=""15"" font=""10"">25 September 1997, DSR 1997:II, p. 591 </text>
</p><p><text top=""666"" left=""108"" width=""171"" height=""15"" font=""31"">EC &#8211; Bananas III (Ecuador) </text></p><p><text top=""666"" left=""330"" width=""446"" height=""15"" font=""10"">Panel Report, <i>European Communities &#8211; Regime for the Importation, Sale </i></text>
</p><p><text top=""1003"" left=""330"" width=""456"" height=""15"" font=""12""><i>Measures on Certain Iron or Steel Fasteners from China</i>, WT/DS397/AB/R, </text>
<text top=""1017"" left=""330"" width=""280"" height=""15"" font=""10"">adopted 28 July 2011, DSR 2011:VII, p. 3995 </text>
</p><p><text top=""1041"" left=""108"" width=""98"" height=""15"" font=""31"">EC &#8211; Hormones </text></p><p><text top=""1041"" left=""330"" width=""446"" height=""15"" font=""10"">Appellate Body Report, <i>EC Measures Concerning Meat and Meat Products </i></text>
<text top=""1056"" left=""330"" width=""454"" height=""15"" font=""12""><i>(Hormones)</i>, WT/DS26/AB/R, WT/DS48/AB/R, adopted 13 February 1998, </text>
<text top=""1070"" left=""330"" width=""123"" height=""15"" font=""10"">DSR 1998:I, p. 135 </text>
</p></page>
<page number=""10"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 10 - </text>
</p><p><text top=""128"" left=""176"" width=""75"" height=""15"" font=""29"">Short Title </text><text top=""128"" left=""467"" width=""184"" height=""15"" font=""29"">Full Case Title and Citation </text></p><p><text top=""147"" left=""108"" width=""158"" height=""15"" font=""31"">EC &#8211; Hormones (Canada) </text></p><p><text top=""147"" left=""330"" width=""388"" height=""15"" font=""10"">Panel Report, <i>EC Measures Concerning Meat and Meat Products </i></text>
<text top=""162"" left=""330"" width=""382"" height=""15"" font=""12""><i>(Hormones), Complaint by Canada</i>, WT/DS48/R/CAN, adopted </text>
<text top=""177"" left=""330"" width=""450"" height=""15"" font=""10"">13 February 1998, as modified by Appellate Body Report WT/DS26/AB/R, </text>
<text top=""191"" left=""330"" width=""230"" height=""15"" font=""10"">WT/DS48/AB/R, DSR 1998:II, p. 235 </text>
</p><p><text top=""215"" left=""108"" width=""130"" height=""15"" font=""31"">EC &#8211; Hormones (US) </text></p><p><text top=""215"" left=""330"" width=""388"" height=""15"" font=""10"">Panel Report, <i>EC Measures Concerning Meat and Meat Products </i></text>
<text top=""229"" left=""330"" width=""442"" height=""15"" font=""12""><i>(Hormones), Complaint by the United States</i>, WT/DS26/R/USA, adopted </text>
<text top=""244"" left=""330"" width=""450"" height=""15"" font=""10"">13 February 1998, as modified by Appellate Body Report WT/DS26/AB/R, </text>
<text top=""259"" left=""330"" width=""235"" height=""15"" font=""10"">WT/DS48/AB/R, DSR 1998:III, p. 699 </text>
</p><p><text top=""282"" left=""108"" width=""200"" height=""15"" font=""31"">EC &#8211; Hormones (Article 21.3(c)) </text></p><p><text top=""282"" left=""330"" width=""451"" height=""15"" font=""10"">Award of the Arbitrator, <i>EC Measures Concerning Meat and Meat Products </i></text>
<text top=""297"" left=""330"" width=""448"" height=""15"" font=""12""><i>(Hormones) &#8211; Arbitration under Article 21.3(c) of the DSU</i>, WT/DS26/15, </text>
<text top=""311"" left=""330"" width=""308"" height=""15"" font=""10"">WT/DS48/13, 29 May 1998, DSR 1998:V, p. 1833 </text>
</p><p><text top=""335"" left=""108"" width=""105"" height=""15"" font=""31"">EC &#8211; IT Products </text></p><p><text top=""335"" left=""330"" width=""423"" height=""15"" font=""10"">Panel Reports, <i>European Communities and its member States &#8211; Tariff </i></text>
<text top=""349"" left=""330"" width=""431"" height=""15"" font=""12""><i>Treatment of Certain Information Technology Products</i>, WT/DS375/R / </text>
<text top=""364"" left=""330"" width=""452"" height=""15"" font=""10"">WT/DS376/R / WT/DS377/R, adopted 21 September 2010, DSR 2010:III, </text>
<text top=""379"" left=""330"" width=""43"" height=""15"" font=""10"">p. 933 </text>
</p><p><text top=""402"" left=""108"" width=""89"" height=""15"" font=""31"">EC &#8211; Sardines </text></p><p><text top=""402"" left=""330"" width=""425"" height=""15"" font=""10"">Appellate Body Report, <i>European Communities &#8211; Trade Description of </i></text>
<text top=""417"" left=""330"" width=""447"" height=""15"" font=""12""><i>Sardines</i>, WT/DS231/AB/R, adopted 23 October 2002, DSR 2002:VIII, p. </text>
<text top=""431"" left=""330"" width=""35"" height=""15"" font=""10"">3359 </text>
</p><p><text top=""455"" left=""108"" width=""89"" height=""15"" font=""31"">EC &#8211; Sardines </text></p><p><text top=""455"" left=""330"" width=""429"" height=""15"" font=""10"">Panel Report, <i>European Communities &#8211; Trade Description of Sardines</i>, </text>
<text top=""470"" left=""330"" width=""412"" height=""15"" font=""10"">WT/DS231/R and Corr.1, adopted 23 October 2002, as modified by </text>
<text top=""484"" left=""330"" width=""397"" height=""15"" font=""10"">Appellate Body Report WT/DS231/AB/R, DSR 2002:VIII, p. 3451 </text>
</p><p><text top=""508"" left=""108"" width=""116"" height=""15"" font=""31"">EC &#8211; Seal Products </text></p><p><text top=""508"" left=""330"" width=""448"" height=""15"" font=""10"">Appellate Body Reports, <i>European Communities &#8211; Measures Prohibiting the </i></text>
<footnote top=""522"" left=""330"" width=""378"" height=""15"" font=""12"" number=""400"" ref=""WT/DS315/AB/R"" dis=""DS315""><ftext top=""628"" left=""108"" width=""194"" height=""15"" font=""31"">EC &#8211; Selected Customs Matters </ftext><ftext top=""628"" left=""330"" width=""411"" height=""15"" font=""10"">Appellate Body Report, <i>European Communities &#8211; Selected Customs </i></ftext>
<ftext top=""642"" left=""330"" width=""428"" height=""15"" font=""12""><i>Matters</i>, WT/DS315/AB/R, adopted 11 December 2006, DSR 2006:IX, </ftext>
</footnote>
</p><p><text top=""537"" left=""330"" width=""243"" height=""15"" font=""10"">WT/DS401/AB/R, adopted 18 June 2014 </text>
</p><p><text top=""560"" left=""108"" width=""116"" height=""15"" font=""31"">EC &#8211; Seal Products </text></p><p><text top=""560"" left=""330"" width=""392"" height=""15"" font=""10"">Panel Reports, <i>European Communities &#8211; Measures Prohibiting the </i></text>
</p><p number=""p."" style=""2""><text top=""657"" left=""330"" width=""51"" height=""15"" font=""10"">p. 3791 </text>
</p><p><text top=""681"" left=""108"" width=""142"" height=""15"" font=""31"">EC &#8211; Tariff Preferences </text></p><p><text top=""681"" left=""330"" width=""411"" height=""15"" font=""10"">Appellate Body Report, <i>European Communities &#8211; Conditions for the </i></text>
<text top=""695"" left=""330"" width=""445"" height=""15"" font=""12""><i>Granting of Tariff Preferences to Developing Countries</i>, WT/DS246/AB/R, </text>
<text top=""710"" left=""330"" width=""276"" height=""15"" font=""10"">adopted 20 April 2004, DSR 2004:III, p. 925 </text>
</p><p><text top=""733"" left=""108"" width=""201"" height=""15"" font=""31"">EC and certain member States &#8211; </text><text top=""748"" left=""108"" width=""116"" height=""15"" font=""31"">Large Civil Aircraft </text></p><p><text top=""733"" left=""330"" width=""458"" height=""15"" font=""10"">Appellate Body Report, <i>European Communities and Certain Member States  </i></text>
<text top=""748"" left=""330"" width=""413"" height=""15"" font=""12""><i>&#8211; Measures Affecting Trade in Large Civil Aircraft</i>, WT/DS316/AB/R, </text>
<text top=""762"" left=""330"" width=""241"" height=""15"" font=""10"">adopted 1 June 2011, DSR 2011:I, p. 7 </text>
</p><p><text top=""786"" left=""108"" width=""142"" height=""15"" font=""31"">Guatemala &#8211; Cement I </text></p><p><text top=""786"" left=""330"" width=""395"" height=""15"" font=""10"">Appellate Body Report, <i>Guatemala &#8211; Anti-Dumping Investigation </i></text>
<text top=""801"" left=""330"" width=""407"" height=""15"" font=""12""><i>Regarding Portland Cement from Mexico</i>, WT/DS60/AB/R, adopted </text>
<text top=""815"" left=""330"" width=""263"" height=""15"" font=""10"">25 November 1998, DSR 1998:IX, p. 3767 </text>
</p><p><text top=""839"" left=""108"" width=""147"" height=""15"" font=""31"">Guatemala &#8211; Cement II </text></p><p><text top=""839"" left=""330"" width=""429"" height=""15"" font=""10"">Panel Report, <i>Guatemala &#8211; Definitive Anti-Dumping Measures on Grey </i></text>
<text top=""853"" left=""330"" width=""453"" height=""15"" font=""12""><i>Portland Cement from Mexico</i>, WT/DS156/R, adopted 17 November 2000, </text>
<text top=""868"" left=""330"" width=""139"" height=""15"" font=""10"">DSR 2000:XI, p. 5295 </text>
</p><p><text top=""892"" left=""108"" width=""176"" height=""15"" font=""31"">India &#8211; Agricultural Products </text></p><p><text top=""892"" left=""330"" width=""428"" height=""15"" font=""10"">Panel Report, <i>India &#8211; Measures Concerning the Importation of Certain </i></text>
<text top=""906"" left=""330"" width=""399"" height=""15"" font=""12""><i>Agricultural Products</i>, WT/DS430/R and Add.1, circulated to WTO </text>
<text top=""921"" left=""330"" width=""330"" height=""15"" font=""10"">Members 14 October 2014 [adoption/appeal pending] </text>
</p><p><text top=""944"" left=""108"" width=""85"" height=""15"" font=""31"">India &#8211; Autos </text></p><p><text top=""944"" left=""330"" width=""395"" height=""15"" font=""10"">Panel Report, <i>India &#8211; Measures Affecting the Automotive Sector</i>, </text>
<text top=""959"" left=""330"" width=""379"" height=""15"" font=""10"">WT/DS146/R, WT/DS175/R and Corr.1, adopted 5 April 2002, </text>
<text top=""973"" left=""330"" width=""134"" height=""15"" font=""10"">DSR 2002:V, p. 1827 </text>
</p><p><text top=""997"" left=""108"" width=""199"" height=""15"" font=""31"">India &#8211; Quantitative Restrictions </text></p><p><text top=""997"" left=""330"" width=""429"" height=""15"" font=""10"">Appellate Body Report, <i>India &#8211; Quantitative Restrictions on Imports of </i></text>
<text top=""1012"" left=""330"" width=""426"" height=""15"" font=""12""><i>Agricultural, Textile and Industrial Products</i>, WT/DS90/AB/R, adopted </text>
<text top=""1026"" left=""330"" width=""268"" height=""15"" font=""10"">22 September 1999, DSR 1999:IV, p. 1763 </text>
</p><p><text top=""1050"" left=""108"" width=""113"" height=""15"" font=""31"">Indonesia &#8211; Autos </text><text top=""1064"" left=""108"" width=""102"" height=""15"" font=""31"">(Article 21.3(c)) </text></p><p><text top=""1050"" left=""330"" width=""413"" height=""15"" font=""10"">Award of the Arbitrator, <i>Indonesia &#8211; Certain Measures Affecting the </i></text>
<text top=""1064"" left=""330"" width=""412"" height=""15"" font=""12""><i>Automobile Industry &#8211; Arbitration under Article 21.3(c) of the DSU</i>, </text>
<text top=""1079"" left=""330"" width=""424"" height=""15"" font=""10"">WT/DS54/15, WT/DS55/14, WT/DS59/13, WT/DS64/12, 7 December </text>
<text top=""1094"" left=""330"" width=""178"" height=""15"" font=""10"">1998, DSR 1998:IX, p. 4029 </text>
</p><p><text top=""1117"" left=""108"" width=""195"" height=""15"" font=""31"">Japan &#8211; Agricultural Products II </text></p><p><text top=""1117"" left=""330"" width=""446"" height=""15"" font=""10"">Appellate Body Report, <i>Japan &#8211; Measures Affecting Agricultural Products</i>, </text>
<text top=""1132"" left=""330"" width=""377"" height=""15"" font=""10"">WT/DS76/AB/R, adopted 19 March 1999, DSR 1999:I, p. 277 </text>
</p></page>
<page number=""11"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""14"" size=""9"" family=""Times"" color=""#000000""/>
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 11 - </text>
</p><p><text top=""128"" left=""176"" width=""75"" height=""15"" font=""29"">Short Title </text><text top=""128"" left=""467"" width=""184"" height=""15"" font=""29"">Full Case Title and Citation </text></p><p><text top=""147"" left=""108"" width=""195"" height=""15"" font=""31"">Japan &#8211; Agricultural Products II </text></p><p><text top=""147"" left=""330"" width=""389"" height=""15"" font=""10"">Panel Report, <i>Japan &#8211; Measures Affecting Agricultural Products</i>, </text>
<text top=""162"" left=""330"" width=""419"" height=""15"" font=""10"">WT/DS76/R, adopted 19 March 1999, as modified by Appellate Body </text>
<text top=""177"" left=""330"" width=""269"" height=""15"" font=""10"">Report WT/DS76/AB/R, DSR 1999:I, p. 315 </text>
</p><p><text top=""200"" left=""108"" width=""189"" height=""15"" font=""31"">Japan &#8211; Alcoholic Beverages II </text></p><p><text top=""200"" left=""330"" width=""381"" height=""15"" font=""10"">Appellate Body Report, <i>Japan &#8211; Taxes on Alcoholic Beverages</i>, </text>
<text top=""215"" left=""330"" width=""428"" height=""15"" font=""10"">WT/DS8/AB/R, WT/DS10/AB/R, WT/DS11/AB/R, adopted 1 November </text>
<text top=""229"" left=""330"" width=""154"" height=""15"" font=""10"">1996, DSR 1996:I, p. 97 </text>
</p><p><text top=""253"" left=""108"" width=""95"" height=""15"" font=""31"">Japan &#8211; Apples </text></p><p><text top=""253"" left=""330"" width=""428"" height=""15"" font=""10"">Appellate Body Report, <i>Japan &#8211; Measures Affecting the Importation of </i></text>
<text top=""268"" left=""330"" width=""423"" height=""15"" font=""12""><i>Apples</i>, WT/DS245/AB/R, adopted 10 December 2003, DSR 2003:IX, </text>
<text top=""282"" left=""330"" width=""51"" height=""15"" font=""10"">p. 4391 </text>
</p><p><text top=""306"" left=""108"" width=""95"" height=""15"" font=""31"">Japan &#8211; Apples </text></p><p><text top=""306"" left=""330"" width=""418"" height=""15"" font=""10"">Panel Report, <i>Japan &#8211; Measures Affecting the Importation of Apples</i>, </text>
<text top=""320"" left=""330"" width=""423"" height=""15"" font=""10"">WT/DS245/R, adopted 10 December 2003, upheld by Appellate Body </text>
<text top=""335"" left=""330"" width=""292"" height=""15"" font=""10"">Report WT/DS245/AB/R, DSR 2003:IX, p. 4481<b> </b></text>
</p><p><text top=""358"" left=""108"" width=""95"" height=""15"" font=""31"">Japan &#8211; Apples </text><text top=""373"" left=""108"" width=""118"" height=""15"" font=""31"">(Article 21.5 &#8211; US) </text></p><p><text top=""358"" left=""330"" width=""426"" height=""15"" font=""10"">Panel Report, <i>Japan &#8211; Measures Affecting the Importation of Apples &#8211; </i></text>
<text top=""373"" left=""330"" width=""451"" height=""15"" font=""12""><i>Recourse to Article 21.5 of the DSU by the United States</i>, WT/DS245/RW, </text>
<text top=""388"" left=""330"" width=""286"" height=""15"" font=""10"">adopted 20 July 2005, DSR 2005:XVI, p. 7911 </text>
</p><p><text top=""411"" left=""108"" width=""87"" height=""15"" font=""31"">Korea &#8211; Dairy </text></p><p><text top=""411"" left=""330"" width=""447"" height=""15"" font=""10"">Appellate Body Report, <i>Korea &#8211; Definitive Safeguard Measure on Imports </i></text>
<text top=""426"" left=""330"" width=""425"" height=""15"" font=""12""><i>of Certain Dairy Products</i>, WT/DS98/AB/R, adopted 12 January 2000, </text>
<text top=""440"" left=""330"" width=""108"" height=""15"" font=""10"">DSR 2000:I, p. 3 </text>
</p><p><text top=""464"" left=""108"" width=""180"" height=""15"" font=""31"">Korea &#8211; Various Measures on </text><text top=""479"" left=""108"" width=""31"" height=""15"" font=""31"">Beef </text></p><p><text top=""464"" left=""330"" width=""422"" height=""15"" font=""10"">Appellate Body Report, <i>Korea &#8211; Measures Affecting Imports of Fresh, </i></text>
<text top=""479"" left=""330"" width=""442"" height=""15"" font=""12""><i>Chilled and Frozen Beef</i>, WT/DS161/AB/R, WT/DS169/AB/R, adopted 10 </text>
<text top=""493"" left=""330"" width=""198"" height=""15"" font=""10"">January 2001, DSR 2001:I, p. 5 </text>
</p><p><text top=""517"" left=""108"" width=""187"" height=""15"" font=""31"">Mexico &#8211; Taxes on Soft Drinks </text></p><p><text top=""517"" left=""330"" width=""443"" height=""15"" font=""10"">Appellate Body Report, <i>Mexico &#8211; Tax Measures on Soft Drinks and Other </i></text>
<text top=""531"" left=""330"" width=""440"" height=""15"" font=""12""><i>Beverages</i>, WT/DS308/AB/R, adopted 24 March 2006, DSR 2006:I, p. 3 </text>
</p><p><text top=""555"" left=""108"" width=""175"" height=""15"" font=""31"">Philippines &#8211; Distilled Spirits </text></p><p><text top=""555"" left=""330"" width=""383"" height=""15"" font=""10"">Appellate Body Reports, <i>Philippines &#8211; Taxes on Distilled Spirits</i>, </text>
<text top=""569"" left=""330"" width=""417"" height=""15"" font=""10"">WT/DS396/AB/R / WT/DS403/AB/R, adopted 20 January 2012, DSR </text>
<text top=""584"" left=""330"" width=""119"" height=""15"" font=""10"">2012:VIII, p. 4163 </text>
</p><p><text top=""608"" left=""108"" width=""126"" height=""15"" font=""31"">Thailand &#8211; H-Beams </text></p><p><text top=""608"" left=""330"" width=""456"" height=""15"" font=""10"">Appellate Body Report, <i>Thailand &#8211; Anti-Dumping Duties on Angles, Shapes </i></text>
<text top=""622"" left=""330"" width=""407"" height=""15"" font=""12""><i>and Sections of Iron or Non-Alloy Steel and H-Beams from Poland</i>, </text>
<text top=""637"" left=""330"" width=""389"" height=""15"" font=""10"">WT/DS122/AB/R, adopted 5 April 2001, DSR 2001:VII, p. 2701 </text>
</p><p><text top=""660"" left=""108"" width=""108"" height=""15"" font=""31"">Turkey &#8211; Textiles </text></p><p><text top=""660"" left=""330"" width=""429"" height=""15"" font=""10"">Panel Report, <i>Turkey &#8211; Restrictions on Imports of Textile and Clothing </i></text>
<text top=""675"" left=""330"" width=""411"" height=""15"" font=""12""><i>Products</i>, WT/DS34/R, adopted 19 November 1999, as modified by </text>
<text top=""690"" left=""330"" width=""379"" height=""15"" font=""10"">Appellate Body Report WT/DS34/AB/R, DSR 1999:VI, p. 2363 </text>
</p><p><text top=""713"" left=""108"" width=""144"" height=""15"" font=""31"">US &#8211; Anti-Dumping and </text><text top=""728"" left=""108"" width=""179"" height=""15"" font=""31"">Countervailing Duties (China) </text></p><p><text top=""713"" left=""330"" width=""406"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Definitive Anti-Dumping and </i></text>
<text top=""728"" left=""330"" width=""431"" height=""15"" font=""12""><i>Countervailing Duties on Certain Products from China</i>, WT/DS379/AB/R, </text>
<text top=""742"" left=""330"" width=""280"" height=""15"" font=""10"">adopted 25 March 2011, DSR 2011:V, p. 2869 </text>
</p><p><text top=""766"" left=""108"" width=""115"" height=""15"" font=""31"">US &#8211; Carbon Steel </text></p><p><text top=""766"" left=""330"" width=""441"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Countervailing Duties on Certain </i></text>
<text top=""780"" left=""330"" width=""383"" height=""15"" font=""12""><i>Corrosion-Resistant Carbon Steel Flat Products from Germany</i>, </text>
<text top=""795"" left=""330"" width=""443"" height=""15"" font=""10"">WT/DS213/AB/R and Corr.1, adopted 19 December 2002, DSR 2002:IX, </text>
<text top=""810"" left=""330"" width=""51"" height=""15"" font=""10"">p. 3779 </text>
</p><p><text top=""833"" left=""108"" width=""136"" height=""15"" font=""31"">US &#8211; Clove Cigarettes </text></p><p><text top=""833"" left=""330"" width=""448"" height=""15"" font=""10"">Panel Report, <i>United States &#8211; Measures Affecting the Production and Sale </i></text>
<text top=""848"" left=""330"" width=""446"" height=""15"" font=""12""><i>of Clove Cigarettes</i>, WT/DS406/R, adopted 24 April 2012, as modified by </text>
<text top=""862"" left=""330"" width=""244"" height=""15"" font=""10"">Appellate Body Report WT/DS406/AB/R </text>
</p><p><text top=""886"" left=""108"" width=""171"" height=""15"" font=""31"">US &#8211; Continued Suspension </text></p><p><text top=""886"" left=""330"" width=""395"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Continued Suspension of </i></text>
<text top=""901"" left=""330"" width=""444"" height=""15"" font=""12""><i>Obligations in the EC &#8211; Hormones Dispute</i>, WT/DS320/AB/R, adopted 14 </text>
<text top=""915"" left=""330"" width=""239"" height=""15"" font=""10"">November 2008, DSR 2008:X, p. 3507 </text>
</p><p><text top=""939"" left=""108"" width=""171"" height=""15"" font=""31"">US &#8211; Continued Suspension </text></p><p><text top=""939"" left=""330"" width=""447"" height=""15"" font=""10"">Panel Report, <i>United States &#8211; Continued Suspension of Obligations in the </i></text>
<text top=""953"" left=""330"" width=""435"" height=""15"" font=""12""><i>EC &#8211; Hormones Dispute</i>, WT/DS320/R, adopted 14 November 2008, as </text>
<text top=""968"" left=""330"" width=""411"" height=""15"" font=""10"">modified by Appellate Body Report WT/DS320/AB/R, DSR 2008:XI, </text>
<text top=""982"" left=""330"" width=""51"" height=""15"" font=""10"">p. 3891 </text>
</p><p><text top=""1006"" left=""108"" width=""149"" height=""15"" font=""31"">US &#8211; Continued Zeroing </text></p><p><text top=""1006"" left=""330"" width=""394"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Continued Existence and </i></text>
<text top=""1021"" left=""330"" width=""384"" height=""15"" font=""12""><i>Application of Zeroing Methodology</i>, WT/DS350/AB/R, adopted </text>
<text top=""1035"" left=""330"" width=""257"" height=""15"" font=""10"">19 February 2009, DSR 2009:III, p. 1291 </text>
</p><p><text top=""1059"" left=""108"" width=""70"" height=""15"" font=""31"">US &#8211; COOL </text></p><p><text top=""1059"" left=""330"" width=""451"" height=""15"" font=""10"">Appellate Body Reports, <i>United States &#8211; Certain Country of Origin Labelling </i></text>
<text top=""1073"" left=""330"" width=""410"" height=""15"" font=""12""><i>(COOL) Requirements</i>, WT/DS384/AB/R / WT/DS386/AB/R, adopted </text>
<text top=""1088"" left=""330"" width=""220"" height=""15"" font=""10"">23 July 2012, DSR 2012:V, p. 2449 </text>
</p></page>
<page number=""12"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""15"" size=""5"" family=""Times"" color=""#000000""/>
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 12 - </text>
</p><p><text top=""128"" left=""176"" width=""75"" height=""15"" font=""29"">Short Title </text><text top=""128"" left=""467"" width=""184"" height=""15"" font=""29"">Full Case Title and Citation </text></p><p><text top=""147"" left=""108"" width=""70"" height=""15"" font=""31"">US &#8211; COOL </text></p><p><text top=""147"" left=""330"" width=""441"" height=""15"" font=""10"">Panel Reports, <i>United States &#8211; Certain Country of Origin Labelling (COOL) </i></text>
<text top=""162"" left=""330"" width=""423"" height=""15"" font=""12""><i>Requirements</i>, WT/DS384/R / WT/DS386/R, adopted 23 July 2012, as </text>
<text top=""177"" left=""330"" width=""444"" height=""15"" font=""10"">modified by Appellate Body Reports WT/DS384/AB/R / WT/DS386/AB/R, </text>
<text top=""191"" left=""330"" width=""139"" height=""15"" font=""10"">DSR 2012:VI, p. 2745 </text>
</p><p><text top=""215"" left=""108"" width=""191"" height=""15"" font=""31"">US &#8211; Corrosion-Resistant Steel </text><text top=""229"" left=""108"" width=""93"" height=""15"" font=""31"">Sunset Review </text></p><p><text top=""215"" left=""330"" width=""437"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Sunset Review of Anti-Dumping </i></text>
<text top=""229"" left=""330"" width=""425"" height=""15"" font=""12""><i>Duties on Corrosion-Resistant Carbon Steel Flat Products from Japan</i>, </text>
<text top=""244"" left=""330"" width=""372"" height=""15"" font=""10"">WT/DS244/AB/R, adopted 9 January 2004, DSR 2004:I, p. 3<b> </b></text>
</p><p><text top=""268"" left=""108"" width=""109"" height=""15"" font=""31"">US &#8211; Cotton Yarn </text></p><p><text top=""268"" left=""330"" width=""455"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Transitional Safeguard Measure on </i></text>
<text top=""282"" left=""330"" width=""395"" height=""15"" font=""12""><i>Combed Cotton Yarn from Pakistan</i>, WT/DS192/AB/R, adopted 5 </text>
<text top=""297"" left=""330"" width=""249"" height=""15"" font=""10"">November 2001, DSR 2001:XII, p. 6027 </text>
</p><p><text top=""320"" left=""108"" width=""89"" height=""15"" font=""31"">US &#8211; Gasoline </text></p><p><text top=""320"" left=""330"" width=""439"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Standards for Reformulated and </i></text>
<text top=""335"" left=""330"" width=""457"" height=""15"" font=""12""><i>Conventional Gasoline</i>, WT/DS2/AB/R, adopted 20 May 1996, DSR 1996:I, </text>
<text top=""349"" left=""330"" width=""28"" height=""15"" font=""10"">p. 3 </text>
</p><p><text top=""373"" left=""108"" width=""135"" height=""15"" font=""31"">US &#8211; Hot-Rolled Steel </text><text top=""388"" left=""108"" width=""102"" height=""15"" font=""31"">(Article 21.3(c)) </text></p><p><text top=""373"" left=""330"" width=""414"" height=""15"" font=""10"">Award of the Arbitrator, <i>United States &#8211; Anti-Dumping Measures on </i></text>
</p><p><text top=""388"" left=""330"" width=""397"" height=""15"" font=""31"">Certain Hot-Rolled Steel Products from Japan &#8211; Arbitration under </text></p><p><text top=""402"" left=""330"" width=""376"" height=""15"" font=""12""><i>Article 21.3(c) of the DSU</i>, WT/DS184/13, 19 February 2002, </text>
<text top=""417"" left=""330"" width=""139"" height=""15"" font=""10"">DSR 2002:IV, p. 1389 </text>
</p><p><text top=""440"" left=""108"" width=""149"" height=""15"" font=""31"">US &#8211; Large Civil Aircraft </text><text top=""455"" left=""108"" width=""13"" height=""15"" font=""31"">(2</text><text top=""454"" left=""121"" width=""9"" height=""9"" font=""31"">nd</text><text top=""455"" left=""131"" width=""73"" height=""15"" font=""31""> complaint) </text></p><p><text top=""440"" left=""330"" width=""447"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Measures Affecting Trade in Large </i></text>
<text top=""455"" left=""330"" width=""369"" height=""15"" font=""12""><i>Civil Aircraft (Second Complaint)</i>, WT/DS353/AB/R, adopted </text>
<text top=""470"" left=""330"" width=""207"" height=""15"" font=""10"">23 March 2012, DSR 2012:I, p. 7 </text>
</p><p><text top=""493"" left=""108"" width=""197"" height=""15"" font=""31"">US &#8211; Oil Country Tubular Goods </text><text top=""508"" left=""108"" width=""99"" height=""15"" font=""31"">Sunset Reviews </text></p><p><text top=""493"" left=""330"" width=""443"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Sunset Reviews of Anti-Dumping </i></text>
<text top=""508"" left=""330"" width=""453"" height=""15"" font=""12""><i>Measures on Oil Country Tubular Goods from Argentina</i>, WT/DS268/AB/R, </text>
<text top=""522"" left=""330"" width=""321"" height=""15"" font=""10"">adopted 17 December 2004, DSR 2004:VII, p. 3257 </text>
</p><p><text top=""546"" left=""108"" width=""129"" height=""15"" font=""31"">US &#8211; Poultry (China) </text></p><p><text top=""546"" left=""330"" width=""415"" height=""15"" font=""10"">Panel Report, <i>United States &#8211; Certain Measures Affecting Imports of </i></text>
<text top=""560"" left=""330"" width=""455"" height=""15"" font=""12""><i>Poultry from China</i>, WT/DS392/R, adopted 25 October 2010, DSR 2010:V, </text>
<text top=""575"" left=""330"" width=""51"" height=""15"" font=""10"">p. 1909 </text>
</p><p><text top=""599"" left=""108"" width=""81"" height=""15"" font=""31"">US &#8211; Shrimp </text></p><p><text top=""599"" left=""330"" width=""418"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Import Prohibition of Certain </i></text>
<text top=""613"" left=""330"" width=""454"" height=""15"" font=""12""><i>Shrimp and Shrimp Products</i>, WT/DS58/AB/R, adopted 6 November 1998, </text>
<text top=""628"" left=""330"" width=""144"" height=""15"" font=""10"">DSR 1998:VII, p. 2755 </text>
</p><p><text top=""651"" left=""108"" width=""81"" height=""15"" font=""31"">US &#8211; Shrimp </text><text top=""666"" left=""108"" width=""152"" height=""15"" font=""31"">(Article 21.5 &#8211; Malaysia) </text></p><p><text top=""651"" left=""330"" width=""418"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Import Prohibition of Certain </i></text>
</p><p><text top=""666"" left=""330"" width=""428"" height=""15"" font=""31"">Shrimp and Shrimp Products &#8211; Recourse to Article 21.5 of the DSU by </text></p><p><text top=""681"" left=""330"" width=""450"" height=""15"" font=""12""><i>Malaysia</i>, WT/DS58/AB/RW, adopted 21 November 2001, DSR 2001:XIII, </text>
<text top=""695"" left=""330"" width=""51"" height=""15"" font=""10"">p. 6481 </text>
</p><p><text top=""719"" left=""108"" width=""157"" height=""15"" font=""31"">US &#8211; Shrimp (Thailand) / </text><text top=""733"" left=""108"" width=""182"" height=""15"" font=""31"">US &#8211; Customs Bond Directive </text></p><p><text top=""719"" left=""330"" width=""452"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Measures Relating to Shrimp from </i></text>
</p><p><text top=""733"" left=""330"" width=""411"" height=""15"" font=""31"">Thailand / United States &#8211; Customs Bond Directive for Merchandise </text></p><p><text top=""748"" left=""330"" width=""408"" height=""15"" font=""12""><i>Subject to Anti-Dumping/Countervailing Duties</i>, WT/DS343/AB/R / </text>
<text top=""762"" left=""330"" width=""413"" height=""15"" font=""10"">WT/DS345/AB/R, adopted 1 August 2008, DSR 2008:VII, p. 2385 / </text>
<text top=""777"" left=""330"" width=""149"" height=""15"" font=""10"">DSR 2008:VIII, p. 2773 </text>
</p><p><text top=""801"" left=""108"" width=""161"" height=""15"" font=""31"">US &#8211; Softwood Lumber IV </text></p><p><text top=""801"" left=""330"" width=""397"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Final Countervailing Duty </i></text>
<text top=""815"" left=""330"" width=""432"" height=""15"" font=""12""><i>Determination with Respect to Certain Softwood Lumber from Canada</i>, </text>
<text top=""830"" left=""330"" width=""407"" height=""15"" font=""10"">WT/DS257/AB/R, adopted 17 February 2004, DSR 2004:II, p. 571 </text>
</p><p><text top=""853"" left=""108"" width=""138"" height=""15"" font=""31"">US &#8211; Tuna II (Mexico) </text></p><p><text top=""853"" left=""330"" width=""398"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Measures Concerning the </i></text>
<text top=""868"" left=""330"" width=""371"" height=""15"" font=""12""><i>Importation, Marketing and Sale of Tuna and Tuna Products</i>, </text>
<text top=""883"" left=""330"" width=""249"" height=""15"" font=""10"">WT/DS381/AB/R, adopted 13 June 2012 </text>
</p><p><text top=""906"" left=""108"" width=""123"" height=""15"" font=""31"">US &#8211; Upland Cotton </text></p><p><text top=""906"" left=""330"" width=""416"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Subsidies on Upland Cotton</i>, </text>
<text top=""921"" left=""330"" width=""369"" height=""15"" font=""10"">WT/DS267/AB/R, adopted 21 March 2005, DSR 2005:I, p. 3 </text>
</p><p><text top=""944"" left=""108"" width=""183"" height=""15"" font=""31"">US &#8211; Wool Shirts and Blouses </text></p><p><text top=""944"" left=""330"" width=""420"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Measure Affecting Imports of </i></text>
<text top=""959"" left=""330"" width=""422"" height=""15"" font=""12""><i>Woven Wool Shirts and Blouses from India</i>, WT/DS33/AB/R, adopted </text>
<text top=""973"" left=""330"" width=""283"" height=""15"" font=""10"">23 May 1997, and Corr.1, DSR 1997:I, p. 323 </text>
</p><p><text top=""997"" left=""108"" width=""119"" height=""15"" font=""31"">US &#8211; Zeroing (EC)  </text><text top=""1012"" left=""108"" width=""117"" height=""15"" font=""31"">(Article 21.5 &#8211; EC) </text></p><p><text top=""997"" left=""330"" width=""380"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Laws, Regulations and </i></text>
</p><p><text top=""1012"" left=""330"" width=""442"" height=""15"" font=""31"">Methodology for Calculating Dumping Margins (""Zeroing"") &#8211; Recourse to </text></p><p><text top=""1026"" left=""330"" width=""452"" height=""15"" font=""12""><i>Article 21.5 of the DSU by the European Communities</i>, WT/DS294/AB/RW </text>
<text top=""1041"" left=""330"" width=""360"" height=""15"" font=""10"">and Corr.1, adopted 11 June 2009, DSR 2009:VII, p. 2911 </text>
</p><p><text top=""1064"" left=""108"" width=""133"" height=""15"" font=""31"">US &#8211; Zeroing (Japan) </text><text top=""1079"" left=""108"" width=""136"" height=""15"" font=""31"">(Article 21.5 &#8211; Japan) </text></p><p><text top=""1064"" left=""330"" width=""448"" height=""15"" font=""10"">Appellate Body Report, <i>United States &#8211; Measures Relating to Zeroing and </i></text>
<text top=""1079"" left=""330"" width=""392"" height=""15"" font=""12""><i>Sunset Reviews &#8211; Recourse to Article 21.5 of the DSU by Japan</i>, </text>
<text top=""1094"" left=""330"" width=""428"" height=""15"" font=""10"">WT/DS322/AB/RW, adopted 31 August 2009, DSR 2009:VIII, p. 3441 </text>
</p></page>
<page number=""13"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 13 - </text>
</p><p><text top=""164"" left=""304"" width=""289"" height=""16"" font=""6"">EXHIBITS REFERRED TO IN THIS REPORT </text>
</p><p><text top=""202"" left=""108"" width=""92"" height=""15"" font=""29"">Panel Exhibit </text><text top=""202"" left=""484"" width=""34"" height=""15"" font=""29"">Title </text></p><p><text top=""224"" left=""108"" width=""47"" height=""15"" font=""10"">ARG-1 </text>
<text top=""224"" left=""213"" width=""579"" height=""15"" font=""10"">Commission Regulation (EU) N&#176; 206/2010 of 12 March, 2010, laying down lists of third </text>
<text top=""239"" left=""213"" width=""577"" height=""15"" font=""10"">countries, territories or parts thereof authorized for the introduction into the European Union </text>
<text top=""253"" left=""213"" width=""578"" height=""15"" font=""10"">of certain animals and fresh meat and the veterinary certification requirements, 2010 O.J. </text>
<text top=""268"" left=""213"" width=""89"" height=""15"" font=""10"">(L 073) 1-121 </text>
<text top=""290"" left=""108"" width=""43"" height=""15"" font=""10"">ARG-4 </text>
<footnote top=""304"" left=""108"" width=""50"" height=""15"" font=""10"" number=""37"" ref="""" dis=""""><ftext top=""1002"" left=""213"" width=""580"" height=""15"" font=""10"">Letter from Hon. Jos&#233; O. Bord&#243;n, Ambassador of Argentina to Hon. Mike Johanns, US </ftext>
<ftext top=""1017"" left=""213"" width=""279"" height=""15"" font=""10"">Secretary of Agriculture (30 November 2005) </ftext>
</footnote>
<text top=""290"" left=""213"" width=""404"" height=""15"" font=""10"">Plan de Erradicaci&#243;n de la Fiebre Aftosa: Resoluci&#243;n SENASA 5/01 </text>
</p><p><text top=""326"" left=""108"" width=""43"" height=""15"" font=""10"">ARG-5 </text>
<text top=""326"" left=""214"" width=""182"" height=""15"" font=""10"">Resoluci&#243;n SENASA N&#186; 35/06 </text>
<text top=""348"" left=""108"" width=""43"" height=""15"" font=""10"">ARG-6 </text>
<text top=""348"" left=""213"" width=""182"" height=""15"" font=""10"">Resoluci&#243;n SENASA N&#186; 36/06 </text>
<text top=""370"" left=""108"" width=""254"" height=""15"" font=""10"">ARG-7 USDA/APHIS, </text>
<text top=""370"" left=""302"" width=""129"" height=""15"" font=""10"">Veterinary </text>
<text top=""370"" left=""371"" width=""122"" height=""15"" font=""10"">Services, </text>
</p><p><text top=""370"" left=""432"" width=""359"" height=""15"" font=""31"">APHIS Evaluation of the Status of the Brazilian State of </text><text top=""384"" left=""213"" width=""578"" height=""15"" font=""31"">Santa Catarina Regarding Foot-and-Mouth Disease, Classical Swine Fever, Swine Vesicular </text></p><p><text top=""399"" left=""213"" width=""365"" height=""15"" font=""12""><i>Disease, and African Swine Fever</i> (revised 16 August 2010) </text>
<text top=""421"" left=""108"" width=""43"" height=""15"" font=""10"">ARG-8 </text>
<text top=""421"" left=""213"" width=""578"" height=""15"" font=""12""><i>Importation of Beef from Uruguay</i>, 68 Fed. Reg. 31940 (USDA/APHIS May 29, 2003) (Final </text>
<text top=""435"" left=""213"" width=""36"" height=""15"" font=""10"">Rule) </text>
<text top=""457"" left=""108"" width=""44"" height=""15"" font=""10"">ARG-9 </text>
<text top=""457"" left=""214"" width=""577"" height=""15"" font=""10"">USDA, Veterinary Services, National Center for Import and Export Regionalization Evaluation </text>
<text top=""472"" left=""213"" width=""577"" height=""15"" font=""10"">Services, <i>Risk Analysis: Risk of Exporting Foot-and-Mouth Disease (FMD) in FMD-Susceptible </i></text>
<footnote top=""486"" left=""213"" width=""578"" height=""15"" font=""31"" number=""42"" ref="""" dis=""""/></p><p><text top=""501"" left=""213"" width=""487"" height=""15"" font=""12""><i>Evaluation of the FMD Status of Argentina, South of the 42 Parallel</i> (June 2005) </text>
<text top=""522"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-10 </text>
<text top=""522"" left=""213"" width=""578"" height=""15"" font=""10"">OIE World Assembly, Resolution XXI, <i>Recognition of the Foot and Mouth Disease Status of </i></text>
<text top=""537"" left=""213"" width=""366"" height=""15"" font=""12""><i>Member Countries</i>, 75th General Session (20-25 May 2007) </text>
<text top=""559"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-12 </text>
<text top=""559"" left=""213"" width=""576"" height=""15"" font=""10"">OIE World Assembly, Resolution No. 14, <i>Recognition of the Foot and Mouth Disease Status of </i></text>
<text top=""573"" left=""213"" width=""311"" height=""15"" font=""12""><i>Members</i>, 79th General Session (22-27 May 2011) </text>
<text top=""595"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-15 </text>
<text top=""595"" left=""213"" width=""577"" height=""15"" font=""12""><i>Importation of Animals and Animal Products</i>, 62 Fed. Reg. 56000 (USDA/APHIS October 28, </text>
<footnote top=""610"" left=""213"" width=""114"" height=""15"" font=""10"" number=""1997"" ref="""" dis=""""/>
</p><p><text top=""632"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-16 </text>
</p><p><text top=""632"" left=""213"" width=""578"" height=""15"" font=""31"">Information From Foreign Regions Applying for Recognition of Animal Health Status: Final </text></p><p><text top=""646"" left=""213"" width=""411"" height=""15"" font=""12""><i>Rule</i>, 77 Fed. Reg. 44107 (USDA/APHIS, 27 July 2012) (Final Rule) </text>
<text top=""668"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-18 </text>
<text top=""668"" left=""213"" width=""190"" height=""15"" font=""10"">Resoluci&#243;n SENASA N&#186; 351/06 </text>
<text top=""690"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-21 </text>
</p><p><text top=""690"" left=""213"" width=""576"" height=""15"" font=""31"">Changes in the Disease Status of the Brazilian State of Santa Catarina with Regard to Certain </text></p><p><text top=""704"" left=""213"" width=""576"" height=""15"" font=""12""><i>Ruminant and Swine Diseases</i>, 75 Fed. Reg. 69851 (USDA/APHIS November 16, 2010) (Final </text>
<text top=""719"" left=""213"" width=""36"" height=""15"" font=""10"">Rule) </text>
<text top=""741"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-22 </text>
<text top=""741"" left=""213"" width=""584"" height=""15"" font=""10"">Committee on Sanitary and Phytosanitary Measures, <i>Summary of the Meeting of </i></text>
<text top=""755"" left=""213"" width=""494"" height=""15"" font=""12""><i>30 June-1 July 2011</i>, Note by the Secretariat, G/SPS/R/63 (12 September 2011) </text>
<text top=""777"" left=""108"" width=""59"" height=""15"" font=""10"">ARG-23 </text>
<text top=""777"" left=""213"" width=""584"" height=""15"" font=""10"">Committee on Sanitary and Phytosanitary Measures, <i>Summary of the Meeting of </i></text>
<text top=""792"" left=""213"" width=""469"" height=""15"" font=""12""><i>10-11 July 2012</i>, Note by the Secretariat, G/SPS/R/67 (11 September 2012) </text>
<text top=""813"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-26 </text>
<text top=""813"" left=""213"" width=""577"" height=""15"" font=""12""><i>Importation of Beef from Argentina</i>, 62 Fed. Reg. 34385 (USDA/APHIS June 26, 1997) (Final </text>
<text top=""828"" left=""213"" width=""36"" height=""15"" font=""10"">Rule) </text>
<text top=""850"" left=""108"" width=""246"" height=""15"" font=""10"">ARG-27 USDA/APHIS, </text>
<text top=""872"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-28 </text>
<text top=""872"" left=""213"" width=""576"" height=""15"" font=""10"">USDA/APHIS, <i>Risk Analysis: Evaluation of risk to the United States (US) of importing Foot and </i></text>
<text top=""886"" left=""213"" width=""531"" height=""15"" font=""12""><i>Mouth Disease (FMD) Virus in Fresh or Frozen Beef from Argentin</i>a (4 December 2000) </text>
<text top=""908"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-29 </text>
<text top=""908"" left=""213"" width=""518"" height=""15"" font=""12""><i>Prohibition of Beef from Argentina</i>, 66 Fed. Reg. 29897 (4 June 2001) (Interim Rule) </text>
<text top=""930"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-30 </text>
<text top=""930"" left=""213"" width=""543"" height=""15"" font=""12""><i>Prohibition of Beef from Argentina</i>, 66 Fed. Reg. 63911 (11 December 2001) (Final Rule) </text>
<text top=""952"" left=""108"" width=""56"" height=""15"" font=""10"">ARG-31 </text>
<text top=""952"" left=""213"" width=""581"" height=""15"" font=""10"">Agri-Food Health &amp; Quality National Service, <i>Information provided by SENASA for the </i></text>
</p><p><text top=""966"" left=""213"" width=""580"" height=""15"" font=""31"">recognition of Argentina as a Region comprised in Article 92.2 Title 9, Code of Federal </text><footnote top=""981"" left=""213"" width=""278"" height=""15"" font=""12"" number=""2002"" ref="""" dis=""""/>
</p><p><text top=""1039"" left=""108"" width=""52"" height=""15"" font=""10"">ARG-38 </text>
<text top=""1039"" left=""213"" width=""578"" height=""15"" font=""10"">Letter from John R. Clifford, Deputy Administrator, Veterinary Services, APHIS, to Jorge N. </text>
<text top=""1053"" left=""213"" width=""291"" height=""15"" font=""10"">Amaya, President, SENASA (10 February 2006) </text>
<text top=""1075"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-39 </text>
<text top=""1075"" left=""213"" width=""578"" height=""15"" font=""10"">Letter dated 22 January 2008 from various legislators of the Agriculture Commission of the </text>
<text top=""1090"" left=""213"" width=""581"" height=""15"" font=""10"">House of Representatives, requesting a hearing review into the proposed rule of the </text>
<text top=""1104"" left=""213"" width=""571"" height=""15"" font=""10"">United States Department of Agriculture to recognize Patagonia as a region free of foot-and-</text>
<text top=""1119"" left=""213"" width=""209"" height=""15"" font=""10"">mouth disease (22 January 2008) </text>
</p></page>
<page number=""14"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 14 - </text>
</p><p><text top=""132"" left=""108"" width=""92"" height=""15"" font=""29"">Panel Exhibit </text><text top=""132"" left=""484"" width=""34"" height=""15"" font=""29"">Title </text></p><p><text top=""154"" left=""108"" width=""57"" height=""15"" font=""10"">ARG-40 </text>
<text top=""154"" left=""213"" width=""576"" height=""15"" font=""10"">Letter from Senator Baucus et al. to Edward Schafer, Secretary,  US  Department  of </text>
<text top=""168"" left=""213"" width=""577"" height=""15"" font=""10"">Agriculture and Jim Nussle, Director, Office of Management and Budget regarding proposed </text>
<text top=""183"" left=""213"" width=""294"" height=""15"" font=""10"">USDA rule on Patagonia South (14 March 2008) </text>
<text top=""205"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-41 </text>
<text top=""205"" left=""213"" width=""577"" height=""15"" font=""10"">Letter from Minister Jos&#233; P&#233;rez Gabilondo to Senator Tester in response to his concern over </text>
<text top=""219"" left=""213"" width=""307"" height=""15"" font=""10"">the access of beef from Argentina (7 March 2008) </text>
<text top=""241"" left=""213"" width=""584"" height=""15"" font=""10"">Letter from Ambassador H&#233;ctor Timerman to Senator Baucus in response to his </text>
<text top=""256"" left=""213"" width=""237"" height=""15"" font=""10"">14 March 2008 letter (20 March 2008) </text>
<text top=""277"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-44 </text>
<text top=""277"" left=""213"" width=""428"" height=""15"" font=""10"">H.R. Res. 1226, 111th Cong. (2009); S. Res. 337, 111th Cong (2009) </text>
<text top=""299"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-45 </text>
<footnote top=""314"" left=""108"" width=""50"" height=""15"" font=""10"" number=""95"" ref="""" dis=""""><ftext top=""1005"" left=""213"" width=""578"" height=""15"" font=""10"">OIE World Assembly, Resolution XX, <i>Recognition of the Foot and Mouth Disease Status of </i></ftext>
<ftext top=""1019"" left=""213"" width=""367"" height=""15"" font=""12""><i>Member Countries</i>, 73rd General Session (22-27 May 2005) </ftext>
</footnote>
<text top=""299"" left=""213"" width=""490"" height=""15"" font=""12""><i>Omnibus Appropriations Act</i>, 2009, Pub. L. No. 111-8, &#167;737, 123 Stat. 524, 559 </text>
</p><p><text top=""336"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-46 </text>
<text top=""336"" left=""213"" width=""577"" height=""15"" font=""10"">Letter from Jorge N. Amaya, President, SENASA, to John R. Clifford, Deputy Administrator, </text>
<text top=""350"" left=""213"" width=""386"" height=""15"" font=""10"">Veterinary Services, APHIS, Note No. 150/2010 (19 July 2010) </text>
<text top=""372"" left=""108"" width=""53"" height=""15"" font=""10"">ARG-47 </text>
<text top=""372"" left=""213"" width=""578"" height=""15"" font=""10"">Letter from John R. Clifford, Deputy Administrator, Veterinary Services, APHIS to Jorge N. </text>
<text top=""386"" left=""213"" width=""304"" height=""15"" font=""10"">Amaya, President, SENASA (24 September 2010) </text>
<text top=""408"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-48 </text>
<text top=""408"" left=""213"" width=""572"" height=""15"" font=""10"">Committee on Sanitary and Phytosanitary Measures, <i>Summary of the Meeting of 19-</i></text>
<text top=""423"" left=""213"" width=""454"" height=""15"" font=""12""><i>20 October 2011</i>, Note by the Secretariat, G/SPS/R/64 (17 January 2012) </text>
<text top=""445"" left=""108"" width=""53"" height=""15"" font=""10"">ARG-50 </text>
<text top=""445"" left=""213"" width=""578"" height=""15"" font=""10"">Information provided by SENASA for the Recognition of Argentina's Patagonia as a Region </text>
<text top=""459"" left=""213"" width=""577"" height=""15"" font=""10"">Comprised in Article 92.2, Title 9, Code Of Federal Regulations in Regard to Foot and Mouth </text>
<text top=""474"" left=""213"" width=""166"" height=""15"" font=""10"">Disease &#8211; FMD (July 2003) </text>
<footnote top=""496"" left=""108"" width=""51"" height=""15"" font=""10"" number=""56"" ref="""" dis=""""><ftext top=""619"" left=""213"" width=""578"" height=""15"" font=""10"">Letter from Jorge N. Amaya, President, SENASA to John R. Clifford, Deputy Administrator, </ftext>
<ftext top=""634"" left=""213"" width=""386"" height=""15"" font=""10"">Veterinary Services, APHIS, Note No. 149/2010 (19 July 2010) </ftext>
</footnote>
</p><p><text top=""510"" left=""108"" width=""58"" height=""15"" font=""10"">USA-104 </text>
</p><p><text top=""496"" left=""213"" width=""580"" height=""15"" font=""31"">Change in Disease Status of the Patagonia South Region of Argentina With Regard to </text></p><p><text top=""510"" left=""213"" width=""579"" height=""15"" font=""12""><i>Rinderpest and Food- and-Mouth Disease, </i>72 Fed. Reg. 475 (5 January 2007) (Proposed </text>
<text top=""525"" left=""213"" width=""36"" height=""15"" font=""10"">Rule) </text>
<text top=""547"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-59 </text>
<footnote top=""561"" left=""108"" width=""58"" height=""15"" font=""10"" number=""111"" ref="""" dis=""""/>
<text top=""547"" left=""213"" width=""576"" height=""15"" font=""10"">Letter from Oscar Astibia, Coordinator of International and Institutional Relations, SENASA, to </text>
<text top=""561"" left=""213"" width=""494"" height=""15"" font=""10"">Yvette P&#233;rez, USDA/APHIS, Buenos Aires, CRI No. 7103/08 (17 December 2008) </text>
<text top=""583"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-60 </text>
<text top=""598"" left=""108"" width=""58"" height=""15"" font=""10"">USA-112 </text>
<text top=""583"" left=""213"" width=""576"" height=""15"" font=""10"">Letter from Oscar Astibia, Coordinator of International and Institutional Relations, SENASA, to </text>
<text top=""598"" left=""213"" width=""473"" height=""15"" font=""10"">Yvette P&#233;rez, USDA/APHIS, Buenos Aires, URI No. 460/09 (30 January 2009) </text>
<text top=""619"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-61 </text>
</p><p><text top=""656"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-62 </text>
<text top=""656"" left=""213"" width=""578"" height=""15"" font=""10"">Letter from John R. Clifford, Deputy Administrator, APHIS, to Jorge N. Amaya, President, </text>
<text top=""670"" left=""213"" width=""189"" height=""15"" font=""10"">SENASA (13 September 2010) </text>
<text top=""692"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-63 </text>
<text top=""692"" left=""213"" width=""578"" height=""15"" font=""12""><i>APHIS Policy Regarding Importation of Animals and Animal Products</i>, 62 Fed. Reg. 56027 </text>
<text top=""707"" left=""213"" width=""256"" height=""15"" font=""10"">(USDA/APHIS, 28 October 1997) (Notice) </text>
<text top=""728"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-64 </text>
</p><p><text top=""728"" left=""213"" width=""577"" height=""15"" font=""31"">Rinderpest, Foot-and-Mouth Disease, Exotic New-Castle Disease, African Swine Fever, Swine </text><text top=""743"" left=""213"" width=""583"" height=""15"" font=""31"">Vesicular Disease, and Bovine Spongiform Encephalopathy: Prohibited and Restricted </text></p><p><text top=""758"" left=""213"" width=""170"" height=""15"" font=""12""><i>Importations</i>, 9 C.F.R. &#167; 94 </text>
<text top=""779"" left=""108"" width=""246"" height=""15"" font=""10"">ARG-65 USDA/APHIS, </text>
</p><p><text top=""779"" left=""302"" width=""487"" height=""15"" font=""31"">Risk assessment: Importation of fresh (chilled or frozen) beef from Uruguay</text> </p><p><text top=""816"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-69 </text>
<text top=""816"" left=""213"" width=""542"" height=""15"" font=""12""><i>Application for recognition of the animal health status of a region</i>, 9 C.F.R. &#167; 92.2 (a)-(f) </text>
<text top=""837"" left=""108"" width=""53"" height=""15"" font=""10"">ARG-79 </text>
<text top=""837"" left=""213"" width=""578"" height=""15"" font=""10"">Letter from John R. Clifford, Deputy Administrator, Veterinary Services, APHIS to Jorge N. </text>
<text top=""852"" left=""213"" width=""265"" height=""15"" font=""10"">Amaya, President, SENASA (27 April 2009) </text>
<text top=""874"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-86 </text>
<text top=""874"" left=""213"" width=""578"" height=""15"" font=""10"">Further information requested by USDA-APHIS of the information provided by SENASA to </text>
<text top=""889"" left=""213"" width=""577"" height=""15"" font=""10"">attain recognition of Argentina's Patagonia as a region, as defined in Section 92.2, title 9, of </text>
<text top=""903"" left=""213"" width=""520"" height=""15"" font=""10"">the Code of Federal Regulations for Foot and Mouth Disease (FMD) (November 2004) </text>
<text top=""925"" left=""108"" width=""53"" height=""15"" font=""10"">ARG-89 </text>
<text top=""925"" left=""213"" width=""578"" height=""15"" font=""10"">OIE World Assembly, Resolution XVII, <i>Recognition of the Foot and Mouth Disease Status of </i></text>
<text top=""939"" left=""213"" width=""371"" height=""15"" font=""12""><i>Member Countries</i>, 70th General Session (26-31 May 2002)  </text>
<text top=""961"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-92 </text>
<text top=""961"" left=""213"" width=""182"" height=""15"" font=""10"">Resoluci&#243;n SENASA N&#186; 25/01 </text>
<text top=""983"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-94 </text>
<text top=""983"" left=""213"" width=""194"" height=""15"" font=""10"">Resoluci&#243;n SENASA N&#186; 112/02  </text>
</p><p><text top=""1041"" left=""108"" width=""61"" height=""15"" font=""10"">ARG-96 </text>
<text top=""1041"" left=""213"" width=""586"" height=""15"" font=""10"">Letter CRI 1968/05, 5 December 2005, reporting APHIS about SENASA strike </text>
<text top=""1056"" left=""213"" width=""123"" height=""15"" font=""10"">(5 December 2005) </text>
<text top=""1078"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-97 </text>
<text top=""1078"" left=""213"" width=""577"" height=""15"" font=""10"">Letter from Dr Jorge Amaya, SENASA, to Dr John Clifford, APHIS, concerning the eradication </text>
<text top=""1092"" left=""213"" width=""395"" height=""15"" font=""10"">of the San Luis del Palmar (Corrientes) outbreak (26 July 2006)  </text>
</p></page>
<page number=""15"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 15 - </text>
</p><p><text top=""132"" left=""108"" width=""92"" height=""15"" font=""29"">Panel Exhibit </text><text top=""132"" left=""484"" width=""34"" height=""15"" font=""29"">Title </text></p><p><text top=""154"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-98 </text>
<text top=""154"" left=""213"" width=""576"" height=""15"" font=""10"">Communication by Argentina to the Committee on Sanitary and Phytosanitary Measures: <i>Foot </i></text>
<text top=""168"" left=""213"" width=""377"" height=""15"" font=""12""><i>And Mouth Disease Situation</i>, G/SPS/GEN/868 (21 July 2008) </text>
<text top=""190"" left=""108"" width=""51"" height=""15"" font=""10"">ARG-99 </text>
<text top=""190"" left=""213"" width=""471"" height=""15"" font=""10"">Letter from Dr Miguez, SENASA to Dr Peter Fernandez, APHIS (13 July 2013) </text>
<text top=""212"" left=""108"" width=""61"" height=""15"" font=""10"">ARG-100 </text>
<text top=""212"" left=""213"" width=""579"" height=""15"" font=""10"">OIE World Assembly, Resolution XX, <i>Recognition of the Foot and Mouth Disease Status of </i></text>
<text top=""226"" left=""213"" width=""365"" height=""15"" font=""12""><i>Member Countries</i>, 71st General Session (18-23 May 2003) </text>
<text top=""248"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-101 </text>
<text top=""248"" left=""213"" width=""578"" height=""15"" font=""10"">OIE World Assembly, Resolution XX, <i>Recognition of the Foot and Mouth Disease Status of </i></text>
<text top=""263"" left=""213"" width=""373"" height=""15"" font=""12""><i>Member Countries</i>, 72nd General Session (23-28 May 2004)  </text>
<text top=""285"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-102 </text>
<text top=""285"" left=""213"" width=""577"" height=""15"" font=""10"">OIE World  Assembly,  Resolution XXVI,  <i>Recognition of the Foot and Mouth Disease Status of </i></text>
<text top=""299"" left=""213"" width=""366"" height=""15"" font=""12""><i>Member Countries</i>, 74th General Session (21-26 May 2006) </text>
<text top=""321"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-103 </text>
<text top=""321"" left=""213"" width=""578"" height=""15"" font=""10"">OIE World Assembly, Resolution XVII, <i>Recognition of the Foot and Mouth Disease Status of </i></text>
<text top=""336"" left=""213"" width=""391"" height=""15"" font=""12""><i>Member Countries</i>, 69th General Session (27 May-1 June 2001) </text>
<text top=""357"" left=""108"" width=""59"" height=""15"" font=""10"">ARG-107 </text>
<text top=""357"" left=""213"" width=""577"" height=""15"" font=""10"">Final Report Of A Mission Carried Out In Argentina From 18 To 29 November 2002 In Order </text>
<text top=""372"" left=""213"" width=""577"" height=""15"" font=""10"">To Evaluate The Controls In Place Over Foot And Mouth Disease And To Assess Public Health </text>
<text top=""386"" left=""213"" width=""501"" height=""15"" font=""10"">Controls Over The Production Of Fresh Meat. (DG(SANCO)/8715/2002 &#8211; MR Final) </text>
<text top=""408"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-108 </text>
<text top=""408"" left=""213"" width=""451"" height=""15"" font=""10"">Decision of the European Commission No. 2002/68/EC (30 January 2002) </text>
<text top=""430"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-109 </text>
<text top=""430"" left=""213"" width=""440"" height=""15"" font=""10"">Decision of the European Commission No. 2002/198/EC (7 March 2002) </text>
<text top=""452"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-110 </text>
<text top=""452"" left=""213"" width=""578"" height=""15"" font=""10"">Final Report Of A Mission Carried Out In Argentina From 19 To 30 April 2004 In Order To </text>
<text top=""466"" left=""213"" width=""576"" height=""15"" font=""10"">Evaluate  Animal  Health  Controls  In  Place  In  Particular  Over  Foot  And  Mouth  Disease,  Public </text>
<text top=""481"" left=""213"" width=""553"" height=""15"" font=""10"">Health Control Systems And Certification Procedures. (DG(SANCO)/7184/2004 &#8211; MR Final) </text>
<text top=""503"" left=""213"" width=""579"" height=""15"" font=""10"">Final Report Of A Mission Carried Out In Argentina From 3 To 13 July 2006 In Order To </text>
<text top=""517"" left=""213"" width=""576"" height=""15"" font=""10"">Evaluate  Animal  Health  Controls  In  Place  In  Particular  Over  Foot  And  Mouth  Disease,  Public </text>
<text top=""532"" left=""213"" width=""553"" height=""15"" font=""10"">Health Control Systems And Certification Procedures. (DG(SANCO)/8203/2006 &#8211; MR Final) </text>
<text top=""554"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-114 </text>
<text top=""554"" left=""213"" width=""451"" height=""15"" font=""10"">Decision of the European Commission No. 2002/45/EC (22 January 2002) </text>
<text top=""576"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-118 </text>
<text top=""576"" left=""213"" width=""192"" height=""15"" font=""10"">2002 edition of 9 C.F.R. &#167; 92.2 </text>
<text top=""597"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-119 </text>
<text top=""597"" left=""213"" width=""577"" height=""15"" font=""10"">Report of the Meeting of the OIE Foot and Mouth Disease and Other Epizootics Commission </text>
<text top=""612"" left=""213"" width=""201"" height=""15"" font=""10"">(Paris, 16, 17 and 22 May 2003) </text>
<text top=""634"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-120 </text>
<text top=""634"" left=""213"" width=""576"" height=""15"" font=""10"">Decision of the European Commission No. 2008/642/EC (31 July 2008), amending Annex II to </text>
<text top=""648"" left=""213"" width=""577"" height=""15"" font=""10"">Council Decision 79/542/EEC as regards the entries for Argentina, Brazil and Paraguay in the </text>
<text top=""663"" left=""213"" width=""578"" height=""15"" font=""10"">list of third countries and parts thereof from which imports into the Community of certain </text>
<text top=""677"" left=""213"" width=""161"" height=""15"" font=""10"">fresh meat are authorized </text>
<text top=""699"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-124 </text>
<text top=""699"" left=""213"" width=""577"" height=""15"" font=""10"">SENASA Notice No. 4056 informing the minimum frequency of supervisory visits to all types </text>
<text top=""714"" left=""213"" width=""288"" height=""15"" font=""10"">of authorized establishments (4 January 2013) </text>
<text top=""736"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-126 </text>
<text top=""736"" left=""213"" width=""191"" height=""15"" font=""10"">9 C.F.R. &#167; 94.1 (1-1-2012 ed.) </text>
<text top=""757"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-128 </text>
<text top=""757"" left=""213"" width=""576"" height=""15"" font=""10"">D.J. Paton, M. Sinclair, R. Rodr&#237;guez, Qualitative assessment of the commodity risk factor for </text>
<text top=""772"" left=""213"" width=""576"" height=""15"" font=""10"">spread of foot-and-mouth disease associated with international trade in deboned beef, OIE ad </text>
<text top=""787"" left=""213"" width=""338"" height=""15"" font=""10"">hoc Group on Trade in Animal Products (October 2009) </text>
<text top=""808"" left=""108"" width=""239"" height=""15"" font=""10"">ARG-133 USDA/APHIS, </text>
<footnote top=""808"" left=""300"" width=""439"" height=""15"" font=""12"" number=""2002"" ref="""" dis=""""/>
<text top=""830"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-134 </text>
<text top=""830"" left=""213"" width=""576"" height=""15"" font=""10"">Resoluci&#243;n SENASA 181/2010. Modificaci&#243;n de la estrategia de vacunaci&#243;n en relaci&#243;n con la </text>
<text top=""845"" left=""213"" width=""195"" height=""15"" font=""10"">erradicaci&#243;n de la fiebre aftosa  </text>
<text top=""867"" left=""108"" width=""59"" height=""15"" font=""10"">ARG-135 </text>
<text top=""867"" left=""213"" width=""576"" height=""15"" font=""10"">Resoluci&#243;n SENASA 540/2010. Cr&#233;ase el Sistema de Registro y Notificaci&#243;n de Enfermedades </text>
<text top=""881"" left=""213"" width=""183"" height=""15"" font=""10"">Denunciables de los Animales </text>
<text top=""903"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-136 </text>
<text top=""903"" left=""213"" width=""466"" height=""15"" font=""10"">Resoluci&#243;n SENASA 3/2007. Plan Nacional de Contenci&#243;n de la Fiebre Aftosa </text>
<text top=""925"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-137 </text>
<text top=""925"" left=""213"" width=""490"" height=""15"" font=""10"">Manual de Procedimientos para la Atenci&#243;n de un Foco. SENASA (October 2001) </text>
<text top=""946"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-138 </text>
<text top=""946"" left=""213"" width=""582"" height=""15"" font=""10"">Resoluci&#243;n SENASA 82/2013. Vacunaci&#243;n antiaftosa en la Zona Patag&#243;nica Norte A. </text>
<text top=""961"" left=""213"" width=""70"" height=""15"" font=""10"">Prohibici&#243;n </text>
<text top=""983"" left=""108"" width=""60"" height=""15"" font=""10"">ARG-139 </text>
<text top=""983"" left=""213"" width=""578"" height=""15"" font=""10"">Resoluci&#243;n SENASA 385/2008. Estrategias de Vacunaci&#243;n Antiaftosa para bovinos/bubalinos </text>
<text top=""997"" left=""213"" width=""180"" height=""15"" font=""10"">en todo el Territorio Nacional </text>
<text top=""1019"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-142 </text>
<text top=""1019"" left=""213"" width=""578"" height=""15"" font=""10"">Resoluci&#243;n SENASA 37/2002. Establ&#233;cense medidas de prevenci&#243;n de difusi&#243;n de la fiebre </text>
<text top=""1034"" left=""213"" width=""576"" height=""15"" font=""10"">aftosa ante la aparici&#243;n de casos cl&#237;nicos de la enfermedad, o ante la existencia de factores de </text>
<text top=""1048"" left=""213"" width=""579"" height=""15"" font=""10"">riesgo tales como el ingreso de animales, productos o f&#243;mites desde zonas infectadas o </text>
<text top=""1063"" left=""213"" width=""398"" height=""15"" font=""10"">presuntamente infectadas, o deficiencias en la cobertura vacuna  </text>
<text top=""1085"" left=""108"" width=""64"" height=""15"" font=""10"">ARG-143 </text>
<text top=""1085"" left=""213"" width=""581"" height=""15"" font=""10"">Resoluci&#243;n SENASA 754/2006. Cr&#233;ase la Clave Unica de Identificaci&#243;n Ganadera, que </text>
<text top=""1099"" left=""213"" width=""580"" height=""15"" font=""10"">identificar&#225; individualmente a cada productor pecuario del pa&#237;s en cada establecimiento </text>
<text top=""1114"" left=""213"" width=""465"" height=""15"" font=""10"">agropecuario. Apru&#233;base el ""Procedimiento para Reidentificaci&#243;n de Bovinos </text>
</p></page>
<page number=""16"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 16 - </text>
</p><p><text top=""132"" left=""108"" width=""92"" height=""15"" font=""29"">Panel Exhibit </text><text top=""132"" left=""484"" width=""34"" height=""15"" font=""29"">Title </text></p><p><text top=""154"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-144 </text>
<text top=""154"" left=""213"" width=""578"" height=""15"" font=""10"">Resoluci&#243;n SENASA 563/2012. Identificaci&#243;n de las especies Bovino y Bubalino. Der&#243;ganse </text>
<text top=""168"" left=""213"" width=""578"" height=""15"" font=""10"">los Art&#237;culos 2&#176;, 3&#176; y 4&#176; de la Resoluci&#243;n N&#176; 370/2006 de la ex Secretar&#237;a de Agricultura, </text>
<text top=""183"" left=""213"" width=""184"" height=""15"" font=""10"">Ganader&#237;a, Pesca y Alimentos </text>
<text top=""205"" left=""108"" width=""61"" height=""15"" font=""10"">ARG-145 </text>
<text top=""205"" left=""213"" width=""578"" height=""15"" font=""10"">Resoluci&#243;n SENASA 15/2003. Cr&#233;ase el ""Sistema de Identificaci&#243;n de Ganado Bovino para </text>
<text top=""219"" left=""213"" width=""576"" height=""15"" font=""10"">Exportaci&#243;n"", que deber&#225; ser aplicado en forma obligatoria en todos los campos inscriptos en </text>
<text top=""234"" left=""213"" width=""577"" height=""15"" font=""10"">el ""Registro de Establecimientos Rurales proveedores de ganado para Faena de Exportaci&#243;n"" </text>
<text top=""248"" left=""213"" width=""577"" height=""15"" font=""10"">y por los Establecimientos que se inscriban en el ""Registro de Establecimientos Pecuarios de </text>
<text top=""263"" left=""213"" width=""482"" height=""15"" font=""10"">Engorde a Corral proveedores de bovinos para faena con destino a exportaci&#243;n </text>
<text top=""285"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-146 </text>
<text top=""285"" left=""213"" width=""580"" height=""15"" font=""10"">Resoluci&#243;n SENASA 391/2003. Inscripci&#243;n de ""Establecimientos Rurales de Origen"", que </text>
<text top=""299"" left=""213"" width=""578"" height=""15"" font=""10"">provean bovinos nacidos y criados en los mismos con destino a ""Establecimientos Rurales </text>
<text top=""314"" left=""213"" width=""389"" height=""15"" font=""10"">Proveedores de Ganado para Faena de Exportaci&#243;n"". Requisitos </text>
<text top=""336"" left=""108"" width=""62"" height=""15"" font=""10"">ARG-147 </text>
<text top=""336"" left=""213"" width=""579"" height=""15"" font=""10"">Decreto 4238/68. Reglamento de Inspecci&#243;n de Productos, Subproductos y Derivados de </text>
<text top=""350"" left=""213"" width=""90"" height=""15"" font=""10"">Origen Animal </text>
<text top=""372"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-148 </text>
<text top=""372"" left=""213"" width=""585"" height=""15"" font=""10"">Resoluci&#243;n SAGPYA 310/2004. Exigencias a las que deber&#225;n ajustarse todos los </text>
<text top=""387"" left=""213"" width=""578"" height=""15"" font=""10"">establecimientos de faena y/o proceso y/o dep&#243;sito interesados en exportar carnes frescas </text>
<text top=""401"" left=""213"" width=""508"" height=""15"" font=""10"">y/o menudencias. Der&#243;ganse las Resoluciones Nros. 1/2003 y 339/2003 &#8211; SENASA </text>
<text top=""423"" left=""108"" width=""60"" height=""15"" font=""10"">ARG-149 </text>
<text top=""423"" left=""213"" width=""578"" height=""15"" font=""10"">Resoluci&#243;n SENASA 810/2009. Apru&#233;base el Certificado Unico de Lavado y Desinfecci&#243;n de </text>
<text top=""438"" left=""213"" width=""291"" height=""15"" font=""10"">Veh&#237;culos para el Transporte de Animales Vivos </text>
<text top=""459"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-151 </text>
<text top=""459"" left=""213"" width=""256"" height=""15"" font=""10"">SENASA Circular No. 3307 (30 July 1997) </text>
<text top=""481"" left=""108"" width=""59"" height=""15"" font=""10"">ARG-152 </text>
<text top=""481"" left=""213"" width=""577"" height=""15"" font=""10"">Resoluci&#243;n SENASA 178/2001. Reglam&#233;ntase el procedimiento que garantiza la identificaci&#243;n </text>
<text top=""496"" left=""213"" width=""576"" height=""15"" font=""10"">del origen de los animales que se movilicen con cualquier destino. Der&#243;gase la Resoluci&#243;n N&#186; </text>
<text top=""510"" left=""213"" width=""71"" height=""15"" font=""10"">1991/2000 </text>
<text top=""532"" left=""108"" width=""58"" height=""15"" font=""10"">ARG-153 </text>
<text top=""532"" left=""213"" width=""583"" height=""15"" font=""10"">Resoluci&#243;n SENASA 33/2002. Apru&#233;base la Gu&#237;a de Procedimientos para Planes de </text>
<text top=""547"" left=""213"" width=""426"" height=""15"" font=""10"">Vacunaci&#243;n y el Formulario para la Auditor&#237;a de Planes de Vacunaci&#243;n </text>
<text top=""569"" left=""108"" width=""50"" height=""15"" font=""10"">USA-25 </text>
<footnote top=""569"" left=""214"" width=""536"" height=""15"" font=""10"" number=""2007"" ref="""" dis=""""/>
<text top=""590"" left=""108"" width=""50"" height=""15"" font=""10"">USA-30 </text>
<text top=""590"" left=""213"" width=""477"" height=""15"" font=""12""><i>Certification of Beef from Argentina</i>, 65 Fed. Reg. 82894 (29 December 2000) </text>
<text top=""612"" left=""108"" width=""50"" height=""15"" font=""10"">USA-32 </text>
<text top=""612"" left=""214"" width=""576"" height=""15"" font=""10"">Information Provided by SENASA to Attain Recognition of Argentina as a Region, as defined in </text>
<text top=""627"" left=""213"" width=""577"" height=""15"" font=""10"">Section 92.2, Title 9, of the Code of Federal Regulations for Foot and Mouth Disease (FMD) </text>
</p><p><text top=""663"" left=""108"" width=""50"" height=""15"" font=""10"">USA-33 </text>
<text top=""663"" left=""213"" width=""578"" height=""15"" font=""10"">SENASA,  <i>National FMD Eradication Plan April, 2001: Report of 2000-2001 FMD Outbreaks, </i></text>
<footnote top=""699"" left=""108"" width=""212"" height=""15"" font=""10"" number=""42"" ref="""" dis=""""><ftext top=""939"" left=""213"" width=""410"" height=""15"" font=""12""><i>Parallel (Patagonia South), to the United States</i> (June 2005), p. 32 </ftext>
</footnote>
</p><p><text top=""699"" left=""266"" width=""109"" height=""15"" font=""10"">Auditing </text>
<text top=""699"" left=""321"" width=""470"" height=""15"" font=""10"">Office of Argentina, <i>SENASA Program for the Fight Against Foot and Mouth </i></text>
<text top=""714"" left=""213"" width=""162"" height=""15"" font=""12""><i>Disease</i> (22 August 2003) </text>
<text top=""736"" left=""108"" width=""50"" height=""15"" font=""10"">USA-49 </text>
<text top=""736"" left=""213"" width=""372"" height=""15"" font=""10"">""Cane Returns to Lead SENASA"", La Naci&#243;n (30 March 2001) </text>
<text top=""758"" left=""108"" width=""50"" height=""15"" font=""10"">USA-50 </text>
<text top=""758"" left=""214"" width=""168"" height=""15"" font=""10"">SENASA Decreto 394/2001 </text>
<text top=""779"" left=""108"" width=""50"" height=""15"" font=""10"">USA-51 </text>
<text top=""779"" left=""213"" width=""580"" height=""15"" font=""10"">Facsimile from Jose Molina, Minister Embassy of Argentina, to Peter Fernandez, APHIS </text>
<text top=""794"" left=""213"" width=""128"" height=""15"" font=""10"">(5 September 2003) </text>
<text top=""816"" left=""108"" width=""51"" height=""15"" font=""10"">USA-54 </text>
<text top=""816"" left=""213"" width=""576"" height=""15"" font=""10"">Veterinary Services (VS), <i>Foot and Mouth Disease Argentina Impact Worksheet</i> (15 February </text>
<text top=""830"" left=""213"" width=""44"" height=""15"" font=""10"">2006)  </text>
<text top=""852"" left=""108"" width=""50"" height=""15"" font=""10"">USA-55 </text>
<text top=""852"" left=""213"" width=""391"" height=""15"" font=""10"">OIE World Assembly, 74th General Session, Final Report (2006) </text>
<text top=""874"" left=""108"" width=""50"" height=""15"" font=""10"">USA-57 </text>
<text top=""896"" left=""108"" width=""50"" height=""15"" font=""10"">USA-58 </text>
<text top=""896"" left=""213"" width=""579"" height=""15"" font=""10"">United States Department of Agriculture (USDA), Veterinary Services, National Center for </text>
<text top=""910"" left=""213"" width=""571"" height=""15"" font=""10"">Import and Export Regionalization Evaluation Services<i>, Risk Analysis: Risk of Exporting Foot-</i></text>
</p><p><text top=""961"" left=""108"" width=""50"" height=""15"" font=""10"">USA-59 </text>
<text top=""961"" left=""214"" width=""182"" height=""15"" font=""10"">Resoluci&#243;n SENASA 58/2001  </text>
<text top=""983"" left=""108"" width=""50"" height=""15"" font=""10"">USA-60 </text>
<text top=""983"" left=""213"" width=""197"" height=""15"" font=""10"">Resoluci&#243;n SENASA 1051/2002  </text>
<text top=""1005"" left=""108"" width=""50"" height=""15"" font=""10"">USA-61 </text>
<text top=""1005"" left=""214"" width=""189"" height=""15"" font=""10"">Resoluci&#243;n SENASA 725/2005  </text>
<text top=""1027"" left=""108"" width=""50"" height=""15"" font=""10"">USA-62 </text>
<text top=""1027"" left=""213"" width=""190"" height=""15"" font=""10"">Resoluci&#243;n SENASA 148/2008  </text>
<text top=""1048"" left=""108"" width=""50"" height=""15"" font=""10"">USA-72 </text>
<text top=""1048"" left=""214"" width=""142"" height=""15"" font=""10"">9 C.F.R. &#167; 92.1 (2013) </text>
<text top=""1070"" left=""108"" width=""50"" height=""15"" font=""10"">USA-75 </text>
<text top=""1070"" left=""213"" width=""143"" height=""15"" font=""10"">7 U.S.C. &#167;8303 (2012) </text>
<text top=""1092"" left=""108"" width=""59"" height=""15"" font=""10"">USA-76 </text>
<text top=""1092"" left=""214"" width=""576"" height=""15"" font=""10"">9 C.F.R. &#167; 92.2 (2013), <i>Process for Foreign Animal Disease Status Evaluations, </i></text>
</p><p><text top=""1106"" left=""213"" width=""288"" height=""15"" font=""31"">Regionalization, Risk Analysis, and Rulemaking</text> </p></page>
<page number=""17"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 17 - </text>
</p><p><text top=""132"" left=""108"" width=""92"" height=""15"" font=""29"">Panel Exhibit </text><text top=""132"" left=""484"" width=""34"" height=""15"" font=""29"">Title </text></p><p><text top=""154"" left=""108"" width=""50"" height=""15"" font=""10"">USA-78 </text>
<text top=""154"" left=""213"" width=""578"" height=""15"" font=""10"">Facsimile from Donald Wimmer (United States Department of Agriculture, Animal and Plant </text>
<text top=""168"" left=""213"" width=""580"" height=""15"" font=""10"">Health Inspection Service (USDA, APHIS) Buenos Aires, Argentina Area Director) to Dr. </text>
<text top=""183"" left=""213"" width=""347"" height=""15"" font=""10"">Bernardo Cane (SENASA, President) (6 November 2002) </text>
<text top=""205"" left=""108"" width=""50"" height=""15"" font=""10"">USA-79 </text>
<text top=""205"" left=""214"" width=""507"" height=""15"" font=""10"">Letter from Dr. Bernardo Cane (SENASA, President) to APHIS (30 December 2002) </text>
<text top=""226"" left=""108"" width=""50"" height=""15"" font=""10"">USA-80 </text>
<text top=""226"" left=""213"" width=""576"" height=""15"" font=""10"">Facsimile from Rodolfo Acerbi (United States  Department  of  Agriculture,  Animal  and  Plant </text>
<text top=""241"" left=""213"" width=""576"" height=""15"" font=""10"">Health  Inspection  Service,  USDA,  APHIS)  to  Philip  Schull  (U.S.  Embassy  in  Argentina)  (29 </text>
<footnote top=""256"" left=""213"" width=""72"" height=""15"" font=""10"" number=""2003"" ref="""" dis=""""/>
</p><p><text top=""277"" left=""108"" width=""50"" height=""15"" font=""10"">USA-81 </text>
<text top=""299"" left=""108"" width=""50"" height=""15"" font=""10"">USA-82 </text>
<text top=""299"" left=""213"" width=""577"" height=""15"" font=""10"">Letter from Pablo Kalnay (United States Department of Agriculture, Animal and Plant Health </text>
<text top=""314"" left=""213"" width=""586"" height=""15"" font=""10"">Inspection Service, USDA, APHIS) to Dr. Jorge N. Amaya (SENASA, President) </text>
<text top=""328"" left=""213"" width=""117"" height=""15"" font=""10"">(14 October 2003) </text>
<text top=""350"" left=""108"" width=""52"" height=""15"" font=""10"">USA-83 </text>
<text top=""350"" left=""214"" width=""577"" height=""15"" font=""10"">Letter from Miguel Santiago Campos (SENASA) to United States Department of Agriculture, </text>
<text top=""365"" left=""213"" width=""466"" height=""15"" font=""10"">Animal and Plant Health Inspection Service, USDA, APHIS (29 August 2003) </text>
<text top=""386"" left=""108"" width=""50"" height=""15"" font=""10"">USA-84 </text>
<text top=""386"" left=""213"" width=""579"" height=""15"" font=""10"">Letter from W. Ron DeHaven (United States Department of Agriculture, Animal and Plant </text>
<text top=""401"" left=""213"" width=""580"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS, Deputy Administrator) to Dr. Jorge N. Amaya </text>
<text top=""416"" left=""213"" width=""238"" height=""15"" font=""10"">(SENASA, President) (3 October 2003) </text>
<text top=""438"" left=""108"" width=""50"" height=""15"" font=""10"">USA-85 </text>
<text top=""438"" left=""214"" width=""576"" height=""15"" font=""10"">Facsimile  from  Thomas  C.  Schissel  (United States  Department  of  Agriculture,  Animal  and </text>
<text top=""452"" left=""213"" width=""578"" height=""15"" font=""10"">Plant Health Inspection Service, USDA, APHIS, Assistant Area Director) to Jorge N. Amaya </text>
<text top=""467"" left=""213"" width=""246"" height=""15"" font=""10"">(SENASA, President) (23 October 2003) </text>
<text top=""488"" left=""108"" width=""50"" height=""15"" font=""10"">USA-86 </text>
<text top=""488"" left=""213"" width=""578"" height=""15"" font=""10"">Facsimile from SENASA to Theresa Boyle (United States Department of Agriculture, Animal </text>
<text top=""503"" left=""213"" width=""526"" height=""15"" font=""10"">and Plant Health Inspection Service, USDA, APHIS, Area Director) (18 February 2004) </text>
<text top=""525"" left=""108"" width=""52"" height=""15"" font=""10"">USA-87 </text>
<text top=""525"" left=""214"" width=""578"" height=""15"" font=""10"">Facsimile from SENASA to Theresa Boyle (United States Department of Agriculture, Animal </text>
<text top=""539"" left=""213"" width=""496"" height=""15"" font=""10"">and Plant Health Inspection Service, USDA, APHIS, Area Director) (30 July 2004) </text>
<text top=""561"" left=""108"" width=""50"" height=""15"" font=""10"">USA-88 </text>
<text top=""561"" left=""213"" width=""576"" height=""15"" font=""10"">Report of the Meeting of the OIE Ad Hoc Group for Evaluation of Country Status for Foot and </text>
<footnote top=""576"" left=""213"" width=""190"" height=""15"" font=""10"" number=""2004"" ref="""" dis=""""/>
</p><p><text top=""598"" left=""108"" width=""54"" height=""15"" font=""10"">USA-90 </text>
<text top=""598"" left=""214"" width=""579"" height=""15"" font=""10"">Letter from John R. Clifford (United States Department of Agriculture, Animal and Plant </text>
<text top=""612"" left=""213"" width=""585"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS) to Dr. Jose Molina (SENASA, Minister) </text>
<text top=""627"" left=""213"" width=""106"" height=""15"" font=""10"">(17 March 2005) </text>
<text top=""648"" left=""108"" width=""50"" height=""15"" font=""10"">USA-91 </text>
<text top=""648"" left=""213"" width=""577"" height=""15"" font=""10"">Letter from Thomas C. Schissel (United States Department of Agriculture, Animal and Plant </text>
<text top=""663"" left=""213"" width=""506"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS) to Arturo Ortiz (SENASA) (21 April 2005) </text>
<text top=""685"" left=""108"" width=""54"" height=""15"" font=""10"">USA-92 </text>
<text top=""685"" left=""214"" width=""579"" height=""15"" font=""10"">Letter from John R. Clifford (United States Department of Agriculture, Animal and Plant </text>
<text top=""699"" left=""213"" width=""583"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS) to Jorge N. Amaya (SENASA, President) </text>
<text top=""714"" left=""213"" width=""85"" height=""15"" font=""10"">(7 July 2005) </text>
<text top=""736"" left=""108"" width=""50"" height=""15"" font=""10"">USA-93 </text>
<text top=""736"" left=""213"" width=""580"" height=""15"" font=""10"">Letter from John R. Clifford (United States Department of Agriculture, Animal and Plant </text>
<text top=""750"" left=""213"" width=""580"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS, Deputy Administrator) to Dr. Jorge N. Amaya </text>
<text top=""765"" left=""213"" width=""233"" height=""15"" font=""10"">(SENASA, President) (4 August 2005) </text>
<text top=""787"" left=""108"" width=""54"" height=""15"" font=""10"">USA-94 </text>
<text top=""787"" left=""214"" width=""579"" height=""15"" font=""10"">Letter from Thomas Schissel (United States Department of Agriculture, Animal and Plant </text>
<text top=""801"" left=""213"" width=""581"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS, Area Director) to Jorge N. Amaya (SENASA, </text>
<text top=""816"" left=""213"" width=""163"" height=""15"" font=""10"">President) (27 June 2006) </text>
<text top=""838"" left=""108"" width=""50"" height=""15"" font=""10"">USA-96 </text>
<text top=""838"" left=""213"" width=""576"" height=""15"" font=""10"">Letter from Dr. Peter J. Fernandez (United States Department of Agriculture, Animal and Plant </text>
<text top=""852"" left=""213"" width=""580"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS, Acting Associate Administrator) to Marcelo S. </text>
<text top=""867"" left=""213"" width=""281"" height=""15"" font=""10"">Miguez (SENASA, President) (13 March 2013) </text>
<text top=""889"" left=""108"" width=""52"" height=""15"" font=""10"">USA-97 </text>
<text top=""889"" left=""214"" width=""578"" height=""15"" font=""10"">Letter from Kevin Shea (United States Department of Agriculture, Animal and Plant Health </text>
<text top=""903"" left=""213"" width=""577"" height=""15"" font=""10"">Inspection Service, USDA, APHIS, Administrator) to Marcelo S. Miguez (SENASA, President) </text>
<text top=""918"" left=""213"" width=""93"" height=""15"" font=""10"">(15 July 2013) </text>
<text top=""940"" left=""108"" width=""50"" height=""15"" font=""10"">USA-98 </text>
<text top=""940"" left=""213"" width=""577"" height=""15"" font=""10"">Information Provided by SENASA to Attain Recognition of Patagonia as a Region, as Defined </text>
<text top=""954"" left=""213"" width=""577"" height=""15"" font=""10"">in Section 92.2, Title 9 of the Code of Federal Regulations for Foot and Mouth Disease (FMD) </text>
</p><p><text top=""991"" left=""108"" width=""53"" height=""15"" font=""10"">USA-99 </text>
<text top=""991"" left=""214"" width=""579"" height=""15"" font=""10"">Facsimile from Theresa Boyle (United States Department of Agriculture, Animal and Plant </text>
<text top=""1005"" left=""213"" width=""578"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS, Area Director) to Dr. Jorge N. Amaya (SENASA, </text>
<text top=""1020"" left=""213"" width=""189"" height=""15"" font=""10"">President) (6 November 2003) </text>
<text top=""1042"" left=""108"" width=""58"" height=""15"" font=""10"">USA-100 </text>
<text top=""1042"" left=""213"" width=""579"" height=""15"" font=""10"">Letter from W. Ron DeHaven (United States Department of Agriculture, Animal and Plant </text>
<text top=""1056"" left=""213"" width=""579"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS) to Dr. Jorge N. Amaya (SENASA, President) (6 </text>
</p><p><text top=""1092"" left=""108"" width=""61"" height=""15"" font=""10"">USA-102 </text>
<text top=""1092"" left=""214"" width=""576"" height=""15"" font=""10"">Letter from W. Ron DeHaven (United States  Department  of  Agriculture,  Animal  and  Plant </text>
<text top=""1107"" left=""213"" width=""583"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS) to Dr. Jorge Amaya (SENASA, President) </text>
<text top=""1122"" left=""213"" width=""98"" height=""15"" font=""10"">(2 March 2004) </text>
</p></page>
<page number=""18"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 18 - </text>
</p><p><text top=""132"" left=""108"" width=""92"" height=""15"" font=""29"">Panel Exhibit </text><text top=""132"" left=""484"" width=""34"" height=""15"" font=""29"">Title </text></p><p><text top=""154"" left=""108"" width=""58"" height=""15"" font=""10"">USA-103 </text>
<text top=""154"" left=""213"" width=""577"" height=""15"" font=""10"">Further Information Requested by the United States Department of Agriculture, Animal and </text>
<text top=""168"" left=""213"" width=""578"" height=""15"" font=""10"">Plant Health Inspection Service (USDA, APHIS) of the Information Provided by SENASA to </text>
<text top=""183"" left=""213"" width=""576"" height=""15"" font=""10"">Attain Recognition of Patagonia as a Region, as Defined in Section 92.2, Title 9 of the Code of </text>
</p><p><text top=""219"" left=""108"" width=""58"" height=""15"" font=""10"">USA-105 </text>
<text top=""219"" left=""214"" width=""464"" height=""15"" font=""10"">OIE World Assembly, 75th General Session, Final Report (20-25 May 2007)  </text>
<text top=""241"" left=""108"" width=""58"" height=""15"" font=""10"">USA-106 </text>
<text top=""241"" left=""213"" width=""577"" height=""15"" font=""10"">Letter from Yvette Perez (United States Department of Agriculture, Animal and Plant Health </text>
<text top=""256"" left=""213"" width=""491"" height=""15"" font=""10"">Inspection Service, USDA, APHIS) to Oscar Astibia (SENASA) (15 October 2008) </text>
<text top=""277"" left=""108"" width=""58"" height=""15"" font=""10"">USA-107 </text>
<text top=""277"" left=""214"" width=""548"" height=""15"" font=""10"">Facsimile from Oscar Astibia (SENASA) to Yvette Perez (USDA, APHIS) (22 October 2008) </text>
<text top=""299"" left=""108"" width=""58"" height=""15"" font=""10"">USA-108 </text>
<text top=""299"" left=""213"" width=""554"" height=""15"" font=""10"">Facsimile from Oscar Astibia, SENASA, to Yvette Perez, USDA, APHIS (11 November 2008) </text>
<text top=""321"" left=""108"" width=""58"" height=""15"" font=""10"">USA-109 </text>
<text top=""321"" left=""214"" width=""193"" height=""15"" font=""10"">Resoluci&#243;n SENASA 1282/2008 </text>
<text top=""343"" left=""108"" width=""58"" height=""15"" font=""10"">USA-132 </text>
</p><p><text top=""343"" left=""213"" width=""576"" height=""15"" font=""31"">Notice of Availability of Evaluations of the Foot-and-Mouth Disease and Rinderpest Status of a </text></p><p><text top=""357"" left=""213"" width=""566"" height=""15"" font=""12""><i>Region of Patagonia, Argentina</i>, 79 Fed. Reg. 3775 (23 January 2014) (Notice of availability) </text>
<text top=""379"" left=""108"" width=""239"" height=""15"" font=""10"">USA-133 USDA/APHIS, </text>
</p><p><text top=""379"" left=""300"" width=""489"" height=""15"" font=""31"">Risk Analysis: Risk of Importing Foot-and-Mouth Disease in Susceptible Species </text><footnote top=""394"" left=""213"" width=""465"" height=""15"" font=""12"" number=""2014"" ref="""" dis=""""/>
</p><p><text top=""415"" left=""108"" width=""58"" height=""15"" font=""10"">USA-149 </text>
<text top=""415"" left=""213"" width=""540"" height=""15"" font=""10"">Dr. Alberto E. Pecker, SENASA, Fiebra Aftosa: Su Paso Por La Argentina (October 2007)  </text>
<text top=""437"" left=""108"" width=""61"" height=""15"" font=""10"">USA-151 </text>
<text top=""437"" left=""214"" width=""579"" height=""15"" font=""10"">Final Report Of A Mission Carried Out In Argentina From 3 To 13 July 2006 In Order To </text>
<text top=""452"" left=""213"" width=""576"" height=""15"" font=""10"">Evaluate  Animal  Health  Controls  In  Place  In  Particular  Over  Foot  And  Mouth  Disease,  Public </text>
<text top=""466"" left=""213"" width=""548"" height=""15"" font=""10"">Health Control Systems And Certification Procedures (DG(SANCO)/7590/2005 &#8211; MR Final) </text>
<text top=""488"" left=""108"" width=""58"" height=""15"" font=""10"">USA-167 </text>
</p><p><text top=""488"" left=""213"" width=""577"" height=""15"" font=""31"">Notice of Determination of the Foot-and-Mouth Disease and Rinderpest Status of a Region of </text></p><p><text top=""503"" left=""213"" width=""422"" height=""15"" font=""12""><i>Patagonia, Argentina</i>, 79 Fed. Reg. 51528 (29 August 2914) (Notice) </text>
<text top=""525"" left=""108"" width=""58"" height=""15"" font=""10"">USA-168 </text>
<text top=""525"" left=""213"" width=""579"" height=""15"" font=""12""><i>Importation of Beef From a Region in Argentina</i>, 79 Fed. Reg. 51508 (29 August 2014) </text>
<text top=""539"" left=""213"" width=""101"" height=""15"" font=""10"">(Proposed Rule) </text>
<text top=""561"" left=""108"" width=""58"" height=""15"" font=""10"">USA-169 </text>
<text top=""561"" left=""213"" width=""577"" height=""15"" font=""10"">APHIS, Veterinary Services, National Import Export Services, <i>Risk Analysis: Foot-and-Mouth </i></text>
</p><p><text top=""576"" left=""213"" width=""579"" height=""15"" font=""31"">Disease Risk from Importation of Fresh (Chilled or Frozen), Matured, Deboned Beef from </text></p></page>
<page number=""19"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 19 - </text>
</p><p><text top=""164"" left=""294"" width=""309"" height=""16"" font=""28"">ABBREVIATIONS USED IN THIS REPORT </text></p><p><text top=""202"" left=""140"" width=""90"" height=""15"" font=""29"">Abbreviation </text><text top=""202"" left=""492"" width=""81"" height=""15"" font=""29"">Description </text></p><p><text top=""224"" left=""108"" width=""37"" height=""15"" font=""10"">AHPA </text>
<text top=""224"" left=""276"" width=""177"" height=""15"" font=""10"">Animal Health Protection Act </text>
<text top=""246"" left=""108"" width=""36"" height=""15"" font=""10"">ALOP </text>
<text top=""246"" left=""276"" width=""191"" height=""15"" font=""10"">Appropriate Level of Protection </text>
<text top=""268"" left=""108"" width=""42"" height=""15"" font=""10"">APHIS </text>
<text top=""268"" left=""276"" width=""265"" height=""15"" font=""10"">Animal and Plant Health Inspection Service<i> </i></text>
<text top=""289"" left=""108"" width=""32"" height=""15"" font=""10"">CFR  </text>
<text top=""289"" left=""276"" width=""259"" height=""15"" font=""10"">United States Code of Federal Regulations </text>
<text top=""311"" left=""108"" width=""335"" height=""15"" font=""10"">Codex Codex </text>
<text top=""311"" left=""317"" width=""157"" height=""15"" font=""10"">Alimentarius Commission </text>
<text top=""333"" left=""108"" width=""30"" height=""15"" font=""10"">DSB </text>
<text top=""333"" left=""276"" width=""155"" height=""15"" font=""10"">Dispute Settlement Body </text>
<text top=""355"" left=""108"" width=""30"" height=""15"" font=""10"">DSU </text>
<text top=""355"" left=""276"" width=""478"" height=""15"" font=""10"">Understanding on Rules and Procedures Governing the Settlement of Disputes </text>
<text top=""377"" left=""108"" width=""62"" height=""15"" font=""10"">Fed. Reg. </text>
<text top=""377"" left=""276"" width=""188"" height=""15"" font=""10"">United States Federal Register </text>
<text top=""398"" left=""108"" width=""406"" height=""15"" font=""10"">FMD Foot-and-Mouth </text>
<text top=""398"" left=""377"" width=""188"" height=""15"" font=""10"">Disease </text>
<footnote top=""420"" left=""108"" width=""71"" height=""15"" font=""10"" number=""1994"" ref="""" dis=""""><ftext top=""442"" left=""108"" width=""32"" height=""15"" font=""10"">IPPC </ftext>
<ftext top=""442"" left=""276"" width=""254"" height=""15"" font=""10"">International Plant Protection Convention </ftext>
<ftext top=""464"" left=""108"" width=""26"" height=""15"" font=""10"">OIE </ftext>
<ftext top=""464"" left=""276"" width=""230"" height=""15"" font=""10"">World Organization for Animal Health </ftext>
<ftext top=""486"" left=""108"" width=""349"" height=""15"" font=""10"">SANCO European </ftext>
<ftext top=""486"" left=""337"" width=""372"" height=""15"" font=""10"">Commission's Directorate-General for Health and Consumers </ftext>
<ftext top=""507"" left=""108"" width=""54"" height=""15"" font=""10"">SENASA </ftext>
<ftext top=""507"" left=""276"" width=""411"" height=""15"" font=""12""><i>Servicio Nacional de Salud Animal</i> (National Animal Health Service) </ftext>
<ftext top=""529"" left=""108"" width=""98"" height=""15"" font=""10"">SPS Agreement </ftext>
<ftext top=""529"" left=""276"" width=""428"" height=""15"" font=""10"">Agreement on the Application of Sanitary and Phytosanitary Measures </ftext>
<ftext top=""551"" left=""108"" width=""98"" height=""15"" font=""10"">SPS Committee </ftext>
<ftext top=""551"" left=""276"" width=""318"" height=""15"" font=""10"">Committee on Sanitary and Phytosanitary Measures </ftext>
<ftext top=""573"" left=""108"" width=""98"" height=""15"" font=""10"">TBT Agreement </ftext>
<ftext top=""573"" left=""276"" width=""261"" height=""15"" font=""10"">Agreement on Technical Barriers to Trade  </ftext>
<ftext top=""594"" left=""108"" width=""101"" height=""15"" font=""10"">Terrestrial Code </ftext>
<ftext top=""594"" left=""276"" width=""189"" height=""15"" font=""10"">Terrestrial Animal Health Code </ftext>
<ftext top=""616"" left=""108"" width=""113"" height=""15"" font=""10"">Terrestrial Manual </ftext>
<ftext top=""616"" left=""276"" width=""381"" height=""15"" font=""10"">Manual of Diagnostic Test and Vaccines for Terrestrial Animals </ftext>
<ftext top=""638"" left=""108"" width=""30"" height=""15"" font=""10"">USC </ftext>
<ftext top=""638"" left=""276"" width=""120"" height=""15"" font=""10"">United States Code </ftext>
<ftext top=""660"" left=""108"" width=""340"" height=""15"" font=""10"">USDA United </ftext>
<ftext top=""660"" left=""319"" width=""171"" height=""15"" font=""10"">States </ftext>
<ftext top=""660"" left=""361"" width=""162"" height=""15"" font=""10"">Department of Agriculture </ftext>
<ftext top=""682"" left=""108"" width=""35"" height=""15"" font=""10"">VCLT </ftext>
<ftext top=""682"" left=""276"" width=""450"" height=""15"" font=""10"">Vienna Convention on the Law of Treaties, Done at Vienna, 23 May 1969, </ftext>
<ftext top=""696"" left=""276"" width=""321"" height=""15"" font=""10"">1155 UNTS 331; 8 International Legal Materials 679 </ftext>
<ftext top=""718"" left=""108"" width=""33"" height=""15"" font=""10"">WTO </ftext>
<ftext top=""718"" left=""276"" width=""159"" height=""15"" font=""10"">World Trade Organization </ftext>
</footnote>
</p></page>
<page number=""20"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""16"" size=""7"" family=""Times"" color=""#000000""/>
	<fontspec id=""17"" size=""5"" family=""Times"" color=""#000000""/>
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 20 - </text>
</p><p><text top=""128"" left=""108"" width=""145"" height=""16"" font=""28"">1  INTRODUCTION </text></p><p number=""1.1"" style=""8""><text top=""162"" left=""108"" width=""217"" height=""16"" font=""28"">1.1  Complaint by Argentina </text></p><p number=""1.1"" style=""8""><text top=""196"" left=""108"" width=""685"" height=""16"" font=""0"">1.1.  On 30 August 2012, Argentina requested consultations with the United States pursuant to </text>
<text top=""213"" left=""108"" width=""686"" height=""16"" font=""0"">Articles 1 and 4 of the Understanding on Rules and Procedures Governing the Settlement of </text>
<text top=""229"" left=""108"" width=""684"" height=""16"" font=""0"">Disputes (DSU), Article XXIII of the General Agreement on Tariffs and Trade 1994 (GATT 1994) </text>
<text top=""246"" left=""108"" width=""687"" height=""16"" font=""0"">and Article 11 of the Agreement on the Application of Sanitary and Phytosanitary Measures </text>
<text top=""262"" left=""108"" width=""500"" height=""16"" font=""0"">(SPS Agreement) with respect to the measures and claims set out below.</text>
<footnote top=""261"" left=""608"" width=""6"" height=""11"" font=""16"" number=""1"" ref="""" dis=""""/>
</p><p number=""1.2"" style=""8""><text top=""296"" left=""108"" width=""401"" height=""16"" font=""0"">1.2.  Consultations were held on 18 and 19 October 2012. </text>
</p><p number=""1.2"" style=""8""><text top=""331"" left=""108"" width=""322"" height=""16"" font=""28"">1.2  Panel establishment and composition </text></p><p number=""1.3"" style=""8""><text top=""365"" left=""108"" width=""682"" height=""16"" font=""0"">1.3.  On 6 December 2012, Argentina requested the establishment of a panel pursuant to Article 6 </text>
<text top=""382"" left=""108"" width=""324"" height=""16"" font=""0"">of the DSU with standard terms of reference.</text>
<footnote top=""380"" left=""432"" width=""6"" height=""11"" font=""16"" number=""2"" ref=""WT/DS447/2"" dis=""""><ftext top=""1080"" left=""155"" width=""91"" height=""15"" font=""10""> WT/DS447/2. </ftext>
</footnote>
<text top=""382"" left=""438"" width=""355"" height=""16"" font=""0""> At its meeting on 28 January 2013, the Dispute </text>
<text top=""398"" left=""108"" width=""685"" height=""16"" font=""0"">Settlement Body (DSB) established a panel pursuant to the request of Argentina in document </text>
<text top=""414"" left=""108"" width=""369"" height=""16"" font=""0"">WT/DS447/2, in accordance with Article 6 of the DSU.</text>
<footnote top=""413"" left=""476"" width=""6"" height=""11"" font=""16"" number=""3"" ref="""" dis=""""/>
</p><p number=""1.4"" style=""8""><text top=""449"" left=""108"" width=""373"" height=""16"" font=""0"">1.4.  The Panel's terms of reference are the following: </text>
<p><text top=""483"" left=""151"" width=""597"" height=""16"" font=""0"">To examine, in the light of the relevant provisions of the covered Agreements cited by </text>
<text top=""500"" left=""151"" width=""598"" height=""16"" font=""0"">the parties to the dispute, the matter referred to the DSB by Argentina in document </text>
<text top=""516"" left=""151"" width=""602"" height=""16"" font=""0"">WT/DS447/2 and to make such findings as will assist the DSB in making the </text>
<text top=""533"" left=""151"" width=""517"" height=""16"" font=""0"">recommendations or in giving the rulings provided for in those Agreements.</text>
<footnote top=""531"" left=""667"" width=""6"" height=""11"" font=""16"" number=""4"" ref=""WT/DS447/3"" dis=""""><ftext top=""1109"" left=""155"" width=""91"" height=""15"" font=""10""> WT/DS447/3. </ftext>
</footnote>
</p></p><p number=""1.5"" style=""8""><text top=""567"" left=""108"" width=""43"" height=""16"" font=""0"">1.5. </text>
<text top=""567"" left=""145"" width=""69"" height=""16"" font=""0"">On 29 </text>
<text top=""567"" left=""202"" width=""43"" height=""16"" font=""0"">July </text>
<text top=""567"" left=""233"" width=""220"" height=""16"" font=""0"">2013, pursuant to Article </text>
<text top=""567"" left=""442"" width=""359"" height=""16"" font=""0"">8.7 of the DSU, Argentina requested the </text>
<text top=""583"" left=""108"" width=""559"" height=""16"" font=""0"">Director-General to determine the composition of the panel. On 8 </text>
<text top=""583"" left=""656"" width=""63"" height=""16"" font=""0"">August </text>
<text top=""583"" left=""708"" width=""93"" height=""16"" font=""0"">2013, the </text>
<text top=""600"" left=""108"" width=""418"" height=""16"" font=""0"">Director-General accordingly composed the Panel as follows: </text>
<p><text top=""634"" left=""151"" width=""92"" height=""16"" font=""0"">Chairperson: </text>
<text top=""634"" left=""278"" width=""108"" height=""16"" font=""0"">Mr Eirik Glenne </text>
</p><p><text top=""667"" left=""151"" width=""90"" height=""16"" font=""0"">Members:   </text>
<text top=""667"" left=""278"" width=""109"" height=""16"" font=""0"">Mr Jaime Coghi </text>
<text top=""683"" left=""278"" width=""110"" height=""16"" font=""0"">Mr David Evans </text>
</p></p><p number=""1.6"" style=""8""><text top=""716"" left=""108"" width=""683"" height=""16"" font=""0"">1.6.  Australia, Brazil, China, the European Union, India, and the Republic of Korea notified their </text>
<text top=""733"" left=""108"" width=""446"" height=""16"" font=""0"">interest in participating in the Panel proceedings as third parties. </text>
</p><p number=""1.3"" style=""8""><text top=""767"" left=""108"" width=""177"" height=""16"" font=""28"">1.3  Panel proceedings </text></p><p number=""1.3"" style=""8""><text top=""801"" left=""108"" width=""111"" height=""16"" font=""28"">1.3.1  General </text></p><p number=""1.7"" style=""8""><text top=""836"" left=""108"" width=""571"" height=""16"" font=""0"">1.7.  After consultation with the parties, the Panel adopted its Working Procedures</text>
<footnote top=""834"" left=""679"" width=""6"" height=""11"" font=""16"" number=""5"" ref="""" dis=""""/>
<text top=""836"" left=""685"" width=""106"" height=""16"" font=""0""> and timetable </text>
<text top=""852"" left=""108"" width=""139"" height=""16"" font=""0"">on 30 August 2013. </text>
</p><p number=""1.8"" style=""8""><text top=""887"" left=""108"" width=""684"" height=""16"" font=""0"">1.8.  The Panel held a first substantive meeting with the parties on 28 and 29 January 2014. A </text>
<text top=""903"" left=""108"" width=""683"" height=""16"" font=""0"">session with the third parties took place on 28 January 2014. The Panel held a meeting with the </text>
<text top=""919"" left=""108"" width=""683"" height=""16"" font=""0"">parties and the experts on 2 September 2014 and a second substantive meeting with the parties </text>
<text top=""936"" left=""108"" width=""206"" height=""16"" font=""0"">on 4 and 5 September 2014.  </text>
</p><p number=""1.9"" style=""8""><text top=""970"" left=""108"" width=""683"" height=""16"" font=""0"">1.9.  On 4 November 2014, the Panel issued the descriptive part of its Report to the parties. The </text>
<text top=""987"" left=""108"" width=""685"" height=""16"" font=""0"">Panel issued its Interim Report to the parties on 24 February 2015. The Panel issued its Final </text>
<text top=""1003"" left=""108"" width=""269"" height=""16"" font=""0"">Report to the parties on 14 April 2015. </text>
<p><text top=""1095"" left=""155"" width=""134"" height=""15"" font=""10""> See WT/DSB/M/328. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 21 - </text>
</p></p></page>
<page number=""21"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""1.10"" style=""8""><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">1.10.  In these panel proceedings, certain filings were not made in accordance with the Working </text>
<text top=""144"" left=""108"" width=""402"" height=""16"" font=""0"">Procedures and revised timetable adopted by the Panel.</text>
<footnote top=""143"" left=""510"" width=""6"" height=""11"" font=""16"" number=""6"" ref="""" dis=""""><ftext top=""788"" left=""155"" width=""626"" height=""15"" font=""10""> In particular, the United States did not file the following documents by the 17:00 deadline specified in </ftext>
</footnote>
<text top=""144"" left=""516"" width=""277"" height=""16"" font=""0""> The Panel acknowledges that parties </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">experience a variety of pressures in seeking to make timely filings. We also observe that no party </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">claimed that its rights were affected in this case and we are not suggesting this occurred here. </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">Nevertheless, we are mindful that failures to file submissions in accordance with the requirements </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">of the Working Procedures could affect parties' rights, especially when submissions are to be filed </text>
<text top=""226"" left=""108"" width=""684"" height=""16"" font=""0"">simultaneously, and that delays can be detrimental to the orderly conduct of panel proceedings. </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">Furthermore, abiding by the Working Procedures is important to guard against such occurrences. </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">Therefore, on 23 May 2014 the Panel adopted modified Working Procedures incorporating changes </text>
<text top=""275"" left=""108"" width=""447"" height=""16"" font=""0"">to the requirements regarding simultaneous filing of submissions.</text>
<footnote top=""274"" left=""555"" width=""6"" height=""11"" font=""16"" number=""7"" ref="""" dis=""""><ftext top=""1036"" left=""155"" width=""601"" height=""15"" font=""10""> See paragraph 23(d) of the modified Working Procedures in Annex A-1, which provides that when </ftext>
<ftext top=""1051"" left=""108"" width=""672"" height=""15"" font=""10"">submissions are to be filed contemporaneously, each party shall file the documents only with the DS Registrar </ftext>
<ftext top=""1066"" left=""108"" width=""679"" height=""15"" font=""10"">and the DS Registrar will serve the documents on the other party only after having received the submissions of </ftext>
<ftext top=""1080"" left=""108"" width=""81"" height=""15"" font=""10"">both parties. </ftext>
</footnote>
</p><p number=""1.3"" style=""8""><text top=""310"" left=""108"" width=""230"" height=""16"" font=""28"">1.3.2  Consultation of experts </text></p><p number=""1.11"" style=""8""><text top=""344"" left=""108"" width=""685"" height=""16"" font=""0"">1.11.  To facilitate the carrying out of its mandate, and in accordance with Article 11.2 of the </text>
<text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">SPS Agreement and Article 13 of the DSU, the Panel consulted with individual scientific experts </text>
<text top=""377"" left=""108"" width=""362"" height=""16"" font=""0"">and the World Organization for Animal Health (OIE). </text>
</p><p number=""1.12"" style=""8""><text top=""411"" left=""108"" width=""682"" height=""16"" font=""0"">1.12.  The initially-adopted Working Procedures and the Timetable of the proceedings were drafted </text>
<text top=""428"" left=""108"" width=""686"" height=""16"" font=""0"">with a view to leaving open the possibility for the Panel to consult scientific experts and/or </text>
<text top=""444"" left=""108"" width=""685"" height=""16"" font=""0"">international organizations. After the first substantive meeting, the Panel asked the parties to </text>
<text top=""461"" left=""108"" width=""683"" height=""16"" font=""0"">indicate their views on whether the Panel should seek scientific and technical advice from experts </text>
<text top=""477"" left=""108"" width=""683"" height=""16"" font=""0"">and/or international organizations. If they were of the view that the Panel should do so, the Panel </text>
<text top=""493"" left=""108"" width=""682"" height=""16"" font=""0"">asked for their views on the following matters: (i) from which international organizations the Panel </text>
<text top=""510"" left=""108"" width=""689"" height=""16"" font=""0"">should seek advice; (ii) from which international organizations the Panel should request </text>
<text top=""526"" left=""108"" width=""682"" height=""16"" font=""0"">suggestions of possible experts; (iii) in what areas of scientific and/or technical expertise the Panel </text>
<text top=""543"" left=""108"" width=""686"" height=""16"" font=""0"">should seek expert advice; (iv) how many experts the Panel should consult in each area of </text>
<text top=""559"" left=""108"" width=""684"" height=""16"" font=""0"">expertise; and (v) whether the Panel should consult experts individually or as part of an expert </text>
<text top=""575"" left=""108"" width=""550"" height=""16"" font=""0"">review group as contemplated in Article 13 and Appendix 4 of the DSU.</text>
<footnote top=""574"" left=""658"" width=""6"" height=""11"" font=""16"" number=""8"" ref="""" dis=""""/>
<text top=""575"" left=""663"" width=""133"" height=""16"" font=""0""> The Panel also </text>
<text top=""592"" left=""108"" width=""682"" height=""16"" font=""0"">encouraged the parties to reach agreement on any specific scientific experts to be consulted by the </text>
<text top=""608"" left=""108"" width=""51"" height=""16"" font=""0"">Panel.  </text>
</p><p number=""1.13"" style=""8""><text top=""643"" left=""108"" width=""685"" height=""16"" font=""0"">1.13.  In their responses to the Panel questions on these matters, both the United States and </text>
<text top=""659"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina responded that they did not consider it necessary for the Panel to consult individual </text>
<text top=""675"" left=""108"" width=""682"" height=""16"" font=""0"">experts. As for consulting relevant international organizations &#8211; the OIE &#8211; the United States stated </text>
<text top=""692"" left=""108"" width=""501"" height=""16"" font=""0"">that it was unable to see how the OIE would be able to assist the Panel.</text>
<footnote top=""690"" left=""608"" width=""6"" height=""11"" font=""16"" number=""9"" ref="""" dis=""""/>
<text top=""692"" left=""614"" width=""176"" height=""16"" font=""0""> Argentina indicated that </text>
<text top=""708"" left=""108"" width=""687"" height=""16"" font=""0"">it would not object to the Panel seeking advice from the OIE concerning its processes and </text>
<text top=""725"" left=""108"" width=""67"" height=""16"" font=""0"">decisions.</text>
<footnote top=""723"" left=""175"" width=""11"" height=""11"" font=""16"" number=""10"" ref="""" dis=""""/>
<text top=""725"" left=""186"" width=""606"" height=""16"" font=""0""> The parties did not reach agreement on any specific experts to be consulted by the </text>
<text top=""741"" left=""108"" width=""684"" height=""16"" font=""0"">Panel. After considering the responses of the parties, the Panel decided to seek advice from the </text>
<p><text top=""803"" left=""108"" width=""656"" height=""15"" font=""10"">paragraph 23(e) of the Working Procedures: its first written submission; its responses to Panel questions in </text>
<text top=""818"" left=""108"" width=""676"" height=""15"" font=""10"">connection with the first substantive meeting; its comments on the Working Procedures and revised timetable; </text>
<text top=""832"" left=""108"" width=""655"" height=""15"" font=""10"">its second written submission; and its responses to the Panel's communications of 3 April and 15 May 2014 </text>
<text top=""847"" left=""108"" width=""633"" height=""15"" font=""10"">concerning the selection of experts. Argentina filed a corrigendum to its responses to Panel questions in </text>
<text top=""861"" left=""108"" width=""644"" height=""15"" font=""10"">connection with the first substantive meeting after the 17:00 deadline specified in paragraph 23(e) of the </text>
<text top=""876"" left=""108"" width=""645"" height=""15"" font=""10"">Working Procedures. Australia did not serve its third-party submission on the parties and the third parties </text>
<text top=""891"" left=""108"" width=""676"" height=""15"" font=""10"">according to the requirements under paragraphs 23(d) and 23(e) of the Working Procedures, and did not meet </text>
<text top=""905"" left=""108"" width=""658"" height=""15"" font=""10"">the 17:00 deadline specified in paragraph 23(e) thereof. Finally, Brazil did not submit the final version of its </text>
<text top=""920"" left=""108"" width=""668"" height=""15"" font=""10"">third-party statement by the deadline specified in paragraph 16(b) of the Working Procedures. With regard to </text>
<text top=""934"" left=""108"" width=""652"" height=""15"" font=""10"">its first written submission, on 10 October 2013 the United States requested an extension of the filing date </text>
<text top=""949"" left=""108"" width=""677"" height=""15"" font=""10"">from 22 October 2013 to 5 November 2013 due to the unforeseen shutdown of the United States Government; </text>
<text top=""963"" left=""108"" width=""665"" height=""15"" font=""10"">the Panel acceded to the United States' request. However, in other instances the parties and third parties did </text>
<text top=""978"" left=""108"" width=""670"" height=""15"" font=""10"">not request an extension even though their filings were late. Although a short grace period was applied to the </text>
<text top=""993"" left=""108"" width=""679"" height=""15"" font=""10"">various instances where filings were not received on time, the delays ranged from 30 minutes to several hours. </text>
<text top=""1007"" left=""108"" width=""657"" height=""15"" font=""10"">On 20 May 2014, the Panel informed the parties that as a result of these late filings, the Panel was going to </text>
<text top=""1022"" left=""108"" width=""534"" height=""15"" font=""10"">amend its working procedures with respect to filings of contemporaneous submissions.  </text>
<footnote top=""1095"" left=""155"" width=""381"" height=""15"" font=""10"" number=""76"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 22 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">OIE with respect to the relevant provisions of the Terrestrial Animal Health Code (Terrestrial Code) </text>
<text top=""144"" left=""108"" width=""688"" height=""16"" font=""0"">as well as from individual experts with respect to, <i>inter alia</i>, risk assessment techniques, </text>
<text top=""160"" left=""108"" width=""272"" height=""16"" font=""0"">veterinary practices and surveillance.</text>
<footnote top=""159"" left=""380"" width=""11"" height=""11"" font=""16"" number=""11"" ref="""" dis=""""><ftext top=""1022"" left=""160"" width=""351"" height=""15"" font=""10""> See Letter from the Panel to the parties (4 March 2014). </ftext>
</footnote>
<text top=""160"" left=""391"" width=""405"" height=""16"" font=""0""> The Panel adopted the Working Procedures for the </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">consultation of experts and amended its timetable to take into account the various steps in the </text>
<text top=""193"" left=""108"" width=""390"" height=""16"" font=""0"">process of consulting the OIE and the individual experts. </text>
</p></p></page>
<page number=""22"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""18"" size=""11"" family=""Times"" color=""#000000""/>
<p number=""1.3"" style=""8""><text top=""228"" left=""108"" width=""194"" height=""16"" font=""28"">1.3.2.1  Expert selection  </text></p><p number=""1.14"" style=""8""><text top=""262"" left=""108"" width=""50"" height=""16"" font=""0"">1.14. </text>
<text top=""262"" left=""153"" width=""356"" height=""16"" font=""0"">Pursuant to the Working Procedures, on 6 </text>
<text top=""262"" left=""500"" width=""55"" height=""16"" font=""0"">March </text>
<text top=""262"" left=""546"" width=""254"" height=""16"" font=""0"">2014 the Panel requested the </text>
<text top=""278"" left=""108"" width=""683"" height=""16"" font=""0"">OIE Secretariat to identify names of possible individual experts in the following fields: veterinary </text>
<text top=""295"" left=""108"" width=""682"" height=""16"" font=""0"">practice, surveillance, and risk assessment in the context of foot-and-mouth disease (FMD). At the </text>
<text top=""311"" left=""108"" width=""687"" height=""16"" font=""0"">same time, the Panel also informed the OIE that it might seek advice in writing from the </text>
<text top=""328"" left=""108"" width=""533"" height=""16"" font=""0"">OIE Secretariat with regard to the relevant provisions of the Terrestrial Code. </text>
</p><p number=""1.15"" style=""8""><text top=""362"" left=""108"" width=""683"" height=""16"" font=""0"">1.15.  On 7 March 2014, the OIE Secretariat responded and provided the WTO with eight names. </text>
<text top=""378"" left=""108"" width=""685"" height=""16"" font=""0"">The WTO Secretariat contacted each of the individuals recommended by the OIE to determine </text>
<text top=""395"" left=""108"" width=""683"" height=""16"" font=""0"">whether they were willing and available to assist the Panel. On 3 April 2014, the Panel forwarded </text>
<text top=""411"" left=""108"" width=""684"" height=""16"" font=""0"">to the parties for comments the names and curricula vitae of those experts who indicated that </text>
<text top=""428"" left=""108"" width=""683"" height=""16"" font=""0"">they were willing to assist the Panel. For reasons of transparency, the Panel informed the parties </text>
<text top=""444"" left=""108"" width=""343"" height=""16"" font=""0"">of all the names proposed by the OIE Secretariat. </text>
</p><p number=""1.16"" style=""8""><text top=""479"" left=""108"" width=""682"" height=""16"" font=""0"">1.16.  In accordance with paragraph 23 of the Working Procedures, the Panel invited the parties to </text>
<text top=""495"" left=""108"" width=""687"" height=""16"" font=""0"">comment on the available potential experts identified and to make known any compelling </text>
<text top=""511"" left=""108"" width=""684"" height=""16"" font=""0"">objections to any of the experts. The parties filed their comments on the proposed experts on </text>
<text top=""528"" left=""108"" width=""682"" height=""16"" font=""0"">15 April 2014. Argentina considered the proposed experts to be well-suited for assisting the Panel, </text>
<text top=""544"" left=""108"" width=""683"" height=""16"" font=""0"">whereas the United States objected to all the proposed experts on the ground that each of them </text>
<text top=""561"" left=""108"" width=""619"" height=""16"" font=""0"">had been ""closely involved in the OIE process for adopting Argentina's current OIE status"".</text>
<footnote top=""559"" left=""727"" width=""11"" height=""11"" font=""16"" number=""12"" ref="""" dis=""""><ftext top=""1036"" left=""160"" width=""458"" height=""15"" font=""10""> Letter from the United States regarding proposed experts (15 April 2014). </ftext>
</footnote>
</p><p number=""1.17"" style=""8""><text top=""595"" left=""108"" width=""685"" height=""16"" font=""0"">1.17.  On 29 April 2014, the Panel contacted the OIE for a second time expressing its wish to </text>
<text top=""611"" left=""108"" width=""683"" height=""16"" font=""0"">enlarge the pool of potential experts. In particular, the Panel asked the OIE to provide additional </text>
<text top=""628"" left=""108"" width=""685"" height=""16"" font=""0"">names of potential experts who had not directly participated in the evaluation of the sanitary </text>
<text top=""644"" left=""108"" width=""685"" height=""16"" font=""0"">situation in Argentina with respect to FMD. On the same day, the Panel invited the parties to </text>
<text top=""661"" left=""108"" width=""572"" height=""16"" font=""0"">identify any experts they considered would be suitable to assist in the proceedings. </text>
</p><p number=""1.18"" style=""8""><text top=""695"" left=""108"" width=""684"" height=""16"" font=""0"">1.18.  On 6 May 2014, the OIE Secretariat provided the names of another seven individuals. For </text>
<text top=""711"" left=""108"" width=""684"" height=""16"" font=""0"">reasons of transparency, the Panel informed the parties of the names of those seven additional </text>
<text top=""728"" left=""108"" width=""682"" height=""16"" font=""0"">experts. Argentina and the United States each provided the names of two experts who they viewed </text>
<text top=""744"" left=""108"" width=""685"" height=""16"" font=""0"">as appropriate to assist the Panel. The Panel contacted the 11 individuals to determine their </text>
<text top=""761"" left=""108"" width=""686"" height=""16"" font=""0"">availability and willingness to assist the Panel. The Panel forwarded to the parties for their </text>
<text top=""777"" left=""108"" width=""684"" height=""16"" font=""0"">comments in accordance with paragraph 23 of the Working Procedures the names and curricula </text>
<text top=""793"" left=""108"" width=""663"" height=""16"" font=""0"">vitae of the available experts. The parties commented on the proposed experts on 19 May 2014. </text>
</p><p number=""1.19"" style=""8""><text top=""828"" left=""108"" width=""689"" height=""16"" font=""0"">1.19.  On 9 May 2014, the Panel sent to the OIE questions concerning the operation and </text>
<text top=""844"" left=""108"" width=""687"" height=""16"" font=""0"">interpretation of the OIE's standards, guidelines and recommendations as embodied in the </text>
<text top=""861"" left=""108"" width=""683"" height=""16"" font=""0"">Terrestrial Code, as well as any other relevant OIE documents. The parties' written submissions, </text>
<text top=""877"" left=""108"" width=""684"" height=""16"" font=""0"">oral statements and responses to questions were also provided to the OIE. The OIE provided its </text>
<text top=""893"" left=""108"" width=""683"" height=""16"" font=""0"">responses to the Panel's questions on 23 June 2014. The parties' provided their comments on the </text>
<text top=""910"" left=""108"" width=""232"" height=""16"" font=""0"">OIE's responses on 17 July 2014. </text>
</p><p number=""1.20"" style=""8""><text top=""944"" left=""108"" width=""682"" height=""16"" font=""0"">1.20.  On 23 May 2014, the Panel informed the parties that it had selected the following experts to </text>
<text top=""961"" left=""108"" width=""686"" height=""16"" font=""0"">assist it: Dr Howard Batho, Dr Etienne Bonbon, Dr Andrew Cupit, and Dr Vitor Salvador Pic&#227;o </text>
<text top=""977"" left=""108"" width=""74"" height=""16"" font=""0"">Gon&#231;alves.</text>
<footnote top=""976"" left=""182"" width=""11"" height=""11"" font=""16"" number=""13"" ref="""" dis=""""><ftext top=""1051"" left=""160"" width=""611"" height=""15"" font=""10""> See Letter from the Panel to the parties selecting the experts (23 May 2014). Dr Howard Batho is a </ftext>
<ftext top=""1066"" left=""108"" width=""667"" height=""15"" font=""10"">Member of the Royal College of Veterinary Surgeons. He retired from the European Commission's Directorate-</ftext>
<ftext top=""1080"" left=""108"" width=""628"" height=""15"" font=""10"">General for Health and Consumers (SANCO) where he was a principle administrator responsible for the </ftext>
<ftext top=""1095"" left=""108"" width=""680"" height=""15"" font=""10"">coordination and requirements of import policy in the area of animal health. He served in a variety of capacities </ftext>
</footnote>
<text top=""977"" left=""194"" width=""243"" height=""16"" font=""0""> Of the experts selected, Dr </text>
<text top=""977"" left=""428"" width=""284"" height=""16"" font=""0"">Cupit was proposed by the United </text>
<text top=""977"" left=""704"" width=""94"" height=""16"" font=""0"">States and </text>
<p><text top=""1109"" left=""108"" width=""632"" height=""15"" font=""10"">relating to veterinary services in the European Commission and the United Kingdom from 1997 until his </text>
<text top=""1124"" left=""108"" width=""674"" height=""15"" font=""10"">retirement in 2010. Dr Batho participated in a number of field missions to South America on behalf of the OIE, </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 23 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">Dr Gon&#231;alves by Argentina. The Panel contacted the four selected experts and informed them that </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">upon receipt of their signed disclosure forms confirming that they had no conflict of interest, the </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">Panel would send them background material and a list of questions to which it wished to have </text>
<text top=""177"" left=""108"" width=""112"" height=""16"" font=""0"">written replies.  </text>
</p></p></page>
<page number=""23"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""1.21"" style=""8""><text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">1.21.  The Panel received responses to its questions by 30 June from Dr Batho, Dr Bonbon, and </text>
<text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">Dr Cupit. On 3 July 2014, the Panel received a letter from Dr Gon&#231;alves stating that he was no </text>
<text top=""244"" left=""108"" width=""345"" height=""16"" font=""0"">longer  able  to  assist  as  an  expert  in  the  dispute.</text>
<footnote top=""243"" left=""453"" width=""11"" height=""11"" font=""16"" number=""14"" ref="""" dis=""""><ftext top=""1080"" left=""160"" width=""619"" height=""15"" font=""10""> Dr Gon&#231;alves stated that due to important and unforeseen personal reasons he would be unavailable </ftext>
</footnote>
<text top=""244"" left=""465"" width=""327"" height=""16"" font=""0""> The parties' provided their comments on the </text>
<text top=""260"" left=""108"" width=""320"" height=""16"" font=""0"">individual experts' responses on 29 July 2014. </text>
</p><p number=""1.22"" style=""8""><text top=""295"" left=""108"" width=""683"" height=""16"" font=""0"">1.22.  On 4 August 2014, the OIE informed the Panel of the members of its delegation who would </text>
<text top=""311"" left=""108"" width=""689"" height=""16"" font=""0"">attend the 2 September expert hearing with the Panel and the parties. By letter dated </text>
<text top=""328"" left=""108"" width=""684"" height=""16"" font=""0"">11 August 2014, the United States expressed concern with one member of the OIE's delegation, </text>
<text top=""344"" left=""108"" width=""682"" height=""16"" font=""0"">noting that it had objected to this person when proposed by the OIE as an individual expert. The </text>
<text top=""360"" left=""108"" width=""682"" height=""16"" font=""0"">United States' objections were based on the fact that the proposed expert was a private consultant </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">based in Buenos Aires and that this could give rise to the ""appearance that [the expert's] opinions </text>
<text top=""393"" left=""108"" width=""682"" height=""16"" font=""0"">could be influenced by the need to maintain relationships with potential sources of consulting work </text>
<text top=""410"" left=""108"" width=""128"" height=""16"" font=""0"">in South America"".</text>
<footnote top=""408"" left=""236"" width=""11"" height=""11"" font=""16"" number=""15"" ref="""" dis=""""><ftext top=""1109"" left=""160"" width=""378"" height=""15"" font=""10""> Letter from the United States to the Panel (11 August 2014). </ftext>
</footnote>
<text top=""410"" left=""247"" width=""543"" height=""16"" font=""0""> The United States also stated that as the individual was not an OIE employee, </text>
<text top=""426"" left=""108"" width=""565"" height=""16"" font=""0"">it was unclear how this person would be able to represent the OIE at the meeting. </text>
</p><p number=""1.23"" style=""8""><text top=""461"" left=""108"" width=""686"" height=""16"" font=""0"">1.23.  On 14 August 2014, the Panel contacted the OIE and informed it of the United States' </text>
<text top=""477"" left=""108"" width=""687"" height=""16"" font=""0"">concerns regarding the individual. While acknowledging that the individual had an in-depth </text>
<text top=""493"" left=""108"" width=""682"" height=""16"" font=""0"">knowledge of the Terrestrial Code, the OIE and its processes, the Panel indicated that it considered </text>
<text top=""510"" left=""108"" width=""682"" height=""16"" font=""0"">that the individual's work as a private consultant based in Argentina could give rise to doubts as to </text>
<text top=""526"" left=""108"" width=""689"" height=""16"" font=""0"">the individual's independence or impartiality if that individual were to participate in the </text>
<text top=""543"" left=""108"" width=""684"" height=""16"" font=""0"">2 September meeting. The Panel, noting this could affect the parties' due process rights and its </text>
<text top=""559"" left=""108"" width=""686"" height=""16"" font=""0"">ability to rely on the OIE's responses at the meeting, accordingly asked the OIE to limit its </text>
<text top=""575"" left=""108"" width=""587"" height=""16"" font=""0"">delegation to the two other persons mentioned in the OIE's 4 August communication. </text>
</p><p number=""1.24"" style=""8""><text top=""610"" left=""108"" width=""684"" height=""16"" font=""0"">1.24.  On 19 August 2014, the OIE responded, clarifying that the member of its delegation had </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">been continuously under contract with the OIE since 1 August 2012 for the performance of duties </text>
<text top=""643"" left=""108"" width=""685"" height=""16"" font=""0"">on behalf of the Organization. It also stated that as the majority of parties' comments on the </text>
<text top=""659"" left=""108"" width=""682"" height=""16"" font=""0"">responses submitted by the OIE to the Panel's questions were related to the OIE's interpretations, </text>
<text top=""675"" left=""108"" width=""684"" height=""16"" font=""0"">processes, procedures and transparency related to its standard setting, it had ""an obligation to </text>
<text top=""692"" left=""108"" width=""683"" height=""16"" font=""0"">[its] 180 Member Countries who have adopted these procedures and norms that the OIE must be </text>
<text top=""708"" left=""108"" width=""646"" height=""16"" font=""0"">represented by the most qualified, knowledgeable and competent individuals at our disposal.""</text>
<footnote top=""707"" left=""754"" width=""11"" height=""11"" font=""16"" number=""16"" ref="""" dis=""""><ftext top=""1124"" left=""160"" width=""390"" height=""15"" font=""10""> Letter from the Director-General of the OIE (19 August 2014).  </ftext>
</footnote>
<text top=""708"" left=""765"" width=""25"" height=""16"" font=""0""> In </text>
<text top=""725"" left=""108"" width=""687"" height=""16"" font=""0"">the OIE's view, the person best placed to properly represent the OIE and provide valuable </text>
<text top=""741"" left=""108"" width=""414"" height=""16"" font=""0"">assistance to the Panel was the individual they had chosen.  </text>
</p><p number=""1.25"" style=""8""><text top=""775"" left=""108"" width=""684"" height=""16"" font=""0"">1.25.  On 26 August 2014, the Panel responded to the OIE's communication, emphasizing that it </text>
<text top=""792"" left=""108"" width=""683"" height=""16"" font=""0"">had an obligation to ensure that the parties' due process rights were respected at each stage and </text>
<text top=""808"" left=""108"" width=""683"" height=""16"" font=""0"">in every aspect of the proceedings. However, in light of the OIE's assurances that the individual </text>
<text top=""825"" left=""108"" width=""688"" height=""16"" font=""0"">was an OIE employee in the sense that the individual had been under contract with the </text>
<text top=""841"" left=""108"" width=""683"" height=""16"" font=""0"">OIE continuously since 1 August 2012 and in view of the comity owed to the OIE Secretariat, the </text>
<text top=""857"" left=""108"" width=""683"" height=""16"" font=""0"">Panel stated that it was prepared to reconsider the individual's attendance at the meeting. In this </text>
<p><text top=""905"" left=""108"" width=""681"" height=""15"" font=""10"">including to Argentina. Dr Etienne Bonbon served in the French Ministry of Agriculture and Fisheries in a variety </text>
<text top=""920"" left=""108"" width=""675"" height=""15"" font=""10"">of capacities. He has also served as an advisor to the Director General of the OIE and the Vice President of the </text>
<text top=""934"" left=""108"" width=""618"" height=""15"" font=""10"">Terrestrial Animal Health Standard Commission. He is currently a counsellor with the European Union </text>
<text top=""949"" left=""108"" width=""642"" height=""15"" font=""10"">delegation to the OECD, UNESCO and international organisations in Paris with particular responsibility for </text>
<text top=""963"" left=""108"" width=""670"" height=""15"" font=""10"">following the European Union and its Agencies' relations with the OIE. Dr Andrew Cupit is Assistant Secretary, </text>
<text top=""978"" left=""108"" width=""642"" height=""15"" font=""10"">Animal Biosecurity Branch, Animal Division, Department of Agriculture, Government of Australia. Dr Vitor </text>
<text top=""993"" left=""108"" width=""672"" height=""15"" font=""10"">Salvador Pic&#227;o Gon&#231;alves is associate professor at the University of Bras&#237;lia, Brazil and lectures on ""Veterinary </text>
<text top=""1007"" left=""108"" width=""646"" height=""15"" font=""10"">Epidemiology"", ""Planning of Animal Health Policies"", ""Methods for Epidemiological Investigation"" and ""Risk </text>
<text top=""1022"" left=""108"" width=""680"" height=""15"" font=""10"">Analysis in Animal Health"". He also acts as an adviser to the Animal Health Department, Ministry of Agriculture, </text>
<text top=""1036"" left=""108"" width=""615"" height=""15"" font=""10"">in Brasilia, on a wide range of topics related to epidemiology and public policies, such as surveillance </text>
<text top=""1051"" left=""108"" width=""654"" height=""15"" font=""10"">strategies, establishment of free zones and compartments, risk assessments, FMD and CSF eradication and </text>
<text top=""1066"" left=""108"" width=""180"" height=""15"" font=""10"">control of endemic diseases.  </text>
</p><p><text top=""1095"" left=""108"" width=""440"" height=""15"" font=""10"">to attend the meeting with the parties and the experts on 2 September. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 24 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">regard, the Panel asked the OIE to confirm a number of matters relating to any potential conflict of </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">interest arising from the individual's private professional activities in Argentina, and that it confirm </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">that the individual as an OIE employee was governed by the OIE's Rules of Conduct and would </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">also be guided by the WTO's Rules of Conduct for the Settlement of Disputes. The Panel indicated </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">that if it received the requisite assurances and the individual were to participate in the meeting, </text>
<text top=""210"" left=""108"" width=""685"" height=""16"" font=""0"">the parties would be given a period of time to question the individual about any professional </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">affiliation with the OIE, any private consulting activities outside the OIE, and whether those </text>
<text top=""242"" left=""108"" width=""684"" height=""16"" font=""0"">activities would have a bearing on the individual's ability to be impartial and independent when </text>
<text top=""259"" left=""108"" width=""295"" height=""16"" font=""0"">answering questions on behalf of the OIE.  </text>
</p></p></page>
<page number=""24"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""1.26"" style=""8""><text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">1.26.  On 28 August 2014, the Panel received the confirmation it was seeking with respect to the </text>
<text top=""310"" left=""108"" width=""685"" height=""16"" font=""0"">individual's private professional activities as well as the fact that although the individual was </text>
<text top=""326"" left=""108"" width=""684"" height=""16"" font=""0"">considered as a private consultant to the OIE, in the sense that the individual did not have the </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">entitlements of an OIE staff member, the OIE Rules of Conduct and undertakings on confidentiality </text>
<text top=""359"" left=""108"" width=""683"" height=""16"" font=""0"">were explicitly stated in the individual's contract and were fully equivalent to those applicable to </text>
<text top=""375"" left=""108"" width=""74"" height=""16"" font=""0"">OIE staff.  </text>
</p><p number=""1.27"" style=""8""><text top=""410"" left=""108"" width=""686"" height=""16"" font=""0"">1.27.  In the context of assisting the Panel in determining the proper allocation of time for </text>
<text top=""426"" left=""108"" width=""684"" height=""16"" font=""0"">statements at the meeting, the United States indicated that it did not wish to avail itself of the </text>
<text top=""443"" left=""108"" width=""685"" height=""16"" font=""0"">opportunity to pose questions at the meeting with the experts to the individual on the OIE's </text>
<text top=""459"" left=""108"" width=""402"" height=""16"" font=""0"">delegation on the matter of impartiality and independence.</text>
<footnote top=""457"" left=""510"" width=""11"" height=""11"" font=""16"" number=""17"" ref="""" dis=""""><ftext top=""1036"" left=""160"" width=""453"" height=""15"" font=""10""> Communication from the United States to the Panel (1 September 2014). </ftext>
</footnote>
</p><p><text top=""493"" left=""108"" width=""169"" height=""16"" font=""28"">2  FACTUAL ASPECTS  </text></p><p number=""2.1"" style=""8""><text top=""528"" left=""108"" width=""442"" height=""16"" font=""28"">2.1  The relevant disease: Foot-and-mouth disease (FMD) </text></p><p number=""2.1"" style=""8""><text top=""562"" left=""108"" width=""685"" height=""16"" font=""0"">2.1.  Foot-and-mouth disease (FMD) is a highly contagious viral disease that primarily affects </text>
<text top=""579"" left=""108"" width=""687"" height=""16"" font=""0"">cloven (divided)-hoofed livestock and wildlife. Although adult animals generally recover, the </text>
<text top=""595"" left=""108"" width=""682"" height=""16"" font=""0"">morbidity rate is very high in non-vaccinated populations, and significant pain and distress occur in </text>
<text top=""611"" left=""108"" width=""690"" height=""16"" font=""0"">some species. High mortality rates can be observed in non-vaccinated young animals. </text>
<text top=""628"" left=""108"" width=""685"" height=""16"" font=""0"">Complications or other pathological conditions resulting from FMD may include decreased milk </text>
<text top=""644"" left=""108"" width=""687"" height=""16"" font=""0"">yield, permanent hoof damage and chronic mastitis (inflammation of mammary glands and </text>
<text top=""661"" left=""108"" width=""682"" height=""16"" font=""0"">udders).  Although  FMD was  once  found  worldwide,  it  has  been  eradicated  from  some  regions </text>
<text top=""677"" left=""108"" width=""686"" height=""16"" font=""0"">including North America and most of Europe. Where it is endemic, this disease is a major </text>
<text top=""693"" left=""108"" width=""683"" height=""16"" font=""0"">constraint to the international livestock trade. Unless strict precautions are followed, FMD can be </text>
<text top=""710"" left=""108"" width=""683"" height=""16"" font=""0"">readily re-introduced into disease-free livestock. Once this occurs, the disease can spread rapidly </text>
<text top=""726"" left=""108"" width=""358"" height=""16"" font=""0"">through a region, particularly if detection is delayed.</text>
<footnote top=""725"" left=""466"" width=""11"" height=""11"" font=""16"" number=""18"" ref="""" dis=""""><ftext top=""1051"" left=""160"" width=""610"" height=""15"" font=""10""> See e.g. website of the World Organization for Animal Health (OIE website), <i>Foot &amp; Mouth Disease: </i></ftext>
<ftext top=""1066"" left=""108"" width=""651"" height=""15"" font=""12""><i>Questions &amp; Answers</i>, http://www.oie.int/fileadmin/Home/eng/Media_Center/docs/pdf/Disease_cards/Q_A-</ftext>
<ftext top=""1080"" left=""108"" width=""287"" height=""15"" font=""10"">FMD-EN.pdf (last accessed 21 February 2014). </ftext>
</footnote>
</p><p number=""2.2"" style=""8""><text top=""761"" left=""108"" width=""683"" height=""16"" font=""0"">2.2.  The FMD virus survives in living tissue and in the breath, saliva, urine, and other excretions </text>
<text top=""777"" left=""108"" width=""683"" height=""16"" font=""0"">of infected animals. It can also survive in contaminated materials and the environment for several </text>
<text top=""793"" left=""108"" width=""682"" height=""16"" font=""0"">months under certain conditions. In cattle, the incubation period varies from two to fourteen days, </text>
<text top=""810"" left=""108"" width=""683"" height=""16"" font=""0"">depending on the dose of the virus and route of infection. FMD can spread when infected animals </text>
<text top=""826"" left=""108"" width=""688"" height=""16"" font=""0"">bring the virus into physical contact with susceptible animals (i.e. cloven (divided) hoofed </text>
<text top=""843"" left=""108"" width=""63"" height=""16"" font=""0"">animals).</text>
<footnote top=""841"" left=""171"" width=""11"" height=""11"" font=""16"" number=""19"" ref="""" dis=""""><ftext top=""1095"" left=""160"" width=""416"" height=""15"" font=""10""> See e.g. OIE website, <i>Foot &amp; Mouth Disease: Questions &amp; Answers</i>, </ftext>
<ftext top=""1109"" left=""108"" width=""681"" height=""15"" font=""10"">http://www.oie.int/fileadmin/Home/eng/Media_Center/docs/pdf/Disease_cards/Q_A-FMD-EN.pdf (last accessed </ftext>
<ftext top=""1124"" left=""108"" width=""122"" height=""15"" font=""10"">21 February 2014). </ftext>
</footnote>
</p><p number=""2.3"" style=""8""><text top=""877"" left=""108"" width=""682"" height=""16"" font=""0"">2.3.  The virus has a variety of potential pathways for disease transmission including transmission </text>
<text top=""893"" left=""108"" width=""682"" height=""16"" font=""0"">through beef, offal, and hides derived from infected animals. Given the virulence and the potential </text>
<text top=""910"" left=""108"" width=""682"" height=""16"" font=""0"">rapid spread of the disease, and the significant direct and indirect costs associated with eradication </text>
<text top=""926"" left=""108"" width=""683"" height=""16"" font=""0"">of an outbreak, most countries that have eradicated the disease impose strict sanitary measures </text>
<text top=""943"" left=""108"" width=""683"" height=""16"" font=""0"">on imports of animal products. Countries that are not FMD-free are usually limited in international </text>
<text top=""959"" left=""108"" width=""684"" height=""16"" font=""0"">markets to sales to other markets that are also not FMD-free or, in some cases, to exports of </text>
<text top=""976"" left=""108"" width=""684"" height=""16"" font=""0"">specific types of meat products (for example, processed meat). These restrictions thus create a </text>
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 25 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">segmented market in which products from countries that are FMD-free sell at a premium (10 to 50 </text>
<text top=""144"" left=""108"" width=""395"" height=""16"" font=""0"">per cent) over products that do not have this designation.</text>
<footnote top=""143"" left=""503"" width=""11"" height=""11"" font=""16"" number=""20"" ref="""" dis=""""><ftext top=""1022"" left=""160"" width=""416"" height=""15"" font=""10""> See e.g. OIE website, <i>Foot &amp; Mouth Disease: Questions &amp; Answers</i>, </ftext>
<ftext top=""1036"" left=""108"" width=""681"" height=""15"" font=""10"">http://www.oie.int/fileadmin/Home/eng/Media_Center/docs/pdf/Disease_cards/Q_A-FMD-EN.pdf (last accessed </ftext>
<ftext top=""1051"" left=""108"" width=""122"" height=""15"" font=""10"">21 February 2014). </ftext>
</footnote>
</p></p></page>
<page number=""25"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""2.4"" style=""8""><text top=""178"" left=""108"" width=""684"" height=""16"" font=""0"">2.4.  One of the tools countries or regions use to move towards eradication of the disease is to </text>
<text top=""195"" left=""108"" width=""416"" height=""16"" font=""0"">vaccinate cattle and other susceptible animals against FMD.  </text>
</p><p number=""2.2"" style=""8""><text top=""229"" left=""108"" width=""207"" height=""16"" font=""28"">2.2  The measures at issue </text></p><p number=""2.5"" style=""8""><text top=""264"" left=""108"" width=""684"" height=""16"" font=""0"">2.5.  In the present dispute, Argentina challenges two sets of measures: (a) the United States' </text>
<text top=""280"" left=""108"" width=""686"" height=""16"" font=""0"">prohibition on importation of fresh (chilled or frozen) beef from the portion of the Argentine </text>
<text top=""296"" left=""108"" width=""683"" height=""16"" font=""0"">territory located north of the Rio Negro (Northern Argentina) and on the importation of animals, </text>
<text top=""313"" left=""108"" width=""685"" height=""16"" font=""0"">meat and other animal products from the Patagonia region as a consequence of the failure to </text>
<text top=""329"" left=""108"" width=""683"" height=""16"" font=""0"">recognize Patagonia as an FMD-free region, contained in 9 CFR 94.1(b) and the 2001 Regulations, </text>
<text top=""346"" left=""108"" width=""684"" height=""16"" font=""0"">and in 9 CFR 94, respectively; and (b) the undue delay in the application of the procedures set </text>
<text top=""362"" left=""108"" width=""686"" height=""16"" font=""0"">forth in Title 9 of the United States' Code of Federal Regulations, Part 92.2 (9 CFR 92.2) to </text>
<text top=""378"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina's requests for importation of fresh (chilled or frozen) beef from Northern Argentina and </text>
<text top=""395"" left=""108"" width=""421"" height=""16"" font=""0"">for the recognition of the Patagonia region as free from FMD. </text>
</p><p number=""2.2"" style=""8""><text top=""429"" left=""108"" width=""689"" height=""16"" font=""28"">2.2.1  Prohibition on importation of fresh (chilled or frozen) beef from Northern </text><text top=""446"" left=""108"" width=""632"" height=""16"" font=""28"">Argentina and animals, meat and other animal products from the Patagonia region </text></p><p number=""2.2"" style=""8""><text top=""480"" left=""108"" width=""450"" height=""16"" font=""28"">2.2.1.1  Title 9 of the Code of Federal Regulations, Part 94  </text></p><p number=""2.6"" style=""8""><text top=""515"" left=""108"" width=""682"" height=""16"" font=""0"">2.6.  The first measure at issue is Title 9 of the United States' Code of Federal Regulations, Part 94 </text>
<text top=""531"" left=""108"" width=""74"" height=""16"" font=""0"">(9 CFR 94)</text>
<footnote top=""529"" left=""182"" width=""11"" height=""11"" font=""16"" number=""21"" ref="""" dis=""""><ftext top=""1066"" left=""160"" width=""629"" height=""15"" font=""31"">Rinderpest, Foot-and-Mouth Disease, Exotic New-Castle Disease, African Swine Fever, Swine Vesicular </ftext><ftext top=""1080"" left=""108"" width=""607"" height=""15"" font=""12""><i>Disease, and Bovine Spongiform Encephalopathy: Prohibited and Restricted Importations</i>, 9 CFR 94 </ftext>
<ftext top=""1095"" left=""108"" width=""209"" height=""15"" font=""10"">(2013 version), (Exhibit ARG-64). </ftext>
</footnote>
<text top=""531"" left=""194"" width=""600"" height=""16"" font=""0"">, which, in its application, effectively prohibits the importation of fresh (chilled or </text>
<text top=""547"" left=""108"" width=""597"" height=""16"" font=""0"">frozen) beef from Northern Argentina and animals, meat and other animal products</text>
<footnote top=""546"" left=""705"" width=""11"" height=""11"" font=""16"" number=""22"" ref="""" dis=""""><ftext top=""1109"" left=""160"" width=""625"" height=""15"" font=""10""> We note, as will be discussed further below, that the measure at issue prohibits specifically ruminants </ftext>
<ftext top=""1124"" left=""108"" width=""389"" height=""15"" font=""10"">and swine as these are the species that are susceptible to FMD. </ftext>
<ftext top=""847"" left=""278"" width=""436"" height=""15"" font=""10"">Rinderpest or foot-and-mouth disease exists in all regions of the world, </ftext>
<ftext top=""1080"" left=""278"" width=""463"" height=""15"" font=""10"">The following regions are declared to be free of rinderpest: Japan, Namibia, </ftext>
<ftext top=""1095"" left=""278"" width=""263"" height=""15"" font=""10"">the Republic of South Africa, and Uruguay. </ftext>
<ftext top=""1124"" left=""108"" width=""276"" height=""15"" font=""10"">9 CFR 94 (2012 version), (Exhibit ARG-126). </ftext>
</footnote>
<text top=""547"" left=""717"" width=""76"" height=""16"" font=""0""> from the </text>
<text top=""564"" left=""108"" width=""353"" height=""16"" font=""0"">Patagonia region. 9 CFR 94 reads, in relevant part: </text>
</p><p number=""94.1"" style=""8""><text top=""598"" left=""151"" width=""604"" height=""16"" font=""0"">94.1 Regions where rinderpest or foot-and-mouth disease exists; importations </text>
<text top=""615"" left=""193"" width=""73"" height=""16"" font=""0"">prohibited.</text>
</p><p number=""(a)"" style=""3""><text top=""649"" left=""151"" width=""598"" height=""16"" font=""0"">(a)   APHIS considers rinderpest or foot-and-mouth disease to exist in all regions of </text>
<text top=""665"" left=""193"" width=""550"" height=""16"" font=""0"">the world except those declared free of one or both of these diseases by APHIS. </text>
</p><p number=""(1)"" style=""4""><text top=""700"" left=""235"" width=""514"" height=""16"" font=""0"">(1)   A list of regions that APHIS has declared free of &#8230; foot and mouth </text>
<text top=""716"" left=""278"" width=""485"" height=""16"" font=""0"">disease are maintained on the APHIS Web site at: </text>
<text top=""733"" left=""278"" width=""458"" height=""16"" font=""0"">http://www.aphis.usda.gov/import_export/animals/animal_disease</text>
<text top=""749"" left=""278"" width=""118"" height=""16"" font=""0"">_status.shtml. &#8230; </text>
</p><p number=""(2)"" style=""4""><text top=""783"" left=""236"" width=""513"" height=""16"" font=""0"">(2)   APHIS will add a region to the list of those it has declared free of </text>
<text top=""800"" left=""278"" width=""471"" height=""16"" font=""0"">rinderpest or foot-and-mouth disease, or both after it conducts an </text>
<text top=""816"" left=""278"" width=""469"" height=""16"" font=""0"">evaluation of the region in accordance with &#167;92.2 and finds that the </text>
<text top=""833"" left=""278"" width=""474"" height=""16"" font=""0"">disease, or diseases, are not present. In the case of a region </text>
<text top=""849"" left=""278"" width=""470"" height=""16"" font=""0"">formerly on this list that is removed due to an outbreak, the region </text>
<text top=""865"" left=""278"" width=""471"" height=""16"" font=""0"">may be returned to the list in accordance with the procedures for </text>
<text top=""882"" left=""278"" width=""472"" height=""16"" font=""0"">reestablishment of a region's disease-free status in &#167;92.4 of this </text>
<text top=""898"" left=""278"" width=""470"" height=""16"" font=""0"">subchapter. APHIS will remove a region from the list of those it has </text>
<text top=""915"" left=""278"" width=""478"" height=""16"" font=""0"">declared free of rinderpest or foot-and-mouth disease upon </text>
<text top=""931"" left=""278"" width=""471"" height=""16"" font=""0"">determining that the disease exists in the region based on reports </text>
<text top=""947"" left=""278"" width=""470"" height=""16"" font=""0"">APHIS receives of outbreaks of the disease from veterinary officials </text>
<text top=""964"" left=""278"" width=""472"" height=""16"" font=""0"">of the exporting country, from the World Organization for Animal </text>
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 26 - </text>
</p><p><text top=""128"" left=""278"" width=""471"" height=""16"" font=""0"">Health (OIE), or from other sources the Administrator determines </text>
<text top=""144"" left=""278"" width=""94"" height=""16"" font=""0"">to be reliable.</text>
<footnote top=""143"" left=""372"" width=""11"" height=""11"" font=""16"" number=""23"" ref="""" dis=""""><ftext top=""701"" left=""160"" width=""601"" height=""15"" font=""10""> The Panel notes that the measure cited is the version of 9 CFR 94 that was in force on the date of </ftext>
<ftext top=""716"" left=""108"" width=""638"" height=""15"" font=""10"">establishment of the Panel (28 January 2013). 9 CFR 94.1(a) was slightly different at the time Argentina </ftext>
<ftext top=""730"" left=""108"" width=""330"" height=""15"" font=""10"">applied for authorization to import. It read as follows: </ftext>
<ftext top=""759"" left=""151"" width=""556"" height=""15"" font=""10"">94.1  Regions where rinderpest or foot-and-mouth disease exists; importations prohibited.</ftext>
<ftext top=""788"" left=""193"" width=""27"" height=""15"" font=""10"">(a)  </ftext>
<ftext top=""788"" left=""235"" width=""489"" height=""15"" font=""10"">Notice is hereby given that, in accordance with the Animal Health Protection Act </ftext>
<ftext top=""803"" left=""235"" width=""508"" height=""15"" font=""10"">(7 USC 8301 et seq.), it has been determined, and official notice has been given to </ftext>
<ftext top=""818"" left=""235"" width=""217"" height=""15"" font=""10"">the Secretary of the Treasury that: </ftext>
</footnote>
</p></p></page>
<page number=""26"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""(b)"" style=""3""><text top=""178"" left=""193"" width=""555"" height=""16"" font=""0"">(b)   The importation of any ruminant or swine or any fresh (chilled or frozen) </text>
<text top=""195"" left=""235"" width=""518"" height=""16"" font=""0"">meat of any ruminant or swine that originates in any region where </text>
<text top=""211"" left=""235"" width=""525"" height=""16"" font=""0"">rinderpest or foot-and-mouth disease exists, as designated in </text>
<text top=""228"" left=""235"" width=""513"" height=""16"" font=""0"">paragraph (a) of this section, or that enters a port in or otherwise transits </text>
<text top=""244"" left=""235"" width=""520"" height=""16"" font=""0"">a region in which rinderpest or foot-and-mouth disease exists, is </text>
<text top=""260"" left=""235"" width=""233"" height=""16"" font=""0"">prohibited &#8230; . (underlining added)</text>
</p><p number=""94.2"" style=""8""><text top=""295"" left=""151"" width=""597"" height=""16"" font=""0"">94.2  Fresh (chilled or frozen) products (other than meat), and milk and milk products </text>
<text top=""311"" left=""151"" width=""169"" height=""16"" font=""0"">of ruminants and swine. </text>
</p><p number=""(a)"" style=""3""><text top=""346"" left=""193"" width=""25"" height=""16"" font=""0"">(a)<b> </b></text>
<text top=""346"" left=""235"" width=""513"" height=""16"" font=""0"">The importation of fresh (chilled or frozen) products (other than meat and </text>
<text top=""362"" left=""235"" width=""514"" height=""16"" font=""0"">milk and milk products) derived from ruminants or swine, originating in, </text>
<text top=""378"" left=""235"" width=""513"" height=""16"" font=""0"">shipped from, or transiting any region designated in &#167;94.1(a) as a region </text>
<text top=""395"" left=""235"" width=""515"" height=""16"" font=""0"">infected with rinderpest or foot-and-mouth disease is prohibited, except </text>
<text top=""411"" left=""235"" width=""396"" height=""16"" font=""0"">as provided in &#167;94.3 and parts 95 and 96 of this chapter. </text>
</p><p number=""(b)"" style=""3""><text top=""446"" left=""193"" width=""560"" height=""16"" font=""0"">(b)<b>  </b>The importation of milk and milk products of ruminants and swine </text>
<text top=""462"" left=""235"" width=""519"" height=""16"" font=""0"">originating in, shipped from, or transiting any region designated in </text>
<text top=""479"" left=""235"" width=""513"" height=""16"" font=""0"">&#167;94.1(a) as a region infected with rinderpest or foot-and-mouth disease is </text>
<text top=""495"" left=""235"" width=""286"" height=""16"" font=""0"">prohibited, except as provided in &#167;94.16. </text>
</p><p number=""2.7"" style=""8""><text top=""529"" left=""108"" width=""684"" height=""16"" font=""0"">2.7.  As the language above indicates, the Animal and Plant Health Inspection Service (APHIS) </text>
<text top=""546"" left=""108"" width=""685"" height=""16"" font=""0"">maintains a list of regions that it has declared free of FMD. Imports into the United States of </text>
<text top=""562"" left=""108"" width=""683"" height=""16"" font=""0"">FMD-susceptible animals and animal products from regions not included in the list are prohibited. </text>
<text top=""579"" left=""108"" width=""687"" height=""16"" font=""0"">Nevertheless, specific products originating in certain regions that do not appear on the list </text>
<text top=""595"" left=""108"" width=""683"" height=""16"" font=""0"">(i.e. regions that APHIS has not declared to be free from FMD) may be eligible for import into the </text>
<text top=""611"" left=""108"" width=""684"" height=""16"" font=""0"">United States' territory provided that they comply with sanitary protocols agreed to with APHIS </text>
<text top=""628"" left=""108"" width=""683"" height=""16"" font=""0"">and set forth in other sections of 9 CFR 94. Argentine fresh (chilled or frozen) beef was imported </text>
<text top=""644"" left=""108"" width=""683"" height=""16"" font=""0"">pursuant to such a provision (former 9 CFR 94.21) between 1997 and 2001. In 2001, in response </text>
<text top=""661"" left=""108"" width=""685"" height=""16"" font=""0"">to FMD outbreaks in Argentina, 9 CFR 94.21 was repealed and Argentine products were made </text>
</p><p number=""(1)"" style=""4""><text top=""847"" left=""236"" width=""27"" height=""15"" font=""10"">(1)  </text>
<footnote top=""861"" left=""278"" width=""391"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""><ftext top=""891"" left=""278"" width=""443"" height=""15"" font=""10"">The following regions are declared to be free of both rinderpest and foot-</ftext>
<ftext top=""905"" left=""278"" width=""450"" height=""15"" font=""10"">and-mouth disease: Australia, Austria, The Bahamas, Barbados, Belgium, </ftext>
<ftext top=""920"" left=""278"" width=""452"" height=""15"" font=""10"">Bermuda, the Brazilian State of Santa Catarina, British Honduras (Belize), </ftext>
<ftext top=""934"" left=""278"" width=""431"" height=""15"" font=""10"">Canada, Channel Islands, Chile, Costa Rica, Czech Republic, Denmark, </ftext>
<ftext top=""949"" left=""278"" width=""447"" height=""15"" font=""10"">Dominican Republic, El Salvador, Estonia, Fiji, Finland, France, Germany, </ftext>
<ftext top=""963"" left=""278"" width=""461"" height=""15"" font=""10"">Greece, Greenland, Guatemala, Haiti, Honduras, Hungary, Iceland, Ireland, </ftext>
<ftext top=""978"" left=""278"" width=""423"" height=""15"" font=""10"">Italy, Jamaica, Latvia, Liechtenstein, Lithuania, Luxembourg, Mexico, </ftext>
<ftext top=""993"" left=""278"" width=""452"" height=""15"" font=""10"">Namibia (excluding the region north of the Veterinary Cordon Fence), The </ftext>
<ftext top=""1007"" left=""278"" width=""445"" height=""15"" font=""10"">Netherlands, New Caledonia, New Zealand, Nicaragua, Norway, Panama, </ftext>
<ftext top=""1022"" left=""278"" width=""431"" height=""15"" font=""10"">Papua New Guinea, Poland, Portugal, Spain, Territory of St. Pierre and </ftext>
<ftext top=""1036"" left=""278"" width=""461"" height=""15"" font=""10"">Miquelon, Sweden, Switzerland, Trinidad and Tobago, Trust Territory of the </ftext>
<ftext top=""1051"" left=""278"" width=""249"" height=""15"" font=""10"">Pacific Islands, and the United Kingdom. </ftext>
</footnote>
</p><p number=""(3)"" style=""4""><text top=""1080"" left=""236"" width=""27"" height=""15"" font=""10"">(3)  </text>
</p></page>
<page number=""27"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 27 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">subject to the prohibitions under 9 CFR 94.1(b). At the time of the Panel's establishment, only </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">Uruguay was listed under this category, and was permitted to export fresh (chilled or frozen) beef </text>
<text top=""160"" left=""108"" width=""455"" height=""16"" font=""0"">to the United States under the protocols contained in 9 CFR 94.22.</text>
<footnote top=""159"" left=""563"" width=""11"" height=""11"" font=""16"" number=""24"" ref="""" dis=""""><ftext top=""963"" left=""160"" width=""323"" height=""15"" font=""10""> 9 CFR 94.1(b)(4) (2013 Version), (Exhibit ARG-64). </ftext>
</footnote>
</p><p number=""2.8"" style=""8""><text top=""195"" left=""108"" width=""685"" height=""16"" font=""0"">2.8.  As discussed below, Argentina also challenges the Interim and Final Rules that repealed </text>
<text top=""211"" left=""108"" width=""688"" height=""16"" font=""0"">9 CFR 94.21 and had the effect of making imports from Argentina subject to the general </text>
<text top=""228"" left=""108"" width=""200"" height=""16"" font=""0"">prohibition in 9 CFR 94.1(b). </text>
</p><p number=""2.2"" style=""8""><text top=""262"" left=""108"" width=""501"" height=""16"" font=""28"">2.2.1.2  APHIS' 2001 Interim and Final Rules amending 9 CFR 94  </text></p><p number=""2.9"" style=""8""><text top=""296"" left=""108"" width=""41"" height=""16"" font=""0"">2.9. </text>
<text top=""296"" left=""145"" width=""290"" height=""16"" font=""0"">Argentina experienced multiple FMD </text>
<text top=""296"" left=""424"" width=""154"" height=""16"" font=""0"">outbreaks between </text>
<text top=""296"" left=""568"" width=""41"" height=""16"" font=""0"">July </text>
<text top=""296"" left=""600"" width=""156"" height=""16"" font=""0"">2000 and January </text>
<text top=""296"" left=""746"" width=""54"" height=""16"" font=""0"">2002. </text>
<text top=""313"" left=""108"" width=""690"" height=""16"" font=""0"">In March 2001 Argentina suspended its exports of fresh (chilled or frozen) beef to the </text>
<text top=""329"" left=""108"" width=""683"" height=""16"" font=""0"">United States. Subsequently, APHIS issued: (a) an Interim Rule published in the Federal Register </text>
<text top=""346"" left=""108"" width=""107"" height=""16"" font=""0"">on 4 June 2001</text>
<footnote top=""344"" left=""215"" width=""11"" height=""11"" font=""16"" number=""25"" ref="""" dis=""""><ftext top=""978"" left=""160"" width=""615"" height=""15"" font=""10""> <i>Prohibition of Beef from Argentina</i>, 66 Fed. Reg. 29897 (4 June 2001) (Interim Rule), (2001 Interim </ftext>
</footnote>
<text top=""346"" left=""226"" width=""547"" height=""16"" font=""0""> and (b) a Final Rule published in the Federal Register on 11 December 2001.</text>
<footnote top=""344"" left=""773"" width=""11"" height=""11"" font=""16"" number=""26"" ref="""" dis=""""><ftext top=""1007"" left=""160"" width=""624"" height=""15"" font=""10""> <i>Prohibition of Beef from Argentina</i>, 66 Fed. Reg. 63911 (11 December 2001) (Final Rule), (2001 Final </ftext>
</footnote>
<text top=""362"" left=""108"" width=""684"" height=""16"" font=""0"">The Panel refers to these Rules collectively as the ""2001 Regulations"". The effect of the Interim </text>
<text top=""378"" left=""108"" width=""685"" height=""16"" font=""0"">Rule was to amend 9 CFR 94 to prohibit the importation of fresh (chilled or frozen) beef from </text>
<text top=""395"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina by removing 9 CFR 94.21 (which, as noted above, had allowed such importation). This </text>
<text top=""411"" left=""108"" width=""683"" height=""16"" font=""0"">amendment was maintained without change in the Final Rule. Thus, as a result of the adoption of </text>
<text top=""428"" left=""108"" width=""682"" height=""16"" font=""0"">the 2001 Regulations, the prohibitions under 9 CFR 94.1(b), which had applied prior to 1997, once </text>
<text top=""444"" left=""108"" width=""613"" height=""16"" font=""0"">again became applicable to FMD-susceptible animals and animal products from Argentina.</text>
<footnote top=""443"" left=""721"" width=""11"" height=""11"" font=""16"" number=""27"" ref="""" dis=""""><ftext top=""1036"" left=""160"" width=""135"" height=""15"" font=""10""> See para. 2.7 above. </ftext>
</footnote>
</p><p number=""2.10"" style=""8""><text top=""479"" left=""108"" width=""685"" height=""16"" font=""0"">2.10.  From 2001 until the date of the establishment of the Panel, APHIS had not issued any </text>
<text top=""495"" left=""108"" width=""685"" height=""16"" font=""0"">further regulations affecting the legal status of imports of fresh (chilled or frozen) beef from </text>
<text top=""511"" left=""108"" width=""603"" height=""16"" font=""0"">Argentina, or on animals, meat and other animal products from the Patagonia region.</text>
<footnote top=""510"" left=""711"" width=""11"" height=""11"" font=""16"" number=""28"" ref="""" dis=""""/>
<text top=""511"" left=""722"" width=""69"" height=""16"" font=""0""> In other </text>
<text top=""528"" left=""108"" width=""685"" height=""16"" font=""0"">words, the version of the CFR in force on the date of establishment of the Panel reflects the </text>
<text top=""544"" left=""108"" width=""384"" height=""16"" font=""0"">amendments made as a result of the 2001 Regulations. </text>
</p><p number=""2.2"" style=""8""><text top=""579"" left=""108"" width=""684"" height=""16"" font=""28"">2.2.2  The United States' alleged undue delay in the application of the procedures set </text><text top=""595"" left=""108"" width=""683"" height=""16"" font=""28"">forth in 9 CFR 92.2 to Argentina's requests for imports of fresh (chilled or frozen) beef </text><text top=""611"" left=""108"" width=""577"" height=""16"" font=""28"">from Northern Argentina and for recognition of Patagonia as free from FMD </text></p><p number=""2.11"" style=""8""><text top=""646"" left=""108"" width=""683"" height=""16"" font=""0"">2.11.  APHIS' approval procedures, detailed in 9 CFR 92.2, entitled ""Requests for recognition of a </text>
<text top=""662"" left=""108"" width=""683"" height=""16"" font=""0"">region or for approval to export animals or animal products<b> </b>&#8230;"", set forth the terms under which a </text>
<text top=""679"" left=""108"" width=""683"" height=""16"" font=""0"">region or country can be recognized as FMD-free or an authorization to import of FMD-susceptible </text>
<text top=""695"" left=""108"" width=""683"" height=""16"" font=""0"">animal products can be obtained. The procedure in 9 CFR 92.2 is the only procedure that permits </text>
<text top=""711"" left=""108"" width=""685"" height=""16"" font=""0"">an applicant to obtain import approval for FMD purposes, whether for a region recognized by </text>
<text top=""728"" left=""108"" width=""560"" height=""16"" font=""0"">APHIS as FMD-free or for a single commodity (i.e. beef) from a country or region.</text>
<footnote top=""726"" left=""668"" width=""11"" height=""11"" font=""16"" number=""29"" ref="""" dis=""""><ftext top=""1080"" left=""160"" width=""616"" height=""15"" font=""10""> These regulations were amended effective August 27, 2012. (See <i>Information From Foreign Regions </i></ftext>
<ftext top=""1095"" left=""108"" width=""674"" height=""15"" font=""12""><i>Applying for Recognition of Animal Health Status: Final Rule</i>, 77 Fed. Reg. 44107 (USDA/APHIS, 27 July 2012) </ftext>
</footnote>
<text top=""728"" left=""679"" width=""111"" height=""16"" font=""0""> This procedure </text>
<text top=""744"" left=""108"" width=""683"" height=""16"" font=""0"">begins when a country submits an application to APHIS for recognition of its entire territory, or a </text>
<text top=""761"" left=""108"" width=""684"" height=""16"" font=""0"">region thereof, as an FMD-free zone (""regionalization request""). 9 CFR 92.1 defines ""region"" as </text>
<text top=""777"" left=""108"" width=""683"" height=""16"" font=""0"">""[a]ny defined geographic land region identifiable by geological, political or surveyed boundaries"". </text>
<text top=""793"" left=""108"" width=""683"" height=""16"" font=""0"">As such, a region for the purposes of APHIS' approval procedures may consist of: (a) a ""national </text>
<text top=""810"" left=""108"" width=""683"" height=""16"" font=""0"">entity (country)""; (b) ""[p]art of a national entity (zone, county, department, municipality, parish, </text>
<text top=""826"" left=""108"" width=""684"" height=""16"" font=""0"">Province, State, etc.)""; (c) ""[p]arts of several national entities combined into an area""; or (d) a </text>
<text top=""843"" left=""108"" width=""459"" height=""16"" font=""0"">""group of national entities (countries) combined into a single area"".</text>
<footnote top=""841"" left=""567"" width=""11"" height=""11"" font=""16"" number=""30"" ref="""" dis=""""><ftext top=""1124"" left=""160"" width=""186"" height=""15"" font=""10""> 9 CFR 92.1 (Exhibit USA-72). </ftext>
<ftext top=""993"" left=""108"" width=""680"" height=""15"" font=""10"">evaluate Argentina's requests in light of the pre-2012 version of 9 CFR 92.2. Indeed, the 2014 risk analyses for </ftext>
<ftext top=""1007"" left=""108"" width=""626"" height=""15"" font=""10"">Northern Argentina and Patagonia both refer to the 11-factor list rather than the new 8-factor list. See </ftext>
<ftext top=""1022"" left=""108"" width=""655"" height=""15"" font=""10"">USDA/APHIS, <i>Risk Analysis: Risk of Importing Foot-and-Mouth Disease in Susceptible Species and Products </i></ftext>
<ftext top=""1051"" left=""108"" width=""673"" height=""15"" font=""10"">(Exhibit USA-133), p. 9; APHIS, Veterinary Services, National Import Export Services, <i>Risk Analysis: Foot-and-</i></ftext>
</footnote>
</p><p number=""2.12"" style=""8""><text top=""877"" left=""108"" width=""687"" height=""16"" font=""0"">2.12.  The application process requires the applicant country to provide information on the </text>
<text top=""893"" left=""108"" width=""176"" height=""16"" font=""0"">following eleven factors:  </text>
<p><text top=""1051"" left=""160"" width=""586"" height=""15"" font=""10""> As will be discussed further in section 7 below, APHIS did issue a Proposed Rule with respect to </text>
<text top=""1066"" left=""108"" width=""296"" height=""15"" font=""10"">Patagonia in 2007, but this was never finalized.  </text>
</p><p><text top=""1109"" left=""108"" width=""191"" height=""15"" font=""10"">(Final Rule), (Exhibit ARG-16)) </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 28 - </text>
</p></p></page>
<page number=""28"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""(1)"" style=""4""><text top=""128"" left=""151"" width=""605"" height=""16"" font=""0"">(1) The authority, organization, and infrastructure of the veterinary services </text>
<text top=""144"" left=""151"" width=""190"" height=""16"" font=""0"">organization in the region;  </text>
</p><p number=""(2)"" style=""4""><text top=""178"" left=""151"" width=""597"" height=""16"" font=""0"">(2) Disease status&#8212;i.e., is the restricted disease agent known to exist in the region? If </text>
<text top=""195"" left=""151"" width=""505"" height=""16"" font=""0"">""yes,"" at what prevalence? If ""no,"" when was the most recent diagnosis?  </text>
</p><p number=""(3)"" style=""4""><text top=""229"" left=""151"" width=""423"" height=""16"" font=""0"">(3) The status of adjacent regions with respect to the agent;  </text>
</p><p number=""(4)"" style=""4""><text top=""264"" left=""151"" width=""598"" height=""16"" font=""0"">(4) The extent of an active disease control program, if any, if the agent is known to </text>
<text top=""280"" left=""151"" width=""139"" height=""16"" font=""0"">exist in the region;  </text>
</p><p number=""(5)"" style=""4""><text top=""314"" left=""151"" width=""598"" height=""16"" font=""0"">(5) The vaccination status of the region. When was the last vaccination? What is the </text>
<text top=""331"" left=""151"" width=""525"" height=""16"" font=""0"">extent of vaccination if it is currently used, and what vaccine is being used?  </text>
</p><p number=""(6)"" style=""4""><text top=""365"" left=""151"" width=""598"" height=""16"" font=""0"">(6) The degree to which the region is separated from regions of higher risk through </text>
<text top=""382"" left=""151"" width=""187"" height=""16"" font=""0"">physical or other barriers;  </text>
</p><p number=""(7)"" style=""4""><text top=""416"" left=""151"" width=""598"" height=""16"" font=""0"">(7) The extent to which movement of animals and animal products is controlled from </text>
<text top=""432"" left=""151"" width=""544"" height=""16"" font=""0"">regions of higher risk, and the level of biosecurity regarding such movements;  </text>
</p><p number=""(8)"" style=""4""><text top=""467"" left=""151"" width=""464"" height=""16"" font=""0"">(8) Livestock demographics and marketing practices in the region;  </text>
</p><p number=""(9)"" style=""4""><text top=""501"" left=""151"" width=""597"" height=""16"" font=""0"">(9) The type and extent of disease surveillance in the region&#8212;e.g., is it passive and/or </text>
<text top=""518"" left=""151"" width=""448"" height=""16"" font=""0"">active; what is the quantity and quality of sampling and testing?  </text>
</p><p number=""(10)"" style=""4""><text top=""552"" left=""151"" width=""275"" height=""16"" font=""0"">(10) Diagnostic laboratory capabilities;  </text>
</p><p number=""(11)"" style=""4""><text top=""587"" left=""151"" width=""604"" height=""16"" font=""0"">(11) Policies and infrastructure for animal disease control in the region&#8212;i.e., </text>
<text top=""603"" left=""151"" width=""206"" height=""16"" font=""0"">emergency response capacity.</text>
<footnote top=""601"" left=""357"" width=""11"" height=""11"" font=""16"" number=""31"" ref="""" dis=""""><ftext top=""934"" left=""160"" width=""610"" height=""15"" font=""10""> See 9 CFR 92.2 (2002 version), (Exhibit ARG-118). We refer here to the version of 9 CFR 92.2 that </ftext>
<ftext top=""949"" left=""108"" width=""649"" height=""15"" font=""10"">was in force at the time of the filing of Argentina's requests for authorization of imports of fresh (chilled or </ftext>
<ftext top=""963"" left=""108"" width=""679"" height=""15"" font=""10"">frozen) beef and for the recognition of Patagonia as FMD-free. As a result of a 2012 amendment to 9 CFR 92.2, </ftext>
</footnote>
</p><p number=""2.13"" style=""8""><text top=""637"" left=""108"" width=""686"" height=""16"" font=""0"">2.13.  After an application is filed, APHIS evaluates the likelihood of entry, establishment, or </text>
<text top=""654"" left=""108"" width=""683"" height=""16"" font=""0"">spread of the disease. As part of the evaluation, APHIS requests the applicant country to provide </text>
<text top=""670"" left=""108"" width=""682"" height=""16"" font=""0"">detailed scientific information as necessary, and typically conducts one or more visits to the region </text>
<text top=""687"" left=""108"" width=""684"" height=""16"" font=""0"">covered by the regionalization request. Upon completion of its evaluation, APHIS communicates </text>
<text top=""703"" left=""108"" width=""682"" height=""16"" font=""0"">the evaluation and its results to the applicant country and other potentially affected and interested </text>
<text top=""719"" left=""108"" width=""562"" height=""16"" font=""0"">parties by publishing a proposed regulatory document in the Federal Register.</text>
<footnote top=""718"" left=""670"" width=""11"" height=""11"" font=""16"" number=""32"" ref="""" dis=""""><ftext top=""1109"" left=""160"" width=""236"" height=""15"" font=""10""> See 9 CFR 92.2(e), (Exhibit ARG-69). </ftext>
</footnote>
<text top=""719"" left=""682"" width=""111"" height=""16"" font=""0""> All potentially </text>
<text top=""736"" left=""108"" width=""684"" height=""16"" font=""0"">affected and interested parties are invited to respond to and submit comments on the proposed </text>
<text top=""752"" left=""108"" width=""685"" height=""16"" font=""0"">regulatory document. After the expiration of the public comment period, APHIS collects all the </text>
<text top=""769"" left=""108"" width=""683"" height=""16"" font=""0"">comments, reviews them, and prepares responses. It reviews the proposed regulatory document </text>
<text top=""785"" left=""108"" width=""395"" height=""16"" font=""0"">in light of these comments and revises it as appropriate.  </text>
</p><p number=""2.14"" style=""8""><text top=""819"" left=""108"" width=""683"" height=""16"" font=""0"">2.14.  As the last step of the process, APHIS issues the final regulatory decision on regionalization </text>
<text top=""836"" left=""108"" width=""685"" height=""16"" font=""0"">in the United States' Federal Register. The final decision sets forth the conditions under which </text>
<text top=""852"" left=""108"" width=""687"" height=""16"" font=""0"">imports are authorized in order to meet the appropriate level of protection (ALOP) of the </text>
<text top=""869"" left=""108"" width=""97"" height=""16"" font=""0"">United States.</text>
<footnote top=""867"" left=""205"" width=""11"" height=""11"" font=""16"" number=""33"" ref="""" dis=""""><ftext top=""1124"" left=""160"" width=""233"" height=""15"" font=""10""> See 9 CFR 92.2(f), (Exhibit ARG-69). </ftext>
</footnote>
<text top=""869"" left=""216"" width=""577"" height=""16"" font=""0""> The country or region thereof that is recognized as an FMD-free zone is then </text>
<text top=""885"" left=""108"" width=""685"" height=""16"" font=""0"">added to the list of regions that are considered free of FMD under 9 CFR 94.1(a)(1) and thus </text>
<text top=""901"" left=""108"" width=""684"" height=""16"" font=""0"">authorized to import. Certain regions listed in 94.1(a)(1) are nevertheless subject to additional </text>
<p><text top=""978"" left=""108"" width=""647"" height=""15"" font=""10"">the 11 factors were consolidated into eight. However, we note that APHIS itself considers it appropriate to </text>
</p><p><text top=""1036"" left=""108"" width=""604"" height=""15"" font=""12""><i>from a region of Patagonia, Argentina</i> (updated January 2014), (2014 Risk Analysis for Patagonia), </text>
</p><p><text top=""1066"" left=""108"" width=""640"" height=""15"" font=""31"">Mouth Disease Risk from Importation of Fresh (Chilled or Frozen), Matured, Deboned Beef from Northern </text></p><p><text top=""1080"" left=""108"" width=""673"" height=""15"" font=""12""><i>Argentina into the United States </i>(April 2014), (2014 Risk Analysis for Northern Argentina), (Exhibit USA-169), </text>
<text top=""1095"" left=""108"" width=""32"" height=""15"" font=""10"">p. 9. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 29 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">protocols set forth in 94.11 if they either (1) supplement their national meat supply through the </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">importation of fresh, chilled or frozen meat of ruminants or swine from countries/regions that are </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">not designated as free of FMD; or (2) they have a common land border with countries/regions that </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">are not designated as free of FMD; or (3) they import ruminants or swine from countries/regions </text>
<text top=""193"" left=""108"" width=""268"" height=""16"" font=""0"">that are not designated as free of FMD.</text>
<footnote top=""192"" left=""376"" width=""11"" height=""11"" font=""16"" number=""34"" ref="""" dis=""""><ftext top=""818"" left=""160"" width=""262"" height=""15"" font=""10""> See 9 CFR 94.11(a)(2), (Exhibit ARG-64). </ftext>
</footnote>
</p></p></page>
<page number=""29"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""2.15"" style=""8""><text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">2.15.  APHIS' approval procedures also contemplate that regions not included in APHIS' list are </text>
<text top=""244"" left=""108"" width=""666"" height=""16"" font=""0"">nevertheless entitled to apply for the right to import a particular product into the United States.</text>
<footnote top=""243"" left=""773"" width=""11"" height=""11"" font=""16"" number=""35"" ref="""" dis=""""><ftext top=""832"" left=""160"" width=""619"" height=""15"" font=""10""> See para. 2.7 above. We note that under APHIS' terminology the definition of a ""region"" includes the </ftext>
<ftext top=""847"" left=""108"" width=""175"" height=""15"" font=""10"">entire territory of a country. </ftext>
</footnote>
<text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">Until 27 August 2012, the application, evaluation, and approval process for the right to import a </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">particular product into the United States was, <i>mutatis mutandis</i>, the same as that set forth for </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">regionalization requests and described in paragraphs 2.11-2.14 above. However, APHIS amended </text>
<text top=""310"" left=""108"" width=""685"" height=""16"" font=""0"">its regulations on 27 August 2012 so as to limit the scope of its application, evaluation, and </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">approval process to regionalization requests, and removed references to requests for approval of </text>
<text top=""342"" left=""108"" width=""541"" height=""16"" font=""0"">imports of a particular type of animal or animal product into the United States.</text>
<footnote top=""341"" left=""649"" width=""11"" height=""11"" font=""16"" number=""36"" ref="""" dis=""""><ftext top=""861"" left=""160"" width=""467"" height=""15"" font=""10""> See e.g. Argentina's first written submission, paras. 83, 607, 647, and 681. </ftext>
</footnote>
<text top=""342"" left=""660"" width=""130"" height=""16"" font=""0""> In its first written </text>
<text top=""359"" left=""108"" width=""687"" height=""16"" font=""0"">submission, the United States asserted that the changes to the regulations do not prevent </text>
<text top=""375"" left=""108"" width=""683"" height=""16"" font=""0"">product-specific requests and that ""APHIS continues to work on and accept applications to permit </text>
<text top=""392"" left=""108"" width=""182"" height=""16"" font=""0"">product-specific requests"".</text>
<footnote top=""390"" left=""290"" width=""11"" height=""11"" font=""16"" number=""37"" ref="""" dis=""""><ftext top=""876"" left=""160"" width=""408"" height=""15"" font=""10""> United States' first written submission, footnote 208 to para. 125. </ftext>
</footnote>
</p><p number=""2.16"" style=""8""><text top=""426"" left=""108"" width=""666"" height=""16"" font=""0"">2.16.  Argentina does not challenge APHIS' approval procedures under 9 CFR 92.2 as such.</text>
<footnote top=""425"" left=""773"" width=""11"" height=""11"" font=""16"" number=""38"" ref="""" dis=""""/>
<text top=""443"" left=""108"" width=""683"" height=""16"" font=""0"">Rather, Argentina takes issue with the alleged undue delay in the application of APHIS' approval </text>
<text top=""459"" left=""108"" width=""686"" height=""16"" font=""0"">procedures to its requests for authorization of imports of fresh (chilled or frozen) beef from </text>
<text top=""475"" left=""108"" width=""684"" height=""16"" font=""0"">Northern Argentina and for recognition of Patagonia as FMD-free. Argentina filed its request to </text>
<text top=""492"" left=""108"" width=""385"" height=""16"" font=""0"">import fresh (chilled or frozen) beef in November 2002.</text>
<footnote top=""490"" left=""493"" width=""11"" height=""11"" font=""16"" number=""39"" ref="""" dis=""""><ftext top=""905"" left=""160"" width=""578"" height=""15"" font=""10""> Information Provided by SENASA to Attain Recognition of Argentina as a Region, as defined in </ftext>
<ftext top=""920"" left=""108"" width=""671"" height=""15"" font=""10"">Section 92.2, Title 9, of the Code of Federal Regulations for Foot and Mouth Disease (FMD) (November 2002), </ftext>
<ftext top=""934"" left=""108"" width=""442"" height=""15"" font=""10"">(Information Provided by SENASA (November 2002)), (Exhibit USA-32). </ftext>
</footnote>
<text top=""492"" left=""505"" width=""286"" height=""16"" font=""0""> It filed its request for the recognition of </text>
<text top=""508"" left=""108"" width=""683"" height=""16"" font=""0"">the portion of Patagonia located south of the 42nd parallel (Patagonia South) as FMD-free within </text>
<text top=""525"" left=""108"" width=""338"" height=""16"" font=""0"">the meaning of 9 CFR 94.1(a) in August 2003.</text>
<footnote top=""523"" left=""446"" width=""11"" height=""11"" font=""16"" number=""40"" ref="""" dis=""""><ftext top=""949"" left=""160"" width=""580"" height=""15"" font=""10""> Information Provided by SENASA to Attain Recognition of Patagonia as a Region, as Defined in </ftext>
<ftext top=""963"" left=""108"" width=""628"" height=""15"" font=""10"">Section 92.2, Title 9 of the Code of Federal Regulations for Foot and Mouth Disease (FMD) (July 2003), </ftext>
<ftext top=""978"" left=""108"" width=""403"" height=""15"" font=""10"">(Information Provided by SENASA (July 2003)), (Exhibit USA-98). </ftext>
</footnote>
<text top=""525"" left=""457"" width=""338"" height=""16"" font=""0""> In December 2008, Argentina extended its </text>
<text top=""541"" left=""108"" width=""683"" height=""16"" font=""0"">request for the recognition of Patagonia as FMD-free to the portion of Patagonia located between </text>
<text top=""557"" left=""108"" width=""396"" height=""16"" font=""0"">the 42nd parallel and the Rio Negro (Patagonia North B).</text>
<footnote top=""556"" left=""504"" width=""11"" height=""11"" font=""16"" number=""41"" ref="""" dis=""""><ftext top=""993"" left=""160"" width=""605"" height=""15"" font=""10""> See Letter from Oscar Astibia, Coordinator of International and Institutional Relations, SENASA, to </ftext>
<ftext top=""1007"" left=""108"" width=""639"" height=""15"" font=""10"">Yvette P&#233;rez, USDA/APHIS, Buenos Aires, CRI No. 7103/08 (17 December 2008), (SENASA's letter of 17 </ftext>
<ftext top=""1022"" left=""108"" width=""641"" height=""15"" font=""10"">December 2008), (Exhibit ARG-59/USA-111); Letter from Oscar Astibia, Coordinator of International and </ftext>
<ftext top=""1036"" left=""108"" width=""596"" height=""15"" font=""10"">Institutional Relations, SENASA, to Yvette P&#233;rez, USDA/APHIS, Buenos Aires, URI No. 460/09 (30 </ftext>
<ftext top=""1051"" left=""108"" width=""503"" height=""15"" font=""10"">January 2009), (SENASA's letter of 30 January 2009), (Exhibit ARG-60/USA-112). </ftext>
</footnote>
<text top=""557"" left=""515"" width=""275"" height=""16"" font=""0""> As of the date of the establishment of </text>
<text top=""574"" left=""108"" width=""687"" height=""16"" font=""0"">the Panel (28 January 2013), APHIS had not issued a Proposed or Final Rule or Notice of </text>
<text top=""590"" left=""108"" width=""292"" height=""16"" font=""0"">Determination in either approval process.  </text>
</p><p number=""2.17"" style=""8""><text top=""625"" left=""108"" width=""683"" height=""16"" font=""0"">2.17.  A chronology of the events relating to the sanitary situation for FMD in Argentina as well as </text>
<text top=""641"" left=""108"" width=""647"" height=""16"" font=""0"">the evaluation of that situation by the OIE and APHIS is attached as Appendix 1 to this Report.</text>
<footnote top=""639"" left=""754"" width=""11"" height=""11"" font=""16"" number=""42"" ref="""" dis=""""><ftext top=""1066"" left=""160"" width=""558"" height=""15"" font=""10""> The Panel drafted the chronology based on the submissions of the parties. Prior to the first </ftext>
<ftext top=""1080"" left=""108"" width=""673"" height=""15"" font=""10"">substantive meeting, the Panel circulated a draft version of the chronology, and asked the parties to comment </ftext>
<ftext top=""1095"" left=""108"" width=""656"" height=""15"" font=""10"">on the document and provide supplemental information where relevant. The Panel incorporated the parties' </ftext>
<ftext top=""1109"" left=""108"" width=""654"" height=""15"" font=""10"">comments into a revised version of the chronology and asked the parties to provide any further comments. </ftext>
</footnote>
</p><p number=""2.2"" style=""8""><text top=""675"" left=""108"" width=""467"" height=""16"" font=""28"">2.2.2.1  Section 737 of the 2009 Omnibus Appropriations Act </text></p><p number=""2.18"" style=""8""><text top=""710"" left=""108"" width=""685"" height=""16"" font=""0"">2.18.  As part of its arguments concerning alleged undue delays in APHIS' approval processes </text>
<text top=""726"" left=""108"" width=""686"" height=""16"" font=""0"">described in paragraphs 2.11-2.16 above, Argentina also takes issue with Section 737 of the </text>
<p><text top=""891"" left=""160"" width=""481"" height=""15"" font=""10""> See Argentina's opening statement at the first meeting of the Panel, para. 57. </text>
</p><p><text top=""1124"" left=""108"" width=""616"" height=""15"" font=""10"">See Panel question No. 78 following the first substantive meeting and the parties' responses thereto. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 30 - </text>
</p><p><text top=""128"" left=""108"" width=""666"" height=""16"" font=""18""><i>2009 Omnibus Appropriations Act</i> adopted by the United States' Congress on 10 March 2009.</text>
<footnote top=""126"" left=""773"" width=""11"" height=""11"" font=""16"" number=""43"" ref="""" dis=""""><ftext top=""905"" left=""160"" width=""596"" height=""15"" font=""10""> <i>Omnibus Appropriations Act</i>, 2009, Pub. L. No. 111-8, &#167;737, 123 Stat. 524, 559, (<i>2009 Omnibus </i></ftext>
<ftext top=""920"" left=""108"" width=""288"" height=""15"" font=""12""><i>Appropriations Act</i>), (Exhibit ARG-45/USA-95). </ftext>
</footnote>
<text top=""144"" left=""108"" width=""248"" height=""16"" font=""0"">Section 737 reads, in relevant part: </text>
</p><p><text top=""178"" left=""151"" width=""599"" height=""16"" font=""0"">None of the funds made available by this Act may be used to pay the salaries and </text>
<text top=""195"" left=""151"" width=""598"" height=""16"" font=""0"">expenses of any individual to conduct any activities that would allow the importation </text>
<text top=""211"" left=""151"" width=""600"" height=""16"" font=""0"">into the United States of any ruminant or swine, or any fresh (including chilled or </text>
<text top=""228"" left=""151"" width=""597"" height=""16"" font=""0"">frozen) meat or product of any ruminant or swine, that is born, raised, or slaughtered </text>
<text top=""244"" left=""151"" width=""603"" height=""16"" font=""0"">in Argentina: <i>Provided</i>, That this section shall not prevent the Secretary from </text>
<text top=""260"" left=""151"" width=""599"" height=""16"" font=""0"">conducting all necessary activities to review this proposal and issue a report on the </text>
<text top=""277"" left=""151"" width=""597"" height=""16"" font=""0"">findings to the Committees on Appropriations of the House and Senate: <i>Provided </i></text>
<text top=""293"" left=""151"" width=""598"" height=""16"" font=""18""><i>further</i>, That this section shall only have effect until the Secretary of Agriculture has </text>
<text top=""310"" left=""151"" width=""600"" height=""16"" font=""0"">reviewed the domestic animal health aspects of the pending proposal to allow the </text>
<text top=""326"" left=""151"" width=""599"" height=""16"" font=""0"">importation of such products into the United States and has issued a report to the </text>
<text top=""342"" left=""151"" width=""300"" height=""16"" font=""0"">Committees on the findings of such review. </text>
</p></p></page>
<page number=""30"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""2.3"" style=""8""><text top=""377"" left=""108"" width=""169"" height=""16"" font=""28"">2.3  Products at issue </text></p><p number=""2.19"" style=""8""><text top=""411"" left=""108"" width=""259"" height=""16"" font=""0"">2.19.  9 CFR 94  applies  to  ruminants</text>
<footnote top=""410"" left=""367"" width=""11"" height=""11"" font=""16"" number=""44"" ref="""" dis=""""><ftext top=""934"" left=""160"" width=""620"" height=""15"" font=""10""> The zoological suborder of ""ruminants"" (""<i>Ruminantia</i>"") consists of even-toed ungulate mammals that </ftext>
<ftext top=""949"" left=""108"" width=""646"" height=""15"" font=""10"">chew the cud regurgitated from their rumen. For purposes of the United States' regulations, these include </ftext>
<ftext top=""963"" left=""108"" width=""478"" height=""15"" font=""10"">""cattle, buffaloes, sheep, goats, deer, antelopes, camels, llamas and giraffes."" </ftext>
</footnote>
<text top=""411"" left=""378"" width=""91"" height=""16"" font=""0""> and ""swine""</text>
<footnote top=""410"" left=""469"" width=""11"" height=""11"" font=""16"" number=""45"" ref="""" dis=""""><ftext top=""978"" left=""160"" width=""567"" height=""15"" font=""10""> Swine refers to any of the animals in the zoological genus ""<i>Sus</i>"", including the domestic pig. </ftext>
</footnote>
<text top=""411"" left=""481"" width=""312"" height=""16"" font=""0""> and products derived from ruminants and </text>
<text top=""428"" left=""108"" width=""685"" height=""16"" font=""0"">swine such as: (i) fresh (chilled or frozen) meat; (ii) milk; (iii) milk products; and (iv) fresh </text>
<text top=""444"" left=""108"" width=""682"" height=""16"" font=""0"">(chilled or frozen) products other than meat, milk, and milk products. The product of relevance to </text>
<text top=""461"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina's claims for Northern Argentina is fresh (chilled or frozen) beef. The products relevant to </text>
<text top=""477"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina's claims for Patagonia are fresh (chilled or frozen) beef, other products of ruminants and </text>
<text top=""493"" left=""108"" width=""322"" height=""16"" font=""0"">swine, as well as the live animals themselves.  </text>
</p><p number=""2.4"" style=""8""><text top=""528"" left=""108"" width=""553"" height=""16"" font=""28"">2.4  Relevant international standards, guidelines, and recommendations </text></p><p number=""2.4"" style=""8""><text top=""562"" left=""108"" width=""240"" height=""16"" font=""28"">2.4.1  The OIE and its mandate </text></p><p number=""2.20"" style=""8""><text top=""597"" left=""108"" width=""53"" height=""16"" font=""0"">2.20. </text>
<text top=""597"" left=""153"" width=""649"" height=""16"" font=""0"">The OIE is an intergovernmental organization that was created through an </text>
<text top=""613"" left=""108"" width=""684"" height=""16"" font=""0"">international agreement signed on 25 January 1924, as a response to the need to fight animal </text>
<text top=""629"" left=""108"" width=""684"" height=""16"" font=""0"">diseases at a global level. In May 2003, the OIE changed its name from Office International des </text>
<text top=""646"" left=""108"" width=""587"" height=""16"" font=""0"">Epizooties to World Organisation for Animal Health, but kept its historical acronym.</text>
<footnote top=""644"" left=""695"" width=""11"" height=""11"" font=""16"" number=""46"" ref="""" dis=""""><ftext top=""993"" left=""160"" width=""525"" height=""15"" font=""10""> OIE website, <i>About us</i>, http://www.oie.int/about-us/ (last accessed 6 October 2014). </ftext>
</footnote>
<text top=""646"" left=""707"" width=""85"" height=""16"" font=""0""> The OIE is </text>
<text top=""662"" left=""108"" width=""332"" height=""16"" font=""0"">tasked with improving animal health worldwide.</text>
<footnote top=""661"" left=""440"" width=""11"" height=""11"" font=""16"" number=""47"" ref="""" dis=""""><ftext top=""1007"" left=""160"" width=""617"" height=""15"" font=""10""> OIE website, <i>Objectives</i>, http://www.oie.int/index.php?id=53#c201 (last accessed 6 October 2014). </ftext>
</footnote>
<text top=""662"" left=""452"" width=""339"" height=""16"" font=""0""> One of its stated objectives is ""sanitary safety"" </text>
<text top=""679"" left=""108"" width=""387"" height=""16"" font=""0"">for ""international trade in animals and animal products"".</text>
<footnote top=""677"" left=""495"" width=""11"" height=""11"" font=""16"" number=""48"" ref="""" dis=""""><ftext top=""1022"" left=""160"" width=""617"" height=""15"" font=""10""> OIE website, <i>Objectives</i>, http://www.oie.int/index.php?id=53#c201 (last accessed 6 October 2014). </ftext>
</footnote>
<text top=""679"" left=""506"" width=""284"" height=""16"" font=""0""> The OIE's activities in this field focus on </text>
<text top=""695"" left=""108"" width=""685"" height=""16"" font=""0"">rules that OIE members ""can use to protect themselves from the introduction of diseases and </text>
<text top=""711"" left=""108"" width=""408"" height=""16"" font=""0"">pathogens, without setting up unjustified sanitary barriers"".</text>
<footnote top=""710"" left=""516"" width=""11"" height=""11"" font=""16"" number=""49"" ref="""" dis=""""><ftext top=""1036"" left=""160"" width=""617"" height=""15"" font=""10""> OIE website, <i>Objectives</i>, http://www.oie.int/index.php?id=53#c201 (last accessed 6 October 2014). </ftext>
</footnote>
</p><p number=""2.21"" style=""8""><text top=""746"" left=""108"" width=""375"" height=""16"" font=""0"">2.21.  As  of October 2014,  the  OIE had  180  members</text>
<footnote top=""744"" left=""483"" width=""11"" height=""11"" font=""16"" number=""50"" ref="""" dis=""""/>
<text top=""746"" left=""495"" width=""297"" height=""16"" font=""0""> and their national delegates constitute a </text>
<text top=""762"" left=""108"" width=""210"" height=""16"" font=""0"">World Assembly of Delegates.</text>
<footnote top=""761"" left=""318"" width=""11"" height=""11"" font=""16"" number=""51"" ref="""" dis=""""><ftext top=""1080"" left=""160"" width=""600"" height=""15"" font=""10""> OIE website, <i>The World Assembly of Delegates</i>, http://www.oie.int/about-us/wo/world-assembly/ </ftext>
<ftext top=""1095"" left=""108"" width=""197"" height=""15"" font=""10"">(last accessed 6 October 2014). </ftext>
</footnote>
<text top=""762"" left=""330"" width=""463"" height=""16"" font=""0""> Both Argentina and the United States are members, as are the </text>
<text top=""779"" left=""108"" width=""677"" height=""16"" font=""0"">third parties to this dispute. In addition to its headquarters in Paris, the OIE has regional and sub-</text>
<text top=""795"" left=""108"" width=""240"" height=""16"" font=""0"">regional offices on every continent.</text>
<footnote top=""793"" left=""348"" width=""11"" height=""11"" font=""16"" number=""52"" ref="""" dis=""""><ftext top=""1109"" left=""160"" width=""546"" height=""15"" font=""10""> OIE website, <i>OIE Regional Representations</i>, http://www.oie.int/en/about-us/wo/regional-</ftext>
<ftext top=""1124"" left=""108"" width=""301"" height=""15"" font=""10"">representations/ (last accessed 6 October 2014). </ftext>
</footnote>
<p><text top=""1051"" left=""160"" width=""613"" height=""15"" font=""10""> OIE website, <i>The 180 OIE Members</i>, http://www.oie.int/about-us/our-members/member-countries/ </text>
<text top=""1066"" left=""108"" width=""197"" height=""15"" font=""10"">(last accessed 6 October 2014). </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 31 - </text>
</p></p></page>
<page number=""31"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""2.4"" style=""8""><text top=""128"" left=""108"" width=""207"" height=""16"" font=""28"">2.4.2  The Terrestrial Code </text></p><p number=""2.22"" style=""8""><text top=""162"" left=""108"" width=""683"" height=""16"" font=""0"">2.22.  The SPS Agreement<i> </i>defines the international standards, guidelines, or recommendations of </text>
<text top=""178"" left=""108"" width=""425"" height=""16"" font=""0"">the OIE as the relevant ones for animal health and zoonoses.</text>
<footnote top=""177"" left=""533"" width=""11"" height=""11"" font=""16"" number=""53"" ref="""" dis=""""/>
<text top=""178"" left=""545"" width=""246"" height=""16"" font=""0""> The international standards of the </text>
<text top=""195"" left=""108"" width=""682"" height=""16"" font=""0"">OIE are published in the form of the Terrestrial Code, the Aquatic Animal Health Code (the Aquatic </text>
<text top=""211"" left=""108"" width=""682"" height=""16"" font=""0"">Code), the Manual of Diagnostic Test and Vaccines for Terrestrial Animals (the Terrestrial Manual), </text>
<text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">and the Manual of Diagnostic Tests for Aquatic Animals (the Aquatic Manual). All new standards </text>
<text top=""244"" left=""108"" width=""686"" height=""16"" font=""0"">and revisions are adopted by the World Assembly, generally on a unanimous basis following </text>
<text top=""260"" left=""108"" width=""526"" height=""16"" font=""0"">consideration of proposals made by the relevant Specialist Commissions.</text>
<footnote top=""259"" left=""633"" width=""11"" height=""11"" font=""16"" number=""54"" ref="""" dis=""""><ftext top=""949"" left=""158"" width=""633"" height=""15"" font=""10""> According to the document ""International Trade: Rights and Obligations of OIE Member Countries"", </ftext>
<ftext top=""963"" left=""108"" width=""682"" height=""15"" font=""10"">referenced in the OIE's responses to the Panel's questions, the ""<i>OIE standards are contained in the Terrestrial </i></ftext>
<ftext top=""978"" left=""108"" width=""681"" height=""15"" font=""31"">Animal Health Code (Terrestrial Code) and Aquatic Animal Health Code (Aquatic Code) and associated Manuals, </ftext><ftext top=""993"" left=""108"" width=""659"" height=""15"" font=""12""><i>for terrestrial and aquatic animals respectively, and in Resolutions of the World Assembly of OIE delegates</i>."" </ftext>
</footnote>
<text top=""260"" left=""645"" width=""148"" height=""16"" font=""0"">. Each OIE member </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">casts one vote. The standard setting process of the OIE is driven by its Members and enables the </text>
<text top=""293"" left=""108"" width=""562"" height=""16"" font=""0"">continuous improvement of standards as new scientific information comes to light.</text>
<footnote top=""292"" left=""670"" width=""11"" height=""11"" font=""16"" number=""55"" ref="""" dis=""""><ftext top=""1007"" left=""160"" width=""605"" height=""15"" font=""10""> OIE website, <i>International Standards</i>, http://www.oie.int/international-standard-setting/overview/ </ftext>
<ftext top=""1022"" left=""108"" width=""205"" height=""15"" font=""10"">(last accessed 23 October 2014). </ftext>
</footnote>
</p><p number=""2.23"" style=""8""><text top=""328"" left=""108"" width=""687"" height=""16"" font=""0"">2.23.  This dispute covers trade in FMD-susceptible animals (i.e. ruminants and swine) and </text>
<text top=""344"" left=""108"" width=""683"" height=""16"" font=""0"">products thereof. Therefore, the relevant code is the Terrestrial Code, which<i> </i>contains standards, </text>
<text top=""360"" left=""108"" width=""685"" height=""16"" font=""0"">guidelines and recommendations designed to prevent the introduction of infectious agents and </text>
<text top=""377"" left=""108"" width=""683"" height=""16"" font=""0"">diseases pathogenic to terrestrial animals and humans into the importing country during trade in </text>
<text top=""393"" left=""108"" width=""691"" height=""16"" font=""0"">terrestrial animals, animal genetic material and animal products. It does this through </text>
<text top=""410"" left=""108"" width=""685"" height=""16"" font=""0"">recommendations on sanitary measures to be used by OIE members in establishing the health </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">regulations applying to the import of animals, animal genetic material and animal products. Such </text>
<text top=""443"" left=""108"" width=""683"" height=""16"" font=""0"">recommendations are the result of the continuous work since 1960 of one of the OIE's Specialist </text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">Commissions, namely the OIE Terrestrial Animal Health Standards Commission. The Commission </text>
<text top=""475"" left=""108"" width=""684"" height=""16"" font=""0"">draws upon the expertise of internationally renowned specialists to prepare draft texts for new </text>
<text top=""492"" left=""108"" width=""684"" height=""16"" font=""0"">articles of the Terrestrial Code or to revise existing articles in the light of advances in veterinary </text>
<text top=""508"" left=""108"" width=""54"" height=""16"" font=""0"">science.</text>
<footnote top=""507"" left=""162"" width=""11"" height=""11"" font=""16"" number=""56"" ref="""" dis=""""><ftext top=""1036"" left=""160"" width=""411"" height=""15"" font=""10""> OIE, <i>Terrestrial Animal Health Code</i> 21st edn (2012), Vol. 1, p. v.  </ftext>
</footnote>
</p><p number=""2.24"" style=""8""><text top=""543"" left=""108"" width=""686"" height=""16"" font=""0"">2.24.  The first edition of the Terrestrial Code was published in 1968. The Terrestrial Code is </text>
<text top=""559"" left=""108"" width=""684"" height=""16"" font=""0"">reviewed on an annual basis, with new editions adopted by the World Assembly of Delegates of </text>
<text top=""575"" left=""108"" width=""686"" height=""16"" font=""0"">OIE members each year in May. The twenty-first edition of the Terrestrial Code, which was </text>
<text top=""592"" left=""108"" width=""690"" height=""16"" font=""0"">adopted by the OIE International Committee at the eightieth General Assembly Session </text>
<text top=""608"" left=""108"" width=""683"" height=""16"" font=""0"">in May 2012, was the version in effect at the time of the establishment of the Panel, and thus is </text>
<text top=""625"" left=""108"" width=""356"" height=""16"" font=""0"">the version that the Panel will refer to in this report.</text>
<footnote top=""623"" left=""464"" width=""11"" height=""11"" font=""16"" number=""57"" ref="""" dis=""""><ftext top=""1051"" left=""160"" width=""556"" height=""15"" font=""10""> In their submissions, the parties have referred to different versions of the Terrestrial Code </ftext>
<ftext top=""1066"" left=""108"" width=""646"" height=""15"" font=""10"">interchangeably. Throughout this Report, the Panel will use the twenty-first edition of the Terrestrial Code </ftext>
<ftext top=""1080"" left=""108"" width=""255"" height=""15"" font=""10"">when referring to the parties' arguments. </ftext>
</footnote>
</p><p number=""2.4"" style=""8""><text top=""659"" left=""108"" width=""429"" height=""16"" font=""28"">2.4.2.1  Objectives and structure of the Terrestrial Code </text></p><p number=""2.25"" style=""8""><text top=""693"" left=""108"" width=""684"" height=""16"" font=""0"">2.25.  The aim of the Terrestrial Code is to set international ""standards for the improvement of </text>
<text top=""710"" left=""108"" width=""685"" height=""16"" font=""0"">terrestrial animal health and welfare and veterinary public health worldwide, including through </text>
<text top=""726"" left=""108"" width=""683"" height=""16"" font=""0"">standards for safe international trade in terrestrial animals (mammals, birds and bees) and their </text>
<text top=""743"" left=""108"" width=""70"" height=""16"" font=""0"">products"".</text>
<footnote top=""741"" left=""178"" width=""11"" height=""11"" font=""16"" number=""58"" ref="""" dis=""""><ftext top=""1095"" left=""160"" width=""406"" height=""15"" font=""10""> OIE, <i>Terrestrial Animal Health Code</i> 21st edn (2012), Vol. 1, p. v. </ftext>
</footnote>
<text top=""743"" left=""189"" width=""602"" height=""16"" font=""0""> According to the Terrestrial Code, these standards consist of health measures based </text>
<text top=""759"" left=""108"" width=""684"" height=""16"" font=""0"">on the latest available scientific evidence and ""should be used"" by the veterinary authorities of </text>
<text top=""775"" left=""108"" width=""686"" height=""16"" font=""0"">importing and exporting countries to, <i>inter alia</i>, prevent the transfer of agents pathogenic to </text>
<text top=""792"" left=""108"" width=""686"" height=""16"" font=""0"">terrestrial animals and/or humans via international trade in terrestrial animals and terrestrial </text>
<text top=""808"" left=""108"" width=""551"" height=""16"" font=""0"">animal products, while avoiding unjustified sanitary barriers to trade.</text>
<footnote top=""807"" left=""659"" width=""11"" height=""11"" font=""16"" number=""59"" ref="""" dis=""""><ftext top=""1109"" left=""160"" width=""406"" height=""15"" font=""10""> OIE, <i>Terrestrial Animal Health Code</i> 21st edn (2012), Vol. 1, p. v. </ftext>
</footnote>
<text top=""808"" left=""671"" width=""119"" height=""16"" font=""0"">  In  sum,  the </text>
<text top=""825"" left=""108"" width=""683"" height=""16"" font=""0"">Terrestrial Code aspires to assure sanitary safety of international trade in terrestrial animals while </text>
<text top=""841"" left=""108"" width=""313"" height=""16"" font=""0"">avoiding unjustified sanitary barriers to trade.</text>
<footnote top=""840"" left=""421"" width=""11"" height=""11"" font=""16"" number=""60"" ref="""" dis=""""><ftext top=""1124"" left=""160"" width=""406"" height=""15"" font=""10""> OIE, <i>Terrestrial Animal Health Code</i> 21st edn (2012), Vol. 1, p. v. </ftext>
<ftext top=""978"" left=""108"" width=""354"" height=""15"" font=""10"">7 October 2014). See discussion in section 2.4.2.2 below. </ftext>
<ftext top=""1080"" left=""108"" width=""643"" height=""15"" font=""10"">http://www.oie.int/fileadmin/Home/eng/Media_Center/docs/pdf/Disease_cards/RINDERPEST-EN.pdf (last </ftext>
<ftext top=""1095"" left=""108"" width=""180"" height=""15"" font=""10"">accessed 13 February 2015). </ftext>
</footnote>
</p><p number=""2.26"" style=""8""><text top=""875"" left=""108"" width=""684"" height=""16"" font=""0"">2.26.  The Terrestrial Code is divided into two volumes. Volume I, entitled ""General provisions"", </text>
<text top=""892"" left=""108"" width=""686"" height=""16"" font=""0"">contains horizontal standards that apply to a wide range of species, production sectors and </text>
<p><text top=""934"" left=""160"" width=""237"" height=""15"" font=""10""> Annex A(3)(b) of the SPS Agreement<i>.</i> </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 32 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">diseases, organized into seven Sections. For instance, this volume includes rules on animal disease </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">diagnosis, surveillance and notification (Section 1), risk analysis (Section 2), quality of veterinary </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">services (Section 3), disease prevention and control (Section 4), trade measures, import/export </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">procedures and veterinary certification (Section 5). The general principles and specific procedures </text>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">for recognition of official disease status are set out in Chapter 1.6 of the Terrestrial Code, with </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">consolidation and updating of the procedures as set out in Resolutions XXII and XXIII, adopted at </text>
<text top=""226"" left=""108"" width=""325"" height=""16"" font=""0"">the seventy-sixth World Assembly in May 2008.</text>
<footnote top=""225"" left=""433"" width=""11"" height=""11"" font=""16"" number=""61"" ref="""" dis=""""><ftext top=""949"" left=""160"" width=""484"" height=""15"" font=""10""> OIE website, <i>Final Report of the 76th General Session, Paris, 25-30 May 2008</i>, </ftext>
</footnote>
</p></p></page>
<page number=""32"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""2.27"" style=""8""><text top=""260"" left=""108"" width=""687"" height=""16"" font=""0"">2.27.  Volume II, in turn, contains standards, guidelines and recommendations applicable to </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">specific diseases, including the recommendations regarding disease surveillance, risk assessment, </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">and zoning and compartmentalization. Specifically, Chapter 8.5 sets out international standards, </text>
<text top=""310"" left=""108"" width=""690"" height=""16"" font=""0"">guidelines and recommendations specific to FMD. It aims to provide for safe trade in </text>
<text top=""326"" left=""108"" width=""684"" height=""16"" font=""0"">FMD-susceptible animals and products thereof by recommending particular mitigating measures </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">for both exporting and importing Members to be adopted depending on the FMD-status designation </text>
<text top=""359"" left=""108"" width=""230"" height=""16"" font=""0"">of the exporting country or zone. </text>
</p><p number=""2.28"" style=""8""><text top=""393"" left=""108"" width=""688"" height=""16"" font=""0"">2.28.  In the OIE context, the term ""sanitary measure"" means ""a measure, such as those </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">described in the various chapters of the Terrestrial Code, destined to protect animal or human </text>
<text top=""426"" left=""108"" width=""689"" height=""16"" font=""0"">health or life within the territory of the OIE Member from risks arising from the entry, </text>
<text top=""443"" left=""108"" width=""293"" height=""16"" font=""0"">establishment and/or spread of a hazard"".</text>
<footnote top=""441"" left=""401"" width=""11"" height=""11"" font=""16"" number=""62"" ref="""" dis=""""><ftext top=""993"" left=""160"" width=""420"" height=""15"" font=""10""> OIE, <i>Terrestrial Animal Health Code</i> 21st edn (2012), Vol. 1, p. xvii. </ftext>
</footnote>
<text top=""443"" left=""412"" width=""379"" height=""16"" font=""0""> According to the Terrestrial Code, ""risk"" refers to the </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">likelihood of the occurrence and the likely magnitude of the biological and economic consequences </text>
<text top=""475"" left=""108"" width=""686"" height=""16"" font=""0"">of an adverse event or effect to animal or human health. ""Risk analysis"" means the process </text>
<text top=""492"" left=""108"" width=""685"" height=""16"" font=""0"">consisting of hazard identification, risk assessment, risk management and risk communication, </text>
<text top=""508"" left=""108"" width=""684"" height=""16"" font=""0"">while ""risk assessment"" means the evaluation of the likelihood and the biological and economic </text>
<text top=""525"" left=""108"" width=""684"" height=""16"" font=""0"">consequences of entry, establishment and spread of a hazard within a territory of an importing </text>
<text top=""541"" left=""108"" width=""56"" height=""16"" font=""0"">country.</text>
<footnote top=""539"" left=""164"" width=""11"" height=""11"" font=""16"" number=""63"" ref="""" dis=""""><ftext top=""1007"" left=""160"" width=""420"" height=""15"" font=""10""> OIE, <i>Terrestrial Animal Health Code</i> 21st edn (2012), Vol. 1, p. xvii. </ftext>
</footnote>
</p><p number=""2.4"" style=""8""><text top=""575"" left=""108"" width=""344"" height=""16"" font=""28"">2.4.2.2  Official recognition of disease status </text></p><p number=""2.29"" style=""8""><text top=""610"" left=""108"" width=""685"" height=""16"" font=""0"">2.29.  In light of the standards set forth in the Terrestrial Code, since 1994 the OIE has been </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">recognizing the status of specific countries or zones with respect to a number of animal diseases. </text>
<text top=""643"" left=""108"" width=""684"" height=""16"" font=""0"">As of 2014, the OIE provides official recognitions for six diseases: African horse sickness (AHS), </text>
<text top=""659"" left=""108"" width=""685"" height=""16"" font=""0"">bovine spongiform encephalopathy (BSE), contagious bovine pleuropneumonia (CBPP), classical </text>
<text top=""675"" left=""108"" width=""451"" height=""16"" font=""0"">swine fever (CSF), <i>peste des petits ruminants</i> (PPR), and FMD.</text>
<footnote top=""674"" left=""558"" width=""11"" height=""11"" font=""16"" number=""64"" ref="""" dis=""""><ftext top=""1022"" left=""160"" width=""603"" height=""15"" font=""10""> See OIE website, <i>Animal Health in the World &#8211; Overview</i>, http://www.oie.int/animal-health-in-the-</ftext>
<ftext top=""1036"" left=""108"" width=""656"" height=""15"" font=""10"">world/ (last accessed 9 January 2015). Previously, the OIE also provided official recognitions for rinderpest. </ftext>
</footnote>
<text top=""675"" left=""570"" width=""222"" height=""16"" font=""0""> The official recognition of the </text>
<text top=""692"" left=""108"" width=""685"" height=""16"" font=""0"">disease status of a country or zone is an ""affirmation"" that such country or zones ""meets the </text>
<text top=""708"" left=""108"" width=""613"" height=""16"" font=""0"">standards set in the Terrestrial Code"" with regard to the control of the disease concerned.</text>
<footnote top=""707"" left=""721"" width=""11"" height=""11"" font=""16"" number=""65"" ref="""" dis=""""/>
</p><p number=""2.30"" style=""8""><text top=""743"" left=""108"" width=""684"" height=""16"" font=""0"">2.30.  The procedures the OIE uses to issue official recognitions are embodied in Chapter 1.6 of </text>
<text top=""759"" left=""108"" width=""687"" height=""16"" font=""0"">the Terrestrial Code. With respect to FMD specifically, detailed procedures are contained in </text>
<text top=""775"" left=""108"" width=""684"" height=""16"" font=""0"">Article 1.6.4. As a first step in the FMD-status recognition process, OIE members must apply for </text>
<text top=""792"" left=""108"" width=""685"" height=""16"" font=""0"">recognition for a country (i.e. the entire territory of a Member) or a zone as FMD-free where </text>
<text top=""808"" left=""108"" width=""683"" height=""16"" font=""0"">vaccination is or is not practised. To do so, they must provide the OIE with a ""dossier"" containing </text>
<text top=""825"" left=""108"" width=""305"" height=""16"" font=""0"">the information specified in Article 1.6.4.</text>
<footnote top=""823"" left=""413"" width=""11"" height=""11"" font=""16"" number=""66"" ref="""" dis=""""/>
<text top=""825"" left=""425"" width=""372"" height=""16"" font=""0""> Such information comprises, <i>inter alia</i>, detailed </text>
<text top=""841"" left=""108"" width=""683"" height=""16"" font=""0"">evidence concerning the following factors: geography of the country or zone concerned; livestock </text>
<text top=""857"" left=""108"" width=""426"" height=""16"" font=""0"">industry; organization of the veterinary system; FMD </text>
<text top=""857"" left=""526"" width=""273"" height=""16"" font=""0"">history and eradication strategies; </text>
<text top=""874"" left=""108"" width=""684"" height=""16"" font=""0"">vaccination; animal identification and movement controls; diagnostic capacity; FMD surveillance; </text>
<text top=""890"" left=""108"" width=""686"" height=""16"" font=""0"">prevention strategies, including at the international level; control measures and contingency </text>
<p><text top=""963"" left=""108"" width=""607"" height=""15"" font=""10"">http://www.oie.int/fileadmin/Home/eng/About_us/docs/pdf/A_RF_2008_webpub.pdf (last accessed </text>
</p><p><text top=""1051"" left=""108"" width=""626"" height=""15"" font=""10"">However, the world was officially declared free of rinderpest in 2011. See OIE website, <i>Animal Disease </i></text>
<text top=""1066"" left=""108"" width=""233"" height=""15"" font=""12""><i>Information Summaries &#8211; Rinderpest</i>, </text>
<footnote top=""1109"" left=""160"" width=""371"" height=""15"" font=""10"" number=""5"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 33 - </text>
</p><p><text top=""128"" left=""108"" width=""369"" height=""16"" font=""0"">planning; and compliance with the Terrestrial Code.</text>
<footnote top=""126"" left=""477"" width=""11"" height=""11"" font=""16"" number=""67"" ref="""" dis=""""><ftext top=""803"" left=""160"" width=""585"" height=""15"" font=""10""> Article 1.6.4 of the Terrestrial Code. The information requirements differ partially depending on </ftext>
<ftext top=""818"" left=""108"" width=""643"" height=""15"" font=""10"">whether a Member is applying for FMD-free status with or without vaccination and whether its application </ftext>
<ftext top=""832"" left=""108"" width=""301"" height=""15"" font=""10"">covers its whole territory or only a zone therein.  </ftext>
</footnote>
<text top=""128"" left=""488"" width=""304"" height=""16"" font=""0""> The OIE does not initiate the recognition </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">procedure on its own initiative. Therefore, Members which do not apply or fail to meet the </text>
<text top=""160"" left=""108"" width=""536"" height=""16"" font=""0"">requirements for recognition do not have an official FMD-status determination.</text>
<footnote top=""159"" left=""644"" width=""11"" height=""11"" font=""16"" number=""68"" ref="""" dis=""""><ftext top=""847"" left=""160"" width=""618"" height=""15"" font=""10""> Transcript of the Panel's meeting with the scientific experts on 2 September 2014 (""Transcript of the </ftext>
<ftext top=""861"" left=""108"" width=""140"" height=""15"" font=""10"">meeting""), para. 1.20. </ftext>
</footnote>
</p></p></page>
<page number=""33"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""2.31"" style=""8""><text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">2.31.  The applicant Member's dossier is evaluated by an<i> ad hoc</i> expert Group, usually composed </text>
<text top=""211"" left=""108"" width=""489"" height=""16"" font=""0"">of 2 or 3 individuals covering a broad range of relevant expertise.</text>
<footnote top=""210"" left=""597"" width=""11"" height=""11"" font=""16"" number=""69"" ref="""" dis=""""/>
<text top=""211"" left=""608"" width=""185"" height=""16"" font=""0""> The Group conducts an </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">assessment of whether the Member complies with the requirements set forth in Chapter 8.5 of the </text>
<text top=""244"" left=""108"" width=""417"" height=""16"" font=""0"">Terrestrial Code, and provides the OIE Scientific Commission</text>
<footnote top=""243"" left=""525"" width=""11"" height=""11"" font=""16"" number=""70"" ref="""" dis=""""><ftext top=""891"" left=""160"" width=""621"" height=""15"" font=""10""> OIE's response to Panel question No. 5. Founded in 1946, the Scientific Commission is elected by the </ftext>
</footnote>
<text top=""244"" left=""536"" width=""254"" height=""16"" font=""0""> with a document summarising their </text>
<text top=""260"" left=""108"" width=""220"" height=""16"" font=""0"">findings and recommendations.</text>
<footnote top=""259"" left=""328"" width=""11"" height=""11"" font=""16"" number=""71"" ref="""" dis=""""/>
<text top=""260"" left=""339"" width=""451"" height=""16"" font=""0""> In turn, the Scientific Commission reviews the <i>ad hoc </i>expert </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">Group's document and issues a report listing the countries or zones that are proposed for official </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">recognition of a particular disease status for consideration of OIE members at the annual World </text>
<text top=""310"" left=""108"" width=""70"" height=""16"" font=""0"">Assembly.</text>
<footnote top=""308"" left=""177"" width=""11"" height=""11"" font=""16"" number=""72"" ref="""" dis=""""><ftext top=""978"" left=""160"" width=""617"" height=""15"" font=""10""> OIE's responses to Panel questions Nos. 5 and 13. The OIE explained that a list of those applications </ftext>
<ftext top=""993"" left=""108"" width=""641"" height=""15"" font=""10"">that do not meet the requirements set forth in Chapter 8.5 of the Terrestrial Code is not circulated to the </ftext>
<ftext top=""1007"" left=""108"" width=""330"" height=""15"" font=""10"">Members. (See Transcript of the meeting, para. 1.24) </ftext>
</footnote>
<text top=""310"" left=""189"" width=""610"" height=""16"" font=""0""> A 60-day ""comment period"" is provided and the comments expressed by </text>
<text top=""326"" left=""108"" width=""666"" height=""16"" font=""0"">OIE members are considered by the Scientific Commission before finalizing the decision proposal.</text>
<footnote top=""325"" left=""773"" width=""11"" height=""11"" font=""16"" number=""73"" ref="""" dis=""""><ftext top=""1022"" left=""160"" width=""554"" height=""15"" font=""10""> OIE's response to Panel question No. 5. See also OIE's response to Panel question No. 13. </ftext>
</footnote>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">At any stage of the process, the Scientific Commission may ask the Director General to deploy a </text>
<text top=""359"" left=""108"" width=""232"" height=""16"" font=""0"">mission to the applicant Member.</text>
<footnote top=""357"" left=""340"" width=""11"" height=""11"" font=""16"" number=""74"" ref="""" dis=""""/>
<text top=""359"" left=""352"" width=""440"" height=""16"" font=""0""> As the last step, the OIE World Assembly adopts a resolution </text>
<text top=""375"" left=""108"" width=""682"" height=""16"" font=""0"">which officially recognizes the applicant country or zone as FMD-free where vaccination is or is not </text>
<text top=""392"" left=""108"" width=""67"" height=""16"" font=""0"">practised.</text>
<footnote top=""390"" left=""175"" width=""11"" height=""11"" font=""16"" number=""75"" ref="""" dis=""""/>
<text top=""392"" left=""186"" width=""606"" height=""16"" font=""0""> Members who have an official recognition must submit an updated dossier annually </text>
<text top=""408"" left=""108"" width=""373"" height=""16"" font=""0"">and the decision on official recognition is re-evaluated.</text>
<footnote top=""407"" left=""481"" width=""11"" height=""11"" font=""16"" number=""76"" ref="""" dis=""""/>
</p><p number=""2.32"" style=""8""><text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">2.32.  When a country or zone previously recognized as FMD-free where vaccination is or is not </text>
<text top=""459"" left=""108"" width=""645"" height=""16"" font=""0"">practised experiences an FMD outbreak, its official disease status is suspended immediately.</text>
<footnote top=""457"" left=""753"" width=""11"" height=""11"" font=""16"" number=""77"" ref="""" dis=""""/>
<text top=""459"" left=""764"" width=""27"" height=""16"" font=""0""> In </text>
<text top=""475"" left=""108"" width=""687"" height=""16"" font=""0"">such a case, the Member concerned may apply for recovery of the status pursuant to the </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">procedures set forth in Article 8.5.9 of the Terrestrial Code. The organ in charge of the recovery </text>
<text top=""508"" left=""108"" width=""683"" height=""16"" font=""0"">procedure is the Scientific Commission, which ""has the mandate, on request, to reinstate official </text>
<text top=""525"" left=""108"" width=""421"" height=""16"" font=""0"">status"" without ""prior consultation with the World Assembly"".</text>
<footnote top=""523"" left=""529"" width=""11"" height=""11"" font=""16"" number=""78"" ref="""" dis=""""/>
<text top=""525"" left=""541"" width=""250"" height=""16"" font=""0""> In order to reach its determination </text>
<text top=""541"" left=""108"" width=""682"" height=""16"" font=""0"">on a recovery request, the Commission may call for a new evaluation by the <i>ad hoc </i>expert Group </text>
<text top=""557"" left=""108"" width=""241"" height=""16"" font=""0"">or undertake the assessment itself.</text>
<footnote top=""556"" left=""348"" width=""11"" height=""11"" font=""16"" number=""79"" ref="""" dis=""""/>
</p><p number=""2.4"" style=""8""><text top=""592"" left=""108"" width=""622"" height=""16"" font=""28"">2.4.3  Relevant standards, guidelines or recommendations invoked by the parties </text></p><p number=""2.33"" style=""8""><text top=""626"" left=""108"" width=""686"" height=""16"" font=""0"">2.33.  Argentina claims that the United States has acted inconsistently with Article 3.1 of the </text>
<text top=""643"" left=""108"" width=""688"" height=""16"" font=""0"">SPS Agreement because it has not based its measures on the following provisions of the </text>
<text top=""659"" left=""108"" width=""686"" height=""16"" font=""0"">OIE Terrestrial Code which it argues constitute relevant international standards, guidelines or </text>
<text top=""675"" left=""108"" width=""682"" height=""16"" font=""0"">recommendations: (a) Chapter 8.5 (in particular Articles 8.5.4, 8.5.5, 8.5.22, 8.5.23, and 8.5.25); </text>
<text top=""692"" left=""108"" width=""296"" height=""16"" font=""0"">(b) Chapters 4.1-4.4; and (c) Sections 1-5.</text>
<footnote top=""690"" left=""404"" width=""11"" height=""11"" font=""16"" number=""80"" ref="""" dis=""""/>
<footnote top=""876"" left=""160"" width=""256"" height=""15"" font=""10"" number=""13"" ref="""" dis=""""/>
<p><text top=""905"" left=""108"" width=""651"" height=""15"" font=""10"">World Assembly for a 3-year term. In addition to evaluating Members' dossiers for disease recognition, the </text>
<text top=""920"" left=""108"" width=""654"" height=""15"" font=""10"">Commission assists in identifying the most appropriate strategies and measures for disease prevention and </text>
<text top=""934"" left=""108"" width=""672"" height=""15"" font=""10"">control. See OIE website, <i>Specialist Commissions</i>, http://www.oie.int/about-us/wo/commissions-master/ (last </text>
<text top=""949"" left=""108"" width=""174"" height=""15"" font=""10"">accessed 10 January 2015). </text>
</p><p><text top=""1080"" left=""160"" width=""256"" height=""15"" font=""10""> OIE's response to Panel question No. 10. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 34 - </text>
</p></p></page>
<page number=""34"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""2.34"" style=""8""><text top=""128"" left=""108"" width=""49"" height=""16"" font=""0"">2.34. </text>
<text top=""128"" left=""153"" width=""197"" height=""16"" font=""0"">According to the United </text>
<text top=""128"" left=""342"" width=""456"" height=""16"" font=""0"">States, the relevant international standards, guidelines or </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">recommendations in this dispute are contained in Article 1.6.5, Chapter 2.1, and Chapter 8.5 of </text>
<text top=""160"" left=""108"" width=""140"" height=""16"" font=""0"">the Terrestrial Code.</text>
<footnote top=""159"" left=""248"" width=""11"" height=""11"" font=""16"" number=""81"" ref="""" dis=""""/>
</p><p number=""2.5"" style=""8""><text top=""195"" left=""108"" width=""318"" height=""16"" font=""28"">2.5  The parties' domestic FMD situations </text></p><p number=""2.5"" style=""8""><text top=""229"" left=""108"" width=""132"" height=""16"" font=""28"">2.5.1  Argentina  </text></p><p number=""2.35"" style=""8""><text top=""264"" left=""108"" width=""685"" height=""16"" font=""0"">2.35.  To provide context for the various different regions of Argentina and the disease status </text>
<text top=""280"" left=""108"" width=""539"" height=""16"" font=""0"">thereof, we provide a map of Argentina and the neighbouring territories below.</text>
<footnote top=""279"" left=""646"" width=""11"" height=""11"" font=""16"" number=""82"" ref="""" dis=""""/>
<p><text top=""1109"" left=""160"" width=""625"" height=""15"" font=""10""> The map is based on that provided by the United States in 2014 Risk Analysis for Northern Argentina, </text>
<text top=""1124"" left=""108"" width=""158"" height=""15"" font=""10"">(Exhibit USA-169), p. 47. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 35 - </text>
</p></p></page>
<page number=""35"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""2.5"" style=""8""><text top=""128"" left=""108"" width=""214"" height=""16"" font=""28"">2.5.1.1  Northern Argentina </text></p><p number=""2.36"" style=""8""><text top=""162"" left=""108"" width=""686"" height=""16"" font=""0"">2.36.  The  OIE recognized  the  entire  Argentine  territory as FMD-free where vaccination is not </text>
<text top=""178"" left=""108"" width=""132"" height=""16"" font=""0"">practised in 2000.</text>
<footnote top=""177"" left=""240"" width=""11"" height=""11"" font=""16"" number=""83"" ref="""" dis=""""><ftext top=""774"" left=""160"" width=""603"" height=""15"" font=""10""> OIE International Committee, Resolution XII, <i>Recognition of the Foot and Mouth Disease Status of </i></ftext>
<ftext top=""788"" left=""108"" width=""645"" height=""15"" font=""12""><i>Member Countries</i>, 68th General Session (22-26 May 2000), http://www.oie.int/doc/ged/D7926.PDF (last </ftext>
<ftext top=""803"" left=""108"" width=""166"" height=""15"" font=""10"">accessed 8 October 2014). </ftext>
</footnote>
<text top=""178"" left=""252"" width=""439"" height=""16"" font=""0""> This FMD-status determination was suspended in May 2001</text>
<footnote top=""177"" left=""690"" width=""11"" height=""11"" font=""16"" number=""84"" ref="""" dis=""""><ftext top=""818"" left=""160"" width=""611"" height=""15"" font=""10""> OIE International Committee, Resolution XVII, <i>Recognition of the Foot and Mouth Disease Status of </i></ftext>
<ftext top=""832"" left=""108"" width=""585"" height=""15"" font=""12""><i>Member Countries</i>, 69th General Session (27 May-1 June 2001), (OIE Resolution XVII of 2001), </ftext>
</footnote>
<text top=""178"" left=""702"" width=""93"" height=""16"" font=""0""> in light of </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">multiple FMD outbreaks in the Argentine territory between July 2000 and April 2001. In July 2003, </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">the OIE recognized the Argentine territory located north of the Rio Negro (Northern Argentina) as </text>
<text top=""228"" left=""108"" width=""286"" height=""16"" font=""0"">FMD-free where vaccination is practised.</text>
<footnote top=""226"" left=""394"" width=""11"" height=""11"" font=""16"" number=""85"" ref="""" dis=""""/>
<text top=""228"" left=""406"" width=""387"" height=""16"" font=""0""> In August 2003, the recognition was suspended as a </text>
<text top=""244"" left=""108"" width=""359"" height=""16"" font=""0"">result of an FMD outbreak in the Province of Salta.</text>
<footnote top=""243"" left=""467"" width=""11"" height=""11"" font=""16"" number=""86"" ref="""" dis=""""/>
<text top=""244"" left=""478"" width=""185"" height=""16"" font=""0""> It was reinstated in 2005</text>
<footnote top=""243"" left=""663"" width=""11"" height=""11"" font=""16"" number=""87"" ref="""" dis=""""><ftext top=""949"" left=""160"" width=""603"" height=""15"" font=""10""> OIE World Assembly, Resolution XX, <i>Recognition of the Foot and Mouth Disease Status of Member </i></ftext>
<ftext top=""963"" left=""108"" width=""609"" height=""15"" font=""12""><i>Countries</i>, 73rd General Session (22-27 May 2005), (OIE Resolution XX of 2005), (Exhibit ARG-95). </ftext>
</footnote>
<text top=""244"" left=""674"" width=""117"" height=""16"" font=""0""> and suspended </text>
<text top=""260"" left=""108"" width=""599"" height=""16"" font=""0"">again in 2006 as a result of one further FMD outbreak in the Province of Corrientes.</text>
<footnote top=""259"" left=""707"" width=""11"" height=""11"" font=""16"" number=""88"" ref="""" dis=""""><ftext top=""978"" left=""160"" width=""410"" height=""15"" font=""10""> OIE, Final Report, 74th General Session (2006), (Exhibit USA-55). </ftext>
</footnote>
<text top=""260"" left=""718"" width=""74"" height=""16"" font=""0""> Northern </text>
<text top=""277"" left=""108"" width=""635"" height=""16"" font=""0"">Argentina's disease status of FMD-free where vaccination is practised was reinstated in 2007</text>
<footnote top=""275"" left=""743"" width=""11"" height=""11"" font=""16"" number=""89"" ref="""" dis=""""><ftext top=""993"" left=""160"" width=""607"" height=""15"" font=""10""> OIE World Assembly, Resolution XXI, <i>Recognition of the Foot and Mouth Disease Status of Member </i></ftext>
<ftext top=""1007"" left=""108"" width=""614"" height=""15"" font=""12""><i>Countries</i>, 75th General Session (20-25 May 2007), (OIE Resolution XXI of 2007), (Exhibit ARG-10). </ftext>
</footnote>
<text top=""277"" left=""755"" width=""35"" height=""16"" font=""0""> and </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">has been renewed annually thereafter. Finally, in 2011 the OIE recognized the border protection </text>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">zone established along the Argentine border with Bolivia, Paraguay and Brazil as FMD-free where </text>
<text top=""326"" left=""108"" width=""163"" height=""16"" font=""0"">vaccination is practised.</text>
<footnote top=""325"" left=""271"" width=""11"" height=""11"" font=""16"" number=""90"" ref="""" dis=""""/>
</p><p number=""2.5"" style=""8""><text top=""360"" left=""108"" width=""143"" height=""16"" font=""28"">2.5.1.2  Patagonia </text></p><p number=""2.37"" style=""8""><text top=""395"" left=""108"" width=""683"" height=""16"" font=""0"">2.37.  Patagonia South has not had an FMD outbreak since 1976, whereas Patagonia North B had </text>
<text top=""411"" left=""108"" width=""186"" height=""16"" font=""0"">its last outbreak in 1994.</text>
<footnote top=""410"" left=""294"" width=""11"" height=""11"" font=""16"" number=""91"" ref="""" dis=""""/>
<text top=""411"" left=""305"" width=""488"" height=""16"" font=""0""> In 2002, the OIE recognized Patagonia South as FMD-free where </text>
<text top=""428"" left=""108"" width=""190"" height=""16"" font=""0"">vaccination is not practised.</text>
<footnote top=""426"" left=""298"" width=""11"" height=""11"" font=""16"" number=""92"" ref="""" dis=""""><ftext top=""1066"" left=""160"" width=""613"" height=""15"" font=""10""> OIE World Assembly, Resolution XVII, <i>Recognition of the Foot and Mouth Disease Status of Member </i></ftext>
<ftext top=""1080"" left=""108"" width=""615"" height=""15"" font=""12""><i>Countries</i>, 70th General Session (26-31 May 2002) (OIE Resolution XVII of 2002), (Exhibit ARG-89). </ftext>
</footnote>
<text top=""428"" left=""310"" width=""461"" height=""16"" font=""0""> In 2007, the same recognition was extended to Patagonia North B.</text>
<footnote top=""426"" left=""770"" width=""11"" height=""11"" font=""16"" number=""93"" ref="""" dis=""""><ftext top=""1095"" left=""160"" width=""290"" height=""15"" font=""10""> OIE Resolution XXI of 2007, (Exhibit ARG-10). </ftext>
</footnote>
</p><p number=""2.5"" style=""8""><text top=""462"" left=""108"" width=""155"" height=""16"" font=""28"">2.5.2  United States </text></p><p number=""2.38"" style=""8""><text top=""497"" left=""108"" width=""449"" height=""16"" font=""0"">2.38.  The United States had its last FMD outbreak in 1929.</text>
<footnote top=""495"" left=""557"" width=""11"" height=""11"" font=""16"" number=""94"" ref="""" dis=""""/>
<text top=""497"" left=""568"" width=""228"" height=""16"" font=""0""> The United States has been </text>
<text top=""513"" left=""108"" width=""687"" height=""16"" font=""0"">FMD-free for over eighty years and does not vaccinate its cattle or other FMD-susceptible </text>
<text top=""529"" left=""108"" width=""54"" height=""16"" font=""0"">species.</text>
<footnote top=""528"" left=""162"" width=""11"" height=""11"" font=""16"" number=""95"" ref="""" dis=""""/>
<text top=""529"" left=""174"" width=""622"" height=""16"" font=""0""> The United States is designated by the OIE as an area that is FMD-free where </text>
<text top=""546"" left=""108"" width=""195"" height=""16"" font=""0"">vaccination is not practised. </text>
</p><p><text top=""580"" left=""108"" width=""497"" height=""16"" font=""28"">3  PARTIES' REQUESTS FOR FINDINGS AND RECOMMENDATIONS </text></p><p number=""3.1"" style=""8""><text top=""615"" left=""108"" width=""684"" height=""16"" font=""0"">3.1.   Argentina argues that the measures at issue are SPS measures covered by Article 1.1 and </text>
<text top=""631"" left=""108"" width=""112"" height=""16"" font=""0"">Annex A(1)(a).  </text>
</p><p number=""3.2"" style=""8""><text top=""665"" left=""108"" width=""685"" height=""16"" font=""0"">3.2.  Argentina requests the Panel to find that the application of the prohibitions contained in </text>
<text top=""682"" left=""108"" width=""686"" height=""16"" font=""0"">9 CFR 94.1(b)  and  the  2001 Regulations to importation of fresh (chilled or frozen) beef from </text>
<text top=""698"" left=""108"" width=""77"" height=""16"" font=""0"">Argentina: </text>
<footnote top=""847"" left=""108"" width=""119"" height=""15"" font=""10"" number=""103"" ref="""" dis=""""/>
<p><text top=""861"" left=""160"" width=""605"" height=""15"" font=""10""> OIE Foot and Mouth Disease and Other Epizootics Commission, <i>Report of the Meeting </i>(16, 17, and </text>
<text top=""876"" left=""108"" width=""93"" height=""15"" font=""10"">22 May 2003), </text>
<footnote top=""891"" left=""108"" width=""655"" height=""15"" font=""10"" number=""2003"" ref="""" dis=""""/>
</p><p><text top=""905"" left=""108"" width=""202"" height=""15"" font=""10"">(last accessed 8 October 2014).  </text>
</p><p><text top=""1022"" left=""160"" width=""573"" height=""15"" font=""10""> OIE World Assembly, Resolution No. 14, <i>Recognition of the Foot and Mouth Disease Status of </i></text>
<text top=""1036"" left=""108"" width=""605"" height=""15"" font=""12""><i>Members</i>, 79th General Session (22-27 May 2011), (OIE Resolution 14 of 2011), (Exhibit ARG-12). </text>
<text top=""1051"" left=""160"" width=""278"" height=""15"" font=""10""> Argentina's first written submission, para. 3. </text>
</p><p><text top=""1109"" left=""160"" width=""303"" height=""15"" font=""10""> United States' first written submission, para. 67. </text>
<text top=""1124"" left=""160"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 105. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 36 - </text>
</p><p><text top=""128"" left=""151"" width=""641"" height=""17"" font=""0"">&#61623;  is inconsistent with the United States' obligations under Articles 1.1, 2.2, 2.3, 3.1, 3.3, </text>
<text top=""144"" left=""176"" width=""354"" height=""16"" font=""0"">5.1, 5.2, 5.4, 5.6, and 10.1 of the SPS Agreement; </text>
</p><p><text top=""178"" left=""151"" width=""643"" height=""17"" font=""0"">&#61623;  is inconsistent with the United States' obligations under Articles I:1 and XI:1 of the </text>
<text top=""195"" left=""176"" width=""85"" height=""16"" font=""0"">GATT 1994. </text>
</p></p></page>
<page number=""36"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""3.3"" style=""8""><text top=""229"" left=""108"" width=""685"" height=""16"" font=""0"">3.3.  Argentina requests that, to the extent the Panel were to find that the application of the </text>
<text top=""246"" left=""108"" width=""682"" height=""16"" font=""0"">prohibitions contained in 9 CFR 94.1(b) to importation of Argentine fresh (chilled or frozen) beef is </text>
<text top=""262"" left=""108"" width=""689"" height=""16"" font=""0"">inconsistent with any of the provisions of the covered Agreements, it also find that the </text>
<text top=""278"" left=""108"" width=""683"" height=""16"" font=""0"">2001 Regulations are, by implication, inconsistent with the same provisions because they bear an </text>
<text top=""295"" left=""108"" width=""476"" height=""16"" font=""0"">""instrumental relationship"" with the prohibitions under 9 CFR 94.1(b).</text>
<footnote top=""293"" left=""584"" width=""11"" height=""11"" font=""16"" number=""96"" ref="""" dis=""""/>
</p><p number=""3.4"" style=""8""><text top=""329"" left=""108"" width=""687"" height=""16"" font=""0"">3.4.  Argentina further requests that the Panel find that the application of the prohibitions </text>
<text top=""346"" left=""108"" width=""687"" height=""16"" font=""0"">contained in 9 CFR 94 to importation of animals, meat and other animal products from the </text>
<text top=""362"" left=""108"" width=""125"" height=""16"" font=""0"">Patagonia region: </text>
<p><text top=""396"" left=""151"" width=""641"" height=""17"" font=""0"">&#61623;  is inconsistent with the United States' obligations under Articles 1.1, 2.2, 2.3, 3.1, 3.3, </text>
<text top=""413"" left=""176"" width=""417"" height=""16"" font=""0"">5.1, 5.2, 5.4, 5.6, 6.1, 6.2, and 10.1 of the SPS Agreement; </text>
</p><p><text top=""447"" left=""151"" width=""643"" height=""17"" font=""0"">&#61623;  is inconsistent with the United States' obligations under Articles I:1 and XI:1 of the </text>
<text top=""464"" left=""176"" width=""85"" height=""16"" font=""0"">GATT 1994. </text>
</p></p><p number=""3.5"" style=""8""><text top=""498"" left=""108"" width=""686"" height=""16"" font=""0"">3.5.  Argentina requests the Panel to find that the United States' application of the approval </text>
<text top=""515"" left=""108"" width=""684"" height=""16"" font=""0"">procedure detailed in 9 CFR 92.2 to imports of fresh (chilled or frozen) beef from Argentina was </text>
<text top=""531"" left=""108"" width=""690"" height=""16"" font=""0"">not undertaken and completed without undue delay and is thus inconsistent with the </text>
<text top=""547"" left=""108"" width=""682"" height=""16"" font=""0"">United States' obligations under Article 8 in conjunction with Annex C(1)(a) of the SPS Agreement. </text>
<text top=""564"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina further requests the Panel to find that such an approval process is inconsistent with </text>
<text top=""580"" left=""108"" width=""684"" height=""16"" font=""0"">Article 8 in conjunction with Annex C(1)(b) of the SPS Agreement because the United States: (i) </text>
<text top=""597"" left=""108"" width=""684"" height=""16"" font=""0"">neither published the standard processing period of each procedure nor did it communicate the </text>
<text top=""613"" left=""108"" width=""343"" height=""16"" font=""0"">anticipated processing to Argentina upon request</text>
<footnote top=""611"" left=""451"" width=""11"" height=""11"" font=""16"" number=""97"" ref="""" dis=""""/>
<text top=""613"" left=""463"" width=""329"" height=""16"" font=""0"">; (ii) did not transmit as soon as possible the </text>
<text top=""629"" left=""108"" width=""683"" height=""16"" font=""0"">results of the procedures in a precise and complete manner to Argentina so that corrective action </text>
<text top=""646"" left=""108"" width=""183"" height=""16"" font=""0"">may be taken if necessary</text>
<footnote top=""644"" left=""291"" width=""11"" height=""11"" font=""16"" number=""98"" ref="""" dis=""""/>
<text top=""646"" left=""302"" width=""489"" height=""16"" font=""0"">; and (iii) did not inform Argentina, upon request, of the stage of the </text>
<text top=""662"" left=""108"" width=""229"" height=""16"" font=""0"">procedures, explaining any delay.</text>
<footnote top=""661"" left=""337"" width=""11"" height=""11"" font=""16"" number=""99"" ref="""" dis=""""/>
</p><p number=""3.6"" style=""8""><text top=""697"" left=""108"" width=""686"" height=""16"" font=""0"">3.6.  Argentina requests the Panel to find that the United States' application of the approval </text>
<text top=""713"" left=""108"" width=""682"" height=""16"" font=""0"">procedure detailed in 9 CFR 92.2 to the request to recognize the Patagonia region as FMD-free was </text>
<text top=""729"" left=""108"" width=""690"" height=""16"" font=""0"">not undertaken and completed without undue delay and is thus inconsistent with the </text>
<text top=""746"" left=""108"" width=""682"" height=""16"" font=""0"">United States' obligations under Article 8 in conjunction with Annex C(1)(a) of the SPS Agreement. </text>
<text top=""762"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina further requests the Panel to find that such an approval process is inconsistent with </text>
<text top=""779"" left=""108"" width=""687"" height=""16"" font=""0"">Article 8 in conjunction with Annex C(1)(b) of the SPS Agreement because United States: (i) </text>
<text top=""795"" left=""108"" width=""684"" height=""16"" font=""0"">neither published the standard processing period of each procedure nor did it communicate the </text>
<text top=""811"" left=""108"" width=""341"" height=""16"" font=""0"">anticipated processing to Argentina upon request</text>
<footnote top=""810"" left=""449"" width=""17"" height=""11"" font=""16"" number=""100"" ref="""" dis=""""/>
<text top=""811"" left=""466"" width=""325"" height=""16"" font=""0"">; (ii) did not transmit as soon as possible the </text>
<text top=""828"" left=""108"" width=""683"" height=""16"" font=""0"">results of the procedures in a precise and complete manner to Argentina so that corrective action </text>
<text top=""844"" left=""108"" width=""181"" height=""16"" font=""0"">may be taken if necessary</text>
<footnote top=""843"" left=""289"" width=""17"" height=""11"" font=""16"" number=""101"" ref="""" dis=""""/>
<text top=""844"" left=""307"" width=""484"" height=""16"" font=""0"">; and (iii) did not inform Argentina, upon request, of the stage of the </text>
<text top=""861"" left=""108"" width=""229"" height=""16"" font=""0"">procedures, explaining any delay.</text>
<footnote top=""859"" left=""337"" width=""17"" height=""11"" font=""16"" number=""102"" ref="""" dis=""""/>
</p><p number=""3.7"" style=""8""><text top=""895"" left=""108"" width=""682"" height=""16"" font=""0"">3.7.  Finally, Argentina requests the Panel to find that Section 737 of the <i>2009 Omnibus </i></text>
<text top=""911"" left=""108"" width=""682"" height=""16"" font=""18""><i>Appropriations Act</i> contributed to the United States' undue delay in approving Argentina's requests </text>
<text top=""928"" left=""108"" width=""518"" height=""16"" font=""0"">by ""effectively block[ing] any progress on [its] requests before APHIS""</text>
<p><text top=""1022"" left=""160"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 164. </text>
<text top=""1036"" left=""160"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 655-656. </text>
<text top=""1051"" left=""160"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 657-658. </text>
<text top=""1066"" left=""160"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 659-660. </text>
<text top=""1080"" left=""165"" width=""332"" height=""15"" font=""10""> Argentina's first written submission, paras. 687-688.  </text>
<text top=""1095"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 689. </text>
<text top=""1109"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 690-691. </text>
<text top=""1124"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 699. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 37 - </text>
</p><p><text top=""128"" left=""108"" width=""524"" height=""16"" font=""0"">completion of the approval process on Argentina's two pending applications""</text>
<footnote top=""126"" left=""631"" width=""17"" height=""11"" font=""16"" number=""104"" ref="""" dis=""""/>
<text top=""128"" left=""649"" width=""141"" height=""16"" font=""0"">, inconsistently with </text>
<text top=""144"" left=""108"" width=""348"" height=""16"" font=""0"">Article 8 and Annex C(1)(a) of the SPS Agreement.</text>
<footnote top=""143"" left=""456"" width=""17"" height=""11"" font=""16"" number=""105"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""353"" height=""15"" font=""10""> Argentina's first written submission, paras. 717 and 721. </ftext>
</footnote>
</p></p></page>
<page number=""37"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""3.8"" style=""8""><text top=""178"" left=""108"" width=""682"" height=""16"" font=""0"">3.8.   In light of the above, Argentina requests, pursuant to Article 19.1 of the DSU, that the Panel </text>
<text top=""195"" left=""108"" width=""653"" height=""16"" font=""0"">recommend that the United States bring its measures into conformity with its WTO obligations. </text>
</p><p number=""3.9"" style=""8""><text top=""229"" left=""108"" width=""685"" height=""16"" font=""0"">3.9.  The United States requests that the Panel reject Argentina' claims in this dispute in their </text>
<text top=""246"" left=""108"" width=""62"" height=""16"" font=""0"">entirety. </text>
</p><p><text top=""280"" left=""108"" width=""249"" height=""16"" font=""28"">4  ARGUMENTS OF THE PARTIES </text></p><p number=""4.1"" style=""8""><text top=""314"" left=""108"" width=""682"" height=""16"" font=""0"">4.1.  The arguments of the parties are reflected in their integrated executive summaries, provided </text>
<text top=""331"" left=""108"" width=""682"" height=""16"" font=""0"">to the Panel in accordance with paragraph 18 of the Working Procedures adopted by the Panel (see </text>
<text top=""347"" left=""108"" width=""228"" height=""16"" font=""0"">Annexes B-1, B-2, B-3 and B-4). </text>
</p><p><text top=""382"" left=""108"" width=""303"" height=""16"" font=""28"">5  ARGUMENTS OF THE THIRD PARTIES </text></p><p number=""5.1"" style=""8""><text top=""416"" left=""108"" width=""685"" height=""16"" font=""0"">5.1.  The arguments of Australia, Brazil, China, and the European Union are reflected in their </text>
<text top=""432"" left=""108"" width=""688"" height=""16"" font=""0"">integrated executive summaries, provided in accordance with paragraph 19 of the Working </text>
<text top=""449"" left=""108"" width=""685"" height=""16"" font=""0"">Procedures adopted by the Panel (see Annexes C-1, C-2, C-3 and C-4). Neither India nor the </text>
<text top=""465"" left=""108"" width=""467"" height=""16"" font=""0"">Republic of Korea submitted written or oral arguments to the Panel. </text>
</p><p><text top=""500"" left=""108"" width=""158"" height=""16"" font=""28"">6  INTERIM REVIEW </text></p><p number=""6.1"" style=""8""><text top=""534"" left=""108"" width=""683"" height=""16"" font=""0"">6.1.  On 24 February 2015, the Panel issued its Interim Report to the parties. On 10 March 2015, </text>
<text top=""551"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina and the United States each submitted written requests for the review of the Interim </text>
<text top=""567"" left=""108"" width=""686"" height=""16"" font=""0"">Report. Neither party requested an interim review meeting. On 24 March 2015, both parties </text>
<text top=""583"" left=""108"" width=""388"" height=""16"" font=""0"">submitted comments on the other's requests for review. </text>
</p><p number=""6.2"" style=""8""><text top=""618"" left=""108"" width=""685"" height=""16"" font=""0"">6.2.  In accordance with Article 15.3 of the DSU, this section of the Panel Report sets out the </text>
<text top=""634"" left=""108"" width=""683"" height=""16"" font=""0"">Panel's response to the parties' requests for review of precise aspects of the Report made at the </text>
<text top=""651"" left=""108"" width=""682"" height=""16"" font=""0"">interim review stage. The Panel modified aspects of its Report in the light of the parties' comments </text>
<text top=""667"" left=""108"" width=""685"" height=""16"" font=""0"">where it considered it appropriate, as explained below. In addition, the Panel also corrected a </text>
<text top=""683"" left=""108"" width=""687"" height=""16"" font=""0"">number of clerical and other non-substantive errors throughout the Report, including those </text>
<text top=""700"" left=""108"" width=""167"" height=""16"" font=""0"">identified by the parties.</text>
<footnote top=""698"" left=""275"" width=""17"" height=""11"" font=""16"" number=""106"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""605"" height=""15"" font=""10""> In particular, the Panel corrected the clerical errors Argentina identified in paras. 7.4, 7.94, 7.170, </ftext>
<ftext top=""1051"" left=""108"" width=""659"" height=""15"" font=""10"">7.237 and footnote 654 thereto, 7.350, 7.482, 7.522, 7.534, 7.542, 7.555, 7.629, 8.1, and 8.3. Argentina's </ftext>
<ftext top=""1066"" left=""108"" width=""647"" height=""15"" font=""10"">request for a correction of a clerical error in para. 7.168 is discussed in para. 6.9 below. The Panel did not </ftext>
<ftext top=""1080"" left=""108"" width=""669"" height=""15"" font=""10"">make the correction Argentina requested in para. 7.491 because the language concerned is a direct quotation </ftext>
<ftext top=""1095"" left=""108"" width=""159"" height=""15"" font=""10"">from the relevant exhibit. </ftext>
</footnote>
</p><p number=""6.1"" style=""8""><text top=""734"" left=""108"" width=""686"" height=""16"" font=""28"">6.1  Whether APHIS' review processes of Argentina's requests were undertaken and </text><text top=""751"" left=""108"" width=""244"" height=""16"" font=""28"">completed without undue delay </text></p><p number=""6.3"" style=""8""><text top=""785"" left=""108"" width=""688"" height=""16"" font=""0"">6.3.  Argentina requests that the Panel clarify its reasoning in paragraph 7.117 that some </text>
<text top=""801"" left=""108"" width=""683"" height=""16"" font=""0"">indicators may be used to gauge the reasonableness of the timing of APHIS' review processes. In </text>
<text top=""818"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina's view, the Panel should expressly refer to the absence of a point of reference in APHIS' </text>
<text top=""834"" left=""108"" width=""685"" height=""16"" font=""0"">regulations, thus implying that APHIS acted improperly by not publishing a standard practice. </text>
<text top=""851"" left=""108"" width=""677"" height=""16"" font=""0"">Argentina suggests adding a footnote to APHIS' 1997 policy document, submitted as Exhibit ARG-</text>
<text top=""867"" left=""108"" width=""686"" height=""16"" font=""0"">129, which provides ""an overview of the actual processing times experienced by APHIS"" in </text>
<text top=""883"" left=""108"" width=""305"" height=""16"" font=""0"">applying Section 92.2 to other Members.</text>
<footnote top=""882"" left=""413"" width=""17"" height=""11"" font=""16"" number=""107"" ref="""" dis=""""/>
<text top=""883"" left=""430"" width=""365"" height=""16"" font=""0""> The United States opposes Argentina's request </text>
<text top=""900"" left=""108"" width=""683"" height=""16"" font=""0"">because the timeframes of APHIS' review processes for countries or regions other than Northern </text>
<text top=""916"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina and Patagonia, contained in Exhibit ARG-129, are ""inapposite"" to the question whether </text>
<text top=""933"" left=""108"" width=""378"" height=""16"" font=""0"">APHIS' processes incurred undue delays in this dispute.</text>
<footnote top=""931"" left=""486"" width=""17"" height=""11"" font=""16"" number=""108"" ref="""" dis=""""/>
<p><text top=""1007"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 701. </text>
<footnote top=""1109"" left=""165"" width=""360"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 38 - </text>
</p></p></page>
<page number=""38"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""6.4"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">6.4.  The Panel does not agree with Argentina that the discussion about the absence of a point of </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">reference should be altered to read ""absence of a point of reference in APHIS' regulations."" A </text>
<text top=""160"" left=""108"" width=""688"" height=""16"" font=""0"">determination of whether a procedure incurs an undue delay under Annex C(1)(a) is not </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">necessarily limited to an assessment of the procedures adopted by the importing Member. This is </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">why the Panel also referred to the guidelines of the OIE in the subsequent sentence. Furthermore, </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">Annex C(1)(b) contemplates that a Member will not publish a standard processing period, but may </text>
<text top=""226"" left=""108"" width=""688"" height=""16"" font=""0"">alternatively communicate the anticipated processing period to an applicant upon request. </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">Therefore, we do not see the relevance of whether APHIS has a standard processing period in its </text>
<text top=""259"" left=""108"" width=""684"" height=""16"" font=""0"">own regulations. Moreover, the Panel notes that this is a general introductory paragraph to the </text>
<text top=""275"" left=""108"" width=""682"" height=""16"" font=""0"">discussion. When the Panel discusses the indicators in more detail in paragraphs 7.134 and 7.154, </text>
<text top=""292"" left=""108"" width=""685"" height=""16"" font=""0"">we refer specifically to the relevant APHIS policies and processing times experienced by other </text>
<text top=""308"" left=""108"" width=""537"" height=""16"" font=""0"">applicants. We therefore see no need to make the change Argentina requests. </text>
</p><p number=""6.5"" style=""8""><text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">6.5.  Argentina also requests that the Panel revise its characterization of Section 737 of the <i>2009</i> </text>
<text top=""359"" left=""108"" width=""682"" height=""16"" font=""18""><i>Omnibus Appropriations Act</i> in paragraphs 7.139-7.140; to consider the measure's ""dilatory effect"" </text>
<text top=""375"" left=""108"" width=""683"" height=""16"" font=""0"">on APHIS' review processes of Argentina's requests, and to complete the analysis on Argentina's </text>
<text top=""392"" left=""108"" width=""310"" height=""16"" font=""0"">claims that Section 737 caused undue delay.</text>
<footnote top=""390"" left=""418"" width=""17"" height=""11"" font=""16"" number=""109"" ref="""" dis=""""/>
<text top=""392"" left=""436"" width=""355"" height=""16"" font=""0""> In particular, Argentina argues that the Secretary </text>
<text top=""408"" left=""108"" width=""689"" height=""16"" font=""0"">of Agriculture's evaluation and report to Congress referred to in Section 737 constitute </text>
<text top=""425"" left=""108"" width=""684"" height=""16"" font=""0"">""supplementary requirements"" outside APHIS' review processes under 9 CFR 92.2, which lack a </text>
<text top=""441"" left=""108"" width=""455"" height=""16"" font=""0"">scientific basis and are applied solely on imports from Argentina.</text>
<footnote top=""439"" left=""563"" width=""17"" height=""11"" font=""16"" number=""110"" ref="""" dis=""""/>
<text top=""441"" left=""580"" width=""211"" height=""16"" font=""0""> Further, Argentina contends, </text>
<text top=""457"" left=""108"" width=""682"" height=""16"" font=""0"">the United States' representative at the SPS Committee repeatedly referred to the requirements in </text>
<text top=""474"" left=""108"" width=""689"" height=""16"" font=""0"">Section 737 to respond to Argentina's concerns concerning the timing of APHIS' review </text>
<text top=""490"" left=""108"" width=""71"" height=""16"" font=""0"">processes.</text>
<footnote top=""489"" left=""179"" width=""17"" height=""11"" font=""16"" number=""111"" ref="""" dis=""""/>
<text top=""490"" left=""197"" width=""596"" height=""16"" font=""0""> In light of the above, Argentina maintains that Section 737 did contribute to the </text>
<text top=""507"" left=""108"" width=""346"" height=""16"" font=""0"">alleged undue delays in APHIS' review processes.  </text>
</p><p number=""6.6"" style=""8""><text top=""541"" left=""108"" width=""683"" height=""16"" font=""0"">6.6.  The United States requests the Panel to reject Argentina's request, as the Panel's reasoning </text>
<text top=""557"" left=""108"" width=""685"" height=""16"" font=""0"">in paragraphs 7.139-7.140 accurately reflects the fact that Section 737 did not prevent APHIS </text>
<text top=""574"" left=""108"" width=""685"" height=""16"" font=""0"">from continuing with its risk assessments and, in any event, ceased to have legal force after </text>
<text top=""590"" left=""108"" width=""140"" height=""16"" font=""0"">30 September 2009.</text>
<footnote top=""589"" left=""248"" width=""17"" height=""11"" font=""16"" number=""112"" ref="""" dis=""""/>
</p><p number=""6.7"" style=""8""><text top=""625"" left=""108"" width=""682"" height=""16"" font=""0"">6.7.  The Panel notes that the implication of Argentina's argument is that because Section 737 is a </text>
<text top=""641"" left=""108"" width=""686"" height=""16"" font=""0"">""supplementary"" requirement to APHIS' processes, it somehow <i>ipso facto</i> creates a ""dilatory"" </text>
<text top=""657"" left=""108"" width=""688"" height=""16"" font=""0"">effect on the review of Argentina's requests in a manner inconsistent with Article 8 and </text>
<text top=""674"" left=""108"" width=""684"" height=""16"" font=""0"">Annex C(1)(a). We have found that Section 737 is an SPS measure in its own right. We concur </text>
<text top=""690"" left=""108"" width=""683"" height=""16"" font=""0"">with the panel in <i>US &#8211; Poultry (China) </i>that such a measure is ""Congress' way of exerting control </text>
<text top=""707"" left=""108"" width=""684"" height=""16"" font=""0"">over the activities of an Executive Branch agency responsible for implementing substantive laws </text>
<text top=""723"" left=""108"" width=""227"" height=""16"" font=""0"">and regulations on SPS matters.""</text>
<footnote top=""721"" left=""335"" width=""17"" height=""11"" font=""16"" number=""113"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""1109"" left=""165"" width=""306"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.119.  </ftext>
</footnote>
<text top=""723"" left=""352"" width=""438"" height=""16"" font=""0""> We accept that in some cases the institution of such legislative </text>
<text top=""739"" left=""108"" width=""684"" height=""16"" font=""0"">review of administrative decisions <i>could</i> result in an undue delay. However, we do not consider </text>
<text top=""756"" left=""108"" width=""687"" height=""16"" font=""0"">that an undue delay occurs <i>automatically</i> whenever a legislature wishes to exert oversight </text>
<text top=""772"" left=""108"" width=""212"" height=""16"" font=""0"">authority over the executive.   </text>
</p><p number=""6.8"" style=""8""><text top=""807"" left=""108"" width=""684"" height=""16"" font=""0"">6.8.  Although the United States' representative's statements regarding the need to comply with </text>
<text top=""823"" left=""108"" width=""683"" height=""16"" font=""0"">an expired law might have been expressed more clearly, the fact remains that the law ceased to </text>
<text top=""839"" left=""108"" width=""683"" height=""16"" font=""0"">have any legal effect at the end of the 2009 fiscal year. Furthermore, as the Panel concluded, on </text>
<text top=""856"" left=""108"" width=""684"" height=""16"" font=""0"">the face of the law itself the Department of Agriculture was not prevented from completing the </text>
<text top=""872"" left=""108"" width=""685"" height=""16"" font=""0"">review process of Argentina's requests &#8211; it simply had to provide a report to Congress on the </text>
<text top=""889"" left=""108"" width=""685"" height=""16"" font=""0"">requisite factors. Based on the above, the Panel declines to make the changes requested by </text>
<text top=""905"" left=""108"" width=""75"" height=""16"" font=""0"">Argentina. </text>
</p><p number=""6.9"" style=""8""><text top=""940"" left=""108"" width=""683"" height=""16"" font=""0"">6.9.  Further, Argentina asks the Panel to modify its description of SENASA Resolution 1282/2008 </text>
<text top=""956"" left=""108"" width=""683"" height=""16"" font=""0"">in paragraph 7.168 by stating that it ""did not relax"" the controls between Patagonia North B and </text>
<text top=""972"" left=""108"" width=""116"" height=""16"" font=""0"">Patagonia South.</text>
<footnote top=""971"" left=""224"" width=""17"" height=""11"" font=""16"" number=""114"" ref="""" dis=""""/>
<footnote top=""1066"" left=""165"" width=""360"" height=""15"" font=""10"" number=""3"" ref="""" dis=""""/>
<p><text top=""1095"" left=""165"" width=""554"" height=""15"" font=""10""> United States' comments on Argentina's request for review of the Interim Report, para. 4. </text>
</p><p><text top=""1124"" left=""165"" width=""360"" height=""15"" font=""10""> Argentina's request for review of the Interim Report, p. 9. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 39 - </text>
</p></p></page>
<page number=""39"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""6.10"" style=""8""><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">6.10.  The United States opposes Argentina's request on the ground that Resolution 1282/2008 did </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">relax controls between Patagonia North B and Patagonia South as ""part of the process of merging </text>
<text top=""160"" left=""108"" width=""347"" height=""16"" font=""0"">the two separate areas into one Patagonia region"".</text>
<footnote top=""159"" left=""455"" width=""17"" height=""11"" font=""16"" number=""115"" ref="""" dis=""""/>
</p><p number=""6.11"" style=""8""><text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">6.11.  The Panel recognizes that the use of the term ""relaxed"" might cause confusion and imply </text>
<text top=""211"" left=""108"" width=""687"" height=""16"" font=""0"">that the border controls were somehow diminished in effectiveness. However, on its face, </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">Resolution 1282/2008 did modify aspects of the controls between Patagonia North B and Patagonia </text>
<text top=""244"" left=""108"" width=""556"" height=""16"" font=""0"">South as part of the process of merging the two separate areas into one region.</text>
<footnote top=""243"" left=""664"" width=""17"" height=""11"" font=""16"" number=""116"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""149"" height=""15"" font=""10""> See para. 7.527 below. </ftext>
</footnote>
<text top=""244"" left=""682"" width=""108"" height=""16"" font=""0""> In an effort to </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">provide more clarity, the Panel will change paragraph 7.168 to state that ""Resolution 1282/2008 </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">modified the regime of controls between Patagonia North B and Patagonia South as part of the </text>
<text top=""293"" left=""108"" width=""502"" height=""16"" font=""0"">process of merging the two separate areas into one Patagonia region &#8230;"". </text>
</p><p number=""6.12"" style=""8""><text top=""328"" left=""108"" width=""683"" height=""16"" font=""0"">6.12.  Finally, Argentina requests that the Panel's analysis reflect Argentina's strong disagreement </text>
<text top=""344"" left=""108"" width=""687"" height=""16"" font=""0"">with the United States' reference to SENASA's ""history of intentional concealment"" of FMD </text>
<text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">outbreaks in paragraph 7.90. In particular, Argentina asks the Panel add language to the effect </text>
<text top=""377"" left=""108"" width=""683"" height=""16"" font=""0"">that Argentina considers the United States' allegations to be contradicted by the facts on record, </text>
<text top=""393"" left=""108"" width=""685"" height=""16"" font=""0"">statements made by APHIS before and after the initiation of the current proceedings, and the </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">assessments made by the sanitary services of other Members. Furthermore, Argentina requests </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">that the Panel add language from Argentina impugning the United States' motives in raising this </text>
<text top=""443"" left=""108"" width=""39"" height=""16"" font=""0"">issue.</text>
<footnote top=""441"" left=""147"" width=""17"" height=""11"" font=""16"" number=""117"" ref="""" dis=""""/>
</p><p number=""6.13"" style=""8""><text top=""477"" left=""108"" width=""687"" height=""16"" font=""0"">6.13.  The United States opposes Argentina's request. In its view, paragraph 7.90 correctly </text>
<text top=""493"" left=""108"" width=""684"" height=""16"" font=""0"">presents the United States' arguments. Further, in its opinion, the factual statements to which </text>
<text top=""510"" left=""108"" width=""687"" height=""16"" font=""0"">Argentina objects are documented in the United States' submissions and supported by the </text>
<text top=""526"" left=""108"" width=""161"" height=""16"" font=""0"">evidence on the record.</text>
<footnote top=""525"" left=""269"" width=""17"" height=""11"" font=""16"" number=""118"" ref="""" dis=""""/>
</p><p number=""6.14"" style=""8""><text top=""561"" left=""108"" width=""684"" height=""16"" font=""0"">6.14.  The Panel takes note of Argentina's disagreement with the characterizations made by the </text>
<text top=""577"" left=""108"" width=""682"" height=""16"" font=""0"">United States. In paragraph 7.136, the Panel has already found those characterizations to have no </text>
<text top=""593"" left=""108"" width=""682"" height=""16"" font=""0"">basis in the facts on the record. Similarly, the Panel does not believe there is a basis on the record </text>
<text top=""610"" left=""108"" width=""684"" height=""16"" font=""0"">for Argentina's characterization of the United States' motives. Furthermore, the Panel notes that </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">paragraph 7.90 is a summary of the <i>United States'</i> arguments. It is not appropriate, in our view, </text>
<text top=""643"" left=""108"" width=""682"" height=""16"" font=""0"">to insert commentary from Argentina into this paragraph. However, in the interest of presenting a </text>
<text top=""659"" left=""108"" width=""683"" height=""16"" font=""0"">complete reflection of the views of the parties, the Panel will add language to paragraph 7.132 so </text>
<text top=""675"" left=""108"" width=""317"" height=""16"" font=""0"">as to reflect Argentina's strong disagreement. </text>
</p><p number=""6.15"" style=""8""><text top=""710"" left=""108"" width=""49"" height=""16"" font=""0"">6.15. </text>
<text top=""710"" left=""153"" width=""645"" height=""16"" font=""0"">For its part, the United States requests the Panel to modify its description, in </text>
<text top=""726"" left=""108"" width=""684"" height=""16"" font=""0"">paragraph 7.157, of documents APHIS published in 2014 with respect to Argentina's request for </text>
<text top=""743"" left=""108"" width=""637"" height=""16"" font=""0"">the recognition of Patagonia under 9 CFR 94.1(a) so as to reflect their formal names.</text>
<footnote top=""741"" left=""745"" width=""17"" height=""11"" font=""16"" number=""119"" ref="""" dis=""""/>
<text top=""743"" left=""762"" width=""32"" height=""16"" font=""0""> In </text>
<text top=""759"" left=""108"" width=""683"" height=""16"" font=""0"">particular, the United States asks the Panel to state that on 23 January 2014 APHIS ""published a </text>
<text top=""775"" left=""108"" width=""683"" height=""16"" font=""0"">risk assessment for Patagonia in a Notice of Availability that recognized the region as FMD free"", </text>
<text top=""792"" left=""108"" width=""683"" height=""16"" font=""0"">and that on 29 August 2014 ""APHIS published a Notice of Determination recognizing Patagonia as </text>
<text top=""808"" left=""108"" width=""73"" height=""16"" font=""0"">FMD-free"".</text>
<footnote top=""807"" left=""181"" width=""17"" height=""11"" font=""16"" number=""120"" ref="""" dis=""""/>
</p><p number=""6.16"" style=""8""><text top=""843"" left=""108"" width=""686"" height=""16"" font=""0"">6.16.  Argentina asserts that the Panel should reject the United States' request, as the risk </text>
<text top=""859"" left=""108"" width=""686"" height=""16"" font=""0"">analysis is not ""in"" the Notice of Availability, but rather constitutes a ""distinct and separate"" </text>
<text top=""875"" left=""108"" width=""72"" height=""16"" font=""0"">document.</text>
<footnote top=""874"" left=""180"" width=""17"" height=""11"" font=""16"" number=""121"" ref="""" dis=""""/>
</p><p number=""6.17"" style=""8""><text top=""910"" left=""108"" width=""682"" height=""16"" font=""0"">6.17.  The Panel wishes to ensure that its Report is clear and in that sense agrees with the United </text>
<text top=""926"" left=""108"" width=""682"" height=""16"" font=""0"">States that it should refer to the relevant documents by their official titles as published. Therefore, </text>
<text top=""943"" left=""108"" width=""438"" height=""16"" font=""0"">the Panel will make the requested changes to paragraph 7.157. </text>
</p><p number=""6.18"" style=""8""><text top=""977"" left=""108"" width=""685"" height=""16"" font=""0"">6.18.  Further, the United States requests that the Panel modify entry 27 in Tables 1 and 2, </text>
<text top=""994"" left=""108"" width=""682"" height=""16"" font=""0"">contained in paragraphs 7.120 and 7.146 respectively, by adding that, during consultations carried </text>
<p><text top=""1036"" left=""165"" width=""562"" height=""15"" font=""10""> United States' comments on Argentina's request for review of the Interim Report, para. 18. </text>
</p><p><text top=""1066"" left=""165"" width=""360"" height=""15"" font=""10""> Argentina's request for review of the Interim Report, p. 8. </text>
<text top=""1080"" left=""165"" width=""562"" height=""15"" font=""10""> United States' comments on Argentina's request for review of the Interim Report, para. 17. </text>
</p><p><text top=""1124"" left=""165"" width=""558"" height=""15"" font=""10""> Argentina's comments on the United States' request for review of the Interim Report, p. 2. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 40 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">out pursuant to Article 4 of the DSU, the United States informed Argentina that in order to move </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">forward with APHIS' review processes of Argentina's requests, APHIS would need to schedule a </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">new site visit to verify the FMD conditions in Northern Argentina and Patagonia. In the same vein, </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">the United States requests that the Panel to modify entry 30 in Tables 1 and 2, contained in </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">paragraphs 7.120 and 7.146 respectively, to the effect that on 13 March 2013 APHIS reiterated its </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">request for authorization to conduct a site visit in Northern Argentina and Patagonia. The United </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">States also asks the Panel to reflect such modifications in the chronology contained in Appendix 1 </text>
<text top=""242"" left=""108"" width=""104"" height=""16"" font=""0"">to the Report.  </text>
</p></p></page>
<page number=""40"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""6.19"" style=""8""><text top=""277"" left=""108"" width=""682"" height=""16"" font=""0"">6.19.  Argentina disagrees with the United States' requests, which it sees as ""a new argument on a </text>
<text top=""293"" left=""108"" width=""564"" height=""16"" font=""0"">matter previously considered settled when the Panel issued its final timeline"".</text>
<footnote top=""292"" left=""672"" width=""17"" height=""11"" font=""16"" number=""122"" ref="""" dis=""""/>
<text top=""293"" left=""689"" width=""104"" height=""16"" font=""0""> According to </text>
<text top=""310"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina, the United States did not officially request a site visit during the consultations in </text>
<text top=""326"" left=""108"" width=""347"" height=""16"" font=""0"">November 2012, but rather did so in March 2013.</text>
<footnote top=""325"" left=""455"" width=""17"" height=""11"" font=""16"" number=""123"" ref="""" dis=""""/>
<text top=""326"" left=""473"" width=""319"" height=""16"" font=""0""> Further, Argentina argues, Article 4.6 of the </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">DSU prevents the United States from basing legal arguments on the exchange between the parties </text>
<text top=""359"" left=""108"" width=""142"" height=""16"" font=""0"">during consultations.</text>
<footnote top=""357"" left=""250"" width=""17"" height=""11"" font=""16"" number=""124"" ref="""" dis=""""/>
</p><p number=""6.20"" style=""8""><text top=""393"" left=""108"" width=""683"" height=""16"" font=""0"">6.20.  The United States' request entails that the Panel make a conclusion as to what took place </text>
<text top=""410"" left=""108"" width=""683"" height=""16"" font=""0"">during the consultations held pursuant to Article 4 of the DSU. We recall that, under Article 4.6 of </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">the DSU consultations are confidential. A panel is not privy to the record of those discussions and </text>
<text top=""443"" left=""108"" width=""231"" height=""16"" font=""0"">should not attempt to create one.</text>
<footnote top=""441"" left=""339"" width=""17"" height=""11"" font=""16"" number=""125"" ref="""" dis=""""/>
<text top=""443"" left=""356"" width=""434"" height=""16"" font=""0""> In light of the above, the Panel will not make the changes the </text>
<text top=""459"" left=""108"" width=""164"" height=""16"" font=""0"">United States requests. </text>
</p><p number=""6.2"" style=""8""><text top=""493"" left=""108"" width=""626"" height=""16"" font=""28"">6.2  The United States' appropriate level of protection for foot-and-mouth disease </text></p><p number=""6.21"" style=""8""><text top=""528"" left=""108"" width=""689"" height=""16"" font=""0"">6.21.  Argentina disagrees with the Panel's conclusion in paragraphs 7.377-7.387 that the </text>
<text top=""544"" left=""108"" width=""684"" height=""16"" font=""0"">language of 7 USC 8303(a), which authorizes the Secretary of Agriculture to prohibit or restrict </text>
<text top=""561"" left=""108"" width=""685"" height=""16"" font=""0"">importation or entry ""of animals, articles, or means of conveyance"" when this is necessary to </text>
<text top=""577"" left=""108"" width=""683"" height=""16"" font=""0"">""prevent the introduction into or dissemination within the United States of any pest or disease of </text>
<text top=""593"" left=""108"" width=""65"" height=""16"" font=""0"">livestock""</text>
<footnote top=""592"" left=""173"" width=""17"" height=""11"" font=""16"" number=""126"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""230"" height=""15"" font=""10""> 7 USC &#167; 8303(a), (Exhibit USA-75).  </ftext>
</footnote>
<text top=""593"" left=""190"" width=""193"" height=""16"" font=""0"">, constitutes a valid ALOP.</text>
<footnote top=""592"" left=""383"" width=""17"" height=""11"" font=""16"" number=""127"" ref="""" dis=""""/>
<text top=""593"" left=""401"" width=""393"" height=""16"" font=""0""> This is because, Argentina asserts, such a statutory </text>
<text top=""610"" left=""108"" width=""420"" height=""16"" font=""0"">authorization is too ""vague, formless and implicitly arbitrary"".</text>
<footnote top=""608"" left=""528"" width=""17"" height=""11"" font=""16"" number=""128"" ref="""" dis=""""/>
</p><p number=""6.22"" style=""8""><text top=""644"" left=""108"" width=""683"" height=""16"" font=""0"">6.22.  The United States observes that Argentina is not requesting any further review on the part </text>
<text top=""661"" left=""108"" width=""532"" height=""16"" font=""0"">of the Panel; therefore, the Panel should not change paragraphs 7.377-7.387.</text>
<footnote top=""659"" left=""640"" width=""17"" height=""11"" font=""16"" number=""129"" ref="""" dis=""""/>
</p><p number=""6.23"" style=""8""><text top=""695"" left=""108"" width=""683"" height=""16"" font=""0"">6.23.  The Panel notes that Argentina makes its statements without making a specific request for </text>
<text top=""711"" left=""108"" width=""684"" height=""16"" font=""0"">review of the Panel's finding. Furthermore, the Panel notes that its determination of the United </text>
<text top=""728"" left=""108"" width=""683"" height=""16"" font=""0"">States' ALOP is based on arguments put forward in the United States' first written submission, its </text>
<text top=""744"" left=""108"" width=""682"" height=""16"" font=""0"">later citation to 7 USC 8303(a) as the source of the language in its first written submission, as well </text>
<text top=""761"" left=""108"" width=""686"" height=""16"" font=""0"">as an examination of the United States' actual measures. Therefore, the Panel will make no </text>
<text top=""777"" left=""108"" width=""463"" height=""16"" font=""0"">changes with respect to its conclusions on the United States' ALOP. </text>
</p><p number=""6.24"" style=""8""><text top=""811"" left=""108"" width=""686"" height=""16"" font=""0"">6.24.  Next, Argentina requests that the Panel delete paragraph 7.383, which it considers as </text>
<text top=""828"" left=""108"" width=""506"" height=""16"" font=""0"">disconnected from the arguments of the parties and the facts in dispute.</text>
<footnote top=""826"" left=""614"" width=""17"" height=""11"" font=""16"" number=""130"" ref="""" dis=""""/>
<text top=""828"" left=""631"" width=""159"" height=""16"" font=""0""> In its view, the Panel </text>
<text top=""844"" left=""108"" width=""683"" height=""16"" font=""0"">failed to properly characterize Argentina's position, as Argentina never argued that ""the measures </text>
<text top=""861"" left=""108"" width=""351"" height=""16"" font=""0"">applied to different Members need to be identical"".</text>
<footnote top=""859"" left=""459"" width=""17"" height=""11"" font=""16"" number=""131"" ref="""" dis=""""/>
<text top=""861"" left=""476"" width=""315"" height=""16"" font=""0""> Moreover, according to Argentina, the Panel </text>
<text top=""877"" left=""108"" width=""682"" height=""16"" font=""0"">conflates the United States' lines of argument before and after the United States presented 7 USC </text>
<text top=""893"" left=""108"" width=""141"" height=""16"" font=""0"">8303(a) as its ALOP.</text>
<footnote top=""892"" left=""249"" width=""17"" height=""11"" font=""16"" number=""132"" ref="""" dis=""""/>
<footnote top=""978"" left=""165"" width=""558"" height=""15"" font=""10"" number=""4"" ref="""" dis=""""/>
<p><text top=""1022"" left=""165"" width=""396"" height=""15"" font=""10""> See e.g. Appellate Body Report, <i>US &#8211; Upland Cotton</i>, para. 287. </text>
<footnote top=""1051"" left=""165"" width=""360"" height=""15"" font=""10"" number=""3"" ref="""" dis=""""/>
<footnote top=""1080"" left=""165"" width=""554"" height=""15"" font=""10"" number=""5"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 41 - </text>
</p></p></page>
<page number=""41"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""6.25"" style=""8""><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">6.25.  The United States disagrees with Argentina and argues that the Panel's reasoning is correct </text>
<text top=""144"" left=""108"" width=""304"" height=""16"" font=""0"">and properly reflects Argentina's arguments.</text>
<footnote top=""143"" left=""412"" width=""17"" height=""11"" font=""16"" number=""133"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""574"" height=""15"" font=""10""> United States' comments on Argentina's request for review of the Interim Report, paras. 6-8. </ftext>
</footnote>
</p><p number=""6.26"" style=""8""><text top=""178"" left=""108"" width=""686"" height=""16"" font=""0"">6.26.  The Panel fails to see how paragraph 7.383 is inapposite to the arguments Argentina </text>
<text top=""195"" left=""108"" width=""687"" height=""16"" font=""0"">adduced. The Panel never implied that Argentina argued that measures applied to different </text>
<text top=""211"" left=""108"" width=""682"" height=""16"" font=""0"">Members need to be identical. However, Argentina did argue that APHIS' identification of different </text>
<text top=""228"" left=""108"" width=""686"" height=""16"" font=""0"">levels of <i>risk  </i>in different Member territories had some bearing on the determination of the </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">appropriate level of <i>protection</i>. It is this argument that the Panel is addressing in paragraph 7.383. </text>
<text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">In that vein, we find the paragraph and its citation to the panel report in <i>Australia &#8211; Salmon</i> </text>
<text top=""277"" left=""108"" width=""447"" height=""16"" font=""0"">relevant to our analysis. The Panel will not delete the paragraph. </text>
</p><p number=""6.27"" style=""8""><text top=""311"" left=""108"" width=""49"" height=""16"" font=""0"">6.27. </text>
<text top=""311"" left=""153"" width=""646"" height=""16"" font=""0"">Finally, Argentina requests that the Panel modify the language of footnote 919 </text>
<text top=""328"" left=""108"" width=""685"" height=""16"" font=""0"">(footnote 968 in the Final Report) in the part where it states that the Panel should take into </text>
<text top=""344"" left=""108"" width=""684"" height=""16"" font=""0"">account the guidance provided by the panel report in <i>India &#8211; Agricultural Products</i> on the legal </text>
<text top=""360"" left=""108"" width=""685"" height=""16"" font=""0"">interpretation of the SPS Agreement ""as necessary"". In particular, Argentina asks the Panel to </text>
<text top=""377"" left=""108"" width=""451"" height=""16"" font=""0"">replace the words ""as necessary"" with the words ""as appropriate"".</text>
<footnote top=""375"" left=""559"" width=""17"" height=""11"" font=""16"" number=""134"" ref="""" dis=""""/>
</p><p number=""6.28"" style=""8""><text top=""411"" left=""108"" width=""471"" height=""16"" font=""0"">6.28.  The United States does not comment on Argentina's request.  </text>
</p><p number=""6.29"" style=""8""><text top=""446"" left=""108"" width=""684"" height=""16"" font=""0"">6.29.  The Panel agrees with Argentina with respect to the language used to refer to the panel </text>
<text top=""462"" left=""108"" width=""683"" height=""16"" font=""0"">report in <i>India &#8211; Agricultural Products. </i>However, upon review, the Panel feels it is appropriate to </text>
<text top=""479"" left=""108"" width=""682"" height=""16"" font=""0"">move this language to the first instance where we cite to that report. Therefore, we will delete the </text>
<text top=""495"" left=""108"" width=""517"" height=""16"" font=""0"">reference in footnote 968 and make the necessary change to footnote 171. </text>
</p><p number=""6.3"" style=""8""><text top=""529"" left=""108"" width=""684"" height=""16"" font=""28"">6.3  Whether the United States took into account the objective of minimizing negative </text><text top=""546"" left=""108"" width=""575"" height=""16"" font=""28"">trade effects when determining its appropriate level of sanitary protection  </text></p><p number=""6.30"" style=""8""><text top=""580"" left=""108"" width=""628"" height=""16"" font=""0"">6.30.  Argentina requests the Panel to ""reconsider"" its reasoning in paragraphs 7.405-7.408</text>
<footnote top=""579"" left=""736"" width=""17"" height=""11"" font=""16"" number=""135"" ref="""" dis=""""/>
<text top=""580"" left=""753"" width=""37"" height=""16"" font=""0""> that </text>
<text top=""597"" left=""108"" width=""684"" height=""16"" font=""0"">the United States has a right to impose a zero risk ALOP for FMD. Argentina maintains that the </text>
<text top=""613"" left=""108"" width=""683"" height=""16"" font=""0"">United States has explicitly rejected that it applies a general ALOP with zero risk; therefore, the </text>
<text top=""629"" left=""108"" width=""228"" height=""16"" font=""0"">Panel's reference is unnecessary.</text>
<footnote top=""628"" left=""336"" width=""17"" height=""11"" font=""16"" number=""136"" ref="""" dis=""""/>
<text top=""629"" left=""354"" width=""437"" height=""16"" font=""0""> Further, in Argentina's opinion, any suggestion on the Panel's </text>
<text top=""646"" left=""108"" width=""683"" height=""16"" font=""0"">part that a Member may adopt different ALOPs for different Members would sit at odds with prior </text>
<text top=""662"" left=""108"" width=""452"" height=""16"" font=""0"">jurisprudence on Articles 2.3, 5.5, and 5.6 of the SPS Agreement.</text>
<footnote top=""661"" left=""560"" width=""17"" height=""11"" font=""16"" number=""137"" ref="""" dis=""""/>
<text top=""662"" left=""577"" width=""213"" height=""16"" font=""0""> Finally, Argentina argues that </text>
<text top=""679"" left=""108"" width=""683"" height=""16"" font=""0"">the Appellate Body's finding in <i>Australia &#8211; Salmon</i> referred to by the Panel is a <i>dictum</i> that does </text>
<text top=""695"" left=""108"" width=""687"" height=""16"" font=""0"">not prevent a conclusion that a Member is required properly to articulate its ALOP under </text>
<text top=""711"" left=""108"" width=""75"" height=""16"" font=""0"">Article 5.4.</text>
<footnote top=""710"" left=""183"" width=""17"" height=""11"" font=""16"" number=""138"" ref="""" dis=""""/>
</p><p number=""6.31"" style=""8""><text top=""746"" left=""108"" width=""684"" height=""16"" font=""0"">6.31.  The United States disagrees with Argentina, which, it argues, misunderstands the Panel's </text>
<text top=""762"" left=""108"" width=""683"" height=""16"" font=""0"">discussion in paragraphs 7.405-7-408. According to the United States, the Panel's central point in </text>
<text top=""779"" left=""108"" width=""683"" height=""16"" font=""0"">those paragraphs is not that the United States does not apply an ALOP with zero risk, but rather </text>
<text top=""795"" left=""108"" width=""683"" height=""16"" font=""0"">that Argentina has not demonstrated that the United States failed to take into consideration the </text>
<text top=""811"" left=""108"" width=""544"" height=""16"" font=""0"">objective of minimizing negative trade effects when determining its ALOP.</text>
<footnote top=""810"" left=""652"" width=""17"" height=""11"" font=""16"" number=""139"" ref="""" dis=""""/>
<text top=""811"" left=""670"" width=""125"" height=""16"" font=""0""> For the United </text>
<text top=""828"" left=""108"" width=""683"" height=""16"" font=""0"">States', the Panel correctly found that even the adoption of a zero ALOP is not sufficient to show </text>
<text top=""844"" left=""108"" width=""568"" height=""16"" font=""0"">that a Member failed to consider the objective of minimizing negative trade effects.</text>
<footnote top=""843"" left=""676"" width=""17"" height=""11"" font=""16"" number=""140"" ref="""" dis=""""/>
</p><p number=""6.32"" style=""8""><text top=""879"" left=""108"" width=""684"" height=""16"" font=""0"">6.32.  Argentina's request for review misconstrues the Panel's reasoning. We recognize that the </text>
<text top=""895"" left=""108"" width=""677"" height=""16"" font=""0"">reasoning of the Appellate Body in <i>Australia &#8211; Salmon </i>is written in the context of explaining an un-</text>
<text top=""911"" left=""108"" width=""685"" height=""16"" font=""0"">appealed portion of the panel report in that case. We nevertheless find value in the Appellate </text>
<text top=""928"" left=""108"" width=""686"" height=""16"" font=""0"">Body's clarification that the reasoning of that panel should not be construed to mean that a </text>
<text top=""944"" left=""108"" width=""686"" height=""16"" font=""0"">Member may not adopt a ""zero risk"" ALOP. In that light, we continue to find the reasoning </text>
<text top=""961"" left=""108"" width=""87"" height=""16"" font=""0"">persuasive.  </text>
<p><text top=""1109"" left=""165"" width=""562"" height=""15"" font=""10""> United States' comments on Argentina's request for review of the Interim Report, para. 10. </text>
<text top=""1124"" left=""165"" width=""562"" height=""15"" font=""10""> United States' comments on Argentina's request for review of the Interim Report, para. 11. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 42 - </text>
</p></p></page>
<page number=""42"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""6.33"" style=""8""><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">6.33.  The reference to a Member's right to impose an ALOP with zero risk is not related </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">specifically to the facts of this case or the United States' ALOP for FMD, which the Panel has </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">concluded is not zero. Rather, the Panel is using this conclusion &#8211; the right of a Member to have a </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">zero risk ALOP &#8211; as an interpretative tool to assist the Panel in understanding what is required to </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">establish a <i>prima facie </i>case under Article 5.4. The Panel maintains its conclusion that, in light of </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">the reasoning of the Appellate Body in <i>Australia &#8211; Salmon</i>, Argentina's allegation that the United </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">States treats Argentina ""as if"" the United States' ALOP were zero is not sufficient, in and of itself, </text>
<text top=""242"" left=""108"" width=""437"" height=""16"" font=""0"">to establish a <i>prima facie </i>case of inconsistency with Article 5.4. </text>
</p><p number=""6.34"" style=""8""><text top=""277"" left=""108"" width=""685"" height=""16"" font=""0"">6.34.  Finally, the Panel can find nowhere in paragraphs 7.405-7.408 where it suggests that a </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">Member may adopt different ALOPs for different Members. Indeed, it is Argentina who claims, in </text>
<text top=""310"" left=""108"" width=""685"" height=""16"" font=""0"">its arguments, that this is what the United States has done and that such conduct somehow </text>
<text top=""326"" left=""108"" width=""682"" height=""16"" font=""0"">relates to the obligation in Article 5.4. Argentina is correct that accepting such ability would depart </text>
<text top=""342"" left=""108"" width=""690"" height=""16"" font=""0"">from the interpretations of prior panels of Article 5.5 &#8211; which is the provision of the </text>
<text top=""359"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Agreement that deals with the consistent application of the concept of the ALOP. We note that </text>
<text top=""375"" left=""108"" width=""346"" height=""16"" font=""0"">Argentina did not make a claim under Article 5.5.  </text>
</p><p number=""6.35"" style=""8""><text top=""410"" left=""108"" width=""656"" height=""16"" font=""0"">6.35.  Based on the foregoing, the Panel will not reconsider its reasoning in these paragraphs.   </text>
</p><p number=""6.4"" style=""8""><text top=""444"" left=""108"" width=""685"" height=""16"" font=""28"">6.4  Whether the United States' measures are more trade-restrictive than required to </text><text top=""461"" left=""108"" width=""248"" height=""16"" font=""28"">achieve the United States' ALOP </text></p><p number=""6.36"" style=""8""><text top=""495"" left=""108"" width=""687"" height=""16"" font=""0"">6.36.  The United States request that the Panel modify its description of the United States' </text>
<text top=""511"" left=""108"" width=""683"" height=""16"" font=""0"">argument in paragraph 7.421 with respect to the relationship between Articles 5.6 and 5.7 of the </text>
<text top=""528"" left=""108"" width=""686"" height=""16"" font=""0"">SPS Agreement. Specifically, it asks the Panel to specify that, in the United States' view, an </text>
<text top=""544"" left=""108"" width=""684"" height=""16"" font=""0"">assessment of a less trade-restrictive alternative under Article 5.6 could not be completed as of </text>
<text top=""561"" left=""108"" width=""682"" height=""16"" font=""0"">the date of the Panel's establishment due to the insufficiency of the scientific evidence available at </text>
<text top=""577"" left=""108"" width=""588"" height=""16"" font=""0"">that time, which made the United States' measures fall within the scope of Article 5.7.</text>
<footnote top=""575"" left=""696"" width=""17"" height=""11"" font=""16"" number=""141"" ref="""" dis=""""/>
</p><p number=""6.37"" style=""8""><text top=""611"" left=""108"" width=""686"" height=""16"" font=""0"">6.37.  Argentina opposes the United States' request on the ground that it contains ""factually </text>
<text top=""628"" left=""108"" width=""430"" height=""16"" font=""0"">inaccurate statements and arguments &#8230; not previously made"".</text>
<footnote top=""626"" left=""538"" width=""17"" height=""11"" font=""16"" number=""142"" ref="""" dis=""""/>
<text top=""628"" left=""555"" width=""235"" height=""16"" font=""0""> For Argentina, the United States' </text>
<text top=""644"" left=""108"" width=""685"" height=""16"" font=""0"">argument that the insufficiency of the evidence concerning Argentina's ability to mitigate and </text>
<text top=""661"" left=""108"" width=""683"" height=""16"" font=""0"">control FMD at the time of the Panel's establishment justified the adoption of a ""valid provisional </text>
<text top=""677"" left=""108"" width=""383"" height=""16"" font=""0"">measure"" under Article 5.7 constitutes a new argument.</text>
<footnote top=""675"" left=""491"" width=""17"" height=""11"" font=""16"" number=""143"" ref="""" dis=""""/>
</p><p number=""6.38"" style=""8""><text top=""711"" left=""108"" width=""682"" height=""16"" font=""0"">6.38.  The Panel notes that the United States did make these arguments before the Panel and sees </text>
<text top=""728"" left=""108"" width=""682"" height=""16"" font=""0"">no reason not to include them in the summary of the United States' arguments. Therefore, we will </text>
<text top=""744"" left=""108"" width=""684"" height=""16"" font=""0"">make the requisite modifications to paragraph 7.421. The Panel takes no position on the United </text>
<text top=""761"" left=""108"" width=""97"" height=""16"" font=""0"">States' view.  </text>
</p><p number=""6.39"" style=""8""><text top=""795"" left=""108"" width=""683"" height=""16"" font=""0"">6.39.  The United States also requests that the Panel modify its description of the United States' </text>
<text top=""811"" left=""108"" width=""682"" height=""16"" font=""0"">argument in paragraph 7.426 with respect to the 2014 risk evaluations for Northern Argentina and </text>
<text top=""828"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia submitted by APHIS during these proceedings. In particular, the United States asserts </text>
<text top=""844"" left=""108"" width=""684"" height=""16"" font=""0"">that it did not argue that the documents in question were outside the Panel's consideration, but </text>
<text top=""861"" left=""108"" width=""691"" height=""16"" font=""0"">rather that since the information contained therein postdates the date of the Panel's </text>
<text top=""877"" left=""108"" width=""683"" height=""16"" font=""0"">establishment, it cannot be used to support Argentina's argument that the scientific evidence was </text>
<text top=""893"" left=""108"" width=""154"" height=""16"" font=""0"">sufficient on that date.</text>
<footnote top=""892"" left=""263"" width=""17"" height=""11"" font=""16"" number=""144"" ref="""" dis=""""/>
</p><p number=""6.40"" style=""8""><text top=""928"" left=""108"" width=""685"" height=""16"" font=""0"">6.40.  Argentina requests that the Panel reject the United States' request, because the United </text>
<text top=""944"" left=""108"" width=""682"" height=""16"" font=""0"">States has not previously expressed that opinion. Argentina also notes that there is a great deal of </text>
<text top=""961"" left=""108"" width=""481"" height=""16"" font=""0"">information in those exhibits that pre-dated the Panel's establishment.</text>
<footnote top=""959"" left=""589"" width=""17"" height=""11"" font=""16"" number=""145"" ref="""" dis=""""/>
</p><p number=""6.41"" style=""8""><text top=""995"" left=""108"" width=""685"" height=""16"" font=""0"">6.41.  As we understand it, the requested change is to add a summary of the United States' </text>
<text top=""1012"" left=""108"" width=""682"" height=""16"" font=""0"">response to Panel question No. 53 following the second substantive meeting, and thus is not a new </text>
<p><text top=""1051"" left=""165"" width=""396"" height=""15"" font=""10""> United States' request for review of the Interim Report, para. 4. </text>
<footnote top=""1066"" left=""165"" width=""558"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""/>
</p><p><text top=""1095"" left=""165"" width=""396"" height=""15"" font=""10""> United States' request for review of the Interim Report, para. 5. </text>
<text top=""1109"" left=""165"" width=""616"" height=""15"" font=""10""> Argentina's comments on the United States' request for review of the Interim Report, p. 3 (referring </text>
<text top=""1124"" left=""108"" width=""581"" height=""15"" font=""10"">to United States' response to Panel question No. 53 following the second substantive meeting). </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 43 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">argument raised during the Interim Review stage. Therefore, we see no reason not to include the </text>
<text top=""144"" left=""108"" width=""688"" height=""16"" font=""0"">response in the summary of the United States' arguments and will make the appropriate </text>
<text top=""160"" left=""108"" width=""229"" height=""16"" font=""0"">modification to paragraph 7.426. </text>
</p></p></page>
<page number=""43"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""6.5"" style=""8""><text top=""195"" left=""108"" width=""299"" height=""16"" font=""28"">6.5  Special and differential treatment  </text></p><p number=""6.42"" style=""8""><text top=""229"" left=""108"" width=""684"" height=""16"" font=""0"">6.42.  Albeit agreeing with the Panel's conclusion in paragraphs 7.689-7.691 that Article 10.1 of </text>
<text top=""246"" left=""108"" width=""684"" height=""16"" font=""0"">the SPS Agreement imposes a positive obligation on Members, Argentina expresses the concern </text>
<text top=""262"" left=""108"" width=""683"" height=""16"" font=""0"">that the Panel's interpretation of said obligation ""sets the bar so high"" for a complaining Member </text>
<text top=""278"" left=""108"" width=""376"" height=""16"" font=""0"">that the provision may become <i>de facto</i> unenforceable.</text>
<footnote top=""277"" left=""484"" width=""17"" height=""11"" font=""16"" number=""146"" ref="""" dis=""""/>
</p><p number=""6.43"" style=""8""><text top=""313"" left=""108"" width=""682"" height=""16"" font=""0"">6.43.  The United States observes that Argentina does not make any request for review; therefore, </text>
<text top=""329"" left=""108"" width=""385"" height=""16"" font=""0"">the Panel should not change the paragraphs in question.</text>
<footnote top=""328"" left=""493"" width=""17"" height=""11"" font=""16"" number=""147"" ref="""" dis=""""/>
</p><p number=""6.44"" style=""8""><text top=""364"" left=""108"" width=""683"" height=""16"" font=""0"">6.44.  The Panel notes that Argentina makes no specific request for review with respect to these </text>
<text top=""380"" left=""108"" width=""683"" height=""16"" font=""0"">paragraphs. The Panel also recalls that it does not address the burden of proof under Article 10.1 </text>
<text top=""396"" left=""108"" width=""633"" height=""16"" font=""0"">in the paragraphs referred to by Argentina. Therefore, the Panel will not make any changes. </text>
</p><p number=""6.45"" style=""8""><text top=""431"" left=""108"" width=""683"" height=""16"" font=""0"">6.45.  Argentina requests that the Panel reconsider its finding in paragraphs 7.695-7.700 that the </text>
<text top=""447"" left=""108"" width=""683"" height=""16"" font=""0"">Appellate Body's interpretation of the word ""consider"" in <i>China &#8211; GOES</i> does not provide guidance </text>
<text top=""464"" left=""108"" width=""686"" height=""16"" font=""0"">as to the allocation of the burden of proof under Article 10.1 and ""adopt the standard and </text>
<text top=""480"" left=""108"" width=""436"" height=""16"" font=""0"">approach found in the Appellate Body Report in <i>China &#8211; GOES</i>"".</text>
<footnote top=""479"" left=""544"" width=""17"" height=""11"" font=""16"" number=""148"" ref="""" dis=""""/>
<text top=""480"" left=""562"" width=""229"" height=""16"" font=""0"">. For Argentina, the fact that the </text>
<text top=""497"" left=""108"" width=""686"" height=""16"" font=""0"">Panel did not follow the Appellate Body's approach and relied instead on the panel in <i>EC &#8211; </i></text>
<text top=""513"" left=""108"" width=""682"" height=""16"" font=""18""><i>Approval and Marketing of Biotech Products</i> risks ""setting an evidentiary basis that cannot be met"" </text>
<text top=""529"" left=""108"" width=""222"" height=""16"" font=""0"">by most complaining Members.  </text>
</p><p number=""6.46"" style=""8""><text top=""564"" left=""108"" width=""682"" height=""16"" font=""0"">6.46.  The United States asks the Panel to reject Argentina's request, as it considers that the Panel </text>
<text top=""580"" left=""108"" width=""682"" height=""16"" font=""0"">properly relied on a ""solidly reasoned panel report"" relating to Article 10.1 instead of drawing upon </text>
<text top=""597"" left=""108"" width=""278"" height=""16"" font=""0"">""inapposite reasoning"" in another report.</text>
<footnote top=""595"" left=""386"" width=""17"" height=""11"" font=""16"" number=""149"" ref="""" dis=""""/>
</p><p number=""6.47"" style=""8""><text top=""631"" left=""108"" width=""683"" height=""16"" font=""0"">6.47.  The Panel disagrees with Argentina and will not accede to its request. First, as explained in </text>
<text top=""647"" left=""108"" width=""682"" height=""16"" font=""0"">paragraph 7.697, the reasoning of the panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> is </text>
<text top=""664"" left=""108"" width=""682"" height=""16"" font=""0"">directly relevant. This cannot be said of an Appellate Body report dealing with similar language but </text>
<text top=""680"" left=""108"" width=""685"" height=""16"" font=""0"">within the very specific context of the Anti-Dumping and SCM Agreements. Second, the Panel </text>
<text top=""697"" left=""108"" width=""683"" height=""16"" font=""0"">specifically stated in paragraph 7.698<b> </b>that while the absence of documentation is not sufficient on </text>
<text top=""713"" left=""108"" width=""683"" height=""16"" font=""0"">its own to make a <i>prima facie</i> case of inconsistency with Article 10.1, it is relevant evidence and </text>
<text top=""729"" left=""108"" width=""684"" height=""16"" font=""0"">has probative value particularly when a developing country has brought its special need to the </text>
<text top=""746"" left=""108"" width=""685"" height=""16"" font=""0"">attention of the importing Member. The Panel does not view this as an insurmountable bar to </text>
<text top=""762"" left=""108"" width=""271"" height=""16"" font=""0"">establishing a claim under Article 10.1. </text>
</p><p number=""6.48"" style=""8""><text top=""797"" left=""108"" width=""51"" height=""16"" font=""0"">6.48. </text>
<text top=""797"" left=""153"" width=""648"" height=""16"" font=""0"">Finally, Argentina requests that the Panel delete the last three sentences of </text>
<text top=""813"" left=""108"" width=""684"" height=""16"" font=""0"">paragraph 7.710, where it states that Article 10.1 imposes an obligation not only on developed </text>
<text top=""829"" left=""108"" width=""685"" height=""16"" font=""0"">country Members, but indeed on all Members. In Argentina's view, the Panel's reading of the </text>
<text top=""846"" left=""108"" width=""686"" height=""16"" font=""0"">provision at issue is not supported by the plain meaning of its terms read in their context. </text>
<text top=""862"" left=""108"" width=""683"" height=""16"" font=""0"">Moreover, Argentina contends that the effect of the Panel's interpretation would be to ""engender </text>
<text top=""879"" left=""108"" width=""683"" height=""16"" font=""0"">broader support for eviscerating the effectiveness of the provision by scaring developing country </text>
<text top=""895"" left=""108"" width=""660"" height=""16"" font=""0"">Members into thinking it would imply fiscal and resource commitments beyond their means"".</text>
<footnote top=""894"" left=""768"" width=""17"" height=""11"" font=""16"" number=""150"" ref="""" dis=""""/>
<text top=""911"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina accepts that the types of assistance it refers to might be ""more of the nature"" of what is </text>
<text top=""928"" left=""108"" width=""685"" height=""16"" font=""0"">covered by Article 9.2. However, Argentina argues that the Panel's reasoning would thus also </text>
<text top=""944"" left=""108"" width=""204"" height=""16"" font=""0"">implicitly undermine Article 9.</text>
<footnote top=""943"" left=""312"" width=""20"" height=""11"" font=""16"" number=""151"" ref="""" dis=""""/>
<footnote top=""1051"" left=""165"" width=""360"" height=""15"" font=""10"" number=""6"" ref="""" dis=""""/>
<p><text top=""1066"" left=""165"" width=""562"" height=""15"" font=""10""> United States' comments on Argentina's request for review of the Interim Report, para. 13. </text>
</p><p><text top=""1095"" left=""165"" width=""562"" height=""15"" font=""10""> United States' comments on Argentina's request for review of the Interim Report, para. 14. </text>
<footnote top=""1109"" left=""165"" width=""360"" height=""15"" font=""10"" number=""7"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 44 - </text>
</p></p></page>
<page number=""44"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""6.49"" style=""8""><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">6.49.  The United States opposes Argentina's request. In its view, the language of Article 10.1 </text>
<text top=""144"" left=""108"" width=""599"" height=""16"" font=""0"">does not limit the applicability of the obligations therein to developed country Members.</text>
<footnote top=""143"" left=""707"" width=""17"" height=""11"" font=""16"" number=""152"" ref="""" dis=""""/>
</p><p number=""6.50"" style=""8""><text top=""178"" left=""108"" width=""682"" height=""16"" font=""0"">6.50.  The Panel agrees with the United States that the language of Article 10.1 nowhere suggests </text>
<text top=""195"" left=""108"" width=""685"" height=""16"" font=""0"">that the obligations contained therein only attach to developed country Members. We disagree </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">with Argentina's argument that it is the <i>Panel's reading </i>of the provision which would impose an </text>
<text top=""228"" left=""108"" width=""686"" height=""16"" font=""0"">obligation on developing countries to provide assistance to their trading partners. The Panel </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">explicitly noted in paragraph 7.710 that ""it would be difficult to find that Article 10.1 includes an </text>
<text top=""260"" left=""108"" width=""685"" height=""16"" font=""0"">obligation for the importing Member to take specific action such as correcting and overcoming </text>
<text top=""277"" left=""108"" width=""688"" height=""16"" font=""0"">failures of capacity in the exporting developing country."" This language does not support </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina's argument that the <i>Panel's</i> interpretation could lead to fiscal and resource commitments </text>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">being imposed on developing and least developing country Members. However, in the interest of </text>
<text top=""326"" left=""108"" width=""684"" height=""16"" font=""0"">clarity the Panel will amend paragraph 7.710 to specify that the obligations relating to technical </text>
<text top=""342"" left=""108"" width=""684"" height=""16"" font=""0"">assistance fall under Article 9 and will delete the reference to which Members the obligation in </text>
<text top=""359"" left=""108"" width=""145"" height=""16"" font=""0"">Article 10.1 applies.  </text>
</p><p number=""6.6"" style=""8""><text top=""393"" left=""108"" width=""344"" height=""16"" font=""28"">6.6  Argentina's claims under the GATT 1994 </text></p><p number=""6.51"" style=""8""><text top=""428"" left=""108"" width=""683"" height=""16"" font=""0"">6.51.  Without making a specific request for review, Argentina expresses its strong disagreement </text>
<text top=""444"" left=""108"" width=""685"" height=""16"" font=""0"">with the Panel's decision in paragraphs 7.730-7.732 to exercise judicial economy on its claims </text>
<text top=""461"" left=""108"" width=""683"" height=""16"" font=""0"">under Article XI:1 of the GATT 1994. In Argentina's opinion, the ""outright prohibition"" maintained </text>
<text top=""477"" left=""108"" width=""684"" height=""16"" font=""0"">by the United States on imports of FMD-susceptible animals and animal products constitutes a </text>
<text top=""493"" left=""108"" width=""324"" height=""16"" font=""0"">""flagran[t]"" example of violation of Article XI:1.</text>
<footnote top=""492"" left=""432"" width=""17"" height=""11"" font=""16"" number=""153"" ref="""" dis=""""/>
</p><p number=""6.52"" style=""8""><text top=""528"" left=""108"" width=""682"" height=""16"" font=""0"">6.52.  The United States observes that Argentina does not make any request for review; therefore, </text>
<text top=""544"" left=""108"" width=""385"" height=""16"" font=""0"">the Panel should not change the paragraphs in question.</text>
<footnote top=""543"" left=""493"" width=""17"" height=""11"" font=""16"" number=""154"" ref="""" dis=""""/>
</p><p number=""6.53"" style=""8""><text top=""579"" left=""108"" width=""682"" height=""16"" font=""0"">6.53.  The Panel disagrees with Argentina that providing a finding on Articles I and XI of the GATT </text>
<text top=""595"" left=""108"" width=""684"" height=""16"" font=""0"">1994 would aid in the resolution of this dispute. As noted in paragraph 7.730 of the Report, all </text>
<text top=""611"" left=""108"" width=""171"" height=""16"" font=""0"">prior panels, except one</text>
<footnote top=""610"" left=""279"" width=""17"" height=""11"" font=""16"" number=""155"" ref="""" dis=""""/>
<text top=""611"" left=""296"" width=""496"" height=""16"" font=""0"">, before which claims have been raised under the SPS Agreement as </text>
<text top=""628"" left=""108"" width=""682"" height=""16"" font=""0"">well as the GATT 1994 have declined to rule on the GATT 1994 claims. All those panels considered </text>
<text top=""644"" left=""108"" width=""682"" height=""16"" font=""0"">that such rulings would not add anything more to the positive resolution of the dispute. The rulings </text>
<text top=""661"" left=""108"" width=""685"" height=""16"" font=""0"">of those panels are consistent with Article 2.4 of the SPS Agreement which states that all SPS </text>
<text top=""677"" left=""108"" width=""685"" height=""16"" font=""0"">measures which conform to the provisions of the SPS Agreement shall be presumed to be in </text>
<text top=""693"" left=""108"" width=""685"" height=""16"" font=""0"">accordance with the obligations in the GATT 1994. We will modify paragraph 7.730 to further </text>
<text top=""710"" left=""108"" width=""680"" height=""16"" font=""0"">clarify our decision in this regard by making specific reference to Article 2.4 of the SPS Agreement. </text>
</p><p><text top=""744"" left=""108"" width=""101"" height=""16"" font=""28"">7  FINDINGS </text></p><p number=""7.1"" style=""8""><text top=""779"" left=""108"" width=""167"" height=""16"" font=""28"">7.1  Order of analysis </text></p><p number=""7.1"" style=""8""><text top=""813"" left=""108"" width=""684"" height=""16"" font=""0"">7.1.  Before commencing the analysis of Argentina's legal claims, we first consider the order in </text>
<text top=""829"" left=""108"" width=""240"" height=""16"" font=""0"">which we will address such claims. </text>
</p><p number=""7.2"" style=""8""><text top=""864"" left=""108"" width=""684"" height=""16"" font=""0"">7.2.  In this dispute, Argentina has made claims under Articles 1.1, 2.2, 2.3, 3.1, 3.3, 5.1, 5.2, </text>
<text top=""880"" left=""108"" width=""684"" height=""16"" font=""0"">5.4, 5.6, 6.1, 6.2, 8, 10.1, and Annex C(1) of the SPS Agreement as well as under Articles I:1 </text>
<text top=""897"" left=""108"" width=""199"" height=""16"" font=""0"">and XI:1 of the GATT 1994.</text>
<footnote top=""895"" left=""307"" width=""17"" height=""11"" font=""16"" number=""156"" ref="""" dis=""""/>
<text top=""897"" left=""325"" width=""469"" height=""16"" font=""0""> Furthermore, when responding to Argentina's claims under the </text>
<text top=""913"" left=""108"" width=""688"" height=""16"" font=""0"">SPS Agreement, the United States raises Articles 5.7 and 6.3. Additionally, in response to </text>
<text top=""929"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina's claims under the GATT 1994, the United States invokes the General Exception in </text>
<text top=""946"" left=""108"" width=""221"" height=""16"" font=""0"">Article XX(b) of the GATT 1994. </text>
<p><text top=""1036"" left=""165"" width=""562"" height=""15"" font=""10""> United States' comments on Argentina's request for review of the Interim Report, para. 15. </text>
<text top=""1051"" left=""165"" width=""360"" height=""15"" font=""10""> Argentina's request for review of the Interim Report, p. 8. </text>
<text top=""1066"" left=""165"" width=""562"" height=""15"" font=""10""> United States' comments on Argentina's request for review of the Interim Report, para. 16. </text>
<footnote top=""1080"" left=""165"" width=""615"" height=""15"" font=""10"" number=""1994"" ref="""" dis=""""/>
</p><p><text top=""1095"" left=""108"" width=""670"" height=""15"" font=""10"">because there was a terms of reference issue with respect to the SPS claims. In that context, making findings </text>
</p><p><text top=""1124"" left=""165"" width=""381"" height=""15"" font=""10""> Argentina's request for the establishment of a panel, pp. 4-5. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 45 - </text>
</p></p></page>
<page number=""45"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.3"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.3.  The Panel must decide in what order it will examine compliance with obligations under two </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">separate covered agreements (SPS and GATT 1994) as well as the order in which it will examine </text>
<text top=""160"" left=""108"" width=""403"" height=""16"" font=""0"">the claims <i>within</i> the SPS Agreement and the GATT 1994.  </text>
</p><p number=""7.1"" style=""8""><text top=""195"" left=""108"" width=""281"" height=""16"" font=""28"">7.1.1  Main arguments of the parties </text></p><p number=""7.4"" style=""8""><text top=""229"" left=""108"" width=""684"" height=""16"" font=""0"">7.4.  Argentina challenges under the SPS Agreement the United States' measures that impose a </text>
<text top=""246"" left=""108"" width=""683"" height=""16"" font=""0"">prohibition on all ruminant and swine products. In particular, Argentina challenges the imposition </text>
<text top=""262"" left=""108"" width=""685"" height=""16"" font=""0"">of the prohibition on fresh (chilled or frozen) beef from Northern Argentina and on ruminants, </text>
<text top=""278"" left=""108"" width=""686"" height=""16"" font=""0"">swine, and products thereof from the Patagonia region (both Patagonia South and Patagonia </text>
<text top=""295"" left=""108"" width=""684"" height=""16"" font=""0"">North B). With the exception of claims with respect to regionalization under Article 6, the claims </text>
<text top=""311"" left=""108"" width=""688"" height=""16"" font=""0"">are the same for both sets of products. Argentina presents them in the following order: </text>
<text top=""328"" left=""108"" width=""685"" height=""16"" font=""0"">Articles 1.1, 3.1, 3.3, 5.1, 5.2, 2.2, 5.7, 5.4, 5.6, 2.3, 6.1 and 6.2 (for Patagonia) and 10.1. </text>
<text top=""344"" left=""108"" width=""683"" height=""16"" font=""0"">Furthermore, Argentina challenges, under Article 8 and Annex C(1), the alleged ""undue delay"" by </text>
<text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">the United States in reviewing Argentina's requests with respect to both Northern Argentina and </text>
<text top=""377"" left=""108"" width=""81"" height=""16"" font=""0"">Patagonia.  </text>
</p><p number=""7.5"" style=""8""><text top=""411"" left=""108"" width=""682"" height=""16"" font=""0"">7.5.  The United States, for its part, argues that the main point of Argentina's claims relates to the </text>
<text top=""428"" left=""108"" width=""683"" height=""16"" font=""0"">timeliness of APHIS' process for determining whether and under what conditions allowing imports </text>
<text top=""444"" left=""108"" width=""623"" height=""16"" font=""0"">from Argentina and/or Patagonia would satisfy the United States' ALOP for FMD.</text>
<footnote top=""443"" left=""730"" width=""17"" height=""11"" font=""16"" number=""157"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""603"" height=""15"" font=""10""> United States' first written submission, paras. 2-3, 172; United States' response to Panel question </ftext>
</footnote>
<text top=""444"" left=""748"" width=""50"" height=""16"" font=""0""> The </text>
<text top=""461"" left=""108"" width=""690"" height=""16"" font=""0"">United States maintains that Argentina does not dispute that the import prohibition on </text>
<text top=""477"" left=""108"" width=""687"" height=""16"" font=""0"">FMD-susceptible animals and animal products from Argentina was warranted at the time of </text>
<text top=""493"" left=""108"" width=""64"" height=""16"" font=""0"">adoption.</text>
<footnote top=""492"" left=""172"" width=""17"" height=""11"" font=""16"" number=""158"" ref="""" dis=""""/>
<text top=""493"" left=""189"" width=""602"" height=""16"" font=""0""> Therefore, the United States argues that the Panel should begin its analysis with the </text>
<text top=""510"" left=""108"" width=""683"" height=""16"" font=""0"">two provisions of the SPS Agreement that it believes concern the timeliness of APHIS' process &#8211; </text>
<text top=""526"" left=""108"" width=""261"" height=""16"" font=""0"">namely Annex C(1)(a) and Article 5.7.</text>
<footnote top=""525"" left=""369"" width=""17"" height=""11"" font=""16"" number=""159"" ref="""" dis=""""/>
</p><p number=""7.6"" style=""8""><text top=""561"" left=""108"" width=""684"" height=""16"" font=""0"">7.6.  The United States argues that an examination of these provisions is what is necessary to </text>
<text top=""577"" left=""108"" width=""139"" height=""16"" font=""0"">resolve this dispute</text>
<footnote top=""575"" left=""247"" width=""17"" height=""11"" font=""16"" number=""160"" ref="""" dis=""""/>
<text top=""577"" left=""264"" width=""529"" height=""16"" font=""0"">, and maintains that even if the Panel were to see the need to further </text>
<text top=""593"" left=""108"" width=""684"" height=""16"" font=""0"">address Argentina's other claims, these two provisions should be placed first in the analysis to </text>
<text top=""610"" left=""108"" width=""425"" height=""16"" font=""0"">avoid ""contorting procedural concerns into substantive ones.""</text>
<footnote top=""608"" left=""533"" width=""17"" height=""11"" font=""16"" number=""161"" ref="""" dis=""""/>
<text top=""610"" left=""550"" width=""241"" height=""16"" font=""0""> Thus, the United States proposes </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">the following order: Article 8 and Annex C(1), Article 5.7, if necessary Articles 5.1, 5.2, 2.2, 5.4, </text>
<text top=""643"" left=""108"" width=""515"" height=""16"" font=""0"">5.6, 2.3, 3.1, 3.3, 6.1, 6.2, and 10.1, and GATT 1994 Articles I:1 and XI:1.</text>
<footnote top=""641"" left=""623"" width=""20"" height=""11"" font=""16"" number=""162"" ref="""" dis=""""/>
</p><p number=""7.1"" style=""8""><text top=""677"" left=""108"" width=""214"" height=""16"" font=""28"">7.1.2  Analysis by the Panel </text></p><p number=""7.7"" style=""8""><text top=""711"" left=""108"" width=""683"" height=""16"" font=""0"">7.7.  With respect to the order between the claims under the GATT 1994 and the SPS Agreement, </text>
<text top=""728"" left=""108"" width=""684"" height=""16"" font=""0"">we note that the parties did not provide particular argumentation as to this sequencing. We do </text>
<text top=""744"" left=""108"" width=""683"" height=""16"" font=""0"">note that Argentina presented its claims under the SPS Agreement first and only then mentioned </text>
<text top=""761"" left=""108"" width=""683"" height=""16"" font=""0"">the GATT 1994. Furthermore, we note that one of the United States' defences to the claim under </text>
<text top=""777"" left=""108"" width=""682"" height=""16"" font=""0"">Articles I:1 and XI:1 of the GATT 1994 is that, in the light of Article 2.4 of the SPS Agreement, its </text>
<text top=""793"" left=""108"" width=""328"" height=""16"" font=""0"">measures are consistent with the GATT </text>
<text top=""793"" left=""427"" width=""373"" height=""16"" font=""0"">1994 by virtue of being consistent with the </text>
<text top=""810"" left=""108"" width=""111"" height=""16"" font=""0"">SPS Agreement.</text>
<footnote top=""808"" left=""219"" width=""17"" height=""11"" font=""16"" number=""163"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""345"" height=""15"" font=""10""> United States' first written submission, paras. 368-373. </ftext>
</footnote>
</p><p number=""7.8"" style=""8""><text top=""844"" left=""108"" width=""682"" height=""16"" font=""0"">7.8.  We concur with the panel in <i>India &#8211; Autos </i>that it is important to consider, first, if a particular </text>
<text top=""861"" left=""108"" width=""687"" height=""16"" font=""0"">order of analysis is compelled by principles of valid interpretative methodology that, if not </text>
<text top=""877"" left=""108"" width=""296"" height=""16"" font=""0"">followed, might constitute an error of law.</text>
<footnote top=""876"" left=""404"" width=""17"" height=""11"" font=""16"" number=""164"" ref=""WT/DS146/R ; WT/DS175/R|WT/DS146/R/Corr.1 ; WT/DS175/R/Corr.1"" dis=""DS175|DS146""><ftext top=""1124"" left=""165"" width=""258"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Autos</i>, para. 7.154. </ftext>
</footnote>
<text top=""877"" left=""421"" width=""370"" height=""16"" font=""0""> That panel also noted that in considering the order </text>
<p><text top=""978"" left=""108"" width=""285"" height=""15"" font=""10"">No. 76 following the first substantive meeting. </text>
<footnote top=""993"" left=""165"" width=""310"" height=""15"" font=""10"" number=""172"" ref="""" dis=""""/>
<footnote top=""1007"" left=""165"" width=""310"" height=""15"" font=""10"" number=""173"" ref=""WT/DS294/AB/RW|WT/DS294/AB/RW/Corr.1|WT/DS294/AB/R|WT/DS294/AB/R/Corr.1"" dis=""DS294""><ftext top=""1080"" left=""165"" width=""450"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Zeroing (EC) (Article 21.5 &#8211; EC)</i>,<i> </i>para. 277. </ftext>
</footnote>
<footnote top=""1036"" left=""165"" width=""310"" height=""15"" font=""10"" number=""174"" ref=""WT/DS276/AB/R"" dis=""DS276""><ftext top=""1095"" left=""165"" width=""522"" height=""15"" font=""10""> Appellate Body Report, <i>Canada &#8211; Wheat Exports and Grain Imports</i>, paras. 126-129. </ftext>
</footnote>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 46 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">selected for examination of the claims, a panel should be aware that the order of analysis may </text>
<text top=""144"" left=""108"" width=""400"" height=""16"" font=""0"">have an impact on the potential to apply judicial economy.</text>
<footnote top=""143"" left=""508"" width=""17"" height=""11"" font=""16"" number=""165"" ref=""WT/DS146/R ; WT/DS175/R|WT/DS146/R/Corr.1 ; WT/DS175/R/Corr.1"" dis=""DS175|DS146""><ftext top=""803"" left=""165"" width=""528"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Autos</i>, para. 7.161. Furthermore, we note that Article 2.4 of the </ftext>
<ftext top=""818"" left=""108"" width=""648"" height=""15"" font=""10"">SPS Agreement provides that SPS measures that conform to the provisions of the SPS Agreement shall be </ftext>
</footnote>
</p></p></page>
<page number=""46"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<fontspec id=""32"" size=""11"" family=""Times"" color=""#000000"" style=""i""/><p number=""7.9"" style=""8""><text top=""178"" left=""108"" width=""686"" height=""16"" font=""0"">7.9.  The Appellate Body enunciated in <i>EC &#8211; Bananas III</i> the test that should be applied to </text>
<text top=""195"" left=""108"" width=""691"" height=""16"" font=""0"">determine the proper order of analysis where two or more provisions from different </text>
<text top=""211"" left=""108"" width=""687"" height=""16"" font=""0"">covered Agreements  appear<i> a priori</i> to apply to the measure in question. According to the </text>
<text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">Appellate Body, the provision from the Agreement that ""deals specifically, and in detail"" with the </text>
<text top=""244"" left=""108"" width=""294"" height=""16"" font=""0"">measures at issue should be analysed first.</text>
<footnote top=""243"" left=""402"" width=""17"" height=""11"" font=""16"" number=""166"" ref="""" dis=""""/>
</p><p number=""7.10"" style=""8""><text top=""278"" left=""108"" width=""683"" height=""16"" font=""0"">7.10.  In <i>EC &#8211; Hormones</i>, where claims under both the GATT 1994 and the SPS Agreement were </text>
<text top=""295"" left=""108"" width=""683"" height=""16"" font=""0"">raised by the complainant, the panel, in a finding not reviewed by the Appellate Body, considered </text>
<text top=""311"" left=""108"" width=""684"" height=""16"" font=""0"">that the SPS Agreement<i>  </i>was to be addressed first because it ""specifically addresses the type of </text>
<text top=""328"" left=""108"" width=""142"" height=""16"" font=""0"">measure in dispute"".</text>
<footnote top=""326"" left=""250"" width=""17"" height=""11"" font=""16"" number=""167"" ref=""WT/DS26/R/USA"" dis=""DS26""><ftext top=""920"" left=""165"" width=""614"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Hormones (Canada)</i>, paras. 8.44-8.45; <i>EC &#8211; Hormones (US)</i>, paras. 8.41-8.42. </ftext>
</footnote>
<text top=""328"" left=""267"" width=""473"" height=""16"" font=""0""> This approach was also followed by the panels in <i>Australia &#8211; Salmon</i></text>
<footnote top=""326"" left=""740"" width=""17"" height=""11"" font=""16"" number=""168"" ref=""WT/DS18/RW|WT/DS18/R/Corr.1|WT/DS18/R|WT/DS18/11"" dis=""DS18""><ftext top=""934"" left=""165"" width=""288"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Salmon</i>, para. 8.39.  </ftext>
</footnote>
<p><text top=""328"" left=""757"" width=""33"" height=""16"" font=""32"">, EC </text><text top=""344"" left=""108"" width=""316"" height=""16"" font=""32"">&#8211; Approval and Marketing of Biotech Products</text><footnote top=""343"" left=""424"" width=""17"" height=""11"" font=""16"" number=""169"" ref=""WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5"" dis=""DS292|DS291|DS293""><ftext top=""949"" left=""165"" width=""481"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>,<i> </i>para. 7.1364. </ftext>
</footnote>
<text top=""344"" left=""441"" width=""153"" height=""16"" font=""32"">, US &#8211; Poultry (China)</text><footnote top=""343"" left=""595"" width=""17"" height=""11"" font=""16"" number=""170"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""963"" left=""165"" width=""329"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>, paras.7.67-7.68. </ftext>
</footnote>
</p><p><text top=""344"" left=""612"" width=""179"" height=""16"" font=""18""><i>, </i>and<i> India &#8211; Agricultural </i></text>
</p><p><text top=""360"" left=""108"" width=""63"" height=""16"" font=""32"">Products.</text><footnote top=""359"" left=""171"" width=""17"" height=""11"" font=""16"" number=""171"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""978"" left=""165"" width=""598"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, paras. 7.115-7.120. We note that the Panel Report in </ftext>
<ftext top=""993"" left=""108"" width=""598"" height=""15"" font=""12""><i>India &#8211; Agricultural Products </i>was circulated to Members on 14 October 2014 and was appealed on </ftext>
<ftext top=""1007"" left=""108"" width=""616"" height=""15"" font=""10"">26 January 2015. Therefore, the report was not yet adopted at the time of the writing of this Report. </ftext>
<ftext top=""1022"" left=""108"" width=""665"" height=""15"" font=""10"">Therefore, the parties did not themselves present arguments referring to this Panel Report. Nevertheless, we </ftext>
<ftext top=""1036"" left=""108"" width=""665"" height=""15"" font=""10"">believe that the Panel should examine all relevant guidance on the legal interpretation of the SPS Agreement </ftext>
<ftext top=""1051"" left=""108"" width=""329"" height=""15"" font=""10"">and therefore will refer to that report as appropriate.  </ftext>
</footnote>
</p></p><p number=""7.11"" style=""8""><text top=""395"" left=""108"" width=""683"" height=""16"" font=""0"">7.11.  The order of analysis of the claims before us therefore depends on whether the Panel finds </text>
<text top=""411"" left=""108"" width=""682"" height=""16"" font=""0"">that the United States' measures are SPS measures within the meaning of Article 1 and Annex A of </text>
<text top=""428"" left=""108"" width=""682"" height=""16"" font=""0"">the SPS Agreement. If so, pursuant to the reasoning in <i>EC &#8211; Hormones </i>and followed in <i>Australia &#8211; </i></text>
<text top=""444"" left=""108"" width=""683"" height=""16"" font=""18""><i>Salmon</i> and other disputes<i>, </i>the SPS Agreement would be considered to constitute <i>lex specialis</i> as </text>
<text top=""461"" left=""108"" width=""682"" height=""16"" font=""0"">it ""deals specifically, and in detail"" with the type of measure at issue and should thus be analysed </text>
<text top=""477"" left=""108"" width=""32"" height=""16"" font=""0"">first.</text>
</p><p number=""7.12"" style=""8""><text top=""511"" left=""108"" width=""682"" height=""16"" font=""0"">7.12.   In light of these considerations, we will commence our analysis by determining whether the </text>
<text top=""528"" left=""108"" width=""682"" height=""16"" font=""0"">United States' measures are SPS measures within the scope of the SPS Agreement. If they are, we </text>
<text top=""544"" left=""108"" width=""683"" height=""16"" font=""0"">will proceed to examine Argentina's claims under that Agreement before then turning to its claims </text>
<text top=""561"" left=""108"" width=""156"" height=""16"" font=""0"">under the GATT 1994. </text>
</p><p number=""7.13"" style=""8""><text top=""595"" left=""108"" width=""684"" height=""16"" font=""0"">7.13.  With respect to the order of analysis of Argentina's claims under the SPS Agreement, the </text>
<text top=""611"" left=""108"" width=""688"" height=""16"" font=""0"">Panel sees potential problems with the orders of analyses proposed by both parties. We </text>
<text top=""628"" left=""108"" width=""685"" height=""16"" font=""0"">understand from the Appellate Body Report in <i>US &#8211; Zeroing (EC) (Article 21.5 &#8211; EC)</i> that in </text>
<text top=""644"" left=""108"" width=""684"" height=""16"" font=""0"">fulfilling their duties under Article 11 of the DSU, panels may ""depart from the sequential order </text>
<text top=""661"" left=""108"" width=""689"" height=""16"" font=""0"">suggested by the complaining party, in particular, when this is required by the correct </text>
<text top=""677"" left=""108"" width=""430"" height=""16"" font=""0"">interpretation or application of the legal provisions at issue.""</text>
<text top=""677"" left=""555"" width=""237"" height=""16"" font=""0""> Indeed, the Appellate Body has </text>
<text top=""693"" left=""108"" width=""683"" height=""16"" font=""0"">stated that, as a general rule, panels are free to structure the order of their analysis as they see </text>
<text top=""710"" left=""108"" width=""14"" height=""16"" font=""0"">fit</text>
<text top=""710"" left=""139"" width=""652"" height=""16"" font=""0"">, provided that their analysis is consistent with the ""structure and logic"" of the provisions at </text>
<text top=""726"" left=""108"" width=""147"" height=""16"" font=""0"">issue in each dispute.</text>
<footnote top=""725"" left=""255"" width=""17"" height=""11"" font=""16"" number=""175"" ref="""" dis=""""/>
<footnote top=""832"" left=""108"" width=""674"" height=""15"" font=""10"" number=""1994"" ref="""" dis=""""/>
<p><text top=""847"" left=""108"" width=""668"" height=""15"" font=""10"">particular the provisions of Article XX(b). Therefore, a finding that the United States' measures are consistent </text>
<text top=""861"" left=""108"" width=""614"" height=""15"" font=""10"">with the SPS Agreement would yield a presumption that they are consistent with Article XX(b) of the </text>
<footnote top=""905"" left=""165"" width=""326"" height=""15"" font=""10"" number=""204"" ref="""" dis=""""/>
</p><p><text top=""1109"" left=""165"" width=""569"" height=""15"" font=""10""> Appellate Body Reports, <i>Canada &#8211; Autos</i>, para. 151; and <i>Canada &#8211; Wheat Exports and Grain </i></text>
<text top=""1124"" left=""108"" width=""123"" height=""15"" font=""12""><i>Imports</i>, para. 109. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 47 - </text>
</p></p></page>
<page number=""47"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.14"" style=""8""><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">7.14.  Argentina argues that the Panel should begin its analysis with Argentina's claims under </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">Article 1.1. The Panel has already noted that it is crucial to begin the analysis with a determination </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">of whether the SPS Agreement is applicable &#8211; and thus an examination of whether the challenged </text>
<text top=""177"" left=""108"" width=""660"" height=""16"" font=""0"">measures are SPS measures within the meaning of Article 1 must be the Panel's starting point.</text>
<footnote top=""175"" left=""768"" width=""17"" height=""11"" font=""16"" number=""176"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""596"" height=""15"" font=""10""> See para. 7.11 above. Furthermore, a determination of whether the measures are SPS measures </ftext>
<ftext top=""978"" left=""108"" width=""659"" height=""15"" font=""10"">within the meaning of Annex A is relevant for the determination of the applicable international standards for </ftext>
<ftext top=""993"" left=""108"" width=""673"" height=""15"" font=""10"">analysis of claims under Article 3 (Annex A(3)), as well as the type of risk assessment required under Article 5 </ftext>
</footnote>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">However, Argentina focuses not on the applicability of the SPS Agreement set forth in the first </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">sentence of Article 1.1, but rather on the obligation in the second sentence that SPS measures </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">""shall be developed and applied in accordance with the provisions of this Agreement"". As will be </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">discussed further below, Argentina's claim under Article 1.1 can only be sustained if the challenged </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">measures are found to be inconsistent with one of the provisions of the SPS Agreement. Therefore, </text>
<text top=""275"" left=""108"" width=""682"" height=""16"" font=""0"">it would make sense to address this claim after the Panel has completed its analysis of Argentina's </text>
<text top=""292"" left=""108"" width=""279"" height=""16"" font=""0"">other claims under the SPS Agreement.  </text>
</p><p number=""7.15"" style=""8""><text top=""326"" left=""108"" width=""687"" height=""16"" font=""0"">7.15.  The United States, for its part, argues that the Panel should begin with Article 8 and </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">Annex C and then move to Article 5.7, and then, only if necessary, the rest of the provisions. The </text>
<text top=""359"" left=""108"" width=""685"" height=""16"" font=""0"">United States argues that determinations under these three provisions could resolve the entire </text>
<text top=""375"" left=""108"" width=""690"" height=""16"" font=""0"">dispute, without the Panel having to address Argentina's other claims, because in the </text>
<text top=""392"" left=""108"" width=""683"" height=""16"" font=""0"">United States' view Argentina's complaint is essentially about the timeliness of the United States' </text>
<text top=""408"" left=""108"" width=""682"" height=""16"" font=""0"">regulatory decision-making rather than the content of the decision. According to the United States, </text>
<text top=""425"" left=""108"" width=""610"" height=""16"" font=""0"">this ""timeliness"" issue is properly addressed under Article 8 and Annex C and Article 5.7. </text>
</p><p number=""7.16"" style=""8""><text top=""459"" left=""108"" width=""683"" height=""16"" font=""0"">7.16.   We note that Argentina has challenged not only the length of the application process, but </text>
<text top=""475"" left=""108"" width=""685"" height=""16"" font=""0"">also the continued maintenance of the import prohibition itself. Furthermore, Argentina argues </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">that the United States has discriminated between Argentina and other WTO Members with respect </text>
<text top=""508"" left=""108"" width=""684"" height=""16"" font=""0"">to the United States' processing of requests for authorization to import. Therefore, regardless of </text>
<text top=""525"" left=""108"" width=""685"" height=""16"" font=""0"">whether the United States' measures fall within the ambit of either Article 5.7 or Article 8 and </text>
<text top=""541"" left=""108"" width=""684"" height=""16"" font=""0"">Annex C, they would not be exempt from the other obligations cited by Argentina, including to </text>
<text top=""557"" left=""108"" width=""683"" height=""16"" font=""0"">apply those measures in a manner that does not arbitrarily or unjustifiably discriminate between </text>
<text top=""574"" left=""108"" width=""62"" height=""16"" font=""0"">Members</text>
<footnote top=""572"" left=""170"" width=""17"" height=""11"" font=""16"" number=""177"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""1022"" left=""165"" width=""590"" height=""15"" font=""10""> See Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.142 (where the panel found that, being entitled </ftext>
</footnote>
<text top=""574"" left=""187"" width=""605"" height=""16"" font=""0"">, adaptation to regional conditions, and special and differential treatment. Under the </text>
<text top=""590"" left=""108"" width=""685"" height=""16"" font=""0"">circumstances, we cannot agree with the United States that the only provisions relevant to a </text>
<text top=""607"" left=""108"" width=""682"" height=""16"" font=""0"">positive resolution to this dispute are those that the United States identifies as the ones related to </text>
<text top=""623"" left=""108"" width=""367"" height=""16"" font=""0"">the ""timeliness"" of its review of Argentina's requests. </text>
</p><p number=""7.17"" style=""8""><text top=""657"" left=""108"" width=""683"" height=""16"" font=""0"">7.17.  At the same time, we recognize that the analysis under Article 8 will involve many factual </text>
<text top=""674"" left=""108"" width=""684"" height=""16"" font=""0"">determinations that are relevant to the Panel's analysis under a number of the other provisions </text>
<text top=""690"" left=""108"" width=""683"" height=""16"" font=""0"">cited by Argentina and the United States. In particular, in the context of Argentina's claim under </text>
<text top=""707"" left=""108"" width=""683"" height=""16"" font=""0"">Article 8 and Annex C(1)(a), the Panel will have to examine the length of time taken to complete </text>
<text top=""723"" left=""108"" width=""688"" height=""16"" font=""0"">the relevant United States' approval procedures to determine if they were undertaken and </text>
<text top=""739"" left=""108"" width=""685"" height=""16"" font=""0"">completed without undue delay. This will require an analysis of the entire evaluation process </text>
<text top=""756"" left=""108"" width=""649"" height=""16"" font=""0"">conducted by APHIS and the sufficiency of the information the Argentine authorities provided.  </text>
</p><p number=""7.18"" style=""8""><text top=""790"" left=""108"" width=""682"" height=""16"" font=""0"">7.18.  In light of the above, the Panel will begin its analysis with whether the challenged measures </text>
<text top=""807"" left=""108"" width=""686"" height=""16"" font=""0"">are SPS measures within the meaning of Article 1 and thus subject to the disciplines of the </text>
<text top=""823"" left=""108"" width=""685"" height=""16"" font=""0"">SPS Agreement. If we find that the measures are subject to the SPS Agreement, we will then </text>
<text top=""839"" left=""108"" width=""564"" height=""16"" font=""0"">proceed to analyse Argentina's claims under Article 8 and Annex C(1)(a) and (b).  </text>
</p><p number=""7.19"" style=""8""><text top=""874"" left=""108"" width=""688"" height=""16"" font=""0"">7.19.  Once we have concluded our analysis under Article 8 and Annex C, we will turn to </text>
<text top=""890"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina's other claims in the following order: harmonization (Articles 3.1 and 3.3);scientific </text>
<text top=""907"" left=""108"" width=""527"" height=""16"" font=""0"">evidence (Article 5.7 and, if necessary, Articles 5.1 and 5.2, and Article 2.2</text>
<footnote top=""905"" left=""635"" width=""17"" height=""11"" font=""16"" number=""178"" ref=""WT/DS76/AB/R|WT/DS367/AB/R"" dis=""DS76|DS367""><ftext top=""1066"" left=""165"" width=""565"" height=""15"" font=""10""> We note that the Appellate Body has interpreted Article 5.7 as being an exemption from the </ftext>
<ftext top=""1080"" left=""108"" width=""672"" height=""15"" font=""10"">applicability of Articles 2.2 and 5.1. (See Appellate Body Report, <i>Japan &#8211; Agricultural Products II</i>, para. 80) As </ftext>
<ftext top=""1095"" left=""108"" width=""667"" height=""15"" font=""10"">Article 5.2 sets forth what a Member must take into account when assessing the risks, it is inextricably linked </ftext>
<ftext top=""1109"" left=""108"" width=""656"" height=""15"" font=""10"">to Article 5.1. (See e.g. Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 208) Therefore, the Panel will only </ftext>
<ftext top=""1124"" left=""108"" width=""618"" height=""15"" font=""10"">address Argentina's claims under Articles 2.2, 5.1, and 5.2 if it finds that Article 5.7 is not applicable. </ftext>
</footnote>
<text top=""907"" left=""652"" width=""140"" height=""16"" font=""0"">), appropriate level </text>
<text top=""923"" left=""108"" width=""683"" height=""16"" font=""0"">of protection (Articles 5.4 and 5.6,); discrimination (Article 2.3); adaptation to regional conditions </text>
<p><text top=""1007"" left=""108"" width=""88"" height=""15"" font=""10"">(Annex A(4)). </text>
</p><p><text top=""1036"" left=""108"" width=""677"" height=""15"" font=""10"">""Basic Rights and Obligations"", Article 2 contains ""overarching and encompassing"" obligations which ""inform all </text>
<text top=""1051"" left=""108"" width=""153"" height=""15"" font=""10"">of the SPS Agreement""). </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 48 - </text>
</p><p><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">(Articles 6.1 and 6.2); special and differential treatment (Article 10.1), and any consequential </text>
<text top=""144"" left=""108"" width=""261"" height=""16"" font=""0"">violations under Articles 1.1 and 3.3.  </text>
</p></p></page>
<page number=""48"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.20"" style=""8""><text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">7.20.  With respect to the order of analysis of Argentina's claims under the GATT 1994, the Panel </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">will address them in the in the order in which the provisions appear in the GATT 1994 as well as </text>
<text top=""211"" left=""108"" width=""521"" height=""16"" font=""0"">the defence raised by the United States under Article XX(b) to both claims.  </text>
</p><p number=""7.2"" style=""8""><text top=""246"" left=""108"" width=""463"" height=""16"" font=""28"">7.2  Whether the United States' measures are SPS measures </text></p><p number=""7.2"" style=""8""><text top=""280"" left=""108"" width=""248"" height=""16"" font=""28"">7.2.1  Relevant legal provisions  </text></p><p number=""7.21"" style=""8""><text top=""314"" left=""108"" width=""683"" height=""16"" font=""0"">7.21.  Article 1 of the SPS Agreement establishes the scope of application of the Agreement, and </text>
<text top=""331"" left=""108"" width=""120"" height=""16"" font=""0"">reads as follows: </text>
</p><p number=""1."" style=""6""><text top=""365"" left=""151"" width=""20"" height=""16"" font=""0"">1. </text>
<text top=""365"" left=""193"" width=""556"" height=""16"" font=""0"">This Agreement applies to all sanitary and phytosanitary measures which may, </text>
<text top=""382"" left=""151"" width=""597"" height=""16"" font=""0"">directly or indirectly, affect international trade. Such measures shall be developed and </text>
<text top=""398"" left=""151"" width=""416"" height=""16"" font=""0"">applied in accordance with the provisions of this Agreement. </text>
</p><p number=""2."" style=""6""><text top=""432"" left=""151"" width=""26"" height=""16"" font=""0"">2.  </text>
<text top=""432"" left=""193"" width=""557"" height=""16"" font=""0"">For the purposes of this Agreement, the definitions provided in Annex A shall </text>
<text top=""449"" left=""151"" width=""46"" height=""16"" font=""0"">apply. </text>
</p><p number=""7.22"" style=""8""><text top=""483"" left=""108"" width=""684"" height=""16"" font=""0"">7.22.  In turn, Annex A(1) of the SPS Agreement sets forth the definition of an SPS measure as </text>
<text top=""500"" left=""108"" width=""177"" height=""16"" font=""0"">""[a]ny measure applied"": </text>
</p><p number=""(a)"" style=""3""><text top=""534"" left=""151"" width=""598"" height=""16"" font=""0"">(a)   to protect animal or plant life or health within the territory of the Member from </text>
<text top=""551"" left=""193"" width=""560"" height=""16"" font=""0"">risks arising from the entry, establishment or spread of pests, diseases, </text>
<text top=""567"" left=""193"" width=""403"" height=""16"" font=""0"">disease-carrying organisms or disease-causing organisms; </text>
</p><p number=""(b)"" style=""3""><text top=""601"" left=""151"" width=""599"" height=""16"" font=""0"">(b)  to protect human or animal life or health within the territory of the Member </text>
<text top=""618"" left=""193"" width=""560"" height=""16"" font=""0"">from risks arising from additives, contaminants, toxins or disease-causing </text>
<text top=""634"" left=""193"" width=""309"" height=""16"" font=""0"">organisms in foods, beverages or feedstuffs; </text>
</p><p number=""(c)"" style=""3""><text top=""669"" left=""151"" width=""599"" height=""16"" font=""0"">(c)  to protect human life or health within the territory of the Member from risks </text>
<text top=""685"" left=""193"" width=""554"" height=""16"" font=""0"">arising from diseases carried by animals, plants or products thereof, or from the </text>
<text top=""701"" left=""193"" width=""298"" height=""16"" font=""0"">entry, establishment or spread of pests; or </text>
</p><p number=""(d)"" style=""3""><text top=""736"" left=""151"" width=""598"" height=""16"" font=""0"">(d)  to prevent or limit damage within the territory of the Member from the entry, </text>
<text top=""752"" left=""193"" width=""232"" height=""16"" font=""0"">establishment or spread of pests. </text>
</p><p><text top=""787"" left=""151"" width=""600"" height=""16"" font=""0"">Sanitary or phytosanitary measures include all relevant laws, decrees, regulations, </text>
<text top=""803"" left=""151"" width=""598"" height=""16"" font=""0"">requirements and procedures including, inter alia, end product criteria, processes and </text>
<text top=""819"" left=""151"" width=""604"" height=""16"" font=""0"">production methods, testing, inspection, certification and approval procedures; </text>
<text top=""836"" left=""151"" width=""599"" height=""16"" font=""0"">quarantine treatments including relevant requirements associated with the transport </text>
<text top=""852"" left=""151"" width=""602"" height=""16"" font=""0"">of animals or plants, or with the materials necessary for their survival during </text>
<text top=""869"" left=""151"" width=""603"" height=""16"" font=""0"">transport; provisions on relevant statistical methods, sampling procedures and </text>
<text top=""885"" left=""151"" width=""598"" height=""16"" font=""0"">methods of risk assessment; packaging and labelling requirements directly related to </text>
<text top=""901"" left=""151"" width=""85"" height=""16"" font=""0"">food safety. </text>
</p><p number=""7.2"" style=""8""><text top=""936"" left=""108"" width=""281"" height=""16"" font=""28"">7.2.2  Main arguments of the parties </text></p><p number=""7.2"" style=""8""><text top=""970"" left=""108"" width=""141"" height=""16"" font=""28"">7.2.2.1  Argentina </text></p><p number=""7.23"" style=""8""><text top=""1005"" left=""108"" width=""682"" height=""16"" font=""0"">7.23.  Argentina argues that all the measures at issue in this dispute are sanitary measures within </text>
<text top=""1021"" left=""108"" width=""438"" height=""16"" font=""0"">the meaning of Article 1.1 and Annex A of the SPS Agreement.  </text>
</p><p number=""7.24"" style=""8""><text top=""1055"" left=""108"" width=""682"" height=""16"" font=""0"">7.24.  In particular, Argentina claims the application of the prohibitions contained in 9 CFR 94.1(b) </text>
<text top=""1072"" left=""108"" width=""682"" height=""16"" font=""0"">to imports of fresh (chilled or frozen) beef from Argentina, as well as the 2001 Regulations through </text>
<text top=""1088"" left=""108"" width=""683"" height=""16"" font=""0"">which APHIS imposed such prohibitions, are applied to protect the health and life of animals from </text>
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 49 - </text>
</p><p><text top=""128"" left=""108"" width=""660"" height=""16"" font=""0"">risks arising from the entry, establishment and spread of FMD within the United States territory.</text>
<footnote top=""126"" left=""768"" width=""17"" height=""11"" font=""16"" number=""179"" ref="""" dis=""""/>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">Moreover, Argentina argues that because the United States' market has been closed to Argentine </text>
<text top=""160"" left=""108"" width=""660"" height=""16"" font=""0"">fresh (chilled or frozen) beef for more than 11 years, this directly affects international trade.</text>
<footnote top=""159"" left=""768"" width=""17"" height=""11"" font=""16"" number=""180"" ref="""" dis=""""/>
<text top=""177"" left=""108"" width=""686"" height=""16"" font=""0"">Accordingly, Argentina asserts that the measures at issue are sanitary measures covered by </text>
<text top=""193"" left=""108"" width=""344"" height=""16"" font=""0"">Article 1.1 and Annex A of the SPS Agreement.</text>
<footnote top=""192"" left=""452"" width=""17"" height=""11"" font=""16"" number=""181"" ref="""" dis=""""/>
<text top=""193"" left=""469"" width=""325"" height=""16"" font=""0""> Argentina maintains that the measures in </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">question are inconsistent with Article 1.1 of the SPS Agreement because they are not applied in </text>
<text top=""226"" left=""108"" width=""343"" height=""16"" font=""0"">accordance with the provisions of that agreement.</text>
<footnote top=""225"" left=""450"" width=""17"" height=""11"" font=""16"" number=""182"" ref="""" dis=""""/>
</p></p></page>
<page number=""49"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.25"" style=""8""><text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">7.25.  Further, in Argentina's opinion, the application of the prohibitions contained in 9 CFR 94 to </text>
<text top=""277"" left=""108"" width=""687"" height=""16"" font=""0"">imports of FMD-susceptible animals and animal products from Patagonia is an SPS measure </text>
<text top=""293"" left=""108"" width=""688"" height=""16"" font=""0"">because such a measure is applied to protect the health and life of animals within the </text>
<text top=""310"" left=""108"" width=""626"" height=""16"" font=""0"">United States from the risks arising from the entry, establishment and spread of FMD</text>
<footnote top=""308"" left=""734"" width=""17"" height=""11"" font=""16"" number=""183"" ref="""" dis=""""/>
<text top=""310"" left=""752"" width=""42"" height=""16"" font=""0""> and </text>
<text top=""326"" left=""108"" width=""357"" height=""16"" font=""0"">directly affects international trade in such products.</text>
<footnote top=""325"" left=""465"" width=""17"" height=""11"" font=""16"" number=""184"" ref="""" dis=""""/>
<text top=""326"" left=""482"" width=""309"" height=""16"" font=""0""> Argentina claims that the measure at issue </text>
<text top=""342"" left=""108"" width=""687"" height=""16"" font=""0"">violates Article 1.1 of the SPS Agreement because it is not applied in accordance with the </text>
<text top=""359"" left=""108"" width=""201"" height=""16"" font=""0"">provisions of that agreement.</text>
<footnote top=""357"" left=""309"" width=""17"" height=""11"" font=""16"" number=""185"" ref="""" dis=""""/>
</p><p number=""7.26"" style=""8""><text top=""393"" left=""108"" width=""685"" height=""16"" font=""0"">7.26.  With respect to APHIS' application of the approval procedures set forth in 9 CFR 92.2 to </text>
<text top=""410"" left=""108"" width=""687"" height=""16"" font=""0"">Argentina's requests for importation of Argentine fresh (chilled or frozen) beef and for the </text>
<text top=""426"" left=""108"" width=""690"" height=""16"" font=""0"">recognition of Patagonia as FMD-free, Argentina notes that successfully completing such </text>
<text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">procedures is a prerequisite for obtaining authorization to import the relevant products into the </text>
<text top=""459"" left=""108"" width=""97"" height=""16"" font=""0"">United States.</text>
<footnote top=""457"" left=""205"" width=""17"" height=""11"" font=""16"" number=""186"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""570"" height=""15"" font=""10""> Argentina's first written submission, para. 606; Argentina's response to Panel question No. 1 </ftext>
</footnote>
<text top=""459"" left=""222"" width=""570"" height=""16"" font=""0""> In turn, Argentina argues, the procedures set forth in 9 CFR 92.2 are aimed at </text>
<text top=""475"" left=""108"" width=""685"" height=""16"" font=""0"">ensuring that the requirements under 9 CFR 94, which allow importation of animal and animal </text>
<text top=""492"" left=""108"" width=""660"" height=""16"" font=""0"">products only from those countries and regions that APHIS has declared free of FMD, are met.</text>
<footnote top=""490"" left=""768"" width=""17"" height=""11"" font=""16"" number=""187"" ref="""" dis=""""/>
<text top=""508"" left=""108"" width=""686"" height=""16"" font=""0"">Therefore, according to Argentina, such procedures are SPS measures within the meaning of </text>
<text top=""525"" left=""108"" width=""166"" height=""16"" font=""0"">Article 1.1 and Annex A.</text>
<footnote top=""523"" left=""273"" width=""17"" height=""11"" font=""16"" number=""188"" ref="""" dis=""""/>
</p><p number=""7.27"" style=""8""><text top=""559"" left=""108"" width=""683"" height=""16"" font=""0"">7.27.  Argentina also claims that Section 737 of the <i>2009 Omnibus Appropriations Act</i> contributed </text>
<text top=""575"" left=""108"" width=""516"" height=""16"" font=""0"">to the undue delays in APHIS' review processes of its two requests.</text>
<footnote top=""574"" left=""624"" width=""17"" height=""11"" font=""16"" number=""189"" ref="""" dis=""""/>
<text top=""575"" left=""641"" width=""154"" height=""16"" font=""0""> For Argentina, the </text>
<text top=""592"" left=""108"" width=""685"" height=""16"" font=""0"">references in Section 737 to ""domestic animal health aspects that are administered by APHIS"" </text>
<text top=""608"" left=""108"" width=""685"" height=""16"" font=""0"">indicate that the stated objective of the Section is to protect animal life and health within the </text>
<text top=""625"" left=""108"" width=""683"" height=""16"" font=""0"">United States from the entry, establishment, or spread of FMD, thus constituting an SPS measure </text>
<text top=""641"" left=""108"" width=""332"" height=""16"" font=""0"">within the meaning of Article 1.1 and Annex A.</text>
<footnote top=""639"" left=""440"" width=""17"" height=""11"" font=""16"" number=""190"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""570"" height=""15"" font=""10""> Argentina's first written submission, para. 711; Argentina's response to Panel question No. 2 </ftext>
<ftext top=""1066"" left=""108"" width=""241"" height=""15"" font=""10"">following the first substantive meeting. </ftext>
</footnote>
<text top=""641"" left=""457"" width=""335"" height=""16"" font=""0""> In Argentina's view, this is buttressed by the </text>
<text top=""657"" left=""108"" width=""682"" height=""16"" font=""0"">textual similarities between Section 737 and Section 727 of the <i>2009 Omnibus Appropriations Act</i> </text>
<text top=""674"" left=""108"" width=""683"" height=""16"" font=""0"">and by the fact that the latter was found to be an SPS measure under Article 1.1 and Annex A by </text>
<text top=""690"" left=""108"" width=""230"" height=""16"" font=""0"">the panel in <i>US &#8211; Poultry (China)</i>.</text>
<footnote top=""689"" left=""338"" width=""17"" height=""11"" font=""16"" number=""191"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""605"" height=""15"" font=""10""> Argentina's first written submission, paras. 709-710; Argentina's response to Panel question No. 2 </ftext>
<ftext top=""1095"" left=""108"" width=""241"" height=""15"" font=""10"">following the first substantive meeting. </ftext>
</footnote>
</p><p number=""7.2"" style=""8""><text top=""725"" left=""108"" width=""169"" height=""16"" font=""28"">7.2.2.2  United States </text></p><p number=""7.28"" style=""8""><text top=""759"" left=""108"" width=""688"" height=""16"" font=""0"">7.28.  The United States does not disagree with Argentina that the measures at issue are </text>
<text top=""775"" left=""108"" width=""469"" height=""16"" font=""0"">SPS measures which fall within the ambit of the SPS Agreement.</text>
<footnote top=""774"" left=""577"" width=""17"" height=""11"" font=""16"" number=""192"" ref="""" dis=""""/>
<text top=""775"" left=""595"" width=""199"" height=""16"" font=""0""> Indeed, the United States </text>
<text top=""792"" left=""108"" width=""689"" height=""16"" font=""0"">confirms that its measures ""are taken for a purpose set forth in Annex A(1)(a) of the </text>
<text top=""808"" left=""108"" width=""117"" height=""16"" font=""0"">SPS Agreement"".</text>
<footnote top=""807"" left=""225"" width=""17"" height=""11"" font=""16"" number=""193"" ref="""" dis=""""/>
<p><text top=""905"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 174. </text>
<footnote top=""934"" left=""165"" width=""328"" height=""15"" font=""10"" number=""413"" ref="""" dis=""""/>
</p><p><text top=""963"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 414. </text>
</p><p><text top=""993"" left=""108"" width=""542"" height=""15"" font=""10"">following the first substantive meeting; Argentina's second written submission, para. 80. </text>
<footnote top=""1007"" left=""165"" width=""312"" height=""15"" font=""10"" number=""337"" ref="""" dis=""""/>
</p><p><text top=""1036"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 704. </text>
</p><p><text top=""1109"" left=""165"" width=""367"" height=""15"" font=""10""> United States' second written submission, Annex, para. 10. </text>
<footnote top=""1124"" left=""165"" width=""537"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 50 - </text>
</p></p></page>
<page number=""50"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.29"" style=""8""><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">7.29.  The United States asserts that because Section 737 ""ceased to exist before this dispute was </text>
<text top=""144"" left=""108"" width=""431"" height=""16"" font=""0"">initiated"" it is not within the terms of reference of this dispute.</text>
<footnote top=""143"" left=""539"" width=""17"" height=""11"" font=""16"" number=""194"" ref="""" dis=""""/>
<text top=""144"" left=""556"" width=""234"" height=""16"" font=""0""> In the United States' view, to be </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">a measure subject to the Panel's terms of reference, ""the measure must be in force when the </text>
<text top=""177"" left=""108"" width=""202"" height=""16"" font=""0"">[DSB] established the panel"".</text>
<footnote top=""175"" left=""310"" width=""17"" height=""11"" font=""16"" number=""195"" ref="""" dis=""""/>
</p><p number=""7.2"" style=""8""><text top=""211"" left=""108"" width=""214"" height=""16"" font=""28"">7.2.3  Analysis by the Panel </text></p><p number=""7.30"" style=""8""><text top=""246"" left=""108"" width=""684"" height=""16"" font=""0"">7.30.  At the outset, we note that we bear an obligation, pursuant to Article 11 of the DSU, to </text>
<text top=""262"" left=""108"" width=""684"" height=""16"" font=""0"">make an objective assessment of the applicability of the relevant agreement. Thus, we proceed </text>
<text top=""278"" left=""108"" width=""683"" height=""16"" font=""0"">with an examination of Article 1 to establish whether we agree with the parties on this threshold </text>
<text top=""295"" left=""108"" width=""686"" height=""16"" font=""0"">issue. We concur with previous panels that Article 1 of the SPS Agreement provides for two </text>
<text top=""311"" left=""108"" width=""682"" height=""16"" font=""0"">requirements that must be fulfilled for the SPS Agreement to apply: (i) the measure at issue must </text>
<text top=""328"" left=""108"" width=""682"" height=""16"" font=""0"">be an SPS measure within the meaning of Article 1 and Annex A(1) of the SPS Agreement; and (ii) </text>
<text top=""344"" left=""108"" width=""294"" height=""16"" font=""0"">it must directly or indirectly affect trade.</text>
<footnote top=""343"" left=""402"" width=""17"" height=""11"" font=""16"" number=""196"" ref=""WT/DS26/R/USA"" dis=""DS26""><ftext top=""1007"" left=""165"" width=""601"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Hormones (United States)</i>, para. 8.36; <i>EC &#8211; Hormones (Canada)</i>, para. 8.39. </ftext>
</footnote>
<text top=""344"" left=""419"" width=""374"" height=""16"" font=""0""> The Panel will thus consider, in turn, whether the </text>
<text top=""360"" left=""108"" width=""393"" height=""16"" font=""0"">United States' measures comply with both requirements. </text>
</p><p number=""7.2"" style=""8""><text top=""395"" left=""108"" width=""684"" height=""16"" font=""28"">7.2.3.1  Whether  the  United States'  measures are SPS measures within the meaning of </text><text top=""411"" left=""108"" width=""92"" height=""16"" font=""28"">Annex A(1) </text></p><p number=""7.31"" style=""8""><text top=""446"" left=""108"" width=""683"" height=""16"" font=""0"">7.31.  The Appellate Body noted in its report in <i>Australia &#8211; Apples</i> that ""[a] fundamental element </text>
<text top=""462"" left=""108"" width=""682"" height=""16"" font=""0"">of  the  definition  of  'SPS measure'  set  out  in  Annex A(1)  is  that  such  a  measure  must  be  one </text>
<text top=""479"" left=""108"" width=""392"" height=""16"" font=""0"">'applied to protect' at least one of the listed interests"".</text>
<footnote top=""477"" left=""500"" width=""17"" height=""11"" font=""16"" number=""197"" ref="""" dis=""""/>
<text top=""479"" left=""517"" width=""275"" height=""16"" font=""0""> The Appellate Body further explained </text>
<text top=""495"" left=""108"" width=""685"" height=""16"" font=""0"">that the word ""applied"" points to the application of a measure, suggesting that a relationship </text>
<text top=""511"" left=""108"" width=""684"" height=""16"" font=""0"">between the measure and one of the objectives identified in Annex A(1) must be present in the </text>
<text top=""528"" left=""108"" width=""688"" height=""16"" font=""0"">measure itself, or otherwise evident from circumstances related to the application of the </text>
<text top=""544"" left=""108"" width=""64"" height=""16"" font=""0"">measure.</text>
<footnote top=""543"" left=""172"" width=""17"" height=""11"" font=""16"" number=""198"" ref="""" dis=""""/>
<text top=""544"" left=""189"" width=""606"" height=""16"" font=""0""> Consequently, the Appellate Body concluded by finding that ""the purpose of a </text>
<text top=""561"" left=""108"" width=""481"" height=""16"" font=""0"">measure is to be ascertained on the basis of objective considerations""</text>
<footnote top=""559"" left=""589"" width=""17"" height=""11"" font=""16"" number=""199"" ref="""" dis=""""/>
<text top=""561"" left=""606"" width=""184"" height=""16"" font=""0""> and a clear and objective </text>
<text top=""577"" left=""108"" width=""689"" height=""16"" font=""0"">relationship must exist between the measure in question and the purposes identified in </text>
<text top=""593"" left=""108"" width=""82"" height=""16"" font=""0"">Annex A(1).</text>
<footnote top=""592"" left=""190"" width=""17"" height=""11"" font=""16"" number=""200"" ref="""" dis=""""/>
<text top=""593"" left=""207"" width=""584"" height=""16"" font=""0""> In particular, the Appellate Body clarified that whether a measure is ""applied &#8230; to </text>
<text top=""610"" left=""108"" width=""684"" height=""16"" font=""0"">protect"" in the sense of Annex A(1)(a) ""must be ascertained not only from the objectives of the </text>
<text top=""626"" left=""108"" width=""686"" height=""16"" font=""0"">measure as expressed by the responding party, but also from the text and structure of the </text>
<text top=""643"" left=""108"" width=""685"" height=""16"" font=""0"">relevant measure, its surrounding regulatory context, and the way in which it is designed and </text>
<text top=""659"" left=""108"" width=""60"" height=""16"" font=""0"">applied.""</text>
<footnote top=""657"" left=""168"" width=""17"" height=""11"" font=""16"" number=""201"" ref="""" dis=""""/>
</p><p number=""7.32"" style=""8""><text top=""693"" left=""108"" width=""685"" height=""16"" font=""0"">7.32.  The second sentence of Annex A(1) sets forth that SPS measures may take the form of </text>
<text top=""710"" left=""108"" width=""686"" height=""16"" font=""0"">""laws, decrees, regulations, requirements and procedures"". This list is modified by the terms </text>
<text top=""726"" left=""108"" width=""683"" height=""16"" font=""0"">""including"" and ""all relevant"". The Appellate Body found that the use of these terms in the second </text>
<text top=""743"" left=""108"" width=""688"" height=""16"" font=""0"">sentence means that measures of a type not expressly listed may nevertheless constitute </text>
<text top=""759"" left=""108"" width=""686"" height=""16"" font=""0"">SPS measures when they are ""'relevant', that is, when they are 'applied' for a purpose that </text>
<text top=""775"" left=""108"" width=""683"" height=""16"" font=""0"">corresponds to one of those listed in subparagraphs (a) through (d). Conversely, the fact that an </text>
<text top=""792"" left=""108"" width=""683"" height=""16"" font=""0"">instrument is of a type listed in the last sentence of Annex A(1) is not, in itself, sufficient to bring </text>
<text top=""808"" left=""108"" width=""425"" height=""16"" font=""0"">such an instrument within the ambit of the SPS Agreement.""</text>
<footnote top=""807"" left=""533"" width=""17"" height=""11"" font=""16"" number=""202"" ref="""" dis=""""/>
<text top=""808"" left=""551"" width=""241"" height=""16"" font=""0""> With respect to the latter half of </text>
<text top=""825"" left=""108"" width=""393"" height=""16"" font=""0"">the second sentence, the Appellate Body concluded that: </text>
<p><text top=""859"" left=""151"" width=""597"" height=""16"" font=""0"">[I]t  is  a  list  of  examples  of  measures  that  may  fall  within  the  definition  of  an </text>
<text top=""875"" left=""151"" width=""601"" height=""16"" font=""0"">SPS measure, provided always that the measure manifests a clear and objective </text>
<text top=""892"" left=""151"" width=""604"" height=""16"" font=""0"">relationship with (is ""applied"" for) at least one of the purposes set out in </text>
<text top=""908"" left=""151"" width=""600"" height=""16"" font=""0"">subparagraphs (a) through (d). The list thus serves to illustrate, through a set of </text>
<text top=""925"" left=""151"" width=""601"" height=""16"" font=""0"">concrete examples, the different types of measures that, when they exhibit the </text>
</p><p><text top=""963"" left=""165"" width=""623"" height=""15"" font=""10""> United States' second written submission, Annex, para. 11. See also United States' response to Panel </text>
<footnote top=""1022"" left=""165"" width=""332"" height=""15"" font=""10"" number=""172"" ref="""" dis=""""><ftext top=""1080"" left=""108"" width=""140"" height=""15"" font=""12""><i>Products</i>, para. 7.139. </ftext>
</footnote>
<footnote top=""1095"" left=""165"" width=""332"" height=""15"" font=""10"" number=""173"" ref="""" dis=""""/>
</p><p><text top=""1124"" left=""165"" width=""332"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>,<i> </i>para. 175. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 51 - </text>
</p><p><text top=""128"" left=""151"" width=""597"" height=""16"" font=""0"">appropriate nexus to one of the specified purposes, will constitute SPS measures and, </text>
<text top=""144"" left=""151"" width=""487"" height=""16"" font=""0"">accordingly, be subject to the disciplines set out in the SPS Agreement.</text>
<footnote top=""143"" left=""637"" width=""17"" height=""11"" font=""16"" number=""203"" ref="""" dis=""""/>
</p></p></page>
<page number=""51"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.33"" style=""8""><text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">7.33.  Therefore, the determination of whether a measure is an SPS measure requires an inquiry </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">into whether the measure is of the type that may fall within the definition of an SPS measure and </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">whether it exhibits an appropriate nexus to one of the specified purposes in subparagraphs (a) </text>
<text top=""228"" left=""108"" width=""648"" height=""16"" font=""0"">through (d). The Panel will thus examine each of the challenged measures for these elements. </text>
</p><p number=""7.2"" style=""8""><text top=""262"" left=""108"" width=""356"" height=""16"" font=""28"">7.2.3.1.1  The 2001 Regulations and 9 CFR 94  </text></p><p number=""7.34"" style=""8""><text top=""296"" left=""108"" width=""49"" height=""16"" font=""0"">7.34. </text>
<text top=""296"" left=""153"" width=""86"" height=""16"" font=""0"">The 2001 </text>
<text top=""296"" left=""231"" width=""153"" height=""16"" font=""0"">Regulations and 9 </text>
<text top=""296"" left=""375"" width=""40"" height=""16"" font=""0"">CFR </text>
<text top=""296"" left=""406"" width=""393"" height=""16"" font=""0"">94 as published in the Federal Register of the </text>
<text top=""313"" left=""108"" width=""683"" height=""16"" font=""0"">United States and the Code of Federal Regulations, respectively, fall within the types of measures </text>
<text top=""329"" left=""108"" width=""685"" height=""16"" font=""0"">included in the indicative list of sanitary and phytosanitary measures set forth in the second </text>
<text top=""346"" left=""108"" width=""175"" height=""16"" font=""0"">sentence of Annex A(1).  </text>
</p><p number=""7.35"" style=""8""><text top=""380"" left=""108"" width=""684"" height=""16"" font=""0"">7.35.  Argentina has indicated, and the United States has not disagreed, that the purpose of the </text>
<text top=""396"" left=""108"" width=""682"" height=""16"" font=""0"">2001 Regulations and of 9 CFR 94 is that identified in Annex A(1)(a) &#8211; i.e. to protect the health of </text>
<text top=""413"" left=""108"" width=""685"" height=""16"" font=""0"">susceptible animals (ruminants and swine) within the territory of the United States from risks </text>
<text top=""429"" left=""108"" width=""391"" height=""16"" font=""0"">arising from the entry, establishment or spread of FMD.</text>
<footnote top=""428"" left=""499"" width=""17"" height=""11"" font=""16"" number=""204"" ref="""" dis=""""/>
<text top=""429"" left=""516"" width=""275"" height=""16"" font=""0""> This purpose can be derived from the </text>
<text top=""446"" left=""108"" width=""683"" height=""16"" font=""0"">text of the measures itself. The 2001 Regulations both refer specifically to the recent outbreak of </text>
<text top=""462"" left=""108"" width=""677"" height=""16"" font=""0"">FMD in Argentina and to the need to ""protect the livestock of the United States from foot-and-</text>
<text top=""479"" left=""108"" width=""114"" height=""16"" font=""0"">mouth disease"".</text>
<footnote top=""477"" left=""222"" width=""17"" height=""11"" font=""16"" number=""205"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""612"" height=""15"" font=""10""> 2001 Interim Rule on Argentina, (Exhibit ARG-29); 2001 Final Rule on Argentina, (Exhibit ARG-30). </ftext>
</footnote>
<text top=""479"" left=""239"" width=""555"" height=""16"" font=""0""> Furthermore, the statutory authority for the Department of Agriculture to </text>
<text top=""495"" left=""108"" width=""684"" height=""16"" font=""0"">implement 9 CFR 94 derives from the permission to prohibit or restrict importation or entry ""of </text>
<text top=""511"" left=""108"" width=""687"" height=""16"" font=""0"">animals, articles, or means of conveyance"" set forth in 7 USC 8303(a) if such actions are </text>
<text top=""528"" left=""108"" width=""660"" height=""16"" font=""0"">necessary to prevent the introduction or dissemination of pests or diseases that affect livestock.</text>
<footnote top=""526"" left=""768"" width=""17"" height=""11"" font=""16"" number=""206"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""580"" height=""15"" font=""10""> Although the terms are not identical, the Panel recognizes that preventing the ""introduction or </ftext>
<ftext top=""1124"" left=""108"" width=""613"" height=""15"" font=""10"">dissemination"" of a disease falls within the scope of preventing its entry, establishment, and spread. </ftext>
</footnote>
<text top=""544"" left=""108"" width=""685"" height=""16"" font=""0"">Thus, the 2001 Regulations and 9 CFR 94 manifest a clear and objective relationship with the </text>
<text top=""561"" left=""108"" width=""251"" height=""16"" font=""0"">purpose set forth in Annex A(1)(a).  </text>
</p><p number=""7.36"" style=""8""><text top=""595"" left=""108"" width=""686"" height=""16"" font=""0"">7.36.  As the 2001 Regulations and 9 CFR 94 fall within the indicative list of measures in the </text>
<text top=""611"" left=""108"" width=""684"" height=""16"" font=""0"">second sentence of Annex A(1) and are applied for the purpose described in Annex A(1)(a), we </text>
<text top=""628"" left=""108"" width=""615"" height=""16"" font=""0"">find that the 2001 Regulations and 9 CFR 94 are SPS measures as defined in Annex A(1). </text>
</p><p number=""7.2"" style=""8""><text top=""662"" left=""108"" width=""662"" height=""16"" font=""28"">7.2.3.1.2  Application of the procedures set forth in 9 CFR 92.2 to Argentina's requests </text></p><p number=""7.37"" style=""8""><text top=""697"" left=""108"" width=""684"" height=""16"" font=""0"">7.37.  The procedure in 9 CFR 92.2 is part of the process to determine whether products from a </text>
<text top=""713"" left=""108"" width=""685"" height=""16"" font=""0"">country or region pose a particular risk of introduction or dissemination of a pest or livestock </text>
<text top=""729"" left=""108"" width=""684"" height=""16"" font=""0"">disease into the United States. The procedure is set forth in the United States' Code of Federal </text>
<text top=""746"" left=""108"" width=""683"" height=""16"" font=""0"">Regulations and thus could fall within the reference to either ""regulations"" or ""procedures"" in the </text>
<text top=""762"" left=""108"" width=""222"" height=""16"" font=""0"">second sentence of Annex A(1). </text>
</p><p number=""7.38"" style=""8""><text top=""797"" left=""108"" width=""686"" height=""16"" font=""0"">7.38.  9 CFR 92.2 describes the information APHIS requires and the process APHIS follows to </text>
<text top=""813"" left=""108"" width=""683"" height=""16"" font=""0"">determine which countries or regions will be authorized to import (those listed in 9 CFR 94.1(a)) </text>
<text top=""829"" left=""108"" width=""687"" height=""16"" font=""0"">and which countries or regions are subject to the prohibition (9 CFR 94.1(b)). As we have </text>
<text top=""846"" left=""108"" width=""687"" height=""16"" font=""0"">concluded that 9 CFR 94 is applied for the purpose set forth in Annex A(1)(a), we likewise </text>
<text top=""862"" left=""108"" width=""682"" height=""16"" font=""0"">conclude that 9 CFR 92.2 also manifests a clear and objective relationship with that purpose. Thus, </text>
<text top=""879"" left=""108"" width=""390"" height=""16"" font=""0"">9 CFR 92.2 is an SPS measure as defined in Annex A(1). </text>
</p><p number=""7.39"" style=""8""><text top=""913"" left=""108"" width=""684"" height=""16"" font=""0"">7.39.  However,  although  9 CFR 92.2  is  <i>de jure</i> applied to protect animal life or health from the </text>
<text top=""929"" left=""108"" width=""684"" height=""16"" font=""0"">entry, establishment or spread of FMD, we note that Argentina is not challenging the content of </text>
<text top=""946"" left=""108"" width=""682"" height=""16"" font=""0"">9 CFR 92.2 ""as such"", but rather APHIS' application of these procedures to Argentina's requests for </text>
<text top=""962"" left=""108"" width=""684"" height=""16"" font=""0"">authorization to import. Therefore, the Panel must determine whether the measure ""as applied"" </text>
<text top=""979"" left=""108"" width=""262"" height=""16"" font=""0"">satisfies the definition in Annex A(1).  </text>
<p><text top=""1022"" left=""165"" width=""332"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 176. </text>
<footnote top=""1036"" left=""165"" width=""587"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""/>
</p><p><text top=""1051"" left=""108"" width=""667"" height=""15"" font=""10"">potential economic ramifications of the entry of FMD into the United States that the United States presents in </text>
<text top=""1066"" left=""108"" width=""678"" height=""15"" font=""10"">its first written submission. See United States' first written submission, paras. 41-47. However, Argentina need </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 52 - </text>
</p></p></page>
<page number=""52"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""19"" size=""11"" family=""Times"" color=""#006284""/>
<p number=""7.40"" style=""8""><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">7.40.  In our view, the reference to ""procedures"" in the second sentence of Annex A(1) is broad </text>
<text top=""144"" left=""108"" width=""691"" height=""16"" font=""0"">enough to encompass both procedures of general application as well as the specific </text>
<text top=""160"" left=""108"" width=""389"" height=""16"" font=""0"">implementation of a procedure in a particular instance.</text>
<footnote top=""159"" left=""497"" width=""17"" height=""11"" font=""16"" number=""207"" ref=""WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1"" dis=""DS292|DS291|DS293""><ftext top=""963"" left=""165"" width=""580"" height=""15"" font=""10""> Our understanding is confirmed by the findings of the panel in <i>EC &#8211; Approval and Marketing of </i></ftext>
<ftext top=""978"" left=""108"" width=""664"" height=""15"" font=""12""><i>Biotech Products</i>, which found that the <i>application</i> of a general moratorium of approvals for placing GMOs on </ftext>
<ftext top=""993"" left=""108"" width=""663"" height=""15"" font=""10"">the market are inconsistent with Article 8 and Annex C(1)(a). (Panel Report, <i>EC &#8211; Approval and Marketing of </i></ftext>
<ftext top=""1007"" left=""108"" width=""251"" height=""15"" font=""12""><i>Biotech Products</i>, paras. 7.1568-7.1569) </ftext>
</footnote>
<text top=""160"" left=""515"" width=""277"" height=""16"" font=""0""> Furthermore, we recall the consistent </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">practice in WTO dispute settlement pursuant to Article 3.3 of the DSU that any act or omission </text>
<text top=""193"" left=""108"" width=""660"" height=""16"" font=""0"">attributable to a Member may be challenged as a ""measure"" for dispute settlement purposes.</text>
<footnote top=""192"" left=""768"" width=""17"" height=""11"" font=""16"" number=""208"" ref="""" dis=""""/>
<text top=""210"" left=""108"" width=""686"" height=""16"" font=""0"">Panels and the Appellate Body have in many instances permitted Members to challenge the </text>
<text top=""226"" left=""108"" width=""605"" height=""16"" font=""0"">specific application of particular laws, regulations, procedures or practices as measures.</text>
<footnote top=""225"" left=""713"" width=""17"" height=""11"" font=""16"" number=""209"" ref=""WT/DS268/AB/R|WT/DS268/AB/RW"" dis=""DS268""><ftext top=""1036"" left=""165"" width=""614"" height=""15"" font=""10""> See e.g. Appellate Body Reports, <i>US &#8211; Oil Country Tubular Goods Sunset Reviews</i>, paras. 167, 172; </ftext>
</footnote>
<text top=""226"" left=""730"" width=""61"" height=""16"" font=""0""> We see </text>
<text top=""242"" left=""108"" width=""525"" height=""16"" font=""0"">no reason why this would be different in the context of the SPS Agreement.  </text>
</p><p number=""7.41"" style=""8""><text top=""277"" left=""108"" width=""687"" height=""16"" font=""0"">7.41.  Therefore, we find that the application of 9 CFR 92.2 to APHIS' review of Argentina's </text>
<text top=""293"" left=""108"" width=""558"" height=""16"" font=""0"">requests for authorization to import is an SPS measure as defined in Annex A(1). </text>
</p><p number=""7.2"" style=""8""><text top=""328"" left=""108"" width=""481"" height=""16"" font=""8""><b>7.2.3.1.3  Section 737 of the <i>2009 Omnibus Appropriations Act</i></b><b> </b></text>
</p><p number=""7.42"" style=""8""><text top=""362"" left=""108"" width=""684"" height=""16"" font=""0"">7.42.  Turning to Section 737 of the <i>2009 Omnibus Appropriations Act</i> (Section 737), Argentina </text>
<text top=""378"" left=""108"" width=""684"" height=""16"" font=""0"">argued in its response to the Panel's questions that such provision is an SPS measure that falls </text>
<text top=""395"" left=""108"" width=""240"" height=""16"" font=""0"">within the scope of Annex A(1)(a).</text>
<footnote top=""393"" left=""348"" width=""17"" height=""11"" font=""16"" number=""210"" ref="""" dis=""""/>
<text top=""395"" left=""365"" width=""426"" height=""16"" font=""0""> We note that Section 737 directly regulates the authority of </text>
<text top=""411"" left=""108"" width=""684"" height=""16"" font=""0"">the Secretary of Agriculture to approve the importation of the relevant products from Argentina </text>
<text top=""428"" left=""108"" width=""682"" height=""16"" font=""0"">and that it prevents him from taking such action until he has ""reviewed the domestic animal health </text>
<text top=""444"" left=""108"" width=""683"" height=""16"" font=""0"">aspects of the pending proposal to allow the importation of such products into the United States </text>
<text top=""461"" left=""108"" width=""514"" height=""16"" font=""0"">and has issued a report to the Committees on the findings of such review.""</text>
<footnote top=""459"" left=""622"" width=""17"" height=""11"" font=""16"" number=""211"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""494"" height=""15"" font=""10""> Section 737 of the <i>2009 Omnibus Appropriations Act</i>, (Exhibit ARG-45/USA-95). </ftext>
</footnote>
<text top=""461"" left=""639"" width=""151"" height=""16"" font=""0""> Thus, the purpose of </text>
<text top=""477"" left=""108"" width=""683"" height=""16"" font=""0"">Section 737 is directly linked to the risks to health of domestic animals in the United States from </text>
<text top=""493"" left=""108"" width=""687"" height=""16"" font=""0"">the potential importation of the relevant Argentine or Patagonian products pursuant to the </text>
<text top=""510"" left=""108"" width=""684"" height=""16"" font=""18""><i>proposal pending</i> at the time, which was the Proposed Rule to designate Patagonia as FMD-free </text>
<text top=""526"" left=""108"" width=""391"" height=""16"" font=""0"">and to permit importation according to certain protocols. </text>
</p><p number=""7.43"" style=""8""><text top=""561"" left=""108"" width=""683"" height=""16"" font=""0"">7.43.  With respect to the second sentence of Annex A(1), we note that Section 737 is a provision </text>
<text top=""577"" left=""108"" width=""684"" height=""16"" font=""0"">of a law enacted by Congress and signed by the President of the United States. As such, it falls </text>
<text top=""593"" left=""108"" width=""660"" height=""16"" font=""0"">within the scope of ""laws, decrees, regulations, requirements and procedures"" in Annex A(1).</text>
<footnote top=""592"" left=""768"" width=""17"" height=""11"" font=""16"" number=""212"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""1095"" left=""165"" width=""302"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>,<i> </i>para. 7.119. </ftext>
</footnote>
<text top=""610"" left=""108"" width=""687"" height=""16"" font=""0"">Given the relationship between the operation of Section 737 and the requirement that the </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">Secretary of Agriculture assure Congress through a specific report on the animal health aspects of </text>
<text top=""643"" left=""108"" width=""684"" height=""16"" font=""0"">permitting importation of ruminant and swine products from Argentina, we find that a sufficient </text>
<text top=""659"" left=""108"" width=""684"" height=""16"" font=""0"">nexus exists between this law and the purpose set forth in Annex A(1)(a). Therefore, the Panel </text>
<text top=""675"" left=""108"" width=""470"" height=""16"" font=""0"">finds that Section 737 is an SPS measure as defined in Annex A(1).  </text>
</p><p number=""7.2"" style=""8""><text top=""710"" left=""108"" width=""684"" height=""16"" font=""28"">7.2.3.2  Whether  the  United States'  measures  directly or indirectly affect international </text><text top=""726"" left=""108"" width=""45"" height=""16"" font=""28"">trade </text></p><p number=""7.44"" style=""8""><text top=""761"" left=""108"" width=""49"" height=""16"" font=""0"">7.44. </text>
<text top=""761"" left=""153"" width=""517"" height=""16"" font=""0"">We now turn to whether the measures imposed by the United </text>
<text top=""761"" left=""662"" width=""136"" height=""16"" font=""0"">States constitute </text>
<text top=""777"" left=""108"" width=""684"" height=""16"" font=""0"">SPS measures that directly or indirectly affect international trade. As explained by the panel in </text>
<text top=""793"" left=""108"" width=""683"" height=""16"" font=""18""><i>India &#8211; Agricultural Products</i>, an import ban, by its very nature, is intended to affect international </text>
<text top=""810"" left=""108"" width=""40"" height=""16"" font=""0"">trade.</text>
<footnote top=""808"" left=""149"" width=""17"" height=""11"" font=""16"" number=""213"" ref=""WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430""><ftext top=""1109"" left=""165"" width=""345"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i> para. 7.157. </ftext>
</footnote>
<text top=""810"" left=""166"" width=""626"" height=""16"" font=""0""> The panels in <i>EC &#8211; Hormones</i> went further and concluded that ""it cannot be contested </text>
<text top=""826"" left=""108"" width=""319"" height=""16"" font=""0"">that an import ban affects international trade"".</text>
<footnote top=""825"" left=""427"" width=""17"" height=""11"" font=""16"" number=""214"" ref=""WT/DS26/R/USA"" dis=""DS26""><ftext top=""1124"" left=""165"" width=""601"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Hormones (United States)</i>, para. 8.23; <i>EC &#8211; Hormones (Canada)</i>, para. 8.26. </ftext>
</footnote>
</p><p number=""7.45"" style=""8""><text top=""861"" left=""108"" width=""684"" height=""16"" font=""0"">7.45.  Although the United States argues that its measures are based on international standards </text>
<text top=""877"" left=""108"" width=""683"" height=""16"" font=""0"">and that it is diligently working to analyse Argentina's applications to import, it does not dispute </text>
<text top=""893"" left=""108"" width=""682"" height=""16"" font=""0"">that the measures in place at the time of establishment of the Panel were total import prohibitions </text>
<text top=""910"" left=""108"" width=""684"" height=""16"" font=""0"">on fresh (chilled or frozen) beef from Northern Argentina and on ruminant and swine products </text>
<text top=""926"" left=""108"" width=""118"" height=""16"" font=""0"">from Patagonia.  </text>
<p><text top=""1022"" left=""165"" width=""495"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Corrosion-Resistant Steel Sunset Review</i>, para. 81. </text>
</p><p><text top=""1051"" left=""108"" width=""187"" height=""15"" font=""12""><i>US &#8211; Carbon Steel</i>, para. 171. </text>
<text top=""1066"" left=""165"" width=""521"" height=""15"" font=""10""> Argentina's response to Panel question No. 2 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 53 - </text>
</p></p></page>
<page number=""53"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.46"" style=""8""><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">7.46.  In particular, we note that the 2001 Regulations and the current version of 9 CFR 94.1(b) </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">specifically prohibit the importation of the relevant products from either Northern Argentina or </text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""0"">Patagonia. Further, the application process in 9 CFR 92.2 specifically states that any existing </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">prohibition remains in place unless and until the outcome of the process leads to a decision to </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">authorize imports. Additionally, Section 737 prevents the Secretary of Agriculture from completing </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">the process under 9 CFR 92.2 until he submits a report to Congress. Therefore, the extension of </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">the time required for the review or the lack of any conclusion to the review of Argentina's </text>
<text top=""242"" left=""108"" width=""690"" height=""16"" font=""0"">applications for imports of fresh (chilled or frozen) beef from Northern Argentina and </text>
<text top=""259"" left=""108"" width=""687"" height=""16"" font=""0"">FMD-susceptible animals and animal products from Patagonia has the effect of keeping the </text>
<text top=""275"" left=""108"" width=""139"" height=""16"" font=""0"">prohibition in place. </text>
</p><p number=""7.47"" style=""8""><text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">7.47.  Thus, consistent with the understandings of the panels in <i>India &#8211; Agricultural Products </i>and </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""18""><i>EC &#8211; Hormones</i>,<i> </i>we conclude that the measures at issue directly or indirectly affect international </text>
<text top=""342"" left=""108"" width=""45"" height=""16"" font=""0"">trade. </text>
</p><p number=""7.2"" style=""8""><text top=""377"" left=""108"" width=""135"" height=""16"" font=""28"">7.2.4  Conclusion </text></p><p number=""7.48"" style=""8""><text top=""411"" left=""108"" width=""686"" height=""16"" font=""0"">7.48.  The Panel has determined that the United States' measures are applied to achieve the </text>
<text top=""428"" left=""108"" width=""682"" height=""16"" font=""0"">purpose set forth in Annex A(1)(a), that they take one of the forms listed in the main paragraph of </text>
<text top=""444"" left=""108"" width=""685"" height=""16"" font=""0"">Annex A(1), and that they directly or indirectly affect international trade. Therefore, the Panel </text>
<text top=""461"" left=""108"" width=""688"" height=""16"" font=""0"">finds that the United States' measures are SPS measures subject to the disciplines of the </text>
<text top=""477"" left=""108"" width=""116"" height=""16"" font=""0"">SPS Agreement. </text>
</p><p number=""7.49"" style=""8""><text top=""511"" left=""108"" width=""684"" height=""16"" font=""0"">7.49.  With respect to the consequential claim under Article 1.1, we will return to this after we </text>
<text top=""528"" left=""108"" width=""433"" height=""16"" font=""0"">have completed our analysis of Argentina's substantive claims. </text>
</p><p number=""7.3"" style=""8""><text top=""562"" left=""108"" width=""379"" height=""16"" font=""28"">7.3  Control, inspection and approval procedures  </text></p><p number=""7.3"" style=""8""><text top=""597"" left=""108"" width=""243"" height=""16"" font=""28"">7.3.1  Relevant legal provisions </text></p><p number=""7.50"" style=""8""><text top=""631"" left=""108"" width=""686"" height=""16"" font=""0"">7.50.  Article 8  of  the  SPS Agreement,  entitled  ""Control, Inspection and Approval Procedures"", </text>
<text top=""647"" left=""108"" width=""120"" height=""16"" font=""0"">reads as follows: </text>
<p><text top=""682"" left=""151"" width=""603"" height=""16"" font=""0"">Members shall observe the provisions of Annex C in the operation of control, </text>
<text top=""698"" left=""151"" width=""598"" height=""16"" font=""0"">inspection and approval procedures, including national systems for approving the use </text>
<text top=""715"" left=""151"" width=""600"" height=""16"" font=""0"">of additives or for establishing tolerances for contaminants in foods, beverages or </text>
<text top=""731"" left=""151"" width=""599"" height=""16"" font=""0"">feedstuffs, and otherwise ensure that their procedures are not inconsistent with the </text>
<text top=""747"" left=""151"" width=""205"" height=""16"" font=""0"">provisions of this Agreement. </text>
</p></p><p number=""7.51"" style=""8""><text top=""782"" left=""108"" width=""684"" height=""16"" font=""0"">7.51.  In turn, Annex C(1) of the SPS Agreement, which is also entitled ""Control, Inspection and </text>
<text top=""798"" left=""108"" width=""318"" height=""16"" font=""0"">Approval Procedures"", reads, in relevant part: </text>
</p><p number=""1."" style=""6""><text top=""833"" left=""151"" width=""25"" height=""16"" font=""0"">1.  </text>
<text top=""833"" left=""193"" width=""556"" height=""16"" font=""0"">Members shall ensure, with respect to any procedure to check and ensure the </text>
<text top=""849"" left=""151"" width=""376"" height=""16"" font=""0"">fulfilment of sanitary or phytosanitary measures, that: </text>
</p><p number=""(a)"" style=""3""><text top=""883"" left=""193"" width=""541"" height=""16"" font=""0"">(a)   such procedures are undertaken and completed without undue delay &#8230; ; </text>
</p><p number=""(b)"" style=""3""><text top=""918"" left=""193"" width=""555"" height=""16"" font=""0"">(b)   the standard processing period of each procedure is published or that the </text>
<text top=""934"" left=""235"" width=""518"" height=""16"" font=""0"">anticipated processing period is communicated to the applicant upon </text>
<text top=""951"" left=""235"" width=""517"" height=""16"" font=""0"">request; when receiving an application, the competent body promptly </text>
<text top=""967"" left=""235"" width=""520"" height=""16"" font=""0"">examines the completeness of the documentation and informs the </text>
<text top=""983"" left=""235"" width=""518"" height=""16"" font=""0"">applicant in a precise and complete manner of all deficiencies; the </text>
<text top=""1000"" left=""235"" width=""520"" height=""16"" font=""0"">competent body transmits as soon as possible the results of the </text>
<text top=""1016"" left=""235"" width=""516"" height=""16"" font=""0"">procedure in a precise and complete manner to the applicant so that </text>
<text top=""1033"" left=""235"" width=""515"" height=""16"" font=""0"">corrective action may be taken if necessary; even when the application </text>
<text top=""1049"" left=""235"" width=""514"" height=""16"" font=""0"">has deficiencies, the competent body proceeds as far as practicable with </text>
<text top=""1066"" left=""235"" width=""515"" height=""16"" font=""0"">the procedure if the applicant so requests; and that upon request, the </text>
<text top=""1082"" left=""235"" width=""514"" height=""16"" font=""0"">applicant is informed of the stage of the procedure, with any delay being </text>
<text top=""1098"" left=""235"" width=""92"" height=""16"" font=""0"">explained; &#8230; </text>
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 54 - </text>
</p></p></page>
<page number=""54"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.52"" style=""8""><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">7.52.  Footnote 7 to Annex C(1) clarifies that ""[c]ontrol, inspection and approval procedures </text>
<text top=""144"" left=""108"" width=""482"" height=""16"" font=""0"">include, <i>inter alia</i>, procedures for sampling, testing and certification"".  </text>
</p><p number=""7.53"" style=""8""><text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">7.53.  As the United States has argued that the procedures at issue in this dispute are not of the </text>
<text top=""195"" left=""108"" width=""686"" height=""16"" font=""0"">type subject to the obligations in Article 8 and Annex C(1), the Panel will address, first, the </text>
<text top=""211"" left=""108"" width=""686"" height=""16"" font=""0"">question of whether Article 8 and Annex C(1) of the SPS Agreement are applicable to APHIS' </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">review processes of Argentina's requests for imports of fresh (chilled or frozen) beef from Northern </text>
<text top=""244"" left=""108"" width=""688"" height=""16"" font=""0"">Argentina and for recognition of Patagonia as FMD-free. If the provisions in question are </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">applicable, the Panel will assess Argentina's claims that the United States' measures at issue are </text>
<text top=""277"" left=""108"" width=""403"" height=""16"" font=""0"">inconsistent with Article 8 and Annex C(1)(a) and C(1)(b). </text>
</p><p number=""7.3"" style=""8""><text top=""311"" left=""108"" width=""683"" height=""16"" font=""28"">7.3.2  Whether the application of the procedures set forth in 9 CFR 92.2 to Argentina's </text><text top=""328"" left=""108"" width=""624"" height=""16"" font=""28"">requests falls within the scope of Article 8 and Annex C(1) of the SPS Agreement  </text></p><p number=""7.3"" style=""8""><text top=""362"" left=""108"" width=""296"" height=""16"" font=""28"">7.3.2.1  Main arguments of the parties </text></p><p number=""7.3"" style=""8""><text top=""396"" left=""108"" width=""156"" height=""16"" font=""28"">7.3.2.1.1  Argentina </text></p><p number=""7.54"" style=""8""><text top=""431"" left=""108"" width=""686"" height=""16"" font=""0"">7.54.  Argentina submits that the procedures set forth in 9 CFR 92.2 constitute an ""approval </text>
<text top=""447"" left=""108"" width=""686"" height=""16"" font=""0"">procedure"" within the meaning of Article 8 and Annex C of the SPS Agreement. It argues, in </text>
<text top=""464"" left=""108"" width=""686"" height=""16"" font=""0"">particular, that because imports of animals or animal products from a region or country are </text>
<text top=""480"" left=""108"" width=""618"" height=""16"" font=""0"">conditioned upon the evaluation of its FMD status under the procedures under 9 CFR 92.2</text>
<footnote top=""479"" left=""726"" width=""17"" height=""11"" font=""16"" number=""215"" ref="""" dis=""""/>
<text top=""480"" left=""744"" width=""47"" height=""16"" font=""0"">, such </text>
<text top=""497"" left=""108"" width=""688"" height=""16"" font=""0"">procedures are ""analogous to the types of procedures specifically articulated in Annex C"", </text>
<text top=""513"" left=""108"" width=""660"" height=""16"" font=""0"">especially procedures for ""sampling, testing and certification"" listed in footnote 7 to Annex C.</text>
<footnote top=""511"" left=""768"" width=""17"" height=""11"" font=""16"" number=""216"" ref="""" dis=""""/>
<text top=""529"" left=""108"" width=""687"" height=""16"" font=""0"">Moreover, Argentina considers that the procedures set forth in 9 CFR 92.2 ""are imposed to </text>
<text top=""546"" left=""108"" width=""685"" height=""16"" font=""0"">'ensure'"" compliance with the requirement under 9 CFR 94 that animal and animal products be </text>
<text top=""562"" left=""108"" width=""687"" height=""16"" font=""0"">imported ""only from those countries and regions which APHIS has declared free of certain </text>
<text top=""579"" left=""108"" width=""174"" height=""16"" font=""0"">diseases, including FMD"".</text>
<footnote top=""577"" left=""282"" width=""17"" height=""11"" font=""16"" number=""217"" ref="""" dis=""""/>
<text top=""579"" left=""299"" width=""491"" height=""16"" font=""0""> Therefore, the application of those procedures to Argentina's requests </text>
<text top=""595"" left=""108"" width=""393"" height=""16"" font=""0"">are subject to the obligations in Article 8 and Annex C(1).</text>
<footnote top=""593"" left=""501"" width=""17"" height=""11"" font=""16"" number=""218"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""613"" height=""15"" font=""10""> Argentina's first written submission, paras. 603-606; Argentina's response to Panel question No. 58 </ftext>
<ftext top=""1007"" left=""108"" width=""241"" height=""15"" font=""10"">following the first substantive meeting. </ftext>
</footnote>
</p><p number=""7.55"" style=""8""><text top=""629"" left=""108"" width=""682"" height=""16"" font=""0"">7.55.  Argentina further argues that the reference in Annex C(1) to ""any procedure"", which aims to </text>
<text top=""646"" left=""108"" width=""688"" height=""16"" font=""0"">""check and ensure the fulfilment of sanitary and phytosanitary measures"" suggests broad </text>
<text top=""662"" left=""108"" width=""443"" height=""16"" font=""0"">construction of the scope of coverage of Article 8 and Annex C.</text>
<footnote top=""661"" left=""550"" width=""17"" height=""11"" font=""16"" number=""219"" ref="""" dis=""""/>
<text top=""662"" left=""568"" width=""223"" height=""16"" font=""0""> Moreover, in Argentina's view, </text>
<text top=""679"" left=""108"" width=""685"" height=""16"" font=""0"">the fact that the lists of measures enumerated in Article 8 and Annex C are introduced by the </text>
<text top=""695"" left=""108"" width=""682"" height=""16"" font=""0"">words ""including"" and ""include, <i>inter alia</i>"", respectively, indicates that such lists are indicative and </text>
<text top=""711"" left=""108"" width=""106"" height=""16"" font=""0"">not exhaustive.</text>
<footnote top=""710"" left=""214"" width=""17"" height=""11"" font=""16"" number=""220"" ref="""" dis=""""/>
<text top=""711"" left=""231"" width=""559"" height=""16"" font=""0""> Moreover, Argentina observes that, according to the Appellate Body, ""measures </text>
<text top=""728"" left=""108"" width=""682"" height=""16"" font=""0"">which are not, technically, 'procedures' but which impede the process of undertaking or completing </text>
<text top=""744"" left=""108"" width=""412"" height=""16"" font=""0"">procedures, may also give rise to a violation"" of Annex C(1).</text>
<footnote top=""743"" left=""520"" width=""17"" height=""11"" font=""16"" number=""221"" ref="""" dis=""""/>
</p><p number=""7.56"" style=""8""><text top=""779"" left=""108"" width=""686"" height=""16"" font=""0"">7.56.  Finally, Argentina takes issue with the United States' argument that the obligations in </text>
<text top=""795"" left=""108"" width=""682"" height=""16"" font=""0"">Article 8 and Annex C are limited to procedures that govern products or substances, as opposed to </text>
<text top=""811"" left=""108"" width=""684"" height=""16"" font=""0"">determinations of the FMD status of countries or regions. For Argentina, ""nowhere in the text of </text>
<text top=""828"" left=""108"" width=""633"" height=""16"" font=""0"">the treaty are the words 'control, inspection and approval procedures' so narrowly qualified"".</text>
<footnote top=""826"" left=""741"" width=""17"" height=""11"" font=""16"" number=""222"" ref="""" dis=""""/>
<p><text top=""905"" left=""165"" width=""587"" height=""15"" font=""10""> Argentina's response to Panel question No. 2 following the first substantive meeting; Argentina' </text>
<text top=""920"" left=""108"" width=""236"" height=""15"" font=""10"">second written submission, para. 341. </text>
<footnote top=""934"" left=""165"" width=""606"" height=""15"" font=""10"" number=""610"" ref="""" dis=""""><ftext top=""978"" left=""108"" width=""594"" height=""15"" font=""10"">No. 58 following the first substantive meeting; Argentina's second written submission, para. 337. </ftext>
</footnote>
</p><p><text top=""949"" left=""108"" width=""502"" height=""15"" font=""10"">meeting of the Panel, para. 85; Argentina's second written submission, para. 338. </text>
</p><p><text top=""1022"" left=""165"" width=""602"" height=""15"" font=""10""> Argentina's opening statement at the first meeting of the Panel, para. 84; Argentina's response to </text>
<footnote top=""1036"" left=""108"" width=""619"" height=""15"" font=""10"" number=""58"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""1080"" left=""108"" width=""647"" height=""15"" font=""10"">second written submission, paras. 332-334 (referring to Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.363). </ftext>
</footnote>
</p><p><text top=""1051"" left=""108"" width=""67"" height=""15"" font=""10"">para. 331. </text>
</p><p><text top=""1095"" left=""165"" width=""598"" height=""15"" font=""10""> Argentina's second written submission, para. 335 (referring to Appellate Body Report, <i>Australia &#8211; </i></text>
<text top=""1109"" left=""108"" width=""156"" height=""15"" font=""12""><i>Apples</i>, paras. 438-440). </text>
<text top=""1124"" left=""165"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 345. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 55 - </text>
</p></p></page>
<page number=""55"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.3"" style=""8""><text top=""128"" left=""108"" width=""184"" height=""16"" font=""28"">7.3.2.1.2  United States </text></p><p number=""7.57"" style=""8""><text top=""162"" left=""108"" width=""683"" height=""16"" font=""0"">7.57.  The United States argues that Article 8 and Annex C do not apply to processes carried out </text>
<text top=""178"" left=""108"" width=""685"" height=""16"" font=""0"">pursuant to 9 CFR 92.2 because the provisions in question do not govern the determination of </text>
<text top=""195"" left=""108"" width=""688"" height=""16"" font=""0"">disease status for geographical areas, but rather address control, inspection and approval </text>
<text top=""211"" left=""108"" width=""225"" height=""16"" font=""0"">procedures for specific products.</text>
<footnote top=""210"" left=""333"" width=""17"" height=""11"" font=""16"" number=""223"" ref="""" dis=""""><ftext top=""891"" left=""165"" width=""620"" height=""15"" font=""10""> United States' first written submission, paras. 176-178; United States' opening statement at the first </ftext>
<ftext top=""905"" left=""108"" width=""677"" height=""15"" font=""10"">meeting of the Panel, para. 28; United States' response to Panel question No. 58 following the first substantive </ftext>
<ftext top=""920"" left=""108"" width=""659"" height=""15"" font=""10"">meeting; United States' second written submission, paras. 51-59; United States' response to Panel question </ftext>
</footnote>
<text top=""211"" left=""350"" width=""441"" height=""16"" font=""0""> In support of its contention, the United States points out that </text>
<text top=""228"" left=""108"" width=""624"" height=""16"" font=""0"">footnote 7 of Annex C makes no reference to examination of disease-free status.</text>
<footnote top=""226"" left=""732"" width=""17"" height=""11"" font=""16"" number=""224"" ref="""" dis=""""/>
<text top=""228"" left=""749"" width=""47"" height=""16"" font=""0""> The </text>
<text top=""244"" left=""108"" width=""685"" height=""16"" font=""0"">United States also notes that the illustrative examples in Annex C of the types of procedures </text>
<text top=""260"" left=""108"" width=""400"" height=""16"" font=""0"">covered do not include disease-free status determinations.</text>
<footnote top=""259"" left=""508"" width=""17"" height=""11"" font=""16"" number=""225"" ref="""" dis=""""/>
<text top=""260"" left=""526"" width=""264"" height=""16"" font=""0""> Finally, the United States argues that </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">subparagraphs (a), (d), (e), (f), (g), and (h) of Annex C(1) provide support for its conclusion that </text>
<text top=""293"" left=""108"" width=""685"" height=""16"" font=""0"">the procedures covered by Annex C are those designed to check and ensure the fulfilment of </text>
<text top=""310"" left=""108"" width=""526"" height=""16"" font=""0"">SPS measures as applied to specific products rather than geographical areas.</text>
<footnote top=""308"" left=""634"" width=""17"" height=""11"" font=""16"" number=""226"" ref="""" dis=""""/>
</p><p number=""7.58"" style=""8""><text top=""344"" left=""108"" width=""684"" height=""16"" font=""0"">7.58.  Furthermore, the United States contends that Article 8 on its face applies only to control, </text>
<text top=""360"" left=""108"" width=""420"" height=""16"" font=""0"">inspection or approval procedures, and not all SPS measures.</text>
<footnote top=""359"" left=""528"" width=""17"" height=""11"" font=""16"" number=""227"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""611"" height=""15"" font=""10""> United States' first written submission, para. 181. United States' response to Panel question No. 58 </ftext>
<ftext top=""1007"" left=""108"" width=""586"" height=""15"" font=""10"">following the first substantive meeting; United States' second written submission, paras. 52-54. </ftext>
</footnote>
<text top=""360"" left=""545"" width=""245"" height=""16"" font=""0""> According to the United States, an </text>
<text top=""377"" left=""108"" width=""683"" height=""16"" font=""0"">understanding that Article 8 and Annex C govern any measures that impose conditions on import </text>
<text top=""393"" left=""108"" width=""376"" height=""16"" font=""0"">would make Annex C applicable to every SPS measure.</text>
<footnote top=""392"" left=""484"" width=""17"" height=""11"" font=""16"" number=""228"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""428"" left=""108"" width=""337"" height=""16"" font=""28"">7.3.2.2  Main arguments of the third parties </text></p><p number=""7.3"" style=""8""><text top=""462"" left=""108"" width=""125"" height=""16"" font=""28"">7.3.2.2.1  Brazil </text></p><p number=""7.59"" style=""8""><text top=""497"" left=""108"" width=""683"" height=""16"" font=""0"">7.59.  Relying on the panel report in <i>Australia &#8211; Salmon (Article 21.5 &#8211; Canada)</i>, Brazil considers </text>
<text top=""513"" left=""108"" width=""685"" height=""16"" font=""0"">that Article 8 and Annex C(1) apply to procedures that have been implemented to ensure the </text>
<text top=""529"" left=""108"" width=""620"" height=""16"" font=""0"">fulfilment of SPS measures, but they do not cover the ""substantive measures"" themselves.</text>
<footnote top=""528"" left=""728"" width=""17"" height=""11"" font=""16"" number=""229"" ref="""" dis=""""/>
<text top=""529"" left=""745"" width=""45"" height=""16"" font=""0""> In its </text>
<text top=""546"" left=""108"" width=""687"" height=""16"" font=""0"">view, determinations of disease status for geographical areas fall within the ambit of such </text>
<text top=""562"" left=""108"" width=""685"" height=""16"" font=""0"">provisions as they are ""part of the procedures to ensure the fulfilment and application of an </text>
<text top=""579"" left=""108"" width=""101"" height=""16"" font=""0"">SPS measure"".</text>
<footnote top=""577"" left=""209"" width=""17"" height=""11"" font=""16"" number=""230"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""613"" left=""108"" width=""124"" height=""16"" font=""28"">7.3.2.2.2  China </text></p><p number=""7.60"" style=""8""><text top=""647"" left=""108"" width=""683"" height=""16"" font=""0"">7.60.  In China's view, Article 8 and Annex C(1) of the SPS Agreement have broad coverage and </text>
<text top=""664"" left=""108"" width=""490"" height=""16"" font=""0"">do not specify or exclude any type of procedures from their application.</text>
<footnote top=""662"" left=""597"" width=""17"" height=""11"" font=""16"" number=""231"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""618"" height=""15"" font=""10""> China's third-party submission, para. 69. See also China's third-party statement, paras. 7-9; China's </ftext>
</footnote>
<text top=""664"" left=""615"" width=""175"" height=""16"" font=""0""> Indeed, China observes, </text>
<text top=""680"" left=""108"" width=""683"" height=""16"" font=""0"">the panel in <i>US &#8211; Poultry (China)</i> considered that Annex C(1) covers any procedure that is aimed </text>
<text top=""697"" left=""108"" width=""391"" height=""16"" font=""0"">at checking and ensuring the fulfilment of SPS measures.</text>
<footnote top=""695"" left=""499"" width=""17"" height=""11"" font=""16"" number=""232"" ref="""" dis=""""/>
<text top=""697"" left=""516"" width=""274"" height=""16"" font=""0""> China also notes that, according to the </text>
<text top=""713"" left=""108"" width=""688"" height=""16"" font=""0"">Appellate Body in <i>Australia &#8211; Apples</i>, Article 8 and Annex C(1) do not necessarily exclude </text>
<text top=""729"" left=""108"" width=""691"" height=""16"" font=""0"">measures other than control, inspection and approval procedures from their scope of </text>
<text top=""746"" left=""108"" width=""78"" height=""16"" font=""0"">application.</text>
<footnote top=""744"" left=""186"" width=""17"" height=""11"" font=""16"" number=""233"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""780"" left=""108"" width=""202"" height=""16"" font=""28"">7.3.2.2.3  European Union </text></p><p number=""7.61"" style=""8""><text top=""815"" left=""108"" width=""685"" height=""16"" font=""0"">7.61.  The European Union disagrees with the United States' contention that the rules against </text>
<text top=""831"" left=""108"" width=""683"" height=""16"" font=""0"">undue delay contained in Article 8 and Annex C of the SPS Agreement apply only to products and </text>
<footnote top=""934"" left=""108"" width=""303"" height=""15"" font=""10"" number=""50"" ref="""" dis=""""/>
<footnote top=""949"" left=""165"" width=""310"" height=""15"" font=""10"" number=""184"" ref="""" dis=""""/>
<p><text top=""978"" left=""165"" width=""345"" height=""15"" font=""10""> United States' first written submission, paras. 185-186. </text>
</p><p><text top=""1022"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 178. </text>
<footnote top=""1036"" left=""165"" width=""337"" height=""15"" font=""10"" number=""24"" ref="""" dis=""""/>
<footnote top=""1095"" left=""165"" width=""596"" height=""15"" font=""10"" number=""69"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 56 - </text>
</p><p><text top=""128"" left=""108"" width=""101"" height=""16"" font=""0"">not to regions.</text>
<footnote top=""126"" left=""209"" width=""17"" height=""11"" font=""16"" number=""234"" ref="""" dis=""""/>
<text top=""128"" left=""227"" width=""564"" height=""16"" font=""0""> In the European Union's view, the language of such provisions does not contain </text>
<text top=""144"" left=""108"" width=""194"" height=""16"" font=""0"">any limitation in this regard</text>
<footnote top=""143"" left=""302"" width=""20"" height=""11"" font=""16"" number=""235"" ref="""" dis=""""/>
<text top=""144"" left=""324"" width=""467"" height=""16"" font=""0"">and indeed does not provide an exhaustive list of procedures that </text>
<text top=""160"" left=""108"" width=""165"" height=""16"" font=""0"">fall within their purview.</text>
<footnote top=""159"" left=""273"" width=""17"" height=""11"" font=""16"" number=""236"" ref="""" dis=""""/>
</p></p></page>
<page number=""56"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.3"" style=""8""><text top=""195"" left=""108"" width=""229"" height=""16"" font=""28"">7.3.2.3  Analysis by the Panel </text></p><p number=""7.62"" style=""8""><text top=""229"" left=""108"" width=""682"" height=""16"" font=""0"">7.62.  Article 8 requires Members to ""observe the provisions of Annex C in the operation of control, </text>
<text top=""246"" left=""108"" width=""685"" height=""16"" font=""0"">inspection and approval procedures"", thereby incorporating the disciplines of Annex C into the </text>
<text top=""262"" left=""108"" width=""684"" height=""16"" font=""0"">operative part of the SPS Agreement. This is consistent with the language of Article 1.3, which </text>
<text top=""278"" left=""108"" width=""682"" height=""16"" font=""0"">states that ""[t]he annexes are an integral part of th[e] Agreement"". Hence, the non-observance of </text>
<text top=""295"" left=""108"" width=""423"" height=""16"" font=""0"">the obligations in Annex C(1) ""implies a violation of Article 8"".</text>
<footnote top=""293"" left=""530"" width=""17"" height=""11"" font=""16"" number=""237"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""876"" left=""165"" width=""302"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.394. </ftext>
</footnote>
</p><p number=""7.63"" style=""8""><text top=""329"" left=""108"" width=""690"" height=""16"" font=""0"">7.63.  The parties do not disagree that the disciplines set out in 9 CFR 92.2 constitute </text>
<text top=""346"" left=""108"" width=""682"" height=""16"" font=""0"">""procedures"", as they establish a specific course of action that both the applicant country or region </text>
<text top=""362"" left=""108"" width=""684"" height=""16"" font=""0"">and APHIS are required to follow in order for the latter to proceed with the ""recognition of the </text>
<text top=""378"" left=""108"" width=""326"" height=""16"" font=""0"">animal health status"" of that country or region.</text>
<footnote top=""377"" left=""434"" width=""17"" height=""11"" font=""16"" number=""238"" ref="""" dis=""""><ftext top=""891"" left=""165"" width=""600"" height=""15"" font=""10""> 9 CFR 92.2, (Exhibit ARG-69). The United States itself describes such disciplines as a ""<i>Process</i> for </ftext>
</footnote>
<text top=""378"" left=""451"" width=""339"" height=""16"" font=""0""> We have already found that such disciplines fall </text>
<text top=""395"" left=""108"" width=""683"" height=""16"" font=""0"">within the reference to either ""regulations"" or ""procedures"" in the second sentence of Annex A(1) </text>
<text top=""411"" left=""108"" width=""155"" height=""16"" font=""0"">of the SPS Agreement.</text>
<footnote top=""410"" left=""263"" width=""17"" height=""11"" font=""16"" number=""239"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""143"" height=""15"" font=""10""> See para. 7.37 above. </ftext>
</footnote>
</p><p number=""7.64"" style=""8""><text top=""446"" left=""108"" width=""685"" height=""16"" font=""0"">7.64.  Therefore, the issue before us is whether the United States' application of 9 CFR 92.2 to </text>
<text top=""462"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina's requests for imports of fresh (chilled or frozen) beef from Northern Argentina and for </text>
<text top=""479"" left=""108"" width=""683"" height=""16"" font=""0"">recognition of Patagonia as FMD-free within the meaning of 9 CFR 94.1(a) constitutes one of the </text>
<text top=""495"" left=""108"" width=""437"" height=""16"" font=""0"">procedures falling within the scope of Article 8 and Annex C(1). </text>
</p><p number=""7.3"" style=""8""><text top=""529"" left=""108"" width=""208"" height=""16"" font=""28"">7.3.2.3.1  ""Any"" procedure </text></p><p number=""7.65"" style=""8""><text top=""564"" left=""108"" width=""686"" height=""16"" font=""0"">7.65.  Argentina maintains that the procedures set out in 9 CFR 92.2 fall within the scope of </text>
<text top=""580"" left=""108"" width=""684"" height=""16"" font=""0"">Article 8 and Annex C(1) because they are approval procedures and because they are aimed at </text>
<text top=""597"" left=""108"" width=""418"" height=""16"" font=""0"">checking and ensuring the fulfilment of an SPS measure.</text>
<footnote top=""595"" left=""526"" width=""17"" height=""11"" font=""16"" number=""240"" ref="""" dis=""""/>
<text top=""597"" left=""543"" width=""251"" height=""16"" font=""0""> The United States responds that </text>
<text top=""613"" left=""108"" width=""682"" height=""16"" font=""0"">Article 8 and Annex C(1), on their face, apply only to control, inspection or approval procedures for </text>
<text top=""629"" left=""108"" width=""116"" height=""16"" font=""0"">specific products</text>
<footnote top=""628"" left=""224"" width=""17"" height=""11"" font=""16"" number=""241"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""611"" height=""15"" font=""10""> United States' first written submission, para. 181. United States' response to Panel question No. 58 </ftext>
<ftext top=""1036"" left=""108"" width=""586"" height=""15"" font=""10"">following the first substantive meeting; United States' second written submission, paras. 52-54. </ftext>
</footnote>
<text top=""629"" left=""241"" width=""551"" height=""16"" font=""0"">, and do not govern the determination of the disease status of geographical </text>
<text top=""646"" left=""108"" width=""42"" height=""16"" font=""0"">areas.</text>
<footnote top=""644"" left=""150"" width=""17"" height=""11"" font=""16"" number=""242"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""620"" height=""15"" font=""10""> United States' first written submission, paras. 176-178; United States' opening statement at the first </ftext>
<ftext top=""1066"" left=""108"" width=""677"" height=""15"" font=""10"">meeting of the Panel, para. 28; United States' response to Panel question No. 58 following the first substantive </ftext>
<ftext top=""1080"" left=""108"" width=""659"" height=""15"" font=""10"">meeting; United States' second written submission, paras. 51-59; United States' response to Panel question </ftext>
</footnote>
</p><p number=""7.66"" style=""8""><text top=""680"" left=""108"" width=""682"" height=""16"" font=""0"">7.66.  We observe first, that while both Article 8 and Annex C are entitled ""Control, Inspection and </text>
<text top=""697"" left=""108"" width=""682"" height=""16"" font=""0"">Approval Procedures"", the text of Annex C(1) imposes obligations on Members with respect to ""any </text>
<text top=""713"" left=""108"" width=""602"" height=""16"" font=""0"">procedure to check and ensure the fulfilment of sanitary or phytosanitary measures"".</text>
<footnote top=""711"" left=""710"" width=""17"" height=""11"" font=""16"" number=""243"" ref=""WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4"" dis=""DS291|DS292|DS392|DS293""><ftext top=""1109"" left=""165"" width=""595"" height=""15"" font=""10""> See Panel Reports, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1491; <i>US &#8211; Poultry </i></ftext>
<ftext top=""1124"" left=""108"" width=""133"" height=""15"" font=""12""><i>(China)</i>, para. 7.352. </ftext>
</footnote>
<text top=""713"" left=""727"" width=""65"" height=""16"" font=""0""> Thus in </text>
<text top=""729"" left=""108"" width=""685"" height=""16"" font=""0"">our opinion, a plain reading of Annex C(1) suggests that the title, while illustrative, does not </text>
<text top=""746"" left=""108"" width=""683"" height=""16"" font=""0"">confine the scope of the measures covered as the United States argues. Rather, it is necessary to </text>
<text top=""762"" left=""108"" width=""675"" height=""16"" font=""0"">examine the text of the provision itself to determine its scope, and thereby the scope of Article 8.  </text>
<footnote top=""818"" left=""165"" width=""618"" height=""15"" font=""10"" number=""106"" ref="""" dis=""""/>
<p><text top=""861"" left=""165"" width=""326"" height=""15"" font=""10""> European Union's third-party submission, para. 107. </text>
</p><p><text top=""905"" left=""108"" width=""661"" height=""15"" font=""10"">Foreign Animal Disease Status Evaluations, Regionalization, Risk Analysis, and Rulemaking"". (See 9 C.F.R. &#167; </text>
<text top=""920"" left=""108"" width=""631"" height=""15"" font=""10"">92.2 (2013), <i>Process for Foreign Animal Disease Status Evaluations, Regionalization, Risk Analysis, and </i></text>
<text top=""934"" left=""108"" width=""656"" height=""15"" font=""12""><i>Rulemaking</i>, (Exhibit USA-76), p. 1 (emphasis added); see also e.g. United States' first written submission, </text>
<text top=""949"" left=""108"" width=""103"" height=""15"" font=""10"">paras. 334-335) </text>
</p><p><text top=""978"" left=""165"" width=""621"" height=""15"" font=""10""> Argentina's first written submission, para. 610; Argentina's opening statement at the first meeting of </text>
<text top=""993"" left=""108"" width=""650"" height=""15"" font=""10"">the Panel, para. 85; Argentina's response to Panel question No. 58 following the first substantive meeting; </text>
<text top=""1007"" left=""108"" width=""346"" height=""15"" font=""10"">Argentina's second written submission, paras. 337-338.  </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 57 - </text>
</p></p></page>
<page number=""57"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.67"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.67.  We note that the provision uses the word ""any"" to modify the word ""procedure"". ""Any"" has </text>
<text top=""144"" left=""108"" width=""687"" height=""16"" font=""0"">been interpreted as indicating that Annex C(1) ""does not specify, nor exclude, any type of </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">'procedures'"" from its scope of application, ""so long as that 'procedure' is aimed at 'checking and </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">ensuring the fulfilment of sanitary or phytosanitary measures', and is undertaken in the context of </text>
<text top=""193"" left=""108"" width=""234"" height=""16"" font=""0"">'control, inspection, or approval'"".</text>
<footnote top=""192"" left=""342"" width=""17"" height=""11"" font=""16"" number=""244"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""920"" left=""165"" width=""306"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.363.  </ftext>
</footnote>
<text top=""193"" left=""359"" width=""432"" height=""16"" font=""0""> Further, the Appellate Body in <i>Australia &#8211; Apples</i> stated that </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">while ""procedures are the direct target"" of Article 8 and Annex C(1), ""it does not follow that other </text>
<text top=""226"" left=""108"" width=""687"" height=""16"" font=""0"">types of measures are precluded, <i>a priori</i>, from being an appropriate target of a claim of </text>
<text top=""242"" left=""108"" width=""247"" height=""16"" font=""0"">inconsistency"" with such provisions.</text>
<footnote top=""241"" left=""355"" width=""17"" height=""11"" font=""16"" number=""245"" ref="""" dis=""""/>
<text top=""242"" left=""372"" width=""419"" height=""16"" font=""0""> According to the Appellate Body, the provisions in question </text>
<text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">""may be infringed through measures other than the control, inspection, and approval procedures </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">themselves"", such ""as actions that prohibit, prevent, or impede undertaking and completing such </text>
<text top=""292"" left=""108"" width=""685"" height=""16"" font=""0"">procedures 'without undue delay', or omissions in the form of a failure to act 'without undue </text>
<text top=""308"" left=""108"" width=""51"" height=""16"" font=""0"">delay'"".</text>
<footnote top=""307"" left=""159"" width=""17"" height=""11"" font=""16"" number=""246"" ref="""" dis=""""/>
</p><p number=""7.68"" style=""8""><text top=""342"" left=""108"" width=""689"" height=""16"" font=""0"">7.68.  Article 8 and Annex C ""cover a broad array of procedures, as the drafters of the </text>
<text top=""359"" left=""108"" width=""685"" height=""16"" font=""18""><i>SPS Agreement</i> did not limit the scope of those 'procedures' to any specific type of 'approval </text>
<text top=""375"" left=""108"" width=""90"" height=""16"" font=""0"">procedures'"".</text>
<footnote top=""374"" left=""198"" width=""17"" height=""11"" font=""16"" number=""247"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""963"" left=""165"" width=""306"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.372.  </ftext>
</footnote>
<text top=""375"" left=""215"" width=""580"" height=""16"" font=""0""> We also note that while Article 8 and Annex C enumerate certain types of </text>
<text top=""392"" left=""108"" width=""345"" height=""16"" font=""0"">procedures as expressly falling within their ambit</text>
<footnote top=""390"" left=""453"" width=""17"" height=""11"" font=""16"" number=""248"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""584"" height=""15"" font=""10""> To recall, ""national systems for approving the use of additives or for establishing tolerances for </ftext>
</footnote>
<text top=""392"" left=""470"" width=""322"" height=""16"" font=""0"">, they set forth lists introduced by the terms </text>
<text top=""408"" left=""108"" width=""688"" height=""16"" font=""0"">""including"" (Article 8) and ""include, <i>inter alia</i>"" (footnote 7 to Annex C). In the context of </text>
<text top=""425"" left=""108"" width=""683"" height=""16"" font=""0"">Annex A(1) of the SPS Agreement, the Appellate Body stated that the use of such terms indicates </text>
<text top=""441"" left=""108"" width=""522"" height=""16"" font=""0"">that the list of measures contained in such a provision ""is only indicative"".</text>
<footnote top=""439"" left=""630"" width=""17"" height=""11"" font=""16"" number=""249"" ref="""" dis=""""/>
<text top=""441"" left=""647"" width=""144"" height=""16"" font=""0""> In our opinion, the </text>
<text top=""457"" left=""108"" width=""683"" height=""16"" font=""0"">same holds true for Article 8 and Annex C. The use of such terms by the drafters shows that the </text>
<text top=""474"" left=""108"" width=""687"" height=""16"" font=""0"">lists of measures contained in the two provisions at issue are merely illustrative and not </text>
<text top=""490"" left=""108"" width=""78"" height=""16"" font=""0"">exhaustive.</text>
<footnote top=""489"" left=""186"" width=""17"" height=""11"" font=""16"" number=""250"" ref="""" dis=""""/>
</p><p number=""7.69"" style=""8""><text top=""525"" left=""108"" width=""682"" height=""16"" font=""0"">7.69.  Having determined, consistently with previous WTO adjudicators, that the drafters intended </text>
<text top=""541"" left=""108"" width=""684"" height=""16"" font=""0"">to include a broad variety of procedures under Annex C(1) and Article 8, we see no basis in the </text>
<text top=""557"" left=""108"" width=""685"" height=""16"" font=""0"">language of those provisions that would support the United States' argument that the covered </text>
<text top=""574"" left=""108"" width=""683"" height=""16"" font=""0"">procedures are limited to those addressing products, and thus that determinations of the disease </text>
<text top=""590"" left=""108"" width=""684"" height=""16"" font=""0"">status of certain geographic regions are excluded from the scope of Article 8 and Annex C. We </text>
<text top=""607"" left=""108"" width=""682"" height=""16"" font=""0"">consider that, by contrasting region-related and product-related determinations, the United States </text>
<text top=""623"" left=""108"" width=""683"" height=""16"" font=""0"">is attempting to make a distinction without a real difference. The ultimate effect of any procedure </text>
<text top=""639"" left=""108"" width=""682"" height=""16"" font=""0"">to designate a particular region with a ""disease status"" is to determine what SPS measures should </text>
<text top=""656"" left=""108"" width=""683"" height=""16"" font=""0"">be applied to the <i>products </i>originating from that region. We can see this in the link between the </text>
<text top=""672"" left=""108"" width=""688"" height=""16"" font=""0"">prohibition in 9 CFR 94 and the evaluation procedures set forth in 9 CFR 92.2. To recall, </text>
<text top=""689"" left=""108"" width=""683"" height=""16"" font=""0"">9 CFR 94.1(b) and 9 CFR 94.2 expressly prohibit the importation of any FMD-susceptible animals </text>
<text top=""705"" left=""108"" width=""685"" height=""16"" font=""0"">or animal products that originate in any region where FMD is deemed to exist. In turn, under </text>
<text top=""721"" left=""108"" width=""684"" height=""16"" font=""0"">9 CFR 94.1, FMD is deemed to exist ""in all regions of the world except those declared free"" by </text>
<text top=""738"" left=""108"" width=""682"" height=""16"" font=""0"">APHIS. The only way to be declared ""FMD-free"" by APHIS is to undergo the procedures set forth in </text>
<text top=""754"" left=""108"" width=""90"" height=""16"" font=""0"">9 CFR 92.2.  </text>
</p><p number=""7.70"" style=""8""><text top=""789"" left=""108"" width=""687"" height=""16"" font=""0"">7.70.  Although the immediate object of the process in 9 CFR 92.2 is related to making a </text>
<text top=""805"" left=""108"" width=""685"" height=""16"" font=""0"">determination about the disease status of the region, the ultimate effect of the process within </text>
<text top=""821"" left=""108"" width=""685"" height=""16"" font=""0"">APHIS' regulatory framework is to determine whether imports will be authorized. In our view, </text>
<text top=""838"" left=""108"" width=""682"" height=""16"" font=""0"">focusing solely on the immediate object of an importing Member's procedures, while losing sight of </text>
<text top=""854"" left=""108"" width=""685"" height=""16"" font=""0"">the ultimate effect of the completion of such procedures, might enable Members to avoid the </text>
<text top=""871"" left=""108"" width=""682"" height=""16"" font=""0"">application of Article 8 and Annex C by simply parsing their regulatory processes between regional </text>
<footnote top=""934"" left=""165"" width=""332"" height=""15"" font=""10"" number=""438"" ref="""" dis=""""/>
<footnote top=""993"" left=""108"" width=""617"" height=""15"" font=""10"" number=""8"" ref="""" dis=""""/>
<p><text top=""1007"" left=""108"" width=""233"" height=""15"" font=""10"">certification"" (footnote 7 to Annex C). </text>
<footnote top=""1022"" left=""165"" width=""614"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""/>
</p><p><text top=""1036"" left=""108"" width=""67"" height=""15"" font=""10"">para. 176. </text>
<text top=""1051"" left=""165"" width=""622"" height=""15"" font=""10""> For example, the panel in <i>US &#8211; Poultry (China) </i>found that equivalence determinations under Article 4 </text>
</p><p><text top=""1124"" left=""108"" width=""267"" height=""15"" font=""10"">Body Report, <i>Australia &#8211; Apples</i>, para. 441. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 58 - </text>
</p><p><text top=""128"" left=""108"" width=""299"" height=""16"" font=""0"">determinations and approvals to import.</text>
<footnote top=""126"" left=""407"" width=""17"" height=""11"" font=""16"" number=""251"" ref=""WT/DS392/R|"" dis=""DS392|""><ftext top=""861"" left=""165"" width=""594"" height=""15"" font=""10""> We find support for our interpretation in the reasoning of the panel in <i>US &#8211; Poultry (China)</i>. That </ftext>
<ftext top=""876"" left=""108"" width=""653"" height=""15"" font=""10"">panel observed that the successful completion of the equivalence determination process undertaken by the </ftext>
<ftext top=""891"" left=""108"" width=""668"" height=""15"" font=""10"">United States' authorities was the only means by which any WTO Member had to export the products at issue </ftext>
<ftext top=""905"" left=""108"" width=""669"" height=""15"" font=""10"">into the United States. (Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.368) The panel attached relevance to this </ftext>
<ftext top=""920"" left=""108"" width=""670"" height=""15"" font=""10"">fact in dismissing the United States' argument that Annex C does not cover equivalence determinations under </ftext>
<ftext top=""934"" left=""108"" width=""314"" height=""15"" font=""10"">Article 4 of the SPS Agreement. (Ibid. para. 7.359) </ftext>
</footnote>
<text top=""128"" left=""424"" width=""372"" height=""16"" font=""0""> Therefore, we conclude that the procedures in </text>
<text top=""144"" left=""108"" width=""597"" height=""16"" font=""0"">9 CFR 92.2 are ""any procedures"" that fall within the scope of Article 8 and Annex C(1). </text>
</p></p></page>
<page number=""58"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.71"" style=""8""><text top=""178"" left=""108"" width=""684"" height=""16"" font=""0"">7.71.  Having found that Article 8 and Annex C(1) do not exclude determinations of the disease </text>
<text top=""195"" left=""108"" width=""685"" height=""16"" font=""0"">status of certain geographic regions from their scope of application, we note that there is one </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">express limitation on the type of procedures falling within the scope of Article 8 and Annex C(1) &#8211; </text>
<text top=""228"" left=""108"" width=""686"" height=""16"" font=""0"">that the procedures be ones aimed at ""checking and ensuring the fulfilment of sanitary or </text>
<text top=""244"" left=""108"" width=""687"" height=""16"" font=""0"">phytosanitary measures"". Therefore, we now turn to assess whether the procedures under </text>
<text top=""260"" left=""108"" width=""228"" height=""16"" font=""0"">9 CFR 92.2 are such procedures. </text>
</p><p number=""7.3"" style=""8""><text top=""295"" left=""108"" width=""523"" height=""16"" font=""28"">7.3.2.3.2  To ""check and ensure"" the ""fulfilment"" of an SPS measure </text></p><p number=""7.72"" style=""8""><text top=""329"" left=""108"" width=""683"" height=""16"" font=""0"">7.72.  The dictionary defines the verb ""to check"" as ""[t]o control (a statement, account, etc.) by </text>
<text top=""346"" left=""108"" width=""683"" height=""16"" font=""0"">some method of comparison; to compare one account, observation, entry, etc., with another, or </text>
<text top=""362"" left=""108"" width=""531"" height=""16"" font=""0"">with certified data, with the object of ensuring accuracy and authenticity"";</text>
<text top=""362"" left=""644"" width=""148"" height=""16"" font=""0"">the related verb ""to </text>
<text top=""378"" left=""108"" width=""682"" height=""16"" font=""0"">check on"" is defined as ""to examine carefully or in detail; to maintain a check on; to ascertain the </text>
<text top=""395"" left=""108"" width=""683"" height=""16"" font=""0"">truth about; &#8230; to check out, to investigate, examine for accuracy, authenticity, or a confirmation </text>
<text top=""411"" left=""108"" width=""74"" height=""16"" font=""0"">of fitness"".</text>
<footnote top=""410"" left=""182"" width=""17"" height=""11"" font=""16"" number=""252"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""263"" height=""15"" font=""10""> <i>Online Oxford English Dictionary</i>, ""check"", </ftext>
<ftext top=""963"" left=""108"" width=""627"" height=""15"" font=""10"">http://www.oed.com/view/Entry/31082?rskey=V1iLGM&amp;result=3#eid (last accessed November 2014). </ftext>
</footnote>
<text top=""411"" left=""199"" width=""591"" height=""16"" font=""0""> The definition of the verb ""to ensure"" is ""[t]o make certain the occurrence or arrival </text>
<text top=""428"" left=""108"" width=""337"" height=""16"" font=""0"">of (an event), or the attainment of (a result)"".</text>
<footnote top=""426"" left=""444"" width=""17"" height=""11"" font=""16"" number=""253"" ref=""WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430""><ftext top=""978"" left=""165"" width=""269"" height=""15"" font=""10""> <i>Online Oxford English Dictionary</i>, ""ensure"", </ftext>
<ftext top=""993"" left=""108"" width=""655"" height=""15"" font=""10"">http://www.oed.com/view/Entry/62745?rskey=6qU6pb&amp;result=2#eid (last accessed November 2014). See </ftext>
<ftext top=""1007"" left=""108"" width=""373"" height=""15"" font=""10"">also Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.668. </ftext>
</footnote>
<text top=""428"" left=""462"" width=""331"" height=""16"" font=""0""> Finally, the verb ""to fulfil"" is defined as ""[to </text>
<text top=""444"" left=""108"" width=""683"" height=""16"" font=""0"">p]rovide fully with what is wished for; satisfy the appetite or desire of; &#8230; Make complete, supply </text>
<text top=""461"" left=""108"" width=""641"" height=""16"" font=""0"">with what is lacking; replace (something); &#8230; Carry out, perform, do (something prescribed)"".</text>
<footnote top=""459"" left=""748"" width=""17"" height=""11"" font=""16"" number=""254"" ref=""WT/DS384/RW ; WT/DS386/RW|WT/DS384/AB/R ; WT/DS386/AB/R|WT/DS384/RW/Add.1 ; WT/DS386/RW/Add.1|WT/DS384/AB/RW ; WT/DS386/AB/RW|WT/DS384/R ; WT/DS386/R"" dis=""DS384|DS386""><ftext top=""1022"" left=""165"" width=""609"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; COOL</i>, para. 362 (referring to Panel Report, <i>US &#8211; COOL</i>, para. 7.692). </ftext>
</footnote>
<text top=""461"" left=""766"" width=""24"" height=""16"" font=""0""> In </text>
<text top=""477"" left=""108"" width=""684"" height=""16"" font=""0"">turn, as observed in paragraph 7.31 above, the Appellate Body defined an SPS measure as one </text>
<text top=""493"" left=""108"" width=""660"" height=""16"" font=""0"">""applied &#8230; to protect"" at least one of the interests listed in Annex A(1) of the SPS Agreement.</text>
<footnote top=""492"" left=""768"" width=""17"" height=""11"" font=""16"" number=""255"" ref="""" dis=""""/>
<text top=""510"" left=""108"" width=""688"" height=""16"" font=""0"">According to the Appellate Body, the word ""applied"" suggests that a ""clear and objective </text>
<text top=""526"" left=""108"" width=""685"" height=""16"" font=""0"">relationship"" between the measure and one of the objectives identified in Annex A(1) must be </text>
<text top=""543"" left=""108"" width=""682"" height=""16"" font=""0"">present in the measure itself, or otherwise evident from circumstances related to the application of </text>
<text top=""559"" left=""108"" width=""682"" height=""16"" font=""0"">the measure, such as ""its surrounding regulatory context"", and the way in which it is designed and </text>
<text top=""575"" left=""108"" width=""64"" height=""16"" font=""0"">operates.</text>
<footnote top=""574"" left=""172"" width=""17"" height=""11"" font=""16"" number=""256"" ref="""" dis=""""/>
</p><p number=""7.73"" style=""8""><text top=""610"" left=""108"" width=""686"" height=""16"" font=""0"">7.73.  As the above definitions indicate, Article 8 and Annex C cover any procedure to make </text>
<text top=""626"" left=""108"" width=""686"" height=""16"" font=""0"">certain that a measure applied to achieve one of the objectives in Annex A(1) is fully implemented.  </text>
</p><p number=""7.74"" style=""8""><text top=""661"" left=""108"" width=""683"" height=""16"" font=""0"">7.74.  We have already found above that the procedures in 9 CFR 92.2 are part of the process to </text>
<text top=""677"" left=""108"" width=""682"" height=""16"" font=""0"">determine whether products from a specific country or region pose a particular risk of introduction </text>
<text top=""693"" left=""108"" width=""326"" height=""16"" font=""0"">or dissemination of FMD into the United States.</text>
<footnote top=""692"" left=""434"" width=""17"" height=""11"" font=""16"" number=""257"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""182"" height=""15"" font=""10""> See paras. 7.37-7.41 above. </ftext>
</footnote>
<text top=""693"" left=""451"" width=""339"" height=""16"" font=""0""> Those procedures, in other words, are designed </text>
<text top=""710"" left=""108"" width=""686"" height=""16"" font=""0"">to ensure compliance with the requirement under 9 CFR 94 that FMD-susceptible animals or </text>
<text top=""726"" left=""108"" width=""683"" height=""16"" font=""0"">animal products be imported into the United States only from countries or regions that APHIS has </text>
<text top=""743"" left=""108"" width=""684"" height=""16"" font=""0"">determined  to  be  FMD-free.  We  also  found  that such a requirement constitutes an SPS measure </text>
<text top=""759"" left=""108"" width=""404"" height=""16"" font=""0"">within the meaning of Annex A(1) of the SPS Agreement.</text>
<footnote top=""757"" left=""511"" width=""17"" height=""11"" font=""16"" number=""258"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""555"" height=""15"" font=""10""> See paras. 7.37-7.41 above. We discuss the United States' ALOP for FMD more in detail in </ftext>
<ftext top=""1109"" left=""108"" width=""165"" height=""15"" font=""10"">paras. 7.377-7.387 below. </ftext>
</footnote>
<text top=""759"" left=""529"" width=""263"" height=""16"" font=""0""> In turn, we note that 9 CFR 94.1 is </text>
<text top=""775"" left=""108"" width=""682"" height=""16"" font=""0"">implemented for the purpose of achieving the objective set forth in 7 USC 8303(a), to ""prevent the </text>
<text top=""792"" left=""108"" width=""645"" height=""16"" font=""0"">introduction into or dissemination within the United States of any pest or disease of livestock.""</text>
<footnote top=""790"" left=""752"" width=""17"" height=""11"" font=""16"" number=""259"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""560"" height=""15"" font=""10""> 7 USC &#167; 8303(a), (Exhibit USA-75). We will discuss 7 USC 8303(a) in section 7.6.2 below.  </ftext>
</footnote>
<footnote top=""1036"" left=""165"" width=""332"" height=""15"" font=""10"" number=""172"" ref="""" dis=""""><ftext top=""1066"" left=""108"" width=""213"" height=""15"" font=""12""><i>Agricultural Products</i>, para. 7.139. </ftext>
</footnote>
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 59 - </text>
</p></p></page>
<page number=""59"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.75"" style=""8""><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">7.75.  In light of the above, we take the view that procedures carried out under 9 CFR 92.2 are </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">aimed at checking and ensuring the fulfilment of another SPS measure, namely 9 CFR 94, which, </text>
<text top=""160"" left=""108"" width=""497"" height=""16"" font=""0"">in turn, is intended to achieve the objective set forth in 7 USC 8303(a).  </text>
</p><p number=""7.3"" style=""8""><text top=""195"" left=""108"" width=""164"" height=""16"" font=""28"">7.3.2.3.3  Conclusion </text></p><p number=""7.76"" style=""8""><text top=""229"" left=""108"" width=""682"" height=""16"" font=""0"">7.76.  Based on the foregoing, we conclude that the application of the disciplines of 9 CFR 92.2 to </text>
<text top=""246"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina's requests for authorization to import fresh (chilled or frozen) beef from Northern </text>
<text top=""262"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina and for recognition of Patagonia as FMD-free fall within the scope of Article 8 and </text>
<text top=""278"" left=""108"" width=""686"" height=""16"" font=""0"">Annex C(1) of the SPS Agreement. Having reached this conclusion, we move on to examine </text>
<text top=""295"" left=""108"" width=""687"" height=""16"" font=""0"">Argentina's claim that there was undue delay in the way the United States undertook and </text>
<text top=""311"" left=""108"" width=""600"" height=""16"" font=""0"">completed these processes contrary to the obligations in Article 8 and Annex (C)(1)(a). </text>
</p><p number=""7.3"" style=""8""><text top=""346"" left=""108"" width=""684"" height=""16"" font=""28"">7.3.3  Whether APHIS' review processes of Argentina's requests were undertaken and </text><text top=""362"" left=""108"" width=""244"" height=""16"" font=""28"">completed without undue delay </text></p><p number=""7.77"" style=""8""><text top=""396"" left=""108"" width=""684"" height=""16"" font=""0"">7.77.  Given the length and complexity of the legal and factual arguments made with respect to </text>
<text top=""413"" left=""108"" width=""682"" height=""16"" font=""0"">this claim, the Panel will first set out the general arguments of the parties and third parties on the </text>
<text top=""429"" left=""108"" width=""683"" height=""16"" font=""0"">interpretation of the obligation in Article 8 and Annex C (1)(a) and then move on to address the </text>
<text top=""446"" left=""108"" width=""686"" height=""16"" font=""0"">arguments with respect to the alleged undue delay in the approval processes for Argentina's </text>
<text top=""462"" left=""108"" width=""683"" height=""16"" font=""0"">applications for authorization to import fresh (chilled or frozen) beef from Northern Argentina and </text>
<text top=""479"" left=""108"" width=""364"" height=""16"" font=""0"">for the Patagonia region to be designated FMD-free.  </text>
</p><p number=""7.3"" style=""8""><text top=""513"" left=""108"" width=""319"" height=""16"" font=""28"">7.3.3.1  General arguments of the parties </text></p><p number=""7.3"" style=""8""><text top=""547"" left=""108"" width=""156"" height=""16"" font=""28"">7.3.3.1.1  Argentina </text></p><p number=""7.78"" style=""8""><text top=""582"" left=""108"" width=""683"" height=""16"" font=""0"">7.78.  Argentina claims that APHIS' application of the procedures under 9 CFR 92.2 to Argentina's </text>
<text top=""598"" left=""108"" width=""683"" height=""16"" font=""0"">requests for imports of fresh (chilled or frozen) beef from Northern Argentina and for recognition </text>
<text top=""615"" left=""108"" width=""682"" height=""16"" font=""0"">of Patagonia as FMD-free incurred undue delays and is therefore inconsistent with the requirement </text>
<text top=""631"" left=""108"" width=""684"" height=""16"" font=""0"">under Article 8 and Annex C(1)(a) of the SPS Agreement that procedures under these provisions </text>
<text top=""647"" left=""108"" width=""389"" height=""16"" font=""0"">be ""undertaken and completed without undue delay"".</text>
<footnote top=""646"" left=""496"" width=""17"" height=""11"" font=""16"" number=""260"" ref="""" dis=""""/>
<text top=""647"" left=""514"" width=""280"" height=""16"" font=""0""> In its responses to Panel questions, </text>
<text top=""664"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina clarified that, in its view, such delays do not concern APHIS' initiation of the approval </text>
<text top=""680"" left=""108"" width=""687"" height=""16"" font=""0"">processes upon reception of the two requests, but rather the completion of such approval </text>
<text top=""697"" left=""108"" width=""71"" height=""16"" font=""0"">processes.</text>
<footnote top=""695"" left=""179"" width=""17"" height=""11"" font=""16"" number=""261"" ref="""" dis=""""/>
</p><p number=""7.79"" style=""8""><text top=""731"" left=""108"" width=""682"" height=""16"" font=""0"">7.79.  Argentina submits that, in determining whether a delay is undue, the Panel should examine </text>
<text top=""747"" left=""108"" width=""208"" height=""16"" font=""0"">the reasons for such a delay.</text>
<footnote top=""746"" left=""316"" width=""17"" height=""11"" font=""16"" number=""262"" ref="""" dis=""""/>
<text top=""747"" left=""333"" width=""459"" height=""16"" font=""0""> Relying on the panel report in <i>EC &#8211; Approval and Marketing of </i></text>
<text top=""764"" left=""108"" width=""683"" height=""16"" font=""18""><i>Biotech Products</i>,<i> </i>Argentina<i> </i>maintains that the relevant ""delay"" to be examined is not only one in </text>
<text top=""780"" left=""108"" width=""660"" height=""16"" font=""0"">undertaking an approval procedure, but also in finishing or concluding that procedure.</text>
<footnote top=""779"" left=""768"" width=""17"" height=""11"" font=""16"" number=""263"" ref="""" dis=""""/>
<text top=""797"" left=""108"" width=""685"" height=""16"" font=""0"">Moreover, in Argentina's view, amendments to approval procedures during the pendency of a </text>
<text top=""813"" left=""108"" width=""683"" height=""16"" font=""0"">request do not erase the delay incurred until that point, nor do they require that undue delay be </text>
<text top=""829"" left=""108"" width=""353"" height=""16"" font=""0"">established prior to and following such amendment.</text>
<footnote top=""828"" left=""461"" width=""17"" height=""11"" font=""16"" number=""264"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""864"" left=""108"" width=""184"" height=""16"" font=""28"">7.3.3.1.2  United States </text></p><p number=""7.80"" style=""8""><text top=""898"" left=""108"" width=""684"" height=""16"" font=""0"">7.80.  The United States disagrees with Argentina's focus on the overall length of time of APHIS' </text>
<text top=""915"" left=""108"" width=""582"" height=""16"" font=""0"">approval processes of Argentina's requests rather than on specific periods of delay.</text>
<footnote top=""913"" left=""689"" width=""17"" height=""11"" font=""16"" number=""265"" ref="""" dis=""""/>
<text top=""915"" left=""707"" width=""85"" height=""16"" font=""0""> Relying on </text>
<text top=""931"" left=""108"" width=""682"" height=""16"" font=""0"">the panel report in <i>EC &#8211; Approval and Marketing of Biotech Products</i>, the United States argues that </text>
<text top=""947"" left=""108"" width=""684"" height=""16"" font=""0"">an assessment of whether a delay is undue must be conducted on a case-by-case basis, taking </text>
<p><text top=""1007"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 596. </text>
<text top=""1022"" left=""165"" width=""528"" height=""15"" font=""10""> Argentina's response to Panel question No. 68 following the first substantive meeting. </text>
<text top=""1036"" left=""165"" width=""592"" height=""15"" font=""10""> Argentina's first written submission, para. 611 (citing Appellate Body Report, <i>Australia &#8211; Apples</i>, </text>
<text top=""1051"" left=""108"" width=""73"" height=""15"" font=""10"">para. 437). </text>
<text top=""1066"" left=""165"" width=""612"" height=""15"" font=""10""> Argentina's first written submission, para. 613 (citing Panel Report, <i>EC &#8211; Approval and Marketing of </i></text>
<text top=""1080"" left=""108"" width=""201"" height=""15"" font=""12""><i>Biotech Products</i>,<i> </i>para. 7.1494). </text>
<text top=""1095"" left=""165"" width=""568"" height=""15"" font=""10""> Argentina's first written submission, para. 617 (referring to Panel Report, <i>EC &#8211; Approval and </i></text>
<text top=""1109"" left=""108"" width=""285"" height=""15"" font=""12""><i>Marketing of Biotech Products</i>,<i> </i>para. 7.1535).  </text>
<text top=""1124"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 202. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 60 - </text>
</p><p><text top=""128"" left=""108"" width=""369"" height=""16"" font=""0"">into account all the relevant facts and circumstances.</text>
<footnote top=""126"" left=""477"" width=""17"" height=""11"" font=""16"" number=""266"" ref="""" dis=""""/>
<text top=""128"" left=""495"" width=""296"" height=""16"" font=""0""> The United States asserts that the length </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">of time of the approval processes of imports of Argentine products conducted by other WTO </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">Members is not a reliable benchmark against which to gauge APHIS' reviews, as different Members </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">may differ in terms of the specific information they require to reach a decision and the ALOP they </text>
<text top=""193"" left=""108"" width=""257"" height=""16"" font=""0"">have determined for the risk at issue.</text>
<footnote top=""192"" left=""364"" width=""17"" height=""11"" font=""16"" number=""267"" ref="""" dis=""""/>
</p></p></page>
<page number=""60"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.81"" style=""8""><text top=""228"" left=""108"" width=""687"" height=""16"" font=""0"">7.81.  In the United States' view, not every delay in undertaking or completing an approval </text>
<text top=""244"" left=""108"" width=""627"" height=""16"" font=""0"">procedure is contrary to the provisions of Annex C(1)(a), but only an unjustifiable one.</text>
<footnote top=""243"" left=""735"" width=""17"" height=""11"" font=""16"" number=""268"" ref="""" dis=""""/>
<text top=""244"" left=""752"" width=""40"" height=""16"" font=""0""> The </text>
<text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">United States considers that this standard is equivalent in nature to that applied to assess what </text>
<text top=""277"" left=""108"" width=""598"" height=""16"" font=""0"">constitutes a ""reasonable period of time"" under Article 5.7 of the SPS Agreement.</text>
<footnote top=""275"" left=""706"" width=""17"" height=""11"" font=""16"" number=""269"" ref="""" dis=""""/>
<text top=""277"" left=""724"" width=""70"" height=""16"" font=""0""> For the </text>
<text top=""293"" left=""108"" width=""685"" height=""16"" font=""0"">United States, possible factors justifying a delay include (i) delays attributable to the applicant </text>
<text top=""310"" left=""108"" width=""309"" height=""16"" font=""0"">itself rather than to the approving Member</text>
<footnote top=""308"" left=""417"" width=""17"" height=""11"" font=""16"" number=""270"" ref="""" dis=""""/>
<text top=""310"" left=""435"" width=""358"" height=""16"" font=""0"">; (ii) the necessity to reasonably determine with </text>
<text top=""326"" left=""108"" width=""562"" height=""16"" font=""0"">adequate confidence whether the relevant SPS requirements have been fulfilled</text>
<footnote top=""325"" left=""670"" width=""17"" height=""11"" font=""16"" number=""271"" ref="""" dis=""""/>
<text top=""326"" left=""687"" width=""105"" height=""16"" font=""0"">; and (iii) the </text>
<text top=""342"" left=""108"" width=""685"" height=""16"" font=""0"">submission or supervening availability of additional relevant information at a late stage of an </text>
<text top=""359"" left=""108"" width=""136"" height=""16"" font=""0"">approval procedure.</text>
<footnote top=""357"" left=""245"" width=""17"" height=""11"" font=""16"" number=""272"" ref="""" dis=""""/>
</p><p number=""7.82"" style=""8""><text top=""393"" left=""108"" width=""687"" height=""16"" font=""0"">7.82.  In the United States' opinion, APHIS had the difficult task of conducting a thorough </text>
<text top=""410"" left=""108"" width=""552"" height=""16"" font=""0"">examination of Argentina's ability to prevent and control FMD within its territory.</text>
<footnote top=""408"" left=""660"" width=""17"" height=""11"" font=""16"" number=""273"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""366"" height=""15"" font=""10""> United States' second written submission, paras. 201, 320. </ftext>
</footnote>
<text top=""410"" left=""677"" width=""113"" height=""16"" font=""0""> It also stresses </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">that obtaining the necessary information to proceed with the approval processes was not easy, as </text>
<text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">the data to be collected were (i) not in the United States; (ii) of substantial scope and breadth </text>
<text top=""459"" left=""108"" width=""687"" height=""16"" font=""0"">including geographical information, internal and cross-border animal movements, quarantine </text>
<text top=""475"" left=""108"" width=""646"" height=""16"" font=""0"">processes, and veterinary infrastructure; and (iii) only accessible with Argentina's cooperation.</text>
<footnote top=""474"" left=""754"" width=""17"" height=""11"" font=""16"" number=""274"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""510"" left=""108"" width=""685"" height=""16"" font=""28"">7.3.3.2  APHIS' review of Argentina's request for imports of fresh (chilled or frozen) </text><text top=""526"" left=""108"" width=""230"" height=""16"" font=""28"">beef from Northern Argentina </text></p><p number=""7.3"" style=""8""><text top=""561"" left=""108"" width=""156"" height=""16"" font=""28"">7.3.3.2.1  Argentina </text></p><p number=""7.83"" style=""8""><text top=""595"" left=""108"" width=""686"" height=""16"" font=""0"">7.83.  Argentina notes that it filed its request for imports of fresh (chilled or frozen) beef in </text>
<text top=""611"" left=""108"" width=""111"" height=""16"" font=""0"">November 2002</text>
<footnote top=""610"" left=""219"" width=""17"" height=""11"" font=""16"" number=""275"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""602"" height=""15"" font=""10""> Argentina's first written submission, para. 620; Argentina's second written submission, para. 349. </ftext>
</footnote>
<text top=""611"" left=""236"" width=""556"" height=""16"" font=""0""> and that at the time of the establishment of the Panel it had not received a </text>
<text top=""628"" left=""108"" width=""687"" height=""16"" font=""0"">decision on such request despite SENASA cooperating fully with all of APHIS' requests for </text>
<text top=""644"" left=""108"" width=""186"" height=""16"" font=""0"">information and site visits.</text>
<footnote top=""643"" left=""294"" width=""17"" height=""11"" font=""16"" number=""276"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""602"" height=""15"" font=""10""> Argentina's first written submission, para. 632; Argentina's second written submission, para. 354. </ftext>
</footnote>
<text top=""644"" left=""311"" width=""480"" height=""16"" font=""0""> Argentina argues that the United States could not need more than </text>
<text top=""661"" left=""108"" width=""357"" height=""16"" font=""0"">11 years to evaluate the FMD status of Argentina</text>
<footnote top=""659"" left=""464"" width=""17"" height=""11"" font=""16"" number=""277"" ref="""" dis=""""/>
<text top=""661"" left=""482"" width=""5"" height=""16"" font=""0"">,</text>
<text top=""661"" left=""493"" width=""300"" height=""16"" font=""0"">especially as the request only sought to </text>
<text top=""677"" left=""108"" width=""494"" height=""16"" font=""0"">reinstate import rights previously granted during the period 1997-2001</text>
<footnote top=""675"" left=""602"" width=""17"" height=""11"" font=""16"" number=""278"" ref="""" dis=""""/>
<text top=""677"" left=""619"" width=""172"" height=""16"" font=""0""> and APHIS had already </text>
<text top=""693"" left=""108"" width=""687"" height=""16"" font=""0"">reviewed the history of FMD outbreaks and other scientific evidence pertaining to Northern </text>
<text top=""710"" left=""108"" width=""71"" height=""16"" font=""0"">Argentina.</text>
<footnote top=""708"" left=""179"" width=""17"" height=""11"" font=""16"" number=""279"" ref="""" dis=""""/>
</p><p number=""7.84"" style=""8""><text top=""744"" left=""108"" width=""684"" height=""16"" font=""0"">7.84.   To provide a sense of what time-frame it views as reasonable for the conclusion of the </text>
<text top=""761"" left=""108"" width=""683"" height=""16"" font=""0"">process, Argentina refers to the Terrestrial Code, which provides that a period of 12 months since </text>
<text top=""777"" left=""108"" width=""686"" height=""16"" font=""0"">the most recent outbreak is a sufficient time, from an epidemiological perspective, to obtain </text>
<p><text top=""832"" left=""165"" width=""613"" height=""15"" font=""10""> United States' first written submission, para. 189 (citing Panel Report, <i>EC &#8211; Approval and Marketing </i></text>
<text top=""847"" left=""108"" width=""626"" height=""15"" font=""12""><i>of Biotech Products</i>, para. 7.1497); United States' opening statement at the first meeting of the Panel, </text>
<text top=""861"" left=""108"" width=""377"" height=""15"" font=""10"">para. 46; United States' second written submission, para. 40. </text>
<footnote top=""876"" left=""165"" width=""545"" height=""15"" font=""10"" number=""59"" ref="""" dis=""""/>
</p><p><text top=""891"" left=""165"" width=""613"" height=""15"" font=""10""> United States' first written submission, para. 190 (citing Panel Report, <i>EC &#8211; Approval and Marketing </i></text>
<text top=""905"" left=""108"" width=""535"" height=""15"" font=""12""><i>of Biotech Products</i>, para. 7.1495); United States' second written submission, para. 60. </text>
<text top=""920"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 244. </text>
<text top=""934"" left=""165"" width=""613"" height=""15"" font=""10""> United States' first written submission, para. 192 (citing Panel Report, <i>EC &#8211; Approval and Marketing </i></text>
<text top=""949"" left=""108"" width=""217"" height=""15"" font=""12""><i>of Biotech Products</i>, para. 7.1497). </text>
<footnote top=""963"" left=""165"" width=""613"" height=""15"" font=""10"" number=""194"" ref="""" dis=""""><ftext top=""1007"" left=""108"" width=""217"" height=""15"" font=""12""><i>of Biotech Products</i>, para. 7.1498). </ftext>
</footnote>
</p><p><text top=""978"" left=""108"" width=""217"" height=""15"" font=""12""><i>of Biotech Products</i>, para. 7.1498). </text>
</p><p><text top=""1036"" left=""165"" width=""321"" height=""15"" font=""10""> United States' second written submission, para. 41. </text>
<footnote top=""1080"" left=""165"" width=""621"" height=""15"" font=""10"" number=""639"" ref="""" dis=""""/>
</p><p><text top=""1095"" left=""108"" width=""433"" height=""15"" font=""10"">the Panel, para. 80; Argentina's second written submission, para. 358. </text>
</p><p><text top=""1124"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 644. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 61 - </text>
</p><p><text top=""128"" left=""108"" width=""114"" height=""16"" font=""0"">FMD-free status.</text>
<footnote top=""126"" left=""222"" width=""17"" height=""11"" font=""16"" number=""280"" ref="""" dis=""""><ftext top=""759"" left=""165"" width=""599"" height=""15"" font=""10""> Argentina's first written submission, para. 639 (citing Articles 8.5.45 and 8.5.46 of the Terrestrial </ftext>
</footnote>
<text top=""128"" left=""239"" width=""551"" height=""16"" font=""0""> Argentina also notes that the time it took to approve Uruguay from the time of </text>
<text top=""144"" left=""108"" width=""237"" height=""16"" font=""0"">its last outbreak was two years.</text>
<footnote top=""143"" left=""345"" width=""17"" height=""11"" font=""16"" number=""281"" ref="""" dis=""""/>
<text top=""144"" left=""362"" width=""432"" height=""16"" font=""0""> Argentina also argues that the FMD situation in Northern </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina is similar to Uruguay's in terms of the timing of the last outbreak and because both </text>
<text top=""177"" left=""108"" width=""552"" height=""16"" font=""0"">regions are recognized by the OIE as FMD-free where vaccination is practised.</text>
<footnote top=""175"" left=""660"" width=""17"" height=""11"" font=""16"" number=""282"" ref="""" dis=""""/>
<text top=""177"" left=""677"" width=""113"" height=""16"" font=""0"">  In  this  regard, </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina also notes that while it had been previously authorized to export fresh (chilled or frozen) </text>
<text top=""210"" left=""108"" width=""488"" height=""16"" font=""0"">beef to the United States, Uruguay had no such previous authorization.</text>
<footnote top=""208"" left=""596"" width=""17"" height=""11"" font=""16"" number=""283"" ref="""" dis=""""/>
<text top=""210"" left=""614"" width=""177"" height=""16"" font=""0""> Argentina also considers </text>
<text top=""226"" left=""108"" width=""682"" height=""16"" font=""0"">that the fact that the European Union and Chile promptly reopened their markets to Argentine beef </text>
<text top=""242"" left=""108"" width=""685"" height=""16"" font=""0"">following the 2003 and 2006 FMD outbreaks is ""indicative of the time reasonably necessary to </text>
<text top=""259"" left=""108"" width=""218"" height=""16"" font=""0"">conduct an evaluation for FMD"".</text>
<footnote top=""257"" left=""326"" width=""17"" height=""11"" font=""16"" number=""284"" ref="""" dis=""""/>
</p></p></page>
<page number=""61"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.85"" style=""8""><text top=""293"" left=""108"" width=""687"" height=""16"" font=""0"">7.85.  Argentina contends that, after its site visit to Northern Argentina following the 2006 </text>
<text top=""310"" left=""108"" width=""684"" height=""16"" font=""0"">FMD outbreak in the Province of Corrientes, APHIS did not request any further information from </text>
<text top=""326"" left=""108"" width=""306"" height=""16"" font=""0"">SENASA, nor did it take any further action.</text>
<footnote top=""325"" left=""414"" width=""17"" height=""11"" font=""16"" number=""285"" ref="""" dis=""""><ftext top=""876"" left=""165"" width=""608"" height=""15"" font=""10""> Argentina's second written submission, paras. 134, 197; Argentina's opening statement at the first </ftext>
<ftext top=""891"" left=""108"" width=""660"" height=""15"" font=""10"">meeting of the Panel, para. 86; Argentina's response to Panel question No. 68 following the first substantive </ftext>
<ftext top=""905"" left=""108"" width=""58"" height=""15"" font=""10"">meeting. </ftext>
</footnote>
<text top=""326"" left=""431"" width=""361"" height=""16"" font=""0""> It also submits that, in response to a letter from </text>
<text top=""342"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina, APHIS stated in September 2010 that it was ""currently drafting a proposed rule that </text>
<text top=""359"" left=""108"" width=""660"" height=""16"" font=""0"">would allow the importation of fresh, chilled or frozen Argentine beef under certain conditions"".</text>
<footnote top=""357"" left=""768"" width=""17"" height=""11"" font=""16"" number=""286"" ref="""" dis=""""/>
<text top=""375"" left=""108"" width=""687"" height=""16"" font=""0"">Similarly, Argentina observes, at the June and October 2011 sessions of SPS Committee, the </text>
<text top=""392"" left=""108"" width=""687"" height=""16"" font=""0"">United States' representative stated that APHIS had completed a risk analysis for Northern </text>
<text top=""408"" left=""108"" width=""71"" height=""16"" font=""0"">Argentina.</text>
<footnote top=""407"" left=""179"" width=""17"" height=""11"" font=""16"" number=""287"" ref="""" dis=""""/>
<text top=""408"" left=""196"" width=""601"" height=""16"" font=""0""> In Argentina's view, the above statements by APHIS and the United States' </text>
<text top=""425"" left=""108"" width=""688"" height=""16"" font=""0"">representative at the SPS Committee indicate that, in September 2010, APHIS had already </text>
<text top=""441"" left=""108"" width=""534"" height=""16"" font=""0"">completed a risk assessment for Northern Argentina which it did not publish</text>
<footnote top=""439"" left=""641"" width=""17"" height=""11"" font=""16"" number=""288"" ref="""" dis=""""/>
<text top=""441"" left=""659"" width=""133"" height=""16"" font=""0"">, or, at least, that </text>
<text top=""457"" left=""108"" width=""380"" height=""16"" font=""0"">APHIS had all the information needed to complete one.</text>
<footnote top=""456"" left=""488"" width=""17"" height=""11"" font=""16"" number=""289"" ref="""" dis=""""/>
<text top=""457"" left=""506"" width=""285"" height=""16"" font=""0""> In this regard, Argentina contends that, </text>
<text top=""474"" left=""108"" width=""682"" height=""16"" font=""0"">under the public international law rules on State responsibility, ""the United States must be held to </text>
<text top=""490"" left=""108"" width=""336"" height=""16"" font=""0"">the evidence of statements"" made by its officials.</text>
<footnote top=""489"" left=""444"" width=""17"" height=""11"" font=""16"" number=""290"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""589"" height=""15"" font=""10""> Argentina's second written submission, para. 265 (referring to Article 4 of the International Law </ftext>
<ftext top=""1007"" left=""108"" width=""618"" height=""15"" font=""10"">Commission's Articles on the Responsibility of States for Internationally Wrongful Acts (ILC Articles)). </ftext>
</footnote>
</p><p number=""7.86"" style=""8""><text top=""525"" left=""108"" width=""686"" height=""16"" font=""0"">7.86.  In Argentina's view, the above events reveal that APHIS had no scientific rationale for </text>
<text top=""541"" left=""108"" width=""660"" height=""16"" font=""0"">waiting over six years after the 2006 FMD outbreak to proceed with the review of its request.</text>
<footnote top=""539"" left=""768"" width=""17"" height=""11"" font=""16"" number=""291"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""577"" height=""15"" font=""10""> Argentina's first written submission, para. 642. Argentina's response to Panel question No. 68 </ftext>
<ftext top=""1036"" left=""108"" width=""572"" height=""15"" font=""10"">following the first substantive meeting; Argentina's second written submission, paras. 30, 32. </ftext>
</footnote>
<text top=""557"" left=""108"" width=""687"" height=""16"" font=""0"">Rather, in its view, the delay in APHIS' approval process is due to a number of elements </text>
<text top=""574"" left=""108"" width=""169"" height=""16"" font=""0"">extraneous to science.</text>
<footnote top=""572"" left=""277"" width=""17"" height=""11"" font=""16"" number=""292"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""622"" height=""15"" font=""10""> Argentina refers, <i>inter alia</i>, to a piece of proposed legislation, the <i>Foot and Mouth Disease Prevention </i></ftext>
<ftext top=""1066"" left=""108"" width=""661"" height=""15"" font=""12""><i>Act</i> of 2008, which was introduced in the United States' Congress in 2008 but never adopted, as evidence of </ftext>
</footnote>
<text top=""574"" left=""294"" width=""503"" height=""16"" font=""0""> Argentina also argues that Section 737 of the <i>2009 Omnibus </i></text>
<text top=""590"" left=""108"" width=""682"" height=""16"" font=""18""><i>Appropriations Act</i> contributed to the undue delay because it precluded any activity on APHIS' part </text>
<text top=""607"" left=""108"" width=""335"" height=""16"" font=""0"">in connection with Argentina's pending requests</text>
<footnote top=""605"" left=""443"" width=""17"" height=""11"" font=""16"" number=""293"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""331"" height=""15"" font=""10""> Argentina's first written submission, paras. 634, 701. </ftext>
</footnote>
<text top=""607"" left=""460"" width=""331"" height=""16"" font=""0""> at least from March 2009 to September 2009, </text>
<text top=""623"" left=""108"" width=""477"" height=""16"" font=""0"">and deterred APHIS from moving forward even after its expiration.</text>
<footnote top=""621"" left=""585"" width=""17"" height=""11"" font=""16"" number=""294"" ref="""" dis=""""/>
<text top=""623"" left=""602"" width=""190"" height=""16"" font=""0""> In this regard, Argentina </text>
<text top=""639"" left=""108"" width=""684"" height=""16"" font=""0"">also argues that Section 737 is very similar to Section 727 of the <i>2009 Omnibus Appropriations </i></text>
<p><text top=""788"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 640. </text>
<footnote top=""803"" left=""165"" width=""621"" height=""15"" font=""10"" number=""641"" ref="""" dis=""""/>
</p><p><text top=""818"" left=""108"" width=""471"" height=""15"" font=""10"">the Panel, para. 92; Argentina's second written submission, paras. 198, 364. </text>
</p><p><text top=""847"" left=""108"" width=""124"" height=""15"" font=""10"">the Panel, para. 93. </text>
</p><p><text top=""920"" left=""165"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 197. </text>
<text top=""934"" left=""165"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 262. </text>
<footnote top=""949"" left=""165"" width=""312"" height=""15"" font=""10"" number=""264"" ref="""" dis=""""/>
</p><p><text top=""978"" left=""108"" width=""471"" height=""15"" font=""10"">response to Panel question No. 27 following the second substantive meeting. </text>
</p><p><text top=""1080"" left=""108"" width=""646"" height=""15"" font=""10"">alleged political interference in APHIS' approval process. (Argentina's first written submission, para. 633). </text>
</p><p><text top=""1109"" left=""165"" width=""621"" height=""15"" font=""10""> Argentina's first written submission, para. 701; Argentina's opening statement at the first meeting of </text>
<text top=""1124"" left=""108"" width=""468"" height=""15"" font=""10"">the Panel, para. 18; Argentina's second written submission, paras. 385-389. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 62 - </text>
</p><p><text top=""128"" left=""108"" width=""22"" height=""16"" font=""32"">Act</text><footnote top=""126"" left=""130"" width=""17"" height=""11"" font=""16"" number=""295"" ref="""" dis=""""/>
</p><p><text top=""128"" left=""147"" width=""648"" height=""16"" font=""0"">, which the panel in <i>US &#8211; Poultry (China)</i> found to impose undue delay in approval </text>
<text top=""144"" left=""108"" width=""404"" height=""16"" font=""0"">procedures inconsistently with Article 8 and Annex C(1)(a).</text>
<footnote top=""143"" left=""512"" width=""17"" height=""11"" font=""16"" number=""296"" ref="""" dis=""""/>
</p></p></page>
<page number=""62"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.87"" style=""8""><text top=""178"" left=""108"" width=""684"" height=""16"" font=""0"">7.87.  Finally, Argentina maintains that APHIS' new request for a site visit to Northern Argentina </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">in March 2013, followed by the actual visit in November 2013, ""do not resolve a gap of six years </text>
<text top=""211"" left=""108"" width=""470"" height=""16"" font=""0"">during which there has been no progress on Argentina's application"".</text>
<footnote top=""210"" left=""578"" width=""17"" height=""11"" font=""16"" number=""297"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""246"" left=""108"" width=""184"" height=""16"" font=""28"">7.3.3.2.2  United States </text></p><p number=""7.88"" style=""8""><text top=""280"" left=""108"" width=""684"" height=""16"" font=""0"">7.88.  The United States argues that Argentina fails to offer any factual support for its claim of </text>
<text top=""296"" left=""108"" width=""660"" height=""16"" font=""0"">undue delay with respect to APHIS' approval process of imports of fresh (chilled or frozen) beef.</text>
<footnote top=""295"" left=""768"" width=""17"" height=""11"" font=""16"" number=""298"" ref="""" dis=""""/>
<text top=""313"" left=""108"" width=""683"" height=""16"" font=""0"">It maintains that, since the filing of Argentina's request in November 2002, APHIS engaged with </text>
<text top=""329"" left=""108"" width=""571"" height=""16"" font=""0"">SENASA by requesting information and conducting site visits to Northern Argentina.</text>
<footnote top=""328"" left=""679"" width=""17"" height=""11"" font=""16"" number=""299"" ref="""" dis=""""><ftext top=""876"" left=""165"" width=""587"" height=""15"" font=""10""> United States' first written submission, paras. 132-143, 197-199; United States' second written </ftext>
</footnote>
</p><p number=""7.89"" style=""8""><text top=""364"" left=""108"" width=""684"" height=""16"" font=""0"">7.89.  The United States asserts that the delays in the approval process are not attributable to </text>
<text top=""380"" left=""108"" width=""567"" height=""16"" font=""0"">APHIS, but rather to a ""lag in informational response time"" on the part of SENASA.</text>
<footnote top=""379"" left=""674"" width=""17"" height=""11"" font=""16"" number=""300"" ref="""" dis=""""/>
<text top=""380"" left=""692"" width=""98"" height=""16"" font=""0""> In particular, </text>
<text top=""396"" left=""108"" width=""684"" height=""16"" font=""0"">the United States observes that (i) SENASA took over one year to answer additional questions </text>
<text top=""413"" left=""108"" width=""596"" height=""16"" font=""0"">posed by APHIS in October 2003 concerning the FMD situation in Northern Argentina</text>
<footnote top=""411"" left=""704"" width=""17"" height=""11"" font=""16"" number=""301"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""612"" height=""15"" font=""10""> United States' first written submission, para. 140; United States' response to Panel question No. 62 </ftext>
<ftext top=""949"" left=""108"" width=""241"" height=""15"" font=""10"">following the first substantive meeting. </ftext>
</footnote>
<text top=""413"" left=""721"" width=""71"" height=""16"" font=""0"">; and (ii) </text>
<text top=""429"" left=""108"" width=""683"" height=""16"" font=""0"">when APHIS requested a new site visit to Northern Argentina in March 2013, SENASA delayed the </text>
<text top=""446"" left=""108"" width=""181"" height=""16"" font=""0"">visit until November 2013.</text>
<footnote top=""444"" left=""289"" width=""17"" height=""11"" font=""16"" number=""302"" ref="""" dis=""""/>
</p><p number=""7.90"" style=""8""><text top=""480"" left=""108"" width=""682"" height=""16"" font=""0"">7.90.  Further, the United States argues that APHIS' delay in processing Argentina's request is due </text>
<text top=""497"" left=""108"" width=""684"" height=""16"" font=""0"">to the changing FMD conditions in the country. The 2003 and 2006 FMD outbreaks in Northern </text>
<text top=""513"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina, for instance, ""raise[d] obvious serious concerns"" with respect to SENASA's ability to </text>
<text top=""529"" left=""108"" width=""394"" height=""16"" font=""0"">prevent and control FMD and required revised analysis.</text>
<footnote top=""528"" left=""502"" width=""17"" height=""11"" font=""16"" number=""303"" ref="""" dis=""""/>
<text top=""529"" left=""519"" width=""273"" height=""16"" font=""0""> Moreover, the United States asserts, </text>
<text top=""546"" left=""108"" width=""684"" height=""16"" font=""0"">SENASA suffered a labour strike in 2005, which gave rise to doubts as to its ability to control </text>
<text top=""562"" left=""108"" width=""34"" height=""16"" font=""0"">FMD.</text>
<footnote top=""561"" left=""142"" width=""17"" height=""11"" font=""16"" number=""304"" ref="""" dis=""""/>
<text top=""562"" left=""160"" width=""633"" height=""16"" font=""0""> The United States also argues that Argentina's ""history of intentional concealment and </text>
<text top=""579"" left=""108"" width=""686"" height=""16"" font=""0"">delayed reporting of outbreaks"" played a ""significant role"" in APHIS' verification of SENASA's </text>
<text top=""595"" left=""108"" width=""683"" height=""16"" font=""0"">information and capability, as it ""called for greater diligence, and for more time"", to conduct such </text>
<text top=""611"" left=""108"" width=""97"" height=""16"" font=""0"">an evaluation.</text>
<footnote top=""610"" left=""205"" width=""17"" height=""11"" font=""16"" number=""305"" ref="""" dis=""""/>
</p><p number=""7.91"" style=""8""><text top=""646"" left=""108"" width=""685"" height=""16"" font=""0"">7.91.  The United States submits that, because the FMD situation on the ground kept evolving </text>
<text top=""662"" left=""108"" width=""682"" height=""16"" font=""0"">throughout the approval process, APHIS did not have all the information necessary to complete its </text>
<text top=""679"" left=""108"" width=""684"" height=""16"" font=""0"">risk assessment for Northern Argentina until it conducted its site visit to Northern Argentina in </text>
<text top=""695"" left=""108"" width=""117"" height=""16"" font=""0"">November 2013.</text>
<footnote top=""693"" left=""225"" width=""17"" height=""11"" font=""16"" number=""306"" ref="""" dis=""""/>
<text top=""695"" left=""243"" width=""551"" height=""16"" font=""0""> Specifically, according to the United States, the November 2013 visit was </text>
<text top=""711"" left=""108"" width=""684"" height=""16"" font=""0"">aimed at ""re-confirm[ing] and updat[ing]"" information in possession of APHIS as a result of the </text>
<text top=""728"" left=""108"" width=""501"" height=""16"" font=""0"">2006 site visit to Northern Argentina and the 2009 site visit to Patagonia.</text>
<footnote top=""726"" left=""609"" width=""17"" height=""11"" font=""16"" number=""307"" ref="""" dis=""""/>
<footnote top=""788"" left=""165"" width=""535"" height=""15"" font=""10"" number=""702"" ref="""" dis=""""/>
<p><text top=""803"" left=""108"" width=""102"" height=""15"" font=""10"">paras. 390-392. </text>
</p><p><text top=""832"" left=""165"" width=""623"" height=""15"" font=""10""> Argentina's second written submission, para. 357; Argentina's opening statement at the first meeting </text>
<text top=""847"" left=""108"" width=""140"" height=""15"" font=""10"">of the Panel, para. 81. </text>
<text top=""861"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 195. </text>
</p><p><text top=""891"" left=""108"" width=""162"" height=""15"" font=""10"">submission, paras. 42-43. </text>
<footnote top=""905"" left=""165"" width=""618"" height=""15"" font=""10"" number=""62"" ref="""" dis=""""/>
</p></p><p number=""omitted)"" style=""3""><text top=""920"" left=""108"" width=""60"" height=""15"" font=""10"">omitted). </text>
<p><text top=""963"" left=""165"" width=""585"" height=""15"" font=""10""> United States' first written submission, para. 200; United States' opening statement at the first </text>
<text top=""978"" left=""108"" width=""193"" height=""15"" font=""10"">meeting of the Panel, para. 14. </text>
<text top=""993"" left=""165"" width=""585"" height=""15"" font=""10""> United States' first written submission, para. 204; United States' opening statement at the first </text>
<text top=""1007"" left=""108"" width=""677"" height=""15"" font=""10"">meeting of the Panel, para. 57; United States' response to Panel question No. 62 following the first substantive </text>
<text top=""1022"" left=""108"" width=""62"" height=""15"" font=""10"">meeting.  </text>
<text top=""1036"" left=""165"" width=""594"" height=""15"" font=""10""> See United States' first written submission, para. 238; United States' response to Panel question </text>
</p><p><text top=""1066"" left=""165"" width=""563"" height=""15"" font=""10""> United States' response to Panel question No. 31 following the second substantive meeting. </text>
<footnote top=""1080"" left=""165"" width=""563"" height=""15"" font=""10"" number=""29"" ref="""" dis=""""><ftext top=""1109"" left=""108"" width=""665"" height=""15"" font=""10"">United States' first written submission, para. 204; United States' response to Panel question No. 30 following </ftext>
<ftext top=""1124"" left=""108"" width=""201"" height=""15"" font=""10"">the second substantive meeting. </ftext>
<ftext top=""1109"" left=""108"" width=""468"" height=""15"" font=""10"">the Panel, para. 94; Argentina's second written submission, paras. 367-368. </ftext>
</footnote>
</p></p></page>
<page number=""63"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 63 - </text>
</p><p number=""7.92"" style=""8""><text top=""128"" left=""108"" width=""689"" height=""16"" font=""0"">7.92.  In this regard, the United States disagrees with Argentina's characterization of the </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">statements by APHIS in April 2009 and September 2010 and by the United States' representative </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">before the SPS Committee in June and October 2011. The United States contends that, at the time </text>
<text top=""177"" left=""108"" width=""689"" height=""16"" font=""0"">such statements were made, APHIS had not completed a risk assessment for Northern </text>
<text top=""193"" left=""108"" width=""66"" height=""16"" font=""0"">Argentina</text>
<footnote top=""192"" left=""174"" width=""17"" height=""11"" font=""16"" number=""308"" ref="""" dis=""""/>
<text top=""193"" left=""191"" width=""366"" height=""16"" font=""0"">, nor did it have enough information to complete one.</text>
<footnote top=""192"" left=""557"" width=""17"" height=""11"" font=""16"" number=""309"" ref="""" dis=""""/>
</p><p number=""7.93"" style=""8""><text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">7.93.  Finally,  the  United States  disagrees with Argentina that Section 737 of the <i>2009 Omnibus </i></text>
<text top=""244"" left=""108"" width=""685"" height=""16"" font=""18""><i>Appropriations Act</i> contributed to delays in APHIS' review processes of Argentina's request. It </text>
<text top=""260"" left=""108"" width=""685"" height=""16"" font=""0"">contends that while Section 737 temporarily discontinued the funding necessary for authorizing </text>
<text top=""277"" left=""108"" width=""682"" height=""16"" font=""0"">meat imports from Argentina, it still preserved the Secretary of Agriculture's powers to review any </text>
<text top=""293"" left=""108"" width=""457"" height=""16"" font=""0"">requests to import meat from Argentina pursuant to 9 CFR 92.2.</text>
<footnote top=""292"" left=""565"" width=""17"" height=""11"" font=""16"" number=""310"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""352"" height=""15"" font=""10""> United States' first written submission, paras. 146, 223.  </ftext>
</footnote>
<text top=""293"" left=""583"" width=""209"" height=""16"" font=""0""> Moreover, the United States </text>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">argues that Section 737, together with the whole <i>2009 Omnibus Appropriations Act</i>, expired less </text>
<text top=""326"" left=""108"" width=""264"" height=""16"" font=""0"">than a year after it was adopted.</text>
<footnote top=""325"" left=""372"" width=""17"" height=""11"" font=""16"" number=""311"" ref="""" dis=""""/>
<text top=""326"" left=""389"" width=""408"" height=""16"" font=""0""> It adds that to the extent that the United States' </text>
<text top=""342"" left=""108"" width=""687"" height=""16"" font=""0"">representative's statements before the SPS Committee could be understood to suggest that </text>
<text top=""359"" left=""108"" width=""689"" height=""16"" font=""0"">Section 737 had a lingering effect on APHIS after its expiration, those statements were </text>
<text top=""375"" left=""108"" width=""64"" height=""16"" font=""0"">incorrect.</text>
<footnote top=""374"" left=""172"" width=""17"" height=""11"" font=""16"" number=""312"" ref="""" dis=""""/>
<text top=""375"" left=""190"" width=""603"" height=""16"" font=""0""> Hence, the United States takes issue with Argentina's assertion that Section 737 is </text>
<text top=""392"" left=""108"" width=""685"" height=""16"" font=""0"">similar to Section 727, which was found to be WTO-inconsistent by the panel in <i>US &#8211; Poultry </i></text>
<text top=""408"" left=""108"" width=""685"" height=""16"" font=""18""><i>(China)</i>, because the latter provision ""completely foreclosed the possibility for 'completion'"" of </text>
<text top=""425"" left=""108"" width=""465"" height=""16"" font=""0"">approval process and ""was still in effect"" at the time of that dispute.</text>
<footnote top=""423"" left=""572"" width=""17"" height=""11"" font=""16"" number=""313"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""459"" left=""108"" width=""663"" height=""16"" font=""28"">7.3.3.3  APHIS' review of Argentina's request for recognition of Patagonia as FMD-free </text></p><p number=""7.3"" style=""8""><text top=""493"" left=""108"" width=""156"" height=""16"" font=""28"">7.3.3.3.1  Argentina </text></p><p number=""7.94"" style=""8""><text top=""528"" left=""108"" width=""682"" height=""16"" font=""0"">7.94.  Argentina complains that, despite having filed its request for the recognition of Patagonia as </text>
<text top=""544"" left=""108"" width=""655"" height=""16"" font=""0"">FMD-free in June 2003 and fully cooperating with APHIS throughout the approval process</text>
<footnote top=""543"" left=""763"" width=""17"" height=""11"" font=""16"" number=""314"" ref="""" dis=""""/>
<text top=""544"" left=""780"" width=""10"" height=""16"" font=""0"">, </text>
<text top=""561"" left=""108"" width=""660"" height=""16"" font=""0"">APHIS had not issued a final determination at the time of the establishment of the Panel.</text>
<footnote top=""559"" left=""768"" width=""17"" height=""11"" font=""16"" number=""315"" ref="""" dis=""""/>
<text top=""577"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina notes that there has been no FMD outbreak in Patagonia South since 1976 and in </text>
<text top=""593"" left=""108"" width=""203"" height=""16"" font=""0"">Patagonia North B since 1994</text>
<footnote top=""592"" left=""311"" width=""17"" height=""11"" font=""16"" number=""316"" ref="""" dis=""""/>
<text top=""593"" left=""328"" width=""5"" height=""16"" font=""0"">,</text>
<text top=""593"" left=""336"" width=""454"" height=""16"" font=""0"">and that the OIE has continuously recognized Patagonia South as </text>
<text top=""610"" left=""108"" width=""682"" height=""16"" font=""0"">FMD-free where vaccination is not practised since 2002 and has extended the same recognition to </text>
<text top=""626"" left=""108"" width=""209"" height=""16"" font=""0"">Patagonia North B since 2007.</text>
<footnote top=""625"" left=""317"" width=""17"" height=""11"" font=""16"" number=""317"" ref="""" dis=""""/>
<text top=""626"" left=""335"" width=""456"" height=""16"" font=""0""> It also notes that APHIS published a favourable risk assessment </text>
<text top=""643"" left=""108"" width=""683"" height=""16"" font=""0"">for Patagonia South in July 2005 and a proposed rule to recognize Patagonia South as FMD-free in </text>
<text top=""659"" left=""108"" width=""97"" height=""16"" font=""0"">January 2007.</text>
<footnote top=""657"" left=""205"" width=""17"" height=""11"" font=""16"" number=""318"" ref="""" dis=""""/>
</p><p number=""7.95"" style=""8""><text top=""693"" left=""108"" width=""685"" height=""16"" font=""0"">7.95.  Argentina points to several instances where it contends, APHIS' process incurred undue </text>
<text top=""710"" left=""108"" width=""683"" height=""16"" font=""0"">delays: (i) the two-year gap (2003-2005) between the filing of its request and the publication of </text>
<text top=""726"" left=""108"" width=""684"" height=""16"" font=""0"">the risk assessment for Patagonia South; (ii) the one-and-a-half year gap (2005-2007) between </text>
<text top=""743"" left=""108"" width=""682"" height=""16"" font=""0"">the publication of that risk assessment and the issuance of the Proposed Rule for the recognition of </text>
<text top=""759"" left=""108"" width=""684"" height=""16"" font=""0"">Patagonia South; (iii) APHIS' failure to proceed with a Final Rule for Patagonia South after the </text>
<text top=""775"" left=""108"" width=""685"" height=""16"" font=""0"">issuance of the Proposed Rule; and (iv) APHIS' failure to proceed with a risk assessment and </text>
<text top=""792"" left=""108"" width=""685"" height=""16"" font=""0"">determination for the entire Patagonia region, comprising both Patagonia South and Patagonia </text>
<text top=""808"" left=""108"" width=""407"" height=""16"" font=""0"">North B, after 2009 (date of APHIS' site visit to the region).</text>
<footnote top=""807"" left=""515"" width=""17"" height=""11"" font=""16"" number=""319"" ref="""" dis=""""/>
<footnote top=""920"" left=""165"" width=""545"" height=""15"" font=""10"" number=""32"" ref="""" dis=""""/>
<p><text top=""934"" left=""165"" width=""563"" height=""15"" font=""10""> United States' response to Panel question No. 27 following the second substantive meeting. </text>
</p><p><text top=""963"" left=""165"" width=""367"" height=""15"" font=""10""> United States' second written submission, Annex, para. 11. </text>
<text top=""978"" left=""165"" width=""537"" height=""15"" font=""10""> United States' response to Panel question No. 6 following the first substantive meeting. </text>
<text top=""993"" left=""165"" width=""621"" height=""15"" font=""10""> United States' first written submission, para. 226. See also United States' response to Panel question </text>
<text top=""1007"" left=""108"" width=""641"" height=""15"" font=""10"">No. 2 following the first substantive meeting; United States' second written submission, Annex, para. 13. </text>
<footnote top=""1022"" left=""165"" width=""293"" height=""15"" font=""10"" number=""672"" ref="""" dis=""""/>
<footnote top=""1036"" left=""165"" width=""293"" height=""15"" font=""10"" number=""671"" ref="""" dis=""""/>
</p><p><text top=""1066"" left=""108"" width=""193"" height=""15"" font=""10"">meeting of the Panel, para. 94. </text>
</p><p><text top=""1095"" left=""165"" width=""621"" height=""15"" font=""10""> Argentina's first written submission, para. 664; Argentina's opening statement at the first meeting of </text>
</p><p><text top=""1124"" left=""165"" width=""528"" height=""15"" font=""10""> Argentina's response to Panel question No. 68 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 64 - </text>
</p></p></page>
<page number=""64"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.96"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.96.  In this regard, Argentina submits that, after the 2009 site visit to Patagonia, APHIS did not </text>
<text top=""144"" left=""108"" width=""322"" height=""16"" font=""0"">request any further information from SENASA.</text>
<footnote top=""143"" left=""430"" width=""17"" height=""11"" font=""16"" number=""320"" ref="""" dis=""""><ftext top=""847"" left=""165"" width=""590"" height=""15"" font=""10""> Argentina's second written submission, paras. 270, 375; Argentina's response to Panel question </ftext>
</footnote>
<text top=""144"" left=""447"" width=""344"" height=""16"" font=""0""> Rather, Argentina remarks, in April 2009 APHIS </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">confirmed that it currently had all the information required, and in September 2010 it stated that it </text>
<text top=""177"" left=""108"" width=""589"" height=""16"" font=""0"">had made significant progress towards the recognition of Patagonia as FMD-free.</text>
<footnote top=""175"" left=""697"" width=""17"" height=""11"" font=""16"" number=""321"" ref="""" dis=""""><ftext top=""876"" left=""165"" width=""590"" height=""15"" font=""10""> Argentina's second written submission, paras. 270, 375; Argentina's response to Panel question </ftext>
</footnote>
<text top=""177"" left=""714"" width=""79"" height=""16"" font=""0""> This was </text>
<text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">confirmed, according to Argentina, by the United States' representative at the SPS Committee </text>
<text top=""210"" left=""108"" width=""180"" height=""16"" font=""0"">in June and October 2011.</text>
<footnote top=""208"" left=""288"" width=""17"" height=""11"" font=""16"" number=""322"" ref="""" dis=""""><ftext top=""905"" left=""165"" width=""378"" height=""15"" font=""10""> Argentina's second written submission, paras. 271-273, 375. </ftext>
</footnote>
<text top=""210"" left=""305"" width=""489"" height=""16"" font=""0""> In Argentina's opinion, the above statements by APHIS and the </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">United States' representative at the SPS Committee indicate that, by 2009-2010, APHIS had </text>
<text top=""242"" left=""108"" width=""610"" height=""16"" font=""0"">already completed a risk assessment for Patagonia as a whole which it did not publish</text>
<footnote top=""241"" left=""718"" width=""17"" height=""11"" font=""16"" number=""323"" ref="""" dis=""""/>
<text top=""242"" left=""735"" width=""57"" height=""16"" font=""0"">, or, at </text>
<text top=""259"" left=""108"" width=""450"" height=""16"" font=""0"">least, that APHIS had all the information needed to complete one.</text>
<footnote top=""257"" left=""557"" width=""17"" height=""11"" font=""16"" number=""324"" ref="""" dis=""""/>
</p><p number=""7.97"" style=""8""><text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">7.97.  As a benchmark for what constitutes a reasonable approval time, Argentina compares the </text>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">duration of the recognition process for Patagonia with those for Japan, the United Kingdom, and </text>
<text top=""326"" left=""108"" width=""420"" height=""16"" font=""0"">Santa Catarina, which APHIS completed more expeditiously.</text>
<footnote top=""325"" left=""528"" width=""17"" height=""11"" font=""16"" number=""325"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""602"" height=""15"" font=""10""> Argentina's first written submission, para. 674; Argentina's second written submission, para. 379. </ftext>
</footnote>
<text top=""326"" left=""545"" width=""246"" height=""16"" font=""0""> Argentina contends that the Final </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">Rule recognizing Santa Catarina as FMD-free in 2010 was part of an agreement reached between </text>
<text top=""359"" left=""108"" width=""476"" height=""16"" font=""0"">the United States and Brazil to settle the <i>US &#8211; Upland Cotton</i> dispute.</text>
<footnote top=""357"" left=""584"" width=""17"" height=""11"" font=""16"" number=""326"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""602"" height=""15"" font=""10""> Argentina's first written submission, para. 677; Argentina's second written submission, para. 225. </ftext>
</footnote>
</p><p number=""7.98"" style=""8""><text top=""393"" left=""108"" width=""684"" height=""16"" font=""0"">7.98.  As with the approval process for fresh (chilled or frozen) beef, Argentina claims that the </text>
<text top=""410"" left=""108"" width=""655"" height=""16"" font=""0"">cause of the delay in the recognition of Patagonia was not supported by scientific considerations</text>
<footnote top=""408"" left=""763"" width=""17"" height=""11"" font=""16"" number=""327"" ref="""" dis=""""/>
<text top=""410"" left=""780"" width=""10"" height=""16"" font=""0"">, </text>
<text top=""426"" left=""108"" width=""280"" height=""16"" font=""0"">but rather due to non-scientific factors.</text>
<footnote top=""425"" left=""388"" width=""17"" height=""11"" font=""16"" number=""328"" ref="""" dis=""""/>
<text top=""426"" left=""405"" width=""387"" height=""16"" font=""0""> Argentina points, in particular, to Section 737 of the </text>
<text top=""443"" left=""108"" width=""683"" height=""16"" font=""18""><i>2009 Omnibus Appropriations Act</i> which, in its view, impeded the completion of APHIS' approval </text>
<text top=""459"" left=""108"" width=""151"" height=""16"" font=""0"">process for Patagonia.</text>
<footnote top=""457"" left=""259"" width=""17"" height=""11"" font=""16"" number=""329"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""331"" height=""15"" font=""10""> Argentina's first written submission, paras. 669, 701. </ftext>
</footnote>
</p><p number=""7.99"" style=""8""><text top=""493"" left=""108"" width=""684"" height=""16"" font=""0"">7.99.  Finally, Argentina contends that the risk assessment and the Proposed Rule for Patagonia </text>
<text top=""510"" left=""108"" width=""686"" height=""16"" font=""0"">issued by APHIS in January 2014 ""do not change the parameters"" of the dispute, as these </text>
<text top=""526"" left=""108"" width=""361"" height=""16"" font=""0"">documents post-date the establishment of the Panel.</text>
<footnote top=""525"" left=""469"" width=""17"" height=""11"" font=""16"" number=""330"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""561"" left=""108"" width=""184"" height=""16"" font=""28"">7.3.3.3.2  United States </text></p><p number=""7.100"" style=""8""><text top=""595"" left=""108"" width=""685"" height=""16"" font=""0"">7.100.  The United States rejects Argentina's allegations of undue delay with respect to APHIS' </text>
<text top=""611"" left=""108"" width=""687"" height=""16"" font=""0"">review process for recognition of Patagonia as FMD-free. It asserts that, since the filing of </text>
<text top=""628"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina's request concerning Patagonia South in July 2003, APHIS continuously engaged with </text>
<text top=""644"" left=""108"" width=""660"" height=""16"" font=""0"">SENASA by requesting supplemental information and scheduling and conducting site visits.</text>
<footnote top=""643"" left=""768"" width=""17"" height=""11"" font=""16"" number=""331"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""405"" height=""15"" font=""10""> United States' first written submission, paras. 150-153, 208-209. </ftext>
</footnote>
<text top=""661"" left=""108"" width=""684"" height=""16"" font=""0"">According to the United States, this process resulted in the publication, in June 2005, of APHIS' </text>
<text top=""677"" left=""108"" width=""683"" height=""16"" font=""0"">risk analysis for Patagonia South and, in January 2007, of a Proposed Rule to recognize Patagonia </text>
<text top=""693"" left=""108"" width=""405"" height=""16"" font=""0"">South as FMD-free within the meaning of 9 CFR 94.1(a).</text>
<footnote top=""692"" left=""513"" width=""17"" height=""11"" font=""16"" number=""332"" ref="""" dis=""""/>
<text top=""693"" left=""531"" width=""262"" height=""16"" font=""0""> The United States further observes </text>
<text top=""710"" left=""108"" width=""684"" height=""16"" font=""0"">that the Proposed Rule was conditional, given that ""FMD continued to pose a risk to Patagonia </text>
<text top=""726"" left=""108"" width=""375"" height=""16"" font=""0"">South because of its geography and trading activity"".</text>
<footnote top=""725"" left=""482"" width=""17"" height=""11"" font=""16"" number=""333"" ref="""" dis=""""/>
<text top=""726"" left=""500"" width=""292"" height=""16"" font=""0""> It also explains that the one-and-a&#8211;half </text>
<text top=""743"" left=""108"" width=""682"" height=""16"" font=""0"">year gap between the publication of the risk assessment for Patagonia South and the publication of </text>
<text top=""759"" left=""108"" width=""682"" height=""16"" font=""0"">the Proposed Rule was due to APHIS' need to comply with the Regulatory Flexibility Act, Executive </text>
<text top=""775"" left=""108"" width=""355"" height=""16"" font=""0"">Order No. 12988, and the Paperwork Reduction Act.</text>
<footnote top=""774"" left=""463"" width=""17"" height=""11"" font=""16"" number=""334"" ref="""" dis=""""/>
<p><text top=""920"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 689. </text>
<text top=""934"" left=""165"" width=""528"" height=""15"" font=""10""> Argentina's response to Panel question No. 24 following the first substantive meeting. </text>
</p><p><text top=""993"" left=""165"" width=""586"" height=""15"" font=""10""> Argentina's first written submission, para. 682. Argentina refers, <i>inter alia</i>, to a letter from four </text>
<text top=""1007"" left=""108"" width=""670"" height=""15"" font=""10"">United States senators to the Administration urging not to adopt the final rule for the recognition of Patagonia </text>
<text top=""1022"" left=""108"" width=""678"" height=""15"" font=""10"">South as FMD-free until the rule has been reviewed by the Office of Management and Budget. (Argentina's first </text>
<text top=""1036"" left=""108"" width=""646"" height=""15"" font=""10"">written submission, para. 679; Argentina's opening statement at the first meeting of the Panel, para. 87). </text>
</p><p><text top=""1066"" left=""165"" width=""455"" height=""15"" font=""10""> Argentina's opening statement at the first meeting of the Panel, para. 98. </text>
<footnote top=""1095"" left=""165"" width=""310"" height=""15"" font=""10"" number=""209"" ref="""" dis=""""/>
</p><p><text top=""1124"" left=""165"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 61 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 65 - </text>
</p></p></page>
<page number=""65"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.101"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.101.  The United States argues that any further delays in the processing of Argentina's request </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">are not attributable to APHIS, but rather to changing FMD and regulatory conditions in Argentina </text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""0"">throughout the review period, as well as to SENASA's inaction in responding to requests for </text>
<text top=""177"" left=""108"" width=""83"" height=""16"" font=""0"">information.</text>
<footnote top=""175"" left=""191"" width=""17"" height=""11"" font=""16"" number=""335"" ref="""" dis=""""><ftext top=""788"" left=""165"" width=""348"" height=""15"" font=""10""> United States' first written submission, paras. 202, 217. </ftext>
</footnote>
<text top=""177"" left=""208"" width=""583"" height=""16"" font=""0""> In particular, the United States contends that SENASA: (i) failed to provide some </text>
<text top=""193"" left=""108"" width=""688"" height=""16"" font=""0"">necessary information as part of its initial request for the recognition of Patagonia South </text>
<text top=""210"" left=""108"" width=""83"" height=""16"" font=""0"">in July 2003</text>
<footnote top=""208"" left=""190"" width=""17"" height=""11"" font=""16"" number=""336"" ref="""" dis=""""><ftext top=""803"" left=""165"" width=""605"" height=""15"" font=""10""> United States' first written submission, paras. 151, 208; United States' response to Panel question </ftext>
</footnote>
<text top=""210"" left=""208"" width=""585"" height=""16"" font=""0"">; (ii) took almost one year to provide additional information requested by APHIS </text>
<text top=""226"" left=""108"" width=""419"" height=""16"" font=""0"">in March 2004 as a follow-up to its visit to Patagonia South</text>
<footnote top=""225"" left=""527"" width=""17"" height=""11"" font=""16"" number=""337"" ref="""" dis=""""><ftext top=""832"" left=""165"" width=""605"" height=""15"" font=""10""> United States' first written submission, paras. 152, 208; United States' response to Panel question </ftext>
</footnote>
<text top=""226"" left=""544"" width=""248"" height=""16"" font=""0"">; and (iii) postponed APHIS' latest </text>
<text top=""242"" left=""108"" width=""385"" height=""16"" font=""0"">site visit to Patagonia, formally requested in March 2013</text>
<footnote top=""241"" left=""493"" width=""17"" height=""11"" font=""16"" number=""338"" ref="""" dis=""""><ftext top=""861"" left=""165"" width=""618"" height=""15"" font=""10""> We note that the United States refers to the fact that it orally mentioned the possibility of a site visit </ftext>
</footnote>
<text top=""242"" left=""510"" width=""158"" height=""16"" font=""0"">, until November 2013.</text>
<footnote top=""241"" left=""668"" width=""17"" height=""11"" font=""16"" number=""339"" ref="""" dis=""""/>
</p><p number=""7.102"" style=""8""><text top=""277"" left=""108"" width=""682"" height=""16"" font=""0"">7.102.  Moreover, the United States stresses that Argentina extended its request for recognition to </text>
<text top=""293"" left=""108"" width=""686"" height=""16"" font=""0"">Patagonia North B in December 2008, i.e. more than five years after its original request for </text>
<text top=""310"" left=""108"" width=""684"" height=""16"" font=""0"">Patagonia South, without providing the necessary supporting information to address the factors </text>
<text top=""326"" left=""108"" width=""168"" height=""16"" font=""0"">listed under 9 CFR 92.2.</text>
<footnote top=""325"" left=""276"" width=""17"" height=""11"" font=""16"" number=""340"" ref="""" dis=""""/>
<text top=""326"" left=""293"" width=""498"" height=""16"" font=""0""> The United States submits that this restructuring of Argentina's initial </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">request altered and delayed the process by requiring APHIS to revise its evaluation to account for </text>
<text top=""359"" left=""108"" width=""686"" height=""16"" font=""0"">the distinct geographical differences between Patagonia South and Patagonia North B and to </text>
<text top=""375"" left=""108"" width=""453"" height=""16"" font=""0"">conduct a new site visit to Patagonia as a whole in February 2009.</text>
<footnote top=""374"" left=""561"" width=""17"" height=""11"" font=""16"" number=""341"" ref="""" dis=""""/>
</p><p number=""7.103"" style=""8""><text top=""410"" left=""108"" width=""685"" height=""16"" font=""0"">7.103.  Finally, the United States points to Argentina's continuous ""revisions to its surveillance </text>
<text top=""426"" left=""108"" width=""634"" height=""16"" font=""0"">regulations and slaughter establishment standards"" throughout the approval process.</text>
<footnote top=""425"" left=""742"" width=""17"" height=""11"" font=""16"" number=""342"" ref="""" dis=""""/>
<text top=""426"" left=""760"" width=""37"" height=""16"" font=""0""> In </text>
<text top=""443"" left=""108"" width=""685"" height=""16"" font=""0"">particular, it refers to Resolution No. 148/2008, which modified the conditions on transport of </text>
<text top=""459"" left=""108"" width=""288"" height=""16"" font=""0"">commercial goods into Patagonia South</text>
<footnote top=""457"" left=""396"" width=""17"" height=""11"" font=""16"" number=""343"" ref="""" dis=""""/>
<text top=""459"" left=""413"" width=""381"" height=""16"" font=""0"">, and Resolution No. 1282/2008, which ""resulted in </text>
<text top=""475"" left=""108"" width=""630"" height=""16"" font=""0"">substantial changes to the methods of detecting and preventing the spread of the disease"".</text>
<footnote top=""474"" left=""738"" width=""17"" height=""11"" font=""16"" number=""344"" ref="""" dis=""""/>
<text top=""475"" left=""755"" width=""35"" height=""16"" font=""0""> The </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">United States claims that the modifications of border control measures such as those contained in </text>
<text top=""508"" left=""108"" width=""683"" height=""16"" font=""0"">Resolution No. 1282/2008, called into question SENASA's ability to prevent FMD from penetrating </text>
<text top=""525"" left=""108"" width=""80"" height=""16"" font=""0"">its borders.</text>
<footnote top=""523"" left=""188"" width=""17"" height=""11"" font=""16"" number=""345"" ref="""" dis=""""/>
<text top=""525"" left=""205"" width=""587"" height=""16"" font=""0""> Furthermore, the United States contends that at the time of APHIS' site visit to </text>
<text top=""541"" left=""108"" width=""654"" height=""16"" font=""0"">Patagonia in February 2009, Resolution No. 1282/2008 had not been fully implemented</text>
<footnote top=""539"" left=""762"" width=""17"" height=""11"" font=""16"" number=""346"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""611"" height=""15"" font=""10""> United States' first written submission, para. 212. United States' response to Panel question No. 34 </ftext>
<ftext top=""1066"" left=""108"" width=""259"" height=""15"" font=""10"">following the second substantive meeting. </ftext>
</footnote>
<text top=""541"" left=""779"" width=""11"" height=""16"" font=""0"">; </text>
<text top=""557"" left=""108"" width=""682"" height=""16"" font=""0"">therefore, it could not adequately assess the impact of the revision on Patagonia's ability to control </text>
<text top=""574"" left=""108"" width=""34"" height=""16"" font=""0"">FMD.</text>
<footnote top=""572"" left=""142"" width=""17"" height=""11"" font=""16"" number=""347"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""611"" height=""15"" font=""10""> United States' first written submission, para. 212. United States' response to Panel question No. 34 </ftext>
<ftext top=""1095"" left=""108"" width=""259"" height=""15"" font=""10"">following the second substantive meeting. </ftext>
</footnote>
</p><p number=""7.104"" style=""8""><text top=""608"" left=""108"" width=""687"" height=""16"" font=""0"">7.104.  In light of the above, the United States maintains that APHIS did not have all the </text>
<text top=""625"" left=""108"" width=""683"" height=""16"" font=""0"">information necessary to complete its risk assessment for Patagonia as a whole (comprising both </text>
<text top=""641"" left=""108"" width=""688"" height=""16"" font=""0"">Patagonia South and Patagonia North B) until it conducted its site visit to the region in </text>
<text top=""657"" left=""108"" width=""114"" height=""16"" font=""0"">November 2013.</text>
<footnote top=""656"" left=""222"" width=""17"" height=""11"" font=""16"" number=""348"" ref="""" dis=""""/>
<text top=""657"" left=""239"" width=""555"" height=""16"" font=""0""> Specifically, according to the United States, the November 2013 visit was </text>
<text top=""674"" left=""108"" width=""684"" height=""16"" font=""0"">aimed at ""re-confirm[ing] and updat[ing]"" information in possession of APHIS as a result of the </text>
<text top=""690"" left=""108"" width=""523"" height=""16"" font=""0"">2006 site visit to Northern Argentina and the 2009 site visit to Patagonia.</text>
<footnote top=""689"" left=""631"" width=""17"" height=""11"" font=""16"" number=""349"" ref="""" dis=""""/>
<text top=""690"" left=""648"" width=""143"" height=""16"" font=""0""> In this regard, the </text>
<text top=""707"" left=""108"" width=""59"" height=""16"" font=""0"">United </text>
<text top=""707"" left=""157"" width=""644"" height=""16"" font=""0"">States disagrees with Argentina's characterization of the statements by APHIS </text>
<text top=""723"" left=""108"" width=""27"" height=""16"" font=""0"">in </text>
<text top=""723"" left=""125"" width=""89"" height=""16"" font=""0"">September </text>
<text top=""723"" left=""204"" width=""216"" height=""16"" font=""0"">2010 and by the United </text>
<text top=""723"" left=""410"" width=""311"" height=""16"" font=""0"">States' representative before the SPS </text>
<text top=""723"" left=""711"" width=""89"" height=""16"" font=""0"">Committee </text>
<footnote top=""818"" left=""108"" width=""285"" height=""15"" font=""10"" number=""62"" ref="""" dis=""""/>
<p><text top=""876"" left=""108"" width=""621"" height=""15"" font=""10"">during consultations with Argentina in November 2012. However, the formal written request was sent </text>
<text top=""891"" left=""108"" width=""95"" height=""15"" font=""10"">in March 2013. </text>
<text top=""905"" left=""165"" width=""585"" height=""15"" font=""10""> United States' first written submission, para. 216; United States' opening statement at the first </text>
<text top=""920"" left=""108"" width=""622"" height=""15"" font=""10"">meeting of the Panel, para. 14; United States' response to Panel question No. 32 following the second </text>
<text top=""934"" left=""108"" width=""131"" height=""15"" font=""10"">substantive meeting. </text>
<footnote top=""949"" left=""165"" width=""310"" height=""15"" font=""10"" number=""215"" ref="""" dis=""""/>
<footnote top=""978"" left=""108"" width=""303"" height=""15"" font=""10"" number=""33"" ref="""" dis=""""/>
</p><p><text top=""993"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 213. </text>
<footnote top=""1007"" left=""165"" width=""310"" height=""15"" font=""10"" number=""210"" ref="""" dis=""""/>
</p><p><text top=""1036"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 211. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 66 - </text>
</p><p><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">in June and October 2011. The United States asserts that, at the time such statements were </text>
<text top=""144"" left=""108"" width=""628"" height=""16"" font=""0"">made, APHIS did not have enough information to complete a risk assessment for Patagonia.</text>
<footnote top=""143"" left=""736"" width=""17"" height=""11"" font=""16"" number=""350"" ref="""" dis=""""/>
</p></p></page>
<page number=""66"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.105"" style=""8""><text top=""178"" left=""108"" width=""689"" height=""16"" font=""0"">7.105.  Finally, for the same reasons outlined in paragraph 7.93 above, the United States </text>
<text top=""195"" left=""108"" width=""682"" height=""16"" font=""0"">disagrees that Section 737 of the <i>2009 Omnibus Appropriations Act</i> contributed to delays in APHIS' </text>
<text top=""211"" left=""108"" width=""280"" height=""16"" font=""0"">review processes of Argentina's request. </text>
</p><p number=""7.3"" style=""8""><text top=""246"" left=""108"" width=""337"" height=""16"" font=""28"">7.3.3.4  Main arguments of the third parties </text></p><p number=""7.3"" style=""8""><text top=""280"" left=""108"" width=""124"" height=""16"" font=""28"">7.3.3.4.1  China </text></p><p number=""7.106"" style=""8""><text top=""314"" left=""108"" width=""682"" height=""16"" font=""0"">7.106.  In China's view, Annex C(1)(a) is ""essentially a good faith obligation requiring Members to </text>
<text top=""331"" left=""108"" width=""684"" height=""16"" font=""0"">proceed with their approval procedures as promptly as possible, taking account of the need to </text>
<text top=""347"" left=""108"" width=""481"" height=""16"" font=""0"">check and ensure the fulfilment of their relevant SPS requirements"".</text>
<footnote top=""346"" left=""589"" width=""17"" height=""11"" font=""16"" number=""351"" ref="""" dis=""""/>
<text top=""347"" left=""607"" width=""185"" height=""16"" font=""0""> In addition, according to </text>
<text top=""364"" left=""108"" width=""684"" height=""16"" font=""0"">China, the terms ""undertake and complete"" in Annex C(1) indicate that approval procedures are </text>
<text top=""380"" left=""108"" width=""660"" height=""16"" font=""0"">not only to be undertaken, but are also to be finished, or concluded without undue delay.</text>
<footnote top=""379"" left=""768"" width=""17"" height=""11"" font=""16"" number=""352"" ref="""" dis=""""/>
<text top=""396"" left=""108"" width=""683"" height=""16"" font=""0"">Moreover, China relies on the panel report in <i>EC &#8211; Approval and Marketing of Biotech Products</i> in </text>
<text top=""413"" left=""108"" width=""684"" height=""16"" font=""0"">stating that an ""undue delay"" is determined not by the length of the delay, but by whether the </text>
<text top=""429"" left=""108"" width=""116"" height=""16"" font=""0"">delay is justified.</text>
<footnote top=""428"" left=""224"" width=""17"" height=""11"" font=""16"" number=""353"" ref="""" dis=""""/>
</p><p number=""7.107"" style=""8""><text top=""464"" left=""108"" width=""686"" height=""16"" font=""0"">7.107.  China considers that a decade-long wait for approval ""constitutes a delay"" within the </text>
<text top=""480"" left=""108"" width=""322"" height=""16"" font=""0"">meaning of Annex C(1) of the SPS Agreement.</text>
<footnote top=""479"" left=""430"" width=""20"" height=""11"" font=""16"" number=""354"" ref="""" dis=""""/>
<text top=""480"" left=""451"" width=""339"" height=""16"" font=""0"">Therefore, the focus of the dispute should be on </text>
<text top=""497"" left=""108"" width=""275"" height=""16"" font=""0"">whether such delay is justifiable or not.</text>
<footnote top=""495"" left=""383"" width=""17"" height=""11"" font=""16"" number=""355"" ref="""" dis=""""/>
<text top=""497"" left=""401"" width=""390"" height=""16"" font=""0""> Furthermore, China takes the view that Section 737 of </text>
<text top=""513"" left=""108"" width=""683"" height=""16"" font=""0"">the <i>2009 Omnibus Appropriations Act</i> precluded the United States from issuing a risk assessment </text>
<text top=""529"" left=""108"" width=""589"" height=""16"" font=""0"">and from even initiating a rulemaking process to permit importation from Argentina.</text>
<footnote top=""528"" left=""697"" width=""17"" height=""11"" font=""16"" number=""356"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""558"" height=""15"" font=""10""> China's third-party submission, para. 73. See also China's third-party statement, para. 10. </ftext>
</footnote>
<text top=""529"" left=""714"" width=""77"" height=""16"" font=""0""> For these </text>
<text top=""546"" left=""108"" width=""633"" height=""16"" font=""0"">reasons, China considers that Argentina's claims with respect to undue delay should prevail. </text>
</p><p number=""7.3"" style=""8""><text top=""580"" left=""108"" width=""202"" height=""16"" font=""28"">7.3.3.4.2  European Union </text></p><p number=""7.108"" style=""8""><text top=""615"" left=""108"" width=""684"" height=""16"" font=""0"">7.108.  According to the European Union, the question arises whether a Member in receipt of an </text>
<text top=""631"" left=""108"" width=""685"" height=""16"" font=""0"">application that it does not yet find complete or convincing is necessarily required to adopt a </text>
<text top=""647"" left=""108"" width=""684"" height=""16"" font=""0"">negative decision or may rather postpone the decision until such time as it has established that </text>
<text top=""664"" left=""108"" width=""435"" height=""16"" font=""0"">products from the applicant Member are suitable for import.</text>
<footnote top=""662"" left=""543"" width=""17"" height=""11"" font=""16"" number=""357"" ref="""" dis=""""/>
<text top=""664"" left=""560"" width=""233"" height=""16"" font=""0""> In the European Union's view, </text>
<text top=""680"" left=""108"" width=""682"" height=""16"" font=""0"">postponing the decision until it can be favourable to imports may curtail the complaining Member's </text>
<text top=""697"" left=""108"" width=""687"" height=""16"" font=""0"">possibility to benefit from a full representation of the matter in the framework of dispute </text>
<text top=""713"" left=""108"" width=""77"" height=""16"" font=""0"">settlement.</text>
<footnote top=""711"" left=""185"" width=""17"" height=""11"" font=""16"" number=""358"" ref="""" dis=""""/>
<text top=""713"" left=""203"" width=""588"" height=""16"" font=""0""> Conversely, requiring the Member to adopt a negative determination would trigger </text>
<text top=""729"" left=""108"" width=""682"" height=""16"" font=""0"">the question as to when such a determination is due and would raise doubts as to its utility in case </text>
<text top=""746"" left=""108"" width=""282"" height=""16"" font=""0"">the circumstances subsequently change.</text>
<footnote top=""744"" left=""390"" width=""17"" height=""11"" font=""16"" number=""359"" ref="""" dis=""""/>
<text top=""746"" left=""408"" width=""384"" height=""16"" font=""0""> For the European Union, the answer to the question </text>
<text top=""762"" left=""108"" width=""361"" height=""16"" font=""0"">should depend on a case-by-case analysis by panels.</text>
<footnote top=""761"" left=""469"" width=""17"" height=""11"" font=""16"" number=""360"" ref="""" dis=""""/>
</p><p number=""7.109"" style=""8""><text top=""797"" left=""108"" width=""684"" height=""16"" font=""0"">7.109.  The European Union takes the view that, especially in the absence of a specific negative </text>
<text top=""813"" left=""108"" width=""684"" height=""16"" font=""0"">decision, the complaining and defending Members should be expected to provide an exhaustive </text>
<text top=""829"" left=""108"" width=""660"" height=""16"" font=""0"">and duly evidenced description of any material relevant to the question of the passage of time.</text>
<footnote top=""828"" left=""768"" width=""17"" height=""11"" font=""16"" number=""361"" ref="""" dis=""""/>
<text top=""846"" left=""108"" width=""682"" height=""16"" font=""0"">Only then, the European Union argues, could a panel make an objective assessment of whether or </text>
<text top=""862"" left=""108"" width=""490"" height=""16"" font=""0"">not the passage of time is justified, based on all the facts and evidence.</text>
<footnote top=""861"" left=""598"" width=""17"" height=""11"" font=""16"" number=""362"" ref="""" dis=""""/>
<footnote top=""963"" left=""165"" width=""257"" height=""15"" font=""10"" number=""70"" ref="""" dis=""""/>
<p><text top=""993"" left=""165"" width=""257"" height=""15"" font=""10""> China's third-party submission, para. 71. </text>
<footnote top=""1007"" left=""165"" width=""257"" height=""15"" font=""10"" number=""72"" ref="""" dis=""""/>
</p><p><text top=""1051"" left=""165"" width=""326"" height=""15"" font=""10""> European Union's third-party submission, para. 108. </text>
<text top=""1066"" left=""165"" width=""326"" height=""15"" font=""10""> European Union's third-party submission, para. 109. </text>
<text top=""1080"" left=""165"" width=""326"" height=""15"" font=""10""> European Union's third-party submission, para. 110. </text>
<text top=""1095"" left=""165"" width=""326"" height=""15"" font=""10""> European Union's third-party submission, para. 111. </text>
<footnote top=""1109"" left=""165"" width=""326"" height=""15"" font=""10"" number=""114"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 67 - </text>
</p></p></page>
<page number=""67"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.3"" style=""8""><text top=""128"" left=""108"" width=""229"" height=""16"" font=""28"">7.3.3.5  Analysis by the Panel </text></p><p number=""7.110"" style=""8""><text top=""162"" left=""108"" width=""683"" height=""16"" font=""0"">7.110.  Annex C(1)(a) of the SPS Agreement requires Members to ensure that control, inspection, </text>
<text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">and approval procedures are ""undertaken and completed without undue delay"". We examine the </text>
<text top=""195"" left=""108"" width=""320"" height=""16"" font=""0"">meaning of each term of the provision in turn. </text>
</p><p number=""7.3"" style=""8""><text top=""229"" left=""108"" width=""302"" height=""16"" font=""28"">7.3.3.5.1  ""Undertaken and completed"" </text></p><p number=""7.111"" style=""8""><text top=""264"" left=""108"" width=""686"" height=""16"" font=""0"">7.111.  We note that Annex C(1)(a) requires that procedures be ""undertaken and completed </text>
<text top=""280"" left=""108"" width=""688"" height=""16"" font=""0"">without undue delay"". Prior panels have focused on each term separately and as distinct </text>
<text top=""296"" left=""108"" width=""640"" height=""16"" font=""0"">obligations. In the past the term ""undertake"" has been understood to refer to the beginning</text>
<footnote top=""295"" left=""748"" width=""17"" height=""11"" font=""16"" number=""363"" ref=""WT/DS400/R ; WT/DS401/R|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS400/R/Add.1 ; WT/DS401/R/Add.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1"" dis=""DS291|DS292|DS400|DS401|DS293""><ftext top=""847"" left=""165"" width=""617"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1494 (explaining that ""[t]he </ftext>
<ftext top=""861"" left=""108"" width=""675"" height=""15"" font=""10"">verb 'undertake' makes clear that Members are required to begin, or start, approval procedures after receiving </ftext>
<ftext top=""876"" left=""108"" width=""664"" height=""15"" font=""10"">an application for approval""). See also Panel Report, <i>EC &#8211; Seal Products</i>, para. 7.562. The panel in <i>EC &#8211; Seal </i></ftext>
<ftext top=""891"" left=""108"" width=""678"" height=""15"" font=""12""><i>Products</i> expressed its opinion in the context of Article 5.2.1 of the TBT Agreement. It also found that, ""[g]iven </ftext>
<ftext top=""905"" left=""108"" width=""669"" height=""15"" font=""10"">the similarity in the text, we agree &#8230; that there are certain parallels in the terms and scope of Article 5.2.1 of </ftext>
<ftext top=""920"" left=""108"" width=""680"" height=""15"" font=""10"">the TBT Agreement and Annex C(1)(a) of the SPS Agreement"". (Panel Report, <i>EC &#8211; Seal Products</i>, para. 7.561) </ftext>
</footnote>
<text top=""296"" left=""765"" width=""26"" height=""16"" font=""0""> or </text>
<text top=""313"" left=""108"" width=""108"" height=""16"" font=""0"">commencement</text>
<footnote top=""311"" left=""216"" width=""17"" height=""11"" font=""16"" number=""364"" ref="""" dis=""""/>
<text top=""313"" left=""233"" width=""557"" height=""16"" font=""0""> of the approval procedure. In turn, panels and the Appellate Body have stated </text>
<text top=""329"" left=""108"" width=""683"" height=""16"" font=""0"">that the term ""complete"" indicates that ""approval procedures are not only to be undertaken, but </text>
<text top=""346"" left=""108"" width=""258"" height=""16"" font=""0"">are also to be finished, or concluded"".</text>
<footnote top=""344"" left=""366"" width=""17"" height=""11"" font=""16"" number=""365"" ref=""WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS392/R|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2"" dis=""DS401|DS291|DS292|DS400|DS293|DS392""><ftext top=""949"" left=""165"" width=""573"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1494. See also Panel </ftext>
<ftext top=""963"" left=""108"" width=""671"" height=""15"" font=""10"">Reports, <i>US &#8211; Poultry (China)</i>, para. 7.383; <i>EC &#8211; Seal Products</i>, para. 7.562; Appellate Body Report, <i>Australia </i></ftext>
</footnote>
</p><p number=""7.112"" style=""8""><text top=""380"" left=""108"" width=""683"" height=""16"" font=""0"">7.112.  We agree with these interpretations. Moreover, we also believe that the term ""undertaken </text>
<text top=""396"" left=""108"" width=""684"" height=""16"" font=""0"">and completed without undue delay"" includes not only no undue delay in the commencement of </text>
<text top=""413"" left=""108"" width=""689"" height=""16"" font=""0"">the procedure and its completion, but also in the intervening process that leads from </text>
<text top=""429"" left=""108"" width=""684"" height=""16"" font=""0"">commencement to completion. We find support for this understanding from the definition of the </text>
<text top=""446"" left=""108"" width=""683"" height=""16"" font=""0"">verb ""to undertake"" which is ""[t]o take upon oneself; to take in hand[;] &#8230; [t]o take in charge; to </text>
<text top=""462"" left=""108"" width=""330"" height=""16"" font=""0"">accept the duty of attending to or looking after""</text>
<footnote top=""461"" left=""438"" width=""17"" height=""11"" font=""16"" number=""366"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""289"" height=""15"" font=""10""> <i>Online Oxford English Dictionary</i>, ""undertake"", </ftext>
<ftext top=""1007"" left=""108"" width=""617"" height=""15"" font=""10"">http://www.oed.com/view/Entry/212141?isAdvanced=false&amp;result=2&amp;rskey=s7YzPE&amp; (last accessed </ftext>
</footnote>
<text top=""462"" left=""456"" width=""334"" height=""16"" font=""0"">, as well as in the reasoning of the panels in <i>EC </i></text>
<text top=""479"" left=""108"" width=""683"" height=""16"" font=""18""><i>&#8211; Approval and Marketing of Biotech Products </i>and <i>US &#8211; Poultry (China) </i>that ""once an application </text>
<text top=""495"" left=""108"" width=""684"" height=""16"" font=""0"">has been received, approval procedures must be started and then carried out from beginning to </text>
<text top=""511"" left=""108"" width=""36"" height=""16"" font=""0"">end"".</text>
<footnote top=""510"" left=""144"" width=""17"" height=""11"" font=""16"" number=""367"" ref=""WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4"" dis=""DS291|DS292|DS392|DS293""><ftext top=""1036"" left=""165"" width=""621"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1494;<i> US &#8211; Poultry (China)</i>, </ftext>
<ftext top=""1051"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.383. </ftext>
</footnote>
<text top=""511"" left=""161"" width=""630"" height=""16"" font=""0""> The requirement to carry out an approval procedure to the end should not be confused </text>
<text top=""528"" left=""108"" width=""683"" height=""16"" font=""0"">with an obligation for the importing Member to <i>approve</i> the importation of the product(s) subject </text>
<text top=""544"" left=""108"" width=""683"" height=""16"" font=""0"">to the procedure. Pursuant to Annex C(1)(a), the importing Member is simply required to issue a </text>
<text top=""561"" left=""108"" width=""460"" height=""16"" font=""0"">final determination regardless of whether it be positive or negative.</text>
<footnote top=""559"" left=""568"" width=""17"" height=""11"" font=""16"" number=""368"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""595"" left=""108"" width=""255"" height=""16"" font=""28"">7.3.3.5.2  ""Without undue delay"" </text></p><p number=""7.113"" style=""8""><text top=""629"" left=""108"" width=""683"" height=""16"" font=""0"">7.113.  We now turn to the interpretation of what constitutes an undue delay within the meaning </text>
<text top=""646"" left=""108"" width=""683"" height=""16"" font=""0"">of Annex C(1)(a). In our view, not every lapse of time amounts to a delay, as a certain period of </text>
<text top=""662"" left=""108"" width=""686"" height=""16"" font=""0"">time is usually necessary for a Member to undertake and complete a control, inspection or </text>
<text top=""679"" left=""108"" width=""683"" height=""16"" font=""0"">approval procedure. The panel in <i>EC &#8211; Approval and Marketing of Biotech Products </i>found that a </text>
<text top=""695"" left=""108"" width=""508"" height=""16"" font=""0"">""delay"" is ""(a period of) time lost by inaction or inability to proceed"".</text>
<footnote top=""693"" left=""616"" width=""17"" height=""11"" font=""16"" number=""369"" ref=""WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7"" dis=""DS292|DS291|DS293""><ftext top=""1109"" left=""165"" width=""596"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1495. See also Appellate </ftext>
</footnote>
<text top=""695"" left=""633"" width=""160"" height=""16"" font=""0""> The requirements in </text>
<text top=""711"" left=""108"" width=""688"" height=""16"" font=""0"">Annex C(1)(b) provide context for this interpretation, particularly the requirements for the </text>
<text top=""728"" left=""108"" width=""685"" height=""16"" font=""0"">competent authorities to ""promptly examine[] the completeness of the documentation"" and to </text>
<text top=""744"" left=""108"" width=""683"" height=""16"" font=""0"">""inform[] the applicant in a precise and complete manner of all deficiencies"". In our view, these </text>
<text top=""761"" left=""108"" width=""682"" height=""16"" font=""0"">requirements support an understanding that the normal course of a procedure requires competent </text>
<text top=""777"" left=""108"" width=""682"" height=""16"" font=""0"">authorities to actively engage with the applicant Member on the substance of its application. Thus, </text>
<text top=""793"" left=""108"" width=""683"" height=""16"" font=""0"">inaction or an inability to proceed on the substance of the application would constitute something </text>
<footnote top=""934"" left=""165"" width=""332"" height=""15"" font=""10"" number=""438"" ref="""" dis=""""/>
<p><text top=""1022"" left=""108"" width=""111"" height=""15"" font=""10"">November 2014). </text>
</p><p><text top=""1066"" left=""165"" width=""615"" height=""15"" font=""10""> This interpretation finds support in the language of Annex C(1)(b), in the part where it requires that </text>
<text top=""1080"" left=""108"" width=""649"" height=""15"" font=""10"">""the competent body transmit[] as soon as possible the results of the procedure in a precise and complete </text>
<text top=""1095"" left=""108"" width=""473"" height=""15"" font=""10"">manner to the applicant so that corrective action may be taken if necessary"". </text>
</p><p><text top=""1124"" left=""108"" width=""267"" height=""15"" font=""10"">Body Report, <i>Australia &#8211; Apples</i>, para. 437. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 68 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">outside the normal course of the procedure and should be considered a delay within the meaning </text>
<text top=""144"" left=""108"" width=""221"" height=""16"" font=""0"">of Article 8 and Annex C(1)(a).  </text>
</p></p></page>
<page number=""68"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.114"" style=""8""><text top=""178"" left=""108"" width=""685"" height=""16"" font=""0"">7.114.  In our view, a determination of whether a delay exists should be made in light of the </text>
<text top=""195"" left=""108"" width=""513"" height=""16"" font=""0"">nature and complexity of the procedure to be undertaken and completed.</text>
<footnote top=""193"" left=""621"" width=""17"" height=""11"" font=""16"" number=""370"" ref="""" dis=""DS184|DS114""><ftext top=""861"" left=""165"" width=""612"" height=""15"" font=""10""> In this regard, we note that, in determining an appropriate period of time for implementation of the </ftext>
<ftext top=""876"" left=""108"" width=""653"" height=""15"" font=""10"">DSB's recommendations or rulings under Article 21.3(c) of the DSU, the arbitrator in <i>US &#8211; Hot-Rolled Steel </i></ftext>
<ftext top=""891"" left=""108"" width=""665"" height=""15"" font=""12""><i>(Article 21.3(c))</i> stated that ""[t]he degree of complexity of the contemplated implementing legislation may &#8230; </ftext>
<ftext top=""905"" left=""108"" width=""673"" height=""15"" font=""10"">bear[] upon the length of time that may reasonably be allocated to the enactment of such legislation"". (Award </ftext>
<ftext top=""920"" left=""108"" width=""671"" height=""15"" font=""10"">of the Arbitrator, <i>US &#8211; Hot-Rolled Steel (Article 21.3(c))</i>, para. 30. See also Award of the Arbitrator, <i>Canada &#8211; </i></ftext>
<ftext top=""934"" left=""108"" width=""312"" height=""15"" font=""12""><i>Pharmaceutical Patents (Article 21.3(c))</i>, para. 50) </ftext>
</footnote>
<text top=""195"" left=""638"" width=""153"" height=""16"" font=""0""> In certain instances, </text>
<text top=""211"" left=""108"" width=""686"" height=""16"" font=""0"">the ordinary or expected time to carry out a procedure may not be easily ascertained. For </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">example, the relevant regulations governing the procedure may not establish a precise time-frame </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">within which each step has to be conducted. In our view, this is the case with 9 CFR 92.2. Indeed, </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">as the United States explained, APHIS does not have a standard or average time-period required </text>
<text top=""277"" left=""108"" width=""292"" height=""16"" font=""0"">for the completion of its review processes.</text>
<footnote top=""275"" left=""400"" width=""17"" height=""11"" font=""16"" number=""371"" ref="""" dis=""""/>
<text top=""277"" left=""418"" width=""373"" height=""16"" font=""0""> Rather, the length of time required for it to evaluate </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">a request ""depend[s] on the specific circumstances of each case"", as applicant Members present </text>
<text top=""310"" left=""108"" width=""685"" height=""16"" font=""0"">different SPS circumstances that ""may also affected by law, policy, governance, and veterinary </text>
<text top=""326"" left=""108"" width=""110"" height=""16"" font=""0"">infrastructures"".</text>
<footnote top=""325"" left=""218"" width=""17"" height=""11"" font=""16"" number=""372"" ref="""" dis=""""/>
<text top=""326"" left=""236"" width=""556"" height=""16"" font=""0""> Therefore, in making our assessment of whether delays occurred with respect </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">to Argentina's applications, the Panel cannot simply compare the time taken to review Argentina's </text>
<text top=""359"" left=""108"" width=""677"" height=""16"" font=""0"">applications to a standard processing time. Instead, the Panel must examine each of the time-</text>
<text top=""375"" left=""108"" width=""686"" height=""16"" font=""0"">periods identified by Argentina as delays to determine whether they were periods when the </text>
<text top=""392"" left=""108"" width=""523"" height=""16"" font=""0"">procedure did not move forward because of inaction or inability to proceed.  </text>
</p><p number=""7.115"" style=""8""><text top=""426"" left=""108"" width=""682"" height=""16"" font=""0"">7.115.  We recall that the panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> explained ""not </text>
<text top=""443"" left=""108"" width=""682"" height=""16"" font=""0"">every delay in the undertaking or completion of approval procedures"" is contrary to the provisions </text>
<text top=""459"" left=""108"" width=""311"" height=""16"" font=""0"">of Annex C(1)(a), but only one that is undue.</text>
<footnote top=""457"" left=""419"" width=""17"" height=""11"" font=""16"" number=""373"" ref=""WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4"" dis=""DS291|DS293|DS292""><ftext top=""978"" left=""165"" width=""481"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1495. </ftext>
</footnote>
<text top=""459"" left=""436"" width=""354"" height=""16"" font=""0""> That panel found that the ordinary meaning of the </text>
<text top=""475"" left=""108"" width=""480"" height=""16"" font=""0"">term undue is ""[g]oing beyond what is warranted"" and ""unjustifiable"".</text>
<footnote top=""474"" left=""588"" width=""17"" height=""11"" font=""16"" number=""374"" ref=""WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9"" dis=""DS291|DS293|DS292""><ftext top=""993"" left=""165"" width=""481"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1495. </ftext>
</footnote>
<text top=""475"" left=""605"" width=""185"" height=""16"" font=""0""> The panel in <i>US &#8211; Poultry </i></text>
<text top=""492"" left=""108"" width=""684"" height=""16"" font=""18""><i>(China)</i> similarly stated that the ordinary meaning of the phrase ""without undue delay"" requires </text>
<text top=""508"" left=""108"" width=""639"" height=""16"" font=""0"">that ""approval procedures be undertaken and completed with no unjustifiable loss of time"".</text>
<footnote top=""507"" left=""747"" width=""17"" height=""11"" font=""16"" number=""375"" ref=""WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS367/AB/R|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2"" dis=""DS292|DS367|DS291|DS392|DS293""><ftext top=""1007"" left=""165"" width=""621"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1495;<i> US &#8211; Poultry (China)</i>, </ftext>
<ftext top=""1022"" left=""108"" width=""517"" height=""15"" font=""10"">para. 7.354. See also See also Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 437. </ftext>
</footnote>
<text top=""508"" left=""765"" width=""27"" height=""16"" font=""0""> In </text>
<text top=""525"" left=""108"" width=""684"" height=""16"" font=""0"">other words, what matters is whether there is a legitimate reason, or justification, for a given </text>
<text top=""541"" left=""108"" width=""283"" height=""16"" font=""0"">delay, not the length of a delay as such.</text>
<footnote top=""539"" left=""391"" width=""17"" height=""11"" font=""16"" number=""376"" ref=""WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9"" dis=""DS291|DS292|DS392|DS293""><ftext top=""1036"" left=""165"" width=""621"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1496;<i> US &#8211; Poultry (China)</i>, </ftext>
<ftext top=""1051"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.354. </ftext>
</footnote>
<text top=""541"" left=""408"" width=""383"" height=""16"" font=""0""> Therefore, the analysis of a claim under Article 8 and </text>
<text top=""557"" left=""108"" width=""685"" height=""16"" font=""0"">Annex C(1)(a) requires two steps. First, the complainant must establish that there has been a </text>
<text top=""574"" left=""108"" width=""505"" height=""16"" font=""0"">delay. Second, the complainant must establish that the delay was undue. </text>
</p><p number=""7.116"" style=""8""><text top=""608"" left=""108"" width=""682"" height=""16"" font=""0"">7.116.  The panels in <i>EC &#8211; Approval and Marketing of Biotech Products </i>and <i>US &#8211; Poultry (China)</i> </text>
<text top=""625"" left=""108"" width=""677"" height=""16"" font=""0"">explained that the determination of what constitutes an undue delay must be made ""on a case-by-</text>
<text top=""641"" left=""108"" width=""439"" height=""16"" font=""0"">case basis, taking account of relevant facts and circumstances"".</text>
<footnote top=""639"" left=""546"" width=""17"" height=""11"" font=""16"" number=""377"" ref=""WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS392/R|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS367/AB/R|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5"" dis=""DS293|DS392|DS291|DS367|DS292""><ftext top=""1066"" left=""165"" width=""579"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1497. See also Panel </ftext>
<ftext top=""1080"" left=""108"" width=""590"" height=""15"" font=""10"">Report, <i>US &#8211; Poultry (China)</i>, para. 7.354; Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 437. </ftext>
</footnote>
<text top=""641"" left=""564"" width=""226"" height=""16"" font=""0""> The panel in <i>EC &#8211; Approval and </i></text>
<text top=""657"" left=""108"" width=""683"" height=""16"" font=""18""><i>Marketing of Biotech Products </i>provided some guidance on the types of circumstances that might </text>
<text top=""674"" left=""108"" width=""683"" height=""16"" font=""0"">justify a delay taken in carrying out a procedure subject to the obligation in Annex C(1)(a). First, </text>
<text top=""690"" left=""108"" width=""686"" height=""16"" font=""0"">delays attributable to action or inaction of an applicant cannot be held against the Member </text>
<text top=""707"" left=""108"" width=""202"" height=""16"" font=""0"">carrying out the procedure.</text>
<footnote top=""705"" left=""310"" width=""17"" height=""11"" font=""16"" number=""378"" ref=""WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7"" dis=""DS293|DS291|DS392|DS292""><ftext top=""1095"" left=""165"" width=""621"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1497;<i> US &#8211; Poultry (China)</i>, </ftext>
<ftext top=""1109"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.354. </ftext>
</footnote>
<text top=""707"" left=""327"" width=""468"" height=""16"" font=""0""> Second, delays which ""are justified in their entirety"" by the </text>
<text top=""723"" left=""108"" width=""683"" height=""16"" font=""0"">Members' need ""to determine with adequate confidence whether their relevant SPS requirements </text>
<text top=""739"" left=""108"" width=""317"" height=""16"" font=""0"">are fulfilled"" should not be considered undue.</text>
<footnote top=""738"" left=""425"" width=""17"" height=""11"" font=""16"" number=""379"" ref=""WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R ; WT/DS292/R ; WT/DS293/R"" dis=""DS291|DS292|DS293""><ftext top=""1124"" left=""165"" width=""487"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1498. </ftext>
<ftext top=""891"" left=""169"" width=""340"" height=""15"" font=""10"">imports of Argentine fresh (chilled or frozen) beef into </ftext>
<ftext top=""905"" left=""169"" width=""243"" height=""15"" font=""10"">the United States pursuant to 9 CFR 92.</ftext>
<ftext top=""927"" left=""169"" width=""343"" height=""15"" font=""10"">Officials from the United States met with Argentina </ftext>
<ftext top=""942"" left=""169"" width=""342"" height=""15"" font=""10"">officials and requested technical documents to allow </ftext>
<ftext top=""956"" left=""169"" width=""207"" height=""15"" font=""10"">for the initiation of a risk analysis.</ftext>
</footnote>
<text top=""739"" left=""442"" width=""349"" height=""16"" font=""0""> Third, if ""new or additional information becomes </text>
<text top=""756"" left=""108"" width=""686"" height=""16"" font=""0"">available at a late stage in an approval procedure"" and that information may reasonably be </text>
<text top=""772"" left=""108"" width=""683"" height=""16"" font=""0"">considered to ""have a potential impact on a Member's determination"", it ""might be justifiable for </text>
<p><text top=""949"" left=""165"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 60 following the first substantive meeting. </text>
<text top=""963"" left=""165"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 66 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 69 - </text>
</p><p><text top=""128"" left=""108"" width=""688"" height=""16"" font=""0"">the Member concerned to delay the completion of the procedure"" in order to assess the </text>
<text top=""144"" left=""108"" width=""83"" height=""16"" font=""0"">information.</text>
<footnote top=""143"" left=""191"" width=""17"" height=""11"" font=""16"" number=""380"" ref=""WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1"" dis=""DS291|DS293|DS292""><ftext top=""993"" left=""165"" width=""487"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1498. </ftext>
</footnote>
</p></p></page>
<page number=""69"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<fontspec id=""33"" size=""9"" family=""Times"" color=""#000000"" style=""b""/><p number=""7.117"" style=""8""><text top=""178"" left=""108"" width=""684"" height=""16"" font=""0"">7.117.  Applying this reasoning to the present dispute, we consider that the period of 11 years </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">following Argentina's requests during which APHIS was conducting the procedure is not, in and of </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">itself, conclusive as to whether such procedures incurred undue delay inconsistently with Article 8 </text>
<text top=""228"" left=""108"" width=""685"" height=""16"" font=""0"">and Annex C(1)(a). Rather, we shall conduct our analysis based on all the relevant facts and </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">circumstances presented by the parties. That being said, it would be difficult for us to gauge the </text>
<text top=""260"" left=""108"" width=""685"" height=""16"" font=""0"">reasonableness of the length of time of APHIS' review processes in the absence of a point of </text>
<text top=""277"" left=""108"" width=""686"" height=""16"" font=""0"">reference. Therefore, we find it useful to rely on a number of indicators that, without being </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">dispositive of our assessment, may nonetheless assist us in our analysis. Such indicators include </text>
<text top=""310"" left=""108"" width=""685"" height=""16"" font=""0"">the standard processing time reflected in APHIS' own policy and practice as well as guidelines </text>
<text top=""326"" left=""108"" width=""146"" height=""16"" font=""0"">provided by the OIE. </text>
</p><p number=""7.118"" style=""8""><text top=""360"" left=""108"" width=""683"" height=""16"" font=""0"">7.118.  We note that a claim of undue delay necessarily refers to acts or omissions over a period </text>
<text top=""377"" left=""108"" width=""683"" height=""16"" font=""0"">of time. In order to precisely define the scope of our review, we consider it necessary to identify </text>
<text top=""393"" left=""108"" width=""683"" height=""16"" font=""0"">an end-date for the period of time we take into account for the purpose of assessing the alleged </text>
<text top=""410"" left=""108"" width=""682"" height=""16"" font=""0"">undue delays in the conduct of APHIS' procedures. The Appellate Body stated in <i>EC &#8211; Chicken Cuts</i> </text>
<text top=""426"" left=""108"" width=""684"" height=""16"" font=""0"">that, as a general rule, the measures subject to a panel's review ""must be measures that are in </text>
<text top=""443"" left=""108"" width=""385"" height=""16"" font=""0"">existence at the time of the establishment of the panel"".</text>
<footnote top=""441"" left=""493"" width=""17"" height=""11"" font=""16"" number=""381"" ref="""" dis=""""/>
<text top=""443"" left=""510"" width=""280"" height=""16"" font=""0""> Further, the panel in <i>EC &#8211; Approval and </i></text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""18""><i>Marketing of Biotech Products</i> conducted its analysis of the parties' claims and arguments under </text>
<text top=""475"" left=""108"" width=""689"" height=""16"" font=""0"">Article 8 and Annex C(1)(a) based on the situation that existed up to the date of its </text>
<text top=""492"" left=""108"" width=""100"" height=""16"" font=""0"">establishment.</text>
<footnote top=""490"" left=""208"" width=""17"" height=""11"" font=""16"" number=""382"" ref=""WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|"" dis=""DS293|DS291|DS292|""><ftext top=""1022"" left=""165"" width=""611"" height=""15"" font=""10""> See Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.456. Indeed, the panel </ftext>
<ftext top=""1036"" left=""108"" width=""640"" height=""15"" font=""10"">disregarded arguments put forward by the defendant in justification for its delays when those arguments </ftext>
<ftext top=""1051"" left=""108"" width=""607"" height=""15"" font=""10"">referred to events which occurred after its establishment. See Ibid. paras. 7.1034, 7.1081, 7.1083. </ftext>
</footnote>
<text top=""492"" left=""225"" width=""567"" height=""16"" font=""0""> In light of the above, we take the view that the appropriate end-date of the </text>
<text top=""508"" left=""108"" width=""682"" height=""16"" font=""0"">period  of  time  to  be  considered  in  order  to  examine  Argentina's  claims  is  the  date  of  the </text>
<text top=""525"" left=""108"" width=""364"" height=""16"" font=""0"">establishment of the Panel, namely 28 January 2013.</text>
<footnote top=""523"" left=""472"" width=""17"" height=""11"" font=""16"" number=""383"" ref=""WT/DS447/3"" dis=""""><ftext top=""1066"" left=""165"" width=""91"" height=""15"" font=""10""> WT/DS447/3. </ftext>
</footnote>
</p><p number=""7.119"" style=""8""><text top=""559"" left=""108"" width=""683"" height=""16"" font=""0"">7.119.  With these considerations in mind, we now turn to Argentina's claims that APHIS' review </text>
<text top=""575"" left=""108"" width=""662"" height=""16"" font=""0"">processes of its requests incurred undue delays inconsistently with Article 8 and Annex C(1)(a).  </text>
</p><p number=""7.3"" style=""8""><text top=""610"" left=""108"" width=""686"" height=""16"" font=""28"">7.3.3.5.3  APHIS' review process of Argentina's request concerning imports of fresh </text><text top=""626"" left=""108"" width=""373"" height=""16"" font=""28"">(chilled or frozen) beef from Northern Argentina </text></p><p number=""7.120"" style=""8""><text top=""661"" left=""108"" width=""684"" height=""16"" font=""0"">7.120.  We shall assess, first, whether APHIS' review process of Argentina's request concerning </text>
<text top=""677"" left=""108"" width=""683"" height=""16"" font=""0"">imports of fresh (chilled or frozen) beef from Northern Argentina incurred a delay. If so, we shall </text>
<text top=""693"" left=""108"" width=""682"" height=""16"" font=""0"">turn to determining whether such a delay was undue. For ease of reference, we include the events </text>
<text top=""710"" left=""108"" width=""688"" height=""16"" font=""0"">relevant to Argentina's request for market access including APHIS' review and the Panel </text>
<text top=""726"" left=""108"" width=""683"" height=""16"" font=""0"">proceedings in Table 1 below. We also refer to the more comprehensive chronology contained in </text>
<text top=""743"" left=""108"" width=""341"" height=""16"" font=""0"">Appendix 1 to this Report for further information. </text>
</p><p><text top=""777"" left=""108"" width=""628"" height=""16"" font=""28"">Table 1: Chronology of events relating to APHIS' review of Argentina's request for </text><text top=""793"" left=""108"" width=""608"" height=""16"" font=""28"">imports of fresh (chilled or frozen) beef from Northern Argentina and the Panel </text><text top=""810"" left=""108"" width=""97"" height=""16"" font=""28"">proceedings </text></p><p><text top=""847"" left=""119"" width=""27"" height=""15"" font=""29"">No. </text><text top=""847"" left=""318"" width=""42"" height=""15"" font=""29"">Event </text><text top=""847"" left=""588"" width=""36"" height=""15"" font=""29"">Date </text><text top=""840"" left=""717"" width=""58"" height=""15"" font=""29"">Interval </text><text top=""854"" left=""712"" width=""69"" height=""15"" font=""29"">(approx.) </text><footnote top=""876"" left=""135"" width=""380"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""/>
<footnote top=""904"" left=""412"" width=""14"" height=""9"" font=""17"" number=""384"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""435"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32). </ftext>
</footnote>
<text top=""876"" left=""520"" width=""73"" height=""15"" font=""33"">Nov. 2002 </text><footnote top=""927"" left=""135"" width=""20"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""/>
<footnote top=""955"" left=""376"" width=""14"" height=""9"" font=""17"" number=""385"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""621"" height=""15"" font=""10""> Letter from Dr. Bernardo Cane (SENASA, President) to APHIS (30 December 2002), (SENASA's letter </ftext>
<ftext top=""1109"" left=""108"" width=""644"" height=""15"" font=""10"">of 30 December 2002), (Exhibit USA-79). In the communication, Argentina confirms that it submitted the </ftext>
</footnote>
</p><p><text top=""927"" left=""520"" width=""93"" height=""15"" font=""33"">16 Dec. 2002 </text></p><p><text top=""1007"" left=""165"" width=""334"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Chicken Cuts</i>, para. 156. </text>
<footnote top=""1124"" left=""108"" width=""594"" height=""15"" font=""10"" number=""16"" ref="""" dis=""""/>
</p></page>
<page number=""70"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 70 - </text>
</p><p><text top=""139"" left=""119"" width=""27"" height=""15"" font=""29"">No. </text><text top=""139"" left=""318"" width=""42"" height=""15"" font=""29"">Event </text><text top=""139"" left=""588"" width=""36"" height=""15"" font=""29"">Date </text><text top=""132"" left=""717"" width=""58"" height=""15"" font=""29"">Interval </text><text top=""147"" left=""712"" width=""69"" height=""15"" font=""29"">(approx.) </text><footnote top=""168"" left=""135"" width=""375"" height=""15"" font=""10"" number=""3"" ref="""" dis=""""/>
</p><p><text top=""183"" left=""169"" width=""320"" height=""15"" font=""10"">health officials met to discuss a range of issues.</text>
<footnote top=""182"" left=""490"" width=""14"" height=""9"" font=""17"" number=""386"" ref="""" dis=""""><ftext top=""788"" left=""165"" width=""594"" height=""15"" font=""10""> Facsimile from Rodolfo Acerbi (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""803"" left=""108"" width=""631"" height=""15"" font=""10"">Inspection Service, USDA, APHIS) to Philip Schull (U.S. Embassy in Argentina) (29 April 2003), (APHIS' </ftext>
<ftext top=""818"" left=""108"" width=""279"" height=""15"" font=""10"">facsimile of 29 April 2003), (Exhibit USA-80). </ftext>
</footnote>
<text top=""197"" left=""169"" width=""343"" height=""15"" font=""10"">During the meeting, the countries confirmed that a </text>
<text top=""212"" left=""169"" width=""368"" height=""15"" font=""10"">technical team would visit Argentina </text>
<footnote top=""227"" left=""169"" width=""295"" height=""15"" font=""10"" number=""2003"" ref="""" dis=""""/>
<footnote top=""226"" left=""464"" width=""14"" height=""9"" font=""17"" number=""387"" ref="""" dis=""""><ftext top=""832"" left=""165"" width=""323"" height=""15"" font=""10""> APHIS' facsimile of 29 April 2003, (Exhibit USA-80). </ftext>
</footnote>
</p><p><text top=""168"" left=""520"" width=""91"" height=""15"" font=""33"">23 Apr. 2003 </text><footnote top=""168"" left=""703"" width=""61"" height=""15"" font=""10"" number=""4"" ref="""" dis=""""/>
<footnote top=""277"" left=""441"" width=""14"" height=""9"" font=""17"" number=""388"" ref="""" dis=""""/>
</p><p><text top=""248"" left=""520"" width=""94"" height=""15"" font=""33"">28 Aug. 2003 </text><footnote top=""299"" left=""135"" width=""375"" height=""15"" font=""10"" number=""5"" ref="""" dis=""""/>
</p><p><text top=""314"" left=""169"" width=""320"" height=""15"" font=""10"">Department of San Martin, Province of Salta.</text>
<footnote top=""313"" left=""490"" width=""14"" height=""9"" font=""17"" number=""389"" ref="""" dis=""""/>
<text top=""329"" left=""169"" width=""341"" height=""15"" font=""10"">SENASA notified APHIS of the situation on the same </text>
<text top=""343"" left=""169"" width=""26"" height=""15"" font=""10"">day.</text>
<footnote top=""342"" left=""196"" width=""14"" height=""9"" font=""17"" number=""390"" ref="""" dis=""""><ftext top=""891"" left=""165"" width=""608"" height=""15"" font=""10""> Letter from Miguel Santiago Campos (SENASA) to United States Department of Agriculture, Animal </ftext>
<ftext top=""905"" left=""108"" width=""655"" height=""15"" font=""10"">and Plant Health Inspection Service, USDA, APHIS (29 August 2003), (SENASA's letter of 29 August 2003), </ftext>
</footnote>
</p><p><text top=""299"" left=""520"" width=""94"" height=""15"" font=""33"">29 Aug. 2003 </text></p><p number=""6."" style=""6""><text top=""365"" left=""135"" width=""20"" height=""15"" font=""10"">6.  </text>
<text top=""365"" left=""169"" width=""339"" height=""15"" font=""10"">Outbreak of Type ""O"" confirmed in the city of Tartagal, </text>
<text top=""379"" left=""169"" width=""346"" height=""15"" font=""10"">Department of San Martin, Province of Salta. A </text>
<text top=""394"" left=""169"" width=""342"" height=""15"" font=""10"">SENASA epidemiological report performed on pigs in </text>
<footnote top=""423"" left=""356"" width=""14"" height=""9"" font=""17"" number=""391"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""531"" height=""15"" font=""10""> Facsimile from Jose Molina, Minister Embassy of Argentina, to Peter Fernandez, APHIS </ftext>
<ftext top=""949"" left=""108"" width=""636"" height=""15"" font=""10"">(5 September 2003), (Argentina's facsimile of 5 September 2003), (Exhibit USA-51); SENASA's letter of </ftext>
<ftext top=""963"" left=""108"" width=""215"" height=""15"" font=""10"">29 August 2003, (Exhibit USA-83). </ftext>
</footnote>
</p><p><text top=""365"" left=""520"" width=""84"" height=""15"" font=""33"">2 Sep. 2003 </text></p><p number=""7."" style=""6""><text top=""445"" left=""135"" width=""391"" height=""15"" font=""10"">7.  APHIS arranged to perform a site visit </text>
<footnote top=""488"" left=""223"" width=""14"" height=""9"" font=""17"" number=""392"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""565"" height=""15"" font=""10""> Letter from Pablo Kalnay (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""993"" left=""108"" width=""650"" height=""15"" font=""10"">Inspection Service, USDA, APHIS) to Dr. Jorge N. Amaya (SENASA, President) (14 October 2003), (APHIS' </ftext>
<ftext top=""1007"" left=""108"" width=""279"" height=""15"" font=""10"">letter of 14 October 2003), (Exhibit USA-82). </ftext>
</footnote>
<footnote top=""511"" left=""135"" width=""20"" height=""15"" font=""10"" number=""8"" ref="""" dis=""""/>
<p><text top=""511"" left=""169"" width=""341"" height=""15"" font=""10"">APHIS requested additional information from SENASA </text>
<text top=""525"" left=""169"" width=""340"" height=""15"" font=""10"">with respect to the FMD outbreak in Salta and notified </text>
<text top=""540"" left=""169"" width=""340"" height=""15"" font=""10"">SENASA of the model APHIS would use to assess the </text>
<text top=""554"" left=""169"" width=""342"" height=""15"" font=""10"">risk of FMD and the ensuing requests for additional </text>
<text top=""569"" left=""169"" width=""249"" height=""15"" font=""10"">information to develop input parameters.</text>
<footnote top=""568"" left=""419"" width=""14"" height=""9"" font=""17"" number=""393"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""590"" height=""15"" font=""10""> Letter from W. Ron DeHaven (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""1036"" left=""108"" width=""616"" height=""15"" font=""10"">Inspection Service, USDA, APHIS, Deputy Administrator) to Dr. Jorge N. Amaya (SENASA, President) </ftext>
<ftext top=""1051"" left=""108"" width=""435"" height=""15"" font=""10"">(3 October 2003), (APHIS' letter of 3 October 2003), (Exhibit USA-84). </ftext>
</footnote>
</p></p><p><text top=""511"" left=""520"" width=""82"" height=""15"" font=""33"">3 Oct. 2003 </text></p><p number=""9."" style=""6""><text top=""591"" left=""135"" width=""375"" height=""15"" font=""10"">9.   An additional APHIS site visit was scheduled to occur </text>
<text top=""605"" left=""169"" width=""341"" height=""15"" font=""10"">on 6 October 2003; however, SENASA notified APHIS </text>
<text top=""620"" left=""169"" width=""128"" height=""15"" font=""10"">of the FMD outbreak.</text>
<footnote top=""619"" left=""297"" width=""14"" height=""9"" font=""17"" number=""394"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""335"" height=""15"" font=""10""> SENASA's letter of 29 August 2003, (Exhibit USA-83). </ftext>
</footnote>
<text top=""620"" left=""312"" width=""159"" height=""15"" font=""10""> APHIS cancelled the visit.</text>
<footnote top=""619"" left=""470"" width=""14"" height=""9"" font=""17"" number=""395"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""315"" height=""15"" font=""10""> APHIS' letter of 3 October 2003, (Exhibit USA-84). </ftext>
</footnote>
</p><p><text top=""591"" left=""520"" width=""82"" height=""15"" font=""33"">6 Oct. 2003 </text></p><p number=""10."" style=""6""><text top=""642"" left=""135"" width=""375"" height=""15"" font=""10"">10.  APHIS reiterated its desire to conduct the site review </text>
<text top=""656"" left=""169"" width=""348"" height=""15"" font=""10"">because the visit was important to further its </text>
<text top=""671"" left=""169"" width=""191"" height=""15"" font=""10"">evaluation of FMD in Argentina.</text>
<footnote top=""670"" left=""360"" width=""14"" height=""9"" font=""17"" number=""396"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""322"" height=""15"" font=""10""> APHIS' letter of 14 October 2003, (Exhibit USA-82). </ftext>
</footnote>
</p><p><text top=""642"" left=""520"" width=""91"" height=""15"" font=""33"">14 Oct. 2003 </text><footnote top=""693"" left=""135"" width=""405"" height=""15"" font=""10"" number=""11"" ref="""" dis=""""/>
<footnote top=""736"" left=""346"" width=""14"" height=""9"" font=""17"" number=""397"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""588"" height=""15"" font=""10""> Further information requested by USDA-APHIS of the information provided by SENASA to attain </ftext>
<ftext top=""1124"" left=""108"" width=""671"" height=""15"" font=""10"">recognition of Argentina as a region, as defined in Section 92.2, Title 9, of the Code of Federal Regulations for </ftext>
</footnote>
<footnote top=""693"" left=""520"" width=""73"" height=""15"" font=""33"" number=""2004"" ref="""" dis=""""><ftext top=""818"" left=""108"" width=""232"" height=""15"" font=""10"">(November 2004), (Exhibit ARG-86).  </ftext>
</footnote></p><p><text top=""847"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 112. </text>
</p><p><text top=""876"" left=""108"" width=""111"" height=""15"" font=""10"">(Exhibit USA-81). </text>
</p><p><text top=""920"" left=""108"" width=""111"" height=""15"" font=""10"">(Exhibit USA-83). </text>
</p></page>
<page number=""71"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 71 - </text>
</p><p><text top=""139"" left=""119"" width=""27"" height=""15"" font=""29"">No. </text><text top=""139"" left=""318"" width=""42"" height=""15"" font=""29"">Event </text><text top=""139"" left=""588"" width=""36"" height=""15"" font=""29"">Date </text><text top=""132"" left=""717"" width=""58"" height=""15"" font=""29"">Interval </text><text top=""147"" left=""712"" width=""69"" height=""15"" font=""29"">(approx.) </text></p><p number=""12."" style=""6""><text top=""168"" left=""135"" width=""378"" height=""15"" font=""10"">12.  Prior to the scheduled visit to Northern Argentina, </text>
<text top=""183"" left=""169"" width=""341"" height=""15"" font=""10"">APHIS requested additional information from SENASA </text>
<text top=""197"" left=""169"" width=""347"" height=""15"" font=""10"">to assist in compiling data to be used in the </text>
<text top=""212"" left=""169"" width=""347"" height=""15"" font=""10"">quantitative and qualitative risk analysis of the </text>
<footnote top=""227"" left=""169"" width=""264"" height=""15"" font=""10"" number=""42"" ref="""" dis=""""><ftext top=""547"" left=""169"" width=""333"" height=""15"" font=""10"">subsequently draft a proposal to allow the importation </ftext>
<ftext top=""562"" left=""169"" width=""202"" height=""15"" font=""10"">of beef under certain conditions"".</ftext>
</footnote>
<footnote top=""226"" left=""433"" width=""14"" height=""9"" font=""17"" number=""398"" ref="""" dis=""""><ftext top=""832"" left=""165"" width=""605"" height=""15"" font=""10""> Letter from Thomas C. Schissel (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""847"" left=""108"" width=""666"" height=""15"" font=""10"">Inspection Service, USDA, APHIS) to Arturo Ortiz (SENASA) (21 April 2005), (APHIS' letter of 21 April 2005), </ftext>
</footnote>
</p><p><text top=""168"" left=""520"" width=""91"" height=""15"" font=""33"">21 Apr. 2005 </text></p><p number=""13."" style=""6""><text top=""248"" left=""135"" width=""380"" height=""15"" font=""10"">13.  APHIS conducted the scheduled site visit to the </text>
<footnote top=""262"" left=""445"" width=""14"" height=""9"" font=""17"" number=""399"" ref="""" dis=""""><ftext top=""876"" left=""165"" width=""580"" height=""15"" font=""10""> Letter from John R. Clifford (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""891"" left=""108"" width=""648"" height=""15"" font=""10"">Inspection Service, USDA, APHIS) to Jorge N. Amaya (SENASA, President) (7 July 2005), (APHIS' letter of </ftext>
<ftext top=""905"" left=""108"" width=""195"" height=""15"" font=""10"">7 July 2005), (Exhibit USA-92). </ftext>
</footnote>
</p><p><text top=""248"" left=""520"" width=""96"" height=""15"" font=""33"">30 May 2005- </text><text top=""263"" left=""520"" width=""83"" height=""15"" font=""33"">3 Jun. 2005 </text><footnote top=""248"" left=""703"" width=""55"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""/>
</p><p number=""14."" style=""6""><text top=""285"" left=""135"" width=""375"" height=""15"" font=""10"">14.  APHIS requested additional information from SENASA </text>
<text top=""299"" left=""169"" width=""246"" height=""15"" font=""10"">in light of a strike by SENASA personnel.</text>
<footnote top=""299"" left=""416"" width=""14"" height=""9"" font=""17"" number=""400"" ref="""" dis=""""><ftext top=""920"" left=""165"" width=""580"" height=""15"" font=""10""> Letter from John R. Clifford (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""934"" left=""108"" width=""616"" height=""15"" font=""10"">Inspection Service, USDA, APHIS, Deputy Administrator) to Dr. Jorge N. Amaya (SENASA, President) </ftext>
<ftext top=""949"" left=""108"" width=""424"" height=""15"" font=""10"">(4 August 2005), (APHIS' letter of 4 August 2005), (Exhibit USA-93). </ftext>
</footnote>
</p><p><text top=""285"" left=""520"" width=""85"" height=""15"" font=""33"">4 Aug. 2005 </text></p><p number=""15."" style=""6""><text top=""321"" left=""135"" width=""322"" height=""15"" font=""10"">15.  SENASA sent a letter to APHIS reporting about </text>
<text top=""336"" left=""169"" width=""325"" height=""15"" font=""10"">SENASA strikes, and stating that such strikes did not </text>
<text top=""350"" left=""169"" width=""162"" height=""15"" font=""10"">affect emergency services.</text>
<footnote top=""350"" left=""331"" width=""14"" height=""9"" font=""17"" number=""401"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""591"" height=""15"" font=""10""> Letter from SENASA to APHIS reporting about SENASA strike, CRI 1968/05 (5 December 2005), </ftext>
<ftext top=""978"" left=""108"" width=""354"" height=""15"" font=""10"">(SENASA's letter of 5 December 2005), (Exhibit ARG-96). </ftext>
</footnote>
</p><p><text top=""321"" left=""520"" width=""84"" height=""15"" font=""33"">5 Dec. 2005 </text></p><p number=""16."" style=""6""><text top=""372"" left=""135"" width=""356"" height=""15"" font=""10"">16.  Two outbreaks of ""type O"" FMD occurred in San Luis </text>
<text top=""387"" left=""169"" width=""227"" height=""15"" font=""10"">del Palmar, Province of CORRIENTES.</text>
<footnote top=""386"" left=""397"" width=""14"" height=""9"" font=""17"" number=""402"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""616"" height=""15"" font=""10""> Veterinary Services (VS), <i>Foot and Mouth Disease Argentina Impact Worksheet</i> (15 February 2006), </ftext>
<ftext top=""1007"" left=""108"" width=""615"" height=""15"" font=""10"">(FMD Impact Worksheet), (Exhibit USA-54). See also OIE Disease Information, Vol. 19, No. 6, p. 96. </ftext>
</footnote>
</p><p><text top=""372"" left=""520"" width=""83"" height=""15"" font=""33"">5 Feb. 2006 </text><footnote top=""372"" left=""703"" width=""61"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""/>
<footnote top=""409"" left=""135"" width=""358"" height=""15"" font=""10"" number=""17"" ref="""" dis=""""/>
</p><p><text top=""423"" left=""169"" width=""337"" height=""15"" font=""10"">in San Luis del Palmar, Province of CORRIENTES to the </text>
<text top=""438"" left=""169"" width=""26"" height=""15"" font=""10"">OIE.</text>
<footnote top=""437"" left=""196"" width=""14"" height=""9"" font=""17"" number=""403"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""493"" height=""15"" font=""10""> OIE, Final Report, 74th General Session (2006), (Exhibit USA-55), pp. 45, 144.  </ftext>
</footnote>
<text top=""452"" left=""169"" width=""315"" height=""15"" font=""10"">SENASA enacted Resolution 35/2006 establishing a </text>
<text top=""467"" left=""169"" width=""312"" height=""15"" font=""10"">sanitary alert which covered a zone comprising the </text>
<text top=""481"" left=""169"" width=""328"" height=""15"" font=""10"">affected department i.e. San Luis del Palmar, and the </text>
<text top=""496"" left=""169"" width=""311"" height=""15"" font=""10"">seven neighbouring departments i.e.: Capital; San </text>
<text top=""511"" left=""169"" width=""281"" height=""15"" font=""10"">Cosme; Itat&#237;; Ber&#243;n de Astrada; General Paz; </text>
<text top=""525"" left=""169"" width=""175"" height=""15"" font=""10"">Mburucuya; and Empedrado.</text>
<footnote top=""524"" left=""345"" width=""14"" height=""9"" font=""17"" number=""404"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""608"" height=""15"" font=""10""> Argentina's first written submission, para. 117; Resoluci&#243;n SENASA N&#186; 35/06, (Resoluci&#243;n SENASA </ftext>
<ftext top=""1051"" left=""108"" width=""169"" height=""15"" font=""10"">35/2006), (Exhibit ARG-5).<b> </b></ftext>
</footnote>
</p><p><text top=""409"" left=""520"" width=""83"" height=""15"" font=""33"">8 Feb. 2006 </text></p><p number=""18."" style=""6""><text top=""547"" left=""135"" width=""373"" height=""15"" font=""10"">18.  APHIS requested information regarding the outbreak in </text>
<text top=""562"" left=""169"" width=""178"" height=""15"" font=""10"">the Province of CORRIENTES.</text>
<footnote top=""561"" left=""348"" width=""14"" height=""9"" font=""17"" number=""405"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""608"" height=""15"" font=""10""> Letter from John R. Clifford, Deputy Administrator, Veterinary Services, APHIS, to Jorge N. Amaya, </ftext>
<ftext top=""1080"" left=""108"" width=""582"" height=""15"" font=""10"">President, SENASA (10 February 2006), (APHIS' letter of 10 February 2006), (Exhibit ARG-38). </ftext>
</footnote>
</p><p><text top=""547"" left=""520"" width=""92"" height=""15"" font=""33"">10 Feb. 2006 </text><footnote top=""583"" left=""135"" width=""387"" height=""15"" font=""10"" number=""19"" ref="""" dis=""""><ftext top=""1066"" left=""108"" width=""662"" height=""15"" font=""12""><i>20 October 2011</i>, Note by the Secretariat, G/SPS/R/64 (17 January 2012), (G/SPS/R/64), (Exhibit ARG-48), </ftext>
</footnote>
</p><p><text top=""598"" left=""169"" width=""344"" height=""15"" font=""10"">Argentina's request for authorization of imports of </text>
<text top=""612"" left=""169"" width=""339"" height=""15"" font=""10"">fresh (chilled or frozen) beef. APHIS informed SENASA </text>
<text top=""627"" left=""169"" width=""343"" height=""15"" font=""10"">that, in order to conclude its risk analysis, APHIS </text>
<text top=""642"" left=""169"" width=""344"" height=""15"" font=""10"">considered it necessary to arrange a visit to the </text>
<text top=""656"" left=""169"" width=""340"" height=""15"" font=""10"">Province of CORRIENTES to evaluate the area affected </text>
<text top=""671"" left=""169"" width=""339"" height=""15"" font=""10"">by the FMD outbreaks. APHIS proposed to conduct the </text>
<text top=""685"" left=""169"" width=""90"" height=""15"" font=""10"">visit in August.</text>
<footnote top=""685"" left=""260"" width=""14"" height=""9"" font=""17"" number=""406"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""587"" height=""15"" font=""10""> Letter from Thomas Schissel (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""1109"" left=""108"" width=""646"" height=""15"" font=""10"">Inspection Service, USDA, APHIS, Area Director) to Jorge N. Amaya (SENASA, President) (27 June 2006), </ftext>
<ftext top=""1124"" left=""108"" width=""309"" height=""15"" font=""10"">(APHIS' letter of 27 June 2006), (Exhibit USA-94). </ftext>
<ftext top=""707"" left=""169"" width=""159"" height=""15"" font=""10"">United States at the WTO.</ftext>
<ftext top=""744"" left=""169"" width=""341"" height=""15"" font=""10"">DC in the framework of the Consultations being held </ftext>
<ftext top=""817"" left=""169"" width=""61"" height=""15"" font=""10"">reference.</ftext>
</footnote>
</p><p><text top=""583"" left=""520"" width=""91"" height=""15"" font=""33"">27 Jun. 2006 </text></p><p><text top=""861"" left=""108"" width=""111"" height=""15"" font=""10"">(Exhibit USA-91). </text>
</p></page>
<page number=""72"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 72 - </text>
</p><p><text top=""139"" left=""119"" width=""27"" height=""15"" font=""29"">No. </text><text top=""139"" left=""318"" width=""42"" height=""15"" font=""29"">Event </text><text top=""139"" left=""588"" width=""36"" height=""15"" font=""29"">Date </text><text top=""132"" left=""717"" width=""58"" height=""15"" font=""29"">Interval </text><text top=""147"" left=""712"" width=""69"" height=""15"" font=""29"">(approx.) </text></p><p number=""20."" style=""6""><text top=""168"" left=""135"" width=""376"" height=""15"" font=""10"">20.  In response to APHIS' request for information of 10 </text>
<text top=""183"" left=""169"" width=""341"" height=""15"" font=""10"">February 2006, SENASA submitted a report to APHIS </text>
<text top=""197"" left=""169"" width=""340"" height=""15"" font=""10"">detailing the actions taken by SENASA in response to </text>
<text top=""212"" left=""169"" width=""339"" height=""15"" font=""10"">the FMD outbreaks in the Province of CORRIENTES and </text>
<text top=""227"" left=""169"" width=""344"" height=""15"" font=""10"">to ensure the preservation of the FMD-free where </text>
<text top=""241"" left=""169"" width=""347"" height=""15"" font=""10"">vaccination is not practised status of Patagonia </text>
<text top=""256"" left=""169"" width=""40"" height=""15"" font=""10"">South.</text>
<footnote top=""255"" left=""209"" width=""14"" height=""9"" font=""17"" number=""407"" ref="""" dis=""""><ftext top=""891"" left=""165"" width=""609"" height=""15"" font=""10""> Letter from Dr Jorge Amaya, SENASA, to Dr John Clifford, APHIS, concerning the eradication of the </ftext>
<ftext top=""905"" left=""108"" width=""679"" height=""15"" font=""10"">San Luis del Palmar (Corrientes) outbreak (26 July 2006), (SENASA's letter of 26 July 2006), (Exhibit ARG-97). </ftext>
</footnote>
</p><p><text top=""168"" left=""520"" width=""87"" height=""15"" font=""33"">26 Jul. 2006 </text><footnote top=""278"" left=""135"" width=""374"" height=""15"" font=""10"" number=""21"" ref="""" dis=""""/>
</p><p><text top=""292"" left=""169"" width=""147"" height=""15"" font=""10"">and performed an audit.</text>
<footnote top=""291"" left=""317"" width=""14"" height=""9"" font=""17"" number=""408"" ref="""" dis=""""><ftext top=""920"" left=""165"" width=""559"" height=""15"" font=""10""> Letter from Jorge N. Amaya, President, SENASA, to John R. Clifford, Deputy Administrator, </ftext>
<ftext top=""934"" left=""108"" width=""629"" height=""15"" font=""10"">Veterinary Services, APHIS, Note No. 150/2010 (19 July 2010), (SENASA's letter of 19 July 2010, Note </ftext>
<ftext top=""949"" left=""108"" width=""209"" height=""15"" font=""10"">No. 150/2010), (Exhibit ARG-46). </ftext>
</footnote>
</p><p><text top=""278"" left=""520"" width=""103"" height=""15"" font=""33"">6-8 Sep. 2006  </text></p><p number=""1.5"" style=""8""><text top=""278"" left=""703"" width=""73"" height=""15"" font=""10"">1.5 months </text>
</p><p number=""22."" style=""6""><text top=""314"" left=""135"" width=""361"" height=""15"" font=""10"">22.  SENASA sent APHIS a letter detailing the information </text>
<text top=""329"" left=""169"" width=""299"" height=""15"" font=""10"">exchange with respect to Argentina's request for </text>
<text top=""343"" left=""169"" width=""325"" height=""15"" font=""10"">authorization to import fresh (chilled or frozen) beef, </text>
<text top=""358"" left=""169"" width=""310"" height=""15"" font=""10"">highlighting its concern at APHIS not being able to </text>
<text top=""372"" left=""169"" width=""332"" height=""15"" font=""10"">reopen access to beef from Argentine territory located </text>
<text top=""387"" left=""169"" width=""299"" height=""15"" font=""10"">North of Rio Negro, and asking that the outcome </text>
<text top=""402"" left=""169"" width=""310"" height=""15"" font=""10"">foreseen for Argentina's request be elucidated in a </text>
<text top=""416"" left=""169"" width=""89"" height=""15"" font=""10"">timely fashion.</text>
<footnote top=""415"" left=""259"" width=""14"" height=""9"" font=""17"" number=""409"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""442"" height=""15"" font=""10""> SENASA's letter of 19 July 2010, Note No. 150/2010, (Exhibit ARG-46). </ftext>
</footnote>
</p><p><text top=""314"" left=""520"" width=""87"" height=""15"" font=""33"">19 Jul. 2010 </text><footnote top=""314"" left=""703"" width=""49"" height=""15"" font=""10"" number=""4"" ref="""" dis=""""/>
</p><p number=""23."" style=""6""><text top=""438"" left=""135"" width=""376"" height=""15"" font=""10"">23.  APHIS responded to SENASA's letter of 19 July 2010 </text>
<text top=""452"" left=""169"" width=""340"" height=""15"" font=""10"">stating that APHIS was ""currently drafting a proposed </text>
<text top=""467"" left=""169"" width=""340"" height=""15"" font=""10"">rule that would allow the importation of fresh, chilled, </text>
<text top=""482"" left=""169"" width=""307"" height=""15"" font=""10"">or frozen Argentine beef under certain conditions"".</text>
<footnote top=""481"" left=""476"" width=""14"" height=""9"" font=""17"" number=""410"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""604"" height=""15"" font=""10""> Letter from John R. Clifford, Deputy Administrator, Veterinary Services, APHIS to Jorge N. Amaya, </ftext>
<ftext top=""993"" left=""108"" width=""606"" height=""15"" font=""10"">President, SENASA (24 September 2010), (APHIS' letter of 24 September 2010), (Exhibit ARG-47). </ftext>
</footnote>
</p><p><text top=""438"" left=""520"" width=""93"" height=""15"" font=""33"">24 Sep. 2010 </text></p><p number=""24."" style=""6""><text top=""503"" left=""135"" width=""353"" height=""15"" font=""10"">24.  The United States stated before the SPS Committee </text>
<text top=""518"" left=""169"" width=""333"" height=""15"" font=""10"">that APHIS had ""completed the risk analysis regarding </text>
<footnote top=""561"" left=""371"" width=""14"" height=""9"" font=""17"" number=""411"" ref="""" dis=""""/>
</p><p><text top=""503"" left=""520"" width=""91"" height=""15"" font=""33"">30 Jun. 2011 </text></p><p><text top=""503"" left=""703"" width=""61"" height=""15"" font=""10"">9 months </text>
</p><p number=""25."" style=""6""><text top=""583"" left=""135"" width=""276"" height=""15"" font=""10"">25.  The United States reiterated before the </text>
<text top=""598"" left=""169"" width=""291"" height=""15"" font=""10"">SPS Committee that APHIS had ""completed the </text>
<text top=""613"" left=""169"" width=""322"" height=""15"" font=""10"">assessment and was drafting a proposal to allow the </text>
<text top=""627"" left=""169"" width=""336"" height=""15"" font=""10"">importation of beef under certain conditions. When the </text>
<text top=""642"" left=""169"" width=""305"" height=""15"" font=""10"">assessment and rules were completed in the near </text>
<text top=""656"" left=""169"" width=""308"" height=""15"" font=""10"">future, the United States would be able to provide </text>
<text top=""671"" left=""169"" width=""210"" height=""15"" font=""10"">market access for Argentine beef"".</text>
<footnote top=""670"" left=""379"" width=""14"" height=""9"" font=""17"" number=""412"" ref="""" dis=""""/>
</p><p><text top=""583"" left=""520"" width=""91"" height=""15"" font=""33"">19 Oct. 2011 </text></p><p number=""3.5"" style=""8""><text top=""583"" left=""703"" width=""73"" height=""15"" font=""10"">3.5 months </text>
</p><p number=""26."" style=""6""><text top=""693"" left=""135"" width=""392"" height=""15"" font=""10"">26.  Argentina requested consultations with the </text>
<footnote top=""707"" left=""328"" width=""14"" height=""9"" font=""17"" number=""413"" ref=""G/L/998/Corr.1 ; G/SPS/GEN/1186/Corr.1 ; WT/DS447/1/Corr.1|G/L/998 ; G/SPS/GEN/1186 ; WT/DS447/1"" dis=""""><ftext top=""1095"" left=""165"" width=""322"" height=""15"" font=""10""> Argentina's request for consultations, WT/DS447/1. </ftext>
</footnote>
</p><p><text top=""693"" left=""520"" width=""94"" height=""15"" font=""33"">30 Aug. 2012 </text><footnote top=""693"" left=""703"" width=""69"" height=""15"" font=""10"" number=""10"" ref="""" dis=""""/>
</p><p number=""27."" style=""6""><text top=""729"" left=""135"" width=""377"" height=""15"" font=""10"">27.  The United States and Argentina met in Washington </text>
<footnote top=""729"" left=""703"" width=""61"" height=""15"" font=""10"" number=""3"" ref="""" dis=""""><ftext top=""750"" left=""108"" width=""394"" height=""16"" font=""28"">7.3.3.5.3.1  Whether the procedure incurred delays </ftext><ftext top=""784"" left=""108"" width=""684"" height=""16"" font=""0"">7.121.  In order to determine whether APHIS' review of Argentina's request for authorization of </ftext>
<ftext top=""801"" left=""108"" width=""686"" height=""16"" font=""0"">imports of fresh (chilled or frozen) beef from Northern Argentina incurred a delay, we must </ftext>
<ftext top=""817"" left=""108"" width=""682"" height=""16"" font=""0"">conduct an assessment of the facts relevant to such procedure. We recall that a ""delay"" is a period </ftext>
<ftext top=""834"" left=""108"" width=""686"" height=""16"" font=""0"">of time lost by inaction or inability to proceed on the part of the authority carrying out the </ftext>
<ftext top=""850"" left=""108"" width=""73"" height=""16"" font=""0"">procedure.</ftext>
</footnote>
</p><p number=""28."" style=""6""><text top=""780"" left=""135"" width=""338"" height=""15"" font=""10"">28.  Argentina requested the establishment of a panel.</text>
<footnote top=""779"" left=""473"" width=""14"" height=""9"" font=""17"" number=""414"" ref=""WT/DS447/2"" dis=""""><ftext top=""1109"" left=""165"" width=""414"" height=""15"" font=""10""> Argentina's request for the establishment of a panel, WT/DS447/2. </ftext>
</footnote>
</p><p><text top=""780"" left=""520"" width=""84"" height=""15"" font=""33"">6 Dec. 2012 </text></p><p><text top=""780"" left=""703"" width=""44"" height=""15"" font=""10"">8 days </text>
<text top=""802"" left=""135"" width=""374"" height=""15"" font=""10"">29.  The DSB established the Panel with standard terms of </text>
<footnote top=""816"" left=""231"" width=""14"" height=""9"" font=""17"" number=""415"" ref="""" dis=""""/>
</p><p><text top=""802"" left=""520"" width=""91"" height=""15"" font=""33"">28 Jan. 2013 </text><footnote top=""1007"" left=""165"" width=""549"" height=""15"" font=""10"" number=""30"" ref="""" dis=""""/>
</p><p><text top=""1022"" left=""108"" width=""649"" height=""15"" font=""12""><i>1 July 2011</i>, Note by the Secretariat, G/SPS/R/63 (12 September 2011), (G/SPS/R/63), (Exhibit ARG-22), </text>
</p><p><text top=""1080"" left=""108"" width=""86"" height=""15"" font=""10"">paras. 96-97. </text>
</p></page>
<page number=""73"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 73 - </text>
</p><p><text top=""139"" left=""119"" width=""27"" height=""15"" font=""29"">No. </text><text top=""139"" left=""318"" width=""42"" height=""15"" font=""29"">Event </text><text top=""139"" left=""588"" width=""36"" height=""15"" font=""29"">Date </text><text top=""132"" left=""717"" width=""58"" height=""15"" font=""29"">Interval </text><text top=""147"" left=""712"" width=""69"" height=""15"" font=""29"">(approx.) </text></p><p><text top=""183"" left=""169"" width=""341"" height=""15"" font=""10"">discussed in the Consultations on 28 November 2012 </text>
<text top=""197"" left=""169"" width=""242"" height=""15"" font=""10"">between Argentina and United </text>
<text top=""197"" left=""398"" width=""124"" height=""15"" font=""10"">States officials, </text>
<text top=""212"" left=""169"" width=""339"" height=""15"" font=""10"">including APHIS' suggestion to conduct a new site visit </text>
<text top=""227"" left=""169"" width=""343"" height=""15"" font=""10"">to Northern Argentina and Patagonia. In the letter, </text>
<text top=""241"" left=""169"" width=""340"" height=""15"" font=""10"">APHIS formally requested permission from SENASA to </text>
<text top=""256"" left=""169"" width=""342"" height=""15"" font=""10"">conduct the site visit in order to progress with the </text>
<text top=""270"" left=""169"" width=""181"" height=""15"" font=""10"">review of Argentina's request.</text>
<footnote top=""270"" left=""351"" width=""14"" height=""9"" font=""17"" number=""416"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""623"" height=""15"" font=""10""> Letter from Dr. Peter J. Fernandez (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""949"" left=""108"" width=""662"" height=""15"" font=""10"">Inspection Service, USDA, APHIS, Acting Associate Administrator) to Marcelo S. Miguez (SENASA, President) </ftext>
<ftext top=""963"" left=""108"" width=""428"" height=""15"" font=""10"">(13 March 2013), (APHIS' letter of 13 March 2013), (Exhibit USA-96). </ftext>
</footnote>
</p><p><text top=""168"" left=""520"" width=""93"" height=""15"" font=""33"">13 Mar. 2013 </text></p><p number=""1.5"" style=""8""><text top=""168"" left=""703"" width=""73"" height=""15"" font=""10"">1.5 months </text>
</p><p number=""31."" style=""6""><text top=""292"" left=""135"" width=""377"" height=""15"" font=""10"">31.  SENASA agreed to the visit proposed by APHIS on </text>
<text top=""307"" left=""169"" width=""341"" height=""15"" font=""10"">13 March 2013, but stated that the sanitary situation </text>
<text top=""321"" left=""169"" width=""183"" height=""15"" font=""10"">in Argentina had not changed.</text>
<footnote top=""321"" left=""353"" width=""14"" height=""9"" font=""17"" number=""417"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""600"" height=""15"" font=""10""> Letter from Dr Miguez, SENASA to Dr Peter Fernandez, APHIS (13 July 2013), (SENASA's letter of </ftext>
<ftext top=""993"" left=""108"" width=""203"" height=""15"" font=""10"">13 July 2013), (Exhibit ARG-99). </ftext>
</footnote>
</p><p><text top=""292"" left=""520"" width=""79"" height=""15"" font=""33"">3 Jul. 2013 </text></p><p number=""3.5"" style=""8""><text top=""292"" left=""703"" width=""73"" height=""15"" font=""10"">3.5 months </text>
</p><p number=""32."" style=""6""><text top=""343"" left=""135"" width=""376"" height=""15"" font=""10"">32.  APHIS replied to SENASA's 3 July 2013 letter stating </text>
<text top=""358"" left=""169"" width=""344"" height=""15"" font=""10"">that it was ready to schedule the agreed visit to </text>
<text top=""372"" left=""169"" width=""341"" height=""15"" font=""10"">Argentina as soon as possible. APHIS also stated its </text>
<text top=""387"" left=""169"" width=""342"" height=""15"" font=""10"">understanding that Argentina preferred that the site </text>
<text top=""402"" left=""169"" width=""340"" height=""15"" font=""10"">visit occur during the last week of October or the first </text>
<text top=""416"" left=""169"" width=""152"" height=""15"" font=""10"">week of November 2013.</text>
<footnote top=""415"" left=""322"" width=""14"" height=""9"" font=""17"" number=""418"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""623"" height=""15"" font=""10""> Letter from Kevin Shea (United States Department of Agriculture, Animal and Plant Health Inspection </ftext>
<ftext top=""1022"" left=""108"" width=""677"" height=""15"" font=""10"">Service, USDA, APHIS, Administrator) to Marcelo S. Miguez (SENASA, President) (15 July 2013), (APHIS' letter </ftext>
<ftext top=""1036"" left=""108"" width=""218"" height=""15"" font=""10"">of 15 July 2013), (Exhibit USA-97). </ftext>
</footnote>
</p><p><text top=""343"" left=""520"" width=""87"" height=""15"" font=""33"">15 Jul. 2013 </text></p><p number=""33."" style=""6""><text top=""438"" left=""135"" width=""376"" height=""15"" font=""10"">33.  The Panel was composed by the Director-General on </text>
<text top=""452"" left=""169"" width=""97"" height=""15"" font=""10"">8 August 2013. </text>
</p><p><text top=""438"" left=""520"" width=""85"" height=""15"" font=""33"">8 Aug. 2013 </text></p><p><text top=""438"" left=""703"" width=""58"" height=""15"" font=""10"">Add time </text>
</p><p number=""34."" style=""6""><text top=""474"" left=""135"" width=""373"" height=""15"" font=""10"">34.  APHIS visited Argentina to conduct the site review with </text>
<text top=""489"" left=""169"" width=""341"" height=""15"" font=""10"">regard to the approval of imports of Argentine fresh </text>
<text top=""503"" left=""169"" width=""292"" height=""15"" font=""10"">(chilled or frozen) beef under certain conditions.</text>
<footnote top=""503"" left=""462"" width=""14"" height=""9"" font=""17"" number=""419"" ref="""" dis=""""/>
</p><p><text top=""474"" left=""520"" width=""155"" height=""15"" font=""33"">1st week of Nov. 2013 </text></p><p number=""35."" style=""6""><text top=""525"" left=""135"" width=""375"" height=""15"" font=""10"">35.  The Panel held the first substantive meeting with the </text>
<text top=""540"" left=""169"" width=""50"" height=""15"" font=""10"">parties. </text>
</p><p><text top=""525"" left=""520"" width=""114"" height=""15"" font=""33"">28-29 Jan. 2014 </text></p><p number=""36."" style=""6""><text top=""562"" left=""135"" width=""381"" height=""15"" font=""10"">36.  APHIS published a risk assessment for Northern </text>
<footnote top=""576"" left=""169"" width=""342"" height=""15"" font=""10"" number=""2014"" ref="""" dis=""""><ftext top=""700"" left=""169"" width=""358"" height=""15"" font=""10"">substantive meeting with the parties on </ftext>
<ftext top=""715"" left=""169"" width=""134"" height=""15"" font=""10"">4-5 September 2014. </ftext>
<ftext top=""671"" left=""520"" width=""154"" height=""15"" font=""33"">1st week of Sep. 2014 </ftext></footnote>
<p><text top=""591"" left=""169"" width=""342"" height=""15"" font=""10"">introduction of FMD stemming from imports of fresh </text>
<text top=""605"" left=""169"" width=""316"" height=""15"" font=""10"">(chilled or frozen) beef from the region was ""low""</text>
<footnote top=""605"" left=""485"" width=""14"" height=""9"" font=""17"" number=""420"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""386"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169). </ftext>
</footnote>
<text top=""605"" left=""500"" width=""9"" height=""15"" font=""10"">, </text>
<text top=""620"" left=""169"" width=""341"" height=""15"" font=""10"">as well as a Proposed Rule to allow imports of such </text>
<text top=""634"" left=""169"" width=""340"" height=""15"" font=""10"">product under the same protocols as those applied to </text>
<text top=""649"" left=""169"" width=""265"" height=""15"" font=""10"">fresh (chilled or frozen) beef from Uruguay.</text>
<footnote top=""648"" left=""434"" width=""14"" height=""9"" font=""17"" number=""421"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""600"" height=""15"" font=""10""> <i>Importation of Beef From a Region in Argentina</i>, 79 Fed. Reg. 51508 (29 August 2014) (Proposed </ftext>
<ftext top=""1095"" left=""108"" width=""438"" height=""15"" font=""10"">Rule), (2014 Proposed Rule on Northern Argentina), (Exhibit USA-168). </ftext>
</footnote>
</p></p><p><text top=""562"" left=""520"" width=""94"" height=""15"" font=""33"">29 Aug. 2014 </text></p><p><text top=""562"" left=""703"" width=""61"" height=""15"" font=""10"">7 months </text>
</p><p number=""37."" style=""6""><text top=""671"" left=""135"" width=""376"" height=""15"" font=""10"">37.  The Panel held the meeting with the parties and the </text>
<text top=""685"" left=""169"" width=""114"" height=""15"" font=""10"">experts on 2 </text>
<text top=""685"" left=""273"" width=""82"" height=""15"" font=""10"">September </text>
<footnote top=""848"" left=""181"" width=""17"" height=""11"" font=""16"" number=""422"" ref=""WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7"" dis=""DS293|DS291|DS292""><ftext top=""1109"" left=""165"" width=""596"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1495. See also Appellate </ftext>
</footnote>
</p><p number=""7.122"" style=""8""><text top=""884"" left=""108"" width=""683"" height=""16"" font=""0"">7.122.  The United States asserts, and Argentina does not disagree, that APHIS began its review </text>
<text top=""901"" left=""108"" width=""682"" height=""16"" font=""0"">process promptly upon receiving Argentina's request for imports of fresh (chilled or frozen) beef in </text>
<p><text top=""1051"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 162. </text>
</p><p><text top=""1124"" left=""108"" width=""267"" height=""15"" font=""10"">Body Report, <i>Australia &#8211; Apples</i>, para. 437. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 74 - </text>
</p><p><text top=""128"" left=""108"" width=""118"" height=""16"" font=""0"">November 2002.</text>
<footnote top=""126"" left=""226"" width=""17"" height=""11"" font=""16"" number=""423"" ref="""" dis=""""><ftext top=""832"" left=""165"" width=""622"" height=""15"" font=""10""> See United States' first written submission, para. 197; Argentina's response to Panel question No. 68 </ftext>
<ftext top=""847"" left=""108"" width=""241"" height=""15"" font=""10"">following the first substantive meeting. </ftext>
</footnote>
<text top=""128"" left=""244"" width=""551"" height=""16"" font=""0""> Indeed, the first meeting between the United States and Argentina with </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">respect to Argentina's request took place one month after the application. At that meeting, APHIS </text>
<text top=""160"" left=""108"" width=""615"" height=""16"" font=""0"">requested SENASA to provide relevant documentation in order to initiate the risk analysis.</text>
<footnote top=""159"" left=""723"" width=""17"" height=""11"" font=""16"" number=""424"" ref="""" dis=""""><ftext top=""861"" left=""165"" width=""354"" height=""15"" font=""10""> SENASA's letter of 30 December 2002, (Exhibit USA-79). </ftext>
</footnote>
</p></p></page>
<page number=""74"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.123"" style=""8""><text top=""195"" left=""108"" width=""689"" height=""16"" font=""0"">7.123.  From that moment until September 2006, exchanges occurred between APHIS and </text>
<text top=""211"" left=""108"" width=""685"" height=""16"" font=""0"">SENASA. APHIS asked SENASA to provide further information concerning the FMD situation in </text>
<text top=""228"" left=""108"" width=""687"" height=""16"" font=""0"">Northern Argentina on several occasions, namely in October 2003, April 2005 and February </text>
<text top=""244"" left=""108"" width=""39"" height=""16"" font=""0"">2006.</text>
<footnote top=""243"" left=""147"" width=""17"" height=""11"" font=""16"" number=""425"" ref="""" dis=""""><ftext top=""876"" left=""165"" width=""555"" height=""15"" font=""10""> SENASA's letter of 30 December 2002, (Exhibit USA-79); APHIS' letter of 3 October 2003, </ftext>
<ftext top=""891"" left=""108"" width=""625"" height=""15"" font=""10"">(Exhibit USA-84); APHIS' letter of 21 April 2005, (Exhibit USA-91); APHIS' letter of 10 February 2006, </ftext>
</footnote>
<text top=""244"" left=""165"" width=""633"" height=""16"" font=""0""> APHIS also conducted two site visits to Northern Argentina in May-June 2005 </text>
<text top=""260"" left=""108"" width=""447"" height=""16"" font=""0"">and September 2006, in accordance with its approval practice.</text>
<footnote top=""259"" left=""555"" width=""17"" height=""11"" font=""16"" number=""426"" ref="""" dis=""""><ftext top=""920"" left=""165"" width=""618"" height=""15"" font=""10""> APHIS' letter of 7 July 2005, (Exhibit USA-92); SENASA's letter of 19 July 2010, Note No. 150/2010, </ftext>
</footnote>
<text top=""260"" left=""573"" width=""221"" height=""16"" font=""0""> These follow-up requests for </text>
<text top=""277"" left=""108"" width=""687"" height=""16"" font=""0"">additional information and the two site visits were in the context of events subsequent to </text>
<text top=""293"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina's initial application, including FMD outbreaks in different parts of Northern Argentina </text>
<text top=""310"" left=""108"" width=""266"" height=""16"" font=""0"">in September 2003 and February 2006</text>
<footnote top=""308"" left=""374"" width=""17"" height=""11"" font=""16"" number=""427"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""602"" height=""15"" font=""10""> Argentina's facsimile of 5 September 2003, (Exhibit USA-51); SENASA's letter of 29 August 2003, </ftext>
<ftext top=""963"" left=""108"" width=""676"" height=""15"" font=""10"">(Exhibit USA-83); FMD Impact Worksheet, (Exhibit USA-54). See also OIE Disease Information, Vol. 19, No. 6, </ftext>
</footnote>
<text top=""310"" left=""392"" width=""277"" height=""16"" font=""0""> and a labour strike at SENASA in 2005.</text>
<footnote top=""308"" left=""669"" width=""21"" height=""11"" font=""16"" number=""428"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""309"" height=""15"" font=""10""> APHIS' letter of 4 August 2005, (Exhibit USA-93). </ftext>
</footnote>
<text top=""310"" left=""690"" width=""101"" height=""16"" font=""0""> The evidence </text>
<text top=""326"" left=""108"" width=""687"" height=""16"" font=""0"">on record shows that SENASA complied with APHIS' requests by submitting the additional </text>
<text top=""342"" left=""108"" width=""537"" height=""16"" font=""0"">information and by agreeing to the proposed site visits to Northern Argentina.</text>
<footnote top=""341"" left=""645"" width=""17"" height=""11"" font=""16"" number=""429"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""556"" height=""15"" font=""10""> APHIS' facsimile of 29 April 2003, (Exhibit USA-80); SENASA's letter of 5 December 2005, </ftext>
<ftext top=""1022"" left=""108"" width=""425"" height=""15"" font=""10"">(Exhibit ARG-96); SENASA's letter of 26 July 2006, (Exhibit ARG-97). </ftext>
</footnote>
<text top=""342"" left=""663"" width=""128"" height=""16"" font=""0""> On one occasion, </text>
<text top=""359"" left=""108"" width=""686"" height=""16"" font=""0"">SENASA took over one year (i.e. from October 2003 to November 2004) to answer additional </text>
<text top=""375"" left=""108"" width=""183"" height=""16"" font=""0"">questions posed by APHIS.</text>
<footnote top=""374"" left=""291"" width=""17"" height=""11"" font=""16"" number=""430"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""614"" height=""15"" font=""10""> See APHIS' letter of 3 October 2003, (Exhibit USA-84); Information on Northern Argentina provided </ftext>
<ftext top=""1051"" left=""108"" width=""300"" height=""15"" font=""10"">by SENASA (November 2004), (Exhibit ARG-86). </ftext>
</footnote>
</p><p number=""7.124"" style=""8""><text top=""410"" left=""108"" width=""687"" height=""16"" font=""0"">7.124.  Based on the foregoing, we consider that, at this stage of the procedure, matters </text>
<text top=""426"" left=""108"" width=""692"" height=""16"" font=""0"">progressed at a reasonable pace and the only delay between the initial application </text>
<text top=""443"" left=""108"" width=""683"" height=""16"" font=""0"">and September 2006 was the 13 months between APHIS' request in October 2003 and SENASA's </text>
<text top=""459"" left=""108"" width=""189"" height=""16"" font=""0"">answer in November 2004. </text>
</p><p number=""7.125"" style=""8""><text top=""493"" left=""108"" width=""687"" height=""16"" font=""0"">7.125.  Following APHIS' site visit to Northern Argentina in September 2006, APHIS did not </text>
<text top=""510"" left=""108"" width=""683"" height=""16"" font=""0"">communicate with SENASA on the application for almost four years. In July 2010, SENASA sent a </text>
<text top=""526"" left=""108"" width=""683"" height=""16"" font=""0"">letter expressing concern regarding APHIS' silence and requesting that the ""outcome foreseen for </text>
<text top=""543"" left=""108"" width=""490"" height=""16"" font=""0"">the request made by Argentina"" be ""elucidated in a timely time-frame.""</text>
<footnote top=""541"" left=""598"" width=""17"" height=""11"" font=""16"" number=""431"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""442"" height=""15"" font=""10""> SENASA's letter of 19 July 2010, Note No. 150/2010, (Exhibit ARG-46). </ftext>
</footnote>
<text top=""543"" left=""616"" width=""174"" height=""16"" font=""0""> On 24 September 2010, </text>
<text top=""559"" left=""108"" width=""682"" height=""16"" font=""0"">APHIS replied that APHIS was ""currently drafting a proposed rule that would allow the importation </text>
<text top=""575"" left=""108"" width=""468"" height=""16"" font=""0"">of fresh, chilled, or frozen Argentine beef under certain conditions"".</text>
<footnote top=""574"" left=""576"" width=""17"" height=""11"" font=""16"" number=""432"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""342"" height=""15"" font=""10""> APHIS' letter of 24 September 2010, (Exhibit ARG-47). </ftext>
</footnote>
<text top=""575"" left=""593"" width=""197"" height=""16"" font=""0""> APHIS added that the time </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">required to complete the procedure was necessary to ensure the thoroughness and transparency </text>
<text top=""608"" left=""108"" width=""188"" height=""16"" font=""0"">of APHIS' decision-making.</text>
<footnote top=""607"" left=""296"" width=""17"" height=""11"" font=""16"" number=""433"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""342"" height=""15"" font=""10""> APHIS' letter of 24 September 2010, (Exhibit ARG-47). </ftext>
</footnote>
<text top=""608"" left=""313"" width=""479"" height=""16"" font=""0""> In June and October 2011, the United States' representative at the </text>
<text top=""625"" left=""108"" width=""684"" height=""16"" font=""0"">SPS Committee sessions, responding to a specific trade concern raised by Argentina, stated that </text>
<text top=""641"" left=""108"" width=""683"" height=""16"" font=""0"">APHIS had ""completed the risk analysis regarding the region north of the 42nd parallel and would </text>
<text top=""657"" left=""108"" width=""604"" height=""16"" font=""0"">subsequently draft a proposal to allow the importation of beef under certain conditions"".</text>
<footnote top=""656"" left=""712"" width=""17"" height=""11"" font=""16"" number=""434"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""334"" height=""15"" font=""10""> G/SPS/R/63, (Exhibit ARG-22), paras. 17-18. See also</ftext>
<ftext top=""1109"" left=""502"" width=""279"" height=""15"" font=""10"">G/SPS/R/64, (Exhibit ARG-48), paras. 96-97. </ftext>
</footnote>
<text top=""657"" left=""729"" width=""61"" height=""16"" font=""0""> Despite </text>
<text top=""674"" left=""108"" width=""688"" height=""16"" font=""0"">these statements concerning the progress on Argentina's request, APHIS did not issue a </text>
<text top=""690"" left=""108"" width=""682"" height=""16"" font=""0"">determination concerning imports of fresh (chilled or frozen) beef from Northern Argentina, nor did </text>
<text top=""707"" left=""108"" width=""689"" height=""16"" font=""0"">it request any further information from SENASA until it suggested a new site visit in </text>
<text top=""723"" left=""108"" width=""491"" height=""16"" font=""0"">November 2012 during the consultations related to these proceedings.  </text>
</p><p number=""7.126"" style=""8""><text top=""757"" left=""108"" width=""687"" height=""16"" font=""0"">7.126.  In March 2013, when these dispute settlement proceedings were already under way, </text>
<text top=""774"" left=""108"" width=""687"" height=""16"" font=""0"">APHIS formally requested permission from SENASA to conduct a new site visit to Northern </text>
<text top=""790"" left=""108"" width=""485"" height=""16"" font=""0"">Argentina in order to progress with the review of Argentina's request.</text>
<footnote top=""789"" left=""593"" width=""17"" height=""11"" font=""16"" number=""435"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""311"" height=""15"" font=""10""> APHIS' letter of 13 March 2013, (Exhibit USA-96). </ftext>
</footnote>
<text top=""790"" left=""610"" width=""180"" height=""16"" font=""0""> SENASA agreed that the </text>
<p><text top=""905"" left=""108"" width=""111"" height=""15"" font=""10"">(Exhibit ARG-38). </text>
</p><p><text top=""934"" left=""108"" width=""111"" height=""15"" font=""10"">(Exhibit ARG-46). </text>
</p></p><p number=""p."" style=""2""><text top=""978"" left=""108"" width=""40"" height=""15"" font=""10"">p. 96. </text>
</p></page>
<page number=""75"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""20"" size=""16"" family=""Times"" color=""#000000""/>
	<fontspec id=""21"" size=""13"" family=""Times"" color=""#000000""/>
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 75 - </text>
</p><p><text top=""128"" left=""108"" width=""322"" height=""16"" font=""0"">site visit should take place in November 2013.</text>
<footnote top=""126"" left=""430"" width=""17"" height=""11"" font=""16"" number=""436"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""612"" height=""15"" font=""10""> SENASA's letter of 13 July 2013, (Exhibit ARG-99); APHIS' letter of 15 July 2013, (Exhibit USA-97). </ftext>
</footnote>
<text top=""128"" left=""447"" width=""344"" height=""16"" font=""0""> APHIS conducted the site visit as scheduled. On </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">29 August 2014, a few days before the second substantive meeting with the parties in these </text>
<text top=""160"" left=""108"" width=""685"" height=""16"" font=""0"">dispute settlement proceedings, APHIS published a risk analysis for Northern Argentina and a </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">Proposed Rule to allow imports of fresh (chilled or frozen) beef from the region under protocols </text>
<text top=""193"" left=""108"" width=""479"" height=""16"" font=""0"">similar to those applied to fresh (chilled or frozen) beef from Uruguay.</text>
<footnote top=""192"" left=""587"" width=""17"" height=""11"" font=""16"" number=""437"" ref="""" dis=""""><ftext top=""1007"" left=""108"" width=""277"" height=""15"" font=""12""><i>Marketing of Biotech Products</i>,<i> </i>para. 7.1495).</ftext>
</footnote>
</p><p number=""7.127"" style=""8""><text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">7.127.  Based on the above, we consider that, during the course of APHIS' review of Argentina's </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">request for authorization of imports of fresh (chilled or frozen) beef from Northern Argentina, there </text>
<text top=""260"" left=""108"" width=""627"" height=""16"" font=""0"">were two periods of inaction which constitute delays within the meaning of Annex C(1)(a):  </text>
</p><p number=""a."" style=""2""><text top=""295"" left=""151"" width=""378"" height=""16"" font=""0"">a.  one from October 2003 until November 2004; and  </text>
</p><p number=""b."" style=""2""><text top=""329"" left=""151"" width=""170"" height=""16"" font=""0"">b.  the other from </text>
<text top=""329"" left=""307"" width=""93"" height=""16"" font=""0"">September </text>
<text top=""329"" left=""386"" width=""101"" height=""16"" font=""0"">2006 until </text>
<text top=""329"" left=""474"" width=""59"" height=""16"" font=""0"">March </text>
<text top=""329"" left=""519"" width=""284"" height=""16"" font=""0"">2013. However, as indicated in </text>
<text top=""346"" left=""176"" width=""620"" height=""16"" font=""0"">paragraph 7.118 above, the Panel will not consider the period after the date of </text>
<text top=""362"" left=""176"" width=""615"" height=""16"" font=""0"">establishment of the Panel in January 2013. Thus, for the purposes of this dispute, the </text>
<text top=""378"" left=""176"" width=""405"" height=""16"" font=""0"">second delay is from September 2006 until January 2013.  </text>
</p><p number=""7.128"" style=""8""><text top=""413"" left=""108"" width=""675"" height=""16"" font=""0"">7.128.  We shall now assess whether such delays are undue within the meaning of Annex C(1)(a). </text>
</p><p number=""7.3"" style=""8""><text top=""447"" left=""108"" width=""325"" height=""16"" font=""28"">7.3.3.5.3.2  Whether the delays are undue </text></p><p number=""7.129"" style=""8""><text top=""482"" left=""108"" width=""690"" height=""16"" font=""0"">7.129.  We recall that a delay is undue if it is ""unwarranted, or otherwise excessive, </text>
<text top=""498"" left=""108"" width=""229"" height=""16"" font=""0"">disproportionate or unjustifiable"".</text>
<footnote top=""497"" left=""337"" width=""17"" height=""11"" font=""16"" number=""438"" ref="""" dis=""""/>
</p><p number=""7.130"" style=""8""><text top=""533"" left=""108"" width=""62"" height=""16"" font=""0"">7.130. </text>
<text top=""533"" left=""162"" width=""216"" height=""16"" font=""0"">As noted in paragraphs </text>
<text top=""533"" left=""364"" width=""310"" height=""16"" font=""0"">7.123-7.124 above, the delay from </text>
<text top=""533"" left=""661"" width=""71"" height=""16"" font=""0"">October </text>
<text top=""533"" left=""719"" width=""84"" height=""16"" font=""0"">2003 to </text>
<text top=""549"" left=""108"" width=""684"" height=""16"" font=""0"">November 2004 was attributable to SENASA not providing APHIS with the additional information </text>
<text top=""565"" left=""108"" width=""682"" height=""16"" font=""0"">requested. APHIS had made such a request in connection with the FMD outbreak in the province of </text>
<text top=""582"" left=""108"" width=""683"" height=""16"" font=""0"">Salta in late August 2003 aimed at checking that the situation in the area had stabilized, that the </text>
<text top=""598"" left=""108"" width=""615"" height=""16"" font=""0"">disease had not spread, and that the outbreak was adequately controlled or eliminated.</text>
<footnote top=""597"" left=""723"" width=""17"" height=""11"" font=""16"" number=""439"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""342"" height=""15"" font=""10""> See APHIS' letter of 3 October 2003, (Exhibit USA-84). </ftext>
</footnote>
<text top=""598"" left=""740"" width=""51"" height=""16"" font=""0""> Given </text>
<text top=""615"" left=""108"" width=""689"" height=""16"" font=""0"">that the information requested from SENASA in this instance was reasonable under the </text>
<text top=""631"" left=""108"" width=""461"" height=""16"" font=""0"">circumstances, this delay cannot be attributed to the United States.</text>
<footnote top=""629"" left=""569"" width=""17"" height=""11"" font=""16"" number=""440"" ref=""WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1"" dis=""DS291|DS292|DS293""><ftext top=""1036"" left=""165"" width=""611"" height=""15"" font=""10""> See Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1498 (where the panel </ftext>
<ftext top=""1051"" left=""108"" width=""678"" height=""15"" font=""10"">stated that if a request for information is not justified by the importing Member's need to check and ensure the </ftext>
</footnote>
</p><p number=""7.131"" style=""8""><text top=""665"" left=""108"" width=""58"" height=""16"" font=""0"">7.131. </text>
<text top=""665"" left=""162"" width=""637"" height=""16"" font=""0"">Therefore, we are left to assess whether the delay in APHIS' review process </text>
<text top=""682"" left=""108"" width=""685"" height=""16"" font=""0"">between September 2006 and January 2013 is undue. Argentina relies on the statements from </text>
<text top=""698"" left=""108"" width=""684"" height=""16"" font=""0"">APHIS in its letters and of the United States' representative to the SPS Committee as evidence </text>
<text top=""715"" left=""108"" width=""685"" height=""16"" font=""0"">that there was no justifiable reason for the delay. The United States, for its part, argues that </text>
<text top=""731"" left=""108"" width=""651"" height=""16"" font=""0"">Argentina misconstrues the statements and it offers several justifications to explain the delay.  </text>
</p><p number=""7.132"" style=""8""><text top=""765"" left=""108"" width=""683"" height=""16"" font=""0"">7.132.  Specifically, the United States points to the outbreaks in Argentina in 2003 and 2006, the </text>
<text top=""782"" left=""108"" width=""687"" height=""16"" font=""0"">labour strike at SENASA in 2005, SENASA's alleged ""history of intentional concealment"" of </text>
<text top=""798"" left=""108"" width=""682"" height=""16"" font=""0"">outbreaks, and the need for additional information that was not received until the November 2013 </text>
<text top=""815"" left=""108"" width=""683"" height=""16"" font=""0"">site visits. Argentina strongly disputes the United States' statements regarding the alleged history </text>
<text top=""831"" left=""108"" width=""682"" height=""16"" font=""0"">of intentional concealment and asserts that they are belied by the facts on record and APHIS' own </text>
<text top=""847"" left=""108"" width=""82"" height=""16"" font=""0"">conclusions.</text>
<footnote top=""846"" left=""190"" width=""17"" height=""11"" font=""16"" number=""441"" ref="""" dis=""""/>
</p><p number=""7.133"" style=""8""><text top=""882"" left=""108"" width=""685"" height=""16"" font=""0"">7.133.  With respect to the United States' argument that the 2003 and 2006 FMD outbreaks in </text>
<text top=""898"" left=""108"" width=""682"" height=""16"" font=""0"">Northern Argentina and the 2005 labour strike at SENASA raised concerns about Argentina's ability </text>
<text top=""915"" left=""108"" width=""186"" height=""16"" font=""0"">to prevent and control FMD</text>
<footnote top=""913"" left=""294"" width=""17"" height=""11"" font=""16"" number=""442"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""623"" height=""15"" font=""10""> United States' first written submission, paras. 204, 238; United States' opening statement at the first </ftext>
<ftext top=""1109"" left=""108"" width=""677"" height=""15"" font=""10"">meeting of the Panel, para. 57; United States' response to Panel question No. 62 following the first substantive </ftext>
<ftext top=""1124"" left=""108"" width=""62"" height=""15"" font=""10"">meeting.  </ftext>
<ftext top=""920"" left=""108"" width=""670"" height=""15"" font=""10"">36/2006 (Exhibit ARG-6); SENASA's letter of 26 July 2006, (Exhibit ARG-97); 2014 Risk Analysis for Northern </ftext>
<ftext top=""934"" left=""108"" width=""225"" height=""15"" font=""10"">Argentina, (Exhibit USA-169), p. 24. </ftext>
</footnote>
<text top=""915"" left=""311"" width=""479"" height=""16"" font=""0"">, we are persuaded that such occurrences reasonably justified APHIS' </text>
<p><text top=""978"" left=""108"" width=""185"" height=""15"" font=""10"">Argentina, (Exhibit USA-168). </text>
</p><p><text top=""1066"" left=""108"" width=""670"" height=""15"" font=""10"">fulfilment of an SPS measure, that request may cause an undue delay within the meaning of Annex C(1)(a)).  </text>
<text top=""1080"" left=""165"" width=""447"" height=""15"" font=""10""> Argentina's opening statement at the first meeting of the Panel, para. 3. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 76 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">requests for additional information and the need for APHIS to conduct two separate site visits to </text>
<text top=""144"" left=""108"" width=""261"" height=""16"" font=""0"">Northern Argentina in 2005 and 2006.</text>
<footnote top=""143"" left=""368"" width=""17"" height=""11"" font=""16"" number=""443"" ref="""" dis=""""><ftext top=""876"" left=""165"" width=""150"" height=""15"" font=""10""> See para. 7.123 above. </ftext>
</footnote>
<text top=""144"" left=""386"" width=""404"" height=""16"" font=""0""> We understand that, from an epidemiological perspective, </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">after a region has experienced an FMD outbreak, time is required before the importing Member </text>
<text top=""177"" left=""108"" width=""688"" height=""16"" font=""0"">can reliably commence an evaluation of whether the region is free of FMD. According to </text>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">Article 8.5.9(c) of the Terrestrial Code, such waiting period is six months from the last outbreak </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">where the authorities of the region affected adopted a stamping-out policy, emergency vaccination </text>
<text top=""226"" left=""108"" width=""192"" height=""16"" font=""0"">and serological surveillance.</text>
<footnote top=""225"" left=""300"" width=""17"" height=""11"" font=""16"" number=""444"" ref="""" dis=""""/>
</p></p></page>
<page number=""76"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.134"" style=""8""><text top=""260"" left=""108"" width=""686"" height=""16"" font=""0"">7.134.  APHIS itself recognized a general range of time from the last outbreak to when an </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">evaluation is possible when it stated that it ""[did] not consider a 3 to 5 year disease-free waiting </text>
<text top=""293"" left=""108"" width=""660"" height=""16"" font=""0"">period to be either necessary or required by international requirements or standards"".</text>
<footnote top=""292"" left=""768"" width=""17"" height=""11"" font=""16"" number=""445"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""600"" height=""15"" font=""10""> <i>Importation of Beef from Uruguay</i>, 68 Fed. Reg. 31940 (USDA/APHIS May 29, 2003) (Final Rule), </ftext>
<ftext top=""963"" left=""108"" width=""417"" height=""15"" font=""10"">(2003 Final Rule on beef from Uruguay), (Exhibit ARG-8), p. 31946. </ftext>
</footnote>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">Furthermore, APHIS noted in a policy document dating October 1997 that, in order to determine </text>
<text top=""326"" left=""108"" width=""684"" height=""16"" font=""0"">the level of risk presented by products originating from a given region, it takes into account a </text>
<text top=""342"" left=""108"" width=""684"" height=""16"" font=""0"">number of factors, including whether ""[t]he restricted agent has not been diagnosed within the </text>
<text top=""359"" left=""108"" width=""380"" height=""16"" font=""0"">region for a period of time appropriate for that agent"".</text>
<footnote top=""357"" left=""488"" width=""17"" height=""11"" font=""16"" number=""446"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""549"" height=""15"" font=""10""> <i>APHIS Policy Regarding Importation of Animals and Animal Products</i>, 62 Fed. Reg. 56027 </ftext>
<ftext top=""993"" left=""108"" width=""565"" height=""15"" font=""10"">(USDA/APHIS, 28 October 1997) (Notice), (1997 APHIS Policy), (Exhibit ARG-63), p. 56029. </ftext>
</footnote>
<text top=""359"" left=""505"" width=""284"" height=""16"" font=""0""> The length of that period of time varies </text>
<text top=""375"" left=""108"" width=""683"" height=""16"" font=""0"">according to the disease and the level of risk. In order to attribute a ""negligible"", ""slight"" or ""low"" </text>
<text top=""392"" left=""108"" width=""452"" height=""16"" font=""0"">level of risk to a region, the period of time for FMD is ""1 year"".</text>
<footnote top=""390"" left=""560"" width=""17"" height=""11"" font=""16"" number=""447"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""613"" height=""15"" font=""10""> 1997 APHIS Policy, (Exhibit ARG-63), pp. 56029-56030. While the waiting period is the same for all </ftext>
<ftext top=""1022"" left=""108"" width=""645"" height=""15"" font=""10"">three levels of risk, other factors, such as vaccination, movement and border controls, etc., justify APHIS' </ftext>
<ftext top=""1036"" left=""108"" width=""178"" height=""15"" font=""10"">distinction between regions.  </ftext>
</footnote>
<text top=""392"" left=""577"" width=""214"" height=""16"" font=""0""> We recognize that the policy </text>
<text top=""408"" left=""108"" width=""688"" height=""16"" font=""0"">document is from 1997 and that there have been advances in diagnostic and serological </text>
<text top=""425"" left=""108"" width=""683"" height=""16"" font=""0"">surveillance that have led the OIE to conclude a six-month waiting period between outbreak and </text>
<text top=""441"" left=""108"" width=""685"" height=""16"" font=""0"">consideration for re-gaining ""free"" status is sufficient. However, we note that the document in </text>
<text top=""457"" left=""108"" width=""684"" height=""16"" font=""0"">question still constitutes the basis on which APHIS operates in evaluating the FMD conditions of </text>
<text top=""474"" left=""108"" width=""622"" height=""16"" font=""0"">applicant countries or regions. Furthermore,  as  will  be  seen  in  more  detail  below</text>
<footnote top=""472"" left=""730"" width=""17"" height=""11"" font=""16"" number=""448"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""157"" height=""15"" font=""10""> See section 7.6.2 below. </ftext>
</footnote>
<text top=""474"" left=""747"" width=""49"" height=""16"" font=""0"">, the </text>
<text top=""490"" left=""108"" width=""683"" height=""16"" font=""0"">United States' claims that its ALOP for FMD is higher than that of the OIE. Therefore, we take the </text>
<text top=""507"" left=""108"" width=""684"" height=""16"" font=""0"">view that while a Member could begin a review within six months of an outbreak, APHIS' 1997 </text>
<text top=""523"" left=""108"" width=""683"" height=""16"" font=""0"">policy provides useful guidance as to the <i>maximum</i> reasonable time for the United States to wait </text>
<text top=""539"" left=""108"" width=""685"" height=""16"" font=""0"">after an outbreak before commencing its review of whether the FMD situation in a country or </text>
<text top=""556"" left=""108"" width=""143"" height=""16"" font=""0"">region has changed. </text>
</p><p number=""7.135"" style=""8""><text top=""590"" left=""108"" width=""688"" height=""16"" font=""0"">7.135.  Read together, the above indicators suggest that APHIS should have been able to </text>
<text top=""607"" left=""108"" width=""686"" height=""16"" font=""0"">commence its assessment of the FMD situation in Northern Argentina after waiting a period </text>
<text top=""623"" left=""108"" width=""682"" height=""16"" font=""0"">ranging from six months to one year following the 2006 outbreak, that is, by February 2007 at the </text>
<text top=""639"" left=""108"" width=""685"" height=""16"" font=""0"">latest. We observe that APHIS did not make any requests for information from SENASA after </text>
<text top=""656"" left=""108"" width=""686"" height=""16"" font=""0"">the September 2006 outbreak and the process did not move forward. Therefore, we are not </text>
<text top=""672"" left=""108"" width=""529"" height=""16"" font=""0"">convinced that the above factors justify APHIS' inaction <i>after</i> February 2007. </text>
</p><p number=""7.136"" style=""8""><text top=""707"" left=""108"" width=""684"" height=""16"" font=""0"">7.136.  As to the United States' argument that SENASA's ""history of intentional concealment and </text>
<text top=""723"" left=""108"" width=""457"" height=""16"" font=""0"">delayed reporting of outbreaks"" justifies the 2007-2013 delay</text>
<footnote top=""721"" left=""565"" width=""17"" height=""11"" font=""16"" number=""449"" ref="""" dis=""""/>
<text top=""723"" left=""583"" width=""212"" height=""16"" font=""0"">, we note that despite the </text>
<text top=""739"" left=""108"" width=""684"" height=""16"" font=""0"">United States' view that Argentina intentionally concealed the full extent of its FMD outbreaks in </text>
<text top=""756"" left=""108"" width=""75"" height=""16"" font=""0"">2000-2002</text>
<footnote top=""754"" left=""183"" width=""17"" height=""11"" font=""16"" number=""450"" ref="""" dis=""""/>
<text top=""756"" left=""200"" width=""593"" height=""16"" font=""0"">, the United States could not identify any subsequent instances in which SENASA </text>
<text top=""772"" left=""108"" width=""560"" height=""16"" font=""0"">failed to promptly notify the OIE and APHIS about FMD outbreaks in Argentina.</text>
<footnote top=""771"" left=""668"" width=""17"" height=""11"" font=""16"" number=""451"" ref="""" dis=""""/>
<text top=""772"" left=""685"" width=""107"" height=""16"" font=""0""> Based on the </text>
<text top=""789"" left=""108"" width=""683"" height=""16"" font=""0"">evidence on record, we find that since Argentina filed its request in November 2002, SENASA has </text>
<text top=""805"" left=""108"" width=""575"" height=""16"" font=""0"">been diligent and timely in disclosing the presence of FMD outbreaks in its territory.</text>
<footnote top=""804"" left=""683"" width=""17"" height=""11"" font=""16"" number=""452"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""602"" height=""15"" font=""10""> SENASA's letter of 29 August 2003, (Exhibit USA-83); Argentina's facsimile of 5 September 2003, </ftext>
<ftext top=""1124"" left=""108"" width=""596"" height=""15"" font=""10"">(Exhibit USA-51); OIE, Final Report, 74th General Session (2006), (Exhibit USA-55), pp. 45, 144. </ftext>
<ftext top=""1066"" left=""108"" width=""468"" height=""15"" font=""10"">the Panel, para. 18; Argentina's second written submission, paras. 385-389. </ftext>
</footnote>
<text top=""805"" left=""700"" width=""90"" height=""16"" font=""0""> APHIS itself </text>
<text top=""821"" left=""108"" width=""683"" height=""16"" font=""0"">recognized SENASA's diligence when, in 2005, it expressed ""confidence"" that ""delayed reporting"" </text>
<p><text top=""891"" left=""165"" width=""603"" height=""15"" font=""10""> We note that Argentina's actions in response to the 2006 outbreak follow the recommendations of </text>
<text top=""905"" left=""108"" width=""658"" height=""15"" font=""10"">Article 8.5.9 of the Terrestrial Code. See Resoluci&#243;n SENASA 35/2006, (Exhibit ARG-5); Resoluci&#243;n SENASA </text>
<footnote top=""1066"" left=""165"" width=""563"" height=""15"" font=""10"" number=""31"" ref="""" dis=""""/>
</p><p><text top=""1080"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 204. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 77 - </text>
</p><p><text top=""128"" left=""108"" width=""290"" height=""16"" font=""0"">like that in 2001 would not happen again.</text>
<footnote top=""126"" left=""398"" width=""17"" height=""11"" font=""16"" number=""453"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""570"" height=""15"" font=""10""> USDA, Veterinary Services, National Center for Import and Export Regionalization Evaluation </ftext>
<ftext top=""993"" left=""108"" width=""649"" height=""15"" font=""10"">Services, <i>Risk Analysis: Risk of Exporting Foot-and-Mouth Disease (FMD) in FMD-Susceptible Species from </i></ftext>
</footnote>
<text top=""128"" left=""415"" width=""375"" height=""16"" font=""0""> Therefore, we do not consider that the United States </text>
<text top=""144"" left=""108"" width=""687"" height=""16"" font=""0"">can validly invoke SENASA's shortcomings &#8211; which the United States itself concluded were </text>
<text top=""160"" left=""108"" width=""602"" height=""16"" font=""0"">remedied prior to February 2007 &#8211; as a justification for APHIS' inaction after that date.  </text>
</p></p></page>
<page number=""77"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.137"" style=""8""><text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">7.137.  We next address Argentina's claim that Section 737 of the <i>2009 Omnibus Appropriations </i></text>
<text top=""211"" left=""108"" width=""470"" height=""16"" font=""18""><i>Act</i> is a non-scientific and undue reason for the delay in the process.</text>
<footnote top=""210"" left=""578"" width=""17"" height=""11"" font=""16"" number=""454"" ref="""" dis=""""/>
<text top=""211"" left=""595"" width=""195"" height=""16"" font=""0""> In support of its argument, </text>
<text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina draws a parallel between Section 737 and the measure found to be inconsistent by the </text>
<text top=""244"" left=""108"" width=""684"" height=""16"" font=""0"">panel in <i>US &#8211; Poultry (China), </i>which prohibited the Secretary of Agriculture from spending any </text>
<text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">budgetary resources towards the approval of Chinese poultry for import into the United States. </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">The United States first argues that because Section 737 expired prior to the establishment of the </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">Panel, it is outside the Panel's terms of reference. Substantively, the United States responds that </text>
<text top=""310"" left=""108"" width=""689"" height=""16"" font=""0"">Section 737 did not affect the Secretary of Agriculture's authority to review Argentina's </text>
<text top=""326"" left=""108"" width=""63"" height=""16"" font=""0"">requests.</text>
<footnote top=""325"" left=""171"" width=""17"" height=""11"" font=""16"" number=""455"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""352"" height=""15"" font=""10""> United States' first written submission, paras. 146, 223.  </ftext>
</footnote>
</p><p number=""7.138"" style=""8""><text top=""360"" left=""108"" width=""685"" height=""16"" font=""0"">7.138.  We note that the panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> took into </text>
<text top=""377"" left=""108"" width=""685"" height=""16"" font=""0"">account approval procedures relating to requests that had been withdrawn at the time of its </text>
<text top=""393"" left=""108"" width=""685"" height=""16"" font=""0"">establishment, on the grounds that such procedures ""constitute[d] factual evidence"" which the </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">panel was ""not only entitled to take into account"", but indeed ""required to take into account in </text>
<text top=""426"" left=""108"" width=""568"" height=""16"" font=""0"">view of its obligation to make an objective assessment of the facts of the case"".</text>
<footnote top=""425"" left=""676"" width=""17"" height=""11"" font=""16"" number=""456"" ref=""WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3"" dis=""DS291|DS293|DS292""><ftext top=""1095"" left=""165"" width=""474"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.548. </ftext>
</footnote>
<text top=""426"" left=""693"" width=""98"" height=""16"" font=""0""> In our view, </text>
<text top=""443"" left=""108"" width=""682"" height=""16"" font=""0"">this is the correct approach. Regardless of whether Section 737 is considered a ""measure at issue"" </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">in that the Panel could make specific findings or recommendations on its consistency with Article 8 </text>
<text top=""475"" left=""108"" width=""684"" height=""16"" font=""0"">and Annex C &#8211; a matter we turn to below &#8211; it can serve as factual evidence as to whether the </text>
<text top=""492"" left=""108"" width=""686"" height=""16"" font=""0"">delay in the processing of Argentina's application was undue. Therefore, we find it useful to </text>
<text top=""508"" left=""108"" width=""685"" height=""16"" font=""0"">examine whether Section 737 had the impact Argentina alleges before turning to address the </text>
<text top=""525"" left=""108"" width=""683"" height=""16"" font=""0"">United States' arguments that the measure cannot be a measure at issue within the Panel's terms </text>
<text top=""541"" left=""108"" width=""91"" height=""16"" font=""0"">of reference. </text>
</p><p number=""7.139"" style=""8""><text top=""575"" left=""108"" width=""689"" height=""16"" font=""0"">7.139.  Argentina claims that Section 737 is directly analogous to the legislative measure </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">considered by the panel in <i>US &#8211; Poultry (China). </i>We do not agree with Argentina. Section 737 did </text>
<text top=""608"" left=""108"" width=""683"" height=""16"" font=""0"">not have the effect of completely blocking all progress on Argentina's application, as was the case </text>
<text top=""625"" left=""108"" width=""685"" height=""16"" font=""0"">for the measure at issue in <i>US &#8211; Poultry (China)</i>. Rather, Section 737 appears to permit the </text>
<text top=""641"" left=""108"" width=""683"" height=""16"" font=""0"">Secretary of Agriculture to move forward with a review of the ""domestic animal health aspects"" of </text>
<text top=""657"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina's requests and to provide ""a report on the findings to the Committees on Appropriations </text>
<text top=""674"" left=""108"" width=""190"" height=""16"" font=""0"">of the House and Senate"".</text>
<footnote top=""672"" left=""298"" width=""17"" height=""11"" font=""16"" number=""457"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""379"" height=""15"" font=""10""> <i>2009 Omnibus Appropriations Act</i>, (Exhibit ARG-45/USA-95). </ftext>
</footnote>
<text top=""674"" left=""315"" width=""478"" height=""16"" font=""0""> A review of the impact of a potential entry or spread of FMD on </text>
<text top=""690"" left=""108"" width=""683"" height=""16"" font=""0"">domestic animal health is consistent with the requirements for a risk assessment set forth in the </text>
<text top=""707"" left=""108"" width=""686"" height=""16"" font=""0"">SPS Agreement. Indeed, the risk being protected against is a risk to the health of domestic </text>
<text top=""723"" left=""108"" width=""686"" height=""16"" font=""0"">animals. In particular, Annex A(4) refers to evaluating the ""potential biological and economic </text>
<text top=""739"" left=""108"" width=""683"" height=""16"" font=""0"">consequences"" of the entry, establishment or spread of a pest or disease, whereas Article 5.3 lists </text>
<text top=""756"" left=""108"" width=""687"" height=""16"" font=""0"">""the potential damage in terms of loss of production or sales in the event of the entry, </text>
<text top=""772"" left=""108"" width=""685"" height=""16"" font=""0"">establishment or spread of a pest or disease"" and ""the costs of control or eradication in the </text>
<text top=""789"" left=""108"" width=""682"" height=""16"" font=""0"">territory of the importing Member"" as factors that must be taken into account in assessing the risk </text>
<text top=""805"" left=""108"" width=""684"" height=""16"" font=""0"">to animal health. Therefore, given that Section 737 appeared to permit the conduct of such an </text>
<text top=""821"" left=""108"" width=""682"" height=""16"" font=""0"">analysis, the effect of the provision does not appear, in and of itself, to amount to an undue delay </text>
<text top=""838"" left=""108"" width=""683"" height=""16"" font=""0"">in an approval process. Furthermore, the United States argued that the failure of the Secretary of </text>
<text top=""854"" left=""108"" width=""683"" height=""16"" font=""0"">Agriculture to produce such a report was not due to any hindrance of authority brought about by </text>
<text top=""871"" left=""108"" width=""683"" height=""16"" font=""0"">Section 737;<i> </i>according to the United States,<i> </i>the report was not produced because the Secretary's </text>
<text top=""887"" left=""108"" width=""393"" height=""16"" font=""0"">review of Argentina's requests had not yet been finalized.</text>
<footnote top=""886"" left=""500"" width=""17"" height=""11"" font=""16"" number=""458"" ref="""" dis=""""/>
</p><p number=""7.140"" style=""8""><text top=""922"" left=""108"" width=""683"" height=""16"" font=""0"">7.140.  Based on the evidence before us, we are not convinced that completion of the evaluation </text>
<text top=""938"" left=""108"" width=""684"" height=""16"" font=""0"">required in Section 737 caused undue delay in the APHIS approval procedures. Having reached </text>
<p><text top=""1007"" left=""108"" width=""659"" height=""15"" font=""31"">Argentina, South of the 42 Parallel (Patagonia South), to the United States: Evaluation of the FMD Status of </text></p><p><text top=""1022"" left=""108"" width=""656"" height=""15"" font=""12""><i>Argentina, South of the 42 Parallel</i> (June 2005), (2005 Risk Analysis for Patagonia South), (Exhibit ARG-9), </text>
<text top=""1036"" left=""108"" width=""40"" height=""15"" font=""10"">p. 23. </text>
<text top=""1051"" left=""165"" width=""621"" height=""15"" font=""10""> Argentina's first written submission, para. 701; Argentina's opening statement at the first meeting of </text>
</p><p><text top=""1124"" left=""165"" width=""537"" height=""15"" font=""10""> United States' response to Panel question No. 7 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 78 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">this conclusion, we need not determine whether Section 737, considered as a measure rather than </text>
<text top=""144"" left=""108"" width=""349"" height=""16"" font=""0"">relevant evidence, is within our terms of reference.</text>
<footnote top=""143"" left=""457"" width=""17"" height=""11"" font=""16"" number=""459"" ref="""" dis=""DS58|DS345""><ftext top=""832"" left=""165"" width=""614"" height=""15"" font=""10""> As we see it, this approach is consistent with that of the Appellate Body in <i>US &#8211; Shrimp (Thailand) / </i></ftext>
<ftext top=""847"" left=""108"" width=""676"" height=""15"" font=""12""><i>US &#8211; Customs Bond Directive</i>. In that dispute, the Appellate Body conducted an analysis of whether a measure </ftext>
</footnote>
</p></p></page>
<page number=""78"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.141"" style=""8""><text top=""178"" left=""108"" width=""684"" height=""16"" font=""0"">7.141.  We now turn to the United States' argument that APHIS did not have all the information </text>
<text top=""195"" left=""108"" width=""456"" height=""16"" font=""0"">necessary to complete its risk assessment for Northern Argentina</text>
<text top=""195"" left=""568"" width=""223"" height=""16"" font=""0"">until the site visit of November </text>
<text top=""211"" left=""108"" width=""39"" height=""16"" font=""0"">2013.</text>
<footnote top=""210"" left=""147"" width=""17"" height=""11"" font=""16"" number=""460"" ref="""" dis=""""/>
<text top=""211"" left=""165"" width=""627"" height=""16"" font=""0""> This argument also raises the issue of the weight to be placed on the statements in the </text>
<text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">letter from APHIS and those made to the SPS Committee of the WTO. APHIS' letter to SENASA </text>
<text top=""244"" left=""108"" width=""131"" height=""16"" font=""0"">of September 2010</text>
<footnote top=""243"" left=""239"" width=""17"" height=""11"" font=""16"" number=""461"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""342"" height=""15"" font=""10""> APHIS' letter of 24 September 2010, (Exhibit ARG-47). </ftext>
</footnote>
<text top=""244"" left=""256"" width=""169"" height=""16"" font=""0""> and the United </text>
<text top=""244"" left=""411"" width=""394"" height=""16"" font=""0"">States' representative's statements before the </text>
<text top=""260"" left=""108"" width=""292"" height=""16"" font=""0"">SPS Committee  in June and October 2011</text>
<footnote top=""259"" left=""400"" width=""17"" height=""11"" font=""16"" number=""462"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""334"" height=""15"" font=""10""> G/SPS/R/63, (Exhibit ARG-22), paras. 17-18. See also</ftext>
<ftext top=""978"" left=""502"" width=""279"" height=""15"" font=""10"">G/SPS/R/64, (Exhibit ARG-48), paras. 96-97. </ftext>
</footnote>
<text top=""260"" left=""417"" width=""379"" height=""16"" font=""0""> suggest that APHIS had enough information to </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">progress with its risk assessment at the time those statements were made. Indeed, APHIS stated </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">that it was ""currently drafting a proposed rule that would allow the importation of fresh, chilled, or </text>
<text top=""310"" left=""108"" width=""330"" height=""16"" font=""0"">frozen Argentine beef under certain conditions""</text>
<footnote top=""308"" left=""438"" width=""17"" height=""11"" font=""16"" number=""463"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""342"" height=""15"" font=""10""> APHIS' letter of 24 September 2010, (Exhibit ARG-47). </ftext>
</footnote>
<text top=""310"" left=""456"" width=""336"" height=""16"" font=""0"">, while the United States' representative at the </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">SPS Committee stated that APHIS had ""completed the risk analysis regarding the region north of </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">the 42nd parallel and would subsequently draft a proposal to allow the importation of beef under </text>
<text top=""359"" left=""108"" width=""131"" height=""16"" font=""0"">certain conditions"".</text>
<footnote top=""357"" left=""239"" width=""17"" height=""11"" font=""16"" number=""464"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""334"" height=""15"" font=""10""> G/SPS/R/63, (Exhibit ARG-22), paras. 17-18. See also</ftext>
<ftext top=""1007"" left=""502"" width=""279"" height=""15"" font=""10"">G/SPS/R/64, (Exhibit ARG-48), paras. 96-97. </ftext>
</footnote>
</p><p number=""7.142"" style=""8""><text top=""393"" left=""108"" width=""683"" height=""16"" font=""0"">7.142.  The United States asserts that the above-mentioned statements should not be understood </text>
<text top=""410"" left=""108"" width=""526"" height=""16"" font=""0"">to suggest that APHIS was ready to finalize the process in 2010-2011.</text>
<footnote top=""408"" left=""634"" width=""17"" height=""11"" font=""16"" number=""465"" ref="""" dis=""""/>
<text top=""410"" left=""652"" width=""143"" height=""16"" font=""0""> Accepting for the </text>
<text top=""426"" left=""108"" width=""684"" height=""16"" font=""0"">moment the United States' interpretation of such statements, this does not deprive them of all </text>
<text top=""443"" left=""108"" width=""685"" height=""16"" font=""0"">value for our purposes. It seems to us that even if the statements in question should not be </text>
<text top=""459"" left=""108"" width=""686"" height=""16"" font=""0"">construed to imply that the risk analysis was complete, they may nevertheless serve as an </text>
<text top=""475"" left=""108"" width=""682"" height=""16"" font=""0"">indication that there was no reason for the continued delay in the finalization of the procedure. The </text>
<text top=""492"" left=""108"" width=""682"" height=""16"" font=""0"">record shows that APHIS did not request SENASA to provide any additional information concerning </text>
<text top=""508"" left=""108"" width=""88"" height=""16"" font=""0"">the FMD </text>
<text top=""508"" left=""182"" width=""503"" height=""16"" font=""0"">situation in Northern Argentina following its site visit of </text>
<text top=""508"" left=""672"" width=""93"" height=""16"" font=""0"">September </text>
<text top=""508"" left=""751"" width=""53"" height=""16"" font=""0"">2006 </text>
<text top=""525"" left=""108"" width=""685"" height=""16"" font=""0"">until March 2013. Moreover, the United States has not pointed to any specific information that </text>
<text top=""541"" left=""108"" width=""685"" height=""16"" font=""0"">APHIS was missing prior to the November 2013 visit, except for the need to ""re-confirm and </text>
<text top=""557"" left=""108"" width=""550"" height=""16"" font=""0"">update"" information already in its possession as the result of prior site visits.</text>
<footnote top=""556"" left=""658"" width=""17"" height=""11"" font=""16"" number=""466"" ref="""" dis=""""/>
<text top=""557"" left=""675"" width=""117"" height=""16"" font=""0""> Read together, </text>
<text top=""574"" left=""108"" width=""688"" height=""16"" font=""0"">these facts indicate to us that APHIS had collected sufficient information concerning the </text>
<text top=""590"" left=""108"" width=""684"" height=""16"" font=""0"">FMD situation in Northern Argentina well before the November 2013 site visit took place. If that </text>
<text top=""607"" left=""108"" width=""685"" height=""16"" font=""0"">were not the case, one would expect APHIS to have communicated to SENASA to request any </text>
<text top=""623"" left=""108"" width=""667"" height=""16"" font=""0"">missing information in order to progress towards the completion of the process. It did not do so.  </text>
</p><p number=""7.143"" style=""8""><text top=""657"" left=""108"" width=""684"" height=""16"" font=""0"">7.143.  Moreover, we disagree with the United States that the need to ""re-confirm and update"" </text>
<text top=""674"" left=""108"" width=""683"" height=""16"" font=""0"">pre-existing information constitutes, in and of itself, a justification for the delay in the completion </text>
<text top=""690"" left=""108"" width=""685"" height=""16"" font=""0"">of a control, inspection or approval procedure. We note that the panel in <i>EC &#8211; Approval and </i></text>
<text top=""707"" left=""108"" width=""683"" height=""16"" font=""18""><i>Marketing of Biotech Products</i> found that when ""<i>new</i> or <i>additional</i>"" relevant information becomes </text>
<text top=""723"" left=""108"" width=""684"" height=""16"" font=""0"">available, a Member may reasonably ""delay the completion of the procedure"" in order to assess </text>
<text top=""739"" left=""108"" width=""14"" height=""16"" font=""0"">it.</text>
<footnote top=""738"" left=""122"" width=""17"" height=""11"" font=""16"" number=""467"" ref=""WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4"" dis=""DS293|DS291|DS292""><ftext top=""1124"" left=""165"" width=""600"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1498 (emphasis added). </ftext>
<ftext top=""741"" left=""163"" width=""228"" height=""15"" font=""10"">recognition of Patagonia as FMD-free.</ftext>
<ftext top=""778"" left=""163"" width=""391"" height=""15"" font=""10"">conducted a site visit to Patagonia South and the Patagonia </ftext>
<ftext top=""792"" left=""163"" width=""389"" height=""15"" font=""10"">buffer zone consisting of Patagonia North A and B to continue </ftext>
<ftext top=""807"" left=""163"" width=""290"" height=""15"" font=""10"">its assessment of the status of FMD in the area.</ftext>
<ftext top=""843"" left=""163"" width=""362"" height=""15"" font=""10"">Patagonia of 1-5 December 2003, APHIS informed SENASA </ftext>
<ftext top=""858"" left=""163"" width=""367"" height=""15"" font=""10"">that it would need to provide additional information to allow </ftext>
<ftext top=""872"" left=""163"" width=""265"" height=""15"" font=""10"">APHIS to proceed with the risk assessment.</ftext>
<ftext top=""1036"" left=""108"" width=""633"" height=""15"" font=""10"">(United States Department of Agriculture, Animal and Plant Health Inspection Service, USDA, APHIS) to </ftext>
<ftext top=""1051"" left=""108"" width=""605"" height=""15"" font=""10"">Dr. Jorge N. Amaya (SENASA, President) (6 November 2003), (APHIS' letter of 6 November 2003), </ftext>
</footnote>
<text top=""739"" left=""139"" width=""653"" height=""16"" font=""0""> However, taking time to assess <i>relevant  </i>new or additional information is not the same as </text>
<text top=""756"" left=""108"" width=""686"" height=""16"" font=""0"">taking time to re-confirm and update information already received. It is inevitable that the </text>
<text top=""772"" left=""108"" width=""683"" height=""16"" font=""0"">situation in any Member or region will change and cannot remain static; the longer the evaluation </text>
<text top=""789"" left=""108"" width=""683"" height=""16"" font=""0"">process takes, the more likely the need to ""re-confirm and update"" the submitted information. In </text>
<p><text top=""861"" left=""108"" width=""637"" height=""15"" font=""10"">at issue was justified under Article XX(d) of the GATT 1994 on an <i>arguendo</i> basis, i.e. assuming that the </text>
<text top=""876"" left=""108"" width=""676"" height=""15"" font=""10"">general exceptions under Article XX were available to the defendant to vis-&#224;-vis claim under Article 18.1 of the </text>
<text top=""891"" left=""108"" width=""680"" height=""15"" font=""10"">Anti-Dumping Agreement. (See Appellate Body Report, <i>US &#8211; Shrimp (Thailand) / US &#8211; Customs Bond Directive</i>, </text>
<text top=""905"" left=""108"" width=""681"" height=""15"" font=""10"">para. 310) Having found that the measure was not justified under Article XX(d), the Appellate Body did not find </text>
<text top=""920"" left=""108"" width=""644"" height=""15"" font=""10"">it necessary to express a view on the question of whether a defence under Article XX was available to the </text>
<text top=""934"" left=""108"" width=""201"" height=""15"" font=""10"">defendant. (See Ibid. para. 319) </text>
<footnote top=""949"" left=""165"" width=""563"" height=""15"" font=""10"" number=""29"" ref="""" dis=""""/>
</p><p><text top=""1022"" left=""165"" width=""600"" height=""15"" font=""10""> See e.g. United States' response to Panel question No. 32 following the first substantive meeting. </text>
</p><p><text top=""1051"" left=""108"" width=""681"" height=""15"" font=""10"">United States' response to Panel question No. 30 following the second substantive meeting. This is confirmed in </text>
<text top=""1066"" left=""108"" width=""586"" height=""15"" font=""10"">the 2014 risk assessment for Northern Argentina that the United States placed on the record on </text>
<text top=""1080"" left=""108"" width=""614"" height=""15"" font=""10"">1 September 2014. A review of the document shows that the information APHIS collected during the </text>
<text top=""1095"" left=""108"" width=""649"" height=""15"" font=""10"">November 2013 site visit was aimed at updating pre-existing information. (See e.g. 2014 Risk Analysis for </text>
<text top=""1109"" left=""108"" width=""405"" height=""15"" font=""10"">Northern Argentina, (Exhibit USA-169), pp. 10, 30-33, 55, 74-75) </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 79 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">our view, to accept the United States' argument as justifying the delay in this case would seriously </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">undermine the obligations in Annex C(1)(a), for if a WTO Member could indefinitely postpone the </text>
<text top=""160"" left=""108"" width=""687"" height=""16"" font=""0"">completion of a procedure by invoking the need to reconfirm information that had become </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">outdated by virtue of its own inaction, this would create a dangerous loophole in the disciplines of </text>
<text top=""193"" left=""108"" width=""644"" height=""16"" font=""0"">that provision and would reward behaviour opposite to the diligence called for by Annex C(1). </text>
</p></p></page>
<page number=""79"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.144"" style=""8""><text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">7.144.  Finally, we address the United States' argument that, by postponing APHIS' latest site visit </text>
<text top=""244"" left=""108"" width=""565"" height=""16"" font=""0"">to Northern Argentina until November 2013, SENASA contributed to APHIS' delay.</text>
<footnote top=""243"" left=""673"" width=""17"" height=""11"" font=""16"" number=""468"" ref="""" dis=""""/>
<text top=""244"" left=""690"" width=""100"" height=""16"" font=""0""> We note that </text>
<text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina is not seeking to support its claim of undue delay with the period between March and </text>
<text top=""277"" left=""108"" width=""688"" height=""16"" font=""0"">November 2013, but rather only up to the date of the establishment of the Panel (28 </text>
<text top=""293"" left=""108"" width=""689"" height=""16"" font=""0"">January 2013). Therefore, whether any delay in that period is attributable to either the </text>
<text top=""310"" left=""108"" width=""435"" height=""16"" font=""0"">United States or Argentina is immaterial to the task before us.  </text>
</p><p number=""7.145"" style=""8""><text top=""344"" left=""108"" width=""687"" height=""16"" font=""0"">7.145.  Based on the foregoing, we conclude that the United States did not undertake and </text>
<text top=""360"" left=""108"" width=""683"" height=""16"" font=""0"">complete the procedure to review Argentina's request for imports of fresh (chilled or frozen) beef </text>
<text top=""377"" left=""108"" width=""684"" height=""16"" font=""0"">from Northern Argentina without undue delay and has therefore acted in a manner inconsistent </text>
<text top=""393"" left=""108"" width=""576"" height=""16"" font=""0"">with Article 8 and Annex C(1)(a) of the SPS Agreement with respect to that request.</text>
</p><p number=""7.3"" style=""8""><text top=""428"" left=""108"" width=""682"" height=""16"" font=""28"">7.3.3.5.4  APHIS' review process of Argentina's request for the recognition of Patagonia </text><text top=""444"" left=""108"" width=""96"" height=""16"" font=""28"">as FMD-free </text></p><p number=""7.146"" style=""8""><text top=""479"" left=""108"" width=""683"" height=""16"" font=""0"">7.146.  As with our findings in the previous section, we shall assess, first, whether APHIS' review </text>
<text top=""495"" left=""108"" width=""682"" height=""16"" font=""0"">process of Argentina's request for the recognition of Patagonia as FMD-free incurred a delay. If so, </text>
<text top=""511"" left=""108"" width=""683"" height=""16"" font=""0"">we shall turn to determining whether such a delay was undue. For ease of reference, we include </text>
<text top=""528"" left=""108"" width=""682"" height=""16"" font=""0"">the events relevant to APHIS' review and the Panel proceedings in Table 2 below. We also refer to </text>
<text top=""544"" left=""108"" width=""534"" height=""16"" font=""0"">the chronology contained in Appendix 1 to this Report for further information. </text>
</p><p><text top=""579"" left=""108"" width=""658"" height=""16"" font=""28"">Table 2: Chronology of events relating to APHIS' review of Argentina's request for the </text><text top=""595"" left=""108"" width=""287"" height=""16"" font=""28"">recognition of Patagonia as FMD-free </text></p><p><text top=""632"" left=""116"" width=""27"" height=""15"" font=""29"">No. </text><text top=""632"" left=""336"" width=""42"" height=""15"" font=""29"">Event </text><text top=""632"" left=""608"" width=""36"" height=""15"" font=""29"">Date </text><text top=""625"" left=""716"" width=""58"" height=""15"" font=""29"">Interval </text><text top=""639"" left=""711"" width=""69"" height=""15"" font=""29"">(approx.) </text><footnote top=""661"" left=""135"" width=""418"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""/>
</p><p><text top=""676"" left=""163"" width=""296"" height=""15"" font=""10"">recognition of Patagonia as a region free of FMD.</text>
<footnote top=""675"" left=""459"" width=""14"" height=""9"" font=""17"" number=""469"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""396"" height=""15"" font=""10""> Information Provided by SENASA (July 2003), (Exhibit USA-98). </ftext>
</footnote>
</p><p><text top=""661"" left=""563"" width=""94"" height=""15"" font=""33"">28 Aug. 2003 </text></p><p><text top=""661"" left=""701"" width=""10"" height=""15"" font=""10"">- </text>
</p><p number=""2."" style=""6""><text top=""697"" left=""135"" width=""418"" height=""15"" font=""10"">2.   APHIS contacted SENASA regarding a 1 December 2003 site </text>
<text top=""712"" left=""163"" width=""130"" height=""15"" font=""10"">visit to Patagonia.</text>
<footnote top=""711"" left=""293"" width=""14"" height=""9"" font=""17"" number=""470"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""593"" height=""15"" font=""10""> Facsimile from Theresa Boyle (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""993"" left=""108"" width=""567"" height=""15"" font=""10"">Inspection Service, USDA, APHIS, Area Director) to Dr. Jorge N. Amaya (SENASA, President) </ftext>
<ftext top=""1007"" left=""108"" width=""484"" height=""15"" font=""10"">(6 November 2003), (APHIS' facsimile of 6 November 2003), (Exhibit USA-99). </ftext>
</footnote>
<text top=""712"" left=""307"" width=""254"" height=""15"" font=""10""> APHIS also requested additional </text>
<text top=""727"" left=""163"" width=""391"" height=""15"" font=""10"">information from SENASA regarding the request for regional </text>
<footnote top=""740"" left=""391"" width=""14"" height=""9"" font=""17"" number=""471"" ref="""" dis=""""/>
</p><p><text top=""697"" left=""563"" width=""85"" height=""15"" font=""33"">6 Nov. 2003 </text></p><p><text top=""697"" left=""701"" width=""61"" height=""15"" font=""10"">2 months </text>
<footnote top=""763"" left=""135"" width=""419"" height=""15"" font=""10"" number=""3"" ref="""" dis=""""/>
<footnote top=""806"" left=""453"" width=""14"" height=""9"" font=""17"" number=""472"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""590"" height=""15"" font=""10""> Letter from W. Ron DeHaven (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""1095"" left=""108"" width=""666"" height=""15"" font=""10"">Inspection Service, USDA, APHIS) to Dr. Jorge Amaya (SENASA, President) (2 March 2004), (APHIS' letter of </ftext>
<ftext top=""1109"" left=""108"" width=""215"" height=""15"" font=""10"">2 March 2004), (Exhibit USA-102). </ftext>
</footnote>
</p><p><text top=""763"" left=""563"" width=""99"" height=""15"" font=""33"">1-5 Dec. 2003 </text><footnote top=""829"" left=""135"" width=""401"" height=""15"" font=""10"" number=""4"" ref="""" dis=""""/>
<footnote top=""872"" left=""427"" width=""14"" height=""9"" font=""17"" number=""473"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""307"" height=""15"" font=""10""> APHIS' letter of 2 March 2004 (Exhibit USA-102). </ftext>
</footnote>
</p><p><text top=""829"" left=""563"" width=""85"" height=""15"" font=""33"">2 Mar. 2004 </text></p><p><text top=""949"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 200. </text>
</p><p><text top=""1022"" left=""165"" width=""560"" height=""15"" font=""10""> United States first written submission, para. 151 (referring to Letter from W. Ron DeHaven </text>
</p><p><text top=""1066"" left=""108"" width=""124"" height=""15"" font=""10"">(Exhibit USA-100)). </text>
</p></page>
<page number=""80"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 80 - </text>
</p><p><text top=""139"" left=""116"" width=""27"" height=""15"" font=""29"">No. </text><text top=""139"" left=""336"" width=""42"" height=""15"" font=""29"">Event </text><text top=""139"" left=""608"" width=""36"" height=""15"" font=""29"">Date </text><text top=""132"" left=""716"" width=""58"" height=""15"" font=""29"">Interval </text><text top=""147"" left=""711"" width=""69"" height=""15"" font=""29"">(approx.) </text></p><p number=""5."" style=""6""><text top=""168"" left=""135"" width=""377"" height=""15"" font=""10"">5.   SENASA responded to the 2 March 2004 letter, providing </text>
<text top=""183"" left=""163"" width=""360"" height=""15"" font=""10"">additional information concerning Patagonia in response to </text>
<text top=""197"" left=""163"" width=""95"" height=""15"" font=""10"">APHIS' request.</text>
<footnote top=""197"" left=""258"" width=""14"" height=""9"" font=""17"" number=""474"" ref="""" dis=""""><ftext top=""832"" left=""165"" width=""596"" height=""15"" font=""10""> Further Information Requested by the United States Department of Agriculture, Animal and Plant </ftext>
<ftext top=""847"" left=""108"" width=""644"" height=""15"" font=""10"">Health Inspection Service (USDA, APHIS) of the Information Provided by SENASA to Attain Recognition of </ftext>
<ftext top=""861"" left=""108"" width=""642"" height=""15"" font=""10"">Patagonia as a Region, as Defined in Section 92.2, Title 9 of the Code of Federal Regulations for Foot and </ftext>
<ftext top=""876"" left=""108"" width=""664"" height=""15"" font=""10"">Mouth Disease (FMD) (November 2004), (Information on Patagonia Provided by SENASA (November 2004)), </ftext>
</footnote>
</p><p><text top=""168"" left=""563"" width=""94"" height=""15"" font=""33"">16 Nov. 2004 </text><footnote top=""168"" left=""701"" width=""61"" height=""15"" font=""10"" number=""8"" ref="""" dis=""""><ftext top=""321"" left=""242"" width=""318"" height=""15"" font=""10"">States Cattlemen's Association, the National </ftext>
<ftext top=""336"" left=""163"" width=""389"" height=""15"" font=""10"">Farmers Union, and American Agri-Women sent a letter to the </ftext>
</footnote>
<footnote top=""219"" left=""135"" width=""390"" height=""15"" font=""10"" number=""6"" ref="""" dis=""""/>
</p><p><text top=""234"" left=""163"" width=""249"" height=""15"" font=""10"">Patagonia South as a region free of FMD.</text>
<footnote top=""233"" left=""411"" width=""14"" height=""9"" font=""17"" number=""475"" ref="""" dis=""""><ftext top=""905"" left=""165"" width=""398"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 32.<b> </b> </ftext>
</footnote>
</p><p><text top=""219"" left=""563"" width=""70"" height=""15"" font=""33"">Jun. 2005 </text><footnote top=""219"" left=""701"" width=""61"" height=""15"" font=""10"" number=""7"" ref="""" dis=""""/>
<footnote top=""270"" left=""532"" width=""14"" height=""9"" font=""17"" number=""476"" ref="""" dis=""""><ftext top=""920"" left=""165"" width=""619"" height=""15"" font=""31"">Change in Disease Status of the Patagonia South Region of Argentina With Regard to Rinderpest and </ftext><ftext top=""934"" left=""108"" width=""635"" height=""15"" font=""12""><i>Food- and-Mouth Disease, </i>72 Fed. Reg. 475 (5 January 2007) (Proposed Rule), (2007 Proposed Rule on </ftext>
<ftext top=""949"" left=""108"" width=""283"" height=""15"" font=""10"">Patagonia South), (Exhibit ARG-56/USA-104). </ftext>
</footnote>
</p><p><text top=""285"" left=""163"" width=""390"" height=""15"" font=""10"">During the ensuing 60-day period, APHIS received comments </text>
<text top=""299"" left=""163"" width=""281"" height=""15"" font=""10"">on the proposed rule from interested parties.  </text>
</p><p><text top=""256"" left=""563"" width=""82"" height=""15"" font=""33"">5 Jan. 2007 </text></p><p number=""1.5"" style=""8""><text top=""256"" left=""701"" width=""61"" height=""15"" font=""10"">1.5 years </text>
<footnote top=""350"" left=""163"" width=""393"" height=""15"" font=""10"" number=""2007"" ref="""" dis=""""/>
</p><p><text top=""365"" left=""163"" width=""391"" height=""15"" font=""10"">proposed rule for Patagonia South, in which they called for </text>
<text top=""379"" left=""163"" width=""392"" height=""15"" font=""10"">further discussion on the matter before APHIS finalize the </text>
<text top=""394"" left=""163"" width=""50"" height=""15"" font=""10"">process.</text>
<footnote top=""393"" left=""213"" width=""14"" height=""9"" font=""17"" number=""477"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""618"" height=""15"" font=""10""> Letter dated 22 January 2008 from various legislators of the Agriculture Commission of the House of </ftext>
<ftext top=""978"" left=""108"" width=""633"" height=""15"" font=""10"">Representatives, requesting a hearing review into the proposed rule of the United States Department of </ftext>
<ftext top=""993"" left=""108"" width=""596"" height=""15"" font=""10"">Agriculture to recognize Patagonia as a region free of foot-and-mouth disease (22 January 2008), </ftext>
</footnote>
</p><p><text top=""321"" left=""563"" width=""91"" height=""15"" font=""33"">22 Jan. 2008 </text></p><p number=""9."" style=""6""><text top=""416"" left=""135"" width=""418"" height=""15"" font=""10"">9.   The Embassy of Argentina in Washington sent a letter to US </text>
<text top=""430"" left=""163"" width=""388"" height=""15"" font=""10"">Senator Jon Tester expressing the view that the Proposed Rule </text>
<text top=""445"" left=""163"" width=""388"" height=""15"" font=""10"">recognizing Patagonia South as FMD-free should be finalized so </text>
<text top=""460"" left=""163"" width=""388"" height=""15"" font=""10"">that commercial relations between the region of Argentina and </text>
<text top=""474"" left=""163"" width=""235"" height=""15"" font=""10"">the United States could be normalized.</text>
<footnote top=""474"" left=""398"" width=""14"" height=""9"" font=""17"" number=""478"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""587"" height=""15"" font=""10""> Letter from Minister Jos&#233; P&#233;rez Gabilondo to Senator Tester in response to his concern over the </ftext>
<ftext top=""1036"" left=""108"" width=""398"" height=""15"" font=""10"">access of beef from Argentina (7 March 2008), (Exhibit ARG-41). </ftext>
</footnote>
</p><p><text top=""416"" left=""563"" width=""85"" height=""15"" font=""33"">7 Mar. 2008 </text></p><p number=""1.5"" style=""8""><text top=""416"" left=""701"" width=""73"" height=""15"" font=""10"">1.5 months </text>
</p><p number=""10."" style=""6""><text top=""496"" left=""135"" width=""261"" height=""15"" font=""10"">10. SENASA introduced Resolution </text>
<text top=""496"" left=""381"" width=""184"" height=""15"" font=""10"">148/2008 to authorize </text>
<text top=""511"" left=""163"" width=""393"" height=""15"" font=""10"">transport of FMD-susceptible animals into Patagonia South </text>
<text top=""525"" left=""163"" width=""175"" height=""15"" font=""10"">from Patagonia North </text>
<text top=""525"" left=""324"" width=""240"" height=""15"" font=""10"">B under additional traceability </text>
<text top=""540"" left=""163"" width=""391"" height=""15"" font=""10"">requirements, in connection with EU regulations recognizing </text>
<text top=""554"" left=""163"" width=""390"" height=""15"" font=""10"">Patagonia South, but not yet Patagonia North B, as FMD-free </text>
<text top=""569"" left=""163"" width=""210"" height=""15"" font=""10"">where vaccination is not practised.</text>
<footnote top=""568"" left=""373"" width=""14"" height=""9"" font=""17"" number=""479"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""304"" height=""15"" font=""10""> Resoluci&#243;n SENASA 148/2008, (Exhibit USA-62). </ftext>
</footnote>
</p><p><text top=""496"" left=""563"" width=""93"" height=""15"" font=""33"">11 Mar. 2008 </text></p><p number=""11."" style=""6""><text top=""591"" left=""135"" width=""416"" height=""15"" font=""10"">11. Several US senators urged the Administration not to adopt the </text>
<text top=""605"" left=""163"" width=""390"" height=""15"" font=""10"">final rule for the recognition of Patagonia South as FMD-free </text>
<text top=""620"" left=""163"" width=""389"" height=""15"" font=""10"">until the rule has been reviewed by the Office of Management </text>
<text top=""634"" left=""163"" width=""74"" height=""15"" font=""10"">and Budget.</text>
<footnote top=""634"" left=""236"" width=""14"" height=""9"" font=""17"" number=""480"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""606"" height=""15"" font=""10""> Letter from Senator Baucus et al. to Edward Schafer, Secretary, US Department of Agriculture and </ftext>
<ftext top=""1080"" left=""108"" width=""649"" height=""15"" font=""10"">Jim Nussle, Director, Office of Management and Budget regarding proposed USDA rule on Patagonia South </ftext>
<ftext top=""1095"" left=""108"" width=""221"" height=""15"" font=""10"">(14 March 2008), (Exhibit ARG-40). </ftext>
</footnote>
</p><p><text top=""591"" left=""563"" width=""93"" height=""15"" font=""33"">14 Mar. 2008 </text></p><p number=""12."" style=""6""><text top=""656"" left=""135"" width=""418"" height=""15"" font=""10"">12. The Embassy of Argentina in Washington sent a letter to US </text>
<text top=""671"" left=""163"" width=""392"" height=""15"" font=""10"">Senator Max Baucus (insert what committee he chaired at </text>
<text top=""685"" left=""163"" width=""389"" height=""15"" font=""10"">time) expressing the view that the Proposed Rule recognizing </text>
<text top=""700"" left=""163"" width=""394"" height=""15"" font=""10"">Patagonia South as FMD-free should be finalized so that </text>
<text top=""715"" left=""163"" width=""389"" height=""15"" font=""10"">commercial relations between the region of Argentina and the </text>
<text top=""729"" left=""163"" width=""211"" height=""15"" font=""10"">United States could be normalized.</text>
<footnote top=""728"" left=""374"" width=""14"" height=""9"" font=""17"" number=""481"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""621"" height=""15"" font=""10""> Letter from Ambassador H&#233;ctor Timerman to Senator Baucus in response to his 14 March 2008 letter </ftext>
<ftext top=""1124"" left=""108"" width=""221"" height=""15"" font=""10"">(20 March 2008), (Exhibit ARG-42). </ftext>
</footnote>
</p><p><text top=""656"" left=""563"" width=""93"" height=""15"" font=""33"">20 Mar. 2008 </text></p><p><text top=""891"" left=""108"" width=""118"" height=""15"" font=""10"">(Exhibit USA-103). </text>
</p><p><text top=""1007"" left=""108"" width=""111"" height=""15"" font=""10"">(Exhibit ARG-39). </text>
</p></page>
<page number=""81"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 81 - </text>
</p><p><text top=""139"" left=""116"" width=""27"" height=""15"" font=""29"">No. </text><text top=""139"" left=""336"" width=""42"" height=""15"" font=""29"">Event </text><text top=""139"" left=""608"" width=""36"" height=""15"" font=""29"">Date </text><text top=""132"" left=""716"" width=""58"" height=""15"" font=""29"">Interval </text><text top=""147"" left=""711"" width=""69"" height=""15"" font=""29"">(approx.) </text></p><p number=""13."" style=""6""><text top=""168"" left=""135"" width=""417"" height=""15"" font=""10"">13. APHIS contacted SENASA with a view to fixing the agenda for </text>
<text top=""183"" left=""163"" width=""388"" height=""15"" font=""10"">a site visit by APHIS, aimed at updating the assessment of the </text>
<text top=""197"" left=""163"" width=""389"" height=""15"" font=""10"">risk for Patagonia South in order to respond to the comments </text>
<p><text top=""227"" left=""163"" width=""103"" height=""15"" font=""10"">Patagonia South.</text>
<footnote top=""226"" left=""266"" width=""14"" height=""9"" font=""17"" number=""482"" ref="""" dis=""""><ftext top=""905"" left=""165"" width=""563"" height=""15"" font=""10""> Letter from Yvette Perez (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""920"" left=""108"" width=""598"" height=""15"" font=""10"">Inspection Service, USDA, APHIS) to Oscar Astibia (SENASA) (15 October 2008), (APHIS' letter of </ftext>
<ftext top=""934"" left=""108"" width=""234"" height=""15"" font=""10"">15 October 2008), (Exhibit USA-106). </ftext>
</footnote>
</p></p><p><text top=""168"" left=""563"" width=""91"" height=""15"" font=""33"">15 Oct. 2008 </text></p><p number=""14."" style=""6""><text top=""248"" left=""135"" width=""416"" height=""15"" font=""10"">14. SENASA sent a letter to APHIS expressing displeasure with the </text>
<text top=""263"" left=""163"" width=""389"" height=""15"" font=""10"">duration of FMD assessment process and noting that, because </text>
<text top=""278"" left=""163"" width=""388"" height=""15"" font=""10"">the situation in Patagonia South had not changed, SENASA did </text>
<text top=""292"" left=""163"" width=""393"" height=""15"" font=""10"">not consider that there were sufficient grounds to accept </text>
<text top=""307"" left=""163"" width=""352"" height=""15"" font=""10"">APHIS' proposed visit schedule for 15-18 December 2008.</text>
<footnote top=""306"" left=""515"" width=""14"" height=""9"" font=""17"" number=""483"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""557"" height=""15"" font=""10""> Facsimile from Oscar Astibia (SENASA) to Yvette Perez (USDA, APHIS) (22 October 2008), </ftext>
<ftext top=""963"" left=""108"" width=""375"" height=""15"" font=""10"">(SENASA's facsimile of 22 October 2008), (Exhibit USA-107). </ftext>
</footnote>
</p><p><text top=""248"" left=""563"" width=""91"" height=""15"" font=""33"">22 Oct. 2008 </text></p><p number=""15."" style=""6""><text top=""329"" left=""135"" width=""403"" height=""15"" font=""10"">15. SENASA sent a new letter to APHIS reiterating its statements </text>
<text top=""343"" left=""163"" width=""122"" height=""15"" font=""10"">of 22 October 2008.</text>
<footnote top=""342"" left=""285"" width=""14"" height=""9"" font=""17"" number=""484"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""563"" height=""15"" font=""10""> Facsimile from Oscar Astibia, SENASA, to Yvette Perez, USDA, APHIS (11 November 2008), </ftext>
<ftext top=""993"" left=""108"" width=""394"" height=""15"" font=""10"">(SENASA's facsimile of 11 November 2008), (Exhibit USA-108).  </ftext>
</footnote>
</p><p><text top=""329"" left=""563"" width=""94"" height=""15"" font=""33"">11 Nov. 2008 </text><footnote top=""329"" left=""701"" width=""52"" height=""15"" font=""10"" number=""20"" ref="""" dis=""""><ftext top=""744"" left=""163"" width=""392"" height=""15"" font=""10"">information was currently required to proceed with APHIS' </ftext>
<ftext top=""758"" left=""163"" width=""77"" height=""15"" font=""10"">rule-making.</ftext>
</footnote>
</p><p number=""16."" style=""6""><text top=""365"" left=""135"" width=""416"" height=""15"" font=""10"">16. SENASA introduced Resolution 1282/2008 as a consequence of </text>
<text top=""379"" left=""163"" width=""390"" height=""15"" font=""10"">the EU's recognition of Patagonia North B as FMD-free where </text>
<text top=""394"" left=""163"" width=""395"" height=""15"" font=""10"">vaccination is not practised. The resolution allowed the </text>
<text top=""409"" left=""163"" width=""389"" height=""15"" font=""10"">movement of FMD-susceptible animals from Patagonia North B </text>
<text top=""423"" left=""163"" width=""389"" height=""15"" font=""10"">into Patagonia South for any purpose, subject to strengthened </text>
<text top=""438"" left=""163"" width=""389"" height=""15"" font=""10"">measures on transport and traceability. The Resolution did not </text>
<text top=""452"" left=""163"" width=""402"" height=""15"" font=""10"">modify the pre-existing requirements for entry of </text>
<text top=""467"" left=""163"" width=""389"" height=""15"" font=""10"">FMD-susceptible animals into the Patagonia region as a whole </text>
<text top=""482"" left=""163"" width=""233"" height=""15"" font=""10"">from FMD-free zones with vaccination.</text>
<footnote top=""481"" left=""396"" width=""14"" height=""9"" font=""17"" number=""485"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""320"" height=""15"" font=""10""> Resoluci&#243;n SENASA 1282/2008, (Exhibit USA-109). </ftext>
</footnote>
</p><p><text top=""365"" left=""563"" width=""93"" height=""15"" font=""33"">16 Dec. 2008 </text><footnote top=""365"" left=""701"" width=""61"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""/>
</p><p number=""17."" style=""6""><text top=""503"" left=""135"" width=""419"" height=""15"" font=""10"">17. SENASA also granted approval for APHIS to visit Patagonia </text>
<text top=""518"" left=""163"" width=""154"" height=""15"" font=""10"">South in February 2009.</text>
<footnote top=""517"" left=""316"" width=""14"" height=""9"" font=""17"" number=""486"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""414"" height=""15"" font=""10""> SENASA's letter of 17 December 2008, (Exhibit ARG-59/USA-111). </ftext>
</footnote>
<text top=""518"" left=""331"" width=""222"" height=""15"" font=""10""> In granting the site visit request, </text>
<text top=""533"" left=""163"" width=""392"" height=""15"" font=""10"">SENASA also requested that APHIS extend the mission to </text>
<text top=""547"" left=""163"" width=""389"" height=""15"" font=""10"">cover Patagonia North B because the zone was recognized by </text>
<text top=""562"" left=""163"" width=""393"" height=""15"" font=""10"">the OIE as a region free of FMD where vaccination is not </text>
<text top=""576"" left=""163"" width=""59"" height=""15"" font=""10"">practiced.</text>
<footnote top=""576"" left=""222"" width=""14"" height=""9"" font=""17"" number=""487"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""530"" height=""15"" font=""10""> SENASA's letter of 17 December 2008, (Exhibit ARG-59/USA-111); SENASA's letter of </ftext>
<ftext top=""1051"" left=""108"" width=""280"" height=""15"" font=""10"">30 January 2009, (Exhibit ARG-60/USA-112). </ftext>
</footnote>
<text top=""576"" left=""237"" width=""327"" height=""15"" font=""10""> For this purpose, SENASA updated the </text>
<text top=""591"" left=""163"" width=""392"" height=""15"" font=""10"">information concerning Patagonia with APHIS, including the </text>
<text top=""605"" left=""163"" width=""391"" height=""15"" font=""10"">data on Patagonia North B that had led to the international </text>
<text top=""620"" left=""163"" width=""390"" height=""15"" font=""10"">recognition of the zone as FMD-free where vaccination is not </text>
<text top=""635"" left=""163"" width=""59"" height=""15"" font=""10"">practised.</text>
<footnote top=""634"" left=""222"" width=""14"" height=""9"" font=""17"" number=""488"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""414"" height=""15"" font=""10""> SENASA's letter of 17 December 2008, (Exhibit ARG-59/USA-111). </ftext>
</footnote>
</p><p><text top=""503"" left=""563"" width=""93"" height=""15"" font=""33"">17 Dec. 2008 </text></p><p><text top=""503"" left=""701"" width=""38"" height=""15"" font=""10"">1 day </text>
</p><p number=""18."" style=""6""><text top=""656"" left=""135"" width=""407"" height=""15"" font=""10"">18. APHIS conducted a site visit to Patagonia, including Patagonia </text>
<text top=""671"" left=""163"" width=""180"" height=""15"" font=""10"">South and Patagonia North B.</text>
<footnote top=""670"" left=""343"" width=""17"" height=""9"" font=""17"" number=""489"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""404"" height=""15"" font=""10""> SENASA's letter of 30 January 2009, (Exhibit ARG-60/USA-112).  </ftext>
</footnote>
</p><p><text top=""656"" left=""563"" width=""115"" height=""15"" font=""33"">23-26 Feb. 2009 </text><footnote top=""707"" left=""186"" width=""14"" height=""9"" font=""17"" number=""490"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""552"" height=""15"" font=""10""> H.R. Res. 1226, 111th Cong. (2009); S. Res. 337, 111th Cong (2009), (Exhibit ARG-44). <b> </b></ftext>
</footnote>
</p><p><text top=""693"" left=""563"" width=""92"" height=""15"" font=""33"">26 Feb. 2009 </text></p><p><text top=""693"" left=""701"" width=""44"" height=""15"" font=""10"">0 days </text>
<footnote top=""758"" left=""240"" width=""14"" height=""9"" font=""17"" number=""491"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""604"" height=""15"" font=""10""> Letter from John R. Clifford, Deputy Administrator, Veterinary Services, APHIS to Jorge N. Amaya, </ftext>
<ftext top=""1124"" left=""108"" width=""529"" height=""15"" font=""10"">President, SENASA (27 April 2009), (APHIS' letter of 27 April 2009), (Exhibit ARG-79). </ftext>
<ftext top=""788"" left=""163"" width=""61"" height=""15"" font=""10"">reference.</ftext>
<ftext top=""824"" left=""163"" width=""391"" height=""15"" font=""10"">the Consultations on 28 November 2012 between Argentina </ftext>
<ftext top=""838"" left=""163"" width=""389"" height=""15"" font=""10"">and United States officials, including APHIS's desire to conduct </ftext>
<ftext top=""853"" left=""163"" width=""390"" height=""15"" font=""10"">a new site visit to Northern Argentina and Patagonia. APHIS </ftext>
<ftext top=""868"" left=""163"" width=""391"" height=""15"" font=""10"">formally requested permission from SENASA to conduct the </ftext>
<ftext top=""882"" left=""163"" width=""390"" height=""15"" font=""10"">site visit in order to progress with the review of Argentina's </ftext>
<ftext top=""897"" left=""163"" width=""50"" height=""15"" font=""10"">request.</ftext>
<ftext top=""809"" left=""701"" width=""73"" height=""15"" font=""10"">1.5 months </ftext>
</footnote>
</p><p><text top=""729"" left=""563"" width=""91"" height=""15"" font=""33"">27 Apr. 2009 </text></p><p><text top=""780"" left=""701"" width=""61"" height=""15"" font=""10"">5 months </text>
</p></page>
<page number=""82"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 82 - </text>
</p><p><text top=""139"" left=""116"" width=""27"" height=""15"" font=""29"">No. </text><text top=""139"" left=""336"" width=""42"" height=""15"" font=""29"">Event </text><text top=""139"" left=""608"" width=""36"" height=""15"" font=""29"">Date </text><text top=""132"" left=""716"" width=""58"" height=""15"" font=""29"">Interval </text><text top=""147"" left=""711"" width=""69"" height=""15"" font=""29"">(approx.) </text></p><p number=""22."" style=""6""><text top=""168"" left=""135"" width=""354"" height=""15"" font=""10"">22. SENASA sent APHIS a letter detailing the information </text>
<text top=""183"" left=""163"" width=""343"" height=""15"" font=""10"">exchange with regard to the recognition of Patagonia as </text>
<text top=""197"" left=""163"" width=""367"" height=""15"" font=""10"">FMD-free, highlighting its concerns over the fact that all the </text>
<text top=""212"" left=""163"" width=""378"" height=""15"" font=""10"">technical stages had been concluded on a scientific basis, and </text>
<text top=""227"" left=""163"" width=""326"" height=""15"" font=""10"">stating that there only remained to be completed the </text>
<text top=""241"" left=""163"" width=""332"" height=""15"" font=""10"">administrative procedures to secure the recognition of </text>
<text top=""256"" left=""163"" width=""64"" height=""15"" font=""10"">Patagonia.</text>
<footnote top=""255"" left=""227"" width=""14"" height=""9"" font=""17"" number=""492"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""621"" height=""15"" font=""10""> Letter from Jorge N. Amaya, President, SENASA to John R. Clifford, Deputy Administrator, Veterinary </ftext>
<ftext top=""963"" left=""108"" width=""660"" height=""15"" font=""10"">Services, APHIS, Note No. 149/2010 (19 July 2010), (SENASA's letter of 19 July 2010, Note No. 149/2010), </ftext>
<ftext top=""978"" left=""108"" width=""163"" height=""15"" font=""10"">(Exhibit ARG-61/USA-56). </ftext>
</footnote>
</p><p><text top=""168"" left=""563"" width=""87"" height=""15"" font=""33"">19 Jul. 2010 </text><footnote top=""168"" left=""701"" width=""69"" height=""15"" font=""10"" number=""10"" ref="""" dis=""""/>
</p><p number=""23."" style=""6""><text top=""278"" left=""135"" width=""416"" height=""15"" font=""10"">23. APHIS responded to SENASA's 19 July 2010 letter with respect </text>
<text top=""292"" left=""163"" width=""390"" height=""15"" font=""10"">to Argentina's application for the recognition of Patagonia as </text>
<text top=""307"" left=""163"" width=""390"" height=""15"" font=""10"">FMD-free, stating that APHIS ""had made significant progress </text>
<text top=""321"" left=""163"" width=""399"" height=""15"" font=""10"">towards recognizing the FMD-free status of southern </text>
<text top=""336"" left=""163"" width=""390"" height=""15"" font=""10"">Patagonia"". APHIS further noted that because it needs to be </text>
<text top=""350"" left=""163"" width=""389"" height=""15"" font=""10"">thorough and transparent in its deliberations, the rule-making </text>
<text top=""365"" left=""163"" width=""148"" height=""15"" font=""10"">process could take time.</text>
<footnote top=""364"" left=""311"" width=""14"" height=""9"" font=""17"" number=""493"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""601"" height=""15"" font=""10""> Letter from John R. Clifford, Deputy Administrator, APHIS, to Jorge N. Amaya, President, SENASA </ftext>
<ftext top=""1007"" left=""108"" width=""625"" height=""15"" font=""10"">(13 September 2010), (APHIS' letter of 13 September 2010), (Exhibit ARG-62). APHIS' letter refers to </ftext>
<ftext top=""1022"" left=""108"" width=""667"" height=""15"" font=""10"">""southern Patagonia"". We note, however, that by this time Argentina's request covered both Patagonia South </ftext>
<ftext top=""1036"" left=""108"" width=""145"" height=""15"" font=""10"">and Patagonia North B. </ftext>
</footnote>
</p><p><text top=""278"" left=""563"" width=""93"" height=""15"" font=""33"">13 Sep. 2010 </text></p><p number=""24."" style=""6""><text top=""387"" left=""135"" width=""380"" height=""15"" font=""10"">24. Argentina presented a specific trade concern (STC) in the </text>
<text top=""402"" left=""163"" width=""379"" height=""15"" font=""10"">SPS Committee, expressing its concern that the United States </text>
<text top=""416"" left=""163"" width=""383"" height=""15"" font=""10"">failed to recognize Patagonia South as a FMD-free, despite the </text>
<text top=""431"" left=""163"" width=""335"" height=""15"" font=""10"">OIE recognition of Patagonia South as FMD-free where </text>
<text top=""445"" left=""163"" width=""243"" height=""15"" font=""10"">vaccination is not practised since 2002. </text>
<p><text top=""474"" left=""163"" width=""363"" height=""15"" font=""10"">The United States replied that APHIS ""had made significant </text>
<text top=""489"" left=""163"" width=""388"" height=""15"" font=""10"">progress in recognizing the FMD-free status of South Patagonia </text>
<text top=""504"" left=""163"" width=""352"" height=""15"" font=""10"">and that, in light of the information Argentina provided in </text>
<text top=""518"" left=""163"" width=""381"" height=""15"" font=""10"">2009, which was used to update the 2005 risk analysis, it was </text>
<text top=""533"" left=""163"" width=""365"" height=""15"" font=""10"">able to conclude that the import of ruminants and ruminant </text>
<text top=""547"" left=""163"" width=""336"" height=""15"" font=""10"">products from this region presented a negligible risk of </text>
<text top=""562"" left=""163"" width=""36"" height=""15"" font=""10"">FMD"".</text>
<footnote top=""561"" left=""199"" width=""14"" height=""9"" font=""17"" number=""494"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""288"" height=""15"" font=""10""> G/SPS/R/63, (Exhibit ARG-22), paras. 17-18.  </ftext>
</footnote>
</p></p><p><text top=""387"" left=""563"" width=""92"" height=""15"" font=""33"">30 Jun. 2011 </text><footnote top=""641"" left=""232"" width=""14"" height=""9"" font=""17"" number=""495"" ref="""" dis=""""><ftext top=""1066"" left=""167"" width=""279"" height=""15"" font=""10"">G/SPS/R/64, (Exhibit ARG-48), paras. 96-97. </ftext>
</footnote>
</p><p><text top=""584"" left=""563"" width=""91"" height=""15"" font=""33"">19 Oct. 2011 </text></p><p number=""3.5"" style=""8""><text top=""584"" left=""701"" width=""73"" height=""15"" font=""10"">3.5 months </text>
</p><p number=""26."" style=""6""><text top=""664"" left=""135"" width=""420"" height=""15"" font=""10"">26. Argentina requested consultations with the United States at </text>
<text top=""678"" left=""163"" width=""57"" height=""15"" font=""10"">the WTO.</text>
<footnote top=""678"" left=""220"" width=""14"" height=""9"" font=""17"" number=""496"" ref=""G/L/998/Corr.1 ; G/SPS/GEN/1186/Corr.1 ; WT/DS447/1/Corr.1|G/L/998 ; G/SPS/GEN/1186 ; WT/DS447/1"" dis=""""><ftext top=""1080"" left=""165"" width=""322"" height=""15"" font=""10""> Argentina's request for consultations, WT/DS447/1. </ftext>
</footnote>
</p><p><text top=""664"" left=""563"" width=""94"" height=""15"" font=""33"">30 Aug. 2012 </text></p><p number=""27."" style=""6""><text top=""700"" left=""135"" width=""417"" height=""15"" font=""10"">27. The United States and Argentina met in Washington DC in the </text>
<text top=""715"" left=""163"" width=""396"" height=""15"" font=""10"">framework of the Consultations being held pursuant to </text>
<footnote top=""729"" left=""163"" width=""133"" height=""15"" font=""10"" number=""4"" ref="""" dis=""""/>
</p><p><text top=""700"" left=""563"" width=""94"" height=""15"" font=""33"">28 Nov. 2012 </text><footnote top=""700"" left=""701"" width=""61"" height=""15"" font=""10"" number=""3"" ref="""" dis=""""/>
</p><p number=""28."" style=""6""><text top=""751"" left=""135"" width=""331"" height=""15"" font=""10"">28. Argentina requested the establishment of a panel.</text>
<footnote top=""750"" left=""466"" width=""14"" height=""9"" font=""17"" number=""497"" ref=""WT/DS447/2"" dis=""""><ftext top=""1095"" left=""165"" width=""414"" height=""15"" font=""10""> Argentina's request for the establishment of a panel, WT/DS447/2. </ftext>
</footnote>
</p><p><text top=""751"" left=""563"" width=""84"" height=""15"" font=""33"">6 Dec. 2012 </text></p><p><text top=""751"" left=""701"" width=""44"" height=""15"" font=""10"">8 days </text>
<text top=""773"" left=""135"" width=""423"" height=""15"" font=""10"">29. The DSB established the Panel with standard terms of </text>
<footnote top=""787"" left=""224"" width=""14"" height=""9"" font=""17"" number=""498"" ref="""" dis=""""/>
</p><p><text top=""773"" left=""563"" width=""91"" height=""15"" font=""33"">28 Jan. 2013 </text></p><p number=""30."" style=""6""><text top=""809"" left=""135"" width=""417"" height=""15"" font=""10"">30. APHIS wrote to SENASA summarizing the issues discussed in </text>
<footnote top=""896"" left=""213"" width=""14"" height=""9"" font=""17"" number=""499"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""311"" height=""15"" font=""10""> APHIS' letter of 13 March 2013, (Exhibit USA-96). </ftext>
</footnote>
</p><p><text top=""809"" left=""563"" width=""93"" height=""15"" font=""33"">13 Mar. 2013 </text></p><p><text top=""1109"" left=""165"" width=""286"" height=""15"" font=""10""> Argentina's first written submission, para. 21. </text>
</p></page>
<page number=""83"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 83 - </text>
</p><p><text top=""139"" left=""116"" width=""27"" height=""15"" font=""29"">No. </text><text top=""139"" left=""336"" width=""42"" height=""15"" font=""29"">Event </text><text top=""139"" left=""608"" width=""36"" height=""15"" font=""29"">Date </text><text top=""132"" left=""716"" width=""58"" height=""15"" font=""29"">Interval </text><text top=""147"" left=""711"" width=""69"" height=""15"" font=""29"">(approx.) </text></p><p number=""31."" style=""6""><text top=""168"" left=""135"" width=""426"" height=""15"" font=""10"">31. SENASA agreed to the visit proposed by APHIS on </text>
<text top=""183"" left=""163"" width=""395"" height=""15"" font=""10"">13 March 2013, but stated that the sanitary situation in </text>
<text top=""197"" left=""163"" width=""168"" height=""15"" font=""10"">Argentina had not changed.</text>
<footnote top=""197"" left=""331"" width=""14"" height=""9"" font=""17"" number=""500"" ref="""" dis=""""><ftext top=""920"" left=""165"" width=""317"" height=""15"" font=""10""> SENASA's letter of 13 July 2013, (Exhibit ARG-99). </ftext>
</footnote>
</p><p><text top=""168"" left=""563"" width=""79"" height=""15"" font=""33"">3 Jul. 2013 </text></p><p number=""3.5"" style=""8""><text top=""168"" left=""701"" width=""73"" height=""15"" font=""10"">3.5 months </text>
</p><p number=""32."" style=""6""><text top=""219"" left=""135"" width=""419"" height=""15"" font=""10"">32. APHIS replied to SENASA's 3 July 2013 letter stating that it </text>
<text top=""234"" left=""163"" width=""388"" height=""15"" font=""10"">was ready to schedule the agreed visit to Argentina as soon as </text>
<text top=""248"" left=""163"" width=""391"" height=""15"" font=""10"">possible. APHIS also stated its understanding that Argentina </text>
<text top=""263"" left=""163"" width=""394"" height=""15"" font=""10"">preferred that the site visit occur during the last week </text>
<footnote top=""278"" left=""163"" width=""288"" height=""15"" font=""10"" number=""2013"" ref="""" dis=""""/>
<footnote top=""277"" left=""451"" width=""14"" height=""9"" font=""17"" number=""501"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""299"" height=""15"" font=""10""> APHIS' letter of 15 July 2013, (Exhibit USA-97). </ftext>
</footnote>
</p><p><text top=""219"" left=""563"" width=""87"" height=""15"" font=""33"">15 Jul. 2013 </text></p><p number=""33."" style=""6""><text top=""299"" left=""135"" width=""335"" height=""15"" font=""10"">33. The Panel was composed by the Director-General. </text>
</p><p><text top=""299"" left=""563"" width=""85"" height=""15"" font=""33"">8 Aug. 2013 </text></p><p number=""34."" style=""6""><text top=""321"" left=""135"" width=""416"" height=""15"" font=""10"">34. APHIS visited Patagonia to conduct the site review with regard </text>
<text top=""336"" left=""163"" width=""270"" height=""15"" font=""10"">to the recognition of the region as FMD-free.</text>
<footnote top=""335"" left=""433"" width=""14"" height=""9"" font=""17"" number=""502"" ref="""" dis=""""/>
<footnote top=""321"" left=""563"" width=""82"" height=""15"" font=""33"" number=""1"" ref="""" dis=""""/><text top=""358"" left=""135"" width=""422"" height=""15"" font=""10"">35. APHIS published a Proposed Rule for recognition of the </text>
<text top=""372"" left=""163"" width=""396"" height=""15"" font=""10"">Patagonia region (comprising both Patagonia South and </text>
<text top=""387"" left=""163"" width=""390"" height=""15"" font=""10"">Patagonia North B) as FMD-free, pursuant to an updated risk </text>
<footnote top=""401"" left=""163"" width=""243"" height=""15"" font=""10"" number=""2014"" ref="""" dis=""""/>
<footnote top=""401"" left=""406"" width=""14"" height=""9"" font=""17"" number=""503"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""622"" height=""15"" font=""31"">Notice of Availability of Evaluations of the Foot-and-Mouth Disease and Rinderpest Status of a Region </ftext><ftext top=""978"" left=""108"" width=""623"" height=""15"" font=""12""><i>of Patagonia, Argentina</i>, 79 Fed. Reg. 3775 (23 January 2014) (Notice of availability), (2014 Notice of </ftext>
<ftext top=""993"" left=""108"" width=""588"" height=""15"" font=""10"">Availability of Risk Analysis for Patagonia), (Exhibit USA-132); 2014 Risk Analysis for Patagonia, </ftext>
</footnote>
</p><p><text top=""358"" left=""563"" width=""117"" height=""15"" font=""33"">23 January 2014 </text><footnote top=""358"" left=""701"" width=""61"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""><ftext top=""611"" left=""108"" width=""394"" height=""16"" font=""28"">7.3.3.5.4.1  Whether the procedure incurred delays </ftext><ftext top=""646"" left=""108"" width=""686"" height=""16"" font=""0"">7.147.  Consistent with our approach in paragraph 7.121 above, we begin our assessment of </ftext>
<ftext top=""662"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina's claim under Article 8 and Annex C(1)(a) with a determination of whether APHIS' </ftext>
<ftext top=""679"" left=""108"" width=""684"" height=""16"" font=""0"">review of Argentina's request for the recognition of Patagonia as FMD-free incurred delays. We </ftext>
<ftext top=""695"" left=""108"" width=""684"" height=""16"" font=""0"">recall that a delay is a period of time lost by inaction or inability to proceed on the part of the </ftext>
<ftext top=""711"" left=""108"" width=""253"" height=""16"" font=""0"">authority carrying out the procedure.</ftext>
</footnote>
</p><p number=""36."" style=""6""><text top=""423"" left=""135"" width=""402"" height=""15"" font=""10"">36. The Panel held the first substantive meeting with the parties. </text>
</p><p><text top=""423"" left=""563"" width=""114"" height=""15"" font=""33"">28-29 Jan. 2014 </text></p><p><text top=""423"" left=""701"" width=""44"" height=""15"" font=""10"">5 days </text>
<text top=""445"" left=""135"" width=""428"" height=""15"" font=""10"">37. APHIS published a Final Rule recognizing Patagonia </text>
<text top=""459"" left=""163"" width=""390"" height=""15"" font=""10"">(comprising both Patagonia South and Patagonia North B) as </text>
<text top=""474"" left=""163"" width=""283"" height=""15"" font=""10"">FMD-free within the meaning of 9 CFR 94.1(a)</text>
<footnote top=""473"" left=""446"" width=""14"" height=""9"" font=""17"" number=""504"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""570"" height=""15"" font=""31"">Notice of Determination of the Foot-and-Mouth Disease and Rinderpest Status of a Region of </ftext><ftext top=""1036"" left=""108"" width=""634"" height=""15"" font=""12""><i>Patagonia, Argentina</i>, 79 Fed. Reg. 51528 (29 August 2914) (Notice), (2014 Notice of Determination on </ftext>
</footnote>
<text top=""474"" left=""460"" width=""91"" height=""15"" font=""10"">, entering into </text>
<text top=""489"" left=""163"" width=""195"" height=""15"" font=""10"">force as from 28 October 2014. </text>
</p><p><text top=""445"" left=""563"" width=""94"" height=""15"" font=""33"">29 Aug. 2014 </text></p><p><text top=""445"" left=""701"" width=""61"" height=""15"" font=""10"">7 months </text>
</p><p number=""38."" style=""6""><text top=""510"" left=""135"" width=""416"" height=""15"" font=""10"">38. The Panel held the meeting with the parties and the experts on </text>
<text top=""525"" left=""163"" width=""391"" height=""15"" font=""10"">2 September 2014 and the second substantive meeting with </text>
<text top=""540"" left=""163"" width=""223"" height=""15"" font=""10"">the parties on 4-5 September 2014. </text>
<text top=""561"" left=""135"" width=""416"" height=""15"" font=""10"">39. APHIS' Final Rule recognizing Patagonia as FMD-free within the </text>
<text top=""576"" left=""163"" width=""278"" height=""15"" font=""10"">meaning of 9 CFR 94.1(a) entered into force. </text>
</p><p><text top=""561"" left=""563"" width=""91"" height=""15"" font=""33"">28 Oct. 2014 </text><footnote top=""710"" left=""361"" width=""17"" height=""11"" font=""16"" number=""505"" ref=""WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1"" dis=""DS292|DS291|DS293""><ftext top=""1066"" left=""165"" width=""596"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1495. See also Appellate </ftext>
</footnote>
</p><p number=""7.148"" style=""8""><text top=""746"" left=""108"" width=""687"" height=""16"" font=""0"">7.148.  At the outset, we note that Argentina's request for the recognition of Patagonia as </text>
<text top=""762"" left=""108"" width=""683"" height=""16"" font=""0"">FMD-free was filed in two distinct steps. In August 2003, Argentina filed a request for recognition </text>
<text top=""779"" left=""108"" width=""637"" height=""16"" font=""0"">limited to Patagonia South (the area of Patagonia located south of the 42nd parallel).</text>
<footnote top=""777"" left=""744"" width=""17"" height=""11"" font=""16"" number=""506"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""396"" height=""15"" font=""10""> Information Provided by SENASA (July 2003), (Exhibit USA-98). </ftext>
</footnote>
<text top=""779"" left=""762"" width=""32"" height=""16"" font=""0""> In </text>
<text top=""795"" left=""108"" width=""682"" height=""16"" font=""0"">December 2008, Argentina extended the scope of its original request to encompass the recognition </text>
<text top=""811"" left=""108"" width=""637"" height=""16"" font=""0"">of Patagonia North B (the area of Patagonia between the 42nd parallel and the Rio Negro).</text>
<footnote top=""810"" left=""745"" width=""17"" height=""11"" font=""16"" number=""507"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""530"" height=""15"" font=""10""> SENASA's letter of 17 December 2008, (Exhibit ARG-59/USA-111); SENASA's letter of </ftext>
<ftext top=""1124"" left=""108"" width=""280"" height=""15"" font=""10"">30 January 2009, (Exhibit ARG-60/USA-112). </ftext>
</footnote>
<text top=""811"" left=""763"" width=""28"" height=""16"" font=""0""> As </text>
<text top=""828"" left=""108"" width=""687"" height=""16"" font=""0"">discussed in further detail below, the two-step nature of Argentina's request is relevant in </text>
<text top=""844"" left=""108"" width=""592"" height=""16"" font=""0"">assessing whether and to what extent APHIS' review thereof incurred an undue delay. </text>
<p><text top=""949"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 162. </text>
</p><p><text top=""1007"" left=""108"" width=""118"" height=""15"" font=""10"">(Exhibit USA-133). </text>
</p><p><text top=""1051"" left=""108"" width=""192"" height=""15"" font=""10"">Patagonia), (Exhibit USA-167). </text>
</p><p><text top=""1080"" left=""108"" width=""267"" height=""15"" font=""10"">Body Report, <i>Australia &#8211; Apples</i>, para. 437. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 84 - </text>
</p></p></page>
<page number=""84"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.149"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.149.  The United States asserts, and Argentina does not disagree, that APHIS began its review </text>
<text top=""144"" left=""108"" width=""690"" height=""16"" font=""0"">process promptly upon receiving Argentina's request for recognition of Patagonia South </text>
<text top=""160"" left=""108"" width=""108"" height=""16"" font=""0"">in August 2003.</text>
<footnote top=""159"" left=""216"" width=""17"" height=""11"" font=""16"" number=""508"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""622"" height=""15"" font=""10""> See United States' first written submission, para. 208; Argentina's response to Panel question No. 68 </ftext>
<ftext top=""949"" left=""108"" width=""241"" height=""15"" font=""10"">following the first substantive meeting. </ftext>
</footnote>
<text top=""160"" left=""233"" width=""558"" height=""16"" font=""0""> Indeed, APHIS and SENASA had a meeting on Argentina's request two months </text>
<text top=""177"" left=""108"" width=""688"" height=""16"" font=""0"">after it was filed. At that meeting, APHIS requested additional information from SENASA </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">concerning the FMD situation in Patagonia South and requested to make a visit to the region to be </text>
<text top=""210"" left=""108"" width=""250"" height=""16"" font=""0"">conducted in December of that year.</text>
<footnote top=""208"" left=""357"" width=""17"" height=""11"" font=""16"" number=""509"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""587"" height=""15"" font=""10""> APHIS' facsimile of 6 November 2003, (Exhibit USA-99); United States first written submission, </ftext>
<ftext top=""978"" left=""108"" width=""479"" height=""15"" font=""10"">para. 151 (referring to APHIS' letter of 6 November 2003, (Exhibit USA-100)). </ftext>
</footnote>
</p><p number=""7.150"" style=""8""><text top=""244"" left=""108"" width=""689"" height=""16"" font=""0"">7.150.  Throughout  the  period August 2003-November 2004, exchanges took place between </text>
<text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">APHIS and SENASA. As agreed by the two agencies, APHIS conducted its site visit to Patagonia </text>
<text top=""277"" left=""108"" width=""686"" height=""16"" font=""0"">South and Patagonia North A and B together with the Canadian Food Inspection Agency in </text>
<text top=""293"" left=""108"" width=""116"" height=""16"" font=""0"">December 2003.</text>
<footnote top=""292"" left=""224"" width=""17"" height=""11"" font=""16"" number=""510"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""311"" height=""15"" font=""10""> APHIS' letter of 2 March 2004, (Exhibit USA-102). </ftext>
</footnote>
<text top=""293"" left=""242"" width=""552"" height=""16"" font=""0""> Three months later, in March 2004, APHIS requested that SENASA provide </text>
<text top=""310"" left=""108"" width=""597"" height=""16"" font=""0"">additional information in order to progress on the risk analysis for Patagonia South.</text>
<footnote top=""308"" left=""705"" width=""17"" height=""11"" font=""16"" number=""511"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""311"" height=""15"" font=""10""> APHIS' letter of 2 March 2004, (Exhibit USA-102). </ftext>
</footnote>
<text top=""310"" left=""723"" width=""70"" height=""16"" font=""0""> SENASA </text>
<text top=""326"" left=""108"" width=""689"" height=""16"" font=""0"">took approximately eight months, i.e. until 16 November 2004, to provide the additional </text>
<text top=""342"" left=""108"" width=""216"" height=""16"" font=""0"">information APHIS requested.</text>
<footnote top=""341"" left=""324"" width=""17"" height=""11"" font=""16"" number=""512"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""525"" height=""15"" font=""10""> Information on Patagonia Provided by SENASA (November 2004), (Exhibit USA-103). </ftext>
</footnote>
<text top=""342"" left=""341"" width=""455"" height=""16"" font=""0""> In June 2005, i.e. approximately six months after SENASA </text>
<text top=""359"" left=""108"" width=""687"" height=""16"" font=""0"">submitted the additional information, APHIS published a risk analysis for Patagonia South, </text>
<text top=""375"" left=""108"" width=""688"" height=""16"" font=""0"">concluding that imports of FMD-susceptible animals and animal products from the region </text>
<text top=""392"" left=""108"" width=""464"" height=""16"" font=""0"">presented a ""low"" risk of introduction of FMD into the United States.</text>
<footnote top=""390"" left=""572"" width=""17"" height=""11"" font=""16"" number=""513"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 76-77. </ftext>
</footnote>
</p><p number=""7.151"" style=""8""><text top=""426"" left=""108"" width=""687"" height=""16"" font=""0"">7.151.  Argentina claims that the two-year period between the filing of its request and the </text>
<text top=""443"" left=""108"" width=""682"" height=""16"" font=""0"">publication of the risk analysis for Patagonia South (2003-2005) constitutes an undue delay on the </text>
<text top=""459"" left=""108"" width=""178"" height=""16"" font=""0"">part of the United States.</text>
<footnote top=""457"" left=""286"" width=""17"" height=""11"" font=""16"" number=""514"" ref="""" dis=""""/>
<text top=""459"" left=""304"" width=""488"" height=""16"" font=""0""> However, the evidence on the record demonstrates that throughout </text>
<text top=""475"" left=""108"" width=""683"" height=""16"" font=""0"">that period APHIS had requested additional information from SENASA, analysed that information, </text>
<text top=""492"" left=""108"" width=""684"" height=""16"" font=""0"">and conducted a site visit to Patagonia. Based on the evidence, there was a period of inaction </text>
<text top=""508"" left=""108"" width=""686"" height=""16"" font=""0"">between March and November 2004 while APHIS was awaiting SENASA's response to APHIS' </text>
<text top=""525"" left=""108"" width=""249"" height=""16"" font=""0"">request for additional information.</text>
<footnote top=""523"" left=""357"" width=""17"" height=""11"" font=""16"" number=""515"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""525"" height=""15"" font=""10""> Information on Patagonia Provided by SENASA (November 2004), (Exhibit USA-103). </ftext>
</footnote>
<text top=""525"" left=""374"" width=""421"" height=""16"" font=""0""> Therefore, we disagree with Argentina that the whole </text>
<text top=""541"" left=""108"" width=""684"" height=""16"" font=""0"">2003-2005 period constitutes a delay. In our view, the only delay in the procedure during the </text>
<text top=""557"" left=""108"" width=""535"" height=""16"" font=""0"">period 2003-2005 was the eight months between March and November 2004. </text>
</p><p number=""7.152"" style=""8""><text top=""592"" left=""108"" width=""685"" height=""16"" font=""0"">7.152.  The evidence on the record does not show any further exchanges between APHIS and </text>
<text top=""608"" left=""108"" width=""686"" height=""16"" font=""0"">SENASA from the publication of the June 2005 risk analysis for Patagonia South and APHIS' </text>
<text top=""625"" left=""108"" width=""682"" height=""16"" font=""0"">publication in January 2007 of a Proposed Rule to change the disease status of Patagonia South to </text>
<text top=""641"" left=""108"" width=""347"" height=""16"" font=""0"">FMD-free and as a consequence to permit imports.</text>
<footnote top=""639"" left=""455"" width=""17"" height=""11"" font=""16"" number=""516"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""426"" height=""15"" font=""10""> 2007 Proposed Rule on Patagonia South, (Exhibit ARG-56/USA-104). </ftext>
</footnote>
<text top=""641"" left=""472"" width=""318"" height=""16"" font=""0""> In Argentina's view, this one-and-a-half-year </text>
<text top=""657"" left=""108"" width=""660"" height=""16"" font=""0"">period of inactivity on APHIS' part constitutes a further undue delay in the approval procedure.</text>
<footnote top=""656"" left=""768"" width=""17"" height=""11"" font=""16"" number=""517"" ref="""" dis=""""/>
<text top=""674"" left=""108"" width=""683"" height=""16"" font=""0"">The United States claims that this was not a period of inactivity or inability to proceed, but rather </text>
<text top=""690"" left=""108"" width=""682"" height=""16"" font=""0"">during this period APHIS was taking steps to comply with the procedural obligations established in </text>
<text top=""707"" left=""108"" width=""633"" height=""16"" font=""0"">the Regulatory Flexibility Act, Executive Order No. 12988, and the Paperwork Reduction Act.</text>
<footnote top=""705"" left=""741"" width=""17"" height=""11"" font=""16"" number=""518"" ref="""" dis=""""/>
<text top=""707"" left=""759"" width=""31"" height=""16"" font=""0""> We </text>
<text top=""723"" left=""108"" width=""683"" height=""16"" font=""0"">do not discount that compliance with domestic legal obligations, such as the ones referenced by </text>
<text top=""739"" left=""108"" width=""685"" height=""16"" font=""0"">the United States, can be part of an ordinary or expected time-period to conduct an approval </text>
<text top=""756"" left=""108"" width=""687"" height=""16"" font=""0"">procedure. However, the United States did not submit the above-mentioned domestic legal </text>
<text top=""772"" left=""108"" width=""683"" height=""16"" font=""0"">instruments as evidence in these proceedings. Nor did the United States provide any evidence of </text>
<text top=""789"" left=""108"" width=""688"" height=""16"" font=""0"">specific actions APHIS took to comply with the aforementioned domestic legal obligations </text>
<text top=""805"" left=""108"" width=""684"" height=""16"" font=""0"">between June 2005  and  January 2007.  Therefore,  in the absence of such evidence we can only </text>
<text top=""821"" left=""108"" width=""683"" height=""16"" font=""0"">conclude that there was inaction on the part of APHIS from June 2005 to January 2007 and hence </text>
<text top=""838"" left=""108"" width=""239"" height=""16"" font=""0"">a delay in the approval procedure. </text>
</p><p number=""7.153"" style=""8""><text top=""872"" left=""108"" width=""688"" height=""16"" font=""0"">7.153.  The January 2007 Proposed Rule for Patagonia South provided for a 60-day period </text>
<text top=""889"" left=""108"" width=""568"" height=""16"" font=""0"">(i.e. until 6 March 2007) for comments to be submitted by interested parties.</text>
<footnote top=""887"" left=""676"" width=""17"" height=""11"" font=""16"" number=""519"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""426"" height=""15"" font=""10""> 2007 Proposed Rule on Patagonia South, (Exhibit ARG-56/USA-104). </ftext>
</footnote>
<text top=""889"" left=""694"" width=""101"" height=""16"" font=""0""> During that </text>
<footnote top=""1051"" left=""165"" width=""528"" height=""15"" font=""10"" number=""68"" ref="""" dis=""""/>
<p><text top=""1109"" left=""165"" width=""549"" height=""15"" font=""10""> United States' response to Panel question No. 61 following the first substantive meeting.  </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 85 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">period, APHIS received a total of 45 comments from the United States and the Argentine industries </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">as well as from private citizens. Some of the comments expressed concerns as to whether </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina was able to prevent and control FMD in Patagonia South and, therefore, about the risks </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">to United States' livestock from allowing the importation of FMD-susceptible animals and products </text>
<text top=""193"" left=""108"" width=""165"" height=""16"" font=""0"">thereof from the region.</text>
<footnote top=""192"" left=""273"" width=""17"" height=""11"" font=""16"" number=""520"" ref="""" dis=""""/>
<text top=""193"" left=""291"" width=""500"" height=""16"" font=""0""> APHIS never finalized the approval for Patagonia South. Rather, almost </text>
<text top=""210"" left=""108"" width=""686"" height=""16"" font=""0"">two years after the publication of the 2007 Proposed Rule, in October 2008 APHIS contacted </text>
<text top=""226"" left=""108"" width=""385"" height=""16"" font=""0"">SENASA requesting a new site visit to Patagonia South.</text>
<footnote top=""227"" left=""492"" width=""14"" height=""9"" font=""17"" number=""521"" ref="""" dis=""""><ftext top=""847"" left=""165"" width=""330"" height=""15"" font=""10""> APHIS' letter of 15 October 2008, (Exhibit USA-106). </ftext>
</footnote>
<text top=""226"" left=""507"" width=""284"" height=""16"" font=""0""> The United States argues that the need </text>
<text top=""242"" left=""108"" width=""426"" height=""16"" font=""0"">for a new site visit was in response to the comments received.</text>
<footnote top=""241"" left=""534"" width=""17"" height=""11"" font=""16"" number=""522"" ref="""" dis=""""/>
</p></p></page>
<page number=""85"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.154"" style=""8""><text top=""277"" left=""108"" width=""686"" height=""16"" font=""0"">7.154.  In our view, it is reasonable to expect that APHIS would need time to address the </text>
<text top=""293"" left=""108"" width=""686"" height=""16"" font=""0"">comments expressed during the 60-day period following the publication of the January 2007 </text>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">Proposed Rule. However, we are not persuaded that responding to such comments would require </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">over one and a half years (i.e. from March 2007 to October 2008). We recall that APHIS' reviews </text>
<text top=""342"" left=""108"" width=""685"" height=""16"" font=""0"">are case-specific and that there is no one particular time-frame in which comments must be </text>
<text top=""359"" left=""108"" width=""686"" height=""16"" font=""0"">analysed and acted upon. The time necessary will depend on the amount and nature of the </text>
<text top=""375"" left=""108"" width=""685"" height=""16"" font=""0"">comments. However, we note that during the course of these proceedings, APHIS published a </text>
<text top=""392"" left=""108"" width=""682"" height=""16"" font=""0"">Notice of availability of the evaluations of the FMD status of Patagonia (comprising both Patagonia </text>
<text top=""408"" left=""108"" width=""359"" height=""16"" font=""0"">South and Patagonia North B) in late January 2014.</text>
<footnote top=""407"" left=""467"" width=""17"" height=""11"" font=""16"" number=""523"" ref="""" dis=""""><ftext top=""876"" left=""165"" width=""472"" height=""15"" font=""10""> 2014 Notice of Availability of Risk Analysis for Patagonia, (Exhibit USA-132). </ftext>
</footnote>
<text top=""408"" left=""484"" width=""307"" height=""16"" font=""0""> The period for interested parties to submit </text>
<text top=""425"" left=""108"" width=""401"" height=""16"" font=""0"">comments on that document expired on 24 March 2014.</text>
<footnote top=""423"" left=""509"" width=""17"" height=""11"" font=""16"" number=""524"" ref="""" dis=""""><ftext top=""891"" left=""165"" width=""527"" height=""15"" font=""10""> 2014 Notice of Availability of Risk Analysis for Patagonia, (Exhibit USA-132), p. 3775. </ftext>
</footnote>
<text top=""425"" left=""526"" width=""267"" height=""16"" font=""0""> APHIS addressed the 33 comments </text>
<text top=""441"" left=""108"" width=""683"" height=""16"" font=""0"">received and issued a final Notice of determination on Patagonia on 29 August 2014, that is, five </text>
<text top=""457"" left=""108"" width=""375"" height=""16"" font=""0"">months after the expiration of the comment period.</text>
<footnote top=""456"" left=""483"" width=""17"" height=""11"" font=""16"" number=""525"" ref="""" dis=""""><ftext top=""905"" left=""165"" width=""392"" height=""15"" font=""10""> 2014 Notice of Determination on Patagonia, (Exhibit USA-167). </ftext>
</footnote>
<text top=""457"" left=""500"" width=""293"" height=""16"" font=""0""> Further, in its approval processes with </text>
<text top=""474"" left=""108"" width=""685"" height=""16"" font=""0"">respect to Uruguay, Santa Catarina and Japan, it took APHIS between four and 13 months to </text>
<text top=""490"" left=""108"" width=""502"" height=""16"" font=""0"">address comments on its proposed rule and issue a final determination.</text>
<footnote top=""489"" left=""610"" width=""17"" height=""11"" font=""16"" number=""526"" ref="""" dis=""""/>
<text top=""490"" left=""627"" width=""164"" height=""16"" font=""0""> The finalization of the </text>
<text top=""507"" left=""108"" width=""483"" height=""16"" font=""0"">proposed rule for the United Kingdom took approximately 28 months.</text>
<footnote top=""505"" left=""590"" width=""17"" height=""11"" font=""16"" number=""527"" ref="""" dis=""""/>
<text top=""507"" left=""608"" width=""183"" height=""16"" font=""0""> We recognize that we do </text>
<text top=""523"" left=""108"" width=""686"" height=""16"" font=""0"">not have the information on the specific circumstances that led to the varying times in the </text>
<text top=""539"" left=""108"" width=""684"" height=""16"" font=""0"">above-mentioned procedures. While not dispositive, they do indicate that, generally, a period of </text>
<text top=""556"" left=""108"" width=""406"" height=""16"" font=""0"">over one and a half years is neither ordinary nor expected.</text>
<footnote top=""554"" left=""514"" width=""17"" height=""11"" font=""16"" number=""528"" ref="""" dis=""""/>
<text top=""556"" left=""531"" width=""259"" height=""16"" font=""0""> Moreover, the United States has not </text>
<text top=""572"" left=""108"" width=""682"" height=""16"" font=""0"">provided evidence as to what, if anything, APHIS was doing with respect to Argentina's application </text>
<text top=""589"" left=""108"" width=""682"" height=""16"" font=""0"">during this time-period. In light of the above, we conclude that there was a delay in the procedure </text>
<text top=""605"" left=""108"" width=""689"" height=""16"" font=""0"">between the end of the comment period (6 March 2007) until APHIS wrote to SENASA </text>
<text top=""621"" left=""108"" width=""124"" height=""16"" font=""0"">in October 2008.  </text>
</p><p number=""7.155"" style=""8""><text top=""656"" left=""108"" width=""682"" height=""16"" font=""0"">7.155.  In December 2008, two months after APHIS requested a new site visit to Patagonia South, </text>
<text top=""672"" left=""108"" width=""275"" height=""16"" font=""0"">SENASA granted approval for the visit.</text>
<footnote top=""671"" left=""383"" width=""17"" height=""11"" font=""16"" number=""529"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""414"" height=""15"" font=""10""> SENASA's letter of 17 December 2008, (Exhibit ARG-59/USA-111). </ftext>
</footnote>
<text top=""672"" left=""400"" width=""392"" height=""16"" font=""0""> At the same time, Argentina extended its request for </text>
<text top=""689"" left=""108"" width=""687"" height=""16"" font=""0"">recognition to Patagonia North B. In making its request, Argentina noted that the OIE had </text>
<text top=""705"" left=""108"" width=""537"" height=""16"" font=""0"">recognized Patagonia North B as FMD-free where vaccination is not practised.</text>
<footnote top=""703"" left=""645"" width=""17"" height=""11"" font=""16"" number=""530"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""615"" height=""15"" font=""10""> SENASA's letter of 17 December 2008, (Exhibit ARG-59/USA-111) and Letter from Mr Oscar Astibia, </ftext>
<ftext top=""1080"" left=""108"" width=""653"" height=""15"" font=""10"">Coordinator of International and Institutional Relations, SENASA, to Ms Yvette P&#233;rez, USDA/APHIS, Buenos </ftext>
<ftext top=""1095"" left=""108"" width=""370"" height=""15"" font=""10"">Aires, URI No. 460/09 (30 January 2009), (Exhibit ARG-60). </ftext>
</footnote>
<text top=""705"" left=""662"" width=""129"" height=""16"" font=""0""> APHIS conducted </text>
<text top=""721"" left=""108"" width=""683"" height=""16"" font=""0"">the site visit to Patagonia as a whole (comprising both Patagonia South and Patagonia North B) in </text>
<text top=""738"" left=""108"" width=""107"" height=""16"" font=""0"">February 2009.</text>
<footnote top=""736"" left=""215"" width=""17"" height=""11"" font=""16"" number=""531"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""400"" height=""15"" font=""10""> SENASA's letter of 30 January 2009, (Exhibit ARG-60/USA-112). </ftext>
</footnote>
<text top=""738"" left=""232"" width=""560"" height=""16"" font=""0""> On 27 April 2009, APHIS sent a letter to SENASA stating that no additional </text>
<text top=""754"" left=""108"" width=""541"" height=""16"" font=""0"">information was ""currently required to proceed with APHIS' rulemaking"".</text>
<footnote top=""753"" left=""648"" width=""17"" height=""11"" font=""16"" number=""532"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""303"" height=""15"" font=""10""> APHIS' letter of 27 April 2009, (Exhibit ARG-79). </ftext>
<ftext top=""1036"" left=""108"" width=""626"" height=""15"" font=""10"">served as a formal written request to schedule the previously discussed site visit. (See APHIS' letter of </ftext>
<ftext top=""1051"" left=""108"" width=""211"" height=""15"" font=""10"">13 March 2013, (Exhibit USA-96)) </ftext>
</footnote>
<text top=""754"" left=""666"" width=""130"" height=""16"" font=""0""> The letter also </text>
<p><text top=""818"" left=""165"" width=""572"" height=""15"" font=""10""> See United States' response to Panel question No. 63 following the first substantive meeting, </text>
<text top=""832"" left=""108"" width=""67"" height=""15"" font=""10"">para. 263. </text>
</p><p><text top=""861"" left=""165"" width=""594"" height=""15"" font=""10""> See United States' response to Panel question No. 33 following the second substantive meeting.  </text>
<footnote top=""920"" left=""165"" width=""594"" height=""15"" font=""10"" number=""36"" ref="""" dis=""""/>
<footnote top=""949"" left=""165"" width=""612"" height=""15"" font=""10"" number=""2014"" ref="""" dis=""""><ftext top=""1036"" left=""108"" width=""531"" height=""15"" font=""10"">respect to the sanitary conditions in Patagonia prior to the establishment of the Panel.  </ftext>
</footnote>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 86 - </text>
</p><p><text top=""128"" left=""108"" width=""444"" height=""16"" font=""0"">established contact points for further discussions ""if necessary"".</text>
<footnote top=""126"" left=""552"" width=""17"" height=""11"" font=""16"" number=""533"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""303"" height=""15"" font=""10""> APHIS' letter of 27 April 2009, (Exhibit ARG-79). </ftext>
</footnote>
<text top=""128"" left=""569"" width=""222"" height=""16"" font=""0""> However, APHIS did not make </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">any requests for additional information of SENASA concerning the FMD situation in Patagonia for </text>
<text top=""160"" left=""108"" width=""149"" height=""16"" font=""0"">another three years.  </text>
</p></p></page>
<page number=""86"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.156"" style=""8""><text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">7.156.  After Argentina inquired into the status of the approval process in July 2010, APHIS sent </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">SENASA a letter dated 13 September 2010 in which it stated that ""APHIS had made significant </text>
<text top=""228"" left=""108"" width=""528"" height=""16"" font=""0"">progress towards recognizing the FMD-free status of southern Patagonia"".</text>
<footnote top=""226"" left=""636"" width=""17"" height=""11"" font=""16"" number=""534"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""615"" height=""15"" font=""10""> APHIS' letter of 13 September 2010, (Exhibit ARG-62). APHIS' letter refers to ""southern Patagonia"". </ftext>
<ftext top=""963"" left=""108"" width=""675"" height=""15"" font=""10"">We note, however, that by this time Argentina's request covered both Patagonia South and Patagonia North B. </ftext>
</footnote>
<text top=""228"" left=""654"" width=""136"" height=""16"" font=""0"">  In June 2011,  the </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">United States' representative at the SPS Committee, responding to a specific trade concern (STC) </text>
<text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">raised by Argentina, stated that APHIS had ""made significant progress in recognizing the FMD-free </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">status of South Patagonia and that, in light of the information Argentina provided in 2009, which </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">was used to update the 2005 risk analysis, it was able to conclude that the import of ruminants </text>
<text top=""310"" left=""108"" width=""531"" height=""16"" font=""0"">and ruminant products from this region presented a negligible risk of FMD"".</text>
<footnote top=""308"" left=""639"" width=""17"" height=""11"" font=""16"" number=""535"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""288"" height=""15"" font=""10""> G/SPS/R/63, (Exhibit ARG-22), paras. 17-18.  </ftext>
</footnote>
<text top=""310"" left=""656"" width=""135"" height=""16"" font=""0""> The United States </text>
<text top=""326"" left=""108"" width=""542"" height=""16"" font=""0"">delegate reiterated this statement before the SPS Committee in October 2011.</text>
<footnote top=""325"" left=""650"" width=""17"" height=""11"" font=""16"" number=""536"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""284"" height=""15"" font=""10""> G/SPS/R/64, (Exhibit ARG-48), paras. 96-97. </ftext>
</footnote>
<text top=""326"" left=""667"" width=""123"" height=""16"" font=""0""> However, APHIS </text>
<text top=""342"" left=""108"" width=""685"" height=""16"" font=""0"">did not issue a determination concerning the recognition of Patagonia as FMD-free, nor did it </text>
<text top=""359"" left=""108"" width=""692"" height=""16"" font=""0"">request any further information of SENASA, until after the Panel's establishment in </text>
<text top=""375"" left=""108"" width=""97"" height=""16"" font=""0"">January 2013.</text>
<footnote top=""374"" left=""205"" width=""17"" height=""11"" font=""16"" number=""537"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""619"" height=""15"" font=""10""> On 13 March 2013 APHIS sent a letter to SENASA indicating that during the Consultations conducted </ftext>
</footnote>
</p><p number=""7.157"" style=""8""><text top=""410"" left=""108"" width=""685"" height=""16"" font=""0"">7.157.  In March 2013, when the current proceedings were already under way, APHIS formally </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">requested SENASA to accept a new site visit to Patagonia in order to progress with the review of </text>
<text top=""443"" left=""108"" width=""138"" height=""16"" font=""0"">Argentina's request.</text>
<footnote top=""441"" left=""246"" width=""17"" height=""11"" font=""16"" number=""538"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""311"" height=""15"" font=""10""> APHIS' letter of 13 March 2013, (Exhibit USA-96). </ftext>
</footnote>
<text top=""443"" left=""264"" width=""504"" height=""16"" font=""0""> SENASA agreed that the site visit should take place in November 2013.</text>
<footnote top=""441"" left=""768"" width=""17"" height=""11"" font=""16"" number=""539"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""612"" height=""15"" font=""10""> SENASA's letter of 13 July 2013, (Exhibit ARG-99); APHIS' letter of 15 July 2013, (Exhibit USA-97). </ftext>
</footnote>
<text top=""459"" left=""108"" width=""685"" height=""16"" font=""0"">APHIS conducted the site visit as scheduled. On 23 January 2014, a few days before the first </text>
<text top=""475"" left=""108"" width=""685"" height=""16"" font=""0"">substantive meeting of the Panel, APHIS published a risk analysis for Patagonia in a Notice of </text>
<text top=""492"" left=""108"" width=""357"" height=""16"" font=""0"">Availability that recognized the region as FMD-free.</text>
<footnote top=""490"" left=""465"" width=""17"" height=""11"" font=""16"" number=""540"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""611"" height=""15"" font=""10""> 2014 Notice of Availability of Risk Analysis for Patagonia, (Exhibit USA-132); 2014 Risk Analysis for </ftext>
</footnote>
<text top=""492"" left=""482"" width=""309"" height=""16"" font=""0""> On 29 August 2014, a few days before the </text>
<text top=""508"" left=""108"" width=""683"" height=""16"" font=""0"">second substantive meeting of the Panel, APHIS published a Notice of Determination recognizing </text>
<text top=""525"" left=""108"" width=""454"" height=""16"" font=""0"">Patagonia as FMD-free, which entered into force two months later.</text>
<footnote top=""523"" left=""561"" width=""17"" height=""11"" font=""16"" number=""541"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""392"" height=""15"" font=""10""> 2014 Notice of Determination on Patagonia, (Exhibit USA-167). </ftext>
</footnote>
</p><p number=""7.158"" style=""8""><text top=""559"" left=""108"" width=""683"" height=""16"" font=""0"">7.158.  The facts described above indicate a period of inaction on the part of APHIS between the </text>
<text top=""575"" left=""108"" width=""686"" height=""16"" font=""0"">site visit to Patagonia in February 2009 and its formal request to conduct a new site visit </text>
<text top=""592"" left=""108"" width=""685"" height=""16"" font=""0"">in March 2013. Therefore, based on the evidence on the record, we take the view that such a </text>
<text top=""608"" left=""108"" width=""683"" height=""16"" font=""0"">period constitutes a delay in the procedure. As mentioned in paragraph 7.118 above, we will not </text>
<text top=""625"" left=""108"" width=""684"" height=""16"" font=""0"">consider time-periods after the Panel's establishment. Therefore, for the purposes of Argentina's </text>
<text top=""641"" left=""108"" width=""428"" height=""16"" font=""0"">claim, the delay is from February 2009 until 28 January 2013. </text>
</p><p number=""7.159"" style=""8""><text top=""675"" left=""108"" width=""685"" height=""16"" font=""0"">7.159.  In sum, the facts outlined above indicate that, during the course of APHIS' review of </text>
<text top=""692"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina's request for the recognition of Patagonia as FMD-free, there were a number of periods </text>
<text top=""708"" left=""108"" width=""685"" height=""16"" font=""0"">of inactivity which constitute ""delays"" within the meaning of Annex C(1)(a). In particular, with </text>
<text top=""725"" left=""108"" width=""348"" height=""16"" font=""0"">respect to the APHIS process for Patagonia South: </text>
</p><p number=""a."" style=""2""><text top=""759"" left=""151"" width=""642"" height=""16"" font=""0"">a.  there was a delay of eight months between March and November 2004, during which </text>
<text top=""775"" left=""176"" width=""444"" height=""16"" font=""0"">APHIS was waiting for SENASA to submit additional information; </text>
</p><p number=""b."" style=""2""><text top=""810"" left=""151"" width=""641"" height=""16"" font=""0"">b.  there was a one-and-a-half-year delay between the issuance of APHIS' risk analysis for </text>
<text top=""826"" left=""176"" width=""609"" height=""16"" font=""0"">Patagonia South in June 2005 and the publication of the Proposed Rule in January 2007; </text>
</p><p number=""c."" style=""2""><text top=""861"" left=""151"" width=""641"" height=""16"" font=""0"">c.  there was a delay between March 2007 &#8211; the expiration of the comment period for the </text>
<text top=""877"" left=""176"" width=""619"" height=""16"" font=""0"">January 2007 Proposed Rule for Patagonia South &#8211; and October 2008, when APHIS </text>
<text top=""893"" left=""176"" width=""276"" height=""16"" font=""0"">requested a new site visit to the region. </text>
</p><p><text top=""1022"" left=""108"" width=""647"" height=""15"" font=""10"">between the parties in November 2012, APHIS had proposed that a new site visit be scheduled. The letter </text>
</p><p><text top=""1109"" left=""108"" width=""186"" height=""15"" font=""10"">Patagonia, (Exhibit USA-133). </text>
</p></page>
<page number=""87"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 87 - </text>
</p><p number=""7.160"" style=""8""><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">7.160.  With respect to APHIS' process for Patagonia as a whole (comprising both Patagonia South </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">and Patagonia North B), there was a delay between February 2009, when APHIS conducted a site </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">visit to the region, and January 2013, when the Panel was established. Thus, for the purpose of </text>
<text top=""177"" left=""108"" width=""377"" height=""16"" font=""0"">this dispute, the delay amounted to almost four years. </text>
</p><p number=""7.161"" style=""8""><text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">7.161.  We now turn to assess whether the above-mentioned delays in APHIS' approval process </text>
<text top=""228"" left=""108"" width=""339"" height=""16"" font=""0"">are undue within the meaning of Annex C(1)(a).  </text>
</p><p number=""7.3"" style=""8""><text top=""262"" left=""108"" width=""311"" height=""16"" font=""28"">7.3.3.5.5  Whether the delays are undue </text></p><p number=""7.162"" style=""8""><text top=""296"" left=""108"" width=""684"" height=""16"" font=""0"">7.162.  In order to assess whether the delays in APHIS' review process outlined in the previous </text>
<text top=""313"" left=""108"" width=""686"" height=""16"" font=""0"">section are undue, we address the justifications offered by the United States to explain such </text>
<text top=""329"" left=""108"" width=""689"" height=""16"" font=""0"">delays. We recall that a delay is undue if it is ""unwarranted, or otherwise excessive, </text>
<text top=""346"" left=""108"" width=""229"" height=""16"" font=""0"">disproportionate or unjustifiable"".</text>
<footnote top=""344"" left=""337"" width=""17"" height=""11"" font=""16"" number=""542"" ref="""" dis=""""/>
</p><p number=""7.163"" style=""8""><text top=""380"" left=""108"" width=""682"" height=""16"" font=""0"">7.163.  We begin our analysis with the delays in APHIS' review of Argentina's original request with </text>
<text top=""396"" left=""108"" width=""189"" height=""16"" font=""0"">respect to Patagonia South.</text>
<footnote top=""395"" left=""297"" width=""17"" height=""11"" font=""16"" number=""543"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""150"" height=""15"" font=""10""> See para. 7.159 above. </ftext>
</footnote>
<text top=""396"" left=""315"" width=""476"" height=""16"" font=""0""> First, with respect to the delay between March and November 2004, </text>
<text top=""413"" left=""108"" width=""682"" height=""16"" font=""0"">we already found in paragraphs 7.150-7.151 above that, during that period, APHIS was waiting for </text>
<text top=""429"" left=""108"" width=""424"" height=""16"" font=""0"">SENASA to submit the additional information requested.</text>
<footnote top=""428"" left=""532"" width=""17"" height=""11"" font=""16"" number=""544"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""525"" height=""15"" font=""10""> Information on Patagonia Provided by SENASA (November 2004), (Exhibit USA-103). </ftext>
</footnote>
<text top=""429"" left=""549"" width=""248"" height=""16"" font=""0""> In turn, as explained by the </text>
<text top=""446"" left=""108"" width=""687"" height=""16"" font=""0"">United States, APHIS' request for additional information was justified by the deficiencies in </text>
<text top=""462"" left=""108"" width=""457"" height=""16"" font=""0"">SENASA's original request for Patagonia South of August 2003.</text>
<footnote top=""461"" left=""565"" width=""17"" height=""11"" font=""16"" number=""545"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""587"" height=""15"" font=""10""> APHIS' facsimile of 6 November 2003, (Exhibit USA-99); United States first written submission, </ftext>
<ftext top=""1036"" left=""108"" width=""479"" height=""15"" font=""10"">para. 151 (referring to APHIS' letter of 6 November 2003, (Exhibit USA-100)). </ftext>
</footnote>
<text top=""462"" left=""582"" width=""212"" height=""16"" font=""0""> Given that the information </text>
<text top=""479"" left=""108"" width=""685"" height=""16"" font=""0"">requested of SENASA in this instance was reasonable in the circumstances, SENASA's delay in </text>
<text top=""495"" left=""108"" width=""402"" height=""16"" font=""0"">providing such information cannot be attributed to APHIS.</text>
<footnote top=""493"" left=""510"" width=""17"" height=""11"" font=""16"" number=""546"" ref=""WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R ; WT/DS292/R ; WT/DS293/R"" dis=""DS293|DS291|DS292""><ftext top=""1051"" left=""165"" width=""611"" height=""15"" font=""10""> See Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1498 (where the panel </ftext>
<ftext top=""1066"" left=""108"" width=""678"" height=""15"" font=""10"">stated that if a request for information is not justified by the importing Member's need to check and ensure the </ftext>
</footnote>
<text top=""495"" left=""527"" width=""263"" height=""16"" font=""0""> Therefore, with respect to this initial </text>
<text top=""511"" left=""108"" width=""680"" height=""16"" font=""0"">stage of the procedure, we do not find an undue delay that can be attributed to the United States.  </text>
</p><p number=""7.164"" style=""8""><text top=""546"" left=""108"" width=""684"" height=""16"" font=""0"">7.164.  Second, with respect to the delay between the publication of the 2005 risk analysis and </text>
<text top=""562"" left=""108"" width=""682"" height=""16"" font=""0"">the publication of the 2007 Proposed Rule for Patagonia South, the United States once again seeks </text>
<text top=""579"" left=""108"" width=""687"" height=""16"" font=""0"">to justify the delay with reference to a variety of domestic legal obligations governing the </text>
<text top=""595"" left=""108"" width=""690"" height=""16"" font=""0"">promulgation of regulations. We have already found in paragraph 7.152 above that the </text>
<text top=""611"" left=""108"" width=""685"" height=""16"" font=""0"">United States did not provide evidence to demonstrate that there was any activity during that </text>
<text top=""628"" left=""108"" width=""684"" height=""16"" font=""0"">period necessary for APHIS to comply with the cited legal instruments. Indeed, the evidence on </text>
<text top=""644"" left=""108"" width=""677"" height=""16"" font=""0"">the record only shows inactivity with no justification. Therefore, we find that the one-and-a-half-</text>
<text top=""661"" left=""108"" width=""399"" height=""16"" font=""0"">year delay is undue within the meaning of Annex C(1)(a). </text>
</p><p number=""7.165"" style=""8""><text top=""695"" left=""108"" width=""687"" height=""16"" font=""0"">7.165.  Third, we address the delay between the expiration of the comment period for the </text>
<text top=""711"" left=""108"" width=""683"" height=""16"" font=""0"">January 2007 Proposed Rule for Patagonia South (March 2007) and APHIS' request to conduct a </text>
<text top=""728"" left=""108"" width=""683"" height=""16"" font=""0"">new site visit to the region (October 2008). The United States argues that the period in question </text>
<text top=""744"" left=""108"" width=""682"" height=""16"" font=""0"">was required for APHIS to address the 45 comments expressed by interested parties. In particular, </text>
<text top=""761"" left=""108"" width=""685"" height=""16"" font=""0"">according to the United States, such comments revealed that ""the risk analysis underlying the </text>
<text top=""777"" left=""108"" width=""655"" height=""16"" font=""0"">proposed rule was missing current information and improperly relied on outdated information""</text>
<footnote top=""775"" left=""763"" width=""17"" height=""11"" font=""16"" number=""547"" ref="""" dis=""""/>
<text top=""777"" left=""780"" width=""10"" height=""16"" font=""0"">, </text>
<text top=""793"" left=""108"" width=""560"" height=""16"" font=""0"">therefore ""APHIS needed additional time to update and reconfirm its conclusions"".</text>
<footnote top=""792"" left=""667"" width=""17"" height=""11"" font=""16"" number=""548"" ref="""" dis=""""/>
</p><p number=""7.166"" style=""8""><text top=""828"" left=""108"" width=""688"" height=""16"" font=""0"">7.166.  We note that although the United States' asserts that it was the comments which </text>
<text top=""844"" left=""108"" width=""686"" height=""16"" font=""0"">precipitated the need for APHIS to seek additional information and reconfirm its conclusions, </text>
<text top=""861"" left=""108"" width=""682"" height=""16"" font=""0"">APHIS waited over one and a half years after the expiration of the comment period to request the </text>
<text top=""877"" left=""108"" width=""683"" height=""16"" font=""0"">new site visit to Patagonia. The United States has not offered any justification as to why this step </text>
<text top=""893"" left=""108"" width=""683"" height=""16"" font=""0"">of its review would require such a lengthy period of time. We have already found that the time it </text>
<text top=""910"" left=""108"" width=""600"" height=""16"" font=""0"">took APHIS to address the comments in question was longer than ordinarily expected.</text>
<footnote top=""908"" left=""708"" width=""17"" height=""11"" font=""16"" number=""549"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""150"" height=""15"" font=""10""> See para. 7.154 above. </ftext>
<ftext top=""963"" left=""108"" width=""681"" height=""15"" font=""10"">submissions, Argentina refers to Section 737 of the <i>2009 Omnibus Appropriations Act</i> as a non-scientific reason </ftext>
<ftext top=""993"" left=""108"" width=""671"" height=""15"" font=""10"">statement at the first meeting of the Panel, para. 18; Argentina's second written submission, paras. 385-389) </ftext>
<ftext top=""1007"" left=""108"" width=""644"" height=""15"" font=""10"">For the reasons set out in paragraphs 7.139 above, we are not convinced that Section 737 caused APHIS' </ftext>
<ftext top=""1022"" left=""108"" width=""41"" height=""15"" font=""10"">delay. </ftext>
</footnote>
<text top=""910"" left=""725"" width=""66"" height=""16"" font=""0""> We also </text>
<text top=""926"" left=""108"" width=""687"" height=""16"" font=""0"">took the view that, in the circumstances of this case, the need to re-confirm and update </text>
<p><text top=""963"" left=""165"" width=""607"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 437 (referring to Panel Report, <i>EC &#8211; Approval and </i></text>
<text top=""978"" left=""108"" width=""277"" height=""15"" font=""12""><i>Marketing of Biotech Products</i>,<i> </i>para. 7.1495).</text>
</p><p><text top=""1080"" left=""108"" width=""666"" height=""15"" font=""10"">fulfilment of an SPS measure, that request may cause an undue delay within the meaning of Annex C(1)(a)). </text>
<footnote top=""1095"" left=""165"" width=""563"" height=""15"" font=""10"" number=""33"" ref="""" dis=""""/>
</p><p><text top=""1109"" left=""165"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 63 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 88 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">pre-existing information which became outdated because of APHIS' inaction does not constitute a </text>
<text top=""144"" left=""108"" width=""387"" height=""16"" font=""0"">justification for delay in the completion of a procedure.</text>
<footnote top=""143"" left=""495"" width=""17"" height=""11"" font=""16"" number=""550"" ref="""" dis=""""><ftext top=""920"" left=""165"" width=""150"" height=""15"" font=""10""> See para. 7.143 above. </ftext>
</footnote>
<text top=""144"" left=""512"" width=""279"" height=""16"" font=""0""> Therefore, we conclude that the delay </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">between March 2007 &#8211; the expiration of the comment period for the January 2007 Proposed Rule &#8211; </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">and October 2008 &#8211; when APHIS' requested a new site visit &#8211; is undue within the meaning of </text>
<text top=""193"" left=""108"" width=""112"" height=""16"" font=""0"">Annex C(1)(a).  </text>
</p></p></page>
<page number=""88"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.167"" style=""8""><text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">7.167.  We now turn to the delay in APHIS' review of Argentina's request concerning Patagonia as </text>
<text top=""244"" left=""108"" width=""510"" height=""16"" font=""0"">a whole (i.e. comprising both Patagonia South and Patagonia North B).</text>
<footnote top=""243"" left=""618"" width=""17"" height=""11"" font=""16"" number=""551"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""150"" height=""15"" font=""10""> See para. 7.160 above. </ftext>
</footnote>
<text top=""244"" left=""635"" width=""158"" height=""16"" font=""0""> In Argentina's view, </text>
<text top=""260"" left=""108"" width=""690"" height=""16"" font=""0"">APHIS' failure to finalize the process by the time of the establishment of the Panel </text>
<text top=""277"" left=""108"" width=""532"" height=""16"" font=""0"">(28 January 2013) constitutes an undue delay in the approval procedure.</text>
<footnote top=""275"" left=""640"" width=""17"" height=""11"" font=""16"" number=""552"" ref="""" dis=""""/>
<text top=""277"" left=""657"" width=""136"" height=""16"" font=""0""> For its part, the </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">United States asserts that APHIS' review of the request was delayed because Argentina: (i) revised </text>
<text top=""310"" left=""108"" width=""330"" height=""16"" font=""0"">the application to include Patagonia North B</text>
<footnote top=""308"" left=""438"" width=""17"" height=""11"" font=""16"" number=""553"" ref="""" dis=""""/>
<text top=""310"" left=""455"" width=""340"" height=""16"" font=""0"">; and (ii) repeatedly revised the regulatory </text>
<text top=""326"" left=""108"" width=""624"" height=""16"" font=""0"">conditions for FMD surveillance, movement control and slaughter procedures in Patagonia.</text>
<footnote top=""325"" left=""732"" width=""17"" height=""11"" font=""16"" number=""554"" ref="""" dis=""""/>
<text top=""326"" left=""749"" width=""41"" height=""16"" font=""0""> As a </text>
<text top=""342"" left=""108"" width=""686"" height=""16"" font=""0"">result, according to the United States, APHIS did not have all the information necessary to </text>
<text top=""359"" left=""108"" width=""564"" height=""16"" font=""0"">complete its risk assessment for Patagonia prior to its site visit of November 2013.</text>
<footnote top=""357"" left=""672"" width=""17"" height=""11"" font=""16"" number=""555"" ref="""" dis=""""/>
</p><p number=""7.168"" style=""8""><text top=""393"" left=""108"" width=""685"" height=""16"" font=""0"">7.168.  We agree with the United States that the expansion, in December 2008, of Argentina's </text>
<text top=""410"" left=""108"" width=""685"" height=""16"" font=""0"">original request to encompass both Patagonia South and Patagonia North B is relevant to our </text>
<text top=""426"" left=""108"" width=""685"" height=""16"" font=""0"">assessment of whether the portion of APHIS' review devoted to Patagonia incurred an undue </text>
<text top=""443"" left=""108"" width=""683"" height=""16"" font=""0"">delay. As to the changes in the regulatory framework for Patagonia, the United States argues that </text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">SENASA's new policy (Resolution 1282/2008) ""posed potential obstacles to Argentina's ability to </text>
<text top=""475"" left=""108"" width=""630"" height=""16"" font=""0"">conform with APHIS' FMD sanitation requirements"" and therefore justified APHIS' delay.</text>
<footnote top=""474"" left=""738"" width=""17"" height=""11"" font=""16"" number=""556"" ref="""" dis=""""/>
<text top=""475"" left=""756"" width=""38"" height=""16"" font=""0""> We </text>
<text top=""492"" left=""108"" width=""684"" height=""16"" font=""0"">note that Resolution 1282/2008 modified the regime of controls between Patagonia North B and </text>
<text top=""508"" left=""108"" width=""685"" height=""16"" font=""0"">Patagonia South as part of the process of merging the two separate areas into one Patagonia </text>
<text top=""525"" left=""108"" width=""43"" height=""16"" font=""0"">region</text>
<footnote top=""523"" left=""151"" width=""17"" height=""11"" font=""16"" number=""557"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""390"" height=""15"" font=""10""> Resoluci&#243;n SENASA 1282/2008, (Exhibit USA-109), Article 1.5. </ftext>
</footnote>
<text top=""525"" left=""168"" width=""624"" height=""16"" font=""0"">, following the OIE's recognition of Patagonia North B as FMD-free where vaccination is </text>
<text top=""541"" left=""108"" width=""684"" height=""16"" font=""0"">not practised &#8211; the status already enjoyed by Patagonia South at that time. Although we do not </text>
<text top=""557"" left=""108"" width=""286"" height=""16"" font=""0"">necessarily agree with the United </text>
<text top=""557"" left=""383"" width=""417"" height=""16"" font=""0"">States' characterization of the potential effects of </text>
<text top=""574"" left=""108"" width=""150"" height=""16"" font=""0"">Resolution 1282/2008</text>
<footnote top=""572"" left=""258"" width=""17"" height=""11"" font=""16"" number=""558"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""196"" height=""15"" font=""10""> See paras. 7.527-7.528 below. </ftext>
</footnote>
<text top=""574"" left=""275"" width=""515"" height=""16"" font=""0"">, we consider that it is reasonable that a change in the very borders of the </text>
<text top=""590"" left=""108"" width=""687"" height=""16"" font=""0"">region APHIS was being asked to recognize as FMD-free as well as the regulatory regime </text>
<text top=""607"" left=""108"" width=""683"" height=""16"" font=""0"">governing that region would require additional inquiries and hence additional time for evaluation. </text>
<text top=""623"" left=""108"" width=""683"" height=""16"" font=""0"">Thus, we find that it was reasonable for APHIS to conduct its site visit to Patagonia as a whole in </text>
<text top=""639"" left=""108"" width=""682"" height=""16"" font=""0"">February 2009 and that therefore, the delay between December 2008 and February 2009 was not </text>
<text top=""656"" left=""108"" width=""52"" height=""16"" font=""0"">undue. </text>
</p><p number=""7.169"" style=""8""><text top=""690"" left=""108"" width=""685"" height=""16"" font=""0"">7.169.  However, we are not persuaded that the events referred to above justify APHIS' delay </text>
<text top=""707"" left=""108"" width=""683"" height=""16"" font=""0"">between the February 2009 site visit to Patagonia and the date of the establishment of the Panel. </text>
<text top=""723"" left=""108"" width=""682"" height=""16"" font=""0"">In particular, we are not convinced by the United States' argument that APHIS did not have all the </text>
<text top=""739"" left=""108"" width=""685"" height=""16"" font=""0"">information necessary to complete its risk assessment for Patagonia prior to November 2013. </text>
<text top=""756"" left=""108"" width=""691"" height=""16"" font=""0"">Indeed, we note the communications from APHIS to SENASA of 27 April 2009 and </text>
<text top=""772"" left=""108"" width=""31"" height=""16"" font=""0"">13 </text>
<text top=""772"" left=""130"" width=""88"" height=""16"" font=""0"">September </text>
<text top=""772"" left=""209"" width=""334"" height=""16"" font=""0"">2010 and the statements by the United </text>
<text top=""772"" left=""535"" width=""264"" height=""16"" font=""0"">States' representative before the </text>
<text top=""789"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Committee in June and October 2011, discussed in paragraphs 7.153-7.156 above. According </text>
<text top=""805"" left=""108"" width=""682"" height=""16"" font=""0"">to Argentina, such communications show that APHIS had already gathered sufficient information to </text>
<text top=""821"" left=""108"" width=""684"" height=""16"" font=""0"">complete the approval process for Patagonia as a whole as a result of its site visit of February </text>
<text top=""838"" left=""108"" width=""49"" height=""16"" font=""0"">2009.  </text>
<p><text top=""949"" left=""165"" width=""563"" height=""15"" font=""10""> Argentina's response to Panel question No. 68 following the first substantive meeting. In its </text>
</p><p><text top=""978"" left=""108"" width=""648"" height=""15"" font=""10"">for the delay in the process. (See e.g. Argentina's first written submission, para. 701; Argentina's opening </text>
</p><p><text top=""1036"" left=""165"" width=""621"" height=""15"" font=""10""> United States' first written submission, para. 215. See also United States' response to Panel question </text>
</p><p><text top=""1066"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 213. </text>
</p><p><text top=""1095"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 159. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 89 - </text>
</p></p></page>
<page number=""89"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.170"" style=""8""><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">7.170.  We have taken note of the United States' argument that the letter from APHIS and the </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">statements made to the SPS Committee should not be construed as an admission on the part of </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">the United States that the risk analysis was in fact completed in 2009. Nevertheless, we do not </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">think that the letter and statements are devoid of value for the purposes of determining whether </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">there has been undue delay in conducting the procedure. Moreover, the record shows that APHIS </text>
<text top=""210"" left=""108"" width=""685"" height=""16"" font=""0"">did not request SENASA to provide any additional information concerning the FMD situation in </text>
<text top=""226"" left=""108"" width=""682"" height=""16"" font=""0"">Patagonia following its site visit of February 2009 until after the Panel was established. Finally, the </text>
<text top=""242"" left=""108"" width=""685"" height=""16"" font=""0"">United States has not pointed to any specific information that APHIS was missing prior to the </text>
<text top=""259"" left=""108"" width=""684"" height=""16"" font=""0"">November 2013 visit, except for the need to ""re-confirm and update"" information already in its </text>
<text top=""275"" left=""108"" width=""316"" height=""16"" font=""0"">possession as the result of prior site visits.</text>
<footnote top=""274"" left=""424"" width=""17"" height=""11"" font=""16"" number=""559"" ref="""" dis=""""/>
<text top=""275"" left=""441"" width=""352"" height=""16"" font=""0""> Based on an examination of the facts in their </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">entirety, we conclude that APHIS had collected sufficient information concerning the FMD situation </text>
<text top=""308"" left=""108"" width=""683"" height=""16"" font=""0"">in Patagonia well before the November 2013 site visit took place. If that were not the case, one </text>
<text top=""324"" left=""108"" width=""682"" height=""16"" font=""0"">would expect APHIS to communicate to SENASA what information was missing in order to progress </text>
<text top=""341"" left=""108"" width=""682"" height=""16"" font=""0"">towards the completion of the process. It did not do so. Thus, we find that the delay subsequent to </text>
<text top=""357"" left=""108"" width=""683"" height=""16"" font=""0"">February 2009 was attributable to the United States. As we discussed in paragraph 7.143 above, </text>
<text top=""374"" left=""108"" width=""687"" height=""16"" font=""0"">circumstances such as those presented in this case, the need to ""re-confirm and update"" </text>
<text top=""390"" left=""108"" width=""688"" height=""16"" font=""0"">pre-existing information does not constitute, in and of itself, justification for delay in the </text>
<text top=""407"" left=""108"" width=""192"" height=""16"" font=""0"">completion of a procedure.  </text>
</p><p number=""7.171"" style=""8""><text top=""441"" left=""108"" width=""685"" height=""16"" font=""0"">7.171.  In light of the above, we find that APHIS' delay between the site visit to Patagonia in </text>
<text top=""457"" left=""108"" width=""682"" height=""16"" font=""0"">February 2009 and the date of the establishment of the Panel (28 January 2013) was undue within </text>
<text top=""474"" left=""108"" width=""215"" height=""16"" font=""0"">the meaning of Annex C(1)(a). </text>
</p><p number=""7.172"" style=""8""><text top=""508"" left=""108"" width=""424"" height=""16"" font=""0"">7.172.  In sum, based on all the foregoing, we conclude that: </text>
</p><p number=""a."" style=""2""><text top=""543"" left=""151"" width=""640"" height=""16"" font=""0"">a.  The delay between March and November 2004 is not undue, therefore the United States </text>
<text top=""559"" left=""176"" width=""407"" height=""16"" font=""0"">did not act inconsistently with Article 8 and Annex C(1)(a); </text>
</p><p number=""b."" style=""2""><text top=""593"" left=""151"" width=""640"" height=""16"" font=""0"">b.  The delay between the issuance of APHIS' risk analysis for Patagonia South (June 2005) </text>
<text top=""610"" left=""176"" width=""620"" height=""16"" font=""0"">and the publication of the Proposed Rule (January 2007) is undue, therefore the </text>
<text top=""626"" left=""176"" width=""468"" height=""16"" font=""0"">United States acted inconsistently with Article 8 and Annex C(1)(a); </text>
</p><p number=""c."" style=""2""><text top=""661"" left=""151"" width=""640"" height=""16"" font=""0"">c.  The delay between the expiration of the comment period for the January 2007 Proposed </text>
<text top=""677"" left=""176"" width=""617"" height=""16"" font=""0"">Rule (March 2007) and APHIS' request for a new site visit (October 2008) is undue, </text>
<text top=""693"" left=""176"" width=""562"" height=""16"" font=""0"">therefore the United States acted inconsistently with Article 8 and Annex C(1)(a); </text>
</p><p number=""d."" style=""2""><text top=""728"" left=""151"" width=""642"" height=""16"" font=""0"">d.  The delay between the site visit to Patagonia in February 2009 and the date of the </text>
<text top=""744"" left=""176"" width=""618"" height=""16"" font=""0"">establishment of the Panel (28 January 2013) is undue, therefore the United States </text>
<text top=""761"" left=""176"" width=""370"" height=""16"" font=""0"">acted inconsistently with Article 8 and Annex C(1)(a). </text>
</p><p number=""7.3"" style=""8""><text top=""795"" left=""108"" width=""686"" height=""16"" font=""28"">7.3.4  Whether APHIS' review processes of Argentina's requests met the procedural </text><text top=""811"" left=""108"" width=""481"" height=""16"" font=""28"">requirements set forth in Annex C(1)(b) of the SPS Agreement </text></p><p number=""7.3"" style=""8""><text top=""846"" left=""108"" width=""261"" height=""16"" font=""28"">7.3.4.1  Arguments of the parties  </text></p><p number=""7.3"" style=""8""><text top=""880"" left=""108"" width=""156"" height=""16"" font=""28"">7.3.4.1.1  Argentina </text></p><p number=""7.173"" style=""8""><text top=""915"" left=""108"" width=""684"" height=""16"" font=""0"">7.173.  Argentina claims that APHIS' review processes of its two requests are inconsistent with </text>
<text top=""931"" left=""108"" width=""307"" height=""16"" font=""0"">Article 8 in conjunction with Annex C(1)(b).  </text>
</p><p number=""7.174"" style=""8""><text top=""965"" left=""108"" width=""682"" height=""16"" font=""0"">7.174.  First, Argentina submits that APHIS did not publish the standard processing period of each </text>
<text top=""982"" left=""108"" width=""686"" height=""16"" font=""0"">procedure. According to Argentina, the application procedures set forth in 9 CFR 92.2 do not </text>
<text top=""998"" left=""108"" width=""390"" height=""16"" font=""0"">indicate APHIS' standard processing period of requests.</text>
<footnote top=""997"" left=""498"" width=""17"" height=""11"" font=""16"" number=""560"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""331"" height=""15"" font=""10""> Argentina's first written submission, paras. 655, 687. </ftext>
</footnote>
<text top=""998"" left=""515"" width=""277"" height=""16"" font=""0""> Moreover, Argentina contends, APHIS </text>
<text top=""1015"" left=""108"" width=""688"" height=""16"" font=""0"">never communicated to Argentina the anticipated processing time for its requests, despite </text>
<text top=""1031"" left=""108"" width=""318"" height=""16"" font=""0"">Argentina's ""specific inquiries on this matter"".</text>
<footnote top=""1030"" left=""426"" width=""17"" height=""11"" font=""16"" number=""561"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""331"" height=""15"" font=""10""> Argentina's first written submission, paras. 656, 688. </ftext>
</footnote>
<text top=""1031"" left=""443"" width=""348"" height=""16"" font=""0""> For instance, Argentina points out, APHIS' letter </text>
<text top=""1048"" left=""108"" width=""682"" height=""16"" font=""0"">of 24 September 2010, concerning Argentina's request for imports of fresh (chilled or frozen) beef, </text>
<p><text top=""1095"" left=""165"" width=""563"" height=""15"" font=""10""> United States' response to Panel question No. 33 following the second substantive meeting. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 90 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">merely stated that ""it is important that APHIS follow the rulemaking process to ensure that our </text>
<text top=""144"" left=""108"" width=""317"" height=""16"" font=""0"">decision-making is thorough and transparent"".</text>
<footnote top=""143"" left=""425"" width=""17"" height=""11"" font=""16"" number=""562"" ref="""" dis=""""/>
<text top=""144"" left=""443"" width=""347"" height=""16"" font=""0""> Similarly, according to Argentina, APHIS' letter of </text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""0"">13 September 2010, concerning Argentina's request for recognition of Patagonia as FMD-free, </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">simply explained that ""APHIS must be transparent and thorough in its deliberations, meaning that </text>
<text top=""193"" left=""108"" width=""274"" height=""16"" font=""0"">[its] rulemaking process can take time"".</text>
<footnote top=""192"" left=""382"" width=""17"" height=""11"" font=""16"" number=""563"" ref="""" dis=""""/>
</p></p></page>
<page number=""90"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.175"" style=""8""><text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">7.175.  Second, Argentina submits that APHIS failed to transmit as soon as possible the results of </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">the procedures in a precise and complete manner to Argentina so that corrective action could be </text>
<text top=""260"" left=""108"" width=""694"" height=""16"" font=""0"">taken if necessary. According to Argentina, APHIS' letters of 27 April 2009 and </text>
<text top=""277"" left=""108"" width=""688"" height=""16"" font=""0"">24 September 2010, coupled with the United States' representative's statements before the </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Committee of June and October 2011, indicate that APHIS had completed risk assessments for </text>
<text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">Northern Argentina and for Patagonia as a whole (comprising both Patagonia South and Patagonia </text>
<text top=""326"" left=""108"" width=""504"" height=""16"" font=""0"">North B), which it did not publish or otherwise communicate to Argentina.</text>
<footnote top=""325"" left=""612"" width=""17"" height=""11"" font=""16"" number=""564"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""359"" height=""15"" font=""10""> Argentina's first written submission, paras. 657-658, 689. </ftext>
</footnote>
</p><p number=""7.176"" style=""8""><text top=""360"" left=""108"" width=""687"" height=""16"" font=""0"">7.176.  Third, Argentina complains that APHIS did not inform Argentina of the stage of the </text>
<text top=""377"" left=""108"" width=""684"" height=""16"" font=""0"">procedures, explaining any delay, despite Argentina's ""repeated inquiries"" into the status of its </text>
<text top=""393"" left=""108"" width=""63"" height=""16"" font=""0"">requests.</text>
<footnote top=""392"" left=""171"" width=""17"" height=""11"" font=""16"" number=""565"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""388"" height=""15"" font=""10""> Argentina's first written submission, paras. 659-660, 690-691. </ftext>
</footnote>
</p><p number=""7.3"" style=""8""><text top=""428"" left=""108"" width=""184"" height=""16"" font=""28"">7.3.4.1.2  United States </text></p><p number=""7.177"" style=""8""><text top=""462"" left=""108"" width=""685"" height=""16"" font=""0"">7.177.  The United States contends that out of the five obligations contained in Annex C(1)(b), </text>
<text top=""479"" left=""108"" width=""683"" height=""16"" font=""0"">only one was mentioned in Argentina's panel request and is therefore within the Panel's terms of </text>
<text top=""495"" left=""108"" width=""683"" height=""16"" font=""0"">reference: the obligation to inform the applicant of the stage of the procedure and to explain any </text>
<text top=""511"" left=""108"" width=""136"" height=""16"" font=""0"">delay upon request.</text>
<footnote top=""510"" left=""244"" width=""17"" height=""11"" font=""16"" number=""566"" ref="""" dis=""""/>
</p><p number=""7.178"" style=""8""><text top=""546"" left=""108"" width=""687"" height=""16"" font=""0"">7.178.  Further, according to the United States, Argentina's claims must fail because APHIS </text>
<text top=""562"" left=""108"" width=""682"" height=""16"" font=""0"">promptly examined the completeness of Argentina's requests upon receipt and notified SENASA of </text>
<text top=""579"" left=""108"" width=""684"" height=""16"" font=""0"">deficiencies in such requests on multiple occasions, explaining that it would need to provide the </text>
<text top=""595"" left=""108"" width=""227"" height=""16"" font=""0"">necessary additional information.</text>
<footnote top=""593"" left=""335"" width=""17"" height=""11"" font=""16"" number=""567"" ref="""" dis=""""/>
<text top=""595"" left=""352"" width=""438"" height=""16"" font=""0""> Moreover, according to the United States, APHIS proceeded as </text>
<text top=""611"" left=""108"" width=""682"" height=""16"" font=""0"">far as practicable with its evaluation of Argentina's requests even when SENASA's applications had </text>
<text top=""628"" left=""108"" width=""83"" height=""16"" font=""0"">deficiencies.</text>
<footnote top=""626"" left=""191"" width=""17"" height=""11"" font=""16"" number=""568"" ref="""" dis=""""/>
<text top=""628"" left=""208"" width=""584"" height=""16"" font=""0""> Finally, the United States argues that Argentina's assertion that APHIS failed to </text>
<text top=""644"" left=""108"" width=""683"" height=""16"" font=""0"">transmit final results of the evaluation process must fail because there were no final ""results"" to </text>
<text top=""661"" left=""108"" width=""333"" height=""16"" font=""0"">transmit at the time Argentina requested them.</text>
<footnote top=""659"" left=""441"" width=""17"" height=""11"" font=""16"" number=""569"" ref="""" dis=""""/>
<text top=""661"" left=""458"" width=""333"" height=""16"" font=""0""> In this regard, the United States relies on the </text>
<text top=""677"" left=""108"" width=""684"" height=""16"" font=""0"">panel report in <i>EC &#8211; Approval and Marketing of Biotech Products</i> to state that the obligation to </text>
<text top=""693"" left=""108"" width=""562"" height=""16"" font=""0"">transmit the results of a procedure does not arise where there are no final results.</text>
<footnote top=""692"" left=""669"" width=""17"" height=""11"" font=""16"" number=""570"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""728"" left=""108"" width=""337"" height=""16"" font=""28"">7.3.4.2  Main arguments of the third parties </text></p><p number=""7.3"" style=""8""><text top=""762"" left=""108"" width=""124"" height=""16"" font=""28"">7.3.4.2.1  China </text></p><p number=""7.179"" style=""8""><text top=""797"" left=""108"" width=""683"" height=""16"" font=""0"">7.179.  China observes that the panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> found </text>
<text top=""813"" left=""108"" width=""682"" height=""16"" font=""0"">that the obligation to transmit the results of the procedure to an applicant under Annex C(1)(b) did </text>
<text top=""829"" left=""108"" width=""683"" height=""16"" font=""0"">not apply because there were no final results which could have been communicated to applicants. </text>
<text top=""846"" left=""108"" width=""682"" height=""16"" font=""0"">However, in China's view, certain intermediate results should also be transmitted to the applicant, </text>
<text top=""862"" left=""108"" width=""686"" height=""16"" font=""0"">namely those pertaining to the conclusion of each step of a control, inspection or approval </text>
<text top=""879"" left=""108"" width=""73"" height=""16"" font=""0"">procedure.</text>
<footnote top=""877"" left=""181"" width=""17"" height=""11"" font=""16"" number=""571"" ref="""" dis=""""/>
<p><text top=""963"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 656. </text>
<text top=""978"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 688. </text>
</p><p><text top=""1022"" left=""165"" width=""321"" height=""15"" font=""10""> United States' second opening statement, para. 76. </text>
<footnote top=""1036"" left=""165"" width=""546"" height=""15"" font=""10"" number=""56"" ref="""" dis=""""/>
<footnote top=""1051"" left=""108"" width=""434"" height=""15"" font=""10"" number=""77"" ref="""" dis=""""/>
</p><p><text top=""1095"" left=""165"" width=""438"" height=""15"" font=""10""> United States' statement at the second meeting of the Panel, para. 78. </text>
<text top=""1109"" left=""165"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 55 following the first substantive meeting. </text>
<footnote top=""1124"" left=""165"" width=""337"" height=""15"" font=""10"" number=""22"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 91 - </text>
</p></p></page>
<page number=""91"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.3"" style=""8""><text top=""128"" left=""108"" width=""202"" height=""16"" font=""28"">7.3.4.2.2  European Union </text></p><p number=""7.180"" style=""8""><text top=""162"" left=""108"" width=""683"" height=""16"" font=""0"">7.180.  The European Union takes the view that if there is no ""result"" of the procedure, then the </text>
<text top=""178"" left=""108"" width=""682"" height=""16"" font=""0"">specific obligation to transmit such a result cannot arise. In its opinion, a ""result"" is a decision on a </text>
<text top=""195"" left=""108"" width=""285"" height=""16"" font=""0"">request, whether definitive or provisional.</text>
<footnote top=""193"" left=""393"" width=""17"" height=""11"" font=""16"" number=""572"" ref="""" dis=""""/>
</p><p number=""7.3"" style=""8""><text top=""229"" left=""108"" width=""229"" height=""16"" font=""28"">7.3.4.3  Analysis by the Panel </text></p><p number=""7.181"" style=""8""><text top=""264"" left=""108"" width=""687"" height=""16"" font=""0"">7.181.  Annex C(1)(b) contains five procedural requirements to be observed by Members in </text>
<text top=""280"" left=""108"" width=""380"" height=""16"" font=""0"">carrying out control, inspection or approval procedures</text>
<footnote top=""279"" left=""488"" width=""17"" height=""11"" font=""16"" number=""573"" ref=""WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8"" dis=""DS392|DS291|DS293|DS292""><ftext top=""978"" left=""165"" width=""621"" height=""15"" font=""10""> Panel Reports,<i> EC &#8211; Approval and Marketing of Biotech Products</i>,<i> </i>para. 7.1574; <i>US &#8211; Poultry (China)</i>, </ftext>
<ftext top=""993"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.357. </ftext>
</footnote>
<text top=""280"" left=""505"" width=""286"" height=""16"" font=""0"">: (i) that the standard processing period </text>
<text top=""296"" left=""108"" width=""683"" height=""16"" font=""0"">of each procedure be published or that the anticipated processing period be communicated to the </text>
<text top=""313"" left=""108"" width=""685"" height=""16"" font=""0"">applicant upon request; (ii) that when receiving an application, the competent body promptly </text>
<text top=""329"" left=""108"" width=""686"" height=""16"" font=""0"">examine the completeness of the documentation and inform the applicant in a precise and </text>
<text top=""346"" left=""108"" width=""682"" height=""16"" font=""0"">complete manner of all deficiencies; (iii) that the competent body transmit as soon as possible the </text>
<text top=""362"" left=""108"" width=""685"" height=""16"" font=""0"">results of the procedure in a precise and complete manner to the applicant so that corrective </text>
<text top=""378"" left=""108"" width=""686"" height=""16"" font=""0"">action may be taken if necessary; (iv) that even when the application has deficiencies, the </text>
<text top=""395"" left=""108"" width=""682"" height=""16"" font=""0"">competent body proceed as far as practicable with the procedure if the applicant so requests; and </text>
<text top=""411"" left=""108"" width=""684"" height=""16"" font=""0"">(v) that upon request, the applicant be informed of the stage of the procedure, with any delay </text>
<text top=""428"" left=""108"" width=""117"" height=""16"" font=""0"">being explained. </text>
</p><p number=""7.182"" style=""8""><text top=""462"" left=""108"" width=""688"" height=""16"" font=""0"">7.182.  Argentina argues the United States did not comply with the first, third, and fifth </text>
<text top=""479"" left=""108"" width=""684"" height=""16"" font=""0"">requirements mentioned above. The United States asserts that Argentina's claims under the first </text>
<text top=""495"" left=""108"" width=""684"" height=""16"" font=""0"">and third requirements of Annex C(1)(b) are not within the Panel's terms of reference because </text>
<text top=""511"" left=""108"" width=""533"" height=""16"" font=""0"">they were not included in Argentina's request for the establishment of Panel.  </text>
</p><p number=""7.183"" style=""8""><text top=""546"" left=""108"" width=""684"" height=""16"" font=""0"">7.183.  First, we assess whether Argentina's claims under Article 8 and Annex C(1)(b) are within </text>
<text top=""562"" left=""108"" width=""682"" height=""16"" font=""0"">the terms of reference of the Panel. To the extent they are, we will then turn to assessing them on </text>
<text top=""579"" left=""108"" width=""89"" height=""16"" font=""0"">their merits. </text>
</p><p number=""7.3"" style=""8""><text top=""613"" left=""108"" width=""683"" height=""16"" font=""28"">7.3.4.3.1  Whether Argentina's claims under Article 8 and Annex C(1)(b) are within the </text><text top=""629"" left=""108"" width=""241"" height=""16"" font=""28"">terms of reference of the Panel </text></p><p number=""7.184"" style=""8""><text top=""664"" left=""108"" width=""390"" height=""16"" font=""0"">7.184.  Article 6.2 of the DSU provides, in relevant part: </text>
<p><text top=""698"" left=""151"" width=""597"" height=""16"" font=""0"">The request for the establishment of a panel shall be made in writing. It shall indicate </text>
<text top=""715"" left=""151"" width=""597"" height=""16"" font=""0"">whether consultations were held, identify the specific measures at issue and provide a </text>
<text top=""731"" left=""151"" width=""599"" height=""16"" font=""0"">brief summary of the legal basis of the complaint sufficient to present the problem </text>
<text top=""747"" left=""151"" width=""54"" height=""16"" font=""0"">clearly. </text>
</p></p><p number=""7.185"" style=""8""><text top=""782"" left=""108"" width=""685"" height=""16"" font=""0"">7.185.  Article 6.2 sets out two key requirements that a complainant must satisfy in its panel </text>
<text top=""798"" left=""108"" width=""683"" height=""16"" font=""0"">request, namely, the ""identification of the specific measures at issue, and the provision of a brief </text>
<text top=""815"" left=""108"" width=""441"" height=""16"" font=""0"">summary of the legal basis of the complaint (or the claims)"".</text>
<footnote top=""813"" left=""549"" width=""17"" height=""11"" font=""16"" number=""574"" ref="""" dis=""""/>
<text top=""815"" left=""567"" width=""226"" height=""16"" font=""0""> Together, these two elements </text>
<text top=""831"" left=""108"" width=""682"" height=""16"" font=""0"">constitute the ""matter referred to the DSB"", so that, if either of them is not properly identified, the </text>
<text top=""847"" left=""108"" width=""408"" height=""16"" font=""0"">matter would not be within the panel's terms of reference.</text>
<footnote top=""846"" left=""516"" width=""17"" height=""11"" font=""16"" number=""575"" ref=""WT/DS213/AB/R/Corr.1|WT/DS213/AB/R"" dis=""DS213|DS398|DS394|DS395""><ftext top=""1036"" left=""165"" width=""551"" height=""15"" font=""10""> Appellate Body Reports, <i>US &#8211; Carbon Steel</i>, para. 125;<i> China &#8211; Raw Materials</i>, para. 219. </ftext>
</footnote>
<text top=""847"" left=""534"" width=""257"" height=""16"" font=""0""> As the Appellate Body has noted, a </text>
<text top=""864"" left=""108"" width=""683"" height=""16"" font=""0"">panel request forms the basis for the terms of reference of panels, in accordance with Article 7.1 </text>
<text top=""880"" left=""108"" width=""80"" height=""16"" font=""0"">of the DSU.</text>
<footnote top=""879"" left=""188"" width=""17"" height=""11"" font=""16"" number=""576"" ref=""WT/DS60/AB/R"" dis=""DS60|DS322|DS398|DS213|DS350|DS395|DS394""><ftext top=""1051"" left=""165"" width=""608"" height=""15"" font=""10""> Appellate Body Reports, <i>Guatemala &#8211; Cement I</i>, paras. 72-73; <i>US &#8211; Carbon Steel</i>, para. 125; <i>US &#8211; </i></ftext>
<ftext top=""1066"" left=""108"" width=""672"" height=""15"" font=""12""><i>Zeroing (Japan) (Article 21.5 &#8211; Japan)</i>, para. 107; <i>US &#8211; Continued Zeroing</i>, para. 160; <i>China &#8211; Raw Materials</i>, </ftext>
</footnote>
<text top=""880"" left=""206"" width=""585"" height=""16"" font=""0""> Moreover, it serves the due process objective of notifying the respondent and third </text>
<text top=""897"" left=""108"" width=""322"" height=""16"" font=""0"">parties of the nature of the complainant's case.</text>
<footnote top=""895"" left=""430"" width=""17"" height=""11"" font=""16"" number=""577"" ref="""" dis=""""/>
<p><text top=""1007"" left=""165"" width=""606"" height=""15"" font=""10""> Appellate Body Reports, <i>US &#8211; Carbon Steel</i>, para. 125 (emphasis omitted); <i>China &#8211; Raw Materials</i>, </text>
<footnote top=""1022"" left=""108"" width=""67"" height=""15"" font=""10"" number=""219"" ref="""" dis=""""/>
</p><p><text top=""1095"" left=""165"" width=""623"" height=""15"" font=""10""> Appellate Body Reports, <i>EC and certain member States &#8211; Large Civil Aircraft</i>, para. 786; <i>US &#8211; Carbon </i></text>
<text top=""1109"" left=""108"" width=""626"" height=""15"" font=""12""><i>Steel</i>, para. 126; <i>Brazil &#8211; Desiccated Coconut</i>, p. 22, DSR 1997:I, 167, at 186;<i> China &#8211; Raw Materials</i>, </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 92 - </text>
</p></p></page>
<page number=""92"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.186"" style=""8""><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">7.186.  In <i>China &#8211; Raw Materials</i>, the Appellate Body stated that ""[i]n order to determine whether </text>
<text top=""144"" left=""108"" width=""687"" height=""16"" font=""0"">a panel request is sufficiently precise to comply with Article 6.2 of the DSU, a panel must </text>
<text top=""160"" left=""108"" width=""414"" height=""16"" font=""0"">scrutinize carefully the language used in the panel request"".</text>
<footnote top=""159"" left=""522"" width=""17"" height=""11"" font=""16"" number=""578"" ref="""" dis=""""/>
<text top=""160"" left=""539"" width=""251"" height=""16"" font=""0""> A panel should read the request as </text>
<text top=""177"" left=""108"" width=""354"" height=""16"" font=""0"">a whole and ""in light of attendant circumstances"".</text>
<footnote top=""175"" left=""462"" width=""17"" height=""11"" font=""16"" number=""579"" ref=""WT/DS363/R/Corr.1|WT/DS363/R|WT/DS98/AB/R/Corr.1|WT/DS98/AB/R|"" dis=""DS363|DS213|DS98|""><ftext top=""861"" left=""165"" width=""614"" height=""15"" font=""10""> Panel Report, <i>China &#8211; Publications and Audiovisual Products</i>, para. 7.53-7.60. That panel found that </ftext>
<ftext top=""876"" left=""108"" width=""675"" height=""15"" font=""10"">the complainant's panel request did not meet the precision requirement under Article 6.2, <i>inter alia</i>, because it </ftext>
<ftext top=""891"" left=""108"" width=""674"" height=""15"" font=""10"">contained language suggesting to the respondent that a certain measure was only being challenged under one </ftext>
<ftext top=""905"" left=""108"" width=""675"" height=""15"" font=""10"">set of provisions, but not under provisions of the covered agreements to which the United States subsequently </ftext>
<ftext top=""920"" left=""108"" width=""664"" height=""15"" font=""10"">referred in its submissions. See Ibid. para. 7.60. See also Appellate Body Reports, <i>Korea &#8211; Dairy</i>, paras. 124-</ftext>
<ftext top=""934"" left=""108"" width=""219"" height=""15"" font=""10"">127; <i>US &#8211; Carbon Steel</i>, para. 127. </ftext>
</footnote>
<text top=""177"" left=""479"" width=""313"" height=""16"" font=""0""> The Appellate Body clarified that while the </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">complainant's submissions ""may be referenced in order to confirm the meaning of the words used </text>
<text top=""210"" left=""108"" width=""685"" height=""16"" font=""0"">in the panel request"", the content of those submissions ""cannot have the effect of curing the </text>
<text top=""226"" left=""108"" width=""269"" height=""16"" font=""0"">failings of a deficient panel request"".</text>
<footnote top=""225"" left=""377"" width=""17"" height=""11"" font=""16"" number=""580"" ref="""" dis=""""/>
<text top=""226"" left=""394"" width=""400"" height=""16"" font=""0""> The Appellate Body also explained that, in order ""to </text>
<text top=""242"" left=""108"" width=""685"" height=""16"" font=""0"">present the problem clearly"", a panel request must ""plainly connect the challenged measure(s) </text>
<text top=""259"" left=""108"" width=""685"" height=""16"" font=""0"">with the provision(s) of the covered agreements claimed to have been infringed, so that the </text>
<text top=""275"" left=""108"" width=""688"" height=""16"" font=""0"">respondent party is aware of the basis for the alleged nullification or impairment of the </text>
<text top=""292"" left=""108"" width=""208"" height=""16"" font=""0"">complaining party's benefits.""</text>
<footnote top=""290"" left=""316"" width=""17"" height=""11"" font=""16"" number=""581"" ref="""" dis=""""/>
<text top=""292"" left=""333"" width=""460"" height=""16"" font=""0""> As the Appellate Body has explained, only by such connection </text>
<text top=""308"" left=""108"" width=""682"" height=""16"" font=""0"">between the measure(s) and the relevant provision(s) can a respondent ""know what case it has to </text>
<text top=""324"" left=""108"" width=""306"" height=""16"" font=""0"">answer, and &#8230; begin preparing its defence"".</text>
<footnote top=""323"" left=""414"" width=""17"" height=""11"" font=""16"" number=""582"" ref="""" dis=""""/>
<text top=""324"" left=""432"" width=""358"" height=""16"" font=""0""> We also note that the Appellate Body has clarified </text>
<text top=""341"" left=""108"" width=""682"" height=""16"" font=""0"">that in situations where ""a provision contains not one single, distinct obligation, but rather multiple </text>
<text top=""357"" left=""108"" width=""686"" height=""16"" font=""0"">obligations, a panel request might need to specify which of the obligations contained in the </text>
<text top=""374"" left=""108"" width=""207"" height=""16"" font=""0"">provision is being challenged"".</text>
<footnote top=""372"" left=""315"" width=""17"" height=""11"" font=""16"" number=""583"" ref="""" dis=""""/>
</p><p number=""7.187"" style=""8""><text top=""408"" left=""108"" width=""683"" height=""16"" font=""0"">7.187.  We note that Section 3 of Argentina's panel request is entitled ""Undue delays in approval </text>
<text top=""425"" left=""108"" width=""86"" height=""16"" font=""0"">procedures"".</text>
<footnote top=""423"" left=""194"" width=""17"" height=""11"" font=""16"" number=""584"" ref=""WT/DS447/2"" dis=""""><ftext top=""1080"" left=""165"" width=""447"" height=""15"" font=""10""> Argentina's request for the establishment of a panel, WT/DS447/2, p. 3. </ftext>
</footnote>
<text top=""425"" left=""212"" width=""580"" height=""16"" font=""0""> In the text of the Section, Argentina claims that the United States' application of </text>
<text top=""441"" left=""108"" width=""682"" height=""16"" font=""0"">the procedures set forth in 9 CFR 92.2, as well as Section 737 of the <i>2009 Omnibus Appropriations </i></text>
<text top=""457"" left=""108"" width=""218"" height=""16"" font=""18""><i>Act</i>, resulted in ""undue delays"".</text>
<footnote top=""456"" left=""326"" width=""17"" height=""11"" font=""16"" number=""585"" ref=""WT/DS447/2"" dis=""""><ftext top=""1095"" left=""165"" width=""467"" height=""15"" font=""10""> Argentina's request for the establishment of a panel, WT/DS447/2, pp. 3-4. </ftext>
</footnote>
<text top=""457"" left=""344"" width=""447"" height=""16"" font=""0""> In addition, Argentina claims that ""[t]he United States has also </text>
<text top=""474"" left=""108"" width=""370"" height=""16"" font=""0"">failed to explain the delays that have occurred"".</text>
<footnote top=""472"" left=""478"" width=""17"" height=""11"" font=""16"" number=""586"" ref=""WT/DS447/2"" dis=""""><ftext top=""1109"" left=""165"" width=""447"" height=""15"" font=""10""> Argentina's request for the establishment of a panel, WT/DS447/2, p. 4. </ftext>
</footnote>
<text top=""474"" left=""496"" width=""300"" height=""16"" font=""0""> In connecting such omissions by the </text>
<text top=""490"" left=""108"" width=""682"" height=""16"" font=""0"">United States to specific provisions of the SPS Agreement, Argentina claims that the United States </text>
<text top=""507"" left=""108"" width=""684"" height=""16"" font=""0"">acted inconsistently with ""Article 8, because the United States has not acted in accordance with </text>
<text top=""523"" left=""108"" width=""199"" height=""16"" font=""0"">the provisions of Annex C.1"".</text>
<footnote top=""521"" left=""307"" width=""17"" height=""11"" font=""16"" number=""587"" ref=""WT/DS447/2"" dis=""""><ftext top=""1124"" left=""165"" width=""447"" height=""15"" font=""10""> Argentina's request for the establishment of a panel, WT/DS447/2, p. 5. </ftext>
</footnote>
</p><p number=""7.188"" style=""8""><text top=""557"" left=""108"" width=""687"" height=""16"" font=""0"">7.188.  Annex C(1) of the SPS Agreement contains a wide array of obligations, contained in </text>
<text top=""574"" left=""108"" width=""683"" height=""16"" font=""0"">subparagraphs (a) through (i). In turn, subparagraph (b) contains five distinct requirements to be </text>
<text top=""590"" left=""108"" width=""683"" height=""16"" font=""0"">observed by Members in carrying out control, inspection or approval procedures. Given the broad </text>
<text top=""607"" left=""108"" width=""682"" height=""16"" font=""0"">and diverse coverage of Annex C(1), we are of the view that, in order to comply with Article 6.2 of </text>
<text top=""623"" left=""108"" width=""683"" height=""16"" font=""0"">the DSU, Argentina was required to specify in a sufficiently clear manner which of the obligations </text>
<text top=""639"" left=""108"" width=""316"" height=""16"" font=""0"">contained in the provision it was challenging.  </text>
</p><p number=""7.189"" style=""8""><text top=""674"" left=""108"" width=""684"" height=""16"" font=""0"">7.189.  In our view, given the specific reference to ""undue delay"" in Annex C(1)(a), the multiple </text>
<text top=""690"" left=""108"" width=""682"" height=""16"" font=""0"">references to ""undue delays"" in the title and text of Section 3 of Argentina's panel request make it </text>
<text top=""707"" left=""108"" width=""682"" height=""16"" font=""0"">clear that Argentina was challenging the United States' measures under Annex C(1)(a). We further </text>
<text top=""723"" left=""108"" width=""682"" height=""16"" font=""0"">consider that the sentence in Section 3 that ""[t]he United States has &#8230; failed to explain the delays </text>
<text top=""739"" left=""108"" width=""683"" height=""16"" font=""0"">that have occurred"" clearly connects Argentina's claims to the fifth requirement of Annex C(1)(b), </text>
<text top=""756"" left=""108"" width=""685"" height=""16"" font=""0"">namely that ""the applicant [be] informed of the stage of the procedure, with any delay being </text>
<text top=""772"" left=""108"" width=""684"" height=""16"" font=""0"">explained"". However, we fail to see in Argentina's panel request any language indicating that it </text>
<text top=""789"" left=""108"" width=""690"" height=""16"" font=""0"">was also challenging the United States' failure to comply with the first requirement of </text>
<footnote top=""832"" left=""165"" width=""587"" height=""15"" font=""10"" number=""220"" ref="""" dis=""DS397""><ftext top=""1066"" left=""108"" width=""324"" height=""15"" font=""12""><i>Dairy</i>, para. 124; <i>EC &#8211; Fasteners (China)</i>, para. 598. </ftext>
</footnote>
<p><text top=""847"" left=""108"" width=""183"" height=""15"" font=""12""><i>Fasteners (China)</i>, para. 562. </text>
</p><p><text top=""1007"" left=""108"" width=""314"" height=""15"" font=""12""><i>Country Tubular Goods Sunset Reviews</i>, para. 162. </text>
<text top=""1022"" left=""165"" width=""595"" height=""15"" font=""10""> Appellate Body Report, <i>Thailand &#8211; H-Beams</i>,<i> </i>para. 88. See also Appellate Body Reports, <i>US &#8211; Oil </i></text>
<text top=""1036"" left=""108"" width=""675"" height=""15"" font=""12""><i>Country Tubular Goods Sunset Review</i>, para. 162; <i>Brazil &#8211; Dessicated Coconut</i>, p.20, DSR 1997:I, 167 at 186. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 93 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">Annex C(1)(b), namely that ""the standard processing period of each procedure [be] published or </text>
<text top=""144"" left=""108"" width=""621"" height=""16"" font=""0"">that the anticipated processing period [be] communicated to the applicant upon request"".  </text>
</p></p></page>
<page number=""93"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.190"" style=""8""><text top=""178"" left=""108"" width=""685"" height=""16"" font=""0"">7.190.  Nor do we consider that the language of Argentina's panel request clearly connects its </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">claims to the third requirement of Annex C(1)(b), namely that ""the competent body transmit[] as </text>
<text top=""211"" left=""108"" width=""682"" height=""16"" font=""0"">soon as possible the results of the procedure in a precise and complete manner to the applicant so </text>
<text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">that corrective action may be taken if necessary"". In this respect, we note that Argentina does </text>
<text top=""244"" left=""108"" width=""687"" height=""16"" font=""0"">allege in the panel request that the United States has admitted at the WTO that the risk </text>
<text top=""260"" left=""108"" width=""689"" height=""16"" font=""0"">assessments were complete. As the United States never published or transmitted a risk </text>
<text top=""277"" left=""108"" width=""690"" height=""16"" font=""0"">assessment, such a statement could, arguably, be related to the third requirement in </text>
<text top=""293"" left=""108"" width=""685"" height=""16"" font=""0"">Annex C(1)(b). However, we note that Argentina makes claims under Articles 5.1 and 5.2 that </text>
<text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">there are no risk assessments. We also note that the final results of the procedure in question may </text>
<text top=""326"" left=""108"" width=""682"" height=""16"" font=""0"">not simply be a risk assessment, but could also include a change in 9 CFR 94.1 to permit imports. </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">Therefore, reading the request as a whole and in light of the attendant circumstances, we find that </text>
<text top=""359"" left=""108"" width=""683"" height=""16"" font=""0"">the third requirement in Annex C(1)(b) was not identified sufficiently in Argentina's panel request </text>
<text top=""375"" left=""108"" width=""220"" height=""16"" font=""0"">to present the problem clearly.  </text>
</p><p number=""7.191"" style=""8""><text top=""410"" left=""108"" width=""682"" height=""16"" font=""0"">7.191.  The Panel is not suggesting that Article 6.2 requires in every instance a recitation of every </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">single phrase or term found in a provision. However, in this instance given the broad reference to </text>
<text top=""443"" left=""108"" width=""682"" height=""16"" font=""0"">Annex C(1) which contains a broad array of obligations, more specificity is required, given that one </text>
<text top=""459"" left=""108"" width=""683"" height=""16"" font=""0"">of the key purposes of the panel request is to adequately notify the respondent of the case it has </text>
<text top=""475"" left=""108"" width=""684"" height=""16"" font=""0"">to defend. Referring specifically to the language in the fifth requirement in Annex C(1)(b) while </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">omitting the language of the first and third requirements, Argentina was effectively notifying the </text>
<text top=""508"" left=""108"" width=""682"" height=""16"" font=""0"">United States that its claims concerned the fifth requirement, but that the other four requirements </text>
<text top=""525"" left=""108"" width=""129"" height=""16"" font=""0"">were not relevant.</text>
<footnote top=""523"" left=""237"" width=""17"" height=""11"" font=""16"" number=""588"" ref=""WT/DS363/R/Corr.1|WT/DS363/R"" dis=""DS363""><ftext top=""1066"" left=""165"" width=""501"" height=""15"" font=""10""> See Panel Report, <i>China &#8211; Publications and Audiovisual Products</i>,<i> </i>paras. 7.53-54. </ftext>
</footnote>
<text top=""525"" left=""254"" width=""538"" height=""16"" font=""0""> Although Argentina may have formulated claims and arguments about the </text>
<text top=""541"" left=""108"" width=""685"" height=""16"" font=""0"">first and third requirements in its submissions, this will not assist Argentina, for it would be </text>
<text top=""557"" left=""108"" width=""683"" height=""16"" font=""0"">improper to allow Argentina to ""cure"" the deficiency in the specificity of its panel request through </text>
<text top=""574"" left=""108"" width=""431"" height=""16"" font=""0"">reference to additional requirements in its written submissions.</text>
<footnote top=""572"" left=""539"" width=""17"" height=""11"" font=""16"" number=""589"" ref="""" dis=""""/>
</p><p number=""7.192"" style=""8""><text top=""608"" left=""108"" width=""689"" height=""16"" font=""0"">7.192.  Based on the foregoing, we find that, of Argentina's claims under Article 8 and </text>
<text top=""625"" left=""108"" width=""674"" height=""16"" font=""0"">Annex C(1)(b), only that relating to the fifth requirement is within the Panel's terms of reference.  </text>
</p><p number=""7.3"" style=""8""><text top=""659"" left=""108"" width=""685"" height=""16"" font=""28"">7.3.4.3.2  Whether  the  United States  informed SENASA, upon request, of the stage of </text><text top=""675"" left=""108"" width=""401"" height=""16"" font=""28"">APHIS' reviews of its requests, explaining any delay </text></p><p number=""7.193"" style=""8""><text top=""710"" left=""108"" width=""688"" height=""16"" font=""0"">7.193.  The fifth requirement of Annex C(1)(b) obliges a Member carrying out an approval </text>
<text top=""726"" left=""108"" width=""683"" height=""16"" font=""0"">procedure to inform the applicant of the stage of the procedure and explain the reasons for any </text>
<text top=""743"" left=""108"" width=""682"" height=""16"" font=""0"">delay. This requirement is qualified by the words ""upon request"", which indicate that the applicant </text>
<text top=""759"" left=""108"" width=""685"" height=""16"" font=""0"">must have formally asked the Member to communicate the information before a claim can be </text>
<text top=""775"" left=""108"" width=""379"" height=""16"" font=""0"">brought alleging the Member's breach of the provision. </text>
</p><p number=""7.194"" style=""8""><text top=""810"" left=""108"" width=""682"" height=""16"" font=""0"">7.194.  At the outset, we recall that APHIS' review processes of Argentina's requests for imports of </text>
<text top=""826"" left=""108"" width=""685"" height=""16"" font=""0"">fresh (chilled or frozen) beef from Northern Argentina and for the recognition of Patagonia as </text>
<text top=""843"" left=""108"" width=""178"" height=""16"" font=""0"">FMD-free incurred delays.</text>
<footnote top=""841"" left=""286"" width=""17"" height=""11"" font=""16"" number=""590"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""263"" height=""15"" font=""10""> See paras. 7.127 and 7.159-7.160 above. </ftext>
</footnote>
<text top=""843"" left=""303"" width=""488"" height=""16"" font=""0""> The evidence on the record shows that SENASA contacted APHIS on </text>
<text top=""859"" left=""108"" width=""682"" height=""16"" font=""0"">more than one occasion requesting explanations as to the state of progress of its two requests for </text>
<text top=""875"" left=""108"" width=""683"" height=""16"" font=""0"">imports of fresh (chilled or frozen) beef from Northern Argentina and for recognition of Patagonia </text>
<text top=""892"" left=""108"" width=""684"" height=""16"" font=""0"">as FMD-free. For instance, on 19 July 2010 SENASA sent APHIS two separate letters &#8211; one for </text>
<text top=""908"" left=""108"" width=""687"" height=""16"" font=""0"">each approval process &#8211; asking that the ""outcomes foreseen for Argentina's request[s]"" be </text>
<text top=""925"" left=""108"" width=""219"" height=""16"" font=""0"">""elucidated"" in a timely fashion.</text>
<footnote top=""923"" left=""327"" width=""17"" height=""11"" font=""16"" number=""591"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""558"" height=""15"" font=""10""> SENASA's letter of 19 July 2010, Note No. 150/2010, (Exhibit ARG-46); SENASA's letter of </ftext>
<ftext top=""1124"" left=""108"" width=""374"" height=""15"" font=""10"">19 July 2010, Note No. 149/2010, (Exhibit ARG-61/USA-56). </ftext>
</footnote>
<text top=""925"" left=""344"" width=""446"" height=""16"" font=""0""> Thus, in our view, the United States was under an obligation to </text>
<text top=""941"" left=""108"" width=""517"" height=""16"" font=""0"">explain the delays in APHIS' approval processes upon Argentina's inquiries. </text>
</p><p number=""7.195"" style=""8""><text top=""976"" left=""108"" width=""683"" height=""16"" font=""0"">7.195.  However, APHIS did not provide precise explanations as to the stage of the procedures or </text>
<text top=""992"" left=""108"" width=""682"" height=""16"" font=""0"">the reasons for the delays. Concerning the approval process for imports of fresh (chilled or frozen) </text>
<text top=""1008"" left=""108"" width=""685"" height=""16"" font=""0"">beef, APHIS simply stated that it was ""important that APHIS follow the rulemaking process to </text>
<p><text top=""1080"" left=""165"" width=""353"" height=""15"" font=""10""> See Appellate Body Report, <i>EC &#8211; Bananas III</i>,<i> </i>para. 143. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 94 - </text>
</p><p><text top=""128"" left=""108"" width=""445"" height=""16"" font=""0"">ensure that [its] decisionmaking is thorough and transparent"".</text>
<footnote top=""126"" left=""553"" width=""17"" height=""11"" font=""16"" number=""592"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""342"" height=""15"" font=""10""> APHIS' letter of 24 September 2010, (Exhibit ARG-47). </ftext>
</footnote>
<text top=""128"" left=""571"" width=""222"" height=""16"" font=""0""> Similarly, with respect to the </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">approval process for Patagonia, APHIS stated that since it needs to be ""transparent and thorough"" </text>
<text top=""160"" left=""108"" width=""432"" height=""16"" font=""0"">in its deliberations, its rulemaking process ""can take time"".</text>
<footnote top=""159"" left=""540"" width=""17"" height=""11"" font=""16"" number=""593"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""342"" height=""15"" font=""10""> APHIS' letter of 13 September 2010, (Exhibit ARG-62). </ftext>
</footnote>
<text top=""160"" left=""557"" width=""237"" height=""16"" font=""0""> Further, throughout the period </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">2009-2011, a number of United States' officials made statements that suggested that APHIS had </text>
<text top=""193"" left=""108"" width=""495"" height=""16"" font=""0"">""made significant progress in reviewing Argentina's two requests"".</text>
<footnote top=""192"" left=""603"" width=""17"" height=""11"" font=""16"" number=""594"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""222"" height=""15"" font=""10""> See paras. 7.125 and 7.156 above. </ftext>
</footnote>
<text top=""193"" left=""620"" width=""176"" height=""16"" font=""0""> In our opinion, such </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">indications do not satisfy the United States' obligation to inform SENASA of the stage of APHIS' </text>
<text top=""226"" left=""108"" width=""392"" height=""16"" font=""0"">reviews and explain the reasons for the delays incurred.  </text>
</p></p></page>
<page number=""94"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.196"" style=""8""><text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">7.196.  Based on the foregoing, we take the view that the United States failed to inform Argentina, </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">upon request, of the stage of APHIS' review processes of Argentina's request or to explain the </text>
<text top=""293"" left=""108"" width=""688"" height=""16"" font=""0"">delays incurred by such procedures. Therefore, we find that the United States has acted </text>
<text top=""310"" left=""108"" width=""493"" height=""16"" font=""0"">inconsistently with Article 8 and the fifth requirement of Annex C(1)(b). </text>
</p><p number=""7.4"" style=""8""><text top=""344"" left=""108"" width=""149"" height=""16"" font=""28"">7.4  Harmonization </text></p><p number=""7.4"" style=""8""><text top=""378"" left=""108"" width=""243"" height=""16"" font=""28"">7.4.1  Relevant legal provisions </text></p><p number=""7.197"" style=""8""><text top=""413"" left=""108"" width=""599"" height=""16"" font=""0"">7.197.  Article 3 of the SPS Agreement, entitled ""Harmonization"" reads in relevant part:</text>
<footnote top=""411"" left=""707"" width=""17"" height=""11"" font=""16"" number=""595"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""609"" height=""15"" font=""10""> Article 3 includes two additional paragraphs: Article 3.4, which provides that ""Members shall play a </ftext>
<ftext top=""1080"" left=""108"" width=""653"" height=""15"" font=""10"">full part, within the limits of their resources, in the relevant international organizations and their subsidiary </ftext>
<ftext top=""1095"" left=""108"" width=""666"" height=""15"" font=""10"">bodies""; and Article 3.5, which reads that the WTO SPS Committee ""shall develop a procedure to monitor the </ftext>
<ftext top=""1109"" left=""108"" width=""646"" height=""15"" font=""10"">process of international harmonization and coordinate efforts in this regard with the relevant international </ftext>
<ftext top=""1124"" left=""108"" width=""446"" height=""15"" font=""10"">organizations"". These paragraphs are not at issue in the present dispute. </ftext>
<ftext top=""1051"" left=""108"" width=""651"" height=""15"" font=""10"">second meeting of the Panel, para. 33; Argentina's response to Panel question No. 12 following the second </ftext>
<ftext top=""1066"" left=""108"" width=""131"" height=""15"" font=""10"">substantive meeting. </ftext>
</footnote>
</p><p number=""1."" style=""6""><text top=""447"" left=""151"" width=""23"" height=""16"" font=""0"">1. </text>
<text top=""447"" left=""193"" width=""559"" height=""16"" font=""0"">To harmonize sanitary and phytosanitary measures on as wide a basis as </text>
<text top=""464"" left=""151"" width=""607"" height=""16"" font=""0"">possible, Members shall base their sanitary or phytosanitary measures on </text>
<text top=""480"" left=""151"" width=""598"" height=""16"" font=""0"">international standards, guidelines or recommendations, where they exist, except as </text>
<text top=""497"" left=""151"" width=""505"" height=""16"" font=""0"">otherwise provided for in this Agreement, an in particular in paragraph 3. </text>
</p><p number=""2."" style=""6""><text top=""531"" left=""151"" width=""20"" height=""16"" font=""0"">2. </text>
<text top=""531"" left=""193"" width=""556"" height=""16"" font=""0"">Sanitary or phytosanitary measures which conform to international standards, </text>
<text top=""547"" left=""151"" width=""599"" height=""16"" font=""0"">guidelines or recommendations shall be deemed to be necessary to protect human, </text>
<text top=""564"" left=""151"" width=""601"" height=""16"" font=""0"">animal or plant life or health, and presumed to be consistent with the relevant </text>
<text top=""580"" left=""151"" width=""337"" height=""16"" font=""0"">provisions of this Agreement and of GATT 1994.  </text>
</p><p number=""3."" style=""6""><text top=""615"" left=""151"" width=""24"" height=""16"" font=""0"">3.  </text>
<text top=""615"" left=""193"" width=""556"" height=""16"" font=""0"">Members may introduce or maintain sanitary or phytosanitary measures which </text>
<text top=""631"" left=""151"" width=""597"" height=""16"" font=""0"">result in a higher level of sanitary or phytosanitary protection than would be achieved </text>
<text top=""647"" left=""151"" width=""607"" height=""16"" font=""0"">by measures based on the relevant international standards, guidelines or </text>
<text top=""664"" left=""151"" width=""597"" height=""16"" font=""0"">recommendations, if there is a scientific justification, or as a consequence of the level </text>
<text top=""680"" left=""151"" width=""600"" height=""16"" font=""0"">of sanitary or phytosanitary protection a Member determines to be appropriate in </text>
<text top=""697"" left=""151"" width=""602"" height=""16"" font=""0"">accordance with the relevant provisions of paragraphs 1 through 8 of Article 5. </text>
<text top=""713"" left=""151"" width=""602"" height=""16"" font=""0"">Notwithstanding the above, all measures which result in a level of sanitary or </text>
<text top=""729"" left=""151"" width=""600"" height=""16"" font=""0"">phytosanitary protection different from that which would be achieved by measures </text>
<text top=""746"" left=""151"" width=""604"" height=""16"" font=""0"">based on international standards guidelines or recommendations shall not be </text>
<text top=""762"" left=""151"" width=""517"" height=""16"" font=""0"">inconsistent with any other provision of this Agreement. (footnote omitted) </text>
</p><p number=""7.198"" style=""8""><text top=""797"" left=""108"" width=""684"" height=""16"" font=""0"">7.198.  Annex A(3)(b) sets forth that ""for animal health and zoonoses, the standards, guidelines </text>
<text top=""813"" left=""108"" width=""682"" height=""16"" font=""0"">and recommendations developed under the auspices of the International Office of Epizootics (OIE)"" </text>
<text top=""829"" left=""108"" width=""638"" height=""16"" font=""0"">shall be the source of the relevant international standards, guidelines and recommendations. </text>
<p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 95 - </text>
</p></p></page>
<page number=""95"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.4"" style=""8""><text top=""128"" left=""108"" width=""691"" height=""16"" font=""28"">7.4.2  Whether  the  United States'  measures are based on relevant international </text><text top=""144"" left=""108"" width=""329"" height=""16"" font=""28"">standards, guidelines or recommendations </text></p><p number=""7.4"" style=""8""><text top=""178"" left=""108"" width=""296"" height=""16"" font=""28"">7.4.2.1  Main arguments of the parties </text></p><p number=""7.4"" style=""8""><text top=""213"" left=""108"" width=""156"" height=""16"" font=""28"">7.4.2.1.1  Argentina </text></p><p number=""7.199"" style=""8""><text top=""247"" left=""108"" width=""688"" height=""16"" font=""0"">7.199.  Argentina argues that the United States' measures are not based on the relevant </text>
<text top=""264"" left=""108"" width=""686"" height=""16"" font=""0"">international standards, guidelines or recommendations contained in the Terrestrial Code. In </text>
<text top=""280"" left=""108"" width=""685"" height=""16"" font=""0"">particular, Argentina identifies Articles 8.5.22 (containing recommendations for imports of fresh </text>
<text top=""296"" left=""108"" width=""686"" height=""16"" font=""0"">meat of FMD-susceptible animals from FMD-free countries or zones where vaccination is not </text>
<text top=""313"" left=""108"" width=""687"" height=""16"" font=""0"">practised) and 8.5.23 (containing recommendations for imports of fresh meat of cattle and </text>
<text top=""329"" left=""108"" width=""687"" height=""16"" font=""0"">buffaloes from FMD-free countries or zones where vaccination is practised) as the relevant </text>
<text top=""346"" left=""108"" width=""487"" height=""16"" font=""0"">standards to which the United States' measures should be compared.</text>
<footnote top=""344"" left=""595"" width=""17"" height=""11"" font=""16"" number=""596"" ref="""" dis=""""><ftext top=""876"" left=""165"" width=""622"" height=""15"" font=""10""> Argentina's first written submission, paras. 185-206. See also Argentina's response to Panel question </ftext>
</footnote>
<text top=""346"" left=""612"" width=""180"" height=""16"" font=""0""> Argentina also identifies </text>
<text top=""362"" left=""108"" width=""682"" height=""16"" font=""0"">the provisions on regionalization in Chapters 4.1 and 4.3 of the Terrestrial Code and Articles 8.5.4 </text>
<text top=""378"" left=""108"" width=""683"" height=""16"" font=""0"">and 8.5.5 on FMD designations for zones and compartments with respect to its claims regarding </text>
<text top=""395"" left=""108"" width=""333"" height=""16"" font=""0"">the treatment of products from Patagonia.</text>
<footnote top=""393"" left=""441"" width=""17"" height=""11"" font=""16"" number=""597"" ref="""" dis=""""><ftext top=""920"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 415-428. </ftext>
</footnote>
<text top=""395"" left=""459"" width=""286"" height=""16"" font=""0""> Argentina further mentions Article </text>
<text top=""395"" left=""736"" width=""63"" height=""16"" font=""0"">8.5.25, </text>
<text top=""411"" left=""108"" width=""381"" height=""16"" font=""0"">Chapter 4.4 and Sections 1-5 of the Terrestrial Code.</text>
<footnote top=""410"" left=""489"" width=""17"" height=""11"" font=""16"" number=""598"" ref="""" dis=""""/>
<text top=""411"" left=""506"" width=""286"" height=""16"" font=""0""> In addition, Argentina argues that the </text>
<text top=""428"" left=""108"" width=""685"" height=""16"" font=""0"">OIE designations of particular FMD status for identified countries or regions constitute relevant </text>
<text top=""444"" left=""108"" width=""682"" height=""16"" font=""0"">standards, guidelines or recommendations, as they are ""official recognition[s]"" issued by the World </text>
<text top=""461"" left=""108"" width=""467"" height=""16"" font=""0"">Assembly of Delegates, the ""highest authority of the organization"".</text>
<footnote top=""459"" left=""574"" width=""17"" height=""11"" font=""16"" number=""599"" ref="""" dis=""""/>
<text top=""461"" left=""592"" width=""199"" height=""16"" font=""0""> In Argentina's opinion, this </text>
<text top=""477"" left=""108"" width=""695"" height=""16"" font=""0"">conclusion is supported by the ordinary meaning of the words ""guidelines"" and </text>
<text top=""493"" left=""108"" width=""139"" height=""16"" font=""0"">""recommendations"".</text>
<footnote top=""492"" left=""247"" width=""17"" height=""11"" font=""16"" number=""600"" ref="""" dis=""""/>
<text top=""493"" left=""264"" width=""526"" height=""16"" font=""0""> Argentina finds support for this view in the OIE's statement, in response to </text>
<text top=""510"" left=""108"" width=""683"" height=""16"" font=""0"">a question from the Panel, that the disease status determinations are adopted in a manner that is </text>
<text top=""526"" left=""108"" width=""587"" height=""16"" font=""0"">directly comparable to those used in developing standards in the Terrestrial Code.</text>
<footnote top=""525"" left=""695"" width=""17"" height=""11"" font=""16"" number=""601"" ref="""" dis=""""/>
<text top=""526"" left=""712"" width=""80"" height=""16"" font=""0""> Argentina </text>
<text top=""543"" left=""108"" width=""682"" height=""16"" font=""0"">argues that to conclude otherwise would have serious implications for Members who conform their </text>
<text top=""559"" left=""108"" width=""682"" height=""16"" font=""0"">measures to the OIE under Article 3.2. In its view, the necessary implication of the finding that the </text>
<text top=""575"" left=""108"" width=""685"" height=""16"" font=""0"">official recognitions of disease status are not guidelines or recommendations is that Members </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">attempting to rely on the OIE official recognitions of disease status would not be protected by the </text>
<text top=""608"" left=""108"" width=""683"" height=""16"" font=""0"">presumption in Article 3.2 and would be subject to challenge for imposing measures without, for </text>
<text top=""625"" left=""108"" width=""368"" height=""16"" font=""0"">instance, conducting an independent risk assessment.</text>
<footnote top=""623"" left=""476"" width=""17"" height=""11"" font=""16"" number=""602"" ref="""" dis=""""/>
</p><p number=""7.200"" style=""8""><text top=""659"" left=""108"" width=""682"" height=""16"" font=""0"">7.200.  Argentina approaches its claims from the standpoint that this is an ""as applied"" case rather </text>
<text top=""675"" left=""108"" width=""164"" height=""16"" font=""0"">than an ""as such"" one.</text>
<footnote top=""674"" left=""272"" width=""17"" height=""11"" font=""16"" number=""603"" ref="""" dis=""""/>
<text top=""675"" left=""289"" width=""503"" height=""16"" font=""0""> In other words, according to Argentina, the issue is not whether the </text>
<text top=""692"" left=""108"" width=""684"" height=""16"" font=""0"">United States' regulatory framework established by APHIS is ""as such"" based on the Terrestrial </text>
<text top=""708"" left=""108"" width=""683"" height=""16"" font=""0"">Code. Argentina argues that its claim is that the specific import measures applied to fresh (chilled </text>
<text top=""725"" left=""108"" width=""683"" height=""16"" font=""0"">or frozen) beef from Northern Argentina and on all animals, meat and other animal products from </text>
<text top=""741"" left=""108"" width=""141"" height=""16"" font=""0"">Patagonia &#8211; i.e. </text>
<text top=""741"" left=""239"" width=""561"" height=""16"" font=""0"">prohibitions &#8211; are not based on the OIE's standards, guidelines or </text>
<text top=""757"" left=""108"" width=""126"" height=""16"" font=""0"">recommendations.</text>
<footnote top=""756"" left=""234"" width=""17"" height=""11"" font=""16"" number=""604"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""598"" height=""15"" font=""10""> Argentina's second written submission, para. 89. See also Ibid. para. 92; Argentina's response to </ftext>
</footnote>
</p><p number=""7.201"" style=""8""><text top=""792"" left=""108"" width=""685"" height=""16"" font=""0"">7.201.  Argentina contends that the United States' measures are ""almost entirely disconnected </text>
<text top=""808"" left=""108"" width=""181"" height=""16"" font=""0"">from"" the Terrestrial Code</text>
<footnote top=""807"" left=""289"" width=""17"" height=""11"" font=""16"" number=""605"" ref="""" dis=""""/>
<text top=""808"" left=""306"" width=""485"" height=""16"" font=""0""> and that APHIS' regulatory system is ""structured in a fundamentally </text>
<text top=""825"" left=""108"" width=""342"" height=""16"" font=""0"">different manner"" from the OIE Terrestrial Code.</text>
<footnote top=""823"" left=""449"" width=""17"" height=""11"" font=""16"" number=""606"" ref="""" dis=""""/>
<text top=""825"" left=""467"" width=""325"" height=""16"" font=""0""> In particular, Argentina notes that while the </text>
<text top=""841"" left=""108"" width=""683"" height=""16"" font=""0"">OIE recognizes both regions where vaccination is practised and not practised as FMD-free, APHIS' </text>
<footnote top=""891"" left=""108"" width=""668"" height=""15"" font=""10"" number=""13"" ref="""" dis=""""><ftext top=""920"" left=""108"" width=""327"" height=""15"" font=""10"">Argentina's second written submission, paras. 89-91. </ftext>
</footnote>
<footnote top=""905"" left=""108"" width=""359"" height=""15"" font=""10"" number=""17"" ref="""" dis=""""/>
<p><text top=""978"" left=""108"" width=""300"" height=""15"" font=""10"">Argentina's second written submission, para. 96. </text>
<footnote top=""993"" left=""165"" width=""438"" height=""15"" font=""10"" number=""12"" ref="""" dis=""""/>
</p><p><text top=""1007"" left=""165"" width=""598"" height=""15"" font=""10""> Argentina's second written submission, para. 97. See also Argentina's response to Panel question </text>
</p><p><text top=""1036"" left=""165"" width=""589"" height=""15"" font=""10""> See e.g. Argentina's second written submission, para. 89; Argentina's opening statement at the </text>
</p><p><text top=""1109"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 197. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 96 - </text>
</p><p><text top=""128"" left=""108"" width=""441"" height=""16"" font=""0"">classification does not recognize the former as being FMD-free.</text>
<footnote top=""126"" left=""549"" width=""17"" height=""11"" font=""16"" number=""607"" ref="""" dis=""""/>
<text top=""128"" left=""567"" width=""225"" height=""16"" font=""0""> Further, Argentina argues that </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">Articles 8.5.22 and 8.5.23 both allow the importation of the relevant products under certain </text>
<text top=""160"" left=""108"" width=""688"" height=""16"" font=""0"">mitigating protocols. In its view, the mitigation protocols imposed by APHIS on products </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">originating from countries where vaccination is practised, set forth in 9 CFR 94.22 are similar to </text>
<text top=""193"" left=""108"" width=""660"" height=""16"" font=""0"">those that the OIE prescribes for FMD-<i>infected</i> regions where a vaccination programme exists.</text>
<footnote top=""192"" left=""768"" width=""17"" height=""11"" font=""16"" number=""608"" ref="""" dis=""""/>
<text top=""210"" left=""108"" width=""686"" height=""16"" font=""0"">Conversely, Argentina contends, the United States' measures applied to its imports constitute </text>
<text top=""226"" left=""108"" width=""160"" height=""16"" font=""0"">""simple prohibition[s]"".</text>
<footnote top=""225"" left=""268"" width=""17"" height=""11"" font=""16"" number=""609"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""447"" height=""15"" font=""10""> Argentina's first written submission, para. 198. See also Ibid. para. 427. </ftext>
</footnote>
<text top=""226"" left=""285"" width=""507"" height=""16"" font=""0""> Therefore, according to Argentina, the United States' measures cannot </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">be said to be based on the Terrestrial Code, because a measure ""that has the opposite meaning </text>
<text top=""259"" left=""108"" width=""688"" height=""16"" font=""0"">and effect of an international standard cannot be said to be 'built upon' an international </text>
<text top=""275"" left=""108"" width=""71"" height=""16"" font=""0"">standard.""</text>
<footnote top=""274"" left=""179"" width=""17"" height=""11"" font=""16"" number=""610"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""614"" height=""15"" font=""10""> Argentina's first written submission, paras. 197 and 200. See also Argentina's opening statement at </ftext>
</footnote>
<text top=""275"" left=""196"" width=""594"" height=""16"" font=""0""> In its view, had the United States based its SPS measures on these standards in the </text>
<text top=""292"" left=""108"" width=""688"" height=""16"" font=""0"">Terrestrial Code, imports from Argentina would have been authorized subject to different </text>
<text top=""308"" left=""108"" width=""688"" height=""16"" font=""0"">mitigating protocols depending on whether they originated from Patagonia or the rest of </text>
<text top=""324"" left=""108"" width=""71"" height=""16"" font=""0"">Argentina.</text>
<footnote top=""323"" left=""179"" width=""17"" height=""11"" font=""16"" number=""611"" ref="""" dis=""""/>
<text top=""324"" left=""196"" width=""598"" height=""16"" font=""0""> Similarly, Argentina argues that Articles 4.3.2 and 4.3.3 of the Terrestrial Code </text>
<text top=""341"" left=""108"" width=""684"" height=""16"" font=""0"">provide for regionalization decisions, but that as of the date of establishment of the Panel, the </text>
<text top=""357"" left=""108"" width=""685"" height=""16"" font=""0"">United States had not recognized Patagonia as a separate region nor applied import protocols </text>
<text top=""374"" left=""108"" width=""387"" height=""16"" font=""0"">specific to the region as foreseen in the Terrestrial Code.</text>
<footnote top=""372"" left=""495"" width=""17"" height=""11"" font=""16"" number=""612"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 426-428. </ftext>
</footnote>
</p></p></page>
<page number=""96"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.202"" style=""8""><text top=""408"" left=""108"" width=""683"" height=""16"" font=""0"">7.202.  Addressing the relationship between Articles 3.1 and 3.3, Argentina argues that the Panel </text>
<text top=""425"" left=""108"" width=""682"" height=""16"" font=""0"">should not misinterpret the Appellate Body's reasoning in <i>EC &#8211; Hormones </i>to mean that Article 3.1 </text>
<text top=""441"" left=""108"" width=""689"" height=""16"" font=""0"">covers SPS measures with more extensive requirements than those found in international </text>
<text top=""457"" left=""108"" width=""684"" height=""16"" font=""0"">standards, so long as the standard served as the ""foundation"" of the measures. In Argentina's </text>
<text top=""474"" left=""108"" width=""683"" height=""16"" font=""0"">view, the term ""except"" in Article 3.1, as referred ""in particular [to] paragraph 3"", constitutes an </text>
<text top=""490"" left=""108"" width=""685"" height=""16"" font=""0"">""exclusive limitation"" to the requirement to base one's measure on an international standard, </text>
<text top=""507"" left=""108"" width=""204"" height=""16"" font=""0"">guideline or recommendation.</text>
<footnote top=""505"" left=""312"" width=""17"" height=""11"" font=""16"" number=""613"" ref="""" dis=""""/>
<text top=""507"" left=""330"" width=""460"" height=""16"" font=""0""> In Argentina's view the language in Article 3.1 indicates a ""binary </text>
<text top=""523"" left=""108"" width=""685"" height=""16"" font=""0"">choice"" whereby a measure cannot, at one and the same time, be based on an international </text>
<text top=""539"" left=""108"" width=""479"" height=""16"" font=""0"">standard, guideline or recommendation and achieve a higher ALOP.</text>
<footnote top=""538"" left=""587"" width=""17"" height=""11"" font=""16"" number=""614"" ref="""" dis=""""/>
<text top=""539"" left=""604"" width=""188"" height=""16"" font=""0""> For Argentina, any other </text>
<text top=""556"" left=""108"" width=""685"" height=""16"" font=""0"">interpretation would render the term ""except"" meaningless, inconsistently with the principle of </text>
<text top=""572"" left=""108"" width=""218"" height=""16"" font=""0"">effective treaty interpretation.</text>
<footnote top=""571"" left=""326"" width=""17"" height=""11"" font=""16"" number=""615"" ref="""" dis=""""/>
<text top=""572"" left=""343"" width=""453"" height=""16"" font=""0""> Indeed, in its view, it would render Articles 3.1 and 3.3 </text>
<text top=""589"" left=""108"" width=""685"" height=""16"" font=""0"">""essentially redundant"" and could lead to the result that ""a Member could potentially establish </text>
<text top=""605"" left=""108"" width=""683"" height=""16"" font=""0"">higher standards without undertaking the rigors of a valid risk assessment pursuant to Article 5"", </text>
<text top=""621"" left=""108"" width=""463"" height=""16"" font=""0"">which would be ""an absurd reading of the treaty language"".</text>
<footnote top=""620"" left=""571"" width=""17"" height=""11"" font=""16"" number=""616"" ref="""" dis=""""/>
<text top=""621"" left=""589"" width=""207"" height=""16"" font=""0""> Argentina notes that the </text>
<text top=""638"" left=""108"" width=""684"" height=""16"" font=""0"">United States claims to apply a higher ALOP than the Terrestrial Code. Pursuant to Argentina's </text>
<text top=""654"" left=""108"" width=""684"" height=""16"" font=""0"">understanding of Article 3, this means that the United States' measures are not consistent with </text>
<text top=""671"" left=""108"" width=""684"" height=""16"" font=""0"">Article 3.1 and must comply with Article 3.3, which in turn requires the United States to comply </text>
<text top=""687"" left=""108"" width=""368"" height=""16"" font=""0"">with the other provisions of the SPS Agreement.</text>
<footnote top=""685"" left=""476"" width=""17"" height=""11"" font=""16"" number=""617"" ref="""" dis=""""/>
<text top=""687"" left=""493"" width=""303"" height=""16"" font=""0""> Argentina contends that, because the </text>
<text top=""703"" left=""108"" width=""456"" height=""16"" font=""0"">United States' measures are inconsistent with Articles 5, 2, 6</text>
<footnote top=""702"" left=""564"" width=""17"" height=""11"" font=""16"" number=""618"" ref="""" dis=""""/>
<text top=""703"" left=""581"" width=""214"" height=""16"" font=""0""> and 10, they are thereby </text>
<text top=""720"" left=""108"" width=""194"" height=""16"" font=""0"">inconsistent with Article 3.3.</text>
<footnote top=""718"" left=""302"" width=""17"" height=""11"" font=""16"" number=""619"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""359"" height=""15"" font=""10""> Argentina's first written submission, paras. 226-227, 229. </ftext>
</footnote>
</p><p number=""7.203"" style=""8""><text top=""754"" left=""108"" width=""683"" height=""16"" font=""0"">7.203.  Nevertheless, Argentina also argues that even if the Panel were to find the United States' </text>
<text top=""771"" left=""108"" width=""682"" height=""16"" font=""0"">measures were based on the relevant international standards, guidelines or recommendations, this </text>
<text top=""787"" left=""108"" width=""683"" height=""16"" font=""0"">would not be dispositive of the Panel's analysis under the other provisions of the SPS Agreement. </text>
<text top=""803"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina argues that its claims under the other provisions are autonomous and continue to stand. </text>
<text top=""820"" left=""108"" width=""683"" height=""16"" font=""0"">According to Argentina, ""it would be an absurd result if a Member could meet the lower threshold </text>
<text top=""836"" left=""108"" width=""683"" height=""16"" font=""0"">of Article 3.1 and still have some sort of safe harbour or other release from the obligations of the </text>
<p><text top=""891"" left=""108"" width=""300"" height=""15"" font=""10"">Argentina's second written submission, para. 98. </text>
</p><p><text top=""963"" left=""108"" width=""263"" height=""15"" font=""10"">the second meeting of the Panel, para. 24. </text>
<text top=""978"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 190-191. </text>
<footnote top=""1007"" left=""165"" width=""528"" height=""15"" font=""10"" number=""14"" ref="""" dis=""""/>
</p><p><text top=""1036"" left=""108"" width=""643"" height=""15"" font=""10"">Argentina's opening statement at the first meeting of the Panel, paras. 33-34; Argentina's second written </text>
<text top=""1051"" left=""108"" width=""605"" height=""15"" font=""10"">submission, para. 98; Argentina's opening statement at the second meeting of the Panel, para. 22. </text>
</p><p><text top=""1080"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 196. </text>
<text top=""1095"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 207. </text>
<text top=""1109"" left=""165"" width=""526"" height=""15"" font=""10""> We recall that Argentina raises claims under Article 6 only with respect to Patagonia.  </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 97 - </text>
</p><p><text top=""128"" left=""108"" width=""243"" height=""16"" font=""0"">remainder of the SPS Agreement.""</text>
<footnote top=""126"" left=""351"" width=""17"" height=""11"" font=""16"" number=""620"" ref="""" dis=""""/>
<text top=""128"" left=""369"" width=""424"" height=""16"" font=""0""> Argentina notes that the United States is not seeking the </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">safe harbour of conformity with the international standards, guidelines or recommendations in </text>
<text top=""160"" left=""108"" width=""688"" height=""16"" font=""0"">Article 3.2. Therefore, in its view the United States' measures must conform to the other </text>
<text top=""177"" left=""108"" width=""686"" height=""16"" font=""0"">provisions of the SPS Agreement, including Articles 2, 5, 6, 8 and 10. Argentina argues that </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">""[t]here is not a single word or phrase in Article 3.1 that would remove this requirement from the </text>
<text top=""210"" left=""108"" width=""184"" height=""16"" font=""0"">United States' obligations.""</text>
<footnote top=""208"" left=""293"" width=""17"" height=""11"" font=""16"" number=""621"" ref="""" dis=""""/>
</p></p></page>
<page number=""97"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.4"" style=""8""><text top=""244"" left=""108"" width=""184"" height=""16"" font=""28"">7.4.2.1.2  United States </text></p><p number=""7.204"" style=""8""><text top=""278"" left=""108"" width=""57"" height=""16"" font=""0"">7.204. </text>
<text top=""278"" left=""162"" width=""95"" height=""16"" font=""0"">The United </text>
<text top=""278"" left=""248"" width=""229"" height=""16"" font=""0"">States considers that Article </text>
<text top=""278"" left=""469"" width=""329"" height=""16"" font=""0"">1.6.4 and Chapters 2.1 and 8.5 of the </text>
<text top=""295"" left=""108"" width=""682"" height=""16"" font=""0"">OIE Terrestrial Code constitute international standards, guidelines or recommendations relevant to </text>
<text top=""311"" left=""108"" width=""464"" height=""16"" font=""0"">this dispute within the meaning of Article 3 of the SPS Agreement.</text>
<footnote top=""310"" left=""572"" width=""17"" height=""11"" font=""16"" number=""622"" ref="""" dis=""""/>
<text top=""311"" left=""589"" width=""202"" height=""16"" font=""0""> However, the United States </text>
<text top=""328"" left=""108"" width=""686"" height=""16"" font=""0"">argues that the disease status designations for FMD do not in themselves constitute relevant </text>
<text top=""344"" left=""108"" width=""689"" height=""16"" font=""0"">international standards, guidelines or recommendations, but rather an application of the </text>
<text top=""360"" left=""108"" width=""349"" height=""16"" font=""0"">OIE Terrestrial Code to specific factual situations.</text>
<footnote top=""359"" left=""456"" width=""17"" height=""11"" font=""16"" number=""623"" ref="""" dis=""""/>
<text top=""360"" left=""474"" width=""319"" height=""16"" font=""0""> In particular, the United States takes issue </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">with Argentina's claim that the term ""recommendation""  encompasses  OIE FMD statuses  and </text>
<text top=""393"" left=""108"" width=""689"" height=""16"" font=""0"">maintains that the word ""recommendation"" should be ""read together with 'standard' and </text>
<text top=""410"" left=""108"" width=""682"" height=""16"" font=""0"">'guideline'"", whose common denominator is that they are not applications of ""country-specific facts </text>
<text top=""426"" left=""108"" width=""132"" height=""16"" font=""0"">to rules or norms"".</text>
<footnote top=""425"" left=""240"" width=""17"" height=""11"" font=""16"" number=""624"" ref="""" dis=""""/>
<text top=""426"" left=""257"" width=""534"" height=""16"" font=""0""> Furthermore, the United States argues that the fact that official recognition </text>
<text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">of FMD disease status is issued in the form of a resolution by the World Assembly of Delegates </text>
<text top=""459"" left=""108"" width=""602"" height=""16"" font=""0"">does not, in and of itself, show that they are standards, guidelines or recommendations.</text>
<footnote top=""457"" left=""710"" width=""17"" height=""11"" font=""16"" number=""625"" ref="""" dis=""""/>
</p><p number=""7.205"" style=""8""><text top=""493"" left=""108"" width=""683"" height=""16"" font=""0"">7.205.  The United States maintains that, with respect to imports of FMD-susceptible animals and </text>
<text top=""510"" left=""108"" width=""684"" height=""16"" font=""0"">animal products from other countries or regions, the Terrestrial Code ""lays out a system that is </text>
<text top=""526"" left=""108"" width=""684"" height=""16"" font=""0"">fundamentally the same in structure and approach to that of the APHIS application system"" and </text>
<text top=""543"" left=""108"" width=""682"" height=""16"" font=""0"">that the two ""mirror each other"", so that APHIS' system can be said to be based on the Terrestrial </text>
<text top=""559"" left=""108"" width=""39"" height=""16"" font=""0"">Code.</text>
<footnote top=""557"" left=""147"" width=""17"" height=""11"" font=""16"" number=""626"" ref="""" dis=""""/>
<text top=""559"" left=""164"" width=""627"" height=""16"" font=""0""> In support of this contention, the United States compares APHIS' procedures with those </text>
<text top=""575"" left=""108"" width=""683"" height=""16"" font=""0"">for the recognition or reinstatement of a region as FMD-free under the Terrestrial Code. It states </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">that under both the Terrestrial Code and APHIS' procedures, a country or region is not considered </text>
<text top=""608"" left=""108"" width=""684"" height=""16"" font=""0"">to be free of FMD until an application is filed by the Member concerned and a determination of </text>
<text top=""625"" left=""108"" width=""418"" height=""16"" font=""0"">FMD-freedom is reached by the OIE or APHIS, respectively.</text>
<footnote top=""623"" left=""526"" width=""17"" height=""11"" font=""16"" number=""627"" ref="""" dis=""""/>
<text top=""625"" left=""544"" width=""248"" height=""16"" font=""0""> For the United States, the factors </text>
<text top=""641"" left=""108"" width=""684"" height=""16"" font=""0"">applicant Members have to address in support of their requests to APHIS mirror those that they </text>
<text top=""657"" left=""108"" width=""355"" height=""16"" font=""0"">have to address when applying for OIE recognition.</text>
<footnote top=""656"" left=""463"" width=""17"" height=""11"" font=""16"" number=""628"" ref="""" dis=""""/>
<text top=""657"" left=""480"" width=""311"" height=""16"" font=""0""> Further, the United States argues, both the </text>
<text top=""674"" left=""108"" width=""688"" height=""16"" font=""0"">Terrestrial Code and APHIS' system provide that an FMD-outbreak in a country or region </text>
<text top=""690"" left=""108"" width=""685"" height=""16"" font=""0"">recognized as FMD-free entails the suspension of such a status, which the country or region </text>
<text top=""707"" left=""108"" width=""682"" height=""16"" font=""0"">affected can recover if a new application is filed and a new determination is reached by the OIE or </text>
<text top=""723"" left=""108"" width=""140"" height=""16"" font=""0"">APHIS, respectively.</text>
<footnote top=""721"" left=""248"" width=""17"" height=""11"" font=""16"" number=""629"" ref="""" dis=""""/>
<text top=""723"" left=""266"" width=""527"" height=""16"" font=""0""> In light of the above, the United States contends that APHIS' regulatory </text>
<text top=""739"" left=""108"" width=""457"" height=""16"" font=""0"">system ""incorporates a substantial portion"" of the Terrestrial Code.</text>
<footnote top=""738"" left=""564"" width=""17"" height=""11"" font=""16"" number=""630"" ref="""" dis=""""/>
</p><p number=""7.206"" style=""8""><text top=""774"" left=""108"" width=""684"" height=""16"" font=""0"">7.206.  The United States observes, however, that some ""notable differences"" exist between the </text>
<text top=""790"" left=""108"" width=""488"" height=""16"" font=""0"">two systems, which stem from the United States' higher ALOP for FMD.</text>
<footnote top=""789"" left=""596"" width=""17"" height=""11"" font=""16"" number=""631"" ref="""" dis=""""/>
<text top=""790"" left=""613"" width=""177"" height=""16"" font=""0""> First, it contends, APHIS </text>
<text top=""807"" left=""108"" width=""682"" height=""16"" font=""0"">always performs site visits as part of its review process, whereas such a step is optional under the </text>
<text top=""823"" left=""108"" width=""83"" height=""16"" font=""0"">OIE system.</text>
<footnote top=""822"" left=""191"" width=""17"" height=""11"" font=""16"" number=""632"" ref="""" dis=""""/>
<text top=""823"" left=""208"" width=""582"" height=""16"" font=""0""> Second, the United States maintains, the OIE's evaluation of the FMD-status of an </text>
<text top=""839"" left=""108"" width=""683"" height=""16"" font=""0"">applicant Member ""often relies entirely"" on the information contained in that Member's dossier, as </text>
<text top=""856"" left=""108"" width=""333"" height=""16"" font=""0"">stated in Article 1.6.4 of the Terrestrial Code.</text>
<footnote top=""854"" left=""441"" width=""17"" height=""11"" font=""16"" number=""633"" ref="""" dis=""""/>
<text top=""856"" left=""458"" width=""335"" height=""16"" font=""0""> Third, the United States asserts that, unlike </text>
<text top=""872"" left=""108"" width=""683"" height=""16"" font=""0"">APHIS' procedures, the OIE's designation process ""does not involve the preparation of a full risk </text>
<footnote top=""905"" left=""165"" width=""532"" height=""15"" font=""10"" number=""15"" ref="""" dis=""""/>
<p><text top=""934"" left=""108"" width=""617"" height=""15"" font=""10"">Argentina's opening statement at the first meeting of the Panel, para. 36; Argentina's second written </text>
<footnote top=""949"" left=""108"" width=""135"" height=""15"" font=""10"" number=""99"" ref="""" dis=""""/>
<footnote top=""963"" left=""165"" width=""545"" height=""15"" font=""10"" number=""13"" ref="""" dis=""""/>
</p><p><text top=""978"" left=""165"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 17 following the first substantive meeting. </text>
<text top=""993"" left=""165"" width=""321"" height=""15"" font=""10""> United States' second written submission, para. 90. </text>
<text top=""1007"" left=""165"" width=""321"" height=""15"" font=""10""> United States' second written submission, para. 97. </text>
<footnote top=""1022"" left=""165"" width=""310"" height=""15"" font=""10"" number=""321"" ref="""" dis=""""/>
</p><p><text top=""1036"" left=""165"" width=""345"" height=""15"" font=""10""> United States' first written submission, paras. 333-334. </text>
<text top=""1051"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 334. </text>
<text top=""1066"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 335. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 98 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">assessment"" taking into account ""the particularized situation of both the exporting and importing </text>
<text top=""144"" left=""108"" width=""73"" height=""16"" font=""0"">Members"".</text>
<footnote top=""143"" left=""181"" width=""17"" height=""11"" font=""16"" number=""634"" ref="""" dis=""""/>
<text top=""144"" left=""198"" width=""597"" height=""16"" font=""0""> Fourth, in the United States' view, the process leading up to the FMD-status </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">determination of a Member is not as transparent as APHIS', in that the OIE does not publish a </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">""lengthy opinion"" to the membership but simply informs the applicant Member of the outcome of </text>
<text top=""193"" left=""108"" width=""660"" height=""16"" font=""0"">the evaluation, with ""a summary record"" of the ""reasons for a positive or negative outcome"".</text>
<footnote top=""192"" left=""768"" width=""17"" height=""11"" font=""16"" number=""635"" ref="""" dis=""""/>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">Finally, according to the United States, APHIS' system ""diverges slightly from the OIE's approach"" </text>
<text top=""226"" left=""108"" width=""500"" height=""16"" font=""0"">by not designating regions where vaccination is practised as ""FMD-free"".</text>
<footnote top=""225"" left=""608"" width=""17"" height=""11"" font=""16"" number=""636"" ref="""" dis=""""/>
<text top=""226"" left=""626"" width=""165"" height=""16"" font=""0""> However, according to </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">the United States, the authorization of imports of fresh (chilled or frozen) beef from Uruguay under </text>
<text top=""259"" left=""108"" width=""685"" height=""16"" font=""0"">the protocols set forth in 9 CFR 94.22 shows that, in certain circumstances, APHIS authorizes </text>
<text top=""275"" left=""108"" width=""687"" height=""16"" font=""0"">imports from countries that are characterized by the OIE as FMD-free where vaccination is </text>
<text top=""292"" left=""108"" width=""67"" height=""16"" font=""0"">practised.</text>
<footnote top=""290"" left=""175"" width=""17"" height=""11"" font=""16"" number=""637"" ref="""" dis=""""/>
</p></p></page>
<page number=""98"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.207"" style=""8""><text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">7.207.  The United States asserts that an SPS measure can be based on the relevant international </text>
<text top=""342"" left=""108"" width=""686"" height=""16"" font=""0"">standards, guidelines and recommendations and at the same time achieve a higher level of </text>
<text top=""359"" left=""108"" width=""73"" height=""16"" font=""0"">protection.</text>
<footnote top=""357"" left=""181"" width=""17"" height=""11"" font=""16"" number=""638"" ref="""" dis=""""/>
<text top=""359"" left=""199"" width=""592"" height=""16"" font=""0""> The United States argues that, in <i>EC &#8211; Hormones</i>, the Appellate Body found that an </text>
<text top=""375"" left=""108"" width=""682"" height=""16"" font=""0"">SPS measure may be based on an international standard by adopting ""some, not necessarily all, of </text>
<text top=""392"" left=""108"" width=""227"" height=""16"" font=""0"">the elements of [that] standard"".</text>
<footnote top=""390"" left=""335"" width=""17"" height=""11"" font=""16"" number=""639"" ref="""" dis=""""/>
<text top=""392"" left=""352"" width=""438"" height=""16"" font=""0""> For the United States, the ""binary choice"" between Articles 3.1 </text>
<text top=""408"" left=""108"" width=""688"" height=""16"" font=""0"">and 3.3 of the SPS Agreement set forth by Argentina erroneously conflates the based on </text>
<text top=""425"" left=""108"" width=""576"" height=""16"" font=""0"">requirement in Article 3.1 with the ""conform to"" requirement in Article 3.2.</text>
<footnote top=""423"" left=""684"" width=""17"" height=""11"" font=""16"" number=""640"" ref="""" dis=""""/>
<text top=""425"" left=""702"" width=""96"" height=""16"" font=""0""> Thus, the </text>
<text top=""441"" left=""108"" width=""682"" height=""16"" font=""0"">United States maintains that its measures are based on the Terrestrial Code even if APHIS reaches </text>
<text top=""457"" left=""108"" width=""685"" height=""16"" font=""0"">a different conclusion from the OIE on a particular application of the criteria for designating a </text>
<text top=""474"" left=""108"" width=""194"" height=""16"" font=""0"">country or zone disease free</text>
<footnote top=""472"" left=""302"" width=""17"" height=""11"" font=""16"" number=""641"" ref="""" dis=""""/>
<text top=""474"" left=""320"" width=""470"" height=""16"" font=""0"">, or if the timing of the OIE designation of disease-free status is not </text>
<text top=""490"" left=""108"" width=""690"" height=""16"" font=""0"">""synchronized with the timeframes of the appropriate regulatory authorities in Member </text>
<text top=""507"" left=""108"" width=""73"" height=""16"" font=""0"">countries.""</text>
<footnote top=""505"" left=""181"" width=""17"" height=""11"" font=""16"" number=""642"" ref="""" dis=""""/>
</p><p number=""7.208"" style=""8""><text top=""541"" left=""108"" width=""682"" height=""16"" font=""0"">7.208.  The United States argues that even if the Panel were to find that its measures comply with </text>
<text top=""557"" left=""108"" width=""574"" height=""16"" font=""0"">Article 3.1, such a finding would not be dispositive of Argentina's other claims</text>
<footnote top=""556"" left=""682"" width=""17"" height=""11"" font=""16"" number=""643"" ref="""" dis=""""/>
<text top=""557"" left=""699"" width=""94"" height=""16"" font=""0"">, because a </text>
<text top=""574"" left=""108"" width=""682"" height=""16"" font=""0"">measure consistent with Article 3.1 ""does not enjoy a presumption of consistency"" with the rest of </text>
<text top=""590"" left=""108"" width=""683"" height=""16"" font=""0"">the SPS Agreement and the GATT 1994. However, the United States notes that if the Panel were </text>
<text top=""607"" left=""108"" width=""685"" height=""16"" font=""0"">to find that the United States' measures comply with the obligations in Article 5, and thus the </text>
<text top=""623"" left=""108"" width=""525"" height=""16"" font=""0"">exception in Article 3.3, they would not be inconsistent with Article 3.1.</text>
<footnote top=""621"" left=""633"" width=""17"" height=""11"" font=""16"" number=""644"" ref="""" dis=""""/>
<text top=""623"" left=""651"" width=""143"" height=""16"" font=""0""> The United States </text>
<text top=""639"" left=""108"" width=""688"" height=""16"" font=""0"">nevertheless also maintains that Article 3.3 of the SPS Agreement does not apply to the </text>
<text top=""656"" left=""108"" width=""684"" height=""16"" font=""0"">United States' measures because APHIS ""has not concluded its regulatory process and issued a </text>
<text top=""672"" left=""108"" width=""682"" height=""16"" font=""0"">final determination on Argentina's requests"", whereas the provision in question only applies ""when </text>
<text top=""689"" left=""108"" width=""539"" height=""16"" font=""0"">an SPS measure has been 'introduced and maintained' in a particular manner"".</text>
<footnote top=""687"" left=""647"" width=""17"" height=""11"" font=""16"" number=""645"" ref="""" dis=""""/>
</p><p number=""7.4"" style=""8""><text top=""723"" left=""108"" width=""337"" height=""16"" font=""28"">7.4.2.2  Main arguments of the third parties </text></p><p number=""7.4"" style=""8""><text top=""757"" left=""108"" width=""150"" height=""16"" font=""28"">7.4.2.2.1  Australia </text></p><p number=""7.209"" style=""8""><text top=""792"" left=""108"" width=""59"" height=""16"" font=""0"">7.209. </text>
<text top=""792"" left=""162"" width=""560"" height=""16"" font=""0"">Relying on past Appellate Body reports, Australia notes that Article </text>
<text top=""792"" left=""712"" width=""88"" height=""16"" font=""0"">3 of the </text>
<text top=""808"" left=""108"" width=""689"" height=""16"" font=""0"">SPS Agreement expressly recognizes the right of WTO Members to determine their own </text>
<text top=""825"" left=""108"" width=""211"" height=""16"" font=""0"">appropriate level of protection.</text>
<footnote top=""823"" left=""319"" width=""17"" height=""11"" font=""16"" number=""646"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""588"" height=""15"" font=""10""> Australia's third-party submission, paras. 9-12; Australia's third-party statement, paras. 10-13. </ftext>
<ftext top=""978"" left=""108"" width=""79"" height=""15"" font=""10"">paras. 5-11. </ftext>
</footnote>
<text top=""825"" left=""336"" width=""454"" height=""16"" font=""0""> Based on the reasoning of the Appellate Body in <i>EC &#8211; Hormones</i>, </text>
<footnote top=""905"" left=""165"" width=""623"" height=""15"" font=""10"" number=""14"" ref=""WT/DS26/AB/R ; WT/DS48/AB/R"" dis=""DS26""><ftext top=""1022"" left=""108"" width=""665"" height=""15"" font=""10"">Appellate Body Report, <i>EC &#8211; Hormones</i>, paras. 165-171). See also United States' second written submission, </ftext>
</footnote>
<p><text top=""920"" left=""165"" width=""329"" height=""15"" font=""10""> United States' second written submission, para. 109. </text>
<footnote top=""978"" left=""165"" width=""617"" height=""15"" font=""10"" number=""73"" ref="""" dis=""""/>
</p><p><text top=""993"" left=""108"" width=""668"" height=""15"" font=""10"">para. 171). See also United States' response to Panel question No. 14 following the first substantive meeting. </text>
</p><p><text top=""1066"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 339. </text>
<text top=""1080"" left=""165"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 16 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""427"" width=""44"" height=""16"" font=""0"">- 99 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">it also asserts that there is a distinction between the terms based on in Article 3.1 and ""conform </text>
<text top=""144"" left=""108"" width=""413"" height=""16"" font=""0"">to"" in Article 3.2, with the latter imposing a higher standard.</text>
<footnote top=""143"" left=""521"" width=""17"" height=""11"" font=""16"" number=""647"" ref=""WT/DS26/AB/R ; WT/DS48/AB/R"" dis=""DS26""><ftext top=""905"" left=""165"" width=""598"" height=""15"" font=""10""> Australia's third-party submission, paras. 14-17 (quoting Appellate Body Report, <i>EC &#8211; Hormones</i>, </ftext>
<ftext top=""920"" left=""108"" width=""366"" height=""15"" font=""10"">para. 163); Australia's third-party statement, paras. 17-18. </ftext>
</footnote>
</p></p></page>
<page number=""99"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.4"" style=""8""><text top=""178"" left=""108"" width=""125"" height=""16"" font=""28"">7.4.2.2.2  Brazil </text></p><p number=""7.210"" style=""8""><text top=""213"" left=""108"" width=""683"" height=""16"" font=""0"">7.210.  In Brazil's view, the architecture of Article 3 of the SPS Agreement does not preclude the </text>
<text top=""229"" left=""108"" width=""682"" height=""16"" font=""0"">possibility that a measure be based on an international standard and, at the same time, achieve a </text>
<text top=""246"" left=""108"" width=""88"" height=""16"" font=""0"">higher ALOP.</text>
<footnote top=""244"" left=""196"" width=""17"" height=""11"" font=""16"" number=""648"" ref="""" dis=""""/>
<text top=""246"" left=""214"" width=""576"" height=""16"" font=""0""> This is because, Brazil argues, the Appellate Body found that the words ""based on"" </text>
<text top=""262"" left=""108"" width=""589"" height=""16"" font=""0"">in Article 3.1 should be read differently from the words ""conform to"" in Article 3.2.</text>
<footnote top=""261"" left=""697"" width=""17"" height=""11"" font=""16"" number=""649"" ref="""" dis=""""/>
<text top=""262"" left=""714"" width=""78"" height=""16"" font=""0""> However, </text>
<text top=""278"" left=""108"" width=""684"" height=""16"" font=""0"">even if the United States' measures were found to be based on the OIE standards, guidelines or </text>
<text top=""295"" left=""108"" width=""687"" height=""16"" font=""0"">recommendations, they should still ""be duly justified by a scientific reason"" in order to be </text>
<text top=""311"" left=""108"" width=""186"" height=""16"" font=""0"">consistent with Article 3.3.</text>
<footnote top=""310"" left=""294"" width=""17"" height=""11"" font=""16"" number=""650"" ref="""" dis=""""/>
<text top=""311"" left=""311"" width=""481"" height=""16"" font=""0""> Finally, Brazil observes that the OIE's FMD-status designations for </text>
<text top=""328"" left=""108"" width=""683"" height=""16"" font=""0"">specific countries or regions are issued ""according to the procedures applicable to the adoption of </text>
<text top=""344"" left=""108"" width=""234"" height=""16"" font=""0"">standards and recommendations"".</text>
<footnote top=""343"" left=""342"" width=""17"" height=""11"" font=""16"" number=""651"" ref="""" dis=""""/>
</p><p number=""7.4"" style=""8""><text top=""378"" left=""108"" width=""124"" height=""16"" font=""28"">7.4.2.2.3  China </text></p><p number=""7.211"" style=""8""><text top=""413"" left=""108"" width=""684"" height=""16"" font=""0"">7.211.  In China's opinion, the two parties are arguing different things, in that Argentina claims </text>
<text top=""429"" left=""108"" width=""684"" height=""16"" font=""0"">that the United States' ""import ban"" on Argentine and Patagonian products is not based on an </text>
<text top=""446"" left=""108"" width=""682"" height=""16"" font=""0"">international standard, whereas the United States argues that APHIS' ""application system"" is based </text>
<text top=""462"" left=""108"" width=""220"" height=""16"" font=""0"">on the international standard.</text>
<footnote top=""461"" left=""328"" width=""17"" height=""11"" font=""16"" number=""652"" ref="""" dis=""""/>
<text top=""462"" left=""345"" width=""450"" height=""16"" font=""0""> According to China, the relevant question is whether the </text>
<text top=""479"" left=""108"" width=""686"" height=""16"" font=""0"">United States' prohibitions on imports from Argentina and Patagonia are based on the OIE's </text>
<text top=""495"" left=""108"" width=""72"" height=""16"" font=""0"">standards.</text>
<footnote top=""493"" left=""180"" width=""17"" height=""11"" font=""16"" number=""653"" ref="""" dis=""""/>
<text top=""495"" left=""197"" width=""598"" height=""16"" font=""0""> In its view, the United States' measures are not based on the OIE standards </text>
<text top=""511"" left=""108"" width=""684"" height=""16"" font=""0"">because, unlike the APHIS regulatory scheme, the Terrestrial Code does not prohibit trade, but </text>
<text top=""528"" left=""108"" width=""682"" height=""16"" font=""0"">simply ""require[s] the exporting country, transit country and importing countries to <i>consider  </i>the </text>
<text top=""544"" left=""108"" width=""496"" height=""16"" font=""0"">animal health situation before determining the requirements for trade"".</text>
<footnote top=""543"" left=""604"" width=""17"" height=""11"" font=""16"" number=""654"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""621"" height=""15"" font=""10""> China's third-party submission, para. 16 (emphasis original); China's third-party statement, para. 11 </ftext>
</footnote>
<text top=""544"" left=""622"" width=""169"" height=""16"" font=""0""> China further observes </text>
<text top=""561"" left=""108"" width=""682"" height=""16"" font=""0"">that, in <i>EC &#8211; Hormones</i>, the Appellate Body left open the question whether, for an SPS measure to </text>
<text top=""577"" left=""108"" width=""684"" height=""16"" font=""0"">be based on an international standard; the measure needs to reflect the same level of sanitary </text>
<text top=""593"" left=""108"" width=""191"" height=""16"" font=""0"">protection as the standard.</text>
<footnote top=""592"" left=""299"" width=""17"" height=""11"" font=""16"" number=""655"" ref="""" dis=""""/>
<text top=""593"" left=""317"" width=""475"" height=""16"" font=""0""> In China's view, the references in Article 3.3 to ""measures which </text>
<text top=""610"" left=""108"" width=""682"" height=""16"" font=""0"">result in a level of sanitary or phytosanitary protection different from <i>that</i> which would be achieved </text>
<text top=""626"" left=""108"" width=""684"" height=""16"" font=""0"">by measures based on international standards, guidelines or recommendations"" suggests that a </text>
<text top=""643"" left=""108"" width=""682"" height=""16"" font=""0"">particular ALOP is implied or reflected in every given international standard, and that in order to be </text>
<text top=""659"" left=""108"" width=""592"" height=""16"" font=""0"">based on such international standard, an SPS measure should achieve the same ALOP.</text>
<footnote top=""657"" left=""699"" width=""17"" height=""11"" font=""16"" number=""656"" ref="""" dis=""""/>
</p><p number=""7.212"" style=""8""><text top=""693"" left=""108"" width=""683"" height=""16"" font=""0"">7.212.  China agrees with the United States that the OIE's FMD-status determinations for specific </text>
<text top=""710"" left=""108"" width=""684"" height=""16"" font=""0"">countries or regions do not constitute standards, guidelines or recommendations, but rather an </text>
<text top=""726"" left=""108"" width=""133"" height=""16"" font=""0"">application thereof.</text>
<footnote top=""725"" left=""241"" width=""17"" height=""11"" font=""16"" number=""657"" ref="""" dis=""""/>
<text top=""726"" left=""258"" width=""533"" height=""16"" font=""0""> However, China also submits that such determinations are ""of value for an </text>
<text top=""743"" left=""108"" width=""688"" height=""16"" font=""0"">importing Member to develop an SPS measure"" and ""for a panel to evaluate whether the </text>
<text top=""759"" left=""108"" width=""685"" height=""16"" font=""0"">SPS measure is based on the OIE standard"", in that they indicate that, in the OIE's view, the </text>
<text top=""775"" left=""108"" width=""570"" height=""16"" font=""0"">SPS characteristics of a specific country or region meet the OIE's standard for FMD.</text>
<footnote top=""774"" left=""677"" width=""17"" height=""11"" font=""16"" number=""658"" ref="""" dis=""""/>
</p><p number=""7.4"" style=""8""><text top=""810"" left=""108"" width=""202"" height=""16"" font=""28"">7.4.2.2.4  European Union </text></p><p number=""7.213"" style=""8""><text top=""844"" left=""108"" width=""682"" height=""16"" font=""0"">7.213.  The European Union argues that Argentina has cited inapposite provisions of the Terrestrial </text>
<text top=""861"" left=""108"" width=""686"" height=""16"" font=""0"">Code in supporting its claims under Article 3.1. In particular, the European Union notes that </text>
<footnote top=""934"" left=""165"" width=""329"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""/>
<footnote top=""963"" left=""165"" width=""577"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""/>
<footnote top=""1007"" left=""165"" width=""379"" height=""15"" font=""10"" number=""15"" ref="""" dis=""""/>
<p><text top=""1051"" left=""108"" width=""373"" height=""15"" font=""10"">(quoting Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 163). </text>
</p><p><text top=""1080"" left=""108"" width=""142"" height=""15"" font=""12""><i>Hormones</i>, para. 168). </text>
<footnote top=""1109"" left=""165"" width=""330"" height=""15"" font=""10"" number=""3"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 100 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina refers to the provisions of the Terrestrial Code dealing with countries that are FMD-free </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">(either with vaccination or without), whereas the challenged measure [9 CFR 94.1(b)] deals with </text>
<text top=""160"" left=""108"" width=""241"" height=""16"" font=""0"">countries that are <i>not</i> FMD-free.</text>
<footnote top=""159"" left=""349"" width=""17"" height=""11"" font=""16"" number=""659"" ref="""" dis=""""/>
<text top=""160"" left=""367"" width=""429"" height=""16"" font=""0""> Furthermore, the European Union asserts that the two </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">Articles of the Terrestrial Code to which Argentina refers (i.e. Articles 8.5.22 and 8.5.23) do not </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">provide any recommendation as to the conditions that a country or region should fulfil in order to </text>
<text top=""210"" left=""108"" width=""382"" height=""16"" font=""0"">fall within one of the relevant FMD-free categories.</text>
<footnote top=""208"" left=""490"" width=""17"" height=""11"" font=""16"" number=""660"" ref="""" dis=""""/>
<text top=""210"" left=""507"" width=""288"" height=""16"" font=""0""> The European Union also notes that </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina does not refer to the Articles of the Terrestrial Code that address procedures to be </text>
<text top=""242"" left=""108"" width=""660"" height=""16"" font=""0"">followed in relation to imports of meat from areas that are not considered to be FMD-free.</text>
<footnote top=""241"" left=""768"" width=""17"" height=""11"" font=""16"" number=""661"" ref="""" dis=""""/>
<text top=""259"" left=""108"" width=""684"" height=""16"" font=""0"">Therefore, the European Union contends that Argentina has not made a <i>prima facie</i> case for its </text>
<text top=""275"" left=""108"" width=""166"" height=""16"" font=""0"">claims under Article 3.1.</text>
<footnote top=""274"" left=""274"" width=""17"" height=""11"" font=""16"" number=""662"" ref="""" dis=""""/>
</p></p></page>
<page number=""100"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.214"" style=""8""><text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">7.214.  Moreover, the European Union argues that because Article 3.3 only applies if a measure is </text>
<text top=""326"" left=""108"" width=""684"" height=""16"" font=""0"">not based on the relevant international standards, to make a <i>prima facie</i> case the complainant </text>
<text top=""342"" left=""108"" width=""686"" height=""16"" font=""0"">must show that the challenged measure is not based on the relevant identified international </text>
<text top=""359"" left=""108"" width=""65"" height=""16"" font=""0"">standard.</text>
<footnote top=""357"" left=""173"" width=""17"" height=""11"" font=""16"" number=""663"" ref="""" dis=""""/>
<text top=""359"" left=""190"" width=""601"" height=""16"" font=""0""> The European Union contends that the same deficiencies in Argentina's identification </text>
<text top=""375"" left=""108"" width=""683"" height=""16"" font=""0"">of the relevant international standards under Article 3.1 apply to its claims under Article 3.3; thus </text>
<text top=""392"" left=""108"" width=""479"" height=""16"" font=""0"">Argentina has also failed to make a <i>prima facie</i> case under Article 3.3.</text>
<footnote top=""390"" left=""587"" width=""17"" height=""11"" font=""16"" number=""664"" ref="""" dis=""""/>
</p><p number=""7.215"" style=""8""><text top=""426"" left=""108"" width=""685"" height=""16"" font=""0"">7.215.  The European Union notes that the Appellate Body in <i>EC &#8211; Hormones</i> did not specify </text>
<text top=""443"" left=""108"" width=""688"" height=""16"" font=""0"">whether a measure achieving a higher ALOP than an international standard, guideline or </text>
<text top=""459"" left=""108"" width=""417"" height=""16"" font=""0"">recommendation may, nonetheless, be ""based"" thereupon.</text>
<footnote top=""457"" left=""525"" width=""17"" height=""11"" font=""16"" number=""665"" ref="""" dis=""""/>
<text top=""459"" left=""542"" width=""251"" height=""16"" font=""0""> In the European Union's opinion, </text>
<text top=""475"" left=""108"" width=""684"" height=""16"" font=""0"">finding that a measure is based on an international standard, guideline or recommendation only </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">where it achieves the same ALOP would conflate the words based on in Article 3.1 and ""conform </text>
<text top=""508"" left=""108"" width=""414"" height=""16"" font=""0"">to"" in Article 3.2, contrary to the decision in <i>EC -</i> <i>Hormones</i>.</text>
<footnote top=""507"" left=""522"" width=""17"" height=""11"" font=""16"" number=""666"" ref="""" dis=""""/>
<text top=""508"" left=""540"" width=""251"" height=""16"" font=""0""> Moreover, the European Union also </text>
<text top=""525"" left=""108"" width=""683"" height=""16"" font=""0"">believes that the words ""based on"" are not dependent on the ""level of protection achieved"" by a </text>
<text top=""541"" left=""108"" width=""577"" height=""16"" font=""0"">measure because: (i) Article 3.1 does not refer to the ""level of protection achieved""</text>
<footnote top=""539"" left=""685"" width=""17"" height=""11"" font=""16"" number=""667"" ref="""" dis=""""/>
<text top=""541"" left=""702"" width=""88"" height=""16"" font=""0""> and (ii) the </text>
<text top=""557"" left=""108"" width=""683"" height=""16"" font=""0"">reference in Article 3.1 to ""except <i>as otherwise provided for in this Agreement</i> and in particular in </text>
<text top=""574"" left=""108"" width=""683"" height=""16"" font=""0"">paragraph 3"" suggests that Article 3.3 is ""just one of the possible legal bases that would allow a </text>
<text top=""590"" left=""108"" width=""528"" height=""16"" font=""0"">Member to adopt a measure that is not 'based on' an international standard"".</text>
<footnote top=""589"" left=""635"" width=""17"" height=""11"" font=""16"" number=""668"" ref="""" dis=""""/>
</p><p number=""7.216"" style=""8""><text top=""625"" left=""108"" width=""684"" height=""16"" font=""0"">7.216.  For the European Union, an SPS measure that selectively incorporates certain aspects of </text>
<text top=""641"" left=""108"" width=""682"" height=""16"" font=""0"">an international standard, guideline or recommendation, and thus ""<i>re-casts</i> as a whole the balance </text>
<text top=""657"" left=""108"" width=""686"" height=""16"" font=""0"">of provisions"" contained therein, does not ""conform to"" nor is it based on the international </text>
<text top=""674"" left=""108"" width=""367"" height=""16"" font=""0"">standard, guideline or recommendation in question.</text>
<footnote top=""672"" left=""474"" width=""17"" height=""11"" font=""16"" number=""669"" ref="""" dis=""""/>
<text top=""674"" left=""492"" width=""301"" height=""16"" font=""0""> In such a case, ""Article 3.3 governs the </text>
<text top=""690"" left=""108"" width=""114"" height=""16"" font=""0"">entire measure"".</text>
<footnote top=""689"" left=""222"" width=""17"" height=""11"" font=""16"" number=""670"" ref="""" dis=""""/>
</p><p number=""7.4"" style=""8""><text top=""725"" left=""108"" width=""229"" height=""16"" font=""28"">7.4.2.3  Analysis by the Panel </text></p><p number=""7.217"" style=""8""><text top=""759"" left=""108"" width=""57"" height=""16"" font=""0"">7.217. </text>
<text top=""759"" left=""162"" width=""56"" height=""16"" font=""0"">Article </text>
<text top=""759"" left=""209"" width=""589"" height=""16"" font=""0"">3 specifies the path towards achieving one of the key purposes of the </text>
<text top=""775"" left=""108"" width=""659"" height=""16"" font=""0"">SPS Agreement as set forth in the Preamble of the SPS Agreement, which states that Members: </text>
<p><text top=""810"" left=""151"" width=""602"" height=""16"" font=""0"">Desir[e] to further the use of harmonized sanitary and phytosanitary measures </text>
<text top=""826"" left=""151"" width=""606"" height=""16"" font=""0"">between Members, on the basis of international standards, guidelines and </text>
<text top=""843"" left=""151"" width=""597"" height=""16"" font=""0"">recommendations developed by the relevant international organizations, including the </text>
<text top=""859"" left=""151"" width=""603"" height=""16"" font=""0"">Codex Alimentarius Commission, the International Office of Epizootics, and the </text>
<text top=""875"" left=""151"" width=""599"" height=""16"" font=""0"">relevant international and regional organizations operating within the framework of </text>
</p><p><text top=""963"" left=""165"" width=""345"" height=""15"" font=""10""> European Union's third-party submission, paras. 32-33. </text>
<text top=""978"" left=""165"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 34. </text>
<text top=""993"" left=""165"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 35. </text>
<text top=""1007"" left=""165"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 37. </text>
<text top=""1022"" left=""165"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 40. </text>
<text top=""1036"" left=""165"" width=""345"" height=""15"" font=""10""> European Union's third-party submission, paras. 41-42. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 101 - </text>
</p><p><text top=""128"" left=""151"" width=""599"" height=""16"" font=""0"">the International Plant Protection Convention, without requiring Members to change </text>
<text top=""144"" left=""151"" width=""519"" height=""16"" font=""0"">their appropriate level of protection of human, animal or plant life or health.</text>
<footnote top=""143"" left=""669"" width=""17"" height=""11"" font=""16"" number=""671"" ref="""" dis=""""/>
</p></p></page>
<page number=""101"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.218"" style=""8""><text top=""178"" left=""108"" width=""684"" height=""16"" font=""0"">7.218.  Although only Articles 3.1 and 3.3 are raised in this dispute, we note that the Appellate </text>
<text top=""195"" left=""108"" width=""687"" height=""16"" font=""0"">Body set forth its understanding of the meaning of the term ""based on"" in Article 3.1 by </text>
<text top=""211"" left=""108"" width=""685"" height=""16"" font=""0"">contrasting it with the term ""conform to"" in Article 3.2. The Appellate Body recognized that a </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">measure that ""conforms to"" and incorporates an international standard is, of course, based on that </text>
<text top=""244"" left=""108"" width=""687"" height=""16"" font=""0"">standard. However, the Appellate Body reasoned that the two provisions must have some </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">distinction between their scopes of application. Thus, while the Appellate Body found the ordinary </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">meaning of ""conform to"" to mean ""'comply with', 'yield or show compliance' with the latter,"" it </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">explained that ""[a] thing is commonly said to be 'based on' another thing when the former 'stands' </text>
<text top=""310"" left=""108"" width=""684"" height=""16"" font=""0"">or is 'founded' or 'built' upon or 'is supported by' the latter."" Therefore, the Appellate Body also </text>
<text top=""326"" left=""108"" width=""682"" height=""16"" font=""0"">concluded that a measure might be based on a standard yet not conform to it if only some, not all, </text>
<text top=""342"" left=""108"" width=""457"" height=""16"" font=""0"">of the elements of the standard are incorporated into the measure.</text>
<footnote top=""341"" left=""565"" width=""17"" height=""11"" font=""16"" number=""672"" ref="""" dis=""""/>
</p><p number=""7.219"" style=""8""><text top=""377"" left=""108"" width=""683"" height=""16"" font=""0"">7.219.  As the panel in <i>India &#8211; Agricultural Products</i> noted, the guidance from the Appellate Body </text>
<text top=""393"" left=""108"" width=""684"" height=""16"" font=""0"">implies that the ""based on"" threshold in Article 3.1 is lower than the ""conform to"" threshold in </text>
<text top=""410"" left=""108"" width=""75"" height=""16"" font=""0"">Article 3.2.</text>
<footnote top=""408"" left=""183"" width=""17"" height=""11"" font=""16"" number=""673"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1036"" left=""165"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.203. </ftext>
</footnote>
<text top=""410"" left=""200"" width=""593"" height=""16"" font=""0""> However, knowing that ""based on"" is less than ""conform to"" is not sufficient for </text>
<text top=""426"" left=""108"" width=""685"" height=""16"" font=""0"">understanding the concept. We find merit in the approach of the panel in <i>India &#8211; Agricultural </i></text>
<text top=""443"" left=""108"" width=""685"" height=""16"" font=""18""><i>Products</i> which found that an understanding of ""based on"" should be guided by the Appellate </text>
<text top=""459"" left=""108"" width=""685"" height=""16"" font=""0"">Body's interpretation of the term ""as a basis for"" in Article 2.4 of the TBT Agreement in <i>EC &#8211; </i></text>
<p><text top=""475"" left=""108"" width=""64"" height=""16"" font=""32"">Sardines.</text><footnote top=""474"" left=""172"" width=""17"" height=""11"" font=""16"" number=""674"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1051"" left=""165"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.266. </ftext>
</footnote>
</p><p><text top=""475"" left=""189"" width=""604"" height=""16"" font=""18""><i>  </i>In  <i>EC &#8211; Sardines, </i>the Appellate Body upheld the panel's finding that the ordinary </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">meaning of the term ""basis"" was ""the principal constituent of anything, the fundamental principle </text>
<text top=""508"" left=""108"" width=""282"" height=""16"" font=""0"">or theory, as of a system of knowledge"".</text>
<footnote top=""507"" left=""390"" width=""20"" height=""11"" font=""16"" number=""675"" ref=""WT/DS231/AB/R|WT/DS231/R|WT/DS231/R/Corr.1"" dis=""DS231""><ftext top=""1066"" left=""165"" width=""575"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Sardines</i>,<i> </i>paras. 243-245. See also Panel Report, <i>EC &#8211; Sardines</i>, </ftext>
<ftext top=""1080"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.110. </ftext>
</footnote>
<text top=""508"" left=""411"" width=""379"" height=""16"" font=""0"">The Appellate Body also concluded that there must be </text>
<text top=""525"" left=""108"" width=""682"" height=""16"" font=""0"">a very strong and very close relationship between two things in order to be able to say that one is </text>
<text top=""541"" left=""108"" width=""184"" height=""16"" font=""0"">""the basis for"" the other.</text>
<footnote top=""539"" left=""292"" width=""17"" height=""11"" font=""16"" number=""676"" ref="""" dis=""""/>
<text top=""541"" left=""309"" width=""484"" height=""16"" font=""0""> Finally, while it declined to define ""in general the nature of the </text>
<text top=""557"" left=""108"" width=""685"" height=""16"" font=""0"">relationship that must exist for an international standard to serve 'as a basis for' a technical </text>
<text top=""574"" left=""108"" width=""683"" height=""16"" font=""0"">regulation"", the Appellate Body did note that ""at a minimum &#8230; something cannot be considered a </text>
<text top=""590"" left=""108"" width=""373"" height=""16"" font=""0"">'basis' for something else if the two are <i>contradictory</i>.""</text>
<footnote top=""589"" left=""481"" width=""17"" height=""11"" font=""16"" number=""677"" ref="""" dis=""""/>
</p></p><p number=""7.220"" style=""8""><text top=""625"" left=""108"" width=""688"" height=""16"" font=""0"">7.220.  Extrapolating from this reasoning, we find it equally viable to say that where an </text>
<text top=""641"" left=""108"" width=""686"" height=""16"" font=""0"">SPS measure and the relevant international standard, guideline or recommendation contradict </text>
<text top=""657"" left=""108"" width=""683"" height=""16"" font=""0"">each other, the SPS measure cannot be said to be based on that international standard, guideline </text>
<text top=""674"" left=""108"" width=""138"" height=""16"" font=""0"">or recommendation.</text>
<footnote top=""672"" left=""246"" width=""17"" height=""11"" font=""16"" number=""678"" ref=""WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430""><ftext top=""1124"" left=""165"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.269. </ftext>
<ftext top=""774"" left=""108"" width=""616"" height=""15"" font=""10"">for products or related processes and production methods, with which compliance is not mandatory."" </ftext>
<ftext top=""788"" left=""108"" width=""662"" height=""15"" font=""10"">(emphasis added) In interpreting this provision and the ISO/IEC Guide, the Appellate Body reasoned in <i>EC &#8211; </i></ftext>
<ftext top=""818"" left=""108"" width=""320"" height=""15"" font=""10"">approval comes about (i.e. consensus, voting, etc.). </ftext>
<ftext top=""905"" left=""108"" width=""681"" height=""15"" font=""10"">versions of the Terrestrial Code in their submissions. The Panel is aware that the latest edition of the Terrestrial </ftext>
<ftext top=""920"" left=""108"" width=""650"" height=""15"" font=""10"">Code is the one that contains the most up-to-date evaluation by the Code Commission reflecting the latest </ftext>
<ftext top=""934"" left=""108"" width=""681"" height=""15"" font=""10"">scientific knowledge. However, the text of the FMD provisions has remained largely the same. Furthermore, the </ftext>
<ftext top=""949"" left=""108"" width=""631"" height=""15"" font=""10"">Panel is mindful of its duty to protect the due process rights of the parties and not have the respondent </ftext>
<ftext top=""963"" left=""108"" width=""628"" height=""15"" font=""10"">answering a case based on information that did not exist at the time of the establishment of the Panel. </ftext>
<ftext top=""978"" left=""108"" width=""627"" height=""15"" font=""10"">Therefore, we concur with the panel in <i>India &#8211; Agricultural Products</i> that the appropriate version of the </ftext>
<ftext top=""993"" left=""108"" width=""681"" height=""15"" font=""10"">Terrestrial Code to serve as a reference point for analysing Argentina's claims under Article 3.1 is the version in </ftext>
<ftext top=""1007"" left=""108"" width=""642"" height=""15"" font=""10"">force on the date of establishment of the Panel, the 21st edition (2012). Therefore, the Panel will refer to </ftext>
<ftext top=""1022"" left=""108"" width=""661"" height=""15"" font=""10"">Chapter 8.5 throughout its findings. See e.g. Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.211-7.213. </ftext>
</footnote>
</p><p number=""7.221"" style=""8""><text top=""708"" left=""108"" width=""686"" height=""16"" font=""0"">7.221.  The Panel will first determine whether the United States' measures are based on the </text>
<text top=""725"" left=""108"" width=""682"" height=""16"" font=""0"">relevant international standards, guidelines or recommendations within the meaning of Article 3.1, </text>
<text top=""741"" left=""108"" width=""474"" height=""16"" font=""0"">before turning to a discussion of Argentina's claim under Article 3.3.  </text>
</p><p number=""7.222"" style=""8""><text top=""775"" left=""108"" width=""682"" height=""16"" font=""0"">7.222.  Pursuant to the text of the provision and guidance from the Appellate Body, an assessment </text>
<text top=""792"" left=""108"" width=""684"" height=""16"" font=""0"">of consistency with Article 3.1 requires a two-step analysis. First, the Panel needs to determine </text>
<text top=""808"" left=""108"" width=""684"" height=""16"" font=""0"">whether one or more of the international standard-setting bodies identified in Annex A(3) have </text>
<text top=""825"" left=""108"" width=""686"" height=""16"" font=""0"">established standards, guidelines or recommendations relevant to the measure(s). If relevant </text>
<text top=""841"" left=""108"" width=""684"" height=""16"" font=""0"">international standards, guidelines or recommendations exist, the Panel must then compare the </text>
<text top=""857"" left=""108"" width=""689"" height=""16"" font=""0"">challenged measure(s) to the international standards, guidelines or recommendations and </text>
<text top=""874"" left=""108"" width=""690"" height=""16"" font=""0"">determine whether the measure(s) are based on the relevant international standard(s), </text>
<text top=""890"" left=""108"" width=""247"" height=""16"" font=""0"">guideline(s) or recommendation(s). </text>
<p><text top=""963"" left=""165"" width=""592"" height=""15"" font=""10""> Preamble to the SPS Agreement, para. 6. We recall that the Appellate Body has determined that </text>
<text top=""978"" left=""108"" width=""598"" height=""15"" font=""10"">harmonization of SPS measures of Members on the basis of international standards is projected in </text>
<text top=""993"" left=""108"" width=""626"" height=""15"" font=""10"">the Agreement, as a <i>goal</i>, yet to be realized in the <i>future.</i> See Appellate Body Report, <i>EC &#8211; Hormones</i>, </text>
<text top=""1007"" left=""108"" width=""71"" height=""15"" font=""10"">para. 165.  </text>
<text top=""1022"" left=""165"" width=""316"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 163. </text>
</p><p><text top=""1095"" left=""165"" width=""307"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Sardines</i>, para. 245. </text>
<text top=""1109"" left=""165"" width=""428"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Sardines</i>,<i> </i>para. 248 (emphasis original). </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 102 - </text>
</p></p></page>
<page number=""102"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.223"" style=""8""><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">7.223.  In making our determination, we will examine whether the United States' measures </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">applicable to imports of fresh (chilled or frozen) beef from Northern Argentina are based on the </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">relevant provisions of the international standard, guideline or recommendation. Then we will turn </text>
<text top=""177"" left=""108"" width=""669"" height=""16"" font=""0"">to perform a similar analysis with respect to the United States' measures applicable to Patagonia. </text>
</p><p number=""7.4"" style=""8""><text top=""211"" left=""108"" width=""496"" height=""16"" font=""28"">7.4.2.3.1  Fresh (chilled or frozen) beef from Northern Argentina </text></p><p number=""7.4"" style=""8""><text top=""246"" left=""108"" width=""686"" height=""16"" font=""28"">7.4.2.3.1.1  Whether a relevant international standard, guideline or recommendation </text><text top=""262"" left=""108"" width=""49"" height=""16"" font=""28"">exists </text></p><p number=""7.224"" style=""8""><text top=""296"" left=""108"" width=""684"" height=""16"" font=""0"">7.224.  With respect to whether a relevant international standard, guideline or recommendation </text>
<text top=""313"" left=""108"" width=""683"" height=""16"" font=""0"">exists, we note that Annex A(3) of the SPS Agreement designates the OIE as the relevant source </text>
<text top=""329"" left=""108"" width=""684"" height=""16"" font=""0"">for standards, guidelines or recommendations for measures relating to animal health. Thus the </text>
<text top=""346"" left=""108"" width=""683"" height=""16"" font=""0"">relevant international standards, guidelines or recommendations for a measure taken pursuant to </text>
<text top=""362"" left=""108"" width=""684"" height=""16"" font=""0"">Annex A(1)(a) &#8211; that is, to protect animal health from the entry, establishment, or spread of a </text>
<text top=""378"" left=""108"" width=""397"" height=""16"" font=""0"">pest or disease &#8211; would be those promulgated by the OIE.</text>
<footnote top=""377"" left=""505"" width=""17"" height=""11"" font=""16"" number=""679"" ref="""" dis=""""><ftext top=""730"" left=""165"" width=""613"" height=""15"" font=""10""> Although not directly relevant in the SPS context, we note that a similar understanding is embodied </ftext>
</footnote>
</p><p number=""7.225"" style=""8""><text top=""413"" left=""108"" width=""689"" height=""16"" font=""0"">7.225.   Both parties identify the Terrestrial Code as the relevant international standards, </text>
<text top=""429"" left=""108"" width=""431"" height=""16"" font=""0"">guidelines or recommendations for the purpose of this dispute.</text>
<footnote top=""428"" left=""538"" width=""17"" height=""11"" font=""16"" number=""680"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""832"" left=""165"" width=""624"" height=""15"" font=""10""> This is supported by the finding of the panel in <i>India &#8211; Agricultural Products</i> that the Terrestrial Code, </ftext>
<ftext top=""847"" left=""108"" width=""669"" height=""15"" font=""10"">in particular Chapter 10.4, contained relevant international standards, guidelines or recommendations. (Panel </ftext>
<ftext top=""861"" left=""108"" width=""314"" height=""15"" font=""10"">Report, <i>India &#8211; Agricultural Products</i>, para. 7.206)  </ftext>
</footnote>
<text top=""429"" left=""556"" width=""234"" height=""16"" font=""0""> Both parties refer to Chapter 8.5 </text>
<text top=""446"" left=""108"" width=""155"" height=""16"" font=""0"">of the Terrestrial Code</text>
<footnote top=""444"" left=""263"" width=""17"" height=""11"" font=""16"" number=""681"" ref="""" dis=""""><ftext top=""876"" left=""165"" width=""616"" height=""15"" font=""10""> We note that the chapter numbers for the FMD provisions have changed from 8.5 in the 21st edition </ftext>
<ftext top=""891"" left=""108"" width=""140"" height=""15"" font=""10"">(2012) to 8.6 in the 22</ftext>
<ftext top=""890"" left=""248"" width=""9"" height=""9"" font=""10"">nd</ftext>
<ftext top=""891"" left=""257"" width=""228"" height=""15"" font=""10""> edition (2013) and now 8.7 in the 23</ftext>
<ftext top=""890"" left=""485"" width=""8"" height=""9"" font=""10"">rd</ftext>
</footnote>
<text top=""446"" left=""280"" width=""384"" height=""16"" font=""0"">, which contains the specific provisions relating to FMD.</text>
<footnote top=""444"" left=""664"" width=""17"" height=""11"" font=""16"" number=""682"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""622"" height=""15"" font=""10""> The United States also refers to Article 1.6.4 which sets forth the required information when applying </ftext>
<ftext top=""1051"" left=""108"" width=""208"" height=""15"" font=""10"">for a status-designation for FMD.  </ftext>
</footnote>
<text top=""446"" left=""682"" width=""109"" height=""16"" font=""0""> Argentina also </text>
<text top=""462"" left=""108"" width=""485"" height=""16"" font=""0"">references Articles 4.3.2 and 4.3.3 with respect to regionalization.</text>
<footnote top=""461"" left=""593"" width=""17"" height=""11"" font=""16"" number=""683"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 415-428. </ftext>
</footnote>
<text top=""462"" left=""610"" width=""184"" height=""16"" font=""0""> Furthermore, Argentina </text>
<text top=""479"" left=""108"" width=""684"" height=""16"" font=""0"">maintains that the OIE's official recognition of disease status is itself an international standard, </text>
<text top=""495"" left=""108"" width=""204"" height=""16"" font=""0"">guideline or recommendation.</text>
<footnote top=""493"" left=""312"" width=""17"" height=""11"" font=""16"" number=""684"" ref="""" dis=""""/>
</p><p number=""7.226"" style=""8""><text top=""529"" left=""108"" width=""683"" height=""16"" font=""0"">7.226.  As noted in section 2.4.2.1, the Terrestrial Code is made up of numerous chapters. Some </text>
<text top=""546"" left=""108"" width=""686"" height=""16"" font=""0"">relate to general matters while others relate to specific diseases and the measures taken to </text>
<text top=""562"" left=""108"" width=""524"" height=""16"" font=""0"">combat them. Chapter 8.5 is the Chapter which specifically addresses FMD.  </text>
</p><p number=""7.227"" style=""8""><text top=""597"" left=""108"" width=""684"" height=""16"" font=""0"">7.227.  Articles 8.5.2 through 8.5.8 detail the different types of status available with respect to </text>
<text top=""613"" left=""108"" width=""682"" height=""16"" font=""0"">FMD and  what  is  required  of  the  exporting  country  or  zone  to  achieve  official  recognition  of  a </text>
<text top=""629"" left=""108"" width=""171"" height=""16"" font=""0"">particular disease status.</text>
<footnote top=""628"" left=""279"" width=""17"" height=""11"" font=""16"" number=""685"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""563"" height=""15"" font=""10""> Article 8.5.5 details the criteria for achieving official recognition as an FMD-free zone where </ftext>
<ftext top=""1109"" left=""108"" width=""150"" height=""15"" font=""10"">vaccination is practised. </ftext>
</footnote>
<text top=""629"" left=""296"" width=""494"" height=""16"" font=""0""> Articles 8.5.12 through 8.5.33 list various recommendations on how to </text>
<text top=""646"" left=""108"" width=""686"" height=""16"" font=""0"">safely import FMD-susceptible animals or various products derived from them depending on </text>
<text top=""662"" left=""108"" width=""486"" height=""16"" font=""0"">whether the exporting country or zone has one of the disease statuses.</text>
<footnote top=""661"" left=""594"" width=""17"" height=""11"" font=""16"" number=""686"" ref="""" dis=""""/>
<p><text top=""745"" left=""108"" width=""641"" height=""15"" font=""10"">in Annex 1.2 of the Agreement on Technical Barriers to Trade which defines a ""standard"" as ""a document </text>
<text top=""759"" left=""108"" width=""678"" height=""15"" font=""12""><i>approved by a recognized body</i> that provides for common and repeated use, rules, guidelines or characteristics </text>
</p><p><text top=""803"" left=""108"" width=""679"" height=""15"" font=""12""><i>Sardines</i> that the relevant issue is whether the document is <i>approved </i>by the recognized body and not how that </text>
</p><p><text top=""891"" left=""493"" width=""285"" height=""15"" font=""10""> edition (2014). The parties have cited various </text>
<footnote top=""1080"" left=""165"" width=""547"" height=""15"" font=""10"" number=""17"" ref="""" dis=""""/>
</p><p><text top=""1124"" left=""165"" width=""256"" height=""15"" font=""10""> OIE's response to Panel question No. 10. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 103 - </text>
</p></p></page>
<page number=""103"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.228"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.228.  In order to determine the relevant provisions of the Terrestrial Code, we consider it useful </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">to first recall the precise measures that are subject to Argentina's claims under Article 3.1. We </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">note that Argentina has not claimed or argued that the APHIS' ""application system"" is not based </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">on the Terrestrial Code. Indeed, Argentina argues that its claims under Article 3.1 do not relate to </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">the United States' regulatory system ""as such"", but rather ""as applied"" to Northern Argentina for </text>
<text top=""210"" left=""108"" width=""225"" height=""16"" font=""0"">fresh (chilled or frozen beef).</text>
<footnote top=""208"" left=""333"" width=""17"" height=""11"" font=""16"" number=""687"" ref="""" dis=""""><ftext top=""847"" left=""165"" width=""621"" height=""15"" font=""10""> Argentina's first written submission, paras. 185-206; see also Argentina's response to Panel question </ftext>
</footnote>
<text top=""210"" left=""350"" width=""446"" height=""16"" font=""0""> Furthermore, our understanding is that Argentina is not </text>
<text top=""226"" left=""108"" width=""687"" height=""16"" font=""0"">challenging APHIS' application of the procedures in 9 CFR 92.2 to Northern Argentina under </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">Article 3.1. Argentina only challenges the import measures imposed &#8211; i.e. a complete prohibition </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">on imports of fresh (chilled or frozen) beef from Northern Argentina. Therefore, the United States' </text>
<text top=""275"" left=""108"" width=""682"" height=""16"" font=""0"">arguments that the application system that APHIS operates for authorization to import is based on </text>
<text top=""292"" left=""108"" width=""683"" height=""16"" font=""0"">the provisions of the Terrestrial Code related to granting a particular disease status because the </text>
<text top=""308"" left=""108"" width=""498"" height=""16"" font=""0"">two systems are ""fundamentally the same in structure and approach""</text>
<footnote top=""307"" left=""606"" width=""17"" height=""11"" font=""16"" number=""688"" ref="""" dis=""""/>
<text top=""308"" left=""624"" width=""169"" height=""16"" font=""0""> is not relevant to the </text>
<text top=""324"" left=""108"" width=""126"" height=""16"" font=""0"">claims before us.  </text>
</p><p number=""7.229"" style=""8""><text top=""359"" left=""108"" width=""689"" height=""16"" font=""0"">7.229.  With respect to Argentina's claims, given that Northern Argentina is a zone that </text>
<text top=""375"" left=""108"" width=""71"" height=""16"" font=""0"">vaccinates</text>
<footnote top=""374"" left=""179"" width=""17"" height=""11"" font=""16"" number=""689"" ref="""" dis=""""><ftext top=""891"" left=""165"" width=""598"" height=""15"" font=""10""> This is evidenced by the OIE official disease status recognition of Northern Argentina as FMD-free </ftext>
<ftext top=""905"" left=""108"" width=""643"" height=""15"" font=""10"">where vaccination is practised. (See OIE Resolution XXI of 2007, (Exhibit ARG-10)) We also note that the </ftext>
<ftext top=""920"" left=""108"" width=""667"" height=""15"" font=""10"">European Commission's risk assessments of Northern Argentina refer to vaccination practices. (See e.g. Final </ftext>
<ftext top=""934"" left=""108"" width=""643"" height=""15"" font=""10"">Report Of A Mission Carried Out In Argentina From 3 To 13 July 2006 In Order To Evaluate Animal Health </ftext>
<ftext top=""949"" left=""108"" width=""662"" height=""15"" font=""10"">Controls In Place In Particular Over Foot And Mouth Disease, Public Health Control Systems And Certification </ftext>
<ftext top=""963"" left=""108"" width=""667"" height=""15"" font=""10"">Procedures. (DG(SANCO)/8203/2006 &#8211; MR Final), (European Commission's 2006 Report), (Exhibit ARG-111), </ftext>
<ftext top=""978"" left=""108"" width=""667"" height=""15"" font=""10"">pp. 11-12) Furthermore, the 2005 APHIS risk assessment of Patagonia South refers to Northern Argentina as </ftext>
</footnote>
<text top=""375"" left=""196"" width=""600"" height=""16"" font=""0"">, the relevant articles of the Terrestrial Code are the product-specific import </text>
<text top=""392"" left=""108"" width=""684"" height=""16"" font=""0"">recommendations to be applied to shipments of fresh (chilled or frozen) beef from countries or </text>
<text top=""408"" left=""108"" width=""684"" height=""16"" font=""0"">zones that vaccinate. Article 8.5.23 is the recommendation for the import measures to apply to </text>
<text top=""425"" left=""108"" width=""683"" height=""16"" font=""0"">fresh meat of cattle and buffaloes (excluding feet, head and viscera) from FMD-free countries or </text>
<text top=""441"" left=""108"" width=""685"" height=""16"" font=""0"">zones where vaccination is practised. Article 8.5.25 sets forth the recommendations for import </text>
<text top=""457"" left=""108"" width=""684"" height=""16"" font=""0"">measures applying to fresh meat of cattle and buffaloes (excluding feet, head and viscera) from </text>
<text top=""474"" left=""108"" width=""689"" height=""16"" font=""0"">FMD-infected countries or zones, where an official control programme for FMD, involving </text>
<text top=""490"" left=""108"" width=""350"" height=""16"" font=""0"">compulsory systematic vaccination of cattle exists. </text>
</p><p number=""7.230"" style=""8""><text top=""525"" left=""108"" width=""683"" height=""16"" font=""0"">7.230.  Argentina argues that, in light of the relationship between the requirements for obtaining </text>
<text top=""541"" left=""108"" width=""689"" height=""16"" font=""0"">an official recognition of disease status described in Articles 8.5.4-8.5.8 and the import </text>
<text top=""557"" left=""108"" width=""683"" height=""16"" font=""0"">recommendations in Articles 8.5.23 and 8.5.25, the official recognitions of FMD disease status are </text>
<text top=""574"" left=""108"" width=""687"" height=""16"" font=""0"">themselves relevant international standards, guidelines or recommendations upon which the </text>
<text top=""590"" left=""108"" width=""682"" height=""16"" font=""0"">United States should base its measures. The United States counters that the official recognitions of </text>
<text top=""607"" left=""108"" width=""682"" height=""16"" font=""0"">disease status are not standards, guidelines or recommendations within the meaning of Article 3 of </text>
<text top=""623"" left=""108"" width=""532"" height=""16"" font=""0"">the SPS Agreement because they are not embodied in the Terrestrial Code</text>
<footnote top=""621"" left=""640"" width=""17"" height=""11"" font=""16"" number=""690"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""592"" height=""15"" font=""10""> The United States only refers to the Terrestrial Code, but we note that the OIE also promulgates </ftext>
<ftext top=""1036"" left=""108"" width=""537"" height=""15"" font=""10"">standards in the Aquatic Code as well as the Terrestrial Manual and the Aquatic Manual. </ftext>
</footnote>
<text top=""623"" left=""658"" width=""135"" height=""16"" font=""0""> and they are not </text>
<text top=""639"" left=""108"" width=""648"" height=""16"" font=""0"">rules or norms, but rather the application of rules or norms to country- or region-specific facts.</text>
<footnote top=""638"" left=""756"" width=""17"" height=""11"" font=""16"" number=""691"" ref="""" dis=""""/>
</p><p number=""7.231"" style=""8""><text top=""674"" left=""108"" width=""688"" height=""16"" font=""0"">7.231.  Annex A does not set forth a specific definition of any of the terms ""standards"", </text>
<text top=""690"" left=""108"" width=""682"" height=""16"" font=""0"">""guidelines"", or ""recommendations"". No panel has yet been faced with determining the meaning of </text>
<text top=""707"" left=""108"" width=""689"" height=""16"" font=""0"">these terms in the context of the SPS Agreement. We agree with the parties that the </text>
<text top=""723"" left=""108"" width=""687"" height=""16"" font=""0"">SPS Agreement does not require a fine distinction between the three terms for its proper </text>
<text top=""739"" left=""108"" width=""78"" height=""16"" font=""0"">application.</text>
<footnote top=""738"" left=""186"" width=""17"" height=""11"" font=""16"" number=""692"" ref="""" dis=""""/>
<text top=""739"" left=""203"" width=""588"" height=""16"" font=""0""> The OIE seems to use the terms interchangeably, labelling the Terrestrial Code as </text>
<text top=""756"" left=""108"" width=""682"" height=""16"" font=""0"">part of its standard-setting activities, while the individual provisions within the Terrestrial Code are </text>
<p><text top=""861"" left=""108"" width=""357"" height=""15"" font=""10"">Nos. 13(a) and (c) following the first substantive meeting. </text>
<text top=""876"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 321. </text>
</p><p><text top=""993"" left=""108"" width=""617"" height=""15"" font=""10"">an area where systematic vaccination occurs. (See generally 2005 Risk Analysis for Patagonia South, </text>
<text top=""1007"" left=""108"" width=""109"" height=""15"" font=""10"">(Exhibit ARG-9))  </text>
</p><p><text top=""1066"" left=""108"" width=""591"" height=""15"" font=""10"">United States' second written submission, para. 88 citing Exhibit USA-152, Exhibit USA-130, and </text>
<text top=""1080"" left=""108"" width=""112"" height=""15"" font=""10"">Exhibit USA-153.  </text>
</p><p><text top=""1124"" left=""108"" width=""182"" height=""15"" font=""10"">written submission, para. 87. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 104 - </text>
</p><p><text top=""128"" left=""108"" width=""205"" height=""16"" font=""0"">entitled ""recommendations"".</text>
<footnote top=""126"" left=""313"" width=""17"" height=""11"" font=""16"" number=""693"" ref="""" dis=""""><ftext top=""847"" left=""165"" width=""573"" height=""15"" font=""10""> The OIE notes that in its view ""all resolutions adopted by its World Assembly (including those </ftext>
<ftext top=""861"" left=""108"" width=""632"" height=""15"" font=""10"">addressing the official recognition of disease status) have the same status. See OIE's response to Panel </ftext>
<ftext top=""876"" left=""108"" width=""292"" height=""15"" font=""10"">question No. 12(a). See also G/SPS/GEN/1256. </ftext>
</footnote>
<text top=""128"" left=""330"" width=""470"" height=""16"" font=""0""> The Codex Alimentarius Commission adopts ""standards"", </text>
<text top=""144"" left=""108"" width=""265"" height=""16"" font=""0"">""guidelines"" and ""codes of practice"".</text>
<footnote top=""143"" left=""373"" width=""17"" height=""11"" font=""16"" number=""694"" ref="""" dis=""""><ftext top=""891"" left=""165"" width=""552"" height=""15"" font=""10""> Codex website, <i>Home</i>, http://www.codexalimentarius.org/codex-home/en/ (last accessed </ftext>
<ftext top=""905"" left=""108"" width=""114"" height=""15"" font=""10"">3 February 2015). </ftext>
</footnote>
<text top=""144"" left=""391"" width=""404"" height=""16"" font=""0""> At the time the SPS Agreement was negotiated, the </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">International Plant Protection Convention (IPPC) did not yet develop international standards, and it </text>
<text top=""177"" left=""108"" width=""465"" height=""16"" font=""0"">was not yet clear how it would refer to their official documents.</text>
<footnote top=""175"" left=""573"" width=""17"" height=""11"" font=""16"" number=""695"" ref="""" dis=""""/>
<text top=""177"" left=""590"" width=""203"" height=""16"" font=""0""> The practices of the three </text>
<text top=""193"" left=""108"" width=""511"" height=""16"" font=""0"">organizations identified in Annex A(3) lends support to our understanding. </text>
</p></p></page>
<page number=""104"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.232"" style=""8""><text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">7.232.  With respect to the official recognition of disease status, we note that it does not have any </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">particular effect in and of itself, but rather serves two purposes. First, it is an affirmation that the </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">exporting country has been determined by the OIE to have complied with the relevant provisions </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">of the Terrestrial Code. Second, it is an important component in determining which of the import </text>
<text top=""293"" left=""108"" width=""686"" height=""16"" font=""0"">recommendations in Articles 8.5.12 through 8.5.33 is applicable to products from a particular </text>
<text top=""310"" left=""108"" width=""686"" height=""16"" font=""0"">exporting country or zone. The OIE strongly encourages its Members to apply those articles </text>
<text top=""326"" left=""108"" width=""382"" height=""16"" font=""0"">according to the official recognition of disease status.</text>
<footnote top=""325"" left=""490"" width=""17"" height=""11"" font=""16"" number=""696"" ref="""" dis=""""><ftext top=""963"" left=""165"" width=""591"" height=""15"" font=""10""> The OIE explains that the achievement of an OIE-recognized status whether for a zone or for an </ftext>
<ftext top=""978"" left=""108"" width=""666"" height=""15"" font=""10"">entire country with or without vaccination is a critically important step on the path to disease eradication and </ftext>
<ftext top=""993"" left=""108"" width=""674"" height=""15"" font=""10"">supports safe trade in animals and animal products. (Transcript of the meeting, para. 1.8) Furthermore, in the </ftext>
<ftext top=""1007"" left=""108"" width=""670"" height=""15"" font=""10"">OIE's view official recognition of a country or zone as FMD-free is an affirmation that the country has satisfied </ftext>
</footnote>
<text top=""326"" left=""508"" width=""285"" height=""16"" font=""0""> However, we note that the Terrestrial </text>
<text top=""342"" left=""108"" width=""685"" height=""16"" font=""0"">Code is structured in the same manner for other diseases for which the OIE does not provide </text>
<text top=""359"" left=""108"" width=""291"" height=""16"" font=""0"">official recognition of the disease status.</text>
<footnote top=""357"" left=""399"" width=""17"" height=""11"" font=""16"" number=""697"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1036"" left=""165"" width=""605"" height=""15"" font=""10""> For example see Chapter 10.4 of the Terrestrial Code on avian influenza which is fully discussed in </ftext>
<ftext top=""1051"" left=""108"" width=""392"" height=""15"" font=""10"">Panel Report, <i>India &#8211; Agricultural Products</i>, paras. 7.228-7.253. </ftext>
</footnote>
<text top=""359"" left=""416"" width=""377"" height=""16"" font=""0""> Furthermore, the Terrestrial Code provides for the </text>
<text top=""375"" left=""108"" width=""685"" height=""16"" font=""0"">possibility of ""self-declaration"" of status for countries or zones that have not achieved official </text>
<text top=""392"" left=""108"" width=""80"" height=""16"" font=""0"">recognition.</text>
<footnote top=""390"" left=""188"" width=""17"" height=""11"" font=""16"" number=""698"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""607"" height=""15"" font=""10""> Terrestrial Code Article 1.6.1. OIE's response to Panel question No. 21 explaining that for over 100 </ftext>
<ftext top=""1080"" left=""108"" width=""671"" height=""15"" font=""10"">OIE listed diseases, freedom from disease in a country or zone is the subject of self-declaration. However, the </ftext>
<ftext top=""1095"" left=""108"" width=""672"" height=""15"" font=""10"">OIE notes that the officially-granted disease free status has much greater weight than a self-declaration made </ftext>
</footnote>
<text top=""392"" left=""206"" width=""586"" height=""16"" font=""0""> It is also possible for an importing Member to make its own determination as to </text>
<text top=""408"" left=""108"" width=""616"" height=""16"" font=""0"">whether an exporting country or zone satisfies the criteria for a particular disease status.</text>
<footnote top=""407"" left=""724"" width=""17"" height=""11"" font=""16"" number=""699"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""276"" height=""15"" font=""10""> See Transcript of the meeting, para. 1.142.  </ftext>
<ftext top=""427"" left=""108"" width=""437"" height=""15"" font=""10"">8.5.25 (for fresh meat of cattle and buffaloes (excluding feet, head and </ftext>
<ftext top=""442"" left=""108"" width=""422"" height=""15"" font=""10"">viscera): Veterinary authorities should require the presentation of an </ftext>
<ftext top=""456"" left=""108"" width=""440"" height=""15"" font=""10"">international veterinary certificate attesting that the entire consignment </ftext>
<ftext top=""471"" left=""108"" width=""56"" height=""15"" font=""10"">of meat: </ftext>
<ftext top=""617"" left=""108"" width=""443"" height=""15"" font=""10"">FMD has not occurred within a ten-kilometre radius of the establishment </ftext>
<ftext top=""631"" left=""108"" width=""119"" height=""15"" font=""10"">during that period; </ftext>
<ftext top=""646"" left=""108"" width=""389"" height=""15"" font=""10""> e) have been transported, in a vehicle which was cleansed and </ftext>
<ftext top=""660"" left=""108"" width=""444"" height=""15"" font=""10"">disinfected before the cattle were loaded directly from the establishment </ftext>
<ftext top=""675"" left=""108"" width=""444"" height=""15"" font=""10"">of origin to the approved abattoir without coming into contact with other </ftext>
<ftext top=""690"" left=""108"" width=""375"" height=""15"" font=""10"">animals which do not fulfil the required conditions for export; </ftext>
<ftext top=""704"" left=""108"" width=""311"" height=""15"" font=""10""> f) have been slaughtered in an approved abattoir. </ftext>
<ftext top=""719"" left=""108"" width=""267"" height=""15"" font=""10"">  i) which is officially designated for export; </ftext>
<ftext top=""733"" left=""108"" width=""431"" height=""15"" font=""10"">  ii) in which no FMD has been detected during the period between the </ftext>
<ftext top=""748"" left=""108"" width=""402"" height=""15"" font=""10"">last disinfection carried out before slaughter and the shipment for </ftext>
<ftext top=""763"" left=""108"" width=""177"" height=""15"" font=""10"">export has been dispatched; </ftext>
<ftext top=""777"" left=""108"" width=""405"" height=""15"" font=""10""> g) have been subjected to ante- and post-mortem inspections for </ftext>
</footnote>
<text top=""408"" left=""741"" width=""49"" height=""16"" font=""0""> Given </text>
<text top=""425"" left=""108"" width=""683"" height=""16"" font=""0"">that the relevant provisions of the Terrestrial Code can operate independently of any OIE official </text>
<text top=""441"" left=""108"" width=""685"" height=""16"" font=""0"">recognition of disease status, we believe it that it makes sense to first consider whether the </text>
<text top=""457"" left=""108"" width=""636"" height=""16"" font=""0"">United States measures are based on either Article 8.5.23 or 8.5.25 of the Terrestrial Code.  </text>
</p><p number=""7.4"" style=""8""><text top=""492"" left=""108"" width=""685"" height=""16"" font=""28"">7.4.2.3.2  Whether  the  United States'  import prohibitions are based on the Terrestrial </text><text top=""508"" left=""108"" width=""42"" height=""16"" font=""28"">Code </text></p><p number=""7.233"" style=""8""><text top=""543"" left=""108"" width=""683"" height=""16"" font=""0"">7.233.  As noted above, our task is to determine whether the challenged measures are ""founded"" </text>
<text top=""559"" left=""108"" width=""684"" height=""16"" font=""0"">or ""built"" upon or ""supported by"" the relevant standards, guidelines or recommendations in the </text>
<text top=""575"" left=""108"" width=""684"" height=""16"" font=""0"">Terrestrial Code such that they serve as a principal constituent or fundamental principle of the </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">United States' measures. Importantly, the United States' measures cannot be said to be based on </text>
<text top=""608"" left=""108"" width=""279"" height=""16"" font=""0"">the Terrestrial Code if they contradict it. </text>
</p><p number=""7.234"" style=""8""><text top=""643"" left=""108"" width=""685"" height=""16"" font=""0"">7.234.  As noted above, the relevant provisions of the Terrestrial Code are Article 8.5.23 and </text>
<text top=""659"" left=""108"" width=""682"" height=""16"" font=""0"">Article 8.5.25. The recommended conditions for importation in both of these articles are compared </text>
<text top=""675"" left=""108"" width=""687"" height=""16"" font=""0"">to the provisions in 9 CFR 94 as applicable to fresh (chilled or frozen) beef from Northern </text>
<text top=""692"" left=""108"" width=""191"" height=""16"" font=""0"">Argentina in Table 3 below. </text>
<p><text top=""920"" left=""165"" width=""589"" height=""15"" font=""10""> IPPC website, <i>History of the IPPC</i>, https://www.ippc.int/about/history (last accessed 3 February </text>
<text top=""934"" left=""108"" width=""658"" height=""15"" font=""10"">2015), noting that the IPPC was designated in the draft of the SPS Agreement in 1989, but did not begin its </text>
<text top=""949"" left=""108"" width=""569"" height=""15"" font=""10"">international standard-setting programme until the IPPC Secretariat was established in 1992. </text>
</p><p><text top=""1022"" left=""108"" width=""538"" height=""15"" font=""10"">the standards contained in the Terrestrial Code. OIE's response to Panel question No. 5. </text>
<footnote top=""1109"" left=""108"" width=""407"" height=""15"" font=""10"" number=""12"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 105 - </text>
</p></p></page>
<page number=""105"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""128"" left=""108"" width=""638"" height=""16"" font=""28"">Table 3: Comparison of Terrestrial Code to US Code of Federal Regulations for fresh </text><text top=""144"" left=""108"" width=""180"" height=""16"" font=""28"">(chilled or frozen) beef </text></p><p><text top=""172"" left=""278"" width=""342"" height=""15"" font=""29"">Northern Argentina: Fresh (chilled or frozen) beef </text><text top=""189"" left=""259"" width=""141"" height=""15"" font=""33"">OIE Terrestrial Code </text><text top=""189"" left=""608"" width=""136"" height=""15"" font=""33"">9 CFR 94 as applied </text></p><p><text top=""207"" left=""204"" width=""252"" height=""15"" font=""14""><b>FMD-free </b>where vaccination is practised<b> </b></text>
</p><p><text top=""207"" left=""630"" width=""94"" height=""15"" font=""33"">FMD-infected </text></p><p number=""8.5"" style=""8""><text top=""223"" left=""108"" width=""437"" height=""15"" font=""10"">8.5.23 (for fresh meat of cattle and buffaloes (excluding feet, head and </text>
<text top=""238"" left=""108"" width=""422"" height=""15"" font=""10"">viscera): Veterinary authorities should require the presentation of an </text>
<text top=""252"" left=""108"" width=""387"" height=""15"" font=""10"">international veterinary certificate attesting that that the entire </text>
<text top=""267"" left=""108"" width=""302"" height=""15"" font=""10"">consignment of meat comes from animals which: </text>
<footnote top=""281"" left=""108"" width=""438"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""><ftext top=""500"" left=""108"" width=""421"" height=""15"" font=""10""> a) have remained in the exporting country for at least three months </ftext>
<ftext top=""515"" left=""108"" width=""115"" height=""15"" font=""10"">prior to slaughter; </ftext>
<ftext top=""529"" left=""108"" width=""421"" height=""15"" font=""10""> b) have remained, during this period, in a part of the country where </ftext>
<ftext top=""544"" left=""108"" width=""429"" height=""15"" font=""10"">cattle are regularly vaccinated against FMD and where official controls </ftext>
<ftext top=""558"" left=""108"" width=""106"" height=""15"" font=""10"">are in operation; </ftext>
<ftext top=""573"" left=""108"" width=""415"" height=""15"" font=""10""> c) have been vaccinated at least twice with the last vaccination not </ftext>
</footnote>
<p><text top=""296"" left=""108"" width=""361"" height=""15"" font=""10"">practised, or which have been imported in accordance with </text>
<text top=""310"" left=""108"" width=""288"" height=""15"" font=""10"">Article 8.5.12, Article 8.5.13, or Article 8.5.14; </text>
<footnote top=""325"" left=""108"" width=""399"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""><ftext top=""835"" left=""108"" width=""392"" height=""15"" font=""10""> a) from which the major lymphatic nodes have been removed;  </ftext>
<ftext top=""850"" left=""108"" width=""446"" height=""15"" font=""10""> b) which, prior to deboning, have been submitted to maturation at a </ftext>
<ftext top=""865"" left=""108"" width=""446"" height=""15"" font=""10"">temperature above +2&#730;C for a minimum period of 24 hours following </ftext>
<ftext top=""879"" left=""108"" width=""446"" height=""15"" font=""10"">slaughter and in which the pH value was below 6.0 when tested in the </ftext>
<ftext top=""894"" left=""108"" width=""228"" height=""15"" font=""10"">middle of both the longissimus dorsi.<b> </b></ftext>
<ftext top=""427"" left=""564"" width=""149"" height=""15"" font=""10"">Imports are prohibited.  </ftext>
<ftext top=""832"" left=""108"" width=""579"" height=""15"" font=""10"">is FMD-free where vaccination is practised can be found in Article 8.5.5 of the Terrestrial Code. </ftext>
<ftext top=""861"" left=""108"" width=""635"" height=""15"" font=""10"">United States notes that it does, in the unique circumstance of Uruguay, permit a country that has been </ftext>
<ftext top=""876"" left=""108"" width=""654"" height=""15"" font=""10"">recognized by the OIE as FMD-free where vaccination is practised to import under the protocols set forth in </ftext>
<ftext top=""891"" left=""108"" width=""670"" height=""15"" font=""10"">9 CFR 94.22. However, the United States argues that, contrary to the position of Argentina the mere fact that </ftext>
<ftext top=""905"" left=""108"" width=""650"" height=""15"" font=""10"">the United States has accepted imports from one country that is recognized by the OIE as FMD-free where </ftext>
<ftext top=""920"" left=""108"" width=""662"" height=""15"" font=""10"">vaccination is practised cannot be dispositive of whether the measures the United States applies to Northern </ftext>
<ftext top=""934"" left=""108"" width=""274"" height=""15"" font=""10"">Argentina are based on the Terrestrial Code. </ftext>
<ftext top=""1109"" left=""108"" width=""630"" height=""15"" font=""10"">of whether a measure needs to reflect the same level of protection as the standard to be based on that </ftext>
<ftext top=""1124"" left=""108"" width=""369"" height=""15"" font=""10"">standard was ""to be left for another day and another case"".  </ftext>
</footnote>
</p><p><text top=""340"" left=""108"" width=""377"" height=""15"" font=""10"">subjected to ante- and post-mortem inspections for FMD with </text>
<text top=""354"" left=""108"" width=""117"" height=""15"" font=""10"">favourable results. </text>
<text top=""223"" left=""564"" width=""145"" height=""15"" font=""10"">Imports are prohibited. </text>
</p></p><p><text top=""383"" left=""133"" width=""393"" height=""15"" font=""33"">FMD infected countries or zones, where an official control </text><text top=""398"" left=""146"" width=""368"" height=""15"" font=""33"">programme for FMD, involving compulsory systematic </text><text top=""412"" left=""238"" width=""185"" height=""15"" font=""33"">vaccination of cattle exists </text><text top=""383"" left=""630"" width=""94"" height=""15"" font=""33"">FMD-infected </text></p><p number=""d)"" style=""3""><text top=""602"" left=""108"" width=""394"" height=""15"" font=""10""> d) were kept for the past 30 days in an establishment, and that </text>
<p><text top=""792"" left=""108"" width=""439"" height=""15"" font=""10"">FMD with favourable results within 24 hours before and after slaughter; </text>
</p></p><p number=""7.235"" style=""8""><text top=""925"" left=""108"" width=""685"" height=""16"" font=""0"">7.235.  The United States argues that it need not apply Article 8.5.23 to Northern Argentina to </text>
<text top=""942"" left=""108"" width=""682"" height=""16"" font=""0"">have its measures be based on the Terrestrial Code, because the official disease status recognition </text>
<text top=""958"" left=""108"" width=""684"" height=""16"" font=""0"">of the OIE is not itself an international standard, guideline or recommendation. As discussed in </text>
<text top=""975"" left=""108"" width=""683"" height=""16"" font=""0"">paragraph 7.231 above, the issue before us is not whether the United States is required to follow </text>
<text top=""991"" left=""108"" width=""682"" height=""16"" font=""0"">the official recognition of disease status that the OIE has granted Northern Argentina, but whether </text>
<text top=""1008"" left=""108"" width=""683"" height=""16"" font=""0"">the import measures it applies in 9 CFR 94.1, as amended by the 2001 Regulations, are based on </text>
<text top=""1024"" left=""108"" width=""150"" height=""16"" font=""0"">the Terrestrial Code.  </text>
</p><p number=""7.236"" style=""8""><text top=""1058"" left=""108"" width=""683"" height=""16"" font=""0"">7.236.  The Terrestrial Code provides in Articles 8.5.23 and 8.5.25 that imports from countries or </text>
<text top=""1075"" left=""108"" width=""682"" height=""16"" font=""0"">zones that vaccinate cattle can be safely traded and should be permitted subject to the mitigating </text>
<text top=""1091"" left=""108"" width=""686"" height=""16"" font=""0"">protocols set forth in those articles. It is undisputed that Northern Argentina vaccinates its </text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 106 - </text>
</p><p><text top=""128"" left=""108"" width=""42"" height=""16"" font=""0"">cattle.</text>
<footnote top=""126"" left=""150"" width=""17"" height=""11"" font=""16"" number=""700"" ref="""" dis=""""><ftext top=""730"" left=""165"" width=""598"" height=""15"" font=""10""> This is evidenced by the OIE official disease status recognition of Northern Argentina as FMD-free </ftext>
<ftext top=""745"" left=""108"" width=""643"" height=""15"" font=""10"">where vaccination is practised. (See OIE Resolution XXI of 2007, (Exhibit ARG-10)) We also note that the </ftext>
<ftext top=""759"" left=""108"" width=""634"" height=""15"" font=""10"">European Commission's risk assessments of Northern Argentina refer to vaccination practices. (See e.g. </ftext>
<ftext top=""774"" left=""108"" width=""630"" height=""15"" font=""10"">European Commission's 2006 Report, (Exhibit ARG-111), pp. 11-12) Furthermore, the 2005 APHIS risk </ftext>
<ftext top=""788"" left=""108"" width=""666"" height=""15"" font=""10"">assessment of Patagonia South refers to Northern Argentina as an area where systematic vaccination occurs. </ftext>
<ftext top=""803"" left=""108"" width=""442"" height=""15"" font=""10"">(See generally 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9)) </ftext>
</footnote>
<text top=""128"" left=""168"" width=""627"" height=""16"" font=""0""> Argentina maintains that Northern Argentina satisfies the criteria for the status of </text>
<text top=""144"" left=""108"" width=""348"" height=""16"" font=""0"">FMD-free region where vaccination is practised.</text>
<footnote top=""143"" left=""456"" width=""17"" height=""11"" font=""16"" number=""701"" ref="""" dis=""""/>
<text top=""144"" left=""473"" width=""321"" height=""16"" font=""0""> The United States explains the distinction </text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""0"">between its measures and those recommended by the Terrestrial Code by noting that under </text>
<text top=""177"" left=""108"" width=""688"" height=""16"" font=""0"">9 CFR 94, the United States does not recognize regions where vaccination is practised as </text>
<text top=""193"" left=""108"" width=""526"" height=""16"" font=""0"">""FMD-free"": rather it considers such countries or zone to be ""FMD-infected"".</text>
<footnote top=""192"" left=""634"" width=""17"" height=""11"" font=""16"" number=""702"" ref="""" dis=""""/>
<text top=""193"" left=""651"" width=""140"" height=""16"" font=""0""> However, as noted </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">above, under the relevant international standards, guidelines or recommendations a country or </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">zone that is FMD-infected and vaccinating would be subject to the protocols in Article 8.5.25, </text>
<text top=""242"" left=""108"" width=""508"" height=""16"" font=""0"">which allow trade in fresh (chilled or frozen) beef under certain conditions.</text>
<footnote top=""241"" left=""616"" width=""17"" height=""11"" font=""16"" number=""703"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""559"" height=""15"" font=""10""> The OIE noted that ""in the situation of a country that has had a recognized status from the </ftext>
<ftext top=""963"" left=""108"" width=""662"" height=""15"" font=""10"">OIE which is based on compulsory systematic vaccination and it has an outbreak and it loses it status due to </ftext>
<ftext top=""978"" left=""108"" width=""636"" height=""15"" font=""10"">that outbreak it certainly continues its vaccination. So the Article 8.5.25 would apply."" (Transcript of the </ftext>
<ftext top=""993"" left=""108"" width=""645"" height=""15"" font=""10"">meeting, para. 1.43) In our view, this confirms our understanding that if Argentina were considered to be </ftext>
<ftext top=""1007"" left=""108"" width=""632"" height=""15"" font=""10"">""infected"" &#8211; as the United States does &#8211; Article 8.5.25 would be the applicable import recommendation. </ftext>
</footnote>
</p></p></page>
<page number=""106"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.237"" style=""8""><text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">7.237.  The United States applies neither Article 8.5.23 nor 8.5.25 to Northern Argentina: instead, </text>
<text top=""293"" left=""108"" width=""363"" height=""16"" font=""0"">it prohibits imports of fresh (chilled or frozen) beef.</text>
<footnote top=""292"" left=""471"" width=""17"" height=""11"" font=""16"" number=""704"" ref="""" dis=""""/>
<text top=""293"" left=""489"" width=""303"" height=""16"" font=""0""> A measure that prohibits trade cannot be </text>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">said to be based on a measure that allows trade under certain conditions. Indeed, in that sense, </text>
<text top=""326"" left=""108"" width=""276"" height=""16"" font=""0"">the two can be said to be <i>contradictory</i>. </text>
</p><p number=""7.238"" style=""8""><text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">7.238.  We note that the United States argues that even though its measures diverge from the </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">Terrestrial Code because the United States has a higher level of protection than that implicit in the </text>
<text top=""393"" left=""108"" width=""682"" height=""16"" font=""0"">relevant provisions of the Terrestrial Code, they are still based on the Terrestrial Code. In support </text>
<text top=""410"" left=""108"" width=""686"" height=""16"" font=""0"">of its understanding, the United States relies on the reasoning of the Appellate Body that a </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">measure might be based on a standard ""if only some, not all, of the elements of the standard are </text>
<text top=""443"" left=""108"" width=""217"" height=""16"" font=""0"">incorporated into the measure"".</text>
<footnote top=""441"" left=""325"" width=""17"" height=""11"" font=""16"" number=""705"" ref="""" dis=""""/>
</p><p number=""7.239"" style=""8""><text top=""477"" left=""108"" width=""685"" height=""16"" font=""0"">7.239.  We agree that ""based on"" does not require the wholesale adoption of the international </text>
<text top=""493"" left=""108"" width=""687"" height=""16"" font=""0"">standard, guideline or recommendation into the measure of the importing Member. As the </text>
<text top=""510"" left=""108"" width=""686"" height=""16"" font=""0"">Appellate Body noted, this would wipe out any distinction between the scope of coverage of </text>
<text top=""526"" left=""108"" width=""684"" height=""16"" font=""0"">Articles 3.1 and 3.2. However, we do not believe that the Appellate Body's conclusion in <i>EC &#8211; </i></text>
<text top=""543"" left=""108"" width=""686"" height=""16"" font=""18""><i>Hormones  </i>stands for the proposition that Members can contradict the international standard, </text>
<text top=""559"" left=""108"" width=""583"" height=""16"" font=""0"">guideline or recommendation and nevertheless be deemed compliant with Article 3.1.</text>
<footnote top=""557"" left=""691"" width=""17"" height=""11"" font=""16"" number=""706"" ref="""" dis=""""/>
</p><p number=""7.240"" style=""8""><text top=""593"" left=""108"" width=""684"" height=""16"" font=""0"">7.240.  We take note of the United States' argument that the difference between the measures </text>
<text top=""610"" left=""108"" width=""683"" height=""16"" font=""0"">that it applies to Northern Argentina and the OIE's standard, guidelines or recommendations is a </text>
<text top=""626"" left=""108"" width=""682"" height=""16"" font=""0"">result of its higher level of protection. We recognize that it is an open question whether a measure </text>
<text top=""643"" left=""108"" width=""683"" height=""16"" font=""0"">that achieves a higher level of protection could in some circumstances nevertheless be based on </text>
<text top=""659"" left=""108"" width=""689"" height=""16"" font=""0"">an international standard, guideline, or recommendation that embodies a lower level of </text>
<text top=""675"" left=""108"" width=""73"" height=""16"" font=""0"">protection.</text>
<footnote top=""674"" left=""181"" width=""17"" height=""11"" font=""16"" number=""707"" ref="""" dis=""""/>
<text top=""675"" left=""199"" width=""594"" height=""16"" font=""0""> It is not necessary for the Panel to answer this broader interpretative question. </text>
<p><text top=""818"" left=""165"" width=""615"" height=""15"" font=""10""> See e.g. Argentina's first written submission, para. 191. The criteria for a zone or compartment that </text>
</p><p><text top=""847"" left=""165"" width=""571"" height=""15"" font=""10""> United States' response to Panel question No. 13 following the first substantive meeting. The </text>
</p><p><text top=""1022"" left=""165"" width=""622"" height=""15"" font=""10""> See e.g. United States' first written submission, para. 299; United States' response to Panel question </text>
<text top=""1036"" left=""108"" width=""285"" height=""15"" font=""10"">No. 19 following the first substantive meeting. </text>
<text top=""1051"" left=""165"" width=""316"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 163. </text>
<text top=""1066"" left=""165"" width=""551"" height=""15"" font=""10""> In this sense, see Appellate Body Report, <i>EC &#8211; Sardines</i>,<i> </i>para. 248; Panel Report, <i>India &#8211; </i></text>
<text top=""1080"" left=""108"" width=""213"" height=""15"" font=""12""><i>Agricultural Products</i>,<i> </i>para. 7.269. </text>
<text top=""1095"" left=""165"" width=""618"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>,<i> </i>para. 168 where the Appellate Body noted that the question </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 107 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">Irrespective of the appropriate level of protection, a measure that contradicts the international </text>
<text top=""144"" left=""108"" width=""506"" height=""16"" font=""0"">standard, guideline or recommendation cannot be said to be based on it.  </text>
</p></p></page>
<page number=""107"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.241"" style=""8""><text top=""178"" left=""108"" width=""685"" height=""16"" font=""0"">7.241.  As noted above, the OIE considers that fresh (chilled or frozen) beef from countries or </text>
<text top=""195"" left=""108"" width=""689"" height=""16"" font=""0"">zones which vaccinate can be safely traded subject to the specific recommendations in </text>
<text top=""211"" left=""108"" width=""183"" height=""16"" font=""0"">Articles 8.5.23 and 8.5.25.</text>
<footnote top=""210"" left=""291"" width=""17"" height=""11"" font=""16"" number=""708"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""587"" height=""15"" font=""10""> The United States has presented a variety of concerns about vaccination and the potential risks </ftext>
<ftext top=""993"" left=""108"" width=""650"" height=""15"" font=""10"">associated with it. Indeed, the United States has identified these as the reasons why it believes its ALOP is </ftext>
<ftext top=""1007"" left=""108"" width=""620"" height=""15"" font=""10"">higher than the level of protection embodied in the Terrestrial Code. The OIE, for its part stresses the </ftext>
<ftext top=""1022"" left=""108"" width=""641"" height=""15"" font=""10"">importance of vaccination as a tool in disease eradication campaigns and that the mitigating measures in </ftext>
<ftext top=""1036"" left=""108"" width=""663"" height=""15"" font=""10"">Articles 8.5.23 (excluding feet, head and viscera) and 8.5.25 (excluding feet, head and viscera and requiring </ftext>
<ftext top=""1051"" left=""108"" width=""666"" height=""15"" font=""10"">deboning and maturation) render the products safe and that science does not justify banning these products. </ftext>
<ftext top=""1066"" left=""108"" width=""602"" height=""15"" font=""10"">(See OIE's responses to Panel question Nos. 20 and 26; and Transcript of the meeting, paras. 1.8, </ftext>
<ftext top=""1080"" left=""108"" width=""85"" height=""15"" font=""10"">1.162-1.163) </ftext>
</footnote>
<text top=""211"" left=""309"" width=""482"" height=""16"" font=""0""> In our view, prohibiting trade in fresh (chilled or frozen) beef from a </text>
<text top=""228"" left=""108"" width=""551"" height=""16"" font=""0"">region that vaccinates contradicts these provisions of the Terrestrial Code.</text>
<footnote top=""226"" left=""659"" width=""17"" height=""11"" font=""16"" number=""709"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1095"" left=""165"" width=""612"" height=""15"" font=""10""> The panel in <i>India &#8211; Agricultural Products</i> reach a similar conclusion with respect to Chapter 10.4 of </ftext>
<ftext top=""1109"" left=""108"" width=""628"" height=""15"" font=""10"">the Terrestrial Code and India's prohibition on poultry products. (See Panel Report, <i>India &#8211; Agricultural </i></ftext>
<ftext top=""1124"" left=""108"" width=""191"" height=""15"" font=""12""><i>Products</i>, paras. 7.270-7.272)  </ftext>
<ftext top=""230"" left=""109"" width=""637"" height=""15"" font=""10"">identification of the subpopulation and the establishment and maintenance of its health status through a </ftext>
<ftext top=""245"" left=""109"" width=""658"" height=""15"" font=""10"">biosecurity plan. The measures used to establish and maintain the distinct animal health status of a zone or </ftext>
<ftext top=""260"" left=""109"" width=""659"" height=""15"" font=""10"">compartment should be appropriate to the particular circumstances, and will depend on the epidemiology of </ftext>
<ftext top=""274"" left=""109"" width=""637"" height=""15"" font=""10"">the disease, environmental factors, the health status of animals in adjacent areas, applicable biosecurity </ftext>
<ftext top=""289"" left=""109"" width=""643"" height=""15"" font=""10"">measures (including movement controls, use of natural and artificial boundaries, the spatial separation of </ftext>
<ftext top=""303"" left=""109"" width=""507"" height=""15"" font=""10"">animals, and commercial management and husbandry practices), and surveillance. </ftext>
<ftext top=""347"" left=""109"" width=""644"" height=""15"" font=""10"">are traceable. Depending on the system of production, identification may be done at the herd, flock lot or </ftext>
<ftext top=""362"" left=""109"" width=""661"" height=""15"" font=""10"">individual animal level. Relevant animal movements into and out of the zone or compartment should be well </ftext>
<ftext top=""376"" left=""109"" width=""678"" height=""15"" font=""10"">documented and controlled. The existence of a valid animal identification system is a prerequisite to assess the </ftext>
<ftext top=""391"" left=""109"" width=""233"" height=""15"" font=""10"">integrity of the zone or compartment. </ftext>
<ftext top=""520"" left=""108"" width=""206"" height=""15"" font=""10"">A zone seeking this status should </ftext>
<ftext top=""564"" left=""108"" width=""16"" height=""15"" font=""10"">a. </ftext>
<ftext top=""578"" left=""108"" width=""16"" height=""15"" font=""10"">b. </ftext>
<ftext top=""651"" left=""108"" width=""16"" height=""15"" font=""10"">a. </ftext>
<ftext top=""651"" left=""151"" width=""628"" height=""15"" font=""10"">surveillance for FMD and FMDV infection in accordance with Articles 8.5.42 to 8.5.47 and Article 8.5.49 </ftext>
<ftext top=""666"" left=""108"" width=""96"" height=""15"" font=""10"">is in operation; </ftext>
<ftext top=""680"" left=""108"" width=""16"" height=""15"" font=""10"">b. </ftext>
<ftext top=""680"" left=""151"" width=""614"" height=""15"" font=""10"">regulatory measures for the early detection, prevention and control of FMD have been implemented; </ftext>
<ftext top=""709"" left=""108"" width=""15"" height=""15"" font=""10"">c. </ftext>
<ftext top=""709"" left=""151"" width=""290"" height=""15"" font=""10"">the boundaries of the proposed FMD free zone; </ftext>
<ftext top=""724"" left=""108"" width=""16"" height=""15"" font=""10"">d. </ftext>
<ftext top=""724"" left=""151"" width=""394"" height=""15"" font=""10"">the boundaries and measures of a protection zone, if applicable; </ftext>
<ftext top=""738"" left=""108"" width=""16"" height=""15"" font=""10"">e. </ftext>
<ftext top=""738"" left=""151"" width=""621"" height=""15"" font=""10"">the system for preventing the entry of the virus (including the control of the movement of susceptible </ftext>
<ftext top=""753"" left=""108"" width=""617"" height=""15"" font=""10"">animals) into the proposed FMD free zone (in particular if the procedure described in Article 8.5.10 is </ftext>
<ftext top=""768"" left=""108"" width=""93"" height=""15"" font=""10"">implemented). </ftext>
<ftext top=""782"" left=""108"" width=""656"" height=""15"" font=""10"">The proposed free zone will be included in the list of FMD free zones where vaccination is not practised only </ftext>
<ftext top=""797"" left=""108"" width=""368"" height=""15"" font=""10"">after the submitted evidence has been accepted by the OIE. </ftext>
<ftext top=""1095"" left=""108"" width=""668"" height=""15"" font=""10"">as this article deals with the requirements for achieving recognition as an FMD-free zone where vaccination is </ftext>
<ftext top=""1109"" left=""108"" width=""665"" height=""15"" font=""10"">practised we do not see the relevance to the Patagonia claim which is regarding an area where vaccination is </ftext>
<ftext top=""1124"" left=""108"" width=""87"" height=""15"" font=""10"">not practised. </ftext>
</footnote>
<text top=""228"" left=""676"" width=""118"" height=""16"" font=""0""> Therefore, we </text>
<text top=""244"" left=""108"" width=""685"" height=""16"" font=""0"">conclude that 9 CFR 94.1, as amended by the 2001 Regulations, is not based on the relevant </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">provisions of the Terrestrial Code and is thus inconsistent with Article 3.1 of the SPS Agreement. </text>
<text top=""277"" left=""108"" width=""686"" height=""16"" font=""0"">Having reached this conclusion, we need not decide whether the OIE's official recognition of </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina as FMD-free where vaccination is practised is itself an international standard, guideline, </text>
<text top=""310"" left=""108"" width=""147"" height=""16"" font=""0"">or recommendation.  </text>
</p><p number=""7.4"" style=""8""><text top=""344"" left=""108"" width=""553"" height=""16"" font=""28"">7.4.2.3.3  FMD susceptible animals and products thereof from Patagonia </text></p><p number=""7.4"" style=""8""><text top=""378"" left=""108"" width=""686"" height=""16"" font=""28"">7.4.2.3.3.1  Whether a relevant international standard, guideline or recommendation </text><text top=""395"" left=""108"" width=""49"" height=""16"" font=""28"">exists </text></p><p number=""7.242"" style=""8""><text top=""429"" left=""108"" width=""684"" height=""16"" font=""0"">7.242.  Argentina also identifies the Terrestrial Code as the source of the international standard, </text>
<text top=""446"" left=""108"" width=""685"" height=""16"" font=""0"">guideline or recommendation relevant to its claims with respect to animals, meat, and animal </text>
<text top=""462"" left=""108"" width=""687"" height=""16"" font=""0"">products from Patagonia. However, Argentina raises not only the specific import measures </text>
<text top=""479"" left=""108"" width=""684"" height=""16"" font=""0"">recommended for FMD-free zones where vaccination is not practised, but also the provisions on </text>
<text top=""495"" left=""108"" width=""611"" height=""16"" font=""0"">regionalization and on establishing an FMD-free zone where vaccination is not practised.  </text>
</p><p number=""7.243"" style=""8""><text top=""529"" left=""108"" width=""688"" height=""16"" font=""0"">7.243.  The general principles for regionalization &#8211; also referred to interchangeably in the </text>
<text top=""546"" left=""108"" width=""683"" height=""16"" font=""0"">Terrestrial Code with ""zoning"" &#8211; are set forth in Chapter 4.3 of the Terrestrial Code. With respect </text>
<text top=""562"" left=""108"" width=""684"" height=""16"" font=""0"">to its claims, Argentina argues that the United States' import prohibitions on animals, meat and </text>
<text top=""579"" left=""108"" width=""688"" height=""16"" font=""0"">animal products from Patagonia are not based on the general considerations set forth in </text>
<text top=""595"" left=""108"" width=""126"" height=""16"" font=""0"">Article 4.3.2 that: </text>
<p><text top=""629"" left=""151"" width=""597"" height=""16"" font=""0"">The exporting country should be able to demonstrate, through detailed documentation </text>
<text top=""646"" left=""151"" width=""599"" height=""16"" font=""0"">provided to the importing country that it has implemented the recommendations in </text>
<text top=""662"" left=""151"" width=""568"" height=""16"" font=""0"">the Terrestrial Code for establishing and maintaining such a zone or compartment. </text>
</p><p><text top=""697"" left=""151"" width=""599"" height=""16"" font=""0"">The importing country should recognise the existence of this zone or compartment </text>
<text top=""713"" left=""151"" width=""597"" height=""16"" font=""0"">when the appropriate measures recommended in the Terrestrial Code are applied and </text>
<text top=""729"" left=""151"" width=""541"" height=""16"" font=""0"">the Veterinary Authority of the exporting country certifies that this is the case. </text>
</p></p><p number=""7.244"" style=""8""><text top=""764"" left=""108"" width=""682"" height=""16"" font=""0"">7.244.  Article 4.3.3 sets forth the principles that an exporting Member should apply when defining </text>
<text top=""780"" left=""108"" width=""169"" height=""16"" font=""0"">a zone or compartment. </text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 108 - </text>
</p><p><text top=""128"" left=""271"" width=""356"" height=""15"" font=""29"">Article 4.3.3 of the Terrestrial Code in relevant part: </text><footnote top=""143"" left=""109"" width=""654"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""><ftext top=""383"" left=""114"" width=""400"" height=""15"" font=""10"">vaccination is not practised or a FMD free compartment, or which </ftext>
<ftext top=""398"" left=""114"" width=""332"" height=""15"" font=""10"">have been imported in accordance with Article 8.5.12, </ftext>
<ftext top=""412"" left=""114"" width=""198"" height=""15"" font=""10"">Article 8.5.13, or Article 8.5.14; </ftext>
</footnote>
</p><p><text top=""158"" left=""109"" width=""566"" height=""15"" font=""10"">basis of natural, artificial and/or legal boundaries, and made public through official channels. </text>
</p></p></page>
<page number=""108"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""5."" style=""6""><text top=""187"" left=""109"" width=""633"" height=""15"" font=""10"">5. Animals and herds belonging to such subpopulations need to be recognisable as such through a clear </text>
<text top=""201"" left=""109"" width=""612"" height=""15"" font=""10"">epidemiological separation from other animals and all things presenting a disease risk. For a zone or </text>
<text top=""216"" left=""109"" width=""610"" height=""15"" font=""10"">compartment, the Veterinary Authority should document in detail the measures taken to ensure the </text>
</p><p number=""6."" style=""6""><text top=""332"" left=""109"" width=""667"" height=""15"" font=""10"">6. Relevant animals within the zone or compartment should be identified in such a way that their movements </text>
</p><p number=""7.245"" style=""8""><text top=""437"" left=""108"" width=""682"" height=""16"" font=""0"">7.245.  With respect to how to define a zone seeking the official recognition of its disease status as </text>
<text top=""454"" left=""108"" width=""682"" height=""16"" font=""0"">being FMD-free where vaccination is not practised, the relevant provision of the Terrestrial Code is </text>
<text top=""470"" left=""108"" width=""88"" height=""16"" font=""0"">Article 8.5.4.</text>
<footnote top=""468"" left=""196"" width=""17"" height=""11"" font=""16"" number=""710"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""559"" height=""15"" font=""10""> We note that Argentina also refers to Article 8.5.5 of the Terrestrial Code in its first written </ftext>
</footnote>
<text top=""470"" left=""213"" width=""193"" height=""16"" font=""0""> Article 8.5.4 provides that: </text>
<p><text top=""505"" left=""327"" width=""242"" height=""15"" font=""29"">Article 8.5.4 of the Terrestrial Code </text><footnote top=""549"" left=""108"" width=""493"" height=""15"" font=""10"" number=""2"" ref="""" dis=""""/>
<footnote top=""564"" left=""151"" width=""389"" height=""15"" font=""10"" number=""12"" ref="""" dis=""""><ftext top=""607"" left=""108"" width=""16"" height=""15"" font=""10"">d. </ftext>
<ftext top=""607"" left=""151"" width=""612"" height=""15"" font=""10"">no vaccinated animal has been introduced into the zone since the cessation of vaccination, except in </ftext>
<ftext top=""622"" left=""108"" width=""193"" height=""15"" font=""10"">accordance with Article 8.5.10; </ftext>
</footnote>
<footnote top=""636"" left=""108"" width=""231"" height=""15"" font=""10"" number=""3"" ref="""" dis=""""><ftext top=""841"" left=""108"" width=""404"" height=""15"" font=""10"">reported to the OIE according to the requirements in Chapter 1.1. </ftext>
</footnote>
</p></p><p number=""4)"" style=""4""><text top=""695"" left=""108"" width=""658"" height=""15"" font=""10"">4) describe in detail and supply documented evidence that these are properly implemented and supervised: </text>
</p><p number=""7.4"" style=""8""><text top=""872"" left=""108"" width=""656"" height=""16"" font=""28"">7.4.2.3.3.2  Whether the United States' prohibitions are based on the Terrestrial Code </text></p><p number=""7.246"" style=""8""><text top=""907"" left=""108"" width=""684"" height=""16"" font=""0"">7.246.  In Argentina's view, for an importing Member's measures to be based on the Terrestrial </text>
<text top=""923"" left=""108"" width=""683"" height=""16"" font=""0"">Code that Member must recognize that there can be a zone that is FMD-free where vaccination is </text>
<text top=""940"" left=""108"" width=""683"" height=""16"" font=""0"">not practised within a country that vaccinates and apply the relevant import recommendations for </text>
<text top=""956"" left=""108"" width=""677"" height=""16"" font=""0"">that disease status to that zone. Therefore, according to Argentina, the United States' country-</text>
<text top=""972"" left=""108"" width=""682"" height=""16"" font=""0"">wide prohibition on products from Argentina, including those from Patagonia, cannot be said to be </text>
<text top=""989"" left=""108"" width=""211"" height=""16"" font=""0"">based on the Terrestrial Code. </text>
<p><text top=""1080"" left=""108"" width=""670"" height=""15"" font=""10"">submission with respect to the Patagonia claim. See Argentina's first written submission, para. 423. However, </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 109 - </text>
</p></p></page>
<page number=""109"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.247"" style=""8""><text top=""128"" left=""108"" width=""688"" height=""16"" font=""0"">7.247.  As noted above, Chapter 8.5 of the Terrestrial Code is based on the premise of </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">differentiating the FMD status of a country, zone or compartment according to certain criteria. For </text>
<text top=""160"" left=""108"" width=""685"" height=""16"" font=""0"">a zone that is FMD-free where vaccination is not practised, the criteria are those described in </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">Article 8.5.4. In addition to the general provisions on establishing disease status, Chapter 8.5 </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">contains numerous product-specific recommendations (Articles 8.5.12 through 8.5.33) foreseeing </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">the measures to be applied by importing countries depending on the FMD-status of the country, </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">zone or compartment from which the products originate. The relevant one for fresh (chilled or </text>
<text top=""242"" left=""108"" width=""645"" height=""16"" font=""0"">frozen) beef from zones that are FMD-free where vaccination is not practised is Article 8.5.22.</text>
<footnote top=""241"" left=""753"" width=""17"" height=""11"" font=""16"" number=""711"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""613"" height=""15"" font=""10""> We note that even though Argentina's request to APHIS for authorization of imports from Patagonia </ftext>
<ftext top=""1022"" left=""108"" width=""621"" height=""15"" font=""10"">includes all products of FMD susceptible animals, including the animals themselves, Argentina has not </ftext>
<ftext top=""1036"" left=""108"" width=""668"" height=""15"" font=""10"">referenced the articles of the Terrestrial Code that deal with products other than fresh (chilled or frozen) beef </ftext>
<ftext top=""1051"" left=""108"" width=""674"" height=""15"" font=""10"">in respect of its claim regarding Patagonia under Article 3.1. With respect to specific import recommendations, </ftext>
<ftext top=""1066"" left=""108"" width=""233"" height=""15"" font=""10"">Argentina has only mentioned 8.5.22. </ftext>
</footnote>
<text top=""242"" left=""771"" width=""19"" height=""16"" font=""0""> A </text>
<text top=""259"" left=""108"" width=""687"" height=""16"" font=""0"">comparison between the conditions for importation set forth in Article 8.5.22 and those in </text>
<text top=""275"" left=""108"" width=""314"" height=""16"" font=""0"">9 CFR 94.1 for Patagonia are set forth below: </text>
<p><text top=""310"" left=""246"" width=""141"" height=""15"" font=""29"">OIE Terrestrial Code </text><text top=""310"" left=""582"" width=""149"" height=""15"" font=""29"">9 CFR 94.1 as applied </text></p></p><p number=""8.5"" style=""8""><text top=""325"" left=""114"" width=""394"" height=""15"" font=""10"">8.5.22: Veterinary authorities should require the presentation of </text>
<text top=""340"" left=""114"" width=""377"" height=""15"" font=""10"">an international veterinary certificate attesting that the entire </text>
<text top=""354"" left=""114"" width=""302"" height=""15"" font=""10"">consignment of meat comes from animals which: </text>
<p><text top=""442"" left=""114"" width=""377"" height=""15"" font=""10"">subjected to ante- and post-mortem inspections for FMD with </text>
<text top=""456"" left=""114"" width=""117"" height=""15"" font=""10"">favourable results. </text>
<text top=""325"" left=""531"" width=""250"" height=""15"" font=""10"">No separate zone recognized. Treatment </text>
<text top=""340"" left=""531"" width=""246"" height=""15"" font=""10"">is the same as for the rest of Argentina. </text>
<text top=""354"" left=""531"" width=""214"" height=""15"" font=""10"">Therefore, imports are prohibited.  </text>
</p></p><p number=""7.248"" style=""8""><text top=""488"" left=""108"" width=""685"" height=""16"" font=""0"">7.248.  The OIE explained that providing for zoning and compartmentalization is an important </text>
<text top=""504"" left=""108"" width=""684"" height=""16"" font=""0"">element in promoting the goal of the Terrestrial Code, which is to provide for safe trade while </text>
<text top=""521"" left=""108"" width=""318"" height=""16"" font=""0"">avoiding unjustified sanitary barriers to trade.</text>
<footnote top=""519"" left=""427"" width=""17"" height=""11"" font=""16"" number=""712"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""174"" height=""15"" font=""10""> Terrestrial Code, Foreword. </ftext>
</footnote>
<text top=""521"" left=""444"" width=""347"" height=""16"" font=""0""> The purpose of establishing zones is to maintain </text>
<text top=""537"" left=""108"" width=""687"" height=""16"" font=""0"">separation in terms of the health status of two distinct populations of animals so that the </text>
<text top=""554"" left=""108"" width=""567"" height=""16"" font=""0"">appropriate health measures can be targeted to the appropriate population.</text>
<footnote top=""552"" left=""675"" width=""17"" height=""11"" font=""16"" number=""713"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""237"" height=""15"" font=""10""> Transcript of the meeting, para. 1.18. </ftext>
</footnote>
<text top=""554"" left=""693"" width=""103"" height=""16"" font=""0""> Zoning and </text>
<text top=""570"" left=""108"" width=""677"" height=""16"" font=""0"">compartmentalization accomplish this goal by recognizing that disease status may not be country-</text>
<text top=""586"" left=""108"" width=""683"" height=""16"" font=""0"">wide and that the application of import measures should be tailored to the status of the exporting </text>
<text top=""603"" left=""108"" width=""682"" height=""16"" font=""0"">area. This general principle is embodied in Articles 4.3.2 and 4.3.3. Article 4.3.2 provides that the </text>
<text top=""619"" left=""108"" width=""687"" height=""16"" font=""0"">importing country should recognize the existence of a zone or compartment: (i) when the </text>
<text top=""636"" left=""108"" width=""684"" height=""16"" font=""0"">appropriate measures recommended in the Terrestrial Code are applied; and (ii) the Veterinary </text>
<text top=""652"" left=""108"" width=""684"" height=""16"" font=""0"">Authority of the exporting country certifies that this is the case. Furthermore, Article 4.3.3 sets </text>
<text top=""668"" left=""108"" width=""473"" height=""16"" font=""0"">forth principles for defining and establishing a zone or compartment. </text>
</p><p number=""7.249"" style=""8""><text top=""703"" left=""108"" width=""684"" height=""16"" font=""0"">7.249.  In our view, the text of Chapter 8.5, read in conjunction with the general obligations on </text>
<text top=""719"" left=""108"" width=""686"" height=""16"" font=""0"">zoning and compartmentalization in Article 4.3.2, indicates that the import recommendations </text>
<text top=""736"" left=""108"" width=""684"" height=""16"" font=""0"">contained therein are not only intended for country-wide purposes, but are intended to apply to </text>
<text top=""752"" left=""108"" width=""688"" height=""16"" font=""0"">zones and compartments. The application by an importing Member of the product-specific </text>
<text top=""769"" left=""108"" width=""689"" height=""16"" font=""0"">recommendations to zones or compartments presupposes that the exporting Member has </text>
<text top=""785"" left=""108"" width=""684"" height=""16"" font=""0"">established such zones or compartments within its territory according to the Terrestrial Code (in </text>
<text top=""801"" left=""108"" width=""683"" height=""16"" font=""0"">this case Articles 4.3.3 and 8.5.4). If an exporting country does so, Article 8.5.22 envisages that </text>
<text top=""818"" left=""108"" width=""682"" height=""16"" font=""0"">the importing Member allow the importation from that zone or compartment subject to the specific </text>
<text top=""834"" left=""108"" width=""689"" height=""16"" font=""0"">recommendations therein. This means that the Terrestrial Code envisages that importing </text>
<text top=""851"" left=""108"" width=""683"" height=""16"" font=""0"">Members, when applying measures to address the risk of entry, establishment or spread of FMD, </text>
<text top=""867"" left=""108"" width=""683"" height=""16"" font=""0"">will recognize that if an exporting Member is not entirely free of FMD without vaccination, it may </text>
<text top=""883"" left=""108"" width=""565"" height=""16"" font=""0"">have zones or compartments that are FMD-free where vaccination is not practised.</text>
<footnote top=""882"" left=""672"" width=""17"" height=""11"" font=""16"" number=""714"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1109"" left=""165"" width=""617"" height=""15"" font=""10""> This approach is consistent with that taken by the panel in <i>India &#8211; Agricultural Products </i>with respect </ftext>
<ftext top=""1124"" left=""108"" width=""662"" height=""15"" font=""10"">to Chapter 10.4 of the Terrestrial Code. See Panel Report, <i>India &#8211; Agricultural Products</i>, paras. 7.254-7.263. </ftext>
</footnote>
</p><p number=""7.250"" style=""8""><text top=""918"" left=""108"" width=""683"" height=""16"" font=""0"">7.250.  We noted above that a Member is not necessarily bound to follow the official recognitions </text>
<text top=""934"" left=""108"" width=""683"" height=""16"" font=""0"">of disease status to be determined to have based its measures on the Terrestrial Code. This does </text>
<text top=""951"" left=""108"" width=""682"" height=""16"" font=""0"">not mean, however, that if a Member wishes to base its measures on the Terrestrial Code, it can </text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 110 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">decline to recognize that an exporting Member has within it zones or compartments that may have </text>
<text top=""144"" left=""108"" width=""558"" height=""16"" font=""0"">a different FMD disease status than the rest of the exporting Member's territory.  </text>
</p></p></page>
<page number=""110"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.251"" style=""8""><text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">7.251.  Prior to the date of establishment of the Panel, the United States applied its measures to </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">imports of animals, meat and other animal products from Argentina on a country-wide basis and </text>
<text top=""211"" left=""108"" width=""682"" height=""16"" font=""0"">did not apply the import conditions recommended in Article 8.5.22 for zones or compartments that </text>
<text top=""228"" left=""108"" width=""449"" height=""16"" font=""0"">are FMD-free where vaccination is not practised. As 9 </text>
<text top=""228"" left=""548"" width=""40"" height=""16"" font=""0"">CFR </text>
<text top=""228"" left=""579"" width=""220"" height=""16"" font=""0"">94.1, as amended by the </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">2001 Regulations, prohibits imports of the relevant products from the entire territory of Argentina, </text>
<text top=""260"" left=""108"" width=""686"" height=""16"" font=""0"">thus not allowing importation of products from a zone (namely, Patagonia), we find that the </text>
<text top=""277"" left=""108"" width=""567"" height=""16"" font=""0"">measures are not based on the Terrestrial Code within the meaning of Article 3.1.  </text>
</p><p number=""7.252"" style=""8""><text top=""311"" left=""108"" width=""683"" height=""16"" font=""0"">7.252.  We understand that the United States has an established process pursuant to 9 CFR 92.2 </text>
<text top=""328"" left=""108"" width=""683"" height=""16"" font=""0"">for the recognition of particular regions &#8211; even those within the territory of a country &#8211; as being </text>
<text top=""344"" left=""108"" width=""687"" height=""16"" font=""0"">FMD-free. Argentina submitted an application to achieve recognition of Patagonia South as </text>
<text top=""360"" left=""108"" width=""682"" height=""16"" font=""0"">FMD-free in 2003. Subsequently, in 2008, Argentina expanded its application to cover an enlarged </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">region that includes both Patagonia South and Patagonia North B &#8211; the Patagonia region. As of the </text>
<text top=""393"" left=""108"" width=""687"" height=""16"" font=""0"">date of the establishment of the Panel, the United States had not completed its review of </text>
<text top=""410"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina's applications. The United States is entitled to conduct its own risk analysis and reach its </text>
<text top=""426"" left=""108"" width=""682"" height=""16"" font=""0"">own conclusions as to whether the Patagonia region is a zone that is FMD-free where vaccination is </text>
<text top=""443"" left=""108"" width=""683"" height=""16"" font=""0"">not practised. However, if the United States applies the current measures on a country-wide basis </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">without any recognition of a zone within Argentina that could be FMD-free where vaccination is not </text>
<text top=""475"" left=""108"" width=""638"" height=""16"" font=""0"">practised, it is not basing those measures on the relevant provisions of the Terrestrial Code.  </text>
</p><p number=""7.4"" style=""8""><text top=""510"" left=""108"" width=""164"" height=""16"" font=""28"">7.4.2.3.4  Conclusion </text></p><p number=""7.253"" style=""8""><text top=""544"" left=""108"" width=""682"" height=""16"" font=""0"">7.253.  We have found that the import prohibitions on fresh (chilled or frozen) beef from Northern </text>
<text top=""561"" left=""108"" width=""688"" height=""16"" font=""0"">Argentina contradict the Terrestrial Code. We have also found that the non-recognition of </text>
<text top=""577"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia as a zone that is FMD-free where vaccination is not practised and to prohibit imports of </text>
<text top=""593"" left=""108"" width=""682"" height=""16"" font=""0"">animals, meat and animal products from that zone also contradicts the Terrestrial Code. Therefore, </text>
<text top=""610"" left=""108"" width=""692"" height=""16"" font=""0"">both measures are not based on the relevant international standards, guidelines or </text>
<text top=""626"" left=""108"" width=""359"" height=""16"" font=""0"">recommendations within the meaning of Article 3.1. </text>
</p><p number=""7.254"" style=""8""><text top=""661"" left=""108"" width=""687"" height=""16"" font=""0"">7.254.  Therefore, we now turn to the question of whether the United States' measures are </text>
<text top=""677"" left=""108"" width=""186"" height=""16"" font=""0"">consistent with Article 3.3. </text>
</p><p number=""7.4"" style=""8""><text top=""711"" left=""108"" width=""684"" height=""16"" font=""28"">7.4.3  Whether  the  United States'  measures  are introduced or maintained consistently </text><text top=""728"" left=""108"" width=""121"" height=""16"" font=""28"">with Article 3.3 </text></p><p number=""7.255"" style=""8""><text top=""762"" left=""108"" width=""685"" height=""16"" font=""0"">7.255.  The United States argues that Article 3.3 is inapplicable in the present dispute because </text>
<text top=""779"" left=""108"" width=""682"" height=""16"" font=""0"">that provision only applies to the introduction or maintenance of SPS measures and APHIS has not </text>
<text top=""795"" left=""108"" width=""502"" height=""16"" font=""0"">yet finished its evaluation of either Northern Argentina or Patagonia.</text>
<footnote top=""793"" left=""610"" width=""17"" height=""11"" font=""16"" number=""715"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""621"" height=""15"" font=""10""> United States' second written submission, para. 99. United States' response to Panel question No. 17 </ftext>
<ftext top=""1007"" left=""108"" width=""259"" height=""15"" font=""10"">following the second substantive meeting. </ftext>
</footnote>
<text top=""795"" left=""627"" width=""166"" height=""16"" font=""0""> The Panel asked the </text>
<text top=""811"" left=""108"" width=""499"" height=""16"" font=""0"">United States to clarify its argument in light of the text of Article 3.3</text>
<footnote top=""810"" left=""607"" width=""17"" height=""11"" font=""16"" number=""716"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""607"" height=""15"" font=""10""> The Panel notes that Article 3.3 refers generally to any provision of this agreement, which includes </ftext>
<ftext top=""1036"" left=""108"" width=""646"" height=""15"" font=""10"">Article 5.7. It also specifically refers to paragraphs 1 through 8 of Article 5 which also includes Article 5.7. </ftext>
</footnote>
<text top=""811"" left=""624"" width=""169"" height=""16"" font=""0""> and in particular with </text>
<text top=""828"" left=""108"" width=""683"" height=""16"" font=""0"">respect to the factual matter of whether 9 CFR 94.1, as amended by the 2001 Regulations, is an </text>
<text top=""844"" left=""108"" width=""333"" height=""16"" font=""0"">SPS measure that is currently being maintained.</text>
<footnote top=""843"" left=""441"" width=""17"" height=""11"" font=""16"" number=""717"" ref="""" dis=""""/>
<text top=""844"" left=""458"" width=""332"" height=""16"" font=""0""> In response, the United States, maintaining its </text>
<text top=""861"" left=""108"" width=""683"" height=""16"" font=""0"">position that the appropriate provision for examining its measures is Article 5.7, did not address </text>
<text top=""877"" left=""108"" width=""685"" height=""16"" font=""0"">the Panel's questions with respect to the nature of the obligation in Article 3.3 or the factual </text>
<text top=""893"" left=""108"" width=""683"" height=""16"" font=""0"">situation vis-&#224;-vis the maintenance of the import prohibitions in 9 CFR 94.1, as amended by the </text>
<text top=""910"" left=""108"" width=""119"" height=""16"" font=""0"">2001 regulations.</text>
<footnote top=""908"" left=""227"" width=""17"" height=""11"" font=""16"" number=""718"" ref="""" dis=""""/>
<text top=""910"" left=""245"" width=""545"" height=""16"" font=""0""> Given that the United States cannot demonstrate the underlying premise of its </text>
<footnote top=""1051"" left=""165"" width=""400"" height=""15"" font=""10"" number=""17"" ref=""WT/DS320/AB/R"" dis=""DS320""><ftext top=""1080"" left=""108"" width=""631"" height=""15"" font=""10"">note that the United States seemed to have altered its understanding of Article 3.3 when it argued that </ftext>
<ftext top=""1095"" left=""108"" width=""669"" height=""15"" font=""10"">""Article 3.3 is not itself an independent obligation. Rather, Article 3.3 serves to foreclose a finding of a breach </ftext>
<ftext top=""1109"" left=""108"" width=""647"" height=""15"" font=""10"">of Article 3.1 in circumstances in which an importing Member chooses not to base its SPS measures on an </ftext>
<ftext top=""1124"" left=""108"" width=""152"" height=""15"" font=""10"">international standard.""  </ftext>
<ftext top=""1080"" left=""108"" width=""678"" height=""15"" font=""10"">if there is a scientific justification, or (b) as a consequence of the level of sanitary or phytosanitary protection a </ftext>
<ftext top=""1095"" left=""108"" width=""662"" height=""15"" font=""10"">Member determines to be appropriate. See also Appellate Body Report, <i>Canada/US &#8211; Continued Suspension</i>, </ftext>
</footnote>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 111 - </text>
</p><p><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">own interpretation &#8211; i.e. the absence of an SPS measure &#8211; we see no need to substantively </text>
<text top=""144"" left=""108"" width=""158"" height=""16"" font=""0"">address this argument.</text>
<footnote top=""143"" left=""266"" width=""17"" height=""11"" font=""16"" number=""719"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""587"" height=""15"" font=""10""> While making no specific finding, the Panel does note that the implications of the United States' </ftext>
<ftext top=""949"" left=""108"" width=""681"" height=""15"" font=""10"">argument could be far reaching to a coherent application of the SPS Agreement. If accepted, it could mean that </ftext>
<ftext top=""963"" left=""108"" width=""669"" height=""15"" font=""10"">a Member could simply avoid the applicability of Article 3.3 and other provisions of the SPS Agreement (other </ftext>
<ftext top=""978"" left=""108"" width=""627"" height=""15"" font=""10"">than Article 8 and Annex C(1)(a)) by refusing to reach a determination and finalize a measure, leaving </ftext>
<ftext top=""993"" left=""108"" width=""583"" height=""15"" font=""10"">exporting Members with no recourse to dispute settlement on the substantive obligations in the </ftext>
<ftext top=""1007"" left=""108"" width=""385"" height=""15"" font=""10"">SPS Agreement while an import prohibition remained in place.  </ftext>
</footnote>
</p></p></page>
<page number=""111"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.256"" style=""8""><text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">7.256.  We recall that Article 3.3 codifies Members' autonomous right to establish their own ALOP </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">and to adopt SPS measures that achieve a higher level of protection than would be achieved by a </text>
<text top=""211"" left=""108"" width=""534"" height=""16"" font=""0"">measure based on international standards, guidelines or recommendations.</text>
<footnote top=""210"" left=""642"" width=""17"" height=""11"" font=""16"" number=""720"" ref=""WT/DS26/AB/R ; WT/DS48/AB/R"" dis=""DS26""><ftext top=""1022"" left=""165"" width=""376"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>,<i> </i>paras. 104 and 172. </ftext>
</footnote>
<text top=""211"" left=""659"" width=""134"" height=""16"" font=""0""> In this case, the </text>
<text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">United States has asserted that its measures achieve a higher level of protection than would be </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">achieved by application of the Terrestrial Code. However, the right under Article 3.3 is not absolute </text>
<text top=""260"" left=""108"" width=""98"" height=""16"" font=""0"">or unqualified.</text>
<footnote top=""259"" left=""206"" width=""17"" height=""11"" font=""16"" number=""721"" ref="""" dis=""""/>
<text top=""260"" left=""223"" width=""567"" height=""16"" font=""0""> Pursuant to Article 3.3 the United States' measures must not be inconsistent with </text>
<text top=""277"" left=""108"" width=""292"" height=""16"" font=""0"">any other provision of the SPS Agreement.</text>
<footnote top=""275"" left=""399"" width=""17"" height=""11"" font=""16"" number=""722"" ref=""WT/DS26/AB/R ; WT/DS48/AB/R"" dis=""DS26""><ftext top=""1051"" left=""165"" width=""615"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, paras. 175-177 finding that the requirement to comply with </ftext>
</footnote>
</p><p number=""7.257"" style=""8""><text top=""311"" left=""108"" width=""684"" height=""16"" font=""0"">7.257.  We have already found that the United States has acted inconsistently with Article 8 and </text>
<text top=""328"" left=""108"" width=""685"" height=""16"" font=""0"">Annex C(1)(a) and (b). Therefore, we find that the United States has acted inconsistently with </text>
<text top=""344"" left=""108"" width=""685"" height=""16"" font=""0"">Article 3.3. However, we note that Argentina also argues that the United States measures are </text>
<text top=""360"" left=""108"" width=""682"" height=""16"" font=""0"">inconsistent with Article 3.3 because they are also inconsistent with Articles 5.1, 5.2, 5.4, 5.6, 2.2, </text>
<text top=""377"" left=""108"" width=""310"" height=""16"" font=""0"">2.3, 6.1, 6.2 and 10 of the SPS Agreement.</text>
<footnote top=""375"" left=""418"" width=""17"" height=""11"" font=""16"" number=""723"" ref="""" dis=""DS18""><ftext top=""1124"" left=""165"" width=""353"" height=""15"" font=""10""> Argentina's first written submission, paras. 227 and 449. </ftext>
<ftext top=""963"" left=""108"" width=""663"" height=""15"" font=""10"">Report, <i>Australia &#8211; Salmon</i> <i>(Article 21.5 &#8211; Canada)</i>, paras. 7.85 and 7.161; and Panel Report, <i>EC &#8211; Approval </i></ftext>
<ftext top=""1066"" left=""108"" width=""654"" height=""15"" font=""10"">evidence is insufficient and that the applicable provision is Article 5.7. Appellate Body Report, <i>US/Canada &#8211; </i></ftext>
</footnote>
<text top=""377"" left=""435"" width=""357"" height=""16"" font=""0""> Therefore, we will return to the issue of whether </text>
<text top=""393"" left=""108"" width=""684"" height=""16"" font=""0"">there are additional inconsistencies with Article 3.3 after we have concluded our analysis of the </text>
<text top=""410"" left=""108"" width=""182"" height=""16"" font=""0"">rest of Argentina's claims. </text>
</p><p number=""7.5"" style=""8""><text top=""444"" left=""108"" width=""211"" height=""16"" font=""28"">7.5  Whether the United </text><text top=""444"" left=""311"" width=""487"" height=""16"" font=""28"">States' measures are based on scientific principles and </text><text top=""461"" left=""108"" width=""348"" height=""16"" font=""28"">maintained with sufficient scientific evidence </text></p><p number=""7.5"" style=""8""><text top=""495"" left=""108"" width=""243"" height=""16"" font=""28"">7.5.1  Relevant legal provisions </text></p><p number=""7.258"" style=""8""><text top=""529"" left=""108"" width=""528"" height=""16"" font=""0"">7.258.  Article 2.2 of the SPS Agreement sets forth the basic obligation that: </text>
<p><text top=""564"" left=""151"" width=""599"" height=""16"" font=""0"">Members shall ensure that any sanitary or phytosanitary measure is applied only to </text>
<text top=""580"" left=""151"" width=""599"" height=""16"" font=""0"">the extent necessary to protect human, animal or plant life or health, is based on </text>
<text top=""597"" left=""151"" width=""597"" height=""16"" font=""0"">scientific principles and is not maintained without sufficient scientific evidence, except </text>
<text top=""613"" left=""151"" width=""423"" height=""16"" font=""0"">as provided for in paragraph 7 of Article 5. (emphasis added) </text>
</p></p><p number=""7.259"" style=""8""><text top=""647"" left=""108"" width=""176"" height=""16"" font=""0"">7.259.  Article 5.7 reads: </text>
<p><text top=""682"" left=""151"" width=""597"" height=""16"" font=""0"">In cases where relevant scientific evidence is insufficient, a Member may provisionally </text>
<text top=""698"" left=""151"" width=""604"" height=""16"" font=""0"">adopt sanitary or phytosanitary measures on the basis of available pertinent </text>
<text top=""715"" left=""151"" width=""600"" height=""16"" font=""0"">information, including that from the relevant international organizations as well as </text>
<text top=""731"" left=""151"" width=""604"" height=""16"" font=""0"">from sanitary or phytosanitary measures applied by other Members. In such </text>
<text top=""747"" left=""151"" width=""598"" height=""16"" font=""0"">circumstances, Members shall seek to obtain the additional information necessary for </text>
<text top=""764"" left=""151"" width=""597"" height=""16"" font=""0"">a more objective assessment of risk and review the sanitary or phytosanitary measure </text>
<text top=""780"" left=""151"" width=""324"" height=""16"" font=""0"">accordingly within a reasonable period of time. </text>
</p></p><p number=""7.260"" style=""8""><text top=""815"" left=""108"" width=""176"" height=""16"" font=""0"">7.260.  Article 5.1 reads: </text>
<p><text top=""849"" left=""151"" width=""598"" height=""16"" font=""0"">Members shall ensure that their sanitary or phytosanitary measures are based on an </text>
<text top=""865"" left=""151"" width=""599"" height=""16"" font=""0"">assessment, as appropriate to the circumstances, of the risks to human, animal or </text>
<text top=""882"" left=""151"" width=""598"" height=""16"" font=""0"">plant life or health, taking into account risk assessment techniques developed by the </text>
<text top=""898"" left=""151"" width=""256"" height=""16"" font=""0"">relevant international organizations.  </text>
</p><p><text top=""1036"" left=""165"" width=""316"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 173. </text>
</p><p><text top=""1066"" left=""108"" width=""675"" height=""15"" font=""10"">all the other provisions of the SPS Agreement (including Article 5) applies both to measures adopted either (a) </text>
</p><p><text top=""1109"" left=""108"" width=""67"" height=""15"" font=""10"">para. 685. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 112 - </text>
</p></p></page>
<page number=""112"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.261"" style=""8""><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">7.261.  Articles 5.2 and 5.3 lists various factors that Members shall take into account when </text>
<text top=""144"" left=""108"" width=""420"" height=""16"" font=""0"">conducting risk assessments. In particular, Article 5.2 reads: </text>
<p><text top=""178"" left=""151"" width=""602"" height=""16"" font=""0"">In the assessment of risks, Members shall take into account available scientific </text>
<text top=""195"" left=""151"" width=""598"" height=""16"" font=""0"">evidence; relevant processes and production methods; relevant inspection, sampling </text>
<text top=""211"" left=""151"" width=""599"" height=""16"" font=""0"">and testing methods; prevalence of specific diseases or pests; existence of pest- or </text>
<text top=""228"" left=""151"" width=""597"" height=""16"" font=""0"">disease- free areas; relevant ecological and environmental conditions; and quarantine </text>
<text top=""244"" left=""151"" width=""137"" height=""16"" font=""0"">or other treatment. </text>
</p></p><p number=""7.262"" style=""8""><text top=""278"" left=""108"" width=""229"" height=""16"" font=""0"">7.262.  Article 5.3 provides that: </text>
<p><text top=""313"" left=""151"" width=""597"" height=""16"" font=""0"">In assessing the risk to animal or plant life or health and determining the measure to </text>
<text top=""329"" left=""151"" width=""598"" height=""16"" font=""0"">be applied for achieving the appropriate level of sanitary or phytosanitary protection </text>
<text top=""346"" left=""151"" width=""600"" height=""16"" font=""0"">from such risk, Members shall take into account as relevant economic factors: the </text>
<text top=""362"" left=""151"" width=""599"" height=""16"" font=""0"">potential damage in terms of loss of production or sales in the event of the entry, </text>
<text top=""378"" left=""151"" width=""597"" height=""16"" font=""0"">establishment or spread of a pest or disease; the costs of control or eradication in the </text>
<text top=""395"" left=""151"" width=""599"" height=""16"" font=""0"">territory of the importing Member; and the relative cost-effectiveness of alternative </text>
<text top=""411"" left=""151"" width=""202"" height=""16"" font=""0"">approaches to limiting risks.  </text>
</p></p><p number=""7.263"" style=""8""><text top=""446"" left=""108"" width=""549"" height=""16"" font=""0"">7.263.  Finally, Annex A(4) of the SPS Agreement defines ""risk assessment"" as: </text>
<p><text top=""480"" left=""151"" width=""597"" height=""16"" font=""0"">The evaluation of the likelihood of entry, establishment or spread of a pest or disease </text>
<text top=""497"" left=""151"" width=""597"" height=""16"" font=""0"">within the territory of an importing Member according to the sanitary or phytosanitary </text>
<text top=""513"" left=""151"" width=""601"" height=""16"" font=""0"">measures which might be applied, and of the associated potential biological and </text>
<text top=""529"" left=""151"" width=""600"" height=""16"" font=""0"">economic consequences; or the evaluation of the potential for adverse effects on </text>
<text top=""546"" left=""151"" width=""598"" height=""16"" font=""0"">human or animal health arising from the presence of additives, contaminants, toxins </text>
<text top=""562"" left=""151"" width=""432"" height=""16"" font=""0"">or disease-causing organisms in food, beverages or feedstuffs. </text>
</p></p><p number=""7.264"" style=""8""><text top=""597"" left=""108"" width=""685"" height=""16"" font=""0"">7.264.  The Appellate Body has observed that Article 2.2 informs, imparts meaning to, and is </text>
<text top=""613"" left=""108"" width=""683"" height=""16"" font=""0"">made operative in other provisions of the SPS Agreement including specific obligations set out in </text>
<text top=""629"" left=""108"" width=""61"" height=""16"" font=""0"">Article 5.</text>
<footnote top=""628"" left=""169"" width=""17"" height=""11"" font=""16"" number=""724"" ref="""" dis=""""/>
<text top=""629"" left=""186"" width=""605"" height=""16"" font=""0""> Thus, in <i>EC &#8211; Hormones, </i>the Appellate Body stated that ""Articles 2.2 and 5.1 should </text>
<text top=""646"" left=""108"" width=""685"" height=""16"" font=""0"">constantly be read together. Article 2.2 informs Article 5.1: the elements that define the basic </text>
<text top=""662"" left=""108"" width=""461"" height=""16"" font=""0"">obligation set out in Article 2.2 impart meaning to Article 5.1.""</text>
<footnote top=""661"" left=""568"" width=""17"" height=""11"" font=""16"" number=""725"" ref="""" dis=""""/>
<text top=""662"" left=""586"" width=""204"" height=""16"" font=""0""> In <i>Australia &#8211; Apples, </i>the </text>
<text top=""679"" left=""108"" width=""660"" height=""16"" font=""0"">Appellate Body concluded that the same type of relationship exists between Articles 2.2 and 5.2.</text>
<footnote top=""677"" left=""768"" width=""17"" height=""11"" font=""16"" number=""726"" ref="""" dis=""""/>
<text top=""695"" left=""108"" width=""683"" height=""16"" font=""0"">Likewise, panels and the Appellate Body have examined the reference to Article 5.7 in Article 2.2 </text>
<text top=""711"" left=""108"" width=""687"" height=""16"" font=""0"">and reasoned that the ability to adopt measures as described in Article 5.7 is a ""qualified </text>
<text top=""728"" left=""108"" width=""293"" height=""16"" font=""0"">exemption"" to the obligation in Article 2.2.</text>
<footnote top=""726"" left=""401"" width=""20"" height=""11"" font=""16"" number=""727"" ref="""" dis=""""/>
<text top=""728"" left=""422"" width=""369"" height=""16"" font=""0"">The panel in <i>EC &#8211; Approval and Marketing of Biotech </i></text>
<text top=""744"" left=""108"" width=""686"" height=""16"" font=""18""><i>Products</i> reached the conclusion that Article 5.7 is a ""qualified right"", finding that Article 5.7 </text>
<text top=""761"" left=""108"" width=""534"" height=""16"" font=""0"">confers a right to maintain a measure otherwise inconsistent with Article 5.1.</text>
<footnote top=""759"" left=""642"" width=""17"" height=""11"" font=""16"" number=""728"" ref=""WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS375/R ; WT/DS376/R ; WT/DS377/R|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7"" dis=""DS293|DS376|DS377|DS291|DS292|DS375""><ftext top=""1095"" left=""165"" width=""607"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, paras. 7.2939, 7.2945 and 7.2969 </ftext>
<ftext top=""1109"" left=""108"" width=""621"" height=""15"" font=""10"">(finding that Article 5.7 is a ""right"" to maintain a measure otherwise inconsistent with Article 2.2) and </ftext>
<ftext top=""1124"" left=""108"" width=""250"" height=""15"" font=""10"">paras. 7.2996-7.2998 and para. 7.3004. </ftext>
<ftext top=""978"" left=""108"" width=""366"" height=""15"" font=""10"">Panel Report, <i>EC &#8211; IT Products</i>, paras. 7.1043 and 7.1048). </ftext>
<ftext top=""1109"" left=""108"" width=""640"" height=""15"" font=""10"">in Article 5.7 are ""broad enough to encompass evidence associated with products originating in a specific </ftext>
</footnote>
<text top=""761"" left=""660"" width=""131"" height=""16"" font=""0""> Regardless of the </text>
<text top=""777"" left=""108"" width=""685"" height=""16"" font=""0"">specific terminology, panels and the Appellate Body have consistently found that Article 5.1 is </text>
<text top=""793"" left=""108"" width=""690"" height=""16"" font=""0"">applicable only if Article 5.7 is not. Therefore, in analysing Argentina's claims and the </text>
<text top=""810"" left=""108"" width=""684"" height=""16"" font=""0"">United States' position that its measures fall within the scope of Article 5.7, we agree with the </text>
<text top=""826"" left=""108"" width=""685"" height=""16"" font=""0"">panel in <i>EC &#8211; Approval and Marketing of Biotech Products </i>that a panel is bound to examine </text>
<footnote top=""934"" left=""165"" width=""598"" height=""15"" font=""10"" number=""180"" ref="""" dis=""""/>
<p><text top=""949"" left=""108"" width=""635"" height=""15"" font=""12""><i>Continued Suspension</i>, para. 674. See also Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 138; Panel </text>
</p><p><text top=""978"" left=""108"" width=""601"" height=""15"" font=""12""><i>and Marketing of Biotech Products</i>, para. 7.3399; Panel Report, <i>US &#8211; Poultry (China)</i>,<i> </i>para. 7.157. </text>
</p><p><text top=""1007"" left=""165"" width=""332"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 339. </text>
<text top=""1022"" left=""165"" width=""597"" height=""15"" font=""10""> Appellate Body Report, <i>Japan &#8211; Agricultural Products II</i>, para. 80; see also Panel Report, <i>Japan &#8211; </i></text>
<text top=""1036"" left=""108"" width=""675"" height=""15"" font=""12""><i>Apples</i>,<i> </i>paras. 8.210-8.212 (referring to Article 5.7 as a ""defence""). See also, the Appellate Body conclusion in </text>
<text top=""1051"" left=""108"" width=""681"" height=""15"" font=""12""><i>US/Canada &#8211; Continued Suspension</i>,<i> </i>that Article 2.2 excludes from its scope situations where relevant scientific </text>
</p><p><text top=""1080"" left=""108"" width=""210"" height=""15"" font=""12""><i>Continued Suspension</i>, para. 674. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 113 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">whether a measure falls within the scope of the exemption in Article 5.7 <i>before</i> turning to an </text>
<text top=""144"" left=""108"" width=""151"" height=""16"" font=""0"">analysis of Article 5.1.</text>
<footnote top=""143"" left=""259"" width=""17"" height=""11"" font=""16"" number=""729"" ref=""WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|"" dis=""DS292|DS291|DS293|""><ftext top=""788"" left=""165"" width=""614"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.3005-7.3007. However, the </ftext>
<ftext top=""803"" left=""108"" width=""669"" height=""15"" font=""10"">panel then proceeded to begin its analysis with Article 5.1, because, in its view, ""in the specific circumstances </ftext>
<ftext top=""818"" left=""108"" width=""663"" height=""15"" font=""10"">of [the] case, the critical legal issue [was] whether the relevant safeguard measures m[e]t the requirements </ftext>
<ftext top=""832"" left=""108"" width=""636"" height=""15"" font=""10"">set out in the text of Article 5.1, not whether they [were] consistent with Article 5.7. Ibid. para. 7.3006. </ftext>
</footnote>
</p></p></page>
<page number=""113"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.265"" style=""8""><text top=""178"" left=""108"" width=""685"" height=""16"" font=""0"">7.265.  Therefore, we will begin our analysis with Article 5.7 and only turn to Articles 5.1, 5.2, </text>
<text top=""195"" left=""108"" width=""147"" height=""16"" font=""0"">and 2.2 if necessary. </text>
</p><p number=""7.5"" style=""8""><text top=""229"" left=""108"" width=""685"" height=""16"" font=""28"">7.5.2  Whether  the  United States'  measures  fall within the scope of the exemption in </text><text top=""246"" left=""108"" width=""83"" height=""16"" font=""28"">Article 5.7 </text></p><p number=""7.5"" style=""8""><text top=""280"" left=""108"" width=""296"" height=""16"" font=""28"">7.5.2.1  Main arguments of the parties </text></p><p number=""7.5"" style=""8""><text top=""314"" left=""108"" width=""156"" height=""16"" font=""28"">7.5.2.1.1  Argentina </text></p><p number=""7.266"" style=""8""><text top=""349"" left=""108"" width=""684"" height=""16"" font=""0"">7.266.  Argentina argues that the United States' measures are not justified by Article 5.7 of the </text>
<text top=""365"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Agreement as they fail to meet at least three of the four cumulative steps required under that </text>
<text top=""382"" left=""108"" width=""66"" height=""16"" font=""0"">provision.</text>
<footnote top=""380"" left=""174"" width=""17"" height=""11"" font=""16"" number=""730"" ref="""" dis=""""><ftext top=""847"" left=""165"" width=""599"" height=""15"" font=""10""> Argentina's first written submission, paras. 282, 287 (referring to Appellate Body Report, <i>Japan &#8211; </i></ftext>
</footnote>
<text top=""382"" left=""192"" width=""599"" height=""16"" font=""0""> Accordingly, Argentina contends, the Panel should analyse such measures within the </text>
<text top=""398"" left=""108"" width=""388"" height=""16"" font=""0"">framework of Articles 5.1 and 5.2 of the SPS Agreement.</text>
<footnote top=""397"" left=""496"" width=""17"" height=""11"" font=""16"" number=""731"" ref="""" dis=""""/>
</p><p number=""7.267"" style=""8""><text top=""432"" left=""108"" width=""689"" height=""16"" font=""0"">7.267.  First,  Argentina  argues  that  9 CFR 94.1(b) is a permanent rather than provisional </text>
<text top=""449"" left=""108"" width=""64"" height=""16"" font=""0"">measure.</text>
<footnote top=""447"" left=""172"" width=""17"" height=""11"" font=""16"" number=""732"" ref="""" dis=""""><ftext top=""891"" left=""165"" width=""578"" height=""15"" font=""10""> Argentina's first written submission, para. 283; Argentina's response to Panel question No. 24 </ftext>
<ftext top=""905"" left=""108"" width=""241"" height=""15"" font=""10"">following the first substantive meeting. </ftext>
</footnote>
<text top=""449"" left=""189"" width=""603"" height=""16"" font=""0""> According to Argentina, the application of the 2001 Regulations and the prohibitions </text>
<text top=""465"" left=""108"" width=""682"" height=""16"" font=""0"">under 9 CFR 94.1 was never provisional in nature, as they would have been maintained indefinitely </text>
<text top=""482"" left=""108"" width=""323"" height=""16"" font=""0"">had Argentina not submitted its applications.</text>
<footnote top=""480"" left=""431"" width=""17"" height=""11"" font=""16"" number=""733"" ref="""" dis=""""><ftext top=""920"" left=""165"" width=""596"" height=""15"" font=""10""> Argentina's second written submission, para. 194; Argentina's response to Panel question No. 24 </ftext>
<ftext top=""934"" left=""108"" width=""241"" height=""15"" font=""10"">following the first substantive meeting. </ftext>
</footnote>
<text top=""482"" left=""448"" width=""345"" height=""16"" font=""0""> In Argentina's view, an SPS measure adopted </text>
<text top=""498"" left=""108"" width=""684"" height=""16"" font=""0"">pursuant to Article 5.1 ""cannot turn into a provisional measure as described in Article 5.7 ""upon </text>
<text top=""515"" left=""108"" width=""361"" height=""16"" font=""0"">receipt of an application from the exporting Member.</text>
<footnote top=""513"" left=""469"" width=""17"" height=""11"" font=""16"" number=""734"" ref="""" dis=""""/>
<text top=""515"" left=""486"" width=""304"" height=""16"" font=""0""> In its opinion, the adoption of a provisional </text>
<text top=""531"" left=""108"" width=""574"" height=""16"" font=""0"">measure under Article 5.7 ""requires some vote or other formal approval process"".</text>
<footnote top=""529"" left=""682"" width=""17"" height=""11"" font=""16"" number=""735"" ref="""" dis=""""/>
<text top=""531"" left=""699"" width=""92"" height=""16"" font=""0""> Conversely, </text>
<text top=""547"" left=""108"" width=""684"" height=""16"" font=""0"">according to Argentina, a permanent measure adopted under Article 5.1 can only be maintained </text>
<text top=""564"" left=""108"" width=""632"" height=""16"" font=""0"">under the conditions set forth in that provision, ""i.e. pursuant to a valid risk assessment"".</text>
<footnote top=""562"" left=""740"" width=""17"" height=""11"" font=""16"" number=""736"" ref="""" dis=""""/>
<text top=""564"" left=""757"" width=""34"" height=""16"" font=""0""> For </text>
<text top=""580"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina, the United States did not ""adopt"" any provisional measures at the time of the filing of </text>
<text top=""597"" left=""108"" width=""641"" height=""16"" font=""0"">Argentina's applications, the only change in circumstances being the applications themselves.</text>
<footnote top=""595"" left=""748"" width=""17"" height=""11"" font=""16"" number=""737"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""588"" height=""15"" font=""10""> Argentina's second written submission, paras. 115, 187. See also Argentina's response to Panel </ftext>
<ftext top=""1022"" left=""108"" width=""672"" height=""15"" font=""10"">question No. 24 following the first substantive meeting; Argentina's responses to Panel questions Nos. 18, 24, </ftext>
</footnote>
<text top=""597"" left=""766"" width=""24"" height=""16"" font=""0""> In </text>
<text top=""613"" left=""108"" width=""686"" height=""16"" font=""0"">its view, accepting the United States' interpretation would ""completely writ[e] out"" the words </text>
<text top=""629"" left=""108"" width=""332"" height=""16"" font=""0"">""provisionally adopt"" from the text of Article 5.7.</text>
<footnote top=""628"" left=""440"" width=""17"" height=""11"" font=""16"" number=""738"" ref="""" dis=""""/>
</p><p number=""7.268"" style=""8""><text top=""664"" left=""108"" width=""686"" height=""16"" font=""0"">7.268.  Second, Argentina maintains that, with respect to the sufficiency of relevant scientific </text>
<text top=""680"" left=""108"" width=""388"" height=""16"" font=""0"">evidence, Articles 5.1 and 5.7 are ""mutually exclusive"".</text>
<footnote top=""679"" left=""496"" width=""17"" height=""11"" font=""16"" number=""739"" ref="""" dis=""""/>
<text top=""680"" left=""514"" width=""278"" height=""16"" font=""0""> Indeed, it maintains, if at the time of </text>
<text top=""697"" left=""108"" width=""683"" height=""16"" font=""0"">the adoption of a provisional measure there is sufficient scientific evidence to conduct a valid risk </text>
<text top=""713"" left=""108"" width=""682"" height=""16"" font=""0"">assessment, then ""by definition there cannot be the requisite lack of scientific evidence required to </text>
<text top=""729"" left=""108"" width=""115"" height=""16"" font=""0"">invoke Article </text>
<text top=""729"" left=""214"" width=""33"" height=""16"" font=""0"">5.7"".</text>
<footnote top=""728"" left=""247"" width=""17"" height=""11"" font=""16"" number=""740"" ref="""" dis=""""/>
<text top=""729"" left=""264"" width=""327"" height=""16"" font=""0""> Argentina takes issue with the United </text>
<text top=""729"" left=""582"" width=""217"" height=""16"" font=""0"">States' argument that the </text>
<text top=""746"" left=""108"" width=""684"" height=""16"" font=""0"">2001 Regulations, through which APHIS imposed its prohibitions on imports of fresh (chilled or </text>
<p><text top=""861"" left=""108"" width=""213"" height=""15"" font=""12""><i>Agricultural Products II</i>, para. 89). </text>
<footnote top=""876"" left=""165"" width=""547"" height=""15"" font=""10"" number=""24"" ref="""" dis=""""/>
<footnote top=""949"" left=""165"" width=""528"" height=""15"" font=""10"" number=""29"" ref="""" dis=""""/>
</p><p><text top=""963"" left=""165"" width=""620"" height=""15"" font=""10""> Argentina's response to Panel question No. 18 following the second substantive meeting (referring to </text>
<footnote top=""1036"" left=""108"" width=""305"" height=""15"" font=""10"" number=""25"" ref="""" dis=""""/>
</p><p><text top=""1051"" left=""165"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 116. </text>
</p><p><text top=""1095"" left=""108"" width=""675"" height=""15"" font=""10"">Argentina's second written submission, para. 117. Argentina acknowledges that the terms ""scientific evidence"" </text>
</p><p><text top=""1124"" left=""108"" width=""590"" height=""15"" font=""10"">country"". (Argentina's response to Panel question No. 21 following the first substantive meeting) </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 114 - </text>
</p></p></page>
<page number=""114"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""frozen)"" style=""3""><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">frozen) beef from Northern Argentina and of FMD-susceptible animals and animal products from </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">Patagonia, were based on a risk assessment. In its view, if such regulations were really based on a </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">risk assessment ""then it necessarily follows that there was sufficient information to conduct such </text>
<text top=""177"" left=""108"" width=""419"" height=""16"" font=""0"">an assessment"", this excluding the applicability of Article 5.7.</text>
<footnote top=""175"" left=""527"" width=""17"" height=""11"" font=""16"" number=""741"" ref="""" dis=""""/>
</p><p number=""7.269"" style=""8""><text top=""211"" left=""108"" width=""687"" height=""16"" font=""0"">7.269.  Third, Argentina argues that even assuming that relevant scientific information was </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">insufficient in 2001, such insufficiency had ceased by the time of the establishment of the Panel in </text>
<text top=""244"" left=""108"" width=""97"" height=""16"" font=""0"">January 2013.</text>
<footnote top=""243"" left=""205"" width=""17"" height=""11"" font=""16"" number=""742"" ref="""" dis=""""/>
<text top=""244"" left=""222"" width=""572"" height=""16"" font=""0""> In its view, SENASA has provided APHIS with all the scientific information </text>
<text top=""260"" left=""108"" width=""685"" height=""16"" font=""0"">necessary for the United States to complete its risk assessments. This, Argentina contends, is </text>
<text top=""277"" left=""108"" width=""687"" height=""16"" font=""0"">evidenced by the fact that APHIS has not requested any additional information of SENASA </text>
<text top=""293"" left=""108"" width=""461"" height=""16"" font=""0"">concerning the FMD situation in Northern Argentina since 2006</text>
<footnote top=""292"" left=""569"" width=""17"" height=""11"" font=""16"" number=""743"" ref="""" dis=""""/>
<text top=""293"" left=""586"" width=""209"" height=""16"" font=""0"">, nor has it asked for any </text>
<text top=""310"" left=""108"" width=""409"" height=""16"" font=""0"">additional information concerning Patagonia since 2009.</text>
<footnote top=""308"" left=""517"" width=""17"" height=""11"" font=""16"" number=""744"" ref="""" dis=""""/>
<text top=""310"" left=""534"" width=""261"" height=""16"" font=""0""> In light of the above, Argentina </text>
<text top=""326"" left=""108"" width=""682"" height=""16"" font=""0"">maintains that the United States failed to seek additional scientific information within a reasonable </text>
<text top=""342"" left=""108"" width=""110"" height=""16"" font=""0"">period of time.</text>
<footnote top=""341"" left=""218"" width=""17"" height=""11"" font=""16"" number=""745"" ref="""" dis=""""/>
<text top=""342"" left=""236"" width=""560"" height=""16"" font=""0""> Moreover, according to Argentina, the United States' argument about the </text>
<text top=""359"" left=""108"" width=""683"" height=""16"" font=""0"">application of the exporting Member under Article 6.3 transforming the pre-existing measure into </text>
<text top=""375"" left=""108"" width=""683"" height=""16"" font=""0"">one covered by Article 5.7 improperly places the burden of providing additional information onto </text>
<text top=""392"" left=""108"" width=""685"" height=""16"" font=""0"">the exporting Member instead of placing the burden of seeking additional information and to </text>
<text top=""408"" left=""108"" width=""343"" height=""16"" font=""0"">review an SPS measure on the importing Member.</text>
<footnote top=""407"" left=""451"" width=""17"" height=""11"" font=""16"" number=""746"" ref="""" dis=""""><ftext top=""978"" left=""165"" width=""614"" height=""15"" font=""10""> Argentina's second written submission, para. 194. See also Ibid. para. 190; Argentina's response to </ftext>
</footnote>
</p><p number=""7.270"" style=""8""><text top=""443"" left=""108"" width=""685"" height=""16"" font=""0"">7.270.  Fourth, Argentina argues that the United States failed to review its measures within a </text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">reasonable period of time. Specifically, Argentina argues, in 2009-2010 APHIS confirmed that it </text>
<text top=""475"" left=""108"" width=""682"" height=""16"" font=""0"">had all the information required to proceed with the risk assessments for Argentine fresh beef and </text>
<text top=""492"" left=""108"" width=""277"" height=""16"" font=""0"">Patagonian FMD-susceptible products.</text>
<footnote top=""490"" left=""385"" width=""17"" height=""11"" font=""16"" number=""747"" ref="""" dis=""""/>
<text top=""492"" left=""402"" width=""396"" height=""16"" font=""0""> In its view, throughout these proceedings, the </text>
<text top=""508"" left=""108"" width=""684"" height=""16"" font=""0"">United States failed to identify any pieces of information that APHIS was still missing after 2006 </text>
<text top=""525"" left=""108"" width=""684"" height=""16"" font=""0"">(concerning Northern Argentina) and 2009 (concerning Patagonia) in order to complete its risk </text>
<text top=""541"" left=""108"" width=""91"" height=""16"" font=""0"">assessments.</text>
<footnote top=""539"" left=""199"" width=""17"" height=""11"" font=""16"" number=""748"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""594"" height=""15"" font=""10""> Argentina's responses to Panel questions Nos. 22 and 48 following the first substantive meeting; </ftext>
</footnote>
<text top=""541"" left=""217"" width=""575"" height=""16"" font=""0""> Argentina contends that the interpretation of ""undue delay"" under Article 8 and </text>
<text top=""557"" left=""108"" width=""683"" height=""16"" font=""0"">Annex C(1) of the SPS Agreement ""should inform"" the analysis of the reasonableness of the time </text>
<text top=""574"" left=""108"" width=""499"" height=""16"" font=""0"">taken by the importing Member to review a measure under Article 5.7.</text>
<footnote top=""572"" left=""607"" width=""17"" height=""11"" font=""16"" number=""749"" ref="""" dis=""""/>
<text top=""574"" left=""625"" width=""167"" height=""16"" font=""0""> Argentina asserts that </text>
<text top=""590"" left=""108"" width=""690"" height=""16"" font=""0"">the United States maintained its measures for thirteen years without conducting a risk </text>
<text top=""607"" left=""108"" width=""682"" height=""16"" font=""0"">assessment, which cannot ""be considered consistent with the requirement that it be done within a </text>
<text top=""623"" left=""108"" width=""190"" height=""16"" font=""0"">reasonable period of time"".</text>
<footnote top=""621"" left=""298"" width=""17"" height=""11"" font=""16"" number=""750"" ref="""" dis=""""/>
<text top=""623"" left=""315"" width=""476"" height=""16"" font=""0""> In support of its argument, Argentina compares the period during </text>
<text top=""639"" left=""108"" width=""682"" height=""16"" font=""0"">which its requests have been under review since its last FMD outbreak with that of Uruguay, which </text>
<text top=""656"" left=""108"" width=""660"" height=""16"" font=""0"">re-gained access to the United States' market less than two years after its last outbreak.</text>
<footnote top=""654"" left=""768"" width=""17"" height=""11"" font=""16"" number=""751"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 282-287. </ftext>
</footnote>
<text top=""672"" left=""108"" width=""683"" height=""16"" font=""0"">Furthermore, Argentina cites APHIS' statement in the rulemaking for Uruguay that a three to five </text>
<text top=""689"" left=""108"" width=""605"" height=""16"" font=""0"">year waiting period is not necessary for reauthorizing imports after an FMD outbreak.</text>
<footnote top=""687"" left=""712"" width=""17"" height=""11"" font=""16"" number=""752"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 282-287. </ftext>
</footnote>
<text top=""689"" left=""730"" width=""62"" height=""16"" font=""0""> Finally, </text>
<text top=""705"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina refers to the Appellate Body's statement in <i>Japan &#8211; Agricultural Products II</i> that a period </text>
<text top=""721"" left=""108"" width=""394"" height=""16"" font=""0"">of less than three years was reasonable under Article 5.7.</text>
<footnote top=""720"" left=""502"" width=""17"" height=""11"" font=""16"" number=""753"" ref="""" dis=""""/>
</p><p number=""7.271"" style=""8""><text top=""756"" left=""108"" width=""687"" height=""16"" font=""0"">7.271.  Furthermore, Argentina does not agree with the United States' argument that when </text>
<text top=""772"" left=""108"" width=""682"" height=""16"" font=""0"">circumstances warrant a new risk assessment the measure must fall within the scope of Article 5.7 </text>
<text top=""789"" left=""108"" width=""689"" height=""16"" font=""0"">to prevent the importing Member from being considered inconsistent with Article 5.1. In </text>
<text top=""805"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina's view, the requirement under Article 5.1 that an SPS measure be based on a risk </text>
<text top=""821"" left=""108"" width=""683"" height=""16"" font=""0"">assessment ""as appropriate to the circumstances"" encompasses the time flexibility needed for the </text>
<p><text top=""905"" left=""165"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 186. </text>
</p><p><text top=""934"" left=""165"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 197. </text>
<footnote top=""949"" left=""165"" width=""346"" height=""15"" font=""10"" number=""195"" ref="""" dis=""""/>
<footnote top=""1007"" left=""165"" width=""601"" height=""15"" font=""10"" number=""48"" ref="""" dis=""""/>
<footnote top=""1022"" left=""108"" width=""270"" height=""15"" font=""10"" number=""196"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 115 - </text>
</p><p><text top=""128"" left=""108"" width=""395"" height=""16"" font=""0"">importing Member to carry out such a risk assessment.</text>
<footnote top=""126"" left=""503"" width=""17"" height=""11"" font=""16"" number=""754"" ref="""" dis=""""/>
<text top=""128"" left=""520"" width=""272"" height=""16"" font=""0""> Moreover, Argentina argues that the </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">implication of the United States' interpretation would be that so long as the importing Member is </text>
<text top=""160"" left=""108"" width=""685"" height=""16"" font=""0"">conducting its review, the exporting Member ""would be prohibited from access to the dispute </text>
<text top=""177"" left=""108"" width=""132"" height=""16"" font=""0"">settlement system""</text>
<footnote top=""175"" left=""240"" width=""17"" height=""11"" font=""16"" number=""755"" ref="""" dis=""""/>
<text top=""177"" left=""257"" width=""521"" height=""16"" font=""0""> and thus ""a provisional measure would always be maintained indefinitely"".  </text>
</p></p></page>
<page number=""115"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.5"" style=""8""><text top=""211"" left=""108"" width=""184"" height=""16"" font=""28"">7.5.2.1.2  United States </text></p><p number=""7.272"" style=""8""><text top=""246"" left=""108"" width=""684"" height=""16"" font=""0"">7.272.  The United States argues that Article 5.7 is the relevant provision of the SPS Agreement </text>
<text top=""262"" left=""108"" width=""687"" height=""16"" font=""0"">applicable to the timeliness of APHIS' reviews of Argentina's requests, which, in its view, </text>
<text top=""278"" left=""108"" width=""300"" height=""16"" font=""0"">constitutes the core issue of this dispute.</text>
<footnote top=""277"" left=""408"" width=""17"" height=""11"" font=""16"" number=""756"" ref="""" dis=""""/>
<text top=""278"" left=""425"" width=""368"" height=""16"" font=""0""> According to the United States, the disciplines of </text>
<text top=""295"" left=""108"" width=""686"" height=""16"" font=""0"">Article 5.7 are informed and complemented by the obligations under Article 6.3, according to </text>
<text top=""311"" left=""108"" width=""683"" height=""16"" font=""0"">which a Member asserting that all or part of its territory is free of a disease ""is obligated to bring </text>
<text top=""328"" left=""108"" width=""628"" height=""16"" font=""0"">forth the necessary evidence to show that it is and is 'likely to remain' free of disease"".</text>
<footnote top=""326"" left=""736"" width=""17"" height=""11"" font=""16"" number=""757"" ref="""" dis=""""/>
<text top=""328"" left=""753"" width=""39"" height=""16"" font=""0""> The </text>
<text top=""344"" left=""108"" width=""684"" height=""16"" font=""0"">United States contends that, upon receipt of a claim of disease freedom, the importing Member </text>
<text top=""360"" left=""108"" width=""610"" height=""16"" font=""0"">usually does not have all the scientific information it needs to review its existing measure</text>
<footnote top=""359"" left=""717"" width=""17"" height=""11"" font=""16"" number=""758"" ref="""" dis=""""/>
<text top=""360"" left=""735"" width=""55"" height=""16"" font=""0"">, and is </text>
<text top=""377"" left=""108"" width=""655"" height=""16"" font=""0"">therefore ""provisionally permitted to maintain and adopt measures"" pursuant to Article 5.7</text>
<footnote top=""375"" left=""763"" width=""17"" height=""11"" font=""16"" number=""759"" ref="""" dis=""""/>
<text top=""377"" left=""780"" width=""10"" height=""16"" font=""0"">, </text>
<text top=""393"" left=""108"" width=""683"" height=""16"" font=""0"">provided it seeks to obtain from the exporting Member the additional information necessary for a </text>
<text top=""410"" left=""108"" width=""473"" height=""16"" font=""0"">more objective risk assessment within a reasonable period of time.</text>
<footnote top=""408"" left=""581"" width=""17"" height=""11"" font=""16"" number=""760"" ref="""" dis=""""/>
<text top=""410"" left=""598"" width=""194"" height=""16"" font=""0""> In turn, the United States </text>
<text top=""426"" left=""108"" width=""682"" height=""16"" font=""0"">argues, a determination of the ""reasonableness"" of the period of time under Article 5.7 is similar to </text>
<text top=""443"" left=""108"" width=""553"" height=""16"" font=""0"">a determination of whether a delay is undue under Article 8 and Annex C(1)(a).  </text>
</p><p number=""7.273"" style=""8""><text top=""477"" left=""108"" width=""683"" height=""16"" font=""0"">7.273.  The United States takes the view that as long as the importing Member is engaged in the </text>
<text top=""493"" left=""108"" width=""686"" height=""16"" font=""0"">process of evaluating the exporting Member's application for recognition of its territory as a </text>
<text top=""510"" left=""108"" width=""684"" height=""16"" font=""0"">disease-free area within a reasonable period of time, ""there is no legal basis for challenging the </text>
<text top=""526"" left=""108"" width=""444"" height=""16"" font=""0"">importing Member's decision to maintain its existing measure"".</text>
<footnote top=""525"" left=""552"" width=""17"" height=""11"" font=""16"" number=""761"" ref="""" dis=""""/>
<text top=""526"" left=""569"" width=""223"" height=""16"" font=""0""> Moreover, it asserts that with </text>
<text top=""543"" left=""108"" width=""685"" height=""16"" font=""0"">""each change in circumstance"" in the exporting Member in terms of its disease situation and </text>
<text top=""559"" left=""108"" width=""605"" height=""16"" font=""0"">regulatory regime, time is required for the importing Member to evaluate such change.</text>
<footnote top=""557"" left=""713"" width=""17"" height=""11"" font=""16"" number=""762"" ref="""" dis=""""/>
<text top=""559"" left=""730"" width=""61"" height=""16"" font=""0""> For the </text>
<text top=""575"" left=""108"" width=""686"" height=""16"" font=""0"">United States, any interpretation to the contrary would imply that ""importing Members must </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">modify their measures immediately upon an exporting Member's assertion"" concerning its disease </text>
<text top=""608"" left=""108"" width=""243"" height=""16"" font=""0"">freedom or low disease prevalence</text>
<footnote top=""607"" left=""351"" width=""17"" height=""11"" font=""16"" number=""763"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""613"" height=""15"" font=""10""> United States' second written submission, paras. 13, 31. See also United States' opening statement </ftext>
<ftext top=""1051"" left=""108"" width=""662"" height=""15"" font=""10"">at the second meeting of the Panel, para. 30; United States' response to Panel question No. 21 following the </ftext>
<ftext top=""1066"" left=""108"" width=""159"" height=""15"" font=""10"">first substantive meeting. </ftext>
</footnote>
<text top=""608"" left=""369"" width=""423"" height=""16"" font=""0"">, thereby bearing ""the risk of disease transmission pending </text>
<text top=""625"" left=""108"" width=""293"" height=""16"" font=""0"">the completion of the risk assessment"".</text>
<footnote top=""623"" left=""401"" width=""17"" height=""11"" font=""16"" number=""764"" ref="""" dis=""""><ftext top=""1080"" left=""165"" width=""586"" height=""15"" font=""10""> United States' second written submission, paras. 14. See also Ibid. paras. 2, 13; United States' </ftext>
</footnote>
<text top=""625"" left=""419"" width=""376"" height=""16"" font=""0""> In this respect, the United States disagrees with </text>
<text top=""641"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina that Article 5.1 provides for reasonable time flexibility for an importing Member to </text>
<text top=""657"" left=""108"" width=""684"" height=""16"" font=""0"">conduct its risk assessment. In its opinion, such ""undefined 'reasonable man' standard"" has ""no </text>
<text top=""674"" left=""108"" width=""339"" height=""16"" font=""0"">apparent basis in the text of the SPS Agreement""</text>
<footnote top=""672"" left=""447"" width=""17"" height=""11"" font=""16"" number=""765"" ref="""" dis=""""/>
<text top=""674"" left=""464"" width=""326"" height=""16"" font=""0"">; rather, the time for the importing Member to </text>
<text top=""690"" left=""108"" width=""307"" height=""16"" font=""0"">conduct its assessment resides in Article 5.7.</text>
<footnote top=""689"" left=""415"" width=""17"" height=""11"" font=""16"" number=""766"" ref="""" dis=""""/>
</p><p number=""7.274"" style=""8""><text top=""725"" left=""108"" width=""683"" height=""16"" font=""0"">7.274.  With respect to the particular measures at issue in this dispute, the United States argues </text>
<text top=""741"" left=""108"" width=""684"" height=""16"" font=""0"">that the 2001 Regulations, which amended 9 CFR 94.1(b) and removed Argentina's authorization </text>
<text top=""757"" left=""108"" width=""685"" height=""16"" font=""0"">to import, were justified at the time of imposition and are currently justified under Article 5.7 </text>
<text top=""774"" left=""108"" width=""688"" height=""16"" font=""0"">""while the United States' review of Argentina's requests for recognition as disease-free is </text>
<footnote top=""818"" left=""165"" width=""584"" height=""15"" font=""10"" number=""24"" ref="""" dis=""""/>
<p><text top=""832"" left=""108"" width=""632"" height=""15"" font=""10"">Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 129; Panel Reports, <i>Australia &#8211; Salmon</i>, para. 8.56; <i>EC &#8211; </i></text>
<text top=""847"" left=""108"" width=""365"" height=""15"" font=""12""><i>Approval and Marketing of Biotech Products</i>, para. 7.3031). </text>
<text top=""861"" left=""165"" width=""304"" height=""15"" font=""10""> Argentina's second written submission, para. 70. </text>
<text top=""876"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 228. </text>
<text top=""891"" left=""165"" width=""600"" height=""15"" font=""10""> United States' response to Panel question No. 22 following the first substantive meeting. See also </text>
<footnote top=""920"" left=""108"" width=""139"" height=""15"" font=""10"" number=""10"" ref="""" dis=""""/>
</p><p><text top=""963"" left=""165"" width=""321"" height=""15"" font=""10""> United States' second written submission, para. 13. </text>
<text top=""978"" left=""165"" width=""325"" height=""15"" font=""10""> United States' second written submission, para. 11.  </text>
</p><p><text top=""1007"" left=""108"" width=""452"" height=""15"" font=""10"">response to Panel question No. 27 following the first substantive meeting. </text>
<footnote top=""1022"" left=""165"" width=""545"" height=""15"" font=""10"" number=""26"" ref="""" dis=""""/>
</p><p><text top=""1095"" left=""108"" width=""379"" height=""15"" font=""10"">opening statement at the first meeting of the Panel, para. 25. </text>
<footnote top=""1109"" left=""165"" width=""563"" height=""15"" font=""10"" number=""20"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 116 - </text>
</p><p><text top=""128"" left=""108"" width=""65"" height=""16"" font=""0"">ongoing.""</text>
<footnote top=""126"" left=""173"" width=""17"" height=""11"" font=""16"" number=""767"" ref="""" dis=""""/>
<text top=""128"" left=""190"" width=""601"" height=""16"" font=""0""> According to the United States, from the moment Argentina filed its applications for </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">approval of imports of FMD-susceptible products, the pre-existing prohibition on such products </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">""can be viewed as provisional until additional necessary information is gathered to accept or reject </text>
<text top=""177"" left=""108"" width=""639"" height=""16"" font=""0"">the application[s]"", thereby falling within the purview of Article 5.7 of the SPS Agreement.</text>
<footnote top=""175"" left=""747"" width=""17"" height=""11"" font=""16"" number=""768"" ref="""" dis=""""/>
<text top=""177"" left=""764"" width=""28"" height=""16"" font=""0""> In </text>
<text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">that vein, the United States takes issue with Argentina's interpretation of the word ""adopt"" in </text>
<text top=""210"" left=""108"" width=""643"" height=""16"" font=""0"">Article 5.7 as requiring some explicit approval process, which it sees as unduly ""formalistic"".</text>
<footnote top=""208"" left=""751"" width=""17"" height=""11"" font=""16"" number=""769"" ref="""" dis=""""/>
<text top=""210"" left=""768"" width=""23"" height=""16"" font=""0""> It </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">also disagrees with Argentina's qualification of the June 2001 Interim Regulation as a ""provisional </text>
<text top=""242"" left=""108"" width=""685"" height=""16"" font=""0"">measure"" and the December 2001 Final Regulation as a ""permanent ban"" on imports of fresh </text>
<text top=""259"" left=""108"" width=""298"" height=""16"" font=""0"">(chilled or frozen) beef from Argentina.</text>
<footnote top=""257"" left=""406"" width=""17"" height=""11"" font=""16"" number=""770"" ref="""" dis=""""/>
<text top=""259"" left=""423"" width=""373"" height=""16"" font=""0""> For the United States, Argentina's distinction is </text>
<text top=""275"" left=""108"" width=""85"" height=""16"" font=""0"">""misleading""</text>
<footnote top=""274"" left=""193"" width=""17"" height=""11"" font=""16"" number=""771"" ref="""" dis=""""/>
<text top=""275"" left=""210"" width=""584"" height=""16"" font=""0"">, because the qualification of the December 2001 Regulation as ""final"" is only </text>
<text top=""292"" left=""108"" width=""683"" height=""16"" font=""0"">relevant to United States' domestic law and does not imply that the United States is permanently </text>
<text top=""308"" left=""108"" width=""417"" height=""16"" font=""0"">prohibiting Argentina from regaining its import authorization.</text>
<footnote top=""307"" left=""525"" width=""17"" height=""11"" font=""16"" number=""772"" ref="""" dis=""""/>
</p></p></page>
<page number=""116"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.275"" style=""8""><text top=""342"" left=""108"" width=""688"" height=""16"" font=""0"">7.275.  The United States argues that the requirement that there be ""insufficient scientific </text>
<text top=""359"" left=""108"" width=""683"" height=""16"" font=""0"">evidence to conduct a risk assessment"" in Article 5.7 is satisfied, because the scientific evidence </text>
<text top=""375"" left=""108"" width=""464"" height=""16"" font=""0"">required to accept or reject Argentina's requests evolved over time</text>
<footnote top=""374"" left=""572"" width=""17"" height=""11"" font=""16"" number=""773"" ref="""" dis=""""/>
<text top=""375"" left=""589"" width=""201"" height=""16"" font=""0""> and had to be evaluated by </text>
<text top=""392"" left=""108"" width=""47"" height=""16"" font=""0"">APHIS.</text>
<footnote top=""390"" left=""155"" width=""17"" height=""11"" font=""16"" number=""774"" ref="""" dis=""""/>
<text top=""392"" left=""173"" width=""621"" height=""16"" font=""0""> In particular, the United States argues that at the time of the filing of Argentina's </text>
<text top=""408"" left=""108"" width=""684"" height=""16"" font=""0"">requests there was uncertainty as to the FMD situation in the country and SENASA's ""ability to </text>
<text top=""425"" left=""108"" width=""524"" height=""16"" font=""0"">impose and maintain internal controls so as to prevent FMD incidents"".</text>
<footnote top=""423"" left=""632"" width=""17"" height=""11"" font=""16"" number=""775"" ref="""" dis=""""/>
<text top=""425"" left=""649"" width=""145"" height=""16"" font=""0""> At that time, the </text>
<text top=""441"" left=""108"" width=""689"" height=""16"" font=""0"">United States contends, APHIS ""took action to choose to receive and review"" Argentina's </text>
<text top=""457"" left=""108"" width=""348"" height=""16"" font=""0"">applications within a reasonable period of time</text>
<footnote top=""456"" left=""456"" width=""17"" height=""11"" font=""16"" number=""776"" ref="""" dis=""""/>
<text top=""457"" left=""473"" width=""322"" height=""16"" font=""0"">, and ""is seeking to obtain the additional </text>
<text top=""474"" left=""108"" width=""164"" height=""16"" font=""0"">information necessary"".</text>
<footnote top=""472"" left=""272"" width=""17"" height=""11"" font=""16"" number=""777"" ref="""" dis=""""/>
<text top=""474"" left=""290"" width=""503"" height=""16"" font=""0""> The United States considers that the time-length of APHIS' approval </text>
<text top=""490"" left=""108"" width=""465"" height=""16"" font=""0"">processes is due to the fact that it is ""so thorough and deliberate"".</text>
<footnote top=""489"" left=""573"" width=""17"" height=""11"" font=""16"" number=""778"" ref="""" dis=""""/>
<text top=""490"" left=""590"" width=""201"" height=""16"" font=""0""> Moreover, it takes the view </text>
<text top=""507"" left=""108"" width=""684"" height=""16"" font=""0"">that the delay in the approval process is reasonable given the delays in SENASA's responses to </text>
<text top=""523"" left=""108"" width=""682"" height=""16"" font=""0"">APHIS' requests for additional information, the FMD outbreaks that occurred in Northern Argentina </text>
<text top=""539"" left=""108"" width=""684"" height=""16"" font=""0"">in 2003 and 2006, and Argentina's intentional concealment of the full extent of the 2000-2002 </text>
<text top=""556"" left=""108"" width=""72"" height=""16"" font=""0"">outbreaks.</text>
<footnote top=""554"" left=""180"" width=""17"" height=""11"" font=""16"" number=""779"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""345"" height=""15"" font=""10""> United States' first written submission, paras. 238-240. </ftext>
</footnote>
</p><p number=""7.276"" style=""8""><text top=""590"" left=""108"" width=""687"" height=""16"" font=""0"">7.276.  The United States also contends that the application of the review procedures under </text>
<text top=""607"" left=""108"" width=""684"" height=""16"" font=""0"">9 CFR 92.2 for Patagonia is also justified because, prior to the filing of Argentina's request, that </text>
<text top=""623"" left=""108"" width=""683"" height=""16"" font=""0"">region was treated as part of the Argentine territory as a whole. The United States maintains that </text>
<text top=""639"" left=""108"" width=""682"" height=""16"" font=""0"">it is undertaking the review and seeking additional information (such as the site visit in November </text>
<text top=""656"" left=""108"" width=""682"" height=""16"" font=""0"">2013) to finish its review within a reasonable period of time given the delays in granting access to </text>
<text top=""672"" left=""108"" width=""222"" height=""16"" font=""0"">that information from Argentina.</text>
<footnote top=""671"" left=""330"" width=""17"" height=""11"" font=""16"" number=""780"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""345"" height=""15"" font=""10""> United States' first written submission, paras. 242-244. </ftext>
</footnote>
</p><p number=""7.5"" style=""8""><text top=""707"" left=""108"" width=""337"" height=""16"" font=""28"">7.5.2.2  Main arguments of the third parties </text></p><p number=""7.5"" style=""8""><text top=""741"" left=""108"" width=""125"" height=""16"" font=""28"">7.5.2.2.1  Brazil </text></p><p number=""7.277"" style=""8""><text top=""775"" left=""108"" width=""683"" height=""16"" font=""0"">7.277.  In Brazil's opinion, the United States' prohibition on Argentine imports was not a measure </text>
<text top=""792"" left=""108"" width=""683"" height=""16"" font=""0"">based on Article 5.1 as ""there was no risk assessment on which these SPS measures were based </text>
<text top=""808"" left=""108"" width=""28"" height=""16"" font=""0"">on"".</text>
<footnote top=""807"" left=""136"" width=""17"" height=""11"" font=""16"" number=""781"" ref="""" dis=""""/>
<text top=""808"" left=""153"" width=""639"" height=""16"" font=""0""> Brazil maintains that while Article 5.7 establishes an exception to the rule in Article 5.1, </text>
<text top=""825"" left=""108"" width=""683"" height=""16"" font=""0"">international standards or recommendations regarding the same situation, together with available </text>
<text top=""841"" left=""108"" width=""683"" height=""16"" font=""0"">and completed risk assessments, may provide levels of scientific information sufficient to exclude </text>
<p><text top=""876"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 233. </text>
<footnote top=""891"" left=""165"" width=""616"" height=""15"" font=""10"" number=""30"" ref="""" dis=""""/>
</p><p><text top=""905"" left=""108"" width=""471"" height=""15"" font=""10"">response to Panel question No. 18 following the second substantive meeting. </text>
<text top=""920"" left=""165"" width=""490"" height=""15"" font=""10""> United States' opening statement at the second meeting of the Panel, para. 39. </text>
<footnote top=""934"" left=""165"" width=""606"" height=""15"" font=""10"" number=""254"" ref="""" dis=""""/>
</p><p><text top=""949"" left=""108"" width=""107"" height=""15"" font=""10"">paras. 250-252). </text>
</p><p><text top=""978"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 255. </text>
</p><p><text top=""1007"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 235. </text>
</p><p><text top=""1036"" left=""165"" width=""325"" height=""15"" font=""10""> United States' second written submission, para. 32.  </text>
<text top=""1051"" left=""165"" width=""623"" height=""15"" font=""10""> United States' first written submission, para. 237. See also United States' second written submission, </text>
<text top=""1066"" left=""108"" width=""594"" height=""15"" font=""10"">heading 4.a; United States' opening statement at the second meeting of the Panel, paras. 41-42. </text>
<text top=""1080"" left=""165"" width=""490"" height=""15"" font=""10""> United States' opening statement at the second meeting of the Panel, para. 48. </text>
<footnote top=""1124"" left=""165"" width=""259"" height=""15"" font=""10"" number=""6"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 117 - </text>
</p><p><text top=""128"" left=""108"" width=""205"" height=""16"" font=""0"">the applicability of Article 5.7.</text>
<footnote top=""126"" left=""313"" width=""17"" height=""11"" font=""16"" number=""782"" ref="""" dis=""""/>
<text top=""128"" left=""331"" width=""460"" height=""16"" font=""0""> Brazil further notes that case law concerning the allocation of the </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">burden of proof under Article 5.7 is ""divergent"", depending on whether the provision in question is </text>
<text top=""160"" left=""108"" width=""689"" height=""16"" font=""0"">interpreted as a ""qualified exemption"" or as an ""autonomous right"" vis-&#224;-vis Articles 2.2 </text>
<text top=""177"" left=""108"" width=""57"" height=""16"" font=""0"">and 5.1.</text>
<footnote top=""175"" left=""165"" width=""17"" height=""11"" font=""16"" number=""783"" ref="""" dis=""""/>
</p></p></page>
<page number=""117"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.278"" style=""8""><text top=""211"" left=""108"" width=""687"" height=""16"" font=""0"">7.278.  Finally, according to Brazil, the main provisions regulating the time required for an </text>
<text top=""228"" left=""108"" width=""685"" height=""16"" font=""0"">importing Member to complete its review of an exporting Member's applications for import are </text>
<text top=""244"" left=""108"" width=""685"" height=""16"" font=""0"">Article 8 in conjunction with Annex C(1) of the SPS Agreement. Read together, such provisions </text>
<text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">aim, in Brazil's view, ""to prevent Members from using lengthy and unjustified SPS procedures as a </text>
<text top=""277"" left=""108"" width=""283"" height=""16"" font=""0"">trade barrier to other Members' imports"".</text>
<footnote top=""275"" left=""390"" width=""17"" height=""11"" font=""16"" number=""784"" ref="""" dis=""""/>
</p><p number=""7.5"" style=""8""><text top=""311"" left=""108"" width=""124"" height=""16"" font=""28"">7.5.2.2.2  China </text></p><p number=""7.279"" style=""8""><text top=""346"" left=""108"" width=""686"" height=""16"" font=""0"">7.279.  China argues that Article 5.7 requires that there be insufficient scientific evidence to </text>
<text top=""362"" left=""108"" width=""685"" height=""16"" font=""0"">conduct a risk assessment at the time of imposition of a measure. According to China, such </text>
<text top=""378"" left=""108"" width=""684"" height=""16"" font=""0"">information could not be sufficient at one point and insufficient at a later point. China contends </text>
<text top=""395"" left=""108"" width=""685"" height=""16"" font=""0"">that it is illogical to argue that a permanent measure becomes provisional because insufficient </text>
<text top=""411"" left=""108"" width=""570"" height=""16"" font=""0"">scientific evidence arose from the process of assessment under the exception rules.</text>
<footnote top=""410"" left=""678"" width=""17"" height=""11"" font=""16"" number=""785"" ref="""" dis=""""/>
</p><p number=""7.280"" style=""8""><text top=""446"" left=""108"" width=""686"" height=""16"" font=""0"">7.280.  China submits that Articles 5.1 and 5.7 are ""applied in a mutually exclusive manner, </text>
<text top=""462"" left=""108"" width=""514"" height=""16"" font=""0"">depending on whether the relevant scientific evidence is sufficient or not"".</text>
<footnote top=""461"" left=""622"" width=""17"" height=""11"" font=""16"" number=""786"" ref="""" dis=""""/>
<text top=""462"" left=""639"" width=""151"" height=""16"" font=""0""> China states that an </text>
<text top=""479"" left=""108"" width=""461"" height=""16"" font=""0"">overly broad application of Article 5.7 would render it meaningless.</text>
<footnote top=""477"" left=""569"" width=""17"" height=""11"" font=""16"" number=""787"" ref="""" dis=""""/>
<text top=""479"" left=""586"" width=""204"" height=""16"" font=""0""> According to China, whether </text>
<text top=""495"" left=""108"" width=""683"" height=""16"" font=""0"">""relevant scientific evidence"" is ""insufficient"" to conduct a risk assessment should be determined </text>
<text top=""511"" left=""108"" width=""168"" height=""16"" font=""0"">on a case-by-case basis.</text>
<footnote top=""510"" left=""276"" width=""17"" height=""11"" font=""16"" number=""788"" ref="""" dis=""""/>
<text top=""511"" left=""293"" width=""497"" height=""16"" font=""0""> China acknowledges that while the existence of international standards </text>
<text top=""528"" left=""108"" width=""684"" height=""16"" font=""0"">and/or other risk assessments may point to the ""sufficiency"" of relevant scientific evidence, it is </text>
<text top=""544"" left=""108"" width=""686"" height=""16"" font=""0"">not conclusive of the question whether a Member has enough information to conduct a risk </text>
<text top=""561"" left=""108"" width=""84"" height=""16"" font=""0"">assessment.</text>
<footnote top=""559"" left=""192"" width=""17"" height=""11"" font=""16"" number=""789"" ref="""" dis=""""/>
<text top=""561"" left=""210"" width=""581"" height=""16"" font=""0""> For China, where a proposed SPS measure targets imports from a specific country </text>
<text top=""577"" left=""108"" width=""683"" height=""16"" font=""0"">or region, the underlying risk assessment must address both the risk present in the disease itself </text>
<text top=""593"" left=""108"" width=""686"" height=""16"" font=""0"">and the potential risk that may be carried by the product originating from said country or </text>
<text top=""610"" left=""108"" width=""48"" height=""16"" font=""0"">region.</text>
<footnote top=""608"" left=""156"" width=""17"" height=""11"" font=""16"" number=""790"" ref="""" dis=""""/>
</p><p number=""7.281"" style=""8""><text top=""644"" left=""108"" width=""682"" height=""16"" font=""0"">7.281.  China sees the United States' arguments as contradictory in that scientific information that </text>
<text top=""661"" left=""108"" width=""685"" height=""16"" font=""0"">was ""sufficient"" to conduct a risk assessment could not become ""insufficient"" when Argentina </text>
<text top=""677"" left=""108"" width=""273"" height=""16"" font=""0"">applied for re-authorization to export.</text>
<footnote top=""675"" left=""381"" width=""17"" height=""11"" font=""16"" number=""791"" ref="""" dis=""""/>
<text top=""677"" left=""398"" width=""396"" height=""16"" font=""0""> For China, when a measure is provisionally adopted </text>
<text top=""693"" left=""108"" width=""614"" height=""16"" font=""0"">pursuant to Article 5.7 the scientific information must be in some aspects insufficient.</text>
<footnote top=""692"" left=""722"" width=""17"" height=""11"" font=""16"" number=""792"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""562"" height=""15"" font=""10""> China's third-party statement, para. 6. See also China's response to Panel question No. 10. </ftext>
</footnote>
<text top=""693"" left=""739"" width=""53"" height=""16"" font=""0""> China </text>
<text top=""710"" left=""108"" width=""687"" height=""16"" font=""0"">further notes that although there is no official definition of a ""provisional measure"" in the </text>
<text top=""726"" left=""108"" width=""515"" height=""16"" font=""0"">SPS Agreement, it should be interpreted to mean a temporary measure</text>
<footnote top=""725"" left=""623"" width=""17"" height=""11"" font=""16"" number=""793"" ref="""" dis=""""/>
<text top=""726"" left=""640"" width=""153"" height=""16"" font=""0""> based on available, </text>
<text top=""743"" left=""108"" width=""146"" height=""16"" font=""0"">relevant information.</text>
<footnote top=""741"" left=""254"" width=""17"" height=""11"" font=""16"" number=""794"" ref="""" dis=""""/>
<text top=""743"" left=""271"" width=""521"" height=""16"" font=""0""> China views the United States' argument that it had sufficient scientific </text>
<text top=""759"" left=""108"" width=""685"" height=""16"" font=""0"">evidence and made the appropriate risk assessment before adopting the import prohibition as </text>
<text top=""775"" left=""108"" width=""563"" height=""16"" font=""0"">suggesting that the United States' measures were not adopted temporarily.</text>
<footnote top=""774"" left=""671"" width=""17"" height=""11"" font=""16"" number=""795"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""554"" height=""15"" font=""10""> China's third-party statement, para. 6. See also China's response to Panel question No. 6. </ftext>
</footnote>
<text top=""775"" left=""688"" width=""108"" height=""16"" font=""0""> Thus, China </text>
<text top=""792"" left=""108"" width=""686"" height=""16"" font=""0"">suggests that the Panel evaluate the post-adoption actions of the United States to determine </text>
<text top=""808"" left=""108"" width=""408"" height=""16"" font=""0"">whether the United States' measures are provisional or not.</text>
<footnote top=""807"" left=""516"" width=""17"" height=""11"" font=""16"" number=""796"" ref="""" dis=""""/>
<footnote top=""920"" left=""165"" width=""259"" height=""15"" font=""10"" number=""8"" ref="""" dis=""""/>
<p><text top=""934"" left=""165"" width=""259"" height=""15"" font=""10""> Brazil's response to Panel question No. 9. </text>
<footnote top=""949"" left=""165"" width=""259"" height=""15"" font=""10"" number=""7"" ref="""" dis=""""/>
</p><p><text top=""963"" left=""165"" width=""257"" height=""15"" font=""10""> China's third-party submission, para. 31. </text>
<footnote top=""978"" left=""165"" width=""268"" height=""15"" font=""10"" number=""10"" ref="""" dis=""""/>
</p><p><text top=""993"" left=""165"" width=""243"" height=""15"" font=""10""> China's third-party statement, para. 2. </text>
<footnote top=""1007"" left=""165"" width=""260"" height=""15"" font=""10"" number=""4"" ref="""" dis=""""/>
<footnote top=""1036"" left=""165"" width=""260"" height=""15"" font=""10"" number=""5"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 118 - </text>
</p></p></page>
<page number=""118"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.5"" style=""8""><text top=""128"" left=""108"" width=""187"" height=""16"" font=""28"">7.5.2.3  European Union </text></p><p number=""7.282"" style=""8""><text top=""162"" left=""108"" width=""685"" height=""16"" font=""0"">7.282.  The European Union urges the Panel to search for a harmonious interpretation of the </text>
<text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">various provisions within the SPS Agreement in general and Article 5 in particular. The European </text>
<text top=""195"" left=""108"" width=""374"" height=""16"" font=""0"">Union points out that the provisions inform each other.</text>
<footnote top=""193"" left=""482"" width=""17"" height=""11"" font=""16"" number=""797"" ref="""" dis=""""><ftext top=""905"" left=""165"" width=""345"" height=""15"" font=""10""> European Union's third-party submission, paras. 60-62. </ftext>
</footnote>
</p><p number=""7.283"" style=""8""><text top=""229"" left=""108"" width=""683"" height=""16"" font=""0"">7.283.  The European Union urges the Panel not to focus on distinctions between ""definitive"" and </text>
<text top=""246"" left=""108"" width=""685"" height=""16"" font=""0"">""provisional"" measures, but rather to seek to answer the question of whether the information </text>
<text top=""262"" left=""108"" width=""481"" height=""16"" font=""0"">adduced supports the position of the importing or exporting Member.</text>
<footnote top=""261"" left=""589"" width=""17"" height=""11"" font=""16"" number=""798"" ref="""" dis=""""/>
<text top=""262"" left=""607"" width=""184"" height=""16"" font=""0""> The European Union also </text>
<text top=""278"" left=""108"" width=""682"" height=""16"" font=""0"">argues that in dispute settlement, panels should take a ""reasonably flexible approach to burden of </text>
<text top=""295"" left=""108"" width=""653"" height=""16"" font=""0"">proof and related issues"" in this context as well as consider ""early use of Article 13 of the DSU.""</text>
<footnote top=""293"" left=""761"" width=""17"" height=""11"" font=""16"" number=""799"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""602"" height=""15"" font=""10""> European Union's third-party submission, paras. 64-65. Article 13 of the DSU refers to the panel's </ftext>
<ftext top=""949"" left=""108"" width=""309"" height=""15"" font=""10"">right to seek information from experts and others. </ftext>
</footnote>
</p><p number=""7.284"" style=""8""><text top=""329"" left=""108"" width=""686"" height=""16"" font=""0"">7.284.  With respect to the present dispute, the European Union notes that the situation is </text>
<text top=""346"" left=""108"" width=""683"" height=""16"" font=""0"">different from other disputes &#8211; namely <i>EC &#8211; Hormones, EC &#8211; Approval and Marketing of Biotech </i></text>
<text top=""362"" left=""108"" width=""682"" height=""16"" font=""18""><i>Products </i>&#8211; where there was controversy about the science. Instead, the European Union notes that </text>
<text top=""378"" left=""108"" width=""682"" height=""16"" font=""0"">the dispute is rather about whether the particular facts in Argentina support or do not support the </text>
<text top=""395"" left=""108"" width=""683"" height=""16"" font=""0"">maintenance of the measure. The European Union does not suggest that Article 5.7 could not be </text>
<text top=""411"" left=""108"" width=""685"" height=""16"" font=""0"">invoked in this type of case, but does argue that this distinction could affect the analysis of </text>
<text top=""428"" left=""108"" width=""687"" height=""16"" font=""0"">whether the measure has been reviewed in a reasonable period of time. In particular, the </text>
<text top=""444"" left=""108"" width=""682"" height=""16"" font=""0"">European Union notes that one might expect the situation of incomplete information to be rectified </text>
<text top=""461"" left=""108"" width=""601"" height=""16"" font=""0"">sooner rather than later when the issue does not relate to the science being insufficient.</text>
<footnote top=""459"" left=""709"" width=""17"" height=""11"" font=""16"" number=""800"" ref="""" dis=""""/>
</p><p number=""7.285"" style=""8""><text top=""495"" left=""108"" width=""687"" height=""16"" font=""0"">7.285.  The European Union submits that this dispute should not be decided based on the </text>
<text top=""511"" left=""108"" width=""683"" height=""16"" font=""0"">applicability of Article 5.1 or Article 5.7, but rather on whether there is undue delay on the part of </text>
<text top=""528"" left=""108"" width=""684"" height=""16"" font=""0"">the United States and whether the maintenance of the measure against Argentina is justified or </text>
<text top=""544"" left=""108"" width=""27"" height=""16"" font=""0"">not.</text>
<footnote top=""543"" left=""135"" width=""17"" height=""11"" font=""16"" number=""801"" ref="""" dis=""""/>
<text top=""544"" left=""152"" width=""640"" height=""16"" font=""0""> The European Union recognizes that there should be no undue delay on the part of the </text>
<text top=""561"" left=""108"" width=""685"" height=""16"" font=""0"">importing Member and that a reasonable period of time in conducting an assessment must be </text>
<text top=""577"" left=""108"" width=""205"" height=""16"" font=""0"">decided on an <i>ad-hoc</i> basis.</text>
<footnote top=""575"" left=""313"" width=""17"" height=""11"" font=""16"" number=""802"" ref="""" dis=""""/>
<text top=""577"" left=""331"" width=""463"" height=""16"" font=""0""> However, it considers that a provisional measure in terms of </text>
<text top=""593"" left=""108"" width=""387"" height=""16"" font=""0"">Article 5.7 could last for many years or even indefinitely.</text>
<footnote top=""592"" left=""495"" width=""17"" height=""11"" font=""16"" number=""803"" ref="""" dis=""""/>
</p><p number=""7.286"" style=""8""><text top=""628"" left=""108"" width=""682"" height=""16"" font=""0"">7.286.  According to the European Union, it would be erroneous to consider Article 5.7 as applying </text>
<text top=""644"" left=""108"" width=""683"" height=""16"" font=""0"">only when a risk assessment does not exist; rather, a risk assessment under Article 5.7 may be </text>
<text top=""661"" left=""108"" width=""660"" height=""16"" font=""0"">less objective than a risk assessment conducted under Article 5.1 owing to insufficient evidence.</text>
<footnote top=""659"" left=""768"" width=""17"" height=""11"" font=""16"" number=""804"" ref="""" dis=""""/>
<text top=""677"" left=""108"" width=""685"" height=""16"" font=""0"">For the European Union, the real difference between an Article 5.1 situation and an Article 5.7 </text>
<text top=""693"" left=""108"" width=""655"" height=""16"" font=""0"">situation turns on the amount<i> </i>of scientific information available to conduct a risk assessment</text>
<footnote top=""692"" left=""763"" width=""17"" height=""11"" font=""16"" number=""805"" ref="""" dis=""""/>
<text top=""693"" left=""780"" width=""10"" height=""16"" font=""0"">, </text>
<text top=""710"" left=""108"" width=""687"" height=""16"" font=""0"">meaning that Article 5.7 measures may be adopted on the basis of a hypothesis based on </text>
<text top=""726"" left=""108"" width=""344"" height=""16"" font=""0"">insufficient, but still relevant, scientific evidence.</text>
<footnote top=""725"" left=""452"" width=""17"" height=""11"" font=""16"" number=""806"" ref="""" dis=""""/>
<text top=""726"" left=""469"" width=""323"" height=""16"" font=""0""> For the European Union, a measure initially </text>
<text top=""743"" left=""108"" width=""686"" height=""16"" font=""0"">adopted under Article 5.1 can be withdrawn and immediately replaced with a measure under </text>
<text top=""759"" left=""108"" width=""587"" height=""16"" font=""0"">Article 5.7 if the initial scientific information about the underlying situation changes.</text>
<footnote top=""757"" left=""695"" width=""17"" height=""11"" font=""16"" number=""807"" ref="""" dis=""""/>
<text top=""759"" left=""712"" width=""79"" height=""16"" font=""0""> According </text>
<text top=""775"" left=""108"" width=""682"" height=""16"" font=""0"">to the European Union, the existence of information from the relevant scientific organisations does </text>
<text top=""792"" left=""108"" width=""687"" height=""16"" font=""0"">not in and of itself exclude the possibility to adopt an Article 5.7 measure, because such </text>
<text top=""808"" left=""108"" width=""686"" height=""16"" font=""0"">information may be insufficient for the purposes of adopting measures that achieve a higher </text>
<text top=""825"" left=""108"" width=""40"" height=""16"" font=""0"">ALOP.</text>
<footnote top=""823"" left=""148"" width=""17"" height=""11"" font=""16"" number=""808"" ref="""" dis=""""/>
<p><text top=""920"" left=""165"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 61. </text>
</p><p><text top=""963"" left=""165"" width=""349"" height=""15"" font=""10""> European Union's third-party submission, paras. 65-66.  </text>
<text top=""978"" left=""165"" width=""322"" height=""15"" font=""10""> European Union's response to Panel question No. 6. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 119 - </text>
</p></p></page>
<page number=""119"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.5"" style=""8""><text top=""128"" left=""108"" width=""229"" height=""16"" font=""28"">7.5.2.4  Analysis by the Panel </text></p><p number=""7.287"" style=""8""><text top=""162"" left=""108"" width=""682"" height=""16"" font=""0"">7.287.  The Appellate Body has explained that Article 5.7 operates as a ""qualified exemption"" from </text>
<text top=""178"" left=""108"" width=""688"" height=""16"" font=""0"">the obligation under Article 2.2 ""not to maintain SPS measures without sufficient scientific </text>
<text top=""195"" left=""108"" width=""71"" height=""16"" font=""0"">evidence"".</text>
<footnote top=""193"" left=""179"" width=""17"" height=""11"" font=""16"" number=""809"" ref="""" dis=""""/>
<text top=""195"" left=""196"" width=""597"" height=""16"" font=""0""> In turn, Article 5.1 is ""a specific application of the basic obligations contained in </text>
<text top=""211"" left=""108"" width=""81"" height=""16"" font=""0"">Article 2.2"".</text>
<footnote top=""210"" left=""189"" width=""17"" height=""11"" font=""16"" number=""810"" ref="""" dis=""""/>
<text top=""211"" left=""206"" width=""584"" height=""16"" font=""0""> Thus, if a measure meets all the requirements of Article 5.7, Articles 2.2 and 5.1 do </text>
<text top=""228"" left=""108"" width=""654"" height=""16"" font=""0"">not apply. The requirements in question have been described by the Appellate Body as follows: </text>
<p><text top=""262"" left=""151"" width=""599"" height=""16"" font=""0"">Article 5.7 of the SPS Agreement sets out four requirements which must be met in </text>
<text top=""278"" left=""151"" width=""597"" height=""16"" font=""0"">order to adopt and maintain a provisional SPS measure. Pursuant to the first sentence </text>
<text top=""295"" left=""151"" width=""580"" height=""16"" font=""0"">of Article 5.7, a Member may provisionally adopt an SPS measure if this measure is: </text>
</p></p><p number=""(1)"" style=""4""><text top=""329"" left=""151"" width=""603"" height=""16"" font=""0"">(1) imposed in respect of a situation where ""relevant scientific information is </text>
<text top=""346"" left=""151"" width=""120"" height=""16"" font=""0"">insufficient""; and </text>
</p><p number=""(2)"" style=""4""><text top=""380"" left=""151"" width=""421"" height=""16"" font=""0"">(2) adopted ""on the basis of available pertinent information"". </text>
<p><text top=""414"" left=""151"" width=""597"" height=""16"" font=""0"">Pursuant to the second sentence of Article 5.7, such a provisional measure may not be </text>
<text top=""431"" left=""151"" width=""414"" height=""16"" font=""0"">maintained unless the Member which adopted the measure: </text>
</p></p><p number=""(1)"" style=""4""><text top=""465"" left=""151"" width=""601"" height=""16"" font=""0"">(1) ""seek[s] to obtain the additional information necessary for a more objective </text>
<text top=""482"" left=""151"" width=""173"" height=""16"" font=""0"">assessment of risk""; and </text>
</p><p number=""(2)"" style=""4""><text top=""516"" left=""151"" width=""536"" height=""16"" font=""0"">(2) ""review[s] the &#8230; measure accordingly within a reasonable period of time"". </text>
<p><text top=""551"" left=""151"" width=""599"" height=""16"" font=""0"">These four requirements are clearly cumulative in nature and are equally important </text>
<text top=""567"" left=""151"" width=""597"" height=""16"" font=""0"">for the purpose of determining consistency with this provision. Whenever one of these </text>
<text top=""583"" left=""151"" width=""562"" height=""16"" font=""0"">four requirements is not met, the measure at issue is inconsistent with Article 5.7.</text>
<footnote top=""582"" left=""713"" width=""17"" height=""11"" font=""16"" number=""811"" ref="""" dis=""""/>
</p></p><p number=""7.288"" style=""8""><text top=""618"" left=""108"" width=""682"" height=""16"" font=""0"">7.288.  The Appellate Body has explained that the first two requirements relate to the <i>adoption </i>of </text>
<text top=""634"" left=""108"" width=""687"" height=""16"" font=""0"">the measure while the latter two requirements ""relate to the <i>maintenance</i> of a provisional </text>
<text top=""651"" left=""108"" width=""654"" height=""16"" font=""0"">SPS measure and highlight the <i>provisional </i>nature of measures adopted pursuant to Article 5.7.""</text>
<footnote top=""649"" left=""762"" width=""17"" height=""11"" font=""16"" number=""812"" ref=""WT/DS245/AB/R"" dis=""DS245""><ftext top=""1095"" left=""165"" width=""494"" height=""15"" font=""10""> Appellate Body Report, <i>Japan &#8211; Apples</i>, fn 318 to para. 176 (emphasis original). </ftext>
</footnote>
</p><p number=""7.289"" style=""8""><text top=""685"" left=""108"" width=""683"" height=""16"" font=""0"">7.289.  In this respect, we note that although the parties have addressed all four requirements in </text>
<text top=""701"" left=""108"" width=""687"" height=""16"" font=""0"">their arguments, Argentina's concerns relate fundamentally to the continued application, or </text>
<text top=""718"" left=""108"" width=""686"" height=""16"" font=""0"">maintenance, of the measure at issue. Therefore, the Panel finds it appropriate to begin by </text>
<text top=""734"" left=""108"" width=""684"" height=""16"" font=""0"">examining the two requirements to seek to obtain additional information necessary for a more </text>
<text top=""751"" left=""108"" width=""683"" height=""16"" font=""0"">objective assessment of risk and to review the measure accordingly within a reasonable period of </text>
<text top=""767"" left=""108"" width=""45"" height=""16"" font=""0"">time.  </text>
</p><p number=""7.290"" style=""8""><text top=""801"" left=""108"" width=""686"" height=""16"" font=""0"">7.290.  As these requirements are cumulative, if we find that the United States has failed to </text>
<text top=""818"" left=""108"" width=""682"" height=""16"" font=""0"">comply with either of the latter two requirements it would be precluded from relying on Article 5.7 </text>
<text top=""834"" left=""108"" width=""492"" height=""16"" font=""0"">to exclude the applicability of other provisions of the SPS Agreement.</text>
<footnote top=""833"" left=""600"" width=""17"" height=""11"" font=""16"" number=""813"" ref="""" dis=""""/>
<text top=""834"" left=""617"" width=""174"" height=""16"" font=""0""> Therefore, we will only </text>
<text top=""851"" left=""108"" width=""683"" height=""16"" font=""0"">turn to the requirements related to the initial adoption of the measure if necessary. Our approach </text>
<text top=""867"" left=""108"" width=""682"" height=""16"" font=""0"">is consistent with the Appellate Body's finding in <i>Japan &#8211; Agricultural Products II </i>that it was proper </text>
<text top=""883"" left=""108"" width=""684"" height=""16"" font=""0"">for the panel to begin its evaluation with whether the importing Member had complied with the </text>
<text top=""900"" left=""108"" width=""686"" height=""16"" font=""0"">requirements in the second sentence and, once it had concluded that the Member had not </text>
<text top=""916"" left=""108"" width=""453"" height=""16"" font=""0"">complied therewith, to decline to examine the other requirements.</text>
<footnote top=""915"" left=""561"" width=""17"" height=""11"" font=""16"" number=""814"" ref="""" dis=""""/>
<p><text top=""978"" left=""165"" width=""597"" height=""15"" font=""10""> Appellate Body Report, <i>Japan &#8211; Agricultural Products II</i>, para. 80. We note that the panel in <i>EC &#8211; </i></text>
<text top=""993"" left=""108"" width=""656"" height=""15"" font=""12""><i>Approval and Marketing of Biotech Products</i> referred to it as a ""qualified right"". Panel Report, <i>EC &#8211; Approval </i></text>
<text top=""1007"" left=""108"" width=""663"" height=""15"" font=""12""><i>and Marketing of Biotech Products</i>, paras. 7.2939, 7.2945, and 7.2969 (finding that Article 5.7 is a ""right"" to </text>
<text top=""1022"" left=""108"" width=""673"" height=""15"" font=""10"">maintain a measure otherwise inconsistent with Article 2.2) and paras. 7.2996-7.2998 (finding that Article 5.7 </text>
<text top=""1036"" left=""108"" width=""556"" height=""15"" font=""10"">is a right to maintain a measure otherwise inconsistent with Article 5.1), and para. 7.3004. </text>
<text top=""1051"" left=""165"" width=""316"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 180. </text>
<text top=""1066"" left=""165"" width=""588"" height=""15"" font=""10""> Appellate Body Report, <i>Japan-Agricultural Products II</i>, para. 89; see also Appellate Body Report </text>
<text top=""1080"" left=""108"" width=""167"" height=""15"" font=""12""><i>Japan &#8211; Apples</i>,<i> </i>para. 179. </text>
<footnote top=""1109"" left=""165"" width=""410"" height=""15"" font=""10"" number=""91"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 120 - </text>
</p></p></page>
<page number=""120"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.291"" style=""8""><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">7.291.  Before moving forward with our analysis, we must first address which party bears the </text>
<text top=""144"" left=""108"" width=""120"" height=""16"" font=""0"">burden of proof.  </text>
</p><p number=""7.292"" style=""8""><text top=""178"" left=""108"" width=""686"" height=""16"" font=""0"">7.292.  The  panel  in  <i>EC &#8211; Approval and Marketing of Biotech Products, </i>operating under the </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">premise that Article 5.7 is a ""qualified right"", concluded that because Article 5.1 is only applicable </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">if Article 5.7 is not, ""when a complaining party presents a claim of violation under Article 5.1, the </text>
<text top=""228"" left=""108"" width=""685"" height=""16"" font=""0"">burden is on the complaining party to establish a prima facie case of inconsistency with both </text>
<text top=""244"" left=""108"" width=""146"" height=""16"" font=""0"">Articles 5.1 and 5.7.""</text>
<footnote top=""243"" left=""254"" width=""17"" height=""11"" font=""16"" number=""815"" ref=""WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1"" dis=""DS293|DS291|DS246|DS292""><ftext top=""832"" left=""165"" width=""588"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.3000. We note that the </ftext>
<ftext top=""847"" left=""108"" width=""679"" height=""15"" font=""10"">panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> based its reasoning on the Appellate Body decision in </ftext>
<ftext top=""861"" left=""108"" width=""649"" height=""15"" font=""12""><i>EC &#8211; Tariff Preferences </i>on similar language in the Enabling Clause, which was issued later in time than the </ftext>
<ftext top=""876"" left=""108"" width=""650"" height=""15"" font=""10"">Appellate Body decision that discussed Article 5.7 of the SPS Agreement. The Appellate Body in <i>EC &#8211; Tariff </i></ftext>
<ftext top=""891"" left=""108"" width=""639"" height=""15"" font=""12""><i>Preferences</i> stated that where the permissive provision constitutes a right rather than an exception, ""the </ftext>
<ftext top=""905"" left=""108"" width=""679"" height=""15"" font=""10"">complaining party bears the burden of establishing that a challenged measure is inconsistent with the provision </ftext>
</footnote>
<text top=""244"" left=""271"" width=""520"" height=""16"" font=""0""> We observe, however, that nothing in the case law on Article 5.7 or other </text>
<text top=""260"" left=""108"" width=""687"" height=""16"" font=""0"">provisions which establish exemptions or provide the ability to derogate from certain WTO </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">obligations supersedes the basic premise that the party asserting something bears the burden of </text>
<text top=""293"" left=""108"" width=""70"" height=""16"" font=""0"">proving it.</text>
<footnote top=""292"" left=""178"" width=""17"" height=""11"" font=""16"" number=""816"" ref="""" dis=""""/>
</p><p number=""7.293"" style=""8""><text top=""328"" left=""108"" width=""682"" height=""16"" font=""0"">7.293.  In light of the above, the Panel finds that the initial burden was on Argentina as part of its </text>
<text top=""344"" left=""108"" width=""684"" height=""16"" font=""0"">case under Article 5.1 to raise the inapplicability of Article 5.7 &#8211; which it did in its first written </text>
<text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">submission. As the United States has chosen to assert that its measures fall within the scope of </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">Article 5.7, it carries the burden to prove that each of the four cumulative requirements have been </text>
<text top=""393"" left=""108"" width=""61"" height=""16"" font=""0"">satisfied.</text>
<footnote top=""392"" left=""169"" width=""17"" height=""11"" font=""16"" number=""817"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""557"" height=""15"" font=""10""> We note that the United States argued that it bore the burden of proof to demonstrate the </ftext>
<ftext top=""1051"" left=""108"" width=""672"" height=""15"" font=""10"">applicability of Article 5.7. See United States' response to Panel question No. 22 following the first substantive </ftext>
<ftext top=""1066"" left=""108"" width=""58"" height=""15"" font=""10"">meeting. </ftext>
</footnote>
</p><p number=""7.5"" style=""8""><text top=""428"" left=""108"" width=""682"" height=""16"" font=""28"">7.5.2.4.1  ""Members shall seek to obtain the additional information necessary for a more </text><text top=""444"" left=""108"" width=""233"" height=""16"" font=""28"">objective assessment of risk""  </text></p><p number=""7.294"" style=""8""><text top=""479"" left=""108"" width=""686"" height=""16"" font=""0"">7.294.  Article 5.7 places the burden of seeking to obtain the additional scientific information </text>
<text top=""495"" left=""108"" width=""560"" height=""16"" font=""0"">necessary to perform a more objective risk assessment on the importing Member.</text>
<footnote top=""493"" left=""667"" width=""17"" height=""11"" font=""16"" number=""818"" ref="""" dis=""""/>
</p><p number=""7.295"" style=""8""><text top=""529"" left=""108"" width=""688"" height=""16"" font=""0"">7.295.  Although Article 5.7 does not impose explicit prerequisites regarding the additional </text>
<text top=""546"" left=""108"" width=""416"" height=""16"" font=""0"">information to be collected or a specific collection procedure</text>
<footnote top=""544"" left=""524"" width=""17"" height=""11"" font=""16"" number=""819"" ref="""" dis=""""/>
<text top=""546"" left=""541"" width=""249"" height=""16"" font=""0"">, the Appellate Body has concluded </text>
<text top=""562"" left=""108"" width=""38"" height=""16"" font=""0"">that: </text>
<p><text top=""597"" left=""151"" width=""598"" height=""16"" font=""0"">the WTO Member adopting a provisional SPS measure should be able to identify the </text>
<text top=""613"" left=""151"" width=""598"" height=""16"" font=""0"">insufficiencies in the relevant scientific evidence, and the steps that it intends to take </text>
<text top=""629"" left=""151"" width=""604"" height=""16"" font=""0"">to obtain the additional information that will be necessary to address these </text>
<text top=""646"" left=""151"" width=""597"" height=""16"" font=""0"">deficiencies in order to make a more objective assessment and review the provisional </text>
<text top=""662"" left=""151"" width=""597"" height=""16"" font=""0"">measure within a reasonable period of time. The additional information to be collected </text>
<text top=""679"" left=""151"" width=""473"" height=""16"" font=""0"">must be ""germane"" to conducting the assessment of the specific risk.</text>
<footnote top=""677"" left=""623"" width=""17"" height=""11"" font=""16"" number=""820"" ref="""" dis=""""/>
</p></p><p number=""7.296"" style=""8""><text top=""713"" left=""108"" width=""689"" height=""16"" font=""0"">7.296.  As the Appellate Body stated in <i>US/Canada &#8211; Continued Suspension</i>, a Member </text>
<text top=""729"" left=""108"" width=""684"" height=""16"" font=""0"">maintaining a provisional measure under Article 5.7 has a duty to actively ""make best efforts to </text>
<text top=""746"" left=""108"" width=""683"" height=""16"" font=""0"">remedy the insufficiencies in the relevant scientific evidence"" with ""additional scientific research"" </text>
<text top=""762"" left=""108"" width=""660"" height=""16"" font=""0"">or ""by gathering information from relevant international organizations or other sources"".</text>
<footnote top=""761"" left=""768"" width=""17"" height=""11"" font=""16"" number=""821"" ref="""" dis=""""/>
<text top=""779"" left=""108"" width=""684"" height=""16"" font=""0"">However, the Member ""is not expected to guarantee specific results"", nor ""to predict the actual </text>
<text top=""795"" left=""108"" width=""690"" height=""16"" font=""0"">results of its efforts to collect additional information at the time when it adopts the </text>
<p><text top=""920"" left=""108"" width=""552"" height=""15"" font=""10"">permitting particular behaviour"". Appellate Body Report, <i>EC &#8211; Tariff Preferences</i>, para. 88. </text>
<text top=""934"" left=""165"" width=""562"" height=""15"" font=""10""> See e.g. Appellate Body Report, <i>Japan &#8211; Apples</i>, para. 157 (""the party that asserts a fact is </text>
<text top=""949"" left=""108"" width=""675"" height=""15"" font=""10"">responsible for providing proof thereof.""). Our view is confirmed by the Appellate Body in <i>Canada &#8211; Renewable </i></text>
<text top=""963"" left=""108"" width=""661"" height=""15"" font=""12""><i>Energy / Canada &#8211; Feed-in Tariff Program </i>(where the Appellate Body concluded that ""the characterization of </text>
<text top=""978"" left=""108"" width=""673"" height=""15"" font=""10"">[a] provision as a derogation does not pre-determine the question as to which party bears the burden of proof </text>
<text top=""993"" left=""108"" width=""653"" height=""15"" font=""10"">with regard to the requirements stipulated in the provision."") (Appellate Body Report, <i>Canada &#8211;</i> <i>Renewable </i></text>
<text top=""1007"" left=""108"" width=""630"" height=""15"" font=""12""><i>Energy / Canada &#8211; Feed-in Tariff Program</i>, para. 5.56 (referring to Appellate Body Report, <i>China &#8211; Raw </i></text>
<text top=""1022"" left=""108"" width=""141"" height=""15"" font=""12""><i>Materials</i>, para. 334))  </text>
<footnote top=""1080"" left=""165"" width=""490"" height=""15"" font=""10"" number=""679"" ref="""" dis=""""/>
</p><p><text top=""1095"" left=""165"" width=""406"" height=""15"" font=""10""> Appellate Body Report, <i>Japan &#8211; </i>Agricultural<i> Products II</i>, para. 92. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 121 - </text>
</p><p><text top=""128"" left=""108"" width=""101"" height=""16"" font=""0"">SPS measure"".</text>
<footnote top=""126"" left=""209"" width=""17"" height=""11"" font=""16"" number=""822"" ref="""" dis=""""/>
<text top=""128"" left=""226"" width=""566"" height=""16"" font=""0""> Thus, the duty to seek additional information in order to review a provisional </text>
<text top=""144"" left=""108"" width=""356"" height=""16"" font=""0"">SPS measure constitutes an ""obligation of means"".  </text>
</p></p></page>
<page number=""121"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.297"" style=""8""><text top=""178"" left=""108"" width=""686"" height=""16"" font=""0"">7.297.  The United States seems to argue that the obligation in Article 6.3 on the exporting </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">Member to ""objectively demonstrate"" its disease freedom would somehow trump the obligation in </text>
<text top=""211"" left=""108"" width=""685"" height=""16"" font=""0"">Article 5.7 to seek to obtain the additional information. Although the risk assessment process </text>
<text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">entails a dynamic exchange between the two Members, in accordance with the general principles </text>
<text top=""244"" left=""108"" width=""96"" height=""16"" font=""0"">of good faith</text>
<footnote top=""243"" left=""203"" width=""17"" height=""11"" font=""16"" number=""823"" ref=""WT/DS321/R/Add.7|WT/DS321/R/Add.6|WT/DS321/R/Add.4|WT/DS321/R/Add.2|WT/DS321/R|WT/DS321/R/Add.5|WT/DS321/R/Add.3|WT/DS321/R/Add.1"" dis=""DS321""><ftext top=""963"" left=""165"" width=""547"" height=""15"" font=""10""> See e.g., albeit in a different context, Panel Report, <i>US/Canada &#8211; Continued Suspension</i>, </ftext>
<ftext top=""978"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.357. </ftext>
</footnote>
<text top=""244"" left=""221"" width=""180"" height=""16"" font=""0""> and mutual cooperation</text>
<footnote top=""243"" left=""401"" width=""17"" height=""11"" font=""16"" number=""824"" ref="""" dis=""""/>
<text top=""244"" left=""418"" width=""376"" height=""16"" font=""0"">, we do not believe that an application from the </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">exporting Member can absolve the importing Member of the obligation to be ""able to <i>identify the </i></text>
<text top=""277"" left=""108"" width=""354"" height=""16"" font=""18""><i>insufficiencies  </i>in the relevant scientific evidence""</text>
<footnote top=""275"" left=""462"" width=""17"" height=""11"" font=""16"" number=""825"" ref="""" dis=""""/>
<text top=""277"" left=""480"" width=""315"" height=""16"" font=""0""> and communicate them to the exporting </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">Member. A plain reading of the provisions supports our view and the United States has not been </text>
<text top=""310"" left=""108"" width=""254"" height=""16"" font=""0"">able to persuade us of its approach.  </text>
</p><p number=""7.298"" style=""8""><text top=""344"" left=""108"" width=""686"" height=""16"" font=""0"">7.298.  Upon direct questioning from the Panel, the United States was unable to identify any </text>
<text top=""360"" left=""108"" width=""683"" height=""16"" font=""0"">specific deficiencies other than the need to update information that had become outdated due to </text>
<text top=""377"" left=""108"" width=""229"" height=""16"" font=""0"">the United States' own inaction.</text>
<footnote top=""375"" left=""336"" width=""17"" height=""11"" font=""16"" number=""826"" ref="""" dis=""""/>
<text top=""377"" left=""354"" width=""440"" height=""16"" font=""0""> We recall our finding in paragraph 7.127b above, that the </text>
<text top=""393"" left=""108"" width=""686"" height=""16"" font=""0"">United States made no efforts after its site visit in September 2006 to seek information from </text>
<text top=""410"" left=""108"" width=""685"" height=""16"" font=""0"">SENASA on the situation in Northern Argentina until after this Panel was established. We also </text>
<text top=""426"" left=""108"" width=""687"" height=""16"" font=""0"">recall our finding in paragraph 7.160 above that with respect to Patagonia (including both </text>
<text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">Patagonia South and Patagonia North B) the United States made no efforts to seek information </text>
<text top=""459"" left=""108"" width=""536"" height=""16"" font=""0"">after its site visit in February 2009 until after the establishment of this Panel.  </text>
</p><p number=""7.299"" style=""8""><text top=""493"" left=""108"" width=""682"" height=""16"" font=""0"">7.299.  In light of the above, we find that the United States has not sought to obtain the additional </text>
<text top=""510"" left=""108"" width=""642"" height=""16"" font=""0"">information necessary for a more objective assessment of the risk as required by Article 5.7.  </text>
</p><p number=""7.5"" style=""8""><text top=""544"" left=""108"" width=""624"" height=""16"" font=""28"">7.5.2.4.2  ""&#8230; review the measure accordingly within a reasonable period of time"" </text></p><p number=""7.300"" style=""8""><text top=""579"" left=""108"" width=""685"" height=""16"" font=""0"">7.300.  In  <i>Japan &#8211; Agricultural Products II</i>, the Appellate Body stated that what constitutes a </text>
<text top=""595"" left=""108"" width=""683"" height=""16"" font=""0"">""reasonable period of time"" within the meaning of Article 5.7 depends, <i>inter alia</i>, on the difficulty </text>
<text top=""611"" left=""108"" width=""541"" height=""16"" font=""0"">of obtaining the information necessary for a more objective assessment of risk.</text>
<footnote top=""610"" left=""649"" width=""17"" height=""11"" font=""16"" number=""827"" ref="""" dis=""""/>
</p><p number=""7.301"" style=""8""><text top=""646"" left=""108"" width=""686"" height=""16"" font=""18""><i>7.301.  </i>The panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> interpreted the terms </text>
<text top=""662"" left=""108"" width=""686"" height=""16"" font=""0"">""reasonable period of time"" in Article 5.7 in a manner similar to the terms ""undue delay"" in </text>
<text top=""679"" left=""108"" width=""103"" height=""16"" font=""0"">Annex C(1)(a).</text>
<footnote top=""677"" left=""211"" width=""17"" height=""11"" font=""16"" number=""828"" ref=""WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8"" dis=""DS293|DS291|DS292""><ftext top=""1066"" left=""165"" width=""606"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, paras. 7.1495-7.1497 (concerning </ftext>
<ftext top=""1080"" left=""108"" width=""321"" height=""15"" font=""10"">Annex C(1)(a)) and 7.3245 (concerning Article 5.7). </ftext>
</footnote>
<text top=""679"" left=""228"" width=""564"" height=""16"" font=""0""> We recall that this concept is not dependent on the length of the delay, but </text>
<text top=""695"" left=""108"" width=""420"" height=""16"" font=""0"">rather whether any delay was legitimate and justifiable</text>
<footnote top=""693"" left=""527"" width=""17"" height=""11"" font=""16"" number=""829"" ref=""WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R ; WT/DS292/R ; WT/DS293/R"" dis=""DS293|DS291|DS292""><ftext top=""1095"" left=""165"" width=""481"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>,<i> </i>para. 7.1496. </ftext>
</footnote>
<text top=""695"" left=""545"" width=""251"" height=""16"" font=""0""> as opposed to unwarranted or </text>
<text top=""711"" left=""108"" width=""70"" height=""16"" font=""0"">excessive.</text>
<footnote top=""710"" left=""178"" width=""17"" height=""11"" font=""16"" number=""830"" ref="""" dis=""""/>
<text top=""711"" left=""195"" width=""599"" height=""16"" font=""0""> Additionally, in the context of Article 21.3(c) arbitrations &#8211; which determine the </text>
<text top=""728"" left=""108"" width=""682"" height=""16"" font=""0"">reasonable period of time for Members to implement the rulings and recommendations of the DSB </text>
<text top=""744"" left=""108"" width=""683"" height=""16"" font=""0"">&#8211; arbitrators have interpreted the term ""reasonable period of time"" to mean ""the shortest period </text>
<text top=""761"" left=""108"" width=""445"" height=""16"" font=""0"">possible within the legal system of the [implementing] Member"".</text>
<footnote top=""759"" left=""553"" width=""17"" height=""11"" font=""16"" number=""831"" ref="""" dis=""DS26""><ftext top=""1124"" left=""165"" width=""416"" height=""15"" font=""10""> Award of the Arbitrator, <i>EC &#8211; Hormones (Article 21.3(c))</i>, para. 26. </ftext>
</footnote>
<text top=""761"" left=""570"" width=""220"" height=""16"" font=""0""> While not directly applicable in </text>
<text top=""777"" left=""108"" width=""686"" height=""16"" font=""0"">these circumstances, it does suggest an understanding that when WTO Members must take </text>
<text top=""793"" left=""108"" width=""685"" height=""16"" font=""0"">legislative or regulatory actions involving complex legal processes to bring their measures into </text>
<text top=""810"" left=""108"" width=""684"" height=""16"" font=""0"">conformity with their WTO obligations reasonableness can be understood to mean as quickly as </text>
<text top=""826"" left=""108"" width=""421"" height=""16"" font=""0"">legally possible while accepting legitimate reasons for delay. <i> </i></text>
</p><p number=""7.302"" style=""8""><text top=""861"" left=""108"" width=""682"" height=""16"" font=""0"">7.302.  Furthermore, the panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> explained that </text>
<text top=""877"" left=""108"" width=""684"" height=""16"" font=""0"">the review of the measure cannot be delayed simply because an assessment incorporating new </text>
<text top=""893"" left=""108"" width=""686"" height=""16"" font=""0"">information would not allow the importing Member to determine ""with a sufficient degree of </text>
<p><text top=""993"" left=""165"" width=""590"" height=""15"" font=""10""> Appellate Body Report, <i>US/Canada &#8211; Continued Suspension</i>, para. 310. See also Appellate Body </text>
<text top=""1007"" left=""108"" width=""429"" height=""15"" font=""10"">Report, <i>EC and certain member States &#8211; Large Civil Aircraft</i>, para. 96. </text>
</p><p><text top=""1036"" left=""165"" width=""395"" height=""15"" font=""10""> See generally United States' response to Panel question No. 26. </text>
<text top=""1051"" left=""165"" width=""406"" height=""15"" font=""10""> Appellate Body Report, <i>Japan &#8211; Agricultural Products II</i>, para. 93. </text>
</p><p><text top=""1109"" left=""165"" width=""332"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 437. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 122 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">precision"" whether a measure different, and presumably less trade-restrictive, than its provisional </text>
<text top=""144"" left=""108"" width=""396"" height=""16"" font=""0"">measure would achieve its appropriate level of protection.</text>
<footnote top=""143"" left=""503"" width=""17"" height=""11"" font=""16"" number=""832"" ref=""WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6"" dis=""DS293|DS291|DS292""><ftext top=""934"" left=""165"" width=""481"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>,<i> </i>para. 7.3245. </ftext>
</footnote>
</p></p></page>
<page number=""122"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.303"" style=""8""><text top=""178"" left=""108"" width=""685"" height=""16"" font=""0"">7.303.  With respect to whether the United States reviewed the measures within a reasonable </text>
<text top=""195"" left=""108"" width=""686"" height=""16"" font=""0"">period of time, we recall that the United States argues that the measure was ""adopted"" for </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">purposes of Article 5.7 when Argentina initially filed its request for authorization to import fresh </text>
<text top=""228"" left=""108"" width=""398"" height=""16"" font=""0"">(chilled or frozen) beef from Northern Argentina in 2002.</text>
<footnote top=""226"" left=""506"" width=""17"" height=""11"" font=""16"" number=""833"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""605"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32). The Panel takes no position </ftext>
<ftext top=""963"" left=""108"" width=""664"" height=""15"" font=""10"">on whether this constitutes ""adoption"" of a measure within the meaning of Article 5.7 of the SPS Agreement. </ftext>
<ftext top=""978"" left=""108"" width=""538"" height=""15"" font=""10"">We simply use this point as a point of reference for our analysis under this requirement. </ftext>
</footnote>
<text top=""228"" left=""523"" width=""268"" height=""16"" font=""0""> Accepting, for the sake of argument, </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">that 2002 is the relevant date for the purpose of determining whether the United States reviewed </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">the measure within a reasonable period of time, we recall our findings in paragraphs 7.131-7.145 </text>
<text top=""277"" left=""108"" width=""685"" height=""16"" font=""0"">above, that APHIS incurred undue delays in its review of Argentina's application for Northern </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina from September 2006 until the time the Panel was established (28 January 2013). We </text>
<text top=""310"" left=""108"" width=""684"" height=""16"" font=""0"">further recall that Argentina filed its request for recognition of Patagonia South as FMD-free in </text>
<text top=""326"" left=""108"" width=""34"" height=""16"" font=""0"">2003</text>
<footnote top=""325"" left=""142"" width=""17"" height=""11"" font=""16"" number=""834"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""396"" height=""15"" font=""10""> Information Provided by SENASA (July 2003), (Exhibit USA-98). </ftext>
</footnote>
<text top=""326"" left=""160"" width=""411"" height=""16"" font=""0"">, and extended it to include Patagonia North B in 2008.</text>
<footnote top=""325"" left=""570"" width=""17"" height=""11"" font=""16"" number=""835"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""530"" height=""15"" font=""10""> SENASA's letter of 17 December 2008, (Exhibit ARG-59/USA-111); SENASA's letter of </ftext>
<ftext top=""1022"" left=""108"" width=""280"" height=""15"" font=""10"">30 January 2009, (Exhibit ARG-60/USA-112). </ftext>
</footnote>
<text top=""326"" left=""588"" width=""206"" height=""16"" font=""0""> In paragraphs 7.162-7.172 </text>
<text top=""342"" left=""108"" width=""687"" height=""16"" font=""0"">above, we found that APHIS incurred undue delays in reviewing its measure as applied to </text>
<text top=""359"" left=""108"" width=""682"" height=""16"" font=""0"">Patagonia from June 2005 to January 2007, from March 2007 to October 2008, and from February </text>
<text top=""375"" left=""108"" width=""685"" height=""16"" font=""0"">2009 until the establishment of the Panel. We see no reason not to apply our reasoning and </text>
<text top=""392"" left=""108"" width=""683"" height=""16"" font=""0"">findings outlined above to our assessment here. Therefore, we find that the United States has not </text>
<text top=""408"" left=""108"" width=""599"" height=""16"" font=""0"">reviewed its measures within a reasonable period of time as required under Article 5.7. </text>
</p><p number=""7.5"" style=""8""><text top=""443"" left=""108"" width=""149"" height=""16"" font=""28"">7.5.2.5  Conclusion </text></p><p number=""7.304"" style=""8""><text top=""477"" left=""108"" width=""682"" height=""16"" font=""0"">7.304.  We have found that the United States did not seek to obtain additional information nor did </text>
<text top=""493"" left=""108"" width=""683"" height=""16"" font=""0"">it review the measure within a reasonable period of time. Having found that the United States did </text>
<text top=""510"" left=""108"" width=""684"" height=""16"" font=""0"">not satisfy either the third or the fourth requirement, there is no need to consider whether the </text>
<text top=""526"" left=""108"" width=""685"" height=""16"" font=""0"">measures were provisionally adopted based on available pertinent information in a case where </text>
<text top=""543"" left=""108"" width=""287"" height=""16"" font=""0"">relevant scientific evidence is insufficient.</text>
<footnote top=""541"" left=""395"" width=""17"" height=""11"" font=""16"" number=""836"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""567"" height=""15"" font=""10""> We note that the parties have provided argumentation on these issues that raises important </ftext>
<ftext top=""1051"" left=""108"" width=""633"" height=""15"" font=""10"">interpretative questions about when Article 5.7 is applicable and the scope of the qualified exemption in </ftext>
<ftext top=""1066"" left=""108"" width=""660"" height=""15"" font=""10"">Article 5.7 &#8211; in particular in respect of the relationship between Article 5.7 and Article 6. However, given the </ftext>
<ftext top=""1080"" left=""108"" width=""629"" height=""15"" font=""10"">circumstances of the present dispute these questions are better left for another day and another case.  </ftext>
</footnote>
<text top=""543"" left=""412"" width=""379"" height=""16"" font=""0""> On the basis of our findings with respect to the third </text>
<text top=""559"" left=""108"" width=""682"" height=""16"" font=""0"">and fourth requirements, the measures do not fall within the scope of Article 5.7 and the qualified </text>
<text top=""575"" left=""108"" width=""682"" height=""16"" font=""0"">exemption to the obligations in Articles 5.1, 5.2 and 2.2 is not available to the United States. Thus, </text>
<text top=""592"" left=""108"" width=""682"" height=""16"" font=""0"">we now turn to assess the conformity of the United States' measures with Articles 5.1, 5.2 and 2.2 </text>
<text top=""608"" left=""108"" width=""160"" height=""16"" font=""0"">of the SPS Agreement. </text>
</p><p number=""7.5"" style=""8""><text top=""643"" left=""108"" width=""579"" height=""16"" font=""28"">7.5.3  Whether the United States' measures are based on a risk assessment </text></p><p number=""7.5"" style=""8""><text top=""677"" left=""108"" width=""296"" height=""16"" font=""28"">7.5.3.1  Main arguments of the parties </text></p><p number=""7.5"" style=""8""><text top=""711"" left=""108"" width=""156"" height=""16"" font=""28"">7.5.3.1.1  Argentina </text></p><p number=""7.305"" style=""8""><text top=""746"" left=""108"" width=""684"" height=""16"" font=""0"">7.305.  Argentina claims that the United States' measures are inconsistent with Articles 5.1 and </text>
<text top=""762"" left=""108"" width=""559"" height=""16"" font=""0"">5.2 of the SPS Agreement because they are not based on a valid risk assessment.</text>
<footnote top=""761"" left=""667"" width=""17"" height=""11"" font=""16"" number=""837"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""353"" height=""15"" font=""10""> Argentina's first written submission, paras. 231 and 255. </ftext>
</footnote>
</p><p number=""7.306"" style=""8""><text top=""797"" left=""108"" width=""683"" height=""16"" font=""0"">7.306.  Argentina argues that the 2001 Regulations, withdrawing authorization of imports of fresh </text>
<text top=""813"" left=""108"" width=""682"" height=""16"" font=""0"">(chilled or frozen) beef from Northern Argentina and FMD-susceptible animals and animal products </text>
<text top=""829"" left=""108"" width=""683"" height=""16"" font=""0"">from Patagonia, do not contain a ""risk assessment"" within the meaning of Article 5.1, but rather </text>
<text top=""846"" left=""108"" width=""682"" height=""16"" font=""0"">""nothing more than a recitation of facts, as well as a statement of the potential negative economic </text>
<text top=""862"" left=""108"" width=""346"" height=""16"" font=""0"">impact of an FMD outbreak in the United States.""</text>
<footnote top=""861"" left=""454"" width=""17"" height=""11"" font=""16"" number=""838"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""578"" height=""15"" font=""10""> Argentina's first written submission, para. 251; Argentina's response to Panel question No. 24 </ftext>
<ftext top=""1124"" left=""108"" width=""259"" height=""15"" font=""10"">following the second substantive meeting. </ftext>
<ftext top=""949"" left=""108"" width=""85"" height=""15"" font=""10"">para. 7.174). </ftext>
<ftext top=""1036"" left=""108"" width=""652"" height=""15"" font=""10"">Argentina and Patagonia, the time that has passed since the most recent outbreaks, and the limitation and </ftext>
<ftext top=""1051"" left=""108"" width=""340"" height=""15"" font=""10"">quick containment and elimination of the last outbreak. </ftext>
</footnote>
<text top=""862"" left=""471"" width=""321"" height=""16"" font=""0""> According to Argentina, this means that the </text>
<text top=""879"" left=""108"" width=""686"" height=""16"" font=""0"">prohibition as applied to Argentina is therefore inconsistent with Article 5.2, which requires a </text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 123 - </text>
</p><p><text top=""128"" left=""108"" width=""585"" height=""16"" font=""0"">Member to take into account <i>inter alia</i> scientific evidence in the assessment of risk.</text>
<footnote top=""126"" left=""693"" width=""17"" height=""11"" font=""16"" number=""839"" ref="""" dis=""""><ftext top=""891"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 253-256. </ftext>
</footnote>
<text top=""128"" left=""711"" width=""81"" height=""16"" font=""0""> Moreover, </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina contends that even if the interim rule adopted in June 2001 was a valid provisional </text>
<text top=""160"" left=""108"" width=""660"" height=""16"" font=""0"">measure, the final regulation adopted in December 2001 has been maintained for over 11 years.</text>
<footnote top=""159"" left=""768"" width=""17"" height=""11"" font=""16"" number=""840"" ref="""" dis=""""/>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">For Argentina, ""reliance on facts from more than eleven years ago does not suffice either as a </text>
<text top=""193"" left=""108"" width=""349"" height=""16"" font=""0"">provisional measure or as a valid risk assessment"".</text>
<footnote top=""192"" left=""457"" width=""17"" height=""11"" font=""16"" number=""841"" ref="""" dis=""""/>
</p></p></page>
<page number=""123"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.307"" style=""8""><text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">7.307.  Argentina notes that the panel in <i>US &#8211; Poultry (China) </i>reasoned that an analysis under </text>
<text top=""244"" left=""108"" width=""684"" height=""16"" font=""0"">Article 5.1 necessarily begins with a determination whether a risk assessment was conducted at </text>
<text top=""260"" left=""108"" width=""20"" height=""16"" font=""0"">all.</text>
<footnote top=""259"" left=""128"" width=""17"" height=""11"" font=""16"" number=""842"" ref="""" dis=""""/>
<text top=""260"" left=""146"" width=""651"" height=""16"" font=""0""> Argentina argues that the United States cannot demonstrate that its measures are </text>
<text top=""277"" left=""108"" width=""467"" height=""16"" font=""0"">""rationally related to a risk assessment"" because one does not exist.</text>
<footnote top=""275"" left=""575"" width=""17"" height=""11"" font=""16"" number=""843"" ref="""" dis=""""/>
</p><p number=""7.308"" style=""8""><text top=""311"" left=""108"" width=""687"" height=""16"" font=""0"">7.308.  Regarding  the  United States'  prohibition  on imports of fresh (chilled or frozen) beef </text>
<text top=""328"" left=""108"" width=""684"" height=""16"" font=""0"">originating in the Argentine territory as a whole, Argentina states that ""there is no current valid </text>
<text top=""344"" left=""108"" width=""372"" height=""16"" font=""0"">risk assessment"" underlying the measure in question.</text>
<footnote top=""343"" left=""480"" width=""17"" height=""11"" font=""16"" number=""844"" ref="""" dis=""""/>
<text top=""344"" left=""498"" width=""293"" height=""16"" font=""0""> According to Argentina, the only publicly </text>
<text top=""360"" left=""108"" width=""683"" height=""16"" font=""0"">available risk assessments regarding Argentina as a whole &#8211; from 1997 and 2000, respectively &#8211; </text>
<text top=""377"" left=""108"" width=""684"" height=""16"" font=""0"">and for Patagonia South specifically &#8211; from 2005 &#8211; were all favourable to imports of Argentine </text>
<text top=""393"" left=""108"" width=""462"" height=""16"" font=""0"">fresh (chilled or frozen) beef subject to certain mitigating protocols.</text>
<footnote top=""392"" left=""570"" width=""17"" height=""11"" font=""16"" number=""845"" ref="""" dis=""""><ftext top=""993"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 237-239. </ftext>
</footnote>
</p><p number=""7.309"" style=""8""><text top=""428"" left=""108"" width=""684"" height=""16"" font=""0"">7.309.  Argentina argues that the sanitary conditions in Argentina have improved radically since </text>
<text top=""444"" left=""108"" width=""682"" height=""16"" font=""0"">imposition of the prohibition in 2001 and thus even if the measure was based on a risk assessment </text>
<text top=""461"" left=""108"" width=""683"" height=""16"" font=""0"">at the time or justified as an emergency measure, it no longer can be considered ""appropriate to </text>
<text top=""477"" left=""108"" width=""685"" height=""16"" font=""0"">the circumstances"" because it bears no rational or objective relationship to Argentina's current </text>
<text top=""493"" left=""108"" width=""133"" height=""16"" font=""0"">sanitary conditions.</text>
<footnote top=""492"" left=""241"" width=""20"" height=""11"" font=""16"" number=""846"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""584"" height=""15"" font=""10""> Argentina's first written submission, paras. 244-246. To support its contention that Argentina's </ftext>
</footnote>
</p><p number=""7.310"" style=""8""><text top=""528"" left=""108"" width=""684"" height=""16"" font=""0"">7.310.  With regard to the United States' prohibition on imports of FMD-susceptible animals and </text>
<text top=""544"" left=""108"" width=""687"" height=""16"" font=""0"">animal products from Patagonia, Argentina argues that, to the extent that APHIS consulted </text>
<text top=""561"" left=""108"" width=""688"" height=""16"" font=""0"">scientific evidence, ""such evidence supported the opposite conclusion from the prohibitive </text>
<text top=""577"" left=""108"" width=""186"" height=""16"" font=""0"">measure"" actually applied.</text>
<footnote top=""575"" left=""294"" width=""17"" height=""11"" font=""16"" number=""847"" ref="""" dis=""""/>
<text top=""577"" left=""311"" width=""481"" height=""16"" font=""0""> In Argentina's opinion, the United States' measures as applied to </text>
<text top=""593"" left=""108"" width=""685"" height=""16"" font=""0"">Patagonia South are ""obvious[ly]"" rationally disconnected from the favourable risk assessment </text>
<text top=""610"" left=""108"" width=""536"" height=""16"" font=""0"">conducted in the region, and are therefore inconsistent with Article 5.1.</text>
<footnote top=""608"" left=""644"" width=""17"" height=""11"" font=""16"" number=""848"" ref="""" dis=""""/>
<text top=""610"" left=""661"" width=""134"" height=""16"" font=""0""> With respect to </text>
<text top=""626"" left=""108"" width=""686"" height=""16"" font=""0"">Patagonia North B, Argentina notes that ""[t]here has never been a risk assessment publicly </text>
<text top=""643"" left=""108"" width=""684"" height=""16"" font=""0"">available"" on Patagonia North B even though Argentina provided to APHIS the relevant scientific </text>
<text top=""659"" left=""108"" width=""660"" height=""16"" font=""0"">information in December 2008, prior to an APHIS fact-finding trip to the region in early 2009.</text>
<footnote top=""657"" left=""768"" width=""17"" height=""11"" font=""16"" number=""849"" ref="""" dis=""""/>
<text top=""675"" left=""108"" width=""683"" height=""16"" font=""0"">Therefore, Argentina concludes, the United States' measures as applied to imports from Patagonia </text>
<text top=""692"" left=""108"" width=""685"" height=""16"" font=""0"">North B are ""not rationally and objectively related"" to a risk assessment that ""does not legally </text>
<text top=""708"" left=""108"" width=""373"" height=""16"" font=""0"">exist"", and hence are inconsistent with Article 5.1.</text>
<footnote top=""707"" left=""481"" width=""17"" height=""11"" font=""16"" number=""850"" ref="""" dis=""""/>
<text top=""708"" left=""498"" width=""297"" height=""16"" font=""0""> Argentina maintains that the ""rational </text>
<text top=""725"" left=""108"" width=""683"" height=""16"" font=""0"">disconnect"" between the underlying scientific evidence and the prohibition imposed indicates that </text>
<text top=""741"" left=""108"" width=""612"" height=""16"" font=""0"">the United States' measures as applied to Patagonia are also inconsistent with Article 5.2.</text>
<footnote top=""739"" left=""720"" width=""17"" height=""11"" font=""16"" number=""851"" ref="""" dis=""""/>
</p><p number=""7.5"" style=""8""><text top=""775"" left=""108"" width=""184"" height=""16"" font=""28"">7.5.3.1.2  United States </text></p><p number=""7.311"" style=""8""><text top=""810"" left=""108"" width=""689"" height=""16"" font=""0"">7.311.  The United States argues that the 2001 Regulations &#8211; through which it withdrew </text>
<text top=""826"" left=""108"" width=""684"" height=""16"" font=""0"">authorization of imports of fresh (chilled or frozen) beef from Argentina &#8211; were based on a risk </text>
<footnote top=""905"" left=""165"" width=""293"" height=""15"" font=""10"" number=""251"" ref="""" dis=""""/>
<p><text top=""934"" left=""165"" width=""586"" height=""15"" font=""10""> Argentina's first written submission, para. 243 (referring to Panel Report, <i>US &#8211; Poultry (China)</i>, </text>
</p><p><text top=""963"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 241. </text>
<text top=""978"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 234. </text>
</p><p><text top=""1022"" left=""108"" width=""632"" height=""15"" font=""10"">sanitary condition has ""improved radically"" since 2001, Argentina refers to the OIE designations of both </text>
</p><p><text top=""1066"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 462. </text>
<text top=""1080"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 454. </text>
<text top=""1095"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 456. </text>
<text top=""1109"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 457. </text>
<text top=""1124"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 463. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 124 - </text>
</p><p><text top=""128"" left=""108"" width=""357"" height=""16"" font=""0"">assessment as appropriate to the circumstances.</text>
<footnote top=""126"" left=""465"" width=""17"" height=""11"" font=""16"" number=""852"" ref="""" dis=""""><ftext top=""876"" left=""165"" width=""612"" height=""15"" font=""10""> United States' first written submission, para. 253; United States' response to Panel question No. 24 </ftext>
<ftext top=""891"" left=""108"" width=""241"" height=""15"" font=""10"">following the first substantive meeting. </ftext>
</footnote>
<text top=""128"" left=""483"" width=""312"" height=""16"" font=""0""> According to the United States, the risk </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">assessment in question was grounded on the ""well-established body of scientific evidence"" showing </text>
<text top=""160"" left=""108"" width=""579"" height=""16"" font=""0"">that FMD ""is one of the most highly contagious and devastating animal disease[s]""</text>
<footnote top=""159"" left=""688"" width=""17"" height=""11"" font=""16"" number=""853"" ref="""" dis=""""/>
<text top=""160"" left=""705"" width=""86"" height=""16"" font=""0"">, as well as </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">an evaluation of the dangers posed by Argentine products in light of the 2000-2001 FMD outbreaks </text>
<text top=""193"" left=""108"" width=""104"" height=""16"" font=""0"">in the country.</text>
<footnote top=""192"" left=""212"" width=""17"" height=""11"" font=""16"" number=""854"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""603"" height=""15"" font=""10""> United States' first written submission, paras. 247, 262. See also United States' response to Panel </ftext>
</footnote>
<text top=""193"" left=""229"" width=""563"" height=""16"" font=""0""> In this regard, the United States observes that, at the time of the outbreaks, </text>
<text top=""210"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina itself recognized the gravity of the situation by voluntarily ceasing exports and the </text>
<text top=""226"" left=""108"" width=""386"" height=""16"" font=""0"">OIE removed Argentina from its list of FMD-free regions.</text>
<footnote top=""225"" left=""494"" width=""17"" height=""11"" font=""16"" number=""855"" ref="""" dis=""""/>
</p></p></page>
<page number=""124"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.312"" style=""8""><text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">7.312.  According to the United States, after APHIS withdrew import authorization from Argentina </text>
<text top=""277"" left=""108"" width=""624"" height=""16"" font=""0"">in 2001, ""there was no reason to believe that it needed to actively revisit that decision""</text>
<footnote top=""275"" left=""731"" width=""17"" height=""11"" font=""16"" number=""856"" ref="""" dis=""""/>
<text top=""277"" left=""749"" width=""43"" height=""16"" font=""0""> until </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina filed its requests pursuant to the procedures set forth in 9 CFR 92.2. Since the filing of </text>
<text top=""310"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina's requests, the United States argues that its prohibitions can be viewed as provisional </text>
<text top=""326"" left=""108"" width=""355"" height=""16"" font=""0"">measures falling within the scope of Article 5.7.</text>
<footnote top=""325"" left=""463"" width=""17"" height=""11"" font=""16"" number=""857"" ref="""" dis=""""/>
<text top=""326"" left=""481"" width=""314"" height=""16"" font=""0""> Indeed, the thrust of the United States' </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">argument with respect to the maintenance of the measures at issue is that since such measures </text>
<text top=""359"" left=""108"" width=""547"" height=""16"" font=""0"">are justified under Article 5.7, they are also consistent with Articles 5.1 and 5.2.</text>
<footnote top=""357"" left=""655"" width=""17"" height=""11"" font=""16"" number=""858"" ref="""" dis=""""/>
</p><p number=""7.313"" style=""8""><text top=""393"" left=""108"" width=""684"" height=""16"" font=""0"">7.313.  According to the United States, APHIS is in the process of conducting a risk assessment </text>
<text top=""410"" left=""108"" width=""689"" height=""16"" font=""0"">that will take a substantial amount of time and that has been complicated by further </text>
<text top=""426"" left=""108"" width=""686"" height=""16"" font=""0"">FMD outbreaks in Argentina, delays in Argentina responding to requests for information, the </text>
<text top=""443"" left=""108"" width=""474"" height=""16"" font=""0"">changing nature of Argentina's application with respect to Patagonia</text>
<footnote top=""441"" left=""582"" width=""17"" height=""11"" font=""16"" number=""859"" ref="""" dis=""""/>
<text top=""443"" left=""600"" width=""191"" height=""16"" font=""0"">, and Argentina's changing </text>
<text top=""459"" left=""108"" width=""248"" height=""16"" font=""0"">OIE status in the intervening years.</text>
<footnote top=""457"" left=""356"" width=""17"" height=""11"" font=""16"" number=""860"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""345"" height=""15"" font=""10""> United States' first written submission, paras. 258-260. </ftext>
</footnote>
<text top=""459"" left=""373"" width=""418"" height=""16"" font=""0""> In sum, the United States concludes, the perceived length </text>
<text top=""475"" left=""108"" width=""682"" height=""16"" font=""0"">of the rulemaking process is due to the fact that APHIS has been working ""with a moving target on </text>
<text top=""492"" left=""108"" width=""135"" height=""16"" font=""0"">the Argentina side"".</text>
<footnote top=""490"" left=""243"" width=""17"" height=""11"" font=""16"" number=""861"" ref="""" dis=""""/>
</p><p number=""7.5"" style=""8""><text top=""526"" left=""108"" width=""337"" height=""16"" font=""28"">7.5.3.2  Main arguments of the third parties </text></p><p number=""7.5"" style=""8""><text top=""561"" left=""108"" width=""125"" height=""16"" font=""28"">7.5.3.2.1  Brazil </text></p><p number=""7.314"" style=""8""><text top=""595"" left=""108"" width=""683"" height=""16"" font=""0"">7.314.  In Brazil's opinion, the United States' prohibition on Argentine imports was not a measure </text>
<text top=""611"" left=""108"" width=""684"" height=""16"" font=""0"">consistent with Article 5.1 as ""there was no risk assessment on which these SPS measures were </text>
<text top=""628"" left=""108"" width=""77"" height=""16"" font=""0"">based on"".</text>
<footnote top=""626"" left=""185"" width=""17"" height=""11"" font=""16"" number=""862"" ref="""" dis=""""/>
<text top=""628"" left=""203"" width=""592"" height=""16"" font=""0""> Brazil maintains that while Article 5.7 establishes an exception to the rule in </text>
<text top=""644"" left=""108"" width=""685"" height=""16"" font=""0"">Article 5.1, international standards or recommendations regarding the same situation, together </text>
<text top=""661"" left=""108"" width=""687"" height=""16"" font=""0"">with available and completed risk assessments, may provide levels of scientific information </text>
<text top=""677"" left=""108"" width=""345"" height=""16"" font=""0"">sufficient to exclude the applicability of Article 5.7.</text>
<footnote top=""675"" left=""453"" width=""17"" height=""11"" font=""16"" number=""863"" ref="""" dis=""""/>
</p><p number=""7.5"" style=""8""><text top=""711"" left=""108"" width=""124"" height=""16"" font=""28"">7.5.3.2.2  China </text></p><p number=""7.315"" style=""8""><text top=""746"" left=""108"" width=""686"" height=""16"" font=""0"">7.315.  China submits that Articles 5.1 and 5.7 are ""applied in a mutually exclusive manner, </text>
<text top=""762"" left=""108"" width=""505"" height=""16"" font=""0"">depending on whether the relevant scientific evidence is sufficient or not"".</text>
<footnote top=""761"" left=""613"" width=""17"" height=""11"" font=""16"" number=""864"" ref="""" dis=""""/>
</p><p number=""7.316"" style=""8""><text top=""797"" left=""108"" width=""685"" height=""16"" font=""0"">7.316.  China points to the panel report in <i>US &#8211; Poultry (China), which</i> set forth a two-step </text>
<text top=""813"" left=""108"" width=""684"" height=""16"" font=""0"">analytical process under Article 5.1 of the SPS Agreement. The report stated that a panel must </text>
<text top=""829"" left=""108"" width=""683"" height=""16"" font=""0"">assess whether: (a) a risk assessment, appropriate to the circumstances, takes into account risk </text>
<p><text top=""905"" left=""165"" width=""621"" height=""15"" font=""10""> United States' first written submission, para. 253. See also United States' response to Panel question </text>
<footnote top=""920"" left=""108"" width=""285"" height=""15"" font=""10"" number=""24"" ref="""" dis=""""/>
</p><p><text top=""993"" left=""165"" width=""616"" height=""15"" font=""10""> United States' opening statement at the first meeting of the Panel, para. 30. See also United States' </text>
<text top=""1007"" left=""108"" width=""471"" height=""15"" font=""10"">response to Panel question No. 18 following the second substantive meeting. </text>
<text top=""1022"" left=""165"" width=""566"" height=""15"" font=""10""> United States' first written submission, para. 246. For a more comprehensive account of the </text>
<text top=""1036"" left=""108"" width=""533"" height=""15"" font=""10"">United States' arguments in connection with Article 5.7, see paras. 7.272-7.276 above. </text>
<text top=""1051"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 263. </text>
</p><p><text top=""1080"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 264. </text>
<text top=""1095"" left=""165"" width=""259"" height=""15"" font=""10""> Brazil's response to Panel question No. 6. </text>
<text top=""1109"" left=""165"" width=""259"" height=""15"" font=""10""> Brazil's response to Panel question No. 8. </text>
<footnote top=""1124"" left=""165"" width=""268"" height=""15"" font=""10"" number=""10"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 125 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">assessment techniques developed by the relevant international organizations; and (b) whether the </text>
<text top=""144"" left=""108"" width=""393"" height=""16"" font=""0"">SPS measure at issue is based on that risk assessment.</text>
<footnote top=""143"" left=""501"" width=""17"" height=""11"" font=""16"" number=""865"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""891"" left=""165"" width=""592"" height=""15"" font=""10""> China's third-party submission, para. 34 (citing Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.173. </ftext>
</footnote>
<text top=""144"" left=""518"" width=""274"" height=""16"" font=""0""> Further, China argues, relying on the </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">Appellate Body report in <i>Japan &#8211; Agricultural Products</i>, that if the Panel were to find that Argentina </text>
<text top=""177"" left=""108"" width=""686"" height=""16"" font=""0"">established a presumption that no scientific evidence or valid risk assessment exists at all, </text>
<text top=""193"" left=""108"" width=""528"" height=""16"" font=""0"">Argentina should prevail unless the United States rebuts such a presumption.</text>
<footnote top=""192"" left=""635"" width=""17"" height=""11"" font=""16"" number=""866"" ref="""" dis=""""/>
</p></p></page>
<page number=""125"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.5"" style=""8""><text top=""228"" left=""108"" width=""202"" height=""16"" font=""28"">7.5.3.2.3  European Union </text></p><p number=""7.317"" style=""8""><text top=""262"" left=""108"" width=""684"" height=""16"" font=""0"">7.317.  The European Union contends that the general import prohibition on imports of animals </text>
<text top=""278"" left=""108"" width=""601"" height=""16"" font=""0"">and products thereof from FMD-infected regions is consistent with Article </text>
<text top=""278"" left=""699"" width=""101"" height=""16"" font=""0"">5.1 of the </text>
<text top=""295"" left=""108"" width=""317"" height=""16"" font=""0"">SPS Agreement if, at the time of its adoption</text>
<footnote top=""293"" left=""425"" width=""17"" height=""11"" font=""16"" number=""867"" ref="""" dis=""""/>
<text top=""295"" left=""442"" width=""349"" height=""16"" font=""0"">, it was supported by a risk assessment showing </text>
<text top=""311"" left=""108"" width=""683"" height=""16"" font=""0"">that: (i) FMD poses risks to human or animal health or life; and (ii) preventing the introduction of </text>
<text top=""328"" left=""108"" width=""588"" height=""16"" font=""0"">infected animals or products thereof is a proper response to the risks posed by FMD.</text>
<footnote top=""326"" left=""696"" width=""17"" height=""11"" font=""16"" number=""868"" ref="""" dis=""""/>
<text top=""328"" left=""713"" width=""77"" height=""16"" font=""0""> According </text>
<text top=""344"" left=""108"" width=""683"" height=""16"" font=""0"">to the European Union, the risk assessment need not include an analysis of which specific regions </text>
<text top=""360"" left=""108"" width=""265"" height=""16"" font=""0"">of the world are actually FMD-infected.</text>
<footnote top=""359"" left=""373"" width=""17"" height=""11"" font=""16"" number=""869"" ref="""" dis=""""/>
</p><p number=""7.318"" style=""8""><text top=""395"" left=""108"" width=""687"" height=""16"" font=""0"">7.318.  For the European Union, the real difference between an Article 5.1 situation and an </text>
<text top=""411"" left=""108"" width=""686"" height=""16"" font=""0"">Article 5.7 situation turns on the amount<i>  </i>of scientific information available to conduct a risk </text>
<text top=""428"" left=""108"" width=""79"" height=""16"" font=""0"">assessment</text>
<footnote top=""426"" left=""187"" width=""17"" height=""11"" font=""16"" number=""870"" ref="""" dis=""""/>
<text top=""428"" left=""205"" width=""587"" height=""16"" font=""0"">, meaning that Article 5.7 measures may be adopted on the basis of a hypothesis </text>
<text top=""444"" left=""108"" width=""406"" height=""16"" font=""0"">based on insufficient, but still relevant, scientific evidence.</text>
<footnote top=""443"" left=""514"" width=""17"" height=""11"" font=""16"" number=""871"" ref="""" dis=""""/>
<text top=""444"" left=""531"" width=""259"" height=""16"" font=""0""> For the European Union, a measure </text>
<text top=""461"" left=""108"" width=""685"" height=""16"" font=""0"">initially adopted under Article 5.1 can be withdrawn and immediately replaced with a measure </text>
<text top=""477"" left=""108"" width=""616"" height=""16"" font=""0"">under Article 5.7 if the initial scientific information about the underlying situation changes.</text>
<footnote top=""475"" left=""724"" width=""17"" height=""11"" font=""16"" number=""872"" ref="""" dis=""""/>
</p><p number=""7.5"" style=""8""><text top=""511"" left=""108"" width=""229"" height=""16"" font=""28"">7.5.3.3  Analysis by the Panel </text></p><p number=""7.319"" style=""8""><text top=""546"" left=""108"" width=""685"" height=""16"" font=""0"">7.319.  In this dispute, Argentina has argued two independent reasons why the United States' </text>
<text top=""562"" left=""108"" width=""682"" height=""16"" font=""0"">measures are inconsistent with Article 5.1. First, that the measures adopted in 2001 that removed </text>
<text top=""579"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina's authorization to import were not based on a risk assessment at the time of their </text>
<text top=""595"" left=""108"" width=""683"" height=""16"" font=""0"">adoption. Second, Argentina argues that even if the measures were based on a risk assessment </text>
<text top=""611"" left=""108"" width=""684"" height=""16"" font=""0"">when they were adopted, they were not maintained based on a valid risk assessment as of the </text>
<text top=""628"" left=""108"" width=""560"" height=""16"" font=""0"">date of establishment of the Panel. The Panel will address each argument in turn. </text>
</p><p number=""7.320"" style=""8""><text top=""662"" left=""108"" width=""683"" height=""16"" font=""0"">7.320.  Argentina has also argued that the United States has acted inconsistently with Article 5.2. </text>
<text top=""679"" left=""108"" width=""685"" height=""16"" font=""0"">The panel in <i>Japan &#8211; Apples</i> clarified that the requirements in Articles 5.1 and 5.2 inform the </text>
<text top=""695"" left=""108"" width=""623"" height=""16"" font=""0"">understanding of what is required for a risk assessment to be consistent with Article 5.1.</text>
<footnote top=""693"" left=""731"" width=""17"" height=""11"" font=""16"" number=""873"" ref=""WT/DS245/R|WT/DS245/RW"" dis=""DS245""><ftext top=""1036"" left=""165"" width=""268"" height=""15"" font=""10""> Panel Report, <i>Japan &#8211; Apples</i>, para. 8.230. </ftext>
</footnote>
<text top=""695"" left=""748"" width=""43"" height=""16"" font=""0""> That </text>
<text top=""711"" left=""108"" width=""684"" height=""16"" font=""0"">panel explained that Articles 5.1 and 5.2 ""directly inform each other, in that paragraph 2 sheds </text>
<text top=""728"" left=""108"" width=""660"" height=""16"" font=""0"">light on the elements that are of relevance in the assessment of risks foreseen in paragraph 1"".</text>
<footnote top=""726"" left=""768"" width=""17"" height=""11"" font=""16"" number=""874"" ref=""WT/DS245/RW|WT/DS367/R|WT/DS245/R"" dis=""DS245|DS367""><ftext top=""1051"" left=""165"" width=""591"" height=""15"" font=""10""> Panel Report, <i>Japan &#8211; Apples</i>, para. 8.230. Similarly, the panel in <i>Australia &#8211; Applies</i> stated that </ftext>
<ftext top=""1066"" left=""108"" width=""645"" height=""15"" font=""10"">""Article 5.2 is inextricably linked to Article 5.1"" and that Article 5.2 should be ""considered when looking at </ftext>
<ftext top=""1080"" left=""108"" width=""364"" height=""15"" font=""10"">Article 5.1"". (Panel Report, <i>Australia &#8211; Apples</i>, para. 7.211) </ftext>
</footnote>
<text top=""744"" left=""108"" width=""470"" height=""16"" font=""0"">The same panel<i> </i>further explained that Article 5.2 ""imparts meaning""</text>
<footnote top=""743"" left=""578"" width=""17"" height=""11"" font=""16"" number=""875"" ref=""WT/DS245/R|WT/DS245/RW"" dis=""DS245""><ftext top=""1095"" left=""165"" width=""268"" height=""15"" font=""10""> Panel Report, <i>Japan &#8211; Apples</i>,<i> </i>para. 8.232. </ftext>
</footnote>
<text top=""744"" left=""595"" width=""195"" height=""16"" font=""0""> to the general obligation in </text>
<text top=""761"" left=""108"" width=""684"" height=""16"" font=""0"">Article 5.1 to base measures on an ""assessment &#8230; of risks"". We agree with that panel and the </text>
<text top=""777"" left=""108"" width=""683"" height=""16"" font=""0"">panel in <i>Australia &#8211; Apples </i>which explained that Article 5.2 should be considered when looking at </text>
<text top=""793"" left=""108"" width=""75"" height=""16"" font=""0"">Article 5.1.</text>
<footnote top=""792"" left=""183"" width=""17"" height=""11"" font=""16"" number=""876"" ref=""WT/DS245/R|WT/DS367/R|WT/DS392/R|WT/DS245/RW"" dis=""DS245|DS367|DS392""><ftext top=""1109"" left=""165"" width=""604"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Apples</i>, para. 7.211 (citing Panel Report in <i>Japan &#8211; Apples</i>,<i> </i>para. 8.230). </ftext>
<ftext top=""1124"" left=""108"" width=""348"" height=""15"" font=""10"">See also Panel Report, <i>US &#8211; Poultry</i> <i>(China)</i>, para. 7.172 </ftext>
</footnote>
<text top=""793"" left=""200"" width=""590"" height=""16"" font=""0""> Therefore, we will conduct our analysis of Argentina's claims under Article 5.2 within </text>
<text top=""810"" left=""108"" width=""395"" height=""16"" font=""0"">the context of our analysis of its claims under Article 5.1. </text>
<p><text top=""905"" left=""165"" width=""589"" height=""15"" font=""10""> China's third-party submission, paras. 35-36 (citing Appellate Body Report, <i>Japan &#8211; Agricultural </i></text>
<text top=""920"" left=""108"" width=""147"" height=""15"" font=""12""><i>Products II</i>, para. 137). </text>
<text top=""934"" left=""165"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 48. </text>
<text top=""949"" left=""165"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 46. </text>
<text top=""963"" left=""165"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 47. </text>
<footnote top=""978"" left=""165"" width=""322"" height=""15"" font=""10"" number=""4"" ref="""" dis=""""/>
</p><p><text top=""1007"" left=""108"" width=""97"" height=""15"" font=""10"">question No. 5. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 126 - </text>
</p></p></page>
<page number=""126"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.321"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.321.  As we begin our analysis, we bear in mind that the Panel's role is not to conduct its own </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">risk assessment based on scientific evidence gathered by the Panel or submitted by the parties </text>
<text top=""160"" left=""108"" width=""207"" height=""16"" font=""0"">during the Panel proceedings.</text>
<footnote top=""159"" left=""315"" width=""17"" height=""11"" font=""16"" number=""877"" ref=""WT/DS26/R/USA"" dis=""DS26""><ftext top=""803"" left=""165"" width=""551"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Hormones (Canada)</i>, para. 8.104; <i>EC &#8211; Hormones (US)</i>, para. 8.101. </ftext>
</footnote>
<text top=""160"" left=""332"" width=""459"" height=""16"" font=""0""> Similarly, the Panel will not impose its own scientific opinion on </text>
<text top=""177"" left=""108"" width=""124"" height=""16"" font=""0"">the United States.</text>
<footnote top=""175"" left=""232"" width=""17"" height=""11"" font=""16"" number=""878"" ref=""WT/DS18/R/Corr.1|WT/DS18/RW|WT/DS76/R|WT/DS18/R|WT/DS18/11"" dis=""DS18|DS76""><ftext top=""818"" left=""165"" width=""623"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Salmon</i>, para. 8.41. See also Panel Report, <i>Japan &#8211; Agricultural Products II</i>, </ftext>
<ftext top=""832"" left=""108"" width=""71"" height=""15"" font=""10"">para. 8.32. </ftext>
</footnote>
<text top=""177"" left=""249"" width=""541"" height=""16"" font=""0""> Our task is not to substitute our own judgement for that of the United States </text>
<text top=""193"" left=""108"" width=""507"" height=""16"" font=""0"">or determine whether the science relied upon was actually ""correct"".</text>
<footnote top=""192"" left=""615"" width=""17"" height=""11"" font=""16"" number=""879"" ref="""" dis=""""/>
<text top=""193"" left=""633"" width=""162"" height=""16"" font=""0""> Instead, our task &#8211; </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">pursuant to the clarification of the Appellate Body in <i>US/Canada &#8211; Continued Suspension</i> &#8211; is to </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">determine the following: (i) whether there is a risk assessment; (ii) if that risk assessment is </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">""appropriate to the circumstances""; (iii) whether the science supports the conclusions in the risk </text>
<text top=""259"" left=""108"" width=""685"" height=""16"" font=""0"">assessment; and finally (iv) whether the importing Member's measures are based on that risk </text>
<text top=""275"" left=""108"" width=""84"" height=""16"" font=""0"">assessment.</text>
<footnote top=""274"" left=""192"" width=""17"" height=""11"" font=""16"" number=""880"" ref="""" dis=""""><ftext top=""861"" left=""165"" width=""565"" height=""15"" font=""10""> In conducting this analysis, the Appellate Body has explained that the role of the Panel is to </ftext>
<ftext top=""876"" left=""108"" width=""634"" height=""15"" font=""10"">determine (a) whether the views upon which an SPS measure is based are from qualified and respected </ftext>
<ftext top=""891"" left=""108"" width=""656"" height=""15"" font=""10"">sources; (b) whether the reasoning articulated on the basis of scientific evidence is objective and coherent; </ftext>
<ftext top=""905"" left=""108"" width=""656"" height=""15"" font=""10"">(c) whether the particular conclusions drawn by the Member assessing the risk find sufficient support in the </ftext>
<ftext top=""920"" left=""108"" width=""656"" height=""15"" font=""10"">scientific evidence relied upon; and (d) whether the results of the risk's assessment sufficiently warrant the </ftext>
</footnote>
</p><p number=""7.322"" style=""8""><text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">7.322.  Article 5.1 requires Members to base their measures on a risk assessment ""appropriate to </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">the circumstances"". We understand that the first step of the analysis for determining whether the </text>
<text top=""342"" left=""108"" width=""684"" height=""16"" font=""0"">risk assessment is appropriate to the circumstances is to decide which of the two types of risk </text>
<text top=""359"" left=""108"" width=""685"" height=""16"" font=""0"">assessment set forth in Annex A(4) should be conducted. Annex A(4) provides for two distinct </text>
<text top=""375"" left=""108"" width=""682"" height=""16"" font=""0"">types of risk assessment: (i) the evaluation of the likelihood of entry, establishment or spread of a </text>
<text top=""392"" left=""108"" width=""687"" height=""16"" font=""0"">pest or disease within the territory of an importing Member according to the sanitary or </text>
<text top=""408"" left=""108"" width=""686"" height=""16"" font=""0"">phytosanitary measures which might be applied; and (ii) the evaluation of the potential for </text>
<text top=""425"" left=""108"" width=""683"" height=""16"" font=""0"">adverse effects on human or animal health arising from the presence of additives, contaminants, </text>
<text top=""441"" left=""108"" width=""684"" height=""16"" font=""0"">toxins, or disease-causing organisms in food, beverages or feedstuffs. While there is no explicit </text>
<text top=""457"" left=""108"" width=""682"" height=""16"" font=""0"">reference in Annex A(4) directing which types of measures fit within which of the two types of risk </text>
<text top=""474"" left=""108"" width=""683"" height=""16"" font=""0"">assessment, concluding which is appropriate can be deduced from the similarities in the texts of </text>
<text top=""490"" left=""108"" width=""685"" height=""16"" font=""0"">the subparagraphs of Annex A(1) and of Annex A(4). Moreover, in the past, panels examining </text>
<text top=""507"" left=""108"" width=""683"" height=""16"" font=""0"">measures taken pursuant to Annex A(1)(a) (such as the measures at issue in the present dispute) </text>
<text top=""523"" left=""108"" width=""576"" height=""16"" font=""0"">have stated that such measures must be based on the first type of risk assessment.</text>
<footnote top=""521"" left=""684"" width=""17"" height=""11"" font=""16"" number=""881"" ref=""WT/DS18/AB/R"" dis=""DS18""><ftext top=""963"" left=""165"" width=""452"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 120 and fns 67 and 69. </ftext>
</footnote>
<text top=""523"" left=""701"" width=""88"" height=""16"" font=""0""> In <i>Australia </i></text>
<text top=""539"" left=""108"" width=""683"" height=""16"" font=""18""><i>&#8211; Salmon,</i> the Appellate Body observed that the ""likelihood"" type of risk assessment requires an </text>
<text top=""556"" left=""108"" width=""682"" height=""16"" font=""0"">analysis of the disease ""according to the SPS measures which might be applied"", and also requires </text>
<text top=""572"" left=""108"" width=""685"" height=""16"" font=""0"">an evaluation ""of the associated potential biological and economic consequences"" of the entry, </text>
<text top=""589"" left=""108"" width=""321"" height=""16"" font=""0"">establishment or spread of the pest or disease.</text>
<footnote top=""587"" left=""429"" width=""17"" height=""11"" font=""16"" number=""882"" ref=""WT/DS18/AB/R"" dis=""DS18""><ftext top=""978"" left=""165"" width=""605"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 121 (emphasis omitted), and fn 69 to para. 123. </ftext>
</footnote>
</p><p number=""7.323"" style=""8""><text top=""623"" left=""108"" width=""682"" height=""16"" font=""0"">7.323.  Another element that should be considered when determining whether a risk assessment is </text>
<text top=""639"" left=""108"" width=""682"" height=""16"" font=""0"">""appropriate to the circumstances"" is whether the requirement in Article 5.1 that Members ""tak[e] </text>
<text top=""656"" left=""108"" width=""685"" height=""16"" font=""0"">into account risk assessment techniques developed by the relevant international organizations"" </text>
<text top=""672"" left=""108"" width=""145"" height=""16"" font=""0"">has been adhered to.</text>
<footnote top=""671"" left=""253"" width=""17"" height=""11"" font=""16"" number=""883"" ref=""WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS245/R|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS245/RW|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7"" dis=""DS291|DS292|DS245|DS293""><ftext top=""993"" left=""165"" width=""591"" height=""15"" font=""10""> We recall that the panel in <i>Japan &#8211; Apples</i>, in examining the obligation in 5.1, reasoned that the </ftext>
<ftext top=""1007"" left=""108"" width=""626"" height=""15"" font=""10"">requirement to ""take into account"" risk assessment techniques developed by the relevant international </ftext>
<ftext top=""1022"" left=""108"" width=""653"" height=""15"" font=""10"">organizations means that such techniques ""should be considered relevant"" for a Member's assessment, but </ftext>
<ftext top=""1036"" left=""108"" width=""678"" height=""15"" font=""10"">that a ""failure to respect every aspect"" thereof ""would not necessarily, <i>per se</i>, signal"" an inconsistency with the </ftext>
<ftext top=""1051"" left=""108"" width=""665"" height=""15"" font=""10"">SPS Agreement. (Panel Report, <i>Japan &#8211; Apples</i>, para. 8.241 (emphasis original). See also Panel Report, <i>EC &#8211; </i></ftext>
<ftext top=""1066"" left=""108"" width=""361"" height=""15"" font=""12""><i>Approval and Marketing of Biotech Products</i>, para. 7.1620) </ftext>
</footnote>
<text top=""672"" left=""270"" width=""460"" height=""16"" font=""0""> Additionally, whether the elements set forth in Articles 5.2 and 5.3</text>
<footnote top=""671"" left=""730"" width=""17"" height=""11"" font=""16"" number=""884"" ref="""" dis=""DS367""><ftext top=""1080"" left=""165"" width=""581"" height=""15"" font=""10""> In <i>Australia &#8211; Apples</i>, the Appellate Body stated that ""[w]hether a risk assessor has taken into </ftext>
<ftext top=""1095"" left=""108"" width=""641"" height=""15"" font=""10"">account the available scientific evidence"" must be ""determined by assessing the relationship between the </ftext>
<ftext top=""1109"" left=""108"" width=""628"" height=""15"" font=""10"">conclusions of the risk assessor and the relevant available scientific evidence."" (Appellate Body Report, </ftext>
</footnote>
<text top=""672"" left=""747"" width=""42"" height=""16"" font=""0""> were </text>
<text top=""689"" left=""108"" width=""687"" height=""16"" font=""0"">taken into account is also relevant to a determination of whether the risk assessment was </text>
<text top=""705"" left=""108"" width=""683"" height=""16"" font=""0"">""appropriate to the circumstances."" The Panel is also mindful that the phrase ""appropriate to the </text>
<text top=""721"" left=""108"" width=""685"" height=""16"" font=""0"">circumstances"" provides some flexibility for Members in the conduct of their risk assessments </text>
<p><text top=""847"" left=""165"" width=""441"" height=""15"" font=""10""> Appellate Body Report, <i>US/Canada &#8211; Continued Suspension</i>,<i> </i>para. 590. </text>
</p><p><text top=""934"" left=""108"" width=""636"" height=""15"" font=""10"">SPS measure at issue. (Appellate Body Report, <i>US/Canada &#8211; Continued Suspension</i>,<i> </i>para. 591. See also </text>
<text top=""949"" left=""108"" width=""366"" height=""15"" font=""10"">Appellate Body Report, <i>Australia &#8211; Apples</i>, paras. 213&#8211;214) </text>
</p><p><text top=""1124"" left=""108"" width=""186"" height=""15"" font=""12""><i>Australia &#8211; Apples</i>, para. 208) </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 127 - </text>
</p><p><text top=""128"" left=""108"" width=""563"" height=""16"" font=""0"">without absolving them of their duty to base their measures on a risk assessment.</text>
<footnote top=""126"" left=""670"" width=""17"" height=""11"" font=""16"" number=""885"" ref=""WT/DS18/R/Corr.1|WT/DS18/11|WT/DS18/RW|WT/DS18/R|WT/DS26/AB/R ; WT/DS48/AB/R"" dis=""DS26|DS18""><ftext top=""861"" left=""165"" width=""618"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 129 and Panel Report, <i>Australia &#8211; Salmon</i>, para. 8.57. </ftext>
</footnote>
<text top=""128"" left=""688"" width=""102"" height=""16"" font=""0""> The Appellate </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">Body has also recognized that the appropriate level of protection of the importing Member may </text>
<text top=""160"" left=""108"" width=""346"" height=""16"" font=""0"">affect the scope or method of the risk assessment.</text>
<footnote top=""159"" left=""454"" width=""17"" height=""11"" font=""16"" number=""886"" ref="""" dis=""""/>
</p></p></page>
<page number=""127"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.324"" style=""8""><text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">7.324.  To the extent the Panel is satisfied that a risk assessment exists and is appropriate to the </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">circumstances, the Panel should next turn to addressing whether the scientific information taken </text>
<text top=""228"" left=""108"" width=""567"" height=""16"" font=""0"">into account by the United States supports the conclusions in its risk assessment</text>
<footnote top=""226"" left=""675"" width=""17"" height=""11"" font=""16"" number=""887"" ref="""" dis=""DS26""><ftext top=""920"" left=""165"" width=""623"" height=""15"" font=""10""> The Appellate Body in <i>EC &#8211; Hormones</i> explained that ""Article 5.1, when contextually read as it should </ftext>
<ftext top=""934"" left=""108"" width=""660"" height=""15"" font=""10"">be, in conjunction with and as informed by Article 2.2 of the <i>SPS Agreement</i>, requires that the results of the </ftext>
<ftext top=""949"" left=""108"" width=""658"" height=""15"" font=""10"">risk assessment must sufficiently warrant &#8211; that is to say, reasonably support &#8211; the SPS measure at stake."" </ftext>
</footnote>
<text top=""228"" left=""692"" width=""99"" height=""16"" font=""0""> and whether </text>
<text top=""244"" left=""108"" width=""686"" height=""16"" font=""0"">the resulting measures are based on that risk assessment. To that end, we recall that the </text>
<text top=""260"" left=""108"" width=""504"" height=""16"" font=""0"">Appellate Body has clarified that a ""rational or objective relationship""</text>
<footnote top=""259"" left=""612"" width=""17"" height=""11"" font=""16"" number=""888"" ref="""" dis=""""/>
<text top=""260"" left=""629"" width=""164"" height=""16"" font=""0""> that ""persists and is </text>
<text top=""277"" left=""108"" width=""80"" height=""16"" font=""0"">observable""</text>
<footnote top=""275"" left=""188"" width=""17"" height=""11"" font=""16"" number=""889"" ref="""" dis=""""/>
<text top=""277"" left=""205"" width=""588"" height=""16"" font=""0""> must exist between an SPS measure and a risk assessment. We also recall our </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">conclusion in section 7.4.2.3 that the reasoning of the Appellate Body in <i>EC &#8211; Sardines, </i>that ""at a </text>
<text top=""310"" left=""108"" width=""688"" height=""16"" font=""0"">minimum &#8230; something cannot be considered a 'basis' for something else if the two are </text>
<text top=""326"" left=""108"" width=""96"" height=""16"" font=""0"">contradictory""</text>
<footnote top=""325"" left=""204"" width=""17"" height=""11"" font=""16"" number=""890"" ref="""" dis=""""/>
<text top=""326"" left=""221"" width=""570"" height=""16"" font=""0""> is equally applicable in the SPS context. In that vein, a measure that contradicts </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">the conclusions of a risk assessment cannot be said to be based upon it. However, the Appellate </text>
<text top=""359"" left=""108"" width=""689"" height=""16"" font=""0"">Body has clarified that while Article 5.1 requires that SPS measures be based on a risk </text>
<text top=""375"" left=""108"" width=""689"" height=""16"" font=""0"">assessment, this does not mean that the SPS measures have to ""conform to"" the risk </text>
<text top=""392"" left=""108"" width=""84"" height=""16"" font=""0"">assessment.</text>
<footnote top=""390"" left=""192"" width=""17"" height=""11"" font=""16"" number=""891"" ref="""" dis=""""/>
</p><p number=""7.325"" style=""8""><text top=""426"" left=""108"" width=""682"" height=""16"" font=""0"">7.325.  In light of the above, the Panel will assess whether a rational or objective relationship that </text>
<text top=""443"" left=""108"" width=""685"" height=""16"" font=""0"">persists and is observable exists between, on the one hand, the United States' imposition and </text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">maintenance of its prohibition on the importation of Argentinian fresh (frozen or chilled) bovine </text>
<text top=""475"" left=""108"" width=""685"" height=""16"" font=""0"">meat and Patagonian ruminant and swine products and, on the other hand, the document or </text>
<text top=""492"" left=""108"" width=""376"" height=""16"" font=""0"">documents it has put forward as its ""risk assessment"". </text>
</p><p number=""7.326"" style=""8""><text top=""526"" left=""108"" width=""688"" height=""16"" font=""0"">7.326.  As noted above, we will conduct this analysis for the 2001 Regulations amending </text>
<text top=""543"" left=""108"" width=""574"" height=""16"" font=""0"">9 CFR 94.1 at the time of adoption as well as for the maintenance of the measures. </text>
</p><p number=""7.5"" style=""8""><text top=""577"" left=""108"" width=""627"" height=""16"" font=""28"">7.5.3.3.1  9 CFR 94.1 as amended by the 2001 Regulations at the time of adoption </text></p><p number=""7.327"" style=""8""><text top=""611"" left=""108"" width=""682"" height=""16"" font=""0"">7.327.  Our first task is to ascertain whether a risk assessment exists as a basis for the adoption of </text>
<text top=""628"" left=""108"" width=""684"" height=""16"" font=""0"">the prohibition on imports from Argentina, first on an interim basis in June 2001 and then as a </text>
<text top=""644"" left=""108"" width=""199"" height=""16"" font=""0"">final rule in December 2001. </text>
</p><p number=""7.328"" style=""8""><text top=""679"" left=""108"" width=""683"" height=""16"" font=""0"">7.328.  Argentina argues that the 2001 Regulations are not based on a risk assessment primarily </text>
<text top=""695"" left=""108"" width=""684"" height=""16"" font=""0"">because they were adopted without the typical step of the publication of a lengthy risk analysis </text>
<text top=""711"" left=""108"" width=""683"" height=""16"" font=""0"">document separate from the notice in the Federal Register of the amendment of 9 CFR 94.1. We </text>
<text top=""728"" left=""108"" width=""684"" height=""16"" font=""0"">do not find this argument convincing. We recall the conclusion of the panel in <i>Japan &#8211; Apples </i></text>
<text top=""744"" left=""108"" width=""683"" height=""16"" font=""18""><i>(Article 21.5 &#8211; United States) </i>that the relevant consideration is not limited to a procedural review </text>
<text top=""761"" left=""108"" width=""684"" height=""16"" font=""0"">as to whether the risk assessment followed a certain form, but is more importantly focused on </text>
<text top=""777"" left=""108"" width=""686"" height=""16"" font=""0"">whether the substance of the risk assessment, that is the scientific evidence which is being </text>
<text top=""793"" left=""108"" width=""416"" height=""16"" font=""0"">evaluated, supports the conclusions of the risk assessment.</text>
<footnote top=""792"" left=""524"" width=""17"" height=""11"" font=""16"" number=""892"" ref=""WT/DS245/R|WT/DS245/RW"" dis=""DS245""><ftext top=""1095"" left=""165"" width=""450"" height=""15"" font=""10""> Panel Report, <i>Japan &#8211; Apples (Article 21.5 &#8211; United States)</i>, para. 8.129. </ftext>
</footnote>
<text top=""793"" left=""541"" width=""250"" height=""16"" font=""0""> In this instance, the United States </text>
<text top=""810"" left=""108"" width=""682"" height=""16"" font=""0"">has identified the June 2001 Interim Rule as containing both the measure and the risk assessment. </text>
<text top=""826"" left=""108"" width=""554"" height=""16"" font=""0"">We see nothing in the Agreement that would prohibit them from doing this.</text>
<footnote top=""825"" left=""662"" width=""17"" height=""11"" font=""16"" number=""893"" ref="""" dis=""DS26""><ftext top=""1109"" left=""165"" width=""579"" height=""15"" font=""10""> Indeed, the Appellate Body explained in <i>EC &#8211; Hormones </i>that ""Article 5.1 does not insist that a </ftext>
<ftext top=""1124"" left=""108"" width=""662"" height=""15"" font=""10"">Member that adopts a sanitary measure shall have carried out its own risk assessment &#8230; [t]he SPS measure </ftext>
<ftext top=""993"" left=""108"" width=""604"" height=""15"" font=""10"">might well find its objective justification in a risk assessment carried out by another Member, or an </ftext>
</footnote>
<text top=""826"" left=""679"" width=""114"" height=""16"" font=""0""> Therefore, we </text>
<p><text top=""876"" left=""108"" width=""621"" height=""15"" font=""10"">See also Appellate Body Reports, <i>Australia &#8211; Salmon</i>, para. 130; <i>US/Canada &#8211; Continued Suspension</i>, </text>
<text top=""891"" left=""108"" width=""334"" height=""15"" font=""10"">para. 562 and <i>Australia &#8211; Apples</i>, paras. 237 and 244. </text>
<text top=""905"" left=""165"" width=""441"" height=""15"" font=""10""> Appellate Body Report, <i>US/Canada &#8211; Continued Suspension</i>,<i> </i>para. 685. </text>
</p><p><text top=""963"" left=""108"" width=""358"" height=""15"" font=""10"">(Appellate Body Report, <i>EC &#8211; Hormones</i>,<i> </i>paras. 193-194)  </text>
<text top=""978"" left=""165"" width=""604"" height=""15"" font=""10""> Appellate Body Report, <i>Japan &#8211; Agricultural Products II</i>, para. 84. See also Appellate Body Report, </text>
<text top=""993"" left=""108"" width=""643"" height=""15"" font=""12""><i>Japan &#8211; Apples</i>, paras. 162 and 163. We also recall that, in the context of its analysis of Article 3.1 of the </text>
<text top=""1007"" left=""108"" width=""670"" height=""15"" font=""10"">SPS Agreement the Appellate Body stated that ""a thing is commonly said to be 'based on' another thing when </text>
<text top=""1022"" left=""108"" width=""667"" height=""15"" font=""10"">the former 'stands' or is 'founded' or 'built' upon or 'is supported by' the latter."" (Appellate Body Report, <i>EC &#8211; </i></text>
<text top=""1036"" left=""108"" width=""229"" height=""15"" font=""12""><i>Hormones</i>,<i> </i>paras. 163, 189 and 193) </text>
<text top=""1051"" left=""165"" width=""316"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 189. </text>
<text top=""1066"" left=""165"" width=""307"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Sardines</i>, para. 248. </text>
<text top=""1080"" left=""165"" width=""441"" height=""15"" font=""10""> Appellate Body Report, <i>US/Canada &#8211; Continued Suspension</i>, para. 528. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 128 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">accept that the United States has identified the June 2001 Interim Rule as the risk assessment </text>
<text top=""144"" left=""108"" width=""188"" height=""16"" font=""0"">underpinning its measure.  </text>
</p></p></page>
<page number=""128"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.329"" style=""8""><text top=""178"" left=""108"" width=""687"" height=""16"" font=""0"">7.329.  On this basis we move on to examine the remaining three questions -if that risk </text>
<text top=""195"" left=""108"" width=""682"" height=""16"" font=""0"">assessment is ""appropriate to the circumstances""; whether the science supports the conclusions in </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">the risk assessment; and finally whether the importing Member's measures are based on that risk </text>
<text top=""228"" left=""108"" width=""94"" height=""16"" font=""0"">assessment.  </text>
</p><p number=""7.330"" style=""8""><text top=""262"" left=""108"" width=""688"" height=""16"" font=""0"">7.330.  With respect to the June 2001 Interim Rule we note that the document refers to </text>
<text top=""278"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina's notification to the OIE and the United States of the confirmation of outbreaks of FMD in </text>
<text top=""295"" left=""108"" width=""683"" height=""16"" font=""0"">a number of Argentine provinces in March 2001. APHIS also notes that SENASA was investigating </text>
<text top=""311"" left=""108"" width=""687"" height=""16"" font=""0"">the outbreaks, conducting extensive serological surveillance and implementing a vaccination </text>
<text top=""328"" left=""108"" width=""684"" height=""16"" font=""0"">programme to attempt to confine the virus. APHIS notes that it is taking the action to prohibit </text>
<text top=""344"" left=""108"" width=""684"" height=""16"" font=""0"">imports ""because the existence of FMD has been confirmed"" in Argentina. APHIS concludes that </text>
<text top=""360"" left=""108"" width=""690"" height=""16"" font=""0"">""imports of infected animal products pose the greatest risk of entry for FMD into the </text>
<text top=""377"" left=""108"" width=""684"" height=""16"" font=""0"">United States."" APHIS also notes that with the exception of North and Central America (north of </text>
<text top=""393"" left=""108"" width=""584"" height=""16"" font=""0"">Panama), Australia and New Zealand, FMD is still present in many areas of the world.</text>
<footnote top=""392"" left=""691"" width=""17"" height=""11"" font=""16"" number=""894"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""316"" height=""15"" font=""10""> 2001 Interim Rule on Argentina, (Exhibit ARG-29). </ftext>
</footnote>
</p><p number=""7.331"" style=""8""><text top=""428"" left=""108"" width=""684"" height=""16"" font=""0"">7.331.  We note that these conclusions are consistent with the OIE's guidance in the Terrestrial </text>
<text top=""444"" left=""108"" width=""682"" height=""16"" font=""0"">Code, namely that once a country experiences an outbreak its disease status is suspended and it is </text>
<text top=""461"" left=""108"" width=""682"" height=""16"" font=""0"">treated as infected. In the case of FMD, it is reasonable to conclude that the science on the disease </text>
<text top=""477"" left=""108"" width=""687"" height=""16"" font=""0"">is sufficiently settled and that the SPS measures applicable to a country or region can be </text>
<text top=""493"" left=""108"" width=""683"" height=""16"" font=""0"">determined on the basis of the existence of an outbreak without the need for additional extensive </text>
<text top=""510"" left=""108"" width=""684"" height=""16"" font=""0"">studies. As the OIE explained at the meeting with the Panel, ""as soon as it has an outbreak [a </text>
<text top=""526"" left=""108"" width=""687"" height=""16"" font=""0"">country] can no longer qualify for being free from FMD"" and suspension of the status is </text>
<text top=""543"" left=""108"" width=""77"" height=""16"" font=""0"">immediate.</text>
<footnote top=""541"" left=""185"" width=""17"" height=""11"" font=""16"" number=""895"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""402"" height=""15"" font=""10""> Transcript of the meeting, para. 1.16; see also Ibid.<i> </i>para. 1.110. </ftext>
</footnote>
<text top=""543"" left=""202"" width=""588"" height=""16"" font=""0""> Argentina itself seems to have recognized this when it suspended exports on its own </text>
<text top=""559"" left=""108"" width=""687"" height=""16"" font=""0"">initiative. Moreover, the OIE clarified that given the epidemiology of FMD, a ""cut and dry"" </text>
<text top=""575"" left=""108"" width=""683"" height=""16"" font=""0"">assessment of whether the country meets the conditions that are specified in the Terrestrial Code </text>
<text top=""592"" left=""108"" width=""155"" height=""16"" font=""0"">is what is appropriate.</text>
<footnote top=""590"" left=""263"" width=""17"" height=""11"" font=""16"" number=""896"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""575"" height=""15"" font=""10""> Transcript of the meeting, para. 1.107 (comparing the evaluation for FMD to one for BSE that </ftext>
<ftext top=""1080"" left=""108"" width=""478"" height=""15"" font=""10"">requires more of an analysis of the effectiveness of certain control measures). </ftext>
</footnote>
<text top=""592"" left=""280"" width=""511"" height=""16"" font=""0""> In particular, the OIE noted that ""we all know that the impact of FMD is </text>
<text top=""608"" left=""108"" width=""684"" height=""16"" font=""0"">high, we are not really in any doubt about that. It is a high impact disease, a trans- boundary </text>
<text top=""625"" left=""108"" width=""425"" height=""16"" font=""0"">animal disease, highly contagious and has serious impact.""</text>
<footnote top=""623"" left=""533"" width=""17"" height=""11"" font=""16"" number=""897"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""245"" height=""15"" font=""10""> Transcript of the meeting, para. 1.128. </ftext>
</footnote>
<text top=""625"" left=""550"" width=""243"" height=""16"" font=""0""> Therefore, the relevant issue in </text>
<text top=""641"" left=""108"" width=""684"" height=""16"" font=""0"">assessing the FMD ""risk"" in a particular country or region relates to ""the probability of the virus </text>
<text top=""657"" left=""108"" width=""310"" height=""16"" font=""0"">being present in the animals and their meat.""</text>
<footnote top=""656"" left=""418"" width=""17"" height=""11"" font=""16"" number=""898"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""245"" height=""15"" font=""10""> Transcript of the meeting, para. 1.128. </ftext>
</footnote>
</p><p number=""7.332"" style=""8""><text top=""692"" left=""108"" width=""684"" height=""16"" font=""0"">7.332.  Furthermore, the June 2001 Interim Rule reaches conclusions about the economic impact </text>
<text top=""708"" left=""108"" width=""685"" height=""16"" font=""0"">of the entry, establishment or spread of the disease and the impact of the SPS measures that </text>
<text top=""725"" left=""108"" width=""682"" height=""16"" font=""0"">might be applied. In particular, APHIS notes that after an outbreak of FMD ""[p]roduction losses are </text>
<text top=""741"" left=""108"" width=""687"" height=""16"" font=""0"">substantial, and costs to eradicate the disease are high."" APHIS concludes that ""[a] single </text>
<text top=""757"" left=""108"" width=""682"" height=""16"" font=""0"">outbreak of FMD in the United States has the potential to close our major livestock export markets </text>
<text top=""774"" left=""108"" width=""683"" height=""16"" font=""0"">overnight. During the eradication process, most exports of meat, animals, and animal byproducts </text>
<text top=""790"" left=""108"" width=""686"" height=""16"" font=""0"">would be curtailed."" APHIS also notes that if an outbreak were not immediately recognized </text>
<text top=""807"" left=""108"" width=""685"" height=""16"" font=""0"">""eradication could take years."" APHIS contrasts the potential loss of export markets with the </text>
<text top=""823"" left=""108"" width=""683"" height=""16"" font=""0"">available data on total earnings from exports of live cattle, swine, beef and veal, pork and dairy </text>
<text top=""839"" left=""108"" width=""684"" height=""16"" font=""0"">products from the United States for the last year of available data (1999). APHIS also notes the </text>
<text top=""856"" left=""108"" width=""683"" height=""16"" font=""0"">limited market share of Argentine beef products in the United States &#8211; 1.7 per cent of total beef </text>
<text top=""872"" left=""108"" width=""683"" height=""16"" font=""0"">imports and that the amount of imports had been declining. APHIS concludes that the prohibition </text>
<text top=""889"" left=""108"" width=""386"" height=""16"" font=""0"">will have little to no effect on supply or consumer prices.</text>
<footnote top=""887"" left=""494"" width=""17"" height=""11"" font=""16"" number=""899"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""316"" height=""15"" font=""10""> 2001 Interim Rule on Argentina, (Exhibit ARG-29). </ftext>
</footnote>
</p><p number=""7.333"" style=""8""><text top=""923"" left=""108"" width=""687"" height=""16"" font=""0"">7.333.  The Panel finds that the June 2001 Interim Rule contains references to the standard </text>
<text top=""940"" left=""108"" width=""684"" height=""16"" font=""0"">scientific understanding of FMD as it was known at the time. It also contains information on the </text>
<text top=""956"" left=""108"" width=""684"" height=""16"" font=""0"">situation on the ground in Argentina as well as examines the economic impact of the measures </text>
<p><text top=""1007"" left=""108"" width=""677"" height=""15"" font=""10"">international organization."" (Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 190, followed by Panel Report, <i>EC &#8211; </i></text>
<text top=""1022"" left=""108"" width=""361"" height=""15"" font=""12""><i>Approval and Marketing of Biotech Products</i>, para. 7.3024) </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 129 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">that might be applied consistently with Annex A(4) and Article 5.3. Therefore, we conclude that </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">the risk assessment contained in the June 2001 Interim Rule is ""appropriate to the circumstances"" </text>
<text top=""160"" left=""108"" width=""237"" height=""16"" font=""0"">within the meaning of Article 5.1.  </text>
</p></p></page>
<page number=""129"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.334"" style=""8""><text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">7.334.  We also find that the undisputed science supports the conclusion in the June 2001 Interim </text>
<text top=""211"" left=""108"" width=""625"" height=""16"" font=""0"">Rule that Argentine products posed a significant risk for introduction of FMD </text>
<text top=""211"" left=""724"" width=""74"" height=""16"" font=""0"">into the </text>
<text top=""228"" left=""108"" width=""97"" height=""16"" font=""0"">United States.</text>
<footnote top=""226"" left=""205"" width=""17"" height=""11"" font=""16"" number=""900"" ref="""" dis=""""><ftext top=""1007"" left=""165"" width=""612"" height=""15"" font=""10""> We note that at the time the measures were adopted the United States did not treat Patagonia as a </ftext>
<ftext top=""1022"" left=""108"" width=""569"" height=""15"" font=""10"">separate region from the rest of Argentina and Argentina had not requested such treatment.  </ftext>
</footnote>
<text top=""228"" left=""222"" width=""570"" height=""16"" font=""0""> While the Terrestrial Code provides for continued trade in some products even </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">after an outbreak, we recall our conclusion that the United States has a higher appropriate level of </text>
<text top=""260"" left=""108"" width=""688"" height=""16"" font=""0"">protection than that embodied in the Terrestrial Code. Therefore, we find that the 2001 </text>
<text top=""277"" left=""108"" width=""686"" height=""16"" font=""0"">amendments to 9 CFR 94.1 to rescind Argentina's authorization to import and to prohibit the </text>
<text top=""293"" left=""108"" width=""685"" height=""16"" font=""0"">importation of animal, meat and animal products from Argentina was rationally related to the </text>
<text top=""310"" left=""108"" width=""448"" height=""16"" font=""0"">science and that the measure was based on the risk assessment. </text>
</p><p number=""7.335"" style=""8""><text top=""344"" left=""108"" width=""685"" height=""16"" font=""0"">7.335.  Therefore, we find that, at the time they were adopted, the 2001 Regulations and the </text>
<text top=""360"" left=""108"" width=""686"" height=""16"" font=""0"">subsequent amendment to 9 CFR 94.1 were based on a risk assessment ""appropriate to the </text>
<text top=""377"" left=""108"" width=""572"" height=""16"" font=""0"">circumstances"" in keeping with the obligations of Article 5.1 of the SPS Agreement. </text>
</p><p number=""7.5"" style=""8""><text top=""411"" left=""108"" width=""339"" height=""16"" font=""28"">7.5.3.3.2  The maintenance of the measures </text></p><p number=""7.336"" style=""8""><text top=""446"" left=""108"" width=""683"" height=""16"" font=""0"">7.336.  Argentina argues that, even if a risk assessment had in fact been conducted for Argentina </text>
<text top=""462"" left=""108"" width=""684"" height=""16"" font=""0"">as a whole at the time of the imposition of the original prohibition, such risk assessment would </text>
<text top=""479"" left=""108"" width=""683"" height=""16"" font=""0"">bear no ""rational or objective relationship"" with the series of favourable changes in circumstances </text>
<text top=""495"" left=""108"" width=""683"" height=""16"" font=""0"">in Argentina. Furthermore, Argentina points to the long periods without an outbreak in Patagonia </text>
<text top=""511"" left=""108"" width=""685"" height=""16"" font=""0"">(1976 for Patagonia South and 1994 for Patagonia North B) as well as APHIS' favourable risk </text>
<text top=""528"" left=""108"" width=""432"" height=""16"" font=""0"">assessment published in 2005 with respect to Patagonia South.</text>
<footnote top=""526"" left=""540"" width=""20"" height=""11"" font=""16"" number=""901"" ref="""" dis=""""/>
</p><p number=""7.337"" style=""8""><text top=""562"" left=""108"" width=""684"" height=""16"" font=""0"">7.337.  The United States for its part does not seek to rebut Argentina's factual allegations, but </text>
<text top=""579"" left=""108"" width=""682"" height=""16"" font=""0"">rather argues that its prohibition ""continue[s] to be justified by the assessment made at the time"" </text>
<text top=""595"" left=""108"" width=""683"" height=""16"" font=""0"">of its adoption while APHIS ""is in the process of reviewing and evaluating"" Argentina's application </text>
<text top=""611"" left=""108"" width=""80"" height=""16"" font=""0"">for imports.</text>
<footnote top=""610"" left=""188"" width=""17"" height=""11"" font=""16"" number=""902"" ref="""" dis=""""/>
<text top=""611"" left=""206"" width=""585"" height=""16"" font=""0""> The United States also argues with respect to the risk assessment on the Patagonia </text>
<text top=""628"" left=""108"" width=""684"" height=""16"" font=""0"">region that it could not be completed because of the changing nature of Argentina's application </text>
<text top=""644"" left=""108"" width=""348"" height=""16"" font=""0"">and regulatory practice with respect to that region.</text>
<footnote top=""643"" left=""456"" width=""17"" height=""11"" font=""16"" number=""903"" ref="""" dis=""""/>
</p><p number=""7.338"" style=""8""><text top=""679"" left=""108"" width=""682"" height=""16"" font=""0"">7.338.  We recall that the Appellate Body has clarified that Articles 2.2 and 5.1 must constantly be </text>
<text top=""695"" left=""108"" width=""97"" height=""16"" font=""0"">read together</text>
<footnote top=""693"" left=""205"" width=""17"" height=""11"" font=""16"" number=""904"" ref="""" dis=""""/>
<text top=""695"" left=""222"" width=""572"" height=""16"" font=""0"">, including the obligation that measures not be <i>maintained  </i>without sufficient </text>
<text top=""711"" left=""108"" width=""606"" height=""16"" font=""0"">scientific evidence. In light of that guidance, the Panel in <i>Japan &#8211; Apples </i>explained that: </text>
<p><text top=""746"" left=""151"" width=""598"" height=""16"" font=""0"">One must not lose sight of the purpose of a risk assessment, which is to serve as a </text>
<text top=""762"" left=""151"" width=""602"" height=""16"" font=""0"">basis for regulatory actions. If the scientific evidence evolves, this may be an </text>
<text top=""779"" left=""151"" width=""603"" height=""16"" font=""0"">indication that the risk assessment should be reviewed or a new assessment </text>
<text top=""795"" left=""151"" width=""599"" height=""16"" font=""0"">undertaken. It would be also legally inconsistent to require, on the one hand, that </text>
<text top=""811"" left=""151"" width=""603"" height=""16"" font=""0"">phytosanitary measures not be maintained without sufficient scientific evidence </text>
<text top=""828"" left=""151"" width=""598"" height=""16"" font=""0"">pursuant to Article 2.2 while, on the other hand, accepting that risk assessments not </text>
<text top=""844"" left=""151"" width=""339"" height=""16"" font=""0"">be renewed in the face of new scientific evidence.</text>
<footnote top=""843"" left=""489"" width=""17"" height=""11"" font=""16"" number=""905"" ref=""WT/DS245/RW|WT/DS245/R"" dis=""DS245""><ftext top=""1095"" left=""165"" width=""260"" height=""15"" font=""10""> Panel Report, <i>Japan &#8211; Apples</i>, para. 7.12. </ftext>
</footnote>
</p></p><p number=""7.339"" style=""8""><text top=""879"" left=""108"" width=""686"" height=""16"" font=""0"">7.339.  The obligation to ""maintain"" a measure based on scientific evidence has a continuing </text>
<text top=""895"" left=""108"" width=""685"" height=""16"" font=""0"">dimension. Indeed, the panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> stated that, </text>
<text top=""911"" left=""108"" width=""688"" height=""16"" font=""0"">since ""relevant circumstances may change over time"", it follows that ""at any given time, </text>
<text top=""928"" left=""108"" width=""682"" height=""16"" font=""0"">SPS measures must be based on an assessment of risks which is appropriate to the circumstances </text>
<text top=""944"" left=""108"" width=""166"" height=""16"" font=""0"">existing at that time"".</text>
<footnote top=""943"" left=""274"" width=""17"" height=""11"" font=""16"" number=""906"" ref=""WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS76/R|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R ; WT/DS292/R ; WT/DS293/R"" dis=""DS293|DS76|DS291|DS292""><ftext top=""1109"" left=""165"" width=""621"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.3031; see also Panel Report, </ftext>
<ftext top=""1124"" left=""108"" width=""310"" height=""15"" font=""12""><i>Japan &#8211; Agricultural Products II</i>, paras. 8.28-8.31. </ftext>
<ftext top=""1051"" left=""108"" width=""126"" height=""15"" font=""10"">paras. 7.370-7.378. </ftext>
<ftext top=""1109"" left=""108"" width=""672"" height=""15"" font=""10"">however, contends that risk assessments aimed at recognizing territories as disease-free do not fall within the </ftext>
<ftext top=""1124"" left=""108"" width=""622"" height=""15"" font=""10"">scope of such a provision. In paras. 7.69-7.70 above, we disagreed with the United States' argument. </ftext>
</footnote>
<text top=""944"" left=""291"" width=""505"" height=""16"" font=""0""> In other words, the ordinary variations in the underlying factual </text>
<text top=""961"" left=""108"" width=""685"" height=""16"" font=""0"">circumstances are to be taken into account by continuously updating the risk assessment and </text>
<p><text top=""1036"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 463. </text>
<text top=""1051"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 257. </text>
<text top=""1066"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 263. </text>
<text top=""1080"" left=""165"" width=""316"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 180. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 130 - </text>
</p><p><text top=""128"" left=""108"" width=""347"" height=""16"" font=""0"">reviewing the measure based thereon accordingly.</text>
<footnote top=""126"" left=""455"" width=""17"" height=""11"" font=""16"" number=""907"" ref=""WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5"" dis=""DS293|DS291|DS292""><ftext top=""920"" left=""165"" width=""611"" height=""15"" font=""10""> Indeed, the panel in EC &#8211; Approval and Marketing of Biotech Products did recognize that a measure </ftext>
<ftext top=""934"" left=""108"" width=""675"" height=""15"" font=""10"">might be ""maintained"" on a different basis from the one originally imposed and therefore the appropriate point </ftext>
<ftext top=""949"" left=""108"" width=""673"" height=""15"" font=""10"">of analysis would be the risk assessment currently being relied upon. Therefore, that panel concluded that, for </ftext>
<ftext top=""963"" left=""108"" width=""660"" height=""15"" font=""10"">the purposes of the dispute, it would examine any risk assessment existing prior to the establishment of the </ftext>
<ftext top=""978"" left=""108"" width=""622"" height=""15"" font=""10"">panel for conformity with Article 5.1. (Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, </ftext>
<ftext top=""993"" left=""108"" width=""88"" height=""15"" font=""10"">para. 7.3034) </ftext>
</footnote>
<text top=""128"" left=""472"" width=""318"" height=""16"" font=""0""> The panel in <i>EC &#8211; Approval and Marketing of </i></text>
<text top=""144"" left=""108"" width=""687"" height=""16"" font=""18""><i>Biotech Products </i>reasoned that when the complainant is challenging the maintenance of a </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">particular measure the relevant question becomes ""whether on the date of establishment of this </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">Panel, each [SPS] measure was based on an assessment of risks which was appropriate to the </text>
<text top=""193"" left=""108"" width=""250"" height=""16"" font=""0"">circumstances existing at that time.""</text>
<footnote top=""192"" left=""358"" width=""17"" height=""11"" font=""16"" number=""908"" ref=""WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8"" dis=""DS292|DS291|DS293""><ftext top=""1007"" left=""165"" width=""481"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.3034. </ftext>
</footnote>
</p></p></page>
<page number=""130"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.340"" style=""8""><text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">7.340.  The United States admits that it was provided with significant new scientific information </text>
<text top=""244"" left=""108"" width=""685"" height=""16"" font=""0"">about the sanitary situation in Argentina and the likelihood of the FMD virus being present in </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia and Northern Argentina in 2002 and in subsequent years until it ceased asking for new </text>
<text top=""277"" left=""108"" width=""686"" height=""16"" font=""0"">information in 2009. Therefore, as discussed by the panel in <i>Japan &#8211; Apples, </i>the scientific </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">information indicates that the risk assessment from 2001 should be reviewed or a new assessment </text>
<text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">undertaken. The fact that the United States contends that APHIS is and has been in the process of </text>
<text top=""326"" left=""108"" width=""408"" height=""16"" font=""0"">conducting a new risk assessment indicates that it agrees.  </text>
</p><p number=""7.341"" style=""8""><text top=""360"" left=""108"" width=""683"" height=""16"" font=""0"">7.341.  According to the United States, if a Member is presented with new scientific evidence that </text>
<text top=""377"" left=""108"" width=""683"" height=""16"" font=""0"">justifies the updating of the risk assessment or the undertaking of a new procedure, the measure </text>
<text top=""393"" left=""108"" width=""682"" height=""16"" font=""0"">falls within the scope of Article 5.7 while that review is taking place. The United States argues that </text>
<text top=""410"" left=""108"" width=""682"" height=""16"" font=""0"">its interpretation presents the only coherent approach to the SPS Agreement because otherwise an </text>
<text top=""426"" left=""108"" width=""685"" height=""16"" font=""0"">importing Member would be instantly in breach of Articles 2.2 and 5.1 any time new scientific </text>
<text top=""443"" left=""108"" width=""683"" height=""16"" font=""0"">information was put forward requiring a new risk assessment unless that measure falls within the </text>
<text top=""459"" left=""108"" width=""145"" height=""16"" font=""0"">scope of Article 5.7.  </text>
</p><p number=""7.342"" style=""8""><text top=""493"" left=""108"" width=""686"" height=""16"" font=""0"">7.342.  We recall that in the present case we have found that Article 5.7 is not applicable. </text>
<text top=""510"" left=""108"" width=""683"" height=""16"" font=""0"">However, we do not consider that it necessarily follows that there is an automatic and immediate </text>
<text top=""526"" left=""108"" width=""682"" height=""16"" font=""0"">breach of Article 2.2 and 5.1. In this regard, we agree with the United States that this would be an </text>
<text top=""543"" left=""108"" width=""683"" height=""16"" font=""0"">illogical reading of Articles 2.2, 5.1, 5.2, and 5.3. We note that the text of Article 5.1 states that </text>
<text top=""559"" left=""108"" width=""684"" height=""16"" font=""0"">what is required is a risk assessment that is ""appropriate to the circumstances"". We recall the </text>
<text top=""575"" left=""108"" width=""684"" height=""16"" font=""0"">guidance of the Appellate Body that ""WTO rules are not so rigid or so inflexible as not to leave </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">room for reasoned judgements in confronting the endless and ever-changing ebb and flow of real </text>
<text top=""608"" left=""108"" width=""294"" height=""16"" font=""0"">facts in real cases in the real world.""</text>
<footnote top=""607"" left=""402"" width=""17"" height=""11"" font=""16"" number=""909"" ref=""WT/DS8/AB/R ; WT/DS10/AB/R ; WT/DS11/AB/R"" dis=""DS8|DS10|DS11""><ftext top=""1022"" left=""165"" width=""572"" height=""15"" font=""10""> Appellate Body Report, <i>Japan &#8211; Alcoholic Beverages II</i>, p. 34, DSR 1996:I, p. 97 at 122-123. </ftext>
</footnote>
<text top=""608"" left=""419"" width=""377"" height=""16"" font=""0""> In our view, the language ""appropriate to the </text>
<text top=""625"" left=""108"" width=""685"" height=""16"" font=""0"">circumstances"" provides the flexibility referred to by the Appellate Body. Furthermore, we find </text>
<text top=""641"" left=""108"" width=""688"" height=""16"" font=""0"">context for our interpretation in Article 8 and Annex C(1)(a). In particular, we recall our </text>
<text top=""657"" left=""108"" width=""686"" height=""16"" font=""0"">understanding in paragraph 7.68 above that Article 8 and Annex C(1) have a broad scope of </text>
<text top=""674"" left=""108"" width=""73"" height=""16"" font=""0"">application</text>
<footnote top=""672"" left=""181"" width=""17"" height=""11"" font=""16"" number=""910"" ref="""" dis=""""/>
<text top=""674"" left=""199"" width=""595"" height=""16"" font=""0""> and the guidance of the Appellate Body that the time taken to conduct a risk </text>
<text top=""690"" left=""108"" width=""453"" height=""16"" font=""0"">assessment could be challenged under Article 8 and Annex C(1).</text>
<footnote top=""689"" left=""561"" width=""17"" height=""11"" font=""16"" number=""911"" ref="""" dis=""""/>
<text top=""690"" left=""578"" width=""214"" height=""16"" font=""0""> Thus, a finding of whether a </text>
<text top=""707"" left=""108"" width=""684"" height=""16"" font=""0"">measure is maintained based on a risk assessment pursuant to Article 5.1 could be informed by </text>
<text top=""723"" left=""108"" width=""681"" height=""16"" font=""0"">whether the risk assessment procedure had been undertaken and completed without undue delay.  </text>
</p><p number=""7.343"" style=""8""><text top=""757"" left=""108"" width=""685"" height=""16"" font=""0"">7.343.   In light of the above, we consider that a Member is not immediately in breach of the </text>
<text top=""774"" left=""108"" width=""684"" height=""16"" font=""0"">obligations in Articles 2.2 and 5.1 to <i>maintain</i> a measure based on a risk assessment when new </text>
<text top=""790"" left=""108"" width=""684"" height=""16"" font=""0"">scientific information arises that requires a revision or updating of the risk assessment that the </text>
<text top=""807"" left=""108"" width=""682"" height=""16"" font=""0"">measure was based on at the time of adoption. In such a situation, an importing Member enjoys a </text>
<text top=""823"" left=""108"" width=""439"" height=""16"" font=""0"">certain reasonable margin of time to conduct the new analysis.  </text>
</p><p number=""7.344"" style=""8""><text top=""857"" left=""108"" width=""683"" height=""16"" font=""0"">7.344.  In the present case, we have determined that the United States had scientific information </text>
<text top=""874"" left=""108"" width=""683"" height=""16"" font=""0"">that warranted either a review of the pre-existing risk assessment or the conduct of a new one. </text>
<p><text top=""1036"" left=""165"" width=""604"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>,<i> </i>para. 438; see also Panel Report, <i>US &#8211; Poultry (China)</i>, </text>
</p><p><text top=""1066"" left=""165"" width=""580"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 441. The United States acknowledges that, in </text>
<footnote top=""1080"" left=""108"" width=""621"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""/>
</p><p><text top=""1095"" left=""108"" width=""659"" height=""15"" font=""10"">United States' response to Panel question No. 58 following the first substantive meeting) The United States, </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 131 - </text>
</p><p><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">While we have determined that the United States' measures do not fall within the scope of </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">Article 5.7, we have also found that the United States does enjoy a certain reasonable margin of </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">time to review the pre-existing risk assessment or conduct a new one. However, we also found in </text>
<text top=""177"" left=""108"" width=""687"" height=""16"" font=""0"">paragraphs 7.145-7.172, that the delays incurred in the reviews of Argentina's applications </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">pursuant to 9 CFR 92.2 were undue within the meaning of Annex C(1)(a). Therefore, even though </text>
<text top=""210"" left=""108"" width=""685"" height=""16"" font=""0"">the United States was still in the process of conducting its risk assessment as of the date of </text>
<text top=""226"" left=""108"" width=""689"" height=""16"" font=""0"">establishment of the Panel, this cannot excuse failure to comply with the obligation in </text>
<text top=""242"" left=""108"" width=""75"" height=""16"" font=""0"">Article 5.1.</text>
<footnote top=""241"" left=""183"" width=""17"" height=""11"" font=""16"" number=""912"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""614"" height=""15"" font=""10""> As noted above, the findings under Article 8 and Annex C(1)(a) inform our finding under Article 5.1. </ftext>
<ftext top=""1036"" left=""108"" width=""659"" height=""15"" font=""10"">We reached this conclusion based on the particular circumstances of this case. Our conclusion should not be </ftext>
</footnote>
</p></p></page>
<page number=""131"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.345"" style=""8""><text top=""277"" left=""108"" width=""688"" height=""16"" font=""0"">7.345.  In light of the scientific information available to the United States on the sanitary </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">conditions in Northern Argentina and Patagonia, which meant that the 2001 risk assessment was </text>
<text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">no longer sufficient to maintain the measures and the undue delay in APHIS' conclusion of the risk </text>
<text top=""326"" left=""108"" width=""682"" height=""16"" font=""0"">assessment, we find that the United States is maintaining the measures on fresh (chilled or frozen) </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">beef from Northern Argentina and on animals, meat and animal products from Patagonia without </text>
<text top=""359"" left=""108"" width=""684"" height=""16"" font=""0"">basing them on a risk assessment. Therefore, the United States' measures are inconsistent with </text>
<text top=""375"" left=""108"" width=""685"" height=""16"" font=""0"">Article 5.1 of the SPS Agreement because they are maintained without being based on a risk </text>
<text top=""392"" left=""108"" width=""323"" height=""16"" font=""0"">assessment appropriate to the circumstances.  </text>
</p><p number=""7.346"" style=""8""><text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">7.346.  With respect to Argentina's claims under Article 5.2, we recall that Article 5.2 informs the </text>
<text top=""443"" left=""108"" width=""685"" height=""16"" font=""0"">requirements for a risk assessment under Article 5.1. Having concluded that the United States' </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">measures are maintained without being based on a risk assessment, there is no basis to make any </text>
<text top=""475"" left=""108"" width=""688"" height=""16"" font=""0"">findings with respect to whether the United States could have taken into account in the </text>
<text top=""492"" left=""108"" width=""395"" height=""16"" font=""0"">assessment of the risks the factors set out in Article 5.2.  </text>
</p><p number=""7.5"" style=""8""><text top=""526"" left=""108"" width=""164"" height=""16"" font=""28"">7.5.3.3.3  Conclusion </text></p><p number=""7.347"" style=""8""><text top=""561"" left=""108"" width=""684"" height=""16"" font=""0"">7.347.  The Panel finds that the June 2001 Interim Rule is a risk assessment ""appropriate to the </text>
<text top=""577"" left=""108"" width=""683"" height=""16"" font=""0"">circumstances"" within the meaning of Articles 5.1, 5.2, 5.3 and Annex A(4). The Panel also finds </text>
<text top=""593"" left=""108"" width=""684"" height=""16"" font=""0"">that at the time the measures were adopted in 2001 they were based on that risk assessment. </text>
<text top=""610"" left=""108"" width=""685"" height=""16"" font=""0"">With respect to the <i>maintenance</i> of the measures, the Panel finds that the scientific evidence </text>
<text top=""626"" left=""108"" width=""686"" height=""16"" font=""0"">required a review or new risk assessment. As of the date of establishment of the Panel the </text>
<text top=""643"" left=""108"" width=""683"" height=""16"" font=""0"">United States had not completed that new risk assessment but was nevertheless maintaining the </text>
<text top=""659"" left=""108"" width=""684"" height=""16"" font=""0"">measures. Recalling that we found the United States to have acted inconsistently with Article 8 </text>
<text top=""675"" left=""108"" width=""685"" height=""16"" font=""0"">and Annex C(1)(a) in the conduct of the risk assessment in that the process incurred undue </text>
<text top=""692"" left=""108"" width=""684"" height=""16"" font=""0"">delays, we also conclude that the measures are not maintained based on a risk assessment as </text>
<text top=""708"" left=""108"" width=""317"" height=""16"" font=""0"">required by Article 5.1 of the SPS Agreement. </text>
</p><p number=""7.5"" style=""8""><text top=""743"" left=""108"" width=""301"" height=""16"" font=""28"">7.5.4  Article 2.2 of the SPS Agreement </text></p><p number=""7.5"" style=""8""><text top=""777"" left=""108"" width=""296"" height=""16"" font=""28"">7.5.4.1  Main arguments of the parties </text></p><p number=""7.5"" style=""8""><text top=""811"" left=""108"" width=""156"" height=""16"" font=""28"">7.5.4.1.1  Argentina </text></p><p number=""7.348"" style=""8""><text top=""846"" left=""108"" width=""686"" height=""16"" font=""0"">7.348.  In Argentina's opinion, ""where an SPS measure is not based on a risk assessment as </text>
<text top=""862"" left=""108"" width=""683"" height=""16"" font=""0"">required in Articles 5.1 and 5.2 of the SPS Agreement, this measure is presumed not to be based </text>
<text top=""879"" left=""108"" width=""571"" height=""16"" font=""0"">on scientific principles and to be maintained without sufficient scientific evidence.""</text>
<footnote top=""877"" left=""679"" width=""17"" height=""11"" font=""16"" number=""913"" ref="""" dis=""""/>
<text top=""879"" left=""696"" width=""95"" height=""16"" font=""0""> Accordingly, </text>
<text top=""895"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina asserts that the United States' violation of Articles 5.1 and 5.2 of the SPS Agreement </text>
<text top=""911"" left=""108"" width=""309"" height=""16"" font=""0"">entails an automatic violation of Article 2.2.</text>
<footnote top=""910"" left=""417"" width=""17"" height=""11"" font=""16"" number=""914"" ref="""" dis=""""/>
<text top=""911"" left=""434"" width=""358"" height=""16"" font=""0""> Alternatively, Argentina details its claim that the </text>
<text top=""928"" left=""108"" width=""686"" height=""16"" font=""0"">application of the United States' measures is not based on scientific principles and they are </text>
<text top=""944"" left=""108"" width=""340"" height=""16"" font=""0"">maintained without sufficient scientific evidence.  </text>
<p><text top=""1066"" left=""108"" width=""514"" height=""15"" font=""10"">with the obligation to maintain a measure based on a risk assessment in Article 5.1. </text>
<text top=""1080"" left=""165"" width=""550"" height=""15"" font=""10""> Argentina's first written submission, para. 472 (citing Panel Report, <i>US &#8211; Poultry (China)</i>, </text>
<text top=""1095"" left=""108"" width=""85"" height=""15"" font=""10"">para. 7.201). </text>
<text top=""1109"" left=""165"" width=""614"" height=""15"" font=""10""> Argentina's first written submission, paras. 258-259 (referring to Appellate Body Report, <i>Australia &#8211; </i></text>
<text top=""1124"" left=""108"" width=""571"" height=""15"" font=""10"">Apples, para. 262, in turn referring to Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 138). </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 132 - </text>
</p></p></page>
<page number=""132"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.349"" style=""8""><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">7.349.  In particular, with regard to the United States' prohibition on imports of fresh (chilled or </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">frozen) beef originating in the Argentine territory as a whole, Argentina refers again to the </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">favourable risk assessments conducted in 1997 and 2000 and the statements of the United States' </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">delegate to the SPS Committee in 2010 concerning the existence of a ""recent favourable risk </text>
<text top=""193"" left=""108"" width=""90"" height=""16"" font=""0"">assessment.""</text>
<footnote top=""192"" left=""198"" width=""17"" height=""11"" font=""16"" number=""915"" ref="""" dis=""""/>
</p><p number=""7.350"" style=""8""><text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">7.350.  Argentina states that the maintenance of such a prohibition is not based on a valid risk </text>
<text top=""244"" left=""108"" width=""84"" height=""16"" font=""0"">assessment.</text>
<footnote top=""243"" left=""192"" width=""17"" height=""11"" font=""16"" number=""916"" ref="""" dis=""""/>
<text top=""244"" left=""210"" width=""581"" height=""16"" font=""0""> It observes that the two publicly available risk assessments conducted with respect </text>
<text top=""260"" left=""108"" width=""685"" height=""16"" font=""0"">to Argentina in 1997 and 2000 both permitted imports of fresh (chilled or frozen) meat from </text>
<text top=""277"" left=""108"" width=""242"" height=""16"" font=""0"">Argentina under certain conditions.</text>
<footnote top=""275"" left=""350"" width=""17"" height=""11"" font=""16"" number=""917"" ref="""" dis=""""/>
<text top=""277"" left=""367"" width=""424"" height=""16"" font=""0""> While recognizing that the 1997 and 2000 risk assessments </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">were superseded by FMD outbreaks in 2001, Argentina notes that no risk assessment has been </text>
<text top=""310"" left=""108"" width=""686"" height=""16"" font=""0"">issued since 2001, when APHIS withdrew approval to import Argentine fresh beef from the </text>
<text top=""326"" left=""108"" width=""218"" height=""16"" font=""0"">Argentine territory as a whole.</text>
<footnote top=""325"" left=""326"" width=""17"" height=""11"" font=""16"" number=""918"" ref="""" dis=""""/>
<text top=""326"" left=""343"" width=""449"" height=""16"" font=""0""> Finally, Argentina notes that certain statements made by the </text>
<text top=""342"" left=""108"" width=""684"" height=""16"" font=""0"">United States' delegate to the SPS Committee in 2011 suggested that ""a recent favourable risk </text>
<text top=""359"" left=""108"" width=""682"" height=""16"" font=""0"">assessment might have been conducted (or at least information was collected and analyzed)"", but </text>
<text top=""375"" left=""108"" width=""248"" height=""16"" font=""0"">not been made publicly available.</text>
<footnote top=""374"" left=""356"" width=""17"" height=""11"" font=""16"" number=""919"" ref="""" dis=""""/>
<text top=""375"" left=""373"" width=""422"" height=""16"" font=""0""> Further, Argentina claims that, while the United States </text>
<text top=""392"" left=""108"" width=""690"" height=""16"" font=""0"">""provided a roadmap of the scientific principles it purportedly relies on"" in the policy </text>
<text top=""408"" left=""108"" width=""686"" height=""16"" font=""0"">implementation rulemaking of October 1997, it ""has not articulated what scientific principles"" </text>
<text top=""425"" left=""108"" width=""411"" height=""16"" font=""0"">underlie the ""prohibition"" as applied to Argentine fresh beef.</text>
<footnote top=""423"" left=""519"" width=""17"" height=""11"" font=""16"" number=""920"" ref="""" dis=""""/>
</p><p number=""7.351"" style=""8""><text top=""459"" left=""108"" width=""683"" height=""16"" font=""0"">7.351.  Argentina cites to the Appellate Body report in <i>Japan &#8211; Agricultural Products II</i> and states </text>
<text top=""475"" left=""108"" width=""683"" height=""16"" font=""0"">that Article 2.2 of the SPS Agreement requires that there be a ""rational or objective"" relationship </text>
<text top=""492"" left=""108"" width=""479"" height=""16"" font=""0"">between an SPS measure and the underlying scientific evidence.</text>
<footnote top=""490"" left=""587"" width=""17"" height=""11"" font=""16"" number=""921"" ref="""" dis=""""/>
<text top=""492"" left=""605"" width=""191"" height=""16"" font=""0""> As for the meaning of </text>
<text top=""508"" left=""108"" width=""682"" height=""16"" font=""0"">""sufficient"" as referred to evidence, Argentina posits that ""'[s]ufficiency requires the existence of a </text>
<text top=""525"" left=""108"" width=""618"" height=""16"" font=""0"">sufficient or adequate relationship"" between an SPS measure and the scientific evidence.</text>
<footnote top=""523"" left=""725"" width=""17"" height=""11"" font=""16"" number=""922"" ref="""" dis=""""/>
<text top=""525"" left=""743"" width=""48"" height=""16"" font=""0""> In its </text>
<text top=""541"" left=""108"" width=""683"" height=""16"" font=""0"">opinion, in order for a measure to be maintained with sufficient evidence, ""there must be at least </text>
<text top=""557"" left=""108"" width=""365"" height=""16"" font=""18""><i>some</i> evidence (derived from the risk assessments)"".</text>
<footnote top=""556"" left=""473"" width=""17"" height=""11"" font=""16"" number=""923"" ref="""" dis=""""/>
<text top=""557"" left=""491"" width=""300"" height=""16"" font=""0""> Because the United States has maintained </text>
<text top=""574"" left=""108"" width=""683"" height=""16"" font=""0"">the ""prohibition"" on imports of Argentine fresh beef ""without having a risk assessment at all"", its </text>
<text top=""590"" left=""108"" width=""273"" height=""16"" font=""0"">measure is inconsistent with Article 2.2.</text>
<footnote top=""589"" left=""381"" width=""17"" height=""11"" font=""16"" number=""924"" ref="""" dis=""""/>
</p><p number=""7.352"" style=""8""><text top=""625"" left=""108"" width=""684"" height=""16"" font=""0"">7.352.  In light of the above, Argentina asserts that the 2001 Regulations repealing 9 CFR 94.21 </text>
<text top=""641"" left=""108"" width=""684"" height=""16"" font=""0"">and hence withdrawing authorization of imports of fresh (chilled or frozen) beef from Argentina </text>
<text top=""657"" left=""108"" width=""330"" height=""16"" font=""0"">are, by implication, inconsistent with Article 2.2.</text>
<footnote top=""656"" left=""438"" width=""17"" height=""11"" font=""16"" number=""925"" ref="""" dis=""""/>
</p><p number=""7.353"" style=""8""><text top=""692"" left=""108"" width=""683"" height=""16"" font=""0"">7.353.  As for the United States' prohibition on imports of ruminants, swine and products thereof </text>
<text top=""708"" left=""108"" width=""683"" height=""16"" font=""0"">from Patagonia, Argentina refers to APHIS' favourable 2005 risk assessment for Patagonia South </text>
<text top=""725"" left=""108"" width=""250"" height=""16"" font=""0"">and the 2007 proposed rulemaking</text>
<footnote top=""723"" left=""358"" width=""17"" height=""11"" font=""16"" number=""926"" ref="""" dis=""""/>
<text top=""725"" left=""375"" width=""418"" height=""16"" font=""0""> as well as the United States' suggestion that ""there is a </text>
<text top=""741"" left=""108"" width=""358"" height=""16"" font=""0"">favorable risk assessment for Patagonia North B.""</text>
<footnote top=""739"" left=""466"" width=""17"" height=""11"" font=""16"" number=""927"" ref="""" dis=""""/>
<text top=""741"" left=""483"" width=""310"" height=""16"" font=""0""> Accordingly, Argentina contends that the </text>
<text top=""757"" left=""108"" width=""689"" height=""16"" font=""0"">United States' violation of Articles 5.1 and 5.2 with respect to Patagonia also entails an </text>
<text top=""774"" left=""108"" width=""208"" height=""16"" font=""0"">inconsistency with Article 2.2. </text>
</p><p number=""7.5"" style=""8""><text top=""808"" left=""108"" width=""184"" height=""16"" font=""28"">7.5.4.1.2  United States </text></p><p number=""7.354"" style=""8""><text top=""843"" left=""108"" width=""684"" height=""16"" font=""0"">7.354.  The United States argues that Argentina has not met its burden of establishing a prima </text>
<text top=""859"" left=""108"" width=""686"" height=""16"" font=""0"">facie case that the United States' measures prohibiting imports of Argentine fresh (chilled or </text>
<footnote top=""920"" left=""165"" width=""293"" height=""15"" font=""10"" number=""264"" ref="""" dis=""""/>
<footnote top=""934"" left=""165"" width=""293"" height=""15"" font=""10"" number=""263"" ref="""" dis=""""/>
<p><text top=""993"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 272. </text>
<footnote top=""1007"" left=""165"" width=""599"" height=""15"" font=""10"" number=""274"" ref="""" dis=""""/>
</p><p><text top=""1022"" left=""108"" width=""140"" height=""15"" font=""12""><i>Products II</i>, para. 84). </text>
<footnote top=""1036"" left=""165"" width=""599"" height=""15"" font=""10"" number=""275"" ref="""" dis=""""/>
</p><p><text top=""1051"" left=""108"" width=""140"" height=""15"" font=""12""><i>Products II</i>, para. 73). </text>
<text top=""1066"" left=""165"" width=""414"" height=""15"" font=""10""> Argentina's first written submission, para. 276 (emphasis original). </text>
<text top=""1080"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 277. </text>
<text top=""1095"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 289. </text>
<footnote top=""1109"" left=""165"" width=""293"" height=""15"" font=""10"" number=""473"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 133 - </text>
</p></p></page>
<page number=""133"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""frozen)"" style=""3""><text top=""128"" left=""108"" width=""487"" height=""16"" font=""0"">frozen) beef are inconsistent with Article 2.2 of the SPS Agreement.</text>
<footnote top=""126"" left=""595"" width=""17"" height=""11"" font=""16"" number=""928"" ref="""" dis=""""/>
<text top=""128"" left=""612"" width=""180"" height=""16"" font=""0""> In particular, Argentina </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">""has presented no argument or evidence different"" from that submitted under Articles 5.7, 5.1, </text>
<text top=""160"" left=""108"" width=""57"" height=""16"" font=""0"">and 5.2.</text>
<footnote top=""159"" left=""165"" width=""17"" height=""11"" font=""16"" number=""929"" ref="""" dis=""""/>
</p><p number=""7.355"" style=""8""><text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">7.355.  As to the requirement under Article 2.2 that an SPS measure be based and maintained on </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">scientific principles, the United States maintains that the 2001 Regulations and the requirement </text>
<text top=""228"" left=""108"" width=""689"" height=""16"" font=""0"">that Argentina re-apply for authorization for importation bear a ""rational [and] objective </text>
<text top=""244"" left=""108"" width=""686"" height=""16"" font=""0"">relationship"" to the scientific evidence. Firstly, all parties ""agree with the OIE that FMD is an </text>
<text top=""260"" left=""108"" width=""457"" height=""16"" font=""0"">extremely dangerous, contagious and debilitating animal disease"".</text>
<footnote top=""259"" left=""564"" width=""17"" height=""11"" font=""16"" number=""930"" ref="""" dis=""""/>
<text top=""260"" left=""582"" width=""209"" height=""16"" font=""0""> Secondly, the OIE Terrestrial </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">Code provides that before trade in animals or their products may occur, ""an importing country </text>
<text top=""293"" left=""108"" width=""569"" height=""16"" font=""0"">must be satisfied that its animal health status will be appropriately protected"".</text>
<footnote top=""292"" left=""677"" width=""17"" height=""11"" font=""16"" number=""931"" ref="""" dis=""""/>
<text top=""293"" left=""694"" width=""99"" height=""16"" font=""0""> Accordingly, </text>
<text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">maintaining the 2001 Regulations while conducting the risk assessment on Argentine fresh beef ""is </text>
<text top=""326"" left=""108"" width=""591"" height=""16"" font=""0"">based on scientific principles related to the transmissibility and consequences"" of FMD.</text>
<footnote top=""325"" left=""698"" width=""17"" height=""11"" font=""16"" number=""932"" ref="""" dis=""""/>
</p><p number=""7.356"" style=""8""><text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">7.356.  As to the requirement under Article 2.2 that an SPS measure not be maintained without </text>
<text top=""377"" left=""108"" width=""684"" height=""16"" font=""0"">sufficient scientific evidence, the United States refers back to its position that the measures are </text>
<text top=""393"" left=""108"" width=""416"" height=""16"" font=""0"">justified under Article 5.7 and thus Article 2.2 is inapplicable.</text>
<footnote top=""392"" left=""524"" width=""17"" height=""11"" font=""16"" number=""933"" ref="""" dis=""""/>
</p><p number=""7.357"" style=""8""><text top=""428"" left=""108"" width=""682"" height=""16"" font=""0"">7.357.  With regard to the aspect of the United States' measures prohibiting imports of ruminants, </text>
<text top=""444"" left=""108"" width=""682"" height=""16"" font=""0"">swine and products thereof from Patagonia, the United States adds that Argentina has ""altered the </text>
<text top=""461"" left=""108"" width=""687"" height=""16"" font=""0"">sanitary conditions in Patagonia South and Patagonia North B"", thereby requiring APHIS to </text>
<text top=""477"" left=""108"" width=""168"" height=""16"" font=""0"">""reassess the situation""</text>
<footnote top=""475"" left=""276"" width=""17"" height=""11"" font=""16"" number=""934"" ref="""" dis=""""/>
<text top=""477"" left=""293"" width=""320"" height=""16"" font=""0""> prior to completing its rulemaking process.</text>
<text top=""477"" left=""620"" width=""174"" height=""16"" font=""0"">In particular, the 2007 </text>
<text top=""493"" left=""108"" width=""683"" height=""16"" font=""0"">proposed regulation was issued with respect to Patagonia South based on information from 2003 </text>
<text top=""510"" left=""108"" width=""688"" height=""16"" font=""0"">but, since 2008, Argentina started altering the sanitary conditions between that area and </text>
<text top=""526"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia North B. The United States argues that, because of the ""many changing variables"" with </text>
<text top=""543"" left=""108"" width=""683"" height=""16"" font=""0"">respect to Patagonia South and Patagonia North B, APHIS measures ""were based and maintained </text>
<text top=""559"" left=""108"" width=""82"" height=""16"" font=""0"">on science"".</text>
<footnote top=""557"" left=""190"" width=""17"" height=""11"" font=""16"" number=""935"" ref="""" dis=""""/>
</p><p number=""7.5"" style=""8""><text top=""593"" left=""108"" width=""337"" height=""16"" font=""28"">7.5.4.2  Main arguments of the third parties </text></p><p number=""7.5"" style=""8""><text top=""628"" left=""108"" width=""124"" height=""16"" font=""28"">7.5.4.2.1  China </text></p><p number=""7.358"" style=""8""><text top=""662"" left=""108"" width=""684"" height=""16"" font=""0"">7.358.  China recalls that when an SPS measure is not based on a risk assessment as required </text>
<text top=""679"" left=""108"" width=""684"" height=""16"" font=""0"">under Article 5.1 of the SPS Agreement, that measure ""can be presumed to be, more generally, </text>
<text top=""695"" left=""108"" width=""684"" height=""16"" font=""0"">neither based on scientific principles nor maintained with sufficient scientific evidence within the </text>
<text top=""711"" left=""108"" width=""163"" height=""16"" font=""0"">meaning of Article 2.2"".</text>
<footnote top=""710"" left=""271"" width=""17"" height=""11"" font=""16"" number=""936"" ref="""" dis=""""/>
<text top=""711"" left=""288"" width=""502"" height=""16"" font=""0""> Further, China recalls that, according to the panel in <i>EC &#8211; Approval and </i></text>
<text top=""728"" left=""108"" width=""683"" height=""16"" font=""18""><i>Marketing of Biotech Products</i>, Article 2.2 requires that: (a) SPS measures be based on scientific </text>
<text top=""744"" left=""108"" width=""611"" height=""16"" font=""0"">principles; and (b) SPS measures not be maintained without sufficient scientific evidence.</text>
<footnote top=""743"" left=""718"" width=""17"" height=""11"" font=""16"" number=""937"" ref="""" dis=""""/>
</p><p number=""7.5"" style=""8""><text top=""779"" left=""108"" width=""229"" height=""16"" font=""28"">7.5.4.3  Analysis by the Panel </text></p><p number=""7.359"" style=""8""><text top=""813"" left=""108"" width=""683"" height=""16"" font=""0"">7.359.  The Panel needs to determine whether the United States' measures are based on scientific </text>
<text top=""829"" left=""108"" width=""682"" height=""16"" font=""0"">principles and are not maintained without sufficient scientific evidence as required by Article 2.2 of </text>
<text top=""846"" left=""108"" width=""683"" height=""16"" font=""0"">the SPS Agreement. Argentina claims that a finding that Article 5.1 or 5.2 has been breached also </text>
<text top=""862"" left=""108"" width=""684"" height=""16"" font=""0"">entails an automatic violation of Article 2.2  of the SPS Agreement. The United States disagrees </text>
<text top=""879"" left=""108"" width=""683"" height=""16"" font=""0"">and asserts that Argentina has not made a <i>prima facie</i> case that the United States' measures are </text>
<text top=""895"" left=""108"" width=""198"" height=""16"" font=""0"">inconsistent with Article 2.2. </text>
<p><text top=""963"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 271. </text>
</p><p><text top=""1051"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 278. </text>
<text top=""1066"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 280. </text>
<text top=""1080"" left=""165"" width=""596"" height=""15"" font=""10""> China's third-party submission, para. 33 (referring to Appellate Body Report, <i>Australia &#8211; Salmon</i>, </text>
<text top=""1095"" left=""108"" width=""484"" height=""15"" font=""10"">para. 138; and Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.201), and para. 38. </text>
<text top=""1109"" left=""165"" width=""611"" height=""15"" font=""10""> China's third-party submission, para. 37 (referring to Panel Report, <i>EC &#8211; Approval and Marketing of </i></text>
<text top=""1124"" left=""108"" width=""526"" height=""15"" font=""12""><i>Biotech Products</i>, para. 7.1424). No other third party argued specifically on this point. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 134 - </text>
</p></p></page>
<page number=""134"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.360"" style=""8""><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">7.360.  As noted in paragraph 7.264 above, Articles 2.2 and 5.1 should constantly be read </text>
<text top=""144"" left=""108"" width=""58"" height=""16"" font=""0"">together</text>
<footnote top=""143"" left=""166"" width=""17"" height=""11"" font=""16"" number=""938"" ref="""" dis=""""/>
<text top=""144"" left=""183"" width=""607"" height=""16"" font=""0"">, because Article 5.1 constitutes ""a specific application of the basic obligations contained </text>
<text top=""160"" left=""108"" width=""99"" height=""16"" font=""0"">in Article 2.2""</text>
<footnote top=""159"" left=""207"" width=""17"" height=""11"" font=""16"" number=""939"" ref=""WT/DS26/AB/R ; WT/DS48/AB/R"" dis=""DS26|DS367""><ftext top=""963"" left=""165"" width=""535"" height=""15"" font=""10""> Appellate Body Reports, <i>EC &#8211; Hormones</i>, para. 180; and <i>Australia &#8211; Apples</i>, para. 209. </ftext>
</footnote>
<text top=""160"" left=""225"" width=""572"" height=""16"" font=""0""> of the SPS Agreement. The same relationship exists between Articles 2.2 </text>
<text top=""177"" left=""108"" width=""57"" height=""16"" font=""0"">and 5.2.</text>
<footnote top=""175"" left=""165"" width=""17"" height=""11"" font=""16"" number=""940"" ref="""" dis=""""/>
<text top=""177"" left=""182"" width=""614"" height=""16"" font=""0""> Furthermore, Article 5.7 serves as a ""qualified exemption"" to the obligation in </text>
<text top=""193"" left=""108"" width=""75"" height=""16"" font=""0"">Article 2.2.</text>
<footnote top=""192"" left=""183"" width=""17"" height=""11"" font=""16"" number=""941"" ref="""" dis=""""/>
</p><p number=""7.361"" style=""8""><text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">7.361.  Given the relationship between the specific sub-paragraphs of Article 5 and the obligations </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">in Article 2.2, the Appellate Body and prior panels have accepted that in the event an SPS measure </text>
<text top=""260"" left=""108"" width=""686"" height=""16"" font=""0"">is not based on a risk assessment as required in Articles 5.1 and 5.2 this measure can be </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">presumed, more generally, not to be based on scientific principles or to be maintained without </text>
<text top=""293"" left=""108"" width=""194"" height=""16"" font=""0"">sufficient scientific evidence.</text>
<footnote top=""292"" left=""302"" width=""17"" height=""11"" font=""16"" number=""942"" ref=""WT/DS18/RW|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS18/11|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS18/R/Corr.1|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS18/AB/R|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS18/R|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1"" dis=""DS292|DS293|DS430|DS18|DS291""><ftext top=""1066"" left=""165"" width=""621"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 138; Panel Report, <i>Australia &#8211; Salmon (Article 21.5 </i></ftext>
<ftext top=""1080"" left=""108"" width=""605"" height=""15"" font=""12""><i>&#8211; Canada)</i>, paras. 7.85 and 7.161; Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, </ftext>
<ftext top=""1095"" left=""108"" width=""347"" height=""15"" font=""10"">para. 7.3399; <i>India &#8211; Agricultural Products</i>, para. 7.332. </ftext>
</footnote>
</p><p number=""7.362"" style=""8""><text top=""328"" left=""108"" width=""686"" height=""16"" font=""0"">7.362.  We have found that the United States' measures are not maintained based on a risk </text>
<text top=""344"" left=""108"" width=""685"" height=""16"" font=""0"">assessment and are inconsistent with Article 5.1 of the SPS Agreement and are not within the </text>
<text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">scope of the qualified exemption in Article 5.7 of the SPS Agreement. Therefore, we further find </text>
<text top=""377"" left=""108"" width=""614"" height=""16"" font=""0"">that the United States' measures are inconsistent with Article 2.2 of the SPS Agreement.  </text>
</p><p number=""7.6"" style=""8""><text top=""411"" left=""108"" width=""271"" height=""16"" font=""28"">7.6  Appropriate level of protection </text></p><p number=""7.6"" style=""8""><text top=""446"" left=""108"" width=""248"" height=""16"" font=""28"">7.6.1  Relevant legal provisions  </text></p><p number=""7.363"" style=""8""><text top=""480"" left=""108"" width=""59"" height=""16"" font=""0"">7.363. </text>
<text top=""480"" left=""162"" width=""57"" height=""16"" font=""0"">Annex </text>
<text top=""480"" left=""209"" width=""149"" height=""16"" font=""0"">A(5) of the SPS </text>
<text top=""480"" left=""348"" width=""451"" height=""16"" font=""0"">Agreement defines the appropriate level of sanitary or </text>
<text top=""497"" left=""108"" width=""255"" height=""16"" font=""0"">phytosanitary protection (ALOP) as:  </text>
<p><text top=""531"" left=""151"" width=""598"" height=""16"" font=""0"">The level of protection deemed appropriate by the Member establishing a sanitary or </text>
<text top=""547"" left=""151"" width=""600"" height=""16"" font=""0"">phytosanitary measure to protect human, animal or plant life or health within its </text>
<text top=""564"" left=""151"" width=""65"" height=""16"" font=""0"">territory. </text>
</p><p><text top=""598"" left=""151"" width=""597"" height=""16"" font=""0"">NOTE: Many Members otherwise refer to this concept as the ""acceptable level of risk"".  </text>
</p></p><p number=""7.364"" style=""8""><text top=""633"" left=""108"" width=""685"" height=""16"" font=""0"">7.364.  Argentina makes claims with respect to two of the three provisions in Article 5 of the </text>
<text top=""649"" left=""108"" width=""416"" height=""16"" font=""0"">SPS Agreement that relate to the ALOP: Articles 5.4 and 5.6.</text>
<footnote top=""647"" left=""524"" width=""17"" height=""11"" font=""16"" number=""943"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""572"" height=""15"" font=""10""> Argentina does not make a claim under Article 5.5 which relates to the objective of achieving </ftext>
<ftext top=""1124"" left=""108"" width=""352"" height=""15"" font=""10"">consistency in the application of the concept of the ALOP. </ftext>
<ftext top=""1095"" left=""108"" width=""522"" height=""15"" font=""10"">62 Fed. Reg. 56000 (USDA/APHIS October 28, 1997) (Final Rule), (Exhibit ARG-15)). </ftext>
</footnote>
</p><p number=""7.365"" style=""8""><text top=""683"" left=""108"" width=""522"" height=""16"" font=""0"">7.365.  Article 5.4 relates to the determination of the ALOP and states that: </text>
<p><text top=""718"" left=""151"" width=""598"" height=""16"" font=""0"">Members should, when determining the appropriate level of sanitary or phytosanitary </text>
<text top=""734"" left=""151"" width=""547"" height=""16"" font=""0"">protection, take into account the objective of minimizing negative trade effects. </text>
</p></p><p number=""7.366"" style=""8""><text top=""769"" left=""108"" width=""683"" height=""16"" font=""0"">7.366.  Article 5.6 relates to the relationship between the measures applied and the achievement </text>
<text top=""785"" left=""108"" width=""357"" height=""16"" font=""0"">of the ALOP. In particular, Article 5.6 provides that: </text>
<p><text top=""819"" left=""151"" width=""603"" height=""16"" font=""0"">Without prejudice to paragraph 2 of Article 3, when establishing or maintaining </text>
<text top=""836"" left=""151"" width=""600"" height=""16"" font=""0"">sanitary or phytosanitary measures to achieve the appropriate level of sanitary or </text>
<text top=""852"" left=""151"" width=""600"" height=""16"" font=""0"">phytosanitary protection, Members shall ensure that such measures are not more </text>
<text top=""869"" left=""151"" width=""603"" height=""16"" font=""0"">trade-restrictive than required to achieve their appropriate level of sanitary or </text>
<text top=""885"" left=""151"" width=""548"" height=""16"" font=""0"">phytosanitary protection, taking into account technical and economic feasibility. </text>
</p><p><text top=""949"" left=""165"" width=""316"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>,<i> </i>para. 180. </text>
<footnote top=""978"" left=""165"" width=""332"" height=""15"" font=""10"" number=""339"" ref="""" dis=""""/>
</p><p><text top=""993"" left=""165"" width=""597"" height=""15"" font=""10""> Appellate Body Report, <i>Japan &#8211; Agricultural Products II</i>, para. 80; see also Panel Report, <i>Japan &#8211; </i></text>
<text top=""1007"" left=""108"" width=""675"" height=""15"" font=""12""><i>Apples</i>,<i> </i>paras. 8.210-8.212 (referring to Article 5.7 as a ""defence""). See also, the Appellate Body conclusion in </text>
<text top=""1022"" left=""108"" width=""681"" height=""15"" font=""12""><i>US/Canada &#8211; Continued Suspension</i>,<i> </i>that Article 2.2 excludes from its scope situations where relevant scientific </text>
<text top=""1036"" left=""108"" width=""654"" height=""15"" font=""10"">evidence is insufficient and that the applicable provision is Article 5.7. Appellate Body Report, <i>US/Canada &#8211; </i></text>
<text top=""1051"" left=""108"" width=""210"" height=""15"" font=""12""><i>Continued Suspension</i>, para. 674. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 135 - </text>
</p><p><text top=""128"" left=""193"" width=""514"" height=""16"" font=""18""><i>Footnote 3  </i>For purposes of paragraph 6 of Article 5, a measure is not </text>
<text top=""144"" left=""193"" width=""516"" height=""16"" font=""0"">more trade-restrictive than required unless there is another measure, </text>
<text top=""160"" left=""193"" width=""522"" height=""16"" font=""0"">reasonably available taking into account technical and economic </text>
<text top=""177"" left=""193"" width=""512"" height=""16"" font=""0"">feasibility, that achieves the appropriate level of sanitary or phytosanitary </text>
<text top=""193"" left=""193"" width=""370"" height=""16"" font=""0"">protection and is significantly less restrictive to trade.<i> </i></text>
</p></p></page>
<page number=""135"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.367"" style=""8""><text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">7.367.  The Appellate Body has found that the obligation in Article 5.6 is closely related to the first </text>
<text top=""244"" left=""108"" width=""224"" height=""16"" font=""0"">obligation set forth in Article 2.2</text>
<footnote top=""243"" left=""332"" width=""17"" height=""11"" font=""16"" number=""944"" ref="""" dis=""""/>
<text top=""244"" left=""349"" width=""442"" height=""16"" font=""0""> that ""Members shall ensure that any sanitary or phytosanitary </text>
<text top=""260"" left=""108"" width=""673"" height=""16"" font=""0"">measure is applied only to the extent necessary to protect human, animal or plant life or health"".  </text>
</p><p number=""7.368"" style=""8""><text top=""295"" left=""108"" width=""685"" height=""16"" font=""0"">7.368.  Argentina has made claims under both Articles 5.4 and 5.6 as well as under the first </text>
<text top=""311"" left=""108"" width=""684"" height=""16"" font=""0"">obligation in Article 2.2. An analysis of all these claims requires an identification of the level of </text>
<text top=""328"" left=""108"" width=""682"" height=""16"" font=""0"">protection that the United States has set as appropriate. With respect to a claim under Article 5.6, </text>
<text top=""344"" left=""108"" width=""682"" height=""16"" font=""0"">the Appellate Body has reasoned that when analysing a claim under Article 5.6, a panel first has to </text>
<text top=""360"" left=""108"" width=""564"" height=""16"" font=""0"">identify the level of protection that the importing Member has set as appropriate.</text>
<footnote top=""359"" left=""672"" width=""17"" height=""11"" font=""16"" number=""945"" ref="""" dis=""""/>
<text top=""360"" left=""690"" width=""101"" height=""16"" font=""0""> Furthermore, </text>
<text top=""377"" left=""108"" width=""683"" height=""16"" font=""0"">the panel in <i>EC &#8211; Approval and Marketing of Biotech Products </i>explained that Articles 2.2 and 5.6 </text>
<text top=""393"" left=""108"" width=""685"" height=""16"" font=""0"">are to be read together and that Article 5.6 is a specific application of the first obligation in </text>
<text top=""410"" left=""108"" width=""75"" height=""16"" font=""0"">Article 2.2.</text>
<footnote top=""408"" left=""183"" width=""17"" height=""11"" font=""16"" number=""946"" ref=""WT/DS367/AB/R|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS18/AB/R|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R ; WT/DS292/R ; WT/DS293/R"" dis=""DS18|DS291|DS367|DS293|DS292""><ftext top=""920"" left=""165"" width=""615"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1433. In <i>Australia &#8211; Apples</i>, </ftext>
<ftext top=""934"" left=""108"" width=""679"" height=""15"" font=""10"">the Appellate Body noted that the relationship between Articles 2.2 and 5.6 had not been squarely decided, but </ftext>
<ftext top=""949"" left=""108"" width=""647"" height=""15"" font=""10"">noted that its ruling in <i>Australia &#8211; Salmon</i> suggested such a relationship. In particular, the Appellate Body </ftext>
<ftext top=""963"" left=""108"" width=""57"" height=""15"" font=""10"">recalled: </ftext>
<ftext top=""978"" left=""151"" width=""578"" height=""15"" font=""10"">After pointing to the phrase 'only to the extent necessary' in Article 2.2 of the <i>SPS Agreement</i>, </ftext>
<ftext top=""993"" left=""151"" width=""509"" height=""15"" font=""10"">the Appellate Body observed, in a footnote in its report in <i>Australia &#8211; Salmon</i>, that: </ftext>
<ftext top=""1007"" left=""193"" width=""545"" height=""15"" font=""10"">[t]he establishment or maintenance of an SPS measure which implies or reflects a higher </ftext>
<ftext top=""1022"" left=""193"" width=""528"" height=""15"" font=""10"">level of protection than the appropriate level of protection determined by an importing </ftext>
<ftext top=""1036"" left=""193"" width=""553"" height=""15"" font=""10"">Member, could constitute a violation of the necessity requirement of Article 2.2. (Appellate </ftext>
<ftext top=""1051"" left=""193"" width=""376"" height=""15"" font=""10"">Body Report, <i>Australia &#8211; Salmon</i>, footnote 166 to para. 213)  </ftext>
<ftext top=""1066"" left=""108"" width=""394"" height=""15"" font=""10"">(Appellate Body Report, <i>Australia &#8211; Apples</i>, fn 504 to para. 340) </ftext>
</footnote>
<text top=""410"" left=""200"" width=""596"" height=""16"" font=""0""> Therefore, an understanding of the ALOP is also required for an analysis of </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina's claim under Article 2.2. Finally, it would be difficult to make a finding as to what the </text>
<text top=""443"" left=""108"" width=""682"" height=""16"" font=""0"">United States took into account in determining its ALOP if we do not know what the United States' </text>
<text top=""459"" left=""108"" width=""61"" height=""16"" font=""0"">ALOP is. </text>
</p><p number=""7.369"" style=""8""><text top=""493"" left=""108"" width=""682"" height=""16"" font=""0"">7.369.  Therefore, before turning to the substance of Argentina's claims, the Panel will first identify </text>
<text top=""510"" left=""108"" width=""684"" height=""16"" font=""0"">the United States' ALOP. Subsequently, we will examine whether Argentina has established the </text>
<text top=""526"" left=""108"" width=""644"" height=""16"" font=""0"">elements of each of its claims under Articles 5.4 and 5.6 and the first obligation in Article 2.2. </text>
</p><p number=""7.6"" style=""8""><text top=""561"" left=""108"" width=""641"" height=""16"" font=""28"">7.6.2  The United States' appropriate level of protection for foot-and-mouth disease </text></p><p number=""7.6"" style=""8""><text top=""595"" left=""108"" width=""296"" height=""16"" font=""28"">7.6.2.1  Main arguments of the parties </text></p><p number=""7.6"" style=""8""><text top=""629"" left=""108"" width=""156"" height=""16"" font=""28"">7.6.2.1.1  Argentina </text></p><p number=""7.370"" style=""8""><text top=""664"" left=""108"" width=""683"" height=""16"" font=""0"">7.370.  Argentina argues that the United States' ALOP is difficult to determine. Argentina cites an </text>
<text top=""680"" left=""108"" width=""683"" height=""16"" font=""0"">APHIS policy document that notes the purpose of the authorization process is ""to determine on a </text>
<text top=""697"" left=""108"" width=""682"" height=""16"" font=""0"">case-by-case basis what import conditions will reduce the risk associated with importations from a </text>
<text top=""713"" left=""108"" width=""282"" height=""16"" font=""0"">particular region to a negligible level.""</text>
<footnote top=""711"" left=""390"" width=""17"" height=""11"" font=""16"" number=""947"" ref="""" dis=""""/>
<text top=""713"" left=""407"" width=""387"" height=""16"" font=""0""> Argentina argues that APHIS assigns a number of </text>
<text top=""729"" left=""108"" width=""684"" height=""16"" font=""0"">different risk levels to products or country/region and that the import measures associated with </text>
<text top=""746"" left=""108"" width=""685"" height=""16"" font=""0"">the different risk levels indicate an incoherent application of an ALOP. In particular, Argentina </text>
<text top=""762"" left=""108"" width=""48"" height=""16"" font=""0"">notes: </text>
<p><text top=""797"" left=""151"" width=""598"" height=""16"" font=""0"">In the June 1997 rulemaking allowing imports from Argentina, APHIS referred to low </text>
<text top=""813"" left=""151"" width=""465"" height=""16"" font=""0"">risk with the possibility to achieve a ""negligible level of risk;""</text>
<footnote top=""811"" left=""615"" width=""17"" height=""11"" font=""16"" number=""948"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""593"" height=""15"" font=""10""> (footnote original) See the June 26, 1997 Final rulemaking at 62 FR 34385 at 34387 and 34389. </ftext>
</footnote>
<text top=""813"" left=""633"" width=""120"" height=""16"" font=""0""> the 2005 risk </text>
<text top=""829"" left=""151"" width=""602"" height=""16"" font=""0"">assessment by APHIS regarding Patagonia South stated that the risk level was </text>
</p><p><text top=""891"" left=""165"" width=""582"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 344 (citing<i> </i>Appellate Body Report, <i>Australia &#8211; </i></text>
<text top=""905"" left=""108"" width=""126"" height=""15"" font=""12""><i>Salmon</i>, para. 208). </text>
</p><p><text top=""1080"" left=""165"" width=""607"" height=""15"" font=""10""> Argentina's first written submission, para. 295 (citing <i>Importation of Animals and Animal Products</i>, </text>
</p><p><text top=""1124"" left=""108"" width=""107"" height=""15"" font=""10"">(Exhibit ARG-26) </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 136 - </text>
</p><p><text top=""128"" left=""151"" width=""40"" height=""16"" font=""0"">""low.""</text>
<footnote top=""126"" left=""191"" width=""17"" height=""11"" font=""16"" number=""949"" ref="""" dis=""""><ftext top=""920"" left=""165"" width=""487"" height=""15"" font=""10""> (footnote original) Risk Assessment for Patagonia at pp 76-77. (Exhibit ARG-9) </ftext>
</footnote>
<text top=""128"" left=""208"" width=""540"" height=""16"" font=""0""> And yet low risk in 1997 meant imports were allowed, while low risk in 2005 </text>
<text top=""144"" left=""151"" width=""603"" height=""16"" font=""0"">meant a continued ban even as applied to the FMD-free region of Patagonia. </text>
<text top=""160"" left=""151"" width=""598"" height=""16"" font=""0"">Moreover, the 2003 rulemaking for Uruguay did not mention a level of risk, while a </text>
<text top=""177"" left=""151"" width=""540"" height=""16"" font=""0"">2002 risk analysis performed on Uruguay suggested a ""low"" risk rating.</text>
<footnote top=""175"" left=""690"" width=""17"" height=""11"" font=""16"" number=""950"" ref="""" dis=""""><ftext top=""934"" left=""165"" width=""338"" height=""15"" font=""10""> (footnote original) 68 Fed. Reg. 31940, May 29, 2003. </ftext>
</footnote>
<text top=""177"" left=""708"" width=""45"" height=""16"" font=""0""> The </text>
<text top=""193"" left=""151"" width=""597"" height=""16"" font=""0"">rulemaking regarding the Brazilian State of Santa Catarina considered the level risk to </text>
<text top=""210"" left=""151"" width=""478"" height=""16"" font=""0"">be ""very low"" and therefore acceptable for imports to commence,</text>
<footnote top=""208"" left=""628"" width=""17"" height=""11"" font=""16"" number=""951"" ref="""" dis=""""><ftext top=""949"" left=""165"" width=""608"" height=""15"" font=""10""> (footnote original) 75 Fed. Reg. 69851, November 16, 2010; <i>see </i>APHIS Evaluation of the Status of </ftext>
<ftext top=""963"" left=""108"" width=""625"" height=""15"" font=""10"">the Brazilian State of Santa Catarina Regarding Foot-and-Mouth Disease, Classical Swine Fever, Swine </ftext>
<ftext top=""978"" left=""108"" width=""503"" height=""15"" font=""10"">Vesicular Disease and African Swine Fever, USDA APHIS Report, August 16, 2010. </ftext>
</footnote>
<text top=""210"" left=""646"" width=""105"" height=""16"" font=""0""> even though </text>
<text top=""226"" left=""151"" width=""426"" height=""16"" font=""0"">""very low"" is not one of the levels identified in the rulemaking.</text>
<footnote top=""225"" left=""576"" width=""17"" height=""11"" font=""16"" number=""952"" ref="""" dis=""""/>
</p></p></page>
<page number=""136"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.371"" style=""8""><text top=""260"" left=""108"" width=""685"" height=""16"" font=""0"">7.371.  Argentina disputes the United States' contention that its ALOP for FMD is expressed in </text>
<text top=""277"" left=""108"" width=""682"" height=""16"" font=""0"">7 USC 8303. In particular, Argentina argues that the section does not express an ALOP, but rather </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">grants the Secretary of Agriculture unfettered discretion to adopt whatever measures he deems </text>
<text top=""310"" left=""108"" width=""72"" height=""16"" font=""0"">necessary.</text>
<footnote top=""308"" left=""180"" width=""17"" height=""11"" font=""16"" number=""953"" ref="""" dis=""""/>
</p><p number=""7.372"" style=""8""><text top=""344"" left=""108"" width=""688"" height=""16"" font=""0"">7.372.  Furthermore, Argentina argues that regardless of whether the United States has a </text>
<text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">determined ALOP for FMD, it acts <i>as if </i>there is a unique ALOP for Argentine products which is </text>
<text top=""377"" left=""108"" width=""34"" height=""16"" font=""0"">zero.</text>
<footnote top=""375"" left=""142"" width=""17"" height=""11"" font=""16"" number=""954"" ref="""" dis=""""><ftext top=""1022"" left=""165"" width=""331"" height=""15"" font=""10""> Argentina's first written submission, paras. 223, 299. </ftext>
</footnote>
<text top=""377"" left=""159"" width=""633"" height=""16"" font=""0""> However, in the context of its arguments relating to Article 5.6 of the SPS Agreement, </text>
<text top=""393"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina argues that the United States' ALOP for fresh (chilled or frozen) beef can be derived </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">from the measures that apply to Uruguay as well as the expected issuance of a proposed rule </text>
<text top=""426"" left=""108"" width=""660"" height=""16"" font=""0"">permitting imports from 13 Brazilian states that are FMD-free where vaccination is practised.</text>
<footnote top=""425"" left=""768"" width=""17"" height=""11"" font=""16"" number=""955"" ref="""" dis=""""/>
<text top=""443"" left=""108"" width=""685"" height=""16"" font=""0"">Similarly, for its claim relating to all ruminant and swine products from Patagonia, Argentina </text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">derives the United States' ALOP by reference to the 2005 risk assessment of Patagonia and the </text>
<text top=""475"" left=""108"" width=""342"" height=""16"" font=""0"">treatment of the Brazilian state of Santa Catarina.</text>
<footnote top=""474"" left=""450"" width=""17"" height=""11"" font=""16"" number=""956"" ref="""" dis=""""><ftext top=""1051"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 501-503. </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""510"" left=""108"" width=""184"" height=""16"" font=""28"">7.6.2.1.2  United States </text></p><p number=""7.373"" style=""8""><text top=""544"" left=""108"" width=""684"" height=""16"" font=""0"">7.373.  In its first written submission the United States argues that the goal of the authorization </text>
<text top=""561"" left=""108"" width=""685"" height=""16"" font=""0"">process set forth in 9 CFR 92.2 is ""to prevent the introduction into or dissemination within the </text>
<text top=""577"" left=""108"" width=""166"" height=""16"" font=""0"">United States of FMD.""</text>
<footnote top=""575"" left=""274"" width=""17"" height=""11"" font=""16"" number=""957"" ref="""" dis=""""/>
<text top=""577"" left=""291"" width=""499"" height=""16"" font=""0"">  In  response  to  a  specific  question  as  to  its  ALOP  for  FMD,  the </text>
<text top=""593"" left=""108"" width=""683"" height=""16"" font=""0"">United States replied that the ALOP of the United States is set out in the Animal Health Protection </text>
<text top=""610"" left=""108"" width=""616"" height=""16"" font=""0"">Act (""AHPA"") in 7 USC 8303, which is the main statutory basis for 9 CFR 92 and 9 CFR 94.</text>
<footnote top=""608"" left=""724"" width=""17"" height=""11"" font=""16"" number=""958"" ref="""" dis=""""/>
</p><p number=""7.374"" style=""8""><text top=""644"" left=""108"" width=""331"" height=""16"" font=""0"">7.374.  In particular, 7 USC 8303(a), provides:  </text>
<p><text top=""679"" left=""151"" width=""598"" height=""16"" font=""0"">[T]he Secretary may prohibit or restrict - (1) the importation or entry of any animal, </text>
<text top=""695"" left=""151"" width=""598"" height=""16"" font=""0"">article, or means of conveyance, or use of any means of conveyance or facility, if the </text>
<text top=""711"" left=""151"" width=""599"" height=""16"" font=""0"">Secretary determines that the prohibition or restriction is necessary to prevent the </text>
<text top=""728"" left=""151"" width=""599"" height=""16"" font=""0"">introduction into or dissemination within the United States of any pest or disease of </text>
<text top=""744"" left=""151"" width=""85"" height=""16"" font=""0"">livestock &#8230; .</text>
<footnote top=""743"" left=""235"" width=""17"" height=""11"" font=""16"" number=""959"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""225"" height=""15"" font=""10""> 7 USC &#167; 8303(a), (Exhibit USA-75). </ftext>
</footnote>
</p></p><p number=""7.375"" style=""8""><text top=""779"" left=""108"" width=""687"" height=""16"" font=""0"">7.375.  The United States argues that this ALOP requires that ""[i]mports of FMD-susceptible </text>
<text top=""795"" left=""108"" width=""453"" height=""16"" font=""0"">animals and animal products into the United States must be safe.""</text>
<footnote top=""793"" left=""561"" width=""17"" height=""11"" font=""16"" number=""960"" ref="""" dis=""""/>
</p><p number=""7.376"" style=""8""><text top=""829"" left=""108"" width=""688"" height=""16"" font=""0"">7.376.  The United States maintains that APHIS' evaluation of a country's application is to </text>
<text top=""846"" left=""108"" width=""682"" height=""16"" font=""0"">determine ""whether, and under what import conditions, if any, specified products from a particular </text>
<text top=""862"" left=""108"" width=""686"" height=""16"" font=""0"">region may be safely exported to the United States without introducing into or disseminating </text>
<text top=""879"" left=""108"" width=""281"" height=""16"" font=""0"">within the United States the FMD virus.""</text>
<footnote top=""877"" left=""388"" width=""17"" height=""11"" font=""16"" number=""961"" ref="""" dis=""""><ftext top=""1124"" left=""165"" width=""579"" height=""15"" font=""10""> United States' first written submission, para. 125 (citing 7 USC &#167; 8303(a), (Exhibit USA-75)).  </ftext>
</footnote>
<text top=""879"" left=""406"" width=""386"" height=""16"" font=""0""> The United States also argues that its ALOP is higher </text>
<p><text top=""993"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 222. </text>
<text top=""1007"" left=""165"" width=""346"" height=""15"" font=""10""> Argentina's second written submission, paras. 153-154. </text>
</p><p><text top=""1036"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 312-313. </text>
</p><p><text top=""1066"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 120. </text>
<footnote top=""1080"" left=""165"" width=""520"" height=""15"" font=""10"" number=""42"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 137 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">than that achieved by applying the OIE standards. In particular, the United States focuses on the </text>
<text top=""144"" left=""108"" width=""690"" height=""16"" font=""0"">differences in its treatment of imports from countries that practice vaccination. In the </text>
<text top=""160"" left=""108"" width=""564"" height=""16"" font=""0"">United States' view, a country that vaccinates for FMD is not free of the disease.</text>
<footnote top=""159"" left=""671"" width=""22"" height=""11"" font=""16"" number=""962"" ref="""" dis=""""/>
<text top=""160"" left=""693"" width=""98"" height=""16"" font=""0""> According to </text>
<text top=""177"" left=""108"" width=""688"" height=""16"" font=""0"">the United States, importation of beef from areas that are designated as FMD-free where </text>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">vaccination is practised could result in importation of beef derived from infected animals, which </text>
<text top=""210"" left=""108"" width=""461"" height=""16"" font=""0"">""would not satisfy the United States' standard of safe importation.""</text>
<footnote top=""208"" left=""568"" width=""17"" height=""11"" font=""16"" number=""963"" ref="""" dis=""""/>
<text top=""210"" left=""586"" width=""205"" height=""16"" font=""0""> Therefore, the United States </text>
<text top=""226"" left=""108"" width=""685"" height=""16"" font=""0"">contends that the OIE guidelines for importation of products from countries or zones that are </text>
<text top=""242"" left=""108"" width=""427"" height=""16"" font=""0"">FMD-free where vaccination is practised do not meet its ALOP.</text>
<footnote top=""241"" left=""535"" width=""21"" height=""11"" font=""16"" number=""964"" ref="""" dis=""""/>
<text top=""242"" left=""555"" width=""235"" height=""16"" font=""0""> The United States also maintains </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">that it is not seeking to achieve a zero ALOP&#8212;indeed, the United States argued in its comments on </text>
<text top=""275"" left=""108"" width=""362"" height=""16"" font=""0"">Dr Bonbon's answers that zero risk is not achievable.</text>
<footnote top=""274"" left=""470"" width=""17"" height=""11"" font=""16"" number=""965"" ref="""" dis=""""/>
</p></p></page>
<page number=""137"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.6"" style=""8""><text top=""310"" left=""108"" width=""229"" height=""16"" font=""28"">7.6.2.2  Analysis by the Panel </text></p><p number=""7.377"" style=""8""><text top=""344"" left=""108"" width=""683"" height=""16"" font=""0"">7.377.  The Appellate Body explained in <i>Australia &#8211; Salmon </i>that there is an implicit obligation in </text>
<text top=""360"" left=""108"" width=""624"" height=""16"" font=""0"">the SPS Agreement for Members to determine their appropriate level of protection.</text>
<footnote top=""359"" left=""732"" width=""17"" height=""11"" font=""16"" number=""966"" ref="""" dis=""""/>
<text top=""360"" left=""749"" width=""46"" height=""16"" font=""0""> The </text>
<text top=""377"" left=""108"" width=""686"" height=""16"" font=""0"">Appellate Body has confirmed that the ALOP need not be determined in quantitative terms. </text>
<text top=""393"" left=""108"" width=""683"" height=""16"" font=""0"">However, the level of protection cannot be determined ""with such vagueness or equivocation that </text>
<text top=""410"" left=""108"" width=""600"" height=""16"" font=""0"">the application of the relevant provisions of the <i>SPS Agreement</i> &#8230; becomes impossible"".</text>
<footnote top=""408"" left=""708"" width=""17"" height=""11"" font=""16"" number=""967"" ref="""" dis=""""/>
</p><p number=""7.378"" style=""8""><text top=""444"" left=""108"" width=""684"" height=""16"" font=""0"">7.378.  The United States maintains that its ALOP for all animal diseases, including FMD, is set </text>
<text top=""461"" left=""108"" width=""685"" height=""16"" font=""0"">forth in 7 USC 8303(a). We disagree with Argentina that Section 8303(a) does not express an </text>
<text top=""477"" left=""108"" width=""684"" height=""16"" font=""0"">ALOP, but is merely a delegation of authority to the Secretary of Agriculture. It is true that the </text>
<text top=""493"" left=""108"" width=""682"" height=""16"" font=""0"">provision provides the Secretary with the discretion to take all necessary measures, but only those </text>
<text top=""510"" left=""108"" width=""683"" height=""16"" font=""0"">measures <i>necessary to</i> <i>prevent the introduction into or dissemination within the United States of </i></text>
<text top=""526"" left=""108"" width=""687"" height=""16"" font=""18""><i>any pest or disease of livestock. </i>It is this portion of Section 8303(a) that expresses the </text>
<text top=""543"" left=""108"" width=""684"" height=""16"" font=""0"">United States' ALOP for animal pests or diseases. We also note that the regulations in 9 CFR 94 </text>
<text top=""559"" left=""108"" width=""685"" height=""16"" font=""0"">and 9 CFR 92.2 specifically derive APHIS' authority from, among other sources, this statutory </text>
<text top=""575"" left=""108"" width=""682"" height=""16"" font=""0"">provision. We have no reason to disagree with the United States' assertion that this is its ALOP for </text>
<text top=""592"" left=""108"" width=""297"" height=""16"" font=""0"">animal pests and diseases, including FMD.  </text>
</p><p number=""7.379"" style=""8""><text top=""626"" left=""108"" width=""682"" height=""16"" font=""0"">7.379.  The panel in <i>India &#8211; Agricultural Products </i>recently held that a similarly expressed ALOP by </text>
<text top=""643"" left=""108"" width=""685"" height=""16"" font=""0"">India &#8211; the prevention of ingress of the disease in question &#8211; did not satisfy the definition in </text>
<text top=""659"" left=""108"" width=""341"" height=""16"" font=""0"">Annex (5), because it did not express a ""level"".</text>
<footnote top=""657"" left=""449"" width=""17"" height=""11"" font=""16"" number=""968"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""993"" left=""165"" width=""354"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.565.  </ftext>
</footnote>
<text top=""659"" left=""466"" width=""326"" height=""16"" font=""0""> While acknowledging that a Member's ALOP </text>
<text top=""675"" left=""108"" width=""684"" height=""16"" font=""0"">need not be expressed in quantitative terms, that panel concluded that an ALOP will ""express a </text>
<text top=""692"" left=""108"" width=""684"" height=""16"" font=""0"">certain threshold that denotes the position of the relevant Member in relation to the intensity, </text>
<text top=""708"" left=""108"" width=""687"" height=""16"" font=""0"">extent, or relative amount of protection or risk that the Member deems to be tolerable or </text>
<text top=""725"" left=""108"" width=""64"" height=""16"" font=""0"">suitable.""</text>
<footnote top=""723"" left=""172"" width=""17"" height=""11"" font=""16"" number=""969"" ref=""WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430""><ftext top=""1007"" left=""165"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.562. </ftext>
</footnote>
</p><p number=""7.380"" style=""8""><text top=""759"" left=""108"" width=""684"" height=""16"" font=""0"">7.380.  We recall that the Appellate Body in <i>Australia &#8211; Salmon</i> reasoned that the ALOP ""is an </text>
<text top=""775"" left=""108"" width=""687"" height=""16"" font=""0"">objective, and that the SPS measure is an instrument chosen to attain or implement that </text>
<text top=""792"" left=""108"" width=""73"" height=""16"" font=""0"">objective.""</text>
<footnote top=""790"" left=""180"" width=""17"" height=""11"" font=""16"" number=""970"" ref="""" dis=""""/>
<text top=""792"" left=""198"" width=""593"" height=""16"" font=""0""> As expressions of a general objective, ALOPs are often set forth in a qualitative and </text>
<text top=""808"" left=""108"" width=""685"" height=""16"" font=""0"">generic manner. The ALOP put forward by the United States in this dispute is formulated in a </text>
<text top=""825"" left=""108"" width=""564"" height=""16"" font=""0"">similar qualitative manner to that accepted by the panel in <i>US &#8211; Poultry (China).</i></text>
<footnote top=""823"" left=""672"" width=""17"" height=""11"" font=""16"" number=""971"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""1036"" left=""165"" width=""616"" height=""15"" font=""10""> In that case the United States' ALOP for poultry products was accepted to be ""healthful, wholesome, </ftext>
<ftext top=""1051"" left=""108"" width=""654"" height=""15"" font=""10"">fit for human food, not adulterated, and contain no dye, chemical, preservative or ingredient which renders </ftext>
<ftext top=""1066"" left=""108"" width=""632"" height=""15"" font=""10"">them unhealthful, un wholesome, adulterated, or unfit for human food."" See Panel Report, <i>US &#8211; Poultry </i></ftext>
<ftext top=""1080"" left=""108"" width=""647"" height=""15"" font=""12""><i>(China)</i>, para. 7.242 (citing Poultry Products Inspection Act 21 USC 466). We also note that the ALOP was </ftext>
<ftext top=""1095"" left=""108"" width=""654"" height=""15"" font=""10"">implemented in a similar way &#8211; an agency of the United States' Department of Agriculture (in that case the </ftext>
<ftext top=""1109"" left=""108"" width=""634"" height=""15"" font=""10"">Food Safety Inspection Service) making specific determinations about the admissibility of products from </ftext>
<ftext top=""1124"" left=""108"" width=""190"" height=""15"" font=""10"">particular countries or regions. </ftext>
<ftext top=""1124"" left=""108"" width=""254"" height=""15"" font=""10"">United States could apply to its products. </ftext>
</footnote>
<text top=""825"" left=""689"" width=""100"" height=""16"" font=""18""><i> </i>Furthermore, </text>
<text top=""841"" left=""108"" width=""682"" height=""16"" font=""0"">the OIE itself, an acknowledged expert in determining appropriate mitigating measures to respond </text>
<text top=""857"" left=""108"" width=""682"" height=""16"" font=""0"">to animal health risks, does not refer to the ALOP achieved by the measures in the Terrestrial Code </text>
<footnote top=""905"" left=""165"" width=""306"" height=""15"" font=""10"" number=""299"" ref="""" dis=""""/>
<p><text top=""949"" left=""165"" width=""477"" height=""15"" font=""10""> United States' comments on the experts' responses to Panel question No. 12. </text>
<text top=""963"" left=""165"" width=""337"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 206. </text>
<text top=""978"" left=""165"" width=""337"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 203. </text>
</p><p><text top=""1022"" left=""165"" width=""337"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 200. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 138 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">in terms of specific levels of tolerance. Indeed, in response to a question from the Panel, the </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">OIE explained the level of protection achieved by the measures in Chapter 8.5 of the Terrestrial </text>
<text top=""160"" left=""108"" width=""116"" height=""16"" font=""0"">Code as follows: </text>
</p><p><text top=""195"" left=""151"" width=""601"" height=""16"" font=""0"">The measures in Chapter 8.5 provide for safe international trade in animals and </text>
<text top=""211"" left=""151"" width=""599"" height=""16"" font=""0"">derived products. As stated in Part A point 2 of the User's Guide to the Terrestrial </text>
<text top=""228"" left=""151"" width=""597"" height=""16"" font=""0"">Code: ""The recommendations in each of the disease chapters &#8230; are designed <i>to </i></text>
<text top=""244"" left=""151"" width=""597"" height=""16"" font=""18""><i>prevent the disease in question being introduced into the importing country </i>(emphasis </text>
<text top=""260"" left=""151"" width=""597"" height=""16"" font=""0"">added), taking into account the nature of the commodity and the animal health status </text>
<text top=""277"" left=""151"" width=""597"" height=""16"" font=""0"">of the exporting country. Correctly applied, OIE recommendations provide for trade in </text>
<text top=""293"" left=""151"" width=""600"" height=""16"" font=""0"">animals and animal products to take place with an <i>optimal level of animal health </i></text>
<text top=""310"" left=""151"" width=""599"" height=""16"" font=""18""><i>security</i> (emphasis added), based on the most up to date scientific information and </text>
<text top=""326"" left=""151"" width=""597"" height=""16"" font=""0"">available techniques."" This applies to all products and all measures in Chapter 8.5 and </text>
<text top=""342"" left=""151"" width=""597"" height=""16"" font=""0"">in other disease chapters. No attempt is made to quantify or differentiate the levels of </text>
<text top=""359"" left=""151"" width=""597"" height=""16"" font=""0"">protection provided in the disease chapters or in the horizontal texts of the Terrestrial </text>
<text top=""375"" left=""151"" width=""39"" height=""16"" font=""0"">Code.</text>
<footnote top=""374"" left=""190"" width=""17"" height=""11"" font=""16"" number=""972"" ref="""" dis=""""/>
</p></p></page>
<page number=""138"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.381"" style=""8""><text top=""410"" left=""108"" width=""687"" height=""16"" font=""0"">7.381.  That being said, the Appellate Body has concluded that if a Member determines its </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">appropriate level of protection with insufficient precision, then ""the appropriate level of protection </text>
<text top=""443"" left=""108"" width=""687"" height=""16"" font=""0"">may be established by [the panel] on the basis of the level of protection reflected in the </text>
<text top=""459"" left=""108"" width=""214"" height=""16"" font=""0"">SPS measure actually applied.""</text>
<footnote top=""457"" left=""322"" width=""17"" height=""11"" font=""16"" number=""973"" ref="""" dis=""""/>
<text top=""459"" left=""340"" width=""451"" height=""16"" font=""0""> This is consistent with the recognition of prior panels that ""any </text>
<text top=""475"" left=""108"" width=""684"" height=""16"" font=""0"">sanitary measure applied to a given situation inherently reflects and achieves a certain level of </text>
<text top=""492"" left=""108"" width=""80"" height=""16"" font=""0"">protection.""</text>
<footnote top=""490"" left=""188"" width=""17"" height=""11"" font=""16"" number=""974"" ref=""WT/DS18/R/Corr.1|WT/DS18/R|WT/DS18/11|WT/DS26/R/USA|WT/DS18/RW"" dis=""DS18|DS26|DS367""><ftext top=""1007"" left=""165"" width=""571"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Salmon</i>, para. 8.107; see also Panel Reports, <i>EC &#8211; Hormones</i> <i>(US)</i>, </ftext>
<ftext top=""1022"" left=""108"" width=""545"" height=""15"" font=""10"">para. 8.168; <i>EC &#8211; Hormones (Canada)</i>,<i> </i>para. 8.171; and <i>Australia &#8211; Apples</i>, para. 7.975. </ftext>
</footnote>
<text top=""492"" left=""205"" width=""586"" height=""16"" font=""0""> In light of the findings of the panel in <i>India &#8211; Agricultural Products </i>and to confirm </text>
<text top=""508"" left=""108"" width=""684"" height=""16"" font=""0"">the threshold of risk the United States is prepared to accept, we will examine the measures the </text>
<text top=""525"" left=""108"" width=""683"" height=""16"" font=""0"">United States applies with respect to FMD as well as compare these to the Terrestrial Code, which </text>
<text top=""541"" left=""108"" width=""682"" height=""16"" font=""0"">the United States argues achieves a lower ALOP with respect to FMD and the particular products at </text>
<text top=""557"" left=""108"" width=""149"" height=""16"" font=""0"">issue in this dispute.  </text>
</p><p number=""7.382"" style=""8""><text top=""592"" left=""108"" width=""684"" height=""16"" font=""0"">7.382.  The United States does not provide for a complete import prohibition on all livestock or </text>
<text top=""608"" left=""108"" width=""686"" height=""16"" font=""0"">products thereof. The United States permits imports from countries or regions that have had </text>
<text top=""625"" left=""108"" width=""684"" height=""16"" font=""0"">outbreaks in the past. As Argentina observes, APHIS permits imports from several countries or </text>
<text top=""641"" left=""108"" width=""684"" height=""16"" font=""0"">regions whose products it has determined present a ""low"" or lower (""very low"" or ""negligible"") </text>
<text top=""657"" left=""108"" width=""29"" height=""16"" font=""0"">risk.</text>
<footnote top=""656"" left=""137"" width=""17"" height=""11"" font=""16"" number=""975"" ref="""" dis=""""><ftext top=""1036"" left=""165"" width=""603"" height=""15"" font=""10""> We note that it is unremarkable that three countries or regions presenting these differing levels of </ftext>
<ftext top=""1051"" left=""108"" width=""650"" height=""15"" font=""10"">risk would all be allowed to import while achieving the same ALOP &#8211; this is because if the risk presented is </ftext>
<ftext top=""1066"" left=""108"" width=""659"" height=""15"" font=""12""><i>negligible</i>, then permitting those shipments would achieve an ALOP of ""low"". The same is true with products </ftext>
<ftext top=""1080"" left=""108"" width=""191"" height=""15"" font=""10"">that present a ""very low"" risk.  </ftext>
</footnote>
<text top=""657"" left=""155"" width=""637"" height=""16"" font=""0""> Indeed, the United States even permits imports from one country that vaccinates against </text>
<text top=""674"" left=""108"" width=""685"" height=""16"" font=""0"">FMD under certain protocols. However, the United States does not determine who may import </text>
<text top=""690"" left=""108"" width=""687"" height=""16"" font=""0"">based on the official recognitions of disease status of the OIE. The United States does not </text>
<text top=""707"" left=""108"" width=""687"" height=""16"" font=""0"">recognize the disease status of ""FMD-free where vaccination is practised"". Furthermore, as </text>
<text top=""723"" left=""108"" width=""682"" height=""16"" font=""0"">discussed in section 7.4 above, the protocols the United States applies to imports are not based on </text>
<text top=""739"" left=""108"" width=""682"" height=""16"" font=""0"">and are more stringent than those set forth in the Terrestrial Code. In particular, the United States </text>
<text top=""756"" left=""108"" width=""685"" height=""16"" font=""0"">places additional mitigating measures in 9 CFR 94.11 on regions that border regions that are </text>
<text top=""772"" left=""108"" width=""580"" height=""16"" font=""0"">FMD-infected or that import products from such regions. Similarly in 9 </text>
<text top=""772"" left=""679"" width=""40"" height=""16"" font=""0"">CFR </text>
<text top=""772"" left=""710"" width=""88"" height=""16"" font=""0"">94.22 the </text>
<text top=""789"" left=""108"" width=""683"" height=""16"" font=""0"">United States imposes mitigating protocols on one country that it determines to be FMD-infected, </text>
<text top=""805"" left=""108"" width=""140"" height=""16"" font=""0"">but that vaccinates.</text>
<footnote top=""804"" left=""248"" width=""17"" height=""11"" font=""16"" number=""976"" ref="""" dis=""""><ftext top=""1095"" left=""165"" width=""609"" height=""15"" font=""10""> The protocols in 94.11 and 94.22 will be discussed in greater detail in respect of Argentina's claims </ftext>
</footnote>
<text top=""805"" left=""265"" width=""527"" height=""16"" font=""0""> Therefore, it would be reasonable to conclude that the qualitative ALOP </text>
<text top=""821"" left=""108"" width=""682"" height=""16"" font=""0"">expressed in 7 USC 8303(a) can be approximately described as being higher than that achieved by </text>
<text top=""838"" left=""108"" width=""469"" height=""16"" font=""0"">the Terrestrial Code and somewhere between ""low risk"" and ""zero"".  </text>
</p><p number=""7.383"" style=""8""><text top=""872"" left=""108"" width=""687"" height=""16"" font=""0"">7.383.  <i> </i>Argentina refers to the varying manners in which APHIS has characterized the risk </text>
<text top=""889"" left=""108"" width=""682"" height=""16"" font=""0"">associated with products from particular countries or regions. According to Argentina, the fact that </text>
<text top=""905"" left=""108"" width=""684"" height=""16"" font=""0"">APHIS determined that particular countries or regions had different risk levels but nevertheless </text>
<text top=""922"" left=""108"" width=""682"" height=""16"" font=""0"">allowed them to import products demonstrates that the United States' ALOP is confused. While we </text>
<text top=""938"" left=""108"" width=""683"" height=""16"" font=""0"">acknowledge that there may be more precise ways to express an ALOP than the one before us in </text>
<p><text top=""978"" left=""165"" width=""270"" height=""15"" font=""10""> OIE's response to Panel question No. 8(a).  </text>
<text top=""993"" left=""165"" width=""337"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 207. </text>
</p><p><text top=""1109"" left=""108"" width=""639"" height=""15"" font=""10"">under Article 5.6 as they are the alternative, less trade-restrictive measures that Argentina proposes the </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 139 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">the current case, we do not agree that the fact that APHIS uses different terms to identify the </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">levels of risk posed by different products from different countries or regions, in and of itself, </text>
<text top=""160"" left=""108"" width=""687"" height=""16"" font=""0"">necessarily means that the appropriate level of protection being achieved is not sufficiently </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">articulated, or that it is different from that expressed in 7 USC 8303(a). Rather, one must look at </text>
<text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">the level of risk identified in combination with the measures applied to determine the level of </text>
<text top=""210"" left=""108"" width=""472"" height=""16"" font=""0"">protection achieved. The panel in <i>Australia &#8211; Salmon</i> explained that: </text>
</p><p><text top=""244"" left=""151"" width=""598"" height=""16"" font=""0"">[T]he level of protection achieved by a specific sanitary measure will also depend on </text>
<text top=""260"" left=""151"" width=""598"" height=""16"" font=""0"">the degree of risk against which that measure is intended to protect. In that sense,&#8230; </text>
<text top=""277"" left=""151"" width=""601"" height=""16"" font=""0"">imposing the same sanitary measure for different situations does not necessarily </text>
<text top=""293"" left=""151"" width=""600"" height=""16"" font=""0"">result in the same level of protection. Indeed, in many situations (e.g. situations </text>
<text top=""310"" left=""151"" width=""597"" height=""16"" font=""0"">representing different risks) the same sanitary measure might result in different levels </text>
<text top=""326"" left=""151"" width=""599"" height=""16"" font=""0"">of protection. On the other hand, different sanitary measures for different situations </text>
<text top=""342"" left=""151"" width=""600"" height=""16"" font=""0"">might ensure the same level of protection. Indeed, one given situation might only </text>
<text top=""359"" left=""151"" width=""597"" height=""16"" font=""0"">represent a small risk for which a lenient sanitary measure will achieve a high level of </text>
<text top=""375"" left=""151"" width=""600"" height=""16"" font=""0"">protection, whereas another situation might pose very high risks requiring a very </text>
<text top=""392"" left=""151"" width=""597"" height=""16"" font=""0"">strict  and  different  sanitary  measure  in  order  to  meet  that  same  high  level  of </text>
<text top=""408"" left=""151"" width=""73"" height=""16"" font=""0"">protection.</text>
<footnote top=""407"" left=""224"" width=""17"" height=""11"" font=""16"" number=""977"" ref=""WT/DS18/R/Corr.1|WT/DS18/R|WT/DS18/11|WT/DS18/RW"" dis=""DS18""><ftext top=""1036"" left=""165"" width=""296"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Salmon</i>, para. 8.123.  </ftext>
</footnote>
<text top=""408"" left=""241"" width=""132"" height=""16"" font=""0""> (emphasis added) </text>
</p></p></page>
<page number=""139"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.384"" style=""8""><text top=""443"" left=""108"" width=""683"" height=""16"" font=""0"">7.384.  The reasoning of the panel is also confirmed with reference to the Terrestrial Code which </text>
<text top=""459"" left=""108"" width=""683"" height=""16"" font=""0"">sets forth different mitigating measures depending on the disease status of an exporting country </text>
<text top=""475"" left=""108"" width=""633"" height=""16"" font=""0"">or zone, but maintains that all measures achieve the same level of protection: ""safe trade"".  </text>
</p><p number=""7.385"" style=""8""><text top=""510"" left=""108"" width=""684"" height=""16"" font=""0"">7.385.  Finally, we address Argentina's argument that regardless of any statutory United States' </text>
<text top=""526"" left=""108"" width=""682"" height=""16"" font=""0"">ALOP for animal pests and diseases, the United States applies its measures <i>as if</i> it has a zero ALOP </text>
<text top=""543"" left=""108"" width=""687"" height=""16"" font=""0"">for products from Argentina. We understand Argentina's argument to be that because the </text>
<text top=""559"" left=""108"" width=""684"" height=""16"" font=""0"">measures currently applied &#8211; i.e. an import prohibition &#8211; achieve a zero level of protection this </text>
<text top=""575"" left=""108"" width=""682"" height=""16"" font=""0"">must be the United States' ALOP for Argentina. First, we note that ALOPs are applied to risks (such </text>
<text top=""592"" left=""108"" width=""688"" height=""16"" font=""0"">as pests, diseases, contaminants, toxins, zoonoses, etc.) that may be transmitted through </text>
<text top=""608"" left=""108"" width=""682"" height=""16"" font=""0"">particular products. ALOPs are not applied to countries or regions. We also recall that the Appellate </text>
<text top=""625"" left=""108"" width=""687"" height=""16"" font=""0"">Body has clarified that the establishment of the level of protection ""is an element in the </text>
<text top=""641"" left=""108"" width=""686"" height=""16"" font=""0"">decision-making process which logically precedes and is separate from the establishment or </text>
<text top=""657"" left=""108"" width=""237"" height=""16"" font=""0"">maintenance of the SPS measure.""</text>
<footnote top=""656"" left=""345"" width=""17"" height=""11"" font=""16"" number=""978"" ref="""" dis=""""/>
</p><p number=""7.386"" style=""8""><text top=""692"" left=""108"" width=""686"" height=""16"" font=""0"">7.386.  It may or may not be the case that the United States applies measures to Argentine </text>
<text top=""708"" left=""108"" width=""683"" height=""16"" font=""0"">products that are more restrictive than necessary to achieve its ALOP; we address this possibility </text>
<text top=""725"" left=""108"" width=""365"" height=""16"" font=""0"">in the context of Argentina's claim under Article 5.6.</text>
<footnote top=""723"" left=""473"" width=""17"" height=""11"" font=""16"" number=""979"" ref="""" dis=""""><ftext top=""1066"" left=""165"" width=""617"" height=""15"" font=""10""> Similarly a claim that the United States was applying more than one level of protection would be the </ftext>
<ftext top=""1080"" left=""108"" width=""591"" height=""15"" font=""10"">subject of a claim under Article 5.5. However, Argentina has not raised a claim under Article 5.5. </ftext>
</footnote>
<text top=""725"" left=""490"" width=""301"" height=""16"" font=""0""> However, accepting Argentina's argument </text>
<text top=""741"" left=""108"" width=""683"" height=""16"" font=""0"">that the measures applied to a particular product from a particular country determines a country </text>
<text top=""757"" left=""108"" width=""684"" height=""16"" font=""0"">specific ALOP for that product would be contrary to the guidance of the Appellate Body that the </text>
<text top=""774"" left=""108"" width=""682"" height=""16"" font=""0"">appropriate level of protection determines the SPS measure to be introduced or maintained, rather </text>
<text top=""790"" left=""108"" width=""565"" height=""16"" font=""0"">than the appropriate level of protection being determined by the SPS measure.</text>
<footnote top=""789"" left=""673"" width=""17"" height=""11"" font=""16"" number=""980"" ref="""" dis=""""/>
<text top=""790"" left=""690"" width=""102"" height=""16"" font=""0""> In our view, </text>
<text top=""807"" left=""108"" width=""682"" height=""16"" font=""0"">assuming that the level of protection <i>achieved </i>by a challenged measure is <i>always</i> the same as the </text>
<text top=""823"" left=""108"" width=""683"" height=""16"" font=""0"">appropriate<i> </i>level of protection <i>determined </i>by the importing Member could have implications for a </text>
<text top=""839"" left=""108"" width=""683"" height=""16"" font=""0"">proper application of Article 5.6 and could thereby increase the possibility for importing Members </text>
<text top=""856"" left=""108"" width=""180"" height=""16"" font=""0"">to evade their obligations.</text>
<footnote top=""854"" left=""288"" width=""17"" height=""11"" font=""16"" number=""981"" ref="""" dis=""""><ftext top=""1109"" left=""165"" width=""621"" height=""15"" font=""10""> Such a manner for determining the ALOP is precisely the type of situation the Appellate Body warned </ftext>
</footnote>
<text top=""856"" left=""305"" width=""485"" height=""16"" font=""0""> Therefore, we cannot agree that even if the application of the import </text>
<text top=""872"" left=""108"" width=""683"" height=""16"" font=""0"">prohibition <i>to Argentina</i> achieved a ""zero"" level of protection this should lead us to conclude that </text>
<text top=""889"" left=""108"" width=""284"" height=""16"" font=""0"">the United States' ALOP for FMD is zero.  </text>
</p><p number=""7.387"" style=""8""><text top=""923"" left=""108"" width=""684"" height=""16"" font=""0"">7.387.  For the reasons set forth above, we conclude that the United States ALOP is ""to prevent </text>
<text top=""940"" left=""108"" width=""683"" height=""16"" font=""0"">the introduction or dissemination of foot-and-mouth disease within the United States"", which can </text>
<text top=""956"" left=""108"" width=""683"" height=""16"" font=""0"">be described as being higher than that achieved by the Terrestrial Code and somewhere between </text>
<text top=""972"" left=""108"" width=""130"" height=""16"" font=""0"">low and zero risk.  </text>
<footnote top=""1051"" left=""165"" width=""460"" height=""15"" font=""10"" number=""203"" ref="""" dis=""""/>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 140 - </text>
</p></p></page>
<page number=""140"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.6"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""28"">7.6.3  Whether the United States took into account the objective of minimizing negative </text><text top=""144"" left=""108"" width=""575"" height=""16"" font=""28"">trade effects when determining its appropriate level of sanitary protection  </text></p><p number=""7.6"" style=""8""><text top=""178"" left=""108"" width=""286"" height=""16"" font=""28"">7.6.4  Main arguments of the parties  </text></p><p number=""7.6"" style=""8""><text top=""213"" left=""108"" width=""141"" height=""16"" font=""28"">7.6.4.1  Argentina </text></p><p number=""7.388"" style=""8""><text top=""247"" left=""108"" width=""683"" height=""16"" font=""0"">7.388.  Argentina argues that the application by the United States of the prohibition on imports of </text>
<text top=""264"" left=""108"" width=""682"" height=""16"" font=""0"">fresh (chilled or frozen) bovine meat from Argentina, as contained in 9 CFR 94.1(b), is inconsistent </text>
<text top=""280"" left=""108"" width=""682"" height=""16"" font=""0"">with the United States' obligations under Article 5.4 of the SPS Agreement. According to Argentina, </text>
<text top=""296"" left=""108"" width=""682"" height=""16"" font=""0"">this is because, in the imposition of the prohibition, the United States did not take into account the </text>
<text top=""313"" left=""108"" width=""320"" height=""16"" font=""0"">objective of minimizing negative trade effects. </text>
</p><p number=""7.389"" style=""8""><text top=""347"" left=""108"" width=""686"" height=""16"" font=""0"">7.389.  Argentina acknowledges the conclusion of the only panel so far to have substantively </text>
<text top=""364"" left=""108"" width=""685"" height=""16"" font=""0"">considered this provision &#8211; <i>EC  </i>&#8211;<i> Hormones</i> &#8211; that Article 5.4 does not impose an affirmative </text>
<text top=""380"" left=""108"" width=""684"" height=""16"" font=""0"">obligation. In particular, Argentina accepts that the <i>EC &#8211; Hormones </i>panel focused on the use of </text>
<text top=""396"" left=""108"" width=""685"" height=""16"" font=""0"">the term ""should"" rather than ""shall"" in the provision and the reference to an ""objective"", but </text>
<text top=""413"" left=""108"" width=""682"" height=""16"" font=""0"">argues nonetheless that the drafters would not have inserted a paragraph in the middle of Article 5 </text>
<text top=""429"" left=""108"" width=""195"" height=""16"" font=""0"">that had no operative effect.</text>
<footnote top=""428"" left=""302"" width=""17"" height=""11"" font=""16"" number=""982"" ref="""" dis=""""/>
</p><p number=""7.390"" style=""8""><text top=""464"" left=""108"" width=""686"" height=""16"" font=""0"">7.390.  According to Argentina, the United States fails to meet the Article 5.4 requirement of </text>
<text top=""480"" left=""108"" width=""682"" height=""16"" font=""0"">taking into account the objective of minimizing negative trade effects because it does not establish </text>
<text top=""497"" left=""108"" width=""221"" height=""16"" font=""0"">its ALOP in a coherent manner.</text>
<footnote top=""495"" left=""329"" width=""17"" height=""11"" font=""16"" number=""983"" ref="""" dis=""""/>
<text top=""497"" left=""346"" width=""446"" height=""16"" font=""0""> This is because, according to Argentina, it assigns one of five </text>
<text top=""513"" left=""108"" width=""682"" height=""16"" font=""0"">different categories of risk to a country/region and/or product on the basis of a number of different </text>
<text top=""529"" left=""108"" width=""51"" height=""16"" font=""0"">factors.</text>
<footnote top=""528"" left=""159"" width=""17"" height=""11"" font=""16"" number=""984"" ref="""" dis=""""/>
</p><p number=""7.391"" style=""8""><text top=""564"" left=""108"" width=""684"" height=""16"" font=""0"">7.391.  In addition, Argentina submits that the United States' ALOP process maximizes negative </text>
<text top=""580"" left=""108"" width=""684"" height=""16"" font=""0"">trade effects for Argentina because the United States singles out Argentine beef and imposes a </text>
<text top=""597"" left=""108"" width=""257"" height=""16"" font=""0"">zero risk ALOP just for Argentine beef</text>
<footnote top=""595"" left=""365"" width=""17"" height=""11"" font=""16"" number=""985"" ref="""" dis=""""/>
<text top=""597"" left=""383"" width=""407"" height=""16"" font=""0"">, whereas, the United States ""has demonstrated by actions </text>
<text top=""613"" left=""108"" width=""683"" height=""16"" font=""0"">that it can take actual steps to reduce the negative trade effects of its approach by adopting an </text>
<text top=""629"" left=""108"" width=""660"" height=""16"" font=""0"">appropriate level of protection in regard to other countries in the region, such as Uruguay"".</text>
<footnote top=""628"" left=""768"" width=""17"" height=""11"" font=""16"" number=""986"" ref="""" dis=""""/>
<text top=""646"" left=""108"" width=""685"" height=""16"" font=""0"">According to Argentina, the United States has assigned risk levels and protocols and provided </text>
<text top=""662"" left=""108"" width=""683"" height=""16"" font=""0"">Uruguay with permission to import, even though APHIS does not recognize Uruguay as FMD-free. </text>
<text top=""679"" left=""108"" width=""683"" height=""16"" font=""0"">All of this is despite the fact that the OIE has classified both Argentina and Uruguay as FMD-free </text>
<text top=""695"" left=""108"" width=""688"" height=""16"" font=""0"">where vaccination is practised which, in Argentina's view, means that their situations are </text>
<text top=""711"" left=""108"" width=""50"" height=""16"" font=""0"">similar.</text>
<footnote top=""710"" left=""158"" width=""17"" height=""11"" font=""16"" number=""987"" ref="""" dis=""""/>
<text top=""711"" left=""175"" width=""616"" height=""16"" font=""0""> As for the United States' ALOP &#8211; 7 USC 8303(a) &#8211; Argentina argues that this is not an </text>
<text top=""728"" left=""108"" width=""682"" height=""16"" font=""0"">ALOP, but rather a statute that accords ""unfettered discretion"" to the Secretary of Agriculture with </text>
<text top=""744"" left=""108"" width=""417"" height=""16"" font=""0"">respect to acceptable levels of FMD risk and its related ALOP.</text>
<footnote top=""743"" left=""525"" width=""17"" height=""11"" font=""16"" number=""988"" ref="""" dis=""""/>
</p><p number=""7.6"" style=""8""><text top=""779"" left=""108"" width=""174"" height=""16"" font=""28"">7.6.4.2  United States  </text></p><p number=""7.392"" style=""8""><text top=""813"" left=""108"" width=""688"" height=""16"" font=""0"">7.392.  The United States disagrees with Argentina's contention that Article 5.4 imposes an </text>
<text top=""829"" left=""108"" width=""155"" height=""16"" font=""0"">affirmative obligation.</text>
<footnote top=""828"" left=""263"" width=""17"" height=""11"" font=""16"" number=""989"" ref="""" dis=""""/>
<text top=""829"" left=""280"" width=""515"" height=""16"" font=""0""> First, it contends that the verb ""should"", unlike ""shall"", expresses </text>
<text top=""846"" left=""108"" width=""232"" height=""16"" font=""0"">exhortation and not an obligation.</text>
<footnote top=""844"" left=""340"" width=""17"" height=""11"" font=""16"" number=""990"" ref="""" dis=""""/>
<text top=""846"" left=""357"" width=""433"" height=""16"" font=""0""> Second, ""take into account"" relates to a consideration and not </text>
<text top=""862"" left=""108"" width=""235"" height=""16"" font=""0"">an outcome of that consideration.</text>
<footnote top=""861"" left=""343"" width=""17"" height=""11"" font=""16"" number=""991"" ref="""" dis=""""/>
<text top=""862"" left=""360"" width=""431"" height=""16"" font=""0""> Third, ""should"" ""be take[n] into account"" indicates a goal or </text>
<text top=""879"" left=""108"" width=""171"" height=""16"" font=""0"">aim and not an outcome.</text>
<footnote top=""877"" left=""279"" width=""17"" height=""11"" font=""16"" number=""992"" ref="""" dis=""""/>
<p><text top=""963"" left=""165"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 292-293. </text>
<footnote top=""978"" left=""165"" width=""293"" height=""15"" font=""10"" number=""295"" ref="""" dis=""""/>
<footnote top=""1007"" left=""165"" width=""293"" height=""15"" font=""10"" number=""299"" ref="""" dis=""""/>
</p><p><text top=""1022"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 300. </text>
</p><p><text top=""1051"" left=""165"" width=""583"" height=""15"" font=""10""> Argentina's response to Panel question No. 40 following the first substantive meeting. See also </text>
<text top=""1066"" left=""108"" width=""308"" height=""15"" font=""10"">Argentina's second written submission, para. 153. </text>
<text top=""1080"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 282. </text>
<footnote top=""1095"" left=""165"" width=""310"" height=""15"" font=""10"" number=""283"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 141 - </text>
</p></p></page>
<page number=""141"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.393"" style=""8""><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">7.393.  The United States also contends that Argentina's argument that Article 5.4 must have </text>
<text top=""144"" left=""108"" width=""128"" height=""16"" font=""0"">operative meaning</text>
<footnote top=""143"" left=""236"" width=""17"" height=""11"" font=""16"" number=""993"" ref="""" dis=""""/>
<text top=""144"" left=""253"" width=""538"" height=""16"" font=""0""> and its consequent urging the Panel to disagree with the conclusions of the </text>
<text top=""160"" left=""108"" width=""624"" height=""16"" font=""0"">panel in <i>EC  </i>&#8211;<i> Hormones</i> is ""mere assertion, without basis in reasoning or law"".</text>
<footnote top=""159"" left=""731"" width=""17"" height=""11"" font=""16"" number=""994"" ref="""" dis=""""/>
<text top=""160"" left=""749"" width=""48"" height=""16"" font=""0""> The </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">United States dismisses Argentina's argument that review of regulations for economic effects in a </text>
<text top=""193"" left=""108"" width=""692"" height=""16"" font=""0"">rulemaking process makes it ""susceptible to non-science-based political and economic </text>
<text top=""210"" left=""108"" width=""77"" height=""16"" font=""0"">pressures"".</text>
<footnote top=""208"" left=""185"" width=""17"" height=""11"" font=""16"" number=""995"" ref="""" dis=""""/>
<text top=""210"" left=""202"" width=""588"" height=""16"" font=""0""> The United States also maintains that Argentina has not connected its allegations to </text>
<text top=""226"" left=""108"" width=""337"" height=""16"" font=""0"">the purpose of Article 5.4: determining the ALOP.</text>
<footnote top=""225"" left=""445"" width=""17"" height=""11"" font=""16"" number=""996"" ref="""" dis=""""/>
</p><p number=""7.6"" style=""8""><text top=""260"" left=""108"" width=""322"" height=""16"" font=""28"">7.6.5  Main arguments of the third parties </text></p><p number=""7.6"" style=""8""><text top=""295"" left=""108"" width=""135"" height=""16"" font=""28"">7.6.5.1  Australia </text></p><p number=""7.394"" style=""8""><text top=""329"" left=""108"" width=""685"" height=""16"" font=""0"">7.394.  Australia agrees with the United States that Article 5.4 of the SPS Agreement does not </text>
<text top=""346"" left=""108"" width=""224"" height=""16"" font=""0"">impose an affirmative obligation.</text>
<footnote top=""344"" left=""332"" width=""17"" height=""11"" font=""16"" number=""997"" ref="""" dis=""""/>
</p><p number=""7.6"" style=""8""><text top=""380"" left=""108"" width=""187"" height=""16"" font=""28"">7.6.5.2  European Union </text></p><p number=""7.395"" style=""8""><text top=""414"" left=""108"" width=""684"" height=""16"" font=""0"">7.395.  The European Union requests the Panel to reject the Article 5.4 claims, considering that </text>
<text top=""431"" left=""108"" width=""685"" height=""16"" font=""0"">the panel's conclusion in <i>EC &#8211; Hormones</i> is correct, for the reasons discussed in that panel's </text>
<text top=""447"" left=""108"" width=""46"" height=""16"" font=""0"">report.</text>
<footnote top=""446"" left=""154"" width=""17"" height=""11"" font=""16"" number=""998"" ref="""" dis=""""/>
</p><p number=""7.6"" style=""8""><text top=""482"" left=""108"" width=""214"" height=""16"" font=""28"">7.6.6  Analysis by the Panel </text></p><p number=""7.396"" style=""8""><text top=""516"" left=""108"" width=""687"" height=""16"" font=""0"">7.396.  Argentina claims that the United States failed to take into account the objective of </text>
<text top=""533"" left=""108"" width=""685"" height=""16"" font=""0"">minimizing negative trade effects when determining its ALOP and that this is inconsistent with </text>
<text top=""549"" left=""108"" width=""682"" height=""16"" font=""0"">Article 5.4 of the SPS Agreement. The Panel recalls that Article 5.4 provides that ""Members should, </text>
<text top=""565"" left=""108"" width=""683"" height=""16"" font=""0"">when determining the appropriate level of sanitary or phytosanitary protection, take into account </text>
<text top=""582"" left=""108"" width=""353"" height=""16"" font=""0"">the objective of minimizing negative trade effects."" </text>
</p><p number=""7.397"" style=""8""><text top=""616"" left=""108"" width=""682"" height=""16"" font=""0"">7.397.  The only other panel to address a claim under Article 5.4 was the panel in <i>EC &#8211; Hormones. </i></text>
<text top=""633"" left=""108"" width=""687"" height=""16"" font=""0"">That panel examined the language in Article 5.4 of the SPS Agreement and concluded that </text>
<text top=""649"" left=""108"" width=""475"" height=""16"" font=""0"">Article 5.4 does not impose an affirmative obligation on Members.</text>
<footnote top=""647"" left=""583"" width=""17"" height=""11"" font=""16"" number=""999"" ref=""WT/DS26/R/USA"" dis=""DS26""><ftext top=""1022"" left=""165"" width=""613"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Hormones (Canada)</i>, para. 8.169; <i>EC &#8211; Hormones (US)</i>, para. 8.166. However, </ftext>
<ftext top=""1036"" left=""108"" width=""645"" height=""15"" font=""10"">the panel explained that the objective of minimizing negative trade effects is nonetheless to be taken into </ftext>
<ftext top=""1051"" left=""108"" width=""436"" height=""15"" font=""10"">account in the interpretation of other provisions of the SPS Agreement. </ftext>
</footnote>
<text top=""649"" left=""600"" width=""193"" height=""16"" font=""0""> The panel's analysis was </text>
<text top=""665"" left=""108"" width=""602"" height=""16"" font=""0"">centred on the use of the words ""should"" (as opposed to ""shall"") and ""objective""</text>
<footnote top=""664"" left=""710"" width=""23"" height=""11"" font=""16"" number=""1000"" ref=""WT/DS26/R/USA"" dis=""DS26""><ftext top=""1066"" left=""170"" width=""551"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Hormones (Canada)</i>, para. 8.169; <i>EC &#8211; Hormones (US)</i>, para. 8.166. </ftext>
</footnote>
<text top=""665"" left=""733"" width=""61"" height=""16"" font=""0""> in the </text>
<text top=""682"" left=""108"" width=""71"" height=""16"" font=""0"">provision. </text>
</p><p number=""7.398"" style=""8""><text top=""716"" left=""108"" width=""683"" height=""16"" font=""0"">7.398.   Argentina contends that this Panel should depart from the reasoning of the panel in <i>EC &#8211; </i></text>
<text top=""733"" left=""108"" width=""688"" height=""16"" font=""18""><i>Hormones  </i>because a proper interpretation of the word ""should"" would impart a stronger </text>
<text top=""749"" left=""108"" width=""686"" height=""16"" font=""0"">connotation and thus a positive obligation on the part of importing Members. In particular, </text>
<text top=""765"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina relies on the Appellate Body Report in <i>Canada &#8211; Aircraft, </i>which was adopted after the </text>
<text top=""782"" left=""108"" width=""684"" height=""16"" font=""0"">panel report in <i>EC &#8211; Hormones</i>, in which the Appellate Body said that the word ""should"" is not </text>
<text top=""798"" left=""108"" width=""654"" height=""16"" font=""0"">always used to imply an exhortation, but can also be used ""to express a duty [or] obligation"".</text>
<footnote top=""797"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1001"" ref="""" dis=""""/>
<text top=""815"" left=""108"" width=""683"" height=""16"" font=""0"">In that case, the Appellate Body examined the word ""should"" in the context of the whole of the </text>
<text top=""831"" left=""108"" width=""684"" height=""16"" font=""0"">provision at issue (Article 13 of the DSU) and concluded that it was used in a normative rather </text>
<text top=""847"" left=""108"" width=""162"" height=""16"" font=""0"">than exhortative sense.</text>
<footnote top=""846"" left=""270"" width=""27"" height=""11"" font=""16"" number=""1002"" ref="""" dis=""""/>
<text top=""847"" left=""296"" width=""494"" height=""16"" font=""0""> The Appellate Body reached a similar conclusion about the meaning of </text>
<text top=""864"" left=""108"" width=""608"" height=""16"" font=""0"">the word ""should"" in Article 11 of the DSU in its report on <i>Mexico &#8211; Taxes on Soft Drinks</i>.</text>
<footnote top=""862"" left=""716"" width=""26"" height=""11"" font=""16"" number=""1003"" ref="""" dis=""""/>
<p><text top=""920"" left=""165"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 294. </text>
<text top=""934"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 284. </text>
<footnote top=""949"" left=""165"" width=""569"" height=""15"" font=""10"" number=""285"" ref="""" dis=""""/>
</p><p><text top=""963"" left=""108"" width=""67"" height=""15"" font=""10"">para. 297. </text>
</p><p><text top=""993"" left=""165"" width=""275"" height=""15"" font=""10""> Australia's third-party submission, para. 21. </text>
<footnote top=""1007"" left=""165"" width=""318"" height=""15"" font=""10"" number=""51"" ref=""WT/DS60/R"" dis=""DS60|DS70""><ftext top=""1124"" left=""108"" width=""681"" height=""15"" font=""12""><i>Canada &#8211; Aircraft</i>, para. 187). See also Panel Report, <i>Guatemala &#8211; Cement II</i>, fn 854 to para. 8.196 (""Although </ftext>
</footnote>
<footnote top=""1080"" left=""170"" width=""328"" height=""15"" font=""10"" number=""187"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 142 - </text>
</p></p></page>
<page number=""142"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.399"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.399.  The Appellate Body acknowledged in both of these reports that the word ""should"" may be </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">used in <i>either </i>the exhortative or normative sense. Therefore, just as the use of the word ""should"" </text>
<text top=""160"" left=""108"" width=""685"" height=""16"" font=""0"">is not always used to imply an exhortation, it is also not always used to express a duty or </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">obligation. Indeed, in <i>Canada &#8211; Aircraft, </i>the Appellate Body explained that its conclusion as to the </text>
<text top=""193"" left=""108"" width=""655"" height=""16"" font=""0"">meaning of the word ""should"" in Article 13.1 was based on the context of Article 13 as a whole. </text>
</p><p number=""7.400"" style=""8""><text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">7.400.  Applying the guidance of the Appellate Body from <i>Canada &#8211; Aircraft </i>and <i>Mexico &#8211; Taxes on </i></text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""18""><i>Soft Drinks </i>does not mandate a conclusion that the panel in <i>EC &#8211; Hormones </i>was incorrect and that </text>
<text top=""260"" left=""108"" width=""688"" height=""16"" font=""0"">Article 5.4 imposes an affirmative obligation. Rather, the Panel must undertake a similar </text>
<text top=""277"" left=""108"" width=""453"" height=""16"" font=""0"">contextual analysis to the use of the word ""should"" in Article 5.4.  </text>
</p><p number=""7.401"" style=""8""><text top=""311"" left=""108"" width=""682"" height=""16"" font=""0"">7.401.  Article 5.4 states that WTO Members <i>should</i> ""take into account the objective of minimizing </text>
<text top=""328"" left=""108"" width=""685"" height=""16"" font=""0"">negative trade effects"" when determining the ALOP. Prior panels and the Appellate Body have </text>
<text top=""344"" left=""108"" width=""298"" height=""16"" font=""0"">interpreted the phrase ""take into account""</text>
<footnote top=""343"" left=""406"" width=""23"" height=""11"" font=""16"" number=""1004"" ref="""" dis=""""><ftext top=""861"" left=""170"" width=""454"" height=""15"" font=""10""> Or similar phrases such as ""taking into account"" and ""taking account of"".  </ftext>
</footnote>
<text top=""344"" left=""429"" width=""297"" height=""16"" font=""0""> to mean ""take into consideration, notice""</text>
<footnote top=""343"" left=""725"" width=""23"" height=""11"" font=""16"" number=""1005"" ref="""" dis=""""/>
<text top=""344"" left=""749"" width=""43"" height=""16"" font=""0"">. The </text>
<text top=""360"" left=""108"" width=""685"" height=""16"" font=""0"">panel in <i>US &#8211; COOL </i>also clarified that an obligation to take something into account does not </text>
<text top=""377"" left=""108"" width=""343"" height=""16"" font=""0"">require any particular result of that consideration.</text>
<footnote top=""375"" left=""451"" width=""23"" height=""11"" font=""16"" number=""1006"" ref=""WT/DS384/RW ; WT/DS386/RW|WT/DS384/RW/Add.1 ; WT/DS386/RW/Add.1|WT/DS384/R ; WT/DS386/R"" dis=""DS384|DS386""><ftext top=""905"" left=""170"" width=""244"" height=""15"" font=""10""> Panel Report, <i>US &#8211; COOL</i>, para. 7.776. </ftext>
</footnote>
<text top=""377"" left=""474"" width=""316"" height=""16"" font=""0""> In the case of Article 5.4, it is the ""objective </text>
<text top=""393"" left=""108"" width=""682"" height=""16"" font=""0"">of minimizing negative trade effects"" that must be taken into account or considered. The Appellate </text>
<text top=""410"" left=""108"" width=""505"" height=""16"" font=""0"">Body in <i>US &#8211; Tuna II (Mexico) </i>noted that an ""objective"" is an aim or goal.</text>
<footnote top=""408"" left=""612"" width=""23"" height=""11"" font=""16"" number=""1007"" ref="""" dis=""""/>
</p><p number=""7.402"" style=""8""><text top=""444"" left=""108"" width=""686"" height=""16"" font=""0"">7.402.  Following the guidance in <i>Canada &#8211; Aircraft</i> and <i>Mexico &#8211; Taxes on Soft Drinks</i>, we </text>
<text top=""461"" left=""108"" width=""684"" height=""16"" font=""0"">examine the use of the word ""should"" in the context of Article 5.4 as a whole, a provision that </text>
<text top=""477"" left=""108"" width=""682"" height=""16"" font=""0"">refers to consideration of a goal without needing to arrive at a particular result. It is difficult in this </text>
<text top=""493"" left=""108"" width=""684"" height=""16"" font=""0"">light to conclude that the word ""should"" as used in Article 5.4 is intended to impose a positive </text>
<text top=""510"" left=""108"" width=""169"" height=""16"" font=""0"">obligation on Members.  </text>
</p><p number=""7.403"" style=""8""><text top=""544"" left=""108"" width=""686"" height=""16"" font=""0"">7.403.  This understanding is reinforced by examining the broader context of the rest of the </text>
<text top=""561"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Agreement. The SPS Agreement contains five instances of the use the word ""should"", whereas </text>
<text top=""577"" left=""108"" width=""682"" height=""16"" font=""0"">the word ""shall"" is used 37 times, illustrating to us that the use of ""should"" as opposed to ""shall"" in </text>
<text top=""593"" left=""108"" width=""685"" height=""16"" font=""0"">any particular provision of this Agreement was a deliberate choice. Moreover, the word ""shall"" </text>
<text top=""610"" left=""108"" width=""147"" height=""16"" font=""0"">appears in Article 5.5</text>
<footnote top=""608"" left=""254"" width=""23"" height=""11"" font=""16"" number=""1008"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""135"" height=""15"" font=""10""> Article 5.5 provides:  </ftext>
<ftext top=""949"" left=""151"" width=""585"" height=""15"" font=""10"">With the objective of achieving consistency in the application of the concept of appropriate level </ftext>
<ftext top=""963"" left=""151"" width=""568"" height=""15"" font=""10"">of sanitary or phytosanitary protection against risks to human life or health, or to animal and </ftext>
<ftext top=""978"" left=""151"" width=""586"" height=""15"" font=""10"">plant life or health, each Member <i>shall </i>avoid arbitrary or unjustifiable distinctions in the levels it </ftext>
<ftext top=""993"" left=""151"" width=""593"" height=""15"" font=""10"">considers to be appropriate in different situations, if such distinctions result in discrimination or a </ftext>
<ftext top=""1007"" left=""151"" width=""548"" height=""15"" font=""10"">disguised restriction on international trade. Members <i>shall</i> cooperate in the Committee, in </ftext>
<ftext top=""1022"" left=""151"" width=""595"" height=""15"" font=""10"">accordance with paragraphs 1, 2 and 3 of Article 12, to develop guidelines to further the practical </ftext>
<ftext top=""1036"" left=""151"" width=""566"" height=""15"" font=""10"">implementation of this provision. In developing the guidelines, the Committee <i>shall</i> take into </ftext>
<ftext top=""1051"" left=""151"" width=""578"" height=""15"" font=""10"">account all relevant factors, including the exceptional character of human health risks to which </ftext>
<ftext top=""1066"" left=""151"" width=""348"" height=""15"" font=""10"">people voluntarily expose themselves. (emphasis added) </ftext>
</footnote>
<text top=""610"" left=""277"" width=""105"" height=""16"" font=""0""> and Article 5.6</text>
<footnote top=""608"" left=""383"" width=""23"" height=""11"" font=""16"" number=""1009"" ref="""" dis=""""/>
<text top=""610"" left=""406"" width=""385"" height=""16"" font=""0""> &#8211; provisions immediately following Article 5.4 and also </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">dealing with the ALOP. The decision of the negotiators to use the word ""should"" in Article 5.4 and </text>
<text top=""643"" left=""108"" width=""683"" height=""16"" font=""0"">then ""shall"" in Articles 5.5 and 5.6 must be given meaning. We consider that to impart the word </text>
<text top=""659"" left=""108"" width=""684"" height=""16"" font=""0"">""should"" in this context with other than an exhortative meaning would frustrate the intention of </text>
<text top=""675"" left=""108"" width=""685"" height=""16"" font=""0"">the negotiators of the SPS Agreement and could result in the Panel adding to the rights and </text>
<text top=""692"" left=""108"" width=""683"" height=""16"" font=""0"">obligations provided in the covered agreements, contrary to the requirements of Article 3.2 of the </text>
<text top=""708"" left=""108"" width=""44"" height=""16"" font=""0"">DSU.  </text>
</p><p number=""7.404"" style=""8""><text top=""743"" left=""108"" width=""682"" height=""16"" font=""0"">7.404.  In sum, having regard to the language of the whole provision as well as the context of the </text>
<text top=""759"" left=""108"" width=""682"" height=""16"" font=""0"">other provisions on the ALOP and the rest of the SPS Agreement, the Panel concludes that the use </text>
<text top=""775"" left=""108"" width=""683"" height=""16"" font=""0"">of the word ""should"" cannot be read as imposing an affirmative obligation on WTO Members such </text>
<text top=""792"" left=""108"" width=""683"" height=""16"" font=""0"">that they must or shall take into account the objective of minimizing negative trade effects when </text>
<p><text top=""832"" left=""108"" width=""668"" height=""15"" font=""10"">the word 'should' is often used colloquially to imply an exhortation, it can also be used 'to express a duty [or] </text>
<text top=""847"" left=""108"" width=""82"" height=""15"" font=""10"">obligation.'"") </text>
</p><p><text top=""876"" left=""170"" width=""603"" height=""15"" font=""10""> Appellate Body Report, <i>Korea &#8211; Various Measures on Beef</i>, para. 111; see also Panel Report, <i>US &#8211; </i></text>
<text top=""891"" left=""108"" width=""122"" height=""15"" font=""12""><i>COOL</i>, para. 7.776. </text>
</p><p><text top=""920"" left=""170"" width=""352"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Tuna II (Mexico)</i>, para. 313 </text>
</p><p><text top=""1080"" left=""170"" width=""131"" height=""15"" font=""10""> Article 5.6 provides: </text>
<text top=""1095"" left=""151"" width=""638"" height=""15"" font=""10"">&#8230;Members <i>shall</i> ensure that such measures are not more trade-restrictive than required to achieve their </text>
<text top=""1109"" left=""151"" width=""612"" height=""15"" font=""10"">appropriate level of sanitary or phytosanitary protection, taking into account technical and economic </text>
<text top=""1124"" left=""151"" width=""289"" height=""15"" font=""10"">feasibility. (footnote omitted, emphasis added) </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 143 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">determining their appropriate level of protection. Therefore, we see no compelling reasons to </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">depart from the reasoning of the panel in <i>EC &#8211; Hormones</i>, and conclude that Article 5.4 does not </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">impose a positive obligation. Thus, the Panel will not make findings with respect to whether the </text>
<text top=""177"" left=""108"" width=""303"" height=""16"" font=""0"">United States has complied with Article 5.4. </text>
</p></p></page>
<page number=""143"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.405"" style=""8""><text top=""211"" left=""108"" width=""686"" height=""16"" font=""0"">7.405.  Assuming, however, for the sake of argument that Article 5.4 does impose a positive </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">obligation, in our view Argentina's claim must nevertheless fail because it has not made a <i>prima </i></text>
<text top=""244"" left=""108"" width=""685"" height=""16"" font=""18""><i>facie  </i>case that the United States failed to consider the objective of minimizing negative trade </text>
<text top=""260"" left=""108"" width=""248"" height=""16"" font=""0"">effects when determining its ALOP.  </text>
</p><p number=""7.406"" style=""8""><text top=""295"" left=""108"" width=""684"" height=""16"" font=""0"">7.406.  In this regard, we recall that the Appellate Body has concluded that generally accepted </text>
<text top=""311"" left=""108"" width=""684"" height=""16"" font=""0"">canons of evidence (in civil law, common law, and, in fact, in most jurisdictions) apply in WTO </text>
<text top=""328"" left=""108"" width=""685"" height=""16"" font=""0"">dispute settlement, i.e. that the burden of proof rests upon the party, whether complaining or </text>
<text top=""344"" left=""108"" width=""493"" height=""16"" font=""0"">defending, who asserts the affirmative of a particular claim or defence.</text>
<footnote top=""343"" left=""601"" width=""23"" height=""11"" font=""16"" number=""1010"" ref=""WT/DS103/AB/RW ; WT/DS113/AB/RW|WT/DS33/AB/R|WT/DS103/AB/R ; WT/DS113/AB/R|WT/DS103/AB/R/Corr.2 ; WT/DS113/AB/R/Corr.2|WT/DS33/AB/R/Corr.1|WT/DS103/AB/R/Corr.1 ; WT/DS113/AB/R/Corr.1|WT/DS103/AB/RW2 ; WT/DS113/AB/RW2"" dis=""DS103|DS33|DS113""><ftext top=""1007"" left=""170"" width=""603"" height=""15"" font=""10""> Appellate Body Report, <i>Canada &#8211; Dairy (Article 21.5 &#8211; New Zealand and US II)</i>, para. 66; see also </ftext>
<ftext top=""1022"" left=""108"" width=""553"" height=""15"" font=""10"">Appellate Body Report, <i>US &#8211; Wool Shirts and Blouses</i>, p. 14, DSR 1997:I, 323 at 335-337. </ftext>
</footnote>
<text top=""344"" left=""624"" width=""166"" height=""16"" font=""0""> To make a <i>prima facie</i> </text>
<text top=""360"" left=""108"" width=""686"" height=""16"" font=""0"">case, a complaining party must present sufficient evidence that, ""in the absence of effective </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">refutation  by  the  defending  party,  requires  a  panel,  as  a  matter  of  law,  to  rule  in  favour  of  the </text>
<text top=""393"" left=""108"" width=""378"" height=""16"" font=""0"">complaining party presenting the prima facie case.""</text>
<footnote top=""392"" left=""486"" width=""23"" height=""11"" font=""16"" number=""1011"" ref="""" dis=""""/>
<text top=""393"" left=""509"" width=""285"" height=""16"" font=""0""> Pursuant to this understanding, it is </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina that bears the burden of proving that the United States did not take into account the </text>
<text top=""426"" left=""108"" width=""571"" height=""16"" font=""0"">objective of minimizing negative trade effects when it determined its ALOP for FMD.</text>
<footnote top=""425"" left=""679"" width=""23"" height=""11"" font=""16"" number=""1012"" ref="""" dis=""""/>
</p><p number=""7.407"" style=""8""><text top=""461"" left=""108"" width=""682"" height=""16"" font=""0"">7.407.  In support of its claims, the only evidence Argentina offers with a view to proving that the </text>
<text top=""477"" left=""108"" width=""683"" height=""16"" font=""0"">United States failed to consider the objective of minimizing negative trade effects is to point out </text>
<text top=""493"" left=""108"" width=""683"" height=""16"" font=""0"">that the United States did not in fact adopt an ALOP that, in Argentina's view, actually minimizes </text>
<text top=""510"" left=""108"" width=""159"" height=""16"" font=""0"">negative trade effects.</text>
<footnote top=""508"" left=""267"" width=""23"" height=""11"" font=""16"" number=""1013"" ref="""" dis=""""/>
<text top=""510"" left=""290"" width=""503"" height=""16"" font=""0""> As noted above, we disagree with Argentina that the United States' </text>
<text top=""526"" left=""108"" width=""685"" height=""16"" font=""0"">ALOP for FMD is not sufficiently clear to apply the SPS Agreement, and that the United States </text>
<text top=""543"" left=""108"" width=""683"" height=""16"" font=""0"">applies an ALOP for Argentina that is ""as if"" it were zero. Even assuming that Argentina is correct </text>
<text top=""559"" left=""108"" width=""686"" height=""16"" font=""0"">that the United States' ALOP is ""as if"" it were zero, this is not sufficient to prove that the </text>
<text top=""575"" left=""108"" width=""683"" height=""16"" font=""0"">United States did not take into account the objective of minimizing negative trade effects when it </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">determined that ALOP. The Appellate Body confirmed in <i>Australia &#8211; Salmon </i>that a WTO Member </text>
<text top=""608"" left=""108"" width=""191"" height=""16"" font=""0"">may set its ALOP at zero.</text>
<footnote top=""607"" left=""299"" width=""23"" height=""11"" font=""16"" number=""1014"" ref="""" dis=""""/>
<text top=""608"" left=""322"" width=""472"" height=""16"" font=""0""> As a zero ALOP would permit the most highly-trade restrictive </text>
<text top=""625"" left=""108"" width=""684"" height=""16"" font=""0"">measures possible, we do not see how a coherent reading of the SPS Agreement could permit a </text>
<text top=""641"" left=""108"" width=""682"" height=""16"" font=""0"">zero ALOP and yet allow another Member to use the adoption of that ALOP as the only evidence in </text>
<text top=""657"" left=""108"" width=""309"" height=""16"" font=""0"">support of a claim of violation of Article 5.4.  </text>
</p><p number=""7.408"" style=""8""><text top=""692"" left=""108"" width=""687"" height=""16"" font=""0"">7.408.  Furthermore, we recall that the concept of ""take into account"" does not mandate a </text>
<text top=""708"" left=""108"" width=""687"" height=""16"" font=""0"">particular result. Thus, the adoption of the least trade-restrictive ALOP is not required by </text>
<text top=""725"" left=""108"" width=""682"" height=""16"" font=""0"">Article 5.4. Our understanding is confirmed by the right of Members to determine their own ALOP, </text>
<text top=""741"" left=""108"" width=""492"" height=""16"" font=""0"">which has been re-affirmed by multiple panels and the Appellate Body.</text>
<footnote top=""739"" left=""600"" width=""23"" height=""11"" font=""16"" number=""1015"" ref="""" dis=""""/>
<text top=""741"" left=""623"" width=""167"" height=""16"" font=""0""> We find that Argentina </text>
<text top=""757"" left=""108"" width=""682"" height=""16"" font=""0"">has not made a <i>prima facie</i> case that the United States failed to take into account the objective of </text>
<text top=""774"" left=""108"" width=""429"" height=""16"" font=""0"">minimizing negative trade effects when determining its ALOP.  </text>
</p><p number=""7.6"" style=""8""><text top=""808"" left=""108"" width=""149"" height=""16"" font=""28"">7.6.6.1  Conclusion </text></p><p number=""7.409"" style=""8""><text top=""843"" left=""108"" width=""682"" height=""16"" font=""0"">7.409.  In sum, the Panel agrees with the panel in <i>EC &#8211; Hormones </i>that Article 5.4 does not impose </text>
<text top=""859"" left=""108"" width=""683"" height=""16"" font=""0"">a positive obligation on Members. Our conclusion was reached following an analysis of the use of </text>
<text top=""875"" left=""108"" width=""683"" height=""16"" font=""0"">the term ""should"" in the context of Article 5.4 as a whole and in the rest of the SPS Agreement. </text>
<text top=""892"" left=""108"" width=""682"" height=""16"" font=""0"">Even assuming, for the sake of the argument, that Argentina could raise a claim under Article 5.4, </text>
<text top=""908"" left=""108"" width=""682"" height=""16"" font=""0"">we find that it has not made a <i>prima facie</i> case as the only evidence and argumentation it has put </text>
<text top=""925"" left=""108"" width=""688"" height=""16"" font=""0"">forward in support of its position is the deduction that because, in Argentina's view, the </text>
<text top=""941"" left=""108"" width=""686"" height=""16"" font=""0"">United States adopted a trade-restrictive ALOP, it must not have considered the objective of </text>
<text top=""958"" left=""108"" width=""436"" height=""16"" font=""0"">minimizing negative trade effects when determining that ALOP. </text>
<p><text top=""1036"" left=""170"" width=""316"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>,<i> </i>para. 104. </text>
<text top=""1051"" left=""170"" width=""375"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Wool Shirts and Blouses</i>, p. 14. </text>
<text top=""1066"" left=""170"" width=""618"" height=""15"" font=""10""> Argentina's second written submission, para. 152; Argentina argues that ""[t]he United States <i>should </i></text>
<text top=""1080"" left=""108"" width=""391"" height=""15"" font=""10"">have adopted an ALOP which minimizes negative trade effects"". </text>
<text top=""1095"" left=""170"" width=""337"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 125. </text>
<text top=""1109"" left=""170"" width=""577"" height=""15"" font=""10""> See Appellate Body Reports, <i>EC &#8211; Hormones</i>,<i> </i>para. 172; <i>US/Canada &#8211; Continued Suspension</i>,<i> </i></text>
<text top=""1124"" left=""108"" width=""392"" height=""15"" font=""10"">para. 692; and Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.244. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 144 - </text>
</p></p></page>
<page number=""144"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.6"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""28"">7.6.7  Whether the United States' measures are more trade-restrictive than required to </text><text top=""144"" left=""108"" width=""248"" height=""16"" font=""28"">achieve the United States' ALOP </text></p><p number=""7.6"" style=""8""><text top=""178"" left=""108"" width=""262"" height=""16"" font=""28"">7.6.7.1  Relevant legal provisions  </text></p><p number=""7.410"" style=""8""><text top=""213"" left=""108"" width=""684"" height=""16"" font=""0"">7.410.  The SPS Agreement contains two provisions that relate to the obligation of ensuring that </text>
<text top=""229"" left=""108"" width=""684"" height=""16"" font=""0"">SPS measures are applied only to the extent required to achieve the regulating Member's ALOP. </text>
<text top=""246"" left=""108"" width=""570"" height=""16"" font=""0"">Article 2.2 of the SPS Agreement, setting forth the basic obligation at issue, reads: </text>
<p><text top=""280"" left=""151"" width=""599"" height=""16"" font=""0"">Members shall ensure that any sanitary or phytosanitary measure is applied only to </text>
<text top=""296"" left=""151"" width=""599"" height=""16"" font=""0"">the extent necessary to protect human, animal or plant life or health, is based on </text>
<text top=""313"" left=""151"" width=""597"" height=""16"" font=""0"">scientific principles and is not maintained without sufficient scientific evidence, except </text>
<text top=""329"" left=""151"" width=""295"" height=""16"" font=""0"">as provided for in paragraph 7 of Article 5. </text>
</p></p><p number=""7.411"" style=""8""><text top=""364"" left=""108"" width=""331"" height=""16"" font=""0"">7.411.  Article 5.6 of the SPS Agreement reads: </text>
<p><text top=""398"" left=""151"" width=""603"" height=""16"" font=""0"">Without prejudice to paragraph 2 of Article 3, when establishing or maintaining </text>
<text top=""414"" left=""151"" width=""600"" height=""16"" font=""0"">sanitary or phytosanitary measures to achieve the appropriate level of sanitary or </text>
<text top=""431"" left=""151"" width=""600"" height=""16"" font=""0"">phytosanitary protection, Members shall ensure that such measures are not more </text>
<text top=""447"" left=""151"" width=""603"" height=""16"" font=""0"">trade-restrictive than required to achieve their appropriate level of sanitary or </text>
<text top=""464"" left=""151"" width=""548"" height=""16"" font=""0"">phytosanitary protection, taking into account technical and economic feasibility. </text>
</p></p><p number=""7.412"" style=""8""><text top=""498"" left=""108"" width=""326"" height=""16"" font=""0"">7.412.  In turn, footnote 3 to Article 5.6 reads: </text>
<p><text top=""533"" left=""151"" width=""597"" height=""16"" font=""0"">For purposes of paragraph 6 of Article 5, a measure is not more trade-restrictive than </text>
<text top=""549"" left=""151"" width=""600"" height=""16"" font=""0"">required unless there is another measure, reasonably available taking into account </text>
<text top=""565"" left=""151"" width=""599"" height=""16"" font=""0"">technical and economic feasibility, that achieves the appropriate level of sanitary or </text>
<text top=""582"" left=""151"" width=""468"" height=""16"" font=""0"">phytosanitary protection and is significantly less restrictive to trade. </text>
</p></p><p number=""7.413"" style=""8""><text top=""616"" left=""108"" width=""682"" height=""16"" font=""0"">7.413.  As explained by the panel in <i>EC &#8211; Hormones</i>, Article 5.6 constitutes a ""specific application"" </text>
<text top=""633"" left=""108"" width=""512"" height=""16"" font=""0"">of the basic obligation provided in the first requirement of Article 2.2.</text>
<footnote top=""631"" left=""620"" width=""23"" height=""11"" font=""16"" number=""1016"" ref=""WT/DS26/R/USA"" dis=""DS26""><ftext top=""978"" left=""170"" width=""536"" height=""15"" font=""10""> Panel Reports, <i>EC &#8211; Hormones</i> <i>(Canada)</i>, para. 8.99; <i>EC &#8211; Hormones</i> <i>(US)</i>, para. 8.96. </ftext>
</footnote>
<text top=""633"" left=""643"" width=""150"" height=""16"" font=""0""> Therefore, we first </text>
<text top=""649"" left=""108"" width=""687"" height=""16"" font=""0"">address whether the United States' measures at issue are consistent with Article 5.6 before </text>
<text top=""665"" left=""108"" width=""565"" height=""16"" font=""0"">moving to an analysis of such measures under the first requirement of Article 2.2. </text>
</p><p number=""7.6"" style=""8""><text top=""700"" left=""108"" width=""296"" height=""16"" font=""28"">7.6.7.2  Main arguments of the parties </text></p><p number=""7.6"" style=""8""><text top=""734"" left=""108"" width=""156"" height=""16"" font=""28"">7.6.7.2.1  Argentina </text></p><p number=""7.414"" style=""8""><text top=""769"" left=""108"" width=""682"" height=""16"" font=""0"">7.414.  Argentina claims that the United States' measures are inconsistent with Article 5.6 because </text>
<text top=""785"" left=""108"" width=""684"" height=""16"" font=""0"">alternative measures are reasonably available to the United States, taking into account technical </text>
<text top=""801"" left=""108"" width=""682"" height=""16"" font=""0"">and economic feasibility, which would achieve its ALOP for FMD while being significantly less trade </text>
<text top=""818"" left=""108"" width=""589"" height=""16"" font=""0"">restrictive than the measures in force as of the time of the establishment of the Panel.</text>
<footnote top=""816"" left=""697"" width=""23"" height=""11"" font=""16"" number=""1017"" ref="""" dis=""""/>
</p><p number=""7.415"" style=""8""><text top=""852"" left=""108"" width=""683"" height=""16"" font=""0"">7.415.  With respect to the United States' prohibition on imports of fresh (chilled or frozen) beef, </text>
<text top=""869"" left=""108"" width=""687"" height=""16"" font=""0"">Argentina identifies the following alternative measures: (i) the import protocols set forth in </text>
<text top=""885"" left=""108"" width=""682"" height=""16"" font=""0"">Article 8.5.23 of the Terrestrial Code, which contains recommendations concerning the importation </text>
<text top=""901"" left=""108"" width=""443"" height=""16"" font=""0"">of meat from countries or zones where vaccination is practised</text>
<footnote top=""900"" left=""551"" width=""23"" height=""11"" font=""16"" number=""1018"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""565"" height=""15"" font=""10""> Argentina's first written submission, para. 307. Argentina also refers to Article 8.5.22 of the </ftext>
<ftext top=""1022"" left=""108"" width=""617"" height=""15"" font=""10"">Terrestrial Code, containing recommendations for importation of meat from countries or zones where </ftext>
<ftext top=""1036"" left=""108"" width=""637"" height=""15"" font=""10"">vaccination is not practiced. We understand that such a provision is not relevant to Argentina's claim, as </ftext>
<ftext top=""1051"" left=""108"" width=""651"" height=""15"" font=""10"">vaccination against FMD is practised in Northern Argentina. Our understanding finds support in Argentina's </ftext>
<ftext top=""1066"" left=""108"" width=""616"" height=""15"" font=""10"">second written submission, where Argentina clarifies that the provision of the Terrestrial Code whose </ftext>
<ftext top=""1080"" left=""108"" width=""643"" height=""15"" font=""10"">application it considers to be an alternative measure is that ""for imports of fresh beef from areas that are </ftext>
</footnote>
<text top=""901"" left=""574"" width=""218"" height=""16"" font=""0"">; and (ii) the import protocols </text>
<text top=""918"" left=""108"" width=""168"" height=""16"" font=""0"">set forth in 9 CFR 94.22.</text>
<footnote top=""916"" left=""276"" width=""23"" height=""11"" font=""16"" number=""1019"" ref="""" dis=""""/>
<p><text top=""993"" left=""170"" width=""298"" height=""15"" font=""10""> Argentina's first written submission, para. 305.  </text>
<footnote top=""1095"" left=""108"" width=""602"" height=""15"" font=""10"" number=""155"" ref="""" dis=""""/>
</p><p><text top=""1109"" left=""170"" width=""589"" height=""15"" font=""10""> Argentina's first written submission, para. 308. See also Argentina's second written submission, </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 145 - </text>
</p></p></page>
<page number=""145"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.416"" style=""8""><text top=""128"" left=""108"" width=""57"" height=""16"" font=""0"">7.416. </text>
<text top=""128"" left=""162"" width=""637"" height=""16"" font=""0"">Argentina contends that both sets of protocols are reasonably available to the </text>
<text top=""144"" left=""108"" width=""583"" height=""16"" font=""0"">United States, as evidenced by the fact that the former are recommended by the OIE</text>
<footnote top=""143"" left=""691"" width=""23"" height=""11"" font=""16"" number=""1020"" ref="""" dis=""""/>
<text top=""144"" left=""714"" width=""76"" height=""16"" font=""0"">, while the </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">latter are currently applied by APHIS to imports of fresh (chilled or frozen) beef from Uruguay and </text>
<text top=""177"" left=""108"" width=""461"" height=""16"" font=""0"">are similar to those APHIS applied to Argentine fresh beef in 1997.</text>
<footnote top=""175"" left=""569"" width=""23"" height=""11"" font=""16"" number=""1021"" ref="""" dis=""""><ftext top=""818"" left=""170"" width=""578"" height=""15"" font=""10""> Argentina's first written submission, para. 308; Argentina's response to Panel question No. 44 </ftext>
<ftext top=""832"" left=""108"" width=""587"" height=""15"" font=""10"">following the first substantive meeting; Argentina's second written submission, paras. 162, 164. </ftext>
</footnote>
<text top=""177"" left=""592"" width=""199"" height=""16"" font=""0""> According to Argentina, the </text>
<text top=""193"" left=""108"" width=""686"" height=""16"" font=""0"">approval of imports of Argentine fresh (chilled or frozen) beef under either set of mitigating </text>
<text top=""210"" left=""108"" width=""540"" height=""16"" font=""0"">protocols would be ""far less restrictive"" than the ""total ban"" currently in place.</text>
<footnote top=""208"" left=""648"" width=""23"" height=""11"" font=""16"" number=""1022"" ref="""" dis=""""/>
<text top=""210"" left=""671"" width=""119"" height=""16"" font=""0""> As to the ability </text>
<text top=""226"" left=""108"" width=""688"" height=""16"" font=""0"">of the proposed alternatives to achieve the United States' ALOP, Argentina notes that the </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">United States has ""rejected"" the protocols under Article 8.5.23 of the Terrestrial Code because it </text>
<text top=""259"" left=""108"" width=""205"" height=""16"" font=""0"">claims to have a higher ALOP.</text>
<footnote top=""257"" left=""313"" width=""23"" height=""11"" font=""16"" number=""1023"" ref="""" dis=""""/>
<text top=""259"" left=""336"" width=""454"" height=""16"" font=""0""> However, according to Argentina, the application of the protocols </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">under 9 CFR 94.22 would achieve the United States' ALOP. In its view, such protocols are similar </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">to the protocols under Article 8.5.25 of the Terrestrial Code for fresh beef from FMD-<i>infected</i> areas </text>
<text top=""308"" left=""108"" width=""219"" height=""16"" font=""0"">where vaccination is practiced</text>
<footnote top=""307"" left=""327"" width=""23"" height=""11"" font=""16"" number=""1024"" ref="""" dis=""""/>
<text top=""308"" left=""350"" width=""444"" height=""16"" font=""0"">, and are therefore ""safe and redundant"" when applied to </text>
<text top=""324"" left=""108"" width=""683"" height=""16"" font=""0"">products originating from regions that, like Northern Argentina, are FMD-free where vaccination is </text>
<text top=""341"" left=""108"" width=""67"" height=""16"" font=""0"">practised.</text>
<footnote top=""339"" left=""175"" width=""23"" height=""11"" font=""16"" number=""1025"" ref="""" dis=""""/>
<text top=""341"" left=""198"" width=""592"" height=""16"" font=""0""> Moreover, Argentina contends, with respect to FMD, that Uruguay has essentially the </text>
<text top=""357"" left=""108"" width=""682"" height=""16"" font=""0"">same sanitary condition as Northern Argentina, as both regions share the same OIE designation as </text>
<text top=""374"" left=""108"" width=""336"" height=""16"" font=""0"">FMD-free regions where vaccination is practised.</text>
<footnote top=""372"" left=""444"" width=""23"" height=""11"" font=""16"" number=""1026"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""580"" height=""15"" font=""10""> Argentina' first written submission, paras. 312-316; Argentina's opening statement at the first </ftext>
<ftext top=""1007"" left=""108"" width=""502"" height=""15"" font=""10"">meeting of the Panel, para. 46; Argentina's second written submission, para. 173. </ftext>
</footnote>
<text top=""374"" left=""467"" width=""324"" height=""16"" font=""0""> Hence, Argentina argues, the same protocols </text>
<text top=""390"" left=""108"" width=""684"" height=""16"" font=""0"">applied to imports from Uruguay would achieve the United States' ALOP if extended to imports </text>
<text top=""407"" left=""108"" width=""177"" height=""16"" font=""0"">from Northern Argentina. </text>
</p><p number=""7.417"" style=""8""><text top=""441"" left=""108"" width=""683"" height=""16"" font=""0"">7.417.  With respect to the United States' prohibition on imports of FMD-susceptible animals and </text>
<text top=""457"" left=""108"" width=""683"" height=""16"" font=""0"">animal products from Patagonia, the alternative measure identified by Argentina is the addition of </text>
<text top=""474"" left=""108"" width=""684"" height=""16"" font=""0"">Patagonia to the list of FMD-free countries or regions under 9 CFR 94.1(a) and the consequent </text>
<text top=""490"" left=""108"" width=""684"" height=""16"" font=""0"">application of the general protocols under 9 CFR 94.11 for such countries or regions that share </text>
<text top=""507"" left=""108"" width=""334"" height=""16"" font=""0"">land borders with regions not included in the list.</text>
<footnote top=""505"" left=""442"" width=""23"" height=""11"" font=""16"" number=""1027"" ref="""" dis=""""/>
</p><p number=""7.418"" style=""8""><text top=""541"" left=""108"" width=""686"" height=""16"" font=""0"">7.418.  In Argentina's opinion, the fact that APHIS recognized Santa Catarina, which has ""a </text>
<text top=""557"" left=""108"" width=""685"" height=""16"" font=""0"">sanitary situation similar to Patagonia"", as FMD-free indicates that the measure in question is </text>
<text top=""574"" left=""108"" width=""292"" height=""16"" font=""0"">reasonably available to the United States.</text>
<footnote top=""572"" left=""400"" width=""23"" height=""11"" font=""16"" number=""1028"" ref="""" dis=""""/>
<text top=""574"" left=""423"" width=""369"" height=""16"" font=""0""> Further, Argentina argues that the authorization of </text>
<text top=""590"" left=""108"" width=""677"" height=""16"" font=""0"">imports from Patagonia under the protocols in 9 CFR 94.11 would be significantly less trade-</text>
<text top=""607"" left=""108"" width=""521"" height=""16"" font=""0"">restrictive than the ""outright prohibitions"" maintained by the United States.</text>
<footnote top=""605"" left=""629"" width=""23"" height=""11"" font=""16"" number=""1029"" ref="""" dis=""""/>
<text top=""607"" left=""652"" width=""139"" height=""16"" font=""0""> As to the ability of </text>
<text top=""623"" left=""108"" width=""682"" height=""16"" font=""0"">the proposed alternative to achieve the United States' ALOP, Argentina maintains that APHIS' 2005 </text>
<text top=""639"" left=""108"" width=""687"" height=""16"" font=""0"">favourable risk assessment and 2007 Proposed Rule for Patagonia South both indicate that </text>
<text top=""656"" left=""108"" width=""683"" height=""16"" font=""0"">allowing imports of FMD-susceptible animals and animal products from that region present a level </text>
<text top=""672"" left=""108"" width=""294"" height=""16"" font=""0"">of risk that meets the United States' ALOP.</text>
<footnote top=""671"" left=""402"" width=""23"" height=""11"" font=""16"" number=""1030"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""602"" height=""15"" font=""10""> Argentina's first written submission, para. 501; Argentina's second written submission, para. 182. </ftext>
</footnote>
<text top=""672"" left=""425"" width=""365"" height=""16"" font=""0""> The same conditions, Argentina contends, prevail in </text>
<text top=""689"" left=""108"" width=""684"" height=""16"" font=""0"">Patagonia North B, as evidenced, <i>inter alia</i>, by the OIE's recognition of the region as FMD-free </text>
<text top=""705"" left=""108"" width=""685"" height=""16"" font=""0"">where vaccination is not practised in 2007 based on Chapters 4.3 and 8.5 of the Terrestrial </text>
<text top=""721"" left=""108"" width=""39"" height=""16"" font=""0"">Code.</text>
<footnote top=""720"" left=""147"" width=""23"" height=""11"" font=""16"" number=""1031"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""615"" height=""15"" font=""10""> Argentina's first written submission, paras. 497, 501; see also Argentina's opening statement at the </ftext>
</footnote>
<text top=""721"" left=""170"" width=""623"" height=""16"" font=""0""> Moreover, in Argentina's opinion, the fact that Patagonia and Santa Catarina have a </text>
<p><text top=""803"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 307. </text>
</p><p><text top=""847"" left=""170"" width=""552"" height=""15"" font=""10""> Argentina's first written submission, para. 320 (quoting Panel Report, <i>Australia &#8211; Salmon</i>, </text>
<text top=""861"" left=""108"" width=""665"" height=""15"" font=""10"">para. 8.182). See also Argentina's response to Panel question No. 44 following the first substantive meeting; </text>
<text top=""876"" left=""108"" width=""308"" height=""15"" font=""10"">Argentina's second written submission, para. 164. </text>
</p><p><text top=""905"" left=""108"" width=""680"" height=""15"" font=""10"">submission, para. 299). Argentina does not offer any arguments concerning the ability of the recommendations </text>
<text top=""920"" left=""108"" width=""484"" height=""15"" font=""10"">under Article 8.5.23 of the Terrestrial Code to achieve the United States' ALOP. </text>
<text top=""934"" left=""170"" width=""601"" height=""15"" font=""10""> Argentina's response to Panel question No. 44 following the first substantive meeting; Argentina's </text>
<text top=""949"" left=""108"" width=""270"" height=""15"" font=""10"">second written submission, paras. 156-161. </text>
<text top=""963"" left=""170"" width=""563"" height=""15"" font=""10""> Argentina' first written submission, paras. 315-316; Argentina's second written submission, </text>
<text top=""978"" left=""108"" width=""67"" height=""15"" font=""10"">para. 177. </text>
<footnote top=""1022"" left=""170"" width=""589"" height=""15"" font=""10"" number=""182"" ref="""" dis=""""/>
</p><p><text top=""1036"" left=""108"" width=""627"" height=""15"" font=""10"">paras. 502-503; Argentina's response to Panel question No. 44 following the first substantive meeting. </text>
<text top=""1051"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 498. </text>
<text top=""1066"" left=""170"" width=""552"" height=""15"" font=""10""> Argentina's first written submission, para. 506 (quoting Panel Report, <i>Australia &#8211; Salmon</i>, </text>
<text top=""1080"" left=""108"" width=""85"" height=""15"" font=""10"">para. 8.182). </text>
</p><p><text top=""1124"" left=""108"" width=""239"" height=""15"" font=""10"">second meeting of the Panel, para. 93. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 146 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">similar sanitary situation and share the same OIE FMD-status designation indicates that imports </text>
<text top=""144"" left=""108"" width=""425"" height=""16"" font=""0"">from the two regions should be treated ""in the same manner"".</text>
<footnote top=""143"" left=""533"" width=""23"" height=""11"" font=""16"" number=""1032"" ref="""" dis=""""/>
</p></p></page>
<page number=""146"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.419"" style=""8""><text top=""178"" left=""108"" width=""685"" height=""16"" font=""0"">7.419.  Argentina argues that APHIS' 2014 risk analyses for Patagonia and Northern Argentina </text>
<text top=""195"" left=""108"" width=""685"" height=""16"" font=""0"">submitted by the United States as Exhibits USA-133 and USA-169, respectively, ""confirm"" and </text>
<text top=""211"" left=""108"" width=""688"" height=""16"" font=""0"">""corroborate"" its claims that the above-mentioned alternative measures would achieve the </text>
<text top=""228"" left=""108"" width=""632"" height=""16"" font=""0"">United States' ALOP if applied to imports of the relevant products from the two regions.</text>
<footnote top=""226"" left=""740"" width=""23"" height=""11"" font=""16"" number=""1033"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""563"" height=""15"" font=""10""> See Argentina's opening statement at the second meeting of the Panel, paras. 14, 93, 102; </ftext>
</footnote>
<text top=""228"" left=""763"" width=""29"" height=""16"" font=""0""> In </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina's opinion, the Panel is ""authorized to consider and rely upon this evidence to the extent </text>
<text top=""260"" left=""108"" width=""478"" height=""16"" font=""0"">it deems necessary to discharge its duty under Article 11 of the DSU"".</text>
<footnote top=""259"" left=""586"" width=""23"" height=""11"" font=""16"" number=""1034"" ref="""" dis=""""/>
</p><p number=""7.420"" style=""8""><text top=""295"" left=""108"" width=""682"" height=""16"" font=""0"">7.420.  Argentina takes issue with the United States' argument that if the importing Member has a </text>
<text top=""311"" left=""108"" width=""684"" height=""16"" font=""0"">higher ALOP than would be achieved by measures based on an international standard, a panel </text>
<text top=""328"" left=""108"" width=""683"" height=""16"" font=""0"">cannot conduct its own assessment of the level of protection achieved by an alternative measure </text>
<text top=""344"" left=""108"" width=""447"" height=""16"" font=""0"">unless the importing Member conducts its own risk assessment.</text>
<footnote top=""343"" left=""555"" width=""23"" height=""11"" font=""16"" number=""1035"" ref="""" dis=""""/>
<text top=""344"" left=""578"" width=""213"" height=""16"" font=""0""> According to Argentina, such </text>
<text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">an argument is ""completely circular"", in that it allows the importing Member to eschew a panel </text>
<text top=""377"" left=""108"" width=""687"" height=""16"" font=""0"">review  simply  by  failing  to  conduct  a  risk  assessment, thus reading Article 5.6 out of the </text>
<text top=""393"" left=""108"" width=""111"" height=""16"" font=""0"">SPS Agreement.</text>
<footnote top=""392"" left=""219"" width=""23"" height=""11"" font=""16"" number=""1036"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""606"" height=""15"" font=""10""> Argentina's second written submission, paras. 167-169; see also Argentina's opening statement at </ftext>
</footnote>
<text top=""393"" left=""242"" width=""549"" height=""16"" font=""0""> Moreover, Argentina asserts that Article 5.7 of the SPS Agreement cannot be </text>
<text top=""410"" left=""108"" width=""514"" height=""16"" font=""0"">invoked as a qualified exemption to the obligations set forth in Article 5.6.</text>
<footnote top=""408"" left=""622"" width=""23"" height=""11"" font=""16"" number=""1037"" ref="""" dis=""""/>
<text top=""410"" left=""645"" width=""146"" height=""16"" font=""0""> In its view, there is </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">""no textual or conceptual reason"" to consider that the obligation to ensure that SPS measures are </text>
<text top=""443"" left=""108"" width=""682"" height=""16"" font=""0"">not more trade-restrictive than required to achieve the ALOP under Article 5.6 would apply only to </text>
<text top=""459"" left=""108"" width=""683"" height=""16"" font=""0"">measures based on risk assessments under Article 5.1 and not to provisionally adopted measures </text>
<text top=""475"" left=""108"" width=""211"" height=""16"" font=""0"">applied pursuant to Article 5.7.</text>
<footnote top=""474"" left=""319"" width=""23"" height=""11"" font=""16"" number=""1038"" ref="""" dis=""""/>
</p><p number=""7.6"" style=""8""><text top=""510"" left=""108"" width=""184"" height=""16"" font=""28"">7.6.7.2.2  United States </text></p><p number=""7.421"" style=""8""><text top=""544"" left=""108"" width=""682"" height=""16"" font=""0"">7.421.  The United States submits that, because of the insufficiency of scientific evidence available </text>
<text top=""561"" left=""108"" width=""682"" height=""16"" font=""0"">at the time of the Panel's establishment, an assessment of a less trade restrictive alternative under </text>
<text top=""577"" left=""108"" width=""682"" height=""16"" font=""0"">Article 5.6 would not be possible to complete. The United States argues that its adoption of a valid </text>
<text top=""593"" left=""108"" width=""684"" height=""16"" font=""0"">provisional measure in accordance with Article 5.7 reflects the core issue of the insufficiency of </text>
<text top=""610"" left=""108"" width=""683"" height=""16"" font=""0"">scientific evidence in connection with Argentina&#8217;s ability to control and to mitigate FMD within its </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">borders. The United States asserts that, because APHIS was still conducting its evaluation of the </text>
<text top=""643"" left=""108"" width=""682"" height=""16"" font=""0"">credibility of the sanitary structures in Northern Argentina and Patagonia, its measures should not </text>
<text top=""659"" left=""108"" width=""420"" height=""16"" font=""0"">be examined under Article 5.6, but rather under Article 5.7.</text>
<footnote top=""657"" left=""528"" width=""23"" height=""11"" font=""16"" number=""1039"" ref="""" dis=""""/>
<text top=""659"" left=""551"" width=""241"" height=""16"" font=""0""> In this regard, the United States </text>
<text top=""675"" left=""108"" width=""683"" height=""16"" font=""0"">disagrees with Argentina's depiction of APHIS' review of its requests as a ""total ban"" because, in </text>
<text top=""692"" left=""108"" width=""682"" height=""16"" font=""0"">its view, APHIS is simply ""implementing due diligence"" vis-&#224;-vis Northern Argentina and Patagonia </text>
<text top=""708"" left=""108"" width=""191"" height=""16"" font=""0"">in light of their FMD history</text>
<footnote top=""707"" left=""299"" width=""23"" height=""11"" font=""16"" number=""1040"" ref="""" dis=""""/>
<text top=""708"" left=""322"" width=""269"" height=""16"" font=""0"">, consistently with the OIE's approach.</text>
<footnote top=""707"" left=""591"" width=""23"" height=""11"" font=""16"" number=""1041"" ref="""" dis=""""/>
<text top=""708"" left=""614"" width=""177"" height=""16"" font=""0""> The United States takes </text>
<text top=""725"" left=""108"" width=""686"" height=""16"" font=""0"">the view that a provisional measure validly maintained by a Member under Article 5.7 while </text>
<text top=""741"" left=""108"" width=""677"" height=""16"" font=""0"">reviewing the level of risks posed by imports from another Member cannot be more trade-</text>
<text top=""757"" left=""108"" width=""410"" height=""16"" font=""0"">restrictive than required to achieve that Member's ALOP</text>
<footnote top=""756"" left=""518"" width=""23"" height=""11"" font=""16"" number=""1042"" ref="""" dis=""""/>
<text top=""757"" left=""541"" width=""253"" height=""16"" font=""0"">, because the insufficiency of the </text>
<text top=""774"" left=""108"" width=""683"" height=""16"" font=""0"">evidence justifying the maintenance of such a measure prevents a ""full, scientific assessment of </text>
<text top=""790"" left=""108"" width=""38"" height=""16"" font=""0"">risks""</text>
<footnote top=""789"" left=""146"" width=""23"" height=""11"" font=""16"" number=""1043"" ref="""" dis=""""/>
<text top=""790"" left=""169"" width=""574"" height=""16"" font=""0""> and thus leaves the determination of the level of risk an ""open scientific question"".</text>
<footnote top=""789"" left=""743"" width=""23"" height=""11"" font=""16"" number=""1044"" ref="""" dis=""""/>
<text top=""790"" left=""766"" width=""24"" height=""16"" font=""0""> In </text>
<text top=""807"" left=""108"" width=""683"" height=""16"" font=""0"">the United States' opinion, it is incumbent upon the exporting Member seeking market access to </text>
<text top=""823"" left=""108"" width=""682"" height=""16"" font=""0"">submit the scientific evidence necessary for such a full assessment of risks, and a panel cannot fill </text>
<text top=""839"" left=""108"" width=""294"" height=""16"" font=""0"">any scientific lacunae left by that Member.</text>
<footnote top=""838"" left=""402"" width=""23"" height=""11"" font=""16"" number=""1045"" ref="""" dis=""""/>
<text top=""839"" left=""425"" width=""366"" height=""16"" font=""0""> For this reason, the United States argues that even </text>
<p><text top=""876"" left=""170"" width=""589"" height=""15"" font=""10""> Argentina's first written submission, para. 502. See also Argentina's second written submission, </text>
<footnote top=""920"" left=""108"" width=""542"" height=""15"" font=""10"" number=""53"" ref="""" dis=""""/>
</p><p><text top=""949"" left=""170"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 167. </text>
</p><p><text top=""978"" left=""108"" width=""263"" height=""15"" font=""10"">the second meeting of the Panel, para. 16. </text>
<footnote top=""993"" left=""170"" width=""547"" height=""15"" font=""10"" number=""39"" ref="""" dis=""""/>
</p><p><text top=""1022"" left=""170"" width=""315"" height=""15"" font=""10""> United States' first written submission, para. 292.  </text>
<text top=""1036"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 293. </text>
<text top=""1051"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 294. </text>
<text top=""1066"" left=""170"" width=""584"" height=""15"" font=""10""> United States' second written submission, para. 104. See also United States' response to Panel </text>
</p><p><text top=""1109"" left=""170"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 46 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 147 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">if the Panel were to find that its measures are not covered by the disciplines of Article 5.7, it </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">should refrain from making findings under Article 5.6, lest it rule on ""complex regulatory issues </text>
<text top=""160"" left=""108"" width=""244"" height=""16"" font=""0"">without the benefit of a full record"".</text>
<footnote top=""159"" left=""352"" width=""23"" height=""11"" font=""16"" number=""1046"" ref="""" dis=""""/>
</p></p></page>
<page number=""147"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.422"" style=""8""><text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">7.422.  Further, the United States argues that Argentina failed to demonstrate that the identified </text>
<text top=""211"" left=""108"" width=""437"" height=""16"" font=""0"">alternative measures would achieve the United States' ALOP.</text>
<footnote top=""210"" left=""545"" width=""23"" height=""11"" font=""16"" number=""1047"" ref="""" dis=""""/>
<text top=""211"" left=""568"" width=""225"" height=""16"" font=""0""> In the United States' view, a </text>
<text top=""228"" left=""108"" width=""687"" height=""16"" font=""0"">determination of whether such alternatives would meet its ALOP depends not only on the </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">geography and the OIE FMD-status of Northern Argentina and Patagonia, but also on the credibility </text>
<text top=""260"" left=""108"" width=""530"" height=""16"" font=""0"">of the sanitary measures in place in such regions to prevent and control FMD.</text>
<footnote top=""259"" left=""637"" width=""23"" height=""11"" font=""16"" number=""1048"" ref="""" dis=""""/>
</p><p number=""7.423"" style=""8""><text top=""295"" left=""108"" width=""686"" height=""16"" font=""0"">7.423.  With respect to Argentina's proposed alternatives to the United States' prohibition on </text>
<text top=""311"" left=""108"" width=""682"" height=""16"" font=""0"">imports of fresh (chilled or frozen) beef, the United States argues, first, that the application of the </text>
<text top=""328"" left=""108"" width=""684"" height=""16"" font=""0"">protocols under Article 8.5.23 of the Terrestrial Code would not meet its ALOP, which is higher </text>
<text top=""344"" left=""108"" width=""157"" height=""16"" font=""0"">than that of the OIE.</text>
<footnote top=""343"" left=""265"" width=""23"" height=""11"" font=""16"" number=""1049"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""612"" height=""15"" font=""10""> United States' first written submission, para. 299; United States' response to Panel question No. 45 </ftext>
</footnote>
<text top=""344"" left=""288"" width=""506"" height=""16"" font=""0""> In particular, the United States asserts that it does not accept the </text>
<text top=""360"" left=""108"" width=""536"" height=""16"" font=""0"">OIE category of FMD-free countries or region where vaccination is practised.</text>
<footnote top=""359"" left=""644"" width=""23"" height=""11"" font=""16"" number=""1050"" ref="""" dis=""""/>
<text top=""360"" left=""667"" width=""124"" height=""16"" font=""0""> This is because, </text>
<text top=""377"" left=""108"" width=""684"" height=""16"" font=""0"">the United States explains, the vaccination of cattle against FMD ""introduces risks related to the </text>
<text top=""393"" left=""108"" width=""683"" height=""16"" font=""0"">immunological response within the vaccinated herd"", as ""some individual animals in the herd may </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">have a limited response"" resulting in ""partial or no immunity"". In addition, the United States is </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">concerned that current FMD vaccines may have residual Non Structural Proteins (NSP) that ""could </text>
<text top=""443"" left=""108"" width=""687"" height=""16"" font=""0"">result in the detection of NSP antibodies in vaccinated animals"", thereby not allowing the </text>
<text top=""459"" left=""108"" width=""385"" height=""16"" font=""0"">differentiation between vaccinated and infected animals.</text>
<footnote top=""457"" left=""492"" width=""23"" height=""11"" font=""16"" number=""1051"" ref="""" dis=""""/>
</p><p number=""7.424"" style=""8""><text top=""493"" left=""108"" width=""686"" height=""16"" font=""0"">7.424.  The United States disagrees with Argentina that the protocols under 9 CFR 94.22 are </text>
<text top=""510"" left=""108"" width=""685"" height=""16"" font=""0"">similar to those recommended by the OIE for imports of meat from FMD-infected countries or </text>
<text top=""526"" left=""108"" width=""526"" height=""16"" font=""0"">regions, as the former are more stringent than the latter on several scores.</text>
<footnote top=""525"" left=""634"" width=""23"" height=""11"" font=""16"" number=""1052"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""368"" height=""15"" font=""10""> United States' second written submission, paras. 112-114.  </ftext>
</footnote>
<text top=""526"" left=""657"" width=""134"" height=""16"" font=""0""> The United States </text>
<text top=""543"" left=""108"" width=""684"" height=""16"" font=""0"">also takes issue with Argentina's argument that because Northern Argentina and Uruguay have </text>
<text top=""559"" left=""108"" width=""685"" height=""16"" font=""0"">similar FMD situations, the protocols applied to Uruguay under 9 CFR 94.22 would achieve the </text>
<text top=""575"" left=""108"" width=""467"" height=""16"" font=""0"">United States' ALOP if applied to imports from Northern Argentina.</text>
<footnote top=""574"" left=""575"" width=""23"" height=""11"" font=""16"" number=""1053"" ref="""" dis=""""/>
<text top=""575"" left=""598"" width=""194"" height=""16"" font=""0""> For the United States, the </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">fact that the two regions share the same OIE FMD-status designation is not dispositive of whether </text>
<text top=""608"" left=""108"" width=""326"" height=""16"" font=""0"">products therefrom pose the same level of risk</text>
<footnote top=""607"" left=""433"" width=""23"" height=""11"" font=""16"" number=""1054"" ref="""" dis=""""/>
<text top=""608"" left=""456"" width=""334"" height=""16"" font=""0"">, because such designations only provide broad </text>
<text top=""625"" left=""108"" width=""683"" height=""16"" font=""0"">indications of the level of risk and the underlying process is mostly confidential and based on the </text>
<text top=""641"" left=""108"" width=""199"" height=""16"" font=""0"">applicant Member's dossier.</text>
<footnote top=""639"" left=""307"" width=""23"" height=""11"" font=""16"" number=""1055"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""552"" height=""15"" font=""10""> United States' second written submission, paras. 109-110. See also Ibid. paras. 118-123. </ftext>
</footnote>
<text top=""641"" left=""330"" width=""465"" height=""16"" font=""0""> According to the United States, differences between Northern </text>
<text top=""657"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina and Uruguay in terms of surface area, cattle population in relation to the number of </text>
<text top=""674"" left=""108"" width=""684"" height=""16"" font=""0"">veterinarians, borders with regions of higher FMD risk, and the credibility of sanitary authorities </text>
<text top=""690"" left=""108"" width=""354"" height=""16"" font=""0"">distinguish the FMD situations in the two regions.</text>
<footnote top=""689"" left=""462"" width=""23"" height=""11"" font=""16"" number=""1056"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""491"" height=""15"" font=""10""> United States' first written submission, para. 297 (referring to paras. 308-310). </ftext>
</footnote>
<text top=""690"" left=""485"" width=""308"" height=""16"" font=""0""> In its view, Argentina has not effectively </text>
<text top=""707"" left=""108"" width=""682"" height=""16"" font=""0"">addressed such factors, nor has it provided any scientific evidence concerning similarities between </text>
<text top=""723"" left=""108"" width=""684"" height=""16"" font=""0"">Northern Argentina and Uruguay, thereby failing to meet the burden set forth by the Appellate </text>
<text top=""739"" left=""108"" width=""183"" height=""16"" font=""0"">Body in <i>Australia &#8211; Apples</i>.</text>
<footnote top=""738"" left=""291"" width=""23"" height=""11"" font=""16"" number=""1057"" ref="""" dis=""""/>
</p><p number=""7.425"" style=""8""><text top=""774"" left=""108"" width=""57"" height=""16"" font=""0"">7.425. </text>
<text top=""774"" left=""162"" width=""585"" height=""16"" font=""0"">Similarly, with respect to Argentina's proposed alternatives to the United </text>
<text top=""774"" left=""738"" width=""60"" height=""16"" font=""0"">States' </text>
<text top=""790"" left=""108"" width=""687"" height=""16"" font=""0"">prohibition on imports of FMD-susceptible animals and animal products from Patagonia, the </text>
<text top=""807"" left=""108"" width=""683"" height=""16"" font=""0"">United States argues that Argentina's claim must fail because Argentina failed to substantiate the </text>
<text top=""823"" left=""108"" width=""599"" height=""16"" font=""0"">underlying premise that Patagonia has a similar FMD situation as Santa Catarina.</text>
<footnote top=""822"" left=""707"" width=""23"" height=""11"" font=""16"" number=""1058"" ref="""" dis=""""/>
<text top=""823"" left=""730"" width=""64"" height=""16"" font=""0""> In the </text>
<text top=""839"" left=""108"" width=""682"" height=""16"" font=""0"">United States' view, the ""key differentiation"" between Patagonia and Santa Catarina is the fact that </text>
<text top=""856"" left=""108"" width=""682"" height=""16"" font=""0"">APHIS was able to ""draw a conclusion as to the appropriateness of the import authorization terms"" </text>
<p><text top=""891"" left=""170"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 57 following the first substantive meeting. </text>
<footnote top=""905"" left=""170"" width=""345"" height=""15"" font=""10"" number=""297"" ref="""" dis=""""/>
</p><p><text top=""920"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 296. </text>
</p><p><text top=""949"" left=""108"" width=""601"" height=""15"" font=""10"">following the first substantive meeting; United States' second written submission, paras. 105-106. </text>
<footnote top=""963"" left=""170"" width=""310"" height=""15"" font=""10"" number=""299"" ref="""" dis=""""/>
</p><p><text top=""1022"" left=""108"" width=""67"" height=""15"" font=""10"">para. 107. </text>
</p><p><text top=""1051"" left=""108"" width=""102"" height=""15"" font=""10"">paras. 108-109. </text>
</p><p><text top=""1095"" left=""170"" width=""596"" height=""15"" font=""10""> United States' response to Panel question No. 44 following the first substantive meeting (quoting </text>
<text top=""1109"" left=""108"" width=""333"" height=""15"" font=""10"">Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 364). </text>
<footnote top=""1124"" left=""170"" width=""310"" height=""15"" font=""10"" number=""298"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 148 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">applied to imports from Santa Catarina, whereas at the time of the Panel's establishment it had </text>
<text top=""144"" left=""108"" width=""512"" height=""16"" font=""0"">not reached such a determination with respect to imports from Patagonia.</text>
<footnote top=""143"" left=""620"" width=""23"" height=""11"" font=""16"" number=""1059"" ref="""" dis=""""/>
<text top=""144"" left=""643"" width=""148"" height=""16"" font=""0""> This is because, the </text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""0"">United States contends, in 2008 SENASA extended its original request for the recognition of </text>
<text top=""177"" left=""108"" width=""687"" height=""16"" font=""0"">Patagonia South to Patagonia North B and introduced ""changes to the sanitary boundaries"" </text>
<text top=""193"" left=""108"" width=""160"" height=""16"" font=""0"">between the two areas.</text>
<footnote top=""192"" left=""268"" width=""23"" height=""11"" font=""16"" number=""1060"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""464"" height=""15"" font=""10""> United States' first written submission, para. 318. See also Ibid. para. 298. </ftext>
</footnote>
</p></p></page>
<page number=""148"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.426"" style=""8""><text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">7.426.  Finally, the United States asserts that the 2014 risk analyses for Patagonia and Northern </text>
<text top=""244"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina, submitted as Exhibits USA-133 and USA-169 respectively, cannot cure Argentina's </text>
<text top=""260"" left=""108"" width=""685"" height=""16"" font=""0"">failure to meet its burden of providing sufficient scientific evidence to show that its proposed </text>
<text top=""277"" left=""108"" width=""685"" height=""16"" font=""0"">alternatives would meet the United States' ALOP, as such documents were submitted after the </text>
<text top=""293"" left=""108"" width=""155"" height=""16"" font=""0"">Panel's establishment.</text>
<footnote top=""292"" left=""262"" width=""23"" height=""11"" font=""16"" number=""1061"" ref="""" dis=""""/>
<text top=""293"" left=""285"" width=""507"" height=""16"" font=""0""> In the United States' opinion, the information submitted reflects data </text>
<text top=""310"" left=""108"" width=""686"" height=""16"" font=""0"">collected by APHIS after the date of the Panel's establishment, and thus cannot be used by </text>
<text top=""326"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina in an attempt to show that scientific evidence was sufficient on that date. The United </text>
<text top=""342"" left=""108"" width=""684"" height=""16"" font=""0"">States further asserts that the Panel may rely on such documents only for a finding as to ""the </text>
<text top=""359"" left=""108"" width=""685"" height=""16"" font=""0"">significant effort and substantial work done by APHIS to ensure that its review of Argentina's </text>
<text top=""375"" left=""108"" width=""316"" height=""16"" font=""0"">application is thorough and well documented"".</text>
<footnote top=""374"" left=""424"" width=""23"" height=""11"" font=""16"" number=""1062"" ref="""" dis=""""/>
</p><p number=""7.6"" style=""8""><text top=""410"" left=""108"" width=""337"" height=""16"" font=""28"">7.6.7.3  Main arguments of the third parties </text></p><p number=""7.6"" style=""8""><text top=""444"" left=""108"" width=""124"" height=""16"" font=""28"">7.6.7.3.1  China </text></p><p number=""7.427"" style=""8""><text top=""479"" left=""108"" width=""686"" height=""16"" font=""0"">7.427.  In China's opinion, because the United States' claims that the Terrestrial Code is not </text>
<text top=""495"" left=""108"" width=""687"" height=""16"" font=""0"">sufficient to achieve its ALOP, it could be reasonably assumed that the measures currently </text>
<text top=""511"" left=""108"" width=""682"" height=""16"" font=""0"">applying to other WTO Members (such as Uruguay and Santa Catarina) have properly achieved the </text>
<text top=""528"" left=""108"" width=""686"" height=""16"" font=""0"">United States' ALOP. For China, the salient factual question centres on whether the sanitary </text>
<text top=""544"" left=""108"" width=""686"" height=""16"" font=""0"">situation of Northern Argentina and Patagonia is comparable to those of Uruguay and Santa </text>
<text top=""561"" left=""108"" width=""62"" height=""16"" font=""0"">Catarina.</text>
<footnote top=""559"" left=""170"" width=""23"" height=""11"" font=""16"" number=""1063"" ref="""" dis=""""/>
<text top=""561"" left=""193"" width=""598"" height=""16"" font=""0""> China notes the Appellate Body's statement in <i>Australia &#8211; Apples</i> that, in conducting </text>
<text top=""577"" left=""108"" width=""682"" height=""16"" font=""0"">an analysis under Article 5.6, a panel must independently assess whether the less trade-restrictive </text>
<text top=""593"" left=""108"" width=""549"" height=""16"" font=""0"">alternatives proposed by the complainant would achieve the respondent's ALOP.</text>
<footnote top=""592"" left=""657"" width=""23"" height=""11"" font=""16"" number=""1064"" ref="""" dis=""""/>
<text top=""593"" left=""680"" width=""110"" height=""16"" font=""0""> Accordingly, in </text>
<text top=""610"" left=""108"" width=""682"" height=""16"" font=""0"">China's opinion, this Panel should reach a determination based on the totality of scientific evidence </text>
<text top=""626"" left=""108"" width=""159"" height=""16"" font=""0"">identified by Argentina.</text>
<footnote top=""625"" left=""267"" width=""23"" height=""11"" font=""16"" number=""1065"" ref="""" dis=""""/>
</p><p number=""7.6"" style=""8""><text top=""661"" left=""108"" width=""202"" height=""16"" font=""28"">7.6.7.3.2  European Union </text></p><p number=""7.428"" style=""8""><text top=""695"" left=""108"" width=""683"" height=""16"" font=""0"">7.428.  In the European Union's view, an SPS measure is more trade restrictive than necessary to </text>
<text top=""711"" left=""108"" width=""686"" height=""16"" font=""0"">achieve the importing Member's ALOP only ""if there is another measure reasonably available </text>
<text top=""728"" left=""108"" width=""683"" height=""16"" font=""0"">taking into account technical and economic feasibility that achieves the ALOP and is significantly </text>
<text top=""744"" left=""108"" width=""173"" height=""16"" font=""0"">less restrictive of trade"".</text>
<footnote top=""743"" left=""281"" width=""23"" height=""11"" font=""16"" number=""1066"" ref="""" dis=""""/>
<text top=""744"" left=""304"" width=""488"" height=""16"" font=""0""> The European Union notes that Argentina does not contest that the </text>
<text top=""761"" left=""108"" width=""687"" height=""16"" font=""0"">United States is FMD-free where vaccination is not practised; nor does Argentina challenge </text>
<text top=""777"" left=""108"" width=""682"" height=""16"" font=""0"">Section 94.1(a), which provides that Argentina is <i>not</i>  a  region  that  is  FMD-free.  The  European </text>
<text top=""793"" left=""108"" width=""685"" height=""16"" font=""0"">Union believes that Argentina bears the onus of proving the existence of such an alternative </text>
<text top=""810"" left=""108"" width=""682"" height=""16"" font=""0"">measure by relying on ""evidence that is scientific in nature, in keeping with the overall design and </text>
<text top=""826"" left=""108"" width=""259"" height=""16"" font=""0"">architecture of the SPS Agreement"".</text>
<footnote top=""825"" left=""367"" width=""23"" height=""11"" font=""16"" number=""1067"" ref="""" dis=""""/>
<text top=""826"" left=""390"" width=""404"" height=""16"" font=""0""> The European Union further considers that the Panel </text>
<text top=""843"" left=""108"" width=""684"" height=""16"" font=""0"">should accept Argentina's claims under Article 5.6 only if the facts of the case establish that a </text>
<text top=""859"" left=""108"" width=""683"" height=""16"" font=""0"">prohibition on imports from territories where FMD exists is not an acceptable measure to prevent </text>
<text top=""875"" left=""108"" width=""686"" height=""16"" font=""0"">the introduction of FMD into the protected territories, taking into consideration the guidance </text>
<text top=""892"" left=""108"" width=""394"" height=""16"" font=""0"">provided by the recommendations in the Terrestrial Code.</text>
<footnote top=""890"" left=""502"" width=""23"" height=""11"" font=""16"" number=""1068"" ref="""" dis=""""/>
<p><text top=""1022"" left=""170"" width=""490"" height=""15"" font=""10""> United States' opening statement at the second meeting of the Panel, para. 67. </text>
<text top=""1036"" left=""170"" width=""563"" height=""15"" font=""10""> United States' response to Panel question No. 53 following the second substantive meeting. </text>
<text top=""1051"" left=""170"" width=""257"" height=""15"" font=""10""> China's third-party submission, para. 45. </text>
<footnote top=""1066"" left=""170"" width=""337"" height=""15"" font=""10"" number=""14"" ref="""" dis=""""/>
</p><p><text top=""1124"" left=""170"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 55. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 149 - </text>
</p></p></page>
<page number=""149"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.6"" style=""8""><text top=""128"" left=""108"" width=""229"" height=""16"" font=""28"">7.6.7.4  Analysis by the Panel </text></p><p number=""7.429"" style=""8""><text top=""162"" left=""108"" width=""684"" height=""16"" font=""0"">7.429.  The issue before the Panel is whether the maintenance of the United States' prohibitions </text>
<text top=""178"" left=""108"" width=""686"" height=""16"" font=""0"">on imports of fresh (chilled or frozen) beef from Northern Argentina and of FMD-susceptible </text>
<text top=""195"" left=""108"" width=""686"" height=""16"" font=""0"">animals and animal products from Patagonia is more restrictive than required to achieve the </text>
<text top=""211"" left=""108"" width=""203"" height=""16"" font=""0"">United States' ALOP for FMD. </text>
</p><p number=""7.430"" style=""8""><text top=""246"" left=""108"" width=""683"" height=""16"" font=""0"">7.430.  In <i>Australia &#8211; Salmon</i>, the Appellate Body confirmed the panel's reasoning that footnote 3 </text>
<text top=""262"" left=""108"" width=""683"" height=""16"" font=""0"">to Article 5.6 provides a three-pronged test to establish a violation of Article 5.6. Specifically, the </text>
<text top=""278"" left=""108"" width=""178"" height=""16"" font=""0"">Appellate Body held that: </text>
<p><text top=""313"" left=""151"" width=""598"" height=""16"" font=""0"">[T]he three elements of this test under Article 5.6 are that there is an SPS measure </text>
<text top=""329"" left=""151"" width=""50"" height=""16"" font=""0"">which: </text>
</p></p><p number=""(1)"" style=""4""><text top=""364"" left=""151"" width=""26"" height=""16"" font=""0"">(1) </text>
<text top=""364"" left=""193"" width=""532"" height=""16"" font=""0"">is reasonably available taking into account technical and economic feasibility; </text>
</p><p number=""(2)"" style=""4""><text top=""398"" left=""151"" width=""26"" height=""16"" font=""0"">(2) </text>
<text top=""398"" left=""193"" width=""554"" height=""16"" font=""0"">achieves the Member's appropriate level of sanitary or phytosanitary protection; </text>
<text top=""414"" left=""193"" width=""30"" height=""16"" font=""0"">and </text>
</p><p number=""(3)"" style=""4""><text top=""449"" left=""151"" width=""26"" height=""16"" font=""0"">(3) </text>
<text top=""449"" left=""193"" width=""490"" height=""16"" font=""0"">is significantly less restrictive to trade than the SPS measure contested.</text>
<footnote top=""447"" left=""683"" width=""23"" height=""11"" font=""16"" number=""1069"" ref="""" dis=""""/>
</p><p number=""7.431"" style=""8""><text top=""483"" left=""108"" width=""685"" height=""16"" font=""0"">7.431.  The burden rests on the complaining party to demonstrate that there is an alternative </text>
<text top=""500"" left=""108"" width=""408"" height=""16"" font=""0"">measure that meets all three requirements in Article 5.6.</text>
<footnote top=""498"" left=""516"" width=""23"" height=""11"" font=""16"" number=""1070"" ref="""" dis=""""/>
<text top=""500"" left=""539"" width=""253"" height=""16"" font=""0""> In the Appellate Body's view, the </text>
<text top=""516"" left=""108"" width=""686"" height=""16"" font=""0"">above-mentioned elements ""are cumulative in the sense that, to establish inconsistency with </text>
<text top=""533"" left=""108"" width=""280"" height=""16"" font=""0"">Article 5.6, all of them have to be met"".</text>
<footnote top=""531"" left=""388"" width=""23"" height=""11"" font=""16"" number=""1071"" ref="""" dis=""""/>
<text top=""533"" left=""411"" width=""380"" height=""16"" font=""0""> Therefore, ""[i]f any of these elements is not fulfilled, </text>
<text top=""549"" left=""108"" width=""424"" height=""16"" font=""0"">the measure in dispute would be consistent with Article 5.6"".</text>
<footnote top=""547"" left=""532"" width=""23"" height=""11"" font=""16"" number=""1072"" ref="""" dis=""""/>
<text top=""549"" left=""555"" width=""236"" height=""16"" font=""0""> The panel in <i>India &#8211; Agricultural </i></text>
<text top=""565"" left=""108"" width=""684"" height=""16"" font=""18""><i>Products</i> considered that the cumulative nature of the three elements entails that a panel may </text>
<text top=""582"" left=""108"" width=""350"" height=""16"" font=""0"">address them in any order it considers appropriate.</text>
<footnote top=""580"" left=""458"" width=""23"" height=""11"" font=""16"" number=""1073"" ref=""WT/DS367/R|WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430|DS367""><ftext top=""1066"" left=""170"" width=""607"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.524. See also Panel Report, <i>Australia &#8211; Apples</i>, </ftext>
<ftext top=""1080"" left=""108"" width=""87"" height=""15"" font=""10"">para. 7.1106. </ftext>
</footnote>
</p><p number=""7.432"" style=""8""><text top=""616"" left=""108"" width=""682"" height=""16"" font=""0"">7.432.  In this dispute, Argentina argues that alternative measures are reasonably available to the </text>
<text top=""633"" left=""108"" width=""682"" height=""16"" font=""0"">United States which would achieve the United States' ALOP for FMD and would be significantly less </text>
<text top=""649"" left=""108"" width=""684"" height=""16"" font=""0"">trade restrictive than the prohibitions in place as of the time of the establishment of the Panel. </text>
<text top=""665"" left=""108"" width=""685"" height=""16"" font=""0"">With respect to the United States' prohibition on imports of fresh (chilled or frozen) beef from </text>
<text top=""682"" left=""108"" width=""523"" height=""16"" font=""0"">Northern Argentina, the alternative measures put forward by Argentina are: </text>
</p><p number=""a."" style=""2""><text top=""716"" left=""151"" width=""645"" height=""16"" font=""0"">a.  The OIE's recommendations for importation of fresh meat of cattle and buffaloes </text>
<text top=""733"" left=""176"" width=""614"" height=""16"" font=""0"">(excluding feet, head and viscera) from FMD-free countries or zones where vaccination is </text>
<text top=""749"" left=""176"" width=""454"" height=""16"" font=""0"">practised, contained in Article 8.5.23 of the Terrestrial Code; and  </text>
</p><p number=""b."" style=""2""><text top=""783"" left=""151"" width=""371"" height=""16"" font=""0"">b.  The mitigating protocols contained in 9 CFR 94.22.</text>
<footnote top=""782"" left=""522"" width=""23"" height=""11"" font=""16"" number=""1074"" ref="""" dis=""""/>
</p><p number=""7.433"" style=""8""><text top=""818"" left=""108"" width=""683"" height=""16"" font=""0"">7.433.  With respect to the United States' prohibitions on imports of FMD-susceptible animals and </text>
<text top=""834"" left=""108"" width=""683"" height=""16"" font=""0"">animal products from Patagonia, the alternative measure identified by Argentina is the addition of </text>
<text top=""851"" left=""108"" width=""684"" height=""16"" font=""0"">the region to the list of FMD-free regions in 9 CFR 94.1(a), coupled with the application of the </text>
<text top=""867"" left=""108"" width=""685"" height=""16"" font=""0"">mitigating protocols set forth in 9 CFR 94.11 for regions included in that list that share a land </text>
<text top=""883"" left=""108"" width=""403"" height=""16"" font=""0"">border with a region not recognized by APHIS as FMD-free.</text>
<footnote top=""882"" left=""511"" width=""23"" height=""11"" font=""16"" number=""1075"" ref="""" dis=""""/>
</p><p number=""7.434"" style=""8""><text top=""918"" left=""108"" width=""190"" height=""16"" font=""0"">7.434.  Argentina  contends</text>
<footnote top=""916"" left=""298"" width=""23"" height=""11"" font=""16"" number=""1076"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""442"" height=""15"" font=""10""> See e.g. Argentina's first written submission, paras. 307-309, 496-499. </ftext>
</footnote>
<text top=""918"" left=""321"" width=""312"" height=""16"" font=""0"">, and the United States does not disagree</text>
<footnote top=""916"" left=""633"" width=""23"" height=""11"" font=""16"" number=""1077"" ref="""" dis=""""/>
<text top=""918"" left=""656"" width=""129"" height=""16"" font=""0"">, that the above-</text>
<text top=""934"" left=""108"" width=""685"" height=""16"" font=""0"">mentioned measures are reasonably available to APHIS. Similarly, the United States does not </text>
<footnote top=""978"" left=""170"" width=""337"" height=""15"" font=""10"" number=""194"" ref="""" dis=""""/>
<p><text top=""993"" left=""170"" width=""601"" height=""15"" font=""10""> Appellate Body Report, <i>Japan &#8211; Agricultural Products II</i>, para. 126. See also Panel Report, <i>India &#8211; </i></text>
<text top=""1007"" left=""108"" width=""213"" height=""15"" font=""12""><i>Agricultural Products</i>, para. 7.525. </text>
</p><p><text top=""1051"" left=""108"" width=""115"" height=""15"" font=""12""><i>Apples</i>, para. 337. </text>
</p><p><text top=""1095"" left=""170"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 155. </text>
<text top=""1109"" left=""170"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 182. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 150 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">contest that allowing imports of fresh (chilled or frozen) beef from Northern Argentina and of </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">FMD-susceptible animals and animal products from Patagonia under certain mitigating protocols </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">would be significantly less trade-restrictive than the challenged prohibitions. The element lying at </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">the core of the parties' disagreement &#8211; and the crux of the matter before the Panel &#8211; is therefore </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">whether the alternative measures identified by Argentina would meet the United States' ALOP for </text>
<text top=""210"" left=""108"" width=""44"" height=""16"" font=""0"">FMD.  </text>
</p></p></page>
<page number=""150"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.435"" style=""8""><text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">7.435.  In <i>Australia &#8211; Apples</i>, the Appellate Body explained that, in order to assess whether a less </text>
<text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">trade-restrictive alternative measure would meet an importing Member's ALOP, a panel must make </text>
<text top=""277"" left=""108"" width=""208"" height=""16"" font=""0"">a number of ""factual findings"".</text>
<footnote top=""275"" left=""316"" width=""23"" height=""11"" font=""16"" number=""1078"" ref="""" dis=""""/>
<text top=""277"" left=""339"" width=""91"" height=""16"" font=""0""> Specifically: </text>
<p><text top=""311"" left=""151"" width=""598"" height=""16"" font=""0"">[The] panel must identify both the level of protection that the importing Member has </text>
<text top=""328"" left=""151"" width=""598"" height=""16"" font=""0"">set as its appropriate level, and the level of protection that would be achieved by the </text>
<text top=""344"" left=""151"" width=""597"" height=""16"" font=""0"">alternative measure put forth by the complainant. Thereupon the panel will be able to </text>
<text top=""360"" left=""151"" width=""597"" height=""16"" font=""0"">make the requisite comparison between the level of protection that would be achieved </text>
<text top=""377"" left=""151"" width=""604"" height=""16"" font=""0"">by the alternative measure and the importing Member's appropriate level of </text>
<text top=""393"" left=""151"" width=""599"" height=""16"" font=""0"">protection. If the level of protection achieved by the proposed alternative meets or </text>
<text top=""410"" left=""151"" width=""602"" height=""16"" font=""0"">exceeds the appropriate level of protection, then (assuming that the other two </text>
<text top=""426"" left=""151"" width=""598"" height=""16"" font=""0"">conditions in Article 5.6 are met) the importing Member's SPS measure is more trade </text>
<text top=""443"" left=""151"" width=""457"" height=""16"" font=""0"">restrictive than necessary to achieve its desired level of protection.</text>
<footnote top=""441"" left=""607"" width=""23"" height=""11"" font=""16"" number=""1079"" ref="""" dis=""""/>
</p></p><p number=""7.436"" style=""8""><text top=""475"" left=""108"" width=""36"" height=""11"" font=""16"">7.436.  </text>
<text top=""477"" left=""144"" width=""647"" height=""16"" font=""0"">In that dispute, the Appellate Body also clarified that Members' obligations under Article 5.6 </text>
<text top=""493"" left=""108"" width=""283"" height=""16"" font=""0"">are distinct from those under Article 5.1.</text>
<footnote top=""492"" left=""391"" width=""23"" height=""11"" font=""16"" number=""1080"" ref="""" dis=""""/>
<text top=""493"" left=""414"" width=""377"" height=""16"" font=""0""> Indeed, according to the Appellate Body, ""Article 5.1 </text>
<text top=""510"" left=""108"" width=""687"" height=""16"" font=""0"">seeks to ensure that a Member's SPS measure has an appropriate scientific basis, whereas </text>
<text top=""526"" left=""108"" width=""685"" height=""16"" font=""0"">Article 5.6 seeks to ensure that appropriate limits are placed on the trade-restrictiveness of a </text>
<text top=""543"" left=""108"" width=""172"" height=""16"" font=""0"">Member's SPS measure.""</text>
<footnote top=""541"" left=""280"" width=""23"" height=""11"" font=""16"" number=""1081"" ref="""" dis=""""/>
<text top=""543"" left=""303"" width=""487"" height=""16"" font=""0""> Thus, the Appellate Body found that it would not be appropriate for a </text>
<text top=""559"" left=""108"" width=""685"" height=""16"" font=""0"">panel to find a measure to be inconsistent of Article 5.6 solely on the ground that the same </text>
<text top=""575"" left=""108"" width=""239"" height=""16"" font=""0"">measure is in breach of Article 5.1.</text>
<footnote top=""574"" left=""347"" width=""23"" height=""11"" font=""16"" number=""1082"" ref="""" dis=""""/>
</p><p number=""7.437"" style=""8""><text top=""610"" left=""108"" width=""682"" height=""16"" font=""0"">7.437.  Rather, according to the Appellate Body, Article 5.6 ""requires the panel itself to objectively </text>
<text top=""626"" left=""108"" width=""682"" height=""16"" font=""0"">assess, <i>inter alia</i>, whether the alternative measure proposed by the complainant would achieve the </text>
<text top=""643"" left=""108"" width=""372"" height=""16"" font=""0"">importing Member's appropriate level of protection.""</text>
<footnote top=""641"" left=""480"" width=""23"" height=""11"" font=""16"" number=""1083"" ref="""" dis=""""/>
<text top=""643"" left=""503"" width=""290"" height=""16"" font=""0""> In the Appellate Body's view, such an </text>
<text top=""659"" left=""108"" width=""589"" height=""16"" font=""0"">assessment is to be conducted on the basis of the scientific evidence on the record.</text>
<footnote top=""657"" left=""697"" width=""23"" height=""11"" font=""16"" number=""1084"" ref="""" dis=""""/>
<text top=""659"" left=""720"" width=""71"" height=""16"" font=""0""> Relevant </text>
<text top=""675"" left=""108"" width=""686"" height=""16"" font=""0"">evidence may include an exporting Member's ""risk assessment &#8230;, if such a risk assessment </text>
<text top=""692"" left=""108"" width=""50"" height=""16"" font=""0"">exists"".</text>
<footnote top=""690"" left=""158"" width=""23"" height=""11"" font=""16"" number=""1085"" ref="""" dis=""""/>
<text top=""692"" left=""181"" width=""613"" height=""16"" font=""0""> Moreover, ""elements of the importing Members' risk assessment as well as other </text>
<text top=""708"" left=""108"" width=""685"" height=""16"" font=""0"">factual elements outside that risk assessment may be relevant in seeking to establish that an </text>
<text top=""725"" left=""108"" width=""431"" height=""16"" font=""0"">alternative measure meets the appropriate level of protection"".</text>
<footnote top=""723"" left=""538"" width=""23"" height=""11"" font=""16"" number=""1086"" ref="""" dis=""""/>
</p><p number=""7.438"" style=""8""><text top=""759"" left=""108"" width=""685"" height=""16"" font=""0"">7.438.  In light of the guidance from the Appellate Body set out above, we disagree with the </text>
<text top=""775"" left=""108"" width=""682"" height=""16"" font=""0"">United States that we are precluded from carrying out our assessment of Argentina's claims under </text>
<text top=""792"" left=""108"" width=""684"" height=""16"" font=""0"">Article 5.6 because, at the time of the establishment of the Panel, APHIS had not completed its </text>
<text top=""808"" left=""108"" width=""682"" height=""16"" font=""0"">own risk analyses for Northern Argentina and Patagonia. Whether the United States' measures are </text>
<text top=""825"" left=""108"" width=""686"" height=""16"" font=""0"">based on a risk assessment as appropriate to the circumstances is a question distinct from </text>
<text top=""841"" left=""108"" width=""683"" height=""16"" font=""0"">whether the alternative measures identified by Argentina would achieve the United States' ALOP. </text>
<text top=""857"" left=""108"" width=""669"" height=""16"" font=""0"">We answered the former question in section 7.5.3.3 above, and we must now address the latter.  </text>
<p><text top=""920"" left=""170"" width=""365"" height=""15"" font=""10""> See e.g. United States' first written submission, para. 292. </text>
<text top=""934"" left=""170"" width=""332"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 368. </text>
<text top=""949"" left=""170"" width=""618"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 344 (referring to Appellate Body Report, <i>Australia &#8211; </i></text>
<text top=""963"" left=""108"" width=""126"" height=""15"" font=""12""><i>Salmon</i>, para. 208). </text>
<footnote top=""978"" left=""170"" width=""618"" height=""15"" font=""10"" number=""341"" ref="""" dis=""""/>
</p><p><text top=""993"" left=""108"" width=""126"" height=""15"" font=""12""><i>Salmon</i>, para. 224). </text>
</p><p><text top=""1022"" left=""170"" width=""332"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 358. </text>
<text top=""1036"" left=""170"" width=""332"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 356. </text>
<text top=""1051"" left=""170"" width=""583"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, paras. 364-365 (referring to Appellate Body Report, </text>
<text top=""1066"" left=""108"" width=""230"" height=""15"" font=""12""><i>Australia &#8211; Salmon</i>, paras. 209-213). </text>
<footnote top=""1080"" left=""170"" width=""618"" height=""15"" font=""10"" number=""365"" ref="""" dis=""""><ftext top=""1124"" left=""108"" width=""161"" height=""15"" font=""12""><i>Salmon</i>, paras. 209-213). </ftext>
</footnote>
</p><p><text top=""1095"" left=""108"" width=""161"" height=""15"" font=""12""><i>Salmon</i>, paras. 209-213). </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 151 - </text>
</p></p></page>
<page number=""151"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.439"" style=""8""><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">7.439.  We note the United States' argument that the maintenance of a provisional measure under </text>
<text top=""144"" left=""108"" width=""57"" height=""16"" font=""0"">Article </text>
<text top=""144"" left=""156"" width=""375"" height=""16"" font=""0"">5.7 would preclude the applicability of Article </text>
<text top=""144"" left=""521"" width=""218"" height=""16"" font=""0"">5.6 as well as of Article </text>
<text top=""144"" left=""730"" width=""69"" height=""16"" font=""0"">5.1. In </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">paragraph 7.304 above, we have concluded that the United States' measures are not covered by </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">the exemption in Article 5.7. Therefore, we see no need to consider the United States' argument </text>
<text top=""193"" left=""108"" width=""488"" height=""16"" font=""0"">further, and find that Article 5.6 is applicable to the measures at issue. </text>
</p><p number=""7.440"" style=""8""><text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">7.440.  According to the standard set forth by the Appellate Body, our first task is to determine the </text>
<text top=""244"" left=""108"" width=""684"" height=""16"" font=""0"">United States' ALOP with respect to FMD. In paragraph 7.387 above, we have already concluded </text>
<text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">that the United States' ALOP for FMD is to prevent the introduction into or dissemination of FMD in </text>
<text top=""277"" left=""108"" width=""685"" height=""16"" font=""0"">the United States' territory. We noted that the United States' ALOP is higher than that of the </text>
<text top=""293"" left=""108"" width=""588"" height=""16"" font=""0"">OIE and we have described this ALOP as being somewhere between low and zero risk.</text>
<footnote top=""292"" left=""695"" width=""23"" height=""11"" font=""16"" number=""1087"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""155"" height=""15"" font=""10""> See para. 7.387 above.  </ftext>
</footnote>
</p><p number=""7.441"" style=""8""><text top=""328"" left=""108"" width=""682"" height=""16"" font=""0"">7.441.  Next, we must assess the level of protection achieved by Argentina's alternative measures, </text>
<text top=""344"" left=""108"" width=""685"" height=""16"" font=""0"">with a view to determining whether such a level of protection is equal to, or higher than, the </text>
<text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">United States' ALOP. Before we undertake such an assessment, we find it useful to make a few </text>
<text top=""377"" left=""108"" width=""178"" height=""16"" font=""0"">preliminary observations. </text>
</p><p number=""7.442"" style=""8""><text top=""411"" left=""108"" width=""683"" height=""16"" font=""0"">7.442.  First, our determination as to the level of protection achieved by the alternative measures </text>
<text top=""428"" left=""108"" width=""683"" height=""16"" font=""0"">identified by Argentina should not be reached in the abstract, but rather proceed from the specific </text>
<text top=""444"" left=""108"" width=""684"" height=""16"" font=""0"">level of risk posed by imports of the relevant products from Northern Argentina and Patagonia. </text>
<text top=""461"" left=""108"" width=""686"" height=""16"" font=""0"">Indeed, according to the Appellate Body, ""imposing the same sanitary measure for different </text>
<text top=""477"" left=""108"" width=""689"" height=""16"" font=""0"">situations does not necessarily result in the same level of protection"", as in ""situations </text>
<text top=""493"" left=""108"" width=""686"" height=""16"" font=""0"">representing different risks &#8230; the same sanitary measure might result in different levels of </text>
<text top=""510"" left=""108"" width=""80"" height=""16"" font=""0"">protection"".</text>
<footnote top=""508"" left=""188"" width=""23"" height=""11"" font=""16"" number=""1088"" ref=""WT/DS18/RW|WT/DS18/11|WT/DS18/R|WT/DS18/R/Corr.1"" dis=""DS18""><ftext top=""1007"" left=""170"" width=""296"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Salmon</i>, para. 8.123.  </ftext>
</footnote>
<text top=""510"" left=""211"" width=""586"" height=""16"" font=""0""> Therefore, we must determine whether applying the alternative measures </text>
<text top=""526"" left=""108"" width=""683"" height=""16"" font=""0"">identified by Argentina to its products would achieve the United States' ALOP, in light of the level </text>
<text top=""543"" left=""108"" width=""223"" height=""16"" font=""0"">of risk posed by those products. </text>
</p><p number=""7.443"" style=""8""><text top=""577"" left=""108"" width=""684"" height=""16"" font=""0"">7.443.  Second, as explained by the Appellate Body, we must conduct our assessment based on </text>
<text top=""593"" left=""108"" width=""683"" height=""16"" font=""0"">the relevant scientific evidence on the record. In this respect, we note that, during the course of </text>
<text top=""610"" left=""108"" width=""685"" height=""16"" font=""0"">these proceedings, the United States placed on the record two documents containing scientific </text>
<text top=""626"" left=""108"" width=""682"" height=""16"" font=""0"">information with regard to the FMD situation in Northern Argentina and Patagonia. In particular, at </text>
<text top=""643"" left=""108"" width=""685"" height=""16"" font=""0"">the first substantive meeting of the Panel in January 2014, the United States submitted a risk </text>
<text top=""659"" left=""108"" width=""54"" height=""16"" font=""0"">analysis</text>
<footnote top=""657"" left=""162"" width=""23"" height=""11"" font=""16"" number=""1089"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""329"" height=""15"" font=""10""> 2014 Risk Analysis for Patagonia, (Exhibit USA-133). </ftext>
</footnote>
<text top=""659"" left=""185"" width=""607"" height=""16"" font=""0""> concerning the Patagonia region as a whole (comprising both Patagonia South and </text>
<text top=""675"" left=""108"" width=""685"" height=""16"" font=""0"">Patagonia North B), which is dated January 2014. Moreover, shortly before the Panel's meeting </text>
<text top=""692"" left=""108"" width=""573"" height=""16"" font=""0"">with the experts in September 2014, the United States published a risk analysis</text>
<footnote top=""690"" left=""680"" width=""23"" height=""11"" font=""16"" number=""1090"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""615"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169). We note that, although not published </ftext>
<ftext top=""1051"" left=""108"" width=""647"" height=""15"" font=""10"">until 29 August 2014, this document has been in the United States' possession since April 2014 (see front-</ftext>
<ftext top=""1066"" left=""108"" width=""652"" height=""15"" font=""10"">page). At that time, the Panel was preparing its written questions to the experts selected to assist it in this </ftext>
<ftext top=""1080"" left=""108"" width=""57"" height=""15"" font=""10"">dispute.  </ftext>
</footnote>
<text top=""692"" left=""703"" width=""89"" height=""16"" font=""0""> concerning </text>
<text top=""708"" left=""108"" width=""686"" height=""16"" font=""0"">Northern Argentina, which is dated 1 April 2014. The United States then submitted the risk </text>
<text top=""725"" left=""108"" width=""150"" height=""16"" font=""0"">analysis to the Panel. </text>
</p><p number=""7.444"" style=""8""><text top=""759"" left=""108"" width=""687"" height=""16"" font=""0"">7.444.  The parties disagree as to the use the Panel should make of the above-referenced </text>
<text top=""775"" left=""108"" width=""682"" height=""16"" font=""0"">documents. According to Argentina, the documents in question are part of the evidence submitted </text>
<text top=""792"" left=""108"" width=""686"" height=""16"" font=""0"">to the Panel, and therefore the Panel should feel ""authorized to consider and rely upon this </text>
<text top=""808"" left=""108"" width=""654"" height=""16"" font=""0"">evidence to the extent it deems necessary to discharge its duty under Article 11 of the DSU"".</text>
<footnote top=""807"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1091"" ref="""" dis=""""/>
<text top=""825"" left=""108"" width=""685"" height=""16"" font=""0"">Conversely, according to the United States, Argentina did not meet its burden of proof, which </text>
<text top=""841"" left=""108"" width=""682"" height=""16"" font=""0"">requires it to show that its proposed alternatives would meet the United States' ALOP; and APHIS' </text>
<text top=""857"" left=""108"" width=""688"" height=""16"" font=""0"">production of the documents at hand after the Panel's establishment cannot cure such a </text>
<text top=""874"" left=""108"" width=""72"" height=""16"" font=""0"">deficiency.</text>
<footnote top=""872"" left=""180"" width=""23"" height=""11"" font=""16"" number=""1092"" ref="""" dis=""""/>
<text top=""874"" left=""203"" width=""588"" height=""16"" font=""0""> If anything, according to the United States, the Panel may rely on the documents </text>
<text top=""890"" left=""108"" width=""684"" height=""16"" font=""0"">for a finding as to ""the significant effort and substantial work done by APHIS to ensure that its </text>
<text top=""907"" left=""108"" width=""464"" height=""16"" font=""0"">review of Argentina's application is thorough and well documented"".</text>
<footnote top=""905"" left=""572"" width=""23"" height=""11"" font=""16"" number=""1093"" ref="""" dis=""""/>
</p><p number=""7.445"" style=""8""><text top=""941"" left=""108"" width=""683"" height=""16"" font=""0"">7.445.  We note that a panel's functions under Article 11 of the DSU include the duty to make ""an </text>
<text top=""958"" left=""108"" width=""684"" height=""16"" font=""0"">objective assessment of the facts of the case"". As we see it, the only way a panel can properly </text>
<footnote top=""1095"" left=""170"" width=""547"" height=""15"" font=""10"" number=""53"" ref="""" dis=""""/>
<p><text top=""1109"" left=""170"" width=""490"" height=""15"" font=""10""> United States' opening statement at the second meeting of the Panel, para. 67. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 152 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">discharge such a duty is by relying on the evidence placed on the record by the parties &#8211; and, in </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">certain circumstances, by exercising its powers under Article 13.1 of the DSU to ""seek information </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">and technical advice from any individual or body which it deems appropriate"". We recall that, prior </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">to the first substantive meeting, we asked the parties to provide any risk assessment in their </text>
<text top=""193"" left=""108"" width=""512"" height=""16"" font=""0"">possession that might be relevant to our assessment of Argentina's claims.</text>
<footnote top=""192"" left=""619"" width=""23"" height=""11"" font=""16"" number=""1094"" ref="""" dis=""""/>
</p></p></page>
<page number=""152"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.446"" style=""8""><text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">7.446.  We consider that once a piece of evidence has been placed on the record, it is a panel's </text>
<text top=""244"" left=""108"" width=""684"" height=""16"" font=""0"">duty to evaluate its content irrespective of which party has submitted it and determine whether </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">that supports the claims or defences relevant to the legal provisions at issue. Doing so does not </text>
<text top=""277"" left=""108"" width=""565"" height=""16"" font=""0"">amount to a panel overstepping its authority to make a case for the complainant.</text>
<footnote top=""275"" left=""673"" width=""23"" height=""11"" font=""16"" number=""1095"" ref=""WT/DS26/AB/R ; WT/DS48/AB/R|WT/DS412/AB/R ; WT/DS426/AB/R"" dis=""DS412|DS26""><ftext top=""949"" left=""170"" width=""594"" height=""15"" font=""10""> See e.g. Appellate Body Report, <i>Canada &#8211; Renewable Energy / Canada &#8211; Feed-in Tariff Program</i>,<i> </i></ftext>
<ftext top=""963"" left=""108"" width=""644"" height=""15"" font=""10"">para. 5.215 (""While a panel cannot make the case for a complainant, it has the competence 'freely to use </ftext>
<ftext top=""978"" left=""108"" width=""680"" height=""15"" font=""10"">arguments submitted by any of the parties &#8211; or to develop its own legal reasoning &#8211; to support its own findings </ftext>
<ftext top=""993"" left=""108"" width=""645"" height=""15"" font=""10"">and conclusions on the matter under its consideration."") (quoting Appellate Body Report, <i>EC &#8211; Hormones</i>, </ftext>
</footnote>
<text top=""277"" left=""696"" width=""95"" height=""16"" font=""0""> The practice </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">of panels and the Appellate Body lends support to this interpretation. For instance, in <i>Japan &#8211; </i></text>
<text top=""310"" left=""108"" width=""685"" height=""16"" font=""18""><i>Apples</i>, the Appellate Body stated that a panel ""has the authority to make findings and draw </text>
<text top=""326"" left=""108"" width=""682"" height=""16"" font=""0"">conclusions on arguments and allegations of fact that are made by the respondent and relevant<i> </i>to </text>
<text top=""342"" left=""108"" width=""258"" height=""16"" font=""0"">a claim pursued by the complainant"".</text>
<footnote top=""341"" left=""365"" width=""23"" height=""11"" font=""16"" number=""1096"" ref="""" dis=""""/>
<text top=""342"" left=""389"" width=""401"" height=""16"" font=""0""> As another example, in <i>India &#8211; Quantitative Restrictions</i>, </text>
<text top=""359"" left=""108"" width=""685"" height=""16"" font=""0"">the Appellate Body did not object to the panel's reliance on the defendant's responses to the </text>
<text top=""375"" left=""108"" width=""653"" height=""16"" font=""0"">complainant's arguments in establishing whether the complainant had made a <i>prima facie</i> case.</text>
<footnote top=""374"" left=""761"" width=""23"" height=""11"" font=""16"" number=""1097"" ref="""" dis=""""/>
</p><p number=""7.447"" style=""8""><text top=""410"" left=""108"" width=""688"" height=""16"" font=""0"">7.447.  Further, the fact that the documents submitted by the United States post-date the </text>
<text top=""426"" left=""108"" width=""682"" height=""16"" font=""0"">establishment of the Panel does not, in our view, prevent us from evaluating their content. As the </text>
<text top=""443"" left=""108"" width=""687"" height=""16"" font=""0"">Appellate Body stated in <i>Canada &#8211; Aircraft</i>, ""a panel is vested with ample and extensive </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">discretionary authority to determine <i>when  </i>it needs information to resolve a dispute and <i>what </i></text>
<text top=""475"" left=""108"" width=""150"" height=""16"" font=""0"">information it needs"".</text>
<footnote top=""474"" left=""258"" width=""23"" height=""11"" font=""16"" number=""1098"" ref="""" dis=""""/>
<text top=""475"" left=""281"" width=""510"" height=""16"" font=""0""> More specifically, in <i>EC &#8211; Selected Customs Matters</i>, the Appellate Body </text>
<text top=""492"" left=""108"" width=""684"" height=""16"" font=""0"">explained that ""[e]vidence in support of a claim challenging measures that are within a panel's </text>
<text top=""508"" left=""108"" width=""683"" height=""16"" font=""0"">terms of reference may pre-date or post-date the establishment of the panel"", therefore a panel </text>
<text top=""525"" left=""108"" width=""685"" height=""16"" font=""0"">""is not precluded from assessing a piece of evidence for the mere reason that it pre-dates or </text>
<text top=""541"" left=""108"" width=""206"" height=""16"" font=""0"">post-dates its establishment"".</text>
<footnote top=""539"" left=""314"" width=""23"" height=""11"" font=""16"" number=""1099"" ref="""" dis=""""/>
<text top=""541"" left=""337"" width=""454"" height=""16"" font=""0""> That being said, as we discussed in paragraph 7.118 above, we </text>
<text top=""557"" left=""108"" width=""685"" height=""16"" font=""0"">consider that the appropriate point in time to be taken into account in assessing the sanitary </text>
<text top=""574"" left=""108"" width=""684"" height=""16"" font=""0"">situation in Argentina for purposes of evaluating the consistency of the United States' measures </text>
<text top=""590"" left=""108"" width=""684"" height=""16"" font=""0"">with the covered agreements is the date of the establishment of the Panel. Therefore, in these </text>
<text top=""607"" left=""108"" width=""682"" height=""16"" font=""0"">circumstances, we do not consider it appropriate to consider factual evidence relating to the period </text>
<text top=""623"" left=""108"" width=""304"" height=""16"" font=""0"">post-dating the establishment of the Panel.  </text>
</p><p number=""7.448"" style=""8""><text top=""657"" left=""108"" width=""682"" height=""16"" font=""0"">7.448.  We are aware that the conclusions reached by APHIS in the risk analyses submitted by the </text>
<text top=""674"" left=""108"" width=""686"" height=""16"" font=""0"">United States concerning the FMD situation in Northern Argentina and Patagonia refer to the </text>
<text top=""690"" left=""108"" width=""682"" height=""16"" font=""0"">circumstances that existed at the time such analyses were completed, i.e. January and April 2014, </text>
<text top=""707"" left=""108"" width=""677"" height=""16"" font=""0"">respectively. However, they also refer to documents produced by Argentina that cover the time-</text>
<text top=""723"" left=""108"" width=""683"" height=""16"" font=""0"">period from 2005 until APHIS' site visit in November 2013. Thus, the conclusions APHIS reached </text>
<text top=""739"" left=""108"" width=""685"" height=""16"" font=""0"">are based on information that both <i>pre-dates  </i>and  <i>post-dates  </i>the establishment of the Panel. </text>
<text top=""756"" left=""108"" width=""682"" height=""16"" font=""0"">Therefore, APHIS' conclusions cannot be dispositive of our assessment of the situation in Northern </text>
<text top=""772"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina and Patagonia as it existed <i>at the time of the establishment of the Panel</i>, i.e. 28 </text>
<text top=""789"" left=""108"" width=""683"" height=""16"" font=""0"">January 2013. Consequently, in evaluating the content of the exhibits in question, it would not be </text>
<text top=""805"" left=""108"" width=""683"" height=""16"" font=""0"">appropriate for us to retrospectively apply the <i>conclusions</i> APHIS reached to the question before </text>
<text top=""821"" left=""108"" width=""684"" height=""16"" font=""0"">us, namely whether, at the time of the Panel's establishment, Argentina's proposed alternative </text>
<text top=""838"" left=""108"" width=""346"" height=""16"" font=""0"">measures would achieve the United States' ALOP.</text>
<footnote top=""836"" left=""454"" width=""23"" height=""11"" font=""16"" number=""1100"" ref="""" dis=""""/>
<text top=""838"" left=""477"" width=""314"" height=""16"" font=""0""> However, to the extent that we are relying </text>
<text top=""854"" left=""108"" width=""683"" height=""16"" font=""0"">on the information that pre-dates the establishment of the Panel &#8211; such as citation to information </text>
<text top=""871"" left=""108"" width=""682"" height=""16"" font=""0"">submitted by Argentina on the sanitary situations in Northern Argentina or Patagonia - and not on </text>
<p><text top=""934"" left=""170"" width=""409"" height=""15"" font=""10""> Panel question No. 27 in advance of the first substantive meeting. </text>
</p><p><text top=""1007"" left=""108"" width=""73"" height=""15"" font=""10"">para. 156). </text>
<text top=""1022"" left=""170"" width=""586"" height=""15"" font=""10""> Appellate Body Report, <i>Japan &#8211; Apples</i>, para. 135 (emphasis omitted). See also Appellate Body </text>
<text top=""1036"" left=""108"" width=""211"" height=""15"" font=""10"">Report, <i>US &#8211; Large Civil Aircraft (2</i></text>
</p><p><text top=""1036"" left=""319"" width=""9"" height=""9"" font=""31"">nd</text></p></p><p number=""complaint)"" style=""3""><text top=""1036"" left=""328"" width=""445"" height=""15"" font=""12""><i> complaint)</i>,<i> </i>paras. 1138-1140, where the Appellate Body clarified that a </text>
<text top=""1051"" left=""108"" width=""677"" height=""15"" font=""10"">panel may, and should, have recourse to its powers under Article 13.1 of the DSU to request relevant evidence </text>
<text top=""1066"" left=""108"" width=""589"" height=""15"" font=""10"">in possession of the respondent that is necessary to objectively assess the complainant's claims. </text>
<text top=""1080"" left=""170"" width=""418"" height=""15"" font=""10""> Appellate Body Report, <i>India &#8211; Quantitative Restrictions</i>, para. 142. </text>
<text top=""1095"" left=""170"" width=""449"" height=""15"" font=""10""> Appellate Body Report, <i>Canada &#8211; Aircraft</i>, para. 192 (emphasis original). </text>
<text top=""1109"" left=""170"" width=""412"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Selected Customs Matters</i>, para. 188. </text>
<text top=""1124"" left=""170"" width=""347"" height=""15"" font=""10""> See Appellate Body Report, <i>US &#8211; Cotton Yarn</i>,<i> </i>para. 78. </text>
</p></page>
<page number=""153"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 153 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">the conclusions APHIS drew from that information, we see no problem in including that information </text>
<text top=""144"" left=""108"" width=""113"" height=""16"" font=""0"">in our analysis.  </text>
</p><p number=""7.449"" style=""8""><text top=""178"" left=""108"" width=""688"" height=""16"" font=""0"">7.449.  Third, we want to clarify the role of individual experts in these proceedings. The </text>
<text top=""195"" left=""108"" width=""682"" height=""16"" font=""0"">United States refers to the Appellate Body's statement in <i>US/Canada &#8211; Continued Suspension</i> that </text>
<text top=""211"" left=""108"" width=""682"" height=""16"" font=""0"">a panel's consultations with experts ""should not seek to test whether the experts would have done </text>
<text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">a risk assessment in the same way and would have reached the same conclusions as the risk </text>
<text top=""244"" left=""108"" width=""69"" height=""16"" font=""0"">assessor"".</text>
<footnote top=""243"" left=""177"" width=""23"" height=""11"" font=""16"" number=""1101"" ref="""" dis=""""/>
<text top=""244"" left=""200"" width=""593"" height=""16"" font=""0""> In our view, the situation in this dispute is different from that with which the </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">Appellate Body was confronted in <i>US/Canada &#8211; Continued Suspension </i>and is directly comparable </text>
<text top=""277"" left=""108"" width=""277"" height=""16"" font=""0"">to that presented in <i>Australia &#8211; Apples</i>.</text>
<footnote top=""275"" left=""385"" width=""23"" height=""11"" font=""16"" number=""1102"" ref=""WT/DS320/R/Add.3|WT/DS320/R/Add.4|WT/DS320/R/Add.6|WT/DS320/R|WT/DS320/R/Add.5|WT/DS320/R/Add.2|WT/DS320/R/Add.7|WT/DS367/R|WT/DS320/R/Add.1"" dis=""DS320|DS321|DS367""><ftext top=""1022"" left=""170"" width=""613"" height=""15"" font=""10""> In <i>US/Canada &#8211; Continued Suspension</i>, the measure at issue was aimed at protecting human life or </ftext>
<ftext top=""1036"" left=""108"" width=""621"" height=""15"" font=""10"">health ""from risks arising from additives, contaminants, toxins or disease-causing organisms in foods, </ftext>
<ftext top=""1051"" left=""108"" width=""662"" height=""15"" font=""10"">beverages or feedstuffs"". (See Panel Reports, <i>US &#8211; Continued Suspension</i>, para. 7.434; <i>Canada &#8211; Continued </i></ftext>
<ftext top=""1066"" left=""108"" width=""647"" height=""15"" font=""12""><i>Suspension</i>, para. 7.425) Conversely, in both <i>Australia &#8211; Apples</i> and the present dispute, the measures at </ftext>
<ftext top=""1080"" left=""108"" width=""667"" height=""15"" font=""10"">issue aim to protect animal life or health ""from risks arising from the entry, establishment or spread of pests, </ftext>
<ftext top=""1095"" left=""108"" width=""657"" height=""15"" font=""10"">diseases, disease-carrying organisms or disease-causing organisms"". (See Panel Report, <i>Australia &#8211; Apples</i>, </ftext>
<ftext top=""1109"" left=""108"" width=""247"" height=""15"" font=""10"">para. 7.139. See also para. 7.48 above) </ftext>
</footnote>
<text top=""277"" left=""408"" width=""383"" height=""16"" font=""0""> Indeed, the experts consulted by the Panel were not </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">tasked with reviewing any risk analysis produced by APHIS with respect to the FMD situations in </text>
<text top=""310"" left=""108"" width=""690"" height=""16"" font=""0"">Northern Argentina and Patagonia for the purpose of evaluating the compliance of the </text>
<text top=""326"" left=""108"" width=""682"" height=""16"" font=""0"">United States' measures with Article 5.1. Rather, the role of the experts here is to assist us in our </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">own assessment of the scientific evidence on the record, consistently with the guidance from the </text>
<text top=""359"" left=""108"" width=""684"" height=""16"" font=""0"">Appellate Body to panels under Article 5.6. In this respect, the Appellate Body distinguished the </text>
<text top=""375"" left=""108"" width=""513"" height=""16"" font=""0"">obligation in Article 5.6 from that under Article 5.1 in the following terms:  </text>
<p><text top=""410"" left=""151"" width=""598"" height=""16"" font=""0"">Caution not to conduct a <i>de novo </i>review is appropriate where a panel reviews a risk </text>
<text top=""426"" left=""151"" width=""602"" height=""16"" font=""0"">assessment conducted by the importing Member's authorities in the context of </text>
<text top=""443"" left=""151"" width=""599"" height=""16"" font=""0"">Article 5.1. However, the situation is different in the context of an Article 5.6 claim. </text>
<text top=""459"" left=""151"" width=""599"" height=""16"" font=""0"">The legal question under Article 5.6 is not whether the authorities of the importing </text>
<text top=""475"" left=""151"" width=""602"" height=""16"" font=""0"">Member have, in conducting the risk assessment, acted in accordance with the </text>
<text top=""492"" left=""151"" width=""597"" height=""16"" font=""0"">obligations of the <i>SPS Agreement</i>. Rather, the legal question is whether the importing </text>
<text top=""508"" left=""151"" width=""418"" height=""16"" font=""0"">Member could have adopted a less trade-restrictive measure.</text>
<footnote top=""507"" left=""569"" width=""23"" height=""11"" font=""16"" number=""1103"" ref="""" dis=""""/>
</p></p><p number=""7.450"" style=""8""><text top=""543"" left=""108"" width=""685"" height=""16"" font=""0"">7.450.  Finally, we are mindful that the task before us, as described by the Appellate Body in </text>
<text top=""559"" left=""108"" width=""686"" height=""16"" font=""18""><i>Australia &#8211; Apples</i>,<i>  </i>is to determine whether the alternative measures identified by Argentina </text>
<text top=""575"" left=""108"" width=""686"" height=""16"" font=""0"">achieve the <i>United States'</i> ALOP. Therefore, in carrying out our analysis, we find it useful to </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">consider the 11 factors that APHIS takes into account when it makes its determinations pursuant </text>
<text top=""608"" left=""108"" width=""104"" height=""16"" font=""0"">to 9 CFR 92.2: </text>
</p><p number=""(1)"" style=""4""><text top=""643"" left=""151"" width=""604"" height=""16"" font=""0"">(1)  The authority, organization, and infrastructure of the veterinary services </text>
<text top=""659"" left=""193"" width=""186"" height=""16"" font=""0"">organization in the region; </text>
</p><p number=""(2)"" style=""4""><text top=""693"" left=""151"" width=""601"" height=""16"" font=""0"">(2)  Disease status (i.e., is the restricted disease agent known to exist in the </text>
<text top=""710"" left=""193"" width=""67"" height=""16"" font=""0"">region?); </text>
</p><p number=""(3)"" style=""4""><text top=""744"" left=""151"" width=""26"" height=""16"" font=""0"">(3) </text>
<text top=""744"" left=""193"" width=""554"" height=""16"" font=""0"">The extent of an active disease control program, if any, if the agent is known to </text>
<text top=""761"" left=""193"" width=""134"" height=""16"" font=""0"">exist in the region; </text>
</p><p number=""(4)"" style=""4""><text top=""795"" left=""151"" width=""26"" height=""16"" font=""0"">(4) </text>
<text top=""795"" left=""193"" width=""255"" height=""16"" font=""0"">The vaccination status of the region; </text>
</p><p number=""(5)"" style=""4""><text top=""829"" left=""151"" width=""26"" height=""16"" font=""0"">(5) </text>
<text top=""829"" left=""193"" width=""393"" height=""16"" font=""0"">The status of adjacent regions with respect to the agent; </text>
</p><p number=""(6)"" style=""4""><text top=""864"" left=""151"" width=""26"" height=""16"" font=""0"">(6) </text>
<text top=""864"" left=""193"" width=""554"" height=""16"" font=""0"">The degree to which the region is separated from adjacent regions of higher risk </text>
<text top=""880"" left=""193"" width=""240"" height=""16"" font=""0"">through physical or other barriers; </text>
</p><p number=""(7)"" style=""4""><text top=""915"" left=""151"" width=""600"" height=""16"" font=""0"">(7)  The extent to which movement of animals and animal products is controlled </text>
<text top=""931"" left=""193"" width=""560"" height=""16"" font=""0"">from regions of higher risk, and the level of biosecurity regarding such </text>
<text top=""947"" left=""193"" width=""90"" height=""16"" font=""0"">movements; </text>
</p><p><text top=""993"" left=""170"" width=""598"" height=""15"" font=""10""> United States' comments on the experts responses to Panel questions, para. 3 (quoting Appellate </text>
<text top=""1007"" left=""108"" width=""382"" height=""15"" font=""10"">Body Report, <i>US/Canada &#8211; Continued Suspension</i>, para. 592). </text>
</p><p><text top=""1124"" left=""170"" width=""336"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Apples</i>, para. 356.  </text>
</p></page>
<page number=""154"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 154 - </text>
</p><p number=""(8)"" style=""4""><text top=""128"" left=""151"" width=""26"" height=""16"" font=""0"">(8) </text>
<text top=""128"" left=""193"" width=""433"" height=""16"" font=""0"">Livestock demographics and marketing practices in the region; </text>
</p><p number=""(9)"" style=""4""><text top=""162"" left=""151"" width=""26"" height=""16"" font=""0"">(9) </text>
<text top=""162"" left=""193"" width=""397"" height=""16"" font=""0"">The type and extent of disease surveillance in the region; </text>
</p><p number=""(10)"" style=""4""><text top=""196"" left=""151"" width=""288"" height=""16"" font=""0"">(10)  Diagnostic laboratory capacity; and </text>
</p><p number=""(11)"" style=""4""><text top=""231"" left=""151"" width=""495"" height=""16"" font=""0"">(11)  Policies and infrastructure for animal disease control in the region.</text>
<footnote top=""229"" left=""645"" width=""23"" height=""11"" font=""16"" number=""1104"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""617"" height=""15"" font=""10""> See e.g. 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 9. As discussed in fn 31 above, </ftext>
<ftext top=""920"" left=""108"" width=""667"" height=""15"" font=""10"">we refer here to the version of 9 CFR 92.2 that was in force at the time of the filing of Argentina's request for </ftext>
</footnote>
</p><p number=""7.451"" style=""8""><text top=""265"" left=""108"" width=""686"" height=""16"" font=""0"">7.451.  We note that these factors are similar to those used by the OIE when it makes its </text>
<text top=""282"" left=""108"" width=""372"" height=""16"" font=""0"">determinations of official recognition of disease status.</text>
<footnote top=""280"" left=""480"" width=""23"" height=""11"" font=""16"" number=""1105"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""606"" height=""15"" font=""10""> Such factors are enumerated in Articles 1.6.4 of the Terrestrial Code, and include: (i) geographical </ftext>
<ftext top=""963"" left=""108"" width=""641"" height=""15"" font=""10"">factors; (ii) livestock industry; (iii) relevant veterinary legislation; (iv) veterinary services; (v) the role of </ftext>
<ftext top=""978"" left=""108"" width=""628"" height=""15"" font=""10"">farmers, industry, private veterinarians and other relevant groups in FMD surveillance and control; (vi) </ftext>
<ftext top=""993"" left=""108"" width=""651"" height=""15"" font=""10"">FMD history in the region; (vii) FMD control and eradication strategies; (viii) vaccines and vaccination; (ix) </ftext>
<ftext top=""1007"" left=""108"" width=""639"" height=""15"" font=""10"">animal identification and movement controls; (x) FMD laboratory diagnosis carried out in the region; (xi) </ftext>
<ftext top=""1022"" left=""108"" width=""655"" height=""15"" font=""10"">organization and capacity of approved laboratories; (xii) serological surveillance; (xiii) slaughterhouses and </ftext>
<ftext top=""1036"" left=""108"" width=""661"" height=""15"" font=""10"">markets; (xiv) coordination with neighbouring countries; (xv) controls in place for swill feeding; (xvi) import </ftext>
<ftext top=""1051"" left=""108"" width=""456"" height=""15"" font=""10"">control procedures; and (xvii) control measures and contingency planning. </ftext>
</footnote>
</p><p number=""7.452"" style=""8""><text top=""316"" left=""108"" width=""689"" height=""16"" font=""0"">7.452.  Where relevant, we also find it useful to refer to the standards, guidelines and </text>
<text top=""332"" left=""108"" width=""683"" height=""16"" font=""0"">recommendations developed by the OIE and embodied in the Terrestrial Code and the Terrestrial </text>
<text top=""349"" left=""108"" width=""683"" height=""16"" font=""0"">Manual. We note that this is consistent with the United States own view. In particular, we recall </text>
<text top=""365"" left=""108"" width=""683"" height=""16"" font=""0"">that APHIS attaches weight to the exporting country's compliance with the relevant provisions of </text>
<text top=""382"" left=""108"" width=""654"" height=""16"" font=""0"">the Terrestrial Code and Terrestrial Manual when reviewing requests filed under 9 CFR 92.2.</text>
<footnote top=""380"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1106"" ref="""" dis=""""/>
<text top=""398"" left=""108"" width=""683"" height=""16"" font=""0"">Finally, while our review is not bound by the disciplines of Article 5.1, we draw guidance from the </text>
<text top=""414"" left=""108"" width=""685"" height=""16"" font=""0"">requirement in that provision that the ""risk assessment techniques developed by the relevant </text>
<text top=""431"" left=""108"" width=""349"" height=""16"" font=""0"">international organizations"" be taken into account. </text>
</p><p number=""7.453"" style=""8""><text top=""465"" left=""108"" width=""687"" height=""16"" font=""0"">7.453.  With these considerations in mind, we now turn to our assessment of whether the </text>
<text top=""482"" left=""108"" width=""685"" height=""16"" font=""0"">alternative measures identified by Argentina would have achieved the United States' ALOP for </text>
<text top=""498"" left=""108"" width=""683"" height=""16"" font=""0"">FMD as of the date of the establishment of the Panel. First, we examine the proposed alternatives </text>
<text top=""515"" left=""108"" width=""687"" height=""16"" font=""0"">for fresh (chilled or frozen) beef from Northern Argentina. Next, we turn to the proposed </text>
<text top=""531"" left=""108"" width=""537"" height=""16"" font=""0"">alternatives for FMD-susceptible animals and animal products from Patagonia. </text>
</p><p number=""7.6"" style=""8""><text top=""565"" left=""108"" width=""682"" height=""16"" font=""28"">7.6.7.4.1  The proposed alternatives to the United States' prohibition on imports of fresh </text><text top=""582"" left=""108"" width=""373"" height=""16"" font=""28"">(chilled or frozen) beef from Northern Argentina </text></p><p number=""7.454"" style=""8""><text top=""616"" left=""108"" width=""683"" height=""16"" font=""0"">7.454.  To determine whether the mitigating effects of the proposed measures would permit fresh </text>
<text top=""633"" left=""108"" width=""684"" height=""16"" font=""0"">(chilled or frozen) beef from Northern Argentina to achieve the United States' ALOP, we find it </text>
<text top=""649"" left=""108"" width=""682"" height=""16"" font=""0"">useful to examine the evidence on the record in light of the 11 factors APHIS used to evaluate the </text>
<text top=""665"" left=""108"" width=""579"" height=""16"" font=""0"">FMD-status of an applicant country or region at the time Argentina filed its request.  </text>
</p><p number=""7.6"" style=""8""><text top=""700"" left=""108"" width=""686"" height=""16"" font=""28"">7.6.7.4.1.1  The authority, organization and infrastructure of the veterinary services </text><text top=""716"" left=""108"" width=""201"" height=""16"" font=""28"">organization in the region </text></p><p number=""7.455"" style=""8""><text top=""751"" left=""108"" width=""683"" height=""16"" font=""0"">7.455.  In its 2005 risk analysis for Patagonia South, APHIS examined numerous aspects relating </text>
<text top=""767"" left=""108"" width=""683"" height=""16"" font=""0"">to SENASA's authority, organization, infrastructure and capacity to prevent and control FMD in the </text>
<text top=""783"" left=""108"" width=""683"" height=""16"" font=""0"">whole Argentine territory. With regard to these factors, APHIS' 2005 findings on SENASA are not </text>
<text top=""800"" left=""108"" width=""684"" height=""16"" font=""0"">limited to the Patagonia region but, cover SENASA's policies and actions in the whole Argentine </text>
<text top=""816"" left=""108"" width=""683"" height=""16"" font=""0"">territory. Further, in Drs Batho and Bonbon's views, there is no reason to believe that SENASA's </text>
<text top=""833"" left=""108"" width=""683"" height=""16"" font=""0"">authority, organization and infrastructure in Northern Argentina would be different from those in </text>
<text top=""849"" left=""108"" width=""72"" height=""16"" font=""0"">Patagonia.</text>
<footnote top=""847"" left=""180"" width=""23"" height=""11"" font=""16"" number=""1107"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""582"" height=""15"" font=""10""> Dr Batho's response to Panel question No. 31; Dr Bonbon's response to Panel question No. 31. </ftext>
</footnote>
<text top=""849"" left=""203"" width=""589"" height=""16"" font=""0""> Dr Cupit did note key relevant differences between SENASA's activities in the two </text>
<text top=""865"" left=""108"" width=""682"" height=""16"" font=""0"">regions in that vaccination of cattle, serological surveillance, and maturation and deboning of fresh </text>
<p><text top=""934"" left=""108"" width=""541"" height=""15"" font=""10"">authorization of imports of fresh (chilled or frozen) beef, submitted as Exhibit ARG-118.  </text>
<footnote top=""1066"" left=""170"" width=""448"" height=""15"" font=""10"" number=""31"" ref="""" dis=""""/>
</p><p><text top=""1095"" left=""108"" width=""628"" height=""15"" font=""10"">Dr Cupit concurred that the 2005 risk assessment for Patagonia South ""could form the basis of the risk </text>
<text top=""1109"" left=""108"" width=""669"" height=""15"" font=""10"">assessment for the Argentine territory as a whole"" with respect to SENASA's capacity. (Dr Cupit's response to </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 155 - </text>
</p><p><text top=""128"" left=""108"" width=""463"" height=""16"" font=""0"">(chilled or frozen) beef are conducted only in Northern Argentina.</text>
<footnote top=""126"" left=""571"" width=""23"" height=""11"" font=""16"" number=""1108"" ref="""" dis=""""/>
<text top=""128"" left=""594"" width=""197"" height=""16"" font=""0""> We specifically look at the </text>
<text top=""144"" left=""108"" width=""398"" height=""16"" font=""0"">evidence concerning vaccination (paragraphs </text>
<text top=""144"" left=""484"" width=""327"" height=""16"" font=""0"">7.468-7.473), serological surveillance </text>
<text top=""160"" left=""108"" width=""609"" height=""16"" font=""0"">(paragraphs 7.489-7.491 and maturation and deboning (paragraphs 7.492-7.493 below. </text>
</p></p></page>
<page number=""155"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.456"" style=""8""><text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">7.456.  APHIS reviewed the legal and administrative sources of SENASA's authority. It observed </text>
<text top=""211"" left=""108"" width=""682"" height=""16"" font=""0"">that a number of laws, decrees and resolutions from the period 1903-2001 enable SENASA to take </text>
<text top=""228"" left=""108"" width=""246"" height=""16"" font=""0"">action to prevent and control FMD.</text>
<footnote top=""226"" left=""354"" width=""23"" height=""11"" font=""16"" number=""1109"" ref="""" dis=""""><ftext top=""891"" left=""170"" width=""414"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 9-10. </ftext>
</footnote>
<text top=""228"" left=""377"" width=""415"" height=""16"" font=""0""> Most of APHIS' assessment in this regard focused on the </text>
<text top=""244"" left=""108"" width=""685"" height=""16"" font=""0"">reorganization of SENASA in 2001-2002, which was intended ""to increase the efficiency of the </text>
<text top=""260"" left=""108"" width=""686"" height=""16"" font=""0"">existing geopolitical system and address international perception that SENASA had not been </text>
<text top=""277"" left=""108"" width=""421"" height=""16"" font=""0"">transparent with its trading partners about its FMD situation"".</text>
<footnote top=""275"" left=""529"" width=""23"" height=""11"" font=""16"" number=""1110"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 10-11. </ftext>
</footnote>
<text top=""277"" left=""552"" width=""238"" height=""16"" font=""0""> SENASA' reorganization included: </text>
<text top=""293"" left=""108"" width=""518"" height=""16"" font=""0"">the centralization of command and control of the animal health programs</text>
<footnote top=""292"" left=""626"" width=""23"" height=""11"" font=""16"" number=""1111"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 11. </ftext>
</footnote>
<text top=""293"" left=""649"" width=""143"" height=""16"" font=""0"">; enhanced internal </text>
<text top=""310"" left=""108"" width=""456"" height=""16"" font=""0"">monitoring, accountability, and compliance with national policies</text>
<footnote top=""308"" left=""564"" width=""23"" height=""11"" font=""16"" number=""1112"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 11. </ftext>
</footnote>
<text top=""310"" left=""587"" width=""206"" height=""16"" font=""0"">; an increased emphasis on </text>
<text top=""326"" left=""108"" width=""104"" height=""16"" font=""0"">border controls</text>
<footnote top=""325"" left=""212"" width=""23"" height=""11"" font=""16"" number=""1113"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 11. </ftext>
</footnote>
<text top=""326"" left=""235"" width=""556"" height=""16"" font=""0"">; the redefinition of the boundaries of regional units in order to achieve a more </text>
<text top=""342"" left=""108"" width=""621"" height=""16"" font=""0"">efficient distribution of personnel according to the level of activity occurring in each region</text>
<footnote top=""341"" left=""729"" width=""23"" height=""11"" font=""16"" number=""1114"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 11. </ftext>
</footnote>
<text top=""342"" left=""752"" width=""38"" height=""16"" font=""0"">; the </text>
<text top=""359"" left=""108"" width=""682"" height=""16"" font=""0"">repartition of tasks between SENASA's central and regional offices in terms of, <i>inter alia</i>, </text>
<text top=""375"" left=""108"" width=""685"" height=""16"" font=""0"">preventive, control, and eradication actions, monitoring of compliance with SENASA's policies, </text>
<text top=""392"" left=""108"" width=""684"" height=""16"" font=""0"">investigation of suspected outbreaks, movement controls, updating of registries and databases, </text>
<text top=""408"" left=""108"" width=""687"" height=""16"" font=""0"">assessment of field staff performance, inspection of slaughtering and processing plants and </text>
<text top=""425"" left=""108"" width=""654"" height=""16"" font=""0"">storage facilities, and the establishment of the methods and test protocols used in laboratories.</text>
<footnote top=""423"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1115"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 12-14. </ftext>
</footnote>
<text top=""441"" left=""108"" width=""682"" height=""16"" font=""0"">The laws and regulations governing SENASA and its structure have remained unchanged since the </text>
<text top=""457"" left=""108"" width=""153"" height=""16"" font=""0"">2005 risk assessment.</text>
<footnote top=""456"" left=""260"" width=""23"" height=""11"" font=""16"" number=""1116"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""458"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), pp. 10-16.  </ftext>
</footnote>
</p><p number=""7.457"" style=""8""><text top=""492"" left=""108"" width=""685"" height=""16"" font=""0"">7.457.  APHIS then reviewed SENASA's financial and human resources. It found that SENASA's </text>
<text top=""508"" left=""108"" width=""684"" height=""16"" font=""0"">2003 budget was of 117 million pesos (equivalent to approximately USD 39 million), and noted </text>
<text top=""525"" left=""108"" width=""683"" height=""16"" font=""0"">that, according to SENASA officials, the system was ""self-sufficient"" because of the fees required </text>
<text top=""541"" left=""108"" width=""159"" height=""16"" font=""0"">for SENASA's services.</text>
<footnote top=""539"" left=""267"" width=""23"" height=""11"" font=""16"" number=""1117"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 15. </ftext>
</footnote>
<text top=""541"" left=""290"" width=""502"" height=""16"" font=""0""> It also found that, in 2005, SENASA employed 3,479 people, out of </text>
<text top=""557"" left=""108"" width=""441"" height=""16"" font=""0"">which 2,558 were permanent staff and 572 were veterinarians.</text>
<footnote top=""556"" left=""549"" width=""23"" height=""11"" font=""16"" number=""1118"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 15. </ftext>
</footnote>
<text top=""557"" left=""572"" width=""219"" height=""16"" font=""0""> It also observed that SENASA </text>
<text top=""574"" left=""108"" width=""241"" height=""16"" font=""0"">could hire contract staff if need be.</text>
<footnote top=""572"" left=""349"" width=""23"" height=""11"" font=""16"" number=""1119"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 15. </ftext>
</footnote>
<text top=""574"" left=""373"" width=""418"" height=""16"" font=""0""> In terms of the veterinarians' licensure and training, APHIS </text>
<text top=""590"" left=""108"" width=""685"" height=""16"" font=""0"">noted that official SENASA veterinarians must renew their professional registration on a yearly </text>
<text top=""607"" left=""108"" width=""684"" height=""16"" font=""0"">basis and must comply with training requirements in line with the main strategies of the 2001 </text>
<text top=""623"" left=""108"" width=""260"" height=""16"" font=""0"">National Eradication Plan for FMD.</text>
<footnote top=""621"" left=""368"" width=""23"" height=""11"" font=""16"" number=""1120"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 17. </ftext>
</footnote>
<text top=""623"" left=""392"" width=""405"" height=""16"" font=""0""> The laws and regulations governing the licensure, </text>
<text top=""639"" left=""108"" width=""618"" height=""16"" font=""0"">qualifications, and training of veterinarians are unchanged from the 2005 risk assessment.</text>
<footnote top=""638"" left=""726"" width=""23"" height=""11"" font=""16"" number=""1121"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""458"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), pp. 17-18.  </ftext>
</footnote>
</p><p number=""7.458"" style=""8""><text top=""674"" left=""108"" width=""684"" height=""16"" font=""0"">7.458.  Next, APHIS turned to the role of SENASA's field offices in the identification of premises </text>
<text top=""690"" left=""108"" width=""685"" height=""16"" font=""0"">and the census of FMD-susceptible animals. It found that all premises with agricultural animal </text>
<text top=""707"" left=""108"" width=""682"" height=""16"" font=""0"">production must register with the National Sanitary Registry of Ag-Producers (RENSPA) and obtain </text>
<text top=""723"" left=""108"" width=""181"" height=""16"" font=""0"">an identification number.</text>
<footnote top=""721"" left=""289"" width=""23"" height=""11"" font=""16"" number=""1122"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 18. </ftext>
</footnote>
<text top=""723"" left=""312"" width=""483"" height=""16"" font=""0""> Each RENSPA number provides information as to the location, </text>
<text top=""739"" left=""108"" width=""654"" height=""16"" font=""0"">ownership or rental status, and number of FMD-susceptible animals on the premises concerned.</text>
<footnote top=""738"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1123"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 18-19. </ftext>
</footnote>
<text top=""756"" left=""108"" width=""684"" height=""16"" font=""0"">It also includes the name of a SENASA veterinarian, who, according to the law, is in charge of </text>
<text top=""772"" left=""108"" width=""442"" height=""16"" font=""0"">reporting problems that he or she may observe on the premises.</text>
<footnote top=""771"" left=""550"" width=""23"" height=""11"" font=""16"" number=""1124"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 18. </ftext>
</footnote>
<text top=""772"" left=""573"" width=""217"" height=""16"" font=""0""> Failure to report animal health </text>
<text top=""789"" left=""108"" width=""683"" height=""16"" font=""0"">problems observed on the premises entails a fine for the owner, the responsible veterinarian, or </text>
<text top=""805"" left=""108"" width=""683"" height=""16"" font=""0"">both, as well as the forfeiture of the indemnity normally paid by SENASA to cattle owners in case </text>
<text top=""821"" left=""108"" width=""306"" height=""16"" font=""0"">of stamping-out following an FMD outbreak.</text>
<footnote top=""820"" left=""414"" width=""23"" height=""11"" font=""16"" number=""1125"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 18. </ftext>
<ftext top=""1036"" left=""108"" width=""427"" height=""15"" font=""10"">stated in para. 7.447 above, the Panel does not rely on this evidence. </ftext>
</footnote>
<text top=""821"" left=""437"" width=""355"" height=""16"" font=""0""> A centralized database containing information on </text>
<text top=""838"" left=""108"" width=""683"" height=""16"" font=""0"">the census of all animals on the premises and the FMD test status of each premise is maintained </text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 156 - </text>
</p><p><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">and updated by SENASA's field officials. Monthly statistical reports are generated from this </text>
<text top=""144"" left=""108"" width=""66"" height=""16"" font=""0"">database.</text>
<footnote top=""143"" left=""174"" width=""23"" height=""11"" font=""16"" number=""1126"" ref="""" dis=""""><ftext top=""861"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 19. </ftext>
</footnote>
<text top=""144"" left=""197"" width=""595"" height=""16"" font=""0""> Argentina submitted information to APHIS covering the period between 2002 and </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">2009, which indicated that identification of premises and the census of FMD-susceptible animals by </text>
<text top=""177"" left=""108"" width=""473"" height=""16"" font=""0"">SENASA had not essentially changed since the 2005 risk assessment.</text>
<footnote top=""175"" left=""581"" width=""23"" height=""11"" font=""16"" number=""1127"" ref="""" dis=""""><ftext top=""876"" left=""170"" width=""598"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), pp. 18-19, 52-54. Although APHIS </ftext>
<ftext top=""891"" left=""108"" width=""637"" height=""15"" font=""10"">also refers to some additional information SENASA provided in November 2013, as stated in para. 7.447 </ftext>
<ftext top=""905"" left=""108"" width=""295"" height=""15"" font=""10"">above, the Panel does not rely on this evidence. </ftext>
</footnote>
</p></p></page>
<page number=""156"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.459"" style=""8""><text top=""211"" left=""108"" width=""688"" height=""16"" font=""0"">7.459.  APHIS further reviewed the controls on the movement of FMD-susceptible animals </text>
<text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">throughout the Argentine territory. It observed that a movement permit (DTA) is required when </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">animals go to slaughter, go to market, cross provincial lines or are exported internationally and, </text>
<text top=""260"" left=""108"" width=""435"" height=""16"" font=""0"">generally, if an animal is moved from one farm to another.</text>
<footnote top=""259"" left=""542"" width=""23"" height=""11"" font=""16"" number=""1128"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 21. </ftext>
</footnote>
<text top=""260"" left=""565"" width=""228"" height=""16"" font=""0""> Movement permits record the </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">RENSPA numbers of both the premises of origin and the premises of destination of every single </text>
<text top=""293"" left=""108"" width=""685"" height=""16"" font=""0"">animal, and allow SENASA to detect unlawful attempts to ship more animals than the census </text>
<text top=""310"" left=""108"" width=""102"" height=""16"" font=""0"">would predict.</text>
<footnote top=""308"" left=""210"" width=""23"" height=""11"" font=""16"" number=""1129"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""398"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 21.  </ftext>
</footnote>
<text top=""310"" left=""233"" width=""562"" height=""16"" font=""0""> The animals being moved must carry visible identification marks and be </text>
<text top=""326"" left=""108"" width=""685"" height=""16"" font=""0"">transported in vehicles approved by SENASA upon checking compliance with the washing and </text>
<text top=""342"" left=""108"" width=""183"" height=""16"" font=""0"">disinfection requirements.</text>
<footnote top=""341"" left=""291"" width=""23"" height=""11"" font=""16"" number=""1130"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 21-22. </ftext>
</footnote>
<text top=""342"" left=""314"" width=""482"" height=""16"" font=""0""> SENASA officials must inspect the animals concerned on the </text>
<text top=""359"" left=""108"" width=""461"" height=""16"" font=""0"">premises of origin and verify official documents before shipment.</text>
<footnote top=""357"" left=""569"" width=""23"" height=""11"" font=""16"" number=""1131"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 22. </ftext>
</footnote>
<text top=""359"" left=""592"" width=""200"" height=""16"" font=""0""> When animals are shipped </text>
<text top=""375"" left=""108"" width=""682"" height=""16"" font=""0"">from farm to farm, the DTA must be returned within 15 days to the local office of destination, and </text>
<text top=""392"" left=""108"" width=""509"" height=""16"" font=""0"">that office will contact the local office of origin of the shipment arrival.</text>
<footnote top=""390"" left=""617"" width=""23"" height=""11"" font=""16"" number=""1132"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 22. </ftext>
</footnote>
<text top=""392"" left=""640"" width=""152"" height=""16"" font=""0""> SENASA's staff, the </text>
<text top=""408"" left=""108"" width=""684"" height=""16"" font=""0"">owners of or persons responsible for the animals, the shippers and the slaughter plants are all </text>
<text top=""425"" left=""108"" width=""526"" height=""16"" font=""0"">jointly liable for failure to comply with the above-referenced requirements.</text>
<footnote top=""423"" left=""634"" width=""23"" height=""11"" font=""16"" number=""1133"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 21. </ftext>
</footnote>
<text top=""425"" left=""657"" width=""134"" height=""16"" font=""0""> SENASA provided </text>
<text top=""441"" left=""108"" width=""682"" height=""16"" font=""0"">information to APHIS covering the period between 2003 and 2007, which indicated that movement </text>
<text top=""457"" left=""108"" width=""588"" height=""16"" font=""0"">controls in Argentina remained essentially unchanged since the 2005 risk assessment.</text>
<footnote top=""456"" left=""696"" width=""23"" height=""11"" font=""16"" number=""1134"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""458"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), pp. 54-56.  </ftext>
</footnote>
</p><p number=""7.460"" style=""8""><text top=""492"" left=""108"" width=""684"" height=""16"" font=""0"">7.460.  Finally, APHIS reviewed SENASA's regulations concerning swill feeding. It found that the </text>
<text top=""508"" left=""108"" width=""685"" height=""16"" font=""0"">only form of swill feeding permitted in Argentina is the feeding of pigs with leftovers of food </text>
<text top=""525"" left=""108"" width=""688"" height=""16"" font=""0"">substances of animal origin coming from stores approved by the competent authority to </text>
<text top=""541"" left=""108"" width=""173"" height=""16"" font=""0"">manufacture or sell food.</text>
<footnote top=""539"" left=""281"" width=""23"" height=""11"" font=""16"" number=""1135"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 22-23. </ftext>
</footnote>
<text top=""541"" left=""304"" width=""486"" height=""16"" font=""0""> Authorization is conditioned on compliance with the requirement that </text>
<text top=""557"" left=""108"" width=""654"" height=""16"" font=""0"">the swill be subjected to a cooking process guaranteeing destruction of pathogenic organisms.</text>
<footnote top=""556"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1136"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 23. </ftext>
</footnote>
<text top=""574"" left=""108"" width=""545"" height=""16"" font=""0"">The laws and regulations governing swill feeding remain unchanged since 2005.</text>
<footnote top=""572"" left=""653"" width=""23"" height=""11"" font=""16"" number=""1137"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""458"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), pp. 18-19.  </ftext>
</footnote>
</p><p number=""7.461"" style=""8""><text top=""608"" left=""108"" width=""684"" height=""16"" font=""0"">7.461.  Based on all the foregoing, APHIS concluded in 2005 that ""Argentina has the veterinary </text>
<text top=""625"" left=""108"" width=""685"" height=""16"" font=""0"">and regulatory infrastructure to adequately monitor and control any incursion of FMD into the </text>
<text top=""641"" left=""108"" width=""63"" height=""16"" font=""0"">country"".</text>
<footnote top=""639"" left=""170"" width=""23"" height=""11"" font=""16"" number=""1138"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 23. </ftext>
</footnote>
<text top=""641"" left=""194"" width=""603"" height=""16"" font=""0""> Specifically, APHIS considered that ""[t]here is sufficient monitoring of animal </text>
<text top=""657"" left=""108"" width=""682"" height=""16"" font=""0"">premises and movements to permit effective surveillance and detection programs that would result </text>
<text top=""674"" left=""108"" width=""412"" height=""16"" font=""0"">in sufficient administration of eradication efforts, if needed"".</text>
<footnote top=""672"" left=""519"" width=""23"" height=""11"" font=""16"" number=""1139"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 23. </ftext>
</footnote>
<text top=""674"" left=""542"" width=""248"" height=""16"" font=""0""> APHIS also ""expressed confidence"" </text>
<text top=""690"" left=""108"" width=""687"" height=""16"" font=""0"">that SENASA's delays in reporting the 2000-2001 FMD outbreaks would not occur again if </text>
<text top=""707"" left=""108"" width=""264"" height=""16"" font=""0"">analogous events were to occur today.</text>
<footnote top=""705"" left=""371"" width=""23"" height=""11"" font=""16"" number=""1140"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 23. </ftext>
<ftext top=""745"" left=""108"" width=""638"" height=""15"" font=""10"">improvements, the risk of FMD-transmission from imports of fresh (chilled or frozen) beef from Northern </ftext>
<ftext top=""759"" left=""108"" width=""550"" height=""15"" font=""10"">Argentina is ""lower than it was in 1997"". (Dr Bonbon's response to Panel question No. 57) </ftext>
</footnote>
</p><p number=""7.462"" style=""8""><text top=""741"" left=""108"" width=""683"" height=""16"" font=""0"">7.462.  We do not see any evidence on the record indicating that, throughout the period leading </text>
<text top=""757"" left=""108"" width=""683"" height=""16"" font=""0"">up to the Panel's establishment, SENASA's authority, organization, infrastructure, and capacity to </text>
<text top=""774"" left=""108"" width=""685"" height=""16"" font=""0"">prevent and control FMD in the Argentine territory changed in a manner that would contradict </text>
<text top=""790"" left=""108"" width=""687"" height=""16"" font=""0"">APHIS' conclusions in 2005. Indeed, as Dr Batho noted, SENASA's infrastructure ""improved </text>
<p><text top=""1022"" left=""151"" width=""605"" height=""15"" font=""10"">Although APHIS also refers to some additional information SENASA provided in November 2013, as </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 157 - </text>
</p><p><text top=""128"" left=""108"" width=""380"" height=""16"" font=""0"">dramatically"" during that period in several respects.</text>
<footnote top=""126"" left=""488"" width=""23"" height=""11"" font=""16"" number=""1141"" ref="""" dis=""""/>
<text top=""128"" left=""511"" width=""284"" height=""16"" font=""0""> For instance, SENASA's 2013 annual </text>
<text top=""144"" left=""108"" width=""516"" height=""16"" font=""0"">budget was 1.3 billion pesos (equivalent to approximately USD 200 million)</text>
<footnote top=""143"" left=""624"" width=""23"" height=""11"" font=""16"" number=""1142"" ref="""" dis=""""><ftext top=""774"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 16. </ftext>
</footnote>
<text top=""144"" left=""647"" width=""143"" height=""16"" font=""0"">, i.e. over five times </text>
<text top=""160"" left=""108"" width=""687"" height=""16"" font=""0"">more than in 2005. Further, in 2013 SENASA employed 5,500 people, of which 1,054 are </text>
<text top=""177"" left=""108"" width=""94"" height=""16"" font=""0"">veterinarians.</text>
<footnote top=""175"" left=""202"" width=""23"" height=""11"" font=""16"" number=""1143"" ref="""" dis=""""><ftext top=""788"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 16. </ftext>
</footnote>
<text top=""177"" left=""225"" width=""566"" height=""16"" font=""0""> Thus, SENASA's personnel doubled<b> </b>from 2005 to 2013. Also, in order to improve </text>
<text top=""193"" left=""108"" width=""686"" height=""16"" font=""0"">animal tracking and movement controls throughout the Argentine territory, in 2006 SENASA </text>
<text top=""210"" left=""108"" width=""693"" height=""16"" font=""0"">instituted a compulsory cattle identification program, requiring that all calves born </text>
<text top=""226"" left=""108"" width=""277"" height=""16"" font=""0"">after September 2007 carry official tags.</text>
<footnote top=""225"" left=""385"" width=""23"" height=""11"" font=""16"" number=""1144"" ref="""" dis=""""><ftext top=""803"" left=""170"" width=""597"" height=""15"" font=""10""> Resoluci&#243;n SENASA 754/2006. Cr&#233;ase la Clave Unica de Identificaci&#243;n Ganadera, que identificar&#225; </ftext>
<ftext top=""818"" left=""108"" width=""632"" height=""15"" font=""10"">individualmente a cada productor pecuario del pa&#237;s en cada establecimiento agropecuario. Apru&#233;base el </ftext>
<ftext top=""832"" left=""108"" width=""623"" height=""15"" font=""10"">""Procedimiento para Reidentificaci&#243;n de Bovinos, (Resoluci&#243;n SENASA 754/2006), (Exhibit ARG-143).  </ftext>
</footnote>
</p></p></page>
<page number=""157"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.463"" style=""8""><text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">7.463.  Other evidence on the record is consistent with APHIS' 2005 conclusions. The European </text>
<text top=""277"" left=""108"" width=""685"" height=""16"" font=""0"">Commission's most recent evaluation of the FMD situation in Argentina available on the record </text>
<text top=""293"" left=""108"" width=""606"" height=""16"" font=""0"">(dated 2006) concludes that the Argentine veterinary authority ""is well organised"".</text>
<footnote top=""292"" left=""714"" width=""23"" height=""11"" font=""16"" number=""1145"" ref="""" dis=""""><ftext top=""847"" left=""170"" width=""394"" height=""15"" font=""10""> European Commission's 2006 Report, (Exhibit ARG-111), p. 21. </ftext>
</footnote>
<text top=""293"" left=""737"" width=""57"" height=""16"" font=""0""> In its </text>
<text top=""310"" left=""108"" width=""686"" height=""16"" font=""0"">evaluations over the period 2002-2006, the Commission did identify some ""deficiencies"" with </text>
<text top=""326"" left=""108"" width=""435"" height=""16"" font=""0"">respect e.g. to animal identification and movement controls.</text>
<footnote top=""325"" left=""543"" width=""23"" height=""11"" font=""16"" number=""1146"" ref="""" dis=""""><ftext top=""861"" left=""170"" width=""617"" height=""15"" font=""10""> See e.g. Final Report Of A Mission Carried Out In Argentina From 18 To 29 November 2002 In Order </ftext>
<ftext top=""876"" left=""108"" width=""678"" height=""15"" font=""10"">To Evaluate The Controls In Place Over Foot And Mouth Disease And To Assess Public Health Controls Over The </ftext>
<ftext top=""891"" left=""108"" width=""634"" height=""15"" font=""10"">Production Of Fresh Meat. (DG(SANCO)/8715/2002 &#8211; MR Final),<i> </i>(European Commission's 2002 Report), </ftext>
<ftext top=""905"" left=""108"" width=""550"" height=""15"" font=""10"">(Exhibit ARG-107), p. 27; European Commission's 2006 Report, (Exhibit ARG-111), p. 21. </ftext>
</footnote>
<text top=""326"" left=""566"" width=""227"" height=""16"" font=""0""> Despite such deficiencies, the </text>
<text top=""342"" left=""108"" width=""624"" height=""16"" font=""0"">Commission concluded that SENASA's ability to prevent and control FMD was ""satisfactory""</text>
<footnote top=""341"" left=""732"" width=""23"" height=""11"" font=""16"" number=""1147"" ref="""" dis=""""/>
<text top=""342"" left=""755"" width=""35"" height=""16"" font=""0""> and </text>
<text top=""359"" left=""108"" width=""686"" height=""16"" font=""0"">progressively reopened its market to fresh (chilled or frozen) beef from Northern Argentina </text>
<text top=""375"" left=""108"" width=""341"" height=""16"" font=""0"">according to the disease history of each province.</text>
<footnote top=""374"" left=""449"" width=""23"" height=""11"" font=""16"" number=""1148"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""514"" height=""15"" font=""10""> See e.g. Decision of the European Commission No. 2002/45/EC (22 January 2002), </ftext>
<ftext top=""949"" left=""108"" width=""575"" height=""15"" font=""10"">(Exhibit ARG-114); Decision of the European Commission No. 2002/68/EC (30 January 2002), </ftext>
<ftext top=""963"" left=""108"" width=""564"" height=""15"" font=""10"">(Exhibit ARG-108); Decision of the European Commission No. 2002/198/EC (7 March 2002), </ftext>
<ftext top=""978"" left=""108"" width=""652"" height=""15"" font=""10"">(Exhibit ARG-109); Commission Regulation (EU) N&#176; 206/2010 of 12 March, 2010, laying down lists of third </ftext>
<ftext top=""993"" left=""108"" width=""678"" height=""15"" font=""10"">countries, territories or parts thereof authorized for the introduction into the European Union of certain animals </ftext>
<ftext top=""1007"" left=""108"" width=""614"" height=""15"" font=""10"">and fresh meat and the veterinary certification requirements, 2010 O.J. (L 073) 1-121, (Commission </ftext>
<ftext top=""1022"" left=""108"" width=""270"" height=""15"" font=""10"">Regulation No. 206/2010), (Exhibit ARG-1). </ftext>
</footnote>
<text top=""375"" left=""472"" width=""319"" height=""16"" font=""0""> In his responses to Panel questions, Dr Cupit </text>
<text top=""392"" left=""108"" width=""682"" height=""16"" font=""0"">confirmed that SENASA imposes ""strict movement controls that operate within Argentina especially </text>
<text top=""408"" left=""108"" width=""683"" height=""16"" font=""0"">between the FMD-free areas with and without vaccination and also the buffer/border region with </text>
<text top=""425"" left=""108"" width=""158"" height=""16"" font=""0"">Paraguay and Bolivia"".</text>
<footnote top=""423"" left=""266"" width=""23"" height=""11"" font=""16"" number=""1149"" ref="""" dis=""""/>
<text top=""425"" left=""289"" width=""503"" height=""16"" font=""0""> Further, in Dr Bonbon's view, the evidence on the record shows that </text>
<text top=""441"" left=""108"" width=""687"" height=""16"" font=""0"">""the capacities of the Argentinian veterinary services &#8230; have improved since 1997"", when </text>
<text top=""457"" left=""108"" width=""585"" height=""16"" font=""0"">Argentina was authorized to export fresh (chilled or frozen) beef to the United States.</text>
<footnote top=""456"" left=""693"" width=""23"" height=""11"" font=""16"" number=""1150"" ref="""" dis=""""/>
</p><p number=""7.464"" style=""8""><text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">7.464.  The evidence on the record indicates that, at the time of the establishment of the Panel, </text>
<text top=""508"" left=""108"" width=""685"" height=""16"" font=""0"">SENASA had the necessary veterinary and regulatory infrastructure to adequately monitor and </text>
<text top=""525"" left=""108"" width=""243"" height=""16"" font=""0"">control FMD in Northern Argentina. </text>
</p><p number=""7.6"" style=""8""><text top=""559"" left=""108"" width=""308"" height=""16"" font=""28"">7.6.7.4.1.2  Disease status of the region </text></p><p number=""7.465"" style=""8""><text top=""593"" left=""108"" width=""685"" height=""16"" font=""0"">7.465.  Northern Argentina experienced multiple outbreaks in several provinces throughout the </text>
<text top=""610"" left=""108"" width=""123"" height=""16"" font=""0"">period 2000-2001</text>
<footnote top=""608"" left=""231"" width=""23"" height=""11"" font=""16"" number=""1151"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""356"" height=""15"" font=""10""> See United States' first written submission, paras. 78-80. </ftext>
</footnote>
<text top=""610"" left=""254"" width=""429"" height=""16"" font=""0""> and an outbreak in the province of Salta in September 2003.</text>
<footnote top=""608"" left=""683"" width=""23"" height=""11"" font=""16"" number=""1152"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""602"" height=""15"" font=""10""> Argentina's facsimile of 5 September 2003, (Exhibit USA-51); SENASA's letter of 29 August 2003, </ftext>
</footnote>
<text top=""610"" left=""707"" width=""84"" height=""16"" font=""0""> Further, in </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">February 2006, a number of infected animals were detected in a farm in the northern province of </text>
<text top=""643"" left=""108"" width=""70"" height=""16"" font=""0"">Corrientes</text>
<footnote top=""641"" left=""178"" width=""23"" height=""11"" font=""16"" number=""1153"" ref="""" dis=""""/>
<text top=""643"" left=""201"" width=""591"" height=""16"" font=""0"">, close to the border with Paraguay. SENASA promptly notified the outbreak to the </text>
<text top=""659"" left=""108"" width=""40"" height=""16"" font=""0"">OIE </text>
<text top=""659"" left=""138"" width=""280"" height=""16"" font=""0"">and to Argentina's trading partners</text>
<footnote top=""657"" left=""418"" width=""23"" height=""11"" font=""16"" number=""1154"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""493"" height=""15"" font=""10""> OIE, Final Report, 74th General Session (2006), (Exhibit USA-55), pp. 45, 144.  </ftext>
</footnote>
<text top=""659"" left=""441"" width=""359"" height=""16"" font=""0""> and immediately took action by adopting </text>
<p><text top=""730"" left=""170"" width=""549"" height=""15"" font=""10""> See Dr Batho's response to Panel question No. 57. Dr Bonbon added that, in light of such </text>
</p><p><text top=""920"" left=""170"" width=""284"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 31. </text>
</p><p><text top=""1036"" left=""170"" width=""288"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 36.  </text>
<text top=""1051"" left=""170"" width=""298"" height=""15"" font=""10""> Dr Bonbon's response to Panel question No. 44. </text>
</p><p><text top=""1095"" left=""108"" width=""111"" height=""15"" font=""10"">(Exhibit USA-83). </text>
<text top=""1109"" left=""170"" width=""296"" height=""15"" font=""10""> See FMD Impact Worksheet, (Exhibit USA-54).  </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 158 - </text>
</p><p><text top=""128"" left=""108"" width=""238"" height=""16"" font=""0"">Resolutions 35/2006 and 36/2006.</text>
<footnote top=""126"" left=""346"" width=""23"" height=""11"" font=""16"" number=""1155"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""605"" height=""15"" font=""10""> Resoluci&#243;n SENASA 35/2006, (Exhibit ARG-5); Resoluci&#243;n SENASA N&#186; 36/06, (Resoluci&#243;n SENASA </ftext>
<ftext top=""949"" left=""108"" width=""169"" height=""15"" font=""10"">36/2006), (Exhibit ARG-6). </ftext>
</footnote>
<text top=""128"" left=""369"" width=""421"" height=""16"" font=""0""> Measures adopted by SENASA included the stamping-out of </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">the infected animals and susceptible species that had been in contact therewith, the imposition of </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">movement restrictions in all the departments sharing borders with the department affected, the </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">establishment of control and disinfection posts around the restricted areas, ring vaccination, and </text>
<text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">active surveillance of susceptible animals in an area of 13 kilometres surrounding the affected </text>
<text top=""210"" left=""108"" width=""66"" height=""16"" font=""0"">premises.</text>
<footnote top=""208"" left=""174"" width=""23"" height=""11"" font=""16"" number=""1156"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""578"" height=""15"" font=""10""> Resoluci&#243;n SENASA 35/2006, (Exhibit ARG-5); Resoluci&#243;n SENASA 36/2006, (Exhibit ARG-6); </ftext>
<ftext top=""978"" left=""108"" width=""317"" height=""15"" font=""10"">SENASA's letter of 26 July 2006, (Exhibit ARG-97).  </ftext>
</footnote>
<text top=""210"" left=""197"" width=""594"" height=""16"" font=""0""> According to APHIS, such measures were effective and the February 2006 outbreak </text>
<text top=""226"" left=""108"" width=""290"" height=""16"" font=""0"">was ""quickly contained and eliminated"".</text>
<footnote top=""225"" left=""398"" width=""23"" height=""11"" font=""16"" number=""1157"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""594"" height=""15"" font=""10""> USDA/APHIS, Veterinary Services, <i>APHIS Evaluation of the Status of the Brazilian State of Santa </i></ftext>
<ftext top=""1007"" left=""108"" width=""681"" height=""15"" font=""31"">Catarina Regarding Foot-and-Mouth Disease, Classical Swine Fever, Swine Vesicular Disease, and African Swine </ftext><ftext top=""1022"" left=""108"" width=""606"" height=""15"" font=""12""><i>Fever</i> (revised 16 August 2010), (2010 Risk Evaluation for Santa Catarina), (Exhibit ARG-7), p. 24. </ftext>
</footnote>
<text top=""226"" left=""421"" width=""373"" height=""16"" font=""0""> These conclusions were shared by the European </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">Commission which, in its 2006 evaluation of the FMD situation in Northern Argentina, stated that, </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">overall, ""the FMD outbreak in the province of Corrientes was controlled in a rapid, transparent and </text>
<text top=""275"" left=""108"" width=""130"" height=""16"" font=""0"">effective manner"".</text>
<footnote top=""274"" left=""238"" width=""23"" height=""11"" font=""16"" number=""1158"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""394"" height=""15"" font=""10""> European Commission's 2006 Report, (Exhibit ARG-111), p. 20. </ftext>
</footnote>
<text top=""275"" left=""261"" width=""533"" height=""16"" font=""0""> There have not been any further FMD outbreaks in Northern Argentina </text>
<text top=""292"" left=""108"" width=""88"" height=""16"" font=""0"">since 2006 . </text>
</p></p></page>
<page number=""158"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.466"" style=""8""><text top=""326"" left=""108"" width=""684"" height=""16"" font=""0"">7.466.  As part of the process for the reinstatement of Northern Argentina's status as FMD-free </text>
<text top=""342"" left=""108"" width=""620"" height=""16"" font=""0"">where vaccination is practised, the OIE conducted a site visit to the region in 2006.</text>
<footnote top=""341"" left=""728"" width=""23"" height=""11"" font=""16"" number=""1159"" ref="""" dis=""""/>
<text top=""342"" left=""751"" width=""43"" height=""16"" font=""0""> The </text>
<text top=""359"" left=""108"" width=""483"" height=""16"" font=""0"">FMD-free where vaccination is practised status was reinstated in 2007</text>
<footnote top=""357"" left=""591"" width=""23"" height=""11"" font=""16"" number=""1160"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""290"" height=""15"" font=""10""> OIE Resolution XXI of 2007, (Exhibit ARG-10). </ftext>
</footnote>
<text top=""359"" left=""614"" width=""176"" height=""16"" font=""0""> and has been confirmed </text>
<text top=""375"" left=""108"" width=""685"" height=""16"" font=""0"">every year thereafter. In 2011, the OIE also recognized the border protection zone established </text>
<text top=""392"" left=""108"" width=""685"" height=""16"" font=""0"">along the Argentine border with Bolivia, Paraguay and Brazil as FMD-free where vaccination is </text>
<text top=""408"" left=""108"" width=""67"" height=""16"" font=""0"">practised.</text>
<footnote top=""407"" left=""175"" width=""23"" height=""11"" font=""16"" number=""1161"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""283"" height=""15"" font=""10""> OIE Resolution 14 of 2011, (Exhibit ARG-12). </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""443"" left=""108"" width=""683"" height=""16"" font=""28"">7.6.7.4.1.3  The extent of an active disease control program, if any, if FMD is known to </text><text top=""459"" left=""108"" width=""143"" height=""16"" font=""28"">exist in the region </text></p><p number=""7.467"" style=""8""><text top=""493"" left=""108"" width=""686"" height=""16"" font=""0"">7.467.  Numerous laws, decrees and regulations adopted between 1968 and 2013 establish a </text>
<text top=""510"" left=""108"" width=""687"" height=""16"" font=""0"">number of requirements and procedures aimed at preventing outbreaks of FMD in Northern </text>
<text top=""526"" left=""108"" width=""476"" height=""16"" font=""0"">Argentina and at controlling the disease should an outbreak occur.</text>
<footnote top=""525"" left=""584"" width=""23"" height=""11"" font=""16"" number=""1162"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""454"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), pp. 29-31. </ftext>
</footnote>
<text top=""526"" left=""607"" width=""185"" height=""16"" font=""0""> The National Eradication </text>
<text top=""543"" left=""108"" width=""688"" height=""16"" font=""0"">Plan for FMD adopted by SENASA in 2001 as a response to the multiple FMD outbreaks </text>
<text top=""559"" left=""108"" width=""682"" height=""16"" font=""0"">experienced throughout the period July 2000-April 2001 sets out SENASA's general objectives and </text>
<text top=""575"" left=""108"" width=""622"" height=""16"" font=""0"">the measures to be put in place in order to eradicate FMD from the Argentine territory.</text>
<footnote top=""574"" left=""730"" width=""23"" height=""11"" font=""16"" number=""1163"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""597"" height=""15"" font=""10""> Plan de Erradicaci&#243;n de la Fiebre Aftosa: Resoluci&#243;n SENASA 5/01, (Resoluci&#243;n SENASA 5/2001), </ftext>
<ftext top=""1124"" left=""108"" width=""155"" height=""15"" font=""10"">(Exhibit ARG-4/USA-37). </ftext>
</footnote>
<text top=""575"" left=""753"" width=""39"" height=""16"" font=""0""> The </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">Plan is complemented by a number of subsequent regulations detailing SENASA's actions for the </text>
<text top=""608"" left=""108"" width=""686"" height=""16"" font=""0"">prevention and control of FMD. Table 4 below provides an overview of the content of such </text>
<text top=""625"" left=""108"" width=""187"" height=""16"" font=""0"">regulations by broad topic. </text>
<p><text top=""1051"" left=""170"" width=""260"" height=""15"" font=""10""> OIE's response to Panel question No. 13.  </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 159 - </text>
</p></p></page>
<page number=""159"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""128"" left=""108"" width=""653"" height=""16"" font=""28"">Table 4: Overview of the regulations in force in Argentina to prevent and control FMD </text><text top=""155"" left=""166"" width=""125"" height=""15"" font=""29"">Action by SENASA </text><text top=""155"" left=""455"" width=""238"" height=""15"" font=""29"">Relevant regulations on the record </text></p><p><text top=""173"" left=""108"" width=""198"" height=""15"" font=""10"">Regionalization of the Argentine </text>
<text top=""187"" left=""108"" width=""194"" height=""15"" font=""10"">territory and implementation of </text>
<text top=""202"" left=""108"" width=""162"" height=""15"" font=""10"">domestic sanitary barriers </text>
<footnote top=""173"" left=""361"" width=""185"" height=""15"" font=""10"" number=""2001"" ref="""" dis=""""/>
<footnote top=""172"" left=""546"" width=""19"" height=""9"" font=""17"" number=""1164"" ref="""" dis=""""><ftext top=""591"" left=""170"" width=""334"" height=""15"" font=""10""> Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37). </ftext>
</footnote>
<text top=""173"" left=""565"" width=""182"" height=""15"" font=""10"">; SENASA Resolution 25/2001</text>
<footnote top=""172"" left=""746"" width=""19"" height=""9"" font=""17"" number=""1165"" ref="""" dis=""""><ftext top=""605"" left=""170"" width=""495"" height=""15"" font=""10""> Resoluci&#243;n SENASA N&#186; 25/01, (Resoluci&#243;n SENASA 25/2001), (Exhibit ARG-92). </ftext>
</footnote>
<text top=""173"" left=""765"" width=""10"" height=""15"" font=""10"">; </text>
<text top=""187"" left=""361"" width=""172"" height=""15"" font=""10"">SENASA Resolution 58/2001</text>
<footnote top=""187"" left=""533"" width=""19"" height=""9"" font=""17"" number=""1166"" ref="""" dis=""""><ftext top=""620"" left=""170"" width=""297"" height=""15"" font=""10""> Resoluci&#243;n SENASA 58/2001, (Exhibit USA-59). </ftext>
</footnote>
<text top=""187"" left=""552"" width=""189"" height=""15"" font=""10"">; SENASA Resolution 112/2002</text>
<footnote top=""187"" left=""741"" width=""19"" height=""9"" font=""17"" number=""1167"" ref="""" dis=""""><ftext top=""635"" left=""170"" width=""510"" height=""15"" font=""10""> Resoluci&#243;n SENASA N&#186; 112/02, (Resoluci&#243;n SENASA 112/2002), (Exhibit ARG-94). </ftext>
</footnote>
<text top=""187"" left=""760"" width=""10"" height=""15"" font=""10"">; </text>
<text top=""202"" left=""361"" width=""187"" height=""15"" font=""10"">SENASA Resolution 1051/2002</text>
<footnote top=""201"" left=""548"" width=""19"" height=""9"" font=""17"" number=""1168"" ref="""" dis=""""><ftext top=""649"" left=""170"" width=""312"" height=""15"" font=""10""> Resoluci&#243;n SENASA 1051/2002, (Exhibit USA-60). </ftext>
</footnote>
<text top=""202"" left=""567"" width=""189"" height=""15"" font=""10"">; SENASA Resolution 725/2005</text>
<footnote top=""201"" left=""756"" width=""19"" height=""9"" font=""17"" number=""1169"" ref="""" dis=""""><ftext top=""664"" left=""170"" width=""304"" height=""15"" font=""10""> Resoluci&#243;n SENASA 725/2005, (Exhibit USA-61). </ftext>
</footnote>
<text top=""202"" left=""775"" width=""10"" height=""15"" font=""10"">; </text>
<text top=""216"" left=""361"" width=""180"" height=""15"" font=""10"">SENASA Resolution 148/2008</text>
<footnote top=""216"" left=""540"" width=""19"" height=""9"" font=""17"" number=""1170"" ref="""" dis=""""><ftext top=""678"" left=""170"" width=""304"" height=""15"" font=""10""> Resoluci&#243;n SENASA 148/2008, (Exhibit USA-62). </ftext>
</footnote>
<text top=""216"" left=""559"" width=""201"" height=""15"" font=""10"">; SENASA Resolution 1282/2008.</text>
<footnote top=""216"" left=""760"" width=""19"" height=""9"" font=""17"" number=""1171"" ref="""" dis=""""><ftext top=""693"" left=""170"" width=""320"" height=""15"" font=""10""> Resoluci&#243;n SENASA 1282/2008, (Exhibit USA-109). </ftext>
</footnote>
<text top=""234"" left=""108"" width=""226"" height=""15"" font=""10"">Strategic and systematic vaccination </text>
<footnote top=""233"" left=""546"" width=""19"" height=""9"" font=""17"" number=""1172"" ref="""" dis=""""><ftext top=""708"" left=""170"" width=""334"" height=""15"" font=""10""> Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37). </ftext>
</footnote>
<text top=""234"" left=""565"" width=""182"" height=""15"" font=""10"">; SENASA Resolution 33/2002</text>
<footnote top=""233"" left=""746"" width=""19"" height=""9"" font=""17"" number=""1173"" ref="""" dis=""""><ftext top=""722"" left=""170"" width=""607"" height=""15"" font=""10""> Resoluci&#243;n SENASA 33/2002. Apru&#233;base la Gu&#237;a de Procedimientos para Planes de Vacunaci&#243;n y el </ftext>
</footnote>
<text top=""234"" left=""765"" width=""10"" height=""15"" font=""10"">; </text>
<text top=""249"" left=""361"" width=""180"" height=""15"" font=""10"">SENASA Resolution 385/2008</text>
<footnote top=""248"" left=""540"" width=""19"" height=""9"" font=""17"" number=""1174"" ref="""" dis=""""><ftext top=""751"" left=""170"" width=""616"" height=""15"" font=""10""> Resoluci&#243;n SENASA 385/2008. Estrategias de Vacunaci&#243;n Antiaftosa para bovinos/bubalinos en todo </ftext>
</footnote>
<text top=""249"" left=""559"" width=""189"" height=""15"" font=""10"">; SENASA Resolution 181/2010</text>
<footnote top=""248"" left=""748"" width=""19"" height=""9"" font=""17"" number=""1175"" ref="""" dis=""""><ftext top=""780"" left=""170"" width=""571"" height=""15"" font=""10""> Resoluci&#243;n SENASA 181/2010. Modificaci&#243;n de la estrategia de vacunaci&#243;n en relaci&#243;n con la </ftext>
<ftext top=""795"" left=""108"" width=""515"" height=""15"" font=""10"">erradicaci&#243;n de la fiebre aftosa, (Resoluci&#243;n SENASA 181/2010), (Exhibit ARG-134). </ftext>
</footnote>
<text top=""249"" left=""767"" width=""10"" height=""15"" font=""10"">; </text>
<text top=""263"" left=""361"" width=""176"" height=""15"" font=""10"">SENASA Resolution 82/2013.</text>
<footnote top=""263"" left=""537"" width=""19"" height=""9"" font=""17"" number=""1176"" ref="""" dis=""""><ftext top=""810"" left=""170"" width=""589"" height=""15"" font=""10""> Resoluci&#243;n SENASA 82/2013. Vacunaci&#243;n antiaftosa en la Zona Patag&#243;nica Norte A. Prohibici&#243;n, </ftext>
<ftext top=""824"" left=""108"" width=""312"" height=""15"" font=""10"">(Resoluci&#243;n SENASA 82/2013), (Exhibit ARG-138). </ftext>
</footnote>
<text top=""281"" left=""108"" width=""192"" height=""15"" font=""10"">Epidemiological and serological </text>
<text top=""295"" left=""108"" width=""80"" height=""15"" font=""10"">surveillance  </text>
<footnote top=""280"" left=""546"" width=""19"" height=""9"" font=""17"" number=""1177"" ref="""" dis=""""><ftext top=""839"" left=""170"" width=""334"" height=""15"" font=""10""> Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37). </ftext>
</footnote>
<text top=""281"" left=""565"" width=""194"" height=""15"" font=""10"">; SENASA Resolution 540/2010.</text>
<footnote top=""280"" left=""758"" width=""19"" height=""9"" font=""17"" number=""1178"" ref="""" dis=""""><ftext top=""853"" left=""170"" width=""524"" height=""15"" font=""10""> Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37); Resoluci&#243;n SENASA 540/2010, </ftext>
</footnote>
</p><p><text top=""313"" left=""108"" width=""145"" height=""15"" font=""10"">Vaccine quality control  </text>
<text top=""313"" left=""361"" width=""184"" height=""15"" font=""10"">SENASA Resolution 351/2006.</text>
<footnote top=""312"" left=""545"" width=""19"" height=""9"" font=""17"" number=""1179"" ref="""" dis=""""><ftext top=""885"" left=""170"" width=""310"" height=""15"" font=""10""> Resoluci&#243;n SENASA N&#186; 351/06, (Exhibit ARG-18). </ftext>
</footnote>
<text top=""331"" left=""108"" width=""237"" height=""15"" font=""10"">Identification of premises and tracking </text>
<text top=""345"" left=""108"" width=""169"" height=""15"" font=""10"">of FMD-susceptible animals </text>
<footnote top=""330"" left=""546"" width=""19"" height=""9"" font=""17"" number=""1180"" ref="""" dis=""""><ftext top=""900"" left=""170"" width=""334"" height=""15"" font=""10""> Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37). </ftext>
</footnote>
<text top=""331"" left=""565"" width=""189"" height=""15"" font=""10"">; SENASA Resolution 754/2006</text>
<footnote top=""330"" left=""754"" width=""19"" height=""9"" font=""17"" number=""1181"" ref="""" dis=""""><ftext top=""914"" left=""170"" width=""313"" height=""15"" font=""10""> Resoluci&#243;n SENASA 754/2006, (Exhibit ARG-143). </ftext>
</footnote>
<text top=""331"" left=""773"" width=""10"" height=""15"" font=""10"">; </text>
<text top=""345"" left=""361"" width=""180"" height=""15"" font=""10"">SENASA Resolution 540/2010</text>
<footnote top=""344"" left=""540"" width=""19"" height=""9"" font=""17"" number=""1182"" ref="""" dis=""""><ftext top=""929"" left=""170"" width=""524"" height=""15"" font=""10""> Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37); Resoluci&#243;n SENASA 540/2010, </ftext>
</footnote>
<text top=""345"" left=""559"" width=""194"" height=""15"" font=""10"">; SENASA Resolution 563/2012.</text>
<footnote top=""344"" left=""753"" width=""19"" height=""9"" font=""17"" number=""1183"" ref="""" dis=""""><ftext top=""961"" left=""170"" width=""580"" height=""15"" font=""10""> Resoluci&#243;n SENASA 563/2012. Identificaci&#243;n de las especies Bovino y Bubalino. Der&#243;ganse los </ftext>
<ftext top=""975"" left=""108"" width=""643"" height=""15"" font=""10"">Art&#237;culos 2&#176;, 3&#176; y 4&#176; de la Resoluci&#243;n N&#176; 370/2006 de la ex Secretar&#237;a de Agricultura, Ganader&#237;a, Pesca y </ftext>
<ftext top=""990"" left=""108"" width=""387"" height=""15"" font=""10"">Alimentos, (Resoluci&#243;n SENASA 563/2012), (Exhibit ARG-144). </ftext>
</footnote>
<text top=""363"" left=""108"" width=""225"" height=""15"" font=""10"">Immediate and mandatory reporting </text>
<text top=""377"" left=""108"" width=""197"" height=""15"" font=""10"">of FMD cases by authorities and </text>
<text top=""392"" left=""108"" width=""95"" height=""15"" font=""10"">private citizens </text>
<footnote top=""362"" left=""546"" width=""19"" height=""9"" font=""17"" number=""1184"" ref="""" dis=""""><ftext top=""1005"" left=""170"" width=""334"" height=""15"" font=""10""> Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37). </ftext>
</footnote>
<text top=""363"" left=""565"" width=""194"" height=""15"" font=""10"">; SENASA Resolution 540/2010.</text>
<footnote top=""362"" left=""758"" width=""19"" height=""9"" font=""17"" number=""1185"" ref="""" dis=""""><ftext top=""1019"" left=""170"" width=""524"" height=""15"" font=""10""> Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37); Resoluci&#243;n SENASA 540/2010, </ftext>
</footnote>
</p><p><text top=""410"" left=""108"" width=""197"" height=""15"" font=""10"">International border controls on </text>
<text top=""424"" left=""108"" width=""232"" height=""15"" font=""10"">movement of FMD-susceptible animal </text>
<text top=""439"" left=""108"" width=""127"" height=""15"" font=""10"">and animal products </text>
<footnote top=""410"" left=""361"" width=""387"" height=""15"" font=""10"" number=""1968"" ref="""" dis=""""/>
<text top=""424"" left=""361"" width=""79"" height=""15"" font=""10"">animal origin</text>
<footnote top=""424"" left=""439"" width=""19"" height=""9"" font=""17"" number=""1186"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""591"" height=""15"" font=""10""> Decreto 4238/68. Reglamento de Inspecci&#243;n de Productos, Subproductos y Derivados de Origen </ftext>
<ftext top=""1066"" left=""108"" width=""291"" height=""15"" font=""10"">Animal, (Decreto 4238/68), (Exhibit ARG-147). </ftext>
</footnote>
<text top=""424"" left=""458"" width=""182"" height=""15"" font=""10"">; SENASA Resolution 58/2001</text>
<footnote top=""424"" left=""640"" width=""19"" height=""9"" font=""17"" number=""1187"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""297"" height=""15"" font=""10""> Resoluci&#243;n SENASA 58/2001, (Exhibit USA-59). </ftext>
</footnote>
<text top=""424"" left=""659"" width=""63"" height=""15"" font=""10"">; SENASA </text>
<text top=""439"" left=""361"" width=""126"" height=""15"" font=""10"">Resolution 178/2001</text>
<footnote top=""438"" left=""487"" width=""19"" height=""9"" font=""17"" number=""1188"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""594"" height=""15"" font=""10""> Resoluci&#243;n SENASA 178/2001. Reglam&#233;ntase el procedimiento que garantiza la identificaci&#243;n del </ftext>
<ftext top=""1109"" left=""108"" width=""622"" height=""15"" font=""10"">origen de los animales que se movilicen con cualquier destino. Der&#243;gase la Resoluci&#243;n N&#186; 1991/2000, </ftext>
</footnote>
<text top=""439"" left=""506"" width=""182"" height=""15"" font=""10"">; SENASA Resolution 37/2002</text>
<footnote top=""438"" left=""687"" width=""19"" height=""9"" font=""17"" number=""1189"" ref="""" dis=""""><ftext top=""497"" left=""170"" width=""596"" height=""15"" font=""10""> Resoluci&#243;n SENASA 37/2002. Establ&#233;cense medidas de prevenci&#243;n de difusi&#243;n de la fiebre aftosa </ftext>
<ftext top=""511"" left=""108"" width=""659"" height=""15"" font=""10"">ante la aparici&#243;n de casos cl&#237;nicos de la enfermedad, o ante la existencia de factores de riesgo tales como el </ftext>
<ftext top=""526"" left=""108"" width=""679"" height=""15"" font=""10"">ingreso de animales, productos o f&#243;mites desde zonas infectadas o presuntamente infectadas, o deficiencias en </ftext>
<ftext top=""541"" left=""108"" width=""440"" height=""15"" font=""10"">la cobertura vacuna, (Resoluci&#243;n SENASA 37/2002), (Exhibit ARG-142). </ftext>
</footnote>
<text top=""439"" left=""706"" width=""63"" height=""15"" font=""10"">; SENASA </text>
<text top=""453"" left=""361"" width=""126"" height=""15"" font=""10"">Resolution 112/2002</text>
<footnote top=""453"" left=""487"" width=""19"" height=""9"" font=""17"" number=""1190"" ref="""" dis=""""><ftext top=""555"" left=""170"" width=""305"" height=""15"" font=""10""> Resoluci&#243;n SENASA 112/2002, (Exhibit ARG-94). </ftext>
</footnote>
<text top=""453"" left=""506"" width=""250"" height=""15"" font=""10"">; SENASA Resolution 15/2003 (imposing </text>
<text top=""468"" left=""361"" width=""408"" height=""15"" font=""10"">special requirements for export of FMD-susceptible products to the </text>
<text top=""483"" left=""361"" width=""101"" height=""15"" font=""10"">European Union)</text>
<footnote top=""482"" left=""462"" width=""19"" height=""9"" font=""17"" number=""1191"" ref="""" dis=""""><ftext top=""570"" left=""170"" width=""554"" height=""15"" font=""10""> Resoluci&#243;n SENASA 15/2003. Cr&#233;ase el ""Sistema de Identificaci&#243;n de Ganado Bovino para </ftext>
<ftext top=""584"" left=""108"" width=""661"" height=""15"" font=""10"">Exportaci&#243;n"", que deber&#225; ser aplicado en forma obligatoria en todos los campos inscriptos en el ""Registro de </ftext>
<ftext top=""599"" left=""108"" width=""678"" height=""15"" font=""10"">Establecimientos Rurales proveedores de ganado para Faena de Exportaci&#243;n"" y por los Establecimientos que se </ftext>
<ftext top=""613"" left=""108"" width=""679"" height=""15"" font=""10"">inscriban en el ""Registro de Establecimientos Pecuarios de Engorde a Corral proveedores de bovinos para faena </ftext>
<ftext top=""628"" left=""108"" width=""475"" height=""15"" font=""10"">con destino a exportaci&#243;n, (Resoluci&#243;n SENASA 15/2003), (Exhibit ARG-145). </ftext>
</footnote>
<text top=""483"" left=""481"" width=""302"" height=""15"" font=""10"">; SENASA Resolution 391/2003 (imposing special </text>
<text top=""497"" left=""361"" width=""425"" height=""15"" font=""10"">requirements for export of FMD-susceptible products to the European </text>
<text top=""512"" left=""361"" width=""40"" height=""15"" font=""10"">Union)</text>
<footnote top=""511"" left=""401"" width=""19"" height=""9"" font=""17"" number=""1192"" ref="""" dis=""""><ftext top=""643"" left=""170"" width=""595"" height=""15"" font=""10""> Resoluci&#243;n SENASA 391/2003. Inscripci&#243;n de ""Establecimientos Rurales de Origen"", que provean </ftext>
<ftext top=""657"" left=""108"" width=""673"" height=""15"" font=""10"">bovinos nacidos y criados en los mismos con destino a ""Establecimientos Rurales Proveedores de Ganado para </ftext>
<ftext top=""672"" left=""108"" width=""534"" height=""15"" font=""10"">Faena de Exportaci&#243;n"". Requisitos, (Resoluci&#243;n SENASA 391/2003), (Exhibit ARG-146). </ftext>
</footnote>
<text top=""512"" left=""420"" width=""189"" height=""15"" font=""10"">; SENASA Resolution 725/2005</text>
<footnote top=""511"" left=""609"" width=""19"" height=""9"" font=""17"" number=""1193"" ref="""" dis=""""><ftext top=""686"" left=""170"" width=""304"" height=""15"" font=""10""> Resoluci&#243;n SENASA 725/2005, (Exhibit USA-61). </ftext>
</footnote>
<text top=""512"" left=""628"" width=""63"" height=""15"" font=""10"">; SENASA </text>
<text top=""526"" left=""361"" width=""126"" height=""15"" font=""10"">Resolution 754/2006</text>
<footnote top=""526"" left=""487"" width=""19"" height=""9"" font=""17"" number=""1194"" ref="""" dis=""""><ftext top=""701"" left=""170"" width=""313"" height=""15"" font=""10""> Resoluci&#243;n SENASA 754/2006, (Exhibit ARG-143). </ftext>
</footnote>
<text top=""526"" left=""506"" width=""189"" height=""15"" font=""10"">; SENASA Resolution 148/2008</text>
<footnote top=""526"" left=""695"" width=""19"" height=""9"" font=""17"" number=""1195"" ref="""" dis=""""><ftext top=""716"" left=""170"" width=""304"" height=""15"" font=""10""> Resoluci&#243;n SENASA 148/2008, (Exhibit USA-62). </ftext>
</footnote>
<text top=""526"" left=""714"" width=""63"" height=""15"" font=""10"">; SENASA </text>
<text top=""541"" left=""361"" width=""126"" height=""15"" font=""10"">Resolution 810/2009</text>
<footnote top=""540"" left=""487"" width=""19"" height=""9"" font=""17"" number=""1196"" ref="""" dis=""""><ftext top=""730"" left=""170"" width=""619"" height=""15"" font=""10""> Resoluci&#243;n SENASA 810/2009. Apru&#233;base el Certificado Unico de Lavado y Desinfecci&#243;n de Veh&#237;culos </ftext>
</footnote>
<text top=""541"" left=""506"" width=""189"" height=""15"" font=""10"">; SENASA Resolution 563/2012</text>
<footnote top=""540"" left=""695"" width=""19"" height=""9"" font=""17"" number=""1197"" ref="""" dis=""""><ftext top=""759"" left=""170"" width=""313"" height=""15"" font=""10""> Resoluci&#243;n SENASA 563/2012, (Exhibit ARG-144). </ftext>
</footnote>
<text top=""541"" left=""714"" width=""63"" height=""15"" font=""10"">; SENASA </text>
<text top=""555"" left=""361"" width=""118"" height=""15"" font=""10"">Resolution 82/2013</text>
<footnote top=""555"" left=""479"" width=""19"" height=""9"" font=""17"" number=""1198"" ref="""" dis=""""><ftext top=""774"" left=""170"" width=""305"" height=""15"" font=""10""> Resoluci&#243;n SENASA 82/2013, (Exhibit ARG-138). </ftext>
</footnote>
<text top=""555"" left=""498"" width=""194"" height=""15"" font=""10"">; SENASA Resolution 238/2013.</text>
<footnote top=""555"" left=""691"" width=""19"" height=""9"" font=""17"" number=""1199"" ref="""" dis=""""><ftext top=""788"" left=""170"" width=""567"" height=""15"" font=""10""> SENASA, <i>Certificado Unico de Lavado y Desinfecci&#243;n. Resoluci&#243;n N&#176; 810/2009. Modificaci&#243;n</i>, </ftext>
<ftext top=""803"" left=""108"" width=""230"" height=""15"" font=""10"">Resoluci&#243;n 238/2013 (28 May 2013). </ftext>
</footnote>
</p><p><text top=""737"" left=""108"" width=""450"" height=""15"" font=""10"">Formulario para la Auditor&#237;a de Planes de Vacunaci&#243;n, (Exhibit ARG-153). </text>
</p><p><text top=""766"" left=""108"" width=""253"" height=""15"" font=""10"">el Territorio Nacional, (Exhibit ARG-139). </text>
<footnote top=""870"" left=""108"" width=""110"" height=""15"" font=""10"" number=""135"" ref="""" dis=""""><ftext top=""1037"" left=""218"" width=""4"" height=""14"" font=""21"">.</ftext>
</footnote>
</p><p><text top=""871"" left=""218"" width=""4"" height=""14"" font=""21"">.</text>
</p><p><text top=""1124"" left=""108"" width=""119"" height=""15"" font=""10"">(Exhibit ARG-152). </text>
</p></page>
<page number=""160"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 160 - </text>
</p><p><text top=""130"" left=""166"" width=""125"" height=""15"" font=""29"">Action by SENASA </text><text top=""130"" left=""455"" width=""238"" height=""15"" font=""29"">Relevant regulations on the record </text></p><p><text top=""147"" left=""108"" width=""225"" height=""15"" font=""10"">Slaughterhouse practices (ante- and </text>
<text top=""162"" left=""108"" width=""218"" height=""15"" font=""10"">post-mortem inspections, deboning </text>
<text top=""177"" left=""108"" width=""174"" height=""15"" font=""10"">and maturation, disinfection </text>
<text top=""191"" left=""108"" width=""125"" height=""15"" font=""10"">requirements, etc.)  </text>
<text top=""162"" left=""361"" width=""79"" height=""15"" font=""10"">animal origin</text>
<footnote top=""161"" left=""439"" width=""19"" height=""9"" font=""17"" number=""1200"" ref="""" dis=""""><ftext top=""818"" left=""170"" width=""234"" height=""15"" font=""10""> Decreto 4238/68, (Exhibit ARG-147). </ftext>
</footnote>
<text top=""162"" left=""458"" width=""205"" height=""15"" font=""10"">; SENASA Circular No. 3307/1997</text>
<footnote top=""161"" left=""663"" width=""19"" height=""9"" font=""17"" number=""1201"" ref="""" dis=""""><ftext top=""832"" left=""170"" width=""384"" height=""15"" font=""10""> SENASA Circular No. 3307 (30 July 1997), (Exhibit ARG-151). </ftext>
</footnote>
<text top=""162"" left=""682"" width=""63"" height=""15"" font=""10"">; SENASA </text>
<text top=""177"" left=""361"" width=""396"" height=""15"" font=""10"">Resolution 15/2003 (imposing special requirements for export of </text>
<text top=""191"" left=""361"" width=""300"" height=""15"" font=""10"">FMD-susceptible products to the European Union)</text>
<footnote top=""190"" left=""661"" width=""19"" height=""9"" font=""17"" number=""1202"" ref="""" dis=""""><ftext top=""847"" left=""170"" width=""305"" height=""15"" font=""10""> Resoluci&#243;n SENASA 15/2003, (Exhibit ARG-145). </ftext>
</footnote>
<text top=""191"" left=""680"" width=""63"" height=""15"" font=""10"">; SENASA </text>
<text top=""206"" left=""361"" width=""403"" height=""15"" font=""10"">Resolution 391/2003 (imposing special requirements for export of </text>
<text top=""220"" left=""361"" width=""300"" height=""15"" font=""10"">FMD-susceptible products to the European Union)</text>
<footnote top=""220"" left=""661"" width=""19"" height=""9"" font=""17"" number=""1203"" ref="""" dis=""""><ftext top=""861"" left=""170"" width=""313"" height=""15"" font=""10""> Resoluci&#243;n SENASA 391/2003, (Exhibit ARG-146). </ftext>
</footnote>
<text top=""220"" left=""680"" width=""62"" height=""15"" font=""10"">; SAGPYA </text>
<text top=""235"" left=""361"" width=""126"" height=""15"" font=""10"">Resolution 310/2004</text>
<footnote top=""234"" left=""487"" width=""19"" height=""9"" font=""17"" number=""1204"" ref="""" dis=""""><ftext top=""876"" left=""170"" width=""615"" height=""15"" font=""10""> Resoluci&#243;n SAGPYA 310/2004. Exigencias a las que deber&#225;n ajustarse todos los establecimientos de </ftext>
<ftext top=""891"" left=""108"" width=""632"" height=""15"" font=""10"">faena y/o proceso y/o dep&#243;sito interesados en exportar carnes frescas y/o menudencias. Der&#243;ganse las </ftext>
<ftext top=""905"" left=""108"" width=""429"" height=""15"" font=""10"">Resoluciones Nros. 1/2003 y 339/2003 &#8211; SENASA, (Exhibit ARG-148). </ftext>
</footnote>
<text top=""235"" left=""506"" width=""201"" height=""15"" font=""10"">; SENASA Notice No. 4056/2013.</text>
<footnote top=""234"" left=""706"" width=""19"" height=""9"" font=""17"" number=""1205"" ref="""" dis=""""/>
<text top=""252"" left=""108"" width=""236"" height=""15"" font=""10"">Sanitary steps concerning susceptible, </text>
<text top=""267"" left=""108"" width=""228"" height=""15"" font=""10"">infected, and contact animals in case </text>
<text top=""282"" left=""108"" width=""93"" height=""15"" font=""10"">of an outbreak </text>
<footnote top=""252"" left=""705"" width=""19"" height=""9"" font=""17"" number=""1206"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""622"" height=""15"" font=""10""> Manual de Procedimientos para la Atenci&#243;n de un Foco. SENASA (October 2001), (Exhibit ARG-137).  </ftext>
</footnote>
<text top=""252"" left=""724"" width=""63"" height=""15"" font=""10"">; SENASA </text>
<text top=""267"" left=""361"" width=""118"" height=""15"" font=""10"">Resolution 35/2002</text>
<footnote top=""266"" left=""479"" width=""19"" height=""9"" font=""17"" number=""1207"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""612"" height=""15"" font=""10""> SENASA, <i>Aprueba el Programa para Investigaciones Epidemiol&#243;gicas y Acciones de Contenci&#243;n ante </i></ftext>
<ftext top=""978"" left=""108"" width=""552"" height=""15"" font=""12""><i>la Presencia de Sospecha de Foco de Fiebre Aftosa</i>, Resoluci&#243;n 35/2002 (4 January 2002). </ftext>
</footnote>
<text top=""267"" left=""498"" width=""182"" height=""15"" font=""10"">; SENASA Resolution 37/2002</text>
<footnote top=""266"" left=""680"" width=""19"" height=""9"" font=""17"" number=""1208"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""305"" height=""15"" font=""10""> Resoluci&#243;n SENASA 37/2002, (Exhibit ARG-142). </ftext>
</footnote>
<text top=""267"" left=""699"" width=""63"" height=""15"" font=""10"">; SENASA </text>
<text top=""282"" left=""361"" width=""415"" height=""15"" font=""10"">Resolution 35/2006 (setting forth measures to contain the outbreak </text>
<text top=""296"" left=""361"" width=""177"" height=""15"" font=""10"">in the Province of Corrientes)</text>
<footnote top=""296"" left=""538"" width=""19"" height=""9"" font=""17"" number=""1209"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""290"" height=""15"" font=""10""> Resoluci&#243;n SENASA 35/2006, (Exhibit ARG-5). </ftext>
</footnote>
<text top=""296"" left=""557"" width=""186"" height=""15"" font=""10"">; SENASA Resolution 36/2006 </text>
<text top=""311"" left=""361"" width=""422"" height=""15"" font=""10"">(establishing stamping-out to contain the outbreak in the Province of </text>
<text top=""325"" left=""361"" width=""67"" height=""15"" font=""10"">Corrientes)</text>
<footnote top=""325"" left=""428"" width=""19"" height=""9"" font=""17"" number=""1210"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""290"" height=""15"" font=""10""> Resoluci&#243;n SENASA 36/2006, (Exhibit ARG-6). </ftext>
</footnote>
<text top=""325"" left=""447"" width=""300"" height=""15"" font=""10"">; 2007 National Plan for the Containment of FMD.</text>
<footnote top=""325"" left=""747"" width=""19"" height=""9"" font=""17"" number=""1211"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""594"" height=""15"" font=""10""> Resoluci&#243;n SENASA 3/2007. Plan Nacional de Contenci&#243;n de la Fiebre Aftosa, (Exhibit ARG-136). </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""359"" left=""108"" width=""369"" height=""16"" font=""28"">7.6.7.4.1.4  The vaccination status of the region </text></p><p number=""7.468"" style=""8""><text top=""393"" left=""108"" width=""684"" height=""16"" font=""0"">7.468.  In Northern Argentina, the entire cattle population is currently required to be vaccinated </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">on a yearly basis. Cattle between 6 and 24 months of age and animals to be moved from one </text>
<text top=""426"" left=""108"" width=""332"" height=""16"" font=""0"">facility to another are vaccinated twice a year.</text>
<footnote top=""424"" left=""440"" width=""23"" height=""11"" font=""16"" number=""1212"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""577"" height=""15"" font=""10""> Resoluci&#243;n SENASA 181/2010, (Exhibit ARG-134); 2014 Risk Analysis for Northern Argentina, </ftext>
<ftext top=""1066"" left=""108"" width=""186"" height=""15"" font=""10"">(Exhibit USA-169), pp. 32-33. </ftext>
</footnote>
<text top=""426"" left=""463"" width=""329"" height=""16"" font=""0""> In the border protection zone, vaccination is </text>
<text top=""442"" left=""108"" width=""482"" height=""16"" font=""0"">conducted twice a year for all categories of cattle, as well as buffaloes.</text>
<footnote top=""441"" left=""590"" width=""23"" height=""11"" font=""16"" number=""1213"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""594"" height=""15"" font=""10""> Resoluci&#243;n SENASA 181/2010, (Exhibit ARG-134). In its 2006 Report, the European Commission </ftext>
<ftext top=""1095"" left=""108"" width=""653"" height=""15"" font=""10"">referred to the special vaccination regime in force in the border protection zone as ""enhanced vaccination"". </ftext>
<ftext top=""1109"" left=""108"" width=""658"" height=""15"" font=""10"">(European Commission's 2006 Report, (Exhibit ARG-111), p. 12) See also, generally, 2014 Risk Analysis for </ftext>
<ftext top=""1124"" left=""108"" width=""311"" height=""15"" font=""10"">Northern Argentina, (Exhibit USA-169), pp. 32-33. </ftext>
<ftext top=""963"" left=""108"" width=""667"" height=""15"" font=""10"">with a view to developing a programme for the control and eradication of FMD in the region. See PANAFTOSA </ftext>
<ftext top=""978"" left=""108"" width=""262"" height=""15"" font=""10"">website, <i>Acerca de PANAFTOSA-OPS/OMS</i>, </ftext>
<ftext top=""993"" left=""108"" width=""634"" height=""15"" font=""10"">http://www.paho.org/panaftosa/index.php?option=com_content&amp;view=article&amp;id=24&amp;Itemid=122 (last </ftext>
<ftext top=""1007"" left=""108"" width=""180"" height=""15"" font=""10"">accessed 5 December 2014). </ftext>
</footnote>
<p><text top=""745"" left=""108"" width=""353"" height=""15"" font=""10"">para el Transporte de Animales Vivos, (Exhibit ARG-149). </text>
</p><p><text top=""920"" left=""170"" width=""581"" height=""15"" font=""10""> SENASA Notice No. 4056 informing the minimum frequency of supervisory visits to all types of </text>
<text top=""934"" left=""108"" width=""395"" height=""15"" font=""10"">authorized establishments (4 January 2013), (Exhibit ARG-124). </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 161 - </text>
</p></p></page>
<page number=""161"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.469"" style=""8""><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">7.469.  Between 2001 and 2010, pursuant to the 2001 National Eradication Program for FMD, a </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">nation-wide vaccination campaign was put in place and reflected differences between Argentine </text>
<text top=""160"" left=""108"" width=""688"" height=""16"" font=""0"">regions in terms of ecosystems, production systems, animal movement patterns, livestock </text>
<text top=""177"" left=""108"" width=""306"" height=""16"" font=""0"">population density and commercial circuits.</text>
<footnote top=""175"" left=""414"" width=""23"" height=""11"" font=""16"" number=""1214"" ref="""" dis=""""><ftext top=""730"" left=""170"" width=""334"" height=""15"" font=""10""> Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37). </ftext>
</footnote>
<text top=""177"" left=""437"" width=""356"" height=""16"" font=""0""> In areas with higher livestock production, cattle </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">density and animal movements, vaccination was undertaken twice a year for all age groups of the </text>
<text top=""210"" left=""108"" width=""127"" height=""16"" font=""0"">bovine population.</text>
<footnote top=""208"" left=""235"" width=""23"" height=""11"" font=""16"" number=""1215"" ref="""" dis=""""><ftext top=""745"" left=""170"" width=""612"" height=""15"" font=""10""> Agri-Food Health &amp; Quality National Service, <i>Information provided by SENASA for the recognition of </i></ftext>
<ftext top=""759"" left=""108"" width=""675"" height=""15"" font=""12""><i>Argentina as a Region comprised in Article 92.2 Title 9, Code of Federal Regulations in regards to FMD </i>(August </ftext>
<ftext top=""774"" left=""108"" width=""671"" height=""15"" font=""10"">2002), (Information provided by SENASA (August 2002)), (Exhibit ARG-31), pp. 25, 35; Information Provided </ftext>
<ftext top=""788"" left=""108"" width=""658"" height=""15"" font=""10"">by SENASA (November 2002), (Exhibit USA-32); Argentina's response to Panel question No. 1 following the </ftext>
<ftext top=""803"" left=""108"" width=""182"" height=""15"" font=""10"">second substantive meeting,. </ftext>
</footnote>
<text top=""210"" left=""258"" width=""533"" height=""16"" font=""0""> In ""marginal areas"", vaccination was undertaken once a year and a second </text>
<text top=""226"" left=""108"" width=""435"" height=""16"" font=""0"">annual vaccination was undertaken only in identified risk farms.</text>
<footnote top=""225"" left=""543"" width=""23"" height=""11"" font=""16"" number=""1216"" ref="""" dis=""""><ftext top=""818"" left=""170"" width=""563"" height=""15"" font=""10""> Information provided by SENASA (August 2002), (Exhibit ARG-31), pp. 25, 35; Information </ftext>
<ftext top=""832"" left=""108"" width=""632"" height=""15"" font=""10"">Provided by SENASA (November 2002), (Exhibit USA-32); Argentina's response to Panel question No. 1 </ftext>
<ftext top=""847"" left=""108"" width=""259"" height=""15"" font=""10"">following the second substantive meeting. </ftext>
</footnote>
</p><p number=""7.470"" style=""8""><text top=""260"" left=""108"" width=""60"" height=""16"" font=""0"">7.470. </text>
<text top=""260"" left=""162"" width=""448"" height=""16"" font=""0"">SENASA uses tetravalent vaccines covering serotypes O</text>
<text top=""267"" left=""610"" width=""6"" height=""11"" font=""16"">1</text>
<text top=""260"" left=""615"" width=""91"" height=""16"" font=""0"">/Campos, A</text>
<text top=""267"" left=""706"" width=""11"" height=""11"" font=""16"">24</text>
<text top=""260"" left=""717"" width=""72"" height=""16"" font=""0"">/Cruzeiro, </text>
<text top=""277"" left=""108"" width=""166"" height=""16"" font=""0"">A/Argentina/2001 and C</text>
<text top=""284"" left=""274"" width=""6"" height=""11"" font=""16"">3</text>
<text top=""277"" left=""280"" width=""57"" height=""16"" font=""0"">/Indaial.</text>
<footnote top=""275"" left=""337"" width=""23"" height=""11"" font=""16"" number=""1217"" ref="""" dis=""""><ftext top=""861"" left=""170"" width=""576"" height=""15"" font=""10""> Argentina's response to Panel question No. 10, paras. 26-28; 2014 Risk Analysis for Northern </ftext>
<ftext top=""876"" left=""108"" width=""229"" height=""15"" font=""10"">Argentina, (Exhibit USA-169), p. 34.  </ftext>
</footnote>
<text top=""277"" left=""360"" width=""430"" height=""16"" font=""0""> These serotypes are similar to those covered by the vaccines </text>
<text top=""293"" left=""108"" width=""337"" height=""16"" font=""0"">administered by Uruguayan authorities in 2002.</text>
<footnote top=""292"" left=""445"" width=""23"" height=""11"" font=""16"" number=""1218"" ref="""" dis=""""><ftext top=""891"" left=""170"" width=""555"" height=""15"" font=""10""> USDA/APHIS, <i>Risk assessment: Importation of fresh (chilled or frozen) beef from Uruguay</i> </ftext>
<ftext top=""905"" left=""108"" width=""498"" height=""15"" font=""10"">(November 2002), (2002 Risk Assessment for Uruguay), (Exhibit ARG-65), p. 26. </ftext>
</footnote>
<text top=""293"" left=""468"" width=""324"" height=""16"" font=""0""> The vaccines produced and administered by </text>
<text top=""310"" left=""108"" width=""406"" height=""16"" font=""0"">SENASA are checked by a national biosafety committee</text>
<footnote top=""308"" left=""514"" width=""23"" height=""11"" font=""16"" number=""1219"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 34. </ftext>
</footnote>
<text top=""310"" left=""537"" width=""257"" height=""16"" font=""0"">, and comply with the safety and </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">efficacy tests established by the OIE's Regional Reference Agency at the <i>Centro Panamericano de </i></text>
<text top=""342"" left=""108"" width=""203"" height=""16"" font=""18""><i>Fiebre Aftosa</i> (PANAFTOSA).</text>
<footnote top=""341"" left=""311"" width=""23"" height=""11"" font=""16"" number=""1220"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""589"" height=""15"" font=""10""> See Dr Cupit's response to Panel question No. 13, para. 120. PANAFTOSA is a regional scientific </ftext>
</footnote>
<text top=""342"" left=""334"" width=""461"" height=""16"" font=""0""> The experts noted that the fact that Northern Argentina is </text>
<text top=""359"" left=""108"" width=""687"" height=""16"" font=""0"">recognized by the OIE as FMD-free where vaccination is practised means that the OIE has </text>
<text top=""375"" left=""108"" width=""686"" height=""16"" font=""0"">determined that the vaccines used are in compliance with the requirements set forth in the </text>
<text top=""392"" left=""108"" width=""130"" height=""16"" font=""0"">Terrestrial Manual.</text>
<footnote top=""390"" left=""238"" width=""23"" height=""11"" font=""16"" number=""1221"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""568"" height=""15"" font=""10""> OIE's response to Panel question No. 11, pp. 11-12. This was confirmed by Dr Bonbon in his </ftext>
</footnote>
<text top=""392"" left=""261"" width=""531"" height=""16"" font=""0""> Moreover, the fact that SENASA's Animal Laboratory is recognized as an </text>
<text top=""408"" left=""108"" width=""683"" height=""16"" font=""0"">OIE Reference Laboratory for FMD has been described by the OIE as a ""very positive factor"" with </text>
<text top=""425"" left=""108"" width=""464"" height=""16"" font=""0"">respect to the ""surveillance element [of] the vaccination campaign"".</text>
<footnote top=""423"" left=""572"" width=""23"" height=""11"" font=""16"" number=""1222"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""237"" height=""15"" font=""10""> Transcript of the meeting, para. 1.62. </ftext>
</footnote>
</p><p number=""7.471"" style=""8""><text top=""459"" left=""108"" width=""57"" height=""16"" font=""0"">7.471. </text>
<text top=""459"" left=""162"" width=""95"" height=""16"" font=""0"">The United </text>
<text top=""459"" left=""249"" width=""550"" height=""16"" font=""0"">States has stated that one of the reasons it does not accept the </text>
<text top=""475"" left=""108"" width=""685"" height=""16"" font=""0"">OIE categorisation of FMD-free regions with vaccination is that current FMD vaccines may have </text>
<text top=""492"" left=""108"" width=""685"" height=""16"" font=""0"">residual Non Structural Proteins (NSP) that ""could result in the detection of NSP antibodies in </text>
<text top=""508"" left=""108"" width=""686"" height=""16"" font=""0"">vaccinated animals"", thereby not allowing the differentiation between vaccinated and infected </text>
<text top=""525"" left=""108"" width=""57"" height=""16"" font=""0"">animals.</text>
<footnote top=""523"" left=""165"" width=""23"" height=""11"" font=""16"" number=""1223"" ref="""" dis=""""/>
<text top=""525"" left=""188"" width=""604"" height=""16"" font=""0""> With respect to the likelihood that vaccines used by SENASA in Northern Argentina </text>
<text top=""541"" left=""108"" width=""686"" height=""16"" font=""0"">contain residual NSP, Dr Cupit stated that the evidence on the record is insufficient to draw </text>
<text top=""557"" left=""108"" width=""512"" height=""16"" font=""0"">conclusions as to the manufacture and quality assurance of such vaccines.</text>
<footnote top=""556"" left=""620"" width=""23"" height=""11"" font=""16"" number=""1224"" ref="""" dis=""""/>
<text top=""557"" left=""643"" width=""148"" height=""16"" font=""0""> He added, however, </text>
<text top=""574"" left=""108"" width=""682"" height=""16"" font=""0"">that the fact that a country or region is recognized by the OIE as FMD-free  where vaccination is </text>
<text top=""590"" left=""108"" width=""684"" height=""16"" font=""0"">practised means that the vaccines in use there meet the requirement that they ""be purified to </text>
<text top=""607"" left=""108"" width=""154"" height=""16"" font=""0"">reduce NSP content"".</text>
<footnote top=""605"" left=""262"" width=""23"" height=""11"" font=""16"" number=""1225"" ref="""" dis=""""/>
<text top=""607"" left=""285"" width=""510"" height=""16"" font=""0""> Further, in his view, ""[w]ith current manufacturing techniques it is </text>
<text top=""623"" left=""108"" width=""688"" height=""16"" font=""0"">possible to exclude the majority of NSPs so that they induce little, if any, NSP-specific </text>
<text top=""639"" left=""108"" width=""70"" height=""16"" font=""0"">antibody"".</text>
<footnote top=""638"" left=""178"" width=""23"" height=""11"" font=""16"" number=""1226"" ref="""" dis=""""/>
<text top=""639"" left=""201"" width=""589"" height=""16"" font=""0""> Thus, Dr Cupit concluded that while the level of NSP in SENASA's vaccines cannot be </text>
<text top=""656"" left=""108"" width=""684"" height=""16"" font=""0"">assumed to be ""zero"", it is reasonable to expect that such vaccines contain ""little"" quantities of </text>
<text top=""672"" left=""108"" width=""98"" height=""16"" font=""0"">such proteins.</text>
<footnote top=""671"" left=""206"" width=""23"" height=""11"" font=""16"" number=""1227"" ref="""" dis=""""/>
<text top=""672"" left=""229"" width=""563"" height=""16"" font=""0""> In Dr Batho's view, SENASA's current vaccines ""would not cause problems for </text>
<p><text top=""949"" left=""108"" width=""675"" height=""15"" font=""10"">centre of the Pan-American Health Organization and the World Health Organization. It was established in 1951 </text>
<footnote top=""1036"" left=""108"" width=""511"" height=""15"" font=""10"" number=""13"" ref="""" dis=""""/>
<footnote top=""1066"" left=""170"" width=""310"" height=""15"" font=""10"" number=""299"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 162 - </text>
</p><p><text top=""128"" left=""108"" width=""401"" height=""16"" font=""0"">differentiating between vaccinated and infected animals"".</text>
<footnote top=""126"" left=""509"" width=""23"" height=""11"" font=""16"" number=""1228"" ref="""" dis=""""/>
<text top=""128"" left=""532"" width=""258"" height=""16"" font=""0"">  Dr Bonbon  stated  that  he  does  not </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">know the vaccines used in Northern Argentina, but expressed the view that the fact that the region </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">is recognized by the OIE as FMD-free where vaccination is practised means that the vaccines used </text>
<text top=""177"" left=""108"" width=""370"" height=""16"" font=""0"">""allow for appropriate surveillance of viral circulation"".</text>
<footnote top=""175"" left=""477"" width=""23"" height=""11"" font=""16"" number=""1229"" ref="""" dis=""""/>
</p></p></page>
<page number=""162"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.472"" style=""8""><text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">7.472.  The coverage of vaccination has consistently exceeded 97% of all the subject population </text>
<text top=""228"" left=""108"" width=""492"" height=""16"" font=""0"">since 2001, and was close to or greater than 99% from 2008 to 2012.</text>
<footnote top=""226"" left=""600"" width=""23"" height=""11"" font=""16"" number=""1230"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""454"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), pp. 33-34. </ftext>
</footnote>
<text top=""228"" left=""623"" width=""168"" height=""16"" font=""0""> In Northern Argentina, </text>
<text top=""244"" left=""108"" width=""684"" height=""16"" font=""0"">only authorized staff trained, registered, accredited, supervised and/or audited by SENASA can </text>
<text top=""260"" left=""108"" width=""139"" height=""16"" font=""0"">administer vaccines.</text>
<footnote top=""259"" left=""247"" width=""23"" height=""11"" font=""16"" number=""1231"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""591"" height=""15"" font=""10""> Final Report Of A Mission Carried Out In Argentina From 3 To 13 July 2006 In Order To Evaluate </ftext>
<ftext top=""949"" left=""108"" width=""674"" height=""15"" font=""10"">Animal Health Controls In Place In Particular Over Foot And Mouth Disease, Public Health Control Systems And </ftext>
<ftext top=""963"" left=""108"" width=""627"" height=""15"" font=""10"">Certification Procedures (DG(SANCO)/7590/2005 &#8211; MR Final), (Exhibit USA-151), pp. 10-11; European </ftext>
<ftext top=""978"" left=""108"" width=""589"" height=""15"" font=""10"">Commission's 2006 Report, (Exhibit ARG-111) p. 10; 2014 Risk Analysis for Northern Argentina, </ftext>
<ftext top=""993"" left=""108"" width=""672"" height=""15"" font=""10"">(Exhibit USA-169), p. 33. We note that this constitutes a significant difference vis-&#224;-vis other regions, such as </ftext>
</footnote>
</p><p number=""7.473"" style=""8""><text top=""295"" left=""108"" width=""683"" height=""16"" font=""0"">7.473.  All of the evidence before us thus indicates that SENASA has systematic and compulsory </text>
<text top=""311"" left=""108"" width=""684"" height=""16"" font=""0"">vaccination practices, uses vaccines in line with the requirements of the Terrestrial Manual, and </text>
<text top=""328"" left=""108"" width=""399"" height=""16"" font=""0"">covers virtually all of the bovine population in the region.  </text>
</p><p number=""7.474"" style=""8""><text top=""362"" left=""108"" width=""682"" height=""16"" font=""0"">7.474.  As to the effectiveness of vaccination in reducing the likelihood of transmission of FMD, the </text>
<text top=""378"" left=""108"" width=""685"" height=""16"" font=""0"">United States argues that the vaccination of cattle against FMD ""introduces risks related to the </text>
<text top=""395"" left=""108"" width=""683"" height=""16"" font=""0"">immunological response within the vaccinated herd"", as ""some individual animals in the herd may </text>
<text top=""411"" left=""108"" width=""442"" height=""16"" font=""0"">have a limited response"" resulting in ""partial or no immunity"".</text>
<footnote top=""410"" left=""550"" width=""23"" height=""11"" font=""16"" number=""1232"" ref="""" dis=""""/>
<text top=""411"" left=""573"" width=""219"" height=""16"" font=""0""> The experts consulted by the </text>
<text top=""428"" left=""108"" width=""685"" height=""16"" font=""0"">panel noted that imports of fresh meat derived from correctly vaccinated animals ""have never </text>
<text top=""444"" left=""108"" width=""363"" height=""16"" font=""0"">caused a transmission of FMD in international trade"".</text>
<footnote top=""443"" left=""471"" width=""23"" height=""11"" font=""16"" number=""1233"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""245"" height=""15"" font=""10""> Transcript of the meeting, para. 1.259. </ftext>
</footnote>
<text top=""444"" left=""494"" width=""296"" height=""16"" font=""0""> According to Dr Cupit, the chain of events </text>
<text top=""461"" left=""108"" width=""684"" height=""16"" font=""0"">that might, in theory, lead to FMD transmission from meat derived from vaccinated cattle is as </text>
<text top=""477"" left=""108"" width=""682"" height=""16"" font=""0"">follows: (a) a vaccinated animal is FMD-infected, but the disease is not detected through ante- and </text>
<text top=""493"" left=""108"" width=""683"" height=""16"" font=""0"">post-mortem inspections; (b) the amount of FMD virus in the animal's meat is sufficient to cause </text>
<text top=""510"" left=""108"" width=""504"" height=""16"" font=""0"">transmission; and (c) the meat is consumed by FMD-susceptible animals.</text>
<footnote top=""508"" left=""611"" width=""23"" height=""11"" font=""16"" number=""1234"" ref="""" dis=""""/>
<text top=""510"" left=""634"" width=""156"" height=""16"" font=""0""> In Dr Cupit's opinion, </text>
<text top=""526"" left=""108"" width=""682"" height=""16"" font=""0"">the likelihood that event (a) described above could occur in a region that, like Northern Argentina, </text>
<text top=""543"" left=""108"" width=""687"" height=""16"" font=""0"">has been vaccinating for a number of years without an FMD outbreak is ""quite low, if not </text>
<text top=""559"" left=""108"" width=""76"" height=""16"" font=""0"">negligible"".</text>
<footnote top=""557"" left=""184"" width=""23"" height=""11"" font=""16"" number=""1235"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""411"" height=""15"" font=""10""> Transcript of the meeting, para. 1.274. See also Ibid. para. 1.279. </ftext>
</footnote>
<text top=""559"" left=""207"" width=""586"" height=""16"" font=""0""> Dr Bonbon concurred that the likelihood of such an event occurring in Northern </text>
<text top=""575"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina is ""very, very, very low"", as vaccination has been practiced in the region for a long </text>
<text top=""592"" left=""108"" width=""35"" height=""16"" font=""0"">time.</text>
<footnote top=""590"" left=""143"" width=""23"" height=""11"" font=""16"" number=""1236"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""245"" height=""15"" font=""10""> Transcript of the meeting, para. 1.277. </ftext>
</footnote>
<text top=""592"" left=""166"" width=""624"" height=""16"" font=""0""> He added that the probability that the entire chain of events leading to FMD-transmission </text>
<text top=""608"" left=""108"" width=""135"" height=""16"" font=""0"">occur is ""remote"".</text>
<footnote top=""607"" left=""243"" width=""23"" height=""11"" font=""16"" number=""1237"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""245"" height=""15"" font=""10""> Transcript of the meeting, para. 1.259. </ftext>
</footnote>
<text top=""608"" left=""266"" width=""530"" height=""16"" font=""0""> The OIE also indicated that vaccination is an effective tool for the </text>
<text top=""625"" left=""108"" width=""296"" height=""16"" font=""0"">prevention, control and eradication of FMD.</text>
<footnote top=""623"" left=""403"" width=""23"" height=""11"" font=""16"" number=""1238"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""237"" height=""15"" font=""10""> Transcript of the meeting, para. 1.65. </ftext>
<ftext top=""1051"" left=""108"" width=""345"" height=""15"" font=""10"">2014), incorporated in 9 CFR 94.1(a), (Exhibit ARG-64). </ftext>
</footnote>
</p><p number=""7.475"" style=""8""><text top=""659"" left=""108"" width=""686"" height=""16"" font=""0"">7.475.  Based on the evidence, we consider that the systematic and compulsory vaccination </text>
<text top=""675"" left=""108"" width=""685"" height=""16"" font=""0"">programme in Northern Argentina effectively reduces the likelihood that an animal in Northern </text>
<text top=""692"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina would become infected with FMD or that if an animal became infected it would transmit </text>
<text top=""708"" left=""108"" width=""153"" height=""16"" font=""0"">the disease to others. </text>
</p><p number=""7.6"" style=""8""><text top=""743"" left=""108"" width=""483"" height=""16"" font=""28"">7.6.7.4.1.5  The status of adjacent regions with respect to FMD </text></p><p number=""7.476"" style=""8""><text top=""777"" left=""108"" width=""685"" height=""16"" font=""0"">7.476.  Northern Argentina shares borders with five regions that are recognized by the OIE as </text>
<text top=""793"" left=""108"" width=""685"" height=""16"" font=""0"">FMD-free where vaccination is practised: (i) 765 kilometres with Bolivia (last FMD outbreak in </text>
<text top=""810"" left=""108"" width=""685"" height=""16"" font=""0"">2007); (ii) 1,570 kilometres with Paraguay (FMD outbreaks in 2003 and 2011); (iii) circa 980 </text>
<text top=""826"" left=""108"" width=""683"" height=""16"" font=""0"">kilometres with the Brazilian States of Paran&#225; (last FMD outbreak in 2005) and Rio Grande do Sul </text>
<text top=""843"" left=""108"" width=""688"" height=""16"" font=""0"">(last FMD outbreak in 2000); and (iv) 866 kilometres with Uruguay (last FMD outbreak in </text>
<p><text top=""1007"" left=""108"" width=""671"" height=""15"" font=""10"">Uruguay in 2002, where vaccines were distributed free of charge to farmers, who would then administer them </text>
<text top=""1022"" left=""108"" width=""486"" height=""15"" font=""10"">directly. (See 2002 Risk Assessment for Uruguay, (Exhibit ARG-65), pp. 26-27) </text>
</p><p><text top=""1066"" left=""170"" width=""276"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 6. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 163 - </text>
</p></p></page>
<page number=""163"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""2001)"" style=""4""><text top=""128"" left=""108"" width=""45"" height=""16"" font=""0"">2001).</text>
<footnote top=""126"" left=""153"" width=""23"" height=""11"" font=""16"" number=""1239"" ref="""" dis=""""><ftext top=""818"" left=""170"" width=""430"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 27.  </ftext>
</footnote>
<text top=""128"" left=""176"" width=""620"" height=""16"" font=""0""> APHIS allows imports of fresh (chilled or frozen) beef from Uruguay into the </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">United States under the protocols contained in 9 CFR 94.22. It also considers the area located in </text>
<text top=""160"" left=""108"" width=""525"" height=""16"" font=""0"">Paraguay near the Argentine border to be ""endemic"" with respect to FMD.</text>
<footnote top=""159"" left=""633"" width=""23"" height=""11"" font=""16"" number=""1240"" ref="""" dis=""""><ftext top=""832"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 23. </ftext>
</footnote>
<text top=""160"" left=""656"" width=""136"" height=""16"" font=""0""> In 2004, SENASA </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">established a 25 kilometre-wide border protection zone (cord&#243;n fronterizo A) along the border with </text>
<text top=""193"" left=""108"" width=""685"" height=""16"" font=""0"">Bolivia and Paraguay. In 2006, it extended the zone to cover the entirety of the border with </text>
<text top=""210"" left=""108"" width=""455"" height=""16"" font=""0"">Paraguay and part of the border with Brazil (cord&#243;n fronterizo B).</text>
<footnote top=""208"" left=""563"" width=""23"" height=""11"" font=""16"" number=""1241"" ref="""" dis=""""><ftext top=""847"" left=""170"" width=""594"" height=""15"" font=""10""> Argentina's first written submission, para. 52; SENASA Resolution 748/2004, referred to in 2014 </ftext>
<ftext top=""861"" left=""108"" width=""634"" height=""15"" font=""10"">Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 23; Final Report Of A Mission Carried Out In </ftext>
<ftext top=""876"" left=""108"" width=""659"" height=""15"" font=""10"">Argentina From 19 To 30 April 2004 In Order To Evaluate Animal Health Controls In Place In Particular Over </ftext>
<ftext top=""891"" left=""108"" width=""674"" height=""15"" font=""10"">Foot And Mouth Disease, Public Health Control Systems And Certification Procedures. (DG(SANCO)/7184/2004 </ftext>
<ftext top=""905"" left=""108"" width=""658"" height=""15"" font=""10"">&#8211; MR Final), (European Commission's 2004 Report), (Exhibit ARG-110), pp. 14, 16; European Commission's </ftext>
<ftext top=""920"" left=""108"" width=""242"" height=""15"" font=""10"">2006 Report, (Exhibit ARG-111), p. 12. </ftext>
</footnote>
<text top=""210"" left=""586"" width=""205"" height=""16"" font=""0""> The border protection zones </text>
<text top=""226"" left=""108"" width=""264"" height=""16"" font=""0"">are subject to special sanitary controls</text>
<footnote top=""225"" left=""372"" width=""23"" height=""11"" font=""16"" number=""1242"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""421"" height=""15"" font=""10""> See European Commission's 2006 Report, (Exhibit ARG-111), p. 12. </ftext>
</footnote>
<text top=""226"" left=""395"" width=""395"" height=""16"" font=""0"">, described in more detail in paragraph 7.483 below, and </text>
<text top=""242"" left=""108"" width=""557"" height=""16"" font=""0"">are recognized by the OIE as FMD-free where vaccination is practised since 2011.</text>
<footnote top=""241"" left=""664"" width=""23"" height=""11"" font=""16"" number=""1243"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""279"" height=""15"" font=""10""> OIE Resolution 14 of 2011, (Exhibit ARG-12) </ftext>
</footnote>
</p><p number=""7.477"" style=""8""><text top=""277"" left=""108"" width=""685"" height=""16"" font=""0"">7.477.  We are aware that the fact that Northern Argentina and the other regions mentioned </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">above are all recognized by the OIE as FMD-free where vaccination is practised does not mean </text>
<text top=""310"" left=""108"" width=""685"" height=""16"" font=""0"">that the OIE conducted a comparative analysis between these regions when determining their </text>
<text top=""326"" left=""108"" width=""97"" height=""16"" font=""0"">FMD-statuses.</text>
<footnote top=""325"" left=""205"" width=""23"" height=""11"" font=""16"" number=""1244"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""245"" height=""15"" font=""10""> Transcript of the meeting, para. 1.123. </ftext>
</footnote>
<text top=""326"" left=""228"" width=""563"" height=""16"" font=""0""> However, the OIE expressed the view that regions that have the same officially </text>
<text top=""342"" left=""108"" width=""636"" height=""16"" font=""0"">recognized FMD status ""should have the same risk mitigation requirements applied to them""</text>
<footnote top=""341"" left=""744"" width=""23"" height=""11"" font=""16"" number=""1245"" ref="""" dis=""""/>
<text top=""342"" left=""767"" width=""23"" height=""16"" font=""0""> in </text>
<text top=""359"" left=""108"" width=""687"" height=""16"" font=""0"">order to achieve the level of protection achieved by the recommendations set forth in the </text>
<text top=""375"" left=""108"" width=""683"" height=""16"" font=""0"">Terrestrial Code, i.e. preventing the disease in question from being introduced into the importing </text>
<text top=""392"" left=""108"" width=""683"" height=""16"" font=""0"">country in light of the sanitary conditions in the exporting country &#8211; what the OIE describes as an </text>
<text top=""408"" left=""108"" width=""277"" height=""16"" font=""0"">""optimal level of animal health security"".</text>
<footnote top=""407"" left=""385"" width=""23"" height=""11"" font=""16"" number=""1246"" ref="""" dis=""""/>
</p><p number=""7.478"" style=""8""><text top=""443"" left=""108"" width=""683"" height=""16"" font=""0"">7.478.  Northern Argentina also borders three regions that are recognized by the OIE as FMD-free </text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">where vaccination is not practised: (i) Chile; (ii) the Brazilian State of Santa Catarina; and (iii) </text>
<text top=""475"" left=""108"" width=""72"" height=""16"" font=""0"">Patagonia.</text>
<footnote top=""474"" left=""180"" width=""23"" height=""11"" font=""16"" number=""1247"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 27. </ftext>
</footnote>
<text top=""475"" left=""203"" width=""590"" height=""16"" font=""0""> At the time of the establishment of the Panel, APHIS recognized both Chile and </text>
<text top=""492"" left=""108"" width=""469"" height=""16"" font=""0"">Santa Catarina as FMD-free within the meaning of 9 CFR 94.1(a)</text>
<footnote top=""490"" left=""577"" width=""23"" height=""11"" font=""16"" number=""1248"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""402"" height=""15"" font=""10""> See APHIS website, <i>Foot-And-Mouth and Rinderpest</i>, available at </ftext>
</footnote>
<text top=""492"" left=""600"" width=""193"" height=""16"" font=""0""> subject to the mitigation </text>
<text top=""508"" left=""108"" width=""688"" height=""16"" font=""0"">protocols under 9 CFR 94.11. APHIS has been applying the same treatment to Patagonia </text>
<text top=""525"" left=""108"" width=""136"" height=""16"" font=""0"">since October 2014.</text>
<footnote top=""523"" left=""245"" width=""23"" height=""11"" font=""16"" number=""1249"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""392"" height=""15"" font=""10""> 2014 Notice of Determination on Patagonia, (Exhibit USA-167). </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""559"" left=""108"" width=""682"" height=""16"" font=""28"">7.6.7.4.1.6  The degree to which the region is separated from adjacent regions of higher </text><text top=""575"" left=""108"" width=""333"" height=""16"" font=""28"">FMD risk through physical or other barriers </text></p><p number=""7.479"" style=""8""><text top=""610"" left=""108"" width=""684"" height=""16"" font=""0"">7.479.  As noted above, Argentina shares in total circa 4,180 kilometres of borders with regions </text>
<text top=""626"" left=""108"" width=""554"" height=""16"" font=""0"">that are considered by the OIE to be FMD-free where vaccination is practised.</text>
<footnote top=""625"" left=""662"" width=""23"" height=""11"" font=""16"" number=""1250"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.476 above. </ftext>
</footnote>
<text top=""626"" left=""685"" width=""107"" height=""16"" font=""0""> Out of those, </text>
<text top=""643"" left=""108"" width=""684"" height=""16"" font=""0"">approximately 757 kilometres of borders are not marked by rivers: 380 kilometres with Bolivia, </text>
<text top=""659"" left=""108"" width=""682"" height=""16"" font=""0"">350 kilometres with Paraguay (deviated course of the Pilcomayo river), and 27 kilometres with the </text>
<text top=""675"" left=""108"" width=""185"" height=""16"" font=""0"">Brazilian State of Paran&#225;.</text>
<footnote top=""674"" left=""293"" width=""23"" height=""11"" font=""16"" number=""1251"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 28-30. </ftext>
</footnote>
<text top=""675"" left=""316"" width=""478"" height=""16"" font=""0""> APHIS observed that some of the rivers along the border with </text>
<text top=""692"" left=""108"" width=""558"" height=""16"" font=""0"">Paraguay and Bolivia are navigable; therefore animals could be shipped across.</text>
<footnote top=""690"" left=""666"" width=""23"" height=""11"" font=""16"" number=""1252"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 42. </ftext>
</footnote>
<text top=""692"" left=""689"" width=""102"" height=""16"" font=""0""> It also found </text>
<text top=""708"" left=""108"" width=""437"" height=""16"" font=""0"">that some other rivers are dry, so animals may cross on foot.</text>
<footnote top=""707"" left=""545"" width=""23"" height=""11"" font=""16"" number=""1253"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 42. </ftext>
</footnote>
<text top=""708"" left=""568"" width=""223"" height=""16"" font=""0""> Finally, we note that Northern </text>
<text top=""725"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina's other border is with Chile a country that is recognized as FMD-free where vaccination </text>
<text top=""741"" left=""108"" width=""686"" height=""16"" font=""0"">is not practised. Furthermore, the border with Chile runs along the Andes mountains, which </text>
<text top=""757"" left=""108"" width=""572"" height=""16"" font=""0"">constitute an effective natural barrier against the cross-border movement of cattle. </text>
<p><text top=""978"" left=""172"" width=""251"" height=""15"" font=""10"">OIE's response to Panel question No. 19. </text>
<text top=""993"" left=""170"" width=""480"" height=""15"" font=""10""> Terrestrial Code, Foreword. See also OIE's response to Panel question No. 10. </text>
</p><p><text top=""1036"" left=""108"" width=""669"" height=""15"" font=""10"">http://www.aphis.usda.gov/import_export/animals/animal_disease_status.shtml (last accessed 27 November </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 164 - </text>
</p></p></page>
<page number=""164"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.480"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.480.  APHIS concluded in 2005 that ""[m]ost of the Argentine border is adequately protected by </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">effective natural barriers to reduce the unrestricted flow of animals and animal products from </text>
<text top=""160"" left=""108"" width=""143"" height=""16"" font=""0"">areas of higher risk"".</text>
<footnote top=""159"" left=""251"" width=""23"" height=""11"" font=""16"" number=""1254"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 30-31. </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""195"" left=""108"" width=""682"" height=""16"" font=""28"">7.6.7.4.1.7  The extent to which movement of animals and animal products is controlled </text><text top=""211"" left=""108"" width=""635"" height=""16"" font=""28"">from regions of higher risk, and the level of biosecurity regarding such movements </text></p><p number=""7.481"" style=""8""><text top=""246"" left=""108"" width=""685"" height=""16"" font=""0"">7.481.  Imports of FMD-susceptible animals and animal products into Northern Argentina occur </text>
<text top=""262"" left=""108"" width=""683"" height=""16"" font=""0"">through 45 international authorized border stations, which include terrestrial, maritime and fluvial </text>
<text top=""278"" left=""108"" width=""135"" height=""16"" font=""0"">ports, and airports.</text>
<footnote top=""277"" left=""243"" width=""23"" height=""11"" font=""16"" number=""1255"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 31-32. </ftext>
</footnote>
<text top=""278"" left=""266"" width=""526"" height=""16"" font=""0""> SENASA officials are assisted at border control points by various security </text>
<text top=""295"" left=""108"" width=""686"" height=""16"" font=""0"">forces, including the National Border Patrol, the Coast Guard, and the National Aeronautical </text>
<text top=""311"" left=""108"" width=""44"" height=""16"" font=""0"">Police.</text>
<footnote top=""310"" left=""152"" width=""23"" height=""11"" font=""16"" number=""1256"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 32. </ftext>
</footnote>
<text top=""311"" left=""175"" width=""620"" height=""16"" font=""0""> In total, some 14,000 agents are assigned to managing the international border </text>
<text top=""328"" left=""108"" width=""58"" height=""16"" font=""0"">stations.</text>
<footnote top=""326"" left=""166"" width=""23"" height=""11"" font=""16"" number=""1257"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""590"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 39; 2014 Risk Analysis for Northern </ftext>
<ftext top=""963"" left=""108"" width=""225"" height=""15"" font=""10"">Argentina, (Exhibit USA-169), p. 37. </ftext>
</footnote>
</p><p number=""7.482"" style=""8""><text top=""362"" left=""108"" width=""685"" height=""16"" font=""0"">7.482.  APHIS also addressed the management of those entry points. It noted that Argentine </text>
<text top=""378"" left=""108"" width=""683"" height=""16"" font=""0"">authorities follow the OIE guidelines regarding imports of products of animal origin considered as </text>
<text top=""395"" left=""108"" width=""172"" height=""16"" font=""0"">possible carriers of FMD.</text>
<footnote top=""393"" left=""280"" width=""23"" height=""11"" font=""16"" number=""1258"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 33. </ftext>
</footnote>
<text top=""395"" left=""303"" width=""489"" height=""16"" font=""0""> In particular, they evaluate the level of risk posed by such products </text>
<text top=""411"" left=""108"" width=""315"" height=""16"" font=""0"">and impose mitigating measures accordingly.</text>
<footnote top=""410"" left=""422"" width=""23"" height=""11"" font=""16"" number=""1259"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 33. </ftext>
</footnote>
<text top=""411"" left=""446"" width=""346"" height=""16"" font=""0""> In order to be lawfully imported into Argentina, </text>
<text top=""428"" left=""108"" width=""684"" height=""16"" font=""0"">all products derived from FMD-susceptible animals must meet the following requirements: (i) an </text>
<text top=""444"" left=""108"" width=""684"" height=""16"" font=""0"">import permit issued by Argentine authorities; (ii) verification of the health certificate issued by </text>
<text top=""461"" left=""108"" width=""684"" height=""16"" font=""0"">the country of origin; (iii) physical inspection, document control and verification identity of the </text>
<text top=""477"" left=""108"" width=""682"" height=""16"" font=""0"">imported products; (iv) a Restricted Transit Permit for shipments of animal products to processing </text>
<text top=""493"" left=""108"" width=""683"" height=""16"" font=""0"">plants with official SENASA veterinary inspection; (v) quarantine of live animals; (vi) sampling of </text>
<text top=""510"" left=""108"" width=""524"" height=""16"" font=""0"">the products by the National Residue Control in Food Products and Hygiene.</text>
<footnote top=""508"" left=""632"" width=""23"" height=""11"" font=""16"" number=""1260"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 34. </ftext>
</footnote>
<text top=""510"" left=""655"" width=""135"" height=""16"" font=""0""> In turn, an import </text>
<text top=""526"" left=""108"" width=""683"" height=""16"" font=""0"">permit is issued upon an analysis of: (i) the type of product that will be imported; (ii) the health </text>
<text top=""543"" left=""108"" width=""684"" height=""16"" font=""0"">status of the exporting region; (iii) the conditions of the slaughtering or processing plant in the </text>
<text top=""559"" left=""108"" width=""685"" height=""16"" font=""0"">region of origin; (iv) the type of shipment; (v) the possible transit of products through other </text>
<text top=""575"" left=""108"" width=""683"" height=""16"" font=""0"">countries; (vi) the efficiency of the border posts at the point of entry into Argentina; and (vii) the </text>
<text top=""592"" left=""108"" width=""216"" height=""16"" font=""0"">expected use of the products.</text>
<footnote top=""590"" left=""324"" width=""23"" height=""11"" font=""16"" number=""1261"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 33-34. </ftext>
</footnote>
<text top=""592"" left=""347"" width=""446"" height=""16"" font=""0""> Inspections are carried out on all products under SENASA's </text>
<text top=""608"" left=""108"" width=""654"" height=""16"" font=""0"">jurisdiction, and consist of questioning, observation, manual inspection of luggage and vehicles.</text>
<footnote top=""607"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1262"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 34. </ftext>
</footnote>
<text top=""625"" left=""108"" width=""606"" height=""16"" font=""0"">Auxiliary means such as organic material scanners and dog squads may also be used.</text>
<footnote top=""623"" left=""714"" width=""23"" height=""11"" font=""16"" number=""1263"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 34. </ftext>
</footnote>
<text top=""625"" left=""737"" width=""54"" height=""16"" font=""0""> As for </text>
<text top=""641"" left=""108"" width=""685"" height=""16"" font=""0"">non-commercial traffic, travellers are checked at control posts, including airports. Penalties for </text>
<text top=""657"" left=""108"" width=""529"" height=""16"" font=""0"">non-compliance with luggage restrictions include the confiscation of property.</text>
<footnote top=""656"" left=""637"" width=""23"" height=""11"" font=""16"" number=""1264"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 35-39. </ftext>
</footnote>
</p><p number=""7.483"" style=""8""><text top=""692"" left=""108"" width=""687"" height=""16"" font=""0"">7.483.  With regards to Northern Argentina's shared borders with Bolivia and Paraguay, the </text>
<text top=""708"" left=""108"" width=""683"" height=""16"" font=""0"">evidence before us indicates that in the border protection zone additional measures are in force, </text>
<text top=""725"" left=""108"" width=""251"" height=""16"" font=""0"">including more frequent vaccination</text>
<footnote top=""723"" left=""359"" width=""23"" height=""11"" font=""16"" number=""1265"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.468 above. </ftext>
</footnote>
<text top=""725"" left=""382"" width=""410"" height=""16"" font=""0"">, enhanced surveillance, stricter movement controls, and </text>
<text top=""741"" left=""108"" width=""343"" height=""16"" font=""0"">cross-border audits and exchange of information.</text>
<footnote top=""739"" left=""451"" width=""23"" height=""11"" font=""16"" number=""1266"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""618"" height=""15"" font=""10""> See European Commission's 2006 Report, (Exhibit ARG-111), p. 12; 2014 Risk Analysis for Northern </ftext>
<ftext top=""1109"" left=""108"" width=""225"" height=""15"" font=""10"">Argentina, (Exhibit USA-169), p. 45. </ftext>
</footnote>
<text top=""741"" left=""474"" width=""317"" height=""16"" font=""0""> Moreover, Argentina participates in bilateral </text>
<text top=""757"" left=""108"" width=""682"" height=""16"" font=""0"">cooperation with Bolivia and Paraguay and in regional efforts under the auspices of PANAFTOSA. In </text>
<text top=""774"" left=""108"" width=""684"" height=""16"" font=""0"">this framework, according to APHIS, ""Argentina incorporated border programs, guaranteeing full </text>
<text top=""790"" left=""108"" width=""687"" height=""16"" font=""0"">notification of the epidemiological situation in the country, development of the vaccination </text>
<text top=""807"" left=""108"" width=""687"" height=""16"" font=""0"">campaigns, joint training and reciprocal guarantees strengthening the Regional and National </text>
<text top=""823"" left=""108"" width=""266"" height=""16"" font=""0"">Epidemiological Surveillance Systems"".</text>
<footnote top=""822"" left=""374"" width=""23"" height=""11"" font=""16"" number=""1267"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 26. </ftext>
<ftext top=""1109"" left=""108"" width=""658"" height=""15"" font=""10"">case of an FMD outbreak are aimed, <i>inter alia</i>, at preventing ""herd to herd transmission through aerosols or </ftext>
</footnote>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 165 - </text>
</p></p></page>
<page number=""165"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.484"" style=""8""><text top=""128"" left=""108"" width=""58"" height=""16"" font=""0"">7.484. </text>
<text top=""128"" left=""162"" width=""437"" height=""16"" font=""0"">SENASA adopted precautionary measures vis-&#224;-vis FMD </text>
<text top=""128"" left=""590"" width=""208"" height=""16"" font=""0"">outbreaks in neighbouring </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">countries a number of times over the last decade. For instance, in 2005, in response to an </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">FMD outbreak in the Brazilian States of Paran&#225; and Mato Grosso do Sul, SENASA implemented a </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">number of preventive measures, including a sanitary alert in the national territory, an import </text>
<text top=""193"" left=""108"" width=""690"" height=""16"" font=""0"">prohibition on FMD-susceptible products from all of Brazil, strengthened epidemiological </text>
<text top=""210"" left=""108"" width=""690"" height=""16"" font=""0"">surveillance, enhanced biosecurity measures, reinforced vaccination and increased border </text>
<text top=""226"" left=""108"" width=""59"" height=""16"" font=""0"">controls.</text>
<footnote top=""225"" left=""167"" width=""23"" height=""11"" font=""16"" number=""1268"" ref="""" dis=""""><ftext top=""891"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 27. </ftext>
</footnote>
<text top=""226"" left=""190"" width=""604"" height=""16"" font=""0""> Further, upon receiving notice of an FMD outbreak in Paraguay in 2001, SENASA </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">""immediately mobilized into action declaring a state of animal health alert throughout the country </text>
<text top=""259"" left=""108"" width=""684"" height=""16"" font=""0"">and strengthening all existing border crossing points to prevent the entry of the FMD virus into </text>
<text top=""275"" left=""108"" width=""77"" height=""16"" font=""0"">Argentina.""</text>
<footnote top=""274"" left=""185"" width=""23"" height=""11"" font=""16"" number=""1269"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 82. </ftext>
</footnote>
</p><p number=""7.485"" style=""8""><text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">7.485.  In light of the above, Dr Batho expressed the view that shared borders with countries that </text>
<text top=""326"" left=""108"" width=""371"" height=""16"" font=""0"">had more recent FMD outbreaks are ""well-managed"".</text>
<footnote top=""325"" left=""479"" width=""23"" height=""11"" font=""16"" number=""1270"" ref="""" dis=""""/>
<text top=""326"" left=""502"" width=""289"" height=""16"" font=""0""> Dr Cupit added that Northern Argentina </text>
<text top=""342"" left=""108"" width=""654"" height=""16"" font=""0"">has ""strict movement controls"" along the ""buffer/border region with Paraguay and Bolivia"".</text>
<footnote top=""341"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1271"" ref="""" dis=""""/>
<text top=""359"" left=""108"" width=""684"" height=""16"" font=""0"">Dr Bonbon stated that, because Northern Argentina is recognized by the OIE as FMD-free where </text>
<text top=""375"" left=""108"" width=""682"" height=""16"" font=""0"">vaccination is practised, ""one can assume"" that its movement control measures are of an adequate </text>
<text top=""392"" left=""108"" width=""56"" height=""16"" font=""0"">efficacy.</text>
<footnote top=""390"" left=""164"" width=""23"" height=""11"" font=""16"" number=""1272"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""614"" height=""15"" font=""10""> Dr Bonbon's response to Panel question No. 36 (referring to his response to Panel question No. 34). </ftext>
</footnote>
<text top=""392"" left=""187"" width=""603"" height=""16"" font=""0""> In 2005, APHIS concluded that in those areas on the Argentine border ""where natural </text>
<text top=""408"" left=""108"" width=""458"" height=""16"" font=""0"">barriers do not exist, government control measures compensate"".</text>
<footnote top=""407"" left=""566"" width=""23"" height=""11"" font=""16"" number=""1273"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 30-31. </ftext>
</footnote>
<text top=""408"" left=""589"" width=""202"" height=""16"" font=""0""> The evidence on the record </text>
<text top=""425"" left=""108"" width=""682"" height=""16"" font=""0"">shows that, during the period leading up to the Panel's establishment, the facts underlying APHIS' </text>
<text top=""441"" left=""108"" width=""687"" height=""16"" font=""0"">conclusions in 2005 have not changed to an extent that would warrant a reversal of such </text>
<text top=""457"" left=""108"" width=""682"" height=""16"" font=""0"">conclusions. Indeed, Argentina submitted evidence to APHIS dating between 2001 and 2012 which </text>
<text top=""474"" left=""108"" width=""677"" height=""16"" font=""0"">indicated that the administration of international land border controls and checks on non-</text>
<text top=""490"" left=""108"" width=""557"" height=""16"" font=""0"">commercial traffic remained essentially the same since APHIS' 2005 risk analysis.</text>
<footnote top=""489"" left=""664"" width=""23"" height=""11"" font=""16"" number=""1274"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""446"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 36-50. </ftext>
</footnote>
</p><p number=""7.486"" style=""8""><text top=""525"" left=""108"" width=""686"" height=""16"" font=""0"">7.486.  Based on the evidence, we consider that the movement controls and other measures </text>
<text top=""541"" left=""108"" width=""686"" height=""16"" font=""0"">applied by the Argentine authorities to prevent the incursion of FMD into Northern Argentina </text>
<text top=""557"" left=""108"" width=""683"" height=""16"" font=""0"">effectively protect the region from ingress of animals and animal products from regions of higher </text>
<text top=""574"" left=""108"" width=""70"" height=""16"" font=""0"">FMD-risk. </text>
</p><p number=""7.6"" style=""8""><text top=""608"" left=""108"" width=""569"" height=""16"" font=""28"">7.6.7.4.1.8  Livestock demographics and marketing practices in the region </text></p><p number=""7.487"" style=""8""><text top=""643"" left=""108"" width=""684"" height=""16"" font=""0"">7.487.  As the experts have indicated, concentration of cattle is a relevant factor for the risk of </text>
<text top=""659"" left=""108"" width=""98"" height=""16"" font=""0"">spread of FMD</text>
<footnote top=""657"" left=""206"" width=""23"" height=""11"" font=""16"" number=""1275"" ref="""" dis=""""/>
<text top=""659"" left=""229"" width=""561"" height=""16"" font=""0"">; the lower the density of the susceptible animal population, the lower the risk of </text>
<text top=""675"" left=""108"" width=""161"" height=""16"" font=""0"">spread of the disease.</text>
<footnote top=""674"" left=""269"" width=""23"" height=""11"" font=""16"" number=""1276"" ref="""" dis=""""/>
<text top=""675"" left=""292"" width=""501"" height=""16"" font=""0""> Northern Argentina has a surface area of approximately 1,106,800 </text>
<text top=""692"" left=""108"" width=""443"" height=""16"" font=""0"">square kilometres and a cattle population of circa 55,000,000.</text>
<footnote top=""690"" left=""551"" width=""23"" height=""11"" font=""16"" number=""1277"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""573"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 51; Argentina's first written </ftext>
</footnote>
<text top=""692"" left=""574"" width=""218"" height=""16"" font=""0""> Thus, the average density of </text>
<text top=""708"" left=""108"" width=""683"" height=""16"" font=""0"">cattle in Northern Argentina is about 49.6 animals per square kilometre. By comparison, Uruguay </text>
<text top=""725"" left=""108"" width=""684"" height=""16"" font=""0"">has a surface area of circa 176,200 square kilometres and a cattle population of approximately </text>
<text top=""741"" left=""108"" width=""83"" height=""16"" font=""0"">10,400,000.</text>
<footnote top=""739"" left=""191"" width=""23"" height=""11"" font=""16"" number=""1278"" ref="""" dis=""""/>
<text top=""741"" left=""214"" width=""576"" height=""16"" font=""0""> Thus, Uruguay has a cattle density of about 59 animals per square kilometre. The </text>
<text top=""757"" left=""108"" width=""683"" height=""16"" font=""0"">experts noted that Northern Argentina also has larger herds than Uruguay, meaning that cattle in </text>
<text top=""774"" left=""108"" width=""294"" height=""16"" font=""0"">the region are clustered in larger groups.</text>
<footnote top=""772"" left=""402"" width=""23"" height=""11"" font=""16"" number=""1279"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""586"" height=""15"" font=""10""> Dr Batho's response to Panel question No. 63; Dr Bonbon's response to Panel question No. 63.  </ftext>
</footnote>
<text top=""774"" left=""425"" width=""367"" height=""16"" font=""0""> While the concentration of animals in a herd may </text>
<text top=""790"" left=""108"" width=""686"" height=""16"" font=""0"">make it easier for FMD to spread within that herd, a greater geographical dispersal of herds </text>
<text top=""807"" left=""108"" width=""552"" height=""16"" font=""0"">facilitates veterinary control and containment in the event of an FMD outbreak.</text>
<footnote top=""805"" left=""659"" width=""23"" height=""11"" font=""16"" number=""1280"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""610"" height=""15"" font=""10""> For instance, as noted by Dr Cupit, active surveillance is properly performed at the herd level. (See </ftext>
</footnote>
<text top=""807"" left=""682"" width=""107"" height=""16"" font=""0""> In light of the </text>
<text top=""823"" left=""108"" width=""686"" height=""16"" font=""0"">above, we consider that the cattle demographics in the region do not constitute a factor of </text>
<text top=""839"" left=""108"" width=""684"" height=""16"" font=""0"">increased risk of spread of FMD in and of themselves or as compared to other regions such as </text>
<text top=""856"" left=""108"" width=""72"" height=""16"" font=""0"">Uruguay.  </text>
<footnote top=""920"" left=""170"" width=""287"" height=""15"" font=""10"" number=""63"" ref="""" dis=""""/>
<p><text top=""934"" left=""170"" width=""284"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 36. </text>
</p><p><text top=""1007"" left=""170"" width=""287"" height=""15"" font=""10""> Dr Batho's response to Panel question No. 50. </text>
</p><p><text top=""1036"" left=""108"" width=""135"" height=""15"" font=""10"">submission, para. 23. </text>
<text top=""1051"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 308. </text>
</p><p><text top=""1095"" left=""108"" width=""659"" height=""15"" font=""10"">Dr Cupit's reponse to Panel question No. 27) Further, according to Dr Bonbon, containment measures in the </text>
</p><p><text top=""1124"" left=""108"" width=""461"" height=""15"" font=""10"">direct or indirect contacts"". (Dr Bonbon's response to Panel question No. 1) </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 166 - </text>
</p></p></page>
<page number=""166"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.488"" style=""8""><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">7.488.  As to market practices in Northern Argentina, there are over 150 SENASA-approved </text>
<text top=""144"" left=""108"" width=""282"" height=""16"" font=""0"">slaughterhouses in Northern Argentina.</text>
<footnote top=""143"" left=""390"" width=""23"" height=""11"" font=""16"" number=""1281"" ref="""" dis=""""><ftext top=""774"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 58. </ftext>
</footnote>
<text top=""144"" left=""413"" width=""381"" height=""16"" font=""0""> In 2005, APHIS reviewed the biosecurity controls </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">established by SENASA in order to accredit a facility. Such controls include that: (i) animals be </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">kept in pens and not be allowed to exit the facility once they have entered it; (ii) all effluent be </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">treated by separating solids, fats, liquids, and chlorinates out before releasing them to the general </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">sewage system; (iii) effluents from the sanitary complex be individually treated by disinfection </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">before being dumped with the rest of the common, treated effluents; and (iv) raw slaughter and </text>
<text top=""242"" left=""108"" width=""472"" height=""16"" font=""0"">slaughter pathology wastes be processed into nonedible by-products.</text>
<footnote top=""241"" left=""580"" width=""23"" height=""11"" font=""16"" number=""1282"" ref="""" dis=""""><ftext top=""788"" left=""170"" width=""619"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 46-47; 2014 Risk Analysis for Northern </ftext>
<ftext top=""803"" left=""108"" width=""253"" height=""15"" font=""10"">Argentina, (Exhibit USA-169), pp. 58-59. </ftext>
</footnote>
</p><p number=""7.489"" style=""8""><text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">7.489.  APHIS further observed that all animals receive an ante-mortem inspection by a SENASA </text>
<text top=""293"" left=""108"" width=""687"" height=""16"" font=""0"">technician upon arrival at the slaughter facility, as well as a post-mortem inspection after </text>
<text top=""310"" left=""108"" width=""394"" height=""16"" font=""0"">slaughter by SENASA field veterinarians and plant staff.</text>
<footnote top=""308"" left=""502"" width=""23"" height=""11"" font=""16"" number=""1283"" ref="""" dis=""""><ftext top=""818"" left=""170"" width=""604"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 47. In 2005, APHIS found that no one </ftext>
</footnote>
<text top=""310"" left=""525"" width=""267"" height=""16"" font=""0""> Further, all carcasses are subject to </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">deboning, consisting of the removal of bone and blood clots, under the supervision of the quality </text>
<text top=""342"" left=""108"" width=""124"" height=""16"" font=""0"">control personnel.</text>
<footnote top=""341"" left=""231"" width=""23"" height=""11"" font=""16"" number=""1284"" ref="""" dis=""""><ftext top=""876"" left=""170"" width=""587"" height=""15"" font=""10""> See Resoluci&#243;n SENASA 58/2001, (Exhibit USA-59), Article 2.5. See also 2014 Risk Analysis for </ftext>
<ftext top=""891"" left=""108"" width=""283"" height=""15"" font=""10"">Northern Argentina, (Exhibit USA-169), p. 60. </ftext>
</footnote>
<text top=""342"" left=""255"" width=""536"" height=""16"" font=""0""> They are then matured for a minimum of 24 hours at a temperature of 2 to </text>
<text top=""359"" left=""108"" width=""683"" height=""17"" font=""0"">10&#61616; C. In the event that, at the end of the process, the pH is above 5.9, the carcass is separated </text>
<text top=""375"" left=""108"" width=""456"" height=""16"" font=""0"">from the export beef and only used for domestic consumption.</text>
<footnote top=""374"" left=""564"" width=""23"" height=""11"" font=""16"" number=""1285"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""587"" height=""15"" font=""10""> See Resoluci&#243;n SENASA 58/2001, (Exhibit USA-59), Article 2.5. See also 2014 Risk Analysis for </ftext>
<ftext top=""920"" left=""108"" width=""283"" height=""15"" font=""10"">Northern Argentina, (Exhibit USA-169), p. 60. </ftext>
</footnote>
<text top=""375"" left=""587"" width=""206"" height=""16"" font=""0""> According to the European </text>
<text top=""392"" left=""108"" width=""689"" height=""16"" font=""0"">Commission's 2006 Report, ""[t]he maturation of beef was correctly carried out and well </text>
<text top=""408"" left=""108"" width=""299"" height=""16"" font=""0"">documented in the establishments visited""</text>
<footnote top=""407"" left=""407"" width=""23"" height=""11"" font=""16"" number=""1286"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""597"" height=""15"" font=""10""> European Commission's 2006 Report, (Exhibit ARG-111), p. 15. See also European Commission's </ftext>
<ftext top=""949"" left=""108"" width=""242"" height=""15"" font=""10"">2004 Report, (Exhibit ARG-110), p. 27. </ftext>
</footnote>
<text top=""408"" left=""430"" width=""355"" height=""16"" font=""0"">, and ""[t]he official controls and records for ante-</text>
<text top=""425"" left=""108"" width=""483"" height=""16"" font=""0"">mortem, post-mortem and maturation were completed and adequate"".</text>
<footnote top=""423"" left=""590"" width=""23"" height=""11"" font=""16"" number=""1287"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""597"" height=""15"" font=""10""> European Commission's 2006 Report, (Exhibit ARG-111), p. 16. See also European Commission's </ftext>
<ftext top=""978"" left=""108"" width=""242"" height=""15"" font=""10"">2004 Report, (Exhibit ARG-110), p. 27. </ftext>
</footnote>
</p><p number=""7.490"" style=""8""><text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">7.490.  In its 1997 risk assessment for Argentina, APHIS assumed that fresh beef deboned and </text>
<text top=""475"" left=""108"" width=""654"" height=""16"" font=""0"">matured to pH 5.8 poses ""negligible risk"", as the FMD virus does not survive such processes.</text>
<footnote top=""474"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1288"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""520"" height=""15"" font=""10""> USDA/APHIS, <i>Risk Assessment: Argentine Beef </i>(June 1997), (Exhibit ARG-27), p. 5. </ftext>
</footnote>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">Dr Cupit observed that, based on the evidence on the record, slaughterhouse procedures used in </text>
<text top=""508"" left=""108"" width=""677"" height=""16"" font=""0"">Northern Argentina, in particular requirements for deboning, maturation, and ante- and post-</text>
<text top=""525"" left=""108"" width=""346"" height=""16"" font=""0"">mortem inspections, conform to OIE requirements</text>
<footnote top=""523"" left=""454"" width=""23"" height=""11"" font=""16"" number=""1289"" ref="""" dis=""""/>
<text top=""525"" left=""477"" width=""314"" height=""16"" font=""0""> and ""should be as efficacious today as they </text>
<text top=""541"" left=""108"" width=""103"" height=""16"" font=""0"">were in 1997"".</text>
<footnote top=""540"" left=""212"" width=""23"" height=""11"" font=""16"" number=""1290"" ref="""" dis=""""/>
<text top=""541"" left=""235"" width=""557"" height=""16"" font=""0""> Dr Batho stated that there is no reason to believe that such procedures were </text>
<text top=""557"" left=""108"" width=""684"" height=""16"" font=""0"">any less effective at the time of the establishment of the Panel than they were in 1997, when </text>
<text top=""574"" left=""108"" width=""576"" height=""16"" font=""0"">Argentina was allowed to export fresh (chilled or frozen) beef to the United States.</text>
<footnote top=""572"" left=""684"" width=""23"" height=""11"" font=""16"" number=""1291"" ref="""" dis=""""/>
<text top=""574"" left=""707"" width=""83"" height=""16"" font=""0""> Dr Bonbon </text>
<text top=""590"" left=""108"" width=""686"" height=""16"" font=""0"">took the view that the evidence on the record shows that ""the capacities of the Argentinian </text>
<text top=""607"" left=""108"" width=""557"" height=""16"" font=""0"">veterinary services, includ[ing] at slaughterhouse[s], have improved since 1997"".</text>
<footnote top=""605"" left=""665"" width=""23"" height=""11"" font=""16"" number=""1292"" ref="""" dis=""""/>
</p><p number=""7.491"" style=""8""><text top=""641"" left=""108"" width=""683"" height=""16"" font=""0"">7.491.  We note that, as of 2005, deboned fresh (chilled or frozen) beef was being imported into </text>
<text top=""658"" left=""108"" width=""684"" height=""16"" font=""0"">Patagonia South from areas in Northern Argentina for local consumption. APHIS found that such </text>
<text top=""674"" left=""108"" width=""682"" height=""16"" font=""0"">beef presented ""a low risk of introducing the FMD virus into the export region"" because, <i>inter alia</i>, </text>
<text top=""690"" left=""108"" width=""485"" height=""16"" font=""0"">""it must go through a maturation process that kills the FMD virus"".</text>
<footnote top=""689"" left=""593"" width=""23"" height=""11"" font=""16"" number=""1293"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""591"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 71. See also Dr Batho's response to </ftext>
</footnote>
<text top=""690"" left=""616"" width=""177"" height=""16"" font=""0""> Dr Cupit observed that </text>
<text top=""707"" left=""108"" width=""683"" height=""16"" font=""0"">""matured, deboned fresh beef from [N]orthern Argentina [has] a very low risk of introducing the </text>
<text top=""723"" left=""108"" width=""682"" height=""16"" font=""0"">FMDV to other export markets as it does to Patagonia"", and ""would pose a similar or identical risk"" </text>
<text top=""740"" left=""108"" width=""328"" height=""16"" font=""0"">irrespective of the market of destination.</text>
<footnote top=""738"" left=""436"" width=""23"" height=""11"" font=""16"" number=""1294"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""608"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 46. We do note that Dr Cupit was privy to both the 2005 </ftext>
</footnote>
<text top=""740"" left=""459"" width=""341"" height=""16"" font=""0""> This further supports a conclusion that </text>
<footnote top=""832"" left=""108"" width=""668"" height=""15"" font=""10"" number=""2014"" ref="""" dis=""""><ftext top=""1124"" left=""108"" width=""663"" height=""15"" font=""10"">question. However, we also note that APHIS' findings from 2005 are identical to those in the 2014 document </ftext>
</footnote>
<footnote top=""1007"" left=""170"" width=""284"" height=""15"" font=""10"" number=""44"" ref="""" dis=""""/>
<p><text top=""1080"" left=""108"" width=""141"" height=""15"" font=""10"">Panel question No. 40. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 167 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">slaughterhouse practices in Northern Argentina, and in particular deboning, maturation, and ante- </text>
<text top=""144"" left=""108"" width=""688"" height=""16"" font=""0"">and post-mortem inspections, are effective tools which significantly reduce of the risk of </text>
<text top=""160"" left=""108"" width=""372"" height=""16"" font=""0"">FMD-transmission from fresh (chilled or frozen) beef.  </text>
</p></p></page>
<page number=""167"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.6"" style=""8""><text top=""195"" left=""108"" width=""526"" height=""16"" font=""28"">7.6.7.4.1.9  The type and extent of disease surveillance in the region </text></p><p number=""7.492"" style=""8""><text top=""229"" left=""108"" width=""683"" height=""16"" font=""0"">7.492.  Since the July 2000 FMD outbreaks, serological sampling (active surveillance) in Argentina </text>
<text top=""246"" left=""108"" width=""685"" height=""16"" font=""0"">has been conducted at least once a year, pursuant to the 2001 National Eradication Plan for </text>
<text top=""262"" left=""108"" width=""34"" height=""16"" font=""0"">FMD.</text>
<footnote top=""261"" left=""142"" width=""23"" height=""11"" font=""16"" number=""1295"" ref="""" dis=""""><ftext top=""847"" left=""170"" width=""569"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 49; Resoluci&#243;n SENASA 5/2001, </ftext>
<ftext top=""861"" left=""108"" width=""155"" height=""15"" font=""10"">(Exhibit ARG-4/USA-37). </ftext>
</footnote>
<text top=""262"" left=""166"" width=""626"" height=""16"" font=""0""> The sampling is conducted according to a two-stage strategy at the herd level and the </text>
<text top=""278"" left=""108"" width=""685"" height=""16"" font=""0"">individual animal level, tailored to each region's number and type of herds, animal movement </text>
<text top=""295"" left=""108"" width=""459"" height=""16"" font=""0"">patterns, geographical and climatic conditions, and disease history.</text>
<footnote top=""293"" left=""567"" width=""23"" height=""11"" font=""16"" number=""1296"" ref="""" dis=""""><ftext top=""876"" left=""170"" width=""590"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 49; 2014 Risk Analysis for Northern </ftext>
<ftext top=""891"" left=""108"" width=""225"" height=""15"" font=""10"">Argentina, (Exhibit USA-169), p. 51. </ftext>
</footnote>
<text top=""295"" left=""590"" width=""200"" height=""16"" font=""0""> The system allows the early </text>
<text top=""311"" left=""108"" width=""424"" height=""16"" font=""0"">detection of FMDV at a statistical confidence level of 95%.</text>
<footnote top=""310"" left=""532"" width=""23"" height=""11"" font=""16"" number=""1297"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""590"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 49; 2014 Risk Analysis for Northern </ftext>
<ftext top=""920"" left=""108"" width=""225"" height=""15"" font=""10"">Argentina, (Exhibit USA-169), p. 64. </ftext>
</footnote>
<text top=""311"" left=""555"" width=""238"" height=""16"" font=""0""> In 2005, APHIS considered the </text>
<text top=""328"" left=""108"" width=""348"" height=""16"" font=""0"">sampling design to be ""both valid and efficient"".</text>
<footnote top=""326"" left=""455"" width=""23"" height=""11"" font=""16"" number=""1298"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 49. </ftext>
</footnote>
<text top=""328"" left=""479"" width=""314"" height=""16"" font=""0""> Although, the objectives, approaches, and </text>
<text top=""344"" left=""108"" width=""684"" height=""16"" font=""0"">intensity may change slightly from year to year, the basic sampling approach is defined in the </text>
<text top=""360"" left=""108"" width=""493"" height=""16"" font=""0"">National Eradication Plan, which remains the same since it was adopted.</text>
<footnote top=""359"" left=""601"" width=""23"" height=""11"" font=""16"" number=""1299"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 64. </ftext>
</footnote>
</p><p number=""7.493"" style=""8""><text top=""395"" left=""108"" width=""685"" height=""16"" font=""0"">7.493.  Dr Cupit observed that Argentina has ""a well-developed passive and active surveillance </text>
<text top=""411"" left=""108"" width=""677"" height=""16"" font=""0"">plan for FMD that has been constantly developed and modified since the FMD outbreaks of 2000-</text>
<text top=""428"" left=""108"" width=""45"" height=""16"" font=""0"">2002"".</text>
<footnote top=""426"" left=""153"" width=""23"" height=""11"" font=""16"" number=""1300"" ref="""" dis=""""/>
<text top=""428"" left=""176"" width=""614"" height=""16"" font=""0""> Further, according to Dr Cupit, ""[t]he testing system and sampling design of Argentina's </text>
<text top=""444"" left=""108"" width=""687"" height=""16"" font=""0"">passive and active surveillance system for FMD appear to conform to the guidelines in the </text>
<text top=""461"" left=""108"" width=""216"" height=""16"" font=""0"">[Terrestrial] Code and Manual"".</text>
<footnote top=""459"" left=""324"" width=""23"" height=""11"" font=""16"" number=""1301"" ref="""" dis=""""/>
<text top=""461"" left=""347"" width=""444"" height=""16"" font=""0""> Indeed, the fact that the OIE recognized Northern Argentina as </text>
<text top=""477"" left=""108"" width=""683"" height=""16"" font=""0"">FMD-free where vaccination is practised means that the active and passive surveillance measures </text>
<text top=""493"" left=""108"" width=""683"" height=""16"" font=""0"">in force in the region meet the requirements set forth in Articles 8.5.42-8.5.47 and 8.5.49 of the </text>
<text top=""510"" left=""108"" width=""116"" height=""16"" font=""0"">Terrestrial Code.</text>
<footnote top=""508"" left=""224"" width=""23"" height=""11"" font=""16"" number=""1302"" ref="""" dis=""""/>
<text top=""510"" left=""247"" width=""515"" height=""16"" font=""0""> This was confirmed by Dr Bonbon in his responses to Panel questions.</text>
<footnote top=""508"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1303"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""392"" height=""15"" font=""10""> See Dr Bonbon's response to Panel question No. 34, para. 280. </ftext>
</footnote>
<text top=""526"" left=""108"" width=""684"" height=""16"" font=""0"">Other evidence on the record does not contradict such conclusions. The European Commission's </text>
<text top=""543"" left=""108"" width=""685"" height=""16"" font=""0"">reports from 2004-2006 noted some shortcomings in the serological surveillance conducted by </text>
<text top=""559"" left=""108"" width=""226"" height=""16"" font=""0"">SENASA in Northern Argentina.</text>
<footnote top=""557"" left=""334"" width=""23"" height=""11"" font=""16"" number=""1304"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""539"" height=""15"" font=""10""> See e.g. European Commission's 2004 Report, (Exhibit ARG-110), pp. 13-16; European </ftext>
<ftext top=""1036"" left=""108"" width=""329"" height=""15"" font=""10"">Commission's 2006 Report, (Exhibit ARG-111), p. 11. </ftext>
</footnote>
<text top=""559"" left=""357"" width=""437"" height=""16"" font=""0""> Despite such deficiencies, the Commission concluded that </text>
<text top=""575"" left=""108"" width=""436"" height=""16"" font=""0"">SENASA's ability to prevent and control FMD was ""satisfactory""</text>
<footnote top=""574"" left=""544"" width=""23"" height=""11"" font=""16"" number=""1305"" ref="""" dis=""""/>
<text top=""575"" left=""567"" width=""224"" height=""16"" font=""0""> and progressively reopened its </text>
<text top=""592"" left=""108"" width=""687"" height=""16"" font=""0"">market to imports of fresh (chilled or frozen) beef from Northern Argentina according the </text>
<text top=""608"" left=""108"" width=""187"" height=""16"" font=""0"">FMD history of each region.</text>
<footnote top=""607"" left=""295"" width=""23"" height=""11"" font=""16"" number=""1306"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""514"" height=""15"" font=""10""> See e.g. Decision of the European Commission No. 2002/45/EC (22 January 2002), </ftext>
<ftext top=""1080"" left=""108"" width=""575"" height=""15"" font=""10"">(Exhibit ARG-114); Decision of the European Commission No. 2002/68/EC (30 January 2002), </ftext>
<ftext top=""1095"" left=""108"" width=""564"" height=""15"" font=""10"">(Exhibit ARG-108); Decision of the European Commission No. 2002/198/EC (7 March 2002), </ftext>
<ftext top=""1109"" left=""108"" width=""461"" height=""15"" font=""10"">(Exhibit ARG-109); Commission Regulation No. 206/2010, (Exhibit ARG-1). </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""643"" left=""108"" width=""336"" height=""16"" font=""28"">7.6.7.4.1.10  Diagnostic laboratory capacity </text></p><p number=""7.494"" style=""8""><text top=""677"" left=""108"" width=""682"" height=""16"" font=""0"">7.494.  In its 2005 risk assessment, APHIS reviewed a number of elements in connection with the </text>
<text top=""693"" left=""108"" width=""688"" height=""16"" font=""0"">organization, structure, and capacity of laboratories in Argentina. It found, <i>inter alia</i>, that </text>
<text top=""710"" left=""108"" width=""686"" height=""16"" font=""0"">Argentine laboratories use an information management system for recording samples and for </text>
<text top=""726"" left=""108"" width=""686"" height=""16"" font=""0"">typing laboratory results to be analysed by epidemiologists. APHIS described the system as </text>
<text top=""743"" left=""108"" width=""503"" height=""16"" font=""0"">""effective and adequate"" and the staff as ""very capable"" in managing it.</text>
<footnote top=""741"" left=""611"" width=""23"" height=""11"" font=""16"" number=""1307"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 65. </ftext>
</footnote>
<text top=""743"" left=""634"" width=""157"" height=""16"" font=""0""> It also observed that </text>
<text top=""759"" left=""108"" width=""688"" height=""16"" font=""0"">the National Reference Laboratory was, at that time, working towards accreditation under </text>
<p><text top=""803"" left=""108"" width=""648"" height=""15"" font=""10"">(see 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 71 and 2014 Risk Analysis for Patagonia, </text>
<text top=""818"" left=""108"" width=""657"" height=""15"" font=""10"">(Exhibit USA-133), pp. 30, 69.) Thus, we have no reason to believe that Dr Cupit's evaluation would be any </text>
<text top=""832"" left=""108"" width=""488"" height=""15"" font=""10"">different for the period from 2005 up to the date of establishment of the Panel.  </text>
<footnote top=""963"" left=""170"" width=""284"" height=""15"" font=""10"" number=""34"" ref="""" dis=""""/>
</p><p><text top=""993"" left=""170"" width=""287"" height=""15"" font=""10""> See OIE's response to Panel question No. 17.  </text>
</p><p><text top=""1051"" left=""170"" width=""284"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 31. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 168 - </text>
</p><p><text top=""128"" left=""108"" width=""236"" height=""16"" font=""0"">international standard ISO 17025.</text>
<footnote top=""126"" left=""344"" width=""23"" height=""11"" font=""16"" number=""1308"" ref="""" dis=""""><ftext top=""891"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 65. </ftext>
</footnote>
<text top=""128"" left=""367"" width=""424"" height=""16"" font=""0""> APHIS also reviewed the collection, treatment, and analysis </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">of diagnostic samples, as well as the technological capability of the laboratories to conduct </text>
<text top=""160"" left=""108"" width=""111"" height=""16"" font=""0"">diagnostic tests.</text>
<footnote top=""159"" left=""219"" width=""23"" height=""11"" font=""16"" number=""1309"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 67. </ftext>
</footnote>
</p></p></page>
<page number=""168"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.495"" style=""8""><text top=""195"" left=""108"" width=""682"" height=""16"" font=""0"">7.495.  APHIS concluded that ""Argentina has the diagnostic capabilities to adequately test samples </text>
<text top=""211"" left=""108"" width=""686"" height=""16"" font=""0"">for the presence of the FMD virus"", that ""quality control activities within the laboratories are </text>
<text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">sufficient"", that ""laboratory equipment is routinely monitored and calibrated"", that ""sufficient staff </text>
<text top=""244"" left=""108"" width=""684"" height=""16"" font=""0"">is available"", and that ""there is an effective and efficient recordkeeping system for storage and </text>
<text top=""260"" left=""108"" width=""130"" height=""16"" font=""0"">retrieval of data"".</text>
<footnote top=""259"" left=""238"" width=""23"" height=""11"" font=""16"" number=""1310"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 68. </ftext>
</footnote>
<text top=""260"" left=""261"" width=""534"" height=""16"" font=""0""> We do not see any evidence on the record indicating that the facts </text>
<text top=""277"" left=""108"" width=""685"" height=""16"" font=""0"">underlying APHIS' 2005 conclusions changed in a way that would warrant a reversal of such </text>
<text top=""293"" left=""108"" width=""686"" height=""16"" font=""0"">conclusions during the period leading up to the Panel's establishment. Rather, in 2006, the </text>
<text top=""310"" left=""108"" width=""596"" height=""16"" font=""0"">National Reference Laboratory was accredited under international standard ISO 17025</text>
<footnote top=""308"" left=""704"" width=""23"" height=""11"" font=""16"" number=""1311"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 76. </ftext>
</footnote>
<text top=""310"" left=""727"" width=""64"" height=""16"" font=""0""> and the </text>
<text top=""326"" left=""108"" width=""654"" height=""16"" font=""0"">laboratory network acquired the capacity to run Polymerase Chain Reaction (PCR) tests for FMD</text>
<footnote top=""325"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1312"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 76. </ftext>
</footnote>
<text top=""342"" left=""108"" width=""427"" height=""16"" font=""0"">&#8211; the lack of which APHIS had found to be a gap in 2005.</text>
<footnote top=""341"" left=""535"" width=""23"" height=""11"" font=""16"" number=""1313"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 66-67. </ftext>
</footnote>
<text top=""342"" left=""558"" width=""234"" height=""16"" font=""0""> Finally, the fact that SENASA's </text>
<text top=""359"" left=""108"" width=""684"" height=""16"" font=""0"">Animal Laboratory is recognized as an OIE Reference Laboratory for FMD has been described by </text>
<text top=""375"" left=""108"" width=""246"" height=""16"" font=""0"">the OIE as a ""very positive factor"".</text>
<footnote top=""374"" left=""354"" width=""23"" height=""11"" font=""16"" number=""1314"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""242"" height=""15"" font=""10""> Transcript of the meeting, para. 1.62.  </ftext>
</footnote>
<text top=""375"" left=""377"" width=""415"" height=""16"" font=""0""> Indeed, in the OIE's view, such a recognition entails that </text>
<text top=""392"" left=""108"" width=""684"" height=""16"" font=""0"">the laboratory ""is capable of providing diagnostic services of a &#8230; world level"" and to ""provide a </text>
<text top=""408"" left=""108"" width=""275"" height=""16"" font=""0"">service at no charge to other countries"".</text>
<footnote top=""407"" left=""383"" width=""23"" height=""11"" font=""16"" number=""1315"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""242"" height=""15"" font=""10""> Transcript of the meeting, para. 1.62.  </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""443"" left=""108"" width=""508"" height=""16"" font=""28"">7.6.7.4.1.11  Policies and infrastructure for animal disease control </text></p><p number=""7.496"" style=""8""><text top=""477"" left=""108"" width=""685"" height=""16"" font=""0"">7.496.  Finally, in its 2005 risk assessment, APHIS reviewed several aspects of the regulatory </text>
<text top=""493"" left=""108"" width=""682"" height=""16"" font=""0"">framework in force in Northern Argentina to ensure disease surveillance and the ability to deal with </text>
<text top=""510"" left=""108"" width=""682"" height=""16"" font=""0"">possible FMD outbreaks in the region. It observed that the law requires immediate and mandatory </text>
<text top=""526"" left=""108"" width=""683"" height=""16"" font=""0"">reporting of FMD, under penalty of severe fines applied by SENASA to any individual or company </text>
<text top=""543"" left=""108"" width=""145"" height=""16"" font=""0"">that fails to comply.</text>
<footnote top=""541"" left=""252"" width=""23"" height=""11"" font=""16"" number=""1316"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 68. </ftext>
</footnote>
<text top=""543"" left=""275"" width=""517"" height=""16"" font=""0""> Producers, animal caretakers, transporters and other people observing </text>
<text top=""559"" left=""108"" width=""690"" height=""16"" font=""0"">animals on a daily basis were found to bewell aware of FMD symptoms and reporting </text>
<text top=""575"" left=""108"" width=""95"" height=""16"" font=""0"">requirements.</text>
<footnote top=""574"" left=""203"" width=""23"" height=""11"" font=""16"" number=""1317"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 68. </ftext>
</footnote>
<text top=""575"" left=""226"" width=""569"" height=""16"" font=""0""> Veterinarians also take part in passive surveillance by conducting routine </text>
<text top=""592"" left=""108"" width=""606"" height=""16"" font=""0"">examinations of livestock during wool-industry related tasks, fairs, and after slaughter.</text>
<footnote top=""590"" left=""714"" width=""23"" height=""11"" font=""16"" number=""1318"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 68. </ftext>
</footnote>
<text top=""592"" left=""737"" width=""54"" height=""16"" font=""0""> APHIS </text>
<text top=""608"" left=""108"" width=""683"" height=""16"" font=""0"">then proceeded to review SENASA's authority to take prompt action in case of an FMD outbreak, </text>
<text top=""625"" left=""108"" width=""434"" height=""16"" font=""0"">including stamping-out of all the affected and contact animals</text>
<footnote top=""623"" left=""542"" width=""23"" height=""11"" font=""16"" number=""1319"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 68-69. </ftext>
</footnote>
<text top=""625"" left=""565"" width=""227"" height=""16"" font=""0"">, as well as training of SENASA </text>
<text top=""641"" left=""108"" width=""56"" height=""16"" font=""0"">officials.</text>
<footnote top=""639"" left=""164"" width=""23"" height=""11"" font=""16"" number=""1320"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 70. </ftext>
</footnote>
</p><p number=""7.497"" style=""8""><text top=""675"" left=""108"" width=""686"" height=""16"" font=""0"">7.497.  Based on the above, APHIS concluded that SENASA ""has the infrastructure and legal </text>
<text top=""692"" left=""108"" width=""654"" height=""16"" font=""0"">authority to declare an emergency and take appropriate action in case of an [FMD] outbreak"".</text>
<footnote top=""690"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1321"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 70. </ftext>
</footnote>
<text top=""708"" left=""108"" width=""683"" height=""16"" font=""0"">We note that these conclusions mirror those reached by APHIS with respect to SENASA's capacity </text>
<text top=""725"" left=""108"" width=""482"" height=""16"" font=""0"">to prevent and control FMD discussed in paragraph 7.461 above.</text>
<footnote top=""723"" left=""590"" width=""23"" height=""11"" font=""16"" number=""1322"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""607"" height=""15"" font=""10""> APHIS' 2014 risk analysis updates and confirms, for the most part, its findings made in 2005. (See </ftext>
<ftext top=""1109"" left=""108"" width=""451"" height=""15"" font=""10"">2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), pp. 78-82) </ftext>
</footnote>
<text top=""725"" left=""613"" width=""183"" height=""16"" font=""0""> Further, the European </text>
<text top=""741"" left=""108"" width=""684"" height=""16"" font=""0"">Commission's 2006 Report confirms that the procedures in place ""permit[] a rapid and effective </text>
<text top=""757"" left=""108"" width=""224"" height=""16"" font=""0"">response to [an] FMD outbreak"".</text>
<footnote top=""756"" left=""331"" width=""23"" height=""11"" font=""16"" number=""1323"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""394"" height=""15"" font=""10""> European Commission's 2006 Report, (Exhibit ARG-111), p. 20. </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""792"" left=""108"" width=""500"" height=""16"" font=""28"">7.6.7.4.1.12  Conclusions on the scientific evidence on the record </text></p><p number=""7.498"" style=""8""><text top=""826"" left=""108"" width=""686"" height=""16"" font=""0"">7.498.  The evidence on the record demonstrates that Northern Argentina has the necessary </text>
<text top=""843"" left=""108"" width=""685"" height=""16"" font=""0"">veterinary capacity and infrastructure to prevent and control FMD in its own territory and the </text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 169 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">capacity to prevent incursions of the disease from neighbouring regions. Such capacity stems from </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">a panoply of interlocking and overlapping sanitary measures aimed at reducing the risk of entry of </text>
<text top=""160"" left=""108"" width=""685"" height=""16"" font=""0"">FMD in the region, including, <i>inter alia</i>: adequate active and passive surveillance programmes, </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">systemic and compulsory vaccination, accurate tracking and identification of animals, effective </text>
<text top=""193"" left=""108"" width=""689"" height=""16"" font=""0"">controls on the movement of FMD-susceptible animals from regions of higher FMD risk, </text>
<text top=""210"" left=""108"" width=""687"" height=""16"" font=""0"">appropriate collection of samples and laboratory capacity, efficacious mitigating measures at </text>
<text top=""226"" left=""108"" width=""683"" height=""16"" font=""0"">slaughterhouses such as deboning and maturation, and comprehensive control policies in case of </text>
<text top=""242"" left=""108"" width=""96"" height=""16"" font=""0"">an outbreak.  </text>
</p></p></page>
<page number=""169"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.499"" style=""8""><text top=""277"" left=""108"" width=""685"" height=""16"" font=""0"">7.499.  We now turn to assessing whether the alternative measures identified by Argentina, if </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">applied to imports of fresh (chilled or frozen) beef from Northern Argentina, would achieve the </text>
<text top=""310"" left=""108"" width=""674"" height=""16"" font=""0"">United States' ALOP for FMD, recalling that we have found that the ALOP is between low and zero. </text>
</p><p number=""7.6"" style=""8""><text top=""344"" left=""108"" width=""683"" height=""16"" font=""28"">7.6.7.4.1.13  Whether the recommendations under Article 8.5.23 of the Terrestrial Code </text><text top=""360"" left=""108"" width=""650"" height=""16"" font=""28"">would achieve the United States' ALOP if applied to imports from Northern Argentina </text></p><p number=""7.500"" style=""8""><text top=""395"" left=""108"" width=""683"" height=""16"" font=""0"">7.500.  The first alternative measure identified by Argentina is the application of Article 8.5.23 of </text>
<text top=""411"" left=""108"" width=""683"" height=""16"" font=""0"">the Terrestrial Code, which recommends that for importation of fresh meat of cattle and buffaloes </text>
<text top=""428"" left=""108"" width=""688"" height=""16"" font=""0"">(excluding feet, head and viscera) from FMD-free countries or zones where vaccination is </text>
<text top=""444"" left=""108"" width=""429"" height=""16"" font=""0"">practised, the veterinary authorities of the importing Member: </text>
<p><text top=""479"" left=""151"" width=""598"" height=""16"" font=""0"">[R]equire the presentation of an international veterinary certificate attesting that the </text>
<text top=""495"" left=""151"" width=""384"" height=""16"" font=""0"">entire consignment of meat comes from animals which: </text>
</p></p><p number=""(1)"" style=""4""><text top=""529"" left=""151"" width=""598"" height=""16"" font=""0"">(1)  have been kept in the FMD free country or zone where vaccination is practised, </text>
<text top=""546"" left=""193"" width=""554"" height=""16"" font=""0"">or which have been imported in accordance with Article 8.5.12, Article 8.5.13 or </text>
<text top=""562"" left=""193"" width=""103"" height=""16"" font=""0"">Article 8.5.14; </text>
</p><p number=""(2)"" style=""4""><text top=""597"" left=""151"" width=""600"" height=""16"" font=""0"">(2)   have been slaughtered in an approved abattoir and have been subjected to </text>
<text top=""613"" left=""193"" width=""467"" height=""16"" font=""0"">ante- and post-mortem inspections for FMD with favourable results. </text>
</p><p number=""7.501"" style=""8""><text top=""647"" left=""108"" width=""683"" height=""16"" font=""0"">7.501.  As the language above indicates Article 8.5.23 recommends that imports of fresh (chilled </text>
<text top=""664"" left=""108"" width=""685"" height=""16"" font=""0"">or frozen) beef be allowed, subject to mitigating protocols centred on movement controls, the </text>
<text top=""680"" left=""108"" width=""493"" height=""16"" font=""0"">approval of slaughter facilities, and ante- and post-mortem inspections. </text>
</p><p number=""7.502"" style=""8""><text top=""715"" left=""108"" width=""685"" height=""16"" font=""0"">7.502.  Argentina does not put forward any specific arguments supporting its position that the </text>
<text top=""731"" left=""108"" width=""682"" height=""16"" font=""0"">recommendations contained in Article 8.5.23, if applied to imports from Northern Argentina, would </text>
<text top=""747"" left=""108"" width=""241"" height=""16"" font=""0"">achieve the United States' ALOP.</text>
<footnote top=""746"" left=""349"" width=""23"" height=""11"" font=""16"" number=""1324"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""595"" height=""15"" font=""10""> Argentina's first written submission, paras. 310-317 in the section entitled ""Alternative Measures </ftext>
<ftext top=""1022"" left=""108"" width=""663"" height=""15"" font=""10"">Would Achieve the Appropriate Level of Sanitary Protection"" contains no reference to Article 8.5.23. See also </ftext>
</footnote>
<text top=""747"" left=""372"" width=""424"" height=""16"" font=""0""> Moreover, Argentina itself appears to accept that the </text>
<text top=""764"" left=""108"" width=""687"" height=""16"" font=""0"">recommendations contained in Article 8.5.23 of the Terrestrial Code would not achieve the </text>
<text top=""780"" left=""108"" width=""683"" height=""16"" font=""0"">United States' ALOP when it states that the United States has rejected the alternative because it </text>
<text top=""797"" left=""108"" width=""682"" height=""16"" font=""0"">claims to apply a higher level ALOP and accepts the United States' right to apply a higher standard </text>
<text top=""813"" left=""108"" width=""689"" height=""16"" font=""0"">that the OIE protocol for fresh beef from areas that are FMD-free where vaccination is </text>
<text top=""829"" left=""108"" width=""67"" height=""16"" font=""0"">practised.</text>
<footnote top=""828"" left=""175"" width=""23"" height=""11"" font=""16"" number=""1325"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""372"" height=""15"" font=""10""> Argentina's second written submission, paras. 155 and 158. </ftext>
</footnote>
</p><p number=""7.503"" style=""8""><text top=""864"" left=""108"" width=""684"" height=""16"" font=""0"">7.503.  To recall, the United States stated that its ALOP for FMD is higher than that achieved by </text>
<text top=""880"" left=""108"" width=""147"" height=""16"" font=""0"">the Terrestrial Code.</text>
<footnote top=""879"" left=""255"" width=""23"" height=""11"" font=""16"" number=""1326"" ref="""" dis=""""/>
<text top=""880"" left=""278"" width=""516"" height=""16"" font=""0""> We concluded that the United States measures are not based on the </text>
<text top=""897"" left=""108"" width=""683"" height=""16"" font=""0"">Terrestrial Code precisely because the United States does not consider regions recognized by the </text>
<text top=""913"" left=""108"" width=""690"" height=""16"" font=""0"">OIE as FMD-free where vaccination is practised to be FMD-free within the meaning of </text>
<text top=""929"" left=""108"" width=""684"" height=""16"" font=""0"">9 CFR 94.1(a), and therefore does not allow imports of fresh (chilled or frozen) beef from such </text>
<text top=""946"" left=""108"" width=""55"" height=""16"" font=""0"">regions.</text>
<footnote top=""944"" left=""163"" width=""23"" height=""11"" font=""16"" number=""1327"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""155"" height=""15"" font=""10""> See para. 7.241 above.  </ftext>
</footnote>
<text top=""946"" left=""186"" width=""605"" height=""16"" font=""0""> Although the United States makes an exception to this general rule for Uruguay, those </text>
<text top=""962"" left=""108"" width=""683"" height=""16"" font=""0"">imports are subject to the mitigating protocols under 9 CFR 94.22, which Argentina has raised as </text>
<p><text top=""1036"" left=""108"" width=""670"" height=""15"" font=""10"">Argentina's response to Panel question No. 44 following the first substantive meeting; and Argentina's second </text>
<text top=""1051"" left=""108"" width=""189"" height=""15"" font=""10"">written submission, para. 156. </text>
</p><p><text top=""1080"" left=""170"" width=""566"" height=""15"" font=""10""> See e.g. United States' first written submission, para. 299; United States' response to Panel </text>
<text top=""1095"" left=""108"" width=""341"" height=""15"" font=""10"">question No. 19 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 170 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">its second proposed alternative measure. Furthermore, Argentina acknowledges that the protocols </text>
<text top=""144"" left=""108"" width=""685"" height=""16"" font=""0"">applied to Uruguay are more stringent than Article 8.5.23 and are substantively similar to the </text>
<text top=""160"" left=""108"" width=""688"" height=""16"" font=""0"">protocols in Article 8.5.25 for imports of fresh beef from areas that are FMD-infected but </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">undergoing a vaccination program. Such measures are designed to mitigate a risk higher than that </text>
<text top=""193"" left=""108"" width=""453"" height=""16"" font=""0"">of products from an FMD-free region which practises vaccination.  </text>
</p></p></page>
<page number=""170"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""22"" size=""5"" family=""Times"" color=""#ffffff""/>
<p number=""7.504"" style=""8""><text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">7.504.  In light of the above, and absent any specific arguments on Argentina's part, we consider </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">that Argentina failed to demonstrate that such recommendations would achieve the United States' </text>
<text top=""260"" left=""108"" width=""633"" height=""16"" font=""0"">ALOP for FMD if applied to imports of fresh (chilled or frozen) beef from Northern Argentina. </text>
</p><p number=""7.6"" style=""8""><text top=""295"" left=""108"" width=""684"" height=""16"" font=""28"">7.6.7.4.1.14  Whether the mitigating protocols set forth in 9 CFR 94.22 would achieve </text><text top=""311"" left=""108"" width=""537"" height=""16"" font=""28"">the United States' ALOP if applied to imports from Northern Argentina </text></p><p number=""7.505"" style=""8""><text top=""346"" left=""108"" width=""685"" height=""16"" font=""0"">7.505.  The second alternative measure Argentina identified is the application of the mitigating </text>
<text top=""362"" left=""108"" width=""684"" height=""16"" font=""0"">protocols set forth under 9 CFR 94.22 to its imports of fresh (chilled or frozen) beef. Argentina </text>
<text top=""378"" left=""108"" width=""683"" height=""16"" font=""0"">contends that because APHIS applies the protocols under 9 CFR 94.22 to imports of fresh (chilled </text>
<text top=""395"" left=""108"" width=""682"" height=""16"" font=""0"">or frozen) beef from Uruguay, the same protocols would achieve the United States' ALOP if applied </text>
<text top=""411"" left=""108"" width=""621"" height=""16"" font=""0"">to Northern Argentina, as the two regions have ""essentially the same"" FMD situation.</text>
<footnote top=""410"" left=""729"" width=""23"" height=""11"" font=""16"" number=""1328"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""580"" height=""15"" font=""10""> Argentina' first written submission, paras. 312-316; Argentina's opening statement at the first </ftext>
<ftext top=""993"" left=""108"" width=""502"" height=""15"" font=""10"">meeting of the Panel, para. 46; Argentina's second written submission, para. 173. </ftext>
</footnote>
<text top=""411"" left=""752"" width=""42"" height=""16"" font=""0""> The </text>
<text top=""428"" left=""108"" width=""684"" height=""16"" font=""0"">United States responds that the fact that the two regions share the same OIE FMD-status is not </text>
<text top=""444"" left=""108"" width=""477"" height=""16"" font=""0"">dispositive of whether products therefrom pose the same level of risk.</text>
<footnote top=""443"" left=""585"" width=""23"" height=""11"" font=""16"" number=""1329"" ref="""" dis=""""/>
</p><p number=""7.506"" style=""8""><text top=""479"" left=""108"" width=""683"" height=""16"" font=""0"">7.506.  We agree with the United States that the mere fact that the OIE recognizes both Northern </text>
<text top=""495"" left=""108"" width=""687"" height=""16"" font=""0"">Argentina and Uruguay as FMD-free where vaccination is practised is not, in and of itself, </text>
<text top=""511"" left=""108"" width=""683"" height=""16"" font=""0"">dispositive as to whether the protocols applied to Uruguay under 9 CFR 94.22 would achieve the </text>
<text top=""528"" left=""108"" width=""372"" height=""16"" font=""0"">United States' ALOP if applied to Northern Argentina.</text>
<footnote top=""526"" left=""480"" width=""23"" height=""11"" font=""16"" number=""1330"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""605"" height=""15"" font=""10""> This is in line with our finding that the import measures and mitigating protocols recommended by </ftext>
<ftext top=""1051"" left=""108"" width=""676"" height=""15"" font=""10"">the Terrestrial Code exist and can operate independently of the OIE's official recognition of disease status for a </ftext>
<ftext top=""1066"" left=""108"" width=""316"" height=""15"" font=""10"">certain country or region. (See para. 7.238 above). </ftext>
</footnote>
<text top=""528"" left=""503"" width=""289"" height=""16"" font=""0""> Rather, mindful of the Appellate Body's </text>
<text top=""544"" left=""108"" width=""684"" height=""16"" font=""0"">guidance in <i>Australia &#8211; Apples</i>, we must conduct our own assessment of whether the protocols </text>
<text top=""561"" left=""108"" width=""684"" height=""16"" font=""0"">under 9 CFR 94.22 would bring the risk posed by imports of fresh (chilled or frozen) beef from </text>
<text top=""577"" left=""108"" width=""516"" height=""16"" font=""0"">Northern Argentina down to a level that achieves the United States' ALOP.  </text>
</p><p number=""7.507"" style=""8""><text top=""611"" left=""108"" width=""683"" height=""16"" font=""0"">7.507.  Table 5 below lists the protocols under 9 CFR 94.22 and provides a description, based on </text>
<text top=""628"" left=""108"" width=""684"" height=""16"" font=""0"">the evidence on the record where relevant, of the effectiveness of each mitigating measure in </text>
<text top=""644"" left=""108"" width=""263"" height=""16"" font=""0"">reducing the risk of FMD-introduction. </text>
</p><p><text top=""679"" left=""108"" width=""636"" height=""16"" font=""28"">Table 5: Protocols under 9 CFR 94.22 and their effectiveness in mitigating FMD risk </text><text top=""706"" left=""108"" width=""192"" height=""15"" font=""29"">Protocols under 9 CFR 94.22</text><footnote top=""705"" left=""300"" width=""19"" height=""9"" font=""22"" number=""1331"" ref="""" dis=""""/>
<text top=""706"" left=""455"" width=""203"" height=""15"" font=""29"">Effectiveness in reducing risk </text></p><p><text top=""726"" left=""108"" width=""320"" height=""15"" font=""10"">The meat is beef from bovines that have been born, </text>
<text top=""741"" left=""108"" width=""326"" height=""15"" font=""10"">raised, and slaughtered in the region constituting the </text>
<text top=""755"" left=""108"" width=""259"" height=""15"" font=""10"">object of the exporting Member's request. </text>
<text top=""726"" left=""455"" width=""324"" height=""15"" font=""10"">This requirement reduces the likelihood of fresh beef </text>
<text top=""741"" left=""455"" width=""290"" height=""15"" font=""10"">from other regions that are FMD-infected being </text>
<text top=""755"" left=""455"" width=""301"" height=""15"" font=""10"">imported into the region subject to the exporting </text>
<text top=""770"" left=""455"" width=""329"" height=""15"" font=""10"">Member's request, and from the latter region into the </text>
<text top=""784"" left=""455"" width=""86"" height=""15"" font=""10"">United States.</text>
<footnote top=""784"" left=""540"" width=""19"" height=""9"" font=""17"" number=""1332"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""568"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 61; Dr Batho's response to Panel question No. 61, </ftext>
<ftext top=""1109"" left=""108"" width=""362"" height=""15"" font=""10"">para. 488; Dr Bonbon's response to Panel question No. 61. </ftext>
</footnote>
<text top=""804"" left=""108"" width=""330"" height=""15"" font=""10"">Foot-and-mouth disease has not been diagnosed in in </text>
<text top=""819"" left=""108"" width=""327"" height=""15"" font=""10"">the region subject to the exporting Member's request </text>
<text top=""833"" left=""108"" width=""197"" height=""15"" font=""10"">within the previous 12 months.  </text>
<text top=""804"" left=""455"" width=""327"" height=""15"" font=""10"">This requirement reduces the likelihood of FMD being </text>
<text top=""819"" left=""455"" width=""312"" height=""15"" font=""10"">present in the territory of the region subject to the </text>
<text top=""833"" left=""455"" width=""330"" height=""15"" font=""10"">exporting Member's request, and therefore in animals </text>
<text top=""848"" left=""455"" width=""311"" height=""15"" font=""10"">slaughtered for the production of fresh beef that is </text>
<text top=""862"" left=""455"" width=""215"" height=""15"" font=""10"">then exported to the United States.</text>
<footnote top=""862"" left=""669"" width=""19"" height=""9"" font=""17"" number=""1333"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""574"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 61; Dr Bonbon's response to Panel question No. 61 </ftext>
</footnote>
</p><p><text top=""1007"" left=""170"" width=""569"" height=""15"" font=""10""> United States' first written submission, para. 297; United States' second written submission, </text>
<text top=""1022"" left=""108"" width=""102"" height=""15"" font=""10"">paras. 108-109. </text>
</p></page>
<page number=""171"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 171 - </text>
</p><p><text top=""130"" left=""108"" width=""192"" height=""15"" font=""29"">Protocols under 9 CFR 94.22</text><text top=""130"" left=""455"" width=""203"" height=""15"" font=""29"">Effectiveness in reducing risk </text></p><p><text top=""150"" left=""108"" width=""313"" height=""15"" font=""10"">The meat comes from bovines that originated from </text>
<text top=""164"" left=""108"" width=""331"" height=""15"" font=""10"">premises where foot-and-mouth disease has not been </text>
<text top=""179"" left=""108"" width=""333"" height=""15"" font=""10"">present during the lifetime of any bovines slaughtered </text>
<text top=""193"" left=""108"" width=""264"" height=""15"" font=""10"">for the export of beef to the United States. </text>
<text top=""150"" left=""455"" width=""319"" height=""15"" font=""10"">Provided that the surveillance system is appropriate </text>
<text top=""164"" left=""455"" width=""331"" height=""15"" font=""10"">to detect cases of FMD and accurate records are kept, </text>
<text top=""179"" left=""455"" width=""331"" height=""15"" font=""10"">this requirement reduces the likelihood of cattle being </text>
<text top=""193"" left=""455"" width=""319"" height=""15"" font=""10"">sourced from properties where FMD is present, thus </text>
<text top=""208"" left=""455"" width=""275"" height=""15"" font=""10"">reducing the risk that FMD-infected cattle be </text>
<text top=""222"" left=""455"" width=""265"" height=""15"" font=""10"">slaughtered for export to the United States.</text>
<footnote top=""222"" left=""720"" width=""19"" height=""9"" font=""17"" number=""1334"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""578"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 61; Dr Bonbon's response to Panel question No. 61. </ftext>
</footnote>
<text top=""242"" left=""108"" width=""331"" height=""15"" font=""10"">The beef came from bovines that were moved directly </text>
<text top=""257"" left=""108"" width=""288"" height=""15"" font=""10"">from the premises of origin to the slaughtering </text>
<text top=""271"" left=""108"" width=""333"" height=""15"" font=""10"">establishment without any contact with other animals. </text>
<text top=""242"" left=""455"" width=""296"" height=""15"" font=""10"">This requirement reduces the likelihood of cattle </text>
<text top=""257"" left=""455"" width=""307"" height=""15"" font=""10"">destined to slaughter for export coming in contact </text>
<text top=""271"" left=""455"" width=""279"" height=""15"" font=""10"">with other cattle of higher potential risk, thus </text>
<text top=""286"" left=""455"" width=""308"" height=""15"" font=""10"">reducing the likelihood of FMD-infected beef being </text>
<text top=""300"" left=""455"" width=""195"" height=""15"" font=""10"">imported into the United States.</text>
<footnote top=""300"" left=""650"" width=""19"" height=""9"" font=""17"" number=""1335"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""578"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 61; Dr Bonbon's response to Panel question No. 61. </ftext>
</footnote>
<text top=""320"" left=""108"" width=""291"" height=""15"" font=""10"">The beef came from bovines that received ante-</text>
<text top=""335"" left=""108"" width=""303"" height=""15"" font=""10"">mortem and post-mortem veterinary inspections, </text>
<text top=""349"" left=""108"" width=""312"" height=""15"" font=""10"">paying particular attention to the head and feet, at </text>
<text top=""364"" left=""108"" width=""302"" height=""15"" font=""10"">the slaughtering establishment, with no evidence </text>
<text top=""378"" left=""108"" width=""165"" height=""15"" font=""10"">found of vesicular disease. </text>
<text top=""320"" left=""455"" width=""325"" height=""15"" font=""10"">Ante-mortem inspections allow the detection of early </text>
<text top=""335"" left=""455"" width=""310"" height=""15"" font=""10"">FMD symptoms (such as dullness, poor appetite, a </text>
<text top=""349"" left=""455"" width=""325"" height=""15"" font=""10"">rise in temperature to 40-41&#176; C, salivation, lethargy, </text>
<text top=""364"" left=""455"" width=""322"" height=""15"" font=""10"">and lameness) as well as advanced symptoms (such </text>
<text top=""378"" left=""455"" width=""286"" height=""15"" font=""10"">as vesicles appearing inside the mouth, on the </text>
<text top=""393"" left=""455"" width=""333"" height=""15"" font=""10"">tongue, cheeks, gums, lips, palate, between the claws </text>
<text top=""408"" left=""455"" width=""251"" height=""15"" font=""10"">of the feet and along the coronary band).</text>
<footnote top=""407"" left=""706"" width=""19"" height=""9"" font=""17"" number=""1336"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""571"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 9; Dr Bonbon's response to Panel question No. 61. </ftext>
</footnote>
<text top=""408"" left=""725"" width=""35"" height=""15"" font=""10""> Post-</text>
<text top=""422"" left=""455"" width=""291"" height=""15"" font=""10"">mortem inspections at slaughterhouses provide </text>
<text top=""437"" left=""455"" width=""312"" height=""15"" font=""10"">further confidence that slaughtered animals do not </text>
<text top=""451"" left=""455"" width=""189"" height=""15"" font=""10"">present vesicular signs of FMD.</text>
<footnote top=""451"" left=""643"" width=""19"" height=""9"" font=""17"" number=""1337"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""578"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 61; Dr Bonbon's response to Panel question No. 61. </ftext>
</footnote>
<text top=""451"" left=""662"" width=""102"" height=""15"" font=""10""> However, ante- </text>
<text top=""466"" left=""455"" width=""315"" height=""15"" font=""10"">and post-mortem inspections are not likely to allow </text>
<text top=""481"" left=""455"" width=""261"" height=""15"" font=""10"">detection of FMD in asymptomatic animals.</text>
<footnote top=""480"" left=""716"" width=""19"" height=""9"" font=""17"" number=""1338"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""578"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 31; Dr Bonbon's response to Panel question No. 16. </ftext>
</footnote>
<text top=""500"" left=""108"" width=""308"" height=""15"" font=""10"">The beef consists only of bovine parts that are, by </text>
<text top=""515"" left=""108"" width=""326"" height=""15"" font=""10"">standard practice, part of the animal's carcass that is </text>
<text top=""529"" left=""108"" width=""299"" height=""15"" font=""10"">placed in a chiller for maturation after slaughter. </text>
<text top=""544"" left=""108"" width=""304"" height=""15"" font=""10"">Bovine parts that may not be imported include all </text>
<text top=""559"" left=""108"" width=""292"" height=""15"" font=""10"">parts of bovine heads, feet, hump, hooves, and </text>
<text top=""573"" left=""108"" width=""100"" height=""15"" font=""10"">internal organs. </text>
<text top=""500"" left=""455"" width=""307"" height=""15"" font=""10"">The sites of localisation of the FMD virus in carrier </text>
<text top=""515"" left=""455"" width=""315"" height=""15"" font=""10"">animals are the feet, throat and viscera. Therefore, </text>
<text top=""529"" left=""455"" width=""332"" height=""15"" font=""10"">removing such tissues reduces the risk that FMD virus </text>
<text top=""544"" left=""455"" width=""235"" height=""15"" font=""10"">will be present in exported fresh meat.</text>
<footnote top=""543"" left=""689"" width=""19"" height=""9"" font=""17"" number=""1339"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""605"" height=""15"" font=""10""> OIE's response to Panel question No. 26; Dr Cupit's response to Panel question No. 61; Dr Batho's </ftext>
<ftext top=""993"" left=""108"" width=""510"" height=""15"" font=""10"">response to Panel question No. 61; Dr Bonbon's response to Panel question No. 61. </ftext>
</footnote>
<text top=""544"" left=""709"" width=""31"" height=""15"" font=""10""> The </text>
<text top=""559"" left=""455"" width=""311"" height=""15"" font=""10"">removal of feet, head and viscera is a requirement </text>
<text top=""573"" left=""455"" width=""272"" height=""15"" font=""10"">under both Articles 8.5.23 and 8.5.25 of the </text>
<text top=""588"" left=""455"" width=""101"" height=""15"" font=""10"">Terrestrial Code.</text>
<footnote top=""587"" left=""555"" width=""19"" height=""9"" font=""17"" number=""1340"" ref="""" dis=""""/>
<text top=""607"" left=""108"" width=""303"" height=""15"" font=""12""><i>Deboning</i>: All bone and visually identifiable blood </text>
<text top=""622"" left=""108"" width=""314"" height=""15"" font=""10"">clots and lymphoid tissue have been removed from </text>
<text top=""637"" left=""108"" width=""58"" height=""15"" font=""10"">the beef. </text>
<text top=""655"" left=""108"" width=""306"" height=""15"" font=""12""><i>Maturation</i>: The beef came from bovine carcasses </text>
<text top=""669"" left=""108"" width=""310"" height=""15"" font=""10"">that were allowed to maturate at 40 to 50&#176; F (4 to </text>
<text top=""684"" left=""108"" width=""330"" height=""15"" font=""10"">10&#176; C) for a minimum of 36 hours after slaughter and </text>
<text top=""699"" left=""108"" width=""323"" height=""15"" font=""10"">that reached a pH of 5.8 or less in the loin muscle at </text>
<text top=""713"" left=""108"" width=""320"" height=""15"" font=""10"">the end of the maturation period. Measurements for </text>
<text top=""728"" left=""108"" width=""318"" height=""15"" font=""10"">pH must be taken at the middle of both <i>longissimus </i></text>
<text top=""742"" left=""108"" width=""321"" height=""15"" font=""12""><i>dorsi</i> muscles. Any carcass in which the pH does not </text>
<text top=""757"" left=""108"" width=""299"" height=""15"" font=""10"">reach 5.8 or less may be allowed to maturate an </text>
<text top=""772"" left=""108"" width=""291"" height=""15"" font=""10"">additional 24 hours and be retested, and, if the </text>
<text top=""786"" left=""108"" width=""323"" height=""15"" font=""10"">carcass still has not reached a pH of 5.8 or less after </text>
<text top=""801"" left=""108"" width=""298"" height=""15"" font=""10"">60 hours, the meat from the carcass may not be </text>
<text top=""815"" left=""108"" width=""188"" height=""15"" font=""10"">exported to the United States. </text>
<text top=""607"" left=""455"" width=""279"" height=""15"" font=""10"">The parties agree that, if properly conducted, </text>
<text top=""622"" left=""455"" width=""313"" height=""15"" font=""10"">deboning and maturation greatly reduce the risk of </text>
<text top=""637"" left=""455"" width=""328"" height=""15"" font=""10"">FMD being transmitted through trade of fresh (chilled </text>
<text top=""651"" left=""455"" width=""94"" height=""15"" font=""10"">or frozen) beef.</text>
<footnote top=""650"" left=""549"" width=""19"" height=""9"" font=""17"" number=""1341"" ref="""" dis=""""/>
<text top=""651"" left=""568"" width=""212"" height=""15"" font=""10""> The experts consider that the risk </text>
<text top=""666"" left=""455"" width=""304"" height=""15"" font=""10"">of FMD-introduction from imports of deboned and </text>
<text top=""680"" left=""455"" width=""303"" height=""15"" font=""10"">matured beef is negligible. According to Dr Cupit, </text>
<text top=""695"" left=""455"" width=""287"" height=""15"" font=""10"">deboning and maturation of beef is ""extremely </text>
<text top=""710"" left=""455"" width=""305"" height=""15"" font=""10"">effective"", as evidenced by the fact that, between </text>
<text top=""724"" left=""455"" width=""282"" height=""15"" font=""10"">2004 and 2013, the European Union imported </text>
<text top=""739"" left=""455"" width=""321"" height=""15"" font=""10"">535,000 tonnes of such beef from Argentina with no </text>
<text top=""753"" left=""455"" width=""95"" height=""15"" font=""10"">FDM outbreaks.</text>
<footnote top=""753"" left=""549"" width=""19"" height=""9"" font=""17"" number=""1342"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""596"" height=""15"" font=""10""> Transcript of the meeting, para. 1.197. See also D.J. Paton, M. Sinclair, R. Rodr&#237;guez, Qualitative </ftext>
<ftext top=""1066"" left=""108"" width=""658"" height=""15"" font=""10"">assessment of the commodity risk factor for spread of foot-and-mouth disease associated with international </ftext>
<ftext top=""1080"" left=""108"" width=""648"" height=""15"" font=""10"">trade in deboned beef, OIE ad hoc Group on Trade in Animal Products (October 2009), (Exhibit ARG-128), </ftext>
</footnote>
<text top=""753"" left=""568"" width=""216"" height=""15"" font=""10""> Drs Batho and Bonbon noted that, </text>
<text top=""768"" left=""455"" width=""326"" height=""15"" font=""10"">to their knowledge, there is no evidence that imports </text>
<text top=""782"" left=""455"" width=""317"" height=""15"" font=""10"">of deboned and matured fresh beef ever resulted in </text>
<text top=""797"" left=""455"" width=""151"" height=""15"" font=""10"">the transmission of FMD.</text>
<footnote top=""796"" left=""605"" width=""19"" height=""9"" font=""17"" number=""1343"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""567"" height=""15"" font=""10""> Dr Batho's response to Panel question No. 7; Dr Bonbon's response to Panel question No. 7. </ftext>
</footnote>
<text top=""797"" left=""624"" width=""135"" height=""15"" font=""10""> In Dr Bonbon's view, </text>
<text top=""812"" left=""455"" width=""322"" height=""15"" font=""10"">deboning and maturation, if properly performed, are </text>
<text top=""826"" left=""455"" width=""289"" height=""15"" font=""10"">sufficient, in and of themselves, to ""completely </text>
<text top=""841"" left=""455"" width=""317"" height=""15"" font=""10"">eliminate [the] virus from [the] meat of an infected </text>
<text top=""855"" left=""455"" width=""50"" height=""15"" font=""10"">animal"".</text>
<footnote top=""855"" left=""505"" width=""19"" height=""9"" font=""17"" number=""1344"" ref="""" dis=""""/>
</p><p><text top=""1007"" left=""170"" width=""256"" height=""15"" font=""10""> OIE's response to Panel question No. 26. </text>
<text top=""1022"" left=""170"" width=""611"" height=""15"" font=""10""> Argentina's response to Panel question No. 9 following the first substantive meeting; United States' </text>
<text top=""1036"" left=""108"" width=""444"" height=""15"" font=""10"">response to Panel question No. 8 following the first substantive meeting. </text>
</p><p number=""p."" style=""2""><text top=""1095"" left=""108"" width=""40"" height=""15"" font=""10"">p. 19. </text>
<p><text top=""1124"" left=""170"" width=""298"" height=""15"" font=""10""> Dr Bonbon's response to Panel question No. 41. </text>
</p></p></page>
<page number=""172"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 172 - </text>
</p><p><text top=""130"" left=""108"" width=""192"" height=""15"" font=""29"">Protocols under 9 CFR 94.22</text></p><p><text top=""129"" left=""300"" width=""19"" height=""9"" font=""22"">1331</text>
</p><p><text top=""130"" left=""455"" width=""203"" height=""15"" font=""29"">Effectiveness in reducing risk </text></p><p><text top=""150"" left=""108"" width=""300"" height=""15"" font=""10"">The beef has not been in contact with meat from </text>
<text top=""164"" left=""108"" width=""317"" height=""15"" font=""10"">regions other than those listed in 9 CFR 94.1(a)(2). </text>
<text top=""150"" left=""455"" width=""309"" height=""15"" font=""10"">This requirement reduces the likelihood that, after </text>
<text top=""164"" left=""455"" width=""289"" height=""15"" font=""10"">slaughter, fresh beef destined for export to the </text>
<text top=""179"" left=""455"" width=""305"" height=""15"" font=""10"">United States is commingled with beef from other </text>
<text top=""193"" left=""455"" width=""299"" height=""15"" font=""10"">regions that are FMD-infected, thus reducing the </text>
<text top=""208"" left=""455"" width=""204"" height=""15"" font=""10"">likelihood of cross-contamination.</text>
<footnote top=""207"" left=""658"" width=""19"" height=""9"" font=""17"" number=""1345"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""569"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 61; Dr Batho's response to Panel question No. 61; </ftext>
</footnote>
<text top=""227"" left=""108"" width=""321"" height=""15"" font=""10"">An authorized veterinary official of the authorities of </text>
<text top=""242"" left=""108"" width=""307"" height=""15"" font=""10"">the region certifies on the foreign meat inspection </text>
<text top=""257"" left=""108"" width=""321"" height=""15"" font=""10"">certificate that the above conditions have been met. </text>
<text top=""227"" left=""455"" width=""257"" height=""15"" font=""10"">For Dr Cupit, this requirement is aimed at </text>
<text top=""242"" left=""455"" width=""312"" height=""15"" font=""10"">strengthening the oversight of control processes in </text>
<text top=""257"" left=""455"" width=""181"" height=""15"" font=""10"">order ""to ensure compliance"".</text>
<footnote top=""256"" left=""635"" width=""19"" height=""9"" font=""17"" number=""1346"" ref="""" dis=""""/>
<text top=""257"" left=""654"" width=""84"" height=""15"" font=""10""> According to </text>
<text top=""271"" left=""455"" width=""327"" height=""15"" font=""10"">Dr Batho, the requirement is ""normal practice"" and is </text>
<text top=""286"" left=""455"" width=""294"" height=""15"" font=""10"">supported by the OIE, in that it ""gives trust and </text>
<text top=""300"" left=""455"" width=""226"" height=""15"" font=""10"">confidence to the importing country"".</text>
<footnote top=""300"" left=""681"" width=""19"" height=""9"" font=""17"" number=""1347"" ref="""" dis=""""/>
<text top=""300"" left=""700"" width=""21"" height=""15"" font=""10""> In </text>
<text top=""315"" left=""455"" width=""287"" height=""15"" font=""10"">Dr Bonbon's view, the requirement is aimed at </text>
<text top=""330"" left=""455"" width=""303"" height=""15"" font=""10"">""guaranteeing the correctness of certification and </text>
<text top=""344"" left=""455"" width=""287"" height=""15"" font=""10"">reducing the risk of non-implementation of the </text>
<text top=""359"" left=""455"" width=""68"" height=""15"" font=""10"">measures"".</text>
<footnote top=""358"" left=""523"" width=""19"" height=""9"" font=""17"" number=""1348"" ref="""" dis=""""/>
<text top=""378"" left=""108"" width=""267"" height=""15"" font=""10"">The establishment in which the bovines are </text>
<text top=""393"" left=""108"" width=""307"" height=""15"" font=""10"">slaughtered allows periodic on-site evaluation and </text>
<text top=""408"" left=""108"" width=""310"" height=""15"" font=""10"">subsequent inspection of its facilities, records, and </text>
<text top=""422"" left=""108"" width=""243"" height=""15"" font=""10"">operations by an APHIS representative.<i> </i></text>
<text top=""378"" left=""455"" width=""317"" height=""15"" font=""10"">The possibility for the importing Member to conduct </text>
<text top=""393"" left=""455"" width=""334"" height=""15"" font=""10"">periodical audits ensures that the mitigating measures </text>
<text top=""408"" left=""455"" width=""262"" height=""15"" font=""10"">in force in the region of origin are properly </text>
<text top=""422"" left=""455"" width=""83"" height=""15"" font=""10"">implemented.</text>
<footnote top=""422"" left=""538"" width=""19"" height=""9"" font=""17"" number=""1349"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""569"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 61; Dr Batho's response to Panel question No. 61; </ftext>
</footnote>
</p><p number=""7.508"" style=""8""><text top=""458"" left=""108"" width=""686"" height=""16"" font=""0"">7.508.  The protocols set forth in 9 CFR 94.22 provide several layers of mitigating measures </text>
<text top=""474"" left=""108"" width=""683"" height=""16"" font=""0"">covering virtually all the stages of the production of fresh (chilled or frozen) beef, from the birth </text>
<text top=""490"" left=""108"" width=""683"" height=""16"" font=""0"">and raising of cattle to the processing (deboning and maturation) of the final product. If properly </text>
<text top=""507"" left=""108"" width=""684"" height=""16"" font=""0"">implemented by the authorities of the exporting Member, such measures operate in concert to </text>
<text top=""523"" left=""108"" width=""682"" height=""16"" font=""0"">effectively minimize the risk of FMD-introduction from imports of fresh (chilled or frozen) beef into </text>
<text top=""540"" left=""108"" width=""241"" height=""16"" font=""0"">the territory of the United States.</text>
<footnote top=""538"" left=""349"" width=""23"" height=""11"" font=""16"" number=""1350"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""589"" height=""15"" font=""10""> In this respect, we note that the protocols in 9 CFR 94.22 do not include requirements as to the </ftext>
<ftext top=""1066"" left=""108"" width=""668"" height=""15"" font=""10"">vaccination of FMD-susceptible animals. This is because, the United States explained, vaccination alone is not </ftext>
<ftext top=""1080"" left=""108"" width=""633"" height=""15"" font=""10"">sufficient to reduce the risk of FMD-introduction from imports of fresh (chilled or frozen) beef. (See e.g. </ftext>
<ftext top=""1095"" left=""108"" width=""665"" height=""15"" font=""10"">United States' first written submission, para. 299; United States' response to Panel question No. 19 following </ftext>
<ftext top=""1109"" left=""108"" width=""188"" height=""15"" font=""10"">the first substantive meeting)  </ftext>
</footnote>
<text top=""540"" left=""372"" width=""421"" height=""16"" font=""0""> Indeed, according to the experts, some of the protocols </text>
<text top=""556"" left=""108"" width=""684"" height=""16"" font=""0"">under 9 CFR 94.22, most notably those relating to the deboning and maturation of carcasses in </text>
<text top=""572"" left=""108"" width=""682"" height=""16"" font=""0"">slaughterhouses, are highly effective in reducing the risk of FMD-introduction from imports of fresh </text>
<text top=""589"" left=""108"" width=""551"" height=""16"" font=""0"">(chilled or frozen) beef even if considered in isolation from the other measures.  </text>
</p><p number=""7.509"" style=""8""><text top=""623"" left=""108"" width=""683"" height=""16"" font=""0"">7.509.  In paragraph 7.498 above, we found, based on the evidence on the record, that Northern </text>
<text top=""640"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina has the necessary veterinary capacity and infrastructure to prevent and control FMD in </text>
<text top=""656"" left=""108"" width=""683"" height=""16"" font=""0"">its own territory and the capacity to prevent incursions of the disease from neighbouring regions. </text>
<text top=""672"" left=""108"" width=""684"" height=""16"" font=""0"">Such capacity stems from a panoply of interlocking and overlapping sanitary measures, some of </text>
<text top=""689"" left=""108"" width=""683"" height=""16"" font=""0"">which mirror the protocols set forth in 9 CFR 94.22 (e.g. insulation of cattle from FMD-susceptible </text>
<text top=""705"" left=""108"" width=""682"" height=""16"" font=""0"">animals at a higher risk, ante- and post-mortem inspections, deboning and maturation). Given the </text>
<text top=""722"" left=""108"" width=""682"" height=""16"" font=""0"">credibility of Northern Argentina's sanitary structures, we see no evidence on the record indicating </text>
<text top=""738"" left=""108"" width=""620"" height=""16"" font=""0"">that SENASA would be unable to adopt and properly implement the protocols in question.  </text>
</p><p number=""7.510"" style=""8""><text top=""772"" left=""108"" width=""684"" height=""16"" font=""0"">7.510.  Based on the foregoing, we conclude, as a matter of fact, that applying the protocols in </text>
<text top=""789"" left=""108"" width=""683"" height=""16"" font=""0"">9 CFR 94.22, to imports of fresh (chilled or frozen) beef from Northern Argentina, would achieve </text>
<text top=""805"" left=""108"" width=""612"" height=""16"" font=""0"">the United States' ALOP for FMD, which we described as being between low and zero risk.</text>
<footnote top=""804"" left=""719"" width=""23"" height=""11"" font=""16"" number=""1351"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.387 above. </ftext>
<ftext top=""978"" left=""108"" width=""644"" height=""15"" font=""10"">Patagonia North B) acknowledged that the laws and regulations governing SENASA and its structure have </ftext>
<ftext top=""993"" left=""108"" width=""659"" height=""15"" font=""10"">remained unchanged since the 2005 risk assessment. (2014 Risk Analysis for Patagonia, (Exhibit USA-133), </ftext>
<ftext top=""1007"" left=""108"" width=""647"" height=""15"" font=""10"">pp. 10-17) Further, APHIS noted that the laws and regulations governing the licensure, qualifications, and </ftext>
<ftext top=""1022"" left=""108"" width=""663"" height=""15"" font=""10"">training of veterinarians are unchanged from the 2005 risk assessment. (See Ibid. pp. 19-20) Argentina also </ftext>
<ftext top=""1036"" left=""108"" width=""676"" height=""15"" font=""10"">submitted information to APHIS dating between 2002 and 2009, which indicated that identification of premises </ftext>
<ftext top=""1080"" left=""108"" width=""658"" height=""15"" font=""10"">2003 and 2007, which indicated that movement controls in Argentina remained essentially unchanged since </ftext>
<ftext top=""1095"" left=""108"" width=""673"" height=""15"" font=""10"">the 2005 risk assessment. (See Ibid. pp. 43-44) Finally, APHIS' 2014 risk analysis for Patagonia indicates that </ftext>
</footnote>
<footnote top=""963"" left=""108"" width=""293"" height=""15"" font=""10"" number=""61"" ref="""" dis=""""/>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 173 - </text>
</p></p></page>
<page number=""173"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.6"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""28"">7.6.7.4.1.15  Conclusions on whether the United States' prohibitions on imports of fresh </text><text top=""144"" left=""108"" width=""684"" height=""16"" font=""28"">(chilled or frozen) beef from Northern Argentina are more restrictive than required to </text><text top=""160"" left=""108"" width=""229"" height=""16"" font=""28"">meet the United States' ALOP </text></p><p number=""7.511"" style=""8""><text top=""195"" left=""108"" width=""687"" height=""16"" font=""0"">7.511.  The United States does not dispute that the protocols set forth in 9 CFR 94.22 are </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">reasonably available to the United States taking into account technical and economic feasibility. </text>
<text top=""228"" left=""108"" width=""689"" height=""16"" font=""0"">There is also no dispute that they would be significantly less trade-restrictive than the </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">United States' prohibitions in place at the time of the establishment of the Panel. Furthermore, we </text>
<text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">have concluded that the application of the protocols set forth in 9 CFR 94.22 to imports of fresh </text>
<text top=""277"" left=""108"" width=""682"" height=""16"" font=""0"">(chilled or frozen) beef from Northern Argentina would achieve the United States' ALOP. Therefore, </text>
<text top=""293"" left=""108"" width=""686"" height=""16"" font=""0"">the United States' prohibitions challenged by Argentina are more restrictive than required to </text>
<text top=""310"" left=""108"" width=""672"" height=""16"" font=""0"">achieve the United States' ALOP, and thus are inconsistent with Article 5.6 of the SPS Agreement. </text>
</p><p number=""7.6"" style=""8""><text top=""344"" left=""108"" width=""687"" height=""16"" font=""28"">7.6.7.4.2  The proposed alternatives to the United States' prohibition on imports of </text><text top=""360"" left=""108"" width=""474"" height=""16"" font=""28"">FMD-susceptible animals and animal products from Patagonia </text></p><p number=""7.512"" style=""8""><text top=""395"" left=""108"" width=""688"" height=""16"" font=""0"">7.512.  Similar to our approach in paragraph 7.454 above, we find it useful to begin our </text>
<text top=""411"" left=""108"" width=""684"" height=""16"" font=""0"">assessment of whether the mitigating effects of the proposed measures would permit imports of </text>
<text top=""428"" left=""108"" width=""683"" height=""16"" font=""0"">FMD-susceptible animals and animal products from Patagonia to achieve the United States' ALOP </text>
<text top=""444"" left=""108"" width=""684"" height=""16"" font=""0"">by reviewing the evidence on the record in light of the 11 factors APHIS used to evaluate the </text>
<text top=""461"" left=""108"" width=""579"" height=""16"" font=""0"">FMD-status of an applicant country or region at the time Argentina filed its request.  </text>
</p><p number=""7.6"" style=""8""><text top=""495"" left=""108"" width=""686"" height=""16"" font=""28"">7.6.7.4.2.1  The authority, organization and infrastructure of the veterinary services </text><text top=""511"" left=""108"" width=""201"" height=""16"" font=""28"">organization in the region </text></p><p number=""7.513"" style=""8""><text top=""546"" left=""108"" width=""686"" height=""16"" font=""0"">7.513.  As discussed in paragraphs 7.455-7.460 above, in its 2005 risk analysis for Patagonia </text>
<text top=""562"" left=""108"" width=""692"" height=""16"" font=""0"">South APHIS reviewed numerous aspects relating to SENASA's authority, organization, </text>
<text top=""579"" left=""108"" width=""683"" height=""16"" font=""0"">infrastructure and capacity to prevent and control FMD in the whole Argentine territory, including </text>
<text top=""595"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia. Its review focused, in particular, on the legal and administrative sources of SENASA's </text>
<text top=""611"" left=""108"" width=""688"" height=""16"" font=""0"">authority, SENASA's financial and human resources, the role of regional offices and local </text>
<text top=""628"" left=""108"" width=""685"" height=""16"" font=""0"">veterinarians in the identification of premises and the tracking of FMD-susceptible animals, the </text>
<text top=""644"" left=""108"" width=""685"" height=""16"" font=""0"">controls on the movement of FMD-susceptible animals throughout the Argentine territory, and </text>
<text top=""661"" left=""108"" width=""328"" height=""16"" font=""0"">SENASA's regulations concerning swill feeding.  </text>
</p><p number=""7.514"" style=""8""><text top=""695"" left=""108"" width=""683"" height=""16"" font=""0"">7.514.  Based on its analysis of such factors, APHIS concluded that ""Argentina has the veterinary </text>
<text top=""711"" left=""108"" width=""685"" height=""16"" font=""0"">and regulatory infrastructure to adequately monitor and control any incursion of FMD into the </text>
<text top=""728"" left=""108"" width=""63"" height=""16"" font=""0"">country"".</text>
<footnote top=""726"" left=""170"" width=""23"" height=""11"" font=""16"" number=""1352"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 23. </ftext>
</footnote>
<text top=""728"" left=""194"" width=""603"" height=""16"" font=""0""> Specifically, APHIS considered that ""[t]here is sufficient monitoring of animal </text>
<text top=""744"" left=""108"" width=""682"" height=""16"" font=""0"">premises and movements to permit effective surveillance and detection programs that would result </text>
<text top=""761"" left=""108"" width=""412"" height=""16"" font=""0"">in sufficient administration of eradication efforts, if needed"".</text>
<footnote top=""759"" left=""519"" width=""23"" height=""11"" font=""16"" number=""1353"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 23. </ftext>
</footnote>
<text top=""761"" left=""542"" width=""248"" height=""16"" font=""0""> APHIS also ""expressed confidence"" </text>
<text top=""777"" left=""108"" width=""687"" height=""16"" font=""0"">that SENASA's delays in reporting the 2000-2001 FMD outbreaks would not occur again if </text>
<text top=""793"" left=""108"" width=""264"" height=""16"" font=""0"">analogous events were to occur today.</text>
<footnote top=""792"" left=""371"" width=""23"" height=""11"" font=""16"" number=""1354"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 23. </ftext>
</footnote>
</p><p number=""7.515"" style=""8""><text top=""828"" left=""108"" width=""685"" height=""16"" font=""0"">7.515.  The facts underlying laws and regulations governing SENASA's authority, organization, </text>
<text top=""844"" left=""108"" width=""683"" height=""16"" font=""0"">infrastructure, and capacity to prevent and control FMD in the Argentine territory did not change </text>
<text top=""861"" left=""108"" width=""315"" height=""16"" font=""0"">from 2005 until the Panel's establishment.</text>
<footnote top=""859"" left=""423"" width=""23"" height=""11"" font=""16"" number=""1355"" ref="""" dis=""""/>
<text top=""861"" left=""446"" width=""349"" height=""16"" font=""0""> Dr Batho noted, that SENASA's infrastructure </text>
<p><text top=""963"" left=""170"" width=""567"" height=""15"" font=""10""> APHIS' 2014 risk analysis for Patagonia as a whole (comprising of both Patagonia South and </text>
<footnote top=""1051"" left=""108"" width=""629"" height=""15"" font=""10"" number=""2005"" ref="""" dis=""""/>
</p><p><text top=""1066"" left=""108"" width=""667"" height=""15"" font=""10"">assessment. (See Ibid. p. 41) Moreover, SENASA provided information to APHIS covering the period between </text>
</p><p><text top=""1124"" left=""108"" width=""69"" height=""15"" font=""10"">pp. 21-22) </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 174 - </text>
</p><p><text top=""128"" left=""108"" width=""391"" height=""16"" font=""0"">""improved dramatically"" since 2005 in several respects.</text>
<footnote top=""126"" left=""499"" width=""23"" height=""11"" font=""16"" number=""1356"" ref="""" dis=""""/>
<text top=""128"" left=""522"" width=""270"" height=""16"" font=""0""> For instance, SENASA's 2013 annual </text>
<text top=""144"" left=""108"" width=""516"" height=""16"" font=""0"">budget was 1.3 billion pesos (equivalent to approximately USD 200 million)</text>
<footnote top=""143"" left=""624"" width=""23"" height=""11"" font=""16"" number=""1357"" ref="""" dis=""""><ftext top=""818"" left=""170"" width=""369"" height=""15"" font=""10""> 2014 Risk Analysis for Patagonia, (Exhibit USA-133), p. 17. </ftext>
</footnote>
<text top=""144"" left=""647"" width=""143"" height=""16"" font=""0"">, i.e. over five times </text>
<text top=""160"" left=""108"" width=""473"" height=""16"" font=""0"">more than in 2005. SENASA's personnel doubled<b> </b>from 2005 to 2013.</text>
<footnote top=""159"" left=""581"" width=""27"" height=""11"" font=""16"" number=""1358"" ref="""" dis=""""><ftext top=""832"" left=""170"" width=""369"" height=""15"" font=""10""> 2014 Risk Analysis for Patagonia, (Exhibit USA-133), p. 17. </ftext>
</footnote>
<text top=""160"" left=""608"" width=""182"" height=""16"" font=""0""> Further, in 2006 SENASA </text>
<text top=""177"" left=""108"" width=""691"" height=""16"" font=""0"">instituted a compulsory cattle identification programme, requiring that all calves born </text>
<text top=""193"" left=""108"" width=""277"" height=""16"" font=""0"">after September 2007 carry official tags.</text>
<footnote top=""192"" left=""385"" width=""23"" height=""11"" font=""16"" number=""1359"" ref="""" dis=""""><ftext top=""847"" left=""170"" width=""313"" height=""15"" font=""10""> Resoluci&#243;n SENASA 754/2006, (Exhibit ARG-143). </ftext>
</footnote>
</p></p></page>
<page number=""174"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.516"" style=""8""><text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">7.516.  Other evidence on the record is consistent with APHIS' 2005 conclusions. The European </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">Commission's most recent evaluation of the FMD situation Argentina available on the record (dated </text>
<text top=""260"" left=""108"" width=""528"" height=""16"" font=""0"">2006) concludes that the Argentine veterinary authority ""is well organised"".</text>
<footnote top=""259"" left=""636"" width=""23"" height=""11"" font=""16"" number=""1360"" ref="""" dis=""""><ftext top=""861"" left=""170"" width=""394"" height=""15"" font=""10""> European Commission's 2006 Report, (Exhibit ARG-111), p. 21. </ftext>
</footnote>
<text top=""260"" left=""659"" width=""132"" height=""16"" font=""0""> In its evaluations </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">over the period 2002-2006, the Commission did identify some ""deficiencies"" with respect e.g. to </text>
<text top=""293"" left=""108"" width=""331"" height=""16"" font=""0"">animal identification and movement controls.</text>
<footnote top=""292"" left=""439"" width=""23"" height=""11"" font=""16"" number=""1361"" ref="""" dis=""""><ftext top=""876"" left=""170"" width=""598"" height=""15"" font=""10""> See e.g. European Commission's 2002 Report, (Exhibit ARG-107), p. 27; European Commission's </ftext>
<ftext top=""891"" left=""108"" width=""242"" height=""15"" font=""10"">2006 Report, (Exhibit ARG-111), p. 21. </ftext>
</footnote>
<text top=""293"" left=""462"" width=""333"" height=""16"" font=""0""> Despite such deficiencies, the Commission </text>
<text top=""310"" left=""108"" width=""535"" height=""16"" font=""0"">concluded that SENASA's ability to prevent and control FMD was ""satisfactory""</text>
<footnote top=""308"" left=""643"" width=""23"" height=""11"" font=""16"" number=""1362"" ref="""" dis=""""/>
<text top=""310"" left=""666"" width=""124"" height=""16"" font=""0""> and reopened its </text>
<text top=""326"" left=""108"" width=""685"" height=""16"" font=""0"">market to imports of FMD-susceptible animals and animal products from Patagonia North B in </text>
<text top=""342"" left=""108"" width=""39"" height=""16"" font=""0"">2008.</text>
<footnote top=""341"" left=""147"" width=""23"" height=""11"" font=""16"" number=""1363"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""579"" height=""15"" font=""10""> Decision of the European Commission No. 2008/642/EC (31 July 2008), amending Annex II to </ftext>
<ftext top=""934"" left=""108"" width=""637"" height=""15"" font=""10"">Council Decision 79/542/EEC as regards the entries for Argentina, Brazil and Paraguay in the list of third </ftext>
<ftext top=""949"" left=""108"" width=""641"" height=""15"" font=""10"">countries and parts thereof from which imports into the Community of certain fresh meat are authorized<i>, </i></ftext>
</footnote>
<text top=""342"" left=""170"" width=""622"" height=""16"" font=""0""> In his responses to Panel questions, Dr Cupit confirmed that SENASA imposes ""strict </text>
<text top=""359"" left=""108"" width=""683"" height=""16"" font=""0"">movement controls that operate within Argentina especially between the FMD-free areas with and </text>
<text top=""375"" left=""108"" width=""138"" height=""16"" font=""0"">without vaccination""</text>
<footnote top=""374"" left=""246"" width=""23"" height=""11"" font=""16"" number=""1364"" ref="""" dis=""""/>
<text top=""375"" left=""269"" width=""282"" height=""16"" font=""0"">, i.e. Northern Argentina and Patagonia.  </text>
</p><p number=""7.517"" style=""8""><text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">7.517.  Thus, the evidence on the record indicates that, at the time of the establishment of the </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">Panel, SENASA had the necessary veterinary and regulatory infrastructure to adequately monitor </text>
<text top=""443"" left=""108"" width=""283"" height=""16"" font=""0"">and control FMD in the Patagonia region. </text>
</p><p number=""7.6"" style=""8""><text top=""477"" left=""108"" width=""308"" height=""16"" font=""28"">7.6.7.4.2.2  Disease status of the region </text></p><p number=""7.518"" style=""8""><text top=""511"" left=""108"" width=""58"" height=""16"" font=""0"">7.518. </text>
<text top=""511"" left=""162"" width=""120"" height=""16"" font=""0"">The last FMD </text>
<text top=""511"" left=""273"" width=""372"" height=""16"" font=""0"">outbreak in Patagonia South occurred in 1976.</text>
<footnote top=""510"" left=""645"" width=""23"" height=""11"" font=""16"" number=""1365"" ref="""" dis=""""/>
<text top=""511"" left=""668"" width=""131"" height=""16"" font=""0""> In 2002, the </text>
<text top=""528"" left=""108"" width=""38"" height=""16"" font=""0"">OIE </text>
<text top=""528"" left=""138"" width=""549"" height=""16"" font=""0"">recognized the region as FMD-free where vaccination is not practised.</text>
<footnote top=""526"" left=""687"" width=""23"" height=""11"" font=""16"" number=""1366"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""295"" height=""15"" font=""10""> OIE Resolution XVII of 2002, (Exhibit ARG-89). </ftext>
</footnote>
<text top=""528"" left=""710"" width=""88"" height=""16"" font=""0""> The last </text>
<text top=""544"" left=""108"" width=""400"" height=""16"" font=""0"">FMD outbreak in Patagonia North B took place in 1994.</text>
<footnote top=""543"" left=""508"" width=""23"" height=""11"" font=""16"" number=""1367"" ref="""" dis=""""/>
<text top=""544"" left=""531"" width=""263"" height=""16"" font=""0""> The region was recognized by the </text>
<text top=""561"" left=""108"" width=""409"" height=""16"" font=""0"">OIE as FMD-free where vaccination is not practised in 2007.</text>
<footnote top=""559"" left=""517"" width=""23"" height=""11"" font=""16"" number=""1368"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""290"" height=""15"" font=""10""> OIE Resolution XXI of 2007, (Exhibit ARG-10). </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""595"" left=""108"" width=""683"" height=""16"" font=""28"">7.6.7.4.2.3  The extent of an active disease control program, if any, if FMD is known to </text><text top=""611"" left=""108"" width=""143"" height=""16"" font=""28"">exist in the region </text></p><p number=""7.519"" style=""8""><text top=""646"" left=""108"" width=""685"" height=""16"" font=""0"">7.519.  As FMD is not known to exist in Patagonia, there is currently no active disease control </text>
<text top=""662"" left=""108"" width=""179"" height=""16"" font=""0"">programme in the region.</text>
<footnote top=""661"" left=""287"" width=""23"" height=""11"" font=""16"" number=""1369"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""601"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 27; 2014 Risk Analysis for Patagonia, </ftext>
<ftext top=""1095"" left=""108"" width=""158"" height=""15"" font=""10"">(Exhibit USA-133), p. 26. </ftext>
</footnote>
<text top=""662"" left=""310"" width=""481"" height=""16"" font=""0""> Passive surveillance includes the obligation for any citizen to report </text>
<text top=""679"" left=""108"" width=""685"" height=""16"" font=""0"">an outbreak, compliance with which is incentivized through compensation in case of accurate </text>
<text top=""695"" left=""108"" width=""67"" height=""16"" font=""0"">reporting.</text>
<footnote top=""693"" left=""175"" width=""23"" height=""11"" font=""16"" number=""1370"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""601"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 27; 2014 Risk Analysis for Patagonia, </ftext>
<ftext top=""1124"" left=""108"" width=""158"" height=""15"" font=""10"">(Exhibit USA-133), p. 26. </ftext>
</footnote>
<p><text top=""774"" left=""170"" width=""549"" height=""15"" font=""10""> See Dr Batho's response to Panel question No. 57. Dr Bonbon added that, in light of such </text>
<text top=""788"" left=""108"" width=""638"" height=""15"" font=""10"">improvements, the risk of FMD-transmission from imports of fresh (chilled or frozen) beef from Northern </text>
<text top=""803"" left=""108"" width=""550"" height=""15"" font=""10"">Argentina is ""lower than it was in 1997"". (Dr Bonbon's response to Panel question No. 57) </text>
</p><p><text top=""905"" left=""170"" width=""284"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 31. </text>
</p><p><text top=""963"" left=""108"" width=""651"" height=""15"" font=""10"">(Exhibit ARG-120). We understand that the European Union had already reopened its market to imports of </text>
<text top=""978"" left=""108"" width=""649"" height=""15"" font=""10"">FMD-susceptible animals and animal products from Patagonia South prior to August 2003. See Argentina's </text>
<text top=""993"" left=""108"" width=""452"" height=""15"" font=""10"">response to Panel question No. 25 following the first substantive meeting. </text>
<text top=""1007"" left=""170"" width=""288"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 36.  </text>
<footnote top=""1022"" left=""170"" width=""278"" height=""15"" font=""10"" number=""3"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 175 - </text>
</p></p></page>
<page number=""175"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.520"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.520.  Most of the laws, decrees and regulations setting forth the measures to be put in place in </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">order to eradicate FMD from the Argentine territory, discussed in paragraph 7.467 above, apply to </text>
<text top=""160"" left=""108"" width=""321"" height=""16"" font=""0"">Patagonia as well as to Northern Argentina.</text>
<footnote top=""159"" left=""429"" width=""23"" height=""11"" font=""16"" number=""1371"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""559"" height=""15"" font=""10""> Amongst the regulations that do <i>not</i> apply to Patagonia are those relating to vaccination of </ftext>
</footnote>
<text top=""160"" left=""452"" width=""342"" height=""16"" font=""0""> Since Patagonia as a whole has not had an </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">FMD outbreak in about 20 years and does not vaccinate against the disease, the most relevant </text>
<text top=""193"" left=""108"" width=""687"" height=""16"" font=""0"">regulations applicable to the region are those aimed at implementing sanitary barriers and </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">movement controls to insulate Patagonia from the entry of FMD-susceptible animals and animal </text>
<text top=""226"" left=""108"" width=""690"" height=""16"" font=""0"">products from regions of higher risk. We analyse such regulations more in detail in </text>
<text top=""242"" left=""108"" width=""220"" height=""16"" font=""0"">paragraphs 7.525-7.528 below. </text>
</p><p number=""7.6"" style=""8""><text top=""277"" left=""108"" width=""369"" height=""16"" font=""28"">7.6.7.4.2.4  The vaccination status of the region </text></p><p number=""7.521"" style=""8""><text top=""311"" left=""108"" width=""684"" height=""16"" font=""0"">7.521.  Because FMD is not known to be present in Patagonia, no vaccination is practiced in the </text>
<text top=""328"" left=""108"" width=""48"" height=""16"" font=""0"">region.</text>
<footnote top=""326"" left=""156"" width=""23"" height=""11"" font=""16"" number=""1372"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""601"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 27; 2014 Risk Analysis for Patagonia, </ftext>
<ftext top=""1036"" left=""108"" width=""158"" height=""15"" font=""10"">(Exhibit USA-133), p. 26. </ftext>
</footnote>
<text top=""328"" left=""179"" width=""613"" height=""16"" font=""0""> APHIS considered in 2005 that this being the case, ""any cattle or swine in that region </text>
<text top=""344"" left=""108"" width=""481"" height=""16"" font=""0"">exposed to the FMD virus would act as good sentinels of an outbreak"".</text>
<footnote top=""343"" left=""589"" width=""23"" height=""11"" font=""16"" number=""1373"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 25. </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""378"" left=""108"" width=""483"" height=""16"" font=""28"">7.6.7.4.2.5  The status of adjacent regions with respect to FMD </text></p><p number=""7.522"" style=""8""><text top=""413"" left=""108"" width=""683"" height=""16"" font=""0"">7.522.  Patagonia shares its Northern land border with one region recognized by the OIE as FMD- </text>
<text top=""429"" left=""108"" width=""683"" height=""16"" font=""0"">free where vaccination is practised, namely Northern Argentina. On the West, it borders a region </text>
<text top=""446"" left=""108"" width=""683"" height=""16"" font=""0"">recognized by the OIE as FMD-free where vaccination is not practised, i.e. Chile. On the East, the </text>
<text top=""462"" left=""108"" width=""284"" height=""16"" font=""0"">region is bordered by the Atlantic Ocean. </text>
</p><p number=""7.6"" style=""8""><text top=""497"" left=""108"" width=""682"" height=""16"" font=""28"">7.6.7.4.2.6  The degree to which the region is separated from adjacent regions of higher </text><text top=""513"" left=""108"" width=""333"" height=""16"" font=""28"">FMD risk through physical or other barriers </text></p><p number=""7.523"" style=""8""><text top=""547"" left=""108"" width=""685"" height=""16"" font=""0"">7.523.  Patagonia is separated from Northern Argentina by the Rio Negro, a constantly flowing </text>
<text top=""564"" left=""108"" width=""310"" height=""16"" font=""0"">watercourse that ""make[s] crossing difficult"".</text>
<footnote top=""562"" left=""418"" width=""23"" height=""11"" font=""16"" number=""1374"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 30. </ftext>
</footnote>
<text top=""564"" left=""441"" width=""349"" height=""16"" font=""0""> The climate of the region is mostly dry and windy </text>
<text top=""580"" left=""108"" width=""415"" height=""16"" font=""0"">in the summer and cold, windy, and snowy in the winter.</text>
<footnote top=""579"" left=""523"" width=""23"" height=""11"" font=""16"" number=""1375"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 30. </ftext>
</footnote>
<text top=""580"" left=""546"" width=""246"" height=""16"" font=""0""> In APHIS' view, ""the terrain and </text>
<text top=""597"" left=""108"" width=""687"" height=""16"" font=""0"">desolate nature of the area act as an effective barrier to disease incursion through illegal </text>
<text top=""613"" left=""108"" width=""238"" height=""16"" font=""0"">trafficking of prohibited products"".</text>
<footnote top=""611"" left=""346"" width=""23"" height=""11"" font=""16"" number=""1376"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 30. </ftext>
</footnote>
<text top=""613"" left=""369"" width=""422"" height=""16"" font=""0""> Dr Cupit confirmed that ""climatic factors such as humidity, </text>
<text top=""629"" left=""108"" width=""654"" height=""16"" font=""0"">rainfall, temperature and prevailing winds"" reduce ""the ability and rate of spread of FMD"".</text>
<footnote top=""628"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1377"" ref="""" dis=""""/>
<text top=""646"" left=""108"" width=""683"" height=""16"" font=""0"">Furthermore, the border with Chile runs along the Andes mountains, which constitute an effective </text>
<text top=""662"" left=""108"" width=""417"" height=""16"" font=""0"">natural barrier against the cross-border movement of cattle. </text>
</p><p number=""7.524"" style=""8""><text top=""697"" left=""108"" width=""685"" height=""16"" font=""0"">7.524.  In light of the above, we agree with APHIS that Patagonia is ""adequately protected by </text>
<text top=""713"" left=""108"" width=""685"" height=""16"" font=""0"">effective natural barriers to reduce the unrestricted flow of animals and animal products from </text>
<text top=""729"" left=""108"" width=""143"" height=""16"" font=""0"">areas of higher risk"".</text>
<footnote top=""728"" left=""251"" width=""23"" height=""11"" font=""16"" number=""1378"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 30. </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""764"" left=""108"" width=""682"" height=""16"" font=""28"">7.6.7.4.2.7  The extent to which movement of animals and animal products is controlled </text><text top=""780"" left=""108"" width=""635"" height=""16"" font=""28"">from regions of higher risk, and the level of biosecurity regarding such movements </text></p><p number=""7.525"" style=""8""><text top=""815"" left=""108"" width=""685"" height=""16"" font=""0"">7.525.  As discussed in paragraphs 7.481-7.485 above, in 2005 APHIS reviewed the movement </text>
<text top=""831"" left=""108"" width=""682"" height=""16"" font=""0"">controls and sanitary barriers in place in Argentina as a whole vis-&#224;-vis incursions of FMD from the </text>
<text top=""847"" left=""108"" width=""683"" height=""16"" font=""0"">entry of susceptible animals and animal products from other countries. APHIS' findings concerned, </text>
<text top=""864"" left=""108"" width=""684"" height=""16"" font=""18""><i>inter alia</i>: the management of international authorized border stations, which include terrestrial, </text>
<text top=""880"" left=""108"" width=""684"" height=""16"" font=""0"">maritime and fluvial ports, and airports; the conditions under which the relevant products may </text>
<text top=""897"" left=""108"" width=""682"" height=""16"" font=""0"">lawfully be imported into Argentina; inspections and controls carried out on the relevant products; </text>
<text top=""913"" left=""108"" width=""682"" height=""16"" font=""0"">and the special measures in force in the area bordering Bolivia, Paraguay, and Brazil. Based on the </text>
<text top=""929"" left=""108"" width=""685"" height=""16"" font=""0"">evidence on the record, we found that the movement controls and other measures applied by </text>
<p><text top=""1007"" left=""108"" width=""442"" height=""15"" font=""10"">FMD-susceptible species and vaccine quality control. See Table 5 above. </text>
</p><p><text top=""1109"" left=""170"" width=""284"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 50. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 176 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">SENASA to prevent the incursion of FMD into Argentina effectively protect the region from ingress </text>
<text top=""144"" left=""108"" width=""445"" height=""16"" font=""0"">of animals and animal products from regions of higher FMD-risk. </text>
</p></p></page>
<page number=""176"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.526"" style=""8""><text top=""178"" left=""108"" width=""686"" height=""16"" font=""0"">7.526.  We now turn to a more specific examination of the movement controls and sanitary </text>
<text top=""195"" left=""108"" width=""686"" height=""16"" font=""0"">barriers aimed at preventing the entry of FMD-susceptible animals and animal products into </text>
<text top=""211"" left=""108"" width=""687"" height=""16"" font=""0"">Patagonia. As a result of the multiple FMD outbreaks in Northern Argentina which occurred </text>
<text top=""228"" left=""108"" width=""683"" height=""16"" font=""0"">throughout 2000 and 2001, SENASA adopted a number of resolutions creating a sanitary barrier </text>
<text top=""244"" left=""108"" width=""654"" height=""16"" font=""0"">aimed at insulating Patagonia South from entry of FMD from the rest of the national territory.</text>
<footnote top=""243"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1379"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""571"" height=""15"" font=""10""> See e.g. Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37); Resoluci&#243;n SENASA 25/2001, </ftext>
<ftext top=""1007"" left=""108"" width=""666"" height=""15"" font=""10"">(Exhibit ARG-92); Resoluci&#243;n SENASA 58/2001, (Exhibit USA-59). See also 2014 Risk Analysis for Patagonia, </ftext>
<ftext top=""1022"" left=""108"" width=""158"" height=""15"" font=""10"">(Exhibit USA-133), p. 29. </ftext>
</footnote>
<text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">In 2002, SENASA established a prohibition on the entry into Patagonia of FMD-susceptible animals </text>
<text top=""277"" left=""108"" width=""634"" height=""16"" font=""0"">except from regions recognized by the OIE as FMD-free where vaccination is not practised.</text>
<footnote top=""275"" left=""742"" width=""23"" height=""11"" font=""16"" number=""1380"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""312"" height=""15"" font=""10""> Resoluci&#243;n SENASA 1051/2002, (Exhibit USA-60). </ftext>
</footnote>
<text top=""277"" left=""765"" width=""26"" height=""16"" font=""0""> In </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">2005, SENASA recognized Patagonia South and Patagonia North B as having the same FMD status, </text>
<text top=""310"" left=""108"" width=""690"" height=""16"" font=""0"">and imposed a number of traceability requirements and controls on the movement of </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">FMD-susceptible animals between the two areas. Specifically, in order to obtain authorization for </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">movement from Patagonia North B to Patagonia South, FMD-susceptible animals: (i) had to remain </text>
<text top=""359"" left=""108"" width=""683"" height=""16"" font=""0"">in the premises of origin for at least 90 days prior to movement application; (ii) had to undergo </text>
<text top=""375"" left=""108"" width=""682"" height=""16"" font=""0"">two FMD serological tests (for cattle and sheep, also two Probang tests), during which they had to </text>
<text top=""392"" left=""108"" width=""685"" height=""16"" font=""0"">be kept in quarantine; (iii) could be moved to destination on condition of obtaining an official </text>
<text top=""408"" left=""108"" width=""684"" height=""16"" font=""0"">dispatch; and (iv) had to be transported in sealed trucks which could not move through zones </text>
<text top=""425"" left=""108"" width=""244"" height=""16"" font=""0"">where FMD vaccination is practiced.</text>
<footnote top=""423"" left=""352"" width=""23"" height=""11"" font=""16"" number=""1381"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""304"" height=""15"" font=""10""> Resoluci&#243;n SENASA 725/2005, (Exhibit USA-61). </ftext>
</footnote>
</p><p number=""7.527"" style=""8""><text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">7.527.  The United States argues that a ""key"" factor casting doubts as to SENASA's capacity to </text>
<text top=""475"" left=""108"" width=""685"" height=""16"" font=""0"">prevent the ingress of FMD-susceptible animals into the region from Northern Argentina is the </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">changes in the regulatory barriers between Patagonia South and Patagonia North B that occurred </text>
<text top=""508"" left=""108"" width=""621"" height=""16"" font=""0"">in 2008 through the adoption of SENASA Regulations Nos. 148/2008 and 1282/2008.</text>
<footnote top=""507"" left=""729"" width=""23"" height=""11"" font=""16"" number=""1382"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""464"" height=""15"" font=""10""> United States' first written submission, para. 318. See also Ibid. para. 298. </ftext>
</footnote>
<text top=""508"" left=""752"" width=""41"" height=""16"" font=""0""> The </text>
<text top=""525"" left=""108"" width=""685"" height=""16"" font=""0"">resolutions in question were adopted in order to meet the import protocols established by the </text>
<text top=""541"" left=""108"" width=""683"" height=""16"" font=""0"">European Union as part of its recognition of Patagonia North B as FMD-free where vaccination is </text>
<text top=""557"" left=""108"" width=""687"" height=""16"" font=""0"">not practised. Resolution 148/2008 imposed additional tracking requirements and movement </text>
<text top=""574"" left=""108"" width=""686"" height=""16"" font=""0"">controls between Patagonia North B and Patagonia South for animals destined to immediate </text>
<text top=""590"" left=""108"" width=""677"" height=""16"" font=""0"">slaughter, including the following: (i) that FMD-susceptible animals be transported in SENASA-</text>
<text top=""607"" left=""108"" width=""683"" height=""16"" font=""0"">authorized trucks with a valid disinfection certificate; (ii) that the owner of the premises of origin </text>
<text top=""623"" left=""108"" width=""684"" height=""16"" font=""0"">submit to SENASA the itinerary that the truck would follow; (iii) that trucks be sealed and not </text>
<text top=""639"" left=""108"" width=""684"" height=""16"" font=""0"">move through zones where FMD vaccination is practiced; (iv) that if the animals are destined to </text>
<text top=""656"" left=""108"" width=""687"" height=""16"" font=""0"">slaughter, the shipment be authorized only to slaughterhouses inspected and authorized by </text>
<text top=""672"" left=""108"" width=""685"" height=""16"" font=""0"">SENASA; (v) that the owner of the premises of destination communicate the reception of the </text>
<text top=""689"" left=""108"" width=""682"" height=""16"" font=""0"">animals to SENASA within 48 hours of arrival; and (vi) that upon arrival at destination, the animals </text>
<text top=""705"" left=""108"" width=""682"" height=""16"" font=""0"">remain separated from all other animals of FMD susceptible species for 21 days, during which they </text>
<text top=""721"" left=""108"" width=""654"" height=""16"" font=""0"">may be sent to slaughter only if authorized by the local SENASA veterinarian.</text>
<footnote top=""720"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1383"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""304"" height=""15"" font=""10""> Resoluci&#243;n SENASA 148/2008, (Exhibit USA-62). </ftext>
</footnote>
<text top=""738"" left=""108"" width=""684"" height=""16"" font=""0"">Resolution 1282/2008 extended such requirements to all movement of FMD-susceptible animals </text>
<text top=""754"" left=""108"" width=""559"" height=""16"" font=""0"">from Patagonia North B to Patagonia South for whatever destination and purpose.</text>
<footnote top=""753"" left=""667"" width=""23"" height=""11"" font=""16"" number=""1384"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""320"" height=""15"" font=""10""> Resoluci&#243;n SENASA 1282/2008, (Exhibit USA-109). </ftext>
</footnote>
</p><p number=""7.528"" style=""8""><text top=""789"" left=""108"" width=""61"" height=""16"" font=""0"">7.528. </text>
<text top=""789"" left=""162"" width=""153"" height=""16"" font=""0"">Neither Resolution </text>
<text top=""789"" left=""303"" width=""209"" height=""16"" font=""0"">148/2008 nor Resolution </text>
<text top=""789"" left=""500"" width=""302"" height=""16"" font=""0"">1282/2008 modified the pre-existing </text>
<text top=""805"" left=""108"" width=""682"" height=""16"" font=""0"">prohibitions on movement of FMD-susceptible animals between Patagonia as a whole and Northern </text>
<text top=""821"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina. Moreover, the Resolutions imposed a set of transportation, reporting, and traceability </text>
<text top=""838"" left=""108"" width=""688"" height=""16"" font=""0"">requirements that strengthened, rather than weakened, SENASA's pre-existing controls on </text>
<text top=""854"" left=""108"" width=""686"" height=""16"" font=""0"">movement of cattle throughout the Patagonia region. Our understanding finds support in the </text>
<text top=""871"" left=""108"" width=""688"" height=""16"" font=""0"">experts' responses to Panel questions. According to Dr Cupit, the movement controls and </text>
<text top=""887"" left=""108"" width=""686"" height=""16"" font=""0"">traceability requirements in Resolution 1282/2008  ""should improve SENASA's FMD surveillance </text>
<text top=""904"" left=""108"" width=""684"" height=""16"" font=""0"">and control measures"" in comparison to the situation that existed in 2000, when Argentina was </text>
<text top=""920"" left=""108"" width=""429"" height=""16"" font=""0"">allowed to export the relevant products to the United States.</text>
<footnote top=""918"" left=""537"" width=""23"" height=""11"" font=""16"" number=""1385"" ref="""" dis=""""/>
<text top=""920"" left=""560"" width=""232"" height=""16"" font=""0""> In his opinion, there are ""strict </text>
<text top=""936"" left=""108"" width=""649"" height=""16"" font=""0"">movement controls"" especially ""between the FMD-free areas with and without vaccination""</text>
<footnote top=""935"" left=""757"" width=""23"" height=""11"" font=""16"" number=""1386"" ref="""" dis=""""/>
<text top=""936"" left=""780"" width=""10"" height=""16"" font=""0"">, </text>
<text top=""953"" left=""108"" width=""684"" height=""16"" font=""0"">i.e. Northern Argentina and Patagonia. Similarly, in Dr Bonbon's view, Resolutions 148/2008 and </text>
<footnote top=""1109"" left=""170"" width=""284"" height=""15"" font=""10"" number=""32"" ref="""" dis=""""/>
<p><text top=""1124"" left=""170"" width=""288"" height=""15"" font=""10""> Dr Cupit's response to Panel question No. 36.  </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 177 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">1282/2008 ""are examples of the improved legal capacity of SENASA"" as compared to the situation </text>
<text top=""144"" left=""108"" width=""58"" height=""16"" font=""0"">in 2000.</text>
<footnote top=""143"" left=""166"" width=""23"" height=""11"" font=""16"" number=""1387"" ref="""" dis=""""/>
<text top=""144"" left=""189"" width=""603"" height=""16"" font=""0""> More generally, Dr Batho stated that surveillance and movement controls ""are much </text>
<text top=""160"" left=""108"" width=""274"" height=""16"" font=""0"">improved now"" compared to 2000.</text>
<footnote top=""159"" left=""382"" width=""23"" height=""11"" font=""16"" number=""1388"" ref="""" dis=""""/>
<text top=""160"" left=""405"" width=""394"" height=""16"" font=""0""> He added that, in his view, the adoption of </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">Resolution 1282/2008 did not ""create uncertainty over the status of the different regions"" because </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">it did not alter the regulatory barriers between Northern Argentina, where vaccination is practiced, </text>
<text top=""210"" left=""108"" width=""342"" height=""16"" font=""0"">and Patagonia, where vaccination is not practiced.</text>
<footnote top=""208"" left=""450"" width=""23"" height=""11"" font=""16"" number=""1389"" ref="""" dis=""""/>
</p></p></page>
<page number=""177"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.529"" style=""8""><text top=""244"" left=""108"" width=""685"" height=""16"" font=""0"">7.529.   The evidence on the record indicates that SENASA has adequate sanitary barriers and </text>
<text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">movement controls in place to prevent the ingress of FMD-susceptible animals and animal products </text>
<text top=""277"" left=""108"" width=""534"" height=""16"" font=""0"">into Patagonia from regions of higher FMD-risk, including Northern Argentina. </text>
</p><p number=""7.6"" style=""8""><text top=""311"" left=""108"" width=""569"" height=""16"" font=""28"">7.6.7.4.2.8  Livestock demographics and marketing practices in the region </text></p><p number=""7.530"" style=""8""><text top=""346"" left=""108"" width=""686"" height=""16"" font=""0"">7.530.  Due to its cold and arid climate, the Patagonia region has low cattle density. Bovine </text>
<text top=""362"" left=""108"" width=""589"" height=""16"" font=""0"">production is secondary, and beef produced in the region is mostly consumed locally.</text>
<footnote top=""361"" left=""696"" width=""23"" height=""11"" font=""16"" number=""1390"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""601"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 44; 2014 Risk Analysis for Patagonia, </ftext>
<ftext top=""934"" left=""108"" width=""162"" height=""15"" font=""10"">(Exhibit USA-133), p. 40.  </ftext>
</footnote>
<text top=""362"" left=""719"" width=""71"" height=""16"" font=""0""> As noted </text>
<text top=""378"" left=""108"" width=""683"" height=""16"" font=""0"">in paragraph 7.491 above, Patagonia imports deboned and matured fresh (chilled or frozen) beef </text>
<text top=""395"" left=""108"" width=""332"" height=""16"" font=""0"">from Northern to meet its consumption demand.</text>
<footnote top=""393"" left=""440"" width=""23"" height=""11"" font=""16"" number=""1391"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""601"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 44; 2014 Risk Analysis for Patagonia, </ftext>
<ftext top=""963"" left=""108"" width=""158"" height=""15"" font=""10"">(Exhibit USA-133), p. 40. </ftext>
</footnote>
<text top=""395"" left=""463"" width=""327"" height=""16"" font=""0""> Conversely, Patagonia contains almost 60% of </text>
<text top=""411"" left=""108"" width=""685"" height=""16"" font=""0"">the entire sheep population of Argentina, with an average population density of 14 sheep per </text>
<text top=""428"" left=""108"" width=""122"" height=""16"" font=""0"">square kilometre.</text>
<footnote top=""426"" left=""230"" width=""23"" height=""11"" font=""16"" number=""1392"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""601"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 44; 2014 Risk Analysis for Patagonia, </ftext>
<ftext top=""993"" left=""108"" width=""158"" height=""15"" font=""10"">(Exhibit USA-133), p. 40. </ftext>
</footnote>
<text top=""428"" left=""253"" width=""539"" height=""16"" font=""0""> In 2005 Argentina was exporting 10,000 tons/year of sheep meat to the </text>
<text top=""444"" left=""108"" width=""483"" height=""16"" font=""0"">European Union, of which 90% came from the Patagonia South region.</text>
<footnote top=""443"" left=""591"" width=""23"" height=""11"" font=""16"" number=""1393"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""601"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 44; 2014 Risk Analysis for Patagonia, </ftext>
<ftext top=""1022"" left=""108"" width=""158"" height=""15"" font=""10"">(Exhibit USA-133), p. 40. </ftext>
</footnote>
</p><p number=""7.531"" style=""8""><text top=""479"" left=""108"" width=""684"" height=""16"" font=""0"">7.531.  Movements of livestock within the Patagonia region are limited and there are no fairs or </text>
<text top=""495"" left=""108"" width=""682"" height=""16"" font=""0"">livestock concentration markets. Annual auctions for breeding rams occur once a year, each selling </text>
<text top=""511"" left=""108"" width=""686"" height=""16"" font=""0"">about 400 animals. Also, large farms carry out their annual breeder auctions on their own </text>
<text top=""528"" left=""108"" width=""689"" height=""16"" font=""0"">premises so breeding livestock transport is limited mainly from farm to farm. Trade in </text>
<text top=""544"" left=""108"" width=""683"" height=""16"" font=""0"">FMD-susceptible animal products is carried out directly from the farm to the slaughterhouse with </text>
<text top=""561"" left=""108"" width=""686"" height=""16"" font=""0"">direct selling of cull animals and lambs to coldstore plants. Lambs are usually destined for </text>
<text top=""577"" left=""108"" width=""49"" height=""16"" font=""0"">export.</text>
<footnote top=""575"" left=""157"" width=""23"" height=""11"" font=""16"" number=""1394"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 45. </ftext>
</footnote>
<text top=""577"" left=""180"" width=""613"" height=""16"" font=""0""> Animals are transported in special vehicles used for this purpose only. The vehicles </text>
<text top=""593"" left=""108"" width=""683"" height=""16"" font=""0"">must comply with SENASA Resolution 97/1999, which requires the official approval of the vehicle, </text>
<text top=""610"" left=""108"" width=""624"" height=""16"" font=""0"">and SENASA Resolution 809/1982, which prescribes, hygiene and sanitation requirements.</text>
<footnote top=""608"" left=""732"" width=""23"" height=""11"" font=""16"" number=""1395"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 45. </ftext>
</footnote>
<text top=""610"" left=""755"" width=""36"" height=""16"" font=""0""> The </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">transportation of FMD-susceptible animals from farm to farm and to slaughterhouses is subject to </text>
<text top=""643"" left=""108"" width=""664"" height=""16"" font=""0"">the same traceability requirements and movement controls discussed in paragraph 7.459 above. </text>
</p><p number=""7.532"" style=""8""><text top=""677"" left=""108"" width=""685"" height=""16"" font=""0"">7.532.  As for slaughterhouse practices, there are 19 facilities in the Patagonia region that are </text>
<text top=""693"" left=""108"" width=""685"" height=""16"" font=""0"">approved by SENASA, three of which are approved for export of sheep meat to the European </text>
<text top=""710"" left=""108"" width=""44"" height=""16"" font=""0"">Union.</text>
<footnote top=""708"" left=""152"" width=""23"" height=""11"" font=""16"" number=""1396"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""601"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 46; 2014 Risk Analysis for Patagonia, </ftext>
<ftext top=""1080"" left=""108"" width=""158"" height=""15"" font=""10"">(Exhibit USA-133), p. 44. </ftext>
</footnote>
<text top=""710"" left=""175"" width=""617"" height=""16"" font=""0""> In 2005, APHIS reviewed the biosecurity controls established by SENASA in order to </text>
<text top=""726"" left=""108"" width=""682"" height=""16"" font=""0"">accredit a facility. Such controls include that: (i) animals be kept in pens and not be allowed to exit </text>
<text top=""743"" left=""108"" width=""683"" height=""16"" font=""0"">the facility once they have entered it; (ii) all effluent be treated by separating solids, fats, liquids, </text>
<text top=""759"" left=""108"" width=""683"" height=""16"" font=""0"">and chlorinates out before releasing them to the general sewage system; (iii) effluents from the </text>
<text top=""775"" left=""108"" width=""683"" height=""16"" font=""0"">sanitary complex be individually treated by disinfection before being dumped with the rest of the </text>
<text top=""792"" left=""108"" width=""684"" height=""16"" font=""0"">common, treated effluents; and (iv) raw slaughter and slaughter pathology wastes be processed </text>
<text top=""808"" left=""108"" width=""191"" height=""16"" font=""0"">into nonedible by-products.</text>
<footnote top=""807"" left=""299"" width=""23"" height=""11"" font=""16"" number=""1397"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""619"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 46-47; 2014 Risk Analysis for Northern </ftext>
<ftext top=""1109"" left=""108"" width=""253"" height=""15"" font=""10"">Argentina, (Exhibit USA-169), pp. 58-59. </ftext>
</footnote>
<text top=""808"" left=""322"" width=""470"" height=""16"" font=""0""> APHIS further observed that all animals receive an ante-mortem </text>
<text top=""825"" left=""108"" width=""683"" height=""16"" font=""0"">inspection by a SENASA technician upon arrival at the slaughterhouse, as well as a post-mortem </text>
<text top=""841"" left=""108"" width=""543"" height=""16"" font=""0"">inspection after slaughter by SENASA field veterinarians and plant staff.</text>
<footnote top=""840"" left=""651"" width=""23"" height=""11"" font=""16"" number=""1398"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""398"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 47.  </ftext>
</footnote>
<text top=""841"" left=""674"" width=""121"" height=""16"" font=""0""> Deboning and </text>
<p><text top=""905"" left=""170"" width=""287"" height=""15"" font=""10""> Dr Batho's response to Panel question No. 33. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 178 - </text>
</p><p><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">maturation of fresh meat are not practised in Patagonian slaughterhouses. In this respect, </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">Dr Batho observed that the European Union does not require such processes to take place in order </text>
<text top=""160"" left=""108"" width=""460"" height=""16"" font=""0"">for the meat to be imported into its territory from Patagonia South.</text>
<footnote top=""159"" left=""567"" width=""23"" height=""11"" font=""16"" number=""1399"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""245"" height=""15"" font=""10""> Transcript of the meeting, para. 1.287. </ftext>
</footnote>
</p></p></page>
<page number=""178"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.533"" style=""8""><text top=""195"" left=""108"" width=""687"" height=""16"" font=""0"">7.533.  Based on the foregoing, APHIS concluded in 2005 that ""[t]he livestock industry in </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia South appears to be well-organized"" and ""aware of necessary biosecurity precautions"", </text>
<text top=""228"" left=""108"" width=""451"" height=""16"" font=""0"">which in turn are ""effective in the prevention of FMD outbreaks""</text>
<footnote top=""226"" left=""559"" width=""23"" height=""11"" font=""16"" number=""1400"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 47. </ftext>
</footnote>
<text top=""228"" left=""582"" width=""210"" height=""16"" font=""0"">. Specifically, with respect to </text>
<text top=""244"" left=""108"" width=""684"" height=""16"" font=""0"">sheep products, APHIS ""did not identify significant risk pathways to consider commercial sheep </text>
<text top=""260"" left=""108"" width=""513"" height=""16"" font=""0"">operations as a likely source for introducing FMD into the United States"".</text>
<footnote top=""259"" left=""621"" width=""23"" height=""11"" font=""16"" number=""1401"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 47-48. </ftext>
</footnote>
<text top=""260"" left=""644"" width=""147"" height=""16"" font=""0""> We do not see any </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">evidence on the record indicating that, throughout the period between 2005 and the date of the </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">Panel's establishment, the facts underlying APHIS' conclusions changed to an extent that would </text>
<text top=""310"" left=""108"" width=""183"" height=""16"" font=""0"">reverse such conclusions.  </text>
</p><p number=""7.6"" style=""8""><text top=""344"" left=""108"" width=""526"" height=""16"" font=""28"">7.6.7.4.2.9  The type and extent of disease surveillance in the region </text></p><p number=""7.534"" style=""8""><text top=""378"" left=""108"" width=""682"" height=""16"" font=""0"">7.534.  As discussed in paragraphs 7.492-7.493 above, in 2005 APHIS reviewed active and passive </text>
<text top=""395"" left=""108"" width=""683"" height=""16"" font=""0"">surveillance conducted by SENASA in the Argentine territory as a whole. This is because, already </text>
<text top=""411"" left=""108"" width=""684"" height=""16"" font=""0"">at that time, ""[s]urveillance activities in the Patagonia Region [were] conducted only under the </text>
<text top=""428"" left=""108"" width=""685"" height=""16"" font=""0"">national surveillance design"", and there were no Patagonia-specific measures in place in that </text>
<text top=""444"" left=""108"" width=""55"" height=""16"" font=""0"">respect.</text>
<footnote top=""443"" left=""163"" width=""23"" height=""11"" font=""16"" number=""1402"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 48. </ftext>
</footnote>
<text top=""444"" left=""186"" width=""480"" height=""16"" font=""0""> This element had not changed by the time the Panel was established.</text>
<footnote top=""443"" left=""666"" width=""23"" height=""11"" font=""16"" number=""1403"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""425"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169), p. 46. </ftext>
</footnote>
<text top=""444"" left=""689"" width=""101"" height=""16"" font=""0""> As discussed, </text>
<text top=""461"" left=""108"" width=""682"" height=""16"" font=""0"">APHIS considered that the two-stage sampling strategy at the herd level and the individual animal </text>
<text top=""477"" left=""108"" width=""683"" height=""16"" font=""0"">level allows the early detection of FMDV at a statistical confidence level of 95% and is ""both valid </text>
<text top=""493"" left=""108"" width=""97"" height=""16"" font=""0"">and efficient"".</text>
<footnote top=""492"" left=""205"" width=""23"" height=""11"" font=""16"" number=""1404"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 49. </ftext>
</footnote>
<text top=""493"" left=""228"" width=""564"" height=""16"" font=""0""> Although, the objectives, approaches, and intensity may change slightly from </text>
<text top=""510"" left=""108"" width=""686"" height=""16"" font=""0"">year to year, the basic sampling approach is defined in the National Eradication Plan, which </text>
<text top=""526"" left=""108"" width=""270"" height=""16"" font=""0"">remains the same since it was adopted.</text>
<footnote top=""525"" left=""378"" width=""23"" height=""11"" font=""16"" number=""1405"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""397"" height=""15"" font=""10""> 2014 Risk Analysis for Patagonia, (Exhibit USA-133), pp. 50-51. </ftext>
</footnote>
</p><p number=""7.535"" style=""8""><text top=""561"" left=""108"" width=""685"" height=""16"" font=""0"">7.535.  APHIS also reviewed several rounds of serological sampling conducted in the Patagonia </text>
<text top=""577"" left=""108"" width=""691"" height=""16"" font=""0"">region between 2001 and 2003, involving bovine, ovine, goats, farm deer, and wild </text>
<text top=""593"" left=""108"" width=""83"" height=""16"" font=""0"">biungulates.</text>
<footnote top=""592"" left=""191"" width=""23"" height=""11"" font=""16"" number=""1406"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 55-63. </ftext>
</footnote>
<text top=""593"" left=""214"" width=""576"" height=""16"" font=""0""> It concluded that such sampling activities, as would ""continue in the future"", were </text>
<text top=""610"" left=""108"" width=""592"" height=""16"" font=""0"">""adequate to detect disease and/or identify and measure viral activity in the area"".</text>
<footnote top=""608"" left=""700"" width=""23"" height=""11"" font=""16"" number=""1407"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 63. </ftext>
</footnote>
<text top=""610"" left=""724"" width=""69"" height=""16"" font=""0""> Further, </text>
<text top=""626"" left=""108"" width=""682"" height=""16"" font=""0"">APHIS stated that the fact that serological sampling in the area resulted in no animals ever testing </text>
<text top=""643"" left=""108"" width=""688"" height=""16"" font=""0"">positive to FMD and no viral activity ever found demonstrates ""the absence of disease in </text>
<text top=""659"" left=""108"" width=""78"" height=""16"" font=""0"">Patagonia"".</text>
<footnote top=""657"" left=""186"" width=""23"" height=""11"" font=""16"" number=""1408"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 63. </ftext>
</footnote>
<text top=""659"" left=""209"" width=""583"" height=""16"" font=""0""> The Panel sees no evidence on the record to indicate the situation changed from </text>
<text top=""675"" left=""108"" width=""341"" height=""16"" font=""0"">2005 until the date of the Panel's establishment.  </text>
</p><p number=""7.6"" style=""8""><text top=""710"" left=""108"" width=""336"" height=""16"" font=""28"">7.6.7.4.2.10  Diagnostic laboratory capacity </text></p><p number=""7.536"" style=""8""><text top=""744"" left=""108"" width=""688"" height=""16"" font=""0"">7.536.  As discussed in paragraphs 7.494-7.495 above, in its 2005 risk assessment APHIS </text>
<text top=""761"" left=""108"" width=""684"" height=""16"" font=""0"">reviewed a number of elements in connection with the organization, structure, and capacity of </text>
<text top=""777"" left=""108"" width=""686"" height=""16"" font=""0"">laboratories in Argentina. It found, <i>inter alia</i>, that Argentine laboratories use an information </text>
<text top=""793"" left=""108"" width=""684"" height=""16"" font=""0"">management system for recording samples and for typing laboratory results to be analysed by </text>
<text top=""810"" left=""108"" width=""684"" height=""16"" font=""0"">epidemiologists. APHIS described the system as ""effective and adequate"" and the staff as ""very </text>
<text top=""826"" left=""108"" width=""169"" height=""16"" font=""0"">capable"" in managing it.</text>
<footnote top=""825"" left=""277"" width=""23"" height=""11"" font=""16"" number=""1409"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 65. </ftext>
</footnote>
<text top=""826"" left=""300"" width=""491"" height=""16"" font=""0""> It also observed that the National Reference Laboratory was, at that </text>
<text top=""843"" left=""108"" width=""565"" height=""16"" font=""0"">time, working towards accreditation under international standard ISO 17025.</text>
<footnote top=""841"" left=""673"" width=""23"" height=""11"" font=""16"" number=""1410"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 65. </ftext>
</footnote>
<text top=""843"" left=""696"" width=""98"" height=""16"" font=""0""> APHIS also </text>
<text top=""859"" left=""108"" width=""682"" height=""16"" font=""0"">reviewed the collection, treatment, and analysis of diagnostic samples, as well as the technological </text>
<text top=""875"" left=""108"" width=""386"" height=""16"" font=""0"">capability of the laboratories to conduct diagnostic tests.</text>
<footnote top=""874"" left=""494"" width=""23"" height=""11"" font=""16"" number=""1411"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 67. </ftext>
<ftext top=""1124"" left=""108"" width=""627"" height=""15"" font=""10"">paras. 502-503; Argentina's response to Panel question No. 44 following the first substantive meeting. </ftext>
</footnote>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 179 - </text>
</p></p></page>
<page number=""179"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.537"" style=""8""><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">7.537.  APHIS concluded that ""Argentina has the diagnostic capabilities to adequately test samples </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">for the presence of the FMD virus"", that ""quality control activities within the laboratories are </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">sufficient"", that ""laboratory equipment is routinely monitored and calibrated"", that ""sufficient staff </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">is available"", and that ""there is an effective and efficient recordkeeping system for storage and </text>
<text top=""193"" left=""108"" width=""130"" height=""16"" font=""0"">retrieval of data"".</text>
<footnote top=""192"" left=""238"" width=""23"" height=""11"" font=""16"" number=""1412"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 68. </ftext>
</footnote>
<text top=""193"" left=""261"" width=""534"" height=""16"" font=""0""> We do not see any evidence on the record indicating that the facts </text>
<text top=""210"" left=""108"" width=""685"" height=""16"" font=""0"">underlying APHIS' 2005 conclusions changed in a way that would warrant a reversal of such </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">conclusions during the period leading up to the Panel's establishment. Rather, in 2006, the </text>
<text top=""242"" left=""108"" width=""596"" height=""16"" font=""0"">National Reference Laboratory was accredited under international standard ISO 17025</text>
<footnote top=""241"" left=""704"" width=""23"" height=""11"" font=""16"" number=""1413"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""369"" height=""15"" font=""10""> 2014 Risk Analysis for Patagonia, (Exhibit USA-133), p. 62. </ftext>
</footnote>
<text top=""242"" left=""727"" width=""64"" height=""16"" font=""0""> and the </text>
<text top=""259"" left=""108"" width=""654"" height=""16"" font=""0"">laboratory network acquired the capacity to run Polymerase Chain Reaction (PCR) tests for FMD</text>
<footnote top=""257"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1414"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""369"" height=""15"" font=""10""> 2014 Risk Analysis for Patagonia, (Exhibit USA-133), p. 63. </ftext>
</footnote>
<text top=""275"" left=""108"" width=""427"" height=""16"" font=""0"">&#8211; the lack of which APHIS had found to be a gap in 2005.</text>
<footnote top=""274"" left=""535"" width=""23"" height=""11"" font=""16"" number=""1415"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""422"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), pp. 66-67. </ftext>
</footnote>
<text top=""275"" left=""558"" width=""234"" height=""16"" font=""0""> Finally, the fact that SENASA's </text>
<text top=""292"" left=""108"" width=""684"" height=""16"" font=""0"">Animal Laboratory is recognized as an OIE Reference Laboratory for FMD has been described by </text>
<text top=""308"" left=""108"" width=""246"" height=""16"" font=""0"">the OIE as a ""very positive factor"".</text>
<footnote top=""307"" left=""354"" width=""23"" height=""11"" font=""16"" number=""1416"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""242"" height=""15"" font=""10""> Transcript of the meeting, para. 1.62.  </ftext>
</footnote>
<text top=""308"" left=""377"" width=""415"" height=""16"" font=""0""> Indeed, in the OIE's view, such a recognition entails that </text>
<text top=""324"" left=""108"" width=""684"" height=""16"" font=""0"">the laboratory ""is capable of providing diagnostic services of a &#8230; world level"" and to ""provide a </text>
<text top=""341"" left=""108"" width=""275"" height=""16"" font=""0"">service at no charge to other countries"".</text>
<footnote top=""339"" left=""383"" width=""23"" height=""11"" font=""16"" number=""1417"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""242"" height=""15"" font=""10""> Transcript of the meeting, para. 1.62.  </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""375"" left=""108"" width=""508"" height=""16"" font=""28"">7.6.7.4.2.11  Policies and infrastructure for animal disease control </text></p><p number=""7.538"" style=""8""><text top=""410"" left=""108"" width=""688"" height=""16"" font=""0"">7.538.  As discussed in paragraphs 7.496-7.497 above, in its 2005 risk assessment APHIS </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">reviewed several aspects of the regulatory framework in force in Argentina as a whole to ensure </text>
<text top=""443"" left=""108"" width=""682"" height=""16"" font=""0"">disease surveillance and the ability to deal with possible FMD outbreaks in the region. It concluded </text>
<text top=""459"" left=""108"" width=""687"" height=""16"" font=""0"">that SENASA ""has the infrastructure and legal authority to declare an emergency and take </text>
<text top=""475"" left=""108"" width=""357"" height=""16"" font=""0"">appropriate action in case of an [FMD] outbreak"".</text>
<footnote top=""474"" left=""465"" width=""26"" height=""11"" font=""16"" number=""1418"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""394"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9), p. 70. </ftext>
</footnote>
<text top=""475"" left=""494"" width=""299"" height=""16"" font=""0"">The European Commission's 2006 Report </text>
<text top=""492"" left=""108"" width=""689"" height=""16"" font=""0"">confirms that the procedures in place ""permit[] a rapid and effective response to [an] </text>
<text top=""508"" left=""108"" width=""106"" height=""16"" font=""0"">FMD outbreak"".</text>
<footnote top=""507"" left=""214"" width=""23"" height=""11"" font=""16"" number=""1419"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""394"" height=""15"" font=""10""> European Commission's 2006 Report, (Exhibit ARG-111), p. 20. </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""543"" left=""108"" width=""500"" height=""16"" font=""28"">7.6.7.4.2.12  Conclusions on the scientific evidence on the record </text></p><p number=""7.539"" style=""8""><text top=""577"" left=""108"" width=""685"" height=""16"" font=""0"">7.539.  The evidence on the record demonstrates that Patagonia has the necessary veterinary </text>
<text top=""593"" left=""108"" width=""685"" height=""16"" font=""0"">capacity and infrastructure to prevent and control FMD in its own territory and the capacity to </text>
<text top=""610"" left=""108"" width=""684"" height=""16"" font=""0"">prevent incursions of the disease from regions of higher FMD-risk. Such capacity stems from a </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">panoply of interlocking and overlapping sanitary measures aimed at reducing the risk of entry of </text>
<text top=""643"" left=""108"" width=""684"" height=""16"" font=""0"">FMD in the region, including, <i>inter alia</i>: accurate tracking and identification of animals, effective </text>
<text top=""659"" left=""108"" width=""689"" height=""16"" font=""0"">controls on the movement of FMD-susceptible animals from regions of higher FMD risk, </text>
<text top=""675"" left=""108"" width=""687"" height=""16"" font=""0"">appropriate collection of samples and laboratory capacity, efficacious mitigating measures at </text>
<text top=""692"" left=""108"" width=""682"" height=""16"" font=""0"">slaughterhouses such as ante- and post-mortem inspections, and comprehensive control policies in </text>
<text top=""708"" left=""108"" width=""683"" height=""16"" font=""0"">case of an outbreak. Such measures are effective tools to ensure that the region remains free of </text>
<text top=""725"" left=""108"" width=""217"" height=""16"" font=""0"">FMD as it has been since 1994. </text>
</p><p number=""7.540"" style=""8""><text top=""759"" left=""108"" width=""685"" height=""16"" font=""0"">7.540.  We now turn to assessing whether the alternative measures identified by Argentina, if </text>
<text top=""775"" left=""108"" width=""682"" height=""16"" font=""0"">applied to imports of FMD-susceptible animals and animal products from Patagonia, would achieve </text>
<text top=""792"" left=""108"" width=""683"" height=""16"" font=""0"">the United States' ALOP for FMD, recalling that we have found that the ALOP is between low and </text>
<text top=""808"" left=""108"" width=""39"" height=""16"" font=""0"">zero. </text>
</p><p number=""7.6"" style=""8""><text top=""843"" left=""108"" width=""684"" height=""16"" font=""28"">7.6.7.4.2.13  Whether the inclusion of Patagonia in the list of FMD-free regions under </text><text top=""859"" left=""108"" width=""683"" height=""16"" font=""28"">9 CFR 94.1(a) and the application of the protocols in 9 CFR 94.11 to imports therefrom </text><text top=""875"" left=""108"" width=""304"" height=""16"" font=""28"">would achieve the United States' ALOP  </text></p><p number=""7.541"" style=""8""><text top=""910"" left=""108"" width=""684"" height=""16"" font=""0"">7.541.  In support of its Article 5.6 claim concerning the United States' prohibition on imports of </text>
<text top=""926"" left=""108"" width=""683"" height=""16"" font=""0"">FMD-susceptible animals and animal products from Patagonia, Argentina identified one alternative </text>
<text top=""943"" left=""108"" width=""684"" height=""16"" font=""0"">measure: namely, the inclusion of Patagonia to the list of FMD-free countries or regions under </text>
<text top=""959"" left=""108"" width=""101"" height=""16"" font=""0"">9 CFR 94.1(a).</text>
<footnote top=""958"" left=""209"" width=""23"" height=""11"" font=""16"" number=""1420"" ref="""" dis=""""/>
<text top=""959"" left=""232"" width=""567"" height=""16"" font=""0""> Further, as Argentina observes, the mitigating protocols set forth in </text>
<footnote top=""1109"" left=""170"" width=""589"" height=""15"" font=""10"" number=""182"" ref="""" dis=""""/>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 180 - </text>
</p><p><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">9 CFR 94.11 apply to imports of FMD-susceptible animal products from some of the regions </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">included in the list, namely regions which: (i) supplement their national meat supply through the </text>
<text top=""160"" left=""108"" width=""685"" height=""16"" font=""0"">importation of fresh, chilled, or frozen meat of ruminants or swine from regions that are not </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">included in the list; (ii) have a common land border with regions that are not included in the list; </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">or (iii) import ruminants or swine from regions that are included in the list under conditions less </text>
<text top=""210"" left=""108"" width=""520"" height=""16"" font=""0"">restrictive than would be acceptable for importation into the United States.</text>
<footnote top=""208"" left=""628"" width=""23"" height=""11"" font=""16"" number=""1421"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""199"" height=""15"" font=""10""> 9 CFR 94.11, (Exhibit ARG-64). </ftext>
</footnote>
<text top=""210"" left=""651"" width=""140"" height=""16"" font=""0""> Because Patagonia </text>
<text top=""226"" left=""108"" width=""686"" height=""16"" font=""0"">borders a region not included in the list, i.e. Northern Argentina, and imports deboned and </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">matured fresh (chilled or frozen) beef therefrom, its inclusion to the list in 9 CFR 94.1(a) would be </text>
<text top=""259"" left=""108"" width=""685"" height=""16"" font=""0"">coupled with the application to imports of animal products therefrom of the general protocols </text>
<text top=""275"" left=""108"" width=""133"" height=""16"" font=""0"">under 9 CFR 94.11.</text>
<footnote top=""274"" left=""241"" width=""23"" height=""11"" font=""16"" number=""1422"" ref="""" dis=""""/>
</p></p></page>
<page number=""180"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.542"" style=""8""><text top=""310"" left=""108"" width=""685"" height=""16"" font=""0"">7.542.  In Argentina's view, the fact that Patagonia shares the same OIE status-recognition as </text>
<text top=""326"" left=""108"" width=""527"" height=""16"" font=""0"">Santa Catarina means that the two regions are in a similar sanitary situation.</text>
<footnote top=""325"" left=""635"" width=""23"" height=""11"" font=""16"" number=""1423"" ref="""" dis=""""/>
<text top=""326"" left=""658"" width=""131"" height=""16"" font=""0""> Indeed, according </text>
<text top=""342"" left=""108"" width=""684"" height=""16"" font=""0"">to Argentina, both regions are FMD-free where vaccination is not practised, but border a region </text>
<text top=""359"" left=""108"" width=""683"" height=""16"" font=""0"">that is not included in APHIS' list under 9 CFR 94.1(a). Therefore, in Argentina' opinion, the fact </text>
<text top=""375"" left=""108"" width=""683"" height=""16"" font=""0"">that Santa Catarina is included in the list in 9 CFR 94.1(a) and is subject to the protocols under </text>
<text top=""392"" left=""108"" width=""682"" height=""16"" font=""0"">9 CFR 94.11 shows that the addition of Patagonia to the same list and the application of the same </text>
<text top=""408"" left=""108"" width=""527"" height=""16"" font=""0"">protocols to imports from the region would achieve the United States' ALOP.</text>
<footnote top=""407"" left=""635"" width=""23"" height=""11"" font=""16"" number=""1424"" ref="""" dis=""""/>
<text top=""408"" left=""658"" width=""133"" height=""16"" font=""0""> The United States </text>
<text top=""425"" left=""108"" width=""683"" height=""16"" font=""0"">responds that Argentina failed to substantiate its claim that Patagonia has a similar FMD situation </text>
<text top=""441"" left=""108"" width=""126"" height=""16"" font=""0"">as Santa Catarina.</text>
<footnote top=""439"" left=""234"" width=""23"" height=""11"" font=""16"" number=""1425"" ref="""" dis=""""/>
</p><p number=""7.543"" style=""8""><text top=""475"" left=""108"" width=""682"" height=""16"" font=""0"">7.543.  We consider that the mere fact that the OIE recognizes both Patagonia and Santa Catarina </text>
<text top=""492"" left=""108"" width=""682"" height=""16"" font=""0"">as FMD-free where vaccination is not practised is not, in and of itself, dispositive as to whether the </text>
<text top=""508"" left=""108"" width=""682"" height=""16"" font=""0"">inclusion of the former in the list under 9 CFR 94.1(a) and the application to products therefrom of </text>
<text top=""525"" left=""108"" width=""498"" height=""16"" font=""0"">the protocols under 9 CFR 94.11 would achieve the United States' ALOP.</text>
<footnote top=""523"" left=""606"" width=""23"" height=""11"" font=""16"" number=""1426"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""605"" height=""15"" font=""10""> This is in line with our finding that the import measures and mitigating protocols recommended by </ftext>
<ftext top=""1095"" left=""108"" width=""662"" height=""15"" font=""10"">the Terrestrial Code can operate independently of the OIE's official recognition of disease status for a certain </ftext>
<ftext top=""1109"" left=""108"" width=""270"" height=""15"" font=""10"">country or region. (See para. 7.238 above). </ftext>
</footnote>
<text top=""525"" left=""629"" width=""162"" height=""16"" font=""0""> Rather, mindful of the </text>
<text top=""541"" left=""108"" width=""682"" height=""16"" font=""0"">Appellate Body's guidance in <i>Australia &#8211; Apples</i>, we must conduct our own assessment of whether </text>
<text top=""557"" left=""108"" width=""688"" height=""16"" font=""0"">the application of such measures to Patagonia would bring the risk posed by imports of </text>
<text top=""574"" left=""108"" width=""684"" height=""16"" font=""0"">FMD-susceptible animals and animal products from the region down to a level that achieves the </text>
<text top=""590"" left=""108"" width=""150"" height=""16"" font=""0"">United States' ALOP.  </text>
</p><p number=""7.544"" style=""8""><text top=""625"" left=""108"" width=""686"" height=""16"" font=""0"">7.544.  The protocols set forth in 9 CFR 94.11 impose a twofold certification requirement on </text>
<text top=""641"" left=""108"" width=""683"" height=""16"" font=""0"">imports of FMD-susceptible animal products into the United States. First, all meat or other animal </text>
<text top=""657"" left=""108"" width=""683"" height=""16"" font=""0"">product from the relevant region, whether in personal-use amounts or commercial lots, shall have </text>
<text top=""674"" left=""108"" width=""682"" height=""16"" font=""0"">been prepared only in an inspected establishment that is eligible to have its products imported into </text>
<text top=""690"" left=""108"" width=""684"" height=""16"" font=""0"">the United States under the relevant United States' regulations, and shall be accompanied by a </text>
<text top=""707"" left=""108"" width=""691"" height=""16"" font=""0"">Department-approved meat inspection certificate or similar certificate approved by the </text>
<text top=""723"" left=""108"" width=""97"" height=""16"" font=""0"">Administrator.</text>
<footnote top=""721"" left=""205"" width=""23"" height=""11"" font=""16"" number=""1427"" ref="""" dis=""""/>
<text top=""723"" left=""228"" width=""562"" height=""16"" font=""0""> Second, meat of ruminants or swine or other animal products from the relevant </text>
<text top=""739"" left=""108"" width=""683"" height=""16"" font=""0"">region must be accompanied by additional certification by a fulltime salaried veterinary official of </text>
<text top=""756"" left=""108"" width=""684"" height=""16"" font=""0"">the agency in the national government of origin. The certificate must give the name and official </text>
<text top=""772"" left=""108"" width=""683"" height=""16"" font=""0"">establishment number of the establishment where the animals were slaughtered, and shall state </text>
<text top=""789"" left=""108"" width=""38"" height=""16"" font=""0"">that: </text>
</p><p number=""a."" style=""2""><text top=""823"" left=""151"" width=""640"" height=""16"" font=""0"">a.  The slaughtering establishment is not permitted to receive animals that originated in, or </text>
<text top=""839"" left=""176"" width=""614"" height=""16"" font=""0"">have ever been in, or that have been aboard a means of conveyance at the time such </text>
<text top=""856"" left=""176"" width=""615"" height=""16"" font=""0"">means of conveyance called at, or landed at a port in, a region not included in the list </text>
<text top=""872"" left=""176"" width=""460"" height=""16"" font=""0"">under 9 CFR 94.1(a) and therefore considered to be FMD-affected; </text>
</p><p><text top=""934"" left=""108"" width=""628"" height=""15"" font=""10"">paras. 502-503; Argentina's response to Panel question No. 44 following the first substantive meeting; </text>
<text top=""949"" left=""108"" width=""668"" height=""15"" font=""10"">9 CFR 94.11, (Exhibit ARG-64). We note that under 9 CFR 94.11, imports of live FMD-susceptible animals are </text>
<text top=""963"" left=""108"" width=""655"" height=""15"" font=""10"">not subject to any restrictions or protocols. Our findings in this section are without prejudice to any general </text>
<text top=""978"" left=""108"" width=""616"" height=""15"" font=""10"">requirements concerning the importation of live animals imposed under other relevant United States' </text>
<text top=""993"" left=""108"" width=""76"" height=""15"" font=""10"">regulations. </text>
<footnote top=""1007"" left=""170"" width=""589"" height=""15"" font=""10"" number=""502"" ref="""" dis=""""/>
</p><p><text top=""1066"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 298. </text>
<footnote top=""1124"" left=""170"" width=""105"" height=""15"" font=""10"" number=""64"" ref="""" dis=""""/>
</p></page>
<page number=""181"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 181 - </text>
</p><p number=""b."" style=""2""><text top=""128"" left=""151"" width=""645"" height=""16"" font=""0"">b.  The slaughtering establishment is not permitted to receive meat or other animal </text>
<text top=""144"" left=""176"" width=""618"" height=""16"" font=""0"">products derived from ruminants or swine which originated in such a FMD-affected </text>
<text top=""160"" left=""176"" width=""615"" height=""16"" font=""0"">region, or meat or other animal products from an FMD-free region transported through </text>
<text top=""177"" left=""176"" width=""615"" height=""16"" font=""0"">an FMD-affected region except in containers sealed with serially numbered seals of the </text>
<text top=""193"" left=""176"" width=""429"" height=""16"" font=""0"">National Government of the non-affected region of origin; and </text>
</p><p number=""c."" style=""2""><text top=""228"" left=""151"" width=""641"" height=""16"" font=""0"">c.  The meat or other animal product covered by the certificate was derived from animals </text>
<text top=""244"" left=""176"" width=""615"" height=""16"" font=""0"">born and raised in the region of origin and the meat or other animal product has never </text>
<text top=""260"" left=""176"" width=""316"" height=""16"" font=""0"">been in any region in which FMD existed; and </text>
</p><p number=""d."" style=""2""><text top=""295"" left=""151"" width=""641"" height=""16"" font=""0"">d.  The meat or other animal product has been processed, stored, and transported to the </text>
<text top=""311"" left=""176"" width=""617"" height=""16"" font=""0"">means of conveyance that will bring the article to the United States in a manner to </text>
<text top=""328"" left=""176"" width=""619"" height=""16"" font=""0"">preclude its being commingled or otherwise in contact with meat or other animal </text>
<text top=""344"" left=""176"" width=""519"" height=""16"" font=""0"">products that do not comply with the conditions contained in this certificate.</text>
<footnote top=""343"" left=""695"" width=""23"" height=""11"" font=""16"" number=""1428"" ref="""" dis=""""/>
</p><p number=""7.545"" style=""8""><text top=""378"" left=""108"" width=""685"" height=""16"" font=""0"">7.545.  As the language above indicates, the protocols under 9 CFR 94.11 set forth a number </text>
<text top=""395"" left=""108"" width=""682"" height=""16"" font=""0"">additional guarantees for the United States' authorities that the measures in force in the region of </text>
<text top=""411"" left=""108"" width=""683"" height=""16"" font=""0"">origin in order to prevent and control FMD are properly implemented, thus reducing the risk that </text>
<text top=""428"" left=""108"" width=""684"" height=""16"" font=""0"">imports of FMD-susceptible animal products from that region cause the introduction of FMD into </text>
<text top=""444"" left=""108"" width=""197"" height=""16"" font=""0"">the United States' territory.  </text>
</p><p number=""7.546"" style=""8""><text top=""479"" left=""108"" width=""682"" height=""16"" font=""0"">7.546.  In paragraph 7.539 above, we found, based on the evidence on the record, that Patagonia </text>
<text top=""495"" left=""108"" width=""684"" height=""16"" font=""0"">has the necessary veterinary capacity and infrastructure to prevent and control FMD in its own </text>
<text top=""511"" left=""108"" width=""682"" height=""16"" font=""0"">territory and the capacity to prevent incursions of the disease from regions of higher FMD-risk. We </text>
<text top=""528"" left=""108"" width=""682"" height=""16"" font=""0"">also noted that such capacity is adequate to ensure that Patagonia maintains its freedom from the </text>
<text top=""544"" left=""108"" width=""683"" height=""16"" font=""0"">disease. Given the credibility of the sanitary structures of Patagonia, we see no evidence on the </text>
<text top=""561"" left=""108"" width=""682"" height=""16"" font=""0"">record indicating that SENASA would be unable to adopt and properly implement the protocols set </text>
<text top=""577"" left=""108"" width=""153"" height=""16"" font=""0"">forth in 9 CFR 94.11.  </text>
</p><p number=""7.547"" style=""8""><text top=""611"" left=""108"" width=""682"" height=""16"" font=""0"">7.547.  Based on the foregoing, we conclude, as a matter of fact, that the addition of Patagonia to </text>
<text top=""628"" left=""108"" width=""685"" height=""16"" font=""0"">the list of FMD-free countries or regions under 9 CFR 94.1(a), coupled with the application to </text>
<text top=""644"" left=""108"" width=""686"" height=""16"" font=""0"">imports of animal products therefrom of the protocols under 9 CFR 94.11, would achieve the </text>
<text top=""661"" left=""108"" width=""585"" height=""16"" font=""0"">United States' ALOP for FMD, which we described as being between low and zero risk.</text>
<footnote top=""659"" left=""693"" width=""23"" height=""11"" font=""16"" number=""1429"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.387 above. </ftext>
<ftext top=""949"" left=""108"" width=""85"" height=""15"" font=""10"">para. 7.260). </ftext>
<ftext top=""1095"" left=""108"" width=""666"" height=""15"" font=""10"">of the Panel, para. 52; Argentina's response to Panel question No. 37 following the first substantive meeting; </ftext>
</footnote>
</p><p number=""7.6"" style=""8""><text top=""695"" left=""108"" width=""688"" height=""16"" font=""28"">7.6.7.4.2.14  Conclusions on whether the United States' prohibitions on imports of </text><text top=""711"" left=""108"" width=""683"" height=""16"" font=""28"">FMD-susceptible animals and animal products from Patagonia are more restrictive than </text><text top=""728"" left=""108"" width=""318"" height=""16"" font=""28"">required to meet the United States' ALOP </text></p><p number=""7.548"" style=""8""><text top=""762"" left=""108"" width=""686"" height=""16"" font=""0"">7.548.  Based on all the foregoing, we conclude that the addition of Patagonia to the list of </text>
<text top=""779"" left=""108"" width=""685"" height=""16"" font=""0"">FMD-free countries or regions under 9 CFR 94.1(a), coupled with the application to imports of </text>
<text top=""795"" left=""108"" width=""683"" height=""16"" font=""0"">animal products therefrom of the protocols set forth in 9 CFR 94.11, (i) is reasonably available to </text>
<text top=""811"" left=""108"" width=""683"" height=""16"" font=""0"">the United States and technically and economically feasible; (ii) would achieve the United States' </text>
<text top=""828"" left=""108"" width=""683"" height=""16"" font=""0"">ALOP; and (iii) would be significantly less trade-restrictive than the United States' prohibitions in </text>
<text top=""844"" left=""108"" width=""685"" height=""16"" font=""0"">place at the time of the establishment of the Panel. Therefore, the United States' prohibitions </text>
<text top=""861"" left=""108"" width=""682"" height=""16"" font=""0"">challenged by Argentina are more restrictive than required to achieve the United States' ALOP, and </text>
<text top=""877"" left=""108"" width=""414"" height=""16"" font=""0"">thus are inconsistent with Article 5.6 of the SPS Agreement. </text>
</p><p number=""7.7"" style=""8""><text top=""911"" left=""108"" width=""37"" height=""16"" font=""28"">7.7 </text><text top=""911"" left=""141"" width=""179"" height=""16"" font=""28"">Whether the United </text><text top=""911"" left=""312"" width=""486"" height=""16"" font=""28"">States' measures arbitrarily or unjustifiably discriminate </text><text top=""928"" left=""108"" width=""686"" height=""16"" font=""28"">between Members where identical or similar conditions prevail or are applied in a </text><text top=""944"" left=""108"" width=""546"" height=""16"" font=""28"">manner which constitutes a disguised restriction on international trade </text></p><p number=""7.7"" style=""8""><text top=""979"" left=""108"" width=""243"" height=""16"" font=""28"">7.7.1  Relevant legal provisions </text></p><p number=""7.549"" style=""8""><text top=""1013"" left=""108"" width=""446"" height=""16"" font=""0"">7.549.  Article 2.3 of the SPS Agreement reads, in relevant part: </text>
<p><text top=""1048"" left=""151"" width=""604"" height=""16"" font=""0"">Members shall ensure that their sanitary and phytosanitary measures do not </text>
<text top=""1064"" left=""151"" width=""600"" height=""16"" font=""0"">arbitrarily or unjustifiably discriminate between Members where identical or similar </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 182 - </text>
</p><p><text top=""128"" left=""151"" width=""598"" height=""16"" font=""0"">conditions prevail, including between their own territory and that of other Members. </text>
<text top=""144"" left=""151"" width=""599"" height=""16"" font=""0"">Sanitary and phytosanitary measures shall not be applied in a manner which would </text>
<text top=""160"" left=""151"" width=""383"" height=""16"" font=""0"">constitute a disguised restriction on international trade. </text>
</p></p></page>
<page number=""182"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.550"" style=""8""><text top=""195"" left=""108"" width=""687"" height=""16"" font=""0"">7.550.  The Appellate Body has clarified that Article 2.3 of the SPS Agreement contains two </text>
<text top=""211"" left=""108"" width=""592"" height=""16"" font=""0"">primary obligations, each of which corresponds to one of the sentences of Article 2.3.</text>
<footnote top=""210"" left=""699"" width=""23"" height=""11"" font=""16"" number=""1430"" ref="""" dis=""""/>
<text top=""211"" left=""723"" width=""68"" height=""16"" font=""0""> The first </text>
<text top=""228"" left=""108"" width=""687"" height=""16"" font=""0"">obligation is contained in the first sentence: ""Members shall ensure that their sanitary and </text>
<text top=""244"" left=""108"" width=""684"" height=""16"" font=""0"">phytosanitary measures do not arbitrarily or unjustifiably discriminate between Members where </text>
<text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">identical or similar conditions prevail "". The second obligation is contained in the second sentence: </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">""Sanitary and phytosanitary measures shall not be applied in a manner which would constitute a </text>
<text top=""293"" left=""108"" width=""304"" height=""16"" font=""0"">disguised restriction on international trade"". </text>
</p><p number=""7.7"" style=""8""><text top=""328"" left=""108"" width=""281"" height=""16"" font=""28"">7.7.2  Main arguments of the parties </text></p><p number=""7.7"" style=""8""><text top=""362"" left=""108"" width=""141"" height=""16"" font=""28"">7.7.2.1  Argentina </text></p><p number=""7.551"" style=""8""><text top=""396"" left=""108"" width=""682"" height=""16"" font=""0"">7.551.  Argentina claims that the United States' measures arbitrarily and unjustifiably discriminate </text>
<text top=""413"" left=""108"" width=""688"" height=""16"" font=""0"">between Members where identical or similar situations prevail and operate as a disguised </text>
<text top=""429"" left=""108"" width=""596"" height=""16"" font=""0"">restriction on international trade, inconsistently with Article 2.3 of the SPS Agreement. </text>
</p><p number=""7.552"" style=""8""><text top=""464"" left=""108"" width=""683"" height=""16"" font=""0"">7.552.  Beginning with arbitrary or unjustifiable discrimination, Argentina notes that the Appellate </text>
<text top=""480"" left=""108"" width=""351"" height=""16"" font=""0"">Body has found similarities between Article </text>
<text top=""480"" left=""450"" width=""263"" height=""16"" font=""0"">2.3 and the chapeau of Article </text>
<text top=""480"" left=""705"" width=""94"" height=""16"" font=""0"">XX of the </text>
<text top=""497"" left=""108"" width=""80"" height=""16"" font=""0"">GATT 1994.</text>
<footnote top=""495"" left=""188"" width=""23"" height=""11"" font=""16"" number=""1431"" ref="""" dis=""""/>
<text top=""497"" left=""211"" width=""581"" height=""16"" font=""0""> Thus, in Argentina's view, the chapeau of Article XX constitutes relevant context </text>
<text top=""513"" left=""108"" width=""654"" height=""16"" font=""0"">for the interpretation of the phrase ""arbitrary or unjustifiable discrimination"" under Article 2.3.</text>
<footnote top=""511"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1432"" ref="""" dis=""""/>
<text top=""529"" left=""108"" width=""683"" height=""16"" font=""0"">Relying on prior panel and Appellate Body reports on the chapeau of Article XX, Argentina argues </text>
<text top=""546"" left=""108"" width=""682"" height=""16"" font=""0"">that the discrimination stemming from the United States' measures ""bears no rational connection"" </text>
<text top=""562"" left=""108"" width=""682"" height=""16"" font=""0"">to their stated objective of protecting the United States' against the introduction, establishment or </text>
<text top=""579"" left=""108"" width=""119"" height=""16"" font=""0"">spread of FMD.</text>
<footnote top=""577"" left=""227"" width=""23"" height=""11"" font=""16"" number=""1433"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""347"" height=""15"" font=""10""> Argentina' first written submission, paras. 329 and 522. </ftext>
</footnote>
<text top=""579"" left=""250"" width=""279"" height=""16"" font=""0""> Argentina claims that the United </text>
<text top=""579"" left=""521"" width=""277"" height=""16"" font=""0"">States' measures discriminate both </text>
<text top=""595"" left=""108"" width=""213"" height=""16"" font=""0"">substantively and procedurally.</text>
<footnote top=""593"" left=""321"" width=""23"" height=""11"" font=""16"" number=""1434"" ref="""" dis=""""/>
</p><p number=""7.553"" style=""8""><text top=""629"" left=""108"" width=""306"" height=""16"" font=""0"">7.553.  As for ""substantive discrimination""</text>
<footnote top=""628"" left=""414"" width=""23"" height=""11"" font=""16"" number=""1435"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""386"" height=""15"" font=""10""> Argentina's second written submission, p. 60, subheading E.1. </ftext>
</footnote>
<text top=""629"" left=""437"" width=""359"" height=""16"" font=""0"">, Argentina submits, first, that by imposing a </text>
<text top=""646"" left=""108"" width=""684"" height=""16"" font=""0"">prohibition on imports of fresh (chilled or frozen) beef from Northern Argentina, while allowing </text>
<text top=""662"" left=""108"" width=""684"" height=""16"" font=""0"">imports of the same products from Uruguay under the mitigating protocols of 9 CFR 94.22, the </text>
<text top=""679"" left=""108"" width=""689"" height=""16"" font=""0"">United States discriminates between the two regions, which are ""in essentially the same </text>
<text top=""695"" left=""108"" width=""70"" height=""16"" font=""0"">situation"".</text>
<footnote top=""693"" left=""178"" width=""23"" height=""11"" font=""16"" number=""1436"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""572"" height=""15"" font=""10""> Argentina's first written submission, para. 268. See also Ibid. para. 326; Argentina's opening </ftext>
<ftext top=""1022"" left=""108"" width=""636"" height=""15"" font=""10"">statement at the first meeting of the Panel, para. 51; Argentina's second written submission, para. 206; </ftext>
</footnote>
<text top=""695"" left=""201"" width=""591"" height=""16"" font=""0""> In Argentina's view, the similarities between Northern Argentina and Uruguay are </text>
<text top=""711"" left=""108"" width=""684"" height=""16"" font=""0"">evidenced by the fact both regions had FMD outbreaks at roughly the same time and are both </text>
<text top=""728"" left=""108"" width=""465"" height=""16"" font=""0"">recognized by the OIE as FMD-free where vaccination is practised.</text>
<footnote top=""726"" left=""573"" width=""23"" height=""11"" font=""16"" number=""1437"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""603"" height=""15"" font=""10""> Argentina's first written submission, para. 330; Argentina's second written submission, para. 213; </ftext>
</footnote>
<text top=""728"" left=""596"" width=""196"" height=""16"" font=""0""> Moreover, Argentina relies </text>
<text top=""744"" left=""108"" width=""683"" height=""16"" font=""0"">on APHIS' statement that ""Uruguay, Argentina and Brazil have an effective cooperative, regional </text>
<text top=""761"" left=""108"" width=""377"" height=""16"" font=""0"">approach to FMD surveillance and control programs"".</text>
<footnote top=""759"" left=""485"" width=""23"" height=""11"" font=""16"" number=""1438"" ref="""" dis=""""/>
<text top=""761"" left=""508"" width=""285"" height=""16"" font=""0""> Finally, Argentina claims that the two </text>
<text top=""777"" left=""108"" width=""649"" height=""16"" font=""0"">regions present similar physical situations and institutional structures for dealing with FMD</text>
<footnote top=""775"" left=""757"" width=""23"" height=""11"" font=""16"" number=""1439"" ref="""" dis=""""/>
<text top=""777"" left=""780"" width=""10"" height=""16"" font=""0"">, </text>
<text top=""793"" left=""108"" width=""684"" height=""16"" font=""0"">including ""sampling methodologies"", ""procedural guidelines for handling outbreaks or suspected </text>
<text top=""810"" left=""108"" width=""684"" height=""16"" font=""0"">situations"", regionally harmonized ""border controls"", ""vaccines"", ""registries/records of producers, </text>
<p><text top=""876"" left=""170"" width=""598"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 252. See also Panel Report, <i>India &#8211; Agricultural </i></text>
<text top=""891"" left=""108"" width=""140"" height=""15"" font=""12""><i>Products</i>, para. 7.388. </text>
<text top=""905"" left=""170"" width=""591"" height=""15"" font=""10""> Argentina' first written submission, para. 327 (citing Appellate Body Report, <i>Australia &#8211; Salmon</i>, </text>
<text top=""920"" left=""108"" width=""73"" height=""15"" font=""10"">para. 251). </text>
<text top=""934"" left=""170"" width=""544"" height=""15"" font=""10""> Argentina' first written submission, para. 328 (citing Panel Report, <i>US &#8211; Poultry (China)</i>, </text>
</p><p><text top=""978"" left=""170"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 205. </text>
</p><p><text top=""1036"" left=""108"" width=""469"" height=""15"" font=""10"">Argentina's opening statement at the second meeting of the Panel, para. 97. </text>
</p><p><text top=""1066"" left=""108"" width=""524"" height=""15"" font=""10"">Argentina's response to Panel question No. 37 following the first substantive meeting. </text>
<text top=""1080"" left=""170"" width=""605"" height=""15"" font=""10""> Argentina's first written submission, para. 333; Argentina's opening statement at the first meeting </text>
</p><p><text top=""1109"" left=""108"" width=""308"" height=""15"" font=""10"">Argentina's second written submission, para. 206. </text>
<text top=""1124"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 334. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 183 - </text>
</p><p><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">vaccination and movement control"", ""sanitary services"", and ""programs for the eradication and </text>
<text top=""144"" left=""108"" width=""110"" height=""16"" font=""0"">control of FMD"".</text>
<footnote top=""143"" left=""218"" width=""23"" height=""11"" font=""16"" number=""1440"" ref="""" dis=""""/>
</p></p></page>
<page number=""183"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.554"" style=""8""><text top=""178"" left=""108"" width=""686"" height=""16"" font=""0"">7.554.  Second, Argentina claims that, by prohibiting imports of FMD-susceptible animals and </text>
<text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">animal products from Patagonia, while recognizing Santa Catarina and Chile as FMD-free under </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">9 CFR 94.1(a) and allowing imports therefrom under the mitigating protocols in 9 CFR 94.11, the </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">United States discriminates between the two regions, which present a ""high degree of similarity"" in </text>
<text top=""244"" left=""108"" width=""196"" height=""16"" font=""0"">terms of sanitary conditions.</text>
<footnote top=""243"" left=""304"" width=""23"" height=""11"" font=""16"" number=""1441"" ref="""" dis=""""/>
<text top=""244"" left=""327"" width=""463"" height=""16"" font=""0""> In Argentina's view, the similarities between Patagonia and Santa </text>
<text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">Catarina are evidenced by the fact that the two regions have had their last FMD outbreaks around </text>
<text top=""277"" left=""108"" width=""100"" height=""16"" font=""0"">the same time</text>
<footnote top=""275"" left=""208"" width=""23"" height=""11"" font=""16"" number=""1442"" ref="""" dis=""""><ftext top=""861"" left=""170"" width=""602"" height=""15"" font=""10""> Argentina's first written submission, para. 520; Argentina's second written submission, para. 223. </ftext>
</footnote>
<text top=""277"" left=""231"" width=""526"" height=""16"" font=""0"">, are recognized by the OIE as FMD-free where vaccination is not practised </text>
<footnote top=""275"" left=""757"" width=""23"" height=""11"" font=""16"" number=""1443"" ref="""" dis=""""><ftext top=""876"" left=""170"" width=""602"" height=""15"" font=""10""> Argentina's first written submission, para. 509; Argentina's second written submission, para. 223. </ftext>
</footnote>
<text top=""277"" left=""780"" width=""10"" height=""16"" font=""0"">, </text>
<text top=""293"" left=""108"" width=""578"" height=""16"" font=""0"">and are part of countries recognized as FMD-free where vaccination is practised.</text>
<footnote top=""292"" left=""686"" width=""23"" height=""11"" font=""16"" number=""1444"" ref="""" dis=""""/>
<text top=""293"" left=""709"" width=""83"" height=""16"" font=""0""> Moreover, </text>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina observes that the last FMD outbreak in Brazil occurred in 2006 and did not affect Santa </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">Catarina, similar to the 2006 FMD outbreak in the Argentine province of Corrientes, which did not </text>
<text top=""342"" left=""108"" width=""115"" height=""16"" font=""0"">affect Patagonia.</text>
<footnote top=""341"" left=""223"" width=""23"" height=""11"" font=""16"" number=""1445"" ref="""" dis=""""/>
<text top=""342"" left=""246"" width=""544"" height=""16"" font=""0""> Argentina further refers to APHIS' focus on regional efforts for the eradication </text>
<text top=""359"" left=""108"" width=""686"" height=""16"" font=""0"">and  control  of  FMD,  especially  in  relation  to  the risk of reintroducing FMD from neighbouring </text>
<text top=""375"" left=""108"" width=""67"" height=""16"" font=""0"">countries.</text>
<footnote top=""374"" left=""175"" width=""23"" height=""11"" font=""16"" number=""1446"" ref="""" dis=""""/>
<text top=""375"" left=""198"" width=""594"" height=""16"" font=""0""> With respect to Chile, Argentina refers to APHIS' 2007 statement that ""the animal </text>
<text top=""392"" left=""108"" width=""403"" height=""16"" font=""0"">health status of Chile and Patagonia South are equivalent"".</text>
<footnote top=""390"" left=""511"" width=""23"" height=""11"" font=""16"" number=""1447"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""596"" height=""15"" font=""10""> Argentina's first written submission, para. 512 (quoting 2007 Proposed Rule on Patagonia South, </ftext>
<ftext top=""963"" left=""108"" width=""176"" height=""15"" font=""10"">(Exhibit ARG-56/USA-104)). </ftext>
</footnote>
</p><p number=""7.555"" style=""8""><text top=""426"" left=""108"" width=""287"" height=""16"" font=""0"">7.555.  As for ""procedural discrimination""</text>
<footnote top=""425"" left=""394"" width=""23"" height=""11"" font=""16"" number=""1448"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""386"" height=""15"" font=""10""> Argentina's second written submission, p. 66, subheading E.2. </ftext>
</footnote>
<text top=""426"" left=""417"" width=""374"" height=""16"" font=""0"">, Argentina claims that United States' prohibitions as </text>
<text top=""443"" left=""108"" width=""682"" height=""16"" font=""0"">applied to the relevant products from Northern Argentina and Patagonia have been ""maintained for </text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">more than a decade without any current valid risk assessment"" taking into account ""the radical </text>
<text top=""475"" left=""108"" width=""346"" height=""16"" font=""0"">improvement on Argentina's sanitary condition"".</text>
<footnote top=""474"" left=""454"" width=""23"" height=""11"" font=""16"" number=""1449"" ref="""" dis=""""/>
<text top=""475"" left=""477"" width=""317"" height=""16"" font=""0""> Conversely, according to Argentina, other </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">Members ""were given risk assessments quite rapidly after significant outbreaks and were moved </text>
<text top=""508"" left=""108"" width=""551"" height=""16"" font=""0"">through the rulemaking process and given import permission accordingly"".</text>
<footnote top=""507"" left=""659"" width=""23"" height=""11"" font=""16"" number=""1450"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""572"" height=""15"" font=""10""> Argentina's first written submission, para. 344. See also Ibid. para. 336; Argentina's opening </ftext>
</footnote>
<text top=""508"" left=""682"" width=""113"" height=""16"" font=""0""> For instance, </text>
<text top=""525"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina observes that Uruguay, which had an FMD outbreak in 2001, was allowed to export </text>
<text top=""541"" left=""108"" width=""458"" height=""16"" font=""0"">fresh (chilled or frozen) beef to the United States again in 2003.</text>
<footnote top=""539"" left=""566"" width=""23"" height=""11"" font=""16"" number=""1451"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""500"" height=""15"" font=""10""> Argentina's second written submission, paras. 227-228. See also Ibid. para. 340. </ftext>
</footnote>
<text top=""541"" left=""589"" width=""202"" height=""16"" font=""0""> Moreover, Argentina notes, </text>
<text top=""557"" left=""108"" width=""685"" height=""16"" font=""0"">the United Kingdom is included in APHIS' list of FMD-free regions under 9 CFR 94.1(a) despite </text>
<text top=""574"" left=""108"" width=""687"" height=""16"" font=""0"">having experienced a ""truly massive"" FMD outbreak in 2000-2001 and another outbreak in </text>
<text top=""590"" left=""108"" width=""39"" height=""16"" font=""0"">2008.</text>
<footnote top=""589"" left=""147"" width=""23"" height=""11"" font=""16"" number=""1452"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""332"" height=""15"" font=""10""> Argentina's first written submission, paras. 342-344.  </ftext>
</footnote>
<text top=""590"" left=""170"" width=""620"" height=""16"" font=""0""> Similarly, Japan is back on APHIS' list despite having suffered an FMD outbreak in 2010, </text>
<text top=""607"" left=""108"" width=""582"" height=""16"" font=""0"">by virtue of a favourable risk assessment conducted ""one year"" after the outbreak.</text>
<footnote top=""605"" left=""690"" width=""23"" height=""11"" font=""16"" number=""1453"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""332"" height=""15"" font=""10""> Argentina's first written submission, paras. 342-344.  </ftext>
</footnote>
<text top=""607"" left=""713"" width=""78"" height=""16"" font=""0""> Argentina </text>
<text top=""623"" left=""108"" width=""682"" height=""16"" font=""0"">concedes that the FMD situations in the United Kingdom and Japan are not necessarily identical to </text>
<text top=""639"" left=""108"" width=""300"" height=""16"" font=""0"">those in Northern Argentina and Patagonia.</text>
<footnote top=""638"" left=""407"" width=""23"" height=""11"" font=""16"" number=""1454"" ref="""" dis=""""/>
<text top=""639"" left=""430"" width=""360"" height=""16"" font=""0""> However, in its view, the condition that is relevant </text>
<text top=""656"" left=""108"" width=""692"" height=""16"" font=""0"">to its procedural discrimination claims is that all the above-mentioned regions ""had </text>
<text top=""672"" left=""108"" width=""682"" height=""16"" font=""0"">FMD outbreaks"" and have an interest in having ""their export rights provided by the [United States] </text>
<text top=""689"" left=""108"" width=""420"" height=""16"" font=""0"">through full access to the United States' regulatory system"".</text>
<footnote top=""687"" left=""528"" width=""23"" height=""11"" font=""16"" number=""1455"" ref="""" dis=""""/>
<text top=""689"" left=""551"" width=""240"" height=""16"" font=""0""> In other words, Argentina claims </text>
<text top=""705"" left=""108"" width=""688"" height=""16"" font=""0"">that it ""has been denied equal access to the US regulatory processes"" enjoyed by other </text>
<text top=""721"" left=""108"" width=""67"" height=""16"" font=""0"">Members.</text>
<footnote top=""720"" left=""175"" width=""23"" height=""11"" font=""16"" number=""1456"" ref="""" dis=""""/>
</p><p number=""7.556"" style=""8""><text top=""756"" left=""108"" width=""689"" height=""16"" font=""0"">7.556.  Next, Argentina claims that the United States measures are applied in a manner </text>
<text top=""772"" left=""108"" width=""683"" height=""16"" font=""0"">constituting a disguised restriction on international trade. Indeed, it contends, ""there could be no </text>
<p><text top=""832"" left=""170"" width=""316"" height=""15"" font=""10""> Argentina's second written submission, para. 209.  </text>
<text top=""847"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 514. </text>
</p><p><text top=""891"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 520. </text>
<text top=""905"" left=""170"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 509-510. </text>
<text top=""920"" left=""170"" width=""618"" height=""15"" font=""10""> Argentina's second written submission, para. 224. See also Argentina's responses to Panel questions </text>
<text top=""934"" left=""108"" width=""337"" height=""15"" font=""10"">Nos. 11 and 37 following the first substantive meeting. </text>
<footnote top=""993"" left=""170"" width=""293"" height=""15"" font=""10"" number=""336"" ref="""" dis=""""/>
</p><p><text top=""1022"" left=""108"" width=""353"" height=""15"" font=""10"">statement at the first meeting of the Panel, paras. 54-55. </text>
</p><p><text top=""1080"" left=""170"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 230. </text>
<text top=""1095"" left=""170"" width=""606"" height=""15"" font=""10""> Argentina's second written submission, para. 231. See also Argentina's response to Panel question </text>
<text top=""1109"" left=""108"" width=""307"" height=""15"" font=""10"">No. 35 following the second substantive meeting.  </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 184 - </text>
</p><p><text top=""128"" left=""108"" width=""558"" height=""16"" font=""0"">greater restriction on international trade than a measure banning imports""</text>
<footnote top=""126"" left=""666"" width=""23"" height=""11"" font=""16"" number=""1457"" ref="""" dis=""""/>
<text top=""128"" left=""689"" width=""106"" height=""16"" font=""0""> continuously </text>
<text top=""144"" left=""108"" width=""557"" height=""16"" font=""0"">maintained ""for eleven years"" without any ""rational, logical or scientific basis"".</text>
<footnote top=""143"" left=""665"" width=""23"" height=""11"" font=""16"" number=""1458"" ref="""" dis=""""/>
<text top=""144"" left=""688"" width=""104"" height=""16"" font=""0""> In particular, </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina maintains that the treatment of Patagonia as opposed to that of Santa Catarina ""is not </text>
<text top=""177"" left=""108"" width=""174"" height=""16"" font=""0"">based on sound science""</text>
<footnote top=""175"" left=""282"" width=""23"" height=""11"" font=""16"" number=""1459"" ref="""" dis=""""/>
<text top=""177"" left=""305"" width=""337"" height=""16"" font=""0"">, but rather on non-scientific domestic interests</text>
<footnote top=""175"" left=""641"" width=""23"" height=""11"" font=""16"" number=""1460"" ref="""" dis=""""/>
<text top=""177"" left=""664"" width=""127"" height=""16"" font=""0"">, as evidenced in </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">particular by the adoption of the ban in Section 737 of the <i>2009 Omnibus Appropriations Act</i> </text>
<text top=""210"" left=""108"" width=""507"" height=""16"" font=""0"">""which restricted the ability of APHIS to proceed to a final rulemaking"".</text>
<footnote top=""208"" left=""615"" width=""23"" height=""11"" font=""16"" number=""1461"" ref="""" dis=""""/>
<text top=""210"" left=""638"" width=""154"" height=""16"" font=""0""> Moreover, Argentina </text>
<text top=""226"" left=""108"" width=""684"" height=""16"" font=""0"">asserts that the 2010 inclusion of Santa Catarina in APHIS' list under 9 CFR 94.1(a) was part of </text>
<text top=""242"" left=""108"" width=""688"" height=""16"" font=""0"">the ""concessions in settlement of the wholly unrelated cotton subsidies dispute with the </text>
<text top=""259"" left=""108"" width=""103"" height=""16"" font=""0"">United States"".</text>
<footnote top=""257"" left=""211"" width=""23"" height=""11"" font=""16"" number=""1462"" ref="""" dis=""""/>
</p></p></page>
<page number=""184"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.7"" style=""8""><text top=""293"" left=""108"" width=""169"" height=""16"" font=""28"">7.7.2.2  United States </text></p><p number=""7.557"" style=""8""><text top=""328"" left=""108"" width=""684"" height=""16"" font=""0"">7.557.  The United States disagrees with Argentina that its measures arbitrarily and unjustifiably </text>
<text top=""344"" left=""108"" width=""685"" height=""16"" font=""0"">discriminate between Members where identical or similar situations prevail. In its view, APHIS' </text>
<text top=""360"" left=""108"" width=""683"" height=""16"" font=""0"">review of applications for the authorization of imports &#8211; that is, ""the process of seeking additional </text>
<text top=""377"" left=""108"" width=""247"" height=""16"" font=""0"">information"" &#8211; is not an SPS </text>
<text top=""377"" left=""347"" width=""363"" height=""16"" font=""0"">measure falling within the purview of Article </text>
<text top=""377"" left=""702"" width=""96"" height=""16"" font=""0"">2.3 of the </text>
<text top=""393"" left=""108"" width=""111"" height=""16"" font=""0"">SPS Agreement.</text>
<footnote top=""392"" left=""219"" width=""23"" height=""11"" font=""16"" number=""1463"" ref="""" dis=""""/>
<text top=""393"" left=""242"" width=""548"" height=""16"" font=""0""> This is because SPS measures are ""applied"" to ""protect animal &#8230; life or health"" </text>
<text top=""410"" left=""108"" width=""457"" height=""16"" font=""0"">and may include ""provisions on &#8230; methods of risk assessment""</text>
<footnote top=""408"" left=""565"" width=""23"" height=""11"" font=""16"" number=""1464"" ref="""" dis=""""/>
<text top=""410"" left=""588"" width=""205"" height=""16"" font=""0"">, whereas Argentina ""is not </text>
<text top=""426"" left=""108"" width=""685"" height=""16"" font=""0"">challenging a method of risk assessment that discriminates against it"", as ""there is nothing in </text>
<text top=""443"" left=""108"" width=""498"" height=""16"" font=""0"">United States' law or regulations on risk assessment that discriminates"".</text>
<footnote top=""441"" left=""606"" width=""23"" height=""11"" font=""16"" number=""1465"" ref="""" dis=""""/>
<text top=""443"" left=""629"" width=""161"" height=""16"" font=""0""> For the United States, </text>
<text top=""459"" left=""108"" width=""683"" height=""16"" font=""0"">it is only the measure that will be adopted following APHIS' review of Argentina's requests that is </text>
<text top=""475"" left=""108"" width=""306"" height=""16"" font=""0"">""applied"" to ""protect animal &#8230; life or health"".</text>
<footnote top=""474"" left=""414"" width=""23"" height=""11"" font=""16"" number=""1466"" ref="""" dis=""""/>
</p><p number=""7.558"" style=""8""><text top=""510"" left=""108"" width=""683"" height=""16"" font=""0"">7.558.  If the Panel were to find that Article 2.3 does, indeed, apply to APHIS' review processes, </text>
<text top=""526"" left=""108"" width=""633"" height=""16"" font=""0"">the United States maintains that Argentina failed to substantiate its discrimination claims.</text>
<footnote top=""525"" left=""741"" width=""23"" height=""11"" font=""16"" number=""1467"" ref="""" dis=""""/>
<text top=""526"" left=""764"" width=""28"" height=""16"" font=""0""> In </text>
<text top=""543"" left=""108"" width=""684"" height=""16"" font=""0"">particular, the United States takes issue with Argentina's argument that, Northern Argentina and </text>
<text top=""559"" left=""108"" width=""683"" height=""16"" font=""0"">Uruguay on the one hand and Patagonia and Santa Catarina on the other, are identical or similar </text>
<text top=""575"" left=""108"" width=""685"" height=""16"" font=""0"">because they share the same OIE FMD disease status. In the United States' opinion, although </text>
<text top=""592"" left=""108"" width=""687"" height=""16"" font=""0"">APHIS considers the OIE's official recognitions of disease status in performing its own risk </text>
<text top=""608"" left=""108"" width=""685"" height=""16"" font=""0"">assessments, such recognitions are not, per se, sufficient to conclude that identical or similar </text>
<text top=""625"" left=""108"" width=""333"" height=""16"" font=""0"">FMD conditions prevail in two or more Members.</text>
<footnote top=""623"" left=""441"" width=""23"" height=""11"" font=""16"" number=""1468"" ref="""" dis=""""/>
<text top=""625"" left=""464"" width=""327"" height=""16"" font=""0""> This is because, the United States argues, the </text>
<text top=""641"" left=""108"" width=""686"" height=""16"" font=""0"">OIE official recognition of FMD disease status for a given region does not take into account </text>
<text top=""657"" left=""108"" width=""683"" height=""16"" font=""0"">important factors, including ""whether the region accepts imports from FMD-infected regions"", the </text>
<text top=""674"" left=""108"" width=""686"" height=""16"" font=""0"">region's ""veterinary services' capacity to detect, prevent and control"" FMD, and the specific </text>
<text top=""690"" left=""108"" width=""561"" height=""16"" font=""0"">SPS measures which are required to meet the United States' ALOP for that region.</text>
<footnote top=""689"" left=""669"" width=""23"" height=""11"" font=""16"" number=""1469"" ref="""" dis=""""/>
</p><p number=""7.559"" style=""8""><text top=""725"" left=""108"" width=""682"" height=""16"" font=""0"">7.559.  The United States highlights differences between the regions identified by Argentina which, </text>
<text top=""741"" left=""108"" width=""684"" height=""16"" font=""0"">in its view, exclude their identity or similarity under Article 2.3. Concerning Northern Argentina </text>
<text top=""757"" left=""108"" width=""683"" height=""16"" font=""0"">and Uruguay, the United States asserts that, at the time of the establishment of the Panel, APHIS </text>
<text top=""774"" left=""108"" width=""684"" height=""16"" font=""0"">had completed a risk analysis for Uruguay and concluded that imports of its products under the </text>
<text top=""790"" left=""108"" width=""468"" height=""16"" font=""0"">protocols in 9 CFR 94.22 would achieve the United States' ALOP.</text>
<footnote top=""789"" left=""576"" width=""23"" height=""11"" font=""16"" number=""1470"" ref="""" dis=""""/>
<text top=""790"" left=""599"" width=""194"" height=""16"" font=""0""> Conversely, at that time </text>
<text top=""807"" left=""108"" width=""684"" height=""16"" font=""0"">APHIS had not yet concluded its risk analysis for Northern Argentina and thus had not reached </text>
<p><text top=""847"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 345. </text>
<text top=""861"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 350. </text>
<text top=""876"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 530. </text>
<text top=""891"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 528. </text>
<text top=""905"" left=""170"" width=""589"" height=""15"" font=""10""> Argentina's first written submission, para. 525. Argentina also refers to a number of statements </text>
<text top=""920"" left=""108"" width=""643"" height=""15"" font=""10"">made by the United States before the SPS Committee that allegedly reveal the existence of non-scientific </text>
<text top=""934"" left=""108"" width=""597"" height=""15"" font=""10"">concerns with respect to imports from Patagonia. (Ibid. paras. 525-527 (referring to G/SPS/R/64, </text>
<text top=""949"" left=""108"" width=""260"" height=""15"" font=""10"">paras. 96-97; and G/SPS/R/67, para. 44). </text>
<text top=""963"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 529. </text>
<footnote top=""978"" left=""170"" width=""612"" height=""15"" font=""10"" number=""303"" ref="""" dis=""""/>
</p><p><text top=""993"" left=""108"" width=""239"" height=""15"" font=""10"">second meeting of the Panel, para. 74. </text>
</p><p><text top=""1051"" left=""170"" width=""604"" height=""15"" font=""10""> United States' second written submission, para. 117; United States' opening statement at the first </text>
<text top=""1066"" left=""108"" width=""661"" height=""15"" font=""10"">meeting of the Panel, para. 70; United States' second written submission, para. 123; United States' opening </text>
<text top=""1080"" left=""108"" width=""349"" height=""15"" font=""10"">statement at the second meeting of the Panel, para. 72.  </text>
<text top=""1095"" left=""170"" width=""329"" height=""15"" font=""10""> United States' second written submission, para. 119. </text>
<text top=""1109"" left=""170"" width=""329"" height=""15"" font=""10""> United States' second written submission, para. 121. </text>
<text top=""1124"" left=""170"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 42 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 185 - </text>
</p><p><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">conclusions as to the appropriateness of the application of the same mitigating protocols to </text>
<text top=""144"" left=""108"" width=""233"" height=""16"" font=""0"">imports from Northern Argentina.</text>
<footnote top=""143"" left=""341"" width=""23"" height=""11"" font=""16"" number=""1471"" ref="""" dis=""""/>
<text top=""144"" left=""364"" width=""428"" height=""16"" font=""0""> In the United States' view, the difference between the time </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">taken to conduct the two reviews is justified by the fact that the two regions are not similarly </text>
<text top=""177"" left=""108"" width=""688"" height=""16"" font=""0"">situated in terms of geography and cross-border FMD introduction, populations of livestock </text>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">susceptible to FMD, volume of veterinary resources, and recent FMD history. The United States </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">notes that Uruguay is a ""small country"" and shares only two terrestrial borders with Brazil and </text>
<text top=""226"" left=""108"" width=""688"" height=""16"" font=""0"">Argentina; it has a ""relatively small population of animals susceptible to FMD""; and ""has </text>
<text top=""242"" left=""108"" width=""684"" height=""16"" font=""0"">infrastructure to carry out FMD control and eradication programs"", with ""105,051 heads of cattle </text>
<text top=""259"" left=""108"" width=""180"" height=""16"" font=""0"">for every veterinarian"".</text>
<footnote top=""257"" left=""288"" width=""23"" height=""11"" font=""16"" number=""1472"" ref="""" dis=""""/>
<text top=""259"" left=""311"" width=""182"" height=""16"" font=""0""> Further, the United </text>
<text top=""259"" left=""482"" width=""318"" height=""16"" font=""0"">States argues, Uruguay did not have </text>
<text top=""275"" left=""108"" width=""686"" height=""16"" font=""0"">FMD outbreaks from 1990 to 2000-2001; it promptly reported the 2001 outbreak, which was </text>
<text top=""292"" left=""108"" width=""654"" height=""16"" font=""0"">""traceable to a strain of FMD virus in Argentina"", and ""was transparent to APHIS authorities"".</text>
<footnote top=""290"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1473"" ref="""" dis=""""/>
<text top=""308"" left=""108"" width=""683"" height=""16"" font=""0"">Conversely, the United States observes, Argentina is ""15 times larger than Uruguay"", and shares </text>
<text top=""324"" left=""108"" width=""684"" height=""16"" font=""0"">longer terrestrial borders with Chile, Bolivia, Paraguay, Brazil, and Uruguay; two of Argentina's </text>
<text top=""341"" left=""108"" width=""685"" height=""16"" font=""0"">neighbouring countries ""have had recent FMD outbreaks""; Argentina has a livestock population </text>
<text top=""357"" left=""108"" width=""686"" height=""16"" font=""0"">""significantly larger"" than does Uruguay, and is less equipped to carry out FMD control and </text>
<text top=""374"" left=""108"" width=""529"" height=""16"" font=""0"">eradication programs, with ""221,519 heads of cattle for every veterinarian"".</text>
<footnote top=""372"" left=""637"" width=""23"" height=""11"" font=""16"" number=""1474"" ref="""" dis=""""/>
<text top=""374"" left=""660"" width=""131"" height=""16"" font=""0""> Finally, according </text>
<text top=""390"" left=""108"" width=""683"" height=""16"" font=""0"">to the United States, the Argentine authorities intentionally kept the full extent of its 2000-2001 </text>
<text top=""407"" left=""108"" width=""191"" height=""16"" font=""0"">FMD outbreaks  confidential.</text>
<footnote top=""405"" left=""299"" width=""23"" height=""11"" font=""16"" number=""1475"" ref="""" dis=""""/>
<text top=""407"" left=""322"" width=""469"" height=""16"" font=""0""> In its view, Argentina has not effectively addressed such factors, </text>
<text top=""423"" left=""108"" width=""682"" height=""16"" font=""0"">nor has it provided any scientific evidence concerning similarities between Northern Argentina and </text>
<text top=""439"" left=""108"" width=""62"" height=""16"" font=""0"">Uruguay.</text>
<footnote top=""438"" left=""170"" width=""23"" height=""11"" font=""16"" number=""1476"" ref="""" dis=""""/>
</p></p></page>
<page number=""185"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.560"" style=""8""><text top=""474"" left=""108"" width=""682"" height=""16"" font=""0"">7.560.  Similarly, the United States takes issue with the alleged similarities between the conditions </text>
<text top=""490"" left=""108"" width=""654"" height=""16"" font=""0"">prevailing in Patagonia, Santa Catarina, and Chile. It contends that the ""key differentiation""</text>
<footnote top=""489"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1477"" ref="""" dis=""""/>
<text top=""507"" left=""108"" width=""682"" height=""16"" font=""0"">between Patagonia and Santa Catarina is the fact that APHIS was able to ""draw a conclusion as to </text>
<text top=""523"" left=""108"" width=""683"" height=""16"" font=""0"">the appropriateness of the import authorization terms"" applied to imports from the latter region, </text>
<text top=""539"" left=""108"" width=""684"" height=""16"" font=""0"">whereas at the time of the Panel's establishment it had not reached such a determination with </text>
<text top=""556"" left=""108"" width=""248"" height=""16"" font=""0"">respect to imports from the former.</text>
<footnote top=""554"" left=""356"" width=""23"" height=""11"" font=""16"" number=""1478"" ref="""" dis=""""/>
<text top=""556"" left=""379"" width=""412"" height=""16"" font=""0""> This is because, the United States contends, in December </text>
<text top=""572"" left=""108"" width=""684"" height=""16"" font=""0"">2008 SENASA extended its original request for the recognition of Patagonia South to Patagonia </text>
<text top=""589"" left=""108"" width=""57"" height=""16"" font=""0"">North B.</text>
<footnote top=""587"" left=""165"" width=""23"" height=""11"" font=""16"" number=""1479"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""464"" height=""15"" font=""10""> United States' first written submission, para. 318. See also Ibid. para. 298. </ftext>
</footnote>
<text top=""589"" left=""188"" width=""605"" height=""16"" font=""0""> Moreover, the United States maintains that while Santa Catarina ""had no sanitary </text>
<text top=""605"" left=""108"" width=""688"" height=""16"" font=""0"">boundary changes"" during APHIS' review of Brazil's application, Argentina ""introduced new </text>
<text top=""621"" left=""108"" width=""654"" height=""16"" font=""0"">changes to the sanitary boundaries between Patagonia South and Patagonia North B in 2008"".</text>
<footnote top=""620"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1480"" ref="""" dis=""""/>
<text top=""638"" left=""108"" width=""684"" height=""16"" font=""0"">In its view, such changes added a ""confounding element"" to APHIS' review, which was initially </text>
<text top=""654"" left=""108"" width=""378"" height=""16"" font=""0"">""premised on certain controls with Patagonia North B""</text>
<footnote top=""653"" left=""486"" width=""23"" height=""11"" font=""16"" number=""1481"" ref="""" dis=""""/>
<text top=""654"" left=""509"" width=""283"" height=""16"" font=""0"">, therefore explaining the ""difference in </text>
<text top=""671"" left=""108"" width=""110"" height=""16"" font=""0"">review periods"".</text>
<footnote top=""669"" left=""218"" width=""23"" height=""11"" font=""16"" number=""1482"" ref="""" dis=""""/>
<text top=""671"" left=""241"" width=""549"" height=""16"" font=""0""> With respect to Chile, the United States maintains that APHIS' 2007 statement </text>
<text top=""687"" left=""108"" width=""684"" height=""16"" font=""0"">regarding its equivalence with Patagonia South simply referred to the fact that the two regions </text>
<text top=""703"" left=""108"" width=""368"" height=""16"" font=""0"">""had the same OIE animal health status recognition"".</text>
<footnote top=""702"" left=""476"" width=""23"" height=""11"" font=""16"" number=""1483"" ref="""" dis=""""/>
<text top=""703"" left=""499"" width=""292"" height=""16"" font=""0""> In its view, such a statement alone does </text>
<text top=""720"" left=""108"" width=""684"" height=""16"" font=""0"">not prove identity or similarity between the two regions ""unless and until APHIS makes a final </text>
<text top=""736"" left=""108"" width=""292"" height=""16"" font=""0"">determination regarding Patagonia South"".</text>
<footnote top=""735"" left=""400"" width=""23"" height=""11"" font=""16"" number=""1484"" ref="""" dis=""""/>
</p><p number=""7.561"" style=""8""><text top=""771"" left=""108"" width=""58"" height=""16"" font=""0"">7.561. </text>
<text top=""771"" left=""162"" width=""590"" height=""16"" font=""0"">Concerning Argentina's allegations of procedural discrimination, the United </text>
<text top=""771"" left=""742"" width=""57"" height=""16"" font=""0"">States </text>
<text top=""787"" left=""108"" width=""682"" height=""16"" font=""0"">maintains that ""differences in time"" in APHIS' review of Argentina's requests as compared to the </text>
<text top=""803"" left=""108"" width=""613"" height=""16"" font=""0"">requests of other Members are ""not a sufficient basis"" to substantiate Argentina's claims.</text>
<footnote top=""802"" left=""721"" width=""23"" height=""11"" font=""16"" number=""1485"" ref="""" dis=""""/>
<text top=""803"" left=""744"" width=""46"" height=""16"" font=""0""> In its </text>
<text top=""820"" left=""108"" width=""685"" height=""16"" font=""0"">view, the process for reaching conclusions as to the FMD status of a region ""depends upon a </text>
<text top=""836"" left=""108"" width=""125"" height=""16"" font=""0"">variety of factors""</text>
<footnote top=""835"" left=""233"" width=""23"" height=""11"" font=""16"" number=""1486"" ref="""" dis=""""/>
<text top=""836"" left=""256"" width=""535"" height=""16"" font=""0"">, including ""the comprehensiveness of the submission of the applicant"" and </text>
<text top=""853"" left=""108"" width=""615"" height=""16"" font=""0"">the applicant's ""responsiveness"" in ""providing answers to follow up questions"".</text>
<footnote top=""851"" left=""723"" width=""23"" height=""11"" font=""16"" number=""1487"" ref="""" dis=""""/>
<text top=""853"" left=""746"" width=""52"" height=""16"" font=""0""> The </text>
<p><text top=""891"" left=""170"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 46 following the first substantive meeting. </text>
<text top=""905"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 307. </text>
<footnote top=""920"" left=""170"" width=""310"" height=""15"" font=""10"" number=""310"" ref="""" dis=""""/>
</p><p><text top=""934"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 309. </text>
</p><p><text top=""963"" left=""170"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 44 following the first substantive meeting. </text>
<footnote top=""978"" left=""170"" width=""310"" height=""15"" font=""10"" number=""318"" ref="""" dis=""""/>
</p><p><text top=""993"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 298. </text>
<footnote top=""1066"" left=""170"" width=""545"" height=""15"" font=""10"" number=""39"" ref="""" dis=""""/>
<footnote top=""1095"" left=""170"" width=""310"" height=""15"" font=""10"" number=""304"" ref="""" dis=""""/>
<footnote top=""1124"" left=""170"" width=""310"" height=""15"" font=""10"" number=""305"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 186 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">United States maintains that the perceived length of the review of Argentina's requests was due to </text>
<text top=""144"" left=""108"" width=""207"" height=""16"" font=""0"">""individualized circumstances""</text>
<footnote top=""143"" left=""315"" width=""23"" height=""11"" font=""16"" number=""1488"" ref="""" dis=""""/>
<text top=""144"" left=""338"" width=""453"" height=""16"" font=""0"">, such as SENASA's delays in responding to APHIS' requests for </text>
<text top=""160"" left=""108"" width=""78"" height=""16"" font=""0"">information</text>
<footnote top=""159"" left=""186"" width=""23"" height=""11"" font=""16"" number=""1489"" ref="""" dis=""""/>
<text top=""160"" left=""209"" width=""585"" height=""16"" font=""0""> and the 2003 and 2006 FMD outbreaks which occurred in Northern Argentina </text>
<text top=""177"" left=""108"" width=""346"" height=""16"" font=""0"">""during the course of the application process"".</text>
<footnote top=""175"" left=""454"" width=""23"" height=""11"" font=""16"" number=""1490"" ref="""" dis=""""/>
<text top=""177"" left=""477"" width=""318"" height=""16"" font=""0""> Accordingly, the United States concludes, </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina ""has not established, merely by asserting a difference in review time, that discrimination </text>
<text top=""210"" left=""108"" width=""314"" height=""16"" font=""0"">occurred in relation to any of its applications"".</text>
<footnote top=""208"" left=""422"" width=""23"" height=""11"" font=""16"" number=""1491"" ref="""" dis=""""/>
</p></p></page>
<page number=""186"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.562"" style=""8""><text top=""244"" left=""108"" width=""686"" height=""16"" font=""0"">7.562.  Moreover, the United States contends that, as admitted by Argentina, the substantive </text>
<text top=""260"" left=""108"" width=""686"" height=""16"" font=""0"">FMD conditions in Northern Argentina, Patagonia, Japan, and the United Kingdom ""are [not] </text>
<text top=""277"" left=""108"" width=""68"" height=""16"" font=""0"">identical"".</text>
<footnote top=""275"" left=""176"" width=""23"" height=""11"" font=""16"" number=""1492"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""608"" height=""15"" font=""10""> United States' first written submission, paras. 312, 314 (citing Argentina's first written submission, </ftext>
<ftext top=""920"" left=""108"" width=""629"" height=""15"" font=""10"">para. 344). See also United States' response to Panel question No. 36 following the second substantive </ftext>
<ftext top=""934"" left=""108"" width=""58"" height=""15"" font=""10"">meeting. </ftext>
</footnote>
<text top=""277"" left=""199"" width=""593"" height=""16"" font=""0""> It notes that both Japan and the United Kingdom are island chains; therefore land </text>
<text top=""293"" left=""108"" width=""481"" height=""16"" font=""0"">crossing of FMD-infected animals over a long border ""is not possible"".</text>
<footnote top=""292"" left=""589"" width=""23"" height=""11"" font=""16"" number=""1493"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""370"" height=""15"" font=""10""> United States' first written submission, paras. 313 and 315. </ftext>
</footnote>
<text top=""293"" left=""612"" width=""178"" height=""16"" font=""0""> Further, it observes that </text>
<text top=""310"" left=""108"" width=""688"" height=""16"" font=""0"">Japan and the United Kingdom have a different FMD history from that of Argentina and </text>
<text top=""326"" left=""108"" width=""72"" height=""16"" font=""0"">Patagonia.</text>
<footnote top=""325"" left=""180"" width=""23"" height=""11"" font=""16"" number=""1494"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""370"" height=""15"" font=""10""> United States' first written submission, paras. 313 and 315. </ftext>
</footnote>
<text top=""326"" left=""203"" width=""592"" height=""16"" font=""0""> In light of the above, the United States considers it ""reasonable"" that APHIS' </text>
<text top=""342"" left=""108"" width=""686"" height=""16"" font=""0"">assessment of regions such as Japan and the United Kingdom would be ""less complex"", and </text>
<text top=""359"" left=""108"" width=""386"" height=""16"" font=""0"">therefore would require less time than that of Argentina.</text>
<footnote top=""357"" left=""494"" width=""23"" height=""11"" font=""16"" number=""1495"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""370"" height=""15"" font=""10""> United States' first written submission, paras. 313 and 316. </ftext>
</footnote>
</p><p number=""7.563"" style=""8""><text top=""393"" left=""108"" width=""686"" height=""16"" font=""0"">7.563.  Finally, the United States disagrees with Argentina that its measures are applied in a </text>
<text top=""410"" left=""108"" width=""682"" height=""16"" font=""0"">manner constituting a disguised restriction on international trade. In its view, the word ""disguised"" </text>
<text top=""426"" left=""108"" width=""682"" height=""16"" font=""0"">as referred to a restriction on international trade ""may mean 'hidden' or 'dissimulated'"". According </text>
<text top=""443"" left=""108"" width=""688"" height=""16"" font=""0"">to the United States, that ""is not the case"" with respect to APHIS' review of Argentina's </text>
<text top=""459"" left=""108"" width=""85"" height=""16"" font=""0"">applications,</text>
<footnote top=""457"" left=""193"" width=""23"" height=""11"" font=""16"" number=""1496"" ref="""" dis=""""/>
<text top=""459"" left=""216"" width=""576"" height=""16"" font=""0""> which took into account ""objective concerns"" such as ""Argentina's FMD history, </text>
<text top=""475"" left=""108"" width=""685"" height=""16"" font=""0"">the series of outbreaks since 2000, the deliberate cover-up of outbreaks, and shifting sanitary </text>
<text top=""492"" left=""108"" width=""221"" height=""16"" font=""0"">boundaries within the country"".</text>
<footnote top=""490"" left=""329"" width=""23"" height=""11"" font=""16"" number=""1497"" ref="""" dis=""""/>
<text top=""492"" left=""352"" width=""440"" height=""16"" font=""0""> In its opinion, APHIS' review process, motivated by the fact </text>
<text top=""508"" left=""108"" width=""683"" height=""16"" font=""0"">that ""an FMD outbreak in the United States would lead to severe economic and social damage"", is </text>
<text top=""525"" left=""108"" width=""361"" height=""16"" font=""0"">in  accordance  with  ""the  principle  of  good  faith""</text>
<footnote top=""523"" left=""469"" width=""23"" height=""11"" font=""16"" number=""1498"" ref="""" dis=""""/>
<text top=""525"" left=""492"" width=""304"" height=""16"" font=""0""> and consistent with the United States' </text>
<text top=""541"" left=""108"" width=""264"" height=""16"" font=""0"">obligations under the SPS Agreement. </text>
</p><p number=""7.7"" style=""8""><text top=""575"" left=""108"" width=""322"" height=""16"" font=""28"">7.7.3  Main arguments of the third parties </text></p><p number=""7.7"" style=""8""><text top=""610"" left=""108"" width=""109"" height=""16"" font=""28"">7.7.3.1  China </text></p><p number=""7.564"" style=""8""><text top=""644"" left=""108"" width=""683"" height=""16"" font=""0"">7.564.  China notes that the parties disagree as to the measure at issue under Article 2.3 of the </text>
<text top=""661"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Agreement. In its view, Argentina defines such a measure as an ""import prohibition"", whereas </text>
<text top=""677"" left=""108"" width=""685"" height=""16"" font=""0"">the United States defines it as its ""regulatory process"". For China, there is no doubt that the </text>
<text top=""693"" left=""108"" width=""685"" height=""16"" font=""0"">""import prohibition"" is an SPS measure subject to the disciplines of Article 2.3, irrespective of </text>
<text top=""710"" left=""108"" width=""362"" height=""16"" font=""0"">whether the ""regulatory process"" is an SPS measure.</text>
<footnote top=""708"" left=""470"" width=""23"" height=""11"" font=""16"" number=""1499"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""616"" height=""15"" font=""10""> We understand China to be referring to the distinction between 9 CFR 94.1(b) and the application of </ftext>
<ftext top=""1066"" left=""108"" width=""334"" height=""15"" font=""10"">the regulatory process under 9 CFR 92.2 to Argentina. </ftext>
</footnote>
</p><p number=""7.565"" style=""8""><text top=""744"" left=""108"" width=""684"" height=""16"" font=""0"">7.565.  China recalls that ""the chapeau of Article XX of the GATT 1994 is relevant and provides </text>
<text top=""761"" left=""108"" width=""631"" height=""16"" font=""0"">guidance in interpreting the 'arbitrary or unjustifiable discrimination' under Article 2.3"".</text>
<footnote top=""759"" left=""739"" width=""23"" height=""11"" font=""16"" number=""1500"" ref="""" dis=""""/>
<text top=""761"" left=""762"" width=""32"" height=""16"" font=""0""> In </text>
<text top=""777"" left=""108"" width=""682"" height=""16"" font=""0"">particular, the analysis of whether the application of a measure results in arbitrary or unjustifiable </text>
<text top=""793"" left=""108"" width=""684"" height=""16"" font=""0"">discrimination ""should focus on the cause of the discrimination, or the rationale put forward to </text>
<text top=""810"" left=""108"" width=""150"" height=""16"" font=""0"">explain its existence"".</text>
<footnote top=""808"" left=""258"" width=""23"" height=""11"" font=""16"" number=""1501"" ref="""" dis=""""/>
<text top=""810"" left=""281"" width=""509"" height=""16"" font=""0""> In other words, an assessment of whether discrimination is ""arbitrary or </text>
<footnote top=""847"" left=""170"" width=""310"" height=""15"" font=""10"" number=""306"" ref="""" dis=""""/>
<footnote top=""993"" left=""170"" width=""310"" height=""15"" font=""10"" number=""320"" ref="""" dis=""""><ftext top=""1036"" left=""108"" width=""85"" height=""15"" font=""10"">para. 7.321). </ftext>
</footnote>
<footnote top=""1080"" left=""170"" width=""513"" height=""15"" font=""10"" number=""51"" ref="""" dis=""""/>
<p><text top=""1095"" left=""108"" width=""131"" height=""15"" font=""10"">paras. 7.260-7.261). </text>
</p><p><text top=""1124"" left=""108"" width=""73"" height=""15"" font=""10"">para. 226). </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 187 - </text>
</p><p><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">unjustifiable"" should be made ""in light of the objectives of the measure and whether the </text>
<text top=""144"" left=""108"" width=""598"" height=""16"" font=""0"">discrimination bears a rational connection to the stated objective of the measure"".</text>
<footnote top=""143"" left=""706"" width=""23"" height=""11"" font=""16"" number=""1502"" ref="""" dis=""""/>
<text top=""144"" left=""729"" width=""65"" height=""16"" font=""0""> Finally, </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">China stresses that ""not all discrimination in the application of measures is necessarily 'arbitrary or </text>
<text top=""177"" left=""108"" width=""649"" height=""16"" font=""0"">unjustifiable' and it is only the arbitrary or unjustifiable inconsistencies that are to be avoided"".</text>
<footnote top=""175"" left=""757"" width=""23"" height=""11"" font=""16"" number=""1503"" ref=""WT/DS26/AB/R ; WT/DS48/AB/R"" dis=""DS26""><ftext top=""920"" left=""170"" width=""612"" height=""15"" font=""10""> China's third-party submission, para. 51 (citing Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 213). </ftext>
</footnote>
</p></p></page>
<page number=""187"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.7"" style=""8""><text top=""211"" left=""108"" width=""187"" height=""16"" font=""28"">7.7.3.2  European Union </text></p><p number=""7.566"" style=""8""><text top=""246"" left=""108"" width=""683"" height=""16"" font=""0"">7.566.  The European Union notes that, when confronted with discrimination claims arising under </text>
<text top=""262"" left=""108"" width=""682"" height=""16"" font=""0"">the SPS Agreement, panels ""have generally focused their analysis on Article 5.5, finding a violation </text>
<text top=""278"" left=""108"" width=""480"" height=""16"" font=""0"">of Article 2.3 only where there was also a violation of Article 5.5"".</text>
<footnote top=""277"" left=""588"" width=""23"" height=""11"" font=""16"" number=""1504"" ref="""" dis=""""/>
<text top=""278"" left=""611"" width=""182"" height=""16"" font=""0""> In the present dispute, </text>
<text top=""295"" left=""108"" width=""355"" height=""16"" font=""0"">Argentina ""does not raise a claim under Article 5.5"".</text>
<footnote top=""293"" left=""463"" width=""23"" height=""11"" font=""16"" number=""1505"" ref="""" dis=""""/>
</p><p number=""7.567"" style=""8""><text top=""329"" left=""108"" width=""686"" height=""16"" font=""0"">7.567.  The European Union goes on to observe that the thrust of Argentina's claims under </text>
<text top=""346"" left=""108"" width=""682"" height=""16"" font=""0"">Article 2.3 is a ""comparison of its own status"" with ""the status of other countries or regions"" under </text>
<text top=""362"" left=""108"" width=""208"" height=""16"" font=""0"">United States' domestic rules.</text>
<footnote top=""361"" left=""316"" width=""23"" height=""11"" font=""16"" number=""1506"" ref="""" dis=""""/>
<text top=""362"" left=""339"" width=""453"" height=""16"" font=""0""> However, 9 CFR 94.1(b) only contains a general prohibition of </text>
<text top=""378"" left=""108"" width=""684"" height=""16"" font=""0"">imports from regions that are not FMD-free, whereas the determination of whether a particular </text>
<text top=""395"" left=""108"" width=""654"" height=""16"" font=""0"">region is FMD-free or not is contained in 9 CFR 94.1(a), which Argentina does not challenge.</text>
<footnote top=""393"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1507"" ref="""" dis=""""/>
<text top=""411"" left=""108"" width=""685"" height=""16"" font=""0"">Accordingly, the European Union ""does not see how Argentina's claims under Article 2.3 of the </text>
<text top=""428"" left=""108"" width=""252"" height=""16"" font=""0"">SPS Agreement could be successful"".</text>
<footnote top=""426"" left=""360"" width=""23"" height=""11"" font=""16"" number=""1508"" ref="""" dis=""""/>
</p><p number=""7.7"" style=""8""><text top=""462"" left=""108"" width=""214"" height=""16"" font=""28"">7.7.4  Analysis by the Panel </text></p><p number=""7.568"" style=""8""><text top=""497"" left=""108"" width=""683"" height=""16"" font=""0"">7.568.  According to the Appellate Body, Article 2.3 is a provision of ""fundamental importance"" in </text>
<text top=""513"" left=""108"" width=""246"" height=""16"" font=""0"">the context of the SPS Agreement.</text>
<footnote top=""511"" left=""354"" width=""23"" height=""11"" font=""16"" number=""1509"" ref="""" dis=""""/>
<text top=""513"" left=""377"" width=""415"" height=""16"" font=""0""> Indeed, it is contained in Article 2, entitled ""Basic Rights </text>
<text top=""529"" left=""108"" width=""591"" height=""16"" font=""0"">and Obligations"", and mirrors the first recital in the Preamble of the SPS Agreement.</text>
<footnote top=""528"" left=""699"" width=""23"" height=""11"" font=""16"" number=""1510"" ref="""" dis=""""/>
<text top=""529"" left=""722"" width=""69"" height=""16"" font=""0""> We note </text>
<text top=""546"" left=""108"" width=""686"" height=""16"" font=""0"">that Argentina links its claims under Article 2.3 to its claims under Article 5.6. Although the </text>
<text top=""562"" left=""108"" width=""682"" height=""16"" font=""0"">Appellate Body has considered that Article 5.5, ""may be seen to be marking out and elaborating a </text>
<text top=""579"" left=""108"" width=""442"" height=""16"" font=""0"">particular route leading to the same destination"" as Article 2.3</text>
<footnote top=""577"" left=""550"" width=""23"" height=""11"" font=""16"" number=""1511"" ref="""" dis=""""/>
<text top=""579"" left=""573"" width=""219"" height=""16"" font=""0"">, no similar decision has been </text>
<text top=""595"" left=""108"" width=""685"" height=""16"" font=""0"">made with respect to Article 5.6. Furthermore, we note that the panel in <i>India &#8211; Agricultural </i></text>
<text top=""611"" left=""108"" width=""682"" height=""16"" font=""18""><i>Products </i>explained that Article 2.3 ""is of a more general character"" than the specific paragraphs of </text>
<text top=""628"" left=""108"" width=""61"" height=""16"" font=""0"">Article 5.</text>
<footnote top=""626"" left=""169"" width=""23"" height=""11"" font=""16"" number=""1512"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1095"" left=""170"" width=""396"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, paras. 7.344-7.355. </ftext>
</footnote>
</p><p number=""7.569"" style=""8""><text top=""662"" left=""108"" width=""683"" height=""16"" font=""0"">7.569.  The Appellate Body noted that the language of Article 2.3 incorporates, <i>inter alia,</i> part of </text>
<text top=""679"" left=""108"" width=""302"" height=""16"" font=""0"">the chapeau to Article XX of the GATT 1994.</text>
<footnote top=""677"" left=""410"" width=""23"" height=""11"" font=""16"" number=""1513"" ref="""" dis=""""/>
<text top=""679"" left=""433"" width=""357"" height=""16"" font=""0""> The chapeau of Article XX of the GATT 1994 reads, </text>
<text top=""695"" left=""108"" width=""116"" height=""16"" font=""0"">in relevant part: </text>
<p><text top=""729"" left=""151"" width=""599"" height=""16"" font=""0"">Subject to the requirement that such measures are not applied in a manner which </text>
<text top=""746"" left=""151"" width=""597"" height=""16"" font=""0"">would constitute a means of <i>arbitrary or unjustifiable discrimination</i> between <i>countries </i></text>
<text top=""762"" left=""151"" width=""597"" height=""16"" font=""18""><i>where the same conditions prevail</i>, or a <i>disguised restriction on international trade</i>, &#8230; </text>
<text top=""779"" left=""151"" width=""598"" height=""16"" font=""0"">nothing in this Agreement shall be construed to prevent the adoption or enforcement </text>
<text top=""795"" left=""151"" width=""603"" height=""16"" font=""0"">by any contracting party of measures [enacted for the purposes listed in the </text>
<text top=""811"" left=""151"" width=""332"" height=""16"" font=""0"">subparagraphs of Article XX]. (emphasis added) </text>
</p><p><text top=""905"" left=""108"" width=""73"" height=""15"" font=""10"">para. 227). </text>
<footnote top=""934"" left=""170"" width=""318"" height=""15"" font=""10"" number=""68"" ref="""" dis=""""/>
<footnote top=""963"" left=""170"" width=""318"" height=""15"" font=""10"" number=""69"" ref="""" dis=""""/>
</p><p><text top=""993"" left=""170"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 71. </text>
<footnote top=""1007"" left=""170"" width=""337"" height=""15"" font=""10"" number=""251"" ref="""" dis=""""><ftext top=""1124"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.260. </ftext>
</footnote>
</p><p><text top=""1036"" left=""170"" width=""604"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 212. This approach was followed, <i>inter alia</i>, in Panel </text>
<text top=""1051"" left=""108"" width=""644"" height=""15"" font=""10"">Reports, <i>Australia &#8211; Salmon (Article 21.5 - Canada)</i>, paras. 7.112-7.114; <i>EC &#8211; Approval and Marketing of </i></text>
<text top=""1066"" left=""108"" width=""605"" height=""15"" font=""12""><i>Biotech Products</i>, paras. 7.1446-7.1448, 7.1765-7.1766 and 7.3405-7.3406; <i>US &#8211; Poultry (China)</i>, </text>
<text top=""1080"" left=""108"" width=""357"" height=""15"" font=""10"">paras. 7.318-7.319; and <i>Australia &#8211; Apples</i>, para. 7.1095. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 188 - </text>
</p></p></page>
<page number=""188"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.570"" style=""8""><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">7.570.  We agree that the language of the chapeau of Article XX of the GATT 1994 presents a </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">number of similarities with that of Article 2.3. As noted by the panel in <i>India &#8211; Agricultural </i></text>
<text top=""160"" left=""108"" width=""685"" height=""16"" font=""18""><i>Products</i>, both provisions speak of arbitrary and unjustifiable discrimination, and a comparison </text>
<text top=""177"" left=""108"" width=""397"" height=""16"" font=""0"">between the ""conditions"" prevailing in different Members.</text>
<footnote top=""175"" left=""505"" width=""23"" height=""11"" font=""16"" number=""1514"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""905"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.400. </ftext>
</footnote>
<text top=""177"" left=""528"" width=""263"" height=""16"" font=""0""> We also observe that the last recital </text>
<text top=""193"" left=""108"" width=""686"" height=""16"" font=""0"">of the Preamble of the SPS Agreement states that the Agreement ""elaborate[s] rules for the </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">application of the provisions of GATT 1994 which relate to the use of [SPS] measures, in particular </text>
<text top=""226"" left=""108"" width=""425"" height=""16"" font=""0"">the provisions of Article XX(b)"", which includes the chapeau.</text>
<footnote top=""225"" left=""533"" width=""23"" height=""11"" font=""16"" number=""1515"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""920"" left=""170"" width=""376"" height=""15"" font=""10""> See Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.400. </ftext>
</footnote>
<text top=""226"" left=""556"" width=""235"" height=""16"" font=""0""> Therefore, we consider that the </text>
<text top=""242"" left=""108"" width=""651"" height=""16"" font=""0"">chapeau of Article XX provides useful context for our interpretation of the terms of Article 2.3.  </text>
</p><p number=""7.571"" style=""8""><text top=""277"" left=""108"" width=""682"" height=""16"" font=""0"">7.571.  With respect to the obligation in the first sentence of Article 2.3, we recall that the panel in </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""18""><i>Australia &#8211; Salmon (Article 21.5 &#8211; Canada) </i>found that three cumulative requirements must be met </text>
<text top=""310"" left=""108"" width=""683"" height=""16"" font=""0"">in order to establish a violation of that provision: (i) that identical or similar conditions prevail in </text>
<text top=""326"" left=""108"" width=""682"" height=""16"" font=""0"">the territory of the Members compared; (ii) that the measure discriminates between the territories </text>
<text top=""342"" left=""108"" width=""533"" height=""16"" font=""0"">of such Members; and (iii) that the discrimination is arbitrary or unjustifiable.</text>
<footnote top=""341"" left=""641"" width=""23"" height=""11"" font=""16"" number=""1516"" ref=""WT/DS18/11|WT/DS18/R|WT/DS18/RW|WT/DS18/R/Corr.1"" dis=""DS18""><ftext top=""934"" left=""170"" width=""437"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Salmon (Article 21.5 &#8211; Canada)</i>, para. 7.111. </ftext>
</footnote>
<text top=""342"" left=""664"" width=""127"" height=""16"" font=""0""> We address each </text>
<text top=""359"" left=""108"" width=""209"" height=""16"" font=""0"">of these requirements in turn. </text>
</p><p number=""7.572"" style=""8""><text top=""393"" left=""108"" width=""682"" height=""16"" font=""0"">7.572.  As to the requirement that identical or similar conditions prevail in the Members compared, </text>
<text top=""410"" left=""108"" width=""683"" height=""16"" font=""0"">we note that the term ""identical"" is defined as ""designating a proposition whose terms express an </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">identity or denote the same thing; of a thing or set of things viewed at different times &#8211; the very </text>
<text top=""443"" left=""108"" width=""468"" height=""16"" font=""0"">same; or of two or more separate things; agreeing in every detail"".</text>
<footnote top=""441"" left=""576"" width=""23"" height=""11"" font=""16"" number=""1517"" ref="""" dis=""""/>
<text top=""443"" left=""599"" width=""192"" height=""16"" font=""0""> In turn, the term ""similar"" </text>
<text top=""459"" left=""108"" width=""689"" height=""16"" font=""0"">is defined as ""of the same substance or structure throughout &#8211; homogenous; having a </text>
<text top=""475"" left=""108"" width=""368"" height=""16"" font=""0"">resemblance or likeness; of the same nature or kind"".</text>
<footnote top=""474"" left=""476"" width=""23"" height=""11"" font=""16"" number=""1518"" ref="""" dis=""""/>
<text top=""475"" left=""499"" width=""291"" height=""16"" font=""0""> Finally, the term ""condition"" is defined as </text>
<text top=""492"" left=""108"" width=""682"" height=""16"" font=""0"">""a way of living or existing""; ""the state of something""; ""the physical state of something""; and ""the </text>
<text top=""508"" left=""108"" width=""320"" height=""16"" font=""0"">physical or mental state of a person or thing"".</text>
<footnote top=""507"" left=""428"" width=""23"" height=""11"" font=""16"" number=""1519"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""618"" height=""15"" font=""10""> <i>Merriam-Webster</i>, available at http://www.merriam-webster.com/dictionary/condition (last accessed </ftext>
<ftext top=""1022"" left=""108"" width=""126"" height=""15"" font=""10"">9 December 2014).  </ftext>
</footnote>
<text top=""508"" left=""451"" width=""339"" height=""16"" font=""0""> In the context of the chapeau of Article XX, the </text>
<text top=""525"" left=""108"" width=""686"" height=""16"" font=""0"">Appellate Body stated in <i>EC &#8211; Seal Products</i> that ""only 'conditions' that are <i>relevant</i> for the </text>
<text top=""541"" left=""108"" width=""682"" height=""16"" font=""0"">purpose of establishing arbitrary or unjustifiable discrimination in the light of the specific character </text>
<text top=""557"" left=""108"" width=""41"" height=""16"" font=""0"">of the</text>
<text top=""557"" left=""154"" width=""590"" height=""16"" font=""0"">measure at issue and the circumstances of a particular case"" should be considered.</text>
<footnote top=""556"" left=""744"" width=""23"" height=""11"" font=""16"" number=""1520"" ref=""WT/DS400/AB/R ; WT/DS401/AB/R"" dis=""DS401|DS400""><ftext top=""1036"" left=""170"" width=""462"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Seal Products</i>, para. 5.299 (emphasis added). </ftext>
</footnote>
<text top=""557"" left=""767"" width=""24"" height=""16"" font=""0""> It </text>
<text top=""574"" left=""108"" width=""683"" height=""16"" font=""0"">further observed that the regulatory objective pursued by the measure at issue may also provide </text>
<text top=""590"" left=""108"" width=""688"" height=""16"" font=""0"">useful guidance on the question of which ""conditions"" prevailing in different Members are </text>
<text top=""607"" left=""108"" width=""73"" height=""16"" font=""0"">""relevant"".</text>
<footnote top=""605"" left=""181"" width=""23"" height=""11"" font=""16"" number=""1521"" ref=""WT/DS400/AB/R ; WT/DS401/AB/R"" dis=""DS401|DS400""><ftext top=""1051"" left=""170"" width=""349"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Seal Products</i>, para. 5.300. </ftext>
</footnote>
</p><p number=""7.573"" style=""8""><text top=""641"" left=""108"" width=""683"" height=""16"" font=""0"">7.573.  Turning to the requirement that the measures discriminate between Members that are in </text>
<text top=""657"" left=""108"" width=""682"" height=""16"" font=""0"">identical or similar conditions, the Appellate Body consistently stated that different treatment does </text>
<text top=""674"" left=""108"" width=""684"" height=""16"" font=""0"">not necessarily amount to discrimination. The focus of a discrimination analysis is whether the </text>
<text top=""690"" left=""108"" width=""684"" height=""16"" font=""0"">measure at issue alters the conditions of competition to the detriment of products originating in </text>
<text top=""707"" left=""108"" width=""683"" height=""16"" font=""0"">the territories of Members other than the Member imposing the measure or between the territory </text>
<text top=""723"" left=""108"" width=""494"" height=""16"" font=""0"">of the Member imposing the measure and that of another Member.</text>
<footnote top=""721"" left=""602"" width=""23"" height=""11"" font=""16"" number=""1522"" ref="""" dis=""""/>
<text top=""723"" left=""625"" width=""169"" height=""16"" font=""0""> In <i>US &#8211; Shrimp</i>, the </text>
<text top=""739"" left=""108"" width=""683"" height=""16"" font=""0"">Appellate Body found that ""discrimination"" in the context of the chapeau of Article XX may result </text>
<text top=""756"" left=""108"" width=""685"" height=""16"" font=""0"">not only when Members in which the same conditions prevail are treated differently, but also </text>
<text top=""772"" left=""108"" width=""689"" height=""16"" font=""0"">where the application of the measure at issue does not allow for any inquiry into the </text>
<text top=""789"" left=""108"" width=""687"" height=""16"" font=""0"">appropriateness of the regulatory programme for the conditions prevailing in the exporting </text>
<text top=""805"" left=""108"" width=""56"" height=""16"" font=""0"">country.</text>
<footnote top=""804"" left=""164"" width=""23"" height=""11"" font=""16"" number=""1523"" ref="""" dis=""""/>
<text top=""805"" left=""187"" width=""603"" height=""16"" font=""0""> Further, according to the Appellate Body, discrimination may arise not only from ""the </text>
<text top=""821"" left=""108"" width=""682"" height=""16"" font=""0"">detailed operating provisions"" of a measure, but also from the application of a measure ""otherwise </text>
<text top=""838"" left=""108"" width=""176"" height=""16"" font=""0"">fair and just on its face"".</text>
<footnote top=""836"" left=""284"" width=""23"" height=""11"" font=""16"" number=""1524"" ref="""" dis=""""/>
<text top=""838"" left=""307"" width=""484"" height=""16"" font=""0""> Finally, the panel in <i>US &#8211; Poultry (China)</i> stated that discrimination </text>
<footnote top=""949"" left=""170"" width=""363"" height=""15"" font=""10"" number=""6"" ref="""" dis=""""><ftext top=""977"" left=""533"" width=""8"" height=""9"" font=""10"">th</ftext>
</footnote>
<p><text top=""948"" left=""533"" width=""8"" height=""9"" font=""10"">th</text>
<footnote top=""949"" left=""541"" width=""223"" height=""15"" font=""10"" number=""2007"" ref="""" dis=""""><ftext top=""993"" left=""108"" width=""99"" height=""15"" font=""10"">Vol. 2, p. 2838. </ftext>
</footnote>
<text top=""963"" left=""108"" width=""99"" height=""15"" font=""10"">Vol. 1, p. 1319. </text>
</p><p><text top=""1066"" left=""170"" width=""596"" height=""15"" font=""10""> See e.g. Appellate Body Reports, <i>EC &#8211; Asbestos</i>, paras. 98-99; <i>Dominican Republic</i> &#8211; <i>Import and </i></text>
<text top=""1080"" left=""108"" width=""422"" height=""15"" font=""12""><i>Sale of Cigarettes</i>, para. 96; <i>Philippines &#8211; Distilled Spirits</i>, para. 256. </text>
<text top=""1095"" left=""170"" width=""560"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Shrimp</i>, para. 165. See also Panel Report, <i>India &#8211; Agricultural </i></text>
<text top=""1109"" left=""108"" width=""438"" height=""15"" font=""12""><i>Products</i>, para. 7.400; Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.292. </text>
<text top=""1124"" left=""170"" width=""300"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Shrimp</i>, para. 160. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 189 - </text>
</p><p><text top=""128"" left=""108"" width=""344"" height=""16"" font=""0"">may stem from both ""'substantive' SPS </text>
<text top=""128"" left=""440"" width=""362"" height=""16"" font=""0"">measures"" and ""procedural and information </text>
<text top=""144"" left=""108"" width=""102"" height=""16"" font=""0"">requirements"".</text>
<footnote top=""143"" left=""209"" width=""23"" height=""11"" font=""16"" number=""1525"" ref=""WT/DS392/R|WT/DS58/AB/RW|WT/DS58/AB/R"" dis=""DS401|DS392|DS400|DS58""><ftext top=""993"" left=""170"" width=""604"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.147. In the context of the chapeau of Article XX of the </ftext>
<ftext top=""1007"" left=""108"" width=""605"" height=""15"" font=""10"">GATT 1994, see Appellate Body Reports, <i>US &#8211; Shrimp</i>, para. 160; <i>EC &#8211; Seal Products</i>, para. 5.302. </ftext>
</footnote>
</p></p></page>
<page number=""189"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.574"" style=""8""><text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">7.574.  Finally, we turn to the requirement that discrimination be ""arbitrary or unjustifiable"". The </text>
<text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">Appellate Body found in <i>Brazil &#8211; Retreaded Tyres</i> that an analysis of whether discrimination is </text>
<text top=""211"" left=""108"" width=""685"" height=""16"" font=""0"">arbitrary or unjustifiable within the meaning of the chapeau of Article XX ""should focus on the </text>
<text top=""228"" left=""108"" width=""574"" height=""16"" font=""0"">cause of the discrimination, or the rationale put forward to explain its existence"".</text>
<footnote top=""226"" left=""682"" width=""23"" height=""11"" font=""16"" number=""1526"" ref="""" dis=""""/>
<text top=""228"" left=""705"" width=""86"" height=""16"" font=""0""> Relying on </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">the Appellate Body's reasoning, the panel in <i>US &#8211; Poultry (China) </i>concluded that the meaning of </text>
<text top=""260"" left=""108"" width=""690"" height=""16"" font=""0"">""arbitrary or unjustifiable discrimination"" in Article 2.3 of the SPS Agreement involves a </text>
<text top=""277"" left=""108"" width=""686"" height=""16"" font=""0"">consideration of whether there is a ""rational connection"" between the reasons given for the </text>
<text top=""293"" left=""108"" width=""463"" height=""16"" font=""0"">discriminatory treatment and ""the stated objective of the measure"".</text>
<footnote top=""292"" left=""571"" width=""23"" height=""11"" font=""16"" number=""1527"" ref=""WT/DS430/R/Add.1|WT/DS430/R|WT/DS392/R"" dis=""DS430|DS392""><ftext top=""1066"" left=""170"" width=""562"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.261. See also Panel Report, <i>India &#8211; Agricultural </i></ftext>
<ftext top=""1080"" left=""108"" width=""140"" height=""15"" font=""12""><i>Products</i>, para. 7.429. </ftext>
</footnote>
</p><p number=""7.575"" style=""8""><text top=""328"" left=""108"" width=""685"" height=""16"" font=""0"">7.575.  Concerning the meaning of ""disguised restriction on international trade"", the Appellate </text>
<text top=""344"" left=""108"" width=""683"" height=""16"" font=""0"">Body in <i>US &#8211; Gasoline</i> stated that such a notion, as contained in the chapeau of Article XX of the </text>
<text top=""360"" left=""108"" width=""495"" height=""16"" font=""0"">GATT 1994, ""includes disguised discrimination in international trade"".</text>
<footnote top=""359"" left=""603"" width=""23"" height=""11"" font=""16"" number=""1528"" ref=""WT/DS2/AB/R"" dis=""DS4|DS2""><ftext top=""1095"" left=""170"" width=""372"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Gasoline</i>, DSR 1996:I, 3, p. 25. </ftext>
</footnote>
<text top=""360"" left=""626"" width=""167"" height=""16"" font=""0""> More specifically, the </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">Appellate Body found that ""'disguised restriction', whatever else it covers, may properly be read as </text>
<text top=""393"" left=""108"" width=""555"" height=""16"" font=""0"">embracing restrictions amounting to arbitrary or unjustifiable discrimination"".</text>
<footnote top=""392"" left=""662"" width=""23"" height=""11"" font=""16"" number=""1529"" ref=""WT/DS2/AB/R"" dis=""DS2|DS4""><ftext top=""1109"" left=""170"" width=""372"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Gasoline</i>, DSR 1996:I, 3, p. 25. </ftext>
</footnote>
<text top=""393"" left=""685"" width=""108"" height=""16"" font=""0""> The panel in </text>
<text top=""410"" left=""108"" width=""687"" height=""16"" font=""18""><i>India &#8211; Agricultural Products</i> applied the same reasoning in its interpretation of ""disguised </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">restriction on international trade"" in Article 2.3 of the SPS Agreement, and stated that such terms </text>
<text top=""443"" left=""108"" width=""566"" height=""16"" font=""0"">""encompass measures that constitute arbitrary or unjustifiable discrimination"".</text>
<footnote top=""441"" left=""674"" width=""23"" height=""11"" font=""16"" number=""1530"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1124"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.476. </ftext>
</footnote>
<text top=""443"" left=""697"" width=""97"" height=""16"" font=""0""> We see no </text>
<text top=""459"" left=""108"" width=""683"" height=""16"" font=""0"">reason to depart from the above-mentioned approach in our assessment of Argentina's claims in </text>
<text top=""475"" left=""108"" width=""682"" height=""16"" font=""0"">this dispute. We thus consider that a finding that the United States' measures result in arbitrary or </text>
<text top=""492"" left=""108"" width=""684"" height=""16"" font=""0"">unjustifiable discrimination would necessarily entail a finding that they are applied in a manner </text>
<text top=""508"" left=""108"" width=""471"" height=""16"" font=""0"">which would constitute a disguised restriction on international trade. </text>
</p><p number=""7.576"" style=""8""><text top=""543"" left=""108"" width=""684"" height=""16"" font=""0"">7.576.  With these considerations in mind, we turn to Argentina's claims that the United States' </text>
<text top=""559"" left=""108"" width=""685"" height=""16"" font=""0"">measures arbitrarily and unjustifiably discriminate between Members where identical or similar </text>
<text top=""575"" left=""108"" width=""683"" height=""16"" font=""0"">conditions prevail. We recall that Argentina submits three distinct claims under the first sentence </text>
<text top=""592"" left=""108"" width=""684"" height=""16"" font=""0"">of Article 2.3, each concerning different regions. In particular, Argentina takes issue with three </text>
<text top=""608"" left=""108"" width=""688"" height=""16"" font=""0"">forms of alleged arbitrary or unjustifiable discrimination stemming from the United States' </text>
<text top=""625"" left=""108"" width=""77"" height=""16"" font=""0"">measures: </text>
</p><p number=""a."" style=""2""><text top=""659"" left=""151"" width=""645"" height=""16"" font=""0"">a.  Discrimination between Northern Argentina and Uruguay: The United States allows </text>
<text top=""675"" left=""176"" width=""614"" height=""16"" font=""0"">imports of fresh (chilled or frozen) beef from Uruguay whereas it does not allow imports </text>
<text top=""692"" left=""176"" width=""615"" height=""16"" font=""0"">of the same products from Northern Argentina, despite the fact that the two regions are </text>
<text top=""708"" left=""176"" width=""616"" height=""16"" font=""0"">in ""essentially the same"" FMD situation; moreover, the United States conducted a risk </text>
<text top=""725"" left=""176"" width=""616"" height=""16"" font=""0"">analysis and issued a positive determination for Uruguay within a reasonable period of </text>
<text top=""741"" left=""176"" width=""616"" height=""16"" font=""0"">time, whereas it has maintained its prohibition on imports of products from Northern </text>
<text top=""757"" left=""176"" width=""336"" height=""16"" font=""0"">Argentina without a risk assessment since 2001; </text>
</p><p number=""b."" style=""2""><text top=""792"" left=""151"" width=""644"" height=""16"" font=""0"">b.  Discrimination between Patagonia and Santa Catarina and Chile: The United States </text>
<text top=""808"" left=""176"" width=""617"" height=""16"" font=""0"">recognizes Santa Catarina and Chile as FMD-free within the meaning of 94.1(a) and </text>
<text top=""825"" left=""176"" width=""618"" height=""16"" font=""0"">therefore allows imports of FMD-susceptible animals and animal products therefrom </text>
<text top=""841"" left=""176"" width=""615"" height=""16"" font=""0"">under the mitigating protocols in 9 CFR 94.11, whereas it does not allow imports of the </text>
<text top=""857"" left=""176"" width=""614"" height=""16"" font=""0"">same products from Patagonia, despite the fact that the three regions are highly similar; </text>
<text top=""874"" left=""176"" width=""615"" height=""16"" font=""0"">moreover, the United States conducted a risk analysis and issued positive determination </text>
<text top=""890"" left=""176"" width=""617"" height=""16"" font=""0"">for Santa Catarina within a reasonable period of time, whereas it has maintained its </text>
<text top=""907"" left=""176"" width=""614"" height=""16"" font=""0"">prohibition on imports of products from Patagonia without a risk assessment since 2001; </text>
<text top=""923"" left=""176"" width=""30"" height=""16"" font=""0"">and </text>
</p><p><text top=""1022"" left=""170"" width=""616"" height=""15"" font=""10""> Appellate Body Report, <i>Brazil &#8211; Retreaded Tyres</i>, para. 226 (referring to Appellate Body Reports, <i>US </i></text>
<text top=""1036"" left=""108"" width=""659"" height=""15"" font=""12""><i>&#8211; Gasoline</i>; <i>US &#8211; Shrimp</i>; and <i>US &#8211; Shrimp (Article 21.5 &#8211; Malaysia)</i>). See also Appellate Body Report, <i>EC &#8211; </i></text>
<text top=""1051"" left=""108"" width=""495"" height=""15"" font=""12""><i>Seal Products</i>, para. 5.303; and Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.261. </text>
</p></page>
<page number=""190"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 190 - </text>
</p><p number=""c."" style=""2""><text top=""128"" left=""151"" width=""641"" height=""16"" font=""0"">c.  Discrimination between Northern Argentina, Patagonia, Japan and the United Kingdom: </text>
<text top=""144"" left=""176"" width=""616"" height=""16"" font=""0"">That United States conducted risk analyses and issued positive determinations on the </text>
<text top=""160"" left=""176"" width=""617"" height=""16"" font=""0"">applications for imports of Japan and the United Kingdom, whereas it maintained its </text>
<text top=""177"" left=""176"" width=""614"" height=""16"" font=""0"">prohibition on imports of products from Northern Argentina and Patagonia without a risk </text>
<text top=""193"" left=""176"" width=""167"" height=""16"" font=""0"">assessment since 2001. </text>
</p><p number=""7.577"" style=""8""><text top=""228"" left=""108"" width=""375"" height=""16"" font=""0"">7.577.  We address each of Argentina's claims in turn. </text>
</p><p number=""7.7"" style=""8""><text top=""262"" left=""108"" width=""501"" height=""16"" font=""28"">7.7.4.1  Discrimination between Northern Argentina and Uruguay </text></p><p number=""7.578"" style=""8""><text top=""296"" left=""108"" width=""682"" height=""16"" font=""0"">7.578.  First, we assess Argentina's claim that, by allowing imports of fresh (chilled or frozen) beef </text>
<text top=""313"" left=""108"" width=""684"" height=""16"" font=""0"">from Uruguay under the protocols in 9 CFR 94.22 and prohibiting imports of the same products </text>
<text top=""329"" left=""108"" width=""684"" height=""16"" font=""0"">from Northern Argentina, the United States arbitrarily or unjustifiably discriminates between the </text>
<text top=""346"" left=""108"" width=""682"" height=""16"" font=""0"">two regions, which it describes as ""essentially the same"". Pursuant to the guidance from the panel </text>
<text top=""362"" left=""108"" width=""683"" height=""16"" font=""0"">in <i>Australia &#8211; Salmon (Article 21.5 &#8211; Canada)</i> we must answer the following questions in order to </text>
<text top=""378"" left=""108"" width=""682"" height=""16"" font=""0"">determine whether Argentina has established its claim: (i) Do similar or identical conditions prevail </text>
<text top=""395"" left=""108"" width=""687"" height=""16"" font=""0"">in Northern Argentina and Uruguay? (ii) If so, do the United States' measures discriminate </text>
<text top=""411"" left=""108"" width=""597"" height=""16"" font=""0"">between the two regions? and (iii) If so, is the discrimination arbitrary or unjustifiable? </text>
</p><p number=""7.7"" style=""8""><text top=""446"" left=""108"" width=""669"" height=""16"" font=""28"">7.7.4.1.1  Do similar or identical conditions prevail in Northern Argentina and Uruguay? </text></p><p number=""7.579"" style=""8""><text top=""480"" left=""108"" width=""687"" height=""16"" font=""0"">7.579.  Beginning with the first question, we must determine what conditions prevailing in </text>
<text top=""497"" left=""108"" width=""682"" height=""16"" font=""0"">Northern Argentina and Uruguay are relevant for the purposes of our comparison. As stated by the </text>
<text top=""513"" left=""108"" width=""684"" height=""16"" font=""0"">Appellate Body, the regulatory objective of the measure, as well as its ""design"", ""architecture"", </text>
<text top=""529"" left=""108"" width=""685"" height=""16"" font=""0"">and ""revealing structure"", inform the interpretation of the relevant conditions prevailing in the </text>
<text top=""546"" left=""108"" width=""155"" height=""16"" font=""0"">territory of a Member.</text>
<footnote top=""544"" left=""263"" width=""23"" height=""11"" font=""16"" number=""1531"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.572 above. </ftext>
</footnote>
<text top=""546"" left=""286"" width=""505"" height=""16"" font=""0""> As noted above, APHIS' regulatory scheme, contained in 9 CFR 94 and </text>
<text top=""562"" left=""108"" width=""684"" height=""16"" font=""0"">9 CFR 92.2, is designed to ensure that FMD-susceptible animals or animal products be imported </text>
<text top=""579"" left=""108"" width=""689"" height=""16"" font=""0"">into the United States only from countries or regions that APHIS has determined to be </text>
<text top=""595"" left=""108"" width=""67"" height=""16"" font=""0"">FMD-free.</text>
<footnote top=""593"" left=""175"" width=""23"" height=""11"" font=""16"" number=""1532"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""240"" height=""15"" font=""10""> See paras. 7.37-7.41 and 7.74 above. </ftext>
</footnote>
<text top=""595"" left=""198"" width=""594"" height=""16"" font=""0""> In turn, we noted that the regulatory scheme in question is implemented for the </text>
<text top=""611"" left=""108"" width=""682"" height=""16"" font=""0"">purpose of achieving the objective set forth in 7 USC 8303(a), namely to ""prevent the introduction </text>
<text top=""628"" left=""108"" width=""575"" height=""16"" font=""0"">into or dissemination within the United States of any pest or disease of livestock.""</text>
<footnote top=""626"" left=""682"" width=""23"" height=""11"" font=""16"" number=""1533"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""225"" height=""15"" font=""10""> 7 USC &#167; 8303(a), (Exhibit USA-75). </ftext>
</footnote>
<text top=""628"" left=""705"" width=""86"" height=""16"" font=""0""> Finally, we </text>
<text top=""644"" left=""108"" width=""685"" height=""16"" font=""0"">note that APHIS allows imports of fresh (chilled or frozen) beef from Uruguay subject to the </text>
<text top=""661"" left=""108"" width=""683"" height=""16"" font=""0"">mitigating protocols in 9 CFR 94.22, despite the fact that Uruguay is not recognized as FMD-free </text>
<text top=""677"" left=""108"" width=""682"" height=""16"" font=""0"">within the meaning of 9 CFR 94.1(a). The United States describes the protocols applied to Uruguay </text>
<text top=""693"" left=""108"" width=""684"" height=""16"" font=""0"">as ""scientifically justified"" requirements without which ""import of beef from Uruguay would not </text>
<text top=""710"" left=""108"" width=""213"" height=""16"" font=""0"">meet the United States' ALOP"".</text>
<footnote top=""708"" left=""321"" width=""23"" height=""11"" font=""16"" number=""1534"" ref="""" dis=""""/>
</p><p number=""7.580"" style=""8""><text top=""744"" left=""108"" width=""683"" height=""16"" font=""0"">7.580.  Based on the above, we consider that APHIS' regulatory framework aims at ensuring that </text>
<text top=""761"" left=""108"" width=""682"" height=""16"" font=""0"">imports of FMD-susceptible animals and animal products into the United States are allowed only if </text>
<text top=""777"" left=""108"" width=""686"" height=""16"" font=""0"">the level of risk posed by such imports, possibly after the application of certain scientifically </text>
<text top=""793"" left=""108"" width=""683"" height=""16"" font=""0"">justified mitigating protocols, achieves the United States' ALOP for FMD. Hence, we consider that </text>
<text top=""810"" left=""108"" width=""682"" height=""16"" font=""0"">the condition that must be identical or similar in Northern Argentina and Uruguay in order to meet </text>
<text top=""826"" left=""108"" width=""682"" height=""16"" font=""0"">the first prong of the test is the level of risk of FMD-introduction posed by imports of fresh (chilled </text>
<text top=""843"" left=""108"" width=""684"" height=""16"" font=""0"">or frozen) beef from the two regions, as well as their ability to meet the United States' ALOP if </text>
<text top=""859"" left=""108"" width=""684"" height=""16"" font=""0"">subjected to similar mitigating protocols. This is consistent with the findings of prior panels. For </text>
<text top=""875"" left=""108"" width=""686"" height=""16"" font=""0"">instance, the panel in <i>Australia &#8211; Salmon (Article 21.5 &#8211; Canada)</i> concluded that similar or </text>
<text top=""892"" left=""108"" width=""684"" height=""16"" font=""0"">identical conditions did not prevail in the territories of the two Members it compared because of </text>
<text top=""908"" left=""108"" width=""435"" height=""16"" font=""0"">""substantial difference[s] of disease status"" between the two.</text>
<footnote top=""907"" left=""543"" width=""23"" height=""11"" font=""16"" number=""1535"" ref=""WT/DS18/11|WT/DS18/R/Corr.1|WT/DS18/R|WT/DS18/RW"" dis=""DS18""><ftext top=""1109"" left=""170"" width=""484"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Salmon (Article 21.5 &#8211; Canada)</i>, paras. 7.113-7.114. </ftext>
</footnote>
<text top=""908"" left=""566"" width=""226"" height=""16"" font=""0""> Similarly, the panel in <i>India &#8211; </i></text>
<text top=""925"" left=""108"" width=""687"" height=""16"" font=""18""><i>Agricultural Products</i> considered that the relevant conditions in its analysis referred to the </text>
<text top=""941"" left=""108"" width=""501"" height=""16"" font=""0"">presence of a certain disease in the territories of the Members compared.</text>
<footnote top=""940"" left=""608"" width=""23"" height=""11"" font=""16"" number=""1536"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1124"" left=""170"" width=""421"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, paras. 7.463 and 7.468. </ftext>
<ftext top=""1022"" left=""108"" width=""494"" height=""15"" font=""10"">Panel questions Nos. 35 and 36; Dr Bonbon's response to Panel question No. 34. </ftext>
<ftext top=""1065"" left=""533"" width=""8"" height=""9"" font=""10"">th</ftext>
<ftext top=""1080"" left=""108"" width=""99"" height=""15"" font=""10"">Vol. 2, p. 2838. </ftext>
<ftext top=""1124"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.285. </ftext>
</footnote>
</p><p number=""7.581"" style=""8""><text top=""976"" left=""108"" width=""682"" height=""16"" font=""0"">7.581.  We are mindful that, in comparing the levels of FMD-risk posed by imports of fresh (chilled </text>
<text top=""992"" left=""108"" width=""686"" height=""16"" font=""0"">or frozen) beef from Northern Argentina and Uruguay, we are not simply required to assess </text>
<text top=""1008"" left=""108"" width=""684"" height=""16"" font=""0"">whether FMD is present in the territory of either region or to take note of the OIE FMD-status </text>
<p><text top=""1095"" left=""170"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 45 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 191 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">assigned to such regions. Indeed, as the United States correctly observes, the level of risk posed </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">by imports from the two regions is not only a function of their disease-prevalence in a given point </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">in time, but also, and most importantly, of the credibility of the sanitary measures in place in such </text>
<text top=""177"" left=""108"" width=""254"" height=""16"" font=""0"">regions to prevent and control FMD.</text>
<footnote top=""175"" left=""362"" width=""23"" height=""11"" font=""16"" number=""1537"" ref="""" dis=""""/>
<text top=""177"" left=""385"" width=""407"" height=""16"" font=""0""> Thus, our assessment must include a comparison of the </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">effectiveness and credibility of the sanitary measures in place in the two regions to prevent and </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">control FMD, as well as the ability of imports from the two regions to meet the United States' ALOP </text>
<text top=""226"" left=""108"" width=""444"" height=""16"" font=""0"">&#8211; with or without the application of certain mitigating protocols.  </text>
</p></p></page>
<page number=""191"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.582"" style=""8""><text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">7.582.  In section 7.6.7.4.1 above, we found that Northern Argentina has the necessary veterinary </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">capacity and infrastructure to prevent and control FMD in its territory and the capacity to prevent </text>
<text top=""293"" left=""108"" width=""683"" height=""16"" font=""0"">incursions of the disease from neighbouring regions, and concluded that, if applied to imports of </text>
<text top=""310"" left=""108"" width=""686"" height=""16"" font=""0"">fresh (chilled or frozen) beef from that region, the protocols set forth in 9 CFR 94.22 would </text>
<text top=""326"" left=""108"" width=""291"" height=""16"" font=""0"">achieve the United States' ALOP for FMD.  </text>
</p><p number=""7.583"" style=""8""><text top=""360"" left=""108"" width=""687"" height=""16"" font=""0"">7.583.  We are not in a position to make specific findings as to the FMD situation and the </text>
<text top=""377"" left=""108"" width=""686"" height=""16"" font=""0"">credibility of the sanitary structures in Uruguay, as the scientific evidence on the record, in </text>
<text top=""393"" left=""108"" width=""251"" height=""16"" font=""0"">particular APHIS' 2002 risk analysis</text>
<footnote top=""392"" left=""359"" width=""23"" height=""11"" font=""16"" number=""1538"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""335"" height=""15"" font=""10""> 2002 Risk Assessment for Uruguay, (Exhibit ARG-65). </ftext>
</footnote>
<text top=""393"" left=""382"" width=""410"" height=""16"" font=""0"">, does not allow us to conduct such an assessment. This </text>
<text top=""410"" left=""108"" width=""686"" height=""16"" font=""0"">understanding finds support in the opinions of the experts, who stated that the information </text>
<text top=""426"" left=""108"" width=""684"" height=""16"" font=""0"">contained in APHIS' 2002 risk analysis for Uruguay does not permit a proper comparison of the </text>
<text top=""443"" left=""108"" width=""437"" height=""16"" font=""0"">prevention and control measures in force in the two regions.</text>
<footnote top=""441"" left=""545"" width=""23"" height=""11"" font=""16"" number=""1539"" ref="""" dis=""""/>
<text top=""443"" left=""568"" width=""225"" height=""16"" font=""0""> We note, however, that upon </text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">concluding its risk analysis in 2002, APHIS was satisfied that the measures in place in Uruguay </text>
<text top=""475"" left=""108"" width=""683"" height=""16"" font=""0"">were adequate to prevent and control the disease, and concluded that imports of fresh (chilled or </text>
<text top=""492"" left=""108"" width=""684"" height=""16"" font=""0"">frozen) beef from that region would achieve the United States' ALOP if the protocols set forth in </text>
<text top=""508"" left=""108"" width=""180"" height=""16"" font=""0"">9 CFR 94.22 were applied.</text>
<footnote top=""507"" left=""288"" width=""23"" height=""11"" font=""16"" number=""1540"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""347"" height=""15"" font=""10""> 2003 Final Rule on beef from Uruguay, (Exhibit ARG-8). </ftext>
</footnote>
<text top=""508"" left=""311"" width=""398"" height=""16"" font=""0""> APHIS thus decided to reopen its market to such imports.</text>
<footnote top=""507"" left=""708"" width=""23"" height=""11"" font=""16"" number=""1541"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""347"" height=""15"" font=""10""> 2003 Final Rule on beef from Uruguay, (Exhibit ARG-8). </ftext>
</footnote>
</p><p number=""7.584"" style=""8""><text top=""543"" left=""108"" width=""684"" height=""16"" font=""0"">7.584.  Based on the foregoing, we take the view that imports of fresh (chilled or frozen) beef </text>
<text top=""559"" left=""108"" width=""683"" height=""16"" font=""0"">from both Northern Argentina and Uruguay, if subject to the protocols under 9 CFR 94.22, would </text>
<text top=""575"" left=""108"" width=""685"" height=""16"" font=""0"">achieve the United States' ALOP for FMD. In light of this similarity, the relevant conditions in </text>
<text top=""592"" left=""108"" width=""682"" height=""16"" font=""0"">Northern Argentina and Uruguay do have ""a resemblance or likeness"" and are ""of the same nature </text>
<text top=""608"" left=""108"" width=""60"" height=""16"" font=""0"">or kind"".</text>
<footnote top=""607"" left=""168"" width=""23"" height=""11"" font=""16"" number=""1542"" ref="""" dis=""""/>
<text top=""608"" left=""191"" width=""600"" height=""16"" font=""0""> Therefore, we conclude that the relevant conditions in the two regions are ""similar"" </text>
<text top=""625"" left=""108"" width=""233"" height=""16"" font=""0"">within the meaning of Article 2.3. </text>
</p><p number=""7.7"" style=""8""><text top=""659"" left=""108"" width=""621"" height=""16"" font=""28"">7.7.4.1.2  Do the United States' measures discriminate between the two regions? </text></p><p number=""7.585"" style=""8""><text top=""693"" left=""108"" width=""685"" height=""16"" font=""0"">7.585.  Turning to the second prong of the test, we recall that discrimination may arise when </text>
<text top=""710"" left=""108"" width=""507"" height=""16"" font=""0"">Members in which the same conditions prevail are treated differently.</text>
<footnote top=""708"" left=""615"" width=""23"" height=""11"" font=""16"" number=""1543"" ref="""" dis=""""/>
<text top=""710"" left=""638"" width=""155"" height=""16"" font=""0""> The Appellate Body </text>
<text top=""726"" left=""108"" width=""686"" height=""16"" font=""0"">found, in the context of Article 5.5 of the SPS Agreement, that one of the ""warning signals"" </text>
<text top=""743"" left=""108"" width=""685"" height=""16"" font=""0"">pointing to the existence of discrimination was the ""rather substantial difference"" between the </text>
<text top=""759"" left=""108"" width=""684"" height=""16"" font=""0"">""import prohibition"" on the relevant products originating in the territory of one Member and the </text>
<text top=""775"" left=""108"" width=""685"" height=""16"" font=""0"">""tolerance for imports"" of another product, presenting a similar level of risk, originating in the </text>
<text top=""792"" left=""108"" width=""202"" height=""16"" font=""0"">territory of another Member.</text>
<footnote top=""790"" left=""310"" width=""23"" height=""11"" font=""16"" number=""1544"" ref="""" dis=""""/>
<text top=""792"" left=""333"" width=""459"" height=""16"" font=""0""> We agree with the Appellate Body and consider that the same </text>
<text top=""808"" left=""108"" width=""686"" height=""16"" font=""0"">reasoning applies to the notion of discrimination under Article 2.3, of which Article 5.5 is a </text>
<text top=""825"" left=""108"" width=""98"" height=""16"" font=""0"">specification.  </text>
</p><p number=""7.586"" style=""8""><text top=""859"" left=""108"" width=""682"" height=""16"" font=""0"">7.586.  Both parties acknowledge, and we agree, that imports of fresh (chilled or frozen) beef from </text>
<text top=""875"" left=""108"" width=""686"" height=""16"" font=""0"">Uruguay are treated differently from imports of the same products from Northern Argentina. </text>
<text top=""892"" left=""108"" width=""689"" height=""16"" font=""0"">Indeed, the former are allowed into the United States under the mitigating protocols in </text>
<text top=""908"" left=""108"" width=""682"" height=""16"" font=""0"">9 CFR 94.22, whereas the latter are prohibited. As observed by the panel in <i>Australia &#8211; Salmon</i>, </text>
<text top=""925"" left=""108"" width=""683"" height=""16"" font=""0"">""even &#8230; the most stringent"" import conditions ""would still be significantly less restrictive to trade </text>
<p><text top=""978"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 296. </text>
</p><p><text top=""1007"" left=""170"" width=""604"" height=""15"" font=""10""> See e.g. Dr Cupit's responses to Panel questions Nos. 34, 35, 36, and 37; Dr Batho's responses to </text>
</p><p><text top=""1066"" left=""170"" width=""363"" height=""15"" font=""10""> <i>Shorter Oxford English Dictionary on Historical Principles</i>, 6</text>
<text top=""1066"" left=""541"" width=""227"" height=""15"" font=""10""> ed. (Oxford University Press, 2007), </text>
</p><p><text top=""1095"" left=""170"" width=""300"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Shrimp</i>, para. 165. </text>
<text top=""1109"" left=""170"" width=""611"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 163. See also Panel Report, <i>US &#8211; Poultry (China)</i>, </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 192 - </text>
</p><p><text top=""128"" left=""108"" width=""209"" height=""16"" font=""0"">than an outright prohibition"".</text>
<footnote top=""126"" left=""317"" width=""23"" height=""11"" font=""16"" number=""1545"" ref=""WT/DS18/11|WT/DS18/RW|WT/DS18/R|WT/DS18/R/Corr.1"" dis=""DS18""><ftext top=""905"" left=""170"" width=""292"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Salmon</i>, para. 8.182. </ftext>
</footnote>
<text top=""128"" left=""340"" width=""454"" height=""16"" font=""0""> We agree that the difference in treatment between Northern </text>
<text top=""144"" left=""108"" width=""691"" height=""16"" font=""0"">Argentine and Uruguayan products is ""rather substantial"". Therefore, we find that the </text>
<text top=""160"" left=""108"" width=""552"" height=""16"" font=""0"">United States' measures discriminate between Northern Argentina and Uruguay. </text>
</p></p></page>
<page number=""192"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.7"" style=""8""><text top=""195"" left=""108"" width=""440"" height=""16"" font=""28"">7.7.4.1.3  Is the discrimination arbitrary or unjustifiable? </text></p><p number=""7.587"" style=""8""><text top=""229"" left=""108"" width=""689"" height=""16"" font=""0"">7.587.  Finally, we must assess whether the discrimination entailed by the United States' </text>
<text top=""246"" left=""108"" width=""682"" height=""16"" font=""0"">measures is arbitrary or unjustifiable. The dictionary definition of the term ""arbitrary"" is ""based on </text>
<text top=""262"" left=""108"" width=""684"" height=""16"" font=""0"">mere opinion or preference as opp[osed] to the real nature of things, capricious, unpredictable, </text>
<text top=""278"" left=""108"" width=""92"" height=""16"" font=""0"">inconsistent"".</text>
<footnote top=""277"" left=""200"" width=""23"" height=""11"" font=""16"" number=""1546"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""920"" left=""170"" width=""591"" height=""15"" font=""10""> <i>Online Oxford English Dictionary</i> (as quoted in Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.259). </ftext>
</footnote>
<text top=""278"" left=""223"" width=""534"" height=""16"" font=""0""> In turn, the term ""unjustifiable"" is defined as ""not justifiable, indefensible""</text>
<footnote top=""277"" left=""757"" width=""23"" height=""11"" font=""16"" number=""1547"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""934"" left=""170"" width=""591"" height=""15"" font=""10""> <i>Online Oxford English Dictionary</i> (as quoted in Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.259). </ftext>
</footnote>
<text top=""278"" left=""780"" width=""10"" height=""16"" font=""0"">, </text>
<text top=""295"" left=""108"" width=""685"" height=""16"" font=""0"">with ""justifiable"" meaning ""[c]apable of being legally or morally justified or shown to be just, </text>
<text top=""311"" left=""108"" width=""687"" height=""16"" font=""0"">righteous, or innocent; defensible"" and ""[c]apable of being maintained, defended, or made </text>
<text top=""328"" left=""108"" width=""44"" height=""16"" font=""0"">good"".</text>
<footnote top=""326"" left=""152"" width=""23"" height=""11"" font=""16"" number=""1548"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""949"" left=""170"" width=""591"" height=""15"" font=""10""> <i>Online Oxford English Dictionary</i> (as quoted in Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.259). </ftext>
</footnote>
</p><p number=""7.588"" style=""8""><text top=""362"" left=""108"" width=""686"" height=""16"" font=""0"">7.588.  In  <i>US &#8211; Gasoline</i>,  <i>US &#8211; Shrimp</i>,  <i>US &#8211; Shrimp (Article 21.5 &#8211; Malaysia)</i>, and <i>Brazil &#8211; </i></text>
<text top=""378"" left=""108"" width=""686"" height=""16"" font=""18""><i>Retreaded Tyres</i>, the Appellate Body explained that an analysis of whether discrimination is </text>
<text top=""395"" left=""108"" width=""685"" height=""16"" font=""0"">arbitrary or unjustifiable within the meaning of the chapeau of Article XX ""should focus on the </text>
<text top=""411"" left=""108"" width=""560"" height=""16"" font=""0"">cause of the discrimination, or the rationale put forward to explain its existence"".</text>
<footnote top=""410"" left=""668"" width=""23"" height=""11"" font=""16"" number=""1549"" ref="""" dis=""""/>
<text top=""411"" left=""691"" width=""99"" height=""16"" font=""0""> In particular, </text>
<text top=""428"" left=""108"" width=""684"" height=""16"" font=""0"">in  <i>Brazil &#8211; Retreaded Tyres</i> the Appellate Body focused its analysis on whether the measure at </text>
<text top=""444"" left=""108"" width=""682"" height=""16"" font=""0"">issue borne a ""rational connection to"" its stated objective of protecting human life or health under </text>
<text top=""461"" left=""108"" width=""213"" height=""16"" font=""0"">subparagraph (b) of Article XX.</text>
<footnote top=""459"" left=""320"" width=""23"" height=""11"" font=""16"" number=""1550"" ref="""" dis=""""/>
<text top=""461"" left=""343"" width=""446"" height=""16"" font=""0""> This approach was adopted by the panel in <i>US &#8211; Poultry (China)</i> </text>
<text top=""477"" left=""108"" width=""381"" height=""16"" font=""0"">in its analysis under Article 2.3 of the SPS Agreement.</text>
<footnote top=""475"" left=""489"" width=""23"" height=""11"" font=""16"" number=""1551"" ref=""WT/DS430/R/Add.1|WT/DS392/R|WT/DS430/R"" dis=""DS430|DS392""><ftext top=""1022"" left=""170"" width=""562"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.261. See also Panel Report, <i>India &#8211; Agricultural </i></ftext>
<ftext top=""1036"" left=""108"" width=""140"" height=""15"" font=""12""><i>Products</i>, para. 7.429. </ftext>
</footnote>
<text top=""477"" left=""512"" width=""279"" height=""16"" font=""0""> Finally, in the context of Article 5.5 of </text>
<text top=""493"" left=""108"" width=""688"" height=""16"" font=""0"">the SPS Agreement, which constitutes a specification of the basic obligation contained in </text>
<text top=""510"" left=""108"" width=""682"" height=""16"" font=""0"">Article 2.3, the Appellate Body upheld the panel's finding that the measure at issue was arbitrarily </text>
<text top=""526"" left=""108"" width=""685"" height=""16"" font=""0"">and unjustifiably discriminatory because it treated differently two products that presented the </text>
<text top=""543"" left=""108"" width=""124"" height=""16"" font=""0"">same level of risk.</text>
<footnote top=""541"" left=""232"" width=""23"" height=""11"" font=""16"" number=""1552"" ref="""" dis=""""/>
</p><p number=""7.589"" style=""8""><text top=""577"" left=""108"" width=""682"" height=""16"" font=""0"">7.589.  Based on the foregoing, we consider that, in our assessment of whether the discrimination </text>
<text top=""593"" left=""108"" width=""683"" height=""16"" font=""0"">between imports of fresh (chilled or frozen) beef from Northern Argentina and Uruguay stemming </text>
<text top=""610"" left=""108"" width=""684"" height=""16"" font=""0"">from the United States' measures is ""arbitrary or unjustifiable"", we must determine whether the </text>
<text top=""626"" left=""108"" width=""684"" height=""16"" font=""0"">regulatory distinction between the two sets of imports bears a rational connection to the stated </text>
<text top=""643"" left=""108"" width=""251"" height=""16"" font=""0"">objective of the measures. To recall</text>
<footnote top=""641"" left=""359"" width=""23"" height=""11"" font=""16"" number=""1553"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.580 above. </ftext>
</footnote>
<text top=""643"" left=""382"" width=""409"" height=""16"" font=""0"">, the objective of the measures at issue is to ensure that </text>
<text top=""659"" left=""108"" width=""682"" height=""16"" font=""0"">imports of FMD-susceptible animals and animal products into the United States are allowed only if </text>
<text top=""675"" left=""108"" width=""685"" height=""16"" font=""0"">the level of risk posed by such imports, possibly after the application of certain ""scientifically </text>
<text top=""692"" left=""108"" width=""684"" height=""16"" font=""0"">justified"" mitigating protocols, achieves the United States' ALOP for FMD. We already found that </text>
<text top=""708"" left=""108"" width=""683"" height=""16"" font=""0"">imports of fresh (chilled or frozen) beef from Northern Argentina have a similar ability to achieve </text>
<text top=""725"" left=""108"" width=""685"" height=""16"" font=""0"">the United States' ALOP as those from Uruguay, subject to the application of the protocols set </text>
<text top=""741"" left=""108"" width=""144"" height=""16"" font=""0"">forth in 9 CFR 94.22.</text>
<footnote top=""739"" left=""253"" width=""23"" height=""11"" font=""16"" number=""1554"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.584 above. </ftext>
</footnote>
<text top=""741"" left=""276"" width=""515"" height=""16"" font=""0""> We also found that, while imports from Uruguay are permitted under the </text>
<text top=""757"" left=""108"" width=""480"" height=""16"" font=""0"">protocols in question, imports from Northern Argentina are prohibited.</text>
<footnote top=""756"" left=""587"" width=""23"" height=""11"" font=""16"" number=""1555"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.586 above. </ftext>
<ftext top=""963"" left=""108"" width=""655"" height=""15"" font=""10"">the first meeting of the Panel, para. 70; United States' response to Panel question No. 44 following the first </ftext>
</footnote>
</p><p number=""7.590"" style=""8""><text top=""792"" left=""108"" width=""684"" height=""16"" font=""0"">7.590.  Taken together, these findings constitute strong indicators, or warning signals, that the </text>
<text top=""808"" left=""108"" width=""682"" height=""16"" font=""0"">United States' measures arbitrarily or unjustifiably discriminate between the two regions. However, </text>
<text top=""825"" left=""108"" width=""683"" height=""16"" font=""0"">before reaching our conclusions, we find it appropriate to consider the United States' explanations </text>
<text top=""841"" left=""108"" width=""675"" height=""16"" font=""0"">as to the rationale underlying the regulatory distinction between Northern Argentina and Uruguay. </text>
<p><text top=""963"" left=""170"" width=""584"" height=""15"" font=""10""> Appellate Body Report, <i>Brazil &#8211; Retreaded Tyres</i>, para. 226 (in turn referring to Appellate Body </text>
<text top=""978"" left=""108"" width=""659"" height=""15"" font=""10"">Reports, <i>US &#8211; Gasoline</i>; <i>US &#8211; Shrimp</i>; and <i>US &#8211; Shrimp (Article 21.5 &#8211; Malaysia)</i>)). See also Appellate Body </text>
<text top=""993"" left=""108"" width=""603"" height=""15"" font=""10"">Report, <i>EC &#8211; Seal Products</i>, para. 5.303. See also Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.261. </text>
<text top=""1007"" left=""170"" width=""372"" height=""15"" font=""10""> Appellate Body Report, <i>Brazil &#8211; Retreaded Tyres</i>, para. 227. </text>
</p><p><text top=""1051"" left=""170"" width=""602"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 158. Further, the Appellate Body suggested that </text>
<text top=""1066"" left=""108"" width=""681"" height=""15"" font=""10"">product being accorded a more favourable treatment could present a <i>higher</i> level of risk than the product being </text>
<text top=""1080"" left=""108"" width=""204"" height=""15"" font=""10"">treated less favourably. See ibid. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 193 - </text>
</p></p></page>
<page number=""193"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.591"" style=""8""><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">7.591.  The first reason adduced by the United States to justify the difference in treatment </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">between imports from Northern Argentina and Uruguay is that, at the time of the establishment of </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">the Panel, APHIS had completed a risk analysis for the latter region and concluded that imports </text>
<text top=""177"" left=""108"" width=""654"" height=""16"" font=""0"">therefrom under the protocols in 9 CFR 94.22 would achieve the United States' ALOP.</text>
<footnote top=""175"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1556"" ref="""" dis=""""/>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">Conversely, the United States contends, at that time APHIS was still conducting a risk analysis </text>
<text top=""210"" left=""108"" width=""685"" height=""16"" font=""0"">with respect to Northern Argentina, therefore its conclusions as to the appropriateness of the </text>
<text top=""226"" left=""108"" width=""578"" height=""16"" font=""0"">application of the same mitigating protocols on imports therefrom were still pending.</text>
<footnote top=""225"" left=""686"" width=""23"" height=""11"" font=""16"" number=""1557"" ref="""" dis=""""/>
</p><p number=""7.592"" style=""8""><text top=""260"" left=""108"" width=""686"" height=""16"" font=""0"">7.592.  We are not convinced by the United States' argument. In section 7.3.3.5.3 above, we </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">found that APHIS' review of the FMD situation in Northern Argentina incurred an undue delay and </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">that, at the time of the Panel's establishment, APHIS has all the necessary information to complete </text>
<text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">its evaluation with respect to Northern Argentina. In our view, a Member's failure to conduct a risk </text>
<text top=""326"" left=""108"" width=""684"" height=""16"" font=""0"">assessment and reach a final conclusion within a reasonable period of time cannot constitute an </text>
<text top=""342"" left=""108"" width=""685"" height=""16"" font=""0"">excuse for not complying with the non-discrimination obligation contained in Article 2.3 of the </text>
<text top=""359"" left=""108"" width=""116"" height=""16"" font=""0"">SPS Agreement. </text>
</p><p number=""7.593"" style=""8""><text top=""393"" left=""108"" width=""683"" height=""16"" font=""0"">7.593.  Next, the United States submits that Argentina failed to show that Northern Argentina and </text>
<text top=""410"" left=""108"" width=""455"" height=""16"" font=""0"">Uruguay are in identical or similar conditions with respect to FMD.</text>
<footnote top=""408"" left=""563"" width=""23"" height=""11"" font=""16"" number=""1558"" ref="""" dis=""""/>
<text top=""410"" left=""586"" width=""205"" height=""16"" font=""0""> In its view, the fact that the </text>
<text top=""426"" left=""108"" width=""685"" height=""16"" font=""0"">two countries or regions share the same OIE FMD-status does not mean that imports of fresh </text>
<text top=""443"" left=""108"" width=""685"" height=""16"" font=""0"">(chilled or frozen) beef therefrom present the same level of risk of FMD-introduction into the </text>
<text top=""459"" left=""108"" width=""97"" height=""16"" font=""0"">United States.</text>
<footnote top=""457"" left=""205"" width=""23"" height=""11"" font=""16"" number=""1559"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""418"" height=""15"" font=""10""> See e.g. United States' second written submission, paras. 119-123. </ftext>
</footnote>
<text top=""459"" left=""228"" width=""564"" height=""16"" font=""0""> Rather, according to the United States, the differences between two regions in </text>
<text top=""475"" left=""108"" width=""684"" height=""16"" font=""0"">terms of surface area, cattle population in relation to the number of veterinarians, borders with </text>
<text top=""492"" left=""108"" width=""682"" height=""16"" font=""0"">regions of higher FMD risk, and the credibility of sanitary authorities distinguish the FMD situations </text>
<text top=""508"" left=""108"" width=""128"" height=""16"" font=""0"">in the two regions.</text>
<footnote top=""507"" left=""236"" width=""23"" height=""11"" font=""16"" number=""1560"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""523"" height=""15"" font=""10""> United States' first written submission, para. 297 (referring to Ibid. paras. 308-310). </ftext>
</footnote>
</p><p number=""7.594"" style=""8""><text top=""543"" left=""108"" width=""682"" height=""16"" font=""0"">7.594.  We agree with the United States that the mere fact that two countries or regions share the </text>
<text top=""559"" left=""108"" width=""684"" height=""16"" font=""0"">same OIE disease status is not, in and of itself, dispositive of the level of risk posed by imports </text>
<text top=""575"" left=""108"" width=""683"" height=""16"" font=""0"">therefrom. Indeed, the OIE confirmed at the meeting with the Panel that, in recognizing a region </text>
<text top=""592"" left=""108"" width=""684"" height=""16"" font=""0"">as FMD-free where vaccination is practised, it does not conduct a comparative analysis between </text>
<text top=""608"" left=""108"" width=""446"" height=""16"" font=""0"">that region and other regions that share the same FMD-status.</text>
<footnote top=""607"" left=""554"" width=""23"" height=""11"" font=""16"" number=""1561"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""573"" height=""15"" font=""10""> Transcript of the meeting, para. 1.123. The OIE stated, that ""[i]f the OIE grants a status to a </ftext>
<ftext top=""1051"" left=""108"" width=""681"" height=""15"" font=""10"">country or a zone, that is an evaluation of the probability of the virus being present. Having granted that status </ftext>
<ftext top=""1066"" left=""108"" width=""661"" height=""15"" font=""10"">the appropriate measures to be applied are those in the Code and, after that, we encourage the countries to </ftext>
<ftext top=""1080"" left=""108"" width=""544"" height=""15"" font=""10"">use those measures because they are safe."" See Transcript of the meeting, para. 1.129.  </ftext>
</footnote>
<text top=""608"" left=""577"" width=""215"" height=""16"" font=""0""> We recall, however, that our </text>
<text top=""625"" left=""108"" width=""685"" height=""16"" font=""0"">assessment of the FMD conditions prevailing in Northern Argentina was not solely based on its </text>
<text top=""641"" left=""108"" width=""685"" height=""16"" font=""0"">OIE FMD-status, but rather on the scientific information on the record, in accordance with the </text>
<text top=""657"" left=""108"" width=""323"" height=""16"" font=""0"">Appellate Body' guidance in <i>Australia &#8211; Apples</i>.</text>
<footnote top=""656"" left=""431"" width=""23"" height=""11"" font=""16"" number=""1562"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""197"" height=""15"" font=""10""> See paras. 7.440-7.449 above. </ftext>
</footnote>
<text top=""657"" left=""454"" width=""336"" height=""16"" font=""0""> Moreover, our assessment took into account all </text>
<text top=""674"" left=""108"" width=""683"" height=""16"" font=""0"">the 11 factors considered by APHIS when reviewing the FMD situation in an applicant country or </text>
<text top=""690"" left=""108"" width=""634"" height=""16"" font=""0"">region under 9 CFR 92.2, as well as the risk assessment techniques developed by the OIE.</text>
<footnote top=""689"" left=""742"" width=""23"" height=""11"" font=""16"" number=""1563"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""197"" height=""15"" font=""10""> See paras. 7.450-7.452 above. </ftext>
</footnote>
<text top=""690"" left=""765"" width=""26"" height=""16"" font=""0""> In </text>
<text top=""707"" left=""108"" width=""683"" height=""16"" font=""0"">our assessment, we found that factors such as the surface area of Northern Argentina, its cattle </text>
<text top=""723"" left=""108"" width=""683"" height=""16"" font=""0"">population in relation to the number of veterinarians, its borders with regions of higher FMD risk, </text>
<text top=""739"" left=""108"" width=""684"" height=""16"" font=""0"">and the credibility of its sanitary authorities did not undermine the ability of imports from that </text>
<text top=""756"" left=""108"" width=""579"" height=""16"" font=""0"">region to meet the United States' ALOP if the protocols in 9 CFR 94.22 were applied.</text>
<footnote top=""754"" left=""687"" width=""23"" height=""11"" font=""16"" number=""1564"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""182"" height=""15"" font=""10""> See section 7.6.7.4.1 above. </ftext>
</footnote>
<text top=""756"" left=""710"" width=""80"" height=""16"" font=""0""> Therefore, </text>
<text top=""772"" left=""108"" width=""683"" height=""16"" font=""0"">we consider that the alleged differences between Northern Argentina and Uruguay pointed to by </text>
<text top=""789"" left=""108"" width=""683"" height=""16"" font=""0"">the United States are not sufficient to show that the two regions do not share similar conditions </text>
<text top=""805"" left=""108"" width=""145"" height=""16"" font=""0"">with respect to FMD. </text>
</p><p number=""7.595"" style=""8""><text top=""839"" left=""108"" width=""683"" height=""16"" font=""0"">7.595.  In light of the above, we consider that the differential treatment between imports of fresh </text>
<text top=""856"" left=""108"" width=""684"" height=""16"" font=""0"">(chilled or frozen) beef from Northern Argentina and Uruguay is not rationally connected to the </text>
<text top=""872"" left=""108"" width=""686"" height=""16"" font=""0"">objective of APHIS' regulatory scheme for FMD, namely the need to ensure that imports of </text>
<p><text top=""920"" left=""170"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 42 following the first substantive meeting. </text>
<text top=""934"" left=""170"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 46 following the first substantive meeting. </text>
<text top=""949"" left=""170"" width=""607"" height=""15"" font=""10""> See e.g. United States' second written submission, para. 117; United States' opening statement at </text>
</p><p><text top=""978"" left=""108"" width=""680"" height=""15"" font=""10"">substantive meeting; United States' second written submission, para. 123; United States' opening statement at </text>
<text top=""993"" left=""108"" width=""267"" height=""15"" font=""10"">the second meeting of the Panel, para. 72.  </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 194 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">FMD-susceptible animals and animal products into the United States are allowed only if the level of </text>
<text top=""144"" left=""108"" width=""687"" height=""16"" font=""0"">risk posed by such imports, possibly after the application of certain ""scientifically justified"" </text>
<text top=""160"" left=""108"" width=""442"" height=""16"" font=""0"">mitigating protocols, achieves the United States' ALOP for FMD.  </text>
</p></p></page>
<page number=""194"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.596"" style=""8""><text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">7.596.  Based on all the foregoing, we conclude that, by importing fresh (chilled or frozen) beef </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">from Uruguay under the protocols in 9 CFR 94.22 and prohibiting imports of the same product </text>
<text top=""228"" left=""108"" width=""687"" height=""16"" font=""0"">from Northern Argentina, the United States' measures arbitrarily or unjustifiably discriminate </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">between Members where the same conditions prevail, inconsistently with the first requirement of </text>
<text top=""260"" left=""108"" width=""239"" height=""16"" font=""0"">Article 2.3 of the SPS Agreement.  </text>
</p><p number=""7.597"" style=""8""><text top=""295"" left=""108"" width=""685"" height=""16"" font=""0"">7.597.  Having made such a determination, we find that addressing Argentina's claim that, by </text>
<text top=""311"" left=""108"" width=""684"" height=""16"" font=""0"">conducting a risk analysis and issuing a positive determination for Uruguay within a reasonable </text>
<text top=""328"" left=""108"" width=""682"" height=""16"" font=""0"">period of time, while maintaining its prohibition on imports from Northern Argentina without a risk </text>
<text top=""344"" left=""108"" width=""683"" height=""16"" font=""0"">assessment since 2001, the United States further discriminates between the two regions in terms </text>
<text top=""360"" left=""108"" width=""685"" height=""16"" font=""0"">of access to APHIS' regulatory process would not aid in securing a positive resolution to this </text>
<text top=""377"" left=""108"" width=""485"" height=""16"" font=""0"">dispute. Therefore, we exercise judicial economy on Argentina's claim. </text>
</p><p number=""7.598"" style=""8""><text top=""411"" left=""108"" width=""683"" height=""16"" font=""0"">7.598.  As discussed in paragraph 7.575 above, we consider that a finding that a measure results </text>
<text top=""428"" left=""108"" width=""687"" height=""16"" font=""0"">in arbitrary or unjustifiable discrimination necessarily entails a finding that it constitutes a </text>
<text top=""444"" left=""108"" width=""682"" height=""16"" font=""0"">disguised restriction on international trade. Therefore, we find that the United States' measures at </text>
<text top=""461"" left=""108"" width=""686"" height=""16"" font=""0"">issue are applied in a manner that constitutes a disguised restriction on international trade, </text>
<text top=""477"" left=""108"" width=""550"" height=""16"" font=""0"">inconsistently with the second requirement of Article 2.3 of the SPS Agreement. </text>
</p><p number=""7.7"" style=""8""><text top=""511"" left=""108"" width=""529"" height=""16"" font=""28"">7.7.4.2  Discrimination between Patagonia, Santa Catarina, and Chile </text></p><p number=""7.599"" style=""8""><text top=""546"" left=""108"" width=""687"" height=""16"" font=""0"">7.599.  We now turn to Argentina's claim that, by recognizing Santa Catarina and Chile as </text>
<text top=""562"" left=""108"" width=""684"" height=""16"" font=""0"">FMD-free within the meaning of 9 CFR 94.1(a) and applying the protocols under 9 CFR 94.11 to </text>
<text top=""579"" left=""108"" width=""683"" height=""16"" font=""0"">imports of FMD-susceptible animal products therefrom, while excluding from its market the same </text>
<text top=""595"" left=""108"" width=""684"" height=""16"" font=""0"">products from Patagonia, the United States arbitrarily or unjustifiably discriminates between the </text>
<text top=""611"" left=""108"" width=""685"" height=""16"" font=""0"">two regions. As stated in paragraph 7.578 above, our assessment will proceed in three steps: </text>
<text top=""628"" left=""108"" width=""683"" height=""16"" font=""0"">(i) Do similar or identical conditions prevail in Patagonia, Santa Catarina, and Chile?; (ii) If so, do </text>
<text top=""644"" left=""108"" width=""689"" height=""16"" font=""0"">the United States' measures discriminate between those regions?; and (iii) If so, is the </text>
<text top=""661"" left=""108"" width=""277"" height=""16"" font=""0"">discrimination arbitrary or unjustifiable? </text>
</p><p number=""7.7"" style=""8""><text top=""695"" left=""108"" width=""685"" height=""16"" font=""28"">7.7.4.2.1  Do similar or identical conditions prevail in Patagonia, Santa Catarina, and </text><text top=""711"" left=""108"" width=""50"" height=""16"" font=""28"">Chile? </text></p><p number=""7.600"" style=""8""><text top=""746"" left=""108"" width=""683"" height=""16"" font=""0"">7.600.  Beginning with the first question, we recall that, as discussed in paragraphs 7.579-7.580 </text>
<text top=""762"" left=""108"" width=""686"" height=""16"" font=""0"">above, the relevant condition that must be identical or similar in two regions in light of the </text>
<text top=""779"" left=""108"" width=""683"" height=""16"" font=""0"">objective, design, architecture, and revealing structure of the United States' measures is the level </text>
<text top=""795"" left=""108"" width=""682"" height=""16"" font=""0"">of risk of FMD-introduction posed by imports of the relevant products from the two regions, as well </text>
<text top=""811"" left=""108"" width=""682"" height=""16"" font=""0"">as their ability to meet the United States' ALOP with or without the application of certain mitigating </text>
<text top=""828"" left=""108"" width=""448"" height=""16"" font=""0"">protocols. We find it appropriate to use the same standard here.  </text>
</p><p number=""7.601"" style=""8""><text top=""862"" left=""108"" width=""689"" height=""16"" font=""0"">7.601.  We are mindful that, in comparing the levels of FMD-risk posed by imports of </text>
<text top=""879"" left=""108"" width=""684"" height=""16"" font=""0"">FMD-susceptible animals and animal products from Patagonia, Santa Catarina and Chile, we are </text>
<text top=""895"" left=""108"" width=""684"" height=""16"" font=""0"">not simply required to assess whether FMD is present in the territory of each region or to take </text>
<text top=""911"" left=""108"" width=""686"" height=""16"" font=""0"">note of the OIE FMD-status assigned to such regions. Indeed, as the United States correctly </text>
<text top=""928"" left=""108"" width=""684"" height=""16"" font=""0"">observes, the level of risk posed by imports from the two regions is not only a function of their </text>
<text top=""944"" left=""108"" width=""682"" height=""16"" font=""0"">disease-prevalence in a given point in time, but also, and most importantly, of the credibility of the </text>
<text top=""961"" left=""108"" width=""497"" height=""16"" font=""0"">sanitary measures in place in such regions to prevent and control FMD.</text>
<footnote top=""959"" left=""605"" width=""23"" height=""11"" font=""16"" number=""1565"" ref="""" dis=""""/>
<text top=""961"" left=""628"" width=""163"" height=""16"" font=""0""> Thus, our assessment </text>
<text top=""977"" left=""108"" width=""682"" height=""16"" font=""0"">must include a comparison of the effectiveness and credibility of the sanitary measures in place in </text>
<text top=""994"" left=""108"" width=""682"" height=""16"" font=""0"">the above-mentioned regions to prevent and control FMD, as well as the ability of imports from the </text>
<text top=""1010"" left=""108"" width=""682"" height=""16"" font=""0"">two regions to meet the United States' ALOP &#8211; with or without the application of certain mitigating </text>
<text top=""1026"" left=""108"" width=""76"" height=""16"" font=""0"">protocols.  </text>
</p><p number=""7.602"" style=""8""><text top=""1061"" left=""108"" width=""683"" height=""16"" font=""0"">7.602.  In section 7.6.7.4.2 above, we found that Patagonia has the necessary veterinary capacity </text>
<text top=""1077"" left=""108"" width=""682"" height=""16"" font=""0"">and infrastructure to prevent and control FMD in its territory and to ensure that the region remains </text>
<p><text top=""1124"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 296. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 195 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">free from the disease, as it has been since 1994. We also found that, if Patagonia were added to </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">the list of FMD-free regions in 9 CFR 94.1(a) and its imports of the relevant products were subject </text>
<text top=""160"" left=""108"" width=""650"" height=""16"" font=""0"">to the protocols set forth in 9 CFR 94.11, the United States' ALOP for FMD would be achieved.  </text>
</p></p></page>
<page number=""195"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.603"" style=""8""><text top=""195"" left=""108"" width=""654"" height=""16"" font=""0"">7.603.  We note that, in 2010, APHIS completed a favourable risk analysis for Santa Catarina.</text>
<footnote top=""193"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1566"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""358"" height=""15"" font=""10""> 2010 Risk Evaluation for Santa Catarina, (Exhibit ARG-7). </ftext>
</footnote>
<text top=""211"" left=""108"" width=""682"" height=""16"" font=""0"">Such an evaluation used a qualitative methodology and was based on the 11 factors set out in the </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">pre-2012 version of 9 CFR 92.2, thus similar in method and scope to our assessment of Patagonia </text>
<text top=""244"" left=""108"" width=""684"" height=""16"" font=""0"">in paragraphs 7.512-7.539 above. Based on its analysis of the 11 factors, APHIS concluded that </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">""Santa Catarina possesses the detection capabilities, reporting systems, and emergency response </text>
<text top=""277"" left=""108"" width=""266"" height=""16"" font=""0"">systems necessary to combat FMD"".</text>
<footnote top=""275"" left=""374"" width=""23"" height=""11"" font=""16"" number=""1567"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""398"" height=""15"" font=""10""> 2010 Risk Evaluation for Santa Catarina, (Exhibit ARG-7), p. 63. </ftext>
</footnote>
<text top=""277"" left=""397"" width=""398"" height=""16"" font=""0""> As a result, APHIS added the region to the list in </text>
<text top=""293"" left=""108"" width=""684"" height=""16"" font=""0"">9 CFR 94.1(a) and allowed imports of FMD-susceptible animal products therefrom subject to the </text>
<text top=""310"" left=""108"" width=""177"" height=""16"" font=""0"">protocols  in  9 CFR 94.11.</text>
<footnote top=""308"" left=""285"" width=""23"" height=""11"" font=""16"" number=""1568"" ref="""" dis=""""><ftext top=""934"" left=""170"" width=""574"" height=""15"" font=""31"">Changes in the Disease Status of the Brazilian State of Santa Catarina with Regard to Certain </ftext><ftext top=""949"" left=""108"" width=""610"" height=""15"" font=""12""><i>Ruminant and Swine Diseases</i>, 75 Fed. Reg. 69851 (USDA/APHIS November 16, 2010) (Final Rule), </ftext>
</footnote>
<text top=""310"" left=""308"" width=""484"" height=""16"" font=""0""> Similarly, APHIS has long recognized Chile as FMD-free within the </text>
<text top=""326"" left=""108"" width=""689"" height=""16"" font=""0"">meaning of 9 CFR 94.1(a) and allows imports of the relevant products therefrom under </text>
<text top=""342"" left=""108"" width=""89"" height=""16"" font=""0"">9 CFR 94.11.</text>
<footnote top=""341"" left=""197"" width=""23"" height=""11"" font=""16"" number=""1569"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""402"" height=""15"" font=""10""> See APHIS website, <i>Foot-And-Mouth and Rinderpest</i>, available at </ftext>
<ftext top=""993"" left=""108"" width=""583"" height=""15"" font=""10"">http://www.aphis.usda.gov/import_export/animals/animal_disease_status.shtml (last accessed </ftext>
<ftext top=""1007"" left=""108"" width=""416"" height=""15"" font=""10"">23 January 2015), incorporated in 9 CFR 94.1(a), (Exhibit ARG-64). </ftext>
</footnote>
</p><p number=""7.604"" style=""8""><text top=""377"" left=""108"" width=""684"" height=""16"" font=""0"">7.604.  Taken together, the findings above indicate that Patagonia, Santa Catarina, and Chile all </text>
<text top=""393"" left=""108"" width=""683"" height=""16"" font=""0"">possess the necessary veterinary capacity and infrastructure to prevent and control FMD. In their </text>
<text top=""410"" left=""108"" width=""682"" height=""16"" font=""0"">responses to Panel questions, the experts took the view that, based on the evidence on the record, </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">several aspects of the sanitary measures in place in Patagonia and Santa Catarina to prevent and </text>
<text top=""443"" left=""108"" width=""333"" height=""16"" font=""0"">control FMD are comparable in terms of efficacy.</text>
<footnote top=""441"" left=""441"" width=""23"" height=""11"" font=""16"" number=""1570"" ref="""" dis=""""/>
<text top=""443"" left=""464"" width=""326"" height=""16"" font=""0""> Moreover, imports of FMD-susceptible animals </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">and animal products from all three regions present a level of risk that, if mitigated by the protocols </text>
<text top=""475"" left=""108"" width=""683"" height=""16"" font=""0"">in 9 CFR 94.11, would achieve the United States' ALOP for FMD. Based on the foregoing, we take </text>
<text top=""492"" left=""108"" width=""688"" height=""16"" font=""0"">the view that the relevant conditions in Patagonia, Santa Catarina and Chile do have ""a </text>
<text top=""508"" left=""108"" width=""428"" height=""16"" font=""0"">resemblance or likeness"" and are ""of the same nature or kind""</text>
<footnote top=""507"" left=""536"" width=""23"" height=""11"" font=""16"" number=""1571"" ref="""" dis=""""/>
<text top=""508"" left=""559"" width=""231"" height=""16"" font=""0"">, and are therefore similar within </text>
<text top=""525"" left=""108"" width=""187"" height=""16"" font=""0"">the meaning of Article 2.3. </text>
</p><p number=""7.7"" style=""8""><text top=""559"" left=""108"" width=""690"" height=""16"" font=""28"">7.7.4.2.2  Do  the  United States'  measures discriminate between Patagonia, Santa </text><text top=""575"" left=""108"" width=""157"" height=""16"" font=""28"">Catarina, and Chile? </text></p><p number=""7.605"" style=""8""><text top=""610"" left=""108"" width=""684"" height=""16"" font=""0"">7.605.  Turning to the second prong of the test, we recall that, as discussed in paragraph 7.585 </text>
<text top=""626"" left=""108"" width=""682"" height=""16"" font=""0"">above, ""discrimination"" may arise when Members in which the same conditions prevail are treated </text>
<text top=""643"" left=""108"" width=""74"" height=""16"" font=""0"">differently.</text>
<footnote top=""641"" left=""182"" width=""23"" height=""11"" font=""16"" number=""1572"" ref="""" dis=""""/>
<text top=""643"" left=""205"" width=""586"" height=""16"" font=""0""> Further, according to the Appellate Body, a warning signal of discrimination is the </text>
<text top=""659"" left=""108"" width=""684"" height=""16"" font=""0"">substantial difference in treatment between an import prohibition on products originating in the </text>
<text top=""675"" left=""108"" width=""683"" height=""16"" font=""0"">territory of one Member and the permission of imports of products presenting an equivalent level </text>
<text top=""692"" left=""108"" width=""366"" height=""16"" font=""0"">of risk originating in the territory of another Member.</text>
<footnote top=""690"" left=""473"" width=""23"" height=""11"" font=""16"" number=""1573"" ref="""" dis=""""/>
<text top=""692"" left=""497"" width=""294"" height=""16"" font=""0""> Indeed, the Appellate Body took the view </text>
<text top=""708"" left=""108"" width=""684"" height=""16"" font=""0"">that ""even &#8230; the most stringent"" import conditions ""would still be significantly less restrictive to </text>
<text top=""725"" left=""108"" width=""239"" height=""16"" font=""0"">trade than an outright prohibition"".</text>
<footnote top=""723"" left=""347"" width=""23"" height=""11"" font=""16"" number=""1574"" ref=""WT/DS18/11|WT/DS18/R/Corr.1|WT/DS18/R|WT/DS18/RW"" dis=""DS18""><ftext top=""1124"" left=""170"" width=""292"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Salmon</i>, para. 8.182. </ftext>
</footnote>
</p><p number=""7.606"" style=""8""><text top=""759"" left=""108"" width=""685"" height=""16"" font=""0"">7.606.  The parties acknowledge, and we agree, that imports of FMD-susceptible animals and </text>
<text top=""775"" left=""108"" width=""684"" height=""16"" font=""0"">animal products from Santa Catarina and Chile are treated differently from imports of the same </text>
<text top=""792"" left=""108"" width=""687"" height=""16"" font=""0"">products from Patagonia. Indeed, the former are allowed into the United States under the </text>
<text top=""808"" left=""108"" width=""686"" height=""16"" font=""0"">mitigating protocols in 9 CFR 94.11, whereas the latter are prohibited. We consider that this </text>
<text top=""825"" left=""108"" width=""687"" height=""16"" font=""0"">difference in treatment is substantial, and therefore find that it amounts to discrimination </text>
<text top=""841"" left=""108"" width=""610"" height=""16"" font=""0"">between, on the one hand, Patagonia and, on the other hand, Santa Catarina and Chile.  </text>
<p><text top=""963"" left=""108"" width=""111"" height=""15"" font=""10"">(Exhibit ARG-21). </text>
</p><p><text top=""1022"" left=""170"" width=""617"" height=""15"" font=""10""> See e.g. Dr Cupit's responses to Panel questions Nos. 38, 39, and 40; Dr Batho's responses to Panel </text>
<text top=""1036"" left=""108"" width=""579"" height=""15"" font=""10"">questions Nos. 38, 39, and 40; Dr Bonbon's responses to Panel questions Nos. 38, 39, and 40. </text>
<text top=""1051"" left=""170"" width=""363"" height=""15"" font=""10""> <i>Shorter Oxford English Dictionary on Historical Principles</i>, 6</text>
<text top=""1050"" left=""533"" width=""8"" height=""9"" font=""10"">th</text>
<text top=""1051"" left=""541"" width=""227"" height=""15"" font=""10""> ed. (Oxford University Press, 2007), </text>
<text top=""1066"" left=""108"" width=""99"" height=""15"" font=""10"">Vol. 2, p. 2838. </text>
<text top=""1080"" left=""170"" width=""300"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Shrimp</i>, para. 165. </text>
<text top=""1095"" left=""170"" width=""611"" height=""15"" font=""10""> Appellate Body Report, <i>Australia &#8211; Salmon</i>, para. 163. See also Panel Report, <i>US &#8211; Poultry (China)</i>, </text>
<text top=""1109"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.285. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 196 - </text>
</p></p></page>
<page number=""196"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.7"" style=""8""><text top=""128"" left=""108"" width=""440"" height=""16"" font=""28"">7.7.4.2.3  Is the discrimination arbitrary or unjustifiable? </text></p><p number=""7.607"" style=""8""><text top=""162"" left=""108"" width=""689"" height=""16"" font=""0"">7.607.  Finally, we must assess whether the discrimination entailed by the United States' </text>
<text top=""178"" left=""108"" width=""682"" height=""16"" font=""0"">measures is arbitrary or unjustifiable. As explained in paragraphs 7.587-7.589 above, we consider </text>
<text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">that, in assessing whether the United States' discrimination between imports of FMD-susceptible </text>
<text top=""211"" left=""108"" width=""689"" height=""16"" font=""0"">animals and animal products from Patagonia, Santa Catarina and Chile is ""arbitrary or </text>
<text top=""228"" left=""108"" width=""685"" height=""16"" font=""0"">unjustifiable"", we must determine whether the regulatory distinction between the two sets of </text>
<text top=""244"" left=""108"" width=""620"" height=""16"" font=""0"">imports bears a rational connection to the stated objective of the measures. To recall</text>
<footnote top=""243"" left=""728"" width=""23"" height=""11"" font=""16"" number=""1575"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.580 above. </ftext>
</footnote>
<text top=""244"" left=""751"" width=""42"" height=""16"" font=""0"">, the </text>
<text top=""260"" left=""108"" width=""682"" height=""16"" font=""0"">objective of the measures at issue is to ensure that imports of FMD-susceptible animals and animal </text>
<text top=""277"" left=""108"" width=""682"" height=""16"" font=""0"">products into the United States are allowed only if the level of risk posed by such imports, possibly </text>
<text top=""293"" left=""108"" width=""690"" height=""16"" font=""0"">after the application of certain ""scientifically justified"" mitigating protocols, achieves the </text>
<text top=""310"" left=""108"" width=""685"" height=""16"" font=""0"">United States' ALOP for FMD. We already found that imports of FMD-susceptible animals from </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia have a similar ability to achieve the United States' ALOP as those from Santa Catarina </text>
<text top=""342"" left=""108"" width=""548"" height=""16"" font=""0"">and Chile, subject to the application of the protocols set forth in 9 CFR 94.11.</text>
<footnote top=""341"" left=""656"" width=""23"" height=""11"" font=""16"" number=""1576"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.604 above. </ftext>
</footnote>
<text top=""342"" left=""679"" width=""111"" height=""16"" font=""0"">  We  also  found </text>
<text top=""359"" left=""108"" width=""687"" height=""16"" font=""0"">that, whereas imports from Santa Catarina and Chile are permitted under the protocols in </text>
<text top=""375"" left=""108"" width=""341"" height=""16"" font=""0"">question, imports from Patagonia are prohibited.  </text>
</p><p number=""7.608"" style=""8""><text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">7.608.  Taken together, these findings constitute strong indicators, or warning signals, that the </text>
<text top=""426"" left=""108"" width=""685"" height=""16"" font=""0"">United States' measures ""arbitrarily or unjustifiably discriminate"" between the above-mentioned </text>
<text top=""443"" left=""108"" width=""688"" height=""16"" font=""0"">regions. However, before reaching our conclusions, we find it appropriate to consider the </text>
<text top=""459"" left=""108"" width=""684"" height=""16"" font=""0"">United States' explanations as to the rationale underlying the regulatory distinction between, on </text>
<text top=""475"" left=""108"" width=""517"" height=""16"" font=""0"">the one hand, Patagonia and, on the other hand, Santa Catarina and Chile. </text>
</p><p number=""7.609"" style=""8""><text top=""510"" left=""108"" width=""429"" height=""16"" font=""0"">7.609.  In the United States' view, the ""key differentiation""</text>
<footnote top=""508"" left=""537"" width=""23"" height=""11"" font=""16"" number=""1577"" ref="""" dis=""""/>
<text top=""510"" left=""560"" width=""234"" height=""16"" font=""0""> between Patagonia and Santa </text>
<text top=""526"" left=""108"" width=""683"" height=""16"" font=""0"">Catarina, justifying the difference in treatment between imports from the two regions, is the fact </text>
<text top=""543"" left=""108"" width=""685"" height=""16"" font=""0"">that, at the time of the establishment of the Panel, APHIS had drawn ""a conclusion as to the </text>
<text top=""559"" left=""108"" width=""654"" height=""16"" font=""0"">appropriateness of the import authorization terms"" applied to imports from Santa Catarina.</text>
<footnote top=""557"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1578"" ref="""" dis=""""/>
<text top=""575"" left=""108"" width=""684"" height=""16"" font=""0"">Conversely, it contends, at that time APHIS was still conducting a risk analysis with respect to </text>
<text top=""592"" left=""108"" width=""684"" height=""16"" font=""0"">Patagonia, and this delay was justified by the fact that, in 2008, SENASA extended its original </text>
<text top=""608"" left=""108"" width=""687"" height=""16"" font=""0"">request for the recognition of Patagonia South to include Patagonia North B and introduced </text>
<text top=""625"" left=""108"" width=""417"" height=""16"" font=""0"">""changes to the sanitary boundaries"" between the two areas.</text>
<footnote top=""623"" left=""525"" width=""23"" height=""11"" font=""16"" number=""1579"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""464"" height=""15"" font=""10""> United States' first written submission, para. 318. See also Ibid. para. 298. </ftext>
</footnote>
</p><p number=""7.610"" style=""8""><text top=""659"" left=""108"" width=""685"" height=""16"" font=""0"">7.610.   We are not convinced by the United States' argument. In section 7.3.3.5.4 above, we </text>
<text top=""675"" left=""108"" width=""683"" height=""16"" font=""0"">found that APHIS' review of the FMD situation in Patagonia incurred an undue delay and that, at </text>
<text top=""692"" left=""108"" width=""684"" height=""16"" font=""0"">the time of the Panel's establishment, APHIS had all the necessary information to complete its </text>
<text top=""708"" left=""108"" width=""683"" height=""16"" font=""0"">evaluation with respect to that region. In particular, while we agreed with the United States that </text>
<text top=""725"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina's extension of its original request to include Patagonia North B and the changes in </text>
<text top=""741"" left=""108"" width=""690"" height=""16"" font=""0"">SENASA's regulatory framework for the Patagonia region justified APHIS' delay between </text>
<text top=""757"" left=""108"" width=""247"" height=""16"" font=""0"">December 2008 and February 2009</text>
<footnote top=""756"" left=""355"" width=""23"" height=""11"" font=""16"" number=""1580"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""197"" height=""15"" font=""10""> See paras. 7.167-7.168 above. </ftext>
</footnote>
<text top=""757"" left=""378"" width=""413"" height=""16"" font=""0"">, we found that such occurrences could not justify APHIS' </text>
<text top=""774"" left=""108"" width=""604"" height=""16"" font=""0"">further delay between February 2009 and the date of the establishment of the Panel.</text>
<footnote top=""772"" left=""712"" width=""23"" height=""11"" font=""16"" number=""1581"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""197"" height=""15"" font=""10""> See paras. 7.169-7.170 above. </ftext>
</footnote>
<text top=""774"" left=""735"" width=""57"" height=""16"" font=""0""> In our </text>
<text top=""790"" left=""108"" width=""686"" height=""16"" font=""0"">view, a Member's failure to conduct a risk assessment and reach a final conclusion within a </text>
<text top=""807"" left=""108"" width=""677"" height=""16"" font=""0"">reasonable period of time cannot constitute an excuse for not complying with the non-</text>
<text top=""823"" left=""108"" width=""683"" height=""16"" font=""0"">discrimination obligation contained in Article 2.3 of the SPS Agreement. Moreover, we found that </text>
<text top=""839"" left=""108"" width=""683"" height=""16"" font=""0"">the enactment of SENASA Resolutions 148/2008 and 1282/2008 did not create uncertainty as to </text>
<text top=""856"" left=""108"" width=""685"" height=""16"" font=""0"">SENASA's ability to control the ingress of FMD-susceptible animals and animal products from </text>
<text top=""872"" left=""108"" width=""687"" height=""16"" font=""0"">Northern Argentina into Patagonia, but rather reinforced traceability and animal movement </text>
<text top=""889"" left=""108"" width=""250"" height=""16"" font=""0"">controls within the Patagonia region.</text>
<footnote top=""887"" left=""358"" width=""23"" height=""11"" font=""16"" number=""1582"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.528 above. </ftext>
</footnote>
</p><p number=""7.611"" style=""8""><text top=""923"" left=""108"" width=""683"" height=""16"" font=""0"">7.611.  As for the discrimination between Patagonia and Chile, we note that the United States did </text>
<text top=""940"" left=""108"" width=""686"" height=""16"" font=""0"">not put forward any arguments as to differences that would warrant a regulatory distinction </text>
<text top=""956"" left=""108"" width=""683"" height=""16"" font=""0"">between such regions. Indeed, the only argument presented by the United States is that the fact </text>
<text top=""972"" left=""108"" width=""686"" height=""16"" font=""0"">that Patagonia and Chile share the same OIE FMD-status recognition is not, in and of itself, </text>
<p><text top=""1051"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 318. </text>
<text top=""1066"" left=""170"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 298. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 197 - </text>
</p><p><text top=""128"" left=""108"" width=""567"" height=""16"" font=""0"">dispositive of whether imports from the two regions should be treated similarly.</text>
<footnote top=""126"" left=""674"" width=""23"" height=""11"" font=""16"" number=""1583"" ref="""" dis=""""/>
<text top=""128"" left=""698"" width=""94"" height=""16"" font=""0""> As noted in </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">paragraph 7.601 above, we agree with the United States that sharing the same OIE FMD-status </text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""0"">recognitions does not, in and of itself, constitute conclusive evidence of identity or similarity </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">between two or more regions. However, since we found that imports from both Patagonia and </text>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">Chile are able to meet the United States' ALOP if subjected to the protocols under 9 CFR 94.11. </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">Moreover, we take the view that it was incumbent on the United States to provide a justification </text>
<text top=""226"" left=""108"" width=""656"" height=""16"" font=""0"">for its discriminatory treatment of such imports, but we find no such justification on the record. </text>
</p></p></page>
<page number=""197"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.612"" style=""8""><text top=""260"" left=""108"" width=""685"" height=""16"" font=""0"">7.612.  In light of the above, we disagree that the elements referred to by the United States </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">justify a regulatory distinction between, Patagonia &#8211; from which imports are prohibited &#8211; on the </text>
<text top=""293"" left=""108"" width=""686"" height=""16"" font=""0"">one hand, and Santa Catarina and Chile &#8211; from which imports are permitted subject to the </text>
<text top=""310"" left=""108"" width=""685"" height=""16"" font=""0"">protocols in 9 CFR 94.11, on the other hand. Thus, we consider that the differential treatment </text>
<text top=""326"" left=""108"" width=""686"" height=""16"" font=""0"">between the above-mentioned regions is not rationally connected to the objective of APHIS' </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">regulatory scheme for FMD, namely the need to ensure that imports of FMD-susceptible animals </text>
<text top=""359"" left=""108"" width=""685"" height=""16"" font=""0"">and animal products into the United States are allowed only if the level of risk posed by such </text>
<text top=""375"" left=""108"" width=""686"" height=""16"" font=""0"">imports, possibly after the application of certain ""scientifically justified"" mitigating protocols, </text>
<text top=""392"" left=""108"" width=""298"" height=""16"" font=""0"">achieves the United States' ALOP for FMD.  </text>
</p><p number=""7.613"" style=""8""><text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">7.613.  Based on all the foregoing, we conclude that, by recognizing Santa Catarina and Chile as </text>
<text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">FMD-free within the meaning of 9 CFR 94.1(a) and applying the protocols in 9 CFR 94.11 to the </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">relevant imports therefrom, while prohibiting imports from Patagonia, the United States' measures </text>
<text top=""475"" left=""108"" width=""686"" height=""16"" font=""0"">arbitrarily or unjustifiably discriminate between Members where the same conditions prevail, </text>
<text top=""492"" left=""108"" width=""365"" height=""16"" font=""0"">inconsistently with Article 2.3 of the SPS Agreement. </text>
</p><p number=""7.614"" style=""8""><text top=""526"" left=""108"" width=""683"" height=""16"" font=""0"">7.614.  Having reached such a conclusion, we are of the view that a finding on Argentina's claim </text>
<text top=""543"" left=""108"" width=""682"" height=""16"" font=""0"">that, by conducting a risk analysis and issuing a positive determination for Santa Catarina within a </text>
<text top=""559"" left=""108"" width=""683"" height=""16"" font=""0"">reasonable period of time, while maintaining its prohibition on imports from Patagonia without a </text>
<text top=""575"" left=""108"" width=""684"" height=""16"" font=""0"">risk assessment since 2001, the United States further discriminates between the two regions in </text>
<text top=""592"" left=""108"" width=""682"" height=""16"" font=""0"">terms of access to APHIS' regulatory process would not aid in securing a positive resolution to this </text>
<text top=""608"" left=""108"" width=""433"" height=""16"" font=""0"">dispute. Therefore, we exercise judicial economy on this claim. </text>
</p><p number=""7.615"" style=""8""><text top=""643"" left=""108"" width=""683"" height=""16"" font=""0"">7.615.  As discussed in paragraph 7.575 above, we consider that a finding that a measure results </text>
<text top=""659"" left=""108"" width=""687"" height=""16"" font=""0"">in arbitrary or unjustifiable discrimination necessarily entails a finding that it constitutes a </text>
<text top=""675"" left=""108"" width=""682"" height=""16"" font=""0"">disguised restriction on international trade. Therefore, we find that the United States' measures at </text>
<text top=""692"" left=""108"" width=""686"" height=""16"" font=""0"">issue are applied in a manner that constitutes a disguised restriction on international trade, </text>
<text top=""708"" left=""108"" width=""550"" height=""16"" font=""0"">inconsistently with the second requirement of Article 2.3 of the SPS Agreement. </text>
</p><p number=""7.7"" style=""8""><text top=""743"" left=""108"" width=""692"" height=""16"" font=""28"">7.7.4.3  Discrimination  between Northern Argentina, Patagonia, Japan, and the </text><text top=""759"" left=""108"" width=""126"" height=""16"" font=""28"">United Kingdom </text></p><p number=""7.616"" style=""8""><text top=""793"" left=""108"" width=""685"" height=""16"" font=""0"">7.616.  Finally, we turn to Argentina's claims that the United States arbitrarily or unjustifiably </text>
<text top=""810"" left=""108"" width=""685"" height=""16"" font=""0"">discriminated between, on the one hand, Northern Argentina and Patagonia and, on the other </text>
<text top=""826"" left=""108"" width=""684"" height=""16"" font=""0"">hand, Japan and the United Kingdom. APHIS completed its risk analyses and issued favourable </text>
<text top=""843"" left=""108"" width=""683"" height=""16"" font=""0"">determinations <i>vis-&#224;-vis</i> imports of FMD-susceptible animals and animal products from Japan and </text>
<text top=""859"" left=""108"" width=""686"" height=""16"" font=""0"">the United Kingdom within approximately two to three years of the filing of the respective </text>
<text top=""875"" left=""108"" width=""211"" height=""16"" font=""0"">applications under 9 CFR 92.2.</text>
<footnote top=""874"" left=""319"" width=""23"" height=""11"" font=""16"" number=""1584"" ref="""" dis=""""/>
<text top=""875"" left=""342"" width=""448"" height=""16"" font=""0""> Conversely, as discussed in more detail in section 7.3.3 above, </text>
<text top=""892"" left=""108"" width=""683"" height=""16"" font=""0"">the United States has maintained its prohibitions on imports of fresh (chilled or frozen) beef from </text>
<text top=""908"" left=""108"" width=""685"" height=""16"" font=""0"">Northern Argentina and of FMD-susceptible animals and animal products from Patagonia since </text>
<text top=""925"" left=""108"" width=""684"" height=""16"" font=""0"">2001. In Argentina's view, by doing so, APHIS granted ""much greater and swifter access to its </text>
<text top=""941"" left=""108"" width=""623"" height=""16"" font=""0"">regulatory systems and processes"" to Japan and the United Kingdom than to Argentina.</text>
<footnote top=""940"" left=""730"" width=""23"" height=""11"" font=""16"" number=""1585"" ref="""" dis=""""/>
<text top=""941"" left=""753"" width=""38"" height=""16"" font=""0""> The </text>
<text top=""958"" left=""108"" width=""686"" height=""16"" font=""0"">United States submits that Argentina's claim must fail because Argentina failed to show that </text>
<text top=""974"" left=""108"" width=""604"" height=""16"" font=""0"">similar or identical conditions with respect to FMD prevail in the regions to be compared.</text>
<footnote top=""972"" left=""712"" width=""23"" height=""11"" font=""16"" number=""1586"" ref="""" dis=""""/>
</p><p number=""7.617"" style=""8""><text top=""1008"" left=""108"" width=""682"" height=""16"" font=""0"">7.617.  Mindful of the test set forth by the panel in <i>Australia &#8211; Salmon (Article 21.5 &#8211; Canada)</i>, we </text>
<text top=""1025"" left=""108"" width=""683"" height=""16"" font=""0"">must answer the following questions in order to determine whether Argentina has established its </text>
<text top=""1041"" left=""108"" width=""682"" height=""16"" font=""0"">claim: (i) Do similar or identical conditions prevail in Northern Argentina, Patagonia, Japan and the </text>
<p><text top=""1080"" left=""170"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 39 following the first substantive meeting. </text>
<text top=""1095"" left=""170"" width=""594"" height=""15"" font=""10""> See United States' response to Panel question No. 36 following the second substantive meeting.  </text>
<text top=""1109"" left=""170"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 229. </text>
<text top=""1124"" left=""170"" width=""383"" height=""15"" font=""10""> See e.g. United States' second written submission, para. 122. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 198 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">United Kingdom? (ii) If so, do the United States' measures discriminate between those regions? </text>
<text top=""144"" left=""108"" width=""422"" height=""16"" font=""0"">and (iii) If so, is the discrimination arbitrary or unjustifiable?  </text>
</p></p></page>
<page number=""198"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.618"" style=""8""><text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">7.618.  Beginning with the first prong of the test, in paragraphs 7.579-7.580 above we found that </text>
<text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">the relevant condition that must be ""identical or similar"" in two or more regions in light of the </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">objective, design, architecture, and revealing structure of the United States' measures is the level </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">of risk of FMD-introduction posed by imports of the relevant products from the two regions, as well </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">as their ability to meet the United States' ALOP with or without the application of certain mitigating </text>
<text top=""260"" left=""108"" width=""76"" height=""16"" font=""0"">protocols.  </text>
</p><p number=""7.619"" style=""8""><text top=""295"" left=""108"" width=""685"" height=""16"" font=""0"">7.619.  Argentina has presented no evidence that such a condition in Northern Argentina and </text>
<text top=""311"" left=""108"" width=""682"" height=""16"" font=""0"">Patagonia is identical or similar to the condition in Japan or the United Kingdom. Indeed, Argentina </text>
<text top=""328"" left=""108"" width=""684"" height=""16"" font=""0"">concedes that the substantive FMD situations of Northern Argentina and Patagonia, on the one </text>
<text top=""344"" left=""108"" width=""585"" height=""16"" font=""0"">hand, and the United Kingdom and Japan, on the other, are not necessarily identical.</text>
<footnote top=""343"" left=""693"" width=""23"" height=""11"" font=""16"" number=""1587"" ref="""" dis=""""/>
<text top=""344"" left=""716"" width=""74"" height=""16"" font=""0""> However, </text>
<text top=""360"" left=""108"" width=""683"" height=""16"" font=""0"">in its view, the condition that is relevant to our assessment here is that all the above-mentioned </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">regions ""had FMD outbreaks"" and have an interest in having ""their export rights provided by the </text>
<text top=""393"" left=""108"" width=""538"" height=""16"" font=""0"">[United States] through full access to the United States' regulatory system"".</text>
<footnote top=""392"" left=""646"" width=""23"" height=""11"" font=""16"" number=""1588"" ref="""" dis=""""/>
<text top=""393"" left=""669"" width=""123"" height=""16"" font=""0""> In other words, </text>
<text top=""410"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina contends that the condition relevant to our assessment is the common desire of the </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">regions at hand to have their market access requests under 9 CFR 92.2 reviewed by APHIS within </text>
<text top=""443"" left=""108"" width=""197"" height=""16"" font=""0"">a reasonable period of time. </text>
</p><p number=""7.620"" style=""8""><text top=""477"" left=""108"" width=""682"" height=""16"" font=""0"">7.620.  We note that, according to the panel in <i>US &#8211; Poultry (China)</i>, discrimination may stem not </text>
<text top=""493"" left=""108"" width=""247"" height=""16"" font=""0"">only from ""'substantive' SPS </text>
<text top=""493"" left=""343"" width=""460"" height=""16"" font=""0"">measures"", but also from ""procedural and information </text>
<text top=""510"" left=""108"" width=""102"" height=""16"" font=""0"">requirements"".</text>
<footnote top=""508"" left=""209"" width=""23"" height=""11"" font=""16"" number=""1589"" ref=""WT/DS58/AB/RW|WT/DS58/AB/R|WT/DS392/R"" dis=""DS400|DS392|DS401|DS58""><ftext top=""1051"" left=""170"" width=""604"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.147. In the context of the chapeau of Article XX of the </ftext>
<ftext top=""1066"" left=""108"" width=""605"" height=""15"" font=""10"">GATT 1994, see Appellate Body Reports, <i>US &#8211; Shrimp</i>, para. 160; <i>EC &#8211; Seal Products</i>, para. 5.302. </ftext>
</footnote>
<text top=""510"" left=""232"" width=""559"" height=""16"" font=""0""> In that dispute, under the measure at issue, China was <i>de jure</i> excluded from </text>
<text top=""526"" left=""108"" width=""684"" height=""16"" font=""0"">accessing the regulatory system of the United States, whereas other Members could access the </text>
<text top=""543"" left=""108"" width=""464"" height=""16"" font=""0"">system by submitting requests for imports of the relevant products.</text>
<footnote top=""541"" left=""572"" width=""23"" height=""11"" font=""16"" number=""1590"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""1080"" left=""170"" width=""329"" height=""15"" font=""10""> See Panel Report, <i>US &#8211; Poultry (China)</i>, para. 7.233. </ftext>
</footnote>
<text top=""543"" left=""595"" width=""195"" height=""16"" font=""0""> In light of the specific facts </text>
<text top=""559"" left=""108"" width=""685"" height=""16"" font=""0"">of that case, that panel found that the relevant condition for the purpose of a comparison of </text>
<text top=""575"" left=""108"" width=""684"" height=""16"" font=""0"">""identical or similar conditions"" was the desire to access the regulatory process of the importing </text>
<text top=""592"" left=""108"" width=""362"" height=""16"" font=""0"">Member for the purpose of gaining market access.</text>
<footnote top=""590"" left=""470"" width=""23"" height=""11"" font=""16"" number=""1591"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""1095"" left=""170"" width=""353"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Poultry (China)</i>, paras. 7.233-7.237.  </ftext>
</footnote>
<text top=""592"" left=""493"" width=""299"" height=""16"" font=""0""> In this respect, the panel's reasoning is </text>
<text top=""608"" left=""108"" width=""683"" height=""16"" font=""0"">similar to that of the Appellate Body in <i>US &#8211; Shrimp</i>, where it stated that discrimination between </text>
<text top=""625"" left=""108"" width=""683"" height=""16"" font=""0"">two exporting countries stemmed from the fact that the measure at issue ""[did] not allow for any </text>
<text top=""641"" left=""108"" width=""684"" height=""16"" font=""0"">inquiry into the appropriateness of the regulatory program for the conditions prevailing in those </text>
<text top=""657"" left=""108"" width=""142"" height=""16"" font=""0"">exporting countries"".</text>
<footnote top=""656"" left=""250"" width=""23"" height=""11"" font=""16"" number=""1592"" ref="""" dis=""""/>
</p><p number=""7.621"" style=""8""><text top=""692"" left=""108"" width=""682"" height=""16"" font=""0"">7.621.  In our view, APHIS' regulatory framework for FMD differs from the measures at issue in <i>US </i></text>
<text top=""708"" left=""108"" width=""685"" height=""16"" font=""18""><i>&#8211; Poultry (China)</i> and <i>US &#8211; Shrimp</i>. Under 9 CFR 92.2, any exporting Member may submit a </text>
<text top=""725"" left=""108"" width=""685"" height=""16"" font=""0"">request for recognition of a region as FMD-free within the meaning of 9 CFR 94.1(a). In other </text>
<text top=""741"" left=""108"" width=""683"" height=""16"" font=""0"">words, the only condition required to <i>activate</i> APHIS' regulatory process is the interest to export </text>
<text top=""757"" left=""108"" width=""685"" height=""16"" font=""0"">FMD-susceptible animals or animal products into the United States, expressed by submitting a </text>
<text top=""774"" left=""108"" width=""682"" height=""16"" font=""0"">request. However, we consider that the conditions required for APHIS' review being <i>completed</i> and </text>
<text top=""790"" left=""108"" width=""685"" height=""16"" font=""0"">a final determination being issued require something more than such an interest. Indeed, the </text>
<text top=""807"" left=""108"" width=""683"" height=""16"" font=""0"">timing and outcome of APHIS' review of a specific request do not depend simply on the desire of </text>
<text top=""823"" left=""108"" width=""686"" height=""16"" font=""0"">the applicant Member to access the United States' market, but rather on the level of risk of </text>
<text top=""839"" left=""108"" width=""682"" height=""16"" font=""0"">FMD-introduction posed by imports of the relevant products from that Member. In other words, as </text>
<text top=""856"" left=""108"" width=""686"" height=""16"" font=""0"">we found above, the approval procedures set forth in 9 CFR 92.2 are part of the process to </text>
<text top=""872"" left=""108"" width=""682"" height=""16"" font=""0"">determine whether the relevant products from a specific country or region pose a particular risk of </text>
<text top=""889"" left=""108"" width=""445"" height=""16"" font=""0"">introduction or dissemination of FMD into the United States.</text>
<footnote top=""887"" left=""553"" width=""23"" height=""11"" font=""16"" number=""1593"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""218"" height=""15"" font=""10""> See paras. 7.37-7.41, 7.74 above. </ftext>
</footnote>
<text top=""889"" left=""576"" width=""219"" height=""16"" font=""0""> As we see it, the design, </text>
<text top=""905"" left=""108"" width=""686"" height=""16"" font=""0"">architecture, and revealing structure of the United States' measure at issue indicate that the </text>
<text top=""922"" left=""108"" width=""682"" height=""16"" font=""0"">length of time APHIS' review of a request may vary considerably based on the complexity of the </text>
<text top=""938"" left=""108"" width=""317"" height=""16"" font=""0"">factual situation in the region being reviewed. </text>
<p><text top=""1007"" left=""170"" width=""312"" height=""15"" font=""10""> Argentina's second written submission, para. 230. </text>
<text top=""1022"" left=""170"" width=""606"" height=""15"" font=""10""> Argentina's second written submission, para. 231. See also Argentina's response to Panel question </text>
<text top=""1036"" left=""108"" width=""307"" height=""15"" font=""10"">No. 35 following the second substantive meeting.  </text>
</p><p><text top=""1109"" left=""170"" width=""300"" height=""15"" font=""10""> Appellate Body Report, <i>US &#8211; Shrimp</i>, para. 165. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 199 - </text>
</p></p></page>
<page number=""199"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.622"" style=""8""><text top=""128"" left=""108"" width=""687"" height=""16"" font=""0"">7.622.   Argentina has not presented any evidence that the specific factual circumstances in </text>
<text top=""144"" left=""108"" width=""686"" height=""16"" font=""0"">Northern Argentina and Patagonia are identical or similar to those in Japan and the United </text>
<text top=""160"" left=""108"" width=""685"" height=""16"" font=""0"">Kingdom in terms of the information presented to APHIS in support of the applications or the </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">complexity of APHIS' evaluation in light of the specific sanitary conditions present in each region. </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">Conversely, the United States pointed to a number of variables that, in its view, justified APHIS' </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">swifter evaluation of the requests of Japan and the United Kingdom vis-&#224;-vis Argentina's requests. </text>
<text top=""226"" left=""108"" width=""682"" height=""16"" font=""0"">Such variables include the fact that both Japan and the United Kingdom are island countries which </text>
<text top=""242"" left=""108"" width=""408"" height=""16"" font=""0"">do not share land borders with regions of higher FMD-risk.</text>
<footnote top=""241"" left=""516"" width=""23"" height=""11"" font=""16"" number=""1594"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""370"" height=""15"" font=""10""> United States' first written submission, paras. 313 and 315. </ftext>
</footnote>
<text top=""242"" left=""539"" width=""252"" height=""16"" font=""0""> Argentina has not addressed these </text>
<text top=""259"" left=""108"" width=""682"" height=""16"" font=""0"">relevant factual differences between the situations in Northern Argentina and Patagonia and those </text>
<text top=""275"" left=""108"" width=""684"" height=""16"" font=""0"">in Japan and the United Kingdom. Therefore, we are not convinced that Argentina has made its </text>
<text top=""292"" left=""108"" width=""682"" height=""16"" font=""0"">case that the relevant conditions in the above-mentioned regions are identical or similar within the </text>
<text top=""308"" left=""108"" width=""160"" height=""16"" font=""0"">meaning of Article 2.3. </text>
</p><p number=""7.623"" style=""8""><text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">7.623.  In light of the above, we find that Argentina failed to demonstrate that the United States' </text>
<text top=""359"" left=""108"" width=""684"" height=""16"" font=""0"">measures arbitrarily or unjustifiably discriminate between, on the one hand, Northern Argentina </text>
<text top=""375"" left=""108"" width=""487"" height=""16"" font=""0"">and Patagonia and, on the other hand, Japan and the United Kingdom. </text>
</p><p number=""7.8"" style=""8""><text top=""410"" left=""108"" width=""291"" height=""16"" font=""28"">7.8  Adaptation to regional conditions </text></p><p number=""7.8"" style=""8""><text top=""444"" left=""108"" width=""243"" height=""16"" font=""28"">7.8.1  Relevant legal provisions </text></p><p number=""7.624"" style=""8""><text top=""479"" left=""108"" width=""684"" height=""16"" font=""0"">7.624.  The text of Article 6 of the SPS Agreement, entitled ""Adaptation to Regional Conditions, </text>
<text top=""495"" left=""108"" width=""685"" height=""16"" font=""0"">Including Pest- or Disease-Free Areas and Areas of Low Pest or Disease Prevalence"", reads as </text>
<text top=""511"" left=""108"" width=""57"" height=""16"" font=""0"">follows: </text>
</p><p number=""1."" style=""6""><text top=""546"" left=""151"" width=""18"" height=""16"" font=""0"">1. </text>
<text top=""546"" left=""193"" width=""554"" height=""16"" font=""0"">Members shall ensure that their sanitary or phytosanitary measures are adapted </text>
<text top=""562"" left=""151"" width=""597"" height=""16"" font=""0"">to the sanitary or phytosanitary characteristics of the area &#8211; whether all of a country, </text>
<text top=""579"" left=""151"" width=""601"" height=""16"" font=""0"">part of a country, or all or parts of several countries &#8211; from which the product </text>
<text top=""595"" left=""151"" width=""603"" height=""16"" font=""0"">originated and to which the product is destined. In assessing the sanitary or </text>
<text top=""611"" left=""151"" width=""597"" height=""16"" font=""0"">phytosanitary characteristics of a region, Members shall take into account, <i>inter alia</i>, </text>
<text top=""628"" left=""151"" width=""599"" height=""16"" font=""0"">the level of prevalence of specific diseases or pests, the existence of eradication or </text>
<text top=""644"" left=""151"" width=""599"" height=""16"" font=""0"">control programmes, and appropriate criteria or guidelines which may be developed </text>
<text top=""661"" left=""151"" width=""299"" height=""16"" font=""0"">by the relevant international organizations. </text>
</p><p number=""2."" style=""6""><text top=""695"" left=""151"" width=""600"" height=""16"" font=""0"">2.   Members shall, in particular, recognize the concepts of pest- or disease-free </text>
<text top=""711"" left=""151"" width=""598"" height=""16"" font=""0"">areas and areas of low pest or disease prevalence. Determination of such areas shall </text>
<text top=""728"" left=""151"" width=""597"" height=""16"" font=""0"">be based on factors such as geography, ecosystems, epidemiological surveillance, and </text>
<text top=""744"" left=""151"" width=""377"" height=""16"" font=""0"">the effectiveness of sanitary or phytosanitary controls. </text>
</p><p number=""3."" style=""6""><text top=""779"" left=""151"" width=""601"" height=""16"" font=""0"">3.   Exporting Members claiming that areas within their territories are pest- or </text>
<text top=""795"" left=""151"" width=""601"" height=""16"" font=""0"">disease-free areas or areas of low pest or disease prevalence shall provide the </text>
<text top=""811"" left=""151"" width=""601"" height=""16"" font=""0"">necessary evidence thereof in order to objectively demonstrate to the importing </text>
<text top=""828"" left=""151"" width=""598"" height=""16"" font=""0"">Member that such areas are, and are likely to remain, pest- or disease-free areas or </text>
<text top=""844"" left=""151"" width=""599"" height=""16"" font=""0"">areas of low pest or disease prevalence, respectively. For this purpose, reasonable </text>
<text top=""861"" left=""151"" width=""598"" height=""16"" font=""0"">access shall be given, upon request, to the importing Member for inspection, testing </text>
<text top=""877"" left=""151"" width=""216"" height=""16"" font=""0"">and other relevant procedures. </text>
</p><p number=""7.625"" style=""8""><text top=""911"" left=""108"" width=""682"" height=""16"" font=""0"">7.625.  Annex A(6) and A(7) set forth the definitions of ""pest- or disease-free areas"" and ""areas of </text>
<text top=""928"" left=""108"" width=""342"" height=""16"" font=""0"">low pest or disease prevalence"", respectively, as: </text>
</p><p number=""6."" style=""6""><text top=""962"" left=""151"" width=""18"" height=""16"" font=""0"">6. </text>
<text top=""962"" left=""193"" width=""554"" height=""16"" font=""18""><i>Pest- or disease-free area</i> &#8211; An area, whether all of a country, part of a country, </text>
<text top=""979"" left=""151"" width=""597"" height=""16"" font=""0"">or all or parts of several countries, as identified by the competent authorities, in which </text>
<text top=""995"" left=""151"" width=""289"" height=""16"" font=""0"">a specific pest or disease does not occur.  </text>
<p><text top=""1030"" left=""151"" width=""52"" height=""16"" font=""0"">NOTE: </text>
<text top=""1030"" left=""236"" width=""516"" height=""16"" font=""0"">A pest- or disease-free area may surround, be surrounded by, or be </text>
<text top=""1046"" left=""151"" width=""597"" height=""16"" font=""0"">adjacent to an area &#8211; whether within part of a country or in a geographic region which </text>
<text top=""1062"" left=""151"" width=""599"" height=""16"" font=""0"">includes parts of or all of several countries &#8211; in which a specific pest or disease is </text>
<text top=""1079"" left=""151"" width=""597"" height=""16"" font=""0"">known to occur but is subject to regional control measures such as the establishment </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 200 - </text>
</p><p><text top=""128"" left=""151"" width=""597"" height=""16"" font=""0"">of protection, surveillance and buffer zones which will confine or eradicate the pest or </text>
<text top=""144"" left=""151"" width=""140"" height=""16"" font=""0"">disease in question. </text>
</p></p></page>
<page number=""200"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7."" style=""6""><text top=""178"" left=""151"" width=""18"" height=""16"" font=""0"">7. </text>
<text top=""178"" left=""193"" width=""555"" height=""16"" font=""18""><i>Area of low pest or disease prevalence</i> &#8211; An area, whether all of a country, part </text>
<text top=""195"" left=""151"" width=""601"" height=""16"" font=""0"">of a country, or all or parts of several countries, as identified by the competent </text>
<text top=""211"" left=""151"" width=""600"" height=""16"" font=""0"">authorities, in which a specific pest or disease occurs at low levels and which is </text>
<text top=""228"" left=""151"" width=""450"" height=""16"" font=""0"">subject to effective surveillance, control or eradication measures. </text>
</p><p number=""7.8"" style=""8""><text top=""262"" left=""108"" width=""281"" height=""16"" font=""28"">7.8.2  Main arguments of the parties </text></p><p number=""7.8"" style=""8""><text top=""296"" left=""108"" width=""141"" height=""16"" font=""28"">7.8.2.1  Argentina </text></p><p number=""7.626"" style=""8""><text top=""331"" left=""108"" width=""682"" height=""16"" font=""0"">7.626.  Argentina claims that the United States' prohibition on imports of FMD-susceptible animals </text>
<text top=""347"" left=""108"" width=""683"" height=""16"" font=""0"">and animal products from Patagonia has been maintained inconsistently with Articles 6.1 and 6.2 </text>
<text top=""364"" left=""108"" width=""687"" height=""16"" font=""0"">of the SPS Agreement. Argentina argues that Articles 6.1 and 6.2 impose ""complementary"" </text>
<text top=""380"" left=""108"" width=""73"" height=""16"" font=""0"">obligations</text>
<footnote top=""379"" left=""181"" width=""23"" height=""11"" font=""16"" number=""1595"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""596"" height=""15"" font=""10""> Argentina's second written submission, para. 238; Argentina's response to Panel question No. 45 </ftext>
<ftext top=""920"" left=""108"" width=""259"" height=""15"" font=""10"">following the second substantive meeting. </ftext>
</footnote>
<text top=""380"" left=""204"" width=""592"" height=""16"" font=""0"">, contending that Article 6.2 ""particularize[s] and supplement[s]"" the broader </text>
<text top=""396"" left=""108"" width=""244"" height=""16"" font=""0"">obligations contained in Article 6.1.</text>
<footnote top=""395"" left=""352"" width=""23"" height=""11"" font=""16"" number=""1596"" ref="""" dis=""""/>
<text top=""396"" left=""375"" width=""416"" height=""16"" font=""0""> Thus, according to Argentina, a measure inconsistent with </text>
<text top=""413"" left=""108"" width=""395"" height=""16"" font=""0"">Article 6.1 is, by implication, inconsistent with Article 6.2.</text>
<footnote top=""411"" left=""503"" width=""23"" height=""11"" font=""16"" number=""1597"" ref="""" dis=""""/>
<text top=""413"" left=""526"" width=""264"" height=""16"" font=""0""> Further, Argentina considers that the </text>
<text top=""429"" left=""108"" width=""685"" height=""16"" font=""0"">factors listed in Articles 6.1 and 6.2 must be considered by the authorities of a Member when </text>
<text top=""446"" left=""108"" width=""684"" height=""16"" font=""0"">evaluating the sanitary status of a region in the context of a risk assessment conducted under </text>
<text top=""462"" left=""108"" width=""303"" height=""16"" font=""0"">Articles 5.1 and 5.2 of the SPS Agreement.</text>
<footnote top=""461"" left=""410"" width=""23"" height=""11"" font=""16"" number=""1598"" ref="""" dis=""""/>
<text top=""462"" left=""434"" width=""358"" height=""16"" font=""0""> Therefore, in its view, a breach of Articles 6.1 or </text>
<text top=""479"" left=""108"" width=""433"" height=""16"" font=""0"">6.2 would necessarily lead to a violation of Articles 5.1 and 5.2.</text>
<footnote top=""477"" left=""541"" width=""23"" height=""11"" font=""16"" number=""1599"" ref="""" dis=""""/>
</p><p number=""7.627"" style=""8""><text top=""513"" left=""108"" width=""685"" height=""16"" font=""0"">7.627.  Beginning with Article 6.1, Argentina submits that the provision in question requires an </text>
<text top=""529"" left=""108"" width=""686"" height=""16"" font=""0"">importing Member to adapt its measure(s) to the SPS characteristics of a region, taking into </text>
<text top=""546"" left=""108"" width=""682"" height=""16"" font=""0"">account the factors listed in the second sentence, including the ""appropriate criteria or guidelines"" </text>
<text top=""562"" left=""108"" width=""380"" height=""16"" font=""0"">developed by the relevant international organizations.</text>
<footnote top=""561"" left=""487"" width=""23"" height=""11"" font=""16"" number=""1600"" ref="""" dis=""""/>
<text top=""562"" left=""510"" width=""275"" height=""16"" font=""0""> In Argentina's view, the OIE's region-</text>
<text top=""579"" left=""108"" width=""478"" height=""16"" font=""0"">specific disease status determinations are such criteria or guidelines.</text>
<footnote top=""577"" left=""586"" width=""23"" height=""11"" font=""16"" number=""1601"" ref="""" dis=""""/>
<text top=""579"" left=""609"" width=""182"" height=""16"" font=""0""> Argentina claims that, in </text>
<text top=""595"" left=""108"" width=""683"" height=""16"" font=""0"">adopting and maintaining its measure, the United States failed to take into account: the ""level of </text>
<text top=""611"" left=""108"" width=""683"" height=""16"" font=""0"">prevalence of specific diseases or pests"" in Patagonia South, which has been free from FMD since </text>
<text top=""628"" left=""108"" width=""535"" height=""16"" font=""0"">1976, and in Patagonia North B, which has been free from FMD since 1994</text>
<footnote top=""626"" left=""643"" width=""23"" height=""11"" font=""16"" number=""1602"" ref="""" dis=""""/>
<text top=""628"" left=""666"" width=""126"" height=""16"" font=""0"">; the ""exemplary </text>
<text top=""644"" left=""108"" width=""683"" height=""16"" font=""0"">eradication and control program"" SENASA put in place, whose adequacy has been acknowledged </text>
<text top=""661"" left=""108"" width=""215"" height=""16"" font=""0"">by APHIS on several occasions</text>
<footnote top=""659"" left=""323"" width=""23"" height=""11"" font=""16"" number=""1603"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 539-541. </ftext>
</footnote>
<text top=""661"" left=""346"" width=""446"" height=""16"" font=""0"">; and the ""appropriate criteria or guidelines"" developed by the </text>
<text top=""677"" left=""108"" width=""684"" height=""16"" font=""0"">OIE, which has recognized the FMD-free where vaccination is not practised status of Patagonia </text>
<text top=""693"" left=""108"" width=""333"" height=""16"" font=""0"">South in 2002 and of Patagonia North B in 2007.</text>
<footnote top=""692"" left=""440"" width=""23"" height=""11"" font=""16"" number=""1604"" ref="""" dis=""""/>
</p><p number=""7.628"" style=""8""><text top=""728"" left=""108"" width=""686"" height=""16"" font=""0"">7.628.  As for Article 6.2, Argentina does not express views as to whether APHIS' regulatory </text>
<text top=""744"" left=""108"" width=""683"" height=""16"" font=""0"">scheme set forth in 9 CFR 92.2 and 9 CFR 94, ""as such"", recognizes the concepts of disease-free </text>
<text top=""761"" left=""108"" width=""301"" height=""16"" font=""0"">areas and areas of low disease prevalence.</text>
<footnote top=""759"" left=""409"" width=""23"" height=""11"" font=""16"" number=""1605"" ref="""" dis=""""/>
<text top=""761"" left=""432"" width=""359"" height=""16"" font=""0""> However, Argentina claims that, as applied to the </text>
<text top=""777"" left=""108"" width=""293"" height=""16"" font=""0"">relevant products originating in Patagonia</text>
<footnote top=""775"" left=""401"" width=""23"" height=""11"" font=""16"" number=""1606"" ref="""" dis=""""/>
<text top=""777"" left=""424"" width=""368"" height=""16"" font=""0"">, the maintenance of the United States' measure is </text>
<text top=""793"" left=""108"" width=""352"" height=""16"" font=""0"">""not based on the factors listed in Article 6.2"".</text>
<footnote top=""792"" left=""460"" width=""23"" height=""11"" font=""16"" number=""1607"" ref="""" dis=""""/>
<text top=""793"" left=""483"" width=""311"" height=""16"" font=""0""> Specifically, according to Argentina, the </text>
<text top=""810"" left=""108"" width=""683"" height=""16"" font=""0"">United States disregarded: the ""geography"" of Patagonia, in particular its isolation from Northern </text>
<text top=""826"" left=""108"" width=""618"" height=""16"" font=""0"">Argentina and its distance from the 2006 FMD outbreak in the province of Corrientes</text>
<footnote top=""825"" left=""726"" width=""23"" height=""11"" font=""16"" number=""1608"" ref="""" dis=""""/>
<text top=""826"" left=""749"" width=""44"" height=""16"" font=""0"">; the </text>
<footnote top=""934"" left=""170"" width=""293"" height=""15"" font=""10"" number=""548"" ref="""" dis=""""/>
<footnote top=""963"" left=""170"" width=""532"" height=""15"" font=""10"" number=""49"" ref="""" dis=""""/>
<footnote top=""993"" left=""170"" width=""528"" height=""15"" font=""10"" number=""53"" ref="""" dis=""""/>
<p><text top=""1022"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 535. </text>
</p><p><text top=""1051"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 542. </text>
<text top=""1066"" left=""170"" width=""547"" height=""15"" font=""10""> Argentina's response to Panel question No. 43 following the second substantive meeting. </text>
<text top=""1080"" left=""170"" width=""605"" height=""15"" font=""10""> Argentina's first written submission, para. 543; Argentina's opening statement at the first meeting </text>
<text top=""1095"" left=""108"" width=""140"" height=""15"" font=""10"">of the Panel, para. 77. </text>
<text top=""1109"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 551. </text>
<text top=""1124"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 554. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 201 - </text>
</p><p><text top=""128"" left=""108"" width=""381"" height=""16"" font=""0"">ecosystem of Patagonia, which is ""naturally FMD-free""</text>
<footnote top=""126"" left=""489"" width=""23"" height=""11"" font=""16"" number=""1609"" ref="""" dis=""""/>
<text top=""128"" left=""512"" width=""280"" height=""16"" font=""0"">; and the FMD surveillance and control </text>
<text top=""144"" left=""108"" width=""535"" height=""16"" font=""0"">programs put in place by SENASA, whose adequacy was recognized by APHIS.</text>
<footnote top=""143"" left=""642"" width=""23"" height=""11"" font=""16"" number=""1610"" ref="""" dis=""""><ftext top=""905"" left=""170"" width=""328"" height=""15"" font=""10""> Argentina's first written submission, paras. 558-565. </ftext>
</footnote>
</p></p></page>
<page number=""201"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.629"" style=""8""><text top=""178"" left=""108"" width=""686"" height=""16"" font=""0"">7.629.  With respect to its own obligations under Article 6.3, Argentina acknowledges that, in </text>
<text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">principle, non-compliance with those obligations ""stands as a potential affirmative defence by a </text>
<text top=""211"" left=""108"" width=""338"" height=""16"" font=""0"">respondent to claims under Articles 6.1 and 6.2"".</text>
<footnote top=""210"" left=""446"" width=""23"" height=""11"" font=""16"" number=""1611"" ref="""" dis=""""/>
<text top=""211"" left=""469"" width=""322"" height=""16"" font=""0""> It maintains, however, that the United States </text>
<text top=""228"" left=""108"" width=""285"" height=""16"" font=""0"">has ""failed to substantiate its assertions""</text>
<footnote top=""226"" left=""393"" width=""23"" height=""11"" font=""16"" number=""1612"" ref="""" dis=""""/>
<text top=""228"" left=""416"" width=""375"" height=""16"" font=""0""> that Argentina did not comply with its obligations to </text>
<text top=""244"" left=""108"" width=""684"" height=""16"" font=""0"">""objectively demonstrate"" the disease-free status of Patagonia within the meaning of Article 6.3. </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina submits that, in 2009, APHIS stated in a letter that it had ""all the information"" required </text>
<text top=""277"" left=""108"" width=""173"" height=""16"" font=""0"">to ""proceed favourably"".</text>
<footnote top=""275"" left=""281"" width=""23"" height=""11"" font=""16"" number=""1613"" ref="""" dis=""""/>
<text top=""277"" left=""304"" width=""489"" height=""16"" font=""0""> According to Argentina, this fact, coupled with the United States' </text>
<text top=""293"" left=""108"" width=""686"" height=""16"" font=""0"">representative's statements before the SPS Committee in 2010 and 2011, demonstrates that </text>
<text top=""310"" left=""108"" width=""384"" height=""16"" font=""0"">""Argentina had fulfilled its obligations under Article 6.3"".</text>
<footnote top=""308"" left=""492"" width=""23"" height=""11"" font=""16"" number=""1614"" ref="""" dis=""""/>
</p><p number=""7.8"" style=""8""><text top=""344"" left=""108"" width=""169"" height=""16"" font=""28"">7.8.2.2  United States </text></p><p number=""7.630"" style=""8""><text top=""378"" left=""108"" width=""59"" height=""16"" font=""0"">7.630. </text>
<text top=""378"" left=""162"" width=""98"" height=""16"" font=""0"">The United </text>
<text top=""378"" left=""250"" width=""550"" height=""16"" font=""0"">States disagrees with Argentina that the prohibition on imports of </text>
<text top=""395"" left=""108"" width=""686"" height=""16"" font=""0"">FMD-susceptible animals and animal products from Patagonia is inconsistent with Articles 6.1 </text>
<text top=""411"" left=""108"" width=""66"" height=""16"" font=""0"">and 6.2.  </text>
</p><p number=""7.631"" style=""8""><text top=""446"" left=""108"" width=""686"" height=""16"" font=""0"">7.631.  The United States argues that the three paragraphs of Article 6 of the SPS Agreement </text>
<text top=""462"" left=""108"" width=""476"" height=""16"" font=""0"">""should be read together"", as they provide ""context for each other"".</text>
<footnote top=""461"" left=""584"" width=""23"" height=""11"" font=""16"" number=""1615"" ref="""" dis=""""/>
<text top=""462"" left=""607"" width=""184"" height=""16"" font=""0""> In its responses to Panel </text>
<text top=""479"" left=""108"" width=""683"" height=""16"" font=""0"">questions, the United States asserts that the recognition of the ""concepts of pest- or disease-free </text>
<text top=""495"" left=""108"" width=""683"" height=""16"" font=""0"">areas and areas of low pest or disease prevalence"" under Article 6.2 is a ""particular step"" towards </text>
<text top=""511"" left=""108"" width=""688"" height=""16"" font=""0"">a Member's fulfilment of its obligation to ensure that SPS measures are adapted to the </text>
<text top=""528"" left=""108"" width=""295"" height=""16"" font=""0"">characteristics of an area under Article 6.1.</text>
<footnote top=""526"" left=""403"" width=""23"" height=""11"" font=""16"" number=""1616"" ref="""" dis=""""/>
</p><p number=""7.632"" style=""8""><text top=""562"" left=""108"" width=""686"" height=""16"" font=""0"">7.632.  With respect to Argentina's claim under Article 6.1, the United States argues that the </text>
<text top=""579"" left=""108"" width=""682"" height=""16"" font=""0"">requirement for the importing Member to ""adapt"" an SPS measure to the sanitary characteristics of </text>
<text top=""595"" left=""108"" width=""682"" height=""16"" font=""0"">an area should be read in light of the requirement in Article 6.3 that the exporting Member ""bring </text>
<text top=""611"" left=""108"" width=""623"" height=""16"" font=""0"">forth the necessary evidence to show that it is and is 'likely to remain' free of disease"".</text>
<footnote top=""610"" left=""731"" width=""23"" height=""11"" font=""16"" number=""1617"" ref="""" dis=""""/>
<text top=""611"" left=""754"" width=""38"" height=""16"" font=""0""> The </text>
<text top=""628"" left=""108"" width=""684"" height=""16"" font=""0"">United States argues that Article 6.3 recognizes that, when confronted with an assertion that an </text>
<text top=""644"" left=""108"" width=""685"" height=""16"" font=""0"">exporting Member is free of a disease, the importing Member will not have sufficient relevant </text>
<text top=""661"" left=""108"" width=""346"" height=""16"" font=""0"">scientific evidence to evaluate that assertion.</text>
<footnote top=""659"" left=""454"" width=""23"" height=""11"" font=""16"" number=""1618"" ref="""" dis=""""/>
<text top=""661"" left=""477"" width=""320"" height=""16"" font=""0""> The United States argues that Article 6 </text>
<text top=""677"" left=""108"" width=""688"" height=""16"" font=""0"">contemplates ""a dynamic process"" whereby ""information is brought to the attention of an </text>
<text top=""693"" left=""108"" width=""684"" height=""16"" font=""0"">importing Member"" and the importing Member ""engages in a process by which it evaluates the </text>
<text top=""710"" left=""108"" width=""594"" height=""16"" font=""0"">information and amends its measures"" in light of the characteristics of that area.</text>
<footnote top=""708"" left=""702"" width=""23"" height=""11"" font=""16"" number=""1619"" ref="""" dis=""""/>
<text top=""710"" left=""725"" width=""69"" height=""16"" font=""0""> For the </text>
<text top=""726"" left=""108"" width=""687"" height=""16"" font=""0"">United States, such a claim of disease freedom and the concomitant need to evaluate new </text>
<text top=""743"" left=""108"" width=""683"" height=""16"" font=""0"">information results in any existing measure becoming a provisional measure that falls within the </text>
<text top=""759"" left=""108"" width=""684"" height=""16"" font=""0"">scope of Article 5.7, which requires that an importing Member review its measure, including any </text>
<text top=""775"" left=""108"" width=""684"" height=""16"" font=""0"">adaptation to the sanitary characteristics of the exporting region, within a reasonable period of </text>
<text top=""792"" left=""108"" width=""35"" height=""16"" font=""0"">time.</text>
<footnote top=""790"" left=""143"" width=""23"" height=""11"" font=""16"" number=""1620"" ref="""" dis=""""/>
<p><text top=""876"" left=""170"" width=""604"" height=""15"" font=""10""> Argentina's first written submission, para. 557. However, we note that Argentina has not provided </text>
<text top=""891"" left=""108"" width=""248"" height=""15"" font=""10"">evidence to substantiate this statement. </text>
</p><p><text top=""934"" left=""108"" width=""308"" height=""15"" font=""10"">Argentina's second written submission, para. 242. </text>
<footnote top=""949"" left=""170"" width=""528"" height=""15"" font=""10"" number=""48"" ref="""" dis=""""/>
<footnote top=""993"" left=""108"" width=""469"" height=""15"" font=""10"" number=""61"" ref="""" dis=""""/>
</p><p><text top=""1022"" left=""170"" width=""563"" height=""15"" font=""10""> United States' response to Panel question No. 46 following the second substantive meeting. </text>
<footnote top=""1036"" left=""170"" width=""600"" height=""15"" font=""10"" number=""22"" ref="""" dis=""""/>
<footnote top=""1080"" left=""170"" width=""600"" height=""15"" font=""10"" number=""54"" ref="""" dis=""""/>
</p><p><text top=""1095"" left=""108"" width=""468"" height=""15"" font=""10"">United States' opening statement at the first meeting of the Panel, para. 56. </text>
<text top=""1109"" left=""170"" width=""600"" height=""15"" font=""10""> United States' response to Panel question No. 29 following the first substantive meeting. See also </text>
<text top=""1124"" left=""108"" width=""541"" height=""15"" font=""10"">United States' response to Panel question No. 51 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 202 - </text>
</p></p></page>
<page number=""202"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.633"" style=""8""><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">7.633.  The United States notes that ""a process of information exchange"" began when APHIS </text>
<text top=""144"" left=""108"" width=""490"" height=""16"" font=""0"">sought information from Argentina in response to Argentina's request.</text>
<footnote top=""143"" left=""598"" width=""23"" height=""11"" font=""16"" number=""1621"" ref="""" dis=""""/>
<text top=""144"" left=""621"" width=""170"" height=""16"" font=""0""> It argues that because </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">of the concerns raised by subsequent FMD outbreaks in Northern Argentina in 2003 and 2006 and </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina's ""shifting [of] sanitary conditions between Patagonia South and Patagonia North B"", and </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">the expansion of Argentina's request for recognition to include Patagonia North B, APHIS extended </text>
<text top=""210"" left=""108"" width=""262"" height=""16"" font=""0"">the time taken to conclude its review.</text>
<footnote top=""208"" left=""370"" width=""23"" height=""11"" font=""16"" number=""1622"" ref="""" dis=""""/>
<text top=""210"" left=""393"" width=""397"" height=""16"" font=""0""> The United States thus asserts that the fact that, at the </text>
<text top=""226"" left=""108"" width=""682"" height=""16"" font=""0"">time of the establishment of the Panel, APHIS was still in the process of ""adapting"" its measure to </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">the SPS characteristics of Patagonia is not due to any inconsistency on its part with Article 6.1, but </text>
<text top=""259"" left=""108"" width=""686"" height=""16"" font=""0"">rather to APHIS' justified uncertainty as to whether Argentina objectively demonstrated that </text>
<text top=""275"" left=""108"" width=""350"" height=""16"" font=""0"">Patagonia was, and was likely to remain, FMD-free.</text>
<footnote top=""274"" left=""458"" width=""23"" height=""11"" font=""16"" number=""1623"" ref="""" dis=""""/>
</p><p number=""7.634"" style=""8""><text top=""310"" left=""108"" width=""687"" height=""16"" font=""0"">7.634.  Further, the United States asserts that, as OIE FMD-status determinations for specific </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">countries or regions do not constitute ""international standards, guidelines or recommendations for </text>
<text top=""342"" left=""108"" width=""684"" height=""16"" font=""0"">the purposes of Article 3, they also do not fall within the scope of ""criteria or guidelines"" under </text>
<text top=""359"" left=""108"" width=""75"" height=""16"" font=""0"">Article 6.1.</text>
<footnote top=""357"" left=""183"" width=""23"" height=""11"" font=""16"" number=""1624"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""613"" height=""15"" font=""10""> United States' response to Panel question No. 53 following the first substantive meeting, para. 219; </ftext>
</footnote>
<text top=""359"" left=""206"" width=""587"" height=""16"" font=""0""> In the United States' opinion, both the terms ""criterion"" and ""guideline"" refer to </text>
<text top=""375"" left=""108"" width=""686"" height=""16"" font=""0"">directing or standardizing principles, whereas the OIE's disease status designations constitute </text>
<text top=""392"" left=""108"" width=""615"" height=""16"" font=""0"">""conclusion[s]"" or ""outcome[s]"" of the application of such principles to a specific situation.</text>
<footnote top=""390"" left=""723"" width=""23"" height=""11"" font=""16"" number=""1625"" ref="""" dis=""""/>
</p><p number=""7.635"" style=""8""><text top=""426"" left=""108"" width=""685"" height=""16"" font=""0"">7.635.  As to Argentina's claim under Article 6.2, the United States argues that the measure at </text>
<text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">issue is consistent with the requirement to ""recognize"" or ""acknowledge[e] the existence of the </text>
<text top=""459"" left=""108"" width=""336"" height=""16"" font=""18""><i>idea</i> or <i>notion</i> of pest- or disease-free areas"".</text>
<footnote top=""457"" left=""444"" width=""23"" height=""11"" font=""16"" number=""1626"" ref="""" dis=""""/>
<text top=""459"" left=""467"" width=""327"" height=""16"" font=""0""> Indeed, the United States observes, APHIS' </text>
<text top=""475"" left=""108"" width=""688"" height=""16"" font=""0"">regulatory framework set forth in 9 CFR 92.2 and 9 CFR 94 does, as such, ""recognize the </text>
<text top=""492"" left=""108"" width=""427"" height=""16"" font=""0"">concepts"" of FMD-free areas and areas of low FMD prevalence.</text>
<footnote top=""490"" left=""535"" width=""23"" height=""11"" font=""16"" number=""1627"" ref="""" dis=""""/>
</p><p number=""7.8"" style=""8""><text top=""526"" left=""108"" width=""322"" height=""16"" font=""28"">7.8.3  Main arguments of the third parties </text></p><p number=""7.8"" style=""8""><text top=""561"" left=""108"" width=""110"" height=""16"" font=""28"">7.8.3.1  Brazil </text></p><p number=""7.636"" style=""8""><text top=""595"" left=""108"" width=""187"" height=""16"" font=""0"">7.636.  Brazil  submits  that</text>
<text top=""595"" left=""302"" width=""490"" height=""16"" font=""0"">Article 6.1 of the SPS Agreement sets forth a general obligation for </text>
<text top=""611"" left=""108"" width=""684"" height=""16"" font=""0"">Members to adapt their measures to the actual SPS characteristics of the ""area"" from which the </text>
<text top=""628"" left=""108"" width=""385"" height=""16"" font=""0"">product originated and to which the product is destined.</text>
<footnote top=""626"" left=""493"" width=""23"" height=""11"" font=""16"" number=""1628"" ref="""" dis=""""/>
<text top=""628"" left=""516"" width=""274"" height=""16"" font=""0""> In turn, according to Brazil, Article 6.2 </text>
<text top=""644"" left=""108"" width=""682"" height=""16"" font=""0"">details the obligations under Article 6.1 by requiring that Members recognize the concepts of pest- </text>
<text top=""661"" left=""108"" width=""683"" height=""16"" font=""0"">or disease-free areas and areas of low pest or disease prevalence, where the exporting Member </text>
<text top=""677"" left=""108"" width=""223"" height=""16"" font=""0"">provides evidence for this claim.</text>
<footnote top=""675"" left=""330"" width=""23"" height=""11"" font=""16"" number=""1629"" ref="""" dis=""""/>
<text top=""677"" left=""353"" width=""437"" height=""16"" font=""0""> Finally, for Brazil Article 6.3 requires the exporting Member to </text>
<text top=""693"" left=""108"" width=""683"" height=""16"" font=""0"">provide the necessary evidence in order to objectively demonstrate to the importing Member that </text>
<text top=""710"" left=""108"" width=""365"" height=""16"" font=""0"">certain areas of its territory are pest- or disease-free.</text>
<footnote top=""708"" left=""473"" width=""23"" height=""11"" font=""16"" number=""1630"" ref="""" dis=""""/>
</p><p number=""7.637"" style=""8""><text top=""744"" left=""108"" width=""684"" height=""16"" font=""0"">7.637.  Brazil also observes that Article 6 should be read in the context of Articles 2.2 and 5.1. </text>
<text top=""761"" left=""108"" width=""683"" height=""16"" font=""0"">Accordingly, when considering the area of an exporting Member that is considered a ""disease-free </text>
<text top=""777"" left=""108"" width=""684"" height=""16"" font=""0"">area"" in light of the evidence provided by that Member under Article 6.3, the importing Member </text>
<text top=""793"" left=""108"" width=""685"" height=""16"" font=""0"">may refuse to recognize a pest- or disease-free area only on the basis of Article 5, especially </text>
<text top=""810"" left=""108"" width=""683"" height=""16"" font=""0"">Article 5.2, which establishes that ""in the assessment of risks, Members shall take into account &#8230; </text>
<text top=""826"" left=""108"" width=""281"" height=""16"" font=""0"">existence of pest- or disease-free areas"".</text>
<footnote top=""825"" left=""389"" width=""23"" height=""11"" font=""16"" number=""1631"" ref="""" dis=""""/>
<footnote top=""905"" left=""170"" width=""590"" height=""15"" font=""10"" number=""57"" ref="""" dis=""""/>
<p><text top=""920"" left=""108"" width=""287"" height=""15"" font=""10"">letter of 30 December 2002, (Exhibit USA-79). </text>
</p><p><text top=""949"" left=""170"" width=""612"" height=""15"" font=""10""> United States' first written submission, para. 342. See also United States' opening statement at the </text>
<text top=""963"" left=""108"" width=""659"" height=""15"" font=""10"">first meeting of the Panel, paras. 56-57; United States' response to Panel question No. 22 following the first </text>
<footnote top=""978"" left=""108"" width=""673"" height=""15"" font=""10"" number=""49"" ref="""" dis=""""/>
</p><p><text top=""1022"" left=""170"" width=""545"" height=""15"" font=""10""> United States' response to Panel question No. 53 following the first substantive meeting. </text>
<footnote top=""1080"" left=""170"" width=""267"" height=""15"" font=""10"" number=""16"" ref="""" dis=""""/>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 203 - </text>
</p></p></page>
<page number=""203"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.8"" style=""8""><text top=""128"" left=""108"" width=""187"" height=""16"" font=""28"">7.8.3.2  European Union </text></p><p number=""7.638"" style=""8""><text top=""162"" left=""108"" width=""688"" height=""16"" font=""0"">7.638.  The European Union takes the view that the three paragraphs of Article 6 of the </text>
<text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">SPS Agreement, read together, ""create a balance of rights and obligations between exporting and </text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""0"">importing Members"". In particular, according to the European Union, the disciplines of Article 6.1 </text>
<text top=""211"" left=""108"" width=""685"" height=""16"" font=""0"">and Article 6.2 apply to both importing and exporting Members, as evidenced by the fact that </text>
<text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">Article 6.1 refers to both the area from which a product ""originated"" and the area to which the </text>
<text top=""244"" left=""108"" width=""147"" height=""16"" font=""0"">product ""is destined"".</text>
<footnote top=""243"" left=""255"" width=""23"" height=""11"" font=""16"" number=""1632"" ref="""" dis=""""/>
</p><p number=""7.639"" style=""8""><text top=""278"" left=""108"" width=""683"" height=""16"" font=""0"">7.639.  According to the European Union, Article 6.3 requires exporting Members wishing to show </text>
<text top=""295"" left=""108"" width=""682"" height=""16"" font=""0"">that certain parts of their territory ""should not be subject to SPS measures"" of importing Members </text>
<text top=""311"" left=""108"" width=""686"" height=""16"" font=""0"">to provide the authorities of the importing Members with evidence necessary to ""objectively </text>
<text top=""328"" left=""108"" width=""654"" height=""16"" font=""0"">demonstrate"" that certain areas are, and are likely to remain, free of the disease in the future.</text>
<footnote top=""326"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1633"" ref="""" dis=""""/>
<text top=""344"" left=""108"" width=""683"" height=""16"" font=""0"">Thus, for the European Union, the obligation of an importing Member to adapt its measure to the </text>
<text top=""360"" left=""108"" width=""683"" height=""16"" font=""0"">SPS characteristics of a particular area of the exporting Member is conditional upon the exporting </text>
<text top=""377"" left=""108"" width=""693"" height=""16"" font=""0"">Member's ability to objectively demonstrate that the specific area possesses those </text>
<text top=""393"" left=""108"" width=""418"" height=""16"" font=""0"">SPS characteristics and is likely to continue possessing them.</text>
<footnote top=""392"" left=""526"" width=""23"" height=""11"" font=""16"" number=""1634"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""339"" height=""15"" font=""10""> European Union's third-party statement, paras. 26-28. </ftext>
</footnote>
</p><p number=""7.8"" style=""8""><text top=""428"" left=""108"" width=""214"" height=""16"" font=""28"">7.8.4  Analysis by the Panel </text></p><p number=""7.640"" style=""8""><text top=""462"" left=""108"" width=""683"" height=""16"" font=""0"">7.640.  We are faced with the need to resolve several issues in connection with the interpretation </text>
<text top=""479"" left=""108"" width=""685"" height=""16"" font=""0"">of Article 6 before we can apply such a provision to Argentina's claims and the United States' </text>
<text top=""495"" left=""108"" width=""682"" height=""16"" font=""0"">defences. In particular, we shall elucidate the meaning of the obligations contained in Articles 6.1, </text>
<text top=""511"" left=""108"" width=""685"" height=""16"" font=""0"">6.2, and 6.3, after which we will turn to an assessment of the interactions between the three </text>
<text top=""528"" left=""108"" width=""86"" height=""16"" font=""0"">paragraphs. </text>
</p><p number=""7.8"" style=""8""><text top=""562"" left=""108"" width=""315"" height=""16"" font=""28"">7.8.4.1  The obligations under Article 6.1 </text></p><p number=""7.641"" style=""8""><text top=""597"" left=""108"" width=""683"" height=""16"" font=""0"">7.641.  The first sentence of Article 6.1 requires all Members to ""ensure"" that their SPS measures </text>
<text top=""613"" left=""108"" width=""684"" height=""16"" font=""0"">are ""adapted"" to the SPS characteristics of the area ""from which the product originated and to </text>
<text top=""629"" left=""108"" width=""683"" height=""16"" font=""0"">which the product is destined"". The term ""area"" is defined in the text of the provision as ""all of a </text>
<text top=""646"" left=""108"" width=""683"" height=""16"" font=""0"">country, part of a country, or all or parts of several countries"". We note that this definition closely </text>
<text top=""662"" left=""108"" width=""682"" height=""16"" font=""0"">mirrors the definition of ""area"" contained in Annex A(6) and A(7) of the SPS Agreement. The panel </text>
<text top=""679"" left=""108"" width=""684"" height=""16"" font=""0"">in  <i>India &#8211; Agricultural Products, </i>which was the first panel to examine Article 6, found that the </text>
<text top=""695"" left=""108"" width=""649"" height=""16"" font=""0"">dictionary definition of the word ""ensure"" is ""[to] make certain the occurrence of [something]""</text>
<footnote top=""693"" left=""757"" width=""23"" height=""11"" font=""16"" number=""1635"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1066"" left=""170"" width=""611"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.668 (quoting <i>Shorter Oxford English Dictionary</i>, </ftext>
<ftext top=""1080"" left=""108"" width=""467"" height=""15"" font=""10"">6th edn, A. Stevenson (ed.) (Oxford University Press, 2007), Vol. I, p. 840). </ftext>
</footnote>
<text top=""695"" left=""780"" width=""10"" height=""16"" font=""0"">, </text>
<text top=""711"" left=""108"" width=""684"" height=""16"" font=""0"">whereas the word ""adapt"" means ""[t]o make &#8230; suitable or fit for a purpose, or conformable to </text>
<text top=""728"" left=""108"" width=""684"" height=""16"" font=""0"">specified conditions, standards, or requirements; &#8230; to make suitable for a new purpose or to a </text>
<text top=""744"" left=""108"" width=""233"" height=""16"" font=""0"">different context or environment"".</text>
<footnote top=""743"" left=""341"" width=""23"" height=""11"" font=""16"" number=""1636"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1095"" left=""170"" width=""619"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.668 (quoting The Oxford English Dictionary, OED </ftext>
<ftext top=""1109"" left=""108"" width=""346"" height=""15"" font=""10"">Online, Oxford University Press, accessed 23 April 2014, </ftext>
<ftext top=""1124"" left=""151"" width=""565"" height=""15"" font=""10"">&lt;http://www.oed.com/view/Entry/2110?rskey=4XPehN&amp;result=2&amp;isAdvanced=false#eid&gt;). </ftext>
</footnote>
</p><p number=""7.642"" style=""8""><text top=""779"" left=""108"" width=""683"" height=""16"" font=""0"">7.642.  In our view, the ""adaptation"" of a measure entails that the measure in question must be </text>
<text top=""795"" left=""108"" width=""683"" height=""16"" font=""0"">tailored or calibrated to the specific SPS characteristics of the area concerned. If, for instance, the </text>
<text top=""811"" left=""108"" width=""683"" height=""16"" font=""0"">area from which a product originates presents a lower level of risk than the rest of the territory of </text>
<text top=""828"" left=""108"" width=""682"" height=""16"" font=""0"">an exporting Member, an importing Member would be required to impose less stringent conditions </text>
<text top=""844"" left=""108"" width=""682"" height=""16"" font=""0"">on imports of products therefrom. The contrary may also be true. If, indeed, the area from which a </text>
<text top=""861"" left=""108"" width=""682"" height=""16"" font=""0"">product originates presents a higher level of risk than the rest of the exporting Member's territory, </text>
<text top=""877"" left=""108"" width=""683"" height=""16"" font=""0"">such an SPS characteristic may warrant the imposition of particularly stringent import restrictions </text>
<text top=""893"" left=""108"" width=""684"" height=""16"" font=""0"">targeting that specific area. We also note that the first sentence of Article 6.1 refers to both the </text>
<text top=""910"" left=""108"" width=""684"" height=""16"" font=""0"">area ""from which the product originated"" <i>and</i> the area ""to which the product is destined"". This </text>
<text top=""926"" left=""108"" width=""685"" height=""16"" font=""0"">indicates that the regulating Member is required to adapt its measure not only to the area of </text>
<text top=""943"" left=""108"" width=""682"" height=""16"" font=""0"">origin, but also to the area of destination of a product. If, for instance, a particular area within the </text>
<text top=""959"" left=""108"" width=""683"" height=""16"" font=""0"">territory of an importing Member has a similar SPS status as the area of origin of a product (e.g. </text>
<p><text top=""1022"" left=""170"" width=""312"" height=""15"" font=""10""> European Union's third-party statement, para. 24. </text>
<text top=""1036"" left=""170"" width=""312"" height=""15"" font=""10""> European Union's third-party statement, para. 25. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 204 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">has the same level of prevalence of a given disease), that Member may be required to tailor its </text>
<text top=""144"" left=""108"" width=""431"" height=""16"" font=""0"">measure by relaxing the restrictions on imports into that area. </text>
</p></p></page>
<page number=""204"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.643"" style=""8""><text top=""178"" left=""108"" width=""685"" height=""16"" font=""0"">7.643.  We agree with the panel in <i>India &#8211; Agricultural Products </i>that the second sentence of </text>
<text top=""195"" left=""108"" width=""684"" height=""16"" font=""0"">Article 6.1 ""presupposes that Members undertake an assessment of the SPS characteristics of a </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">region"" and contains ""a list of factors that shall be taken into account by Members in undertaking </text>
<text top=""228"" left=""108"" width=""129"" height=""16"" font=""0"">such assessment"".</text>
<footnote top=""226"" left=""237"" width=""23"" height=""11"" font=""16"" number=""1637"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""949"" left=""170"" width=""354"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.657.  </ftext>
</footnote>
<text top=""228"" left=""260"" width=""532"" height=""16"" font=""0""> The use of the words ""<i>inter alia</i>"" indicates that this is a non-exhaustive </text>
<text top=""244"" left=""108"" width=""25"" height=""16"" font=""0"">list.</text>
<footnote top=""243"" left=""133"" width=""23"" height=""11"" font=""16"" number=""1638"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""963"" left=""170"" width=""354"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.657.  </ftext>
</footnote>
<text top=""244"" left=""156"" width=""634"" height=""16"" font=""0""> The three factors listed in the provisions are: (i) the level of prevalence of specific diseases </text>
<text top=""260"" left=""108"" width=""683"" height=""16"" font=""0"">or pests; (ii) the existence of eradication or control programmes; and (iii) appropriate criteria or </text>
<text top=""277"" left=""108"" width=""450"" height=""16"" font=""0"">guidelines developed by the relevant international organizations.  </text>
</p><p number=""7.644"" style=""8""><text top=""311"" left=""108"" width=""685"" height=""16"" font=""0"">7.644.  We recall our finding from paragraph 7.408 above, that the requirement to ""take into </text>
<text top=""328"" left=""108"" width=""683"" height=""16"" font=""0"">account"" a particular factor requires consideration of the factor and does not mandate a particular </text>
<text top=""344"" left=""108"" width=""682"" height=""16"" font=""0"">result or determination. We note that the obligation to ""take into account"" the factors enumerated </text>
<text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">in the second sentence is intrinsically connected to the obligations relating to the assessment of </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">risks under Article 5 of the SPS Agreement. In particular, Article 5.2 requires Members conducting </text>
<text top=""393"" left=""108"" width=""683"" height=""16"" font=""0"">a risk assessment to ""take into account"", <i>inter alia</i>, the ""prevalence of specific diseases or pests"" </text>
<text top=""410"" left=""108"" width=""686"" height=""16"" font=""0"">and the ""existence of pest- or disease-free areas"" when assessing the risks as required by </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">Article 5.1. Therefore, it is reasonable to conclude that the assessment of the SPS characteristics </text>
<text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">of an area, taking into account the factors listed in the second sentence of Article 6.1 could be </text>
<text top=""459"" left=""108"" width=""343"" height=""16"" font=""0"">conducted as part of a Member's risk assessment.</text>
<footnote top=""457"" left=""451"" width=""23"" height=""11"" font=""16"" number=""1639"" ref="""" dis=""""><ftext top=""978"" left=""170"" width=""595"" height=""15"" font=""10""> Our statement should not be read to preclude the possibility of other situations where Article 6.1 </ftext>
<ftext top=""993"" left=""108"" width=""327"" height=""15"" font=""10"">could be applied in the absence of a risk assessment. </ftext>
</footnote>
<text top=""459"" left=""474"" width=""316"" height=""16"" font=""0""> Therefore, we find some merit in Argentina's </text>
<text top=""475"" left=""108"" width=""683"" height=""16"" font=""0"">argument that, if a Member did not comply with the second sentence of Article 6.1, this would be </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">relevant for a determination of whether the Member complied with Article 5.1 and had taken into </text>
<text top=""508"" left=""108"" width=""308"" height=""16"" font=""0"">account the factors in Article 5.2 as required.</text>
<footnote top=""507"" left=""416"" width=""23"" height=""11"" font=""16"" number=""1640"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""579"" height=""15"" font=""10""> This understanding does not preclude the possibility that an importing Member could adapt its </ftext>
<ftext top=""1022"" left=""108"" width=""667"" height=""15"" font=""10"">SPS measures to regional conditions even in the absence of a risk assessment, such as in a situation where a </ftext>
<ftext top=""1036"" left=""108"" width=""654"" height=""15"" font=""10"">measure falls within the scope of Article 5.7 or the Member is basing the measures on the Terrestrial Code. </ftext>
</footnote>
</p><p number=""7.645"" style=""8""><text top=""543"" left=""108"" width=""683"" height=""16"" font=""0"">7.645.  As to the meaning of the term ""region"" in the second sentence of Article 6.1, the parties </text>
<text top=""559"" left=""108"" width=""683"" height=""16"" font=""0"">agree that, for the purposes of this dispute, the term can be used interchangeably with the term </text>
<text top=""575"" left=""108"" width=""193"" height=""16"" font=""0"">""area"" in the first sentence.</text>
<footnote top=""574"" left=""302"" width=""23"" height=""11"" font=""16"" number=""1641"" ref="""" dis=""""/>
<text top=""575"" left=""325"" width=""467"" height=""16"" font=""0""> Moreover, the OIE uses the terms ""region"", ""zone"" and ""area"" as </text>
<text top=""592"" left=""108"" width=""225"" height=""16"" font=""0"">referring to the same concept.</text>
<footnote top=""590"" left=""333"" width=""23"" height=""11"" font=""16"" number=""1642"" ref="""" dis=""""/>
<text top=""592"" left=""356"" width=""438"" height=""16"" font=""0""> Accordingly, we do not consider it necessary to attribute </text>
<text top=""608"" left=""108"" width=""582"" height=""16"" font=""0"">different meanings to the words ""area"" and ""region"" for the purposes of this dispute. </text>
</p><p number=""7.646"" style=""8""><text top=""643"" left=""108"" width=""682"" height=""16"" font=""0"">7.646.  Based on the foregoing, we consider that the two sentences of Article 6.1 set forth a logical </text>
<text top=""659"" left=""108"" width=""686"" height=""16"" font=""0"">progression that those Members adopting and applying SPS measures are required to follow. </text>
<text top=""675"" left=""108"" width=""685"" height=""16"" font=""0"">According to the second sentence, a Member must ""assess"" the SPS characteristics of a given </text>
<text top=""692"" left=""108"" width=""685"" height=""16"" font=""0"">area, taking into account, <i>inter alia</i>, the level of prevalence of specific diseases or pests, the </text>
<text top=""708"" left=""108"" width=""684"" height=""16"" font=""0"">existence of eradication or control programmes, and appropriate criteria or guidelines developed </text>
<text top=""725"" left=""108"" width=""684"" height=""16"" font=""0"">by the relevant international organizations. Once the SPS characteristics of the area have been </text>
<text top=""741"" left=""108"" width=""593"" height=""16"" font=""0"">assessed, the Member is required to ""adapt"" it's SPS measure to such characteristics.  </text>
</p><p number=""7.8"" style=""8""><text top=""775"" left=""108"" width=""315"" height=""16"" font=""28"">7.8.4.2  The obligations under Article 6.2 </text></p><p number=""7.647"" style=""8""><text top=""810"" left=""108"" width=""683"" height=""16"" font=""0"">7.647.  The first sentence of Article 6.2 requires that Members ""recognize"" the ""concepts"" of two </text>
<text top=""826"" left=""108"" width=""684"" height=""16"" font=""0"">specific types of areas: (i) ""pest- or disease-free areas""; and (ii) ""areas of low pest or disease </text>
<text top=""843"" left=""108"" width=""85"" height=""16"" font=""0"">prevalence"".</text>
<footnote top=""841"" left=""193"" width=""23"" height=""11"" font=""16"" number=""1643"" ref=""WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430""><ftext top=""1095"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.659. </ftext>
</footnote>
<text top=""843"" left=""216"" width=""575"" height=""16"" font=""0""> The panel in <i>India &#8211; Agricultural Products</i> concluded that the ordinary meaning of </text>
<text top=""859"" left=""108"" width=""682"" height=""16"" font=""0"">the word ""recognize"" is ""[a]cknowledge the existence, legality, or validity of, [especially] by formal </text>
<text top=""875"" left=""108"" width=""583"" height=""16"" font=""0"">approval or sanction; accord notice or attention to; treat as worthy of consideration"".</text>
<footnote top=""874"" left=""691"" width=""23"" height=""11"" font=""16"" number=""1644"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1109"" left=""170"" width=""610"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.668 (quoting Appellate Body Report, <i>US &#8211; Tuna </i></ftext>
</footnote>
<text top=""875"" left=""714"" width=""76"" height=""16"" font=""0""> In turn, it </text>
<text top=""892"" left=""108"" width=""682"" height=""16"" font=""0"">found that the term ""concept"" means ""an abstract idea"" or ""an idea of a class of objects; a general </text>
<footnote top=""1051"" left=""170"" width=""601"" height=""15"" font=""10"" number=""52"" ref="""" dis=""""/>
<p><text top=""1080"" left=""170"" width=""283"" height=""15"" font=""10""> See OIE's response to Panel question No. 21. </text>
</p><p><text top=""1124"" left=""108"" width=""148"" height=""15"" font=""12""><i>II (Mexico)</i>, para. 361). </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 205 - </text>
</p><p><text top=""128"" left=""108"" width=""108"" height=""16"" font=""0"">notion or idea"".</text>
<footnote top=""126"" left=""216"" width=""23"" height=""11"" font=""16"" number=""1645"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""978"" left=""170"" width=""593"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.670 (quoting <i>The Oxford Dictionaries Online</i>, </ftext>
<ftext top=""993"" left=""108"" width=""669"" height=""15"" font=""10"">accessed 10 April 2014, &lt;http://www.oxforddictionaries.com/definition/english/concept?q=concept&gt; and <i>The </i></ftext>
<ftext top=""1007"" left=""108"" width=""538"" height=""15"" font=""12""><i>Oxford English Dictionary</i>, OED Online, Oxford University Press, accessed 10 April 2014, </ftext>
<ftext top=""1022"" left=""108"" width=""455"" height=""15"" font=""10"">&lt;http://www.oed.com/view/Entry/38130?rskey=vaS8sT&amp;result=1#eid&gt;). </ftext>
</footnote>
<text top=""128"" left=""239"" width=""552"" height=""16"" font=""0""> Read together, those terms indicate that Members are required to accept the </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">authority and validity of the general notions of ""pest- or disease-free areas and areas of low pest </text>
<text top=""160"" left=""108"" width=""687"" height=""16"" font=""0"">or disease prevalence"" and to treat them as worthy of consideration in the adoption and </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">application of their SPS measures. The panel in <i>India &#8211; Agricultural Products</i> found that because </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">the first sentence of Article 6.2 simply requires Members to acknowledge particular <i>abstract ideas</i>, </text>
<text top=""210"" left=""108"" width=""683"" height=""16"" font=""0"">it sets forth ""a less exigent obligation"" than that of ""ensuring"" that a measure is ""adapted"" to the </text>
<text top=""226"" left=""108"" width=""326"" height=""16"" font=""0"">SPS characteristics of an area under Article 6.1.</text>
<footnote top=""225"" left=""434"" width=""23"" height=""11"" font=""16"" number=""1646"" ref=""WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430""><ftext top=""1036"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.670. </ftext>
</footnote>
</p></p></page>
<page number=""205"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.648"" style=""8""><text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">7.648.  In turn, the second sentence of Article 6.2 provides that the ""determination"" of pest- or </text>
<text top=""277"" left=""108"" width=""683"" height=""16"" font=""0"">disease-free areas and areas of low pest or disease prevalence ""shall be based on factors such as </text>
<text top=""293"" left=""108"" width=""689"" height=""16"" font=""0"">geography, ecosystems, epidemiological surveillance, and the effectiveness of sanitary or </text>
<text top=""310"" left=""108"" width=""677"" height=""16"" font=""0"">phytosanitary controls"". The list of factors that such a determination must be based on is non-</text>
<text top=""326"" left=""108"" width=""335"" height=""16"" font=""0"">exhaustive, as indicated by the words ""such as"".</text>
<footnote top=""325"" left=""443"" width=""23"" height=""11"" font=""16"" number=""1647"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1051"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.663. </ftext>
</footnote>
<text top=""326"" left=""466"" width=""324"" height=""16"" font=""0""> We note that we have explained the meaning </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">of the words ""based on"" in the context of Article 3.1 in paragraphs 7.218-7.220 above. We see no </text>
<text top=""359"" left=""108"" width=""686"" height=""16"" font=""0"">reason not to apply the same meaning to the terms ""based on"" in the second sentence of </text>
<text top=""375"" left=""108"" width=""684"" height=""16"" font=""0"">Article 6.2. Therefore, we conclude that an analysis of the factors listed therein must sufficiently </text>
<text top=""392"" left=""108"" width=""684"" height=""16"" font=""0"">warrant or reasonably support the determination of pest- or disease-free areas or areas of low </text>
<text top=""408"" left=""108"" width=""191"" height=""16"" font=""0"">pest or disease prevalence. </text>
</p><p number=""7.8"" style=""8""><text top=""443"" left=""108"" width=""315"" height=""16"" font=""28"">7.8.4.3  The obligations under Article 6.3 </text></p><p number=""7.649"" style=""8""><text top=""477"" left=""108"" width=""683"" height=""16"" font=""0"">7.649.  We now turn to examining the content of Article 6.3. As observed by the panel in <i>India &#8211; </i></text>
<text top=""493"" left=""108"" width=""688"" height=""16"" font=""18""><i>Agricultural Products</i>, Article 6.3 sets forth a number of obligations which, unlike those in </text>
<text top=""510"" left=""108"" width=""682"" height=""16"" font=""0"">Articles 6.1 and 6.2, are not addressed to WTO Members generally, but rather to <i>exporting</i> </text>
<text top=""526"" left=""108"" width=""684"" height=""16"" font=""0"">Members that claim to have areas within their territory that are pest- or disease-free areas or </text>
<text top=""543"" left=""108"" width=""288"" height=""16"" font=""0"">areas of low pest or disease prevalence.</text>
<footnote top=""541"" left=""396"" width=""23"" height=""11"" font=""16"" number=""1648"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1066"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.674. </ftext>
</footnote>
<text top=""543"" left=""419"" width=""371"" height=""16"" font=""0"">  In  particular,  an  exporting  Member  making  such  a </text>
<text top=""559"" left=""108"" width=""684"" height=""16"" font=""0"">claim must provide evidence to the importing Member to objectively demonstrate that its areas </text>
<text top=""575"" left=""108"" width=""682"" height=""16"" font=""0"">are, and are likely to remain, pest- or disease-free or areas of low pest or disease prevalence. The </text>
<text top=""592"" left=""108"" width=""683"" height=""16"" font=""0"">Member shall also provide reasonable access to the importing Member for inspection, testing and </text>
<text top=""608"" left=""108"" width=""683"" height=""16"" font=""0"">other relevant procedures. As the plain language of Article 6.3 indicates, the exporting Member is </text>
<text top=""625"" left=""108"" width=""677"" height=""16"" font=""0"">not only required to objectively demonstrate that areas within its territory are pest- or disease-</text>
<text top=""641"" left=""108"" width=""684"" height=""16"" font=""0"">free or of low pest or disease prevalence at a given point in time, but also that such areas are </text>
<text top=""657"" left=""108"" width=""398"" height=""16"" font=""0"">""likely to remain"" in the same pest- or disease-condition.  </text>
</p><p number=""7.650"" style=""8""><text top=""692"" left=""108"" width=""682"" height=""16"" font=""0"">7.650.  The United States argues that an exporting Member's claim that an area within its territory </text>
<text top=""708"" left=""108"" width=""687"" height=""16"" font=""0"">is pest- or disease-free or of low pest or disease prevalence under Article 6.3 triggers the </text>
<text top=""725"" left=""108"" width=""687"" height=""16"" font=""0"">application of Article 5.7. In such a situation, according to the United States, the importing </text>
<text top=""741"" left=""108"" width=""684"" height=""16"" font=""0"">Member is allowed to maintain a provisional measure vis-&#224;-vis the area concerned for the time </text>
<text top=""757"" left=""108"" width=""443"" height=""16"" font=""0"">reasonably necessary to evaluate the exporting Member's claim. </text>
</p><p number=""7.651"" style=""8""><text top=""792"" left=""108"" width=""684"" height=""16"" font=""0"">7.651.  The implication of the United States' argument is that, so long as a measure falls within </text>
<text top=""808"" left=""108"" width=""683"" height=""16"" font=""0"">the scope of Article 5.7, they would not be inconsistent with Article 6.1 and 6.2. In our view, an </text>
<text top=""825"" left=""108"" width=""683"" height=""16"" font=""0"">exporting Member's claim under Article 6.3 may, in certain circumstances, give rise to a situation </text>
<text top=""841"" left=""108"" width=""684"" height=""16"" font=""0"">whereby the importing Member does not have enough information to conduct a risk assessment </text>
<text top=""857"" left=""108"" width=""682"" height=""16"" font=""0"">taking into account whether the area subject to the claim is pest- or disease-free or of low pest or </text>
<text top=""874"" left=""108"" width=""134"" height=""16"" font=""0"">disease prevalence.</text>
<footnote top=""872"" left=""242"" width=""23"" height=""11"" font=""16"" number=""1649"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""612"" height=""15"" font=""10""> We note that Article 5.2 requires Members to take into account ""&#8230;prevalence of specific diseases or </ftext>
<ftext top=""1095"" left=""108"" width=""642"" height=""15"" font=""10"">pests; existence of pest- or disease-free areas&#8230;"". Therefore, the disciplines of Article 6.3 may be seen as </ftext>
<ftext top=""1109"" left=""108"" width=""639"" height=""15"" font=""10"">informing the obligations of Members to maintain their measures with sufficient scientific evidence under </ftext>
<ftext top=""1124"" left=""108"" width=""468"" height=""15"" font=""10"">Articles 2.2, 5.1 and 5.2, and thus in some circumstances, under Article 5.7. </ftext>
</footnote>
<text top=""874"" left=""265"" width=""525"" height=""16"" font=""0""> This might be the case, for example, where the exporting Member does not </text>
<text top=""890"" left=""108"" width=""683"" height=""16"" font=""0"">provide the scientific information necessary to substantiate its assertion. In such instances, if the </text>
<text top=""907"" left=""108"" width=""682"" height=""16"" font=""0"">other three requirements of Article 5.7 are also satisfied, then the measure governing the imports </text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 206 - </text>
</p><p><text top=""128"" left=""108"" width=""593"" height=""16"" font=""0"">subject to the claim under Article 6.3 would fall within the scope of Article 5.7.</text>
<footnote top=""126"" left=""701"" width=""23"" height=""11"" font=""16"" number=""1650"" ref="""" dis=""""><ftext top=""847"" left=""170"" width=""585"" height=""15"" font=""10""> It may also be the case that an exporting Member's claim under Article 6.3 would not implicate </ftext>
<ftext top=""861"" left=""108"" width=""144"" height=""15"" font=""10"">Article 5.7 in any way.  </ftext>
</footnote>
<text top=""128"" left=""724"" width=""70"" height=""16"" font=""0""> In that </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">situation, a panel may have to determine whether the qualified exemption in Article 5.7 extends to </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">the obligations in Articles 6.1 and 6.2. However, as noted in section 7.5.2.4 above, we have found </text>
<text top=""177"" left=""108"" width=""682"" height=""16"" font=""0"">that the United States' measures do not fall within the scope of Article 5.7 and do not benefit from </text>
<text top=""193"" left=""108"" width=""688"" height=""16"" font=""0"">the qualified exemption therein. Therefore, we do not need to address the United States' </text>
<text top=""210"" left=""108"" width=""494"" height=""16"" font=""0"">arguments with respect to the relationship between Articles 6.3 and 5.7.</text>
<footnote top=""208"" left=""602"" width=""23"" height=""11"" font=""16"" number=""1651"" ref="""" dis=""""><ftext top=""876"" left=""170"" width=""617"" height=""15"" font=""10""> For instance, Article 5.2 requires that the importing Member take into account the existence of pest- </ftext>
<ftext top=""891"" left=""108"" width=""629"" height=""15"" font=""10"">or disease-free areas in assessing the risks under Article 5.1. Therefore, if an exporting Member claims </ftext>
<ftext top=""905"" left=""108"" width=""665"" height=""15"" font=""10"">disease-freedom for a portion of its territory under Article 6.3 and provides all relevant information such that </ftext>
<ftext top=""920"" left=""108"" width=""656"" height=""15"" font=""10"">there is no insufficiency of the scientific evidence, Article 5.7 would not be applicable. Rather, the importing </ftext>
<ftext top=""934"" left=""108"" width=""520"" height=""15"" font=""10"">Member would simply review and update its risk assessment pursuant to Article 5.1.  </ftext>
</footnote>
</p></p></page>
<page number=""206"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.8"" style=""8""><text top=""244"" left=""108"" width=""684"" height=""16"" font=""28"">7.8.4.4  The relationship between the obligations contained in the three paragraphs of </text><text top=""260"" left=""108"" width=""68"" height=""16"" font=""28"">Article 6 </text></p><p number=""7.652"" style=""8""><text top=""295"" left=""108"" width=""685"" height=""16"" font=""0"">7.652.  The parties have offered claims, defences and arguments touching on the relationship </text>
<text top=""311"" left=""108"" width=""683"" height=""16"" font=""0"">between the obligations contained in Articles 6.1, 6.2, and 6.3. To recall, Argentina considers that </text>
<text top=""328"" left=""108"" width=""686"" height=""16"" font=""0"">Articles 6.1 and 6.2 establish ""complementary obligations"" with respect to the United States' </text>
<text top=""344"" left=""108"" width=""123"" height=""16"" font=""0"">measure at issue</text>
<footnote top=""343"" left=""231"" width=""23"" height=""11"" font=""16"" number=""1652"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""596"" height=""15"" font=""10""> Argentina's second written submission, para. 238; Argentina's response to Panel question No. 45 </ftext>
<ftext top=""963"" left=""108"" width=""259"" height=""15"" font=""10"">following the second substantive meeting. </ftext>
</footnote>
<text top=""344"" left=""254"" width=""539"" height=""16"" font=""0"">, whereas Article 6.3 stands as a potential ""affirmative defence"" vis-&#224;-vis </text>
<text top=""360"" left=""108"" width=""359"" height=""16"" font=""0"">claims put forward under Articles 6.1 and/or 6.2.</text>
<footnote top=""359"" left=""467"" width=""23"" height=""11"" font=""16"" number=""1653"" ref="""" dis=""""/>
<text top=""360"" left=""491"" width=""304"" height=""16"" font=""0""> The United States, for its part, invokes </text>
<text top=""377"" left=""108"" width=""514"" height=""16"" font=""0"">Article 6.3 only in connection with Argentina's claim under Article 6.1</text>
<footnote top=""375"" left=""622"" width=""23"" height=""11"" font=""16"" number=""1654"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""372"" height=""15"" font=""10""> See United States' first written submission, paras. 342-353. </ftext>
</footnote>
<text top=""377"" left=""645"" width=""150"" height=""16"" font=""0"">, stating that such </text>
<text top=""393"" left=""108"" width=""683"" height=""16"" font=""0"">provisions entail ""a dynamic process"" between the exporting and the importing Member aimed at </text>
<text top=""410"" left=""108"" width=""374"" height=""16"" font=""0"">determining the disease status of the area concerned.</text>
<footnote top=""408"" left=""482"" width=""23"" height=""11"" font=""16"" number=""1655"" ref="""" dis=""""/>
<text top=""410"" left=""505"" width=""286"" height=""16"" font=""0""> The United States further contends that </text>
<text top=""426"" left=""108"" width=""683"" height=""16"" font=""0"">the claim under Article 6.2 must fail because the measure at issue does, ""as such"", recognize the </text>
<text top=""443"" left=""108"" width=""463"" height=""16"" font=""0"">concepts of disease-free areas and areas of low disease prevalence.</text>
<footnote top=""441"" left=""570"" width=""23"" height=""11"" font=""16"" number=""1656"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""372"" height=""15"" font=""10""> See United States' first written submission, paras. 354-358. </ftext>
</footnote>
</p><p number=""7.653"" style=""8""><text top=""477"" left=""108"" width=""688"" height=""16"" font=""0"">7.653.  Article 6 does not provide an explicit indication of the manner in which its three </text>
<text top=""493"" left=""108"" width=""268"" height=""16"" font=""0"">paragraphs interact with one another.</text>
<footnote top=""492"" left=""376"" width=""23"" height=""11"" font=""16"" number=""1657"" ref=""WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430""><ftext top=""1066"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.665. </ftext>
</footnote>
<text top=""493"" left=""399"" width=""394"" height=""16"" font=""0""> In our view, such interactions must be discerned by </text>
<text top=""510"" left=""108"" width=""333"" height=""16"" font=""0"">means of an assessment of Article 6 as a whole. </text>
</p><p number=""7.654"" style=""8""><text top=""544"" left=""108"" width=""684"" height=""16"" font=""0"">7.654.  As discussed in paragraph 7.641 above, Article 6.1 sets forth a general obligation for all </text>
<text top=""561"" left=""108"" width=""527"" height=""16"" font=""0"">Members to adapt their measures to the SPS characteristics of a given area</text>
<footnote top=""559"" left=""635"" width=""23"" height=""11"" font=""16"" number=""1658"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""592"" height=""15"" font=""10""> Furthermore, we note that Article 6.1 does not only address the sanitary status of the area from </ftext>
<ftext top=""1095"" left=""108"" width=""514"" height=""15"" font=""10"">which a product originates, but also that of the area to which a product is destined.  </ftext>
</footnote>
<text top=""561"" left=""658"" width=""133"" height=""16"" font=""0"">, including but not </text>
<text top=""577"" left=""108"" width=""683"" height=""16"" font=""0"">limited to the prevalence of specific diseases or pests. Meanwhile, Articles 6.2 and 6.3 both focus </text>
<text top=""593"" left=""108"" width=""688"" height=""16"" font=""0"">explicitly on ""pest- or disease-free areas"" and ""areas of low pest or disease prevalence"". </text>
<text top=""610"" left=""108"" width=""682"" height=""16"" font=""0"">Accordingly, we consider that, by its own terms, Article 6.1 has a broader scope of application than </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">Articles 6.2 and 6.3, in that it covers not only pest- or disease-free areas or areas of low pest or </text>
<text top=""643"" left=""108"" width=""685"" height=""16"" font=""0"">disease prevalence, but indeed <i>all</i> potential SPS characteristics of areas that may warrant the </text>
<text top=""659"" left=""108"" width=""230"" height=""16"" font=""0"">""adaptation"" of an SPS measure.</text>
<footnote top=""657"" left=""338"" width=""23"" height=""11"" font=""16"" number=""1659"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""155"" height=""15"" font=""10""> See para. 7.642 above.  </ftext>
</footnote>
<text top=""659"" left=""361"" width=""429"" height=""16"" font=""0""> The reasoning of the panel in <i>India &#8211; Agricultural Products</i> </text>
<text top=""675"" left=""108"" width=""684"" height=""16"" font=""0"">supports our view that the scope of SPS characteristics covered by Articles 6.2 and 6.3 is more </text>
<text top=""692"" left=""108"" width=""685"" height=""16"" font=""0"">limited than that of Article 6.1. Indeed, that panel found that the words ""in particular"" at the </text>
<text top=""708"" left=""108"" width=""683"" height=""16"" font=""0"">beginning of Article 6.2 indicate that pest- or disease-free areas and areas of low pest or disease </text>
<text top=""725"" left=""108"" width=""687"" height=""16"" font=""0"">prevalence constitute a subset of all<i>  </i>types of sanitary characteristics that are covered by </text>
<text top=""741"" left=""108"" width=""61"" height=""16"" font=""0"">Article 6.</text>
<footnote top=""739"" left=""169"" width=""23"" height=""11"" font=""16"" number=""1660"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1124"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.671. </ftext>
<ftext top=""978"" left=""108"" width=""161"" height=""15"" font=""10"">G/SPS/48 (16 May 2008). </ftext>
</footnote>
</p><p number=""7.655"" style=""8""><text top=""775"" left=""108"" width=""682"" height=""16"" font=""0"">7.655.  Articles 6.2 and 6.3 set out in more detail the disciplines that must be followed in order to </text>
<text top=""792"" left=""108"" width=""683"" height=""16"" font=""0"">enable a Member to comply with the obligation to ""adapt"" its measure to such SPS characteristics </text>
<text top=""808"" left=""108"" width=""685"" height=""16"" font=""0"">as pest or disease freedom or low pest or disease prevalence. We note that the disciplines in </text>
<p><text top=""978"" left=""170"" width=""583"" height=""15"" font=""10""> Argentina's response to Panel question No. 49 following the first substantive meeting. See also </text>
<text top=""993"" left=""108"" width=""308"" height=""15"" font=""10"">Argentina's second written submission, para. 242. </text>
<footnote top=""1022"" left=""170"" width=""600"" height=""15"" font=""10"" number=""54"" ref="""" dis=""""/>
</p><p><text top=""1036"" left=""108"" width=""468"" height=""15"" font=""10"">United States' opening statement at the first meeting of the Panel, para. 56. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 207 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">question contain obligations on both the importing and the exporting Members. This indicates that </text>
<text top=""144"" left=""108"" width=""683"" height=""16"" font=""0"">Article 6 contemplates an interaction in good faith between the two Members, ultimately aimed at </text>
<text top=""160"" left=""108"" width=""338"" height=""16"" font=""0"">the ""adaptation"" of a measure under Article 6.1.  </text>
</p></p></page>
<page number=""207"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.656"" style=""8""><text top=""195"" left=""108"" width=""685"" height=""16"" font=""0"">7.656.  Specifically, the first sentence of Article 6.2 requires, first, that the importing Member </text>
<text top=""211"" left=""108"" width=""686"" height=""16"" font=""0"">""recognize"" the concepts of ""pest- or disease-free areas"" and ""areas of low pest or disease </text>
<text top=""228"" left=""108"" width=""684"" height=""16"" font=""0"">prevalence"". This means that the Member must provide for the possibility that certain areas be </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">determined to be pest- or disease- free areas or areas of low pest or disease prevalence, as well </text>
<text top=""260"" left=""108"" width=""687"" height=""16"" font=""0"">as specify the requirements that an area has to meet in order to fall within one of those </text>
<text top=""277"" left=""108"" width=""75"" height=""16"" font=""0"">categories.</text>
<footnote top=""275"" left=""183"" width=""23"" height=""11"" font=""16"" number=""1661"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""934"" left=""170"" width=""376"" height=""15"" font=""10""> See Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.698. </ftext>
</footnote>
<text top=""277"" left=""206"" width=""591"" height=""16"" font=""0""> This interpretation is confirmed by the <i>Guidelines to Further the Practical </i></text>
<text top=""293"" left=""108"" width=""351"" height=""16"" font=""18""><i>Implementation of Article 6</i> (Article 6 Guidelines)</text>
<footnote top=""292"" left=""459"" width=""23"" height=""11"" font=""16"" number=""1662"" ref="""" dis=""""/>
<text top=""293"" left=""482"" width=""312"" height=""16"" font=""0""> adopted by the SPS Committee in 2008, </text>
<text top=""310"" left=""108"" width=""354"" height=""16"" font=""0"">which, at paragraph 4, recommend that Members:  </text>
<p><text top=""344"" left=""151"" width=""597"" height=""16"" font=""0"">[P]ublish the basis for recognition of pest- or disease-free areas and areas of low pest </text>
<text top=""360"" left=""151"" width=""599"" height=""16"" font=""0"">or disease prevalence and a description of the general process used, including the </text>
<text top=""377"" left=""151"" width=""604"" height=""16"" font=""0"">information generally required to evaluate such requests and a contact point </text>
<text top=""393"" left=""151"" width=""598"" height=""16"" font=""0"">responsible for requests for recognition of pest-or disease-free areas or areas of low </text>
<text top=""410"" left=""151"" width=""191"" height=""16"" font=""0"">pest or disease prevalence. </text>
</p></p><p number=""7.657"" style=""8""><text top=""444"" left=""108"" width=""683"" height=""16"" font=""0"">7.657.  As we see it, the above requirement constitutes a logical prerequisite to the ""adaptation"" </text>
<text top=""461"" left=""108"" width=""684"" height=""16"" font=""0"">of a measure under Article 6.1. Indeed, where the general regulatory framework of the Member </text>
<text top=""477"" left=""108"" width=""683"" height=""16"" font=""0"">concerned does not permit the recognition of the general concepts of pest- or disease-free areas </text>
<text top=""493"" left=""108"" width=""682"" height=""16"" font=""0"">and areas of low pest or disease prevalence, the possibility to ""adapt"" its measures to the pest- or </text>
<text top=""510"" left=""108"" width=""683"" height=""16"" font=""0"">disease-freedom or low pest or disease prevalence of a specific area may be precluded from the </text>
<text top=""526"" left=""108"" width=""47"" height=""16"" font=""0"">outset.</text>
<footnote top=""525"" left=""155"" width=""23"" height=""11"" font=""16"" number=""1663"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""993"" left=""170"" width=""376"" height=""15"" font=""10""> See Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.680. </ftext>
</footnote>
<text top=""526"" left=""178"" width=""615"" height=""16"" font=""0""> In support of this interpretation, we observe that the panel in <i>India &#8211; Agricultural </i></text>
<text top=""543"" left=""108"" width=""682"" height=""16"" font=""18""><i>Products</i> found that India's failure to set up a regulatory framework recognizing such concepts was </text>
<text top=""559"" left=""108"" width=""438"" height=""16"" font=""0"">inconsistent with Article 6.2 and, ""consequentially"", Article 6.1.</text>
<footnote top=""557"" left=""546"" width=""23"" height=""11"" font=""16"" number=""1664"" ref=""WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430""><ftext top=""1007"" left=""170"" width=""376"" height=""15"" font=""10""> See Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.709. </ftext>
</footnote>
<text top=""559"" left=""569"" width=""222"" height=""16"" font=""0""> We note that Argentina is not </text>
<text top=""575"" left=""108"" width=""684"" height=""16"" font=""0"">arguing that the United States does not have an appropriate regulatory framework in place that </text>
<text top=""592"" left=""108"" width=""682"" height=""16"" font=""0"">""as such"" does recognizes the concept of pest or disease free areas. Rather Argentina is making an </text>
<text top=""608"" left=""108"" width=""583"" height=""16"" font=""0"">""as applied"" claim with respect to the recognition of Patagonia as a disease free area.</text>
<footnote top=""607"" left=""690"" width=""23"" height=""11"" font=""16"" number=""1665"" ref="""" dis=""""/>
</p><p number=""7.658"" style=""8""><text top=""643"" left=""108"" width=""687"" height=""16"" font=""0"">7.658.  We recall the United States' argument that APHIS' general regulatory framework for </text>
<text top=""659"" left=""108"" width=""682"" height=""16"" font=""0"">FMD set forth in 9 CFR 92.2 and 9 CFR 94, as such, recognizes the concepts of FMD-free areas and </text>
<text top=""675"" left=""108"" width=""202"" height=""16"" font=""0"">areas of low FMD-prevalence.</text>
<footnote top=""674"" left=""310"" width=""23"" height=""11"" font=""16"" number=""1666"" ref="""" dis=""""/>
<text top=""675"" left=""333"" width=""457"" height=""16"" font=""0""> We agree. Indeed, 9 CFR 94.1(a) expressly refers to regions that </text>
<text top=""692"" left=""108"" width=""682"" height=""16"" font=""0"">APHIS has declared to be free of FMD, and which are therefore allowed to import ruminants, swine </text>
<text top=""708"" left=""108"" width=""457"" height=""16"" font=""0"">and fresh (chilled or frozen) meat thereof into the United States.</text>
<footnote top=""707"" left=""565"" width=""23"" height=""11"" font=""16"" number=""1667"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""191"" height=""15"" font=""10""> 9 CFR 94.0, (Exhibit ARG-64). </ftext>
</footnote>
<text top=""708"" left=""588"" width=""204"" height=""16"" font=""0""> In turn, 9 CFR 94.0 defines </text>
<text top=""725"" left=""108"" width=""684"" height=""16"" font=""0"">""region"" as ""[a]ny defined geographic land area identifiable by geological, political, or surveyed </text>
<text top=""741"" left=""108"" width=""686"" height=""16"" font=""0"">boundaries"", this comprising ""[a] national entity (country); [p]art of a national entity (zone, </text>
<text top=""757"" left=""108"" width=""682"" height=""16"" font=""0"">county, department, municipality, parish, Province, State, etc.)[; p]arts of several national entities </text>
<text top=""774"" left=""108"" width=""686"" height=""16"" font=""0"">combined into an area; or [a] group of national entities (countries) combined into a single </text>
<text top=""790"" left=""108"" width=""41"" height=""16"" font=""0"">area"".</text>
<footnote top=""789"" left=""149"" width=""23"" height=""11"" font=""16"" number=""1668"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""191"" height=""15"" font=""10""> 9 CFR 94.0, (Exhibit ARG-64). </ftext>
</footnote>
<text top=""790"" left=""172"" width=""619"" height=""16"" font=""0""> As this language indicates, APHIS' regulatory framework allows for the consideration of </text>
<text top=""807"" left=""108"" width=""683"" height=""16"" font=""0"">the specific FMD situations of regions within or across the territories of WTO Members and for the </text>
<text top=""823"" left=""108"" width=""410"" height=""16"" font=""0"">adaptation of the import conditions to such characteristics.  </text>
</p><p number=""7.659"" style=""8""><text top=""857"" left=""108"" width=""684"" height=""16"" font=""0"">7.659.  Where the importing Member, such as the United States, has an appropriate regulatory </text>
<text top=""874"" left=""108"" width=""686"" height=""16"" font=""0"">framework in place, the exporting Member may submit a claim that <i>specific</i> areas within its </text>
<text top=""890"" left=""108"" width=""513"" height=""16"" font=""0"">territory are pest- or disease-free or of low pest or disease prevalence.</text>
<footnote top=""889"" left=""620"" width=""23"" height=""11"" font=""16"" number=""1669"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1109"" left=""170"" width=""570"" height=""15"" font=""10""> In this regard, the panel in <i>India &#8211; Agricultural Products</i> stated that, logically, ""the importing </ftext>
<ftext top=""1124"" left=""108"" width=""680"" height=""15"" font=""10"">Member must have already recognized in its SPS measures the concepts of pest- or disease-free areas or areas </ftext>
<ftext top=""993"" left=""108"" width=""633"" height=""15"" font=""10"">of low pest or disease prevalence, as required under Article 6.2, in order for it to receive and consider a </ftext>
<ftext top=""1007"" left=""108"" width=""609"" height=""15"" font=""10"">request for recognition under Article 6.3."" (Panel Report,<i> India &#8211; Agricultural Products</i>, para. 7.677) </ftext>
</footnote>
<text top=""890"" left=""644"" width=""149"" height=""16"" font=""0""> When an exporting </text>
<p><text top=""949"" left=""170"" width=""607"" height=""15"" font=""31"">Guidelines to Further the Practical Implementation of Article 6 of the Agreement on the Application </text></p><p><text top=""963"" left=""108"" width=""640"" height=""15"" font=""12""><i>Of Sanitary and Phytosanitary Measures</i> adopted by the SPS Committee at its meeting of 2-3 April 2008, </text>
</p><p><text top=""1022"" left=""170"" width=""605"" height=""15"" font=""10""> Argentina's first written submission, para. 543; Argentina's opening statement at the first meeting </text>
<text top=""1036"" left=""108"" width=""140"" height=""15"" font=""10"">of the Panel, para. 77. </text>
</p><p><text top=""1066"" left=""108"" width=""468"" height=""15"" font=""10"">United States' opening statement at the first meeting of the Panel, para. 61. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 208 - </text>
</p><p><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">Member does so, it is required, under Article 6.3 to ""provide the necessary evidence"" to the </text>
<text top=""144"" left=""108"" width=""404"" height=""16"" font=""0"">importing Member to ""objectively demonstrate"" its claim</text>
<footnote top=""143"" left=""512"" width=""23"" height=""11"" font=""16"" number=""1670"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1022"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.676. </ftext>
</footnote>
<text top=""144"" left=""535"" width=""258"" height=""16"" font=""0""> and to give the authorities of the </text>
<text top=""160"" left=""108"" width=""684"" height=""16"" font=""0"">importing Member reasonable access for inspection, testing and other relevant procedures upon </text>
<text top=""177"" left=""108"" width=""687"" height=""16"" font=""0"">request. In other words, Article 6.3 contemplates an exchange of information between the </text>
<text top=""193"" left=""108"" width=""682"" height=""16"" font=""0"">exporting and the importing Members, whereby the former provides evidence concerning the pest- </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">or disease status of areas located within its territory, and the latter evaluates such information </text>
<text top=""226"" left=""108"" width=""597"" height=""16"" font=""0"">with a view to adapting its measure to the SPS characteristics of the areas concerned.  </text>
</p></p></page>
<page number=""208"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.660"" style=""8""><text top=""260"" left=""108"" width=""687"" height=""16"" font=""0"">7.660.  Article 6.3 does not specify what constitutes the ""necessary evidence"" the exporting </text>
<text top=""277"" left=""108"" width=""345"" height=""16"" font=""0"">Member has to provide. However, as noted above</text>
<footnote top=""275"" left=""453"" width=""23"" height=""11"" font=""16"" number=""1671"" ref="""" dis=""""><ftext top=""1036"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.648 above. </ftext>
</footnote>
<text top=""277"" left=""476"" width=""314"" height=""16"" font=""0"">, the second sentence of Article 6.2 provides </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">a non-exhaustive list of factors ""such as geography, ecosystems, epidemiological surveillance, and </text>
<text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">the effectiveness of sanitary or phytosanitary controls"" that the importing Member shall consider in </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">reaching a determination concerning the area that is claimed to be pest- or disease-free or of low </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">pest or disease prevalence. Thus, if an exporting Member wishes to ""objectively demonstrate"" the </text>
<text top=""359"" left=""108"" width=""685"" height=""16"" font=""0"">disease free status of an area the information submitted should address the factors listed in </text>
<text top=""375"" left=""108"" width=""683"" height=""16"" font=""0"">Article 6.2 in addition to any other information that would assist the importing Member in making </text>
<text top=""392"" left=""108"" width=""682"" height=""16"" font=""0"">its determination. The Article 6 Guidelines are also informative regarding the evidence that should </text>
<text top=""408"" left=""108"" width=""682"" height=""16"" font=""0"">be provided by the exporting Member, as well as the factors that should normally be considered by </text>
<text top=""425"" left=""108"" width=""285"" height=""16"" font=""0"">the importing Member in such a situation.</text>
<footnote top=""423"" left=""393"" width=""23"" height=""11"" font=""16"" number=""1672"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""235"" height=""15"" font=""10""> See Article 6 Guidelines, paras. 8-10. </ftext>
</footnote>
</p><p number=""7.661"" style=""8""><text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">7.661.  If, as a result of the interactive process outlined above, the importing Member determines </text>
<text top=""475"" left=""108"" width=""683"" height=""16"" font=""0"">that the area subject to the exporting Member's claim is, indeed, pest- or disease-free or of low </text>
<text top=""492"" left=""108"" width=""683"" height=""16"" font=""0"">pest or disease prevalence, it is required to ""adapt"" its measure to the pest- or disease status of </text>
<text top=""508"" left=""108"" width=""683"" height=""16"" font=""0"">that area, for instance by imposing less stringent conditions on imports of products therefrom. In </text>
<text top=""525"" left=""108"" width=""677"" height=""16"" font=""0"">adapting its measure, the importing Member shall take into account, besides pest- or disease-</text>
<text top=""541"" left=""108"" width=""683"" height=""16"" font=""0"">prevalence, the other factors listed in the second sentence of Article 6.1, namely the existence of </text>
<text top=""557"" left=""108"" width=""682"" height=""16"" font=""0"">eradication or control programmes and appropriate criteria or guidelines developed by the relevant </text>
<text top=""574"" left=""108"" width=""569"" height=""16"" font=""0"">international organizations, as well as other relevant factors not specifically listed.  </text>
</p><p number=""7.662"" style=""8""><text top=""608"" left=""108"" width=""682"" height=""16"" font=""0"">7.662.  Article 6.3 does not expressly establish the consequences of the exporting Member's failure </text>
<text top=""625"" left=""108"" width=""688"" height=""16"" font=""0"">to ""objectively demonstrate"" its claim of pest- or disease-freedom or low pest or disease </text>
<text top=""641"" left=""108"" width=""684"" height=""16"" font=""0"">prevalence with respect to a given area. The panel in <i>India &#8211; Agricultural Products</i> rejected the </text>
<text top=""657"" left=""108"" width=""684"" height=""16"" font=""0"">idea that such a failure may entail a bar of an exporting Member's claims before a panel under </text>
<text top=""674"" left=""108"" width=""683"" height=""16"" font=""0"">Articles 6.1 and/or 6.2. Indeed, the panel stated that Article 6.3 ""is not directly linked to the first </text>
<text top=""690"" left=""108"" width=""686"" height=""16"" font=""0"">two paragraphs of Article 6, or to what Members must do generally with respect to adapting </text>
<text top=""707"" left=""108"" width=""637"" height=""16"" font=""0"">measures to SPS characteristics of certain areas, or in recognizing specific area concepts"".</text>
<footnote top=""705"" left=""744"" width=""23"" height=""11"" font=""16"" number=""1673"" ref=""WT/DS430/R/Add.1|WT/DS430/R"" dis=""DS430""><ftext top=""1066"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.674. </ftext>
</footnote>
<text top=""707"" left=""768"" width=""24"" height=""16"" font=""0""> It </text>
<text top=""723"" left=""108"" width=""682"" height=""16"" font=""0"">further observed that ""[t]here is no conditional language"" linking the obligations under Articles 6.1 </text>
<text top=""739"" left=""108"" width=""684"" height=""16"" font=""0"">and 6.2 ""to Article 6.3, to an extraneous event such as the request of an exporting Member to </text>
<text top=""756"" left=""108"" width=""414"" height=""16"" font=""0"">recognize an area, or to any other event or situation"".</text>
<footnote top=""754"" left=""522"" width=""23"" height=""11"" font=""16"" number=""1674"" ref=""WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430""><ftext top=""1080"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.675. </ftext>
</footnote>
<text top=""756"" left=""545"" width=""250"" height=""16"" font=""0""> Thus, the panel concluded that </text>
<text top=""772"" left=""108"" width=""685"" height=""16"" font=""0"">Articles 6.1 and 6.2 ""create free-standing obligations rather than obligations contingent upon a </text>
<text top=""789"" left=""108"" width=""683"" height=""16"" font=""0"">request from a Member claiming that areas within its territory are pest- or disease-free, pursuant </text>
<text top=""805"" left=""108"" width=""99"" height=""16"" font=""0"">to Article 6.3"".</text>
<footnote top=""804"" left=""207"" width=""23"" height=""11"" font=""16"" number=""1675"" ref=""WT/DS430/R/Add.1|WT/DS430/R|WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430|DS430""><ftext top=""1095"" left=""170"" width=""606"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.679. In that dispute, the panel rejected India's </ftext>
<ftext top=""1109"" left=""108"" width=""675"" height=""15"" font=""10"">argument that the importing Member does not have to comply with Article 6.2 until it received a claim of pest- </ftext>
<ftext top=""1124"" left=""108"" width=""605"" height=""15"" font=""10"">or disease-freedom or low pest or disease prevalence under Article 6.3. (Ibid. paras. 7.698-7.707)  </ftext>
</footnote>
</p><p number=""7.663"" style=""8""><text top=""839"" left=""108"" width=""683"" height=""16"" font=""0"">7.663.  We agree that the obligations in 6.1 and 6.2 are not necessarily contingent on the actions </text>
<text top=""856"" left=""108"" width=""682"" height=""16"" font=""0"">of the exporting Member under Article 6.3. In particular, we note that Article 6.1 refers to adapting </text>
<text top=""872"" left=""108"" width=""684"" height=""16"" font=""0"">measures not only to the SPS characteristics of the area from which the product originates, but </text>
<text top=""889"" left=""108"" width=""683"" height=""16"" font=""0"">also the area to which the product is destined. In looking at the SPS characteristics of the area to </text>
<text top=""905"" left=""108"" width=""686"" height=""16"" font=""0"">which the product is destined, there is no need for a claim from the exporting Member or </text>
<text top=""922"" left=""108"" width=""683"" height=""16"" font=""0"">information from that Member. Similarly, if the Member can adapt the measure without a specific </text>
<text top=""938"" left=""108"" width=""683"" height=""16"" font=""0"">claim because it is applying the disease status designations of an international organization such </text>
<text top=""954"" left=""108"" width=""487"" height=""16"" font=""0"">as the OIE, then there would be no need for a claim under Article 6.3.  </text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 209 - </text>
</p></p></page>
<page number=""209"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.664"" style=""8""><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">7.664.  However, we take the view that in some circumstances the ability of the importing Member </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">to adapt a measure under Article 6.1 is dependent on the exporting Member's compliance with </text>
<text top=""160"" left=""108"" width=""682"" height=""16"" font=""0"">Article 6.3. Indeed, in our opinion, Article 6.3 recognizes that, in certain cases, exporting Members </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">are well if not best placed to gather information about the SPS conditions of geographical areas </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">located within their territories, and that, without their cooperation, the ""objective demonstration"" </text>
<text top=""210"" left=""108"" width=""686"" height=""16"" font=""0"">of the pest- or disease status of the areas concerned to the importing Member may prove </text>
<text top=""226"" left=""108"" width=""684"" height=""16"" font=""0"">impossible. Furthermore, it would not be logical to expect an importing Member to necessarily </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">adapt its measures to the disease statuses of any and all areas, regions or parts of countries the </text>
<text top=""259"" left=""108"" width=""687"" height=""16"" font=""0"">world over absent solicitation or provision of relevant information on the part of exporting </text>
<text top=""275"" left=""108"" width=""295"" height=""16"" font=""0"">Members wishing to obtain market access. </text>
</p><p number=""7.665"" style=""8""><text top=""310"" left=""108"" width=""684"" height=""16"" font=""0"">7.665.  The  panel  in  <i>India &#8211; Agricultural</i> products acknowledged this eventuality where it stated </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">that, ""under certain circumstances, a link may be made"" between the information required for the </text>
<text top=""342"" left=""108"" width=""685"" height=""16"" font=""0"">assessment of SPS characteristics of an area envisaged by Article 6.1 and the obligation of an </text>
<text top=""359"" left=""108"" width=""684"" height=""16"" font=""0"">exporting Member to provide ""the necessary evidence"" under Article 6.3 that an area within its </text>
<text top=""375"" left=""108"" width=""554"" height=""16"" font=""0"">territory is pest- or disease-free or is an area of low pest or disease prevalence.</text>
<footnote top=""374"" left=""662"" width=""23"" height=""11"" font=""16"" number=""1676"" ref=""WT/DS430/R|WT/DS430/R/Add.1"" dis=""DS430""><ftext top=""1066"" left=""170"" width=""349"" height=""15"" font=""10""> Panel Report, <i>India &#8211; Agricultural Products</i>, para. 7.676. </ftext>
</footnote>
<text top=""375"" left=""685"" width=""106"" height=""16"" font=""0""> We note that, </text>
<text top=""392"" left=""108"" width=""682"" height=""16"" font=""0"">in this dispute, Argentina did file a request for the recognition of Patagonia as FMD-free within the </text>
<text top=""408"" left=""108"" width=""188"" height=""16"" font=""0"">meaning  of  9 CFR 94.1(a).</text>
<footnote top=""407"" left=""296"" width=""23"" height=""11"" font=""16"" number=""1677"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""580"" height=""15"" font=""10""> See Information provided by SENASA for the Recognition of Argentina's Patagonia as a Region </ftext>
<ftext top=""1095"" left=""108"" width=""623"" height=""15"" font=""10"">Comprised in Article 92.2, Title 9, Code Of Federal Regulations in Regard to Foot and Mouth Disease &#8211; </ftext>
<ftext top=""1109"" left=""108"" width=""219"" height=""15"" font=""10"">FMD (July 2003), (Exhibit ARG-50). </ftext>
</footnote>
<text top=""408"" left=""319"" width=""471"" height=""16"" font=""0"">  In  other  words,  it  claimed  that  an  area  within  its  territory  is  a </text>
<text top=""425"" left=""108"" width=""690"" height=""16"" font=""0"">disease-free area. In our view, this constitutes one of the ""circumstances"" linking the </text>
<text top=""441"" left=""108"" width=""683"" height=""16"" font=""0"">United States' obligations under Articles 6.1 and 6.2 and Argentina's obligations under Article 6.3. </text>
<text top=""457"" left=""108"" width=""685"" height=""16"" font=""0"">Therefore, we consider that Argentina's claim that the United States' prohibition on imports of </text>
<text top=""474"" left=""108"" width=""690"" height=""16"" font=""0"">FMD-susceptible animals, meat and animal products from Patagonia is inconsistent with </text>
<text top=""490"" left=""108"" width=""686"" height=""16"" font=""0"">Articles 6.1 and 6.2 is properly addressed in the light of our examination whether Argentina </text>
<text top=""507"" left=""108"" width=""684"" height=""16"" font=""0"">provided the necessary evidence to ""objectively demonstrate"" that Patagonia is, and is likely to </text>
<text top=""523"" left=""108"" width=""685"" height=""16"" font=""0"">remain, free of FMD pursuant to Article 6.3. Our analysis must also include an assessment of </text>
<text top=""539"" left=""108"" width=""683"" height=""16"" font=""0"">whether Argentina granted reasonable access, upon request, to APHIS for inspection, testing and </text>
<text top=""556"" left=""108"" width=""186"" height=""16"" font=""0"">other relevant procedures. </text>
</p><p number=""7.666"" style=""8""><text top=""590"" left=""108"" width=""687"" height=""16"" font=""0"">7.666.  Given that Argentina did make the claim and its compliance with the obligation in </text>
<text top=""607"" left=""108"" width=""683"" height=""16"" font=""0"">Article 6.3 is linked to the United States' ability to adapt the measure pursuant to Article 6.1, we </text>
<text top=""623"" left=""108"" width=""683"" height=""16"" font=""0"">do not consider it necessary to settle the issue of whether the United States could have or should </text>
<text top=""639"" left=""108"" width=""684"" height=""16"" font=""0"">have invoked Article 6.3 as an affirmative defence against Argentina's claims under Articles 6.1 </text>
<text top=""656"" left=""108"" width=""62"" height=""16"" font=""0"">and 6.2. </text>
</p><p number=""7.667"" style=""8""><text top=""690"" left=""108"" width=""684"" height=""16"" font=""0"">7.667.  In sum we are of the view that Article 6.1 sets forth the overarching obligation and the </text>
<text top=""707"" left=""108"" width=""684"" height=""16"" font=""0"">ability of a Member to implement that obligation may be dependent on its own compliance with </text>
<text top=""723"" left=""108"" width=""683"" height=""16"" font=""0"">Article 6.2 and the exporting Member's compliance with Article 6.3. Given the facts of the present </text>
<text top=""739"" left=""108"" width=""684"" height=""16"" font=""0"">dispute where the United States does have a regulatory system that recognizes the concept of </text>
<text top=""756"" left=""108"" width=""682"" height=""16"" font=""0"">disease free areas and Argentina has submitted a claim for disease freedom for Patagonia, the two </text>
<text top=""772"" left=""108"" width=""685"" height=""16"" font=""0"">relevant preconditions for the application of Article 6.1 exist and it is appropriate to begin our </text>
<text top=""789"" left=""108"" width=""349"" height=""16"" font=""0"">analysis with Argentina's claims under Article 6.1.  </text>
</p><p number=""7.8"" style=""8""><text top=""823"" left=""108"" width=""688"" height=""16"" font=""28"">7.8.4.5  Whether the United States recognized the concept of FMD-free areas and </text><text top=""839"" left=""108"" width=""459"" height=""16"" font=""28"">adapted its measure to the SPS characteristics of Patagonia </text></p><p number=""7.668"" style=""8""><text top=""874"" left=""108"" width=""688"" height=""16"" font=""0"">7.668.  We now turn to Argentina's claims that the United States acted inconsistently with </text>
<text top=""890"" left=""108"" width=""685"" height=""16"" font=""0"">Article 6.1 by failing to adapt its measure to the FMD-free SPS characteristics of the Patagonia </text>
<text top=""907"" left=""108"" width=""686"" height=""16"" font=""0"">region. In our assessment, we find it useful to refer to the steps of the interactive process </text>
<text top=""923"" left=""108"" width=""313"" height=""16"" font=""0"">described in paragraphs 7.654-7.665 above.  </text>
</p><p number=""7.669"" style=""8""><text top=""958"" left=""108"" width=""683"" height=""16"" font=""0"">7.669.  At the time of the establishment of the Panel, APHIS had not yet recognized Patagonia as </text>
<text top=""974"" left=""108"" width=""684"" height=""16"" font=""0"">separate from the rest of the Argentine territory. Indeed, the 2001 Regulations, adopted in the </text>
<text top=""990"" left=""108"" width=""684"" height=""16"" font=""0"">aftermath of the FMD outbreaks in Northern Argentina during the period July 2000-March 2001, </text>
<text top=""1007"" left=""108"" width=""686"" height=""16"" font=""0"">prohibited imports of all FMD-susceptible animals, meat and animal products from the entire </text>
<text top=""1023"" left=""108"" width=""523"" height=""16"" font=""0"">Argentine territory, comprising of both Northern Argentina and Patagonia.</text>
<footnote top=""1022"" left=""631"" width=""23"" height=""11"" font=""16"" number=""1678"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""612"" height=""15"" font=""10""> 2001 Interim Rule on Argentina, (Exhibit ARG-29); 2001 Final Rule on Argentina, (Exhibit ARG-30). </ftext>
<ftext top=""1022"" left=""108"" width=""672"" height=""15"" font=""10"">Therefore, as of 28 October 2014, imports of relevant products from Patagonia are authorized pursuant to the </ftext>
<ftext top=""1036"" left=""108"" width=""222"" height=""15"" font=""10"">mitigating protocols in 9 CFR 94.11. </ftext>
</footnote>
<text top=""1023"" left=""654"" width=""138"" height=""16"" font=""0""> The United States </text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 210 - </text>
</p><p><text top=""128"" left=""108"" width=""688"" height=""16"" font=""0"">has maintained its prohibition for all the above-mentioned products, without distinguishing </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">between products originating in Northern Argentina and products originating in Patagonia, from </text>
<text top=""160"" left=""108"" width=""439"" height=""16"" font=""0"">2001 up to and including the date of establishment of the Panel.</text>
<footnote top=""159"" left=""547"" width=""23"" height=""11"" font=""16"" number=""1679"" ref="""" dis=""""/>
</p></p></page>
<page number=""210"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.670"" style=""8""><text top=""195"" left=""108"" width=""686"" height=""16"" font=""0"">7.670.  In order to determine whether the United States' omission to recognize Patagonia as </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">separate from the rest of the Argentina territory amounts to a violation of its obligations under </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">Articles 6.1 to adapt its measures to the SPS characteristics of the region, we must assess whether </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">such an omission was justified by Argentina's failure to objectively demonstrate that, at the time </text>
<text top=""260"" left=""108"" width=""551"" height=""16"" font=""0"">of the Panel's establishment, Patagonia was and was likely to remain FMD-free.  </text>
</p><p number=""7.671"" style=""8""><text top=""295"" left=""108"" width=""684"" height=""16"" font=""0"">7.671.  We note that the primary argument of the United States for why they have not adapted </text>
<text top=""311"" left=""108"" width=""687"" height=""16"" font=""0"">their measure is that APHIS has not yet determined that Patagonia is indeed disease-free. </text>
<text top=""328"" left=""108"" width=""461"" height=""16"" font=""0"">However , in our analysis under Article 8 and Annex C(1)(a) above</text>
<footnote top=""326"" left=""569"" width=""23"" height=""11"" font=""16"" number=""1680"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""197"" height=""15"" font=""10""> See paras. 7.169-7.170 above. </ftext>
</footnote>
<text top=""328"" left=""592"" width=""198"" height=""16"" font=""0"">, we found that, at the time </text>
<text top=""344"" left=""108"" width=""685"" height=""16"" font=""0"">of the establishment of the Panel, APHIS itself was satisfied that it had sufficient information </text>
<text top=""360"" left=""108"" width=""687"" height=""16"" font=""0"">concerning the FMD situation in Patagonia to proceed with the finalization of its review of </text>
<text top=""377"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina's request and the issuance of a determination thereon. This was evidenced, <i>inter alia</i>, by </text>
<text top=""393"" left=""108"" width=""685"" height=""16"" font=""0"">the fact that, after the 2009 site visit, APHIS did not request any additional information from </text>
<text top=""410"" left=""108"" width=""683"" height=""16"" font=""0"">SENASA concerning the FMD situation in Patagonia; that on 27 April 2009 APHIS sent a letter to </text>
<text top=""426"" left=""108"" width=""686"" height=""16"" font=""0"">SENASA stating that no additional information was currently required to proceed with APHIS' </text>
<text top=""443"" left=""108"" width=""76"" height=""16"" font=""0"">rulemaking</text>
<footnote top=""441"" left=""184"" width=""23"" height=""11"" font=""16"" number=""1681"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""303"" height=""15"" font=""10""> APHIS' letter of 27 April 2009, (Exhibit ARG-79). </ftext>
</footnote>
<text top=""443"" left=""207"" width=""590"" height=""16"" font=""0"">; and that in June and October 2011 the United States' representative to the </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">SPS Committee stated that ""in light of the information Argentina provided in 2009, which was used </text>
<text top=""475"" left=""108"" width=""683"" height=""16"" font=""0"">to update the 2005 risk analysis, [APHIS] was able to conclude that the import of ruminants and </text>
<text top=""492"" left=""108"" width=""528"" height=""16"" font=""0"">ruminant products from th[at] region presented a negligible risk of FMD"".</text>
<footnote top=""490"" left=""636"" width=""23"" height=""11"" font=""16"" number=""1682"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""618"" height=""15"" font=""10""> G/SPS/R/63, (Exhibit ARG-22), paras. 17-18. See also G/SPS/R/64, (Exhibit ARG-48), paras. 96-97. </ftext>
</footnote>
<text top=""492"" left=""659"" width=""133"" height=""16"" font=""0""> Moreover, in our </text>
<text top=""508"" left=""108"" width=""682"" height=""16"" font=""0"">analysis under Article 5.6 above, we concluded that, at the time of the establishment of the Panel, </text>
<text top=""525"" left=""108"" width=""685"" height=""16"" font=""0"">the information available to APHIS showed that Patagonia was free of FMD and that allowing </text>
<text top=""541"" left=""108"" width=""684"" height=""16"" font=""0"">imports of FMD-susceptible animals, meat and animal products from that region subject to the </text>
<text top=""557"" left=""108"" width=""561"" height=""16"" font=""0"">general protocols set forth in 9 CFR 94.11 would achieve the United States' ALOP.</text>
<footnote top=""556"" left=""669"" width=""23"" height=""11"" font=""16"" number=""1683"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""182"" height=""15"" font=""10""> See section 7.6.7.4.2 above. </ftext>
</footnote>
<text top=""557"" left=""692"" width=""98"" height=""16"" font=""0""> Therefore, in </text>
<text top=""574"" left=""108"" width=""684"" height=""16"" font=""0"">our view, Argentina satisfied its obligation to ""objectively demonstrate"" that Patagonia is and is </text>
<text top=""590"" left=""108"" width=""182"" height=""16"" font=""0"">likely to remain FMD-free. </text>
</p><p number=""7.672"" style=""8""><text top=""625"" left=""108"" width=""686"" height=""16"" font=""0"">7.672.  As to the issue whether, during the period leading up to the Panel's establishment, </text>
<text top=""641"" left=""108"" width=""685"" height=""16"" font=""0"">Argentina granted reasonable access, upon request, to APHIS for inspection, testing and other </text>
<text top=""657"" left=""108"" width=""687"" height=""16"" font=""0"">relevant procedures, we have already noted that Argentina agreed to APHIS' site visits to </text>
<text top=""674"" left=""108"" width=""350"" height=""16"" font=""0"">Patagonia in December 2003 and February 2009.</text>
<footnote top=""672"" left=""458"" width=""23"" height=""11"" font=""16"" number=""1684"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""222"" height=""15"" font=""10""> See paras. 7.150 and 7.155 above. </ftext>
</footnote>
<text top=""674"" left=""481"" width=""311"" height=""16"" font=""0""> We also disagreed with the United States' </text>
<text top=""690"" left=""108"" width=""686"" height=""16"" font=""0"">argument that, until the November 2013 site visit, APHIS' review of Argentina's request for </text>
<text top=""707"" left=""108"" width=""685"" height=""16"" font=""0"">Patagonia was reasonably delayed because APHIS needed to ensure that the information in its </text>
<text top=""723"" left=""108"" width=""685"" height=""16"" font=""0"">possession as a result of the 2006 site visit to Northern Argentina and the 2009 site visit to </text>
<text top=""739"" left=""108"" width=""169"" height=""16"" font=""0"">Patagonia was ""current"".</text>
<footnote top=""738"" left=""277"" width=""23"" height=""11"" font=""16"" number=""1685"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""150"" height=""15"" font=""10""> See para. 7.170 above. </ftext>
</footnote>
</p><p number=""7.673"" style=""8""><text top=""774"" left=""108"" width=""682"" height=""16"" font=""0"">7.673.  In addition to our finding under Article 8 and Annex C(1)(a) that the United States had not </text>
<text top=""790"" left=""108"" width=""684"" height=""16"" font=""0"">undertaken and completed its review without undue delay, we also found that the United States </text>
<text top=""807"" left=""108"" width=""687"" height=""16"" font=""0"">had not reviewed the measure within a reasonable period of time within the meaning of </text>
<text top=""823"" left=""108"" width=""687"" height=""16"" font=""0"">Article 5.7. The Panel is of the view that, in light of our prior findings, the fact that the </text>
<text top=""839"" left=""108"" width=""684"" height=""16"" font=""0"">United States had not yet completed its review of Patagonia, cannot serve to excuse it from its </text>
<text top=""856"" left=""108"" width=""684"" height=""16"" font=""0"">obligations under Article 6.1. We also recall our finding under Article 5.6 that the United States' </text>
<text top=""872"" left=""108"" width=""685"" height=""16"" font=""0"">measures are more trade-restrictive than required to achieve its ALOP because Patagonia is a </text>
<text top=""889"" left=""108"" width=""687"" height=""16"" font=""0"">region that has been FMD-free since 1994 and has the necessary veterinary capacity and </text>
<text top=""905"" left=""108"" width=""687"" height=""16"" font=""0"">infrastructure to prevent and control FMD in its own territory and the capacity to prevent </text>
<text top=""922"" left=""108"" width=""399"" height=""16"" font=""0"">incursions of the disease from regions of higher FMD-risk. </text>
<p><text top=""993"" left=""170"" width=""551"" height=""15"" font=""10""> In particular, the United States published the 2014 Notice of Determination on Patagonia, </text>
<text top=""1007"" left=""108"" width=""620"" height=""15"" font=""10"">(Exhibit USA-167). The Notice indicated that the measure would take effect 60 days after publication. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 211 - </text>
</p></p></page>
<page number=""211"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.674"" style=""8""><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">7.674.  Based on the foregoing, we consider that, at the time of the Panel's establishment, </text>
<text top=""144"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina had met its burden of providing the evidence necessary to ""objectively demonstrate"" </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">that Patagonia as a whole (comprising of both Patagonia South and Patagonia North B) was, and </text>
<text top=""177"" left=""108"" width=""685"" height=""16"" font=""0"">was likely to remain, FMD-free. Therefore, we find that the United States' failure to recognize </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">Patagonia as FMD-free is a failure to adapt its general prohibition on imports of FMD-susceptible </text>
<text top=""210"" left=""108"" width=""684"" height=""16"" font=""0"">animals and animal products from Argentina to the specific SPS characteristics of the Patagonia </text>
<text top=""226"" left=""108"" width=""485"" height=""16"" font=""0"">region and is thus inconsistent with Article 6.1 of the SPS Agreement.  </text>
</p><p number=""7.675"" style=""8""><text top=""260"" left=""108"" width=""685"" height=""16"" font=""0"">7.675.  We note that Argentina also makes an ""as applied"" claim under Article 6.2 because it </text>
<text top=""277"" left=""108"" width=""688"" height=""16"" font=""0"">argues the United States has not specifically applied its general regulatory framework for </text>
<text top=""293"" left=""108"" width=""689"" height=""16"" font=""0"">recognizing disease free areas, i.e. 9 CFR 92.2, to Patagonia. We recall our discussion in </text>
<text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">paragraph 7.658 above that APHIS' regulatory system generally recognizes the concept of disease </text>
<text top=""326"" left=""108"" width=""683"" height=""16"" font=""0"">free areas. In an ""as applied"" situation like that in the present dispute, it is the Panel's view that </text>
<text top=""342"" left=""108"" width=""683"" height=""16"" font=""0"">any measures the United States takes to bring its measures into conformity with Article 6.1 would </text>
<text top=""359"" left=""108"" width=""683"" height=""16"" font=""0"">have the additional result of remedying any potential inconsistency with Article 6.2 if one were to </text>
<text top=""375"" left=""108"" width=""682"" height=""16"" font=""0"">exist. We do not see that a finding on Argentina's ""as applied"" claim under Article 6.2 would aid in </text>
<text top=""392"" left=""108"" width=""685"" height=""16"" font=""0"">providing a positive resolution to this dispute. Therefore, we exercise judicial economy on this </text>
<text top=""408"" left=""108"" width=""45"" height=""16"" font=""0"">claim. </text>
</p><p number=""7.9"" style=""8""><text top=""443"" left=""108"" width=""299"" height=""16"" font=""28"">7.9  Special and differential treatment  </text></p><p number=""7.9"" style=""8""><text top=""477"" left=""108"" width=""243"" height=""16"" font=""28"">7.9.1  Relevant legal provisions </text></p><p number=""7.676"" style=""8""><text top=""511"" left=""108"" width=""399"" height=""16"" font=""0"">7.676.  Article 10.1 of the SPS Agreement sets forth that: </text>
<p><text top=""546"" left=""151"" width=""599"" height=""16"" font=""0"">In the preparation and application of sanitary or phytosanitary measures, Members </text>
<text top=""562"" left=""151"" width=""602"" height=""16"" font=""0"">shall take account of the special needs of developing country Members, and in </text>
<text top=""579"" left=""151"" width=""354"" height=""16"" font=""0"">particular of the least-developed country Members. </text>
</p></p><p number=""7.9"" style=""8""><text top=""613"" left=""108"" width=""281"" height=""16"" font=""28"">7.9.2  Main arguments of the parties </text></p><p number=""7.9"" style=""8""><text top=""647"" left=""108"" width=""141"" height=""16"" font=""28"">7.9.2.1  Argentina </text></p><p number=""7.677"" style=""8""><text top=""682"" left=""108"" width=""685"" height=""16"" font=""0"">7.677.  Argentina argues that the purpose of the obligation in Article 10.1 is to maintain trade </text>
<text top=""698"" left=""108"" width=""686"" height=""16"" font=""0"">flows from developing country Members to the maximum extent possible. Argentina looks to </text>
<text top=""715"" left=""108"" width=""686"" height=""16"" font=""0"">Article 10.2 as context for the obligation in Article 10.1. In particular, Argentina argues that </text>
<text top=""731"" left=""108"" width=""78"" height=""16"" font=""0"">Article 10.2</text>
<footnote top=""729"" left=""186"" width=""23"" height=""11"" font=""16"" number=""1686"" ref="""" dis=""""><ftext top=""1022"" left=""170"" width=""277"" height=""15"" font=""10""> Article 10.2 of the SPS Agreement provides: </ftext>
<ftext top=""1036"" left=""151"" width=""582"" height=""15"" font=""10"">Where the appropriate level of sanitary or phytosanitary protection allows scope for the phased </ftext>
<ftext top=""1051"" left=""151"" width=""557"" height=""15"" font=""10"">introduction of new sanitary or phytosanitary measures, longer time-frames for compliance </ftext>
<ftext top=""1066"" left=""151"" width=""566"" height=""15"" font=""10"">should be accorded on products of interest to developing country Members so as to maintain </ftext>
<ftext top=""1080"" left=""151"" width=""190"" height=""15"" font=""10"">opportunities for their exports. </ftext>
</footnote>
<text top=""731"" left=""209"" width=""582"" height=""16"" font=""0""> lends support to the view that the broad and unqualified obligation in Article 10.1 </text>
<text top=""747"" left=""108"" width=""682"" height=""16"" font=""0"">to  take  account  of  the  special  needs  of  developing  country  Members  should  be  with  a  view  to </text>
<text top=""764"" left=""108"" width=""447"" height=""16"" font=""0"">maintaining trade flows from developing country Members.</text>
<footnote top=""762"" left=""555"" width=""23"" height=""11"" font=""16"" number=""1687"" ref="""" dis=""""><ftext top=""1095"" left=""170"" width=""416"" height=""15"" font=""10""> Argentina's first written submission, paras. 354, 355,567, and 568. </ftext>
</footnote>
<text top=""764"" left=""578"" width=""219"" height=""16"" font=""0""> Argentina claims that the </text>
<text top=""780"" left=""108"" width=""685"" height=""16"" font=""0"">United States has taken every effort to stop the flow of trade from Argentina, not maintain it. </text>
<text top=""797"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina contrasts what it calls the denial of access for Argentina to the relevant administrative </text>
<text top=""813"" left=""108"" width=""683"" height=""16"" font=""0"">process, with the high level of access and speed accorded to developed country Members such as </text>
<text top=""829"" left=""108"" width=""216"" height=""16"" font=""0"">the United Kingdom and Japan.</text>
<footnote top=""828"" left=""324"" width=""23"" height=""11"" font=""16"" number=""1688"" ref="""" dis=""""/>
<text top=""829"" left=""347"" width=""444"" height=""16"" font=""0""> According to Argentina, the United States acted with alacrity in </text>
<text top=""846"" left=""108"" width=""686"" height=""16"" font=""0"">re-opening access to the United States' market for beef from the United Kingdom and Japan </text>
<text top=""862"" left=""108"" width=""682"" height=""16"" font=""0"">following FMD outbreaks in these countries and that these, among other developed countries, have </text>
<text top=""879"" left=""108"" width=""683"" height=""16"" font=""0"">returned to the permanent list of countries which the United States considers FMD-free. According </text>
<text top=""895"" left=""108"" width=""683"" height=""16"" font=""0"">to Argentina, they were given prompt risk assessments and, shortly thereafter, final rulemakings </text>
<text top=""911"" left=""108"" width=""513"" height=""16"" font=""0"">which put them back on the permissive list referenced in 9 CFR 94.1(a)(1).</text>
<footnote top=""910"" left=""621"" width=""23"" height=""11"" font=""16"" number=""1689"" ref="""" dis=""""/>
</p><p number=""7.678"" style=""8""><text top=""946"" left=""108"" width=""686"" height=""16"" font=""0"">7.678.  It is Argentina's view that developing country Members should be given priority and </text>
<text top=""962"" left=""108"" width=""682"" height=""16"" font=""0"">support for risk assessments and rulemakings, not pushed aside for years while developed country </text>
<text top=""979"" left=""108"" width=""685"" height=""16"" font=""0"">Members have their interests taken care of promptly. Consequently, Argentina argues that the </text>
<p><text top=""1109"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 357. </text>
<text top=""1124"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 356. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 212 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""0"">United States has failed to accord Argentina special and differential treatment in the preparation </text>
<text top=""144"" left=""108"" width=""589"" height=""16"" font=""0"">and application of its SPS measures as required by Article 10.1 of the SPS Agreement.</text>
<footnote top=""143"" left=""697"" width=""23"" height=""11"" font=""16"" number=""1690"" ref="""" dis=""""/>
</p></p></page>
<page number=""212"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.679"" style=""8""><text top=""178"" left=""108"" width=""685"" height=""16"" font=""0"">7.679.  Furthermore, Argentina notes that the United States itself identified a ""special need"" &#8211; </text>
<text top=""195"" left=""108"" width=""682"" height=""16"" font=""0"">namely a lack of veterinary capacity in SENASA to control FMD. Argentina argues that, pursuant to </text>
<text top=""211"" left=""108"" width=""683"" height=""16"" font=""0"">Article 10.1, the United States was under an obligation to help remedy any deficiencies it found in </text>
<text top=""228"" left=""108"" width=""439"" height=""16"" font=""0"">Argentina's ability to satisfy United States' sanitary standards.</text>
<footnote top=""226"" left=""546"" width=""23"" height=""11"" font=""16"" number=""1691"" ref="""" dis=""""/>
<text top=""228"" left=""569"" width=""223"" height=""16"" font=""0""> Argentina also argues, in this </text>
<text top=""244"" left=""108"" width=""686"" height=""16"" font=""0"">respect, that there is no qualification of the obligation in Article 10.1 based on which party </text>
<text top=""260"" left=""108"" width=""188"" height=""16"" font=""0"">identifies the special needs.</text>
<footnote top=""259"" left=""296"" width=""23"" height=""11"" font=""16"" number=""1692"" ref="""" dis=""""/>
</p><p number=""7.9"" style=""8""><text top=""295"" left=""108"" width=""169"" height=""16"" font=""28"">7.9.2.2  United States </text></p><p number=""7.680"" style=""8""><text top=""329"" left=""108"" width=""684"" height=""16"" font=""0"">7.680.  The United States responds that, to the extent possible, it takes into account developing </text>
<text top=""346"" left=""108"" width=""684"" height=""16"" font=""0"">country Members' needs in meeting its obligations under the SPS Agreement. The United States </text>
<text top=""362"" left=""108"" width=""685"" height=""16"" font=""0"">notes that many countries at or even below Argentina's income level have been designated as </text>
<text top=""378"" left=""108"" width=""372"" height=""16"" font=""0"">FMD-free by APHIS and obtained import authorization.</text>
<footnote top=""377"" left=""480"" width=""23"" height=""11"" font=""16"" number=""1693"" ref="""" dis=""""><ftext top=""993"" left=""170"" width=""612"" height=""15"" font=""10""> United States' first written submission, paras. 359, 361. The United States uses World Bank data to </ftext>
<ftext top=""1007"" left=""108"" width=""672"" height=""15"" font=""10"">argue that based on GDP or GNI, the following countries that have the right to export to the United States are </ftext>
<ftext top=""1022"" left=""108"" width=""675"" height=""15"" font=""10"">at or below Argentina's development level (i) Belize; (ii) Dominican Republic; (iii) El Salvador; (iv) Guatemala; </ftext>
<ftext top=""1036"" left=""108"" width=""451"" height=""15"" font=""10"">(v) Haiti; (vi) Honduras; (vii) Jamaica; (viii) Namibia; and (ix) Nicaragua. </ftext>
</footnote>
</p><p number=""7.681"" style=""8""><text top=""413"" left=""108"" width=""683"" height=""16"" font=""0"">7.681.  The United States recalls that ""the obligation laid down in Article 10.1 is for the importing </text>
<text top=""429"" left=""108"" width=""686"" height=""16"" font=""0"">Member to 'take account' of developing country Members' needs. The dictionary defines the </text>
<text top=""446"" left=""108"" width=""685"" height=""16"" font=""0"">expression 'take account of' as 'consider along with other factors before reaching a decision'"". </text>
<text top=""462"" left=""108"" width=""682"" height=""16"" font=""0"">Consistent with this, the United States argues that Article 10.1 does not prescribe a specific result </text>
<text top=""479"" left=""108"" width=""111"" height=""16"" font=""0"">to be achieved.""</text>
<footnote top=""477"" left=""218"" width=""23"" height=""11"" font=""16"" number=""1694"" ref="""" dis=""""/>
</p><p number=""7.682"" style=""8""><text top=""513"" left=""108"" width=""684"" height=""16"" font=""0"">7.682.  The United States also argues that Argentina has not adduced any arguments explaining </text>
<text top=""529"" left=""108"" width=""685"" height=""16"" font=""0"">the special needs related to its developing country status. In response to a question from the </text>
<text top=""546"" left=""108"" width=""342"" height=""16"" font=""0"">Panel, the United States clarifies that in its view:  </text>
<p><text top=""580"" left=""151"" width=""599"" height=""16"" font=""0"">[T]he developing country Member claiming a breach of that obligation should show </text>
<text top=""597"" left=""151"" width=""597"" height=""16"" font=""0"">how it communicated its ""special needs"" to the other Member. Otherwise, the Member </text>
<text top=""613"" left=""151"" width=""599"" height=""16"" font=""0"">that is the subject of the claim would have no opportunity to ""take account"" of the </text>
<text top=""629"" left=""151"" width=""306"" height=""16"" font=""0"">developing country Member's ""special need"".</text>
<footnote top=""628"" left=""456"" width=""23"" height=""11"" font=""16"" number=""1695"" ref="""" dis=""""/>
</p></p><p number=""7.683"" style=""8""><text top=""664"" left=""108"" width=""686"" height=""16"" font=""0"">7.683.  At the second hearing of the Panel with the parties, the United States disputed that </text>
<text top=""680"" left=""108"" width=""689"" height=""16"" font=""0"">Article 10.1 obliges the importing Member to provide technical assistance or remedy the </text>
<text top=""697"" left=""108"" width=""682"" height=""16"" font=""0"">deficiencies in the developing country's ability to satisfy sanitary standards, arguing that there was </text>
<text top=""713"" left=""108"" width=""683"" height=""16"" font=""0"">no support in the text for Argentina's position. In any event the United States submits that it has </text>
<text top=""729"" left=""108"" width=""686"" height=""16"" font=""0"">provided support to Argentina in combatting FMD through technical assistance and other aid </text>
<text top=""746"" left=""108"" width=""91"" height=""16"" font=""0"">programmes.</text>
<footnote top=""744"" left=""199"" width=""23"" height=""11"" font=""16"" number=""1696"" ref="""" dis=""""/>
</p><p number=""7.9"" style=""8""><text top=""780"" left=""108"" width=""322"" height=""16"" font=""28"">7.9.3  Main arguments of the third parties </text></p><p number=""7.9"" style=""8""><text top=""815"" left=""108"" width=""109"" height=""16"" font=""28"">7.9.3.1  China </text></p><p number=""7.684"" style=""8""><text top=""849"" left=""108"" width=""687"" height=""16"" font=""0"">7.684.  According to China, the burden of proof placed on developing country Members in </text>
<text top=""865"" left=""108"" width=""682"" height=""16"" font=""0"">Article 10.1 claims should be treated with special care. China argues that it is difficult to prove that </text>
<text top=""882"" left=""108"" width=""683"" height=""16"" font=""0"">a developed country Member has simply ignored its obligation under Article 10.1. It submits that </text>
<text top=""898"" left=""108"" width=""683"" height=""16"" font=""0"">such requirement would amount to asking a developing country Member to prove something that </text>
<p><text top=""949"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 359. </text>
<text top=""963"" left=""170"" width=""304"" height=""15"" font=""10""> Argentina's second written submission, para. 20. </text>
<footnote top=""978"" left=""170"" width=""522"" height=""15"" font=""10"" number=""52"" ref="""" dis=""""/>
</p><p><text top=""1051"" left=""170"" width=""613"" height=""15"" font=""10""> United States' first written submission, para. 360 (citing Panel Report, <i>EC &#8211; Approval and Marketing </i></text>
<text top=""1066"" left=""108"" width=""217"" height=""15"" font=""12""><i>of Biotech Products</i>, para. 7.1620). </text>
</p><p><text top=""1095"" left=""170"" width=""605"" height=""15"" font=""10""> United States' first written submission, para. 365. The United States refers to providing training to </text>
<text top=""1109"" left=""108"" width=""652"" height=""15"" font=""10"">Argentinian veterinary services and economic assistance in building veterinary infrastructure. We note that </text>
<text top=""1124"" left=""108"" width=""295"" height=""15"" font=""10"">some of this assistance took place in the 1960s. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 213 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">does not exist and that requiring the developing country Members to make efforts to collect such </text>
<text top=""144"" left=""108"" width=""327"" height=""16"" font=""0"">non-existing evidence is logically unsustainable.</text>
<footnote top=""143"" left=""435"" width=""23"" height=""11"" font=""16"" number=""1697"" ref="""" dis=""""/>
</p></p></page>
<page number=""213"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.685"" style=""8""><text top=""178"" left=""108"" width=""682"" height=""16"" font=""0"">7.685.  China submits that whenever an importing Member ""takes account of"" the special needs of </text>
<text top=""195"" left=""108"" width=""505"" height=""16"" font=""0"">a developing Member this should be reflected in relevant documentation.</text>
<footnote top=""193"" left=""612"" width=""23"" height=""11"" font=""16"" number=""1698"" ref="""" dis=""""/>
<text top=""195"" left=""635"" width=""154"" height=""16"" font=""0""> In this context China </text>
<text top=""211"" left=""108"" width=""684"" height=""16"" font=""0"">refers to the Appellate Body finding in <i>China &#8211; GOES</i>, that ""[t]he notion of the word ""consider"", </text>
<text top=""228"" left=""108"" width=""682"" height=""16"" font=""0"">when cast as an obligation upon a decision maker, is to oblige it to take something into account in </text>
<text top=""244"" left=""108"" width=""683"" height=""16"" font=""0"">reaching its decision"". Although acknowledging that the Appellate Body's finding was made in the </text>
<text top=""260"" left=""108"" width=""684"" height=""16"" font=""0"">context of Article 3.2 of the Anti-Dumping Agreement, China submits that it sheds light on the </text>
<text top=""277"" left=""108"" width=""684"" height=""16"" font=""0"">interpretation of take account of under Article 10.1 of the SPS Agreement. This is especially so </text>
<text top=""293"" left=""108"" width=""600"" height=""16"" font=""0"">since the term ""take account of"" has been equated with consider by the Appellate Body.</text>
<footnote top=""292"" left=""707"" width=""23"" height=""11"" font=""16"" number=""1699"" ref="""" dis=""""/>
</p><p number=""7.9"" style=""8""><text top=""328"" left=""108"" width=""187"" height=""16"" font=""28"">7.9.3.2  European Union </text></p><p number=""7.686"" style=""8""><text top=""362"" left=""108"" width=""684"" height=""16"" font=""0"">7.686.  The European Union expresses doubt whether the ""vague"" and non-specific language of </text>
<text top=""378"" left=""108"" width=""684"" height=""16"" font=""0"">Article 10.1 can serve as the basis for a claim in dispute settlement as it does not spell out any </text>
<text top=""395"" left=""108"" width=""214"" height=""16"" font=""0"">specific obligation on Members.</text>
<footnote top=""393"" left=""322"" width=""23"" height=""11"" font=""16"" number=""1700"" ref="""" dis=""""/>
</p><p number=""7.687"" style=""8""><text top=""429"" left=""108"" width=""683"" height=""16"" font=""0"">7.687.  The European Union argues that in any event Argentina's assertion that the United States </text>
<text top=""446"" left=""108"" width=""682"" height=""16"" font=""0"">failed to take account of the developing countries' special needs is contradicted by Argentina's own </text>
<text top=""462"" left=""108"" width=""688"" height=""16"" font=""0"">assertion that the United States' ""application"" of the SPS measure was more favourable to </text>
<text top=""479"" left=""108"" width=""682"" height=""16"" font=""0"">Uruguay and the Santa Catarina region of Brazil, which are both developing countries. According to </text>
<text top=""495"" left=""108"" width=""686"" height=""16"" font=""0"">the European Union, this shows that the United States does take account of the developing </text>
<text top=""511"" left=""108"" width=""688"" height=""16"" font=""0"">countries' special needs. Thus, there is ""no breach of whatever obligation is embodied in </text>
<text top=""528"" left=""108"" width=""244"" height=""16"" font=""0"">Article 10.1 of the SPS Agreement.""</text>
<footnote top=""526"" left=""352"" width=""23"" height=""11"" font=""16"" number=""1701"" ref="""" dis=""""/>
</p><p number=""7.9"" style=""8""><text top=""562"" left=""108"" width=""214"" height=""16"" font=""28"">7.9.4  Analysis by the Panel </text></p><p number=""7.688"" style=""8""><text top=""597"" left=""108"" width=""683"" height=""16"" font=""0"">7.688.  The issue before the Panel is whether Argentina has demonstrated that the United States </text>
<text top=""613"" left=""108"" width=""683"" height=""16"" font=""0"">failed to take into account the special needs of Argentina as a developing country when preparing </text>
<text top=""629"" left=""108"" width=""685"" height=""16"" font=""0"">and applying its SPS measures as required by Article 10.1. To make such a determination, the </text>
<text top=""646"" left=""108"" width=""684"" height=""16"" font=""0"">Panel will need to first clarify the nature of the obligation in the provision and then apply that </text>
<text top=""662"" left=""108"" width=""683"" height=""16"" font=""0"">interpretation to the facts of the case. Before moving to the specific requirements in Article 10.1, </text>
<text top=""679"" left=""108"" width=""688"" height=""16"" font=""0"">we first address an important preliminary issue, namely whether Article 10.1 is a positive </text>
<text top=""695"" left=""108"" width=""682"" height=""16"" font=""0"">obligation that can be subject to dispute settlement. Second, we address the burden of proof when </text>
<text top=""711"" left=""108"" width=""204"" height=""16"" font=""0"">making an Article 10.1 claim. </text>
</p><p number=""7.9"" style=""8""><text top=""746"" left=""108"" width=""401"" height=""16"" font=""28"">7.9.4.1  Whether Article 10.1 is a positive obligation </text></p><p number=""7.689"" style=""8""><text top=""780"" left=""108"" width=""683"" height=""16"" font=""0"">7.689.  The European Union argued in its third-party submission that Article 10.1 is too vague to </text>
<text top=""797"" left=""108"" width=""683"" height=""16"" font=""0"">be the subject of dispute settlement. Neither Argentina nor the United States indicated that they </text>
<text top=""813"" left=""108"" width=""686"" height=""16"" font=""0"">shared this view. That being said, the Panel is nonetheless under an independent obligation </text>
<text top=""829"" left=""108"" width=""686"" height=""16"" font=""0"">pursuant to Article 11 of the DSU to make an objective assessment of the matter, including </text>
<text top=""846"" left=""108"" width=""684"" height=""16"" font=""0"">whether the provision can serve as the basis for a claim of violation. We do not agree with the </text>
<text top=""862"" left=""108"" width=""683"" height=""16"" font=""0"">European Union that the allegedly general and vague language of the provision does not set forth </text>
<text top=""879"" left=""108"" width=""687"" height=""16"" font=""0"">a specific obligation for positive action, thus removing it from the ambit of WTO dispute </text>
<text top=""895"" left=""108"" width=""87"" height=""16"" font=""0"">settlement.  </text>
</p><p number=""7.690"" style=""8""><text top=""929"" left=""108"" width=""684"" height=""16"" font=""0"">7.690.  First, many other provisions of the SPS Agreement &#8211; including Articles 5.1, 5.2 and 6.1 </text>
<text top=""946"" left=""108"" width=""683"" height=""16"" font=""0"">which are also raised in this dispute &#8211; and of the other covered agreements contain requirements </text>
<text top=""962"" left=""108"" width=""683"" height=""16"" font=""0"">for Members to ""take into account"" certain techniques, factors, international standards, and so on, </text>
<text top=""979"" left=""108"" width=""463"" height=""16"" font=""0"">which have been interpreted by panels and the Appellate Body.</text>
<footnote top=""977"" left=""571"" width=""23"" height=""11"" font=""16"" number=""1702"" ref=""WT/DS245/R|WT/DS414/AB/R|WT/DS245/RW|WT/DS367/AB/R"" dis=""DS367|DS245|DS414""><ftext top=""1095"" left=""170"" width=""556"" height=""15"" font=""10""> See Panel Report, <i>Japan &#8211; Apples</i>,<i> </i>para. 8.230; Appellate Body Report, <i>Australia &#8211; Apples</i>,<i> </i></ftext>
<ftext top=""1109"" left=""108"" width=""658"" height=""15"" font=""10"">para. 207. See also Appellate Body Report, <i>China &#8211; GOES</i>, para. 130 and fn 216 thereto (equating the term </ftext>
<ftext top=""1124"" left=""108"" width=""495"" height=""15"" font=""10"">""consider"" in Article 3.2 of the Anti-Dumping Agreement to ""take into account"").  </ftext>
</footnote>
<text top=""979"" left=""594"" width=""200"" height=""16"" font=""0""> Therefore, the use of the </text>
<p><text top=""1022"" left=""170"" width=""257"" height=""15"" font=""10""> China's third-party submission, para. 59. </text>
<footnote top=""1036"" left=""170"" width=""257"" height=""15"" font=""10"" number=""60"" ref="""" dis=""""/>
</p><p><text top=""1066"" left=""170"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 74. </text>
<text top=""1080"" left=""170"" width=""318"" height=""15"" font=""10""> European Union's third-party submission, para. 79. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 214 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">phrase ""shall take account of"" in a provision does not make it so vague that it cannot constitute a </text>
<text top=""144"" left=""108"" width=""130"" height=""16"" font=""0"">positive obligation.</text>
<footnote top=""143"" left=""238"" width=""23"" height=""11"" font=""16"" number=""1703"" ref="""" dis=""""><ftext top=""818"" left=""170"" width=""599"" height=""15"" font=""10""> We note that in our determination under Article 5.4 we found that a provision which stated that a </ftext>
<ftext top=""832"" left=""108"" width=""654"" height=""15"" font=""10"">Member ""should"" take account of the objective to minimize negative trade effects did not impose a positive </ftext>
<ftext top=""847"" left=""108"" width=""643"" height=""15"" font=""10"">obligation. That determination was made by evaluating all the phrases used in the provision as well as its </ftext>
<ftext top=""861"" left=""108"" width=""675"" height=""15"" font=""10"">overall context. Article 5.4 is distinguished from the Article 10.1 in that it says ""should"" rather than ""shall"" and </ftext>
<ftext top=""876"" left=""108"" width=""482"" height=""15"" font=""10"">is even more attenuated by requiring the taking into account of an ""objective"". </ftext>
</footnote>
<text top=""144"" left=""261"" width=""530"" height=""16"" font=""0""> With respect to the term ""special needs"", the panel in <i>EC &#8211; Approval and </i></text>
<text top=""160"" left=""108"" width=""686"" height=""16"" font=""18""><i>Marketing of Biotech Products</i> stated that Article 10.1 was ""equivalent"" to Article 12.3 of the </text>
<text top=""177"" left=""108"" width=""110"" height=""16"" font=""0"">TBT Agreement.</text>
<footnote top=""175"" left=""218"" width=""23"" height=""11"" font=""16"" number=""1704"" ref=""WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R ; WT/DS292/R ; WT/DS293/R"" dis=""DS292|DS291|DS293""><ftext top=""891"" left=""170"" width=""548"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, fn 1330 to para. 7.1615. </ftext>
</footnote>
<text top=""177"" left=""241"" width=""552"" height=""16"" font=""0""> The panel in <i>US &#8211; Clove Cigarettes,</i> although noting the vagueness of the </text>
<text top=""193"" left=""108"" width=""684"" height=""16"" font=""0"">expression ""special development, financial and trade needs"", nevertheless examined the specific </text>
<text top=""210"" left=""108"" width=""591"" height=""16"" font=""0"">socio-economic context of Indonesia and made a finding under Article </text>
<text top=""210"" left=""688"" width=""113"" height=""16"" font=""0"">12.3 of the </text>
<text top=""226"" left=""108"" width=""110"" height=""16"" font=""0"">TBT Agreement.</text>
<footnote top=""225"" left=""218"" width=""23"" height=""11"" font=""16"" number=""1705"" ref=""WT/DS406/R"" dis=""DS406""><ftext top=""905"" left=""170"" width=""313"" height=""15"" font=""10""> Panel Report, <i>US &#8211; Clove Cigarettes</i>, para. 7.627.  </ftext>
</footnote>
<text top=""226"" left=""241"" width=""550"" height=""16"" font=""0""> We are aware that the panel in <i>Brazil &#8211; Aircraft, </i>in examining a claim under </text>
<text top=""242"" left=""108"" width=""683"" height=""16"" font=""0"">Article 27.4 of the SCM Agreement, which refers to a developing country Member's ""development </text>
<text top=""259"" left=""108"" width=""683"" height=""16"" font=""0"">needs"", found that an inquiry into what those needs are is ""of a peculiarly economic and political </text>
<text top=""275"" left=""108"" width=""654"" height=""16"" font=""0"">nature, and notably ill-suited to review by a panel whose function is fundamentally legal.""</text>
<footnote top=""274"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1706"" ref=""WT/DS46/RW2|WT/DS46/R|WT/DS46/RW"" dis=""DS46""><ftext top=""920"" left=""170"" width=""263"" height=""15"" font=""10""> Panel Report, <i>Brazil &#8211; Aircraft</i>, para. 7.89. </ftext>
</footnote>
<text top=""292"" left=""108"" width=""683"" height=""16"" font=""0"">However, we concur with the reasoning of the panels in <i>EC &#8211; Approval and Marketing of Biotech </i></text>
<text top=""308"" left=""108"" width=""683"" height=""16"" font=""18""><i>Products </i>and <i>US &#8211; Clove Cigarettes </i>that, such provisions impose positive obligations and must be </text>
<text top=""324"" left=""108"" width=""209"" height=""16"" font=""0"">subject to dispute settlement.</text>
<footnote top=""323"" left=""317"" width=""23"" height=""11"" font=""16"" number=""1707"" ref="""" dis=""DS59|DS64|DS54|DS55""><ftext top=""934"" left=""170"" width=""611"" height=""15"" font=""10""> Additionally, we note that in the arbitration over the reasonable period of time in <i>Indonesia &#8211; Autos</i> </ftext>
<ftext top=""949"" left=""108"" width=""631"" height=""15"" font=""10"">the arbitrator considered whether Indonesia's status as a ""developing country &#8230; in a dire economic and </ftext>
<ftext top=""963"" left=""108"" width=""665"" height=""15"" font=""10"">financial situation"" justified the awarding of an extended period of time for compliance with the DSB's rulings </ftext>
<ftext top=""978"" left=""108"" width=""646"" height=""15"" font=""10"">and recommendations. The arbitrator observed that, under Article 21.2 of the DSU, ""[p]articular attention </ftext>
<ftext top=""993"" left=""108"" width=""647"" height=""15"" font=""10"">should be paid to matters affecting the interests of developing country Members with respect to measures </ftext>
<ftext top=""1007"" left=""108"" width=""663"" height=""15"" font=""10"">which have been subject to dispute settlement"", and considered it ""appropriate to give full weight to matters </ftext>
<ftext top=""1022"" left=""108"" width=""670"" height=""15"" font=""10"">affecting the interests of Indonesia"", thereby extending the reasonable period of time by an extra six months. </ftext>
<ftext top=""1036"" left=""108"" width=""454"" height=""15"" font=""10"">See Award of the Arbitrator, <i>Indonesia &#8211; Autos (Article 21.3(c))</i>, para. 24. </ftext>
</footnote>
<text top=""324"" left=""340"" width=""452"" height=""16"" font=""0""> To do otherwise might render unenforceable many special and </text>
<text top=""341"" left=""108"" width=""685"" height=""16"" font=""0"">differential treatment provisions throughout the covered agreements and upset the balance of </text>
<text top=""357"" left=""108"" width=""519"" height=""16"" font=""0"">rights and obligations between developed and developing country Members.</text>
<footnote top=""356"" left=""626"" width=""23"" height=""11"" font=""16"" number=""1708"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""581"" height=""15"" font=""10""> We are mindful of the requirement of Article 3.2 of the DSU that a panel should not add to nor </ftext>
<ftext top=""1066"" left=""108"" width=""343"" height=""15"" font=""10"">detract from the obligations in the covered agreements. </ftext>
</footnote>
</p></p></page>
<page number=""214"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.691"" style=""8""><text top=""392"" left=""108"" width=""685"" height=""16"" font=""0"">7.691.  Therefore, in our view Article 10.1 does impose a positive obligation that is subject to </text>
<text top=""408"" left=""108"" width=""685"" height=""16"" font=""0"">dispute settlement and we will turn to Argentina's claim that the United States did not act in </text>
<text top=""425"" left=""108"" width=""219"" height=""16"" font=""0"">conformity with that obligation. </text>
</p><p number=""7.9"" style=""8""><text top=""459"" left=""108"" width=""576"" height=""16"" font=""28"">7.9.4.2  Shall take account of special needs of developing country Members </text></p><p number=""7.9"" style=""8""><text top=""493"" left=""108"" width=""429"" height=""16"" font=""28"">7.9.4.2.1  Special needs of developing country Members </text></p><p number=""7.692"" style=""8""><text top=""528"" left=""108"" width=""682"" height=""16"" font=""0"">7.692.  With regard to the phrase ""special needs of developing country Members"", we find that the </text>
<text top=""544"" left=""108"" width=""684"" height=""16"" font=""0"">provision is written broadly so as to encompass both the needs of developing country Members </text>
<text top=""561"" left=""108"" width=""685"" height=""16"" font=""0"">generally, and the needs of a particular developing country Member. We find support for this </text>
<text top=""577"" left=""108"" width=""682"" height=""16"" font=""0"">interpretation in the context provided by Article 10.2, which links special and differential treatment </text>
<text top=""593"" left=""108"" width=""686"" height=""16"" font=""0"">to particular ALOPs and ""products of interest"". In light of the wide varieties of products that </text>
<text top=""610"" left=""108"" width=""682"" height=""16"" font=""0"">developing countries produce and the equally wide variety of ALOPs that could be applied to those </text>
<text top=""626"" left=""108"" width=""683"" height=""16"" font=""0"">products, a reading that limited the scope of Article 10.1 to some generic need experienced by all </text>
<text top=""643"" left=""108"" width=""684"" height=""16"" font=""0"">developing countries would deprive the provision of meaning. That being said, we note that the </text>
<text top=""659"" left=""108"" width=""684"" height=""16"" font=""0"">definition of an SPS measure is broad and also encompasses measures that are applicable to all </text>
<text top=""675"" left=""108"" width=""684"" height=""16"" font=""0"">products &#8211; such as sampling methods, testing, inspection, certification and approval procedures. </text>
<text top=""692"" left=""108"" width=""682"" height=""16"" font=""0"">Reading Article 10.1 as <i>only </i>applying to the needs of individual developing countries would remove </text>
<text top=""708"" left=""108"" width=""653"" height=""16"" font=""0"">the obligation for those SPS measures of general application and we see no basis for doing so.  </text>
</p><p number=""7.693"" style=""8""><text top=""743"" left=""108"" width=""684"" height=""16"" font=""0"">7.693.  The dictionary defines ""special"" as ""distinguished from others of the kind by a particular </text>
<text top=""759"" left=""108"" width=""311"" height=""16"" font=""0"">quality or feature; distinctive in some way"".</text>
<footnote top=""757"" left=""418"" width=""23"" height=""11"" font=""16"" number=""1709"" ref="""" dis=""""><ftext top=""1080"" left=""170"" width=""589"" height=""15"" font=""10""> Shorter Oxford English Dictionary, 6th edn, A. Stevenson (ed.) (Oxford University Press, 2007), </ftext>
<ftext top=""1095"" left=""108"" width=""104"" height=""15"" font=""10"">Vol. 2, p. 1903). </ftext>
</footnote>
<text top=""759"" left=""441"" width=""350"" height=""16"" font=""0""> The dictionary defines ""need"" as ""a condition of </text>
<text top=""775"" left=""108"" width=""296"" height=""16"" font=""0"">lacking or requiring some special thing"".</text>
<footnote top=""774"" left=""404"" width=""23"" height=""11"" font=""16"" number=""1710"" ref="""" dis=""""><ftext top=""1109"" left=""170"" width=""589"" height=""15"" font=""10""> Shorter Oxford English Dictionary, 6th edn, A. Stevenson (ed.) (Oxford University Press, 2007), </ftext>
<ftext top=""1124"" left=""108"" width=""104"" height=""15"" font=""10"">Vol. 2, p. 2943). </ftext>
</footnote>
<text top=""775"" left=""427"" width=""367"" height=""16"" font=""0""> We recall that the panel in <i>EC &#8211; Approval and </i></text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 215 - </text>
</p><p><text top=""128"" left=""108"" width=""684"" height=""16"" font=""18""><i>Marketing of Biotech Products</i> equated the term ""special needs"" in 10.1 with the term ""special </text>
<text top=""144"" left=""108"" width=""688"" height=""16"" font=""0"">development, financial and trade needs of the developing country"" in Article 12.3 of the </text>
<text top=""160"" left=""108"" width=""110"" height=""16"" font=""0"">TBT Agreement.</text>
<footnote top=""159"" left=""218"" width=""26"" height=""11"" font=""16"" number=""1711"" ref=""WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6"" dis=""DS292|DS291|DS293""><ftext top=""905"" left=""170"" width=""548"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, fn 1330 to para. 7.1615. </ftext>
</footnote>
</p></p></page>
<page number=""215"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.9"" style=""8""><text top=""195"" left=""108"" width=""240"" height=""16"" font=""28"">7.9.4.2.2  Shall take account of </text></p><p number=""7.694"" style=""8""><text top=""229"" left=""108"" width=""683"" height=""16"" font=""0"">7.694.  With regard to the requirement to take account of special needs the use of the word shall </text>
<text top=""246"" left=""108"" width=""230"" height=""16"" font=""0"">indicates a mandatory obligation.</text>
<footnote top=""244"" left=""338"" width=""23"" height=""11"" font=""16"" number=""1712"" ref="""" dis=""""><ftext top=""920"" left=""170"" width=""554"" height=""15"" font=""10""> We note that a non-binding Secretariat document entitled ""Implementation of Special and </ftext>
<ftext top=""934"" left=""108"" width=""658"" height=""15"" font=""10"">Differential Treatment Provisions in WTO Agreements and Decisions, Mandatory and Non-Mandatory Special </ftext>
<ftext top=""949"" left=""108"" width=""528"" height=""15"" font=""10"">and Differential Treatment Provisions"" classifies Article 10.1 as a mandatory provision, </ftext>
<ftext top=""963"" left=""108"" width=""633"" height=""15"" font=""10"">WT/COMTD/W/77/Rev.1/Add.1/Corr.1. The Appellate Body has commented on the mandatory nature of </ftext>
</footnote>
<text top=""246"" left=""361"" width=""430"" height=""16"" font=""0""> The United States does not dispute the mandatory nature of </text>
<text top=""262"" left=""108"" width=""687"" height=""16"" font=""0"">the obligation. Furthermore, both parties agree that take account of requires the importing </text>
<text top=""278"" left=""108"" width=""509"" height=""16"" font=""0"">Member to consider the special needs of the developing country Member.</text>
<footnote top=""277"" left=""617"" width=""23"" height=""11"" font=""16"" number=""1713"" ref="""" dis=""""><ftext top=""1007"" left=""170"" width=""588"" height=""15"" font=""10""> United States' first written submission, paras. 344 and 360; see also United States' response to </ftext>
</footnote>
<text top=""278"" left=""640"" width=""151"" height=""16"" font=""0""> Prior panels and the </text>
<text top=""295"" left=""108"" width=""492"" height=""16"" font=""0"">Appellate Body have interpreted the phrase ""take into account""</text>
<footnote top=""293"" left=""600"" width=""23"" height=""11"" font=""16"" number=""1714"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""454"" height=""15"" font=""10""> Or similar phrases such as ""taking into account"" and ""taking account of"".  </ftext>
</footnote>
<text top=""295"" left=""623"" width=""174"" height=""16"" font=""0""> to mean ""take into </text>
<text top=""311"" left=""108"" width=""152"" height=""16"" font=""0"">consideration, notice"".</text>
<footnote top=""310"" left=""260"" width=""23"" height=""11"" font=""16"" number=""1715"" ref="""" dis=""""/>
<text top=""311"" left=""283"" width=""506"" height=""16"" font=""0""> More specifically, the panel in <i>US &#8211; COOL </i>also clarified that an obligation </text>
<text top=""328"" left=""108"" width=""634"" height=""16"" font=""0"">to take something into account does not require any particular result of that consideration.</text>
<footnote top=""326"" left=""742"" width=""23"" height=""11"" font=""16"" number=""1716"" ref=""WT/DS384/RW ; WT/DS386/RW|WT/DS384/RW/Add.1 ; WT/DS386/RW/Add.1|WT/DS384/R ; WT/DS386/R"" dis=""DS386|DS384""><ftext top=""1095"" left=""170"" width=""244"" height=""15"" font=""10""> Panel Report, <i>US &#8211; COOL</i>, para. 7.776. </ftext>
</footnote>
<text top=""328"" left=""765"" width=""26"" height=""16"" font=""0""> In </text>
<text top=""344"" left=""108"" width=""682"" height=""16"" font=""0"">the case of Article 10.1, it is the special needs of developing country Members, and in particular of </text>
<text top=""360"" left=""108"" width=""585"" height=""16"" font=""0"">the least developed country Members that must be taken into account or considered. </text>
</p><p number=""7.9"" style=""8""><text top=""395"" left=""108"" width=""186"" height=""16"" font=""28"">7.9.4.3  Burden of proof </text></p><p number=""7.695"" style=""8""><text top=""429"" left=""108"" width=""686"" height=""16"" font=""0"">7.695.  In applying Article 10.1 to the facts of this case, it is necessary to first address the </text>
<text top=""446"" left=""108"" width=""684"" height=""16"" font=""0"">arguments of the Parties regarding burden of proof. The United States urges the Panel to adopt </text>
<text top=""462"" left=""108"" width=""683"" height=""16"" font=""0"">the approach taken by the panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i>,<i> </i>which was </text>
<text top=""479"" left=""108"" width=""682"" height=""16"" font=""0"">made in the specific context of Article 10.1 of the SPS Agreement. That panel held that Article 10.1 </text>
<text top=""495"" left=""108"" width=""687"" height=""16"" font=""0"">does not specifically require the importing Member to document how it has complied with </text>
<text top=""511"" left=""108"" width=""683"" height=""16"" font=""0"">Article 10.1 and the absence of references in the challenged measures to how developing country </text>
<text top=""528"" left=""108"" width=""683"" height=""16"" font=""0"">Members' needs were taken into account is not sufficient for the purposes of establishing a claim </text>
<text top=""544"" left=""108"" width=""127"" height=""16"" font=""0"">under Article 10.1.</text>
<footnote top=""543"" left=""235"" width=""23"" height=""11"" font=""16"" number=""1717"" ref=""WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6"" dis=""DS291|DS292|DS293""><ftext top=""1109"" left=""170"" width=""474"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>,<i> </i>para. 7.1623. </ftext>
</footnote>
</p><p number=""7.696"" style=""8""><text top=""579"" left=""108"" width=""682"" height=""16"" font=""0"">7.696.  Argentina, for its part, argues that the Appellate Body's ruling in <i>China &#8211; GOES</i>, stands for </text>
<text top=""595"" left=""108"" width=""684"" height=""16"" font=""0"">the opposite principle to that set forth by the panel in <i>EC &#8211; Approval and Marketing of Biotech </i></text>
<text top=""611"" left=""108"" width=""682"" height=""16"" font=""18""><i>Products. </i>In particular, Argentina notes that the Appellate Body interpreted the term ""consider"" as </text>
<text top=""628"" left=""108"" width=""682"" height=""16"" font=""0"">being synonymous with ""taking account of"" and found that to comply with an obligation to consider </text>
<text top=""644"" left=""108"" width=""682"" height=""16"" font=""0"">a particular factor in an injury determination, the importing Member must document how it did so. </text>
<text top=""661"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina asks the Panel to interpret the language in Article 10.1 in the same manner and also </text>
<text top=""677"" left=""108"" width=""685"" height=""16"" font=""0"">conclude that the absence of a risk assessment or a rulemaking notice from the United States </text>
<text top=""693"" left=""108"" width=""432"" height=""16"" font=""0"">means that it did not comply with the obligation in Article 10.1.</text>
<footnote top=""692"" left=""540"" width=""23"" height=""11"" font=""16"" number=""1718"" ref="""" dis=""""/>
</p><p number=""7.697"" style=""8""><text top=""728"" left=""108"" width=""682"" height=""16"" font=""0"">7.697.  We note that the Appellate Body's interpretation of ""consider"" in <i>China &#8211; GOES, </i>was made </text>
<text top=""744"" left=""108"" width=""683"" height=""16"" font=""0"">in the context of a dispute under the Anti-Dumping and SCM Agreements. In particular, we note </text>
<text top=""761"" left=""108"" width=""688"" height=""16"" font=""0"">that the Anti-Dumping and SCM Agreements have very specific obligations with respect to </text>
<text top=""777"" left=""108"" width=""688"" height=""16"" font=""0"">publication and documentation of decisions. Although the SPS Agreement does have some </text>
<text top=""793"" left=""108"" width=""687"" height=""16"" font=""0"">provisions that encourage transparency and communication to the interested Members and </text>
<text top=""810"" left=""108"" width=""682"" height=""16"" font=""0"">exporters, they are not as detailed as those in the Anti-Dumping and SCM Agreements. Therefore, </text>
<text top=""826"" left=""108"" width=""683"" height=""16"" font=""0"">we do not find it appropriate to simply transplant wholesale the Appellate Body's interpretation in </text>
<text top=""843"" left=""108"" width=""687"" height=""16"" font=""18""><i>China &#8211; GOES </i>concerning a provision about how to determine injury into an SPS provision </text>
<p><text top=""978"" left=""108"" width=""666"" height=""15"" font=""10"">obligations containing the word ""shall"". (See e.g. Appellate Body Reports, <i>EC &#8211; Fasteners (China)</i>, para. 366; </text>
<text top=""993"" left=""108"" width=""241"" height=""15"" font=""10"">and <i>EC &#8211; Tariff Preferences</i>,<i> </i>para. 246) </text>
<footnote top=""1022"" left=""108"" width=""644"" height=""15"" font=""10"" number=""34"" ref="""" dis=""""/>
</p><p><text top=""1066"" left=""170"" width=""603"" height=""15"" font=""10""> Appellate Body Report, <i>Korea &#8211; Various Measures on Beef</i>, para. 111; see also Panel Report, <i>US &#8211; </i></text>
<text top=""1080"" left=""108"" width=""122"" height=""15"" font=""12""><i>COOL</i>, para. 7.776. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 216 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">concerning special and differential treatment that requires the importing Member ""to take account </text>
<text top=""144"" left=""108"" width=""33"" height=""16"" font=""0"">of"".  </text>
</p></p></page>
<page number=""216"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.698"" style=""8""><text top=""178"" left=""108"" width=""683"" height=""16"" font=""0"">7.698.  In the context of Article 10.1, we agree with the panel in <i>EC &#8211; Approval and Marketing of </i></text>
<text top=""195"" left=""108"" width=""683"" height=""16"" font=""18""><i>Biotech Products</i> and find that the absence of documentation in the form of a risk assessment or </text>
<text top=""211"" left=""108"" width=""687"" height=""16"" font=""0"">final measure is not sufficient in itself for Argentina to establish a <i>prima facie</i> case under </text>
<text top=""228"" left=""108"" width=""688"" height=""16"" font=""0"">Article 10.1. However, we are cognisant that in considering what is required to show an </text>
<text top=""244"" left=""108"" width=""686"" height=""16"" font=""0"">inconsistency with Article 10.1 we cannot create a potentially insurmountable burden on the </text>
<text top=""260"" left=""108"" width=""88"" height=""16"" font=""0"">complainant.</text>
<footnote top=""259"" left=""196"" width=""23"" height=""11"" font=""16"" number=""1719"" ref="""" dis=""""/>
<text top=""260"" left=""219"" width=""573"" height=""16"" font=""0""> This is all the more so in the context of the obligation in Article 10.1 which is </text>
<text top=""277"" left=""108"" width=""682"" height=""16"" font=""0"">aimed at protecting the interests of developing countries. Therefore, we want to clarify that we do </text>
<text top=""293"" left=""108"" width=""682"" height=""16"" font=""0"">not understand the panel's reasoning in <i>EC &#8211; Approval and Marketing of Biotech Products</i> to stand </text>
<text top=""310"" left=""108"" width=""682"" height=""16"" font=""0"">for the proposition that there is no way to satisfy the burden of proof under Article 10.1. While the </text>
<text top=""326"" left=""108"" width=""685"" height=""16"" font=""0"">absence of documentation <i>alone</i> will not suffice to establish a violation, the absence of such </text>
<text top=""342"" left=""108"" width=""682"" height=""16"" font=""0"">documentation is relevant evidence and will be particularly probative in a situation where a special </text>
<text top=""359"" left=""108"" width=""584"" height=""16"" font=""0"">need has been expressly identified and brought to the importing Member's attention. </text>
</p><p number=""7.699"" style=""8""><text top=""393"" left=""108"" width=""687"" height=""16"" font=""0"">7.699.  In particular, it is our view that the burden of proof in Article 10.1 begins with a </text>
<text top=""410"" left=""108"" width=""686"" height=""16"" font=""0"">determination of whether a specific special need of a developing country Member has been </text>
<text top=""426"" left=""108"" width=""68"" height=""16"" font=""0"">identified.</text>
<footnote top=""425"" left=""176"" width=""23"" height=""11"" font=""16"" number=""1720"" ref=""WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5"" dis=""DS293|DS291|DS292""><ftext top=""716"" left=""170"" width=""583"" height=""15"" font=""10""> We recall the reasoning of the panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> that a </ftext>
<ftext top=""730"" left=""108"" width=""617"" height=""15"" font=""10"">developing country does not have to specifically <i>ask</i> that its special needs be taken into account. The </ftext>
<ftext top=""745"" left=""108"" width=""676"" height=""15"" font=""10"">requirement to take into account the special needs of developing country Members is inherent in the obligation </ftext>
<ftext top=""759"" left=""108"" width=""669"" height=""15"" font=""10"">in Article 10.1 without any action required on the part of the developing country Member. However, as will be </ftext>
<ftext top=""774"" left=""108"" width=""657"" height=""15"" font=""10"">discussed further below, the importing Member does need to be aware that a special need exists. See Panel </ftext>
<ftext top=""788"" left=""108"" width=""440"" height=""15"" font=""10"">Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1625. </ftext>
</footnote>
<text top=""426"" left=""199"" width=""594"" height=""16"" font=""0""> In that respect, we note that the United States is of the view that the exporting </text>
<text top=""443"" left=""108"" width=""684"" height=""16"" font=""0"">Member must identify its special needs and that Argentina did not do so. Argentina argues that </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">there is no qualification of the obligation in Article 10.1 based on which party identifies the special </text>
<text top=""475"" left=""108"" width=""45"" height=""16"" font=""0"">needs.</text>
<footnote top=""474"" left=""153"" width=""23"" height=""11"" font=""16"" number=""1721"" ref="""" dis=""""/>
<text top=""475"" left=""176"" width=""615"" height=""16"" font=""0""> According to Argentina it depends on the facts of the specific measure and the specific </text>
<text top=""492"" left=""108"" width=""682"" height=""16"" font=""0"">case. We agree with Argentina. In the Panel's view there are multiple ways in which a special need </text>
<text top=""508"" left=""108"" width=""682"" height=""16"" font=""0"">could be brought to the attention of the importing Member. It could be that the developing country </text>
<text top=""525"" left=""108"" width=""682"" height=""16"" font=""0"">knows of a need that it needs to remedy and should make that known to the importing country, </text>
<text top=""541"" left=""108"" width=""684"" height=""16"" font=""0"">this would make sense from a practical viewpoint as the developing country Member would be </text>
<text top=""557"" left=""108"" width=""236"" height=""16"" font=""0"">identifying its own special needs.</text>
<footnote top=""556"" left=""344"" width=""23"" height=""11"" font=""16"" number=""1722"" ref="""" dis=""""><ftext top=""818"" left=""170"" width=""559"" height=""15"" font=""10""> Such an understanding of the process would be consistent with ""The Procedure to Enhance </ftext>
<ftext top=""832"" left=""108"" width=""662"" height=""15"" font=""10"">Transparency of Special and Differential Treatment in Favour of Developing Country Members"" developed by </ftext>
<ftext top=""847"" left=""108"" width=""283"" height=""15"" font=""10"">the SPS Committee. That Procedure provides: </ftext>
</footnote>
<text top=""557"" left=""367"" width=""426"" height=""16"" font=""0""> Conversely, the importing country could identify a special </text>
<text top=""574"" left=""108"" width=""682"" height=""16"" font=""0"">need, for example while conducting its risk assessment, and convey that to the developing country </text>
<text top=""590"" left=""108"" width=""60"" height=""16"" font=""0"">Member.</text>
<footnote top=""589"" left=""168"" width=""23"" height=""11"" font=""16"" number=""1723"" ref="""" dis=""""/>
<text top=""590"" left=""191"" width=""600"" height=""16"" font=""0""> The Panel underlines however, that while we consider that an importing country may </text>
<text top=""607"" left=""108"" width=""686"" height=""16"" font=""0"">identify a special need, we do not consider that the burden is on the importing Member to </text>
<text top=""623"" left=""108"" width=""299"" height=""16"" font=""18""><i>necessarily</i> identify any such special need.  </text>
<p><text top=""701"" left=""170"" width=""284"" height=""15"" font=""10""> China's third-party submission, paras. 59-60. </text>
</p><p><text top=""803"" left=""170"" width=""522"" height=""15"" font=""10""> Argentina's response to Panel question No. 52 after the second substantive meeting. </text>
</p><p><text top=""861"" left=""151"" width=""588"" height=""15"" font=""10"">Step 5: If an exporting Member identifies significant difficulties with the proposed measure, that </text>
<text top=""876"" left=""151"" width=""553"" height=""15"" font=""10"">Member may, in its comments, request an opportunity to discuss and resolve the potential </text>
<text top=""891"" left=""151"" width=""237"" height=""15"" font=""10"">difficulty with the notifying Member &#8230;. </text>
</p><p><text top=""920"" left=""151"" width=""586"" height=""15"" font=""10"">Step 6: If, following the entry into force of a new regulation (including an emergency measure), </text>
<text top=""934"" left=""151"" width=""593"" height=""15"" font=""10"">an exporting Member identifies significant difficulties which its exports face in complying with the </text>
<text top=""949"" left=""151"" width=""546"" height=""15"" font=""10"">new regulation, it may request an opportunity to discuss its difficulties with the importing </text>
<text top=""963"" left=""151"" width=""578"" height=""15"" font=""10"">Member to attempt to resolve the issue of concern, especially where no time, or an insufficient </text>
<text top=""978"" left=""151"" width=""594"" height=""15"" font=""10"">period of time, has been provided for comments. In the case of such a request from an exporting </text>
<text top=""993"" left=""151"" width=""586"" height=""15"" font=""10"">developing country Member, the importing Member would, in any discussions, examine whether </text>
<text top=""1007"" left=""151"" width=""593"" height=""15"" font=""10"">and how the identified problem could best be addressed to take into account the special needs of </text>
<text top=""1022"" left=""151"" width=""518"" height=""15"" font=""10"">the interested exporting developing country Member, so as to enable it to satisfy the </text>
<text top=""1036"" left=""151"" width=""189"" height=""15"" font=""10"">requirements of the measure.  </text>
<text top=""1051"" left=""170"" width=""582"" height=""15"" font=""10""> We note that with respect to all Members, Annex C(1)(b) provides that the importing Member: </text>
<text top=""1066"" left=""108"" width=""659"" height=""15"" font=""10"">informs the applicant in a precise and complete manner of all deficiencies; the competent body transmits as </text>
<text top=""1080"" left=""108"" width=""630"" height=""15"" font=""10"">soon as possible the results of the procedure in a precise and complete manner to the applicant so that </text>
<text top=""1095"" left=""108"" width=""664"" height=""15"" font=""10"">corrective action may be taken if necessary; even when the application has deficiencies, the competent body </text>
<text top=""1109"" left=""108"" width=""643"" height=""15"" font=""10"">proceeds as far as practicable with the procedure if the applicant so requests; and that upon request, the </text>
<text top=""1124"" left=""108"" width=""512"" height=""15"" font=""10"">applicant is informed of the stage of the procedure, with any delay being explained. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 217 - </text>
</p></p></page>
<page number=""217"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.700"" style=""8""><text top=""128"" left=""108"" width=""685"" height=""16"" font=""0"">7.700.  If a developing country Member can demonstrate that its special needs were expressly </text>
<text top=""144"" left=""108"" width=""688"" height=""16"" font=""0"">identified to or by the importing Member <i>and</i> can show a lack of documentation of the </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">consideration that is likely enough to shift the burden on to the importing Member to show how it </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">took account of those special needs. Conversely, if the importing Member was not made aware of </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">the special needs of the developing country Member, we consider that it will be more difficult for </text>
<text top=""210"" left=""108"" width=""682"" height=""16"" font=""0"">the developing country Member to make its case. This is consistent with the reasoning of the panel </text>
<text top=""226"" left=""108"" width=""684"" height=""16"" font=""0"">in  <i>EC &#8211; Approval and Marketing of Biotech Products</i>, that the European Communities could not </text>
<text top=""242"" left=""108"" width=""684"" height=""16"" font=""0"">have known that the products being reviewed were those of a developing country, because the </text>
<text top=""259"" left=""108"" width=""685"" height=""16"" font=""0"">European Communities had not been made aware that any of the applicants seeking to place </text>
<text top=""275"" left=""108"" width=""565"" height=""16"" font=""0"">biotech products on the European market was an Argentine company or individual.</text>
<footnote top=""274"" left=""673"" width=""23"" height=""11"" font=""16"" number=""1724"" ref="""" dis=""""/>
</p><p number=""7.9"" style=""8""><text top=""310"" left=""108"" width=""589"" height=""16"" font=""28"">7.9.4.4  Whether the United States took account of Argentina's special needs </text></p><p number=""7.701"" style=""8""><text top=""344"" left=""108"" width=""683"" height=""16"" font=""0"">7.701.  Turning to Argentina's claims in this case, Argentina has argued that the United States did </text>
<text top=""360"" left=""108"" width=""684"" height=""16"" font=""0"">not take account of two special needs: first, its special need is for it to have full and speedy or </text>
<text top=""377"" left=""108"" width=""684"" height=""16"" font=""0"">priority access to the approval process at a level above that given to developed countries; and </text>
<text top=""393"" left=""108"" width=""684"" height=""16"" font=""0"">second, the special need it argues the United States identified namely SENASA's alleged lack of </text>
<text top=""410"" left=""108"" width=""516"" height=""16"" font=""0"">sufficient veterinary capacity to control FMD. We will consider each in turn. </text>
</p><p number=""7.9"" style=""8""><text top=""444"" left=""108"" width=""193"" height=""16"" font=""28"">7.9.4.4.1  Priority access </text></p><p number=""7.702"" style=""8""><text top=""479"" left=""108"" width=""682"" height=""16"" font=""0"">7.702.  Argentina submits that the special need it identified was to have full and speedy or priority </text>
<text top=""495"" left=""108"" width=""683"" height=""16"" font=""0"">access to the approval process at a level above that given to developed countries. We recognize </text>
<text top=""511"" left=""108"" width=""684"" height=""16"" font=""0"">that, in a particular case, it may be that a product is so central to the economy of a developing </text>
<text top=""528"" left=""108"" width=""687"" height=""16"" font=""0"">country that its special need could be precisely that the approval procedures need priority </text>
<text top=""544"" left=""108"" width=""685"" height=""16"" font=""0"">consideration. However, Argentina has expressed this concept of priority access in broad and </text>
<text top=""561"" left=""108"" width=""682"" height=""16"" font=""0"">general terms without making specific reference to products of particular interest to the developing </text>
<text top=""577"" left=""108"" width=""228"" height=""16"" font=""0"">country or other considerations.  </text>
</p><p number=""7.703"" style=""8""><text top=""611"" left=""108"" width=""682"" height=""16"" font=""0"">7.703.  The panel in <i>EC &#8211; Approval and Marketing of Biotech Products</i> found that ""Article 10.1 does </text>
<text top=""628"" left=""108"" width=""682"" height=""16"" font=""0"">not provide that the importing Member must invariably accord special and differential treatment in </text>
<text top=""644"" left=""108"" width=""683"" height=""16"" font=""0"">a case where a measure has led, or may lead, to a decrease, or a slower increase, in developing </text>
<text top=""661"" left=""108"" width=""119"" height=""16"" font=""0"">country exports"".</text>
<footnote top=""659"" left=""227"" width=""23"" height=""11"" font=""16"" number=""1725"" ref=""WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6"" dis=""DS293|DS291|DS292""><ftext top=""1109"" left=""170"" width=""481"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1620. </ftext>
</footnote>
<text top=""661"" left=""250"" width=""541"" height=""16"" font=""0""> Indeed, that panel went on to note that ""[t]here is nothing in Article 10.1 to </text>
<text top=""677"" left=""108"" width=""684"" height=""16"" font=""0"">suggest that in weighing and balancing the various interests at stake, the [importing Member] </text>
<text top=""693"" left=""108"" width=""557"" height=""16"" font=""0"">must necessarily give priority to the needs of Argentina as a developing country.""</text>
<footnote top=""692"" left=""664"" width=""23"" height=""11"" font=""16"" number=""1726"" ref=""WT/DS291/R/Add.6 ; WT/DS292/R/Add.6 ; WT/DS293/R/Add.6|WT/DS291/R/Add.8 ; WT/DS292/R/Add.8 ; WT/DS293/R/Add.8|WT/DS291/R/Add.2 ; WT/DS292/R/Add.2 ; WT/DS293/R/Add.2|WT/DS291/R/Add.1 ; WT/DS292/R/Add.1 ; WT/DS293/R/Add.1|WT/DS291/R/Add.5 ; WT/DS292/R/Add.5 ; WT/DS293/R/Add.5|WT/DS291/R ; WT/DS292/R ; WT/DS293/R|WT/DS291/R/Add.4 ; WT/DS292/R/Add.4 ; WT/DS293/R/Add.4|WT/DS291/R/Corr.1 ; WT/DS292/R/Corr.1 ; WT/DS293/R/Corr.1|WT/DS291/R/Add.7 ; WT/DS292/R/Add.7 ; WT/DS293/R/Add.7|WT/DS291/R/Add.9 ; WT/DS292/R/Add.9 ; WT/DS293/R/Add.9|WT/DS291/R/Add.3 ; WT/DS292/R/Add.3 ; WT/DS293/R/Add.3"" dis=""DS291|DS292|DS293""><ftext top=""1124"" left=""170"" width=""485"" height=""15"" font=""10""> Panel Report, <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.1621.  </ftext>
</footnote>
</p><p number=""7.704"" style=""8""><text top=""728"" left=""108"" width=""683"" height=""16"" font=""0"">7.704.  We agree with this interpretation and believe it supports a conclusion that failure to give </text>
<text top=""744"" left=""108"" width=""682"" height=""16"" font=""0"">priority access as described by Argentina in this case does not constitute a violation of Article 10.1. </text>
<text top=""761"" left=""108"" width=""683"" height=""16"" font=""0"">We recall that the term ""take account of"" does not mandate any particular conclusion. Accepting </text>
<text top=""777"" left=""108"" width=""686"" height=""16"" font=""0"">Argentina's interpretation would mean that no weighing and balancing of various interests is </text>
<text top=""793"" left=""108"" width=""683"" height=""16"" font=""0"">involved and implies an automatic and mandatory response by the importing Member to put the </text>
<text top=""810"" left=""108"" width=""684"" height=""16"" font=""0"">developing country at the front of the line for risk assessments. We see nothing in the text of </text>
<text top=""826"" left=""108"" width=""685"" height=""16"" font=""0"">Article 10.1 that requires importing Members to always do risk assessments for products from </text>
<text top=""843"" left=""108"" width=""249"" height=""16"" font=""0"">developing countries first or faster.  </text>
</p><p number=""7.705"" style=""8""><text top=""877"" left=""108"" width=""683"" height=""16"" font=""0"">7.705.  Therefore, we find that with respect to the special need of priority access, Argentina has </text>
<text top=""893"" left=""108"" width=""289"" height=""16"" font=""0"">not established a violation of Article 10.1. </text>
</p><p number=""7.9"" style=""8""><text top=""928"" left=""108"" width=""304"" height=""16"" font=""28"">7.9.4.4.2  Sufficient veterinary capacity </text></p><p number=""7.706"" style=""8""><text top=""962"" left=""108"" width=""684"" height=""16"" font=""0"">7.706.  We now turn to consider Argentina's claim that the United States should have taken into </text>
<text top=""979"" left=""108"" width=""682"" height=""16"" font=""0"">account SENASA's alleged ""insufficient veterinary capacity"". As an initial point, the Panel notes that </text>
<text top=""995"" left=""108"" width=""686"" height=""16"" font=""0"">an adequate and efficient veterinary service is undoubtedly vital in enabling any country to </text>
<text top=""1012"" left=""108"" width=""682"" height=""16"" font=""0"">maintain effective surveillance in its territory both as regards vaccination, where applicable, and so </text>
<text top=""1028"" left=""108"" width=""685"" height=""16"" font=""0"">as to enable the country to respond quickly to any foot-and-mouth outbreak. Thus, a lack of </text>
<text top=""1044"" left=""108"" width=""682"" height=""16"" font=""0"">veterinary capacity in a developing country may very well need to be addressed before it can have </text>
<text top=""1061"" left=""108"" width=""683"" height=""16"" font=""0"">market access for products that are important to its development needs. Therefore, consideration </text>
<p><text top=""1095"" left=""170"" width=""450"" height=""15"" font=""10""> Panel Report,<i> EC &#8211; Approval and Marketing of Biotech Products</i>, fn 1334. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 218 - </text>
</p><p><text top=""128"" left=""108"" width=""682"" height=""16"" font=""0"">of this lack of capacity can be a special need that a Member preparing or applying an SPS measure </text>
<text top=""144"" left=""108"" width=""395"" height=""16"" font=""0"">should take account of within the meaning of Article 10.1.</text>
<footnote top=""143"" left=""503"" width=""23"" height=""11"" font=""16"" number=""1727"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""591"" height=""15"" font=""10""> We discuss below in this section of our findings whether there is any obligation on the importing </ftext>
<ftext top=""1066"" left=""108"" width=""546"" height=""15"" font=""10"">Member to offer assistance to remedy any deficiencies identified pursuant to Article 10.1. </ftext>
</footnote>
</p></p></page>
<page number=""218"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.707"" style=""8""><text top=""178"" left=""108"" width=""684"" height=""16"" font=""0"">7.707.  In light of the foregoing, we therefore conclude that, in principle, the lack of veterinary </text>
<text top=""195"" left=""108"" width=""465"" height=""16"" font=""0"">capacity could be a special need within the meaning of Article 10.1. </text>
</p><p number=""7.708"" style=""8""><text top=""229"" left=""108"" width=""685"" height=""16"" font=""0"">7.708.  However, in the context of discussing the alleged special need of veterinary capacity, </text>
<text top=""246"" left=""108"" width=""684"" height=""16"" font=""0"">Argentina argues that pursuant to Article 10.1 if there was any deficiency in SENASA's capacity, </text>
<text top=""262"" left=""108"" width=""686"" height=""16"" font=""0"">then the United States had an ""obligation to provide the necessary assistance to correct and </text>
<text top=""278"" left=""108"" width=""246"" height=""16"" font=""0"">overcome such failures of capacity"".</text>
<footnote top=""277"" left=""354"" width=""23"" height=""11"" font=""16"" number=""1728"" ref="""" dis=""""/>
<text top=""278"" left=""377"" width=""362"" height=""16"" font=""0""> We see several problems with Argentina's position.  </text>
</p><p number=""7.709"" style=""8""><text top=""313"" left=""108"" width=""684"" height=""16"" font=""0"">7.709.  First and foremost, we believe Argentina misreads the obligation in Article 10.1 to take </text>
<text top=""329"" left=""108"" width=""685"" height=""16"" font=""0"">account of special needs and conflates it with an obligation to remedy any shortcomings of a </text>
<text top=""346"" left=""108"" width=""684"" height=""16"" font=""0"">developing country. We find no support for this conclusion in the text or context of Article 10.1. </text>
<text top=""362"" left=""108"" width=""685"" height=""16"" font=""0"">Indeed, any obligation to provide technical assistance of any kind is found in Article 9 entitled </text>
<text top=""378"" left=""108"" width=""690"" height=""16"" font=""0"">""Technical Assistance"". The Panel specifically asked Argentina to provide a textual and </text>
<text top=""395"" left=""108"" width=""684"" height=""16"" font=""0"">interpretative basis for its reasoning. Argentina's response recognizes that Article 10.1 does not </text>
<text top=""411"" left=""108"" width=""688"" height=""16"" font=""0"">specify any particular form of assistance. However, Argentina argues that this is because </text>
<text top=""428"" left=""108"" width=""689"" height=""16"" font=""0"">Article 10.1 ""focuses on measure-specific situations whereas Article 9 deals with technical </text>
<text top=""444"" left=""108"" width=""149"" height=""16"" font=""0"">assistance generally.""</text>
<footnote top=""443"" left=""257"" width=""23"" height=""11"" font=""16"" number=""1729"" ref="""" dis=""""/>
<text top=""444"" left=""280"" width=""511"" height=""16"" font=""0""> We find this argument unpersuasive. Argentina cannot point to anything </text>
<text top=""461"" left=""108"" width=""683"" height=""16"" font=""0"">in the text of Article 10.1 to indicate that it applies to <i>specific </i>technical assistance while Article 9 </text>
<text top=""477"" left=""108"" width=""685"" height=""16"" font=""0"">applies to <i>general  </i>technical assistance. In our view, Article 9.2 refers to the product involved </text>
<text top=""493"" left=""108"" width=""683"" height=""16"" font=""0"">indicating that Article 9 covers general and specific technical assistance and that Article 10 relates </text>
<text top=""510"" left=""108"" width=""173"" height=""16"" font=""0"">to other subject matter.  </text>
</p><p number=""7.710"" style=""8""><text top=""544"" left=""108"" width=""686"" height=""16"" font=""0"">7.710.  In addition to the fact that any obligations with respect to the provision of technical </text>
<text top=""561"" left=""108"" width=""683"" height=""16"" font=""0"">assistance are covered by Article 9, we recall that an obligation to ""take account of"" mandates no </text>
<text top=""577"" left=""108"" width=""687"" height=""16"" font=""0"">particular conclusion or action. Therefore, we cannot conclude that Article 10.1 includes an </text>
<text top=""593"" left=""108"" width=""682"" height=""16"" font=""0"">obligation for the importing Member to provide technical assistance to correct or overcome failures </text>
<text top=""610"" left=""108"" width=""682"" height=""16"" font=""0"">of capacity in the exporting developing country that might also be considered special needs within </text>
<text top=""626"" left=""108"" width=""685"" height=""16"" font=""0"">the meaning of Article 10.1. For these reasons, we find that Article 10.1 does not require the </text>
<text top=""643"" left=""108"" width=""524"" height=""16"" font=""0"">United States to remedy any alleged lack of veterinary capacity in SENASA.  </text>
</p><p number=""7.711"" style=""8""><text top=""677"" left=""108"" width=""685"" height=""16"" font=""0"">7.711.  Nevertheless, Article 10.1 does impose an obligation to take account of special needs, </text>
<text top=""693"" left=""108"" width=""682"" height=""16"" font=""0"">including, potentially, a lack of veterinary capacity. In considering this issue we are cognisant that </text>
<text top=""710"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina did not actually identify veterinary capacity as a special need either during the period its </text>
<text top=""726"" left=""108"" width=""686"" height=""16"" font=""0"">application was being considered by the United States, or during these proceedings. Rather, </text>
<text top=""743"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina maintains that it is the United States<i> </i>that identified this need and thus was required to </text>
<text top=""759"" left=""108"" width=""682"" height=""16"" font=""0"">take account of it in the preparation and application of its SPS measures. Argentina does not point </text>
<text top=""775"" left=""108"" width=""685"" height=""16"" font=""0"">to any APHIS documentation that states that APHIS views veterinary capacity to be lacking in </text>
<text top=""792"" left=""108"" width=""682"" height=""16"" font=""0"">Argentina. Rather, Argentina bases its argument that the United States identified lack of veterinary </text>
<text top=""808"" left=""108"" width=""686"" height=""16"" font=""0"">capacity as a special need on the United States' submissions to the Panel. In particular, in </text>
<text top=""825"" left=""108"" width=""396"" height=""16"" font=""0"">response to a question from the Panel, Argentina argues: </text>
<p><text top=""859"" left=""151"" width=""604"" height=""16"" font=""0"">[T]he United States points to technical assistance for training eight Argentine </text>
<text top=""875"" left=""151"" width=""602"" height=""16"" font=""0"">scientists in the decade from 1999-2009 and to financial assistance it provided </text>
<text top=""892"" left=""151"" width=""184"" height=""16"" font=""0"">Argentina in the <i>1960's</i>.</text>
<footnote top=""890"" left=""334"" width=""23"" height=""11"" font=""16"" number=""1730"" ref="""" dis=""""/>
<text top=""892"" left=""357"" width=""396"" height=""16"" font=""0""> The US' own reference to technical and financial </text>
<text top=""908"" left=""151"" width=""599"" height=""16"" font=""0"">assistance provided to Argentina in the past in connection to imports susceptible to </text>
<text top=""925"" left=""151"" width=""597"" height=""16"" font=""0"">FMD is an admission by the United States that they are relevant to Argentina's special </text>
<text top=""941"" left=""151"" width=""601"" height=""16"" font=""0"">needs as a developing country. The only deficiency that the US has identified is </text>
<text top=""958"" left=""151"" width=""598"" height=""16"" font=""0"">alleged problems with SENASA. If that was the United States' reason for its inaction, </text>
<text top=""974"" left=""151"" width=""490"" height=""16"" font=""0"">then it could have addressed this ""special need"" by supporting SENASA.</text>
<footnote top=""972"" left=""641"" width=""23"" height=""11"" font=""16"" number=""1731"" ref="""" dis=""""/>
</p><p><text top=""1080"" left=""170"" width=""304"" height=""15"" font=""10""> Argentina's second written submission, para. 20. </text>
<footnote top=""1095"" left=""170"" width=""547"" height=""15"" font=""10"" number=""51"" ref="""" dis=""""><ftext top=""1095"" left=""108"" width=""625"" height=""15"" font=""10"">rather that they were evaluating them and that APHIS has now concluded that SENASA does meet the </ftext>
<ftext top=""1109"" left=""108"" width=""161"" height=""15"" font=""10"">United States' standards.  </ftext>
</footnote>
</p><p><text top=""1109"" left=""170"" width=""319"" height=""15"" font=""10""> (footnote original) United States FWS at para. 113. </text>
<text top=""1124"" left=""170"" width=""528"" height=""15"" font=""10""> Argentina's response to Panel question No. 74 following the first substantive meeting. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 219 - </text>
</p></p></page>
<page number=""219"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.712"" style=""8""><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">7.712.  Argentina further argues that the United States' defence of its failure to approve imports </text>
<text top=""144"" left=""108"" width=""654"" height=""16"" font=""0"">from Argentina is based on an attack on SENASA which ""is inaccurate, unfair and indefensible.""</text>
<footnote top=""143"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1732"" ref="""" dis=""""/>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">Nevertheless, Argentina contends that it is ""important in the context of Article 10.1 to understand </text>
<text top=""177"" left=""108"" width=""683"" height=""16"" font=""0"">that, if the lack of capability of SENASA was, in fact, the reason for the US denial of Argentina's </text>
<text top=""193"" left=""108"" width=""683"" height=""16"" font=""0"">applications for the past 12 years, then the United States had an obligation under Article 10.1 to </text>
<text top=""210"" left=""108"" width=""126"" height=""16"" font=""0"">assist Argentina.""</text>
<footnote top=""208"" left=""234"" width=""23"" height=""11"" font=""16"" number=""1733"" ref="""" dis=""""/>
<text top=""210"" left=""257"" width=""539"" height=""16"" font=""0""> Argentina does not provide specific citations or quotations from the </text>
<text top=""226"" left=""108"" width=""687"" height=""16"" font=""0"">United States' submissions that it believes support its contention that the United States has </text>
<text top=""242"" left=""108"" width=""682"" height=""16"" font=""0"">identified a lack of capacity at SENASA. As Argentina admits, the identification of this special need </text>
<text top=""259"" left=""108"" width=""684"" height=""16"" font=""0"">is a supposition deduced from the United States arguments made to this Panel in the context of </text>
<text top=""275"" left=""108"" width=""683"" height=""16"" font=""0"">WTO dispute settlement and not from any identification <i>by APHIS </i>of a lack of veterinary capacity </text>
<text top=""292"" left=""108"" width=""388"" height=""16"" font=""0"">at SENASA in any documentation or communications.</text>
<footnote top=""290"" left=""496"" width=""23"" height=""11"" font=""16"" number=""1734"" ref="""" dis=""""><ftext top=""1051"" left=""170"" width=""604"" height=""15"" font=""10""> Argentina's second written submission, paras. 20 and 279; Argentina's response to Panel question </ftext>
</footnote>
<text top=""292"" left=""519"" width=""275"" height=""16"" font=""0""> Indeed, at least since 2005, APHIS </text>
<text top=""308"" left=""108"" width=""687"" height=""16"" font=""0"">documentation tends to support the opposite conclusion. Therefore, we find that veterinary </text>
<text top=""324"" left=""108"" width=""682"" height=""16"" font=""0"">capacity was not identified by either Argentina or the United States as a special need of Argentina. </text>
<text top=""341"" left=""108"" width=""683"" height=""16"" font=""0"">In these circumstances, we do not consider that Argentina has made a <i>prima facie</i> case that the </text>
<text top=""357"" left=""108"" width=""682"" height=""16"" font=""0"">United States has acted inconsistently with Article 10.1 by failing to take account of an alleged lack </text>
<text top=""374"" left=""108"" width=""240"" height=""16"" font=""0"">of veterinary capacity at SENASA.  </text>
</p><p number=""7.9"" style=""8""><text top=""408"" left=""108"" width=""149"" height=""16"" font=""28"">7.9.4.5  Conclusion </text></p><p number=""7.713"" style=""8""><text top=""443"" left=""108"" width=""683"" height=""16"" font=""0"">7.713.  For the reasons outlined above, we do not consider that Argentina has satisfied its burden </text>
<text top=""459"" left=""108"" width=""682"" height=""16"" font=""0"">of proof to establish that the United States did not take account of its special needs as required by </text>
<text top=""475"" left=""108"" width=""88"" height=""16"" font=""0"">Article 10.1. </text>
</p><p number=""7.10"" style=""8""><text top=""510"" left=""108"" width=""234"" height=""16"" font=""28"">7.10  Consequential violations </text></p><p number=""7.10"" style=""8""><text top=""544"" left=""108"" width=""505"" height=""16"" font=""28"">7.10.1  Argentina's claims under Article 1.1 of the SPS Agreement </text></p><p number=""7.10"" style=""8""><text top=""579"" left=""108"" width=""259"" height=""16"" font=""28"">7.10.1.1  Relevant legal provision </text></p><p number=""7.714"" style=""8""><text top=""613"" left=""108"" width=""335"" height=""16"" font=""0"">7.714.  Article 1.1 of the SPS Agreement states: </text>
<p><text top=""647"" left=""151"" width=""603"" height=""16"" font=""0"">This Agreement applies to all sanitary and phytosanitary measures which may, </text>
<text top=""664"" left=""151"" width=""597"" height=""16"" font=""0"">directly or indirectly, affect international trade. Such measures shall be developed and </text>
<text top=""680"" left=""151"" width=""416"" height=""16"" font=""0"">applied in accordance with the provisions of this Agreement. </text>
</p></p><p number=""7.10"" style=""8""><text top=""715"" left=""108"" width=""305"" height=""16"" font=""28"">7.10.1.2  Main arguments of the parties </text></p><p number=""7.10"" style=""8""><text top=""749"" left=""108"" width=""165"" height=""16"" font=""28"">7.10.1.2.1  Argentina </text></p><p number=""7.715"" style=""8""><text top=""783"" left=""108"" width=""684"" height=""16"" font=""0"">7.715.  Argentina notes that as 9 CFR 94.1(b) and the 2001 Regulations are SPS measures, they </text>
<text top=""800"" left=""108"" width=""687"" height=""16"" font=""0"">may only be applied to the extent that they are ""in accordance with the provision of this </text>
<text top=""816"" left=""108"" width=""682"" height=""16"" font=""0"">[SPS] Agreement"". Argentina submits that as the measures are inconsistent with the provisions of </text>
<text top=""833"" left=""108"" width=""75"" height=""16"" font=""0"">the SPS </text>
<text top=""833"" left=""175"" width=""624"" height=""16"" font=""0"">Agreement, as a consequence they are inconsistent with the requirements of </text>
<text top=""849"" left=""108"" width=""75"" height=""16"" font=""0"">Article 1.1.</text>
<footnote top=""847"" left=""183"" width=""23"" height=""11"" font=""16"" number=""1735"" ref="""" dis=""""><ftext top=""1124"" left=""170"" width=""389"" height=""15"" font=""10""> Argentina's first written submission, paras. 181, 184, and 414. </ftext>
<ftext top=""891"" left=""108"" width=""510"" height=""15"" font=""10"">conducted in accordance with the provisions of this Agreement."" (footnote omitted) </ftext>
<ftext top=""920"" left=""108"" width=""676"" height=""15"" font=""10"">imposition of a countervailing duty on any product of the territory of any Member imported into the territory of </ftext>
<ftext top=""1095"" left=""108"" width=""663"" height=""15"" font=""10"">either (a) if there is a scientific justification, or (b) as a consequence of the level of sanitary or phytosanitary </ftext>
<ftext top=""1109"" left=""108"" width=""667"" height=""15"" font=""10"">protection a Member determines to be appropriate). See also Appellate Body Report, <i>Canada/US &#8211; Continued </i></ftext>
</footnote>
</p><p number=""7.10"" style=""8""><text top=""883"" left=""108"" width=""193"" height=""16"" font=""28"">7.10.1.2.2  United States </text></p><p number=""7.716"" style=""8""><text top=""918"" left=""108"" width=""577"" height=""16"" font=""0"">7.716.  The United States presents no specific arguments with respect to this claim. </text>
<footnote top=""1007"" left=""170"" width=""591"" height=""15"" font=""10"" number=""279"" ref="""" dis=""""/>
<p><text top=""1022"" left=""108"" width=""388"" height=""15"" font=""10"">submission is devoted to explaining the capabilities of SENASA. </text>
</p><p><text top=""1080"" left=""108"" width=""649"" height=""15"" font=""10"">the United States stated that it had never said that SENASA did not meet the United States' standards but </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 220 - </text>
</p></p></page>
<page number=""220"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.10"" style=""8""><text top=""128"" left=""108"" width=""346"" height=""16"" font=""28"">7.10.1.3  Main arguments of the third parties </text></p><p number=""7.10"" style=""8""><text top=""162"" left=""108"" width=""211"" height=""16"" font=""28"">7.10.1.3.1  European Union </text></p><p number=""7.717"" style=""8""><text top=""196"" left=""108"" width=""682"" height=""16"" font=""0"">7.717.  The European Union doubts whether Article 1.1 of the SPS Agreement, by itself, may serve </text>
<text top=""213"" left=""108"" width=""682"" height=""16"" font=""0"">as a legal basis for a claim in WTO dispute settlement proceedings, asserting that it serves merely </text>
<text top=""229"" left=""108"" width=""683"" height=""16"" font=""0"">to define the scope of the SPS Agreement. The European Union submits that Article 1.1 does not </text>
<text top=""246"" left=""108"" width=""687"" height=""16"" font=""0"">contain any specific obligation for WTO Members, and is independent from the obligations </text>
<text top=""262"" left=""108"" width=""677"" height=""16"" font=""0"">contained in the other provisions of the SPS Agreement. It states that ""a Member's potential non-</text>
<text top=""278"" left=""108"" width=""677"" height=""16"" font=""0"">compliance with the general reference of Article 1.1 would always depend absolutely on non-</text>
<text top=""295"" left=""108"" width=""684"" height=""16"" font=""0"">compliance with some other provision of the SPS Agreement"". As a consequence, no legal claim </text>
<text top=""311"" left=""108"" width=""389"" height=""16"" font=""0"">can be based solely on Article 1.1 of the SPS Agreement.</text>
<footnote top=""310"" left=""497"" width=""23"" height=""11"" font=""16"" number=""1736"" ref="""" dis=""""><ftext top=""847"" left=""170"" width=""345"" height=""15"" font=""10""> European Union's third-party submission, paras. 22-25. </ftext>
</footnote>
</p><p number=""7.10"" style=""8""><text top=""346"" left=""108"" width=""239"" height=""16"" font=""28"">7.10.1.4  Analysis by the Panel </text></p><p number=""7.718"" style=""8""><text top=""380"" left=""108"" width=""682"" height=""16"" font=""0"">7.718.  We note that there are provisions in other covered agreements that are not dissimilar from </text>
<text top=""396"" left=""108"" width=""192"" height=""16"" font=""0"">the language in Article </text>
<text top=""396"" left=""291"" width=""136"" height=""16"" font=""0"">1.1 of the SPS </text>
<text top=""396"" left=""419"" width=""259"" height=""16"" font=""0"">Agreement. In particular, Article </text>
<text top=""396"" left=""669"" width=""116"" height=""16"" font=""0"">1 of the Anti-</text>
<text top=""413"" left=""108"" width=""140"" height=""16"" font=""0"">Dumping Agreement</text>
<footnote top=""411"" left=""248"" width=""23"" height=""11"" font=""16"" number=""1737"" ref="""" dis=""""/>
<text top=""413"" left=""271"" width=""265"" height=""16"" font=""0""> and Article 10 of the SCM Agreement</text>
<footnote top=""411"" left=""537"" width=""23"" height=""11"" font=""16"" number=""1738"" ref="""" dis=""""/>
<text top=""413"" left=""560"" width=""231"" height=""16"" font=""0""> also call for all measures taken </text>
<text top=""429"" left=""108"" width=""686"" height=""16"" font=""0"">under each respective agreement to be consistent with the terms of that agreement. Panels </text>
<text top=""446"" left=""108"" width=""683"" height=""16"" font=""0"">regularly make findings of consequential violation of these provisions when complainants include </text>
<text top=""462"" left=""108"" width=""151"" height=""16"" font=""0"">them in their claims.</text>
<footnote top=""461"" left=""258"" width=""23"" height=""11"" font=""16"" number=""1739"" ref=""WT/DS414/RW/Add.1|WT/DS414/R|WT/DS414/R/Add.1|WT/DS427/R|WT/DS427/R/Add.1|WT/DS414/RW"" dis=""DS414|DS427""><ftext top=""978"" left=""170"" width=""604"" height=""15"" font=""10""> See e.g. Panel Report, <i>China &#8211; Broiler Products</i>,<i> </i>paras. 7.512-7.613; Panel Report, <i>China &#8211; GOES</i>, </ftext>
<ftext top=""993"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.681. </ftext>
</footnote>
<text top=""462"" left=""282"" width=""512"" height=""16"" font=""0""> The Appellate Body has explained that ""to succeed in a claim under </text>
<text top=""479"" left=""108"" width=""687"" height=""16"" font=""0"">Article 1 of the Anti-Dumping Agreement or Article 10 of the SCM Agreement, a complaining </text>
<text top=""495"" left=""108"" width=""685"" height=""16"" font=""0"">Member need only establish that anti-dumping or countervailing duties were imposed and the </text>
<text top=""511"" left=""108"" width=""698"" height=""16"" font=""0"">imposing Member acted inconsistently with one of its obligations under the </text>
<text top=""528"" left=""108"" width=""146"" height=""16"" font=""0"">relevant Agreement.""</text>
<footnote top=""526"" left=""254"" width=""23"" height=""11"" font=""16"" number=""1740"" ref="""" dis=""""/>
</p><p number=""7.719"" style=""8""><text top=""562"" left=""108"" width=""687"" height=""16"" font=""0"">7.719.  Although no complainant has previously raised a claim of consequential violation of </text>
<text top=""579"" left=""108"" width=""685"" height=""16"" font=""0"">Article 1.1 of the SPS Agreement, we see no reason why we should not consider this claim by </text>
<text top=""595"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina. We note that we have found that 9 CFR 94.1, as amended by the 2001 Regulations, is </text>
<text top=""611"" left=""108"" width=""683"" height=""16"" font=""0"">inconsistent with Articles 3.1, 3.3, 5.1, 2.2, 5.6, 2.3, and with respect to Patagonia Article 6.1 of </text>
<text top=""628"" left=""108"" width=""688"" height=""16"" font=""0"">the SPS Agreement. Therefore, we find that it is also inconsistent with Article 1.1 of the </text>
<text top=""644"" left=""108"" width=""120"" height=""16"" font=""0"">SPS Agreement.  </text>
</p><p number=""7.10"" style=""8""><text top=""679"" left=""108"" width=""509"" height=""16"" font=""28"">7.10.2  Argentina's claims under Article 3.3 of the SPS Agreement  </text></p><p number=""7.720"" style=""8""><text top=""713"" left=""108"" width=""683"" height=""16"" font=""0"">7.720.  We recall that Article 3.3 codifies Members' autonomous right to establish their own ALOP </text>
<text top=""729"" left=""108"" width=""683"" height=""16"" font=""0"">and to adopt SPS measures that achieve a higher level of protection than would be achieved by a </text>
<text top=""746"" left=""108"" width=""520"" height=""16"" font=""0"">measure based on international standards, guidelines or recommendations.</text>
<footnote top=""744"" left=""628"" width=""23"" height=""11"" font=""16"" number=""1741"" ref=""WT/DS26/AB/R ; WT/DS48/AB/R"" dis=""DS26""><ftext top=""1036"" left=""170"" width=""376"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>,<i> </i>paras. 104 and 172. </ftext>
</footnote>
<text top=""746"" left=""651"" width=""140"" height=""16"" font=""0""> We also recall that </text>
<text top=""762"" left=""108"" width=""393"" height=""16"" font=""0"">the right under Article 3.3 is not absolute or unqualified</text>
<footnote top=""761"" left=""501"" width=""23"" height=""11"" font=""16"" number=""1742"" ref="""" dis=""""/>
<text top=""762"" left=""524"" width=""266"" height=""16"" font=""0"">  and  to  be  consistent  with  Article 3.3 </text>
<text top=""779"" left=""108"" width=""92"" height=""16"" font=""0"">the United </text>
<text top=""779"" left=""191"" width=""607"" height=""16"" font=""0"">States' measures must not be inconsistent with any other provision of the </text>
<text top=""795"" left=""108"" width=""111"" height=""16"" font=""0"">SPS Agreement.</text>
<footnote top=""793"" left=""219"" width=""23"" height=""11"" font=""16"" number=""1743"" ref=""WT/DS26/AB/R ; WT/DS48/AB/R"" dis=""DS26""><ftext top=""1066"" left=""170"" width=""591"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, paras. 175-177 (finding that the requirement to comply </ftext>
</footnote>
<p><text top=""861"" left=""170"" width=""612"" height=""15"" font=""10""> Article 1 of the Anti-Dumping Agreement provides: ""An anti-dumping measure shall be applied only </text>
<footnote top=""876"" left=""108"" width=""659"" height=""15"" font=""10"" number=""1994"" ref="""" dis=""""><ftext top=""949"" left=""108"" width=""673"" height=""15"" font=""10"">this Agreement. Countervailing duties may only be imposed pursuant to investigations initiated and conducted </ftext>
<ftext top=""963"" left=""108"" width=""654"" height=""15"" font=""10"">in accordance with the provisions of this Agreement and the Agreement on Agriculture. (footnotes omitted) </ftext>
</footnote>
</p><p><text top=""905"" left=""170"" width=""606"" height=""15"" font=""10""> Article 10 of the SCM Agreement states: Members shall take all necessary steps to ensure that the </text>
</p><p><text top=""1007"" left=""170"" width=""609"" height=""15"" font=""10""> Appellate Body Reports, <i>US &#8211; Anti-dumping and Countervailing Duties (China)</i>, para. 358 and <i>US &#8211; </i></text>
<text top=""1022"" left=""108"" width=""199"" height=""15"" font=""12""><i>Softwood Lumber IV</i>,<i> </i>para. 143. </text>
</p><p><text top=""1051"" left=""170"" width=""316"" height=""15"" font=""10""> Appellate Body Report, <i>EC &#8211; Hormones</i>, para. 173. </text>
</p><p><text top=""1080"" left=""108"" width=""643"" height=""15"" font=""10"">with all the other provisions of the SPS Agreement (including Article 5) applies both to measures adopted </text>
</p><p><text top=""1124"" left=""108"" width=""144"" height=""15"" font=""12""><i>Suspension</i>, para. 685. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 221 - </text>
</p></p></page>
<page number=""221"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.721"" style=""8""><text top=""128"" left=""108"" width=""686"" height=""16"" font=""0"">7.721.  We already found in paragraph 7.257 that the United States acted inconsistently with </text>
<text top=""144"" left=""108"" width=""682"" height=""16"" font=""0"">Article 3.3 because of its violation of Article 8 and Annex C(1)(a) and (b). We noted that we would </text>
<text top=""160"" left=""108"" width=""683"" height=""16"" font=""0"">return to Article 3.3 after we had completed our analysis of the rest of Argentina's claims. Having </text>
<text top=""177"" left=""108"" width=""684"" height=""16"" font=""0"">found that the United States measures are also inconsistent with Articles 5.1, 2.2, 5.6, 2.3, 6.1, </text>
<text top=""193"" left=""108"" width=""687"" height=""16"" font=""0"">and 1.1 of the SPS Agreement, we find that these are separate and additional bases for </text>
<text top=""210"" left=""108"" width=""214"" height=""16"" font=""0"">inconsistencies with Article 3.3.</text>
<footnote top=""208"" left=""322"" width=""23"" height=""11"" font=""16"" number=""1744"" ref="""" dis=""""><ftext top=""1066"" left=""170"" width=""353"" height=""15"" font=""10""> Argentina's first written submission, paras. 227 and 449. </ftext>
</footnote>
</p><p number=""7.11"" style=""8""><text top=""244"" left=""108"" width=""353"" height=""16"" font=""28"">7.11  Argentina's claims under the GATT 1994 </text></p><p number=""7.722"" style=""8""><text top=""278"" left=""108"" width=""683"" height=""16"" font=""0"">7.722.  Argentina also claims that the United States' measures are inconsistent with provisions of </text>
<text top=""295"" left=""108"" width=""347"" height=""16"" font=""0"">the GATT 1994, in particular Articles I:1 and XI:1. </text>
</p><p number=""7.11"" style=""8""><text top=""329"" left=""108"" width=""291"" height=""16"" font=""28"">7.11.1  Main arguments of the parties </text></p><p number=""7.11"" style=""8""><text top=""364"" left=""108"" width=""151"" height=""16"" font=""28"">7.11.1.1  Argentina </text></p><p number=""7.11"" style=""8""><text top=""398"" left=""108"" width=""304"" height=""16"" font=""28"">7.11.1.1.1  Article I:1 of the GATT 1994 </text></p><p number=""7.723"" style=""8""><text top=""432"" left=""108"" width=""684"" height=""16"" font=""0"">7.723.  Argentina submits that the application of the United States' measures against Argentine </text>
<text top=""449"" left=""108"" width=""686"" height=""16"" font=""0"">beef and ruminant and swine products from Patagonia is inconsistent with Article I:1 of the </text>
<text top=""465"" left=""108"" width=""683"" height=""16"" font=""0"">GATT 1994 because the United States grants advantages to other WTO Members in respect of like </text>
<text top=""482"" left=""108"" width=""683"" height=""16"" font=""0"">products that are not immediately and unconditionally accorded to Argentina. Argentina relies on </text>
<text top=""498"" left=""108"" width=""683"" height=""16"" font=""0"">WTO case law in stating that there are three steps in determining whether there is a violation of </text>
<text top=""515"" left=""108"" width=""683"" height=""16"" font=""0"">the Article I MFN obligation: is there (i) an ""advantage"" offered (ii) on a ""like product"" of another </text>
<text top=""531"" left=""108"" width=""686"" height=""16"" font=""0"">Member that (iii) has not been offered ""immediately and unconditionally"" to the complaining </text>
<text top=""547"" left=""108"" width=""62"" height=""16"" font=""0"">Member?</text>
<footnote top=""546"" left=""170"" width=""23"" height=""11"" font=""16"" number=""1745"" ref="""" dis=""""/>
</p><p number=""7.724"" style=""8""><text top=""582"" left=""108"" width=""683"" height=""16"" font=""0"">7.724.  For the first step, Argentina argues that there are two ""advantages"" at issue. The first is </text>
<text top=""598"" left=""108"" width=""683"" height=""16"" font=""0"">the ability to export to the United States. Argentina states that this advantage was accorded to, </text>
<text top=""615"" left=""108"" width=""683"" height=""16"" font=""0"">for example, Uruguay, which is similarly situated to Argentina as an area that is FMD-free where </text>
<text top=""631"" left=""108"" width=""164"" height=""16"" font=""0"">vaccination is practised.</text>
<footnote top=""629"" left=""272"" width=""23"" height=""11"" font=""16"" number=""1746"" ref="""" dis=""""/>
<text top=""631"" left=""295"" width=""495"" height=""16"" font=""0""> With respect to Patagonia, Argentina argues that it is similarly situated </text>
<text top=""647"" left=""108"" width=""505"" height=""16"" font=""0"">to Santa Catarina, which is permitted to export to the United States.</text>
<footnote top=""646"" left=""613"" width=""23"" height=""11"" font=""16"" number=""1747"" ref="""" dis=""""/>
<text top=""647"" left=""636"" width=""157"" height=""16"" font=""0""> The second type of </text>
<text top=""664"" left=""108"" width=""683"" height=""16"" font=""0"">""advantage"" Argentina refers to is access to and the completion of APHIS' regulatory process for </text>
<text top=""680"" left=""108"" width=""686"" height=""16"" font=""0"">conducting a risk assessment and concluding a final rulemaking to permit imports. Argentina </text>
<text top=""697"" left=""108"" width=""687"" height=""16"" font=""0"">compares its situation to that of Uruguay, which had the advantage of a risk assessment </text>
<text top=""713"" left=""108"" width=""686"" height=""16"" font=""0"">conducted in 2003, two years after an outbreak, and compares Patagonia to Santa Catarina. </text>
<text top=""729"" left=""108"" width=""682"" height=""16"" font=""0"">Noting that while APHIS has never published either the risk assessment it carried out for Patagonia </text>
<text top=""746"" left=""108"" width=""684"" height=""16"" font=""0"">in 2005 or a final rulemaking, Argentina alleges that Santa Catarina has had a risk assessment </text>
<text top=""762"" left=""108"" width=""683"" height=""16"" font=""0"">completed and that it gained import rights pursuant to the settlement of the <i>US &#8211; Upland Cotton </i></text>
<text top=""779"" left=""108"" width=""59"" height=""16"" font=""0"">dispute. </text>
</p><p number=""7.725"" style=""8""><text top=""813"" left=""108"" width=""684"" height=""16"" font=""0"">7.725.  As for the requirement that the products be ""like"", Argentina submits that products are </text>
<text top=""829"" left=""108"" width=""684"" height=""16"" font=""0"">fresh (chilled or frozen) beef from Argentina and other WTO Members, including Uruguay, and </text>
<text top=""846"" left=""108"" width=""683"" height=""16"" font=""0"">ruminants and swine from Patagonia and other WTO Members, including Brazil (Santa Catarina), </text>
<text top=""862"" left=""108"" width=""682"" height=""16"" font=""0"">Chile, Japan, or the United Kingdom. Argentina argues that the products are ""like"" according to the </text>
<text top=""879"" left=""108"" width=""682"" height=""16"" font=""0"">four criteria of ""likeness"" first set forth by the GATT panel in <i>Border Tax Adjustments. </i>According to </text>
<text top=""895"" left=""108"" width=""683"" height=""16"" font=""0"">Argentina, the products are named similarly, physically identical, marketed in a similar way, have </text>
<text top=""911"" left=""108"" width=""427"" height=""16"" font=""0"">the same end-uses, and are perceived similarly by consumers.</text>
<footnote top=""910"" left=""535"" width=""23"" height=""11"" font=""16"" number=""1748"" ref=""WT/DS392/R"" dis=""DS392""><ftext top=""1124"" left=""170"" width=""359"" height=""15"" font=""10""> Argentina's first written submission, paras. 369, 582-584. </ftext>
<ftext top=""1095"" left=""108"" width=""670"" height=""15"" font=""10"">must be in conformity with the SPS Agreement and thus consideration of such a defence would lead the panel </ftext>
<ftext top=""1109"" left=""108"" width=""637"" height=""15"" font=""10"">right back to its analysis of conformity with the SPS Agreement. See Panel Report, <i>US &#8211; Poultry (China)</i>,<i> </i></ftext>
<ftext top=""1124"" left=""108"" width=""79"" height=""15"" font=""10"">para. 7.481. </ftext>
</footnote>
</p><p number=""7.726"" style=""8""><text top=""946"" left=""108"" width=""682"" height=""16"" font=""0"">7.726.  The third step requires the complainant to establish that the advantage on the like product </text>
<text top=""962"" left=""108"" width=""682"" height=""16"" font=""0"">has not been ""immediately and unconditionally offered"" to it. In this regard, Argentina asserts that </text>
<text top=""979"" left=""108"" width=""683"" height=""16"" font=""0"">it is unable to export the relevant products while other Members, like Uruguay and Brazil, can do </text>
<p><text top=""1080"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 361. </text>
<text top=""1095"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 364. </text>
<text top=""1109"" left=""170"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 577. </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 222 - </text>
</p><p><text top=""128"" left=""108"" width=""683"" height=""16"" font=""0"">so. Argentina also submits that it has not been immediately accorded access to the United States' </text>
<text top=""144"" left=""108"" width=""505"" height=""16"" font=""0"">regulatory system in particular when compared with other WTO Members.</text>
<footnote top=""143"" left=""613"" width=""23"" height=""11"" font=""16"" number=""1749"" ref="""" dis=""""><ftext top=""949"" left=""170"" width=""388"" height=""15"" font=""10""> Argentina's first written submission, paras. 371-374, 585-588. </ftext>
</footnote>
</p></p></page>
<page number=""222"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.11"" style=""8""><text top=""178"" left=""108"" width=""314"" height=""16"" font=""28"">7.11.1.1.2  Article XI:1 of the GATT 1994 </text></p><p number=""7.727"" style=""8""><text top=""213"" left=""108"" width=""682"" height=""16"" font=""0"">7.727.  Argentina asserts that the relevant measures result in a prohibition on importation of fresh </text>
<text top=""229"" left=""108"" width=""686"" height=""16"" font=""0"">(chilled or frozen beef) from Argentina and all ruminant and swine products from Patagonia. </text>
<text top=""246"" left=""108"" width=""683"" height=""16"" font=""0"">According to Argentina, this constitutes a zero quota and is thus clearly prohibited by Article XI:1 </text>
<text top=""262"" left=""108"" width=""125"" height=""16"" font=""0"">of the GATT 1994.</text>
<footnote top=""261"" left=""233"" width=""23"" height=""11"" font=""16"" number=""1750"" ref="""" dis=""""><ftext top=""963"" left=""170"" width=""331"" height=""15"" font=""10""> Argentina's first written submission, paras. 379, 592. </ftext>
</footnote>
</p><p number=""7.11"" style=""8""><text top=""296"" left=""108"" width=""179"" height=""16"" font=""28"">7.11.1.2  United States </text></p><p number=""7.11"" style=""8""><text top=""331"" left=""108"" width=""304"" height=""16"" font=""28"">7.11.1.2.1  Article I:1 of the GATT 1994 </text></p><p number=""7.728"" style=""8""><text top=""365"" left=""108"" width=""687"" height=""16"" font=""0"">7.728.  The United States does not answer specifically the arguments made by Argentina in </text>
<text top=""382"" left=""108"" width=""686"" height=""16"" font=""0"">relation to the GATT 1994 Article I:1 three-step test. It asserts that its application system is </text>
<text top=""398"" left=""108"" width=""684"" height=""16"" font=""0"">necessary to protect animal life or health, consistent with the SPS Agreement and Article XX(b). </text>
<text top=""414"" left=""108"" width=""682"" height=""16"" font=""0"">The United States notes that, pursuant to Article 2.4 of the SPS Agreement, if a measure complies </text>
<text top=""431"" left=""108"" width=""685"" height=""16"" font=""0"">with the SPS Agreement, then it is presumed to comply with Article XX(b). The United States </text>
<text top=""447"" left=""108"" width=""684"" height=""16"" font=""0"">concludes by stating that because it has satisfied its obligations under the SPS Agreement and </text>
<text top=""464"" left=""108"" width=""305"" height=""16"" font=""0"">Article XX(b), it has not breached Article I:1.</text>
<footnote top=""462"" left=""413"" width=""23"" height=""11"" font=""16"" number=""1751"" ref="""" dis=""""/>
</p><p number=""7.11"" style=""8""><text top=""498"" left=""108"" width=""314"" height=""16"" font=""28"">7.11.1.2.2  Article XI:1 of the GATT 1994 </text></p><p number=""7.729"" style=""8""><text top=""533"" left=""108"" width=""687"" height=""16"" font=""0"">7.729.  The United States does not answer specifically the arguments made by Argentina in </text>
<text top=""549"" left=""108"" width=""682"" height=""16"" font=""0"">relation to Article XI:1. Rather, it asserts that its application system is necessary to protect animal </text>
<text top=""565"" left=""108"" width=""687"" height=""16"" font=""0"">life or health, consistent with the SPS Agreement and Article XX(b) of the GATT 1994. The </text>
<text top=""582"" left=""108"" width=""682"" height=""16"" font=""0"">United States notes that pursuant to Article 2.4 of the SPS Agreement, if a measure complies with </text>
<text top=""598"" left=""108"" width=""682"" height=""16"" font=""0"">the SPS Agreement, then it is presumed to comply with Article XX(b). The United States concludes </text>
<text top=""615"" left=""108"" width=""682"" height=""16"" font=""0"">by stating that because it has satisfied its obligations under the SPS Agreement and Article XX(b), </text>
<text top=""631"" left=""108"" width=""218"" height=""16"" font=""0"">it has not breached Article XI:1.</text>
<footnote top=""629"" left=""326"" width=""23"" height=""11"" font=""16"" number=""1752"" ref="""" dis=""""/>
</p><p number=""7.11"" style=""8""><text top=""665"" left=""108"" width=""224"" height=""16"" font=""28"">7.11.2  Analysis by the Panel </text></p><p number=""7.730"" style=""8""><text top=""700"" left=""108"" width=""683"" height=""16"" font=""0"">7.730.  We recall that a panel need only address those claims that must be addressed to resolve </text>
<text top=""716"" left=""108"" width=""685"" height=""16"" font=""0"">the matter at issue in the dispute. A finding of violation on the principal claim may make it </text>
<text top=""733"" left=""108"" width=""685"" height=""16"" font=""0"">unnecessary to continue and rule on alternative claims or on those made under other covered </text>
<text top=""749"" left=""108"" width=""85"" height=""16"" font=""0"">agreements.</text>
<footnote top=""747"" left=""193"" width=""23"" height=""11"" font=""16"" number=""1753"" ref=""WT/DS33/AB/R|WT/DS33/AB/R/Corr.1"" dis=""DS33""><ftext top=""1007"" left=""170"" width=""586"" height=""15"" font=""10""> Appellate Body Report, <i>US </i>&#8211;<i> Wool Shirts and Blouses</i>,<i> </i>pp. 17-20, DSR 1997:I, 323 at 339-340. </ftext>
</footnote>
<text top=""749"" left=""216"" width=""579"" height=""16"" font=""0""> In particular, with respect to disputes where claims are raised under the </text>
<text top=""765"" left=""108"" width=""683"" height=""16"" font=""0"">GATT 1994 and the SPS Agreement, panels often decide that it is not necessary to make findings </text>
<text top=""782"" left=""108"" width=""158"" height=""16"" font=""0"">under the GATT 1994.</text>
<footnote top=""780"" left=""266"" width=""23"" height=""11"" font=""16"" number=""1754"" ref=""WT/DS26/R/USA"" dis=""DS26|DS291|DS245|DS293|DS292|DS18|DS430""><ftext top=""1022"" left=""170"" width=""607"" height=""15"" font=""10""> See e.g. Panel Reports, <i>EC &#8211; Hormones (US)</i>, para. 8.272; <i>EC &#8211; Hormones (Canada)</i>, para. 8.275; </ftext>
<ftext top=""1036"" left=""108"" width=""627"" height=""15"" font=""12""><i>Australia &#8211; Salmon</i>, para. 8.185; <i>Japan &#8211; Apples</i>, para. 8.328; <i>EC &#8211; Approval and Marketing of Biotech </i></ftext>
<ftext top=""1051"" left=""108"" width=""487"" height=""15"" font=""12""><i>Products</i>, paras. 7.3422 and 7.3429; <i>India </i>&#8211;<i> Agricultural Products</i>, para. 7.803. </ftext>
</footnote>
<text top=""782"" left=""289"" width=""504"" height=""16"" font=""0""> Prior panels have recognized that the relationship between the two </text>
<text top=""798"" left=""108"" width=""683"" height=""16"" font=""0"">agreements could lead to circular reasoning that does not aid in providing a positive resolution to </text>
<text top=""815"" left=""108"" width=""684"" height=""16"" font=""0"">the dispute. The panel in <i>Australia &#8211; Salmon </i>reasoned that where any findings of inconsistency </text>
<text top=""831"" left=""108"" width=""687"" height=""16"" font=""0"">with GATT 1994 provisions would also require an examination of whether the measure was </text>
<text top=""847"" left=""108"" width=""682"" height=""16"" font=""0"">justified under Article XX(b) of the GATT 1994, the Panel would be led back to the SPS Agreement, </text>
<text top=""864"" left=""108"" width=""403"" height=""16"" font=""0"">with which the panel had already found inconsistencies.</text>
<footnote top=""862"" left=""511"" width=""23"" height=""11"" font=""16"" number=""1755"" ref=""WT/DS18/11|WT/DS18/R|WT/DS18/RW|WT/DS18/R/Corr.1"" dis=""DS18|DS392""><ftext top=""1066"" left=""170"" width=""599"" height=""15"" font=""10""> Panel Report, <i>Australia &#8211; Salmon</i>, para. 7.19. The panel in <i>US &#8211; Poultry (China)</i> reached a similar </ftext>
</footnote>
<text top=""864"" left=""534"" width=""259"" height=""16"" font=""0""> Such a conclusion is bolstered by </text>
<text top=""880"" left=""108"" width=""366"" height=""16"" font=""0"">Article 2.4 of the SPS Agreement, which states that:  </text>
<footnote top=""978"" left=""170"" width=""310"" height=""15"" font=""10"" number=""368"" ref="""" dis=""""/>
<p><text top=""1080"" left=""108"" width=""676"" height=""15"" font=""10"">conclusion when it determined that for an SPS measure to be justified under Article XX(b) of the GATT 1994, it </text>
</p><p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 223 - </text>
</p><p><text top=""128"" left=""151"" width=""600"" height=""16"" font=""0"">[S]anitary or phytosanitary measures which conform to the relevant provisions of </text>
<text top=""144"" left=""151"" width=""600"" height=""16"" font=""0"">this Agreement shall be presumed to be in accordance with the obligations of the </text>
<text top=""160"" left=""151"" width=""597"" height=""16"" font=""0"">Members under the provisions of the GATT 1994 which relate to the use of sanitary or </text>
<text top=""177"" left=""151"" width=""361"" height=""16"" font=""0"">phytosanitary measures, in particular Article XX(b).  </text>
</p></p></page>
<page number=""223"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""7.731"" style=""8""><text top=""211"" left=""108"" width=""682"" height=""16"" font=""0"">7.731.  In light of the above, the Panel considers that when the United States brings its measures </text>
<text top=""228"" left=""108"" width=""686"" height=""16"" font=""0"">into conformity with the SPS Agreement, any inconsistency with the GATT 1994 will also be </text>
<text top=""244"" left=""108"" width=""682"" height=""16"" font=""0"">addressed. Under the circumstances, we see no reason to disagree with the consistent approach of </text>
<text top=""260"" left=""108"" width=""90"" height=""16"" font=""0"">prior panels. </text>
</p><p number=""7.732"" style=""8""><text top=""295"" left=""108"" width=""687"" height=""16"" font=""0"">7.732.  We recall our findings above that the United States' measures are inconsistent with </text>
<text top=""311"" left=""108"" width=""683"" height=""16"" font=""0"">Articles 1.1, 2.2, 2.3, 3.1, 3.3, 5.1, 5.6, 6.1, 8 and Annex C(1)(a) and (b) of the SPS Agreement. </text>
<text top=""328"" left=""108"" width=""682"" height=""16"" font=""0"">Having made findings under the SPS claims, we conclude that it is not necessary to make findings </text>
<text top=""344"" left=""108"" width=""654"" height=""16"" font=""0"">under the GATT 1994 claims as they would not contribute to a positive resolution of the matter.</text>
<footnote top=""343"" left=""762"" width=""23"" height=""11"" font=""16"" number=""1756"" ref=""WT/DS321/R/Add.3|WT/DS321/R/Add.1|WT/DS321/R/Add.2|WT/DS321/R/Add.4|WT/DS321/R/Add.5|WT/DS321/R/Add.7|WT/DS321/R/Add.6|WT/DS321/R"" dis=""DS321|DS292|DS245|DS291|DS18|DS293""><ftext top=""1095"" left=""170"" width=""556"" height=""15"" font=""10""> See e.g. Panel Reports, <i>US/Canada &#8211; Continued Suspension</i>, para. 7.853; <i>Japan &#8211; Apples</i>, </ftext>
<ftext top=""1109"" left=""108"" width=""630"" height=""15"" font=""10"">para. 8.328; <i>Japan &#8211; Apples (Article 21.5 &#8211; US)</i>, paras. 8.202-8.203; <i>EC&#8211;Hormones (US)</i>, para. 8.272; </ftext>
<ftext top=""1124"" left=""108"" width=""625"" height=""15"" font=""12""><i>Australia &#8211; Salmon</i>, para. 8.185; and <i>EC &#8211; Approval and Marketing of Biotech Products</i>, para. 7.3429.  </ftext>
</footnote>
<text top=""360"" left=""108"" width=""683"" height=""16"" font=""0"">Therefore, we consider it appropriate to exercise judicial economy over Argentina's claims under </text>
<text top=""377"" left=""108"" width=""623"" height=""16"" font=""0"">Articles I:1 and XI:1 of the GATT 1994 and the United States' defence under Article XX(b). </text>
</p><p><text top=""411"" left=""108"" width=""350"" height=""16"" font=""28"">8  CONCLUSIONS AND RECOMMENDATION(S) </text></p><p number=""8.1"" style=""8""><text top=""446"" left=""108"" width=""682"" height=""16"" font=""0"">8.1.  As described in greater detail above, the Panel finds in respect of Argentina's claims pursuant </text>
<text top=""462"" left=""108"" width=""194"" height=""16"" font=""0"">to the SPS Agreement that: </text>
</p><p number=""a."" style=""2""><text top=""497"" left=""151"" width=""643"" height=""16"" font=""0"">a.  The United States' measures (9 CFR 94.1, as amended by the 2001 Regulations, the </text>
<text top=""513"" left=""176"" width=""614"" height=""16"" font=""0"">application of 9 CFR 92.2 to Argentina's applications for authorization to import for fresh </text>
<text top=""529"" left=""176"" width=""618"" height=""16"" font=""0"">(chilled or frozen) beef from Northern Argentina, and FMD-susceptible animals and </text>
<text top=""546"" left=""176"" width=""618"" height=""16"" font=""0"">animal products from Patagonia, and Section 737) are SPS measures subject to the </text>
<text top=""562"" left=""176"" width=""234"" height=""16"" font=""0"">disciplines of the SPS Agreement. </text>
</p><p number=""b."" style=""2""><text top=""597"" left=""151"" width=""450"" height=""16"" font=""0"">b.  With respect to Article 8 and Annex C(1) the Panel finds that: </text>
</p><p number=""i."" style=""2""><text top=""631"" left=""176"" width=""622"" height=""16"" font=""0"">i.  The application of the disciplines of 9 CFR 92.2 to Argentina's requests for </text>
<text top=""647"" left=""202"" width=""589"" height=""16"" font=""0"">authorization to import fresh (chilled or frozen) beef from Northern Argentina and for </text>
<text top=""664"" left=""202"" width=""595"" height=""16"" font=""0"">recognition of Patagonia as FMD-free falls within the scope of Article 8 and </text>
<text top=""680"" left=""202"" width=""247"" height=""16"" font=""0"">Annex C(1) of the SPS Agreement.  </text>
</p><p><text top=""715"" left=""176"" width=""616"" height=""16"" font=""0"">ii.  That the United States has not undertaken and completed the procedure to review </text>
<text top=""731"" left=""202"" width=""593"" height=""16"" font=""0"">Argentina's request for imports of fresh (chilled or frozen) beef from Northern </text>
<text top=""747"" left=""202"" width=""588"" height=""16"" font=""0"">Argentina without undue delay and has therefore acted in a manner inconsistent with </text>
<text top=""764"" left=""202"" width=""353"" height=""16"" font=""0"">Article 8 and Annex C(1)(a) of the SPS Agreement. </text>
</p><p><text top=""798"" left=""176"" width=""615"" height=""16"" font=""0"">iii.  That the United States has not undertaken and completed the review of Argentina's </text>
<text top=""815"" left=""202"" width=""589"" height=""16"" font=""0"">request for recognition of Patagonia as FMD-free without undue delay and it has thus </text>
<text top=""831"" left=""202"" width=""526"" height=""16"" font=""0"">acted inconsistently with Article 8 and Annex C(1)(a) of the SPS Agreement. </text>
</p><p><text top=""865"" left=""176"" width=""281"" height=""16"" font=""0"">iv.  Argentina's claims under Article </text>
<text top=""865"" left=""448"" width=""350"" height=""16"" font=""0"">8 and the first and third requirements of </text>
<text top=""882"" left=""202"" width=""398"" height=""16"" font=""0"">Annex C(1)(b) are outside the Panel's terms of reference. </text>
</p><p number=""v."" style=""2""><text top=""916"" left=""176"" width=""614"" height=""16"" font=""0"">v.  By failing to inform Argentina, upon request, of the stage of APHIS' review processes </text>
<text top=""933"" left=""202"" width=""593"" height=""16"" font=""0"">or to explain the delays incurred by such procedures, the United States acted </text>
<text top=""949"" left=""202"" width=""493"" height=""16"" font=""0"">inconsistently with Article 8 and the fifth requirement of Annex C(1)(b). </text>
</p><p number=""c."" style=""2""><text top=""983"" left=""151"" width=""641"" height=""16"" font=""0"">c.  The Panel finds that 9 CFR 94.1, as amended by the 2001 Regulations, is not based on </text>
<text top=""1000"" left=""176"" width=""614"" height=""16"" font=""0"">the relevant provisions of the Terrestrial Code and is thus inconsistent with Article 3.1 of </text>
<text top=""1016"" left=""176"" width=""142"" height=""16"" font=""0"">the SPS Agreement. </text>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 224 - </text>
</p></p></page>
<page number=""224"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p number=""d."" style=""2""><text top=""128"" left=""151"" width=""640"" height=""16"" font=""0"">d.  The Panel finds the United States did not seek to obtain additional information nor did it </text>
<text top=""144"" left=""176"" width=""615"" height=""16"" font=""0"">review the measures within a reasonable period of time. Therefore, the Panel finds that </text>
<text top=""160"" left=""176"" width=""615"" height=""16"" font=""0"">the measures do not fall within the scope of Article 5.7 and the qualified exemption to </text>
<text top=""177"" left=""176"" width=""545"" height=""16"" font=""0"">the obligations in Articles 5.1, 5.2 and 2.2 is not available to the United States. </text>
</p><p number=""e."" style=""2""><text top=""211"" left=""151"" width=""452"" height=""16"" font=""0"">e.  With respect to Articles 5.1, 5.2, and 2.2 the Panel finds that: </text>
</p><p number=""i."" style=""2""><text top=""246"" left=""176"" width=""615"" height=""16"" font=""0"">i.  The June 2001 Interim Rule is a risk assessment ""appropriate to the circumstances"" </text>
<text top=""262"" left=""202"" width=""589"" height=""16"" font=""0"">within the meaning of Article 5.1, 5.2, 5.3 and Annex A(4). The Panel also finds that </text>
<text top=""278"" left=""202"" width=""592"" height=""16"" font=""0"">at the time the measures were adopted in 2001 they were based on that risk </text>
<text top=""295"" left=""202"" width=""589"" height=""16"" font=""0"">assessment. Therefore, at the time the measures were adopted they were consistent </text>
<text top=""311"" left=""202"" width=""176"" height=""16"" font=""0"">with Articles 5.1 and 5.2. </text>
</p><p><text top=""346"" left=""176"" width=""618"" height=""16"" font=""0"">ii.  The Panel also finds that the scientific evidence required a review or new risk </text>
<text top=""362"" left=""202"" width=""596"" height=""16"" font=""0"">assessment, which the United States had not completed as of the date of </text>
<text top=""378"" left=""202"" width=""591"" height=""16"" font=""0"">establishment of the Panel. Therefore, the Panel finds that the measures are not </text>
<text top=""395"" left=""202"" width=""509"" height=""16"" font=""0"">maintained based on a risk assessment as required by Article </text>
<text top=""395"" left=""702"" width=""97"" height=""16"" font=""0"">5.1 of the </text>
<text top=""411"" left=""202"" width=""589"" height=""16"" font=""0"">SPS Agreement. Such failure cannot be justified by the fact that the risk assessment </text>
<text top=""428"" left=""202"" width=""591"" height=""16"" font=""0"">process was ongoing because the United States acted inconsistently with Article 8 </text>
<text top=""444"" left=""202"" width=""589"" height=""16"" font=""0"">and Annex C(1)(a) in the conduct of the risk assessment in that the process incurred </text>
<text top=""461"" left=""202"" width=""593"" height=""16"" font=""0"">undue delays. Therefore, the maintenance of the measures is inconsistent with </text>
<text top=""477"" left=""202"" width=""589"" height=""16"" font=""0"">Article 5.1. Having found that there was no risk assessment, the Panel finds no basis </text>
<text top=""493"" left=""202"" width=""354"" height=""16"" font=""0"">to move forward with an analysis under Article 5.2. </text>
</p><p><text top=""528"" left=""176"" width=""622"" height=""16"" font=""0"">iii.  As a consequence of the violation of Article 5.1, the Panel finds that the </text>
<text top=""544"" left=""202"" width=""427"" height=""16"" font=""0"">United States' measures are also inconsistent with Article 2.2. </text>
</p><p number=""f."" style=""2""><text top=""579"" left=""151"" width=""643"" height=""16"" font=""0"">f.  The Panel concludes that Article 5.4 does not impose a positive obligation on WTO </text>
<text top=""595"" left=""176"" width=""622"" height=""16"" font=""0"">Members. Even assuming, <i>arguendo</i>, that Argentina could raise a claim under </text>
<text top=""611"" left=""176"" width=""574"" height=""16"" font=""0"">Article 5.4, the Panel finds that it has not made a <i>prima facie</i> case of inconsistency. </text>
</p><p number=""g."" style=""2""><text top=""646"" left=""151"" width=""352"" height=""16"" font=""0"">g.  With respect to Article 5.6 the Panel finds that: </text>
</p><p number=""i."" style=""2""><text top=""680"" left=""176"" width=""618"" height=""16"" font=""0"">i.  The United States' prohibitions on imports of fresh (chilled or frozen) beef from </text>
<text top=""697"" left=""202"" width=""597"" height=""16"" font=""0"">Northern Argentina are more trade-restrictive than required to achieve the </text>
<text top=""713"" left=""202"" width=""434"" height=""16"" font=""0"">United States' ALOP, and thus are inconsistent with Article 5.6. </text>
</p><p><text top=""747"" left=""176"" width=""617"" height=""16"" font=""0"">ii.  The United States' prohibitions on imports of FMD-susceptible animals and animal </text>
<text top=""764"" left=""202"" width=""592"" height=""16"" font=""0"">products from Patagonia are more trade-restrictive than required to achieve the </text>
<text top=""780"" left=""202"" width=""434"" height=""16"" font=""0"">United States' ALOP, and thus are inconsistent with Article 5.6. </text>
</p><p number=""h."" style=""2""><text top=""815"" left=""151"" width=""352"" height=""16"" font=""0"">h.  With respect to Article 2.3 the Panel finds that: </text>
</p><p number=""i."" style=""2""><text top=""849"" left=""176"" width=""619"" height=""16"" font=""0"">i.  By allowing imports of fresh (chilled or frozen) beef from Uruguay under the </text>
<text top=""865"" left=""202"" width=""591"" height=""16"" font=""0"">protocols set forth in 9 CFR 94.22, while prohibiting imports of the same product </text>
<text top=""882"" left=""202"" width=""590"" height=""16"" font=""0"">from Northern Argentina, the United States arbitrarily or unjustifiably discriminates </text>
<text top=""898"" left=""202"" width=""591"" height=""16"" font=""0"">between Members where identical or similar conditions prevail, inconsistently with </text>
<text top=""915"" left=""202"" width=""79"" height=""16"" font=""0"">Article 2.3. </text>
</p><p><text top=""949"" left=""176"" width=""615"" height=""16"" font=""0"">ii.  The Panel exercises judicial economy on Argentina's claim that, by conducting a risk </text>
<text top=""965"" left=""202"" width=""589"" height=""16"" font=""0"">analysis and issuing a positive determination for Uruguay within a reasonable period </text>
<text top=""982"" left=""202"" width=""589"" height=""16"" font=""0"">of time, while maintaining its prohibition on imports from Northern Argentina without </text>
<text top=""998"" left=""202"" width=""592"" height=""16"" font=""0"">a risk assessment since 2001, the United States discriminated between the two </text>
<text top=""1015"" left=""202"" width=""387"" height=""16"" font=""0"">regions in terms of access to APHIS' regulatory process. </text>
</p><p><text top=""1049"" left=""176"" width=""620"" height=""16"" font=""0"">iii.  By recognizing Santa Catarina and Chile as FMD-free within the meaning of </text>
<text top=""1066"" left=""202"" width=""589"" height=""16"" font=""0"">9 CFR 94.1(a) and allowing imports of FMD-susceptible animals and animal products </text>
<text top=""1082"" left=""202"" width=""589"" height=""16"" font=""0"">therefrom under the protocols in 9 CFR 94.11, while prohibiting imports of the same </text>
<text top=""1098"" left=""202"" width=""590"" height=""16"" font=""0"">products from Patagonia, the United States arbitrarily or unjustifiably discriminates </text>
<text top=""1115"" left=""202"" width=""591"" height=""16"" font=""0"">between Members where identical or similar conditions prevail, inconsistently with </text>
<text top=""1131"" left=""202"" width=""79"" height=""16"" font=""0"">Article 2.3. </text>
</p></page>
<page number=""225"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 225 - </text>
</p><p><text top=""128"" left=""176"" width=""615"" height=""16"" font=""0"">iv.  The Panel exercises judicial economy on Argentina's claim that, by conducting a risk </text>
<text top=""144"" left=""202"" width=""589"" height=""16"" font=""0"">analysis and issuing a positive determination for Santa Catarina within a reasonable </text>
<text top=""160"" left=""202"" width=""589"" height=""16"" font=""0"">period of time, while maintaining its prohibition on imports from Patagonia without a </text>
<text top=""177"" left=""202"" width=""588"" height=""16"" font=""0"">risk assessment since 2001, the United States discriminated between the two regions </text>
<text top=""193"" left=""202"" width=""333"" height=""16"" font=""0"">in terms of access to APHIS' regulatory process. </text>
</p><p number=""v."" style=""2""><text top=""228"" left=""176"" width=""619"" height=""16"" font=""0"">v.  Argentina failed to demonstrate that the United States' measures arbitrarily or </text>
<text top=""244"" left=""202"" width=""595"" height=""16"" font=""0"">unjustifiably discriminate between, on the one hand, Northern Argentina and </text>
<text top=""260"" left=""202"" width=""457"" height=""16"" font=""0"">Patagonia and, on the other hand, Japan and the United Kingdom. </text>
</p><p number=""i."" style=""2""><text top=""295"" left=""151"" width=""338"" height=""16"" font=""0"">i.  With respect to Article 6 the Panel finds that: </text>
</p><p number=""i."" style=""2""><text top=""329"" left=""176"" width=""617"" height=""16"" font=""0"">i.  By failing to adapt its measures to the sanitary characteristics of Patagonia, the </text>
<text top=""346"" left=""202"" width=""348"" height=""16"" font=""0"">United States acted inconsistently with Article 6.1. </text>
</p><p><text top=""380"" left=""176"" width=""620"" height=""16"" font=""0"">ii.  The Panel exercises judicial economy on Argentina's claim that, by failing to </text>
<text top=""396"" left=""202"" width=""591"" height=""16"" font=""0"">recognize the concepts of FMD-free areas or areas of low disease prevalence, the </text>
<text top=""413"" left=""202"" width=""348"" height=""16"" font=""0"">United States acted inconsistently with Article 6.2. </text>
</p><p number=""j."" style=""2""><text top=""447"" left=""151"" width=""645"" height=""16"" font=""0"">j.  Argentina has not established that the United States acted inconsistently with its </text>
<text top=""464"" left=""176"" width=""586"" height=""16"" font=""0"">obligations under Article 10.1 by failing to take account of Argentina's special needs.  </text>
</p><p number=""k."" style=""2""><text top=""498"" left=""151"" width=""41"" height=""16"" font=""0"">k.   </text>
<text top=""498"" left=""181"" width=""256"" height=""16"" font=""0"">Having found that the United </text>
<text top=""498"" left=""426"" width=""321"" height=""16"" font=""0"">States acted inconsistently with Article </text>
<text top=""498"" left=""736"" width=""64"" height=""16"" font=""0"">8 and </text>
<text top=""515"" left=""176"" width=""56"" height=""16"" font=""0"">Annex </text>
<text top=""515"" left=""223"" width=""244"" height=""16"" font=""0"">C(1)(a) and (b), and Articles </text>
<text top=""515"" left=""459"" width=""340"" height=""16"" font=""0"">5.1, 2.2, 5.6, 2.3, 6.1, and 1.1 of the </text>
<text top=""531"" left=""176"" width=""614"" height=""16"" font=""0"">SPS Agreement, the Panel finds that the United States has also acted inconsistently with </text>
<text top=""547"" left=""176"" width=""79"" height=""16"" font=""0"">Article 3.3. </text>
</p><p number=""l."" style=""2""><text top=""582"" left=""151"" width=""640"" height=""16"" font=""0"">l.  Having found that 9 CFR 94.1, as amended by the 2001 Regulations, is inconsistent with </text>
<text top=""598"" left=""176"" width=""614"" height=""16"" font=""0"">Articles 3.1, 3.3, 5.1, 2.2, 5.6, 2.3, and 6.1 of the SPS Agreement, we find that it is also </text>
<text top=""615"" left=""176"" width=""353"" height=""16"" font=""0"">inconsistent with Article 1.1 of the SPS Agreement. </text>
</p><p number=""8.2"" style=""8""><text top=""649"" left=""108"" width=""686"" height=""16"" font=""0"">8.2.   In respect of the Argentina's claims under the GATT 1994, the Panel noted that it had </text>
<text top=""665"" left=""108"" width=""684"" height=""16"" font=""0"">already found that the United States' measures are inconsistent with Articles 1.1, 2.2, 2.3, 3.1, </text>
<text top=""682"" left=""108"" width=""685"" height=""16"" font=""0"">3.3, 5.1, 5.6, 6.1, 8 and Annex C(1)(a) and (b) of the SPS Agreement. Therefore, the Panel </text>
<text top=""698"" left=""108"" width=""683"" height=""16"" font=""0"">exercised judicial economy over Argentina's claims under Articles I:1 and XI:1 of the GATT 1994 </text>
<text top=""715"" left=""108"" width=""479"" height=""16"" font=""0"">and the United States' defence under Article XX(b) of the GATT 1994. </text>
</p><p number=""8.3"" style=""8""><text top=""749"" left=""108"" width=""682"" height=""16"" font=""0"">8.3.  Under Article 3.8 of the DSU, in cases where there is infringement of the obligations assumed </text>
<text top=""765"" left=""108"" width=""688"" height=""16"" font=""0"">under a covered agreement, the action is considered <i>prima facie</i> to constitute a case of </text>
<text top=""782"" left=""108"" width=""683"" height=""16"" font=""0"">nullification or impairment of benefits under that agreement. Accordingly, we conclude that to the </text>
<text top=""798"" left=""108"" width=""688"" height=""16"" font=""0"">extent that the United States has acted inconsistently with the specified provisions of the </text>
<text top=""815"" left=""108"" width=""667"" height=""16"" font=""0"">SPS Agreement, it has nullified or impaired benefits accruing to Argentina under that agreement. </text>
</p><p number=""8.4"" style=""8""><text top=""849"" left=""108"" width=""683"" height=""16"" font=""0"">8.4.  Pursuant to Article 19.1 of the DSU, having found that the United States acted inconsistently </text>
<text top=""865"" left=""108"" width=""682"" height=""16"" font=""0"">with its obligations under Articles 1.1, 2.2, 2.3 3.1, 3.3, 5.1, 5.6, 6.1, 8 and Annex C(1)(a) and (b) </text>
<text top=""882"" left=""108"" width=""687"" height=""16"" font=""0"">of the SPS Agreement, we recommend that the DSB request the United States to bring its </text>
<text top=""898"" left=""108"" width=""502"" height=""16"" font=""0"">measures into conformity with its obligations under the SPS Agreement.  </text>
</p><p><text top=""949"" left=""374"" width=""149"" height=""16"" font=""26"">_______________ </text></p></page>
<page number=""226"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""35"" size=""5"" family=""Times"" color=""#000000"" style=""i""/><fontspec id=""34"" size=""5"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""23"" size=""8"" family=""Times"" color=""#006284""/>
	<fontspec id=""24"" size=""5"" family=""Times"" color=""#000000""/>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 226 - </text>
</p><p><text top=""128"" left=""400"" width=""80"" height=""16"" font=""28"">APPENDIX</text><text top=""128"" left=""483"" width=""14"" height=""16"" font=""28"">1 </text></p><p><text top=""171"" left=""186"" width=""530"" height=""16"" font=""6"">CHRONOLOGY OF EVENTS RELATING TO THE UNITED STATES' EVALUATION  </text>
<text top=""187"" left=""227"" width=""443"" height=""16"" font=""6"">OF THE FOOT-AND-MOUTH DISEASE SITUATION IN ARGENTINA </text>
</p><p><text top=""235"" left=""365"" width=""96"" height=""15"" font=""33"">Type of Event </text><text top=""256"" left=""105"" width=""601"" height=""15"" font=""33"">Internal Argentine Event &#8211; including outbreaks and introduction of domestic regulations </text><text top=""256"" left=""733"" width=""34"" height=""15"" font=""33"">Bold </text></p><p><text top=""277"" left=""105"" width=""70"" height=""15"" font=""31"">OIE events </text><text top=""277"" left=""733"" width=""40"" height=""15"" font=""31"">Italics </text></p><p><text top=""299"" left=""105"" width=""261"" height=""15"" font=""10"">WTO notifications and current proceedings </text>
<text top=""299"" left=""733"" width=""33"" height=""15"" font=""10"">Plain </text>
<text top=""320"" left=""105"" width=""489"" height=""15"" font=""10"">US regulatory process &#8211; including communications with Argentina and site visits </text>
<text top=""320"" left=""733"" width=""53"" height=""15"" font=""10"">Shading </text>
</p><p><text top=""378"" left=""157"" width=""693"" height=""15"" font=""33"">Date Event </text></p><p><text top=""401"" left=""108"" width=""35"" height=""15"" font=""10"">1929 </text>
<text top=""401"" left=""254"" width=""258"" height=""15"" font=""10"">Last outbreak of FMD in the United States.</text>
<footnote top=""400"" left=""512"" width=""5"" height=""9"" font=""17"" number=""1"" ref="""" dis=""""/>
<text top=""423"" left=""108"" width=""71"" height=""15"" font=""10"">1964-1987 </text>
<text top=""423"" left=""254"" width=""238"" height=""15"" font=""10"">Continued FMD outbreaks in Argentina.</text>
<footnote top=""422"" left=""492"" width=""5"" height=""9"" font=""17"" number=""2"" ref="""" dis=""""><ftext top=""445"" left=""121"" width=""65"" height=""15"" font=""33"">October </ftext></footnote>
<text top=""446"" left=""108"" width=""100"" height=""15"" font=""10"">25 August 1997 </text>
<text top=""446"" left=""254"" width=""538"" height=""15"" font=""10"">The United States authorized the importation of fresh (chilled or frozen) beef from </text>
<text top=""460"" left=""254"" width=""405"" height=""15"" font=""10"">Argentina, following a risk assessment completed in June 1997.</text>
<footnote top=""460"" left=""659"" width=""5"" height=""9"" font=""17"" number=""3"" ref="""" dis=""""><ftext top=""914"" left=""155"" width=""525"" height=""15"" font=""10""> <i>Importation of Beef from Argentina</i>, 62 Fed. Reg. 34385 (26 June 1997) (Final Rule), </ftext>
</footnote>
<text top=""460"" left=""664"" width=""128"" height=""15"" font=""10"">  The authorization </text>
<text top=""475"" left=""254"" width=""538"" height=""15"" font=""10"">included a set of mitigating protocols to bring the imports of Argentine beef into </text>
<text top=""489"" left=""254"" width=""254"" height=""15"" font=""10"">compliance with the United States' ALOP. </text>
</p><p><text top=""512"" left=""108"" width=""95"" height=""15"" font=""33"">30 April 1999 </text><text top=""512"" left=""254"" width=""417"" height=""15"" font=""33"">Anti-FMD vaccination was suspended in all Argentine regions.</text><footnote top=""511"" left=""672"" width=""5"" height=""9"" font=""34"" number=""4"" ref="""" dis=""""/></p><p><text top=""534"" left=""108"" width=""83"" height=""15"" font=""31"">22 May 2000 </text><text top=""534"" left=""254"" width=""514"" height=""15"" font=""31"">OIE recognized Argentina as an FMD-free country where vaccination is not practised.</text><footnote top=""534"" left=""769"" width=""5"" height=""9"" font=""35"" number=""5"" ref="""" dis=""""><ftext top=""957"" left=""155"" width=""588"" height=""15"" font=""10""> Argentina's first written submission, para. 105. United States' first written submission, para. 71 </ftext>
</footnote></p><p><text top=""557"" left=""108"" width=""91"" height=""15"" font=""33"">20 July 2000 </text><text top=""557"" left=""254"" width=""350"" height=""15"" font=""33"">Type O Outbreak in Clorinda, Province of FORMOSA.</text><footnote top=""556"" left=""604"" width=""5"" height=""9"" font=""34"" number=""6"" ref="""" dis=""""><ftext top=""1001"" left=""155"" width=""603"" height=""15"" font=""10""> SENASA, <i>National FMD Eradication Plan April, 2001: Report of 2000-2001 FMD Outbreaks, Actions </i></ftext>
</footnote><text top=""580"" left=""108"" width=""91"" height=""15"" font=""33"">22 July 2000 </text><text top=""580"" left=""254"" width=""503"" height=""15"" font=""33"">Cattle from a neighbouring country were illegally imported into Argentina.</text><footnote top=""579"" left=""757"" width=""5"" height=""9"" font=""34"" number=""7"" ref="""" dis=""""><ftext top=""1045"" left=""155"" width=""616"" height=""15"" font=""10""> United States first written submission, para. 72 (referring to <i>Certification of Beef from Argentina</i>, 65 </ftext>
<ftext top=""1059"" left=""108"" width=""355"" height=""15"" font=""10"">Fed. Reg. 82894 (29 December 2000) (Exhibit USA-30)).  </ftext>
</footnote><text top=""602"" left=""108"" width=""93"" height=""15"" font=""33"">27 July 2000 </text><text top=""602"" left=""254"" width=""537"" height=""15"" font=""33"">Type O Outbreak in Concepcion del Uruguay department of the Province of </text><text top=""617"" left=""254"" width=""87"" height=""15"" font=""33"">ENTRE RIOS.</text><footnote top=""616"" left=""342"" width=""5"" height=""9"" font=""34"" number=""8"" ref="""" dis=""""><ftext top=""1074"" left=""155"" width=""465"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 3.  </ftext>
</footnote><text top=""639"" left=""108"" width=""91"" height=""15"" font=""33"">28 July 2000 </text><text top=""639"" left=""254"" width=""378"" height=""15"" font=""33"">Type O Outbreak in Mercedes, Province of CORRIENTES.</text><footnote top=""639"" left=""633"" width=""5"" height=""9"" font=""34"" number=""9"" ref="""" dis=""""><ftext top=""1089"" left=""155"" width=""465"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 3.  </ftext>
</footnote><text top=""662"" left=""108"" width=""102"" height=""15"" font=""33"">2 August 2000 </text><text top=""662"" left=""254"" width=""539"" height=""15"" font=""33"">Type  O  Outbreak  reported  in  the Pilag&#224;s Department of the Province of </text><text top=""676"" left=""254"" width=""71"" height=""15"" font=""33"">FORMOSA.</text><footnote top=""676"" left=""326"" width=""11"" height=""9"" font=""34"" number=""10"" ref="""" dis=""""><ftext top=""1103"" left=""160"" width=""461"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 3. </ftext>
</footnote><text top=""699"" left=""108"" width=""102"" height=""15"" font=""33"">4 August 2000 </text><text top=""699"" left=""254"" width=""390"" height=""15"" font=""33"">Type A Outbreak in Tercero Arriba, Province of CORDOBA.</text><footnote top=""698"" left=""645"" width=""11"" height=""9"" font=""34"" number=""11"" ref="""" dis=""""><ftext top=""1118"" left=""160"" width=""461"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 4. </ftext>
</footnote><text top=""721"" left=""108"" width=""102"" height=""15"" font=""33"">9 August 2000 </text><text top=""721"" left=""254"" width=""469"" height=""15"" font=""33"">Type A Outbreak in Gral. Villegas district, Province of BUENOS AIRES.</text><footnote top=""721"" left=""724"" width=""11"" height=""9"" font=""34"" number=""12"" ref="""" dis=""""><ftext top=""1132"" left=""160"" width=""465"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 4.  </ftext>
</footnote><text top=""744"" left=""108"" width=""109"" height=""15"" font=""33"">9 August 2000 </text><text top=""744"" left=""254"" width=""542"" height=""15"" font=""33"">Out of concern for maintaining the international status of exports of </text><text top=""758"" left=""254"" width=""542"" height=""15"" font=""33"">FMD-susceptible products, SENASA decided to keep the FMD situation </text><text top=""773"" left=""254"" width=""541"" height=""15"" font=""33"">confidential until further data would permit a better evaluation of the </text><text top=""788"" left=""254"" width=""64"" height=""15"" font=""33"">situation.</text><footnote top=""787"" left=""318"" width=""11"" height=""9"" font=""34"" number=""13"" ref="""" dis=""""/><footnote top=""870"" left=""155"" width=""310"" height=""15"" font=""10"" number=""106"" ref="""" dis=""""/>
<footnote top=""884"" left=""155"" width=""545"" height=""15"" font=""10"" number=""2007"" ref="""" dis=""""/>
</p><p><text top=""899"" left=""108"" width=""118"" height=""15"" font=""10"">(Exhibit USA-149). </text>
<footnote top=""928"" left=""108"" width=""111"" height=""15"" font=""10"" number=""26"" ref="""" dis=""""><ftext top=""1103"" left=""160"" width=""461"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 4. </ftext>
</footnote>
</p><p><text top=""943"" left=""155"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 103. </text>
<footnote top=""986"" left=""108"" width=""116"" height=""15"" font=""10"" number=""25"" ref="""" dis=""""><ftext top=""1089"" left=""160"" width=""461"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 4. </ftext>
</footnote>
</p><p><text top=""1016"" left=""108"" width=""661"" height=""15"" font=""12""><i>adopted and Contingency Program in Case of FMD Risks</i> (February 2002) (SENASA National FMD Eradication </text>
<text top=""1030"" left=""108"" width=""257"" height=""15"" font=""10"">Plan 2001-2002), (Exhibit USA-33), p. 3.  </text>
</p><p><text top=""1147"" left=""160"" width=""583"" height=""15"" font=""10""> United States' first written submission, para. 84; General Auditing Office of Argentina, <i>SENASA </i></text>
<text top=""1161"" left=""108"" width=""558"" height=""15"" font=""12""><i>Program for the Fight Against Foot and Mouth Disease</i> (22 August 2003), (Exhibit USA-42). </text>
</p></page>
<page number=""227"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 227 - </text>
</p><p><text top=""135"" left=""157"" width=""693"" height=""15"" font=""33"">Date Event </text><text top=""157"" left=""108"" width=""113"" height=""15"" font=""33"">10 August 2000 </text><text top=""157"" left=""254"" width=""537"" height=""15"" font=""33"">Argentina notified the OIE that it had detected FMD disease in animals that </text><text top=""172"" left=""254"" width=""538"" height=""15"" font=""33"">had illegally entered the North-eastern provinces of Argentina through the </text><text top=""186"" left=""254"" width=""114"" height=""15"" font=""33"">Northern border.</text><footnote top=""186"" left=""369"" width=""11"" height=""9"" font=""34"" number=""14"" ref="""" dis=""""/><text top=""209"" left=""108"" width=""111"" height=""15"" font=""33"">14 August 2000 </text><text top=""209"" left=""254"" width=""535"" height=""15"" font=""33"">Type A Suspect case reported in Rio Segundo (centre-north of the Province of </text><text top=""223"" left=""254"" width=""78"" height=""15"" font=""33"">CORDOBA).</text><footnote top=""223"" left=""332"" width=""11"" height=""9"" font=""34"" number=""15"" ref="""" dis=""""><ftext top=""870"" left=""160"" width=""603"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 4. SENASA also mentions </ftext>
<ftext top=""884"" left=""108"" width=""675"" height=""15"" font=""10"">that seven outbreaks followed between 23 August 2000 and 25 September 2000<b>. </b>SENASA also mentioned that </ftext>
<ftext top=""899"" left=""108"" width=""656"" height=""15"" font=""10"">the period between 21 August 2000 to 15 September 2000 was the first in which there were 4 outbreaks in </ftext>
<ftext top=""914"" left=""108"" width=""318"" height=""15"" font=""10"">General Roca and in Rio Segundo at the same time. </ftext>
</footnote><text top=""223"" left=""343"" width=""452"" height=""15"" font=""33""> The district was located to the south of the Province of </text><text top=""238"" left=""254"" width=""540"" height=""15"" font=""33"">CORDOBA where the first outbreaks occurred. By mid - November, the </text><text top=""253"" left=""254"" width=""537"" height=""15"" font=""33"">epidemic had spread to the centre &#8211; west of the Province of CORDOBA and </text><text top=""267"" left=""254"" width=""539"" height=""15"" font=""33"">had entered San Luis. The first outbreaks in San Luis were reported in </text><footnote top=""282"" left=""254"" width=""500"" height=""15"" font=""33"" number=""2001"" ref="""" dis=""""><ftext top=""707"" left=""255"" width=""322"" height=""15"" font=""33"">7 outbreaks of FMD reported in November 2001</ftext></footnote><footnote top=""281"" left=""754"" width=""11"" height=""9"" font=""34"" number=""16"" ref="""" dis=""""><ftext top=""928"" left=""160"" width=""461"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 3. </ftext>
</footnote></p><p><text top=""304"" left=""108"" width=""100"" height=""15"" font=""10"">16 August 2000 </text>
<text top=""304"" left=""254"" width=""536"" height=""15"" font=""10"">Argentina confirmed to APHIS that one of the animals imported on 22 July 2000 was </text>
<text top=""319"" left=""254"" width=""112"" height=""15"" font=""10"">infected with FMD.</text>
<footnote top=""318"" left=""367"" width=""10"" height=""9"" font=""17"" number=""17"" ref="""" dis=""""><ftext top=""943"" left=""160"" width=""316"" height=""15"" font=""10""> 2001 Interim Rule on Argentina, (Exhibit ARG-29). </ftext>
</footnote>
</p><p><text top=""341"" left=""108"" width=""115"" height=""15"" font=""33"">21 August 2000 </text><text top=""341"" left=""254"" width=""539"" height=""15"" font=""33"">Type O Outbreak reported in the Las Palmas District, Bermejo County in </text><text top=""356"" left=""254"" width=""127"" height=""15"" font=""33"">Province of CHACO</text><text top=""362"" left=""381"" width=""3"" height=""9"" font=""34"">.</text><footnote top=""355"" left=""384"" width=""27"" height=""9"" font=""34"" number=""18"" ref="""" dis=""""><ftext top=""957"" left=""160"" width=""461"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 3. </ftext>
</footnote><footnote top=""378"" left=""108"" width=""95"" height=""15"" font=""10"" number=""27"" ref="""" dis=""""><ftext top=""1118"" left=""160"" width=""475"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 16. </ftext>
</footnote>
</p><p><text top=""393"" left=""108"" width=""98"" height=""15"" font=""10"">6 October 2000 </text>
<text top=""378"" left=""254"" width=""536"" height=""15"" font=""10"">APHIS conducted a site visit to Argentina in conjunction with OIE staff, with a view to </text>
<text top=""393"" left=""254"" width=""541"" height=""15"" font=""10"">gathering information necessary to conduct a risk assessment for Argentina in </text>
<text top=""408"" left=""254"" width=""536"" height=""15"" font=""10"">connection with Argentina's report that FMD-infected bovines had been imported into </text>
<text top=""422"" left=""254"" width=""325"" height=""15"" font=""10"">Argentina illegally from Paraguay on 10 August 2000.</text>
<footnote top=""422"" left=""579"" width=""10"" height=""9"" font=""17"" number=""20"" ref="""" dis=""""><ftext top=""986"" left=""160"" width=""621"" height=""15"" font=""10""> USDA/APHIS, <i>Risk Analysis: Evaluation of risk to the United States (US) of importing Foot and Mouth </i></ftext>
<ftext top=""1001"" left=""108"" width=""637"" height=""15"" font=""12""><i>Disease (FMD) Virus in Fresh or Frozen Beef from Argentin</i>a (4 December 2000), (2000 Risk Analysis for </ftext>
</footnote>
<footnote top=""445"" left=""178"" width=""46"" height=""15"" font=""33"" number=""2000"" ref="""" dis=""""><ftext top=""534"" left=""254"" width=""235"" height=""15"" font=""33"">The president of SENASA resigned.</ftext></footnote></p><p><text top=""445"" left=""254"" width=""543"" height=""15"" font=""33"">Type O Outbreak reported in the Capital district of the Province of </text><text top=""459"" left=""254"" width=""74"" height=""15"" font=""33"">MISIONES.</text><footnote top=""459"" left=""329"" width=""11"" height=""9"" font=""34"" number=""21"" ref="""" dis=""""><ftext top=""1030"" left=""160"" width=""461"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 3. </ftext>
</footnote><text top=""482"" left=""108"" width=""103"" height=""15"" font=""33"">Mid-November </text><footnote top=""510"" left=""291"" width=""11"" height=""9"" font=""34"" number=""22"" ref="""" dis=""""><ftext top=""1045"" left=""160"" width=""429"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33). </ftext>
</footnote><footnote top=""533"" left=""490"" width=""11"" height=""9"" font=""34"" number=""23"" ref="""" dis=""""/></p><p><text top=""556"" left=""108"" width=""112"" height=""15"" font=""10"">4 December 2000 </text>
<text top=""556"" left=""254"" width=""535"" height=""15"" font=""10"">APHIS publishes a favourable risk analysis on fresh or frozen beef from Argentina. The </text>
<text top=""571"" left=""254"" width=""537"" height=""15"" font=""10"">risk identified was associated to Argentina's report that 10 bovines, 4 of which were </text>
<text top=""585"" left=""254"" width=""439"" height=""15"" font=""10"">FMD-infected, had been imported into Argentina illegally from Paraguay.</text>
<footnote top=""585"" left=""693"" width=""10"" height=""9"" font=""17"" number=""24"" ref="""" dis=""""><ftext top=""1074"" left=""160"" width=""321"" height=""15"" font=""10""> 2000 Risk Analysis for Argentina, (Exhibit ARG-28). </ftext>
</footnote>
</p><p><text top=""608"" left=""108"" width=""131"" height=""15"" font=""33"">11 December 2000 </text><text top=""608"" left=""254"" width=""503"" height=""15"" font=""33"">Type O Outbreak reported in the Vera district of the Province of SANTA FE.</text><text top=""630"" left=""108"" width=""131"" height=""15"" font=""33"">18 December 2000 </text><text top=""630"" left=""254"" width=""464"" height=""15"" font=""33"">Type O Outbreak reported in the San Christobal district of SANTA FE.</text></p><p><text top=""653"" left=""108"" width=""120"" height=""15"" font=""10"">29 December 2000 </text>
<text top=""653"" left=""254"" width=""540"" height=""15"" font=""10"">APHIS published an interim rule allowing the importation of beef imports from </text>
<text top=""667"" left=""254"" width=""537"" height=""15"" font=""10"">Argentina to resume under 9 CFR 94.21 and amended that section to add additional </text>
<text top=""682"" left=""254"" width=""186"" height=""15"" font=""10"">conditions on the importation. </text>
<footnote top=""726"" left=""585"" width=""11"" height=""9"" font=""34"" number=""28"" ref="""" dis=""""><ftext top=""1132"" left=""160"" width=""475"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 16. </ftext>
</footnote></p><p><text top=""779"" left=""254"" width=""351"" height=""15"" font=""33"">were affected by and 166278 were exposed to FMD.</text><footnote top=""778"" left=""605"" width=""11"" height=""9"" font=""34"" number=""29"" ref="""" dis=""""/><footnote top=""801"" left=""565"" width=""11"" height=""9"" font=""34"" number=""30"" ref="""" dis=""""><ftext top=""841"" left=""160"" width=""614"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p.16. See also United States' </ftext>
<ftext top=""855"" left=""108"" width=""236"" height=""15"" font=""10"">first written submission, paras. 78-81. </ftext>
</footnote></p><p><text top=""971"" left=""151"" width=""10"" height=""9"" font=""17"">19</text>
<text top=""972"" left=""160"" width=""465"" height=""15"" font=""10""> SENASA National FMD Eradication Plan 2001-2002, (Exhibit USA-33), p. 4.  </text>
</p><p><text top=""1059"" left=""160"" width=""303"" height=""15"" font=""10""> United States' first written submission, para. 90. </text>
<footnote top=""1147"" left=""160"" width=""633"" height=""15"" font=""10"" number=""78"" ref="""" dis=""""/>
</p><p><text top=""1161"" left=""108"" width=""276"" height=""15"" font=""10"">(November 2002), (Exhibit USA-32), p. 16).  </text>
</p></page>
<page number=""228"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 228 - </text>
</p><p><text top=""135"" left=""157"" width=""693"" height=""15"" font=""33"">Date Event </text><text top=""157"" left=""255"" width=""535"" height=""15"" font=""33"">SENASA introduced a new president, who resigned after 10 days, thus leading </text><text top=""172"" left=""254"" width=""428"" height=""15"" font=""33"">to the reappointment of a former president to head the agency.</text><footnote top=""171"" left=""683"" width=""11"" height=""9"" font=""34"" number=""31"" ref="""" dis=""""><ftext top=""870"" left=""160"" width=""491"" height=""15"" font=""10""> ""Cane Returns to Lead SENASA"", La Naci&#243;n (30 March 2001), (Exhibit USA-49). </ftext>
</footnote></p><p><text top=""194"" left=""108"" width=""96"" height=""15"" font=""31"">12 March 2001 </text><text top=""194"" left=""254"" width=""536"" height=""15"" font=""31"">Argentina reported to the OIE and the US that they had detected an FMD outbreak in </text><text top=""209"" left=""254"" width=""536"" height=""15"" font=""31"">the Province of BUENOS AIRES. A few days later Argentina informed the OIE and the </text><text top=""223"" left=""254"" width=""269"" height=""15"" font=""31"">US of outbreaks in four additional provinces.</text><footnote top=""223"" left=""524"" width=""10"" height=""9"" font=""35"" number=""32"" ref="""" dis=""""><ftext top=""884"" left=""160"" width=""430"" height=""15"" font=""10""> 2001 Interim Rule on Argentina, (Exhibit ARG-29), pp. 29897-29898. </ftext>
</footnote></p><p><text top=""246"" left=""108"" width=""104"" height=""15"" font=""33"">12 March 2001 </text><text top=""246"" left=""254"" width=""506"" height=""15"" font=""33"">Argentina suspended its exports of fresh (chilled or frozen) beef to the US.</text><footnote top=""245"" left=""760"" width=""11"" height=""9"" font=""34"" number=""33"" ref="""" dis=""""/><text top=""268"" left=""254"" width=""302"" height=""15"" font=""33"">359 outbreaks of FMD reported in April 2001</text><footnote top=""268"" left=""556"" width=""11"" height=""9"" font=""34"" number=""34"" ref="""" dis=""""><ftext top=""914"" left=""160"" width=""614"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p.16. See also United States' </ftext>
<ftext top=""928"" left=""108"" width=""236"" height=""15"" font=""10"">first written submission, paras. 78-81. </ftext>
</footnote><text top=""291"" left=""108"" width=""20"" height=""15"" font=""33"">1 </text><text top=""291"" left=""121"" width=""43"" height=""15"" font=""33"">April </text><footnote top=""319"" left=""441"" width=""11"" height=""9"" font=""34"" number=""35"" ref="""" dis=""""><ftext top=""943"" left=""160"" width=""291"" height=""15"" font=""10""> SENASA Decreto 394/2001, (Exhibit USA-50).  </ftext>
</footnote></p><p><text top=""343"" left=""108"" width=""88"" height=""15"" font=""33"">6 April 2001 </text><text top=""343"" left=""254"" width=""536"" height=""15"" font=""33"">SENASA adopted Resolution 5/01, setting forth the National FMD Eradication </text><text top=""357"" left=""254"" width=""34"" height=""15"" font=""33"">Plan.</text><footnote top=""357"" left=""288"" width=""11"" height=""9"" font=""34"" number=""36"" ref="""" dis=""""><ftext top=""957"" left=""160"" width=""334"" height=""15"" font=""10""> Resoluci&#243;n SENASA 5/2001, (Exhibit ARG-4/USA-37). </ftext>
</footnote><text top=""380"" left=""108"" width=""33"" height=""15"" font=""33"">26 </text><text top=""380"" left=""129"" width=""48"" height=""15"" font=""33"">April </text><footnote top=""423"" left=""433"" width=""11"" height=""9"" font=""34"" number=""37"" ref="""" dis=""""><ftext top=""972"" left=""160"" width=""298"" height=""15"" font=""10""> Resoluci&#243;n SENASA 25/2001, (Exhibit ARG-92). </ftext>
</footnote></p><p><text top=""424"" left=""443"" width=""348"" height=""15"" font=""33"">  This supersedes Resolution 9/2001 adopted on </text><text top=""438"" left=""254"" width=""109"" height=""15"" font=""33"">28 March 2001. </text><text top=""461"" left=""108"" width=""91"" height=""15"" font=""33"">24 May 2001 </text><text top=""461"" left=""254"" width=""313"" height=""15"" font=""33"">SENASA implemented Resolution No 58/2001.</text><footnote top=""460"" left=""567"" width=""11"" height=""9"" font=""34"" number=""38"" ref="""" dis=""""><ftext top=""986"" left=""160"" width=""301"" height=""15"" font=""10""> Resoluci&#243;n SENASA 58/2001, (Exhibit USA-59).  </ftext>
</footnote></p><p><text top=""483"" left=""108"" width=""84"" height=""15"" font=""31"">30 May 2001 </text><text top=""483"" left=""254"" width=""536"" height=""15"" font=""31"">OIE removed Argentina from the list of countries free of FMD where vaccination is not </text><text top=""498"" left=""254"" width=""59"" height=""15"" font=""31"">practised.</text><footnote top=""497"" left=""314"" width=""10"" height=""9"" font=""35"" number=""39"" ref="""" dis=""""><ftext top=""1001"" left=""160"" width=""302"" height=""15"" font=""10""> OIE Resolution XVII of 2001, (Exhibit ARG-103). </ftext>
</footnote><footnote top=""520"" left=""551"" width=""27"" height=""9"" font=""34"" number=""40"" ref="""" dis=""""><ftext top=""1016"" left=""160"" width=""479"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 16.  </ftext>
</footnote></p><p><text top=""543"" left=""108"" width=""79"" height=""15"" font=""10"">4 June 2001 </text>
<text top=""543"" left=""254"" width=""536"" height=""15"" font=""10"">The United States published an interim rule on 4 June 2001, with retroactive effect as </text>
<text top=""557"" left=""254"" width=""536"" height=""15"" font=""10"">from February 19, 2001, which prohibited imports of fresh beef from Argentina, as an </text>
<text top=""572"" left=""254"" width=""267"" height=""15"" font=""10"">emergency measure following the outbreak.</text>
<footnote top=""571"" left=""521"" width=""10"" height=""9"" font=""17"" number=""42"" ref="""" dis=""""/>
<footnote top=""594"" left=""556"" width=""11"" height=""9"" font=""34"" number=""43"" ref="""" dis=""""><ftext top=""1074"" left=""160"" width=""475"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 16. </ftext>
</footnote><footnote top=""616"" left=""551"" width=""11"" height=""9"" font=""34"" number=""44"" ref="""" dis=""""><ftext top=""1089"" left=""160"" width=""475"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 16. </ftext>
</footnote><footnote top=""639"" left=""563"" width=""11"" height=""9"" font=""34"" number=""45"" ref="""" dis=""""><ftext top=""1103"" left=""160"" width=""475"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 16. </ftext>
</footnote><footnote top=""661"" left=""589"" width=""11"" height=""9"" font=""34"" number=""46"" ref="""" dis=""""><ftext top=""1118"" left=""160"" width=""475"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 16. </ftext>
</footnote><footnote top=""684"" left=""560"" width=""11"" height=""9"" font=""34"" number=""47"" ref="""" dis=""""><ftext top=""1132"" left=""160"" width=""475"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 16. </ftext>
</footnote><footnote top=""707"" left=""576"" width=""11"" height=""9"" font=""34"" number=""48"" ref="""" dis=""""><ftext top=""1147"" left=""160"" width=""475"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 16. </ftext>
</footnote></p><p><text top=""730"" left=""108"" width=""120"" height=""15"" font=""10"">11 December 2001 </text>
<text top=""730"" left=""254"" width=""537"" height=""15"" font=""10"">The interim rule of 4 June 2001 prohibiting import of fresh beef from Argentina was </text>
<text top=""744"" left=""254"" width=""538"" height=""15"" font=""10"">imposed as a final rule. Upon its publication in the Federal Register, the final rule </text>
<text top=""759"" left=""254"" width=""537"" height=""15"" font=""10"">terminated the authorization at 9 CFR 94.21 which had allowed access of fresh meat </text>
<text top=""773"" left=""254"" width=""95"" height=""15"" font=""10"">from Argentina.</text>
<footnote top=""773"" left=""350"" width=""10"" height=""9"" font=""17"" number=""49"" ref="""" dis=""""><ftext top=""1161"" left=""160"" width=""300"" height=""15"" font=""10""> 2001 Final Rule on Argentina, (Exhibit ARG-30). </ftext>
<ftext top=""943"" left=""108"" width=""58"" height=""15"" font=""10"">meeting. </ftext>
</footnote>
</p><p><text top=""899"" left=""160"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 107. </text>
</p><p><text top=""1030"" left=""151"" width=""10"" height=""9"" font=""17"">41</text>
</p><p><text top=""1045"" left=""108"" width=""232"" height=""15"" font=""10"">(November 2002), (Exhibit USA-32)). </text>
</p></page>
<page number=""229"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 229 - </text>
</p><p><text top=""135"" left=""157"" width=""693"" height=""15"" font=""33"">Date Event </text><text top=""157"" left=""108"" width=""110"" height=""15"" font=""33"">December 2001 </text><text top=""157"" left=""254"" width=""321"" height=""15"" font=""33"">2 outbreaks of FMD reported in December 2001</text><footnote top=""156"" left=""575"" width=""11"" height=""9"" font=""34"" number=""50"" ref="""" dis=""""><ftext top=""782"" left=""160"" width=""619"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 16. See also United States' </ftext>
<ftext top=""797"" left=""108"" width=""236"" height=""15"" font=""10"">first written submission, paras. 78-81. </ftext>
</footnote><text top=""180"" left=""108"" width=""33"" height=""15"" font=""33"">18 </text><text top=""180"" left=""129"" width=""69"" height=""15"" font=""33"">January </text><footnote top=""180"" left=""187"" width=""50"" height=""15"" font=""33"" number=""2002"" ref="""" dis=""""><ftext top=""276"" left=""254"" width=""535"" height=""15"" font=""10"">SENASA submitted a request for authorization of imports of Argentine fresh (chilled or </ftext>
<ftext top=""291"" left=""254"" width=""352"" height=""15"" font=""10"">frozen) beef into the United States, pursuant to 9 CFR 92.</ftext>
</footnote><text top=""180"" left=""255"" width=""227"" height=""15"" font=""33"">SENASA adopted Resolution </text><text top=""180"" left=""470"" width=""330"" height=""15"" font=""33"">112/02, which prohibited the entry of </text><text top=""194"" left=""254"" width=""470"" height=""15"" font=""33"">FMD-vaccinated animals into Patagonia North B and Patagonia South.</text><footnote top=""194"" left=""725"" width=""11"" height=""9"" font=""34"" number=""51"" ref="""" dis=""""><ftext top=""811"" left=""160"" width=""305"" height=""15"" font=""10""> Resoluci&#243;n SENASA 112/2002, (Exhibit ARG-94). </ftext>
</footnote><text top=""217"" left=""108"" width=""117"" height=""15"" font=""33"">23 January 2002 </text><text top=""217"" left=""254"" width=""412"" height=""15"" font=""33"">Argentina reported an outbreak in the Province of CORDOBA.</text><footnote top=""216"" left=""667"" width=""11"" height=""9"" font=""34"" number=""52"" ref="""" dis=""""><ftext top=""826"" left=""160"" width=""479"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32), p. 14.  </ftext>
</footnote><footnote top=""253"" left=""314"" width=""10"" height=""9"" font=""35"" number=""53"" ref="""" dis=""""/><footnote top=""290"" left=""606"" width=""10"" height=""9"" font=""17"" number=""54"" ref="""" dis=""""><ftext top=""855"" left=""160"" width=""439"" height=""15"" font=""10""> Information Provided by SENASA (November 2002), (Exhibit USA-32).  </ftext>
</footnote>
</p><p><text top=""313"" left=""108"" width=""113"" height=""15"" font=""10"">6 November 2002 </text>
<text top=""313"" left=""254"" width=""537"" height=""15"" font=""10"">APHIS sent a fax to SENASA proposing to arrange a meeting between SENASA and </text>
<text top=""328"" left=""254"" width=""202"" height=""15"" font=""10"">APHIS' area director in Colombia.</text>
<footnote top=""327"" left=""456"" width=""10"" height=""9"" font=""17"" number=""55"" ref="""" dis=""""><ftext top=""870"" left=""160"" width=""605"" height=""15"" font=""10""> Facsimile from Donald Wimmer (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""884"" left=""108"" width=""647"" height=""15"" font=""10"">Inspection Service (USDA, APHIS) Buenos Aires, Argentina Area Director) to Dr. Bernardo Cane (SENASA, </ftext>
<ftext top=""899"" left=""108"" width=""304"" height=""15"" font=""10"">President) (6 November 2002), (Exhibit USA-78). </ftext>
</footnote>
<text top=""351"" left=""108"" width=""120"" height=""15"" font=""10"">16 December 2002 </text>
<text top=""351"" left=""254"" width=""537"" height=""15"" font=""10"">Officials from the United States met with Argentina officials and requested technical </text>
<text top=""365"" left=""254"" width=""328"" height=""15"" font=""10"">documents to allow for the initiation of a risk analysis.</text>
<footnote top=""365"" left=""583"" width=""12"" height=""9"" font=""17"" number=""56"" ref="""" dis=""""><ftext top=""914"" left=""160"" width=""613"" height=""15"" font=""10""> SENASA's letter of 30 December 2002, (Exhibit USA-79). In the communication, Argentina confirms </ftext>
</footnote>
</p><p><text top=""388"" left=""108"" width=""683"" height=""15"" font=""33"">30 December 2002  SENASA passed Resolution 1051/2002, which repealed Resolution 112/2002 </text><text top=""402"" left=""254"" width=""537"" height=""15"" font=""33"">and modified the precautions for the preservation of the FMD-free status of </text><text top=""417"" left=""254"" width=""272"" height=""15"" font=""33"">Patagonia South and Patagonia North B.</text><footnote top=""416"" left=""526"" width=""11"" height=""9"" font=""34"" number=""57"" ref="""" dis=""""><ftext top=""957"" left=""160"" width=""312"" height=""15"" font=""10""> Resoluci&#243;n SENASA 1051/2002, (Exhibit USA-60). </ftext>
</footnote></p><p><text top=""439"" left=""108"" width=""86"" height=""15"" font=""10"">23 April 2003 </text>
<text top=""439"" left=""254"" width=""536"" height=""15"" font=""10"">Officials from the United States and Argentina animal health officials met to discuss a </text>
<text top=""454"" left=""254"" width=""99"" height=""15"" font=""10"">range of issues.</text>
<footnote top=""453"" left=""353"" width=""10"" height=""9"" font=""17"" number=""58"" ref="""" dis=""""><ftext top=""972"" left=""160"" width=""323"" height=""15"" font=""10""> APHIS' facsimile of 29 April 2003, (Exhibit USA-80). </ftext>
</footnote>
<text top=""454"" left=""363"" width=""428"" height=""15"" font=""10""> During the meeting, the countries confirmed that a technical team </text>
<footnote top=""469"" left=""254"" width=""426"" height=""15"" font=""10"" number=""2003"" ref="""" dis=""""><ftext top=""731"" left=""254"" width=""538"" height=""15"" font=""10"">information in connection with Argentina's request for imports of fresh (chilled or </ftext>
<ftext top=""746"" left=""254"" width=""78"" height=""15"" font=""10"">frozen) beef.</ftext>
</footnote>
<footnote top=""468"" left=""681"" width=""10"" height=""9"" font=""17"" number=""59"" ref="""" dis=""""><ftext top=""986"" left=""160"" width=""323"" height=""15"" font=""10""> APHIS' facsimile of 29 April 2003, (Exhibit USA-80). </ftext>
</footnote>
</p><p><text top=""491"" left=""108"" width=""48"" height=""15"" font=""31"">18-23 </text><text top=""491"" left=""148"" width=""37"" height=""15"" font=""31"">May </text><footnote top=""505"" left=""327"" width=""10"" height=""9"" font=""35"" number=""60"" ref="""" dis=""""><ftext top=""1001"" left=""160"" width=""603"" height=""15"" font=""10""> OIE World Assembly, Resolution XX, <i>Recognition of the Foot and Mouth Disease Status of Member </i></ftext>
<ftext top=""1016"" left=""108"" width=""436"" height=""15"" font=""12""><i>Countries</i>, 71st General Session (18-23 May 2003), (Exhibit ARG-100). </ftext>
</footnote></p><p><text top=""543"" left=""254"" width=""278"" height=""15"" font=""31"">FMD-free zone where vaccination is practised.</text><footnote top=""542"" left=""533"" width=""10"" height=""9"" font=""35"" number=""61"" ref="""" dis=""""/></p><p><text top=""565"" left=""108"" width=""100"" height=""15"" font=""10"">28 August 2003 </text>
<text top=""565"" left=""254"" width=""536"" height=""15"" font=""10"">SENASA submitted a formal request to APHIS requesting the recognition of Patagonia </text>
<text top=""580"" left=""254"" width=""145"" height=""15"" font=""10"">as a region free of FMD.</text>
<footnote top=""579"" left=""400"" width=""10"" height=""9"" font=""17"" number=""62"" ref="""" dis=""""><ftext top=""1059"" left=""160"" width=""396"" height=""15"" font=""10""> Information Provided by SENASA (July 2003), (Exhibit USA-98). </ftext>
</footnote>
</p><p><text top=""602"" left=""108"" width=""106"" height=""15"" font=""31"">28 August 2003  </text><text top=""602"" left=""254"" width=""536"" height=""15"" font=""31"">SENASA notified the OIE of the presence of animals with symptoms similar to FMD in </text><text top=""617"" left=""254"" width=""395"" height=""15"" font=""31"">the city of Tartagal, Department of San Martin, Province of Salta.</text><footnote top=""616"" left=""649"" width=""10"" height=""9"" font=""35"" number=""63"" ref="""" dis=""""/></p><p><text top=""640"" left=""108"" width=""115"" height=""15"" font=""33"">29 August 2003 </text><text top=""640"" left=""254"" width=""538"" height=""15"" font=""33"">Suspicion of an FMD outbreak in the city of Tartagal, Department of San </text><text top=""654"" left=""254"" width=""178"" height=""15"" font=""33"">Martin, Province of Salta.</text><footnote top=""654"" left=""432"" width=""11"" height=""9"" font=""34"" number=""64"" ref="""" dis=""""/><text top=""654"" left=""443"" width=""349"" height=""15"" font=""33"">  SENASA notified APHIS of the situation on the </text><text top=""669"" left=""254"" width=""68"" height=""15"" font=""33"">same day.</text><footnote top=""668"" left=""323"" width=""11"" height=""9"" font=""34"" number=""65"" ref="""" dis=""""><ftext top=""1118"" left=""160"" width=""335"" height=""15"" font=""10""> SENASA's letter of 29 August 2003, (Exhibit USA-83). </ftext>
</footnote><footnote top=""705"" left=""546"" width=""10"" height=""9"" font=""35"" number=""66"" ref="""" dis=""""/></p><p><text top=""728"" left=""108"" width=""131"" height=""15"" font=""33"">2 September 2003 </text><text top=""728"" left=""254"" width=""537"" height=""15"" font=""33"">Outbreak of Type ""O"" confirmed in the city of Tartagal, Department of San </text><text top=""743"" left=""254"" width=""535"" height=""15"" font=""33"">Martin, Province of Salta. A SENASA epidemiological report performed on pigs </text></p><p><text top=""841"" left=""160"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 133. </text>
<footnote top=""928"" left=""108"" width=""665"" height=""15"" font=""10"" number=""16"" ref="""" dis=""""><ftext top=""1045"" left=""108"" width=""258"" height=""15"" font=""10"">17 and 22 May 2003), (Exhibit ARG-119). </ftext>
</footnote>
</p><p><text top=""1074"" left=""160"" width=""293"" height=""15"" font=""10""> Argentina's first written submission, para. 112. </text>
<footnote top=""1103"" left=""108"" width=""111"" height=""15"" font=""10"" number=""81"" ref="""" dis=""""><ftext top=""1103"" left=""108"" width=""550"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS, Area Director) (30 July 2004), (Exhibit USA-87). </ftext>
</footnote>
</p></page>
<page number=""230"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 230 - </text>
</p><p><text top=""135"" left=""157"" width=""693"" height=""15"" font=""33"">Date Event </text><text top=""153"" left=""254"" width=""538"" height=""15"" font=""33"">in the establishment concerned revealed that 16 pigs were infected, 2 of </text><text top=""168"" left=""254"" width=""77"" height=""15"" font=""33"">which died.</text><footnote top=""167"" left=""332"" width=""11"" height=""9"" font=""34"" number=""67"" ref="""" dis=""""><ftext top=""826"" left=""160"" width=""381"" height=""15"" font=""10""> Argentina's facsimile of 5 September 2003, (Exhibit USA-51). </ftext>
</footnote><footnote top=""167"" left=""346"" width=""11"" height=""9"" font=""34"" number=""68"" ref="""" dis=""""><ftext top=""841"" left=""160"" width=""335"" height=""15"" font=""10""> SENASA's letter of 29 August 2003, (Exhibit USA-83). </ftext>
</footnote></p><p><text top=""205"" left=""254"" width=""384"" height=""15"" font=""10"">bordering Bolivia. However, the visit was cancelled by SENASA.</text>
<footnote top=""205"" left=""639"" width=""10"" height=""9"" font=""17"" number=""69"" ref="""" dis=""""><ftext top=""855"" left=""160"" width=""322"" height=""15"" font=""10""> APHIS' letter of 14 October 2003, (Exhibit USA-82). </ftext>
</footnote>
<text top=""228"" left=""108"" width=""98"" height=""15"" font=""10"">3 October 2003 </text>
<text top=""228"" left=""254"" width=""536"" height=""15"" font=""10"">APHIS' requested additional information from SENASA with respect to the outbreak in </text>
<text top=""242"" left=""254"" width=""535"" height=""15"" font=""10"">Salta and notified SENASA of the model APHIS would use to assess the risk of FMD and </text>
<text top=""257"" left=""254"" width=""464"" height=""15"" font=""10"">the ensuing requests for additional information to develop input parameters.</text>
<footnote top=""256"" left=""718"" width=""10"" height=""9"" font=""17"" number=""70"" ref="""" dis=""""><ftext top=""870"" left=""160"" width=""315"" height=""15"" font=""10""> APHIS' letter of 3 October 2003, (Exhibit USA-84). </ftext>
</footnote>
<text top=""279"" left=""108"" width=""98"" height=""15"" font=""10"">6 October 2003 </text>
<text top=""279"" left=""254"" width=""538"" height=""15"" font=""10"">An additional APHIS site visit was scheduled to occur on 6 October 2003, however, </text>
<text top=""294"" left=""254"" width=""273"" height=""15"" font=""10"">SENASA notified APHIS of the FMD outbreak.</text>
<footnote top=""293"" left=""527"" width=""10"" height=""9"" font=""17"" number=""71"" ref="""" dis=""""><ftext top=""884"" left=""160"" width=""335"" height=""15"" font=""10""> SENASA's letter of 29 August 2003, (Exhibit USA-83). </ftext>
</footnote>
<text top=""294"" left=""537"" width=""159"" height=""15"" font=""10""> APHIS cancelled the visit.</text>
<footnote top=""293"" left=""695"" width=""10"" height=""9"" font=""17"" number=""72"" ref="""" dis=""""><ftext top=""899"" left=""160"" width=""315"" height=""15"" font=""10""> APHIS' letter of 3 October 2003, (Exhibit USA-84). </ftext>
</footnote>
<text top=""317"" left=""108"" width=""106"" height=""15"" font=""10"">14 October 2003 </text>
<text top=""317"" left=""254"" width=""536"" height=""15"" font=""10"">APHIS reiterated its desire to conduct the site review because the visit was important </text>
<text top=""331"" left=""254"" width=""271"" height=""15"" font=""10"">to further its evaluation of FMD in Argentina.</text>
<footnote top=""330"" left=""526"" width=""10"" height=""9"" font=""17"" number=""73"" ref="""" dis=""""><ftext top=""914"" left=""160"" width=""322"" height=""15"" font=""10""> APHIS' letter of 14 October 2003, (Exhibit USA-82). </ftext>
</footnote>
<text top=""354"" left=""108"" width=""106"" height=""15"" font=""10"">30 October 2003 </text>
<text top=""354"" left=""254"" width=""467"" height=""15"" font=""10"">APHIS and SENASA arranged a bilateral meeting to convene in Buenos Aires.</text>
<footnote top=""353"" left=""721"" width=""12"" height=""9"" font=""17"" number=""74"" ref="""" dis=""""><ftext top=""928"" left=""160"" width=""624"" height=""15"" font=""10""> Facsimile from Thomas C. Schissel (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""943"" left=""108"" width=""603"" height=""15"" font=""10"">Inspection Service, USDA, APHIS, Assistant Area Director) to Jorge N. Amaya (SENASA, President) </ftext>
<ftext top=""957"" left=""108"" width=""236"" height=""15"" font=""10"">(23 October 2003), (Exhibit USA-85).  </ftext>
</footnote>
<text top=""376"" left=""108"" width=""113"" height=""15"" font=""10"">6 November 2003 </text>
<text top=""376"" left=""254"" width=""479"" height=""15"" font=""10"">APHIS contacted SENASA regarding a 1 December 2003 site visit to Patagonia.</text>
<footnote top=""376"" left=""734"" width=""10"" height=""9"" font=""17"" number=""75"" ref="""" dis=""""><ftext top=""972"" left=""160"" width=""350"" height=""15"" font=""10""> APHIS' facsimile of 6 November 2003, (Exhibit USA-99). </ftext>
</footnote>
<text top=""376"" left=""743"" width=""46"" height=""15"" font=""10""> APHIS </text>
<text top=""391"" left=""254"" width=""536"" height=""15"" font=""10"">also requested additional information from SENASA regarding the request for regional </text>
<text top=""405"" left=""254"" width=""228"" height=""15"" font=""10"">recognition of Patagonia as FMD-free.</text>
<footnote top=""405"" left=""482"" width=""10"" height=""9"" font=""17"" number=""76"" ref="""" dis=""""><ftext top=""986"" left=""160"" width=""337"" height=""15"" font=""10""> APHIS' letter of 6 November 2003, (Exhibit USA-100). </ftext>
</footnote>
<text top=""428"" left=""108"" width=""125"" height=""15"" font=""10"">1-5 December 2003 </text>
<text top=""428"" left=""254"" width=""536"" height=""15"" font=""10"">APHIS, together with the Canadian Food Inspection Agency, conducted a site visit to </text>
<text top=""442"" left=""254"" width=""536"" height=""15"" font=""10"">Patagonia South and the Patagonia buffer zone consisting of Patagonia North A and B </text>
<text top=""457"" left=""254"" width=""362"" height=""15"" font=""10"">to continue its assessment of the status of FMD in the area.</text>
<footnote top=""456"" left=""616"" width=""10"" height=""9"" font=""17"" number=""77"" ref="""" dis=""""><ftext top=""1001"" left=""160"" width=""311"" height=""15"" font=""10""> APHIS' letter of 2 March 2004, (Exhibit USA-102). </ftext>
</footnote>
<text top=""480"" left=""108"" width=""112"" height=""15"" font=""10"">18 February 2004 </text>
<text top=""480"" left=""254"" width=""537"" height=""15"" font=""10"">SENASA responded to APHIS&#8217; request for a second bilateral meeting to reconvene in </text>
<text top=""494"" left=""254"" width=""189"" height=""15"" font=""10"">Buenos Aires on 8 March 2004.</text>
<footnote top=""494"" left=""443"" width=""10"" height=""9"" font=""17"" number=""78"" ref="""" dis=""""><ftext top=""1016"" left=""160"" width=""619"" height=""15"" font=""10""> Facsimile from SENASA to Theresa Boyle (United States Department of Agriculture, Animal and Plant </ftext>
<ftext top=""1030"" left=""108"" width=""580"" height=""15"" font=""10"">Health Inspection Service, USDA, APHIS, Area Director) (18 February 2004), (Exhibit USA-86). </ftext>
</footnote>
<text top=""517"" left=""108"" width=""87"" height=""15"" font=""10"">2 March 2004 </text>
<text top=""517"" left=""254"" width=""523"" height=""15"" font=""10"">In a follow-up letter sent to SENASA after the APHIS site visit between 1-5 December </text>
<footnote top=""545"" left=""644"" width=""10"" height=""9"" font=""17"" number=""79"" ref="""" dis=""""><ftext top=""1045"" left=""160"" width=""311"" height=""15"" font=""10""> APHIS' letter of 2 March 2004, (Exhibit USA-102). </ftext>
</footnote>
</p><p><text top=""568"" left=""108"" width=""48"" height=""15"" font=""31"">23-28 </text><text top=""568"" left=""148"" width=""36"" height=""15"" font=""31"">May </text><footnote top=""568"" left=""177"" width=""42"" height=""15"" font=""31"" number=""2004"" ref="""" dis=""""/><text top=""568"" left=""254"" width=""543"" height=""15"" font=""31"">The OIE confirmed the recognition of Patagonia South as FMD-free without </text><text top=""583"" left=""254"" width=""72"" height=""15"" font=""31"">vaccination.</text><footnote top=""582"" left=""327"" width=""10"" height=""9"" font=""35"" number=""80"" ref="""" dis=""""><ftext top=""1059"" left=""160"" width=""603"" height=""15"" font=""10""> OIE World Assembly, Resolution XX, <i>Recognition of the Foot and Mouth Disease Status of Member </i></ftext>
<ftext top=""1074"" left=""108"" width=""440"" height=""15"" font=""12""><i>Countries</i>, 72nd General Session (23-28 May 2004), (Exhibit ARG-101). </ftext>
</footnote></p><p><text top=""606"" left=""108"" width=""82"" height=""15"" font=""10"">28 July 2004 </text>
<text top=""606"" left=""254"" width=""536"" height=""15"" font=""10"">SENASA and APHIS had an additional bilateral meeting in Buenos Aires, as agreed on </text>
<text top=""620"" left=""254"" width=""112"" height=""15"" font=""10"">18 February 2004.</text>
<footnote top=""657"" left=""440"" width=""10"" height=""9"" font=""35"" number=""82"" ref="""" dis=""""><ftext top=""1118"" left=""160"" width=""611"" height=""15"" font=""10""> Report of the Meeting of the OIE Ad Hoc Group for Evaluation of Country Status for Foot and Mouth </ftext>
<ftext top=""1132"" left=""108"" width=""268"" height=""15"" font=""10"">Disease (October 2004), (Exhibit USA-88).  </ftext>
</footnote></p><p><text top=""680"" left=""108"" width=""120"" height=""15"" font=""10"">16 November 2004 </text>
<text top=""680"" left=""254"" width=""485"" height=""15"" font=""10"">SENASA responded to the 2 March 2004 letter, providing additional information </text>
<text top=""694"" left=""254"" width=""318"" height=""15"" font=""10"">concerning Patagonia in response to APHIS' request.</text>
<footnote top=""694"" left=""573"" width=""10"" height=""9"" font=""17"" number=""83"" ref="""" dis=""""><ftext top=""1147"" left=""160"" width=""525"" height=""15"" font=""10""> Information on Patagonia Provided by SENASA (November 2004), (Exhibit USA-103). </ftext>
</footnote>
<footnote top=""745"" left=""332"" width=""10"" height=""9"" font=""17"" number=""84"" ref="""" dis=""""><ftext top=""1161"" left=""160"" width=""580"" height=""15"" font=""10""> Information on Northern Argentina provided by SENASA (November 2004), (Exhibit ARG-86).  </ftext>
</footnote>
</p><p><text top=""1089"" left=""160"" width=""619"" height=""15"" font=""10""> Facsimile from SENASA to Theresa Boyle (United States Department of Agriculture, Animal and Plant </text>
</p></page>
<page number=""231"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 231 - </text>
</p><p><text top=""135"" left=""157"" width=""693"" height=""15"" font=""33"">Date Event </text><footnote top=""157"" left=""108"" width=""87"" height=""15"" font=""31"" number=""2005"" ref="""" dis=""""><ftext top=""445"" left=""254"" width=""494"" height=""15"" font=""10"">APHIS concluded and produced the risk analysis evaluating Patagonia South as a </ftext>
<ftext top=""459"" left=""254"" width=""116"" height=""15"" font=""10"">region free of FMD.</ftext>
</footnote></p><p><text top=""157"" left=""254"" width=""536"" height=""15"" font=""31"">The OIE Ad HOC Group which had evaluated SENASA's request to retain the status of </text><text top=""172"" left=""254"" width=""535"" height=""15"" font=""31"">FMD-free with vaccination for Argentina recommended that Argentina be recognized as </text><text top=""186"" left=""254"" width=""161"" height=""15"" font=""31"">FMD-free with vaccination.</text><footnote top=""186"" left=""416"" width=""10"" height=""9"" font=""35"" number=""85"" ref="""" dis=""""><ftext top=""914"" left=""160"" width=""611"" height=""15"" font=""10""> Report of the Meeting of the OIE Ad Hoc Group for Evaluation of Country Status for Foot and Mouth </ftext>
<ftext top=""928"" left=""108"" width=""268"" height=""15"" font=""10"">Disease (October 2004), (Exhibit USA-88).  </ftext>
</footnote></p><p><text top=""209"" left=""108"" width=""95"" height=""15"" font=""10"">17 March 2005 </text>
<text top=""209"" left=""254"" width=""536"" height=""15"" font=""10"">APHIS sent a letter to SENASA recalling that, in an earlier communication, APHIS had </text>
<footnote top=""223"" left=""254"" width=""536"" height=""15"" font=""10"" number=""42"" ref="""" dis=""""><ftext top=""310"" left=""254"" width=""212"" height=""15"" font=""31"">FMD-free zones with vaccination.</ftext></footnote>
</p><p><text top=""238"" left=""254"" width=""535"" height=""15"" font=""10"">June 2005. APHIS proposed to prepone the visit to 30 May 2005, and specified that the </text>
<text top=""253"" left=""254"" width=""536"" height=""15"" font=""10"">purpose of the visit was to gather information for the purposes of a quantitative risk </text>
<text top=""267"" left=""254"" width=""538"" height=""15"" font=""10"">assessment in order to determine whether Argentina may resume imports of fresh </text>
<text top=""282"" left=""254"" width=""142"" height=""15"" font=""10"">(chilled or frozen) beef.</text>
<footnote top=""281"" left=""397"" width=""10"" height=""9"" font=""17"" number=""86"" ref="""" dis=""""><ftext top=""943"" left=""160"" width=""580"" height=""15"" font=""10""> Letter from John R. Clifford (United States Department of Agriculture, Animal and Plant Health </ftext>
<ftext top=""957"" left=""108"" width=""664"" height=""15"" font=""10"">Inspection Service, USDA, APHIS) to Dr. Jose Molina (SENASA, Minister) (17 March 2005), (Exhibit USA-90). </ftext>
</footnote>
<text top=""304"" left=""108"" width=""86"" height=""15"" font=""10"">21 April 2005 </text>
<text top=""304"" left=""254"" width=""541"" height=""15"" font=""10"">Prior to the scheduled visit to Northern Argentina, APHIS requested additional </text>
<text top=""319"" left=""254"" width=""535"" height=""15"" font=""10"">information from SENASA to assist in compiling data to be used in the quantitative and </text>
<footnote top=""333"" left=""703"" width=""10"" height=""9"" font=""17"" number=""87"" ref="""" dis=""""><ftext top=""972"" left=""160"" width=""303"" height=""15"" font=""10""> APHIS' letter of 21 April 2005, (Exhibit USA-91). </ftext>
</footnote>
</p><p><text top=""356"" left=""108"" width=""88"" height=""15"" font=""31"">24 May 2005  </text><text top=""356"" left=""254"" width=""536"" height=""15"" font=""31"">The OIE restored the FMD-free with vaccination status of Argentina's territory located </text><footnote top=""370"" left=""414"" width=""10"" height=""9"" font=""35"" number=""88"" ref="""" dis=""""><ftext top=""986"" left=""160"" width=""284"" height=""15"" font=""10""> OIE Resolution XX of 2005, (Exhibit ARG-95). </ftext>
</footnote><text top=""371"" left=""423"" width=""366"" height=""15"" font=""31""> By the same Resolution, the OIE confirmed the recognition </text><text top=""385"" left=""254"" width=""317"" height=""15"" font=""31"">of Patagonia South as FMD-free without vaccination.</text><footnote top=""384"" left=""572"" width=""10"" height=""9"" font=""35"" number=""89"" ref="""" dis=""""><ftext top=""1001"" left=""160"" width=""284"" height=""15"" font=""10""> OIE Resolution XX of 2005, (Exhibit ARG-95). </ftext>
</footnote></p><p><text top=""408"" left=""108"" width=""128"" height=""15"" font=""10"">30 May-3 June 2005 </text>
<footnote top=""422"" left=""303"" width=""10"" height=""9"" font=""17"" number=""90"" ref="""" dis=""""><ftext top=""1016"" left=""160"" width=""291"" height=""15"" font=""10""> APHIS' letter of 7 July 2005, (Exhibit USA-92). </ftext>
</footnote>
<footnote top=""459"" left=""371"" width=""10"" height=""9"" font=""17"" number=""91"" ref="""" dis=""""><ftext top=""1030"" left=""160"" width=""358"" height=""15"" font=""10""> 2005 Risk Analysis for Patagonia South, (Exhibit ARG-9).<b> </b> </ftext>
</footnote>
</p><p><text top=""482"" left=""108"" width=""74"" height=""15"" font=""10"">7 July 2005 </text>
<text top=""482"" left=""254"" width=""538"" height=""15"" font=""10"">APHIS sent a follow-up letter to SENASA summarizing comments and observations </text>
<text top=""496"" left=""254"" width=""537"" height=""15"" font=""10"">made by its veterinary services during the visit to the Argentina region north of the </text>
<footnote top=""510"" left=""337"" width=""10"" height=""9"" font=""17"" number=""92"" ref="""" dis=""""><ftext top=""1045"" left=""160"" width=""291"" height=""15"" font=""10""> APHIS' letter of 7 July 2005, (Exhibit USA-92). </ftext>
</footnote>
</p><p><text top=""534"" left=""108"" width=""93"" height=""15"" font=""10"">4 August 2005 </text>
<text top=""534"" left=""254"" width=""537"" height=""15"" font=""10"">APHIS requested additional information from SENASA in light of a strike by SENASA </text>
<text top=""548"" left=""254"" width=""63"" height=""15"" font=""10"">personnel.</text>
<footnote top=""548"" left=""318"" width=""10"" height=""9"" font=""17"" number=""93"" ref="""" dis=""""><ftext top=""1059"" left=""160"" width=""309"" height=""15"" font=""10""> APHIS' letter of 4 August 2005, (Exhibit USA-93). </ftext>
</footnote>
</p><p><text top=""571"" left=""108"" width=""410"" height=""15"" font=""33"">15 November 2005  SENASA introduced Resolution No 725.</text><footnote top=""571"" left=""520"" width=""215"" height=""15"" font=""33"" number=""94"" ref="""" dis=""""><ftext top=""1074"" left=""160"" width=""304"" height=""15"" font=""10""> Resoluci&#243;n SENASA 725/2005, (Exhibit USA-61). </ftext>
</footnote><text top=""585"" left=""254"" width=""483"" height=""15"" font=""33"">equivalence requirements between the regions, Patagonia North B and </text><text top=""600"" left=""254"" width=""372"" height=""15"" font=""33"">Patagonia South by imposing traceability requirements</text><footnote top=""599"" left=""627"" width=""13"" height=""9"" font=""34"" number=""95"" ref="""" dis=""""/><text top=""600"" left=""640"" width=""136"" height=""15"" font=""33""> Resolution No. 725 </text><text top=""614"" left=""254"" width=""512"" height=""15"" font=""33"">maintained the general ban on transport to Patagonia South and Patagonia </text><text top=""629"" left=""254"" width=""509"" height=""15"" font=""33"">North B of animals susceptible to FMD; in addition, the resolution specified </text><text top=""644"" left=""254"" width=""477"" height=""15"" font=""33"">traceability requirements for animals traveling through the two zones.</text><footnote top=""643"" left=""731"" width=""11"" height=""9"" font=""34"" number=""96"" ref="""" dis=""""/></p><p><text top=""666"" left=""108"" width=""120"" height=""15"" font=""10"">30 November 2005 </text>
<text top=""666"" left=""254"" width=""537"" height=""15"" font=""10"">The Argentine Ambassador in a letter to the Secretary for Agriculture in the United </text>
<text top=""681"" left=""254"" width=""536"" height=""15"" font=""10"">States requested the USDA to expedite the administrative procedures to allow access </text>
<text top=""695"" left=""254"" width=""349"" height=""15"" font=""10"">of fresh beef from Argentina to the United States market.</text>
<footnote top=""695"" left=""603"" width=""10"" height=""9"" font=""17"" number=""97"" ref="""" dis=""""><ftext top=""1118"" left=""160"" width=""603"" height=""15"" font=""10""> Letter from Hon. Jos&#233; O. Bord&#243;n, Ambassador of Argentina to Hon. Mike Johanns, US Secretary of </ftext>
<ftext top=""1132"" left=""108"" width=""317"" height=""15"" font=""10"">Agriculture (30 November 2005), (Exhibit ARG-37). </ftext>
</footnote>
</p><p><text top=""718"" left=""108"" width=""123"" height=""15"" font=""33"">5 December 2005 </text><text top=""718"" left=""254"" width=""512"" height=""15"" font=""33"">SENASA sent a letter to APHIS reporting about SENASA strikes, and stating </text><text top=""732"" left=""254"" width=""349"" height=""15"" font=""33"">that such strikes did not affect emergency services.</text><footnote top=""732"" left=""603"" width=""11"" height=""9"" font=""34"" number=""98"" ref="""" dis=""""><ftext top=""1147"" left=""160"" width=""347"" height=""15"" font=""10""> SENASA's letter of 5 December 2005, (Exhibit ARG-96). </ftext>
</footnote><text top=""755"" left=""108"" width=""115"" height=""15"" font=""33"">5 February 2006 </text><text top=""755"" left=""254"" width=""518"" height=""15"" font=""33"">Two outbreaks of ""type O"" FMD occurred in San Luis del Palmar, Province of </text><text top=""770"" left=""254"" width=""92"" height=""15"" font=""33"">CORRIENTES.</text><footnote top=""769"" left=""346"" width=""11"" height=""9"" font=""34"" number=""99"" ref="""" dis=""""><ftext top=""1161"" left=""160"" width=""609"" height=""15"" font=""10""> FMD Impact Worksheet, (Exhibit USA-54). See also OIE Disease Information, Vol. 19, No. 6, p. 96. </ftext>
</footnote><footnote top=""1089"" left=""160"" width=""310"" height=""15"" font=""10"" number=""101"" ref="""" dis=""""/>
</p></page>
<page number=""232"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
	<fontspec id=""36"" size=""7"" family=""Times"" color=""#000000"" style=""b""/><fontspec id=""25"" size=""7"" family=""Times"" color=""#000000""/>
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 232 - </text>
</p><p><text top=""135"" left=""157"" width=""693"" height=""15"" font=""33"">Date Event </text><text top=""157"" left=""108"" width=""115"" height=""15"" font=""33"">8 February 2006 </text><text top=""157"" left=""254"" width=""517"" height=""15"" font=""33"">The president of SENASA notified the FMD outbreaks in San Luis del Palmar, </text><text top=""173"" left=""254"" width=""245"" height=""15"" font=""33"">Province of CORRIENTES to the OIE.</text><footnote top=""170"" left=""499"" width=""19"" height=""11"" font=""36"" number=""100"" ref="""" dis=""""><ftext top=""899"" left=""165"" width=""493"" height=""15"" font=""10""> OIE, Final Report, 74th General Session (2006), (Exhibit USA-55), pp. 45, 144.  </ftext>
</footnote><text top=""192"" left=""254"" width=""492"" height=""15"" font=""33"">SENASA enacted Resolution 35/2006 establishing a sanitary alert which </text><text top=""206"" left=""254"" width=""518"" height=""15"" font=""33"">covered a zone comprising the affected department i.e. San Luis del Palmar, </text><text top=""221"" left=""254"" width=""533"" height=""15"" font=""33"">and the seven neighbouring departments i.e.: Capital; San Cosme; Itat&#237;; Ber&#243;n </text><text top=""235"" left=""254"" width=""364"" height=""15"" font=""33"">de Astrada; General Paz; Mburucuya; and Empedrado.</text></p><p><text top=""258"" left=""108"" width=""112"" height=""15"" font=""10"">10 February 2006 </text>
<text top=""258"" left=""254"" width=""546"" height=""15"" font=""10"">APHIS requested information regarding the outbreak in the Province of </text>
<text top=""273"" left=""254"" width=""84"" height=""15"" font=""10"">CORRIENTES.</text>
<footnote top=""272"" left=""338"" width=""14"" height=""9"" font=""17"" number=""102"" ref="""" dis=""""><ftext top=""928"" left=""165"" width=""329"" height=""15"" font=""10""> APHIS' letter of 10 February 2006, (Exhibit ARG-38). </ftext>
</footnote>
</p><p><text top=""295"" left=""108"" width=""67"" height=""15"" font=""31"">May 2006 </text><footnote top=""309"" left=""467"" width=""14"" height=""9"" font=""35"" number=""103"" ref="""" dis=""""><ftext top=""943"" left=""165"" width=""489"" height=""15"" font=""10""> OIE, Final Report, 74th General Session (2006), (Exhibit USA-55), pp. 45, 144.<b> </b></ftext>
</footnote><text top=""310"" left=""481"" width=""312"" height=""15"" font=""31"">  The OIE, however, maintained the FMD-free </text><text top=""324"" left=""254"" width=""281"" height=""15"" font=""31"">without vaccination status of Patagonia South.</text><footnote top=""324"" left=""536"" width=""14"" height=""9"" font=""35"" number=""104"" ref="""" dis=""""><ftext top=""957"" left=""165"" width=""616"" height=""15"" font=""10""> OIE World Assembly, Resolution XXVI, <i>Recognition of the Foot and Mouth Disease Status of Member </i></ftext>
<ftext top=""972"" left=""108"" width=""437"" height=""15"" font=""12""><i>Countries</i>, 74th General Session (21-26 May 2006), (Exhibit ARG-102). </ftext>
</footnote></p><p><text top=""347"" left=""108"" width=""86"" height=""15"" font=""10"">27 June 2006 </text>
<text top=""347"" left=""254"" width=""537"" height=""15"" font=""10"">APHIS contacted SENASA in connection with Argentina's request for authorization of </text>
<text top=""361"" left=""254"" width=""537"" height=""15"" font=""10"">imports of fresh (chilled or frozen) beef. APHIS informed SENASA that, in order to </text>
<text top=""376"" left=""254"" width=""538"" height=""15"" font=""10"">conclude its risk analysis, APHIS considered it necessary to arrange a visit to the </text>
<text top=""391"" left=""254"" width=""536"" height=""15"" font=""10"">Province of CORRIENTES to evaluate the area affected by the FMD outbreaks. APHIS </text>
<text top=""405"" left=""254"" width=""241"" height=""15"" font=""10"">proposed to conduct the visit in August.</text>
<footnote top=""404"" left=""496"" width=""14"" height=""9"" font=""17"" number=""105"" ref="""" dis=""""><ftext top=""986"" left=""165"" width=""303"" height=""15"" font=""10""> APHIS' letter of 27 June 2006, (Exhibit USA-94). </ftext>
</footnote>
<text top=""428"" left=""108"" width=""82"" height=""15"" font=""10"">26 July 2006 </text>
<text top=""428"" left=""254"" width=""535"" height=""15"" font=""10"">In response to APHIS' request for information of 10 February 2006, SENASA submitted </text>
<text top=""442"" left=""254"" width=""538"" height=""15"" font=""10"">a report to APHIS detailing the actions taken by SENASA in response to the FMD </text>
<text top=""457"" left=""254"" width=""539"" height=""15"" font=""10"">outbreaks in the Province of CORRIENTES and to ensure the preservation of the </text>
<text top=""471"" left=""254"" width=""341"" height=""15"" font=""10"">FMD-free without vaccination status of Patagonia South.</text>
<footnote top=""471"" left=""595"" width=""14"" height=""9"" font=""17"" number=""106"" ref="""" dis=""""><ftext top=""1001"" left=""165"" width=""317"" height=""15"" font=""10""> SENASA's letter of 26 July 2006, (Exhibit ARG-97). </ftext>
</footnote>
<text top=""494"" left=""108"" width=""629"" height=""15"" font=""10"">6-8 September 2006   APHIS visited the areas affected by the FMD outbreaks and performed an audit.</text>
<footnote top=""493"" left=""737"" width=""14"" height=""9"" font=""17"" number=""107"" ref="""" dis=""""><ftext top=""1016"" left=""165"" width=""442"" height=""15"" font=""10""> SENASA's letter of 19 July 2010, Note No. 150/2010, (Exhibit ARG-46). </ftext>
</footnote>
<text top=""517"" left=""108"" width=""98"" height=""15"" font=""10"">5 January 2007 </text>
<text top=""517"" left=""254"" width=""536"" height=""15"" font=""10"">APHIS published a proposed rule in the Federal Register to change the disease status </text>
<text top=""531"" left=""254"" width=""197"" height=""15"" font=""10"">of Patagonia South to FMD-free.</text>
<footnote top=""530"" left=""452"" width=""14"" height=""9"" font=""17"" number=""108"" ref="""" dis=""""><ftext top=""1030"" left=""165"" width=""426"" height=""15"" font=""10""> 2007 Proposed Rule on Patagonia South, (Exhibit ARG-56/USA-104). </ftext>
</footnote>
<text top=""531"" left=""466"" width=""324"" height=""15"" font=""10"">  During the ensuing 60-day period, APHIS received </text>
<text top=""546"" left=""254"" width=""348"" height=""15"" font=""10"">comments on the proposed rule from interested parties.  </text>
<footnote top=""568"" left=""108"" width=""45"" height=""15"" font=""33"" number=""2007"" ref="""" dis=""""/></p><p><text top=""568"" left=""254"" width=""542"" height=""15"" font=""33"">SENASA redefined its regional units by issuing Resolutions 225/2006, </text><text top=""583"" left=""254"" width=""538"" height=""15"" font=""33"">335/2007, and 362/2007, and created a Regional Operative Unit (Unidad </text><text top=""597"" left=""254"" width=""536"" height=""15"" font=""33"">Regional Operative) (ROU) within the Central Unit (Vice-presidential Unit) to </text><text top=""612"" left=""254"" width=""390"" height=""15"" font=""33"">coordinate activities of the 14 Regional Operative Offices.</text><footnote top=""611"" left=""644"" width=""16"" height=""9"" font=""34"" number=""109"" ref="""" dis=""""><ftext top=""1045"" left=""165"" width=""369"" height=""15"" font=""10""> 2014 Risk Analysis for Patagonia, (Exhibit USA-133), p. 14. </ftext>
</footnote></p><p><text top=""635"" left=""108"" width=""112"" height=""15"" font=""31"">22 February 2007 </text><text top=""635"" left=""254"" width=""535"" height=""15"" font=""31"">On 22 February 2007, after completing its evaluation, the OIE Ad Hoc Group submitted </text><text top=""649"" left=""254"" width=""538"" height=""15"" font=""31"">its recommendations to the Scientific Commission concerning the reinstatement of </text><text top=""664"" left=""254"" width=""538"" height=""15"" font=""31"">Argentina's disease-free with vaccination status and the enlargement of Argentina's </text><text top=""678"" left=""254"" width=""212"" height=""15"" font=""31"">FMD-free without vaccination area.</text><footnote top=""678"" left=""466"" width=""14"" height=""9"" font=""35"" number=""110"" ref="""" dis=""""/><text top=""701"" left=""108"" width=""85"" height=""15"" font=""31"">22 May 2007 </text><text top=""701"" left=""254"" width=""538"" height=""15"" font=""31"">The OIE reinstated the FMD-free with vaccination status of Northern Argentina and </text><text top=""715"" left=""254"" width=""537"" height=""15"" font=""31"">extended the zone recognized as FMD-free without vaccination to include Patagonia </text><text top=""730"" left=""254"" width=""50"" height=""15"" font=""31"">North B.</text><footnote top=""729"" left=""305"" width=""14"" height=""9"" font=""35"" number=""111"" ref="""" dis=""""><ftext top=""1089"" left=""165"" width=""592"" height=""15"" font=""10""> OIE Resolution XXI of 2007, (Exhibit ARG-10); OIE World Assembly, 75th General Session, Final </ftext>
<ftext top=""1103"" left=""108"" width=""236"" height=""15"" font=""10"">Report (20-25 May 2007), (USA-105). </ftext>
</footnote></p><p><text top=""752"" left=""108"" width=""106"" height=""15"" font=""10"">22 January 2008 </text>
<text top=""752"" left=""254"" width=""536"" height=""15"" font=""10"">The United States Cattlemen's Association, the National Farmers Union, and American </text>
<text top=""767"" left=""254"" width=""537"" height=""15"" font=""10"">Agri-Women sent a letter to the House Committee on Agriculture with regard to the </text>
<footnote top=""796"" left=""528"" width=""14"" height=""9"" font=""17"" number=""112"" ref="""" dis=""""><ftext top=""1118"" left=""165"" width=""618"" height=""15"" font=""10""> Letter dated 22 January 2008 from various legislators of the Agriculture Commission of the House of </ftext>
<ftext top=""1132"" left=""108"" width=""633"" height=""15"" font=""10"">Representatives, requesting a hearing review into the proposed rule of the United States Department of </ftext>
<ftext top=""1147"" left=""108"" width=""596"" height=""15"" font=""10"">Agriculture to recognize Patagonia as a region free of foot-and-mouth disease (22 January 2008), </ftext>
</footnote>
</p><p><text top=""914"" left=""165"" width=""580"" height=""15"" font=""10""> Argentina's first written submission, para. 117; Resoluci&#243;n SENASA 35/2006, (Exhibit ARG-5).<b> </b></text>
</p><p><text top=""1074"" left=""108"" width=""111"" height=""15"" font=""10"">(Exhibit USA-57). </text>
</p><p><text top=""1161"" left=""108"" width=""111"" height=""15"" font=""10"">(Exhibit ARG-39). </text>
</p></page>
<page number=""233"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 233 - </text>
</p><p><text top=""135"" left=""157"" width=""693"" height=""15"" font=""33"">Date Event </text></p><p><text top=""157"" left=""108"" width=""87"" height=""15"" font=""10"">7 March 2008 </text>
<text top=""157"" left=""254"" width=""539"" height=""15"" font=""10"">The Embassy of Argentina in Washington sent a letter to US Senator Jon Tester </text>
<text top=""172"" left=""254"" width=""536"" height=""15"" font=""10"">expressing the view that the Proposed Rule recognizing Patagonia South as FMD-free </text>
<text top=""186"" left=""254"" width=""536"" height=""15"" font=""10"">should be finalized so that commercial relations between the region of Argentina and </text>
<text top=""201"" left=""254"" width=""235"" height=""15"" font=""10"">the United States could be normalized.</text>
<footnote top=""200"" left=""490"" width=""14"" height=""9"" font=""17"" number=""113"" ref="""" dis=""""><ftext top=""899"" left=""165"" width=""587"" height=""15"" font=""10""> Letter from Minister Jos&#233; P&#233;rez Gabilondo to Senator Tester in response to his concern over the </ftext>
<ftext top=""914"" left=""108"" width=""398"" height=""15"" font=""10"">access of beef from Argentina (7 March 2008), (Exhibit ARG-41). </ftext>
</footnote>
</p><p><text top=""223"" left=""108"" width=""35"" height=""15"" font=""33"">11 </text><text top=""223"" left=""129"" width=""59"" height=""15"" font=""33"">March </text><text top=""223"" left=""174"" width=""52"" height=""15"" font=""33"">2008 </text><text top=""223"" left=""254"" width=""251"" height=""15"" font=""33"">SENASA introduced Resolution </text><text top=""223"" left=""492"" width=""310"" height=""15"" font=""33"">148/2008 to authorize transport of </text><text top=""238"" left=""254"" width=""536"" height=""15"" font=""33"">FMD-susceptible animals into Patagonia South from Patagonia North B under </text><text top=""253"" left=""254"" width=""542"" height=""15"" font=""33"">additional traceability requirements, in connection with EU regulations </text><text top=""267"" left=""254"" width=""539"" height=""15"" font=""33"">recognizing Patagonia South, but not yet Patagonia North B, as FMD-free </text><text top=""282"" left=""254"" width=""137"" height=""15"" font=""33"">without vaccination.</text><footnote top=""281"" left=""392"" width=""16"" height=""9"" font=""34"" number=""114"" ref="""" dis=""""><ftext top=""928"" left=""165"" width=""304"" height=""15"" font=""10""> Resoluci&#243;n SENASA 148/2008, (Exhibit USA-62). </ftext>
</footnote></p><p><text top=""304"" left=""108"" width=""95"" height=""15"" font=""10"">14 March 2008 </text>
<text top=""304"" left=""254"" width=""539"" height=""15"" font=""10"">Several US Senators urged the Administration not to adopt the final rule for the </text>
<text top=""319"" left=""254"" width=""537"" height=""15"" font=""10"">recognition of Patagonia South as FMD-free until the rule has been reviewed by the </text>
<text top=""333"" left=""254"" width=""210"" height=""15"" font=""10"">Office of Management and Budget.</text>
<footnote top=""333"" left=""465"" width=""14"" height=""9"" font=""17"" number=""115"" ref="""" dis=""""><ftext top=""943"" left=""165"" width=""606"" height=""15"" font=""10""> Letter from Senator Baucus et al. to Edward Schafer, Secretary, US Department of Agriculture and </ftext>
<ftext top=""957"" left=""108"" width=""649"" height=""15"" font=""10"">Jim Nussle, Director, Office of Management and Budget regarding proposed USDA rule on Patagonia South </ftext>
<ftext top=""972"" left=""108"" width=""221"" height=""15"" font=""10"">(14 March 2008), (Exhibit ARG-40). </ftext>
</footnote>
<text top=""356"" left=""108"" width=""95"" height=""15"" font=""10"">20 March 2008 </text>
<text top=""356"" left=""254"" width=""539"" height=""15"" font=""10"">The Embassy of Argentina in Washington sent letter to US Senator Max Baucus </text>
<text top=""371"" left=""254"" width=""536"" height=""15"" font=""10"">expressing the view that the Proposed Rule recognizing Patagonia South as FMD-free </text>
<text top=""385"" left=""254"" width=""537"" height=""15"" font=""10"">should be finalized so that the commercial relations between the region of Argentina </text>
<text top=""400"" left=""254"" width=""262"" height=""15"" font=""10"">and the United States could be normalized.</text>
<footnote top=""399"" left=""516"" width=""14"" height=""9"" font=""17"" number=""116"" ref="""" dis=""""><ftext top=""986"" left=""165"" width=""621"" height=""15"" font=""10""> Letter from Ambassador H&#233;ctor Timerman to Senator Baucus in response to his 14 March 2008 letter </ftext>
<ftext top=""1001"" left=""108"" width=""221"" height=""15"" font=""10"">(20 March 2008), (Exhibit ARG-42). </ftext>
</footnote>
<text top=""422"" left=""108"" width=""82"" height=""15"" font=""10"">21 July 2008 </text>
<text top=""422"" left=""254"" width=""535"" height=""15"" font=""10"">Argentina submitted communication G/SPS/GEN/868 to the SPS Committee concerning </text>
<text top=""437"" left=""254"" width=""105"" height=""15"" font=""10"">its FMD situation.</text>
<footnote top=""436"" left=""360"" width=""14"" height=""9"" font=""17"" number=""117"" ref="""" dis=""""><ftext top=""1016"" left=""165"" width=""605"" height=""15"" font=""10""> Communication by Argentina to the Committee on Sanitary and Phytosanitary Measures: <i>Foot And </i></ftext>
<ftext top=""1030"" left=""108"" width=""465"" height=""15"" font=""12""><i>Mouth Disease Situation</i>, G/SPS/GEN/868 (21 July 2008), (Exhibit ARG-98). </ftext>
</footnote>
<text top=""459"" left=""108"" width=""106"" height=""15"" font=""10"">15 October 2008 </text>
<text top=""459"" left=""254"" width=""537"" height=""15"" font=""10"">APHIS contacted SENASA with a view to fixing the agenda for a site visit by APHIS, </text>
<text top=""474"" left=""254"" width=""536"" height=""15"" font=""10"">aimed at updating the assessment of the risk for Patagonia South in order to respond </text>
</p><p><text top=""503"" left=""254"" width=""40"" height=""15"" font=""10"">South.</text>
<footnote top=""502"" left=""294"" width=""14"" height=""9"" font=""17"" number=""118"" ref="""" dis=""""><ftext top=""1045"" left=""165"" width=""330"" height=""15"" font=""10""> APHIS' letter of 15 October 2008, (Exhibit USA-106). </ftext>
</footnote>
<text top=""526"" left=""108"" width=""106"" height=""15"" font=""10"">22 October 2008 </text>
<text top=""526"" left=""254"" width=""539"" height=""15"" font=""10"">SENASA sent a letter to APHIS expressing displeasure with the duration of FMD </text>
<text top=""540"" left=""254"" width=""535"" height=""15"" font=""10"">assessment process and noting that, because the situation in Patagonia South had not </text>
<text top=""555"" left=""254"" width=""535"" height=""15"" font=""10"">changed, SENASA did not consider that there were sufficient grounds to accept APHIS' </text>
<text top=""569"" left=""254"" width=""307"" height=""15"" font=""10"">proposed visit schedule for 15-18 December 2008.</text>
<footnote top=""569"" left=""561"" width=""14"" height=""9"" font=""17"" number=""119"" ref="""" dis=""""><ftext top=""1059"" left=""165"" width=""369"" height=""15"" font=""10""> SENASA's facsimile of 22 October 2008, (Exhibit USA-107). </ftext>
</footnote>
<text top=""592"" left=""108"" width=""120"" height=""15"" font=""10"">11 November 2008 </text>
<text top=""592"" left=""254"" width=""469"" height=""15"" font=""10"">SENASA sent a letter to APHIS reiterating its statements of 22 October 2008.</text>
<footnote top=""591"" left=""723"" width=""14"" height=""9"" font=""17"" number=""120"" ref="""" dis=""""><ftext top=""1074"" left=""165"" width=""387"" height=""15"" font=""10""> SENASA's facsimile of 11 November 2008, (Exhibit USA-108).  </ftext>
</footnote>
</p><p><text top=""614"" left=""108"" width=""686"" height=""15"" font=""33"">16 December 2008  SENASA introduced Resolution 1282/2008 as a consequence of the EU's </text><text top=""629"" left=""254"" width=""541"" height=""15"" font=""33"">recognition of Patagonia North B as FMD-free without vaccination. The </text><text top=""644"" left=""254"" width=""536"" height=""15"" font=""33"">resolution relaxed the movement of FMD-susceptible animals from Patagonia </text><text top=""658"" left=""254"" width=""541"" height=""15"" font=""33"">North B into Patagonia South for any purpose subject to strengthened </text><text top=""673"" left=""254"" width=""531"" height=""15"" font=""33"">measures on transport and traceability. The resolution did not modify the pre-</text><text top=""687"" left=""254"" width=""535"" height=""15"" font=""33"">existing requirements for entry of FMD-susceptible animals into the Patagonia </text><text top=""702"" left=""254"" width=""384"" height=""15"" font=""33"">region as a whole from FMD-free zones with vaccination.</text><footnote top=""701"" left=""638"" width=""16"" height=""9"" font=""34"" number=""121"" ref="""" dis=""""><ftext top=""1089"" left=""165"" width=""320"" height=""15"" font=""10""> Resoluci&#243;n SENASA 1282/2008, (Exhibit USA-109). </ftext>
</footnote></p><p><text top=""725"" left=""108"" width=""120"" height=""15"" font=""10"">17 December 2008 </text>
<footnote top=""725"" left=""254"" width=""516"" height=""15"" font=""10"" number=""2009"" ref="""" dis=""""/>
<footnote top=""724"" left=""771"" width=""14"" height=""9"" font=""17"" number=""122"" ref="""" dis=""""><ftext top=""1103"" left=""165"" width=""414"" height=""15"" font=""10""> SENASA's letter of 17 December 2008, (Exhibit ARG-59/USA-111). </ftext>
</footnote>
<text top=""739"" left=""254"" width=""539"" height=""15"" font=""10"">In granting the site visit request, SENASA also requested that APHIS extend the </text>
<text top=""754"" left=""254"" width=""536"" height=""15"" font=""10"">mission to cover Patagonia North B because the zone was recognized by the OIE as a </text>
<text top=""768"" left=""254"" width=""346"" height=""15"" font=""10"">region free of FMD where vaccination is not practiced.</text>
<footnote top=""768"" left=""601"" width=""14"" height=""9"" font=""17"" number=""123"" ref="""" dis=""""><ftext top=""1118"" left=""165"" width=""550"" height=""15"" font=""10""> SENASA's letter of 17 December 2008, (Exhibit ARG-59/USA-111); SENASA's letter of 30 </ftext>
<ftext top=""1132"" left=""108"" width=""261"" height=""15"" font=""10"">January 2009, (Exhibit ARG-60/USA-112). </ftext>
</footnote>
<text top=""768"" left=""615"" width=""177"" height=""15"" font=""10""> For this purpose, SENASA </text>
<text top=""783"" left=""254"" width=""539"" height=""15"" font=""10"">updated the information concerning Patagonia with APHIS, including the data on </text>
<text top=""797"" left=""254"" width=""535"" height=""15"" font=""10"">Patagonia North B that had led to the international recognition of the zone as FMD-free </text>
<text top=""812"" left=""254"" width=""121"" height=""15"" font=""10"">without vaccination.</text>
<footnote top=""811"" left=""376"" width=""14"" height=""9"" font=""17"" number=""124"" ref="""" dis=""""><ftext top=""1147"" left=""165"" width=""550"" height=""15"" font=""10""> SENASA's letter of 17 December 2008, (Exhibit ARG-59/USA-111); SENASA's letter of 30 </ftext>
<ftext top=""1161"" left=""108"" width=""261"" height=""15"" font=""10"">January 2009, (Exhibit ARG-60/USA-112). </ftext>
<ftext top=""816"" left=""108"" width=""106"" height=""15"" font=""10"">28 January 2013 </ftext>
<ftext top=""816"" left=""255"" width=""392"" height=""15"" font=""10"">The DSB established the Panel with standard terms of reference.</ftext>
</footnote>
</p></page>
<page number=""234"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 234 - </text>
</p><p><text top=""135"" left=""157"" width=""693"" height=""15"" font=""33"">Date Event </text></p><p><text top=""157"" left=""108"" width=""655"" height=""15"" font=""10"">23-26 February 2009  APHIS conducted a site visit to Patagonia, including Patagonia South and Patagonia </text>
<text top=""172"" left=""254"" width=""50"" height=""15"" font=""10"">North B.</text>
<footnote top=""171"" left=""305"" width=""17"" height=""9"" font=""17"" number=""125"" ref="""" dis=""""><ftext top=""943"" left=""165"" width=""352"" height=""15"" font=""10""> SENASA's letter of 30 January 2009, (Exhibit USA-112).  </ftext>
</footnote>
<text top=""194"" left=""108"" width=""112"" height=""15"" font=""10"">26 February 2009 </text>
<footnote top=""194"" left=""639"" width=""14"" height=""9"" font=""17"" number=""126"" ref="""" dis=""""><ftext top=""957"" left=""165"" width=""552"" height=""15"" font=""10""> H.R. Res. 1226, 111th Cong. (2009); S. Res. 337, 111th Cong (2009), (Exhibit ARG-44). <b> </b></ftext>
</footnote>
<text top=""217"" left=""108"" width=""86"" height=""15"" font=""10"">27 April 2009 </text>
<text top=""217"" left=""254"" width=""539"" height=""15"" font=""10"">APHIS sent SENASA a letter stating that no additional information was currently </text>
<text top=""231"" left=""254"" width=""270"" height=""15"" font=""10"">required to proceed with APHIS' rulemaking.</text>
<footnote top=""231"" left=""524"" width=""14"" height=""9"" font=""17"" number=""127"" ref="""" dis=""""><ftext top=""972"" left=""165"" width=""303"" height=""15"" font=""10""> APHIS' letter of 27 April 2009, (Exhibit ARG-79). </ftext>
</footnote>
<text top=""254"" left=""108"" width=""125"" height=""15"" font=""10"">30 September 2009 </text>
<text top=""276"" left=""108"" width=""82"" height=""15"" font=""10"">19 July 2010 </text>
<text top=""276"" left=""254"" width=""482"" height=""15"" font=""10"">SENASA sent APHIS a letter detailing the information exchange with respect to </text>
<text top=""291"" left=""254"" width=""467"" height=""15"" font=""10"">Argentina's request for authorization to import fresh (chilled or frozen) beef, </text>
<text top=""306"" left=""254"" width=""478"" height=""15"" font=""10"">highlighting its concern at APHIS not being able to reopen access to beef from </text>
<text top=""320"" left=""254"" width=""516"" height=""15"" font=""10"">Argentine territory located North of r&#237;o Negro, and asking that the outcome foreseen </text>
<text top=""335"" left=""254"" width=""343"" height=""15"" font=""10"">for Argentina's request be elucidated in a timely fashion.</text>
<footnote top=""334"" left=""598"" width=""14"" height=""9"" font=""17"" number=""128"" ref="""" dis=""""><ftext top=""986"" left=""165"" width=""442"" height=""15"" font=""10""> SENASA's letter of 19 July 2010, Note No. 150/2010, (Exhibit ARG-46). </ftext>
</footnote>
<text top=""357"" left=""108"" width=""82"" height=""15"" font=""10"">19 July 2010 </text>
<text top=""357"" left=""254"" width=""501"" height=""15"" font=""10"">SENASA sent APHIS a letter detailing the information exchange with regard to the </text>
<text top=""372"" left=""254"" width=""535"" height=""15"" font=""10"">recognition of Patagonia as FMD-free, highlighting its concerns over the fact that all the </text>
<text top=""386"" left=""254"" width=""481"" height=""15"" font=""10"">technical stages had been concluded on a scientific basis, and stating that only </text>
<text top=""401"" left=""254"" width=""518"" height=""15"" font=""10"">remained to be completed the administrative procedures to secure the recognition of </text>
<text top=""416"" left=""254"" width=""64"" height=""15"" font=""10"">Patagonia.</text>
<footnote top=""415"" left=""318"" width=""14"" height=""9"" font=""17"" number=""129"" ref="""" dis=""""><ftext top=""1001"" left=""165"" width=""493"" height=""15"" font=""10""> SENASA's letter of 19 July 2010, Note No. 149/2010, (Exhibit ARG-61/USA-56). </ftext>
</footnote>
<text top=""438"" left=""108"" width=""125"" height=""15"" font=""10"">13 September 2010 </text>
<text top=""438"" left=""254"" width=""541"" height=""15"" font=""10"">APHIS responded to SENASA's 19 July 2010 letter with respect to Argentina's </text>
<text top=""453"" left=""254"" width=""535"" height=""15"" font=""10"">application for the recognition of Patagonia as FMD-free, stating that APHIS ""had made </text>
<text top=""467"" left=""254"" width=""537"" height=""15"" font=""10"">significant progress towards recognizing the FMD-free status of southern Patagonia"". </text>
<text top=""482"" left=""254"" width=""538"" height=""15"" font=""10"">APHIS further noted that because it needs to be thorough and transparent in its </text>
<text top=""496"" left=""254"" width=""335"" height=""15"" font=""10"">deliberations, the rule-making process could take time.</text>
<footnote top=""496"" left=""589"" width=""14"" height=""9"" font=""17"" number=""130"" ref="""" dis=""""><ftext top=""1016"" left=""165"" width=""342"" height=""15"" font=""10""> APHIS' letter of 13 September 2010, (Exhibit ARG-62). </ftext>
</footnote>
<text top=""519"" left=""108"" width=""125"" height=""15"" font=""10"">24 September 2010 </text>
<text top=""519"" left=""254"" width=""535"" height=""15"" font=""10"">APHIS responded to SENASA's letter of 19 July 2010 stating that APHIS was ""currently </text>
<text top=""534"" left=""254"" width=""537"" height=""15"" font=""10"">drafting a proposed rule that would allow the importation of fresh, chilled, or frozen </text>
<text top=""548"" left=""254"" width=""248"" height=""15"" font=""10"">Argentine beef under certain conditions"".</text>
<footnote top=""548"" left=""503"" width=""14"" height=""9"" font=""17"" number=""131"" ref="""" dis=""""><ftext top=""1030"" left=""165"" width=""342"" height=""15"" font=""10""> APHIS' letter of 24 September 2010, (Exhibit ARG-47). </ftext>
</footnote>
<text top=""571"" left=""108"" width=""86"" height=""15"" font=""10"">30 June 2011 </text>
<text top=""571"" left=""255"" width=""511"" height=""15"" font=""10"">The United States stated before the SPS Committee that APHIS had ""completed the </text>
<text top=""585"" left=""254"" width=""515"" height=""15"" font=""10"">risk analysis regarding the region north of the 42nd parallel and would subsequently </text>
<text top=""600"" left=""254"" width=""451"" height=""15"" font=""10"">draft a proposal to allow the importation of beef under certain conditions"".</text>
<footnote top=""599"" left=""705"" width=""14"" height=""9"" font=""17"" number=""132"" ref="""" dis=""""><ftext top=""1045"" left=""165"" width=""288"" height=""15"" font=""10""> G/SPS/R/63, (Exhibit ARG-22), paras. 17-18.  </ftext>
</footnote>
<text top=""622"" left=""108"" width=""106"" height=""15"" font=""10"">19 October 2011 </text>
<text top=""622"" left=""255"" width=""533"" height=""15"" font=""10"">The United States reiterated before the SPS Committee that APHIS had ""completed the </text>
<text top=""637"" left=""254"" width=""527"" height=""15"" font=""10"">assessment and was drafting a proposal to allow the importation of beef under certain </text>
<text top=""652"" left=""254"" width=""505"" height=""15"" font=""10"">conditions. When the assessment and rules were completed in the near future, the </text>
<text top=""666"" left=""254"" width=""449"" height=""15"" font=""10"">United States would be able to provide market access for Argentine beef"".</text>
<footnote top=""666"" left=""703"" width=""14"" height=""9"" font=""17"" number=""133"" ref="""" dis=""""/>
<text top=""689"" left=""108"" width=""82"" height=""15"" font=""10"">10 July 2012 </text>
<text top=""689"" left=""254"" width=""453"" height=""15"" font=""10"">Argentina raised the same STC at the 53rd Meeting of the SPS Committee.</text>
<footnote top=""688"" left=""707"" width=""14"" height=""9"" font=""17"" number=""134"" ref="""" dis=""""><ftext top=""1074"" left=""165"" width=""603"" height=""15"" font=""10""> Committee on Sanitary and Phytosanitary Measures, <i>Summary of the Meeting of 10-11 July 2012</i>, </ftext>
<ftext top=""1089"" left=""108"" width=""537"" height=""15"" font=""10"">Note by the Secretariat, G/SPS/R/67 (11 September 2012), (Exhibit ARG-23), para. 43. </ftext>
</footnote>
<text top=""711"" left=""108"" width=""100"" height=""15"" font=""10"">30 August 2012 </text>
<text top=""711"" left=""254"" width=""423"" height=""15"" font=""10"">Argentina requested consultations with the United States at the WTO.</text>
<footnote top=""711"" left=""677"" width=""14"" height=""9"" font=""17"" number=""135"" ref=""G/L/998/Corr.1 ; G/SPS/GEN/1186/Corr.1 ; WT/DS447/1/Corr.1|G/L/998 ; G/SPS/GEN/1186 ; WT/DS447/1"" dis=""""><ftext top=""1103"" left=""165"" width=""322"" height=""15"" font=""10""> Argentina's request for consultations, WT/DS447/1. </ftext>
</footnote>
<text top=""734"" left=""108"" width=""124"" height=""15"" font=""10"">28 November 2012 </text>
<text top=""734"" left=""254"" width=""539"" height=""15"" font=""10"">The United States and Argentina met in Washington DC in the framework of the </text>
<text top=""748"" left=""254"" width=""351"" height=""15"" font=""10"">Consultations being held pursuant to Article 4 of the DSU.</text>
<footnote top=""748"" left=""605"" width=""14"" height=""9"" font=""17"" number=""136"" ref="""" dis=""""><ftext top=""1118"" left=""165"" width=""311"" height=""15"" font=""10""> APHIS' letter of 13 March 2013, (Exhibit USA-96). </ftext>
</footnote>
<text top=""771"" left=""108"" width=""112"" height=""15"" font=""10"">6 December 2012 </text>
<text top=""771"" left=""254"" width=""304"" height=""15"" font=""10"">Argentina requested the establishment of a panel.</text>
<footnote top=""770"" left=""558"" width=""14"" height=""9"" font=""17"" number=""137"" ref=""WT/DS447/2"" dis=""""><ftext top=""1132"" left=""165"" width=""414"" height=""15"" font=""10""> Argentina's request for the establishment of a panel, WT/DS447/2. </ftext>
</footnote>
<text top=""793"" left=""108"" width=""120"" height=""15"" font=""10"">17 December 2012 </text>
<text top=""793"" left=""254"" width=""449"" height=""15"" font=""10"">The United States did not accept the request for establishment of a panel.</text>
<footnote top=""793"" left=""703"" width=""14"" height=""9"" font=""17"" number=""138"" ref="""" dis=""""/>
<footnote top=""815"" left=""646"" width=""14"" height=""9"" font=""17"" number=""139"" ref="""" dis=""""/>
</p><p><text top=""1147"" left=""165"" width=""286"" height=""15"" font=""10""> Argentina's first written submission, para. 20. </text>
<text top=""1161"" left=""165"" width=""286"" height=""15"" font=""10""> Argentina's first written submission, para. 21. </text>
</p></page>
<page number=""235"" position=""absolute"" top=""0"" left=""0"" height=""1263"" width=""892"">
<p><text top=""87"" left=""423"" width=""52"" height=""16"" font=""0"">- 235 - </text>
</p><p><text top=""135"" left=""157"" width=""693"" height=""15"" font=""33"">Date Event </text></p><p><text top=""157"" left=""108"" width=""95"" height=""15"" font=""10"">13 March 2013 </text>
<text top=""157"" left=""254"" width=""538"" height=""15"" font=""10"">APHIS wrote to SENASA summarizing the issues discussed in the Consultations on </text>
<text top=""172"" left=""254"" width=""537"" height=""15"" font=""10"">28 November 2012 between Argentina and United States officials, including APHIS's </text>
<text top=""186"" left=""254"" width=""535"" height=""15"" font=""10"">desire to conduct a new site visit to Northern Argentina and Patagonia. APHIS formally </text>
<text top=""201"" left=""254"" width=""536"" height=""15"" font=""10"">requested permission from SENASA to conduct the site visit in order to progress with </text>
<text top=""215"" left=""254"" width=""205"" height=""15"" font=""10"">the review of Argentina's request.</text>
<footnote top=""215"" left=""460"" width=""14"" height=""9"" font=""17"" number=""140"" ref="""" dis=""""><ftext top=""1059"" left=""165"" width=""311"" height=""15"" font=""10""> APHIS' letter of 13 March 2013, (Exhibit USA-96). </ftext>
</footnote>
<text top=""238"" left=""108"" width=""74"" height=""15"" font=""10"">3 July 2013 </text>
<text top=""238"" left=""254"" width=""536"" height=""15"" font=""10"">SENASA agreed to the visit proposed by APHIS on 13 March 2013, but stated that the </text>
<text top=""253"" left=""254"" width=""292"" height=""15"" font=""10"">sanitary situation in Argentina had not changed.</text>
<footnote top=""252"" left=""546"" width=""14"" height=""9"" font=""17"" number=""141"" ref="""" dis=""""><ftext top=""1074"" left=""165"" width=""317"" height=""15"" font=""10""> SENASA's letter of 13 July 2013, (Exhibit ARG-99). </ftext>
</footnote>
<text top=""275"" left=""108"" width=""82"" height=""15"" font=""10"">15 July 2013 </text>
<text top=""275"" left=""254"" width=""535"" height=""15"" font=""10"">APHIS replied to SENASA's 3 July 2013 letter stating that it was ready to schedule the </text>
<text top=""290"" left=""254"" width=""535"" height=""15"" font=""10"">agreed visit to Argentina as soon as possible. APHIS also stated its understanding that </text>
<text top=""304"" left=""254"" width=""535"" height=""15"" font=""10"">Argentina preferred that the site visit occur during the last week of October or the first </text>
<footnote top=""319"" left=""254"" width=""152"" height=""15"" font=""10"" number=""2013"" ref="""" dis=""""><ftext top=""364"" left=""254"" width=""538"" height=""15"" font=""10"">APHIS visited Argentina to conduct the site review with regard to the approval of </ftext>
<ftext top=""378"" left=""254"" width=""455"" height=""15"" font=""10"">imports of Argentine fresh (chilled or frozen) beef under certain conditions.</ftext>
</footnote>
<footnote top=""318"" left=""407"" width=""14"" height=""9"" font=""17"" number=""142"" ref="""" dis=""""><ftext top=""1089"" left=""165"" width=""299"" height=""15"" font=""10""> APHIS' letter of 15 July 2013, (Exhibit USA-97). </ftext>
</footnote>
</p><p><text top=""341"" left=""108"" width=""93"" height=""15"" font=""10"">8 August 2013 </text>
<text top=""341"" left=""255"" width=""307"" height=""15"" font=""10"">The Panel was composed by the Director-General. </text>
<footnote top=""364"" left=""108"" width=""74"" height=""15"" font=""10"" number=""1"" ref="""" dis=""""/>
<footnote top=""378"" left=""710"" width=""14"" height=""9"" font=""17"" number=""143"" ref="""" dis=""""/>
</p><p><text top=""401"" left=""108"" width=""106"" height=""15"" font=""10"">23 January 2014 </text>
<text top=""401"" left=""254"" width=""536"" height=""15"" font=""10"">APHIS published a Proposed Rule for recognition of the Patagonia region (comprising </text>
<text top=""416"" left=""254"" width=""535"" height=""15"" font=""10"">both Patagonia South and Patagonia North B) as FMD-free, pursuant to an updated risk </text>
<footnote top=""430"" left=""254"" width=""243"" height=""15"" font=""10"" number=""2014"" ref="""" dis=""""><ftext top=""556"" left=""254"" width=""535"" height=""15"" font=""10"">The Panel held the meeting with the parties and the experts on 2 September 2014 and </ftext>
<ftext top=""571"" left=""254"" width=""449"" height=""15"" font=""10"">the second substantive meeting with the parties on 4-5 September 2014. </ftext>
<ftext top=""593"" left=""108"" width=""106"" height=""15"" font=""10"">28 October 2014 </ftext>
<ftext top=""593"" left=""254"" width=""543"" height=""15"" font=""10"">APHIS' Final Rule recognizing Patagonia as FMD-free within the meaning of </ftext>
<ftext top=""608"" left=""254"" width=""206"" height=""15"" font=""10"">9 CFR 94.1(a) entered into force. </ftext>
</footnote>
<footnote top=""430"" left=""497"" width=""14"" height=""9"" font=""17"" number=""144"" ref="""" dis=""""><ftext top=""1118"" left=""165"" width=""611"" height=""15"" font=""10""> 2014 Notice of Availability of Risk Analysis for Patagonia, (Exhibit USA-132); 2014 Risk Analysis for </ftext>
</footnote>
</p><p><text top=""453"" left=""108"" width=""127"" height=""15"" font=""10"">28-29 January 2014 </text>
<text top=""453"" left=""255"" width=""374"" height=""15"" font=""10"">The Panel held the first substantive meeting with the parties. </text>
<text top=""475"" left=""108"" width=""100"" height=""15"" font=""10"">29 August 2014 </text>
<footnote top=""504"" left=""446"" width=""14"" height=""9"" font=""17"" number=""145"" ref="""" dis=""""><ftext top=""1147"" left=""165"" width=""386"" height=""15"" font=""10""> 2014 Risk Analysis for Northern Argentina, (Exhibit USA-169). </ftext>
</footnote>
</p><p><text top=""504"" left=""461"" width=""318"" height=""15"" font=""10""> as well as a Proposed Rule to allow imports of such </text>
<text top=""519"" left=""254"" width=""504"" height=""15"" font=""10"">product under the same protocols as those applied to fresh (chilled or frozen) beef </text>
<text top=""534"" left=""254"" width=""88"" height=""15"" font=""10"">from Uruguay.</text>
<footnote top=""533"" left=""342"" width=""17"" height=""9"" font=""17"" number=""146"" ref="""" dis=""""><ftext top=""1161"" left=""165"" width=""391"" height=""15"" font=""10""> 2014 Proposed Rule on Northern Argentina, (Exhibit USA-168). </ftext>
</footnote>
</p><p><text top=""643"" left=""398"" width=""101"" height=""16"" font=""26"">__________</text> </p><p><text top=""1103"" left=""165"" width=""310"" height=""15"" font=""10""> United States' first written submission, para. 162. </text>
</p></page>
</pdf2xml>",133460,12
